Supplementary Table S2

Recursive Self-Improvement in Healthcare AI Agents. Unified search of 4 November 2026, covering January2023 through that date. Screening and extraction used large-language-model assistance against written criteria; borderline-category rules were set by the authors. Author spotchecks remain pending. The original70-record sample covers only the initial three-source cohort.

Queries

arxiv

S1: (abs:%22LLM%20agent%22+OR+abs:%22LLM%20agents%22+OR+abs:%22language%20model%20agent%22+OR+abs:%22language%20model%20agents%22+OR+abs:agentic+OR+abs:multi-agent+OR+abs:agent)+AND+(abs:self-evolving+OR+abs:self-improving+OR+abs:self-improvement+OR+abs:self-evolution+OR+abs:evolvable+OR+abs:%22evolving%20agent%22+OR+abs:%22persistent%20memory%22+OR+abs:%22long-term%20memory%22+OR+abs:%22experience%20memory%22+OR+abs:%22experience%20library%22+OR+abs:%22skill%20library%22+OR+abs:%22skill%20evolution%22+OR+abs:%22continual%20learning%22+OR+abs:%22lifelong%20learning%22+OR+abs:notebook+OR+abs:reflection+OR+abs:%22online%20adaptation%22)+AND+(abs:medical+OR+abs:clinical+OR+abs:healthcare+OR+abs:radiology+OR+abs:patient+OR+abs:diagnosis+OR+abs:diagnostic)+AND+submittedDate:[202301010000+TO+202611042359]

S2: (abs:%22recursive%20self-improvement%22+OR+abs:%22recursive%20self-improving%22+OR+abs:%22recursively%20self-improving%22)+AND+(abs:medical+OR+abs:clinical+OR+abs:healthcare+OR+abs:radiology+OR+abs:patient+OR+abs:diagnosis+OR+abs:diagnostic)+AND+submittedDate:[202301010000+TO+202611042359]

Run 2026-11-04 02:30 JST; cutoff 2026-11-04; 715 records.

pubmed

main: ("LLM agent"[tiab] OR "LLM agents"[tiab] OR "language model agent"[tiab] OR "language model agents"[tiab] OR agentic[tiab] OR "multi-agent"[tiab] OR agent[tiab]) AND ("self-evolving"[tiab] OR "self-improving"[tiab] OR "self-improvement"[tiab] OR "self-evolution"[tiab] OR evolvable[tiab] OR "evolving agent"[tiab] OR "persistent memory"[tiab] OR "long-term memory"[tiab] OR "experience memory"[tiab] OR "experience library"[tiab] OR "skill library"[tiab] OR "skill evolution"[tiab] OR "continual learning"[tiab] OR "lifelong learning"[tiab] OR notebook[tiab] OR reflection[tiab] OR "online adaptation"[tiab]) AND (medical[tiab] OR clinical[tiab] OR healthcare[tiab] OR radiology[tiab] OR patient[tiab] OR diagnosis[tiab] OR diagnostic[tiab]) AND 2023/01/01:2026/11/04[dp]

rsi: ("recursive self-improvement"[tiab] OR "recursive self-improving"[tiab] OR "recursively self-improving"[tiab]) AND (medical[tiab] OR clinical[tiab] OR healthcare[tiab] OR radiology[tiab] OR patient[tiab] OR diagnosis[tiab] OR diagnostic[tiab]) AND 2023/01/01:2026/11/04[dp]

Run 2026-11-04 02:30 JST; cutoff 2026-11-04; 76 records.

europepmc

S1: (TITLE:"large language model" OR TITLE:"large language models" OR TITLE:"LLM agent" OR TITLE:"LLM agents" OR TITLE:"language model agent" OR TITLE:agentic OR TITLE:"multi-agent" OR ABSTRACT:"large language model" OR ABSTRACT:"large language models" OR ABSTRACT:"LLM agent" OR ABSTRACT:"LLM agents" OR ABSTRACT:"language model agent" OR ABSTRACT:agentic OR ABSTRACT:"multi-agent") AND (TITLE:"self-evolving" OR TITLE:"self-improving" OR TITLE:"self-improvement" OR TITLE:"self-evolution" OR TITLE:evolvable OR TITLE:"evolving agent" OR TITLE:"persistent memory" OR TITLE:"long-term memory" OR TITLE:"experience memory" OR TITLE:"experience library" OR TITLE:"skill library" OR TITLE:"skill evolution" OR TITLE:"continual learning" OR TITLE:"lifelong learning" OR TITLE:notebook OR TITLE:reflection OR TITLE:"online adaptation" OR ABSTRACT:"self-evolving" OR ABSTRACT:"self-improving" OR ABSTRACT:"self-improvement" OR ABSTRACT:"self-evolution" OR ABSTRACT:evolvable OR ABSTRACT:"evolving agent" OR ABSTRACT:"persistent memory" OR ABSTRACT:"long-term memory" OR ABSTRACT:"experience memory" OR ABSTRACT:"experience library" OR ABSTRACT:"skill library" OR ABSTRACT:"skill evolution" OR ABSTRACT:"continual learning" OR ABSTRACT:"lifelong learning" OR ABSTRACT:notebook OR ABSTRACT:reflection OR ABSTRACT:"online adaptation") AND (TITLE:medical OR TITLE:clinical OR TITLE:healthcare OR TITLE:radiology OR TITLE:patient OR TITLE:diagnosis OR TITLE:diagnostic OR ABSTRACT:medical OR ABSTRACT:clinical OR ABSTRACT:healthcare OR ABSTRACT:radiology OR ABSTRACT:patient OR ABSTRACT:diagnosis OR ABSTRACT:diagnostic) AND FIRST_PDATE:[2023-01-01 TO 2026-11-04]

S2: (TITLE:"recursive self-improvement" OR TITLE:"recursive self-improving" OR TITLE:"recursively self-improving" OR ABSTRACT:"recursive self-improvement" OR ABSTRACT:"recursive self-improving" OR ABSTRACT:"recursively self-improving") AND (TITLE:medical OR TITLE:clinical OR TITLE:healthcare OR TITLE:radiology OR TITLE:patient OR TITLE:diagnosis OR TITLE:diagnostic OR ABSTRACT:medical OR ABSTRACT:clinical OR ABSTRACT:healthcare OR ABSTRACT:radiology OR ABSTRACT:patient OR ABSTRACT:diagnosis OR ABSTRACT:diagnostic) AND FIRST_PDATE:[2023-01-01 TO 2026-11-04]

Run 2026-11-04 02:44 JST; cutoff 2026-11-04; 148 records.

OpenAlex

Scope title_and_abstract.search; publication_date 2023-01-01 through 2026-11-04. S1 returned10,627 and S2 returned56, with31 in common, giving10,652 distinct IDs. The59 IDs missed by relevance cursor pagination were recovered by disjoint calendar-year enumeration and exact-ID reconciliation. Date scope, vocabulary and eligibility rules were unchanged.

S1 ("LLM agent" OR "LLM agents" OR "language model agent" OR "language model agents" OR "agentic" OR "multi-agent" OR "agent") AND ("self-evolving" OR "self-improving" OR "self-improvement" OR "self-evolution" OR "evolvable" OR "evolving agent" OR "persistent memory" OR "long-term memory" OR "experience memory" OR "experience library" OR "skill library" OR "skill evolution" OR "continual learning" OR "lifelong learning" OR "notebook" OR "reflection" OR "online adaptation") AND ("medical" OR "clinical" OR "healthcare" OR "radiology" OR "patient" OR "diagnosis" OR "diagnostic")

S2 ("recursive self-improvement" OR "recursive self-improving" OR "recursively self-improving") AND ("medical" OR "clinical" OR "healthcare" OR "radiology" OR "patient" OR "diagnosis" OR "diagnostic")

Outcome counts

11,622 raw query hits;10,720 unique records;902 duplicates.33 records matched31 previously charted studies.10,687 records were screened and210 entered the full-text stage.52 studies were included and158 excluded, including13 primary reports not obtained and2 author-approved reporting-quality exclusions during revision. The85-study map combines31 re-confirmed studies,52 new inclusions (34 initial;18 OpenAlex), and2 purposive comparators. Previous decisions and revision reasons are retained in the records.

F1 non-primary research; F2 healthcare not the primary focus; F3 not an LLM acting agent; F4 no retained cross-case experience under the written rules; F5 primary report not obtained; F6 duplicate of an already included study. Actual primary-report access outcomes are retained individually. F7 denotes an author-approved reporting-quality exclusion made during manuscript revision; previous decisions are preserved. No aggregate reporting-quality score is used.

All records

idtitledatesourcesarxivdoistageoutcomereasonopenalex_idssource_usedsource_completeness
1Artifacts and Technical Considerations at Contrast-enhanced US.2023PubMed10.1148/rg.220093Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
2From eye-blinks to state construction: Diagnostic benchmarks for online representation learning.2023PubMed10.1177/10597123221085039Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
3Towards trust-based governance of health data research.2023EuropePMC; PubMed10.1007/s11019-022-10134-8Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
4Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic management.2023PubMed10.1080/17474086.2023.2169126Title/abstractExcludedNot primary research: Clinical pharmacology review of anti-Xa monitoring; not an agent study.
5Integration of Silica Nanorattles with Manganese-Doped In 2 S 3 /InOOH to Enable Ultrasound-Mediated Tumor Theranostics.2023PubMed10.1021/acsami.2c18095Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
6[End of life and cancer: Understanding the ethical issues of voluntary assisted dying].2023PubMed10.1016/j.bulcan.2023.01.005Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
7A label-free electrochemical immunosensor based on 11-mercaptoundecanoic acid grafted chitosan and poly(N-methylaniline) for the detection of carcinoembryonic antigen.2023PubMed10.1016/j.bioelechem.2023.108446Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
8[Artificial Intelligence in Medicine. Ethical reflections from the thought of Edmund Pellegrino].2023PubMed10.30444/cb.140Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
9Root coverage with apical tunnel approach using propolis as a root conditioning agent: A case report with 2-year follow-up and review of the literature.2023PubMed10.1002/cre2.751Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
10[Understanding the mode of transmission of malaria agents: an astonishing series of hypotheses, observations, research and controversy].2023PubMed10.48327/mtsi.v3i1.2023.312Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
11Aesthetic Attitude Based on Kant's Aesthetics of Caring Relationships in Nursing.2023PubMed10.3390/healthcare11162324Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
12Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells.2023PubMed10.1021/acsnano.3c02575Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
13Bactericidal Activity of Silver-Doped Chitosan Coatings via Electrophoretic Deposition on Ti 6 Al 4 V Additively Manufactured Substrates.2023PubMed10.3390/polym15204130Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
14Same Pathogen, Different Manifestations: A Case of Extrapulmonary Tuberculosis.2023PubMed10.7759/cureus.50436Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
15Reinforced Labels: Multi-Agent Deep Reinforcement Learning for Point-Feature Label Placement2023-03-02arXiv2303.0138810.1109/tvcg.2023.3313729Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
16Towards Explainable and Safe Conversational Agents for Mental Health: A Survey2023-04-25arXiv2304.13191Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
17A Domain-Independent Agent Architecture for Adaptive Operation in Evolving Open Worlds2023-06-09arXiv2306.0627210.1016/j.artint.2024.104161Title/abstractExcludedNot healthcare or clinical: Non-LLM, non-healthcare agent or RL system.
18SMARLA: A Safety Monitoring Approach for Deep Reinforcement Learning Agents2023-08-03arXiv2308.0259410.1109/tse.2024.3491496Title/abstractExcludedNot healthcare or clinical: Non-LLM, non-healthcare agent or RL system.
19Who is ChatGPT? Benchmarking LLMs' Psychological Portrayal Using PsychoBench2023-10-02arXiv2310.01386Title/abstractExcludedNot primary research: Psychological benchmark of LLMs; systems do not adapt.
20Reinforcement learning in large, structured action spaces: A simulation study of decision support for spinal cord injury rehabilitation2023-10-23arXiv2310.14976Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
21Visually Grounded Continual Language Learning with Selective Specialization2023-10-24arXiv2310.1557110.18653/v1/2023.findings-emnlp.469Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
22A Multilingual Virtual Guide for Self-Attachment Technique2023-10-25arXiv2310.1836610.1109/cogmi56440.2022.00025Title/abstractExcludedNot an LLM agent: Conversational agent not LLM-agent; no persistent improvement from experience.
23Towards AI-assisted cardiology: a reflection on the performance and limitations of using large language models in clinical decision-making.2023-12-04EuropePMC10.4244/eij-d-23-00461Title/abstractExcludedNot primary research: No abstract; commentary on LLM limitations in cardiology.
24AVA: Towards Autonomous Visualization Agents through Visual Perception-Driven Decision-Making2023-12-07arXiv2312.04494Title/abstractExcludedNot healthcare or clinical: Non-healthcare LLM agent (visualization or charts).
25[Significance of natural language processing and chat-based generative language models].2023-12-18EuropePMC10.1007/s00063-023-01098-5Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
26Credentialing Character: A Virtue Ethics Approach to Professionalizing Healthcare Ethics Consultation Services.2024PubMed10.1007/s10730-023-09505-2Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
27A coupling, stabilizing, and shaping strategy for breast ultrasound computed tomography (USCT) with a ring array transducer.2024PubMed10.1016/j.ultras.2023.107212Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
28Pharmacotherapy for leptomeningeal disease in breast cancer.2024PubMed10.1016/j.ctrv.2023.102653Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
29Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.2024PubMed10.1186/s40035-023-00388-4Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
30Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging.2024PubMed10.2147/ijn.s462917Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
31Subjective Experience and Perceived Benefits in Clients with Schizophrenia Following Participation in Metacognition Reflection and Insight Therapy (MERIT).2024PubMed10.3390/bs14060450Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
32Decoding the Reference Letter: Strategies to Reduce Unintentional Gender Bias in Letters of Recommendation.2024EuropePMC; PubMed10.15766/mep_2374-8265.11419Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
33Artificial Intelligent Agent Architecture and Clinical Decision-Making in the Healthcare Sector.2024PubMed10.7759/cureus.64115Title/abstractExcludedNot primary research: Theoretical overview of agent architectures; not a primary study.
34Intrathecal ziconotide for the treatment of chronic pain: a collection of clinical experiences and literature review.2024PubMed10.26355/eurrev_202408_36640Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
35Lawsonia intracellularis regulates nuclear factor-κB signalling pathway during infection.2024PubMed10.1371/journal.pone.0310804Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
36EHRAgent: Code Empowers Large Language Models for Few-shot Complex Tabular Reasoning on Electronic Health Records2024-01-13arXiv2401.07128Full textIncludedshi2024ehragent
37Peer review of GPT-4 technical report and systems card.2024-01-18EuropePMC10.1371/journal.pdig.0000417Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
38ArgMed-Agents: Explainable Clinical Decision Reasoning with LLM Disscusion via Argumentation Schemes2024-03-10arXiv2403.06294Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
39Recurrent Events Modeling Based on a Reflected Brownian Motion with Application to Hypoglycemia2024-03-14arXiv2403.09042Title/abstractExcludedNot an LLM agent: Non-LLM model (segmentation or statistical model).
40Generative Artificial Intelligence as a Tool for Teaching Communication in Nutrition and Dietetics Education-A Novel Education Innovation.2024-03-22EuropePMC10.3390/nu16070914Title/abstractExcludedNo persistent cross-case improvement: LLM simulated patient platform for dietetics teaching; no persistent agent improvement.
41Exploring LLM Multi-Agents for ICD Coding2024-04-01arXiv2406.15363Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
42IryoNLP at MEDIQA-CORR 2024: Tackling the Medical Error Detection & Correction Task On the Shoulders of Medical Agents2024-04-23arXiv2404.15488Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
43Exploring the Promise and Challenges of Artificial Intelligence in Biomedical Research and Clinical Practice.2024-05-01EuropePMC10.1097/fjc.0000000000001546Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
44Agent Hospital: A Simulacrum of Hospital with Evolvable Medical Agents2024-05-05arXiv2405.02957Already chartedIncluded (re-confirmed)medhospital2024
45Orbital learning: a novel, actively orchestrated decentralised learning for healthcare.2024-05-07EuropePMC10.1038/s41598-024-60915-9Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
46AgentClinic: a multimodal agent benchmark to evaluate AI in simulated clinical environments2024-05-13arXiv2405.07960Already chartedIncluded (re-confirmed)schmidgall2026agentclinic
473D Vessel Reconstruction from Sparse-View Dynamic DSA Images via Vessel Probability Guided Attenuation Learning2024-05-17arXiv2405.1070510.1016/j.media.2026.104088Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
48Coaching Copilot: Blended Form of an LLM-Powered Chatbot and a Human Coach to Effectively Support Self-Reflection for Leadership Growth2024-05-24arXiv2405.1525010.1145/3640794.3665549Title/abstractExcludedNo persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement.
49Improving medical reasoning through retrieval and self-reflection with retrieval-augmented large language models.2024-06-01EuropePMC10.1093/bioinformatics/btae238Title/abstractExcludedNo persistent cross-case improvement: Retrieval plus self-reflection tokens with one-off fine-tuning; static retrieval.
50The Role of Humanization and Robustness of Large Language Models in Conversational Artificial Intelligence for Individuals With Depression: A Critical Analysis.2024-07-02EuropePMC10.2196/56569Title/abstractExcludedNo persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement.
51AgentPoison: Red-teaming LLM Agents via Poisoning Memory or Knowledge Bases2024-07-17arXiv2407.12784Title/abstractExcludedNo persistent cross-case improvement: Red-teaming attack on agent memory; not an improvement method.
52Agentic LLM Workflows for Generating Patient-Friendly Medical Reports2024-08-02arXiv2408.01112Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
53Large language models in medical ethics: useful but not expert.2024-08-21EuropePMC10.1136/jme-2023-109770Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
54The digital Balint: using AI in reflective practice.2024-08-23EuropePMC10.1080/14739879.2024.2372606Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
55Chatting Up Attachment: Using LLMs to Predict Adult Bonds2024-08-31arXiv2409.00347Title/abstractExcludedNo persistent cross-case improvement: LLM persona or simulation evaluation; no persistent cross-case improvement.
56MAGDA: Multi-agent guideline-driven diagnostic assistance2024-09-10arXiv2409.06351Title/abstractExcludedNo persistent cross-case improvement: MAGDA zero-shot guideline agents; self-refine within case.
57Surveying the MLLM Landscape: A Meta-Review of Current Surveys2024-09-17arXiv2409.18991Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
58Agent Aggregator with Mask Denoise Mechanism for Histopathology Whole Slide Image Analysis2024-09-18arXiv2409.1166410.1145/3664647.3681425Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
59Depression Diagnosis Dialogue Simulation: Self-improving Psychiatrist with Tertiary Memory2024-09-20arXiv2409.15084Already chartedIncluded (re-confirmed)lan2024amc
60OMG-RL:Offline Model-based Guided Reward Learning for Heparin Treatment2024-09-20arXiv2409.1329910.1016/j.bea.2025.100198Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
61Demonstrating the Continual Learning Capabilities and Practical Application of Discrete-Time Active Inference2024-09-30arXiv2410.00240Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
62Muli-Agent AI Systems in Healthcare: Technical and Clinical Analysis2024-10-02EuropePMC10.20944/preprints202410.0182.v1Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
63Prompt Engineering a Schizophrenia Chatbot: Utilizing a Multi-Agent Approach for Enhanced Compliance with Prompt Instructions2024-10-10arXiv2410.12848Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
64AGENTiGraph: An Interactive Knowledge Graph Platform for LLM-based Chatbots Utilizing Private Data2024-10-15arXiv2410.11531Title/abstractExcludedNo persistent cross-case improvement: Knowledge-graph chatbot platform; static KG retrieval.
65Large Language Models can Help with Biostatistics and Coding Needed in Radiology Research.2024-10-15EuropePMC10.1016/j.acra.2024.09.042Title/abstractExcludedNo persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement.
66Active inference and deep generative modeling for cognitive ultrasound2024-10-17arXiv2410.1331010.1109/tuffc.2024.3466290Title/abstractExcludedNot an LLM agent: Active inference ultrasound (cognitive ultrasound perspective); not LLM agent.
67AutoFLUKA: A Large Language Model Based Framework for Automating Monte Carlo Simulations in FLUKA2024-10-19arXiv2410.15222Title/abstractExcludedNot healthcare or clinical: Non-clinical tool (pharmacovigilance documentation or Monte Carlo physics automation).
68Jailbreaking and Mitigation of Vulnerabilities in Large Language Models2024-10-20arXiv2410.1523610.63336/eureka.47Title/abstractExcludedNot primary research: Jailbreak/vulnerability assessment; not an improving agent.
69Retrieval-Augmented Medical Large Language Models2024-10-22EuropePMC10.20944/preprints202410.1658.v1Title/abstractExcludedNo persistent cross-case improvement: Static retrieval-augmented model; no agent loop.
70ReflecTool: Towards Reflection-Aware Tool-Augmented Clinical Agents2024-10-23arXiv2410.17657Full textIncludedliao2025reflectool
71Towards Next-Generation Medical Agent: How o1 is Reshaping Decision-Making in Medical Scenarios2024-11-16arXiv2411.14461Title/abstractExcludedNo persistent cross-case improvement: Compares backbone LLMs in medical agents; no improvement loop.
72Developer Challenges on Large Language Models: A Study of Stack Overflow and OpenAI Developer Forum Posts2024-11-16arXiv2411.10873Title/abstractExcludedNot healthcare or clinical: Not healthcare; general LLM developer or inference-scaling study.
73Regulator-Manufacturer AI Agents Modeling: Mathematical Feedback-Driven Multi-Agent LLM Framework2024-11-22arXiv2411.15356Title/abstractExcludedNot healthcare or clinical: Regulatory-affairs LLM agent simulation; not clinical; adaptation within simulation unclear.
74How Well Can Modern LLMs Act as Agent Cores in Radiology Environments?2024-12-12arXiv2412.09529Title/abstractExcludedNot primary research: Benchmark or evaluation framework; evaluated systems do not adapt.
75LLMs Can Simulate Standardized Patients via Agent Coevolution2024-12-16arXiv2412.11716Already chartedIncluded (re-confirmed)du2025evopatient
76Multi-OphthaLingua: A Multilingual Benchmark for Assessing and Debiasing LLM Ophthalmological QA in LMICs2024-12-18arXiv2412.14304Title/abstractExcludedNo persistent cross-case improvement: Fixed LLM evaluation or debiasing benchmark.
77Metaphorical markers of pain catastrophizing, depression, anxiety, and pain interference in people with chronic pain.2025PubMed10.1016/j.jpain.2024.104733Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
78Developmental Coaching for Clinician Educators: Just What the Doctor Ordered.2025EuropePMC; PubMed10.1097/ceh.0000000000000586Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
79A feasibility study of automating radiotherapy planning with large language model agents.2025EuropePMC; PubMed10.1088/1361-6560/adbff1Title/abstractExcludedNo persistent cross-case improvement: GPT-Plan retrieves historical plans from fixed store; iterates within case. Possible static RAG only.
80AI-Enhanced Virtual Reality Self-Talk for Psychological Counseling: Formative Qualitative Study.2025EuropePMC; PubMed10.2196/67782Title/abstractExcludedNo persistent cross-case improvement: VR counseling agent formative study; no persistent improvement.
81Hybrid structure combining essential oil derivatives and polydopamine for anti-bacterial coatings.2025PubMed10.1016/j.colsurfb.2025.114679Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
82Experience with isavuconazole in the treatment of mucormycosis and breakthrough fungal infections.2025PubMed10.1016/j.riam.2025.01.005Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
83Performance of single-agent and multi-agent language models in Spanish language medical competency exams.2025EuropePMC; PubMed10.1186/s12909-025-07250-3Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
84Uncertainty management strategies in clinical reasoning: perceptions of nurses in post-anesthesia care units.2025PubMed10.1186/s12912-025-03193-8Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
85Artificial intelligence in nursing care: A reflection from the ethics of care.2025PubMed10.1177/09697330251366619Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
86Multiagent AI Systems in Health Care: Envisioning Next-Generation Intelligence.2025EuropePMC; PubMed10.12788/fp.0589Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
87Immunoglobulin GM (γ marker) and FcγR genotypes interact to contribute to the magnitude of ADCC against SARS CoV-2 S-transfected cells.2025PubMed10.1007/s00251-025-01385-9Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
88A foundational architecture for AI agents in healthcare.2025EuropePMC; PubMed10.1016/j.xcrm.2025.102374Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
89A Neuroaffirmative, Self-Determination Theory-Based Psychosocial Intervention for Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Feasibility Study.2025EuropePMC; PubMed10.2196/69943Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
90β-glucan-loaded nano-niosomes ameliorate spatial and associative memory impairment in a D-galactose-induced aging rat model via modulation of microglial pyroptosis and autophagy.2025PubMed10.1016/j.biopha.2025.118834Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
91A dynamically tunable terahertz human serum albumin biosensor based on Dirac semimetal nanozyme.2025PubMed10.3389/fbioe.2025.1736291Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
92A retrieval-augmented knowledge mining method with deep thinking LLMs for biomedical research and clinical support.2025-01-01EuropePMC10.1093/gigascience/giaf109Title/abstractExcludedNo persistent cross-case improvement: Retrieval-augmented knowledge mining; static, not persistent agent learning.
93ENTAgents: AI Agents for Complex Knowledge Otolaryngology2025-01-07EuropePMC10.1101/2025.01.01.25319863Title/abstractExcludedNo persistent cross-case improvement: ENTAgents uses Reflexion within a question; RAG static.
94Agentic Retrieval-Augmented Generation: A Survey on Agentic RAG2025-01-15arXiv2501.09136Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
95IntellAgent: A Multi-Agent Framework for Evaluating Conversational AI Systems2025-01-19arXiv2501.11067Title/abstractExcludedNot primary research: Benchmark framework for conversational AI; not clinical.
96Developing an Agent-Based Mathematical Model for Simulating Post-Irradiation Cellular Response: A Crucial Component of a Digital Twin Framework for Personalized Radiation Treatment2025-01-21arXiv2501.11875Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
97Towards Safe AI Clinicians: A Comprehensive Study on Large Language Model Jailbreaking in Healthcare2025-01-27arXiv2501.18632Title/abstractExcludedNot primary research: Jailbreak/vulnerability assessment; not an improving agent.
98Al-Khwarizmi: Discovering Physical Laws with Foundation Models2025-02-03arXiv2502.01702Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
99Agentic AI for Scaling Diagnosis and Care in Neurodegenerative Disease2025-02-06arXiv2502.06842Title/abstractExcludedNot primary research: Roadmap/perspective on agentic AI in ADRD care; not primary.
100CASC-AI: Consensus-aware Self-corrective Learning for Noise Cell Segmentation2025-02-11arXiv2502.07302Title/abstractExcludedNot an LLM agent: Non-LLM model (segmentation or statistical model).
101Foundations of AI for future physicians: A practical, accessible curriculum.2025-02-12EuropePMC10.1080/0142159x.2025.2463492Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
102Nuclear Deployed: Analyzing Catastrophic Risks in Decision-making of Autonomous LLM Agents2025-02-17arXiv2502.11355Title/abstractExcludedNot healthcare or clinical: Catastrophic-risk CBRN agent decision analysis; not clinical.
103Benchmarking Automatic Speech Recognition coupled LLM Modules for Medical Diagnostics2025-02-18arXiv2502.13982Title/abstractExcludedNo persistent cross-case improvement: Benchmark of ASR plus LLM modules; no agent improvement.
104Building virtual patients for training mental health professionals2025-02-20EuropePMC10.31234/osf.io/epqtc_v2Title/abstractExcludedNo persistent cross-case improvement: Virtual patient engine with within-dialogue memory; no cross-case improvement.
105A Comprehensive Survey on the Trustworthiness of Large Language Models in Healthcare2025-02-21arXiv2502.15871Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
106METAL: A Multi-Agent Framework for Chart Generation with Test-Time Scaling2025-02-24arXiv2502.17651Title/abstractExcludedNot healthcare or clinical: Non-clinical tool (pharmacovigilance documentation or Monte Carlo physics automation).
107Can Multimodal LLMs Perform Time Series Anomaly Detection?2025-02-25arXiv2502.17812Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
108MEDDxAgent: A Unified Modular Agent Framework for Explainable Automatic Differential Diagnosis2025-02-26arXiv2502.19175Title/abstractExcludedNo persistent cross-case improvement: MEDDxAgent iterative diagnosis within a case only.
109GEMA-Score: Granular Explainable Multi-Agent Scoring Framework for Radiology Report Evaluation2025-03-07arXiv2503.05347Title/abstractExcludedNo persistent cross-case improvement: Multi-agent report scoring metric; agents do not adapt across cases.
110Towards Conversational AI for Disease Management2025-03-08arXiv2503.06074Title/abstractExcludedNo persistent cross-case improvement: AMIE management agent with in-context guideline retrieval; no cross-case learning.
111Assessment of the Efficiency of a ChatGPT-Based Tool, MyGenAssist, in an Industry Pharmacovigilance Department for Case Documentation: Cross-Over Study.2025-03-10EuropePMC10.2196/65651Title/abstractExcludedNo persistent cross-case improvement: Cross-over efficiency study of a fixed LLM tool; no agent improvement.
112Diagnostic performance of multimodal large language models in radiological quiz cases: the effects of prompt engineering and input conditions.2025-03-11EuropePMC10.14366/usg.25012Title/abstractExcludedNo persistent cross-case improvement: Prompt or fixed-model diagnostic evaluation; no agent improvement.
113COVID-19 Pneumonia Diagnosis Using Medical Images: Deep Learning-Based Transfer Learning Approach2025-03-16arXiv2503.1264210.2196/75015Title/abstractExcludedNot an LLM agent: Non-LLM clinical or lab work; no LLM agent.
114MDTeamGPT: A Self-Evolving LLM-based Multi-Agent Framework for Multi-Disciplinary Team Medical Consultation2025-03-18arXiv2503.13856Full textIncludedchen2026mdteamgpt
115[The use of large language models in medicine and in radiology in particular].2025-03-19EuropePMC10.1007/s00117-025-01433-1Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
116AI-Driven Mental Healthcare 5.0: A Survey of Opportunities and Challenges in Leveraging Large Language Models and Generative AI2025-03-25EuropePMC10.22541/au.174291179.92552739/v1Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
117DEMENTIA-PLAN: An Agent-Based Framework for Multi-Knowledge Graph Retrieval-Augmented Generation in Dementia Care2025-03-26arXiv2503.20950Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
118Specialized Large Language Model Outperforms Neurologists at Complex Diagnosis in Blinded Case-Based Evaluation.2025-03-27EuropePMC10.3390/brainsci15040347Title/abstractExcludedNo persistent cross-case improvement: Prompt or fixed-model diagnostic evaluation; no agent improvement.
119Self-Evolving Multi-Agent Simulations for Realistic Clinical Interactions2025-03-28arXiv2503.22678Already chartedIncluded (re-confirmed)almansoori2025medagentsim
120Agentic Large Language Models, a survey2025-03-29arXiv2503.2303710.1613/jair.1.18675Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
121Survey and Experiments on Mental Disorder Detection via Social Media: From Large Language Models and RAG to Agents2025-04-03arXiv2504.0280010.1109/icdew67478.2025.00027Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
122NAACL2025 Tutorial: Adaptation of Large Language Models2025-04-04arXiv2504.03931Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
123Beyond Single-Turn: A Survey on Multi-Turn Interactions with Large Language Models2025-04-07arXiv2504.04717Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
124Prism: Dynamic and Flexible Benchmarking of LLMs Code Generation with Monte Carlo Tree Search2025-04-07arXiv2504.05500Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
125Evaluating the Bias in LLMs for Surveying Opinion and Decision Making in Healthcare2025-04-11arXiv2504.08260Title/abstractExcludedNo persistent cross-case improvement: LLM persona or simulation evaluation; no persistent cross-case improvement.
126Learning to Be A Doctor: Searching for Effective Medical Agent Architectures2025-04-15arXiv2504.11301Full textIncludedzhuang2025doctor
127Rethinking Inference-Time Scaling: Efficiency Limits and Linguistic Signals2025-04-18arXiv2504.14047Title/abstractExcludedNot healthcare or clinical: Not healthcare; general LLM developer or inference-scaling study.
128Do Large Language Models know who did what to whom?2025-04-23arXiv2504.1688410.1162/opmi.a.365Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
129LLM Agent Swarm for Hypothesis-Driven Drug Discovery2025-04-24arXiv2504.17967Title/abstractExcludedNot healthcare or clinical: Drug discovery agent swarm; no clinical task.
130Knowledge-Driven Agentic Scientific Corpus Distillation Framework for Biomedical Large Language Models Training2025-04-28arXiv2504.19565Title/abstractExcludedNo persistent cross-case improvement: Corpus distillation for LLM training; not an improving clinical agent.
131From LLM Reasoning to Autonomous AI Agents: A Comprehensive Review2025-04-28arXiv2504.19678Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
132AKIBoards: A Structure-Following Multiagent System for Predicting Acute Kidney Injury2025-04-29arXiv2504.20368Title/abstractExcludedNo persistent cross-case improvement: Learned global structure and fine-tuned agents; no evident experience-driven loop; unclear.
133SSRLBot: Designing and Developing a Large Language Model-based Agent using Socially Shared Regulated Learning2025-05-02arXiv2505.00945Title/abstractExcludedNo persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning.
134Human-AI Governance (HAIG): A Trust-Utility Approach2025-05-03arXiv2505.0165110.1016/j.jrt.2026.100167Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
135A Survey of Slow Thinking-based Reasoning LLMs using Reinforced Learning and Inference-time Scaling Law2025-05-05arXiv2505.02665Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
136Vision-Language-Action (VLA) Models: Concepts, Progress, Applications and Challenges2025-05-07arXiv2505.04769Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
137Multi-agent Embodied AI: Advances and Future Directions2025-05-08arXiv2505.05108Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
138MARK: Memory Augmented Refinement of Knowledge2025-05-08arXiv2505.05177Full textExcludedHealthcare not the primary focus: Borderline: framed as domain-general enterprise chatbot memory (healthcare, law, manufacturing; Abstract, §1.1); MedMCQA is the only test domain (§2.2). Cross-session memory reuse itself qualifies.
139AI Agents vs. Agentic AI: A Conceptual Taxonomy, Applications and Challenges2025-05-15arXiv2505.1046810.1016/j.inffus.2025.103599Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
140MedAgentBoard: Benchmarking Multi-Agent Collaboration with Conventional Methods for Diverse Medical Tasks2025-05-18arXiv2505.12371Title/abstractExcludedNot primary research: Benchmark or evaluation framework; evaluated systems do not adapt.
141A Survey of Attacks on Large Language Models2025-05-18arXiv2505.12567Title/abstractExcludedNot primary research: Survey, review, tutorial or perspective; not a primary study.
142Silent teachers: Narratives from the simulation lab.2025-05-20EuropePMC10.1111/medu.15711Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
143USTBench: Benchmarking and Dissecting Spatiotemporal Reasoning of LLMs as Urban Agents2025-05-23arXiv2505.17572Title/abstractExcludedNot healthcare or clinical: Not healthcare; non-clinical ML or agent work.
144CPathAgent: An Agent-based Foundation Model for Interpretable High-Resolution Pathology Image Analysis Mimicking Pathologists' Diagnostic Logic2025-05-26arXiv2505.20510Title/abstractExcludedNo persistent cross-case improvement: Trained pathology agent via multi-stage SFT; no improvement loop.
145FUAS-Agents: Autonomous Multi-Modal LLM Agents for Treatment Planning in Focused Ultrasound Ablation Surgery2025-05-27arXiv2505.21418Title/abstractExcludedNo persistent cross-case improvement: FUAS-Agents reflect within a case; no persistent learning evident.
146Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care.2025-06-01EuropePMC10.1001/jamaoncol.2025.0694Title/abstractExcludedNot primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study.
147MAPLE: Multi-Agent Adaptive Planning with Long-Term Memory for Table Reasoning2025-06-06arXiv2506.05813Title/abstractExcludedNot healthcare or clinical: Long-term-memory table reasoning agent, but evaluated on WikiTQ and TabFact, not healthcare.
148OriGene: A Self-Evolving Virtual Disease Biologist Automating Therapeutic Target Discovery2025-06-06EuropePMC10.1101/2025.06.03.657658Full textExcludedHealthcare not the primary focus: Therapeutic target discovery with organoid and tumor-fragment validation, not clinical care or diagnosis (Abstract, Results); template-library evolution described (§4.3) but not separately quantified.
149Patient-Specific Deep Reinforcement Learning for Automatic Replanning in Head-and-Neck Cancer Proton Therapy2025-06-11arXiv2506.10073Title/abstractExcludedNot an LLM agent: Non-LLM method (RL, federated or imaging model).
150Sectoral Coupling in Linguistic State Space2025-06-15arXiv2506.12927Title/abstractExcludedNot healthcare or clinical: Abstract formal framework for belief sectors; no healthcare application.
151From RAG to Agentic: Validating Islamic-Medicine Responses with LLM Agents2025-06-18arXiv2506.15911Title/abstractExcludedNo persistent cross-case improvement: Evaluation pipeline comparing direct, RAG and agentic configs; no cross-case learning.
152Leveraging the Long-Term Health Monitoring Dataset for Personalized Healthcare: A Large Language Model Approach.2025-07-01EuropePMC10.1109/embc58623.2025.11254888Title/abstractExcludedRule P1 per-patient memory only
153Are You Listening to Me? Fine-Tuning Chatbots for Empathetic Dialogue2025-07-03arXiv2507.02537Title/abstractExcludedNo persistent cross-case improvement: Supervised fine-tuning of empathetic chatbots on a fixed dataset.
154Multi-Agent Reasoning for Cardiovascular Imaging Phenotype Analysis2025-07-04arXiv2507.03460Title/abstractExcludedNo persistent cross-case improvement: Multi-agent consensus within one analysis; no retained experience.
155The Agency Gap in AI-Supported Writing: How Reactive and Proactive Agent Designs Shape Multimodal Reasoning2025-07-06arXiv2507.04398Title/abstractExcludedNo persistent cross-case improvement: Reactive vs proactive writing agent in students; no persistent improvement.
156Quantitative Single-particle Profiling of Extracellular Vesicles via Fluorescent Nanoparticle Tracking Analysis2025-07-07arXiv2507.04655Title/abstractExcludedNot an LLM agent: Nanoparticle tracking protocol; no LLM.
157An autonomous agent for auditing and improving the reliability of clinical AI models2025-07-08arXiv2507.05755Full textExcludedNo persistent cross-case improvement: Each audit is a fresh dialogue; re-audit used "a fresh instance ... without any knowledge of the ... previous audit" (§2.2). Gains go to the audited CNN, not the agent.
158Mixed Methods Feasibility Study of Socrates 2.0, an AI-Based Cognitive Reappraisal Tool for Reducing Mental Health Symptoms2025-07-08EuropePMC10.31234/osf.io/6qhw5_v1Title/abstractExcludedNo persistent cross-case improvement: Feasibility study of multi-agent reappraisal tool; no cross-case learning described.
1594KAgent: Agentic Any Image to 4K Super-Resolution2025-07-09arXiv2507.07105Title/abstractExcludedNot healthcare or clinical: General image super-resolution agent; not clinical.
160Prompt Engineering in Segment Anything Model: Methodologies, Applications, and Emerging Challenges2025-07-13arXiv2507.09562Title/abstractExcludedNot primary research: Survey of SAM prompt engineering.
161InsightX Agent: An LMM-based Agentic Framework with Integrated Tools for Reliable X-ray NDT Analysis2025-07-20arXiv2507.1489910.1109/tr.2026.3668946Title/abstractExcludedNot healthcare or clinical: Industrial X-ray NDT, not healthcare.
162Leveraging Knowledge Graphs and LLM Reasoning to Identify Operational Bottlenecks for Warehouse Planning Assistance2025-07-23arXiv2507.17273Title/abstractExcludedNot healthcare or clinical: Warehouse simulation analysis.
163An Empirical Study on Embodied Artificial Intelligence Robot (EAIR) Software Bugs2025-07-24arXiv2507.18267Title/abstractExcludedNot healthcare or clinical: Empirical study of robot software bugs.
164A Survey of Self-Evolving Agents: What, When, How, and Where to Evolve on the Path to Artificial Super Intelligence2025-07-28arXiv2507.21046Title/abstractExcludedNot primary research: Survey of self-evolving agents.
165Privacy Protection for Chinese Electronic Medical Records Using Large Language Models: Effectiveness Evaluation and Application of LLM Models in Medical Data Tasks2025-07-28EuropePMC10.1101/2025.07.27.25332177Title/abstractExcludedNo persistent cross-case improvement: LLM evaluation for EMR de-identification; no persistent adaptation.
166Addressing Benchmarking Gaps in Large Language Models for Health and Medicine with Dynamic Red-Teaming2025-07-30arXiv2508.00923Full textExcludedNo persistent cross-case improvement: Attacker orchestrator adapts only within each item over up to five rounds from a predefined tool set (Results, Methods); nothing retained across items; audited LLMs do not adapt.
167Enhanced guidance on artificial intelligence for medical publication and communication professionals.2025-08-01EuropePMC10.1080/03007995.2025.2556012Title/abstractExcludedNot primary research: Commentary on AI guidance for publication professionals.
168HealthFlow: A Self-Evolving AI Agent with Meta Planning for Autonomous Healthcare Research2025-08-04arXiv2508.02621Already chartedIncluded (re-confirmed)zhu2026healthflow
169Stretchable and self-adhesive triboelectric sensor for real-time musculoskeletal monitoring and personalized recovery2025-08-05arXiv2508.11655Title/abstractExcludedNot an LLM agent: Wearable triboelectric sensor; no LLM.
170ConfAgents: A Conformal-Guided Multi-Agent Framework for Cost-Efficient Medical Diagnosis2025-08-06arXiv2508.04915Full textExcludedNo persistent cross-case improvement: Conformal calibration over a fixed labeled knowledge base and static RAG on the MSD Manual (§3.2, §4.2); nothing learned is retained. Screening note described HealthFlow (ids 168/292).
171Continual Learning for VLMs: A Survey and Taxonomy Beyond Forgetting2025-08-06arXiv2508.04227Title/abstractExcludedNot primary research: Survey of continual learning for VLMs.
172GroundAct: Can LLM Agents Ground Actions in Environmental States?2025-08-07arXiv2508.05614Title/abstractExcludedNot healthcare or clinical: Benchmark of action grounding, non-clinical.
173Towards Embodied Agentic AI: Review and Classification of LLM- and VLM-Driven Robot Autonomy and Interaction2025-08-07arXiv2508.05294Title/abstractExcludedNot primary research: Survey of embodied agentic AI.
174Mediator-Guided Multi-Agent Collaboration among Open-Source Models for Medical Decision-Making2025-08-08arXiv2508.05996Title/abstractExcludedNo persistent cross-case improvement: Mediator-guided multi-agent collaboration without training; single-case reflection.
175EndoCogniAgent: Closed-Loop Agentic Reasoning with Self-Consistency Validation for Endoscopic Diagnosis2025-08-10arXiv2508.07292Title/abstractExcludedNo persistent cross-case improvement: Closed-loop reasoning with self-consistency within a single case.
176Ethics2vec: aligning automatic agents and human preferences2025-08-11arXiv2508.07673Title/abstractExcludedNot healthcare or clinical: Ethics alignment of agents, not clinical.
177FEAT: A Multi-Agent Forensic AI System with Domain-Adapted Large Language Model for Automated Cause-of-Death Analysis2025-08-11arXiv2508.07950Full textExcludedNo persistent cross-case improvement: Memory & Reflection is a per-case dynamic case file (Methods, Reflection & Memory Module); the forensic LLM is fine-tuned once; no cross-case retention is described or tested.
178PASS: Probabilistic Agentic Supernet Sampling for Interpretable and Adaptive Chest X-Ray Reasoning2025-08-14arXiv2508.10501Full textExcludedNot an LLM agent (no tools or environment interaction, or non-LLM controller)
179A Self-Correcting Multi-Agent LLM Framework for Language-Based Physics Simulation and Explanation2025-08-14EuropePMC10.21203/rs.3.rs-7313618/v1Title/abstractExcludedNot healthcare or clinical: Physics simulation framework.
180CORE: Measuring Multi-Agent LLM Interaction Quality under Game-Theoretic Pressures2025-08-16arXiv2508.11915Title/abstractExcludedNot healthcare or clinical: Game-theoretic dialogue metric, non-clinical.
181MedKGent: A Large Language Model Agent Framework for Constructing Temporally Evolving Medical Knowledge Graph2025-08-17arXiv2508.12393Full textExcludedNo persistent cross-case improvement: KG is built from PubMed abstracts, not task experience; QA uses frozen LLMs with static KG RAG, no feedback from cases (Results, QA evaluation; Methods, RAG).
182You Don't Know Until You Click:Automated GUI Testing for Production-Ready Software Evaluation2025-08-17arXiv2508.14104Title/abstractExcludedNot healthcare or clinical: Software GUI testing benchmark.
183Exploring Autonomous Agents: A Closer Look at Why They Fail When Completing Tasks2025-08-18arXiv2508.13143Title/abstractExcludedNot healthcare or clinical: Agent failure analysis, non-clinical.
184CardAIc-Agents: A Multimodal Framework with Hierarchical Adaptation for Cardiac Care Support2025-08-18arXiv2508.13256Full textExcludedNo persistent cross-case improvement: Curated static cardiac knowledge base; 'stepwise update' revises the plan within one case; cross-turn memory is within-case (Sections 2.1, 2.2).
185Expertise-aware Multi-LLM Recruitment and Collaboration for Medical Decision-Making2025-08-19arXiv2508.13754Title/abstractExcludedNo persistent cross-case improvement: Static expertise table from public corpus; per-query recruitment and debate.
186End-to-End Agentic RAG System Training for Traceable Diagnostic Reasoning2025-08-21arXiv2508.15746Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
187Beyond Prediction: Reinforcement Learning as the Defining Leap in Healthcare AI2025-08-28arXiv2508.21101Title/abstractExcludedNot primary research: Survey of RL in healthcare.
188HiVA: Self-organized Hierarchical Variable Agent via Goal-driven Semantic-Topological Evolution2025-08-29arXiv2509.00189Title/abstractExcludedNot healthcare or clinical: General agent workflow evolution; no healthcare tasks.
189Instruction-Level Weight Shaping: A Framework for Self-Improving AI Agents2025-08-29arXiv2509.00251Title/abstractExcludedNot healthcare or clinical: Self-improving instructions evaluated in enterprise support, not healthcare.
190Lagrangian Relaxation for Multi-Action Partially Observable Restless Bandits: Heuristic Policies and Indexability2025-08-30arXiv2509.00415Title/abstractExcludedNot an LLM agent: Restless bandit theory; no LLM.
191ChatCLIDS: Simulating Persuasive AI Dialogues to Promote Closed-Loop Insulin Adoption in Type 1 Diabetes Care2025-08-31arXiv2509.0089110.1609/aaai.v40i46.41305Title/abstractExcludedNot primary research: Benchmark of persuasive dialogue for diabetes; evaluated LLMs not adapting across cases.
192Q-Learning-Driven Adaptive Rewiring for Cooperative Control in Heterogeneous Networks2025-09-01arXiv2509.01057Title/abstractExcludedNot healthcare or clinical: Q-learning network cooperation, non-clinical.
193Towards Personalized Explanations for Health Simulations: A Mixed-Methods Framework for Stakeholder-Centric Summarization2025-09-04arXiv2509.04646Title/abstractExcludedNo persistent cross-case improvement: LLM summarization of health simulations; no persistent learning.
194Hybrid Memory-Retrieval Model: Enhancing Trust in Medical Chatbots2025-09-08EuropePMC10.32388/r6ojq5Full textExcludedNo persistent cross-case improvement: Memory stores each user's own query-response pairs for that user (P1-type); document RAG corpus is static; Phi-2 chatbot, agent status weak (Sections V.A, V.C, V.E).
195From Coordination to Personalization: A Trust-Aware Simulation Framework for Emergency Department Decision Support2025-09-09arXiv2510.15896Title/abstractExcludedNot an LLM agent: Trust-based ED simulation agents; not LLM-based.
196Detecting Model Drifts in Non-Stationary Environment Using Edit Operation Measures2025-09-14arXiv2509.11367Title/abstractExcludedNot an LLM agent: RL drift detection; no LLM agent.
197Leveraging Large Language Models to Advance Certification, Physician Learning, and Diagnostic Excellence.2025-09-15EuropePMC10.3122/jabfm.2024.240385r1Title/abstractExcludedNot primary research: Commentary on LLMs for physician certification.
198A Knowledge-driven Adaptive Collaboration of LLMs for Enhancing Medical Decision-making2025-09-18arXiv2509.14998Title/abstractExcludedNo persistent cross-case improvement: Dynamic expert recruitment within a case; no retained experience.
199Failure Makes the Agent Stronger: Enhancing Accuracy through Structured Reflection for Reliable Tool Interactions2025-09-23arXiv2509.18847Title/abstractExcludedNot healthcare or clinical: Tool-use reflection training on general benchmarks, not healthcare.
200MACD: Multi-Agent Clinical Diagnosis with Self-Learned Knowledge for LLM2025-09-24arXiv2509.20067Full textIncludedli2025macd
201A co-evolving agentic AI system for medical imaging analysis2025-09-24arXiv2509.20279Already chartedIncluded (re-confirmed)coevolving2025
202RadAgents: Multimodal Agentic Reasoning for Chest X-ray Interpretation with Radiologist-like Workflows2025-09-24arXiv2509.20490Title/abstractExcludedNo persistent cross-case improvement: Radiologist-like multi-agent workflow within a case; no persistent learning.
203Rethinking Explainable Disease Prediction: Synergizing Accuracy and Reliability via Reflective Cognitive Architecture2025-09-25arXiv2509.21266Full textExcludedNot an LLM agent (no tools or environment interaction, or non-LLM controller)
204Leveraging LLM Agents for Automated Video Game Testing2025-09-26arXiv2509.22170Title/abstractExcludedNot healthcare or clinical: Game testing agent.
205Transparent Visual Reasoning via Object-Centric Agent Collaboration2025-09-28arXiv2509.23757Title/abstractExcludedNot an LLM agent: End-to-end trained interpretable visual classifier, not LLM agent.
206PSG-Agent: Personality-Aware Safety Guardrail for LLM-based Agents2025-09-28arXiv2509.23614Title/abstractExcludedRule P2 healthcare not the study focus
207PAME-AI: Patient Messaging Creation and Optimization using Agentic AI2025-09-29arXiv2509.24263Full textExcludedNo persistent cross-case improvement: Borderline: one analysis-to-generation pass from a prior RCT to 20 new messages; second RCT tests messages, not a retained, reused artifact (Sections 4.1, 4.4, 5); F2 also arguable.
208SoK: Measuring What Matters for Closed-Loop Security Agents2025-10-02arXiv2510.01654Title/abstractExcludedNot healthcare or clinical: Cybersecurity closed-loop agents SoK.
209Say One Thing, Do Another? Diagnosing Reasoning-Execution Gaps in VLM-Powered Mobile-Use Agents2025-10-02arXiv2510.02204Title/abstractExcludedNot healthcare or clinical: Mobile-use agent evaluation, non-clinical.
210Adaptive and Explainable AI Agents for Anomaly Detection in Critical IoT Infrastructure using LLM-Enhanced Contextual Reasoning2025-10-04arXiv2510.03859Title/abstractExcludedNot healthcare or clinical: IoT anomaly detection proposal; healthcare only mentioned.
211RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases2025-10-07arXiv2510.05764Full textExcludedHealthcare not the primary focus: Borderline: drug-repurposing discovery, not clinical care; persistent heuristic library and prompt updates do exist across tasks (Sections 3.5, 4.1-4.2, Fig. 2).
212Inclusivity and Innovation: A Pilot Study on Free AI Models for Clinical Supervision in Gestalt Therapy (GT)2025-10-09EuropePMC10.20944/preprints202510.0727.v1Title/abstractExcludedNo persistent cross-case improvement: Prompt framework comparison for supervision; no persistent adaptation.
213Agentic Systems in Radiology: Design, Applications, Evaluation, and Challenges2025-10-10arXiv2510.09404Title/abstractExcludedNot primary research: Review of agentic systems in radiology.
214Traj-CoA: Patient Trajectory Modeling via Chain-of-Agents for Lung Cancer Risk Prediction2025-10-12arXiv2510.10454Title/abstractExcludedNo persistent cross-case improvement: Shared memory built within one patient timeline; not reused across patients.
215TraceAegis: Securing LLM-Based Agents via Hierarchical and Behavioral Anomaly Detection2025-10-13arXiv2510.11203Title/abstractExcludedNot healthcare or clinical: Agent security anomaly detection, non-clinical.
216MedKGEval: A Knowledge Graph-Based Multi-Turn Evaluation Framework for Open-Ended Patient Interactions with Clinical LLMs2025-10-14arXiv2510.12224Title/abstractExcludedNot primary research: Evaluation framework/benchmark for clinical LLMs; systems do not adapt.
217Large Language Model Agents for Biomedicine: A Comprehensive Review of Methods, Evaluations, Challenges, and Future Directions2025-10-14EuropePMC10.22541/au.175795684.47167615/v2Title/abstractExcludedNot primary research: Review of biomedical LLM agents.
218The Digital Standardized Patient: An Artificial Intelligence Coach for Cultural Dexterity in Surgical Care.2025-10-15EuropePMC10.1097/xcs.0000000000001505Title/abstractExcludedNo persistent cross-case improvement: Feasibility study of LLM standardized patient; no cross-case learning.
219Towards Error Centric Intelligence I, Beyond Observational Learning2025-10-16arXiv2510.15128Title/abstractExcludedNot primary research: Position/theory paper on error-centric intelligence.
220A Survey of LLM-based Multi-agent Systems in Medicine2025-10-20EuropePMC10.20944/preprints202510.1448.v1Title/abstractExcludedNot primary research: Survey of medical multi-agent systems.
221Med-VRAgent: A Framework for Medical Visual Reasoning-Enhanced Agents2025-10-21arXiv2510.18424Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
222InspectCoder: Dynamic Analysis-Enabled Self Repair through interactive LLM-Debugger Collaboration2025-10-21arXiv2510.18327Title/abstractExcludedNot healthcare or clinical: Code repair agent.
223Photoresponsive HOF-Based Platforms for Large Language Model-Assisted Multimodal Diagnosis of Metabolic Diseases.2025-10-23EuropePMC10.1021/acs.analchem.5c04807Title/abstractExcludedNot an LLM agent: Chemical sensor with GPT-4o interpretation; not an agent.
224Human-AI Collaborative Uncertainty Quantification2025-10-27arXiv2510.23476Title/abstractExcludedNot healthcare or clinical: Human-AI uncertainty quantification, non-clinical.
225OpsAgent: An Evolving Multi-agent System for Incident Management in Microservices2025-10-28arXiv2510.24145Title/abstractExcludedNot healthcare or clinical: Microservice incident management.
226Evolving Interactive Diagnostic Agents in a Virtual Clinical Environment2025-10-28arXiv2510.24654Already chartedIncluded (re-confirmed)qiu2025diaggym
227FT-ARM: Fine-Tuned Agentic Reflection Multimodal Language Model for Pressure Ulcer Severity Classification with Reasoning2025-10-28arXiv2510.24980Title/abstractExcludedNo persistent cross-case improvement: Single-case self-reflection plus one-off fine-tuning for pressure ulcer staging.
228Towards actionable hypotension prediction -- predicting catecholamine therapy initiation in the intensive care unit2025-10-28arXiv2510.24287Title/abstractExcludedNot an LLM agent: Conventional ML prediction in ICU; no LLM.
229TheraMind: A Strategic and Adaptive Agent for Longitudinal Psychological Counseling2025-10-29arXiv2510.25758Full textExcludedNo persistent cross-case improvement: P1: cross-session memory and therapy reselection use only the same simulated patient's history; nothing is retained across patients (Sections 3.1.2, 3.2).
230CGM-Led Multimodal Tracking with Chatbot Support: An Autoethnography in Sub-Health2025-10-29arXiv2510.25381Title/abstractExcludedNo persistent cross-case improvement: Autoethnography of CGM and chatbot; no agent learning.
231Cloning Deterministic Worlds: The Critical Role of Latent Geometry in Long-Horizon World Models2025-10-30arXiv2510.26782Title/abstractExcludedNot healthcare or clinical: World model for mazes.
232Learning from experts: A self-improving LLM framework for study population generation in clinical research.2025-10-30EuropePMC10.1016/j.ijmedinf.2025.106171Full textExcludedNot an LLM agent: Borderline: single-call in-context LLM generation with retrieved expert-correction records, no agentic behaviour; correction store from training set is reused on test (Sections 2.2, 2.3, Fig. 6).
233Prompt-dependent performance of multimodal AI model in oral diagnosis: a comprehensive analysis of accuracy, narrative quality, calibration, and latency versus human experts.2025-10-30EuropePMC10.1038/s41598-025-22979-zTitle/abstractExcludedNo persistent cross-case improvement: Prompt strategy comparison for oral diagnosis.
234Navigating the intersection of clinical and artificial intelligence in nurse practitioner practice.2025-11-01EuropePMC10.1097/jxx.0000000000001193Title/abstractExcludedNot primary research: Reflective commentary on AI in nursing.
235LMT++: Adaptively Collaborating LLMs With Multi-Specialized Teachers for Continual VQA in Robotic Surgical Videos.2025-11-01EuropePMC10.1109/tmi.2025.3581108Title/abstractExcludedNot an LLM agent: Continual learning of VQA models with LLM teacher; not an LLM agent.
236MicroRemed: Benchmarking LLMs in Microservices Remediation2025-11-03arXiv2511.01166Title/abstractExcludedNot healthcare or clinical: Microservice remediation benchmark.
237ASAP: an Agentic Solution to Auto-optimize Performance of Large-Scale LLM Training2025-11-05arXiv2511.03844Title/abstractExcludedNot healthcare or clinical: LLM training performance optimization agents.
238Towards Human-AI-Robot Collaboration and AI-Agent based Digital Twins for Parkinson's Disease Management: Review and Outlook2025-11-08arXiv2511.06036Title/abstractExcludedNot primary research: Review and outlook on Parkinson digital twins.
239A Mathematical Framework for AI Singularity: Conditions, Bounds, and Control of Recursive Improvement2025-11-08arXiv2511.10668Title/abstractExcludedNot healthcare or clinical: Mathematical framework for AI self-improvement; no healthcare.
240TwinOR: Photorealistic Digital Twins of Dynamic Operating Rooms for Embodied AI Research2025-11-10arXiv2511.0741210.1007/s11548-026-03644-wTitle/abstractExcludedNot an LLM agent: OR digital twin infrastructure; no LLM agent.
241Refine and Align: Confidence Calibration through Multi-Agent Interaction in VQA2025-11-14arXiv2511.11169Title/abstractExcludedNo persistent cross-case improvement: Debate-based calibration within a question.
242Multi-agent Self-triage System with Medical Flowcharts2025-11-16arXiv2511.1243910.1038/s44360-026-00112-2Title/abstractExcludedNo persistent cross-case improvement: Multi-agent triage over fixed flowcharts; no learning.
243MedDCR: Learning to Design Agentic Workflows for Medical Coding2025-11-17arXiv2511.13361Full textIncludedzheng2026meddcr
244Fault2Flow: An AlphaEvolve-Optimized Human-in-the-Loop Multi-Agent System for Fault-to-Workflow Automation2025-11-17arXiv2511.12916Title/abstractExcludedNot healthcare or clinical: Power grid fault workflow.
245MedBench v4: A Robust and Scalable Benchmark for Evaluating Chinese Medical Language Models, Multimodal Models, and Intelligent Agents2025-11-18arXiv2511.14439Title/abstractExcludedNot primary research: Benchmark of Chinese medical models and agents.
246OEMA: Ontology-Enhanced Multi-Agent Collaboration Framework for Zero-Shot Clinical Named Entity Recognition2025-11-19EuropePMC; PubMed; arXiv2511.1521110.1093/jamiaopen/ooag049Full textExcludedNo persistent cross-case improvement: Self-annotated corpus is built once by zero-shot annotation of unlabeled training text, then retrieved statically; no outcome feedback or cross-case updating (§3.2.1–3.2.2, §4.1).
247MRG-R3: Retrieval-Reflection-Reward via Multimodal LLMs Advances Clinical Automated Medical Report Generation2025-11-20EuropePMC10.21203/rs.3.rs-7914595/v1Title/abstractExcludedNo persistent cross-case improvement: Retrieval from fixed store, reflection and RL on report generation; not an agent improvement loop.
248PathAgent: Toward Interpretable Analysis of Whole-slide Pathology Images via Large Language Model-based Agentic Reasoning2025-11-21arXiv2511.17052Title/abstractExcludedNo persistent cross-case improvement: Training-free agent reasoning within one slide.
249DR Tulu: Reinforcement Learning with Evolving Rubrics for Deep Research2025-11-24arXiv2511.19399Title/abstractExcludedNot healthcare or clinical: Deep research agent RL, not healthcare.
250MTBBench: A Multimodal Sequential Clinical Decision-Making Benchmark in Oncology2025-11-25arXiv2511.20490Title/abstractExcludedNot primary research: Benchmark of oncology tumor-board decisions.
251PathReasoning: A multimodal reasoning agent for query-based ROI navigation on whole-slide images2025-11-26arXiv2511.21902Title/abstractExcludedNo persistent cross-case improvement: Iterative ROI navigation within one slide.
252Auditable Context-Aware HFMD Forecasting with Structured LLM Agents2025-11-28arXiv2511.23276Title/abstractExcludedNo persistent cross-case improvement: Two-agent forecasting without persistent learning.
253Can Large Language Models Foster Reflective Practice? A Dialogically-Informed Exploration by a Trainee-Educator Dyad.2025-11-28EuropePMC10.1007/s40670-025-02570-xTitle/abstractExcludedNot primary research: Commentary on LLMs and reflective practice.
254Reinventing Clinical Dialogue: Agentic Paradigms for LLM Enabled Healthcare Communication2025-12-01arXiv2512.01453Title/abstractExcludedNot primary research: Survey of agentic clinical dialogue.
255Shared Decision-Making with Palliative Care Specialist.2025-12-01EuropePMC10.14475/jhpc.2025.28.4.131Title/abstractExcludedNot primary research: Review of shared decision-making in palliative care.
256Process-Centric Analysis of Agentic Software Systems2025-12-02arXiv2512.0239310.1145/3798271Title/abstractExcludedNot healthcare or clinical: Trajectory analysis of software agents.
257Colon-X: Advancing Intelligent Colonoscopy toward Clinical Reasoning2025-12-03arXiv2512.03667Title/abstractExcludedNo persistent cross-case improvement: Dataset and reasoning study of MLLMs for colonoscopy; no agent loop.
258Advancing Chinese Conversation-based Patient Guidance with a Benchmark and Knowledge-Evolvable Assistant.2025-12-03EuropePMC10.1109/jbhi.2025.3639805Full textIncludedlu2025kea
259AI-Facilitated Cognitive Reappraisal via Socrates 2.0: Mixed Methods Feasibility Study.2025-12-05EuropePMC10.2196/80461Title/abstractExcludedNo persistent cross-case improvement: Feasibility study of Socrates 2.0 (duplicate of record 158); no cross-case learning.
260SGEMAS: A Self-Growing Ephemeral Multi-Agent System for Unsupervised Online Anomaly Detection via Entropic Homeostasis2025-12-08arXiv2512.14708Title/abstractExcludedNot an LLM agent: Non-LLM bio-inspired agents for ECG.
261VIGIL: A Reflective Runtime for Self-Healing Agents2025-12-08arXiv2512.07094Title/abstractExcludedNot healthcare or clinical: General self-healing agent runtime, not healthcare.
262Ophiuchus: Incentivizing Tool-augmented "Think with Images" for Joint Medical Segmentation, Understanding and Reasoning2025-12-16arXiv2512.14157Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
263Physician Associate Student Use of Large Language Models to Support Learning: A Phenomenological Study.2025-12-24EuropePMC10.1097/jpa.0000000000000733Title/abstractExcludedNot an LLM agent: Qualitative interview study of student LLM use.
264Multi-Agent AI Systems for Biological and Clinical Data Analysis2025-12-30EuropePMC10.20944/preprints202512.2602.v1Title/abstractExcludedNot primary research: Review of multi-agent biomedical systems.
265Artificial intelligence guidance in ethically challenging clinical scenarios in child and adolescent psychiatry: a qualitative study in the context of Turkiye.2025-12-30EuropePMC10.1186/s12910-025-01323-0Title/abstractExcludedNo persistent cross-case improvement: Qualitative comparison of LLM ethics guidance.
266MAMA-Memeia! Multi-Aspect Multi-Agent Collaboration for Depressive Symptoms Identification in Memes2025-12-31arXiv2512.25015Title/abstractExcludedNo persistent cross-case improvement: Multi-agent discussion for meme classification; within-case.
267Hierarchical agent reflection for aligning LLM reasoning with clinical diagnostic processes.2026EuropePMC; PubMed10.1007/s13755-025-00410-1Title/abstractExcludedNo persistent cross-case improvement: Agent reflection generates notes for one-off supervised fine-tuning.
268Phronesis and Ethical Nursing Practice: Insights From Nursing Ontology.2026PubMed10.1111/nin.70074Title/abstractExcludedNot primary research: Philosophical essay on nursing ethics.
269EvoMDT: a self-evolving multi-agent system for structured clinical decision-making in multi-cancer.2026EuropePMC; PubMed10.1038/s41746-025-02304-8Already chartedIncluded (re-confirmed)liu2026evomdt
270How interprofessional simulation supports medical students' transition to clinical practice.2026EuropePMC; PubMed10.1186/s41077-025-00392-wTitle/abstractExcludedNot an LLM agent: Qualitative simulation education study.
271Agentic AI in Radiology: Evolution from Large Language Models to Future Clinical Integration.2026EuropePMC; PubMed10.1148/ryai.250651Title/abstractExcludedNot primary research: Review of agentic AI in radiology.
272Early diagnosis of axial spondyloarthritis in primary care using multi-agent systems.2026EuropePMC; PubMed10.1038/s41746-026-02372-4Full textIncludedji2026spagents
273Artificial intelligence and medicine: an epistemological inquiry.2026PubMed10.1136/medhum-2025-013509Title/abstractExcludedNot primary research: Epistemological essay on AI in medicine.
274FHIR-AgentEval: A Modular Sandbox for Benchmarking Clinical LLM Agents with an Evaluation of Memory-Augmented Configurations.2026EuropePMC; PubMed10.21203/rs.3.rs-8746188/v1Full textIncludedmokssit2026fhiragenteval
275Transgender people and nursing: Ethical reflections between care and invisibility.2026PubMed10.1177/09697330261418162Title/abstractExcludedNot primary research: Theoretical essay on nursing ethics.
276Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.2026PubMed10.1128/cmr.00228-25Title/abstractExcludedNot primary research: Clinical opinion on antifungal drug.
277DILIConsult: A Multi-Agent Large Language Model Framework for Evaluating Drug-Induced Liver Injury in ICU Settings.2026EuropePMC; PubMed10.1002/phar.70131Title/abstractExcludedNo persistent cross-case improvement: Agentic pipeline for DILI; no persistent learning.
278Tabular LLMs for Interpretable Few-Shot Alzheimer's Disease Prexdiction with Multimodal Biomedical Data.2026PubMed10.1145/3765612.3767229Title/abstractExcludedNot an LLM agent: Fine-tuned tabular LLM classifier; not an agent.
279AgentClinic: a multimodal benchmark for tool-using clinical AI agents.2026EuropePMC; PubMed10.1038/s41746-026-02674-7Already chartedIncluded (re-confirmed)schmidgall2026agentclinic
280Large Language Model and Pediatric Neurosurgery - A Neurosurgeon's Perspective on the Artificial Nervous System.2026EuropePMC; PubMed10.3340/jkns.2026.0029Title/abstractExcludedNot primary research: Narrative review of LLMs in neurosurgery.
281Reconfiguring work: artificial intelligence, agentic AI, and the future of the radiology profession.2026EuropePMC; PubMed10.1093/bjrai/ubag006Title/abstractExcludedNot primary research: Perspective on agentic AI and radiology profession.
282The next paradigm in bioinformatics: a review of multi-agent systems and foundational models for end-to-end scientific discovery.2026EuropePMC; PubMed10.1093/bib/bbag245Title/abstractExcludedNot primary research: Review of multi-agent bioinformatics.
283ReclAIm: A Multiagent Framework for Monitoring and Correcting Performance Decline in Medical Imaging AI.2026EuropePMC; PubMed10.1148/ryai.250923Already chartedIncluded (re-confirmed)tzanis2026reclaim
284Acquired enamel pellicle engineering and the use of vitamin e as a preventive strategy for dental erosion.2026PubMed10.1016/j.jdent.2026.106808Title/abstractExcludedNot primary research: Narrative review of dental erosion.
285Designing Artificial Intelligence Tools to Strengthen Human Connection in Healthcare: The CoCo Experience.2026PubMed10.1177/23743735261461903Title/abstractExcludedNo persistent cross-case improvement: Description of Mayo communication agent; no learning loop.
286Building CAR-E: A Novel Artificial Intelligence Agent for Coaching Conversations.2026EuropePMC; PubMed10.5334/pme.2563Full textExcludedHealthcare not the primary focus: Coaching conversations in medical education without clinical cases; also long-term memory is per-user history and refinement was human-led redesign (Steps taken; Table 1).
287The Next Paradigm in Medical AI: A Survey of Agentic AI in Biomedicine.2026EuropePMC; PubMed10.1109/rbme.2026.3704162Title/abstractExcludedNot primary research: Survey of agentic AI in biomedicine.
288Agent4CD: Generative Agent for Cognitive Diagnosis in Intelligent Education.2026EuropePMC; PubMed10.1109/tnnls.2026.3706957Title/abstractExcludedNot healthcare or clinical: Cognitive diagnosis in general education.
289From glycemic control to neuroprotection: alogliptin as a repurposed candidate for Huntington's disease.2026PubMed10.1007/s11011-026-01942-5Title/abstractExcludedNot an LLM agent: Pharmacology study of alogliptin.
290Medical AI Agents for Clinical Decision Support: Viewpoint Using the Planning, Action, Reflection, and Memory (PARM) Analytical Lens.2026EuropePMC; PubMed10.2196/92584Title/abstractExcludedNot primary research: Viewpoint on medical AI agents.
291Closed-loop agentic AI in drug discovery.2026EuropePMC; PubMed10.1039/d6md00319bTitle/abstractExcludedNot primary research: Review of agentic drug discovery.
292HealthFlow: automating electronic health record analysis via a strategically self-evolving multi-agent framework.2026EuropePMC; PubMed10.1038/s41746-026-03097-0Already chartedIncluded (re-confirmed)zhu2026healthflow
293Cross-interface persistent memory for large language model-assisted radiology research workflows: a Claude-based proof-of-concept technical development.2026EuropePMC; PubMed10.3389/fradi.2026.1890122Full textExcludedHealthcare not the primary focus: Memory carries software-development project context; authors state it is not a clinical tool and processes no patient data (Abstract; Methods scope paragraph).
294Questioning the Foundations of Research Methodologies in Nursing: A Reflection Based on Problematology.2026PubMed10.1111/nup.70116Title/abstractExcludedNot primary research: Reflective essay on nursing research methods.
295Developing agency through experiences of misalignment: A path to becoming a physician.2026EuropePMC; PubMed10.1111/medu.70334Title/abstractExcludedNot an LLM agent: Qualitative study of medical student agency.
296Opening doors together: Agentic engagement as a relational practice in medical education.2026EuropePMC; PubMed10.1080/0142159x.2026.2738746Title/abstractExcludedNot an LLM agent: Qualitative interview study.
297Skill-guided agentic reasoning enables longitudinal synthesis of myeloma records at expert-level concordance.2026EuropePMC; PubMed10.1038/s41698-026-01733-2Full textExcludedNo persistent cross-case improvement: The 42-module clinical skill library is predefined and selected at runtime; no experience-driven creation or updating of skills is reported (Methods, Clinical skill library).
298PARDA: A Perceive-Act-Reflect-Distill Agent for Source-Free Unsupervised Domain Adaptation.2026PubMed10.1109/tmi.2026.3744091Title/abstractExcludedNo persistent cross-case improvement: Closed-loop domain adaptation distilled to a student model; unclear LLM-agent and cross-case retention.
299Agentic artificial intelligence for code status extraction from clinical notes: a cross-model comparison of single agent, reflective agent, and multiagent extractor-reviewer system.2026EuropePMC; PubMed10.1093/jamia/ocag179Title/abstractExcludedNo persistent cross-case improvement: Single, reflective and multi-agent extraction compared; no persistent learning.
300Auditable Automation of Activated Sludge Modeling for Wastewater Treatment Diagnosis Using LLM-Agents.2026EuropePMC; PubMed10.1021/acs.est.6c09278Title/abstractExcludedNot healthcare or clinical: Wastewater modeling agent.
301Can emotions be professional? A decolonial reframing of professional identity formation.2026PubMed10.3389/fmed.2026.1952561Title/abstractExcludedNot primary research: Conceptual argument on professional identity formation; not a system
302ClinicalReTrial: Clinical Trial Redesign with Self-Evolving Agents2026-01-01arXiv2601.00290Full textIncludedxing2026clinicalretrial
303An Agentic Software Framework for Data Governance under DPDP2026-01-03arXiv2601.01101Title/abstractExcludedNot healthcare or clinical: Data governance under DPDP; not clinical
304Digital Twin AI: Opportunities and Challenges from Large Language Models to World Models2026-01-04arXiv2601.01321Title/abstractExcludedNot primary research: Digital twin AI overview framework; not primary clinical system
305Clinical Knowledge Graph Construction and Evaluation with Multi-LLMs via Retrieval-Augmented Generation2026-01-05arXiv2601.01844Title/abstractExcludedNo persistent cross-case improvement: Multi-agent KG construction with RAG; no cross-case learning
306Model confrontation and collaboration: A debate intelligence framework for enhancing medical reasoning in large language models.2026-01-05EuropePMC10.1016/j.xcrm.2025.102547Title/abstractExcludedNo persistent cross-case improvement: Multi-LLM debate within a single question; no persistence
307Replacing Tunable Parameters in Weather and Climate Models with State-Dependent Functions using Reinforcement Learning2026-01-07arXiv2601.0426810.1029/2026ms005745Title/abstractExcludedNot healthcare or clinical: Weather/climate model RL; not healthcare
308From Laboratory to Real-World Applications: Benchmarking Agentic Code Reasoning at the Repository Level2026-01-07arXiv2601.03731Title/abstractExcludedNot healthcare or clinical: Code reasoning benchmark; not healthcare
309AgentDevel: Reframing Self-Evolving LLM Agents as Release Engineering2026-01-08arXiv2601.04620Title/abstractExcludedNot healthcare or clinical: General agent release-engineering; no clinical task
310Memory Poisoning Attack and Defense on Memory Based LLM-Agents2026-01-09arXiv2601.05504Title/abstractExcludedNot healthcare or clinical: Memory poisoning on generic agents; not clinical
311MedEinst: Benchmarking the Einstellung Effect in Medical LLMs through Counterfactual Differential Diagnosis2026-01-10arXiv2601.06636Title/abstractExcludedNot primary research: Benchmark of static LLMs; no adaptation
312Hallucinations Live in Variance2026-01-11arXiv2601.07058Title/abstractExcludedNot healthcare or clinical: Generic reliability/variance paper; not clinical
313Route, Retrieve, Reflect, Repair: Self-Improving Agentic Framework for Visual Detection and Linguistic Reasoning in Medical Imaging2026-01-13arXiv2601.08192Full textIncludedsayeedi2026r4
314AI Agents Need Memory Control Over More Context2026-01-15arXiv2601.11653Title/abstractExcludedNot healthcare or clinical: Generic agent memory control; not clinical
315A Survey of Agentic Reasoning for Large Language Models: Towards Recursively Self-Improving and Collective Agents2026-01-18arXiv2601.12538Title/abstractExcludedNot primary research: Survey of agentic reasoning
316HyperWalker: Dynamic Hypergraph-Based Deep Diagnosis for Multi-Hop Clinical Modeling across EHR and X-Ray in Medical VLMs2026-01-20arXiv2601.13919Full textExcludedNo persistent cross-case improvement: Appendix A: hypergraph pre-built from training data, Walker trained offline, adapters tuned by TTT for each single test sample; nothing retained across test cases. Walker is a scoring network.
317AgentEHR: Advancing Autonomous Clinical Decision-Making via Retrospective Summarization2026-01-20arXiv2601.13918Full textIncludedliao2026agentehr
318TruthTensor: Evaluating LLMs through Human Imitation on Prediction Market under Drift and Holistic Reasoning2026-01-20arXiv2601.13545Title/abstractExcludedNot healthcare or clinical: Prediction market evaluation; not clinical
319Epistemic and ethical limits of large language models in evidence-based medicine: from knowledge to judgment.2026-01-20EuropePMC10.3389/fdgth.2025.1706383Title/abstractExcludedNo persistent cross-case improvement: Empirical evaluation of static LLMs on EBM tasks
320XInsight: Integrative Stage-Consistent Psychological Counseling Support Agents for Digital Well-Being2026-01-21arXiv2603.06583Title/abstractExcludedNo persistent cross-case improvement: Multi-agent counseling workflow; adaptation within client session only
321From Passive Metric to Active Signal: The Evolving Role of Uncertainty Quantification in Large Language Models2026-01-22arXiv2601.15690Title/abstractExcludedNot primary research: Survey on uncertainty quantification
322D-Optimality-Guided Reinforcement Learning for Efficient Open-Loop Calibration of a 3-DOF Ankle Rehabilitation Robot2026-01-22arXiv2601.15707Title/abstractExcludedNot an LLM agent: RL calibration of rehab robot; not an LLM agent
323Robust Tool Use via Fission-GRPO: Learning to Recover from Execution Errors2026-01-22arXiv2601.15625Title/abstractExcludedNot healthcare or clinical: General tool-use RL training; not healthcare
324Comparison of online radiologists and large language model chatbots in responding to common radiology-related questions in Chinese: a cross-sectional comparative analysis.2026-01-22EuropePMC10.21037/qims-2025-1716Title/abstractExcludedNot an LLM agent: Cross-sectional comparison of chatbots vs radiologists; no agent adaptation
325EvoConfig: Self-Evolving Multi-Agent Systems for Efficient Autonomous Environment Configuration2026-01-23arXiv2601.16489Title/abstractExcludedNot healthcare or clinical: Software environment configuration; not healthcare
326CreditAudit: 2$^\text{nd}$ Dimension for LLM Evaluation and Selection2026-01-23arXiv2602.02515Title/abstractExcludedNot healthcare or clinical: LLM evaluation method; not healthcare
327Sentipolis: Emotion-Aware Agents for Social Simulations2026-01-25arXiv2601.18027Title/abstractExcludedNot healthcare or clinical: Social simulation emotion agents; not clinical
328Planner-Auditor Twin: Agentic Discharge Planning with FHIR-Based LLM Planning, Guideline Recall, Optional Caching and Self-Improvement2026-01-28arXiv2601.21113Full textExcludedNo persistent cross-case improvement: Sec. 2.3: self-improvement regenerates within the request; buffer replay re-runs the same flagged cases (N=7). Borderline: 'context caching' is never defined, so cross-patient reuse is unverifiable.
329Conversation for Non-verifiable Learning: Self-Evolving LLMs through Meta-Evaluation2026-01-29arXiv2601.21464Title/abstractExcludedNot healthcare or clinical: Self-evolving LLM for non-verifiable tasks; not clinical
330Payoff-Free Coordination Reveals Hidden Quantum Correlation Structure2026-01-29arXiv2601.21139Title/abstractExcludedNot healthcare or clinical: Quantum coordination model; not healthcare
331EvoClinician: A Self-Evolving Agent for Multi-Turn Medical Diagnosis via Test-Time Evolutionary Learning2026-01-30arXiv2601.22964Already chartedIncluded (re-confirmed)he2026evoclinician
332RE-MCDF: Closed-Loop Multi-Expert LLM Reasoning for Knowledge-Grounded Clinical Diagnosis2026-02-01arXiv2602.01297Title/abstractExcludedNo persistent cross-case improvement: Closed-loop multi-expert diagnosis within one case; no persistence
333Think Like a Doctor: Conversational Diagnosis through the Exploration of Diagnostic Knowledge Graphs2026-02-02arXiv2602.01995Title/abstractExcludedNo persistent cross-case improvement: KG-guided conversational diagnosis; per-case only
334MedSAM-Agent: Empowering Interactive Medical Image Segmentation with Multi-turn Agentic Reinforcement Learning2026-02-03arXiv2602.03320Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
335MeetBench-XL: Calibrated Multi-Dimensional Evaluation and Learned Dual-Policy Agents for Real-Time Meetings2026-02-03arXiv2602.03285Title/abstractExcludedNot healthcare or clinical: Enterprise meeting agents; not healthcare
336SE-Bench: Benchmarking Self-Evolution with Knowledge Internalization2026-02-04arXiv2602.04811Title/abstractExcludedNot healthcare or clinical: Self-evolution benchmark for knowledge internalization; not clinical
337AI Chatbot Suicide Risk Detection and Response: Human Validation Study of the Open-Source VERA-MH Safety Evaluation2026-02-04arXiv2602.0508810.2196/92817Title/abstractExcludedNot an LLM agent: Human validation of chatbot safety evaluation; not an adapting agent
338"A Safe First Step": Design and Evaluation of an Emotionally Expressive AI Virtual Patient for Clinical Simulation in Speech-Language Pathology Training2026-02-04EuropePMC10.21203/rs.3.rs-8588902/v1Title/abstractExcludedNo persistent cross-case improvement: AI virtual patient for SLP training; no cross-case learning
339TemporalBench: A Benchmark for Evaluating LLM-Based Agents on Contextual and Event-Informed Time Series Tasks2026-02-05arXiv2602.13272Title/abstractExcludedNot healthcare or clinical: Time series benchmark; not healthcare
340From Conflict to Consensus: Boosting Medical Reasoning via Multi-Round Agentic RAG2026-02-06arXiv2603.03292Title/abstractExcludedNo persistent cross-case improvement: Multi-round agentic RAG within a single question
341The Value of Variance: Mitigating Debate Collapse in Multi-Agent Systems via Uncertainty-Driven Policy Optimization2026-02-06arXiv2602.07186Title/abstractExcludedNot healthcare or clinical: Multi-agent debate policy optimization; generic reasoning
342Agentic Unlearning: When LLM Agent Meets Machine Unlearning2026-02-06arXiv2602.17692Title/abstractExcludedNot healthcare or clinical: Agentic unlearning; generic
343VenusBench-Mobile: A Challenging and User-Centric Benchmark for Mobile GUI Agents with Capability Diagnostics2026-02-06arXiv2604.06182Title/abstractExcludedNot healthcare or clinical: Mobile GUI benchmark; not healthcare
344MedCoG: Maximizing LLM Inference Density in Medical Reasoning via Meta-Cognitive Regulation2026-02-08arXiv2602.07905Title/abstractExcludedNo persistent cross-case improvement: Meta-cognitive regulation of knowledge use per query; no accumulation
345EvoCorps: An Evolutionary Multi-Agent Framework for Depolarizing Online Discourse2026-02-09arXiv2602.08529Title/abstractExcludedNot healthcare or clinical: Online discourse depolarization; not healthcare
346Situation Graph Prediction for User Perspective Modeling2026-02-10arXiv2602.13319Title/abstractExcludedNot healthcare or clinical: User perspective modeling; not clinical
347Virtual Immersion in Biomedical Engineering (VIBE): Exposing undergraduates to culturally sensitive engineering design and professional experiences at scale2026-02-10EuropePMC10.64898/2026.02.08.704621Title/abstractExcludedNot healthcare or clinical: Biomedical engineering education programme; not clinical agent
348ASQ-PHI: An adversarial synthetic data benchmark for clinical de-identification and search utility.2026-02-11EuropePMC10.1016/j.dib.2026.112586Title/abstractExcludedNot primary research: De-identification benchmark; no adapting system
349Historical Perspectives in Medicine using a Large Language Model: Emulating an 18th Century Physician2026-02-12EuropePMC10.64898/2026.02.10.26345990Title/abstractExcludedNo persistent cross-case improvement: LLM emulating historical physician for education; no learning loop
350Vital Trace: Protocol-Constrained Patient-State Reasoning for Longitudinal Clinical Trajectories2026-02-13arXiv2602.12833Title/abstractExcludedNo persistent cross-case improvement: Persistent patient-state memory within one ICU trajectory; no cross-patient learning
351NeuroWeaver: An Autonomous Evolutionary Agent for Exploring the Programmatic Space of EEG Analysis Pipelines2026-02-13arXiv2602.13473Full textExcludedHealthcare not the primary focus: Sec. 1 and 3.1: general EEG/BCI pipeline AutoML including emotion and workload tasks, not healthcare-primary; also per-dataset search, nothing carried across tasks (Sec. 2.4). Borderline on scope.
352Learning to Remember: End-to-End Training of Memory Agents for Long-Context Reasoning2026-02-13arXiv2602.18493Title/abstractExcludedNot healthcare or clinical: Generic memory agent training; not healthcare
353AnomaMind: Agentic Time Series Anomaly Detection with Tool-Augmented Reasoning2026-02-14arXiv2602.13807Title/abstractExcludedNot healthcare or clinical: Time series anomaly detection agent; not healthcare
354Does Socialization Emerge in AI Agent Society? A Case Study of Moltbook2026-02-15arXiv2602.14299Title/abstractExcludedNot healthcare or clinical: Agent society analysis; not healthcare
355AgentFixer: From Failure Detection to Fix Recommendations in LLM Agentic Systems2026-02-18arXiv2603.29848Title/abstractExcludedNot healthcare or clinical: Generic agent failure diagnosis; not healthcare
356MedClarify: An information-seeking AI agent for medical diagnosis with case-specific follow-up questions2026-02-19arXiv2602.17308Title/abstractExcludedNo persistent cross-case improvement: Information-seeking follow-up questions per case; no persistence
357Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation2026-02-22arXiv2602.19012Title/abstractExcludedNot an LLM agent: Statistical dose-finding method; not LLM
358Data mining in pediatric radiology in the era of artificial intelligence.2026-02-25EuropePMC10.1007/s00247-026-06551-zTitle/abstractExcludedNot primary research: Review of data mining in pediatric radiology
359ESAA: Event Sourcing for Autonomous Agents in LLM-Based Software Engineering2026-02-26arXiv2602.23193Title/abstractExcludedNot healthcare or clinical: Software engineering agents; not healthcare
360Tell Me What To Learn: Generalizing Neural Memory to be Controllable in Natural Language2026-02-26arXiv2602.23201Title/abstractExcludedNot healthcare or clinical: Neural memory method; not healthcare
361Structure Matters: Evaluating Multi-Agents Orchestration in Generative Therapeutic Chatbots2026-02-28arXiv2603.00774Title/abstractExcludedNo persistent cross-case improvement: Evaluates therapeutic chatbot orchestration designs; no learning loop
362TARSE: Test-Time Adaptation via Retrieval of Skills and Experience for Reasoning Agents2026-03-01arXiv2603.01241Full textExcludedNo persistent cross-case improvement: Sec. 4-5: skills and experience libraries curated offline from guidelines and QA rationales, fixed at test; per-query TTT restarts from base parameters; no cross-case retention.
363ASTRA-bench: Evaluating Tool-Use Agent Reasoning and Action Planning with Personal User Context2026-03-02arXiv2603.01357Title/abstractExcludedNot healthcare or clinical: Personal assistant benchmark; not healthcare
364AMemGym: Interactive Memory Benchmarking for Assistants in Long-Horizon Conversations2026-03-02arXiv2603.01966Title/abstractExcludedNot healthcare or clinical: Memory benchmark for assistants; not healthcare
365AOI: Turning Failed Trajectories into Training Signals for Autonomous Cloud Diagnosis2026-03-03arXiv2603.03378Title/abstractExcludedNot healthcare or clinical: Cloud SRE agents; not healthcare
366Conversational Learning Diagnosis via Reasoning Multi-Turn Interactive Learning2026-03-03arXiv2603.03236Title/abstractExcludedNot healthcare or clinical: Education learning diagnosis; not clinical
367Specification-Driven Generation and Evaluation of Discrete-Event World Models via the DEVS Formalism2026-03-04arXiv2603.03784Title/abstractExcludedNot healthcare or clinical: World models for business processes; not healthcare
368EvoTool: Self-Evolving Tool-Use Policy Optimization in LLM Agents via Blame-Aware Mutation and Diversity-Aware Selection2026-03-05arXiv2603.04900Title/abstractExcludedNot healthcare or clinical: Generic tool-use policy evolution; not healthcare
369Tool-Genesis: A Task-Driven Tool Creation Benchmark for Self-Evolving Language Agent2026-03-05arXiv2603.05578Title/abstractExcludedNot healthcare or clinical: Tool creation benchmark; not healthcare
370Evolving Medical Imaging Agents via Experience-driven Self-skill Discovery2026-03-06arXiv2603.05860Already chartedIncluded (re-confirmed)fan2026macro
371The World Won't Stay Still: Programmable Evolution for Agent Benchmarks2026-03-06arXiv2603.05910Title/abstractExcludedNot healthcare or clinical: Agent benchmark with evolving environments; not healthcare
372Dual-Agent Multiple-Model Reinforcement Learning for Event-Triggered Human-Robot Co-Adaptation in Decoupled Task Spaces2026-03-06arXiv2603.06163Title/abstractExcludedNot an LLM agent: RL rehab robot control; not an LLM agent
373Sensitivity-Aware Retrieval-Augmented Intent Clarification2026-03-06arXiv2603.06025Title/abstractExcludedNot healthcare or clinical: Conversational search clarification; not healthcare
374\$OneMillion-Bench: How Far are Language Agents from Human Experts?2026-03-09arXiv2603.07980Title/abstractExcludedNot primary research: Multi-domain agent benchmark
375GPT-Powered Chatbot-Based Positive Psychology Intervention for Well-Being Among Parents of Children With Autism Spectrum Disorder: Single-Arm Mixed Methods Study.2026-03-09EuropePMC10.2196/85060Title/abstractExcludedNo persistent cross-case improvement: Single-arm study of GPT chatbot intervention; no agent learning loop
376Real-Time Trust Verification for Safe Agentic Actions using TrustBench2026-03-10arXiv2603.09157Title/abstractExcludedNot healthcare or clinical: Generic agent action trust verification; not healthcare
377Emulating Clinician Cognition via Self-Evolving Deep Clinical Research2026-03-11arXiv2603.10677Already chartedIncluded (re-confirmed)ren2026dxevolve
378UltrasoundAgents: Hierarchical Multi-Agent Evidence-Chain Reasoning for Breast Ultrasound Diagnosis2026-03-11arXiv2603.10852Full textIncludedzhu2026ultrasoundagents
379When OpenClaw Meets Hospital: Toward an Agentic Operating System for Dynamic Clinical Workflows2026-03-12arXiv2603.11721Title/abstractExcludedNo persistent cross-case improvement: Agentic hospital OS; memory is patient-record retrieval and curated skills, not learned
380Improving TCM question answering through tree-organized self-reflective retrieval with LLMs.2026-03-12EuropePMC10.3389/fmed.2026.1752778Title/abstractExcludedNo persistent cross-case improvement: TCM QA with tree retrieval and per-query reflection; static store
381TheraAgent: Multi-Agent Framework with Self-Evolving Memory and Evidence-Calibrated Reasoning for PET Theranostics2026-03-14arXiv2603.13676Full textIncludedchen2026theraagent
382OpenHospital: A Thing-in-itself Arena for Evolving and Benchmarking LLM-based Collective Intelligence2026-03-16arXiv2603.14771Full textIncludedliu2026openhospital
383Elder-Sim: A Psychometrically Validated Platform for Personality-Stable Elderly Digital Twins2026-03-16EuropePMC; arXiv2604.1634310.64898/2026.03.25.26349036Title/abstractExcludedNo persistent cross-case improvement: Per-twin persistent memory and LoRA for personality consistency; no cross-case improvement
384AgentTrace: Causal Graph Tracing for Root Cause Analysis in Deployed Multi-Agent Systems2026-03-16arXiv2603.14688Title/abstractExcludedNot healthcare or clinical: Multi-agent failure root cause analysis; not healthcare
385GUI-CEval: A Hierarchical and Comprehensive Chinese Benchmark for Mobile GUI Agents2026-03-16arXiv2603.15039Title/abstractExcludedNot healthcare or clinical: Mobile GUI benchmark; not healthcare
386The Internet of Physical AI Agents: Interoperability, Longevity, and the Cost of Getting It Wrong2026-03-16arXiv2603.15900Title/abstractExcludedNot healthcare or clinical: Physical AI agents internet vision; not healthcare
387GNNVerifier: Graph-based Verifier for LLM Task Planning2026-03-16arXiv2603.14730Title/abstractExcludedNot healthcare or clinical: Task planning verifier; not healthcare
388Probe-then-Plan: Environment-Aware Planning for Industrial E-commerce Search2026-03-16arXiv2603.1526210.1145/3805712.3808459Title/abstractExcludedNot healthcare or clinical: E-commerce search; not healthcare
389A Two-Dimensional Framework for AI Agent Design Patterns: Cognitive Function and Execution Topology2026-03-16arXiv2605.13850Title/abstractExcludedNot primary research: Taxonomy of agent design patterns
390Using large language models to assist qualitative thematic analysis of student reflections on advance care planning education.2026-03-16EuropePMC10.1186/s12909-026-08851-2Title/abstractExcludedNo persistent cross-case improvement: LLM-assisted thematic analysis of student reflections; no agent loop
391Empowering Women in Academic Emergency Medicine: A Time-Efficient Workshop Incorporating Large Language Models to Enhance Leadership Skills.2026-03-16EuropePMC10.1002/aet2.70128Title/abstractExcludedNo persistent cross-case improvement: Workshop using LLMs for leadership training; no agent loop
392VIGIL: Towards Edge-Extended Agentic AI for Enterprise IT Support2026-03-17arXiv2603.16110Title/abstractExcludedNot healthcare or clinical: Enterprise IT support agents; not healthcare
393Tabular LLMs for Interpretable Few-Shot Alzheimer's Disease Prediction with Multimodal Biomedical Data2026-03-17arXiv2603.17191Title/abstractExcludedNo persistent cross-case improvement: Few-shot tabular LLM for Alzheimer prediction; no agent loop
394Kestrel: Grounding Self-Refinement for LVLM Hallucination Mitigation2026-03-17arXiv2603.16664Title/abstractExcludedNot healthcare or clinical: LVLM hallucination mitigation; generic
395Learning to Predict, Discover, and Reason in High-Cardinality Event Sequences2026-03-17arXiv2603.16313Title/abstractExcludedNot healthcare or clinical: Automotive event sequences; not healthcare
396A modular clinical thinking navigation system: an exploration in the '101 Project' diagnostics textbook reform.2026-03-18EuropePMC10.1186/s12909-026-09023-yTitle/abstractExcludedNot an LLM agent: Textbook-based clinical thinking navigation system; not LLM agent
397Blocking the Reflection: Milestones and Hurdles for Digital Twins in Mental Health.2026-03-19EuropePMC10.1055/a-2816-2869Title/abstractExcludedNot primary research: Perspective on mental health digital twins
398Deep reflective reasoning in interdependence constrained structured data extraction from clinical notes for digital health2026-03-20arXiv2603.20435Title/abstractExcludedNo persistent cross-case improvement: Iterative self-critique within one note; no persistence
399Wearable Foundation Models Should Go Beyond Static Encoders2026-03-20arXiv2603.19564Title/abstractExcludedNot primary research: Position paper on wearable foundation models
400Integration of Artificial Intelligence Into Extended Reality Debriefing in Healthcare Simulation: A Narrative Review.2026-03-20EuropePMC10.2147/amep.s578857Title/abstractExcludedNot primary research: Narrative review
401WirelessBench: A Tolerance-Aware LLM Agent Benchmark for Wireless Network Intelligence2026-03-22arXiv2603.21251Title/abstractExcludedNot healthcare or clinical: Wireless networking benchmark; not healthcare
402Anatomical Prior-Driven Framework for Autonomous Robotic Cardiac Ultrasound Standard View Acquisition2026-03-22arXiv2603.21134Title/abstractExcludedNot an LLM agent: Robotic cardiac ultrasound acquisition; not LLM agent
403ARYA: A Physics-Constrained Composable & Deterministic World Model Architecture2026-03-22arXiv2603.21340Title/abstractExcludedNot healthcare or clinical: World model architecture; not healthcare
404SOLAR: A Self-Optimizing Open-Ended Autonomous Agent for Lifelong Learning and Continual Adaptation2026-03-23arXiv2605.20189Title/abstractExcludedNot healthcare or clinical: General lifelong learning agent; medical only one eval task
405Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment2026-03-23arXiv2603.21597Title/abstractExcludedNo persistent cross-case improvement: Multi-agent dementia assessment; no persistent learning
406GSEM: Graph-based Self-Evolving Memory for Experience Augmented Clinical Reasoning2026-03-23arXiv2603.22096Already chartedIncluded (re-confirmed)han2026gsem
407Privacy-PreservingLLM Middleware in LIS: Edge-Computing for Coagulation InterpretationUnder High-Dimensional Noise2026-03-23EuropePMC10.21203/rs.3.rs-9171815/v1Title/abstractExcludedNo persistent cross-case improvement: Edge LLM RAG middleware with per-query retries; no persistence
408Large language model scoring of medical student reflection essays: Accuracy and reproducibility of prompt-model variations2026-03-24EuropePMC10.64898/2026.03.20.26348918Title/abstractExcludedNo persistent cross-case improvement: Prompt-model comparison for essay scoring; no agent loop
409A Scalable Four-Level Functional Hierarchy for Evaluating Large Language Models: Hallucination, Self-Monitoring, and the Hypothesized Structural Advantages of Arabic and Chinese2026-03-24EuropePMC10.20944/preprints202603.1858.v1Title/abstractExcludedNot primary research: Conceptual evaluation hierarchy for LLMs; not clinical system
410Multi-Agent Reasoning with Consistency Verification Improves Uncertainty Calibration in Medical MCQA2026-03-25arXiv2603.24481Title/abstractExcludedNo persistent cross-case improvement: Multi-agent verification for calibration within a question
411AnalogAgent: Self-Improving Analog Circuit Design Automation with LLM Agents2026-03-25arXiv2603.23910Title/abstractExcludedNot healthcare or clinical: Analog circuit design agent; not healthcare
412DUPLEX: Agentic Dual-System Planning via LLM-Driven Information Extraction2026-03-25arXiv2603.2390910.1109/icras70064.2026.11717896Title/abstractExcludedNot healthcare or clinical: Robot task planning; not healthcare
413SkinGPT-X: A Self-Evolving Collaborative Multi-Agent System for Transparent and Trustworthy Dermatological Diagnosis2026-03-27arXiv2603.26122Full textIncludedchen2026skingptx
414ClinicalAgents: Multi-Agent Orchestration for Clinical Decision Making with Dual-Memory2026-03-27arXiv2603.2618210.1145/3770855.3818931Already chartedIncluded (re-confirmed)clinicalagents2026
415StressWeb: A Diagnostic Benchmark for Web Agent Robustness under Realistic Interaction Variability2026-03-27arXiv2604.16385Title/abstractExcludedNot healthcare or clinical: Web agent robustness benchmark; not healthcare
416Autonomous Agent-Orchestrated Digital Twins (AADT): Leveraging the OpenClaw Framework for State Synchronization in Rare Genetic Disorders2026-03-28arXiv2603.27104Title/abstractExcludedNo persistent cross-case improvement: OpenClaw digital twin synchronization with agent skills; state updates, no learned reuse evident
417PubMed Reasoner: Dynamic Reasoning-based Retrieval for Evidence-Grounded Biomedical Question Answering2026-03-28arXiv2603.27335Title/abstractExcludedNo persistent cross-case improvement: Per-query retrieval refinement for biomedical QA; no persistence
418Harnessing Artificial Intelligence to Deliver Growth Mindset Education in a Pre-matriculation Curriculum for Incoming Medical Students.2026-03-28EuropePMC10.7759/cureus.106023Title/abstractExcludedNo persistent cross-case improvement: AI-supported growth mindset education; no agent learning loop
419EffiSkill: Agent Skill Based Automated Code Efficiency Optimization2026-03-29arXiv2603.27850Title/abstractExcludedNot healthcare or clinical: Code efficiency skills; not healthcare
420Let the Agent Steer: Closed-Loop Ranking Optimization via Influence Exchange2026-03-29arXiv2603.27765Title/abstractExcludedNot healthcare or clinical: Recommendation ranking optimization; not healthcare
421FeDMRA: Federated Incremental Learning with Dynamic Memory Replay Allocation2026-03-30arXiv2603.28455Title/abstractExcludedNot an LLM agent: Federated incremental learning with replay; not LLM agent
422MiroEval: Benchmarking Multimodal Deep Research Agents in Process and Outcome2026-03-30arXiv2603.28407Title/abstractExcludedNot healthcare or clinical: Deep research agent benchmark; not healthcare
423An Artifact-based Agent Framework for Adaptive and Reproducible Medical Image Processing2026-03-31arXiv2604.21936Title/abstractExcludedNo persistent cross-case improvement: Imaging workflow agent with static rule library and provenance; no learning
424CausalPulse: An Industrial-Grade Neurosymbolic Multi-Agent Copilot for Causal Diagnostics in Smart Manufacturing2026-03-31arXiv2603.29755Title/abstractExcludedNot healthcare or clinical: Manufacturing causal diagnostics; not healthcare
425Bias Patterns in the Application of LLMs for Clinical Decision Support: A Comprehensive Study.2026-03-31EuropePMC10.32481/djph.2026.03.10Title/abstractExcludedNo persistent cross-case improvement: Bias evaluation of static LLMs in clinical decision support
426Toward Vibe Medicine: A Self-Evolving Multi-Agent Framework for Clinical Decision Support2026-04-01arXiv2606.1550410.1016/j.metrad.2026.100223Already chartedIncluded (re-confirmed)zhang2026vibemed
427PsychAgent: An Experience-Driven Lifelong Learning Agent for Self-Evolving Psychological Counselor2026-04-01arXiv2604.00931Already chartedIncluded (re-confirmed)yang2026psychagent
428Breakdowns in Conversational AI: Interactional Failures in Emotionally and Ethically Sensitive Contexts2026-04-03arXiv2604.02713Title/abstractExcludedNo persistent cross-case improvement: Qualitative analysis of conversational AI breakdowns; no adapting system
429Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis2026-04-03arXiv2604.02678Title/abstractExcludedNo persistent cross-case improvement: Agentic trial meta-analysis pipeline; no cross-task learning
430Towards Next-Generation Healthcare: A Survey of Medical Embodied AI for Perception, Decision-Making, and Action2026-04-05arXiv2606.15647Title/abstractExcludedNot primary research: Survey of medical embodied AI
431RoboPhD: Evolving Diverse Complex Agents Under Tight Evaluation Budgets2026-04-06arXiv2604.04347Title/abstractExcludedNot healthcare or clinical: Generic agent evolution algorithms; not healthcare
432Springdrift: An Auditable Persistent Runtime for LLM Agents with Case-Based Memory, Normative Safety, and Ambient Self-Perception2026-04-06arXiv2604.04660Title/abstractExcludedNot healthcare or clinical: Generic persistent agent runtime; not healthcare
433PSY-STEP: Structuring Therapeutic Targets and Action Sequences for Proactive Counseling Dialogue Systems2026-04-06arXiv2604.04448Title/abstractExcludedNo persistent cross-case improvement: CBT counseling dataset and dialogue system; no persistent learning loop
434Enhancing LLM-based medical decision-making by test-time knowledge acquisition.2026-04-06EuropePMC10.1007/s13755-026-00449-8Full textExcludedNot an LLM agent (no tools or environment interaction, or non-LLM controller)
435EMSDialog: Synthetic Multi-person Emergency Medical Service Dialogue Generation from Electronic Patient Care Reports via Multi-LLM Agents2026-04-08arXiv2604.07549Title/abstractExcludedNo persistent cross-case improvement: Synthetic EMS dialogue generation with per-dialogue self-refinement
436Joint Optimization of Reasoning and Dual-Memory for Self-Learning Diagnostic Agent2026-04-08arXiv2604.07269Full textIncludedli2026sea
437Generate, Filter, Control, Replay: A Comprehensive Survey of Rollout Strategies for LLM Reinforcement Learning2026-04-08arXiv2605.02913Title/abstractExcludedNot primary research: Survey of rollout strategies for LLM RL
438Self-Preference Bias in Rubric-Based Evaluation of Large Language Models2026-04-08arXiv2604.06996Title/abstractExcludedNot healthcare or clinical: Judge self-preference bias; not healthcare
439Aligning Agents via Planning: A Benchmark for Trajectory-Level Reward Modeling2026-04-09arXiv2604.08178Title/abstractExcludedNot healthcare or clinical: Agent reward model benchmark; not healthcare
440Constraint-Aware Corrective Memory for Language-Based Drug Discovery Agents2026-04-10arXiv2604.09308Title/abstractExcludedNot healthcare or clinical: Drug discovery agent corrective memory; no clinical task
441NetForge RL: A Multi-Agent Simulation Environment for Cyber Defense with Durative Actions2026-04-10arXiv2604.09523Title/abstractExcludedNot healthcare or clinical: Cyber defense RL environment; not healthcare
442The Enduring Promise of Personalising Patient Preference Prediction.2026-04-10EuropePMC10.1007/s12152-026-09635-7Title/abstractExcludedNot primary research: Ethics commentary on patient preference prediction
443On simulation, artificial intelligence, and the spirit of the Shokunin.2026-04-10EuropePMC10.1186/s41077-026-00435-wTitle/abstractExcludedNot primary research: Commentary on simulation and AI
444TrajOnco: a multi-agent framework for temporal reasoning over longitudinal EHR for multi-cancer early detection2026-04-12arXiv2604.10386Title/abstractExcludedNo persistent cross-case improvement: Zero-shot multi-agent EHR reasoning; long-term memory within patient only
445VCC-DSA: A Novel Vascular Consistency Constrained DSA Imaging Model for Motion Artifact Suppression2026-04-12PubMed; arXiv2604.1070010.1016/j.media.2026.104070Title/abstractExcludedNot an LLM agent: DSA imaging model; not LLM agent
446Camyla: Scaling Autonomous Research in Medical Image Segmentation2026-04-12arXiv2604.10696Full textExcludedNo persistent cross-case improvement: Global memory re-initialized per dataset (Algorithm 1 line 8, Sec 3.4); 62 runs are 31 datasets x 2 independent runs (App 17). Also borderline F2 (research automation).
447Governed Reasoning for Institutional AI2026-04-12arXiv2604.10658Title/abstractExcludedNo persistent cross-case improvement: Governed decision framework, prior authorization examples; no learning from experience
448VERITAS: A Multi-Agent Co-Scientist for Verifiable Image-Derived Hypothesis Testing2026-04-13arXiv2604.12144Title/abstractExcludedNo persistent cross-case improvement: Multi-agent imaging hypothesis testing; no persistent learning evident
449CodeTracer: Towards Traceable Agent States2026-04-13arXiv2604.11641Title/abstractExcludedNot healthcare or clinical: Code agent tracing; not healthcare
450A Framework for Longitudinal Health AI Agents2026-04-13arXiv2604.12019Title/abstractExcludedNot primary research: Conceptual framework with use cases for longitudinal health agents; not empirical system
451QuarkMedSearch: A Long-Horizon Deep Search Agent for Exploring Medical Intelligence2026-04-14arXiv2604.12867Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
452Cross-Domain Query Translation for Network Troubleshooting: A Multi-Agent LLM Framework with Privacy Preservation and Self-Reflection2026-04-14arXiv2604.1335310.1109/eucnc/6gsummit68295.2026.11577467Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
453Evo-MedAgent: Beyond One-Shot Diagnosis with Agents That Remember, Reflect, and Improve2026-04-15arXiv2604.14475Already chartedIncluded (re-confirmed)shen2026evomedagent
454Can LLMs Accurately Score Medical Diagnoses and Clinical Reasoning?2026-04-16arXiv2604.1489210.1007/978-3-032-30710-1_44Title/abstractExcludedNot primary research: LLM jury scoring of diagnoses; evaluation study, not adapting agent.
455Benchmarks for Trajectory Safety Evaluation and Diagnosis in OpenClaw and Codex: ATBench-Claw and ATBench-Codex2026-04-16arXiv2604.14858Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
456Harnessing Pre-Resolution Signals for Future Prediction Agents2026-04-17arXiv2604.15719Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
457If Only My CGM Could Speak: A Privacy-Preserving Agent for Question Answering over Continuous Glucose Data2026-04-18arXiv2604.17133Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
458PRISM: Probing Reasoning, Instruction, and Source Memory in LLM Hallucinations2026-04-18arXiv2604.16909Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
459Towards Self-Improving Error Diagnosis in Multi-Agent Systems2026-04-19arXiv2604.17658Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
460AIT Academy: Cultivating the Complete Agent with a Confucian Three-Domain Curriculum2026-04-20arXiv2604.17989Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
461TEAM-SimHRA: A Team-Based Simulation Framework for Human Reliability Analysis Using Multi-Agent Large Language Models2026-04-21arXiv2605.23927Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
462RL-ABC: Reinforcement Learning for Accelerator Beamline Control2026-04-21arXiv2604.1914610.1016/j.cpc.2026.110407Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
463MedSkillAudit: A Domain-Specific Audit Framework for Medical Research Agent Skills2026-04-22arXiv2604.20441Title/abstractExcludedNo persistent cross-case improvement: Audit framework scoring existing agent skills; no adaptation loop.
464When Agents Look the Same: Quantifying Distillation-Induced Similarity in Tool-Use Behaviors2026-04-23arXiv2604.21255Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
465Transient Turn Injection: Exposing Stateless Multi-Turn Vulnerabilities in Large Language Models2026-04-23arXiv2604.21860Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
466Seeing the Whole Elephant: A Benchmark for Failure Attribution in LLM-based Multi-Agent Systems2026-04-24arXiv2604.22708Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
467Self-Correction as Feedback Control: Error Dynamics, Stability Thresholds, and Prompt Interventions in LLMs2026-04-24arXiv2604.22273Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
468GSAR: Typed Grounding for Hallucination Detection and Recovery in Multi-Agent LLMs2026-04-25arXiv2604.23366Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
469Green Shielding: A User-Centric Approach Towards Trustworthy AI2026-04-27arXiv2604.24700Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
470TSAssistant: A Human-in-the-Loop Agentic Framework for Automated Target Safety Assessment2026-04-27arXiv2604.23938Title/abstractExcludedNo persistent cross-case improvement: Drug target safety report agents; persistent memory stores enforce constraints, not learned from experience.
471Frontier Coding Agents Can Now Implement an AlphaZero Self-Play Machine Learning Pipeline For Connect Four That Performs Comparably to an External Solver2026-04-27arXiv2604.25067Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
472Plausible but Wrong: A case study on Agentic Failures in Astrophysical Workflows2026-04-28arXiv2604.25345Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
473Agentic Architect: An Agentic AI Framework for Architecture Design Exploration and Optimization2026-04-28arXiv2604.25083Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
474Detecting Clinical Discrepancies in Health Coaching Agents: A Dual-Stream Memory and Reconciliation Architecture2026-04-29arXiv2604.27045Title/abstractExcludedRule P1 per-patient memory only
475Performance of large language models and prompt engineering strategies for data extraction in systematic reviews.2026-04-29EuropePMC10.3389/fdgth.2026.1799623Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
476SAAG: Structured Agent Assessment and Grounding2026-04-30arXiv2607.18245Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
477Healthcare AI GYM for Medical Agents2026-05-01arXiv2605.02943Full textIncludedjeong2026healthcaregym
478Virtual Speech Therapist: A Clinician-in-the-Loop AI Agent for Speech Therapy Planning2026-05-01arXiv2605.01101Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
479Evaluating a Consumer LLM for Suicide Risk Response Calibration: A Pilot Study.2026-05-01EuropePMC10.3233/shti260331Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
480MAP-Law: Coverage-Driven Retrieval Control for Multi-Turn Legal Consultation2026-05-02arXiv2605.01486Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
481Catching the Infection Before It Spreads: Foresight-Guided Defense in Multi-Agent Systems2026-05-03arXiv2605.01758Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
482From Where Things Are to What They Are For: Benchmarking Spatial-Functional Intelligence in Multimodal LLMs2026-05-04arXiv2605.02130Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
483CASCADE: Case-Based Continual Adaptation for Large Language Models During Deployment2026-05-05arXiv2605.06702Title/abstractExcludedRule P2 healthcare not the study focus
484LATS-RCA: Language Agent Tree Search for Root Cause Analysis in Microservices2026-05-05arXiv2605.03505Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
485Device-Induced Thrombus Formation in Cerebral Aneurysms: Linking Patient-Specific Clot Modeling and Functional Occlusion to Virtual Angiographic Assessment2026-05-05arXiv2605.03536Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
486MemReranker: Reasoning-Aware Reranking for Agent Memory Retrieval2026-05-07arXiv2605.06132Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
487AI-Care: A Conversational Agentic System for Task Coordination in Alzheimer's Disease Care2026-05-08arXiv2605.08480Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
488Mirror, Mirror on the Wall: Can VLM Agents Tell Who They Are at All?2026-05-09arXiv2605.08816Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
489CodeClinic: Evaluating Automation of Coding Skills for Clinical Reasoning Agents2026-05-10arXiv2605.09675Full textIncludedossowski2026codeclinic
490MAGE: Multi-Agent Self-Evolution with Co-Evolutionary Knowledge Graphs2026-05-11arXiv2605.10064Full textExcludedHealthcare not the primary focus: General self-evolution framework on nine benchmarks; MedQA-USMLE is one domain extension and authors state it is not a clinical system (Sec 4.1, Table 2). Rule P2.
491DeepRefine: Agentic Knowledge Refinement via Reinforcement Learning2026-05-11arXiv2605.10488Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
492AnomalyClaw: A Universal Visual Anomaly Detection Agent via Tool-Grounded Refutation2026-05-11arXiv2605.10397Full textExcludedHealthcare not the primary focus: Universal anomaly detection on 12 domains (CrossDomainVAD-12, Sec 4.1); medical sources are 4 of 12 (DermaMNIST, BraTS, BMAD-Liver, HyperKvasir). Rule P2.
493Generating synthetic electronic health record data using agent-based models to evaluate machine learning robustness under mass casualty incidents2026-05-11arXiv2605.09951Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
494PrimeKG-CL: A Continual Graph Learning Benchmark on Evolving Biomedical Knowledge Graphs2026-05-11arXiv2605.10529Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
495SAGE: A Self-Evolving Agentic Graph-Memory Engine for Structure-Aware Associative Memory2026-05-12arXiv2605.12061Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
496On-Policy Self-Evolution via Failure Trajectories for Agentic Safety Alignment2026-05-12arXiv2605.11882Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
497EvolveMem:Self-Evolving Memory Architecture via AutoResearch for LLM Agents2026-05-13arXiv2605.13941Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
498SkillFlow: Flow-Driven Recursive Skill Evolution for Agentic Orchestration2026-05-13arXiv2605.14089Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
499An Agentic LLM-Based Framework for Population-Scale Mental Health Screening2026-05-13arXiv2605.13046Full textExcludedNo persistent cross-case improvement: Pipeline configuration swept once on DAIC-WOZ validation and locked (Sec IV-D, Table III); no reuse on later held-out cases reported. Borderline: tuned-workflow reading; also F3 (stage agents apply fixed rules).
500Is Agentic AI Ready for Real-World Hardware Engineering? A Deep Dive with Phoenix-bench2026-05-13arXiv2605.15226Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
501RealICU: Do LLM Agents Understand Long-Context ICU Data? A Benchmark Beyond Behavior Imitation2026-05-13arXiv2605.13542Full textExcludedNo persistent cross-case improvement: ICU-Evo memory is initialized per ICU stay and updated only within that stay (Sec 4.1, App C.3 Algorithm 2); rule P1. Baselines are within-stay context or RAG (App A.1).
502Large Language Models Lack Temporal Awareness of Medical Knowledge2026-05-13arXiv2605.13045Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
503Agentifying Patient Dynamics within LLMs through Interacting with Clinical World Model2026-05-14arXiv2605.14723Full textIncludedwu2026sepsisagent
504DermAgent: A Self-Reflective Agentic System for Dermatological Image Analysis with Multi-Tool Reasoning and Traceable Decision-Making2026-05-14arXiv2605.14403Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
505Towards In-Depth Root Cause Localization for Microservices with Multi-Agent Recursion-of-Thought2026-05-14arXiv2605.14866Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
506FuzzAgent: Multi-Agent System for End-to-End Evolutionary Library Fuzzing2026-05-14arXiv2605.14431Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
507After the Interface: Relocating Human Agency in the Age of Conversational AI2026-05-14arXiv2605.1506410.1145/3816046.3816301Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
508From Text to Voice: A Reproducible and Verifiable Framework for Evaluating Tool Calling LLM Agents2026-05-14arXiv2605.15104Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
509Accurate and Efficient Long-Term Memory for LLM Agents2026-05-15arXiv2607.16211Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
510STAR: A Stage-attributed Triage and Repair framework for RCA Agents in Microservices2026-05-15arXiv2605.15581Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
511SEMA-RAG: A Self-Evolving Multi-Agent Retrieval-Augmented Generation Framework for Medical Reasoning2026-05-16arXiv2605.17101Title/abstractExcludedNo persistent cross-case improvement: Self-evolving retrieval within a question across rounds; no persistence across cases evident.
512Representation Signatures and Risk-Feedback Alignment in LLM Trading Agents2026-05-16arXiv2605.28850Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
513Designing for Being-With: Presence Without Personhood in Conversational Human-AI Interaction2026-05-16arXiv2605.17194Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
514GraphMind: From Operational Traces to Self-Evolving Workflow Automation2026-05-17arXiv2605.17617Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
515SkillGenBench: Benchmarking Skill Generation Pipelines for LLM Agents2026-05-18arXiv2605.18693Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
516KISS - Knowledge Infrastructure for Scientific Simulation: A Scaffolding for Agentic Earth Science2026-05-18arXiv2605.17856Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
517AI-powered digital innovations in pharmaceuticals research & development: Current landscape and case examples.2026-05-18EuropePMC10.1080/10543406.2026.2670522Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
518Library Drift: Diagnosing and Fixing a Silent Failure Mode in Self-Evolving LLM Skill Libraries2026-05-19arXiv2605.19576Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
519KernelBrain: Coarse-to-Fine, Budget-Aware Search for Agentic GPU Kernel Optimization2026-05-19arXiv2608.02611Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
520What Do Evolutionary Coding Agents Evolve?2026-05-19arXiv2605.20086Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
521MedExpMem: Adapting Experience Memory for Differential Diagnosis2026-05-20arXiv2605.22872Already chartedIncluded (re-confirmed)feng2026medexpmem
522Trace2Skill: Verifier-Guided Skill Evolution for Long-Context EDA Agents2026-05-20arXiv2605.21810Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
523MemConflict: Evaluating Long-Term Memory Systems Under Memory Conflicts2026-05-20arXiv2605.20926Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
524Benchmarking Large Language Models and Prompt Engineering Strategies in Microsatellite Instability Cancers: Evaluation Study.2026-05-21EuropePMC10.2196/88614Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
525SkillEvolBench: Benchmarking the Evolution from Episodic Experience to Procedural Skills2026-05-22arXiv2605.24117Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
526Human-in-the-Loop Multi-Agent Ventilator Decision Support with Contextual Bandit Preference Learning2026-05-22arXiv2605.23320Full textIncludedli2026vdss
527Self-Evolving Agent Engineering for Healthcare: Methodologies and Applications2026-05-22EuropePMC10.20944/preprints202605.1547.v1Title/abstractExcludedNot primary research: Review of self-evolving agent engineering in healthcare; not primary research.
528SEAL: Synergistic Co-Evolution of Agents and Learning Environments2026-05-23arXiv2605.24426Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
529DemoEvolve: Demonstration-Guided Harness Evolution under Sparse Feedback2026-05-23arXiv2605.24539Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
530IterInject: Indirect Prompt Injection Against LLM Agents via Feedback-Guided Iterative Optimization2026-05-23arXiv2605.24659Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
531Eureka: Intelligent Feature Engineering for Enterprise AI Cloud Resource Demand Prediction2026-05-24arXiv2605.2529710.1007/978-981-92-0378-9_33Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
532CyberEvolver: Structured Self-Evolution for Cybersecurity Agents On the Fly2026-05-25arXiv2605.26195Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
533RepoMirage: Probing Repository Context Reasoning in Code Agents with Perturbations2026-05-25arXiv2605.26177Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
534Language-Specific Differences in Large Language Model Diagnostic Reasoning: A Translation-Controlled Clinical Vignette Study.2026-05-25EuropePMC10.3390/jcm15114082Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
535SkillGrad: Optimizing Agent Skills Like Gradient Descent2026-05-26arXiv2605.27760Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
536TCP-MCP: Landscape-Guided Co-Evolution of Prompts and Communication Topologies for Multi-Agent Systems2026-05-27arXiv2605.27850Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
537MaskClaw: Edge-Side Personalized Privacy Arbitration for GUI Agents with Behavior-Driven Skill Evolution2026-05-27arXiv2605.28646Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
538Digital Registrar: A Schema-First Framework for Multi-Cancer Privacy-Preserving Pathology Abstraction via Local LLMs.2026-05-27EuropePMC10.3390/diagnostics16111644Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
539BenchTrace: A Benchmark for Testing Reflection Ability and Controlled Evolution in LLM Agents2026-05-28arXiv2605.29225Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
540GRASP: Gated Regression-Aware Skill Proposer for Self-Improving LLM Agents2026-05-28arXiv2605.29668Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
541Specialize Roles, Mix Deployments: Pushing the Cost-Accuracy Frontier of LLM Agent Teams2026-05-28arXiv2606.20629Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
542WorldMemArena: Evaluating Multimodal Agent Memory Through Action-World Interaction2026-05-28arXiv2605.29341Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
543LLM-ALSO: LLM-Driven Adaptive Learning-Signal Optimization for Multi-Agent Reinforcement Learning2026-05-28arXiv2605.29293Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
544Honest Lying: Understanding Memory Confabulation in Reflexive Agents2026-05-28arXiv2605.29463Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
545AgentOdyssey: Open-Ended Long-Horizon Text Game Generation for Test-Time Continual Learning Agents2026-05-29arXiv2606.24893Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
546What Drives LLM Self-Reflection? A Controlled Ablation of Uncertainty Routing in Armed Conflict Forecasting2026-05-29arXiv2608.12322Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
547VIABLE: A Visually Impaired Assistance Benchmark for VLM-as-a-Judge Evaluation2026-05-29arXiv2605.31351Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
548Verifier-First Evaluation of Agentic LLMs for Infrastructure-as-Code Generation2026-05-29arXiv2607.20478Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
549EGOSTREAM: A Diagnostic Benchmark for Streaming Episodic Memory in Egocentric Vision2026-05-29arXiv2605.31557Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
550Teaching Personalized Doctor-Patient Communication with AI: PerTRAIN - a Prototype for Interpersonally Responsive Virtual Patients in Medical Education.2026-05-29EuropePMC10.5334/pme.2379Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
551ANDES: Agent Native Data Evolving Synthesis Tool for Autonomous Instruction Alignment2026-05-31arXiv2606.01279Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
552DrugClaw and DrugAudit: A Primary-Source-Grounded Agent and Authority-Aware Benchmark for Drug-Information Question Answering2026-05-31arXiv2606.01434Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
553Traj-Evolve: A Self-Evolving Multi-Agent System for Patient Trajectory Modeling in Lung Cancer Early Detection2026-06-01arXiv2606.02812Full textIncludedzeng2026trajevolve
554ClinicalMC: A Benchmark for Multi-Course Clinical Decision-Making with Large Language Models2026-06-02arXiv2606.03157Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
555EvoTrainer: Co-Evolving LLM Policies and Training Harnesses for Autonomous Agentic Reinforcement Learning2026-06-02arXiv2606.03108Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
556The Saturation Trap and the Subjectivity of Intervention Timing: Why Affect-Based Triggers and LLM Judges Fail to Time Interventions on Autonomous Agents2026-06-02arXiv2606.04296Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
557Deliberate Evolution: Agentic Reasoning for Sample-Efficient Symbolic Regression with LLMs2026-06-03arXiv2606.04360Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
558Policy-Conditioned Counterfactual Credit for Verifiable Reinforcement Learning of Long-Horizon Language Agents2026-06-03arXiv2606.05263Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
559From Failed Trajectories to Reliable LLM Agents: Diagnosing and Repairing Harness Flaws2026-06-04arXiv2606.06324Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
560Elmes*: Automated Construction of Fine-Grained Evaluation Rubrics for Large Language Models in Long-Tail Educational Scenarios2026-06-04arXiv2606.06546Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
561SubtleMemory: A Benchmark for Fine-Grained Relational Memory Discrimination in Long-Horizon AI Agents2026-06-04arXiv2606.05761Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
562MADE: Beyond Scoring via a Multilingual Agentic Diagnosing Engine for Fine-Grained Evaluation Insights2026-06-05arXiv2606.07020Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
563SSR: Can Simulated Patients Learn to Stigmatize Themselves? Modeling Self-Stigma through Internal Monologue2026-06-06arXiv2606.08254Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
564Mitigating hallucinations in healthcare AI: a systematic review of evidence-based strategies.2026-06-06EuropePMC10.1186/s12913-026-14851-1Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
565Experience Makes Skillful: Enabling Generalizable Medical Agent Reasoning via Self-Evolving Skill Memory2026-06-08arXiv2606.09365Already chartedIncluded (re-confirmed)sun2026skemex
566Multi-Turn Evaluation of Deep Research Agents Under Process-Level Feedback2026-06-08arXiv2606.09748Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
567LargeMonitor: Monitoring Online Task-Free Continual Learning via Large Pretrained Models2026-06-08arXiv2606.09430Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
568Complexity synchronization as a diagnostic and control principle for adaptive systems2026-06-09arXiv2606.10948Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
569HERO: Hindsight-Enhanced Reflection from Environment Observations for Agentic Self-Distillation2026-06-10arXiv2606.11559Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
570Arbor: Tree Search as a Cognition Layer for Autonomous Agents2026-06-10arXiv2606.12563Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
571Embodied-BenchClaw: An Autonomous Multi-Agent System for Embodied Spatial Intelligence Benchmark Construction2026-06-10arXiv2606.11909Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
572LatentDx: Latent Multi-Agent Communication for Cross-Hospital Rare-Disease Diagnosis2026-06-11arXiv2606.13945Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
573The Containment Gap: How Deployed Agentic AI Frameworks Fail Public-Facing Safety Requirements2026-06-11arXiv2606.12797Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
574Reasoning for Mobile User Experience with Multimodal LLMs: Task, Benchmark, and Approach2026-06-11arXiv2606.13192Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
575Augmenting large language models with clinical knowledge graph for personalized perioperative fluid therapy question answering.2026-06-11EuropePMC10.1371/journal.pdig.0001474Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
576Experience-Sensitive Game Learning: A Behavioral Study of Humans and Language Agents2026-06-15arXiv2608.07490Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
577MemSlides: A Hierarchical Memory Driven Agent Framework for Personalized Slide Generation with Multi-turn Local Revision2026-06-15arXiv2606.17162Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
578SEAGym: An Evaluation Environment for Self-Evolving LLM Agents2026-06-16arXiv2606.17546Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
579RubricsTree: Scalable and Evolving Open-Ended Evaluation of Personal Health Agents across Health Memory and Medical Skills2026-06-16arXiv2606.18203Title/abstractExcludedNot primary research: Evaluation rubric framework for health agents; evaluator evolves, not the agents; used as reward.
580Talking to Your Data: Exploring Embodied Conversation as an Interface for Personal Health Reflection2026-06-16arXiv2606.17767Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
581RTSGameBench: An RTS Benchmark for Strategic Reasoning by Vision-Language Models2026-06-17arXiv2606.18950Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
582EmoPatient: An Emotion-Directed Patient Simulator for Realistic Palliative Care Communication Training2026-06-17arXiv2608.07495Title/abstractExcludedNo persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning.
583AgenticDB: Self-Evolving Reconfiguration Framework for Database Workloads2026-06-18arXiv2606.20318Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
584Empowering Polymeric Materials Discovery by Artificial Intelligence2026-06-18arXiv2606.20753Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
585Automating SKILL.md Generation for Computer-Using Agents via Interaction Trajectory Mining2026-06-18arXiv2606.20363Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
586ARTEMIS: Agent-guided Reliability-aware Temporal Mask Evolution for Imperfectly Supervised Video Polyp Segmentation2026-06-18arXiv2606.20161Title/abstractExcludedNo persistent cross-case improvement: Debate VLM agent selects anchors within video; no cross-case retention evident.
587Measuring What Persists: Conditioning Mechanisms and a Geometric Framework for AI Agent Identity2026-06-20arXiv2606.21843Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
588Hypothesis-Driven Skill Optimization for LLM Agents2026-06-21arXiv2606.22330Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
589Evo-RAD: Navigating Rare Retinal Disease Diagnosis via Self-Evolving Agentic Retrieval2026-06-22arXiv2606.22955Full textExcludedNot an LLM agent: Sec 2.1-2.3: the retrieval agent is a 2-layer GCN policy trained by GRPO and diagnosis is majority vote; an LLM only expands label tags. Published MICCAI 2026 (LNCS).
590EHR-Complex: Benchmarking Medical Agents for Complex Clinical Reasoning2026-06-22arXiv2606.23301Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
591Self-Evolution for Multi-Turn Tool-Calling Agents via Divergence-Point Preference Learning2026-06-22arXiv2606.23112Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
592Density-dependent growth emerges from Bayesian adaptation of phenotype2026-06-24arXiv2606.25918Title/abstractExcludedNot an LLM agent: Not an LLM-based agent system.
593Evidence-Driven LLM Agent for C-to-Synthesizable-C Conversion and Verification2026-06-25arXiv2606.28409Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
594GenWorld: Empirically Grounded Urban Simulation Infrastructure for Scalable LLM-Agent Studies2026-06-26arXiv2606.27650Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
595An Agentic AI Pipeline for Appliance-Level Energy Anomaly Detection and LLM-Driven Recommendations2026-06-26arXiv2606.28467Title/abstractExcludedNot healthcare or clinical: Not a healthcare or clinical application.
596Artificial Intelligence, Cognitive Abundance, and the Multi-Layered Competence of Health Professionals.2026-06-26EuropePMC10.1097/ceh.0000000000000656Title/abstractExcludedNot primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt.
597An AI agent for treatment reasoning over a biomedical tool universe2026-06-27arXiv2606.28692Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
598MedEvoEval: Evaluating Continual Evolution of Doctor Agents through Simulated Clinical Episodes2026-06-27arXiv2606.28900Full textIncludedzhang2026medevoeval
599How much of an LLM-generated clinical corpus is actually new? A production-scale measurement of content redundancy for provenance classification2026-06-28arXiv2606.29605Title/abstractExcludedNo persistent cross-case improvement: Measures redundancy of LLM-generated clinical corpus; no agent improvement loop.
600CLQT: A Closed-Loop, Cost-Aware, Strategy-Consistent Benchmark for Diagnostic Evaluation of LLM Portfolio-Management Agents2026-06-29arXiv2606.29771Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
601SEVA: Self-Evolving Verification Agent with Process Reward for Fact Attribution2026-06-29arXiv2606.29713Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
602TopoAgent: An Agentic Framework for Automated Topology Learning in Medical Imaging2026-06-29arXiv2606.29763Full textIncludedmeng2026topoagent
603One Reflection Is Not Enough: Self-Correcting Autonomous Research via Multi-Hypothesis Failure Attribution2026-06-30arXiv2606.31478Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
604Counterexamples as Feedback for Agent Self-Correction2026-07-01arXiv2609.02892Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
605Evaluating Agentic Harness Systems for Autonomous Computational Pathology2026-07-01arXiv2607.02598Title/abstractExcludedNot primary research: Benchmark of existing pathology harnesses; systems do not adapt.
606Adversarial Pragmatics for AI Safety Evaluation: A Diagnostic Framework and Seed Benchmark for Language-Mediated Control2026-07-01arXiv2607.01153Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
607Behavior-Adaptive Conversational Agents: Toward a Fluid Personality Framework2026-07-01arXiv2607.01034Title/abstractExcludedNot primary research: Conceptual framework sketch for adaptive persona; no evaluated system.
608KRCA: An Efficient Root Cause Analysis System in Hyper-scale Microservice Systems via Agentic AI2026-07-02arXiv2607.01788Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
609Benchmarking Motivational Interviewing Competence of Large Language Models.2026-07-04EuropePMC10.1159/000553455Title/abstractExcludedNot primary research: Benchmark of LLM motivational interviewing competence; no agent.
610Measuring Harness-Induced Belief Divergence in Multi-Step LLM Agents2026-07-05arXiv2607.04528Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
611EvoAgentBench: Benchmarking Agent Self-Evolution via Ability Transfer2026-07-06arXiv2607.05202Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
612Structured Large Language Model Workflows for Motivational Interviewing in Health Behavior Change: Proof-of-Concept Study.2026-07-06EuropePMC10.2196/94036Title/abstractExcludedNo persistent cross-case improvement: Structured-workflow MI coaching agent; no persistent learning across users.
613AgentTether: Graph-Guided Diagnosis and Runtime Intervention for Reliable LLM Agent Operation2026-07-07arXiv2607.06273Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
614LLM Agents for Deliberative Collaboration: A Study on Joint Decision Making Under Partial Observability2026-07-07arXiv2607.06157Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
615Diagnosing Semantic Handoff Failures in Agent-Orchestrated Vision-Language-Action Skill Composition2026-07-07arXiv2607.06256Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
616Cost-Effective Agent Harnesses for Abstract Reasoning and Generalization on ARC-AGI-12026-07-07arXiv2607.06764Title/abstractExcludedNot healthcare or clinical: Persona dialogue emotion modelling; healthcare only a listed use.
617From Triggers to Emotions: A CPM-Grounded Appraisal Multi-Agent for Dynamic Emotional Evolution in Persona-Based Dialogue2026-07-08arXiv2607.07824Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
618Self-Adaptive Anomaly Detection with Reinforcement Learning and Human Feedback in Connected Vehicles2026-07-09arXiv2607.08373Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
619Cerebro Tune: A novel Bio-Inspired Hybrid Metaheuristic for Hyperparameter Optimizations in Deep Learning Using Cellular Automata and Reinforcement Learning2026-07-09EuropePMC10.21203/rs.3.rs-10103501/v1Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
620LongMedBench: Benchmarking Medical Agents for Long-Horizon Clinical Decision-Making2026-07-10arXiv2607.09322Full textExcludedNot primary research: Benchmark paper; evaluated long-context, RAG and Mem0 systems only hold each patient's own visit history and do not adapt across patients (Sec 2.1, 3.1); P1 also applies.
621SAGEAgent: A Self-Evolving Agent for Cost-Aware Modality Acquisition in Multimodal Survival Prediction2026-07-10arXiv2607.09521Full textIncludedqu2026sageagent
622All Explanations are Wrong, But Many Are Useful: Exploring the Rashomon Explanation Set with Large Language Models2026-07-10arXiv2607.09502Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
623Q-Learning Lab: Teaching Reinforcement Learning Through Learner-Generated Trace Analysis2026-07-12arXiv2607.10802Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
624The Path to Self-Evolving Clinical Systems: Scaling Medical Agents from Assistance to Autonomy2026-07-13arXiv2607.11175Title/abstractExcludedNot primary research: Survey of medical agents.
625OpsMem: Dual-Memory Reasoning with Cross-Memory Resonance for Failure Diagnosis2026-07-13arXiv2607.11357Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
626NextFund: A Unified Performance Tracking Platform for Agentic Portfolio Management2026-07-13arXiv2607.11141Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
627Human AI Construction of Bayesian Networks for Operational Decision Support -- A Virtual Survey Approach2026-07-13arXiv2607.14141Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
628AutoMem: A Text-Gradient Recursive Self-Improvement Framework for Automated Memory Architectures Search2026-07-14arXiv2608.14621Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
629MemOps: Benchmarking Lifecycle Memory Operations in Long-Horizon Conversations2026-07-14arXiv2607.12893Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
630HarnessBank: Semantic Gene-Bank Search with Gated Verification for Agent-Harness Self-Evolution2026-07-15arXiv2607.13683Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
631Cura 1T: Healthcare Foundation Model via Recursive Self-Improvement2026-07-15arXiv2607.15314Full textIncludedchen2026cura
632A Self-Evolving Agent for Longitudinal Personal Health Management2026-07-15arXiv2607.13940Already chartedIncluded (re-confirmed)li2026healthclaw
633One-for-All Adaptive Radiotherapy Planning Agent: A Foundation Framework for Daily CBCT-guided Radiotherapy2026-07-16arXiv2607.14870Title/abstractExcludedNo persistent cross-case improvement: Radiotherapy planning foundation-model agent; no cross-case learning described.
634OmniaBench: Benchmarking General AI Agents Across Diverse Scenarios2026-07-16arXiv2607.14989Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
635SCITUS: A Multi-Jurisdictional Framework for Adapting NIST AI RMF to the Canadian Regulatory Context2026-07-16arXiv2607.15051Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
6363D Geometric Tooth Alignment Planning via Deep Reinforcement Learning2026-07-16arXiv2607.14544Title/abstractExcludedNot an LLM agent: DRL tooth alignment, no LLM.
637Fantastic Adaptive Taxonomies and How to Use Them2026-07-17arXiv2607.16387Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
638Review: Techniques in Egocentric Multi-View Image Analysis: Advances, Challenges, and Future Directions.2026-07-17EuropePMC10.3390/jimaging12070324Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
639PERA: A Perceive-Reason-Act Interface Bridging Sensing, Cognitive Reasoning, and Trustworthy Agentic Response for 6G2026-07-18arXiv2607.16896Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
640Enhancing Personalized Bladder Cancer Treatment Through Reinforcement Learning: A Recurrent Patient State Transition Decision Support Framework2026-07-18arXiv2607.16916Title/abstractExcludedNot an LLM agent: DQN bladder cancer treatment simulation, no LLM.
641Evolving Self-Organising Agents Without Fitness: Three Falsifiable Experiments from Constraint-Driven Selection to Developmental Encoding2026-07-18arXiv2607.2163010.1145/3795101.3814687Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
642Can Motivational Interviewing be delivered using Artificial Intelligence chatbots? Evaluating the capability of GPT-4o.2026-07-18EuropePMC10.1016/j.pec.2026.109782Title/abstractExcludedNot an LLM agent: GPT-4o chatbot evaluation for MI; not an agent, no learning.
643SR-Agent: An Experience-Driven Agentic Framework for Post-Ranking Strategy Refinement in E-Commerce Recommendation2026-07-20arXiv2607.17719Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
644LLMs and Agentic AI Systems for Smart Grids: A Tutorial on Architectures and Applications2026-07-20arXiv2607.18147Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
645Oracle Gap and Signal Fidelity: A Fixed-Pool Diagnostic for Test-Time Collaboration2026-07-20arXiv2607.17531Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
646jina-reranker-v3.5: An Efficient Listwise Reranker with Hybrid Attention and Self-Distillation2026-07-20arXiv2607.18152Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
647Verifiable Self-Evolution for Open-Ended Dialogue Skills via Future-Feedback Prediction2026-07-21arXiv2607.18973Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
648AgentDebugX: An Open-Source Toolkit for Failure Observability, Attribution, and Recovery in LLM Agents2026-07-21arXiv2607.18754Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
649TOUR: A Trajectory-Level Unlearning Benchmark for Offline Reinforcement Learning2026-07-23arXiv2607.21111Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
650AgentOmnia: Scaling Agentic Models for Full-Scenario Applications2026-07-25arXiv2607.23124Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
651MulRobBench: A Decision-Level Benchmark for Safe and Security-Policy-Compliant Multimodal UAV Agents2026-07-26arXiv2607.23870Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
652Falsifiable Commitment Planning for Self-Correcting Web Agents2026-07-27arXiv2607.24167Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
653Keep It InMind: Benchmarking the Implicit-Association Blind Spot in Agent Memory2026-07-27arXiv2607.24368Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
654PatientAgentBench: A Benchmark Framework for Evaluating Patient-Facing Health AI Agents2026-07-28arXiv2607.25485Title/abstractExcludedNot primary research: Benchmark of patient-facing agents; systems do not adapt.
655SkillMentor: LLM Agent Self-Evolution via Learning Blind-Spot Diagnosis2026-07-29arXiv2607.27360Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
656Leveraging Trajectory Graphs for Pre-Execution Error Diagnosis in Agentic LLM Systems2026-07-29arXiv2607.27443Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
657Rethinking AI in Medical Imaging: Assumptions, Reality, and Reframing; Towards Physician-Centered Agentic Reasoning2026-07-29arXiv2607.27428Title/abstractExcludedNot primary research: Position paper on medical imaging AI.
658VeriSkill: A Self-Evolution Framework for Program Verification Skills2026-07-30arXiv2607.27733Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
659Reflection or Re-Generation? Why LLM Revision Fails Where Human Revision Succeeds2026-07-31arXiv2607.28908Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
660AgentHPOBench: A Benchmark For Evaluating LLM Agents as Sequential Hyperparameter Optimizers2026-07-31arXiv2607.29626Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
661Alignment Is Local: A Paired Diagnostic for GUI Agents under User-Side Persuasion2026-07-31arXiv2607.29199Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
662The Multi-Lab Enterprise: Governance, FinOps, and Telemetry Challenges of Multi-Model AI Adoption2026-07-31arXiv2609.31622Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
663TrajWiki: Source-Grounded Memory Trajectories for Long-Horizon Dialogue Agents2026-08-02arXiv2608.00967Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
664EntailLLM: Verifying Agent-Generated Vulnerability Discovery Paths with Domain Knowledge via Logic Programming2026-08-03arXiv2608.01763Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
665GDPevo: Evaluating Agent Self-Evolution on Real Business Tasks2026-08-04arXiv2608.03764Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
666DiagChain: A Diagnostic Benchmark for Evaluating LLM Agents on Evidence-Grounded Attack Chain Reconstruction2026-08-04arXiv2608.03591Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
667TumorBoard: Evidence-Grounded Multi-Agent Decision Support for Longitudinal Neuro-Oncology2026-08-04arXiv2608.03190Title/abstractExcludedNo persistent cross-case improvement: Multi-agent neuro-oncology decision support; per-case state only.
668DP-MemView: A Memory Interface for Attribute-Level Transcript Privacy in Long-Term LLM Agents2026-08-04arXiv2608.03130Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
669PAST-Bench: Benchmarking the Foundations of Recursive Self-Improvement in Personal Agents2026-08-04arXiv2608.04003Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
670A-SR: Self-Evolving Agentic LLMs for Symbolic Regression via Hierarchical Coordination2026-08-05arXiv2608.04872Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
671Agentic Reinforcement Learning with Observation-Calibrated Self-Distillation2026-08-05arXiv2608.04788Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
672SkillHEX: Improving Agent Skills via Hypothesis-Driven Autonomous Exploration and Exploitation2026-08-06arXiv2608.05628Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
673SkillTFM: Gated Skill Evolution for Training-Free Adaptation of Tabular Foundation Models2026-08-06arXiv2608.06137Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
674Controlled Memory Interference in Continual LLM Agents2026-08-07arXiv2608.07622Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
675An Agentic AI Framework Overcomes Fundamental Limitations of Large Language Models for Glaucoma Detection from Fundus Photography2026-08-07arXiv2608.07651Title/abstractExcludedNo persistent cross-case improvement: Glaucoma agentic workflow with single-case reflection; no persistence.
676Gated-BEPO: Confidence-Gated Bellman Credit Assignment for Large Language Model Agents2026-08-07arXiv2608.06861Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
677EMAS: Stabilizing Multi-Agent System Evolution through Evidence-Guided Revision2026-08-07arXiv2608.07196Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
678Lingjing: A Simulation Testbed for Multi-Agent Embodied Tasks in Open-Ended Cities2026-08-08arXiv2608.08045Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
679SkillSmith: Enhancing Locally Deployed Agents via Automatic Skill Construction and Evolution2026-08-08arXiv2608.08037Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
680Branch2Skill: Efficient Skill Evolution Through Reasoning Trees2026-08-09arXiv2608.08677Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
681An Agentic Generative Large Language Model for Treatment Planning of Colorectal Cancer2026-08-10arXiv2608.09142Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
682SiriusDeliver: Automating Data Warehouse Delivery at Tencent2026-08-10arXiv2608.09185Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
683SpecPath: Testing Coding Agents Across Contract-Equivalent Specification Histories2026-08-10arXiv2608.09799Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
684STAIR: Effective Incident Response Using an End-to-End Agentic Planning Framework2026-08-10arXiv2608.09524Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
685MIRA: Medical Image Reflection for Agentic Diagnosis2026-08-11arXiv2608.10827Full textIncludedwang2026mira
686ComBodied Agents: a New Paradigm of Human-Centric Agentic AI2026-08-11arXiv2608.10915Title/abstractExcludedNot primary research: Position/paradigm paper on human-centric agents.
687BioKG Explorer: Interactive Visual Analytics for Biomedical Knowledge Graph Exploration over PrimeKG2026-08-11EuropePMC10.21203/rs.3.rs-10004105/v2Title/abstractExcludedNot an LLM agent: Visual analytics tool for biomedical knowledge graph; no agent loop.
688Diagnosis Before Recovery: Turning Agent Failures into Selective Self-Correction2026-08-12arXiv2608.11772Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
689CAKE: Compiler-Agent Co-Design for Frontier Kernel Evolution2026-08-12arXiv2608.12629Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
690Large Language Models for Mental Health Prediction: Scoping Review of Bias and Clinical Utility Documentation in 2019-2024.2026-08-13EuropePMC10.2196/88082Title/abstractExcludedNot primary research: Scoping review.
691PACE-Bench: Benchmarking Physics Adaptation via Code Evolution in Dynamic Environments2026-08-14arXiv2608.14441Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
692BaT: Towards Self-Evolving Medical Research Agent with Stage Rubrics2026-08-17arXiv2608.16211Full textIncludedliu2026bat
693HarnessEval-W: Agentifying the Evaluation of Visual Worlds2026-08-17arXiv2608.16859Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
694Bounded Recursive Self-Improvement Under Human Governance: Evidence from a Seven-Cycle Reinforcement Learning Contour Experiment2026-08-17EuropePMC10.20944/preprints202608.0975.v2Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
695D$^2$ACCI: A Dual-Loop Diagnostic Protocol for Evidence-Preserving Agent Memory2026-08-18arXiv2608.17756Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
696Adaptive Memory and Reflection Multi-Agent System for Medical Question Answering2026-08-19arXiv2608.19029Full textIncludedmurugesan2026amr
697EVADE: Evidence-Verified Agentic Diagnosis with Escape2026-08-19arXiv2608.18833Title/abstractExcludedNo persistent cross-case improvement: Training-free single-case zoom and verification for VLM diagnosis.
698Competence, Not Accuracy: A Diagnostic for Reference-Free Judge Gates in Skill Optimization2026-08-19arXiv2608.18719Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
699MileGPO: Milestone Inference with Local Evidence for Graph-Based Policy Optimization of Long-Horizon LLM Agents2026-08-20arXiv2608.19803Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
700Sparse Multi-Stage Expert-Agent Routing for Complex Clinical Reasoning2026-08-22arXiv2608.21948Title/abstractExcludedNo persistent cross-case improvement: Clinical multi-agent routing; memory only across stages within a case.
701MSM-Mem: A Universal Medical Structured Multimodal Memory Framework for Medical AI Agents2026-08-22arXiv2608.2181010.48550/arxiv.1905.02269Full textExcludedNo persistent cross-case improvement: P1: episodic and visual retrieval is filtered by patient_id and semantic memory is per-patient, so memory is reused only for the same patient (App A.1.1(e)-(f)).
702GUI-Primitives: Diagnosing Spatial Reasoning Failures in Vision-Language GUI Grounding2026-08-22arXiv2608.21832Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
703MediSkill-Evo: Process-Constrained Self-Evolution for Evidence-Grounded Clinical Interaction2026-08-24arXiv2608.23397Full textIncludedwu2026mediskillevo
704A Source-Grounded Framework for Constructing and Evaluating Progressive Multimodal Diagnostic Dialogues from Clinical Case Reports2026-08-24arXiv2608.22713Title/abstractExcludedNot primary research: Benchmark construction from case reports; no adaptive system.
705CDEG: Learning Decision-Critical Evidence for Long-Horizon Diagnostic Agents2026-08-24arXiv2608.22899Full textIncludeddai2026cdeg
706AutoSaddler: Automatic Harness Optimization with Durable Updates from Agent Execution Traces2026-08-24arXiv2608.23041Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
707Resilience Matters for Embodied Agents System: New Metrics, Systematic Evaluation, and Optimization2026-08-24arXiv2608.23839Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
708EviDx: Evidence-Aware Active Diagnosis with Scaffolded LLM Agents2026-08-25arXiv2608.24570Title/abstractExcludedNo persistent cross-case improvement: Active diagnosis scaffold; per-case evidence states only.
709RecurSE: Bounded Recursive Self-Evaluation for LLM Rubric Judges2026-08-25arXiv2608.24231Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
710Reflection- and Curriculum-Based Instruction Tuning for Diabetes-Specialized Large Language Models: Model Development and Evaluation Study.2026-08-25EuropePMC10.2196/92843Title/abstractExcludedNot an LLM agent: Instruction-tuned diabetes LLM; one-off fine-tuning, not an agent.
711From General Agents to RCA Experts: A Self-Evolving Harness for Root Cause Analysis2026-08-26arXiv2608.25661Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
712VISA: Agentic Self-Evolving Data Synthesis for Multimodal Instruction Following2026-08-26arXiv2608.26013Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
713A Practical Guide to Becoming a Clinical Problem Solving Discussant.2026-08-26EuropePMC10.1007/s11606-026-10699-7Title/abstractExcludedNot primary research: Practical guide for clinicians; not research system.
714ORDDAR: Observation-Driven Reasoning for Distortion-Resilient Decision, Action, and Cognitive Recovery2026-08-27arXiv2608.28704Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
715From Atomic to Agentic: Towards Interpretable Evaluation of LLMs' Agentic Mathematical Capabilities2026-08-27arXiv2608.26950Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
716EvoUndo: Recoverability-Constrained Self-Evolution for LLM Agent Harnesses2026-08-28arXiv2608.28363Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
717openJiuwen: Beyond Static Harnesses for Long-Horizon Coding Agents2026-08-28arXiv2608.27969Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
718Pandora’s Toolbox: A Survey of Generalist Agent Security from the Lifecycle Perspective2026-08-28EuropePMC10.20944/preprints202608.2066.v1Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
719MedCache: Efficient and Temporally Valid Memory for Longitudinal Clinical Agents2026-08-30arXiv2608.29528Title/abstractExcludedRule P1 per-patient memory only
720DataFoundry: Evolving Data Preparators via Recursive Self-Improvement2026-08-30arXiv2608.29966Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
721Understanding Stage-Wise Utility-Risk Trade-offs in LLM Agent Memory2026-08-31arXiv2608.30177Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
722ATLAS: Dual-Horizon Diagnostic Evaluation for Tool-Use Agents in Meituan Xiaotua2026-08-31arXiv2608.30685Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
723S3C-LLM: Skill-Code Guided Agentic Language Models for Spectrum-to-Structure Elucidation2026-08-31arXiv2608.30910Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
724UTILMEM: Benchmarking Evidence Utilization in Long-Term Conversational Memory2026-08-31arXiv2608.30508Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
725RingMoClaw: An Experience-Inspired Multi-Agent Framework for Self-Evolving Research in Remote Sensing2026-09-01arXiv2609.00814Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
726Jailbreaking Text-to-Image Models Through Cracks: Navigating Heterogeneous Safety Filters via Multi-Agent Debate2026-09-01arXiv2609.01168Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
727Reveree: Diagnosing LLM Reverse-Engineering Agents2026-09-01arXiv2609.01185Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
728Embodied artificial intelligence in robotic orthopaedic surgery: from intelligent assistance to adaptive surgical autonomy.2026-09-01EuropePMC10.1007/s11701-026-03913-5Title/abstractExcludedNot primary research: Narrative review of embodied AI in orthopaedic surgery.
729Accountable AI with Grounded, Faithful, Consistent, Actionable Rationales: A Case Study in Clinical Trial Matching with VERDICT2026-09-03arXiv2609.03366Title/abstractExcludedNo persistent cross-case improvement: Clinical trial matching accountability case study; no cross-case learning.
730AI models as consciousness attributors: how LLMs ascribe consciousness to other agents.2026-09-03EuropePMC10.3389/fpsyg.2026.1926286Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
731A Structured Debate-Mixture-of-Agents Framework for Complex Clinical Diagnostic Decision Support2026-09-04arXiv2609.05069Title/abstractExcludedNo persistent cross-case improvement: Debate multi-agent diagnosis; adaptation within single case only.
732Interchangeable in Role, Not in History: Replacing Members of Formed LLM Teams2026-09-04arXiv2609.05279Title/abstractExcludedRule P2 healthcare not the study focus
733ViT3Flow: A Test-Time Training Transformer MeanFlow for Postoperative Radiograph Synthesis in Scoliosis2026-09-04arXiv2609.05579Title/abstractExcludedNot an LLM agent: Radiograph synthesis model, not LLM agent.
734Closing the Consistency Gap: Self-Evolving Agents That Learn to Stay on Course2026-09-08arXiv2609.08832Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
735Evaluating the Teaching Effectiveness of Interactive Virtual Platform Based on Artificial Intelligence for Obstetrics and Gynecology Residency Training.2026-09-09EuropePMC10.2147/amep.s634648Title/abstractExcludedNo persistent cross-case improvement: AI virtual teaching platform for OB/GYN residents; no agent improvement loop.
736AlamX: A Privacy-Preserving Local AI Framework for Symptom-Based Disease Prediction and Conversational Clinical Triage2026-09-09EuropePMC10.21203/rs.3.rs-10960720/v1Title/abstractExcludedNot an LLM agent: Local ML symptom triage; not LLM agent learning.
737A comparative evaluation of LLM-generated and clinician-written psychotherapy session summaries.2026-09-09EuropePMC10.1080/10503307.2026.2729093Title/abstractExcludedNot an LLM agent: Evaluation of LLM psychotherapy summaries; no agent or learning.
738Asclepius: An Adaptive Harness for Long-Horizon Clinical Agents2026-09-11arXiv2609.13543Already chartedIncluded (re-confirmed)yuan2026asclepius
739MedRoundsQA: A Persona and Difficulty Aware Evaluation for Multi-Turn Medical Consultations2026-09-11arXiv2609.12851Title/abstractExcludedNot primary research: Multi-turn medical consultation benchmark; systems do not adapt.
740ParaRecover: A Process-Level Benchmark for Error Localization and Recovery in Parallel Tool-Use Agents2026-09-11arXiv2609.12345Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
741PiMiX 2.02: Toward AI-Driven Data Fusion in Radiographic Imaging and Tomography2026-09-11arXiv2609.13347Title/abstractExcludedNot an LLM agent: Imaging data fusion instrument, not LLM agent.
742HarnessBandit: Joint Learnability-Transferability Scheduling for Multi-Harness Agentic Reinforcement Learning2026-09-12arXiv2609.13739Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
743EMR: Self-Evolving Medical Multi-Agent System via Experience Mining and Reuse2026-09-14arXiv2609.15161Already chartedIncluded (re-confirmed)shi2026emr
744Mapping U.S. Federal AI Governance Against Sector Vulnerability2026-09-14arXiv2609.16260Title/abstractExcludedNot healthcare or clinical: Not healthcare or clinical application.
745CLEAR: Cross-Source Evidence Adjudication for Large Language Models in Medicine2026-09-14arXiv2609.16301Title/abstractExcludedNo persistent cross-case improvement: Cross-source evidence adjudication per query; static retrieval.
746AnchorGUI: Asymmetric Memory for Dual-Scale Learning in GUI Navigation2026-09-14arXiv2609.1545710.1007/978-3-032-37447-9_6Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
747AURA: Agentic Diagnosis and Refinement for Production Recommender Systems at Scale2026-09-15arXiv2609.16625Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
748DriveMCP: An Agentic AI framework for Advanced Driver Assistance System2026-09-15arXiv2609.17247Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
749Agentic Image Restoration Links Closed-Loop Controllers with Protocol-Aware Evaluation2026-09-15EuropePMC10.20944/preprints202609.1256.v1Title/abstractExcludedNot primary research: Review/perspective of agentic image restoration.
750Recursive Reasoning or Statistical Extrapolation? In-Context Learning in Multi-Agent Interdependent Decision-Making2026-09-16arXiv2609.18591Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
751Where Should Agents Live? Energy-Memory Characterization of Agentic AI for the Edge-Cloud Continuum2026-09-16arXiv2609.18283Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
752MAGMA-GEN: Validated Recovery Supervision from Ambiguous Failures via Counterfactual Re-Execution2026-09-17arXiv2609.20056Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
753LearnActCoder: Role-Aware Error Memory for Adaptive Clinical Coding Agents2026-09-17arXiv2609.19721Full textIncludedghaffari2026learnactcoder
754The economics of accuracy for medical reasoning with large language models.2026-09-18EuropePMC10.1371/journal.pdig.0001182Title/abstractExcludedNot an LLM agent: Test-time scaling and fine-tuning comparison on medical QA; no agent.
755RPMem: Learning Long-Term Recurrent Parametric Memory Across Sessions for LLM Agents2026-09-20arXiv2609.23466Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
756MedRSI: Recursive Self-Improvement for Medical Agents via Clinically Aligned Self-Evolution2026-09-21arXiv2609.24838Already chartedIncluded (re-confirmed)wu2026medrsi
757From Pattern Recognizers to Personalized Companions: A Survey of Large Language Models in Mental Health2026-09-21arXiv2609.25186Title/abstractExcludedNot primary research: Survey of LLMs in mental health.
758Reinforcement Learning with Decomposed Subtasks2026-09-22arXiv2609.27035Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
759Propose, Don't Judge: An Anytime-Valid Referee for LLM Agents That Mine Investment Factors2026-09-22arXiv2609.27051Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
760Process-Oriented, Behaviorally Anchored Assessment of Clinical Reasoning in Large Language Models and the Effect of Extended Thinking: Protocol for a Prospective, Multigroup, Comparative Study.2026-09-22EuropePMC10.2196/103220Title/abstractExcludedNot primary research: Protocol-only study on clinical reasoning assessment.
761Verifiable Hidden Dynamics Play: Generating Agentic RL Environments from Solved Mechanisms2026-09-23arXiv2609.27321Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
762EVAGE: Autonomous MEV Generation and Adaptation via Multi-Agent Harness2026-09-23arXiv2609.27424Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
763PASTABench: Proactive Assessment of Sequential Trajectories for Agent Safety2026-09-23arXiv2609.28197Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
764Probing Stability-Plasticity Tradeoffs in Agent Memory through Cognitive Experimental Paradigms2026-09-24arXiv2609.30558Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
765Research with AI Agents: How Agentic Systems Are Changing Scientific Work2026-09-25arXiv2609.31219Title/abstractExcludedNot primary research: Review of agentic systems in scientific work.
766SenseAgent: An LLM Agent for Adaptive Cross-Domain IMU Sensing2026-09-25arXiv2609.32000Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
767ReVision3D: Attribution-Guided Recursive Self-Improvement for 3D Medical Perception2026-09-26arXiv2609.32984Already chartedIncluded (re-confirmed)lee2026revision3d
768Sivia: Learning to Draw, Learning to Learn2026-09-27arXiv2609.33386Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
769V-Gym: Enhancing Agentic Visual Reasoning via Skill-Data Co-Evolution2026-09-28arXiv2609.34682Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
770GenMem: Generative Symbolic Memory for Self-Evolving Harness2026-09-28arXiv2609.34633Title/abstractExcludedNot healthcare or clinical: Generalist memory method; medical reasoning only one of several benchmarks.
771ResonAct: Streaming Metrics for Runtime Diagnosis and Self-Healing in Multi-Agent Systems2026-09-28arXiv2609.34701Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
772UniOPSD: Unifying Outcome and Hindsight Feedback for Agentic Reinforcement Learning2026-09-28arXiv2609.34810Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
773Same Winners, Different Success Rates: Evaluating How LLM Agents Recover from Failures2026-09-28arXiv2609.34215Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
774Evo2Team: When Do Evolved Skills Transfer? From Selection to Deployment2026-09-28arXiv2609.34135Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
775SIPO: Selective-Inference Policy Optimization for Tree-Structured Agentic RL2026-09-28arXiv2609.34805Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
776Reliability Engineering for AI Systems: Challenges, Methods, and Directions2026-09-28arXiv2609.35316Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
777JET: Judge-Guided Evolution at Test Time for Agent Programs2026-09-28arXiv2609.34126Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
778NeuronSifter: An Agent-in-Twin for Prioritizing Central Nervous System Interventions with World Action Models2026-09-28arXiv2609.35445Full textExcludedNot an LLM agent: Numerical belief-state planner; an LLM is only an optional proposal backend (Sec 4.4; App A.1.7). Also non-clinical intervention prioritization; current v4 withdrawn, v3 assessed.
779PrivMeSA: Privacy-Aware Self-Evolving Multi-Agent System for Medicine via Local-Remote LLM Collaboration2026-09-29arXiv2609.38458Already chartedIncluded (re-confirmed)wang2026privmesa
780On-Policy Visual Evidence Distillation2026-09-29arXiv2609.36838Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
781MedForge-RSI: Medical Deepfake Detection via Recursive Self-Improvement2026-09-29arXiv2609.36549Already chartedIncluded (re-confirmed)chen2026medforge
782OceanMind: A multi-agent AI system for ocean diagnosis2026-09-30arXiv2610.03780Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
783From Given to Gathered Evidence: Agentic Learning for Longitudinal Medical Reasoning2026-09-30arXiv2609.39566Full textIncludedshao2026case
784ReLiveGym: Evaluating Long-Lived Agents over Weeks of Replayed Reality2026-09-30arXiv2610.00710Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
785Can Terminal Agents Trust Their Own Verification? Diagnosing and Improving Self-Verification2026-09-30arXiv2609.38812Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
786EmbodiRSI: Recursive Self-Improvement for Data-Efficient Robot Adaptation2026-09-30arXiv2609.38905Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
787NarrativeSteward: Coordinating Delegation, Guidance, and Verification in Agent-Assisted Interactive Narrative Authoring2026-09-30arXiv2609.39333Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
788RoboAssist: Interactive Human-Humanoid Planning for Long-Horizon Surgical Assistance2026-09-30arXiv2609.39384Title/abstractExcludedNo persistent cross-case improvement: Surgical assistance planning; within-task replanning, no cross-case learning.
789EgoTools: Towards Tool-Centric Reasoning in Real-World Egocentric Videos2026-09-30arXiv2609.39378Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
790My FAULT: Self-Diagnosis as Credit Assignment in Self-Evolving Agentic Reinforcement Learning2026-10-01arXiv2610.01161Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
791DeFA: Dependency-Guided Failure Attribution for LLM Agents2026-10-01arXiv2610.01256Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
792GUI-HARVEST: Self-Improving GUI Agents through Evidence-Driven Harness Evolution2026-10-01arXiv2610.00948Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
793YouRA: A Persistent-State Architecture for Evidence-Traceable Autonomous Research Agents2026-10-01arXiv2610.01097Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
794Permutation Robustness Is Not Enough: Action Collapse in Multi-Agent Transformer Policies2026-10-02arXiv2610.02848Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
795Training Numerical Intelligence via Auto-Diagnosis and Skill Discovery2026-10-02arXiv2610.03872Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
796ARISE: Adaptive Agentic Reasoning with Image-grounded Self-Evaluation for Interpretable IBD Assessment2026-10-03arXiv2610.04777Title/abstractExcludedNo persistent cross-case improvement: Single-case 5-stage agentic workflow for IBD imaging; no retained learning.
797templar: agentic induction and evolution of standardized radiology reporting templates from large-scale clinical corpora2026-10-04arXiv2610.05247Already chartedIncluded (re-confirmed)hu2026templar
798AutoSciBench: Autonomous Benchmark Generation for Evaluating Scientific Agents2026-10-04arXiv2610.05140Title/abstractExcludedNot healthcare or clinical: Benchmark-generation agent across sciences; clinical imaging one domain, not clinical task.
799AI Agents as a Research Team: A Human-Supervised Case Study in Stellar Spectroscopy2026-10-04arXiv2610.05424Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
800AIProver: Agentic Auto-Formalization of Mathematical Research via Certificate-Driven Evolving Harness2026-10-04arXiv2610.05367Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
801RF-Agent: Hierarchical Language-Agent Control for Instruction-Conditioned Active Spectrum Sensing2026-10-04arXiv2610.05485Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
802PsyCIDRA: A Dual-Agent Framework for Psychiatric Interviewing and Diagnostic Reasoning2026-10-05arXiv2610.07473Title/abstractExcludedNo persistent cross-case improvement: Psychiatric interview agent uses fixed expert-written skills; no experience-driven update.
803PACMI: Provenance-Aware Cascading Memory Invalidation for Long-Term LLM Agents2026-10-05arXiv2610.05732Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
804VERA: Scaling Verifiable Environments for Agentic co-Evolution2026-10-05arXiv2610.05923Full textExcludedHealthcare not the primary focus: P2: general model-harness co-evolution method evaluated on two domains, AutoCoWorkBench and AutoMedBench (Sec 3-4, App A). Borderline: medical research is the motivating example and half the evaluation.
805Second-Order Problem Solving for Recursive Self-Improvement in Formal Verification2026-10-05arXiv2610.05701Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
806The Right Memory in the Wrong Context: Verifying Retrieval Admissibility in Long-Term Agent Memory2026-10-05arXiv2610.07309Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
807MedZERO: Self-Evolving Agents for Open-Ended Medical Reasoning Through Controlled Knowledge Accumulation2026-10-06arXiv2610.08327Already chartedIncluded (re-confirmed)dang2026medzero
808PhysEvo: Astra Can Act, Let It2026-10-06arXiv2610.08995Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
809LiveMACE: Process-Aware Evaluation of LLM Agent Capabilities in Evolving Markets2026-10-07arXiv2610.09872Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
810Know the Shape, Find the Fault: Topology-Conditioned Diagnosis of Multi-Agent LLM Failures2026-10-07arXiv2610.10126Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
811Conversational Task Disambiguation over Tabular Data: Leakage-Aware Formulation, Benchmark Suite, and Training2026-10-07arXiv2610.10740Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
812OOM-RL II: Reality Is an Oracle, Not a Debugger Provenance-Constrained Diagnosis in Continually Evolving Agent-Engineered Systems2026-10-07arXiv2610.10256Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
813TRACE: Diagnosing Verifier Brittleness in Agentic Evaluation2026-10-08arXiv2610.11678Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
814RoboRSI: Stable, efficient, and reusable robot self-evolution in complex real-world environments2026-10-08arXiv2610.12424Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
815What Output-Only Review Cannot Verify: Study Contracts for Research Agents2026-10-08arXiv2610.11754Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
816Learning from Expert-Corrected Misdiagnoses: A Self-Evolving Consultation Agent for Traditional Chinese Medicine after Failed Treatment2026-10-09arXiv2610.40663Already chartedIncluded (re-confirmed)wang2026tcmsea
817ClawLoop: Self-Improving Agents via Harness-Native Training Loop2026-10-09arXiv2610.14118Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
818MemForm: Benchmarking Memory Formation Poisoning in LLM Agents2026-10-10arXiv2610.14431Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
819VitaBench: Memory Lifecycles Beyond Retrieval2026-10-10arXiv2610.14731Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
820A Self-Defining Operator for Distributed Applications2026-10-10arXiv2610.14547Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
821Sensitivity or Criterion? Measuring and Moving When Language Models Act2026-10-11arXiv2610.15415Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
822EvoQuantLab: Training-Free Dual-Loop Evolution for Auditable Quantitative Research2026-10-12arXiv2610.17130Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
823Beyond Successful Play: Diagnosing Opponent Modeling in Large Language Models2026-10-12arXiv2610.17310Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
824Uncovering Robustness Weaknesses in LLM Agents via Persona Evolution with Task-Integrity Constraints2026-10-12arXiv2610.16155Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
825Verifier-Harness Co-Evolution for Training-Free Self-Improvement on Open-Ended Tasks2026-10-13arXiv2610.17609Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
826EmbodiedEvo: Self-Evolving Coding Agent For Physical Intelligence2026-10-13arXiv2610.18867Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
827StateHarness: Maintaining Evolving Project State for Long-Horizon Coding Agents2026-10-13arXiv2610.17616Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
828Failure Recovery via Belief Updates and World Modeling for Long-Horizon Agents2026-10-13arXiv2610.18082Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
829What Human-AI Interaction Leaves Behind: Residual Human States -- A Trajectory-Based Framework and Multi-Study Analysis2026-10-13arXiv2610.18765Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
830ECG-RSI: Recursive Self-Improvement through Targeted Electrocardiogram Waveform Evolution2026-10-13arXiv2610.17718Already chartedIncluded (re-confirmed)wang2026ecgrsi
831Reclaiming human clinical reasoning in generative AI-enabled healthcare: a perspective on cognitive agency, skill evolution, and accountability.2026-10-13EuropePMC10.3389/fpubh.2026.1979099Title/abstractExcludedNot primary research: Perspective on clinical reasoning with GenAI.
832PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making2026-10-14arXiv2610.19762Full textExcludedF7: Sample size and learning/test separation are not reported. The claimed more-than-twofold EM advantage is unsupported by Table2:13.58% versus9.86%, approximately1.38-fold. Previously included; author-approved revision5November2026.
833When Non-Adversarial Noise Hurts Learning: Benchmarking Skill Self-Evolution in Agents2026-10-14arXiv2610.19910Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
834HEM-Med: A Hierarchical Agentic Memory Framework for Safe Multi-Center Medication Recommendation2026-10-14arXiv2610.20191Full textExcludedNot an LLM agent: LLM (DeepSeek-v4-flash) only annotates training records offline; recommendation uses count-based memories, a supervised reranker and DDI decoding, not an LLM agent (Sec IV-A to IV-E).
835StepSafe: Learning Timely Intervention with Context-Aware Safety Reasoning2026-10-14arXiv2610.20960Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
836PhySGA: A Physics-Space Grounded Agentic Framework for Generalizable and Interactive 3D Composition2026-10-14arXiv2610.20560Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
837AdCoEvo: A Co-Evolving Multi-Agent Advertising Delivery System2026-10-14arXiv2610.19454Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
838A Self-Improving Agent that Grows its Own DSL: Oracle-Free Operator Induction for Exact Question Answering2026-10-14arXiv2610.20809Title/abstractExcludedNot healthcare or clinical: Self-growing DSL agent; clinical-encounter QA only an extension domain.
839MedPAO-VL: Interpretable and Protocol-Compliant Agent for Structured Radiology Report Generation2026-10-15arXiv2610.21794Title/abstractExcludedNo persistent cross-case improvement: Radiology report agent with per-case iterative self-correction only.
840TRACER: A Multimodal Harness for Patient Care in Hospitals2026-10-15arXiv2610.21266Title/abstractExcludedNo persistent cross-case improvement: Training-free ICU video/record harness; no learning across cases.
841OPRD: On-Policy Reminder Distillation for Long-Horizon Coding Agents2026-10-15arXiv2610.21496Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
842Beyond Downstream QA: Rethinking How We Evaluate Agent Memory2026-10-15arXiv2610.22209Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
843Recursive Reward Improvement via Adversarial Meta-Prompt Evolution2026-10-15arXiv2610.21040Full textExcludedHealthcare not the primary focus: P2: general open-ended expert-task method; loops also target PRBench and ProfBench (Sec 4.4, App H). Borderline: HealthBench Professional is the main target; solver's agent status also marginal.
844Unified Multiparadigm Fusion Intelligence for Rare Disease Diagnosis2026-10-16arXiv2610.24024Title/abstractExcludedNo persistent cross-case improvement: Fusion with static case retrieval and per-case agentic reflection; no retained learning evident.
845MobileInject: Evaluating Reasoning-to-Action Security of MLLM-Based Mobile Agents under Cross-Modal Consistency Injection2026-10-16arXiv2610.23307Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
846Pronouncing Hard Words: Phoneme Adaptation of a Pretrained Conversational Text to Speech Model2026-10-16arXiv2610.24164Title/abstractExcludedNot an LLM agent: TTS phoneme adaptation for drug names; not an agent.
847Organon : From Evolutionary Search to Recursive Self-Improving Agents for Scientific Discovery2026-10-17arXiv2610.33046Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
848Mining the Self-Rewriting System: A Vision for Data Mining on AI-Native Infrastructure2026-10-18arXiv2610.25374Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
849MemDerive: A Diagnostic Benchmark for Agent Memory over Evolving Data2026-10-18arXiv2610.25373Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
850Which Agent's Skill Should Change? Group-Relative Credit Assignment for Evolving Multi-Agent Teams2026-10-19arXiv2610.27227Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
851Does Multi-Agent Collaboration Reduce Hallucination in Clinical Tasks?2026-10-19arXiv2610.27027Title/abstractExcludedNo persistent cross-case improvement: Evaluation of multi-agent hallucination in clinical tasks; no persistent adaptation.
852BetaMem: Learning to Remember a Changing World for Embodied Agents2026-10-19arXiv2610.26554Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
853MARC: Mechanism-Aware Reflective Correction for Articulated Object Code Generation2026-10-19arXiv2610.33060Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
854Elicitation or Expansion? Demystifying Gains from Agent Harness Optimization2026-10-20arXiv2610.27889Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
855When Does Experience Memory Help Closed-Loop LLM Driving Agents? A Controlled Evaluation with Resampled Warmup Pools, Token-Matched Fillers, and Audited Baselines2026-10-20arXiv2610.27714Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
856KPHarness: Co-Evolving Knowledge and Probing for Long-Horizon Gaming Harnesses2026-10-20arXiv2610.27417Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
857HGM-Dual: Lineage-Aware Guided Agent Harness Optimization for Long-Horizon Planning2026-10-21arXiv2610.30042Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
858CORD: Conflict-Aware Optimization for Joint RL and Distillation in Agents2026-10-21arXiv2610.29965Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
859VeruSteer: Learning What to Repair Next in Verus2026-10-21arXiv2610.29755Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
860RIPPLE: Recovery Internalization through Process-Level Policy Learning and Effect-Aware Credit for Long-Horizon Agentic Coding2026-10-22arXiv2610.31276Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
861The Value of Memory in Language Agents2026-10-22arXiv2610.31303Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
862An LLM-based decision aid for collaborative decision-making in juvenile idiopathic arthritis: A multimethod evaluation.2026-10-22EuropePMC10.1371/journal.pdig.0001655Title/abstractExcludedNo persistent cross-case improvement: LLM decision aid for juvenile arthritis; no learning across cases.
863TGR-EvoDAG: A DAG-based Multi-Agent Code Evolution Framework for Generative Recommendation on Tencent2026-10-23arXiv2610.32326Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
864DMAIC-Bench: From Self-Reflection to Self-Restraint for Agents in Multi-Stage Analytical Tasks2026-10-23arXiv2610.32305Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
865Understanding Communication Failures in Multi-Agent LLM Systems2026-10-23arXiv2610.32060Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
866SkillShift-Bench: Benchmarking Skill Learning under Environment Evolution for Web Agents2026-10-24arXiv2610.33528Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
867Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis2026-10-24arXiv2610.33592Title/abstractExcludedNo persistent cross-case improvement: Evaluation audit of rare-disease LLM systems; no adaptive agent.
868Continual Learning Exam: Benchmarking Long-Horizon RSI and Experiential Learning in LLM Agents2026-10-25arXiv2610.33956Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
869ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents2026-10-26arXiv2610.34878Full textIncludedchen2026clinverse
870Beyond Federated Learning: Decentralized Agentic Systems for Self-Evolving Clinical Intelligence2026-10-26arXiv2610.35453Title/abstractExcludedNot primary research: Perspective proposing decentralized agentic systems for clinical intelligence.
871CohortFlow: A Steerable Clinical Cohort Curation Agent with Localized Semantic Correction2026-10-26arXiv2610.36100Title/abstractExcludedNo persistent cross-case improvement: Cohort curation agent with within-task persistent execution graph; no cross-task learning.
872Same Story, Different Lens: A Multi-Agent System for Cross-Outlet News Framing Analysis2026-10-26arXiv2610.35208Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
873Trustworthy Recursive Self-Improvement in the Era of Large Models: Foundation, Risks, Evaluation and Open Challenges2026-10-26arXiv2610.35193Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
874Systematic Scoring Differences in Large Language Model-Based Clinical Benchmarking Reveal Evaluator-Dependent Divergence: Controlled Evaluation Study.2026-10-26EuropePMC10.2196/103962Title/abstractExcludedNot an LLM agent: LLM-as-evaluator scoring differences in clinical benchmarking; not an agent.
875The View from Nowhere: Population-Centered Agent Evolution2026-10-27arXiv2610.36660Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
876GARDEN: Generalist Autonomous Reward Design Through Evidence Navigation for Cooperative Multi-Agent Reinforcement Learning2026-10-27arXiv2610.37926Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
877Self-Evolving Recommender Systems: A Survey and an Evaluation Audit2026-10-28EuropePMC10.20944/preprints202610.2336.v2Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
878Try Before You Evolve: Ranking-Scored Trials for Recursive Self-Improvement of Recommender Systems2026-10-29arXiv2610.39352Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
879Can Personal Requirements Become Supervision for Planning?2026-10-29arXiv2610.40992Full textExcludedNo persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment
880Advancing Clinical Genomic Analysis with a Skill-Centred Agent2026-10-29arXiv2610.40556Title/abstractExcludedNo persistent cross-case improvement: Clinical genomics agent with curated static skill library; no learning from experience.
881Before the Next Rollout: Diagnosing Skill Utility Shifts from Policy Updates2026-10-29arXiv2610.39358Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
882KARMA: Training-Free Knowledge-Atomic Harness Evolution for Industrial Advertising Agents2026-10-29arXiv2610.39884Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
883A prospective randomized study of patient-centered AI for clinical visit preparation2026-10-30arXiv2610.41437Title/abstractExcludedNo persistent cross-case improvement: Randomized study of visit-preparation chatbot; no cross-case adaptation.
884From Evaluation to Evolution: Benchmarking Image Editing and Evolving Image Models2026-10-30arXiv2610.41210Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
885Exo: An Architecture for Self-Improving Systems at Runtime2026-10-30arXiv2611.00463Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
886MATS: A Multi-Agent Framework for Controllable and Reflective Tumor Synthesis2026-10-30arXiv2610.41159Title/abstractExcludedNo persistent cross-case improvement: Tumor synthesis multi-agent; closed-loop reflection within each generation only.
887Think in 360°: Benchmarking and Bootstrapping Panoramic Video Reasoning2026-10-30arXiv2610.42082Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
888Do Transaction Prices Reflect Visual Preference? A Diagnostic Study with Multimodal Language Models2026-10-30arXiv2610.41358Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
889Verify--Backtrack Loop: Structured Precondition Recovery for Long-Horizon Language Agents2026-10-30arXiv2610.41564Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
890From Single-Agent Self-Discovery to Multi-Agent Adaptation: Scaling Laws of Partner Feedback and Convention Rigidity in Meta Reinforcement Learning Algorithms2026-11-01arXiv2611.01742Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
891Accounting for Irregular State Transitions through Belief Estimation in Online Medical Consultation2026-11-01arXiv2611.01474Full textExcludedNo persistent cross-case improvement: PRISM is trained once by SFT and GRPO against fixed LLM-annotated reference labels (App B.2.2); belief is within-dialogue; nothing is retained across cases.
892State-Aware Virtual Patient Simulation for Training Psychiatrists in Challenging Clinical Scenarios2026-11-01arXiv2611.02067Full textExcludedNot primary research: v1 is labelled work in progress and describes the pipeline and LinUCB selector (Sec III) without any experiments or results. Borderline: cross-session bandit learning only proposed, F4 also arguable.
893CARE: Grounded Recursive Self-Improvement for Production Customer-Service Agents2026-11-02arXiv2611.02839Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
894Multi-Modal Multi-Agent System for Bridge Operation and Maintenance based on Large Language Model2026-11-02arXiv2611.02738Title/abstractExcludedNot healthcare or clinical: Not healthcare; general-domain LLM agent or other domain.
895When Prediction Shapes the Future: A BlueSky Agenda for Reflexive Time Series Analysis2026-11-02arXiv2611.02511Title/abstractExcludedNot primary research: Non-health; survey, benchmark, evaluation or position work.
W43871225472022 Association for Vascular Access Scientific Meeting: Poster Abstracts2023-01-01OpenAlex10.2309/jvad-28-03-49Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387122547
W4386046933A Molecular Update and Review of Current Trials in Paediatric Low-Grade Gliomas2023-01-01OpenAlex10.1159/000533703Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386046933
W4383873176A Scoping Review of Highly Cited Published Articles in the Iranian Endodontic Journal: A Reflection of Trends in Endodontic Research.2023-01-01OpenAlex10.22037/iej.v18i2.42524Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383873176
W4388763471Abstracts Presented at the 2023 Advancing Healthcare Innovation Summit: Nov 11, 2023 (Virtual)2023-01-01OpenAlex10.36401/iddb-23-x1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388763471
W4317931807Advanced approaches for the diagnosis and chemoprevention of canine vector-borne pathogens and parasites—Implications for the Asia-Pacific region and beyond2023-01-01OpenAlex10.1016/bs.apar.2022.12.001Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4317931807
W4313573002Advances and Challenges of the Decade: The Ever-Changing Clinical and Genetic Landscape of Immunodeficiency2023-01-01OpenAlex10.1016/j.jaip.2022.11.007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313573002
W4410996421Advances in AI-Augmented Network Fault Detection and Self-Optimization in Multi-Layer Mobile Systems2023-01-01OpenAlex10.54660/.jfmr.2023.4.2.110-129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410996421
W4385385648Advancing XNAzymes as Nucleic Acid Therapeutics2023-01-01OpenAlex10.1007/978-981-19-9776-1_75Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385385648
W7112730859Advancing the capabilities of base editing and protein delivery2023-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7112730859
W4396526058An Integrative Review on the Oncology Nurse Navigator Role in the Canadian Context2023-01-01OpenAlex10.5737/23688076334385Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396526058
W4323821306Antiarrhythmic Drug Therapy for Ventricular Arrhythmias: The Changing Role in the Modern Era2023-01-01OpenAlex10.1159/000529968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323821306
W4383619189Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment2023-01-01OpenAlex10.1177/17588359231183679Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383619189
W4327771094Antileprotic drugs2023-01-01OpenAlex10.1016/b978-0-323-90575-6.00016-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327771094
W4323026409Antimicrobial Resistance of Escherichia Coli Isolated from Cecum and Carcasses Samples of Broiler Chickens2023-01-01OpenAlex10.2991/978-94-6463-112-8_4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4323026409
W4316340211Análisis de la Guía de excelencia para la realización de ensayos clínicos en farmacia hospitalaria2023-01-01OpenAlex10.1016/j.farma.2022.10.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4316340211
W4380901188Application of Mulberry and Mulberry Silkworm By-Products for Medical Uses2023-01-01OpenAlex10.1007/978-3-031-28478-6_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380901188
W4409809834Application of the EDAS Method in Artificial Intelligence A Comprehensive Analysis2023-01-01OpenAlex10.55124/jaim.v1i2.254Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409809834
W4382237099Authors’ reply to George and Gupta et al.2023-01-01OpenAlex10.4103/crst.crst_89_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382237099
W7112040949Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers:an emerging entity2023-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7112040949
W4387896838Biological Methods for Drug Delivery2023-01-01OpenAlex10.1007/978-981-99-6564-9_1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387896838
W4385235582Biology in AI: New Frontiers in Hardware, Software, and Wetware Modeling of Cognition2023-01-01OpenAlex10.1162/artl_e_00412Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385235582
W7216880609Biomimetic platforms for modeling in vitro the functional unit of the exocrine pancreas2023-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216880609
W4380789988Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer2023-01-01OpenAlex10.1177/17562872231182219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380789988
W4367461339Bronchoscopy Education: New Insights2023-01-01OpenAlex10.1007/978-3-031-22610-6_6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367461339
W4313437612Bulk Fill Composites: Adhesion and Interfacial Adaptation2023-01-01OpenAlex10.1007/978-3-031-16388-3_3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4313437612
W4327655900COVID-19 Pandemic and Vaccination2023-01-01OpenAlex10.1007/978-3-031-24903-7_2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327655900
W4367032859COVID-19 associated mucormycosis a recent challenge2023-01-01OpenAlex10.4322/acr.2023.427Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367032859
W4386527884COVID-19: An Overview of Virology, Mutations, Pathology, Epidemiology, Diagnosis, Preventions, and Treatments2023-01-01OpenAlex10.1007/978-981-99-3664-9_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386527884
W7111865399Characterizing Functional Genetic Diversity in Mycobacterium tuberculosis2023-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7111865399
W4383959934Chat Generative Pretrained Transformer: A Disruptive or Constructive Technology?2023-01-01OpenAlex10.4103/jicdro.jicdro_37_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383959934
W4365512576ChatGPT: A comprehensive review on background, applications, key challenges, bias, ethics, limitations and future scope2023-01-01OpenAlex10.1016/j.iotcps.2023.04.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365512576
W4362015242Chemoprevention of neuroblastoma: progress and promise beyond uncertainties2023-01-01OpenAlex10.20517/2394-4722.2022.40Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362015242
W4389064782Chemotherapy-Related Toxicities and Management2023-01-01OpenAlex10.1007/978-3-031-41413-8_13Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389064782
W4391801353Chromatography and Anti-Biofilm Activity of Chiral Carbon Nanoparticles2023-01-01OpenAlex10.7302/22326Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391801353
W4324381470Clinical Benefit and Safety of Microneedle Patches Composed of Magnesium: A Pilot Study in Acne Patients2023-01-01OpenAlex10.1155/2023/7667296Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4324381470
W4390884169Commentary2023-01-01OpenAlex10.2344/155994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390884169
W4367330987Comparison of the Qualities of Sevoflurane and Halothane in Paediatric Anaesthesia2023-01-01OpenAlex10.4103/njm.njm_126_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367330987
W4362636229Conceptual Change and Developmental Teaching: Comment on Gennen2023-01-01OpenAlex10.1159/000530505Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362636229
W4365397536Current status of Cancer Nanotheranostics: Emerging strategies for cancer management2023-01-01OpenAlex10.7150/ntno.82263Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365397536
W4382284123Diarrhea Could Be a Triggering Factor in Atypical Hemolytic Uremic Syndrome in Children2023-01-01OpenAlex10.4103/pnjb.pnjb_4_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382284123
W4391030016Dissociative Identity Disorder and the Human Brain; Neuroanatomy2023-01-01OpenAlex10.1007/978-3-031-39854-4_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391030016
W4381300788Efficacy of Butorphanol and Tramadol as an Adjuvant to Levobupivacaine for Postoperative Analgesia in Brachial Plexus Block – A Randomized Double-Blind Study2023-01-01OpenAlex10.13107/ijra.2023.v04i01.068Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4381300788
W4386386144Efficacy of Celecoxib and Diclofenac Sodium in the Management of Postoperative Pain, Swelling and Mouth Opening after Surgical Removal of Impacted Third Molars: A Split-mouth Randomised Clinical Study2023-01-01OpenAlex10.7860/jcdr/2023/63808.18307Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386386144
W4362577180Environment poisoning in reinforcement learning: attacks and resilience2023-01-01OpenAlex10.32657/10356/164969Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362577180
W4389610283Ethics Challenges in Pediatric Research2023-01-01OpenAlex10.5863/1551-6776-28.8.680Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389610283
W4383000032Exploring Chatgpt: An Extensive Examination of its Background, Applications, Key Challenges, Bias, Ethics, Limitations, and Future Prospects2023-01-01OpenAlex10.2139/ssrn.4499278Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383000032
W4385589100Exploring the antimicrobial potential of biologically synthesized zero valent iron nanoparticles2023-01-01OpenAlex10.1515/chem-2022-0355Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385589100
W4386038155Exploring the therapeutic potential of stem cells in glaucoma: A promising frontier for vision restoration2023-01-01OpenAlex10.4103/kjo.kjo_93_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386038155
W4366319347From flint tools to robotics: The Journey of OMFS through time!2023-01-01OpenAlex10.4103/njms.njms_43_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366319347
W4386107118Functionalized Nanoemulsions: Could Be a Promising Approach for Theranostic Applications2023-01-01OpenAlex10.1007/978-981-99-0538-6_7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386107118
W4393041048Fundamentals of Medicinal Chemistry- For the Students of Medicinal Chemistry, Pharmaceutical Sciences, Pharmacology, and Biochemistry2023-01-01OpenAlex10.18231/978-81-962763-2-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393041048
W4391226056Fungal Zoonosis and One Health2023-01-01OpenAlex10.47278/book.zoon/2023.165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391226056
W4385355164Fungal-mediated synthesis of gold and titanium nanoparticles and their application in agriculture2023-01-01OpenAlex10.1016/b978-0-443-15262-7.00010-3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385355164
W4411195375Green intensive care unit in burn care: A sustainable approach to health care2023-01-01OpenAlex10.4103/ijb.ijb_9_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411195375
W4319590105Green synthesized nanoparticles in hepatic disorder2023-01-01OpenAlex10.1016/b978-0-323-91195-5.00014-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319590105
W4382567563Human Herpesviruses: Human Herpesvirus 62023-01-01OpenAlex10.1007/978-1-4939-9544-8_37-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382567563
W4319294780IGF-1 and GLP-1 signaling: potential therapeutic target for neurological disorders – correspondence2023-01-01OpenAlex10.1097/ms9.0000000000000164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319294780
W4362569645Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment2023-01-01OpenAlex10.20517/2394-4722.2022.92Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362569645
W4313595882Immunosuppression2023-01-01OpenAlex10.1007/978-981-19-6045-1_41Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4313595882
W4372053931Immunotherapy and Cancer: The Pharmacists’ Perspective2023-01-01OpenAlex10.1007/978-3-030-80962-1_215-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4372053931; https://openalex.org/W4414891897
W4414737920Improving the Design of Antibody Drug Conjugates and Bispecific Agents for Cancer Therapy2023-01-01OpenAlex10.7302/8439Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414737920
W4313530627In the Limelight: January 20232023-01-01OpenAlex10.1016/j.mayocp.2022.11.013Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4313530627
W4377835499Indian vaccine on COVID-19, competitive analysis2023-01-01OpenAlex10.1063/5.0138203Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377835499
W4390503001Intrathecal Analgesics: Choices and Optimization of Delivery2023-01-01OpenAlex10.1007/978-3-031-39558-1_29Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390503001
W4362684655Is there an optimal sequence of biologic therapies for inflammatory bowel disease?2023-01-01OpenAlex10.1177/17562848231159452Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362684655
W4386874652JIM Reading List2023-01-01OpenAlex10.17849/insm-50-1-74-79.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386874652
W4391186626Juvenile Xanthogranuloma: the benignity behind an atypical lesion2023-01-01OpenAlex10.25060/residpediatr-2023.v13n4-720Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391186626; https://openalex.org/W4387397602
W4364861988Langerhans Cell Granulomatosis and Smoking-Related Interstitial Lung Diseases2023-01-01OpenAlex10.1007/978-3-031-12950-6_18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4364861988
W4399121590Life Writing in the Posthuman Anthropocene ed. by Ina Batzke, Lea Espinoza Garrido, and Linda M. Hess (review)2023-01-01OpenAlex10.1353/bio.2023.a928386Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399121590
W4390800269Longevity and Clinical Performance of Direct Posterior Restorations2023-01-01OpenAlex10.52533/johs.2023.30907Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390800269
W4383959980Longitudinal extensive myelopathy (LEM): a case with investigation pitfalls2023-01-01OpenAlex10.5327/1516-3180.141s1.657Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383959980
W4387351461Mastocytosis2023-01-01OpenAlex10.1007/978-3-031-15130-9_59Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387351461
W4400794823Medicalised Ketogenic Therapy Practice2023-01-01OpenAlex10.34074/thes.6419Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400794823
W4384788607Microbial Nanotechnology: Current Development and Potential Applications in the Field of Biotechnology2023-01-01OpenAlex10.1007/978-3-031-31104-8_2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4384788607
W4388503537Model Checking-Based Decision Support System for Fault Diagnosis: A Comprehensive Framework and Application in Electric Power Systems2023-01-01OpenAlex10.2139/ssrn.4626676Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388503537
W4392053027Modelling, design, fabrication and characterization of engineered human myocardium made with melt electrowriting and cardiac cells derived from hiPSCs2023-01-01OpenAlex10.15581/10171/69152Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392053027
W4391139481Molecular Techniques Used for Diagnosis of Zoonotic Diseases2023-01-01OpenAlex10.47278/book.zoon/2023.029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391139481
W4391332310Multidisciplinary treatment after doxorubicin extravasation: Improvement of range of motion in the elbow joint2023-01-01OpenAlex10.29289/259453942023v33s1060Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391332310
W4388238998Nab-Paclitaxel-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles as Microtubule B-Tubulin Stabilizer in the Management of Pancreatic Cancer2023-01-01OpenAlex10.37047/jos.2022-94097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388238998
W4327518338Nasopharyngeal rapid diagnostic testing to reduce unnecessary antibiotic use and individualize management of acute otitis media2023-01-01OpenAlex10.1017/ash.2023.127Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327518338
W4361014800New Systemic Therapies in Salivary Gland Cancer2023-01-01OpenAlex10.1007/978-3-031-23175-9_20Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361014800
W4313427904New developments and concepts in the diagnosis and management of diabetes insipidus (AVP‐deficiency and resistance)2023-01-01OpenAlex10.1111/jne.13233Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313427904
W4386775038Nursing advanced training: Person-centeredness and technology for innovative pedagogy2023-01-01OpenAlex10.1016/b978-0-443-15248-1.00010-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386775038
W4379352933Oncolytic virotherapy in lung cancer2023-01-01OpenAlex10.1016/bs.ircmb.2023.05.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379352933
W4365804305PH Roundtable: Pros and Cons of the 2022 ERS/ESC Guidelines: Practicality vs Real World View2023-01-01OpenAlex10.21693/1933-088x-22.1.71Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365804305
W4365804235PHA 2022 International Pulmonary Hypertension Conference Abstracts2023-01-01OpenAlex10.21693/1933-088x-22.1.4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365804235
W4313537568PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales2023-01-01OpenAlex10.1016/j.jtauto.2023.100188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313537568
W4392235025Pathophysiology and Management Approaches for Traumatic Brain Injury2023-01-01OpenAlex10.1007/978-981-99-6807-7_7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392235025
W4323343900Pediatric Heart Transplant Immunosuppression2023-01-01OpenAlex10.1007/978-981-19-6909-6_28Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323343900
W4381199224Phage design and directed evolution to evolve phage for therapy2023-01-01OpenAlex10.1016/bs.pmbts.2023.03.019Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4381199224
W4321504792Pharmacology, Psychopharmacology, and Adverse Drug Reactions2023-01-01OpenAlex10.1007/978-3-031-20792-1_44Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321504792
W4384917338Philosophy for Healthcare Professions Education: A Tool for Thinking and Practice2023-01-01OpenAlex10.1007/978-981-15-3344-0_21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384917338
W4385670952Photoresponsive Inorganic Nanomaterials in Oncology2023-01-01OpenAlex10.1177/15330338231192850Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385670952
W4386336912Polymer-based nanocarriers for biomedical and environmental applications2023-01-01OpenAlex10.1515/epoly-2023-0049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386336912
W4386763956Prelude to Tackling Contemporary Crises: William James and a Psychological Springboard to Political Change2023-01-01OpenAlex10.5406/21564795.44.1.02Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386763956
W4387467827Pulmonary Complications of Lung Cancer Treatment2023-01-01OpenAlex10.1007/978-3-031-38412-7_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387467827
W4376478093Pulsing and Detection Strategies for Contrast-Enhanced Ultrasound: A Narrative Review2023-01-01OpenAlex10.1109/ojuffc.2023.3275936Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376478093
W4323905491Raynaud's phenomenon: A brush up!2023-01-01OpenAlex10.4103/idoj.idoj_311_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323905491
W4317433933Recent advancements in critical care: Part I2023-01-01OpenAlex10.4103/ija.ija_1005_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317433933
W4387757202Recent advances in DNA nanomaterials for cancer diagnosis and treatment2023-01-01OpenAlex10.1515/ntrev-2023-0135Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387757202
W4386847264Recovery, Transplantation, Destination, or Anything Following MCS?2023-01-01OpenAlex10.1007/978-3-030-86172-8_56-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386847264
W4375935214Remembrances of Virology Past2023-01-01OpenAlex10.1007/978-3-031-21999-3_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4375935214
W4362648147Replies to Cruft, Radzik, and Misak2023-01-01OpenAlex10.1111/phpr.12962Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362648147
W4318168031Reporting From the First EHA Research Conference: Exciting Science With Panoramic Views2023-01-01OpenAlex10.1097/hs9.0000000000000816Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318168031
W4387197444Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope?2023-01-01OpenAlex10.1177/20552076231203879Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387197444
W4390594548Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer2023-01-01OpenAlex10.56434/j.arch.esp.urol.20237610.88Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390594548
W4321098233SYMPOSIUM2023-01-01OpenAlex10.4103/0019-5545.368867Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321098233
W4386711912Selective Laser Sintering (SLS) in Pharmaceuticals2023-01-01OpenAlex10.1007/978-981-99-2404-2_4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386711912
W4367050138Serum from Men with the Severe Form of COVID‐19 Impairs the Nitric Oxide Signaling Pathway in Isolated Corpus Cavernosum from Mice: An In Vitro Study2023-01-01OpenAlex10.1155/2023/9059973Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4367050138
W4389104124Severe Fungal and Parasitic Infections in the Intensive Care Unit2023-01-01OpenAlex10.1007/978-3-031-36398-6_13Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389104124
W4388796630Small Molecules as Vectors for Radiopharmaceutical Therapy2023-01-01OpenAlex10.1007/978-3-031-39005-0_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388796630
W4386393971Small molecules and conjugates as theranostic agents2023-01-01OpenAlex10.1039/d3cb00073gTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4386393971
W4414101819Social media and disability: the impact of influencers on building digital citizenship2023-01-01OpenAlex10.56294/neuro202368Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414101819
W4323063321Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials2023-01-01OpenAlex10.1177/17588359231157632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323063321
W4385195126Stem Cell Transplant for Hodgkin Lymphoma2023-01-01OpenAlex10.1007/978-981-19-5802-1_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385195126
W4399013095Survival trends for patients with primary brain tumors worldwide: What have we learnt?2023-01-01OpenAlex10.4103/glioma.glioma_1_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399013095
W4387374107Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic2023-01-01OpenAlex10.1016/j.crstbi.2023.100107Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387374107
W4385354170Targeted breast cancer treatment: progress and challenges2023-01-01OpenAlex10.1016/b978-0-323-91763-6.00014-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385354170
W7172583968Technology as a Change Agent for Social Work Supervision2023-01-01OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7172583968
W4368282482The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Systematic Review2023-01-01OpenAlex10.17925/ohr.2023.19.1.27Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4368282482
W4319936169The Immune Landscape and Therapy of Upper Tract Urothelial Carcinoma2023-01-01OpenAlex10.1007/16833_2023_127Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319936169
W4380442399The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer2023-01-01OpenAlex10.20517/cdr.2022.146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380442399
W4411910882Therapeutic Targets in Hepatic Fibrosis: Overcoming Current Limitations2023-01-01OpenAlex10.54660/.ijmrge.2023.4.2.865-869Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411910882
W4388578865Time to act sustainably: Why can’t we wait any longer?2023-01-01OpenAlex10.1590/0034-7167-2022-0813Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388578865
W7126292376Time-resolved recovery of intracellular magnetic nanoparticles2023-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7126292376
W4368250577Touched and Changed: Self-Reflexivity and Reciprocity in Fieldwork2023-01-01OpenAlex10.1162/afar_a_00705Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4368250577
W4386183270Towards a Science/Education of Late Neoliberal Bodies2023-01-01OpenAlex10.1007/978-3-031-39330-3_6Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386183270
W4396689266Transverse Sinus Isolated-Type Dural Arteriovenous Fistula Mimicking Ischemic Stroke: A Cautionary Note for Emergency Neurologists; Transvenous Embolization, Fistula Disconnection, and Complete Clinical Recovery2023-01-01OpenAlex10.1007/978-3-030-85411-9_61-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396689266; https://openalex.org/W4404698064
W4391150102UNDERSTANDING THE EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS AND DIAGNOSTIC APPROACHES OF FUNGAL INFECTIONS2023-01-01OpenAlex10.52458/9789388996846.nsp2023.eb.ch-19Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4391150102
W4391457447Unraveling the Enigma: Navigating Challenges in the Diagnosis and Treatment of Neurocysticercosis – A Thorough Exploration Review2023-01-01OpenAlex10.18103/mra.v12i1.4902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391457447
W4392416362Uso de rellenadores dérmicos de ácido hialurónico para el tratamiento de patología periocular asociada a parálisis facial y a otras causas de malposición palpebral2023-01-01OpenAlex10.4321/repisalud.18867Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392416362
W4378801504Vaccine Design: An Introduction2023-01-01OpenAlex10.1007/978-1-0716-3239-0_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378801504
W7131828295Viral vector platforms within the gene therapy landscape2023-01-01OpenAlex10.29228/jrp.502Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131828295
W4388376699Volumetric and Regenerative Components of Fat Graft: Positioning in the Fat-Nanofat Spectrum2023-01-01OpenAlex10.1007/978-3-031-10881-5_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388376699
W4318391617[Translated article] Analysis of the guide to excellence in the conduct of clinical trials in hospital pharmacy2023-01-01OpenAlex10.1016/j.farma.2022.12.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318391617
W4313647650A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation2023-01-06OpenAlex10.3390/ijms24021084Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313647650
W4313595711Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America2023-01-06OpenAlex10.1080/16078454.2022.2158015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313595711
W4313641086Targeting the DNA damage response for cancer therapy2023-01-06OpenAlex10.1042/bst20220681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313641086
W4313649292To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma2023-01-06OpenAlex10.1007/s12070-022-03455-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4313649292
W4313894787Local Antibiotics in the Treatment of Diabetic Foot Infections: A Narrative Review2023-01-09OpenAlex10.3390/antibiotics12010124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313894787
W4313898011Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance2023-01-10OpenAlex10.21037/cdt-22-497Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4313898011
W4389316415Decision letter: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance2023-01-11OpenAlex10.7554/elife.85023.sa1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389316415
W4389316426Editor's evaluation: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance2023-01-11OpenAlex10.7554/elife.85023.sa0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389316426
W4315574349Integrated Data Analysis Uncovers New COVID-19 Related Genes and Potential Drug Re-Purposing Candidates2023-01-11OpenAlex10.3390/ijms24021431Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4315574349
W7112636188Biochemical and mechanical changes of the extracellular matrix during lung metastasis2023-01-12OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7112636188
W4315797958Applicability of a colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for SARS-CoV-2 detection in high exposure risk setting2023-01-13OpenAlex10.1016/j.ijid.2023.01.010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4315797958
W4315797128International consensus recommendations on the management of people with haemophilia B2023-01-13OpenAlex10.17615/akp4-ah24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4315797128
W4316012746Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian Hamsters2023-01-13OpenAlex10.1101/2023.01.12.523876Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4316012746
W4316143370Key considerations for clinical trials in psychopharmacology2023-01-14OpenAlex10.1002/wps.21061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4316143370
W4316362821Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization2023-01-16OpenAlex10.3389/fmicb.2023.1125426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4316362821
W4322745931Estimation of the fluorescence emission spectrum of dental composite resin samples of varying thickness2023-01-16OpenAlex10.2352/ei.2023.35.15.color-190Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322745931
W4316591192Evolution of Antiphospholipid Syndrome2023-01-16OpenAlex10.1055/s-0042-1760333Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4316591192
W7201845015Metastatik Lezyon Tedavi Algoritması2023-01-16OpenAlex10.37609/akya.2214.c17124Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201845015
W4317040262Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment2023-01-17OpenAlex10.5501/wjv.v12.i1.22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317040262
W4317042806Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer2023-01-17OpenAlex10.3390/cancers15030566Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317042806
W4317863204HER2-low expression in breast oncology: treatment implications in the smart chemotherapy era2023-01-17OpenAlex10.1097/cej.0000000000000781Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317863204
W4317211921Myconanotechnology for Cancer Current Status and Future Prospects2023-01-18OpenAlex10.1201/9781003327356-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317211921
W4317510582Study on the Collaboration between University and Educational Centers Mentors in the Development of the In-School Education Placements in Official University Degrees Qualifying for the Teaching Profession: The Case of the University of Santiago de Compostela2023-01-18OpenAlex10.3390/educsci13020104Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4317510582
W4317209583The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases2023-01-18OpenAlex10.1111/jcmm.17669Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317209583
W4317434686Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma2023-01-18OpenAlex10.3390/cancers15030589Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317434686
W4317508225Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity2023-01-18OpenAlex2210.1401710.3390/antibiotics12020204Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317508225
W4317469188Dysphagia and Lung Disease in Children With Spinal Muscular Atrophy Treated With Disease-Modifying Agents2023-01-19OpenAlex10.1212/wnl.0000000000206826Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317469188
W4317470220Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road ahead2023-01-19OpenAlex10.1016/j.critrevonc.2023.103913Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317470220
W4317435358Pleuroparenchymal Fibroelastosis (PPFE)2023-01-19OpenAlex10.1201/9781003089384-11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317435358
W4362710844Progresses on metal-organic framework materials for bacterial infection treatment2023-01-19OpenAlex10.1360/tb-2022-0974Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362710844
W4317616069Ankylosing Spondylitis Pathogenesis and Pathophysiology2023-01-20OpenAlex10.5772/intechopen.109164Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317616069
W4317520087Encephalitis and cytokine storm secondary to respiratory viruses in children: Two case reports2023-01-20OpenAlex10.3389/fped.2022.1049724Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317520087
W4317745838Indonesian Vegetables: Searching for Antioxidant and Antidiabetic Therapeutic Agents2023-01-20OpenAlex10.3390/ddc2010002Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4317745838
W4318993711Moving the Needle: Accelerating Drug Discovery in Nephrology2023-01-20OpenAlex10.1681/asn.0000000000000052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318993711
W4317651620Ischaemic heart disease: antithrombotic treatment and new therapeutic targets2023-01-21OpenAlex10.1093/eurheartj/ehac816Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317651620
W4317734946Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach2023-01-21OpenAlex10.3390/metabo13020162Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317734946
W4317702939Network models in bioinformatics: modeling and analysis for complex diseases2023-01-21OpenAlex10.1093/bib/bbad016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317702939
W4317761498Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up2023-01-23OpenAlex10.1016/j.annonc.2022.12.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317761498
W4317863041Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.2023-01-24OpenAlex10.1200/jco.2023.41.4_suppl.tps618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317863041
W4317890310The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation.2023-01-24OpenAlex10.1200/jco.2023.41.4_suppl.tps774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4317890310
W4317829865Trace Element Equilibrium in Acute Heart Failure and the Effect of Empagliflozin2023-01-24OpenAlex10.1002/ejhf.2779Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4317829865
W4318039958Immune-Epithelial Cross Talk in Regeneration and Repair2023-01-25OpenAlex10.1146/annurev-immunol-101721-062818Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318039958
W4318185011Clinical pharmacology of SGLT-2 inhibitors in heart failure2023-01-26OpenAlex10.1080/17512433.2023.2173574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318185011
W4318184345PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS: OVERLAPPING CHALLENGES IN DIAGNOSIS AND TREATMENT2023-01-26OpenAlex10.1093/ibd/izac247.055Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4318184345
W4318203454Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges2023-01-26OpenAlex10.3390/jcm12030953Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318203454
W4318046542The role of transplantation in Hodgkin lymphoma2023-01-26OpenAlex10.3389/fonc.2022.1054314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318046542
W4318263160Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis2023-01-27OpenAlex10.1080/17512433.2023.2173172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318263160
W4318455405Clinical Practice Guidelines for Assessment and Management of Patients Presenting with Psychosocial Crisis2023-01-29OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_485_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318455405
W4318455333Clinical Practice Guidelines for the Use of Transcranial Direct Current Stimulation in Psychiatry2023-01-29OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_496_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318455333
W4318588149Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective2023-01-30OpenAlex10.3389/fcell.2022.1081644Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318588149
W4318539912DOP55 The increasing burden of direct and indirect costs of IBD2023-01-30OpenAlex10.1093/ecco-jcc/jjac190.0095Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318539912
W4318473239Immunomodulatory nanosystems: An emerging strategy to combat viral infections2023-01-30OpenAlex10.1016/j.bbiosy.2023.100073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318473239
W4318482093Kidney Transplant Practice in Pandemic Times2023-01-30OpenAlex10.2215/cjn.0000000000000092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318482093
W4318591331An overview of novel therapies in advanced clinical testing for acute myeloid leukemia2023-01-31OpenAlex10.1080/17474086.2023.2174521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4318591331
W4319068852Evidence for Utilization of Injectable Biologic Augmentation in Primary Rotator Cuff Repair: A Systematic Review of Data From 2010 to 20222023-02-01OpenAlex10.1177/23259671221150037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319068852
W7218677298IMMUNOTHERAPY AGENTS USE FOR TREATMENT OF WARTS2023-02-01OpenAlex10.47750/pnr.2023.14.03.50Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7218677298
W4377094376Innovations triggered by India’s bold vision to end tuberculosis2023-02-01OpenAlex10.4103/ijmr.ijmr_373_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377094376
W4320894692Introduction to the CLER National Report of Findings 2022: The COVID-19 Pandemic and Its Impact on the Clinical Learning Environment2023-02-01OpenAlex10.4300/jgme-d-22-00938.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4320894692
W4319333210Methods to madness: The utility of complex systems science in a mad, mad world2023-02-01OpenAlex10.1111/cdoe.12824Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319333210
W4319320977MicroRNA biosensors for detection of gastrointestinal cancer2023-02-01OpenAlex10.1016/j.cca.2023.117245Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319320977
W4323049577Nipple Day2023-02-01OpenAlex10.14321/fourthgenre.25.1.0034Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4323049577
W7120318727Organizational support perceived by social service public employees: study in the state of Rio Grande do Sul2023-02-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7120318727
W4318997133Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents2023-02-01OpenAlex10.2147/jir.s395137Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4318997133
W4321167944SARS-CoV-2/Omicron subvariants: global outbreak upsurge and expected upcoming threats2023-02-01OpenAlex10.1097/js9.0000000000000240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321167944
W4364862149The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement2023-02-01OpenAlex10.5005/japi-11001-0209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4364862149
W4318818698Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐192023-02-01OpenAlex10.1002/ped4.12362Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4318818698
W4362078397Anna Lvovsky. Vice Patrol: Cops, Courts, and the Struggle over Urban Gay Life before Stonewall.2023-02-02OpenAlex10.1093/ahr/rhad118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362078397
W4319063485Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential2023-02-03OpenAlex10.1002/cmdc.202200666Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4319063485
W4319162246Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma2023-02-03OpenAlex10.3389/fgene.2023.1038924Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319162246
W4319156410The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study2023-02-03OpenAlex10.2196/44277Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319156410
W4319067804Ultrasonography2023-02-03OpenAlex10.1002/9781119533221.ch4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4319067804
W4319071746Hepatitis delta: Epidemiology to recent advances in therapeutic agents2023-02-04OpenAlex10.1097/hep.0000000000000331Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4319071746
W4319321093Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II2023-02-06OpenAlex10.3389/fmed.2023.1136157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319321093
W4319303916Hyperthermie maligne de l’anesthésie2023-02-06OpenAlex10.1016/j.anrea.2023.01.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319303916
W4319304575Nouvelle AMM : crizotinib dans le lymphome anaplasique à grandes cellules systémique ALK positif en pédiatrie2023-02-06OpenAlex10.1016/j.bulcan.2022.12.011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319304575
W4319332953Preparing cardiovascular patients for the operative theatre2023-02-06OpenAlex10.1093/ehjacc/zuad005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319332953
W7218932286“Antimicrobial Susceptibility Pattern and Biofilm Producing Capacity of Wound Infection Isolates – A Clinico-microbiological Study from Tertiary Care Center of Central Gujarat.”2023-02-06OpenAlex10.47750/pnr.2023.14.03.077Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218932286
W4319599511Engineered Biosensors for Diagnosing Multidrug Resistance in Microbial and Malignant Cells2023-02-07OpenAlex10.3390/bios13020235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319599511
W4319444960Treatment of extranodal NK/T-cell lymphoma: From past to future2023-02-07OpenAlex10.3389/fimmu.2023.1088685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4319444960
W4319461517Structural and Functional Analysis of a Highly Active Designed Phosphotriesterase for the Detoxification of Organophosphate Nerve Agents Reveals an Unpredicted Conformation of the Active Site Loop2023-02-08OpenAlex10.1021/acs.biochem.2c00666Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319461517
W4321004789Viral Respiratory Tract Infections in the Immunocompromised Child2023-02-08OpenAlex10.1097/inf.0000000000003855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321004789
W4319662820iPRESTO: Automated discovery of biosynthetic sub-clusters linked to specific natural product substructures2023-02-09OpenAlex10.1371/journal.pcbi.1010462Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4319662820
W4319827715Initial experience with Scepter Mini dual lumen balloon for embolization of cerebrovascular diseases2023-02-10OpenAlex10.7461/jcen.2023.e2022.10.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4319827715
W4319878116Knowledge sharing in a dynamic, multi-level organization: an agent-based modeling approach2023-02-10OpenAlex10.1007/s10588-023-09373-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4319878116
W4320039092Emerging Technologies in Water Treatment: Recent Advances2023-02-11OpenAlex10.5772/intechopen.109063Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4320039092
W4320168159Endoscopic fluorescent lymphography for gastric cancer2023-02-12OpenAlex10.4253/wjge.v15.i2.32Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4320168159
W4320492679Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer2023-02-13OpenAlex10.3390/ijms24043719Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4320492679
W4320496094Editorial: An update on pediatric skeletal system infections2023-02-13OpenAlex10.3389/fped.2023.1128126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4320496094
W4320719837Getting to the Heart of the Issue: Demographics of Hypertrophic Cardiomyopathy2023-02-14OpenAlex10.1016/j.amjmed.2022.07.024Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4320719837
W4320727862Self-Poisoning With Household Bleach in an Elderly Man2023-02-14OpenAlex10.7759/cureus.34957Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4320727862
W4320857324Transitions of care for advanced cancer in post‐acute and long‐term care2023-02-15OpenAlex10.1111/jgs.18291Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4320857324
W4321133142Oral submucous fibrosis: A review on current treatment approaches2023-02-16OpenAlex10.30574/wjbphs.2023.13.2.0088Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321133142
W4321097482Selected Articles from This Issue2023-02-16OpenAlex10.1158/1078-0432.ccr-29-4-hiTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321097482
W4321113920Trends and perspectives on the commercialization of bioactive glasses2023-02-16OpenAlex10.1016/j.actbio.2023.02.020Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4321113920
W4321375676Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond2023-02-17OpenAlex10.3390/cancers15041286Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321375676
W4386058266Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients2023-02-17OpenAlex10.1097/hpc.0000000000000314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386058266
W4321373043Drug Delivery Systems in Regenerative Medicine: An Updated Review2023-02-18OpenAlex10.3390/pharmaceutics15020695Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321373043
W4321351407A theology of chaplaincy from below: changing the locus of theological agency2023-02-19OpenAlex10.1080/1756073x.2023.2168230Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4321351407
W4321459206How I manage mantle cell lymphoma: indolent versus aggressive disease2023-02-20OpenAlex10.1111/bjh.18697Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321459206
W4324136534Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021.2023-02-20OpenAlex10.1200/jco.2023.41.6_suppl.689Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4324136534
W4324136820Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.2023-02-20OpenAlex10.1200/jco.2023.41.6_suppl.76Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4324136820
W4324136453Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US.2023-02-20OpenAlex10.1200/jco.2023.41.6_suppl.572Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4324136453
W4324137093Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818).2023-02-20OpenAlex10.1200/jco.2023.41.6_suppl.tps272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324137093
W4321434834Anthony Monaco, MD, FACS (1932–2022)2023-02-21OpenAlex10.1097/tp.0000000000004506Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321434834
W4321435607Antimicrobial Nanomaterials as Advanced Coatings for Self-Sanitizing of Textile Clothing and Personal Protective Equipment2023-02-21OpenAlex10.1021/acsomega.2c06343Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321435607
W4321499941COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels2023-02-21OpenAlex10.3390/cells12050684Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321499941
W4321464108Clinical and pathophysiological understanding of the hepatorenal syndrome: Still wrong or still not exactly right?2023-02-21OpenAlex10.12998/wjcc.v11.i6.1261Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321464108
W4321463970Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report2023-02-21OpenAlex10.12998/wjcc.v11.i6.1372Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321463970
W4321434650Infected Pseudoaneurysm of the Radial Artery2023-02-21OpenAlex10.1055/a-2039-3563Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321434650
W43217492342022 International Conference on Life, Health and Modern Medicine2023-02-22OpenAlex10.1097/md.0000000000032897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321749234
W4321601037A Fatal Case of Staphylococcus capitis Endocarditis in a Patient With Transcatheter Aortic Valve Replacement2023-02-22OpenAlex10.7759/cureus.35333Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321601037
W4321509620Anabolic steroids2023-02-22OpenAlex10.1016/b978-0-12-824315-2.00306-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321509620
W4321479775Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology2023-02-22OpenAlex10.1002/cnr2.1796Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321479775
W4321496757Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go2023-02-22OpenAlex10.3389/fonc.2023.1148321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321496757
W4321600787Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor2023-02-23OpenAlex10.1002/ajh.26890Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321600787
W4321614711Paediatric sepsis-associated encephalopathy (SAE): a comprehensive review2023-02-23OpenAlex10.1186/s10020-023-00621-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321614711
W4321764355Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario2023-02-24OpenAlex10.1016/j.ctrv.2023.102528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4321764355
W4321785455Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia2023-02-24OpenAlex10.1002/jha2.663Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4321785455
W4322013288Post-Residency Life: How to Build a Successful Career2023-02-25OpenAlex10.1176/appi.pn.2023.03.3.23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4322013288
W4322718549Dynamics of Human Immunodeficiency Virus Type 1 A6 Variant Transmissions Between Poland and Ukraine2023-02-28OpenAlex10.1093/cid/ciad062Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4322718549
W4323319963Editorial: Widely used and novel approaches of the measurement of arterial stiffness and central hemodynamic parameters: Is there a consensus on the horizon?2023-02-28OpenAlex10.3389/fphys.2023.1167257Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323319963
W4322744177Harms, Wrongs, and Medical Moral Injury2023-02-28OpenAlex10.1177/09539468231160015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4322744177
W4322617573LI-RADS: Looking Back, Looking Forward2023-02-28OpenAlex10.1148/radiol.222801Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4322617573
W7215704627Therapeutic pathway of Malian patients suffering from chronic skin diseases at the Dermatology Hospital of Bamako2023-02-28OpenAlex10.5281/hsd.v24i3.4318Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215704627
W4415068082VIRAL DELIVERY SYSTEMS WITHIN THE GENE THERAPY LANDSCAPE2023-02-28OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415068082
W4323351096A235 “WHAT’S SPRUE WITH YOU?”: OLMESARTAN-INDUCED ENTEROPATHY AS AN UNCOMMON MIMICKER OF CELIAC DISEASE2023-03-01OpenAlex10.1093/jcag/gwac036.235Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323351096
W4385670201AIDS dementia complex and neuropsychiatric symptoms : a case report2023-03-01OpenAlex10.1192/j.eurpsy.2023.2039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385670201
W4367018740Abstract Number ‐ 211: Flow Diversion in Direct Carotid‐Cavernous Fistulas: Case Report and Literature Review2023-03-01OpenAlex10.1161/svin.03.suppl_1.211Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367018740
W4322772196Abstract OT1-20-02: Intralesional injection of anti-PD-1 (pembrolizumab) and OX40L/IL-23/IL-36 mRNAs (mRNA-2752) results in regression of DCIS characterized by lymphocytic infiltrates2023-03-01OpenAlex10.1158/1538-7445.sabcs22-ot1-20-02Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322772196
W4322773958Abstract P1-08-07: Educational Opportunities to Improve HER2 Testing and Use of Newer Therapies for HER2-Positive MBC Among Community Healthcare Professionals2023-03-01OpenAlex10.1158/1538-7445.sabcs22-p1-08-07Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322773958
W4322771157Abstract P2-21-10: Tumour associated macrophages in Breast Cancer - Are they critical players in response to Neo Adjuvant Chemotherapy?2023-03-01OpenAlex10.1158/1538-7445.sabcs22-p2-21-10Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322771157
W4360843144Advances in Diagnosis and Therapy of Retinal Diseases2023-03-01OpenAlex10.1097/apo.0000000000000604Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4360843144
W4385669381An update on the Pharmacological and Psychotherapeutic Management of Treatment Resistant OCD2023-03-01OpenAlex10.1192/j.eurpsy.2023.104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385669381
W4365152314CLINICO-MYCOLOGICAL STUDY OF TINEA CAPITIS2023-03-01OpenAlex10.36106/ijar/4201629Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365152314
W4322620372Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy2023-03-01OpenAlex10.1038/s41388-023-02646-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322620372
W4362521695Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment.2023-03-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362521695
W4323971864Conspectus on nanodiagnostics as an incipient platform for detection of oral potentially malignant disorders and oral squamous cell carcinoma2023-03-01OpenAlex10.1097/js9.0000000000000021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323971864
W4362576970Embedding guidelines into clinical practice2023-03-01OpenAlex10.1002/pdi.2447Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362576970
W4322754341Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents2023-03-01OpenAlex10.1182/blood.2022018827Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322754341
W4323923462Introduction to the Carceral Edgelands: Special Issue2023-03-01OpenAlex10.1111/johs.12416Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323923462
W4361251175Networking Print in Shakespeare’s England: Influence, Agency, and Revolutionary Change2023-03-01OpenAlex10.1215/00267929-10189216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361251175
W4323971787Outbreak of tomato flu in India raising concerns: is it a false alarm or are we welcoming a new pandemic?2023-03-01OpenAlex10.1097/js9.0000000000000229Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323971787
W4362674090PART 1: RAAS Blockers – Are They All The Same?2023-03-01OpenAlex10.31762/ahj2332.0101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362674090
W4361196045Prime Time to Focus on Gastrointestinal Endoscopy Quality Improvement2023-03-01OpenAlex10.1055/s-0043-1762918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361196045
W4323533348Systematic review of the management of brain metastases from hormone receptor positive breast cancer2023-03-01OpenAlex10.1007/s11060-023-04276-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323533348
W4362726050The Public Health Perspective of Gonococcal Infection in Neonates2023-03-01OpenAlex10.4103/ijcm.ijcm_1478_21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362726050
W4322631727Thrombotic thrombocytopenic purpura in caplacizumab era – An individualized approach2023-03-01OpenAlex10.1016/j.transci.2023.103682Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322631727
W4322758997Toward an adequate understanding of phenomenological and hermeneutic‐phenomenological nursing research2023-03-01OpenAlex10.1111/nhs.13015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4322758997
W4377093081[Autoimmune/inflammatory syndrome induced by adjuvants. Case report].2023-03-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377093081
W4327680973[Pharmacologic Therapy for Bone Metastases-Current Strategies and Future Directions].2023-03-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4327680973
W4322769284Evolving Treatment Patterns in Diabetic Macular Edema Between 2015 and 20202023-03-02OpenAlex10.1177/24741264231156096Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322769284
W4322768234Using the planetary health framework to assess phytotherapeutic agents in the treatment of benign prostatic hyperplasia2023-03-02OpenAlex10.1016/j.purol.2023.02.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4322768234
W4361228304AI-informed mental health care: A Bibliometric Analysis and Systematic Review (Preprint)2023-03-04OpenAlex10.2196/preprints.46987Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361228304
W4323067070ATR‐FTIR spectrum analysis of plasma samples for rapid identification of recovered COVID ‐19 individuals2023-03-04OpenAlex10.1002/jbio.202200166Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323067070
W4353015451Myocarditis: causes, mechanisms, and evolving therapies2023-03-04OpenAlex10.1080/14728222.2023.2193330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4353015451
W4323267579Safety of Andexanet Alfa Use in Cardiac Surgery2023-03-05OpenAlex10.1053/j.jvca.2023.02.039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323267579
W4397037624Study to Evaluate the Effectiveness of Structured Teaching Programme on Knowledge of Primary School Teachers Regarding Identification of Behavioral Related Emotional Problems among Children between Six to Ten Years in Selected Primary Schools at Bangalore2023-03-05OpenAlex10.21275/sr23301203634Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397037624
W4323311630Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care2023-03-06OpenAlex10.3390/biomedicines11030790Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323311630
W4323315678Editorial: Leishmania genome variability: Impacts on parasite evolution, parasitism and leishmaniases control2023-03-06OpenAlex10.3389/fcimb.2023.1171962Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323315678
W4323348833Definition der Hüftdysplasie im Jahr 20232023-03-07OpenAlex10.1007/s00132-023-04353-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323348833
W4323662042Emergence of Multidrug Resistance Microbes: Bacteria, Fungi, and Viruses2023-03-07OpenAlex10.2174/9789815080056123020005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323662042
W4323356434Escherichia coli2023-03-07OpenAlex10.1201/9781003155447-11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323356434
W4323351497Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?2023-03-07OpenAlex10.1093/clinchem/hvad016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323351497
W4323362942The biology and treatment of leiomyosarcomas2023-03-07OpenAlex10.1016/j.critrevonc.2023.103955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323362942
W4323652154Patient‐centricity: Research's new shibboleth?2023-03-08OpenAlex10.1111/jep.13830Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323652154
W4323545761Strategies to target the cancer driver MYC in tumor cells2023-03-08OpenAlex10.3389/fonc.2023.1142111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323545761
W4323531728Supporting critically conscious integrated care: A toolbox for the health professions2023-03-08OpenAlex10.1111/tct.13569Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323531728
W4323653382Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach2023-03-09OpenAlex10.1371/journal.pone.0282587Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323653382
W4323666640Situating personality disorder within its maladaptive narrative identity ecology2023-03-09OpenAlex10.3389/fpsyt.2023.1117525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4323666640
W4323665760The Ethics of Monadic Identity in Leibniz's Thought2023-03-09OpenAlex10.18662/brain/14.1/434Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4323665760
W4323860102Editorial: Application of the biogenic silver nanoparticles as antimicrobial and anticancer agents2023-03-10OpenAlex10.3389/fchem.2023.1180027Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4323860102
W4323921292Spectral imaging enables contrast agent–free real-time ischemia monitoring in laparoscopic surgery2023-03-10OpenAlex10.1126/sciadv.add6778Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4323921292
W4323928385Acute profound thrombocytopenia induced by tirofiban in stent assisted embolization of intracranial ruptured aneurysm-a rare case report2023-03-11OpenAlex10.1016/j.heliyon.2023.e14504Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4323928385
W4324296881Asynchronous Decentralized Federated Lifelong Learning for Landmark Localization in Medical Imaging2023-03-12OpenAlex2303.0678310.48550/arxiv.2303.06783Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4324296881
W4327597315Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience2023-03-13OpenAlex10.17650/1818-8346-2023-18-1-12-19Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327597315
W4324088165Editorial: Recent Advances on Myocardium Physiology, Volume II2023-03-13OpenAlex10.3389/fphys.2023.1170396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324088165
W4324117788Targeted therapies in advanced biliary tract cancers—a narrative review2023-03-14OpenAlex10.21037/cco-22-93Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324117788
W4324128561Thrombolytic treatment of life-threatening pulmonary embolism in times of alteplase shortage2023-03-14OpenAlex10.1093/eurheartj/ehad120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324128561
W4361005422A review on spinal muscular atrophy: An inherited neuromuscular disease2023-03-15OpenAlex10.18231/j.ijcaap.2023.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361005422
W4375865426Clinical Experience with Epigenetic Drugs in Lymphoid Malignancies2023-03-15OpenAlex10.1002/9781119819950.ch16Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4375865426
W4324378503Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option2023-03-15OpenAlex10.3389/fimmu.2023.1118246Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324378503
W4324359014Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility2023-03-15OpenAlex10.1186/s12967-023-04041-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4324359014
W4327619162Brain science in American courts: the culpable neurotransmitters2023-03-16OpenAlex10.1108/jfp-05-2022-0028Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4327619162
W7212465267Checkpoint and inflammatory markers in chronic colitis and colorectal cancer2023-03-16OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212465267
W4327692917Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research2023-03-17OpenAlex10.1016/j.clgc.2023.03.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327692917
W4327747194Postural evaluation in horses submitted to perineural anesthetic blocks in the thoracic limbs2023-03-17OpenAlex10.56238/devopinterscie-030Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4327747194
W4327694592The Clinical Journey of a Patient with Familial Mediterranean Fever: One Gene, Three Diseases2023-03-17OpenAlex10.1055/a-2000-5516Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327694592
W4327906119A Significant Role of Nontypeable Haemophilus influenzae in Acute Otitis Media in Bulgarian Children2023-03-20OpenAlex10.1055/s-0043-1764213Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4327906119
W7139491100Developing an ethical framework of AI in healthcare : reflections for the construction of an operational ethical framework through the example of medical oncology2023-03-20OpenAlexTitle/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7139491100
W4360613302Bonding Technologies in Young Permanent Molars: A Case Series2023-03-21OpenAlex10.5005/jp-journals-10005-2503Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4360613302
W4328052280Emerging, re‐emerging and/or atypically behaving infectious diseases2023-03-21OpenAlex10.1111/apa.16744Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4328052280
W4328094108Telemedicine, E-Health, and Multi-Agent Systems for Chronic Pain Management2023-03-21OpenAlex10.3390/clinpract13020042Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4328094108
W4353041088The management of polypharmacy in people living with HIV2023-03-22OpenAlex10.24875/aidsrev.m23000059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4353041088
W436061512630 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma2023-03-23OpenAlex10.3390/cancers15071929Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4360615126
W4360611871Fluorescent Magnetic Quantum Dots in Bioimaging2023-03-23OpenAlex10.1201/9781003319870-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4360611871
W4360620253Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection2023-03-23OpenAlex10.1016/j.jtbi.2023.111470Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4360620253
W4360874527An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?2023-03-24OpenAlex10.1016/j.cjca.2023.03.019Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4360874527
W4360949464Recent advances in targeted therapies in acute myeloid leukemia2023-03-25OpenAlex10.1186/s13045-023-01424-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4360949464
W4360976444Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading2023-03-26OpenAlex10.1186/s12967-023-04064-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4360976444
W43610078272023 update on the clinical management of gastroparesis2023-03-27OpenAlex10.1080/17474124.2023.2196404Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361007827
W4380628180Author response: Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX32023-03-27OpenAlex10.7554/elife.78601.sa2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380628180
W4361011332Editorial: Insights in integrative physiology: 20212023-03-27OpenAlex10.3389/fphys.2023.1186581Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361011332
W4366005792All-Fabric Triboelectric Nanogenerator (AF-TENG) Smart Face Mask: Remote Long-Rate Breathing Monitoring and Apnea Alarm2023-03-28OpenAlex10.5281/zenodo.7835255Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366005792
W4362601118Cardiac medications in obstetric patients2023-03-28OpenAlex10.1097/hco.0000000000001039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362601118
W4361204288Crystallized Intelligence Wisdom Repository Management System with a Conversational Agent2023-03-28OpenAlex10.5539/ies.v16n2p150Full textExcludedF3: The medical-student repository chatbot uses pattern matching, intent classification, retrieval and conventional RNN-style generation. Its implemented system does not establish an LLM-based acting agent.https://openalex.org/W4361204288https://doi.org/10.5539/ies.v16n2p150
W4361190156Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment2023-03-28OpenAlex10.1007/s13105-023-00954-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361190156
W4361216707Recent advances in 3D printed microneedles and their skin delivery application in the treatment of various diseases2023-03-28OpenAlex10.1016/j.jddst.2023.104395Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361216707
W4361190668Time for the Next Step in Clinical Trial Evolution?2023-03-28OpenAlex10.1002/ana.26655Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361190668
W4361284754Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?2023-03-29OpenAlex10.1158/1078-0432.ccr-23-0393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361284754
W4361270396Mania Associated with Cabergoline: a Brazilian Case Report2023-03-29OpenAlex10.22533/at.ed.15932023270310Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4361270396
W4361195771Pentosan polysulfate maculopathy: a brief primer for general practitioners, ophthalmologists, optometrists and urologists2023-03-29OpenAlex10.5694/mja2.51913Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4361195771
W4361198241Polymeric Stimuli Responsive Theranostic Agents2023-03-29OpenAlex10.1201/9781003411468-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4361198241
W4361197110Sedation strategies in patients undergoing extracorporeal cardiopulmonary resuscitation2023-03-29OpenAlex10.1093/ehjacc/zuad028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361197110
W4361305979Stress induced immunomodulation and the risk of infections during major sporting events: Implications for the FIFA World Cup 20222023-03-29OpenAlex10.1016/j.jiph.2023.03.024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361305979
W4361195507Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past2023-03-29OpenAlex10.1016/s2352-3026(23)00064-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4361195507
W4361259762Chaotic fractals: Why chaos is the dynamic of carcinogenesis2023-03-30OpenAlex10.1002/cai2.63Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361259762
W4392724684Data from A Chemosensitization Screen Identifies TP53RK, a Kinase that Restrains Apoptosis after Mitotic Stress2023-03-30OpenAlex10.1158/0008-5472.c.6500558.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392724684; https://openalex.org/W4361822730
W4361256348Data from Cellular Targets of Gefitinib2023-03-30OpenAlex10.1158/0008-5472.c.6493059.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4361256348; https://openalex.org/W4361268539
W4407264566FREQUENCY OF INTRANASAL ADHESIONS IN SEPTOPLASTY WITHOUT NASAL SPLINTS IN CASES OF NASAL SEPTAL DEVIATION2023-03-30OpenAlex10.53555/sbcmpj45Full textExcludedF3: The original surgical methods and results describe 198 human septoplasty cases, without a computational LLM agent. The DoctorAssist abstract was mis-indexed and is not the surgical method.https://openalex.org/W4407264566https://www.researchgate.net/publication/388818830_FREQUENCY_OF_INTRANASAL_ADHESIONS_IN_SEPTOPLASTY_WITHOUT_NASAL_SPLINTS_IN_CASES_OF_NASAL_SEPTAL_DEVIATIONoriginal methods and results, public full-text copy; publisher PDF fetch403
W4367315570Prevalence of Hypertension among HIV/AIDS Patients Attending a Tertiary Hospital in North-East Nigeria2023-03-30OpenAlex10.21522/tijph.2013.11.01.art031Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367315570
W4361953531Data from Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting2023-03-31OpenAlex10.1158/1078-0432.c.6529751.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4361953531; https://openalex.org/W4361959648
W7119370029EXPRESSÃO DA PROTEÍNA P16 COMO ELEMENTO PREDITIVO DA EVOLUÇÃO DAS LESÕES INTRAEPITELIAIS DE BAIXO GRAU: UMA REVISÃO SISTEMÁTICA2023-03-31OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119370029
W4362460255Inflammatory bowel disease in pregnancy and breastfeeding2023-03-31OpenAlex10.1038/s41575-023-00758-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362460255
W4385966177Muscle activity and emotional behavior changes in rats with chronic brain ischemia via comprehensive pathogenetic correction2023-03-31OpenAlex10.12775/jehs.2023.13.03.054Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385966177
W4362474810Precision Oncology Targets in Biliary Tract Cancer2023-03-31OpenAlex10.3390/cancers15072105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362474810
W4362519871The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-22023-03-31OpenAlex10.1016/j.antiviral.2023.105590Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362519871
W4365151472Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer2023-03-31OpenAlex10.52679/tabcj.2023.0002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365151472
W43627363322023-04-01OpenAlex10.13040/ijpsr.0975-8232.14(4).1649-59Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362736332
W4362586435(655) Outcomes of Immunosuppression Reduction During Covid-19 Infection in Heart Transplant Patients2023-04-01OpenAlex10.1016/j.healun.2023.02.669Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362586435
W4367675661A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input2023-04-01OpenAlex10.36849/jdd.7456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367675661
W4366438848A review of Zenalb 20 with the focus on its application in the clinical setting for patients requiring low sodium or chloride albumin2023-04-01OpenAlex10.1093/rpsppr/rqad015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366438848
W4362693009A review on drug-induced dry eye disease2023-04-01OpenAlex10.4103/ijo.ijo_2782_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362693009
W4367186666Afterword2023-04-01OpenAlex10.1215/00138282-10293195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367186666
W4380050464Air pollution and cardiovascular heath in a changing climate2023-04-01OpenAlex10.1097/cp9.0000000000000051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380050464
W4387506418Aldosterone Pathway Blockade Therapies for Resistant Hypertension: An Update2023-04-01OpenAlex10.4103/rcm.rcm_30_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387506418
W4364382146Autonomous optimization of neuroprosthetic stimulation parameters that drive the motor cortex and spinal cord outputs in rats and monkeys2023-04-01OpenAlex10.1016/j.xcrm.2023.101008Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4364382146
W4366424702CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code2023-04-01OpenAlex10.2147/lctt.s403461Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366424702
W7112302890Cyberbiosecurity. A short review2023-04-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7112302890
W4367056539David L. Mathewson. Voice and Mood: A Linguistic Approach2023-04-01OpenAlex10.5325/bullbiblrese.33.1.0098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367056539
W4362575878Emergence and History2023-04-01OpenAlex10.1215/21599785-10253259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362575878
W4385494283Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy2023-04-01OpenAlex10.4103/crst.crst_176_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385494283
W4366000193Is meat eating morally defensible? Contemporary ethical considerations2023-04-01OpenAlex10.1093/af/vfac097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366000193
W4376620946Lived Experience in Social Work: An Underutilised Expertise2023-04-01OpenAlex10.1093/bjsw/bcad028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376620946
W4362692839Newer paradigms in dry eye disease research2023-04-01OpenAlex10.4103/ijo.ijo_599_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362692839
W4366831664P146 Pragmatic Biologic Tapering Combining Clinical and Ultrasound Assessment in Patients with Rheumatoid Arthritis in Routine Clinical Practice - Predictors of Failure from a Regional Centre in UK2023-04-01OpenAlex10.1093/rheumatology/kead104.187Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366831664
W4382045356Practicing pediatric regional anesthesia: Children are not small adults2023-04-01OpenAlex10.4103/joacp.joacp_248_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382045356
W4362577626Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?2023-04-01OpenAlex10.3390/cancers15072113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362577626
W4385494354Rare kidney tumor2023-04-01OpenAlex10.4103/crst.crst_275_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385494354
W4376621004The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine2023-04-01OpenAlex10.6004/jadpro.2023.14.3.18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376621004
W4362502160The Old Meets the New: Efficacy and Mechanisms of Biophotonic Therapies in Viral and Microbial Illness2023-04-01OpenAlex10.9734/bpi/ramb/v4/5464eTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362502160
W7163874347There Is No Consensus on the Myocardial Ischemia/Reperfusion Injury Induction Methods in Animal Studies2023-04-01OpenAlex10.22037/jpem.v10i1.41497Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163874347
W4377094254Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada2023-04-01OpenAlex10.1177/08830738231176588Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377094254
W4367174488Understanding Nephrotic Syndrome Using Kidney Transcriptome Profiling and Computational Studies2023-04-01OpenAlex10.34067/kid.0000000000000117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367174488
W4386135055Author response: Novel pathogen introduction triggers rapid evolution in animal social movement strategies2023-04-02OpenAlex10.7554/elife.81805.sa2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386135055
W4387983788The Rising Horizon of Silver Diamine Fluoride as an Anti-Caries Agent in Pediatric Dentistry: A Narrative Literature Review2023-04-02OpenAlex10.5866/2023.13.10013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387983788
W4392699170Data from GPER-Targeted, 99mTc-Labeled, Nonsteroidal Ligands Demonstrate Selective Tumor Imaging and In Vivo Estrogen Binding2023-04-03OpenAlex10.1158/1541-7786.c.6539791.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392699170; https://openalex.org/W4392688829
W4392699980Data from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers2023-04-03OpenAlex10.1158/1541-7786.c.6541339.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392699980; https://openalex.org/W4362541716
W4392697529Data from Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors2023-04-03OpenAlex10.1158/1535-7163.c.6537469.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392697529; https://openalex.org/W4392681501
W4392689822Data from Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model2023-04-03OpenAlex10.1158/1940-6207.c.6543790Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392689822; https://openalex.org/W4392701179
W4362542062Data from UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells2023-04-03OpenAlex10.1158/1541-7786.c.6541335Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362542062; https://openalex.org/W4392700163
W4362579266ERCP: a very personal history2023-04-03OpenAlex10.1097/cld.0000000000000028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362579266
W4362559529Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones2023-04-03OpenAlex10.3390/jcm12072675Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362559529
W4362544012Abstract 1568: Mechanistic studies of KL-50, a novel imidazotetrazine for the treatment of MGMT-/MMR- gliomas and glioblastoma2023-04-04OpenAlex10.1158/1538-7445.am2023-1568Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362544012
W4362593475Abstract 2694: Blockade of the cyclooxygenase-2 prevents chemotherapy-induced cognitive impairments2023-04-04OpenAlex10.1158/1538-7445.am2023-2694Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362593475
W4362593197Abstract 3172: Mapping the molecular landscape of acute myeloid leukemia enables prediction of drug response from proteogenomic data2023-04-04OpenAlex10.1158/1538-7445.am2023-3172Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362593197
W4362596037Abstract 3578: Using a novel [68Ga]-radiolabeled peptide to detect cell surface expression of calreticulin in pancreatic adenocarcinoma2023-04-04OpenAlex10.1158/1538-7445.am2023-3578Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362596037
W4362534914Abstract 3922: Assessing clonal evolution of myeloid neoplasms by flow cytometry guided, cell-enriched next generation sequencing2023-04-04OpenAlex10.1158/1538-7445.am2023-3922Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362534914
W4362595634Abstract 4675: Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy2023-04-04OpenAlex10.1158/1538-7445.am2023-4675Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362595634
W4380029736Abstract 6253: SP-3164, a novel molecular glue degrader with activity in preclinical models of multiple myeloma2023-04-04OpenAlex10.1158/1538-7445.am2023-6253Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380029736
W4362594095Abstract 6390: N17350 is an emerging therapeutic modality that selectively kills cancer cells and stimulates anti-tumor immunity2023-04-04OpenAlex10.1158/1538-7445.am2023-6390Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362594095
W4379984252Abstract 6625: Mathematical modeling of single-cell data reveals the key role of stochasticity - not fitness - in determining the clonal origins of relapse in childhood leukemia2023-04-04OpenAlex10.1158/1538-7445.am2023-6625Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4379984252
W4362592333Abstract 973: Uncovering gene signatures of Ewings sarcoma drug sensitivity during the evolution of resistance2023-04-04OpenAlex10.1158/1538-7445.am2023-973Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362592333
W4362595630Abstract PL02-04: Malignancies in People with HIV: Successes and Challenges at the Intersection of Virology, Immunology, and Oncology2023-04-04OpenAlex10.1158/1538-7445.am2023-pl02-04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362595630
W4362521758Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania2023-04-04OpenAlex10.1371/journal.ppat.1010893Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362521758
W4362548499Data from Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes2023-04-04OpenAlex10.1158/2643-3230.c.6551018Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362548499; https://openalex.org/W4362547593
W4362547037Data from Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade2023-04-04OpenAlex10.1158/2767-9764.c.6550542.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362547037; https://openalex.org/W4362525199
W4362561271Editorial: Emerging concepts in Mycobacterium tuberculosis pathogenesis: Host-pathogen interaction and stress adaption mechanisms2023-04-04OpenAlex10.3389/fcimb.2023.1148756Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362561271
W4362612931Determination of the Antioxidant and Antiproliferative Properties of Pomegranate Peel Extract Obtained by Ultrasound on HCT-116 Colorectal Cancer Cell Line2023-04-05OpenAlex10.3390/pr11041111Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362612931
W4362695654Epidemiological profile of pesticide poisoning cases in the State of Sergipe, Brazil: a retrospective analysis from 2007 to 20212023-04-05OpenAlex10.33448/rsd-v12i4.41127Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362695654
W4362609757Evolving Diagnostic and Management Advances in Coronary Heart Disease2023-04-05OpenAlex10.3390/life13040951Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4362609757
W4362640955Financial toxicity of oral therapies in advanced prostate cancer2023-04-05OpenAlex10.1016/j.urolonc.2023.03.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362640955
W4362634632The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer2023-04-05OpenAlex10.1016/j.hoc.2023.02.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362634632
W4362666608Car-T Hücre Tedavi Sistemi2023-04-06OpenAlex10.53478/tuba.978-625-8352-48-1.ch19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362666608
W4362660027Focal liver lesions in the setting of chronic liver disease2023-04-06OpenAlex10.1016/b978-0-323-87479-3.00022-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362660027
W4362689982Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival2023-04-07OpenAlex10.21037/jtd-22-1481Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362689982
W4362692726Comparison of human monkeypox, chickenpox and smallpox: a comprehensive review of pathology and dermatological manifestations2023-04-07OpenAlex10.1080/03007995.2023.2200122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4362692726
W4362697953Health-related Quality of Life and Cost Effectiveness of Treatment: Components to Be Included in Clinical Decision-making2023-04-07OpenAlex10.1016/j.euo.2023.03.011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362697953
W4362722515Is There a Role of Artificial Intelligence in Preclinical Imaging?2023-04-08OpenAlex10.1053/j.semnuclmed.2023.03.003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4362722515
W4362723845Effect of probiotics as an immune modulator for the management of COVID-192023-04-09OpenAlex10.1007/s00203-023-03504-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4362723845
W4363624516Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking2023-04-10OpenAlex10.1101/2023.04.08.536123Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4363624516
W4367299816Changing the strategic paradigm for the treatment of adult acute myeloid leukemia2023-04-10OpenAlex10.5124/jkma.2023.66.4.234Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367299816
W4377103548Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention2023-04-10OpenAlex10.4103/1673-5374.373664Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377103548
W4377103910TREM2 as an evolving therapeutic target in Alzheimer’s disease2023-04-10OpenAlex10.4103/1673-5374.371360Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377103910
W4363677308The More Things Change…2023-04-10OpenAlex10.1016/j.thorsurg.2023.02.002Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4363677308
W4365483731Back to the Future II—A Comprehensive Update on the Rapidly Evolving Field of Lymphatic Imaging and Interventions2023-04-11OpenAlex10.1097/rli.0000000000000966Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365483731
W4365142399Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy2023-04-11OpenAlex10.3390/cancers15082240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365142399
W4364361731This Month in Anesthesiology2023-04-11OpenAlex10.1097/aln.0000000000004561Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4364361731
W4365143025Dynamics and specificities of T cells in cancer immunotherapy2023-04-12OpenAlex10.1038/s41568-023-00560-yTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4365143025
W4365148457Orthobiologics in the knee2023-04-12OpenAlex10.1016/j.mporth.2023.03.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365148457
W4367173556The Management of Relapsed and Refractory Multiple Myeloma2023-04-12OpenAlex10.46883/2023.25920991Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367173556
W4365795802Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs2023-04-13OpenAlex10.4103/1673-5374.373685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365795802
W4365443195Imaging Patients with Kidney Failure2023-04-13OpenAlex10.1148/rg.220116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365443195
W4365795766Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease2023-04-13OpenAlex10.4103/1673-5374.374003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365795766
W4365443688Protracted viral infections in patients with multiple myeloma receiving bispecific T-cell engager therapy targeting B-cell maturation antigen2023-04-13OpenAlex10.3324/haematol.2023.283003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365443688
W4365795794Repurposing niclosamide for the treatment of neurological disorders2023-04-13OpenAlex10.4103/1673-5374.373705Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4365795794
W4365450922Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer2023-04-13OpenAlex10.1016/j.ccell.2023.04.005Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4365450922
W4365511661Abstract LB130: Single-cell multiomics analysis of myelodysplastic syndrome predicts clinical response to DNA methylation inhibitor therapy2023-04-14OpenAlex10.1158/1538-7445.am2023-lb130Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365511661
W4365483035New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)2023-04-14OpenAlex10.1007/s11864-023-01076-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4365483035
W4366217148Emerging evidence and treatment paradigm of non-small cell lung cancer2023-04-17OpenAlex10.1186/s13045-023-01436-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366217148
W4366089987Mediality as a Mode of Existence: Technologies, Bodies, Matters2023-04-17OpenAlex10.14220/trns.2023.2.1.147Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366089987
W4379519343Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update2023-04-17OpenAlex10.3233/jpd-239901Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379519343
W4366083030Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections2023-04-17OpenAlex10.1128/cmr.00059-22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366083030
W4366263118Hybrid morphologies of paramagnetic manganese-based nanoparticles as theranostics2023-04-18OpenAlex10.1016/j.cej.2023.142970Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366263118
W4366308855Temperature-Induced Contrast Enhancement for Radar-Based Breast Tumor Detection at K-Band Using Tissue Mimicking Phantoms2023-04-18OpenAlex10.1109/jerm.2023.3265510Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366308855
W4366350970Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects2023-04-19OpenAlex10.1080/14779072.2023.2201437Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366350970
W4366438945CAR T-Cell Therapy Shows Superior PFS in R/R Multiple Myeloma2023-04-19OpenAlex10.1097/01.cot.0000932004.13185.49Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366438945
W4366439897Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature2023-04-19OpenAlex10.1038/s41698-023-00375-yTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366439897
W4366578520Genomic features, antimicrobial susceptibility, and epidemiological insights into Burkholderia cenocepacia clonal complex 31 isolates from bloodstream infections in India2023-04-19OpenAlex10.3389/fcimb.2023.1151594Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366578520
W4366491558Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy2023-04-20OpenAlex10.1016/j.prp.2023.154473Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366491558
W4366464218What Is the Best Surgical Intervention for Patients With Idiopathic Intracranial Hypertension?2023-04-20OpenAlex10.1097/wno.0000000000001856Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366464218
W4366699714Antimicrobial agents2023-04-21OpenAlex10.1016/b978-0-12-824315-2.00946-5Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4366699714
W4366774890Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis2023-04-21OpenAlex10.1186/s12879-023-08209-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366774890
W4366603023Provider-directed analgesia for dental pain2023-04-21OpenAlex10.1080/17512433.2023.2206118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366603023
W4366779516Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon2023-04-23OpenAlex10.1016/j.gore.2023.101186Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366779516
W4366779319The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments2023-04-23OpenAlex10.1016/j.jhep.2023.04.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366779319
W3090350409A comparative study of bacterial contamination between open heart surgery wards and neurosurgery wards2023-04-24OpenAlex10.25130/tjphs.2013.11.1.1.1.14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W3090350409
W4366817338Aircraft noise and cardiovascular risk: are we witnessing an evolving risk factor of the future?2023-04-24OpenAlex10.1093/eurjpc/zwad129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366817338
W4366819512Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors2023-04-24OpenAlex10.1080/07853890.2023.2203946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4366819512
W4366821757Evolving from Didactic to Dialogic: How to Improve Faculty Development and Support Faculty Developers by Using Action Research2023-04-24OpenAlex10.1080/10401334.2023.2204091Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366821757
W4366815263The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Define Relevant Molecular Interactions with the Host2023-04-24OpenAlex10.20944/preprints202304.0823.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366815263
W4366988345Withania somnifera seed oil exhibits antibiofilm properties against drug-resistant Candida auris clinical isolate through modulation in cell permeability2023-04-24OpenAlex10.1093/jambio/lxad087Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366988345
W4386310383A Dual Beta Blocker and Calcium Channel Blocker Overdose in a Patient with Substance Abuse2023-04-25OpenAlex10.59657/2837-4681.brs.23.025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386310383
W4378716441Depression as a Prodromal Symptom of Neurodegenerative Diseases2023-04-25OpenAlex10.1272/jnms.jnms.2023_90-216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378716441
W4366992539Hormones and COVID-192023-04-25OpenAlex10.1016/j.mayocp.2023.04.010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366992539
W4366989494Ten characteristics of high-quality planetary health education—Results from a qualitative study with educators, students as educators and study deans at medical schools in Germany2023-04-25OpenAlex10.3389/fpubh.2023.1143751Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4366989494
W4367047646Bringing the Promise of Artificial Intelligence to Critical Care: What the Experience With Sepsis Analytics Can Teach Us2023-04-26OpenAlex10.1097/ccm.0000000000005894Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367047646
W4367056836The NOMS approach to metastatic tumors: Integrating new technologies to improve outcomes2023-04-26OpenAlex10.1016/j.recot.2023.04.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367056836
W4367185912Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria2023-04-27OpenAlex10.1097/mjt.0000000000001609Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367185912
W4367311096A global perspective on gun violence injuries2023-04-28OpenAlex10.1016/j.injury.2023.04.050Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367311096
W4367302247Clade-Specific MPXV PCR Assays2023-04-28OpenAlex10.1101/2023.04.24.538151Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367302247
W4367301771Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients2023-04-28OpenAlex10.1016/j.cpccr.2023.100242Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367301771
W4367307485Radiotherapeutic palliation of bone marrow diseases—leukemia and multiple myeloma2023-04-28OpenAlex10.1016/b978-0-323-87688-9.00028-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367307485
W4367298189The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer2023-04-28OpenAlex10.1007/s12149-023-01839-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367298189
W4367316583USE OF SODIUM-GLUCOSE TRANSPORT PROTEIN 2 (SGLT2) INHIBITORS IN DIABETIC KIDNEY DISEASE (DKD)2023-04-28OpenAlex10.53555/nnmhs.v9i4.1653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367316583
W4367301444Infodemic- A new rapidly evolving virtual communicable pandemic with global threat! Hypothetical or real?2023-04-29OpenAlex10.53346/wjapmr.2023.4.2.0023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367301444
W4367553231A kórházi túlélést meghatározó tényezők a COVID–19-járvány 3. és 4. hulláma idején súlyos koronavírus-fertőzéssel intenzív osztályra felvett betegekben2023-04-30OpenAlex10.1556/650.2023.32762Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367553231
W4382398399El microbio: Camino biológico a través de la especie humana2023-04-30OpenAlex10.52808/bmsa.8e7.632.00Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382398399
W4375951405Emicizumab Prophylaxis in Patients with Hemophilia A Undergoing Immune Tolerance Induction Therapy: A Systematic Review2023-04-30OpenAlex10.17480/psk.2023.67.2.75Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4375951405
W4377246392(417) Erectile Function after Treatment for Non-ischemic Priapism2023-05-01OpenAlex10.1093/jsxmed/qdad060.391Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377246392
W43786113051015 Chasing after Sleep in ROHHAD syndrome2023-05-01OpenAlex10.1093/sleep/zsad077.1015Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4378611305
W4367595323A Rare Presentation of Hydralazine-Induced Lupus in the Setting of Pericarditis With Concomitant Angioedema2023-05-01OpenAlex10.7759/cureus.38376Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367595323
W4367599184Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition2023-05-01OpenAlex10.1038/s41589-023-01320-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4367599184
W4380051196Beliefs as dispositions to make judgments2023-05-01OpenAlex10.1111/phpr.12993Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380051196
W4372333625Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.2023-05-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4372333625
W4377041222Commentary: Current concepts, recent updates, and future treatment options for Pythium insidiosum keratitis2023-05-01OpenAlex10.4103/ijo.ijo_80_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377041222
W4379507096Different diabetes2023-05-01OpenAlex10.1002/pdi.2451Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379507096
W4366820609Efficacy of a chairside extraoral suction system in the reduction of aerosol contamination.2023-05-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4366820609
W4391897684From Doctor–Patient to Doctor–Community: Embedding a Public Health Approach in Psychiatry2023-05-01OpenAlex10.4103/wsp.wsp_34_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391897684
W4378234224Insights into the Role of Inflammation in the Management of Atherosclerosis2023-05-01OpenAlex10.2147/jir.s276982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378234224
W4381309666Leveraging Innovation to Mitigate Risk During Heart Surgery2023-05-01OpenAlex10.14503/thij-23-8214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381309666
W4367692965Multiplying Preclinical Models for Multiple Myeloma2023-05-01OpenAlex10.1097/hs9.0000000000000898Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367692965
W4377044073My tryst with academia – Reflections from an era gone by2023-05-01OpenAlex10.4103/ijo.ijo_865_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377044073
W4367601934Navigating Available Treatment Options for Carbapenem-ResistantAcinetobacter baumannii-calcoaceticusComplex Infections2023-05-01OpenAlex10.1093/cid/ciad094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4367601934
W4376868640New Books across the Disciplines2023-05-01OpenAlex10.1215/10829636-10416684Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376868640
W4387756545Optimal Health in Rheumatology: The Unmet Need of the Hour?2023-05-01OpenAlex10.4103/injr.injr_114_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387756545
W4382619420P40 REAL-WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD-LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE2023-05-01OpenAlex10.1097/01.hs9.0000936288.27701.b7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382619420
W4376134798P60 EVOLVING OUTCOMES OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA: 20-YEARS SINGLE CENTER EXPERIENCE2023-05-01OpenAlex10.1097/01.hs9.0000936368.13093.f4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376134798
W4367673975Patient characteristics, management, and outcomes of acute myocardial infarction due to unprotected left main stem occlusion: insights from a real-world multicentre registry over a 12-year period2023-05-01OpenAlex10.1093/ehjacc/zuad036.053Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4367673975
W4379157893Prostate Cancer Survivorship Today: Support that Spans the Journey2023-05-01OpenAlex10.1016/j.euf.2023.05.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379157893
W4380075693Quality incident management2023-05-01OpenAlex10.1111/1744-1633.12634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380075693
W4377291466Standardizing Anaphylaxis Treatment in Pediatric Care Settings2023-05-01OpenAlex10.1097/pq9.0000000000000652Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377291466
W4367553815Synthesis and Determination of Antimicrobial Efficacies of Secondary Metabolite of Streptomyces longisporoflavus and its 3D-Protein Structural Prediction2023-05-01OpenAlex10.9734/jamps/2023/v25i3605Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4367553815
W4385318580TRANSCON 2022 B: Poster Papers2023-05-01OpenAlex10.4103/0973-6247.377173Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385318580
W4382316222TRANSMEDCON 2022: E-Poster Abstracts2023-05-01OpenAlex10.4103/0973-6247.377170Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382316222
W4376106538Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1/2-Mutated Breast Cancers in the High-Risk, Early-Stage Setting2023-05-01OpenAlex10.1200/po.22.00446Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376106538
W4381469772The Evolving Story of JAK Inhibitors for Treating Alopecia Areata: A Review of Current Progress and Future Directions.2023-05-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381469772
W4389631329William James, W. E. B. Du Bois, and the Art of New Religious Ideals2023-05-01OpenAlex10.5406/21564795.44.2.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389631329
W4367671353Tools and/or Agents? Reflections on Sedlakova and Trachsel’s Discussion of Conversational Artificial Intelligence2023-05-02OpenAlex10.1080/15265161.2023.2191053Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4367671353
W4368372535Aspergillosis: an Update on Clinical Spectrum, Diagnostic Schemes, and Management2023-05-04OpenAlex10.1007/s12281-023-00461-5Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4368372535
W4368366360Dravet Syndrome2023-05-04OpenAlex10.1201/9781003296478-23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4368366360
W4368366246Engineered Monoamine Oxidase-Catalyzed Deracemization of Sterically Hindered Acylaminomethyl-tetrahydroisoquinoline: Asymmetric Synthesis of (R)-(−)-Praziquantel and Its Analogues2023-05-04OpenAlex10.1021/acssuschemeng.3c00985Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4368366246
W4368340750Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs2023-05-04OpenAlex10.1016/j.jhepr.2023.100784Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4368340750
W4368357532Maintenance therapy in acute myeloid leukemia: advances and controversies2023-05-04OpenAlex10.3324/haematol.2022.281810Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4368357532
W4376630468Molecular Target and Action Mechanism of Anti-Cancer Agents2023-05-04OpenAlex10.3390/ijms24098259Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4376630468
W4368360221Professional Identity Formation in Medical Education: Some Virtue-Based Insights2023-05-04OpenAlex10.1080/10401334.2023.2209067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4368360221
W4368365635Prospects for gene therapy2023-05-04OpenAlex10.1201/9781003423805-11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4368365635
W4372348786Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum2023-05-05OpenAlex10.1016/j.nefroe.2023.04.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4372348786
W4372295529Machine and deep learning in inflammatory bowel disease2023-05-05OpenAlex10.1097/mog.0000000000000945Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4372295529
W4377564595Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development2023-05-05OpenAlex10.3389/fmed.2023.1155751Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377564595
W4375932677Offline reinforcement learning methods for real-world problems2023-05-08OpenAlex10.1016/bs.adcom.2023.03.001Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4375932677
W4375956021Pathogenicity and virulence of Clostridium botulinum2023-05-08OpenAlex10.1080/21505594.2023.2205251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4375956021
W4381597844HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept2023-05-09OpenAlex10.3390/cancers15102664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381597844
W4376121851Influence of corticosteroid treatment on CXCR4 expression in DLBCL2023-05-10OpenAlex10.1186/s13550-023-00993-4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4376121851
W4376876243Pure and Other Phenomenologically Oriented Psychology2023-05-10OpenAlex10.1163/15691624-20231417Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4376876243
W4376105661Treatment of Nondiabetic Kidney Diseases with Sodium-Glucose Cotransporter-2 Inhibitors2023-05-10OpenAlex10.2215/cjn.0000000000000194Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376105661
W4376127662Assessment‐based management of placenta‐mediated pregnancy complications: Pragmatism until a precision medicine approach evolves2023-05-11OpenAlex10.1111/bjh.18856Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376127662
W4376131143Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials2023-05-11OpenAlex10.1111/dom.15109Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376131143
W4376110134Moving beyond ruxolitinib failure in myelofibrosis: evolving strategies for second line therapy2023-05-11OpenAlex10.1080/14656566.2023.2213435Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376110134
W4376155506Russell’s viper venom: from diagnostic to bypassing agent for hemophilia?2023-05-11OpenAlex10.1016/j.jtha.2023.02.026Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4376155506
W4376223654Update on Overactive Bladder Therapeutic Options2023-05-11OpenAlex10.1097/mjt.0000000000001637Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376223654
W4379095029Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review2023-05-12OpenAlex10.1007/s40429-023-00478-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379095029
W4376276000Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference2023-05-12OpenAlex10.1186/s13045-023-01446-0Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4376276000
W4376598195Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy2023-05-13OpenAlex10.1007/s10238-023-01087-0Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4376598195
W4376603710Anorectal Manifestations of Treatment-Refractory Monkeypox Requiring Surgical Intervention2023-05-15OpenAlex10.1177/00031348231177931Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376603710
W4376605714Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update2023-05-15OpenAlex10.1136/jnis-2022-019844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376605714
W4376616656JFTR's venues and voices for family theorizing and critical review2023-05-15OpenAlex10.1111/jftr.12513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376616656
W4376613277Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer2023-05-15OpenAlex10.1016/j.clbc.2023.05.003Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4376613277
W4376643389Protein kinases: drug targets for immunological disorders2023-05-15OpenAlex10.1038/s41577-023-00877-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4376643389
W4376645773Editorial: Purinergic pharmacology, Volume II2023-05-16OpenAlex10.3389/fphar.2023.1200187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376645773
W4376637817Management of scalp arteriovenous malformations: a rising trend towards percutaneous direct puncture embolization technique—our experience2023-05-16OpenAlex10.1177/02841851231174458Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376637817
W4376646299The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease2023-05-16OpenAlex10.1080/1744666x.2023.2214728Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376646299
W4377042074Editorial: The clinical application and progress of precise diagnosis and treatment of thyroid tumors2023-05-17OpenAlex10.3389/fendo.2023.1214596Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377042074
W4377043274Essential Role of CgErg6p in Maintaining Oxidative Stress Tolerance and Iron Homeostasis in Candida glabrata2023-05-17OpenAlex10.3390/jof9050579Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4377043274
W4376872922Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice2023-05-17OpenAlex10.1007/s11864-023-01103-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4376872922
W4376872265Photodynamic therapy in the root canal treatment of primary teeth: A systematic review of clinical trials2023-05-17OpenAlex10.1111/ipd.13088Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4376872265
W4377010905Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies2023-05-18OpenAlex10.1007/s12325-023-02512-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377010905
W4387585237In vitro antibacterial effect of the extracts of Maranta arundinacea rhizomes against selected pathogens2023-05-18OpenAlex10.12692/ijb/22.5.160-167Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387585237
W4377139906Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer2023-05-19OpenAlex10.1038/s41392-023-01468-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377139906
W4377101625Liver Pathology: Diagnostic Challenges, Practical Considerations and Emerging Concepts2023-05-19OpenAlex10.1016/j.path.2023.04.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377101625
W4377138221Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective2023-05-19OpenAlex10.1016/j.mcpro.2023.100578Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377138221
W4377143134Adenovirotherapy delivering cross-hybrid IgGA Fc engineering PD-L1 inhibitors for enhanced cancer immunotherapy2023-05-20OpenAlex10.1016/j.omto.2023.05.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377143134
W4377140517Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review2023-05-20OpenAlex10.1007/s40257-023-00786-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377140517
W4377220356All Hands Needed for Intentional Professionalism2023-05-22OpenAlex10.1097/01.asw.0000933960.02727.4bTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377220356
W4378083698Anaerobic Gram-Negative Bacteria: Role as a Reservoir of Antibiotic Resistance2023-05-22OpenAlex10.3390/antibiotics12050942Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4378083698
W4377220820Culture-Independent Workflow for Nanopore MinION-Based Sequencing of Influenza A Virus2023-05-22OpenAlex10.1128/spectrum.04946-22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377220820
W4377287503Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st Century2023-05-22OpenAlex10.1055/s-0043-1769588Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377287503
W4409643886The role of recruitment and selection on organizational performance2023-05-22OpenAlex10.63544/ijss.v2i2.37Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409643886
W4378086119“ThermoTRP” Channel Expression in Cancers: Implications for Diagnosis and Prognosis (Practical Approach by a Pathologist)2023-05-22OpenAlex10.3390/ijms24109098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378086119
W4378087326ASSESSING THE CURRENT THREAT OF MONKEYPOX EPIDEMIC EMERGENCE2023-05-23OpenAlex10.31718/2077-1096.23.2.1.73Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4378087326
W4377862148Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis2023-05-23OpenAlex10.1038/s41375-023-01915-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4377862148
W4377565273Kidney Preservation Strategies to Improve Transplant Outcomes2023-05-23OpenAlex10.2215/cjn.0000000000000212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377565273
W4377966648Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies2023-05-24OpenAlex10.1200/jco.23.00013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4377966648
W4386192865Approach to multidrug resistant bacterial infections2023-05-24OpenAlex10.3329/bjm.v34i20.66143Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386192865
W4377988719Exploring the usability of a chatbot-based conversational dietary assessment tool among cardiovascular patients2023-05-24OpenAlex10.1093/eurjpc/zwad125.281Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4377988719
W4377989391Melancholia as a clinical and metapsychological agent2023-05-24OpenAlex10.4324/9781003336754-11Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4377989391
W4378173467Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias2023-05-25OpenAlex10.1093/ajhp/zxad108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378173467
W4378191996The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update2023-05-25OpenAlex10.1016/j.healun.2022.12.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378191996
W4378218494Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology2023-05-25OpenAlex10.1016/j.neo.2023.100909Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378218494
W4381284050Pharmacologic and Other Noninvasive Treatments of the Aging Face: A Review of the Current Evidence2023-05-26OpenAlex10.1097/prs.0000000000010767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381284050
W4378530541The role of therapy in the outcome of patients with myelofibrosis2023-05-27OpenAlex10.1002/cncr.34851Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4378530541
W4378619346Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies2023-05-28OpenAlex10.3390/life13061272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378619346
W4378648779Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis2023-05-29OpenAlex10.1016/j.leukres.2023.107331Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4378648779
W4379801139AB1062 RENAL INVOLVEMENT IN SPONDYLOARTHRITIS2023-05-30OpenAlex10.1136/annrheumdis-2023-eular.1542Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379801139
W4378801833Antifungal Stewardship Programs in Children: Challenges and Opportunities2023-05-30OpenAlex10.1097/inf.0000000000003967Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378801833
W4378783539Cell membrane‐coated nanoparticles for the treatment of cancer2023-05-30OpenAlex10.1002/ctm2.1285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378783539
W4378807316Editorial: Kawasaki disease: an ongoing enigma tangled with the appearance of MIS-C2023-05-30OpenAlex10.3389/fped.2023.1209723Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378807316
W4379052900Innovative biomaterials for the treatment of periodontal disease2023-05-30OpenAlex10.3389/fdmed.2023.1163562Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379052900
W4380626179#2663 KIDNEY INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES2023-06-01OpenAlex10.1093/ndt/gfad063c_2663Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380626179
W4380626214#2664 CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS WITH LYSOZYME NEPHROPATHY AND CMML RENAL INFILTRATION DISPLAY MARKERS OF SEVERE DISEASE2023-06-01OpenAlex10.1093/ndt/gfad063c_2664Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380626214
W4379282447A real-world evaluation of treatment (Tx) patterns and outcomes of acute myeloid leukemia (AML) induction therapies in the community setting.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e19006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379282447
W4379337376AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.tps5634Full textExcludedF1: This is a trial-in-progress treatment protocol; agents are pharmacological treatments, not an evaluated adaptive LLM system.https://openalex.org/W4379337376; https://openalex.org/W4403250793https://scholars.duke.edu/publication/1686924complete conference trial-in-progress abstract including Methods
W4379281510Advanced cervical cancer therapy: Comparison of contemporary expert and healthcare professional recommendations from an online treatment decision tool.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.5528Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379281510
W4380681639An Appraisal of Infection Control in the Built Environment: The Architect's Perspective2023-06-01OpenAlex10.13189/ujph.2023.110305Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380681639
W4379281699Associations between androgen-directed treatments and AR mutational landscapes in the circulating tumor DNA of a real-world metastatic prostate cancer cohort.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.5061Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379281699
W4379337740Awareness, preferences, and experiences of thrombosis and thromboprophylaxis in adults commencing systemic anticancer therapies: TARGET-TP trial.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e24129Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379337740
W4382025360BI20 Generalized pustular psoriasis in a patient receiving pembrolizumab for metastatic lung adenocarcinoma2023-06-01OpenAlex10.1093/bjd/ljad113.188Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382025360
W4387493190Caracterização molecular de isolados do vírus Varicela Zoster em amostras de líquido cefalorraquidiano de pacientes com quadro de meningite, encefalite ou meningoencefalite aguda2023-06-01OpenAlex10.11606/d.5.2023.tde-20092023-123627Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387493190
W4381715712ChatGPT: revolutionizing cardiothoracic surgery research through artificial intelligence2023-06-01OpenAlex10.1093/icvts/ivad090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381715712
W4380301317Clinical Pathologic Conference Case 5: Asymptomatic Patient Referred for Evaluation of Her Mouth2023-06-01OpenAlex10.1016/j.oooo.2022.11.021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380301317
W4379285819Comparison of real-world outcomes over time in a large population-based cohort of patients with metastatic breast cancer.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e13112Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379285819
W4386596146Composition of Populations and Durations of Persistence of Bordetella pertussis Bacteria in Patients with Whooping Cough and Contact Persons2023-06-01OpenAlex10.3103/s0891416823020064Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386596146
W4379281968Correlating expression of NaPi2b and FRa in high grade serous ovarian cancer (HGSOC).2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.5545Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379281968
W4382025247DP12 Painful oral keratosis and skin lesions: a paraneoplastic diagnostic conundrum2023-06-01OpenAlex10.1093/bjd/ljad113.225Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382025247
W4380871835Dairying and the evolution and consequences of lactase persistence in humans2023-06-01OpenAlex10.1093/af/vfad022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380871835
W4379799462Evaluation and management of abnormal liver enzymes in the liver transplant recipient: When, why, and what now?2023-06-01OpenAlex10.1097/cld.0000000000000057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379799462
W4378952150Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum2023-06-01OpenAlex10.1161/jaha.122.028892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4378952150
W4385476378Evolving landscape of targeted treatment options for HER2-positive gastric/gastroesophageal adenocarcinomas.2023-06-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385476378
W4379338743Expression of CD47 and CALR in myeloproliferative neoplasms: Potential new therapeutical targets.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e19079Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4379338743
W4379113734Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling2023-06-01OpenAlex10.1200/edbk_390428Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379113734
W4383868484Improving the Scientific Impact of Medical Physics: Challenges and Opportunities: Editor‐in‐Chief 2014–20202023-06-01OpenAlex10.1002/mp.16022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383868484
W4379285637Integrating radiation therapy with CDK4/6 inhibitors for breast cancer: A systematic review and meta-analysis of toxicity.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e13075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379285637
W4380361168LGG-10. TREATMENT-RELATED MYELODYSPLASTIC SYNDROME FOLLOWING CHEMOTHERAPY FOR PEDIATRIC LOW-GRADE GLIOMA2023-06-01OpenAlex10.1093/neuonc/noad073.220Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380361168
W4380078557MY HODGKIN, MY HEALTH: FEASIBILITY OF A MOBILE APPLICATION TO COLLECT LONG TERM FOLLOW UP DATA ABOUT HODGKIN PATIENTS2023-06-01OpenAlex10.1002/hon.3165_531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380078557
W4379795864Nonfactor Therapies for Hemophilia2023-06-01OpenAlex10.1097/hs9.0000000000000911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379795864
W4378978412Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology2023-06-01OpenAlex10.1016/j.ajog.2022.05.014Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4378978412
W4382799175P-253 Single agent immunotherapy in advanced oesophago-gastric (OG) cancer: An option for frail patients2023-06-01OpenAlex10.1016/j.annonc.2023.04.309Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4382799175
W4379792967POS1413 PRECLINICAL EVIDENCE FOR THE GLUCOCORTICOID-SPARING POTENTIAL OF A DUAL TLR7/8 INHIBITOR IN AUTOIMMUNE DISEASES2023-06-01OpenAlex10.1136/annrheumdis-2023-eular.2555Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4379792967
W4382025348PS11 Dupilumab for moderate-to-severe atopic dermatitis: transformative changes in quality of life and low burden of treatment — a mixed-methods study2023-06-01OpenAlex10.1093/bjd/ljad113.363Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382025348
W4387269955Pathogenesis, Diseases, Immune Response, and Chemotherapy of Genus Simplexvirus2023-06-01OpenAlex10.59393/amb23390202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387269955
W4379283636Phase I solid tumor trials (PHIstt) in the era of precision oncology (PO): A systematic survey.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e13603Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379283636
W4392116189Precision in Anesthesia for Awake Craniotomies: Confronting Surgical Challenges2023-06-01OpenAlex10.1055/s-0044-1779597Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392116189
W4384023470Recent advances in the treatment of IBD: Targets, mechanisms and related therapies2023-06-01OpenAlex10.1016/j.cytogfr.2023.07.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384023470
W4379282834Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.3149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379282834; https://openalex.org/W4388658908
W4379329732State-of-the-art management of HER2-negative early breast cancer: Treatment patterns among healthcare professionals and concordance with expert recommendations.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.553Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379329732
W4379282576Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.7530Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379282576
W4379284018Temporal trends of atypical drug access at an academic oncology unit: The Verona University Hospital experience.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e13651Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379284018
W4382364605The Trial of Superdebthunterbot2023-06-01OpenAlex10.1525/aft.2023.50.2.51Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4382364605
W4379336130The emerging use of immunotherapy as a treatment option in metastatic renal cell carcinoma: Real-world evidence from a single UK tertiary cancer centre.2023-06-01OpenAlex10.1200/jco.2023.41.16_suppl.e16509Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379336130
W4379979750The evolving therapy of DLBCL: Bispecific antibodies2023-06-01OpenAlex10.1002/hon.3154Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379979750
W4383872234Through the executive director's lens: AAPM moves, grows and thrives2023-06-01OpenAlex10.1002/mp.16153Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383872234
W4379185340Messenger RNA Expression and Quantification of L-plastin in Subgingival Tissue Samples of Generalized Severe Chronic Periodontitis Patients with and without Type 2 Diabetes Mellitus2023-06-02OpenAlex10.5005/jp-journals-10015-2202Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379185340
W4380489086Mineralizing agents to manage early carious lesions. Part I: mode of action2023-06-02OpenAlex10.12968/denu.2023.50.6.490Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4380489086
W4379232324PRISMA Systematic Literature Review, including with Meta-Analysis vs. Chatbot/GPT (AI) regarding Current Scientific Data on the Main Effects of the Calf Blood Deproteinized Hemoderivative Medicine (Actovegin) in Ischemic Stroke2023-06-02OpenAlex10.3390/biomedicines11061623Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379232324
W4379197128Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review2023-06-02OpenAlex10.1093/ehjci/jead124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379197128
W4379328615The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia2023-06-04OpenAlex10.1016/j.beha.2023.101485Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379328615
W4379471304Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection2023-06-05OpenAlex10.3389/fmicb.2023.1201505Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4379471304
W4379435254Editorial: Editors' introduction2023-06-05OpenAlex10.1108/pdsp-05-2023-009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379435254
W4379386535Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases2023-06-05OpenAlex10.3389/fimmu.2023.1197364Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379386535
W4379800542Structural transformation and reparative obligation: Reinterpreting the beneficiary pays principle2023-06-05OpenAlex10.1111/josp.12524Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4379800542
W4379799725Ammi majus2023-06-07OpenAlex10.1201/9781003413004-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379799725
W7120632025Autism spectrum disorders in the scope of public health policies2023-06-07OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7120632025
W4379739848Awakening the Future: Exploring Awake or Minimalistic Transcatheter Aortic Valve Replacement and the Evolving Role of Sedation Strategies2023-06-07OpenAlex10.1053/j.jvca.2023.05.049Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379739848
W4384134344Cellular therapy in CLL/iNHL: Therapeutic agents in the pipeline2023-06-07OpenAlex10.58931/cht.2023.2232Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4384134344
W4379649100Editorial: Clinical teaching and practice in intensive care medicine and anesthesiology2023-06-07OpenAlex10.3389/fmed.2023.1207363Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379649100
W4379740272Evolving role of cytoreduction and HIPEC for colorectal cancer2023-06-07OpenAlex10.1016/j.scrs.2023.100970Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379740272
W4384134175Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates2023-06-07OpenAlex10.58931/cht.2023.2233Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384134175
W4383888433"The History of the Study of the Etiology, Pathogenesis, Diagnosis, Treatment, and Prevention of Syphilis, in the Reflection of Philately, Numismatics and Bonistics"2023-06-08OpenAlex10.26717/bjstr.2023.50.008030Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383888433
W4380052484Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance2023-06-08OpenAlex10.3389/fimmu.2023.1219870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380052484
W4379768632SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)2023-06-08OpenAlex10.1007/s12094-023-03206-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4379768632
W4379927849“It’s my life, not theirs!” Therapeutic itineraries and refugee reflections on referral health care in western Tanzania2023-06-08OpenAlex10.1371/journal.pgph.0001655Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4379927849
W4380084234ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis2023-06-09OpenAlex10.3390/biom13060968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380084234
W4405720004Meningoencephalitis of Unknown Origin in Dogs2023-06-09OpenAlex10.22456/1679-9216.126781Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405720004
W4380203878Structure of a 10-23 deoxyribozyme exhibiting a homodimer conformation2023-06-10OpenAlex10.1038/s42004-023-00924-3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380203878
W4380264946Parathyroid Crisis: A Case of Elective Parathyroidectomy2023-06-11OpenAlex10.7759/cureus.40251Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380264946
W4380355469Mink is an important possible route of introducing viral respiratory infections into the human population2023-06-12OpenAlex10.1002/vms3.1177Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380355469
W4380322140OCT in Cariology2023-06-12OpenAlex10.1201/9781351104562-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380322140
W4380486529RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways2023-06-12OpenAlex10.1101/2023.06.09.544432Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380486529
W4380682625An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity2023-06-14OpenAlex10.1172/jci158978Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380682625
W4380577154Surface Engineering of Nanoparticles toward Cancer Theranostics2023-06-14OpenAlex10.1021/acs.accounts.3c00122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380577154
W4380634180A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry2023-06-15OpenAlex10.1002/jca.22067Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4380634180
W7217926719Asepsia y antisepsia en procedimientos quirúrgicos dentales2023-06-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217926719
W4380768790Counteracting antibiotic resistance enzymes and efflux pumps2023-06-15OpenAlex10.1016/j.mib.2023.102334Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4380768790
W4380767841EASL Recognition Award Recipient 2023: Prof. Julia A. Wendon2023-06-15OpenAlex10.1016/j.jhep.2023.03.036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380767841
W4380740792The North American perspective on short-term mechanical circulatory support for cardiogenic shock: could differences in policy be driving differences in temporary mechanical circulatory support use?2023-06-15OpenAlex10.1093/ehjacc/zuad065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380740792
W4380880178A Pharmacologic Update2023-06-16OpenAlex10.1016/j.cnur.2023.05.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4380880178
W4381106273The Update in the Treatments of Surgical Wound Healing: An Overview2023-06-16OpenAlex10.5281/zenodo.8049223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381106273
W4384566608915 Safety and simulation: delivering early phase clinical trials for children and young people2023-06-19OpenAlex10.1136/archdischild-2023-rcpch.685Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384566608
W4381336333A Case Report on Pityriasis Rubra Pilaris (PRP) and Multisystem Inflammatory Syndrome in Children (MIS-C)2023-06-19OpenAlex10.52403/ijrr.20230638Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4381336333
W4381486222Haemodynamic support for paediatric septic shock: a global perspective2023-06-21OpenAlex10.1016/s2352-4642(23)00103-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381486222
W4381480388The prothrombotic tendency of metabolic-associated fatty liver disease2023-06-21OpenAlex10.1016/j.jtha.2023.06.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381480388
W4382723254Ex vivo study of the kinetics of ovarian tissue optical properties under the influence of 40%-glucose2023-06-22OpenAlex10.18500/1817-3020-2023-23-2-120-127Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4382723254
W4381805609Hepatitis C Elimination: Opportunities and Challenges in 20232023-06-22OpenAlex10.3390/v15071413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381805609
W4403085197Adenosine Deaminase Activity in Serum of Diabetics: A Reflection of Glycemic Profile?2023-06-23OpenAlex10.20956/ijab.v7i1.24466Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403085197
W4381711275Platelet concentrates – A panacea for periodontal regeneration.2023-06-23OpenAlex10.7126/cumudj.1128860Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381711275
W4381943608Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer2023-06-24OpenAlex10.1186/s13045-023-01464-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381943608
W4381597466Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches2023-06-24OpenAlex10.1080/14656566.2023.2228686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4381597466
W4381948594Bladder Cancer Prevention: Potential Molecular Targets and Their Clinically Relevant Agents2023-06-26OpenAlex10.1007/s40495-023-00326-yTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4381948594
W4382456736MET Inhibitors for Papillary Renal Cell Carcinoma2023-06-26OpenAlex10.3233/kca-230005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382456736
W4382197469An Overview of the Therapeutic Development of Cholangiocarcinoma with Special Emphasis on Targeted and Biologic Therapies2023-06-28OpenAlex10.1007/s11901-023-00607-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382197469
W4382401694Dental Applications of Essential Oils2023-06-28OpenAlex10.1002/9781119829614.ch38Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382401694
W4382369490Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas2023-06-28OpenAlex10.3390/pharmaceutics15071844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382369490
W4382561852Clinical applications of circulating tumor DNA in indolent B-cell lymphomas2023-06-29OpenAlex10.1053/j.seminhematol.2023.06.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382561852
W4382599985Design Strategy2023-06-29OpenAlex10.7551/mitpress/14842.001.0001Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4382599985
W4382775608Editorial: Global excellence in rheumatology: Europe2023-06-29OpenAlex10.3389/fmed.2023.1242449Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382775608
W4382539255History and Trends in Industrial Toxicology2023-06-29OpenAlex10.1002/0471125474.tox001.pub3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382539255
W4382774910Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children2023-06-29OpenAlex10.3390/ijms241310874Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4382774910
W4382700793General anaesthesia for dentistry2023-06-30OpenAlex10.1016/j.mpaic.2023.05.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382700793
W4404830039Inflammation and its relationship to oral cavity2023-06-30OpenAlex10.70921/medev.v29i2.1012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404830039
W7216607525Old problems in the face of new challenges2023-06-30OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216607525
W4382753300The Impact of Patient Infection Rate on Emergency Department Patient Flow: Hybrid Simulation Study in a Norwegian Case2023-06-30OpenAlex10.3390/healthcare11131904Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382753300
W4396564591The Promise of Exosomes as Drug Delivery Systems2023-06-30OpenAlex10.55627/pharma.002.01.0332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396564591
W44054664225-Fluorouracil-induced bilateral serpentine supravenous hyperpigmentation2023-07-01OpenAlex10.4103/ijdd.ijdd_3_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405466422
W7160013357A One Health perspective reconciling medical mycology and fungal phytopathology2023-07-01OpenAlex10.63049/ohm.26.31.4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160013357
W4390148626Abstracts of the Asian Congress of Pediatric Nephrology 20232023-07-01OpenAlex10.4103/ajpn.ajpn_14_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390148626
W4386425130Acute Nonvariceal Gastrointestinal Bleeding: A Comprehensive Review and Approach for an Interventional Radiologist2023-07-01OpenAlex10.1055/s-0043-1770915Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386425130
W4385306263Advancements of ALK inhibition of non-small cell lung cancer: a literature review2023-07-01OpenAlex10.21037/tlcr-22-619Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385306263
W4387799192An E-mail interview with Prof. Mohammed Hafeez2023-07-01OpenAlex10.4103/tp.tp_51_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387799192
W4384912502Are we missing the silver lining of COVID-19 pandemic: An analytical study to determine effects of three COVID-19 peaks on antimicrobial susceptibility of Staphylococcus aureus isolates2023-07-01OpenAlex10.4103/jfmpc.jfmpc_2420_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384912502
W4385152678Detection of Opportunistic Fungi from the Bronchoalveolar Lavage Specimens of Patients with Pulmonary Diseases2023-07-01OpenAlex10.4103/abr.abr_297_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385152678
W4385398387E-102 Super-selective intra-arterial treatment of glioblastoma: current state and future directions2023-07-01OpenAlex10.1136/jnis-2023-snis.202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385398387
W4392413732Environmentalism, Radicalism, Activism2023-07-01OpenAlex10.14321/jstudradi.17.2.0001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392413732
W4401494460Evolving paradigms in ocular surface squamous neoplasia management: A shift toward topical pharmacotherapy2023-07-01OpenAlex10.4103/odjo.odjo_13_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401494460
W4390713867G20 and medical education: Embracing a holistic vision for health care2023-07-01OpenAlex10.4103/ijcfm.ijcfm_106_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390713867
W4387028252Hepatocellular carcinoma in India: Time for a new focus2023-07-01OpenAlex10.4103/crst.crst_277_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387028252
W4384120513Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders2023-07-01OpenAlex10.1002/jia2.26120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384120513
W4388563620Mind and World in Aristotle’s De Anima2023-07-01OpenAlex10.1215/00318108-10469525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388563620
W4383303157Person‐centred care: shifting the power dynamic in the delivery of adolescent and youth‐friendly health services2023-07-01OpenAlex10.1002/jia2.26116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383303157
W4384699497Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights2023-07-01OpenAlex10.2147/jhc.s341195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384699497
W4390995313Revolutions Aesthetic: A Cultural History of Ba‘thist Syria2023-07-01OpenAlex10.5325/bustan.14.1.0090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390995313
W4384156956The value of IMmotion010 for rare kidney cancer histologies – Authors' reply2023-07-01OpenAlex10.1016/s0140-6736(23)01066-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384156956
W4383302277Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond2023-07-01OpenAlex10.1016/j.hlc.2023.05.018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383302277
W4387167124Unraveling the Complex Web2023-07-01OpenAlex10.4103/hm.hm-d-23-00036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387167124
W4382931413“White Girls, They Get You Every Time”: Get Out 's Horror of Miscegenation and Its Conception of the Black Bro'mance2023-07-01OpenAlex10.5406/19346018.75.2.02Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4382931413
W4383058815Clonal architecture and single‐cell transcriptome landscape in Richter's syndrome2023-07-03OpenAlex10.1111/bjh.18952Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383058815
W4382918428Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom2023-07-03OpenAlex10.1111/dom.15196Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382918428
W4386900147GOVERNING THE WARS; THEORY, LEGISLATION, HUMAN RIGHTS, HUMAN SECURITY, AND ETHICS2023-07-03OpenAlex10.48064/equinox.1119677Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386900147
W4383104021Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia2023-07-03OpenAlex10.3390/biomedicines11071886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383104021
W4382918716Stereotactic Body Radiation Therapy Salvage for Lymph Node Recurrent Prostate Cancer in the Era of PSMA PET Imaging2023-07-03OpenAlex10.1007/s11934-023-01174-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4382918716
W4385262311Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies2023-07-03OpenAlex10.1080/14728222.2023.2240018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385262311
W4383068574The Evolving Landscape of Immunotherapy in Uterine Cancer: A Comprehensive Review2023-07-03OpenAlex10.3390/life13071502Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383068574
W4383227428Androgen deprivation therapy in metastatic salivary duct carcinoma of submandibular gland – A case report2023-07-04OpenAlex10.25259/ijms_343_2021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383227428
W4385357905School principals as translators – examining Swedish school principals’ translations of the standards-based curriculum2023-07-04OpenAlex10.1080/00220272.2023.2234006Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385357905
W4383069328The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Identify a Possible Interplay between Conserved Viral RNA Sequences and Host RNA Binding Proteins (RBPs)2023-07-04OpenAlex10.3390/ijms241311051Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4383069328
W4386407716AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends2023-07-05OpenAlex10.1093/clinchem/hvad106Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386407716
W4383187111Acute Pancreatitis Review2023-07-05OpenAlex10.5152/tjg.2023.23175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383187111
W4383262633Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment2023-07-05OpenAlex10.1016/j.ejim.2023.06.026Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4383262633
W4383186457Insulin analogs as an add-on to metformin after failure to oral treatment in type 2 diabetic patients increase diastole duration. The INSUlin Regimens and VASCular Functions (INSUVASC) study2023-07-05OpenAlex10.23736/s2724-5683.23.06139-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383186457
W4383313548Antibiotic usage and susceptibility patterns in Uncomplicated UTI in a Tertiary Hospital in South India2023-07-06OpenAlex10.1101/2023.07.02.23292129Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383313548
W4383314197Highly Parallelized Screening of Functionally Enhanced XNA Aptamers in Uniform Hydrogel Particles2023-07-06OpenAlex10.1021/acssynbio.3c00189Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4383314197
W4383343296Managing Adverse Effects of Novel Therapeutic Agents in Gynecologic Malignancies2023-07-06OpenAlex10.1007/s42399-023-01518-9Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4383343296
W4383483914Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia2023-07-06OpenAlex10.1210/clinem/dgad395Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383483914
W4383302336Surfing the web as a patient with IBD: New horizons2023-07-06OpenAlex10.1002/ueg2.12437Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383302336
W4383533122Arborealities, or Making Trees Matter in Elif Shafak’s The Island of Missing Trees2023-07-07OpenAlex10.1093/isle/isad040Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4383533122
W4383482539Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease2023-07-07OpenAlex10.1097/cm9.0000000000002792Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383482539
W4383536350Local immunotherapy of glioblastoma: A comprehensive review of the concept2023-07-07OpenAlex10.1016/j.jneuroim.2023.578146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383536350
W4383645757Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular Protection2023-07-08OpenAlex10.1016/j.cjca.2023.07.007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383645757
W4383710785An Explicative Review on the Current Advancement in Schiff Base-Metal Complexes as Anticancer Agents Evolved in the Past Decade: Medicinal Chemistry Aspects2023-07-10OpenAlex10.2174/1573406419666230707105221Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4383710785
W4383873255Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics2023-07-10OpenAlex10.1002/pbc.30563Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383873255
W4383895589Multidrug-resistant infections in war victims in Ukraine2023-07-11OpenAlex10.1016/s1473-3099(23)00391-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4383895589
W4383998899Biochemical and cellular basis of oxidative stress: Implications for disease onset2023-07-12OpenAlex10.1002/jcp.31071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383998899
W4383998538Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer2023-07-12OpenAlex10.1158/1078-0432.ccr-23-0079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4383998538
W4384039032Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks2023-07-12OpenAlex10.3390/v15071533Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384039032; https://openalex.org/W4375949504
W4384155254Adenitis as Initial Mycobacterium marinum Presentation2023-07-13OpenAlex10.7759/cureus.41833Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384155254
W4384340510Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies2023-07-14OpenAlex10.1038/s41375-023-01968-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384340510
W4384338524Exposure to organophosphorus compounds: best practice in managing timely, effective emergency responses2023-07-14OpenAlex10.1097/mej.0000000000001060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384338524
W4384401069Immunotherapy in biliary tract cancer: The race has begun!2023-07-14OpenAlex10.1111/liv.15651Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384401069
W4384300259Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape2023-07-14OpenAlex10.1007/s12098-023-04741-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384300259
W4384523601Biventricular mechanical circulatory support. History and current state of the problem2023-07-15OpenAlex10.15825/1995-1191-2023-2-49-56Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384523601
W4384405610Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center2023-07-15OpenAlex10.1080/10428194.2023.2232489Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384405610
W4384636524Tocilizumab; A potential remedy against the ever-evolving threat of Coronavirus-2 (SARS-CoV-2)2023-07-15OpenAlex10.47391/jpma.8551Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384636524
W4384523650Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease2023-07-16OpenAlex10.2174/97898151650121230101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384523650
W4384525304Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece2023-07-17OpenAlex10.1556/030.2023.02071Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384525304
W4384521344Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents2023-07-17OpenAlex10.1016/j.phymed.2023.154973Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4384521344
W4384819777Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma2023-07-17OpenAlex10.1016/j.oraloncology.2023.106520Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384819777
W4384559034Molecular mechanisms governing antifungal drug resistance2023-07-17OpenAlex10.1038/s44259-023-00007-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384559034
W43848203252023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes2023-07-19OpenAlex10.1186/s13098-023-01121-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384820325
W4384663153Antithrombotic therapy with Transcatheter aortic valve replacement2023-07-19OpenAlex10.1002/phar.2847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384663153
W4384936511Comparative assessment of mechanical and chemical fluid diversion techniques during hydraulic fracturing in horizontal wells2023-07-19OpenAlex10.1016/j.petsci.2023.07.013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4384936511
W4384664443Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders2023-07-19OpenAlex10.2174/1872210517666230718115651Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384664443
W4384819845The complementarity of DDR, nucleic acids and anti-tumour immunity2023-07-19OpenAlex10.1038/s41586-023-06069-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4384819845
W4384818758Disease Assessments in Patients with Glioblastoma2023-07-20OpenAlex10.1007/s11912-023-01440-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384818758
W4385065897Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders2023-07-20OpenAlex10.3389/fpsyg.2023.1242921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385065897
W4384920179Preparation for the next pandemic: challenges in strengthening surveillance2023-07-20OpenAlex10.1080/22221751.2023.2240441Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4384920179
W4385065440A reinforcement learning-based approach for online optimal control of self-adaptive real-time systems2023-07-21OpenAlex10.1007/s00521-023-08778-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385065440
W4385387767Newer strategies from the use of blood and blood products: Lessons learned from recent wars2023-07-21OpenAlex10.1016/b978-0-323-69787-3.00077-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385387767
W4385071630Biofunctionalized Gold Nanoparticles Obtained from Two Different Plant Extracts and its Chemical and Structural Comparison2023-07-22OpenAlex10.1093/micmic/ozad067.640Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385071630
W4385240955Epidemiology of Antimicrobial Resistance Genes in Staphyloccocus aureus Isolates from a Public Database in a One Health Perspective—Sample Characteristics and Isolates’ Sources2023-07-24OpenAlex10.3390/antibiotics12071225Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385240955
W4385211224Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects2023-07-24OpenAlex10.4252/wjsc.v15.i7.687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385211224
W4385241738Recent Progress in the Characterization, Synthesis, Delivery Procedures, Treatment Strategies, and Precision of Antimicrobial Peptides2023-07-24OpenAlex10.3390/ijms241411864Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385241738
W7207175745Improved Middle Ear Imaging with Optical Coherence Tomography for Clinical Otology2023-07-25OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7207175745
W4385237517Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy2023-07-25OpenAlex10.1186/s12967-023-04360-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385237517
W4385439671Editorial: Modulation of human immune parameters by anticancer therapies, volume II2023-07-26OpenAlex10.3389/fimmu.2023.1249099Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385439671
W4385307049Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance2023-07-26OpenAlex10.3390/jcdd10080316Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385307049
W4385341905Immersive Innovation: Exploring Interactive Virtual Reality through Distributed Simulations2023-07-26OpenAlex10.5772/intechopen.1002004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385341905
W4385264865Microsatellite Instability in Colorectal Cancer: The Evolving Role of Immunotherapy2023-07-26OpenAlex10.1097/dcr.0000000000003017Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385264865
W4385368349The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus2023-07-26OpenAlex10.3390/life13081626Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385368349
W4385296762Access to physiotherapy services in South African settings: stretching a hand to under-resourced communities with students as agents of change2023-07-27OpenAlex10.3389/fresc.2023.1164525Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385296762
W4385327348Editorial: Recent advances in pediatric inflammatory diseases2023-07-27OpenAlex10.3389/fped.2023.1237625Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385327348
W4385347882Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review2023-07-27OpenAlex10.3390/ijms241512030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385347882
W4385326122Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations2023-07-27OpenAlex10.1016/j.eclinm.2023.102113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385326122
W4385372357Administering Freedom: The State of Emancipation after the Freedmen's Bureau by Dale Kretz (review)2023-07-28OpenAlex10.1353/soh.2023.a903219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385372357
W4385331055Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients2023-07-28OpenAlex10.1111/ajd.14138Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385331055
W4385410353Picking Up Where the Authors Left Off: Reading Research in Medical Education2023-07-28OpenAlex10.1097/acm.0000000000005373Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385410353
W4385355308Post-COVID-192023-07-28OpenAlex10.4103/jalh.jalh_10_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385355308
W4385331443Rectal cancer treatment: an embarrassment of riches?2023-07-28OpenAlex10.1111/ans.18634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385331443
W4385423642Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies2023-07-30OpenAlex10.3390/biology12081069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385423642
W4385395674The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials2023-07-31OpenAlex10.22465/juo.234600300015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385395674
W4387493518Between Science and Society: Charting the Space of Science Fiction2023-08-01OpenAlex10.5325/style.57.3.0408Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387493518
W4385463186How I Manage Chronic Lymphocytic Leukemia2023-08-01OpenAlex10.3390/hematolrep15030047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385463186
W4385484379O03 The effect of antibiotic selection on collateral susceptibility and evolvability of uropathogenic Escherichia coli2023-08-01OpenAlex10.1093/jacamr/dlad077.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385484379
W4385702177P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA2023-08-01OpenAlex10.1097/01.hs9.0000968924.19161.daTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385702177
W4385705968P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA INDUCTION THERAPIES IN THE COMMUNITY SETTING2023-08-01OpenAlex10.1097/01.hs9.0000968968.68222.8cTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385705968
W4385667173P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”.2023-08-01OpenAlex10.1097/01.hs9.0000969104.08302.5eTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385667173
W4385955746P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY2023-08-01OpenAlex10.1097/01.hs9.0000969496.68553.26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385955746
W4385697853PB1826: CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA2023-08-01OpenAlex10.1097/01.hs9.0000974148.35451.e1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385697853
W4385655405PB1943: THE EFFECTS OF AN ONLINE CURRICULUM BASED APPROACH TO CME ON HEMATOLOGIST/ONCOLOGISTS’ ABILITY TO TREAT PATIENTS WITH BTK INHIBITORS FOR B-CELL MALIGNANCIES2023-08-01OpenAlex10.1097/01.hs9.0000974588.94917.4eTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385655405
W4386102497PB1965: INSIGHTS INTO RELAPSED AND REFRACTORY CHRONIC MYELOID LEUKEMIA: MOLECULAR-GENETIC, BIOCHEMICAL AND PROGNOSIS PATTERNS2023-08-01OpenAlex10.1097/01.hs9.0000974676.34187.44Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386102497
W4385705889PB2242: ACUTE LYMPHOBLASTIC LEUKEMIA SECONDARY TO ESSENTIAL THROMBOCYTHEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS2023-08-01OpenAlex10.1097/01.hs9.0000975704.04209.78Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385705889
W4385654999PB2437: ASSOCIATION OF WILMS TUMOR GENE 1 EXPRESSION WITH OVERALL SURVIVAL AFTER AZACYTIDINE AND DONOR LYMPHOCYTE INFUSIONS: A RETROSPECTIVE SINGLE CENTER ANALYSIS2023-08-01OpenAlex10.1097/01.hs9.0000976456.87899.bdTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385654999
W4387383121REPRESENTATION OF THE SCENARIO «CONFLICT IN THE BRITISH ROYAL FAMILY» IN THE BRITISH MASS-MEDIA DISCOURSE2023-08-01OpenAlex10.24195/2616-5317-2023-36-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387383121
W4385770707Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm2023-08-01OpenAlex10.21037/cco-23-22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385770707
W4385550410Superbugs or multidrug resistant microbes: A new threat to the society2023-08-01OpenAlex10.1002/hsr2.1480Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385550410
W4385753183The WHO CNS 5th Edition: A Quandary for the Surgical Neurooncologist and Adult Diffuse Glioma Patients in LMICs2023-08-01OpenAlex10.1055/s-0043-1771473Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385753183
W4385478772Evolving microbial patterns of acute mastoiditis in pediatric patients undergoing mastoidectomy2023-08-02OpenAlex10.1016/j.ijporl.2023.111690Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385478772
W4385476298Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity2023-08-02OpenAlex10.1021/acsinfecdis.3c00063Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385476298
W4385491920Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles2023-08-02OpenAlex10.3390/ijms241512347Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385491920
W4385484261Youth Capacity Building and Leadership Through CBPR and Conflict Transformation with the Montagnard Refugee‐Origin Community2023-08-02OpenAlex10.1002/jls.21857Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385484261
W4385514156Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma2023-08-03OpenAlex10.1001/jamaoncol.2023.2677Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385514156
W4385520482Editorial: Innovative technologies and materials for treatments of hepatobiliary and pancreatic diseases2023-08-03OpenAlex10.3389/fbioe.2023.1260144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385520482
W4386945206Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update2023-08-03OpenAlex10.1080/13543776.2023.2262136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386945206
W4385577486Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer2023-08-04OpenAlex10.3390/cancers15153969Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385577486
W4385579436Molecular Studies of Phages- Klebsiella pneumoniae in a Mucoid Environment: Innovative use of mucolytic agents prior to the administration of lytic phages2023-08-04OpenAlex10.1101/2023.08.02.551690Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385579436
W4385605341ChatGPT: The transformative influence of generative AI on science and healthcare2023-08-06OpenAlex10.1016/j.jhep.2023.07.028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385605341
W4385616628The Role of Estrogen Therapy as a Protective Factor for Alzheimer’s Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature2023-08-06OpenAlex10.7759/cureus.43053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385616628
W4385628231Promising Marker for Treatment Response in Prostate Cancer2023-08-07OpenAlex10.1097/01.cot.0000967172.88593.deTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385628231
W7120725545(Multi)letramentos, leitura e interpretação do gênero charge: contribuição para formação do leitor proficiente2023-08-08OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7120725545
W4385752273El enfoque de NOMS para los tumores metastásicos: integración de nuevas tecnologías para mejorar los resultados2023-08-08OpenAlex10.1016/j.recot.2023.08.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385752273
W4385648796Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP22023-08-08OpenAlex10.1016/j.critrevonc.2023.104090Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385648796
W4385689343Reflections before the storm: the AI reproduction of biased imagery in global health visuals2023-08-09OpenAlex10.1016/s2214-109x(23)00329-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385689343
W4385748343A translational blueprint for developing intraoperative imaging agents via radiopharmaceutical-guided drug design2023-08-10OpenAlex10.1016/j.cbpa.2023.102376Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385748343
W4385719479Treponema pallidum resistance to azithromycin in France: A nationwide retrospective study from 2010 to 20222023-08-10OpenAlex10.1111/jdv.19399Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385719479
W4405176579Chlamydia2023-08-11OpenAlex10.1002/9781683674849.mcm0066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405176579; https://openalex.org/W4406364861
W4386152360Current Treatments in Mantle Cell Lymphoma2023-08-11OpenAlex10.46883/2023.25921002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386152360; https://openalex.org/W4386122362
W4385753955Data Modeling and Processing in Location Based Services: A Collaborative Research Agenda2023-08-11OpenAlex10.5194/ica-abs-6-95-2023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385753955
W4385753901Editorial: Use of DCE-MRI in female affecting cancers2023-08-11OpenAlex10.3389/fonc.2023.1260469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385753901
W4385812296Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma2023-08-12OpenAlex10.3390/jcm12165261Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385812296
W4385779786GENOMIC INVESTIGATION ON THE ANTIMICROBIAL ACTIVITIES AND TOXICOLOGICAL STUDIES OF ANDROGRAPHIS PANICULATA (VINEGAR) LEAF AND STEM ON ED HUMAN PATHOGENS2023-08-12OpenAlex10.56726/irjmets43735Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385779786
W4385780874Novel targets for immune-checkpoint inhibition in cancer2023-08-12OpenAlex10.1016/j.ctrv.2023.102614Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385780874
W4385783349Spike protein mutations and structural insights of pangolin lineage B.1.1.25 with implications for viral pathogenicity and ACE2 binding affinity2023-08-12OpenAlex10.1038/s41598-023-40005-yTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385783349
W4385898627At what point are we on the way to optimally treat multiple myeloma patients over 75 years of age in 2023?2023-08-14OpenAlex10.17219/acem/168685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385898627
W4385799549The Impact of Artificial Intelligence on Chatbot Technology: A Study on the Current Advancements and Leading Innovations2023-08-14OpenAlex10.47672/ejt.1561Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385799549
W4385827571Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis2023-08-15OpenAlex10.1007/s13365-023-01165-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385827571
W4385827915Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder2023-08-15OpenAlex10.1080/14656566.2023.2248893Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385827915
W4386970218Perception and Acceptance of Medical Chatbot Among Undergraduates in Ekiti State University, Nigeria2023-08-15OpenAlex10.37745/bje.2013/vol11n11114Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386970218
W4385878518Novel Cellular and Immunotherapy: Toxicities and Perioperative Implications2023-08-16OpenAlex10.3390/curroncol30080554Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385878518
W4385985410Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients2023-08-17OpenAlex10.3389/fonc.2023.1273598Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385985410
W4385951031Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer2023-08-17OpenAlex10.1038/s41571-023-00808-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4385951031
W4386023440Malnutrición y hábitos alimenticios: una visión en el personal de salud2023-08-17OpenAlex10.58995/lb.redlic.16Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386023440
W4385994562Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms2023-08-17OpenAlex10.3390/microorganisms11082101Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4385994562
W4385969682The Evolving Role of Nurse Educators and Leaders in Dismantling Racism in Nursing and Advocating for Health Equity and Justice2023-08-18OpenAlex10.1097/01.nep.0000000000001186Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385969682
W4385989001Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects2023-08-18OpenAlex10.1016/j.apsb.2023.08.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4385989001
W4386072652Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota2023-08-21OpenAlex10.1093/eurheartj/ehad521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386072652
W4386033865Cantharidin analogue alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the activation of NF-κB signaling2023-08-21OpenAlex10.1016/j.ejmech.2023.115731Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386033865
W4386033214O12/125 CHOICE, prospective multicenter study of endovascular treatment for cerebral AVMs treated with SQUID: clinical and angiographic results at 1 year2023-08-21OpenAlex10.1136/jnis-2023-esmint.12Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386033214
W4386084162Perioperative Hemotherapy Management in Left Ventricular Assist Device Surgery2023-08-21OpenAlex10.14503/thij-23-8216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386084162
W4386027444Prostate-Specific Membrane Antigen-Ligand Therapy2023-08-21OpenAlex10.1016/j.rcl.2023.07.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386027444
W4386073978A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions2023-08-22OpenAlex10.1038/s41598-023-40973-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386073978
W4386054850Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer?2023-08-22OpenAlex10.1200/op.23.00416Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386054850
W4386083694Integrating the Age-Friendly Health Systems Movement in Veterans Health Administration: National Advance Care Planning via Group Visits and the 4Ms Framework2023-08-22OpenAlex10.1093/hsw/hlad022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386083694
W4386055614Living donor uterus transplant in the UK: A case report2023-08-22OpenAlex10.1111/1471-0528.17639Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386055614
W4386084863Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia2023-08-22OpenAlex10.1111/bjh.19060Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386084863
W4386499305Understanding The Acute Interventions for Complicated Pleural Effusions2023-08-22OpenAlex10.19080/ijoprs.2023.06.555696Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386499305
W4386098256Emergence of Monkeypox (MPX): A Close Relative of Small Pox During COVID-19 Era2023-08-23OpenAlex10.2174/1871526523666230823105945Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386098256
W4386102279Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects2023-08-23OpenAlex10.1016/j.scitotenv.2023.166419Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386102279
W4386089067Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies2023-08-23OpenAlex10.1016/j.esmoop.2023.101618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386089067
W4386116273A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease2023-08-24OpenAlex10.14309/ajg.0000000000002485Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386116273
W4386156942Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression2023-08-25OpenAlex10.2337/dci23-0030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386156942
W4386221403Metabolomics in Pulmonary Hypertension—A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology2023-08-25OpenAlex10.3390/ijms241713227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386221403
W4386161086Re-Engineering the Hospital Discharge to Improve the Transition From Hospital to Home2023-08-25OpenAlex10.4018/jhms.328775Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386161086
W4386194645Advantages of using general anesthesia2023-08-26OpenAlex10.56238/seveniiimulti2023-202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386194645
W4386195456Perception of medical students in the internship developed in the discipline of integration teaching service and community I (IESC I)2023-08-26OpenAlex10.56238/seveniiimulti2023-196Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386195456
W4386242064In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer2023-08-27OpenAlex10.1093/jncics/pkad062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386242064
W4386213563Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III2023-08-28OpenAlex10.1055/s-0043-1772841Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386213563
W4386252768Novel high‐strength polyester composite scaffolds for bone regeneration2023-08-28OpenAlex10.1002/pat.6178Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386252768
W4386256836Approaches to Maximize Safety for Patients with Kidney Diseases after the End of COVID-19 Public Health Emergency2023-08-29OpenAlex10.2215/cjn.0000000000000303Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386256836
W438627368404 Biologic disease modifying drugs in SLE2023-08-30OpenAlex10.1136/lupus-2023-la.4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386273684
W4386271128ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy2023-08-30OpenAlex10.1016/s2152-2650(23)01338-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386271128
W4386274920Finding Meaning in Life2023-08-30OpenAlex10.1097/prs.0000000000010534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386274920
W4386271540Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation2023-08-30OpenAlex10.3324/haematol.2023.282898Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386271540
W4386647370Management of Oral Candidiasis in People Living With HIV2023-08-30OpenAlex10.30649/denta.v17i2.5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386647370
W4387136039#195 Understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim analysis from the OC-NOW survey (2023)2023-09-01OpenAlex10.1136/ijgc-2023-esgo.532Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387136039
W4387142209#242 Designing a clinical trial with chat generative pre-trained transformer (ChatGPT) on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer2023-09-01OpenAlex10.1136/ijgc-2023-esgo.541Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387142209
W4387497081#36915 D37 – the green footprint of regional anesthesia2023-09-01OpenAlex10.1136/rapm-2023-esra.675Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387497081
W4387505290#36942 Neurological complications and infections after neuraxial analgesia during labor2023-09-01OpenAlex10.1136/rapm-2023-esra.667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387505290
W4386822621Central nervous system histoplasmosis in an immunocompetent 5-year-old patient: a case report2023-09-01OpenAlex10.1055/s-0043-1774626Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386822621
W4386822554Childhood encephalitis: a challenging diagnosis2023-09-01OpenAlex10.1055/s-0043-1774627Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386822554
W4387516225Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment.2023-09-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387516225
W4386822868Encephalomyelitis by adenovirus2023-09-01OpenAlex10.1055/s-0043-1774629Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386822868
W4386887616Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer2023-09-01OpenAlex10.2147/btt.s426392Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386887616
W4387003787P-192 Increased serum CRBN levels are associated with improved survival in MM patients2023-09-01OpenAlex10.1016/s2152-2650(23)01810-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387003787
W4386380344Passive Sentences and Abstract Agents in German School Books2023-09-01OpenAlex10.1515/eujal-2022-0036Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4386380344
W4386822639Post-covid Guillain-Barre syndrome with atypical clinical presentation2023-09-01OpenAlex10.1055/s-0043-1774631Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386822639
W4386936293Sculpting Molecules in Silico: A Comprehensive Review of the Latest Innovations in Computer-Aided Drug Design to Revolutionize the Way Drugs are Engineered and Optimized2023-09-01OpenAlex10.55041/ijsrem25763Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386936293
W4386822488Septic thrombosis of the cavernous sinus secondary to meningitis: case report from a referral hospital in Espirito Santo2023-09-01OpenAlex10.1055/s-0043-1774634Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386822488
W4387157463Targeting Cytokines in Inflammatory Bowel Disease.2023-09-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387157463
W4386419777The Classification and Selection of Adhesive Agents; an Overview for the General Dentist2023-09-01OpenAlex10.2147/ccide.s425024Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4386419777
W4388899098Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System2023-09-01OpenAlex10.1200/go.23.00271Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388899098
W4386878148Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials2023-09-02OpenAlex10.1080/13543784.2023.2259309Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386878148
W4386391330Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes2023-09-02OpenAlex10.1016/j.molstruc.2023.136557Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386391330
W4386402473Contrast-Induced Nephropathy: An Overview2023-09-03OpenAlex10.1007/s44229-023-00040-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386402473
W4386423219Exploring SGLT-2 Inhibitors: Benefits beyond the Glucose-Lowering Effect—What Is New in 2023?2023-09-04OpenAlex10.3390/endocrines4030045Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386423219
W4386466167Improving patient communication on sunscreen choice: Updating mechanistic misconceptions2023-09-04OpenAlex10.1002/jvc2.251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386466167
W4387297304In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors2023-09-04OpenAlex10.1093/jacamr/dlad107Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387297304
W4386416293Malaysian and Chinese King Cobra Venom Cytotoxicity in Melanoma and Neonatal Foreskin Fibroblasts Is Mediated by Age and Geography2023-09-04OpenAlex10.3390/toxins15090549Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386416293
W4386860182Comprehensive Analysis of Scalded Skin Syndrome: Clinical Exploration, Underlying Pathophysiology and Advanced Therapeutic Approaches2023-09-06OpenAlex10.47191/ijmscrs/v3-i9-23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386860182
W4386498934Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis2023-09-07OpenAlex10.1186/s12967-023-04481-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386498934
W4386503826Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease2023-09-07OpenAlex10.1016/j.ekir.2023.09.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386503826
W4386530327The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?2023-09-08OpenAlex10.1007/s40256-023-00610-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386530327
W4387970629A Randomized, Embedded, Multifactorial Adaptive Platform trial for ILD (REMAP-ILD): The conceptual design2023-09-09OpenAlex10.1183/13993003.congress-2023.oa2588Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387970629
W4386580924The role and participation of immune cells in the endometrial tumor microenvironment2023-09-09OpenAlex10.1016/j.pharmthera.2023.108526Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386580924
W4386593039ASO Author Reflections: Preventing Nephrotoxicities in Ovarian Cancer Patients Undergoing HIPEC2023-09-11OpenAlex10.1245/s10434-023-14268-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386593039
W4386599425Advancing the Systems Science Paradigm in Public Health Through Intervention and Evaluation2023-09-11OpenAlex10.1097/fch.0000000000000382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386599425
W4386593328Nucleic Acid Based Testing (NABing): A Game Changer Technology for Public Health2023-09-11OpenAlex10.1007/s12033-023-00870-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386593328
W4386601373Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy2023-09-11OpenAlex10.3390/cancers15184509Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386601373
W4386592056The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy2023-09-11OpenAlex10.1097/hep.0000000000000572Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386592056
W4386629386A Descriptive Review of Medication Overuse HEADACHE-from Pathophysiology to the Clinic2023-09-12OpenAlex10.20944/preprints202309.0760.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386629386
W4386624408Immunomodulatory cytokines and clonal dynamics in low‐risk myelodysplastic syndromes patients treated with luspatercept2023-09-12OpenAlex10.1002/ajh.27072Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386624408
W4386624533Modern therapies of nonsmall cell lung cancer2023-09-12OpenAlex10.1007/s13353-023-00786-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386624533
W4386646814Sequential management of postmenopausal health and osteoporosis: An update2023-09-12OpenAlex10.1016/j.maturitas.2023.107846Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386646814
W4389314959Author response: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance2023-09-13OpenAlex10.7554/elife.85023.sa2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389314959
W4386705320Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 20232023-09-13OpenAlex10.1158/2326-6066.cir-23-0672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386705320
W4386701529Definitions and implications of the pharmacokinetic-pharmacodynamic parameters of antibiotics in pediatric clinical practice2023-09-13OpenAlex10.1016/j.idnow.2023.104781Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386701529
W4386704685Management of type 2 diabetes in the new era2023-09-13OpenAlex10.1007/s42000-023-00488-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386704685
W4386741374Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy2023-09-14OpenAlex10.3390/biom13091388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386741374
W4386726541Commentary on: Wound Healing Complications With Tranexamic Acid: Not the Silver Bullet After All2023-09-14OpenAlex10.1093/asj/sjad294Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386726541
W4386784975Abstract IA12: Fluorescence guided surgery: Rapidly evolving applications2023-09-15OpenAlex10.1158/1557-3265.aacrahns23-ia12Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386784975
W4386835698Editorial: Advanced polymeric biomaterial technologies for biomedical applications2023-09-15OpenAlex10.3389/fmats.2023.1278259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386835698
W4386836616Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer2023-09-15OpenAlex10.3389/fbioe.2023.1288806Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386836616
W4386781405Migraine in older adults2023-09-15OpenAlex10.1016/s1474-4422(23)00206-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386781405
W4386775955The principles of curative antibiotic treatments2023-09-15OpenAlex10.1016/j.idnow.2023.104780Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386775955
W4386797192Dietary management of eosinophilic oesophagitis2023-09-16OpenAlex10.5694/mja2.52101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386797192
W4386808342Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape2023-09-16OpenAlex10.1093/bjd/ljad345Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386808342
W4386849674Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy2023-09-18OpenAlex10.3389/fonc.2023.1289397Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386849674
W4386865727Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies2023-09-19OpenAlex10.1016/j.clml.2023.09.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386865727
W4386862621The biofilm proteome of Staphylococcus aureus and its implications for therapeutic interventions to biofilm-associated infections2023-09-19OpenAlex10.1016/bs.apcsb.2023.08.002Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4386862621
W4386863650The role of bacteriophages in shaping bacterial composition and diversity in the human gut2023-09-19OpenAlex10.3389/fmicb.2023.1232413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386863650
W4386878049Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification2023-09-20OpenAlex10.1007/s40265-023-01938-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386878049
W4387241356Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences2023-09-20OpenAlex10.1097/yic.0000000000000510Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387241356
W4386930725Editorial: Microbial production of medicinally important agents2023-09-20OpenAlex10.3389/fmicb.2023.1274087Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4386930725
W4386895086Exploring the Use of Diabetic Medications for Non-Diabetic Conditions: A Comprehensive Literature Review2023-09-20OpenAlex10.47672/ajhmn.1586Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386895086
W4387345885Infection Control in Dentistry: An Evaluation2023-09-21OpenAlex10.36348/sjodr.2023.v08i09.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387345885
W4386917538Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer2023-09-21OpenAlex10.1200/op.23.00273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386917538
W4386921854Special Report: Advancing Mood Disorder Care—From Parsimony to Precision2023-09-21OpenAlex10.1176/appi.pn.2023.10.10.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386921854
W4386950971Thinking Small, Stinking Big: The World of Microbial Odors2023-09-21OpenAlex10.1093/infdis/jiad405Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386950971
W4386947382Update on Outbreak of Fungal Meningitis Among US Residents Who Received Epidural Anesthesia at Two Clinics in Matamoros, Mexico2023-09-22OpenAlex10.1093/cid/ciad570Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4386947382
W4386997696Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers2023-09-24OpenAlex10.1053/j.semnuclmed.2023.08.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386997696
W4386995596Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges2023-09-24OpenAlex10.3390/biomedicines11102619Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4386995596
W4387007883Does perioperative immunotherapy reduce the risk of second primary cancers?2023-09-25OpenAlex10.1016/j.ejca.2023.113355Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387007883
W4387008467From FDG and beyond: the evolving potential of nuclear medicine2023-09-25OpenAlex10.1007/s12149-023-01865-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387008467
W4387023753Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues2023-09-25OpenAlex10.7759/cureus.45884Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387023753
W4387002147Nurse leaders thriving2023-09-25OpenAlex10.1097/nmg.0000000000000054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387002147
W4391310423Oncogenic Viruses: A Comparative Evolutionary Study2023-09-25OpenAlex10.21786/bbrc/16.3.4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391310423
W4387025551Pharmacometric approaches to improve theranostics2023-09-25OpenAlex10.33540/1920Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387025551
W4388424002MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?2023-09-26OpenAlex10.1097/qco.0000000000000966Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388424002
W4387078214A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP)2023-09-27OpenAlex10.1007/s10067-023-06781-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387078214
W4387094769Chalcones as Anti-Infective Agents for Effective Management of Tuberculosis2023-09-27OpenAlex10.1080/10406638.2023.2261593Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4387094769
W4387098332Clinical Profile and Outcomes of Patients With Hypercalcemia in an Indian Tertiary Care Center2023-09-27OpenAlex10.7759/cureus.46062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387098332
W4387077835Direct Oral Anticoagulants: An Overview of Indications, Pharmacokinetics, Comorbidities, and Perioperative Management2023-09-27OpenAlex10.1097/crd.0000000000000618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387077835
W4387081420OA02 Hip pain in the young and active patient? Don’t forget FAI2023-09-27OpenAlex10.1093/rap/rkad070.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387081420
W4387080987P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy2023-09-27OpenAlex10.1093/rap/rkad070.028Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387080987
W4387080918P10 Collapse, confusion and acute kidney injury presenting in the context of bullous skin disease in a young male patient2023-09-27OpenAlex10.1093/rap/rkad070.031Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387080918
W4387168392Right Ventricular Dysfunction During Left Ventricular Assist Device Implantation: Roles of Anesthesiologists2023-09-27OpenAlex10.1097/mat.0000000000002049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387168392
W4387115660Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects2023-09-28OpenAlex10.1093/neuonc/noad191Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387115660
W4387127060Management of nonfermenting gram-negative infections: a critique of the guidelines2023-09-28OpenAlex10.1097/qco.0000000000000982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387127060
W4387128891Treatment of evolving cancers will require dynamic decision support2023-09-28OpenAlex10.1016/j.annonc.2023.08.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387128891
W4387208766Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking2023-09-29OpenAlex10.1016/j.immuni.2023.09.003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387208766
W4400307840Artificial intelligence and psychiatry: applications and challenges2023-09-29OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400307840
W4387220437Current directions in the treatment of classical Hodgkin lymphoma2023-09-29OpenAlex10.1002/jha2.784Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387220437
W4387215306DEEPENING THEORETICAL KNOWLEDGE AND EXPLORING THE PROPERTIES OF LOCAL ANESTHETICS2023-09-29OpenAlex10.51891/rease.v9i9.11142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387215306
W4387157772Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill2023-09-29OpenAlex10.1002/phar.2871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387157772
W4387206556Impact of Concurrent Targeted Therapy and Immunotherapy on the Incidence of Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases2023-09-29OpenAlex10.1016/j.ijrobp.2023.06.839Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387206556
W4387206501Stereotactic Radiosurgery (SRS) for Brain Metastasis in the Era of Evolving Systemic Treatment (Immunotherapy or Targeted Therapy) in Patients with Non-Small Cell Lung Cancer (NSCLC)2023-09-29OpenAlex10.1016/j.ijrobp.2023.06.885Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387206501
W4387233555ANTIBIOGRAM OF STAPHYLOCOCCUS AUREUS AMONG CLINICAL ISOLATES AT A TERTIARY CARE HOSPITAL IN LAHORE2023-09-30OpenAlex10.51642/ppmj.v34i03.607Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387233555
W4387752510Advancements in Dermatological Therapies2023-09-30OpenAlex10.54393/tt.v4i03.137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387752510
W4387221797After Dobbs: Reflections on political and legal anthropology2023-09-30OpenAlex10.1111/plar.12535Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387221797
W4387259012An Evaluation of Experimental Calcium Ion-Leachable Nanocomposite Glass Ionomer Cements2023-09-30OpenAlex10.3390/nano13192690Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387259012
W4387160414IDRM: Brain tumor image segmentation with boosted RIME optimization2023-09-30OpenAlex10.1016/j.compbiomed.2023.107551Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387160414
W438749359355.3 Evolving Nonstandard Tic Treatment Approaches2023-10-01OpenAlex10.1016/j.jaac.2023.07.399Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387493593
W4387234618A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities2023-10-01OpenAlex10.3390/brainsci13101408Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387234618
W4388972493A diagnostic conundrum in Bardet–Biedl syndrome: when genetic diagnosis precedes clinical diagnosis2023-10-01OpenAlex10.1530/edm-23-0055Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4388972493
W4387380835Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines2023-10-01OpenAlex10.3904/kjm.2023.98.5.223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387380835
W4389632445Antimicrobial Resistance – We Need to Put in Serious Steps to Thwart It!2023-10-01OpenAlex10.4103/injms.injms_171_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389632445
W4389811826Authors’ Reply to Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn’s Disease—A Systematic Review and Network Meta-analysis2023-10-01OpenAlex10.1093/crocol/otad075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389811826
W4387247820CAVITARY PULMONARY NODULES: A RARE MANIFESTATION OF RHEUMATOID ARTHRITIS2023-10-01OpenAlex10.1016/j.chest.2023.07.3572Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387247820
W4387711162Cancer Pharmacology2023-10-01OpenAlex10.1891/9780826149336Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387711162
W4399147498Comparative Efficacy of Polidocanol and Sodium Tetradecyl Sulfate in the Management of Oral Mucoceles – A Comparative Study2023-10-01OpenAlex10.4103/jiaomr.jiaomr_84_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399147498
W4387303635Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol2023-10-01OpenAlex10.1136/bmjopen-2023-073071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387303635
W4387267583Current updates in HCC screening and treatment2023-10-01OpenAlex10.1097/cld.0000000000000083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387267583
W4388200887Drug development, clinical trials, and regulatory requirements2023-10-01OpenAlex10.1093/med/9780192869227.003.0030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388200887
W4388248510Health Care Chatbot2023-10-01OpenAlex10.55041/ijsrem26399Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388248510
W4387587017Lupus Miliaris Disseminatus Faciei – Lest we Forget: A Report of Two Cases2023-10-01OpenAlex10.4103/cdr.cdr_52_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387587017
W4387255308MULTISYSTEM INVOLVEMENT OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME2023-10-01OpenAlex10.1016/j.chest.2023.07.474Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387255308
W4387439933Navigating the maze of treatment strategies for RA‐ILD : Insights and innovations for better patient outcomes2023-10-01OpenAlex10.1111/1756-185x.14830Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387439933
W4388597967PB0324 Burden of Symptoms and Healthcare Resource Utilization (HCRU) and Costs in U.S. Patients with Thrombotic Thrombocytopenic Purpura (TTP)2023-10-01OpenAlex10.1016/j.rpth.2023.101459Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388597967
W4387253834PHENOBARBITAL-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS: A CASE REPORT2023-10-01OpenAlex10.1016/j.chest.2023.07.1733Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387253834
W4387256853POLYURIA IN THE ICU SETTING: IS DEXMEDETOMIDINE TO BLAME?2023-10-01OpenAlex10.1016/j.chest.2023.07.1595Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387256853
W4398235252POSTER ABSTRACT2023-10-01OpenAlex10.4103/0970-9371.388619Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398235252
W4387666280Palliative care integration for patients on phase I cancer clinical trials2023-10-01OpenAlex10.1016/j.currproblcancer.2023.101022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387666280
W4387733033S3276 Ustekinumab and Tofacitinib Combination Therapy: Success in a Difficult Case of Crohn’s Disease With Enteropathic Arthritis2023-10-01OpenAlex10.14309/01.ajg.0000962744.99545.eeTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387733033
W4387248829SUCCESSFUL ENDOVASCULAR INTERVENTION FOR ACUTE BASILAR ARTERY OCCLUSION: A CASE REPORT AND REVIEW OF MANAGEMENT STRATEGIES2023-10-01OpenAlex10.1016/j.chest.2023.07.1337Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387248829
W4387253212TUMOR LYSIS SYNDROME DUE TO CONCURRENT ADMINISTRATION OF PAXLOVID AND RUXOLITINIB2023-10-01OpenAlex10.1016/j.chest.2023.07.1829Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387253212
W4387970000The evolution of pharmacovigilance: the contributions of Michael D Rawlins2023-10-01OpenAlex10.1097/fad.0000000000000070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387970000
W4387232261The implications of antithrombotic agents on subdural hematoma evacuation: what does "reversal" truly entail?2023-10-01OpenAlex10.3171/2023.7.focus23354Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387232261
W4387253247UNIQUE PRESENTATION OF A RARE LYMPHOMA: ANAPLASTIC LARGE CELL LYMPHOMA WITH CARDIAC INVOLVEMENT2023-10-01OpenAlex10.1016/j.chest.2023.07.2291Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387253247
W4387451452“This carpenter wende he were in despeir”: Misinterpretation and the Nightmare in Chaucer's Miller's Tale2023-10-01OpenAlex10.5406/1945662x.122.4.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387451452
W4400183948A Fresh Beginning to an Old Conversation: Thoughts on Leon Hoffman’s “We Don’t Trust YOU: Reflections on Anti-Racism in Psychoanalysis”2023-10-02OpenAlex10.1080/00107530.2024.2323918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400183948
W4387253190Personalized treatment in localized pancreatic cancer2023-10-02OpenAlex10.1007/s10353-023-00814-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387253190
W4387296889Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?2023-10-02OpenAlex10.1111/ajco.14030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387296889
W4387309617Editorial: Green nanomaterials: prospective biotechnological applications2023-10-03OpenAlex10.3389/fmicb.2023.1280398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387309617
W4387357252Managing pediatric Crohn’s disease: recent insights2023-10-03OpenAlex10.1080/17474124.2023.2267431Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387357252
W4387954387Reflection on Collaborative Action: Fostering Collaborative Diagnostic Reasoning in an Agent-Based Medical Simulation2023-10-03OpenAlex10.22318/cscl2023.596913Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4387954387
W4387325873For better or for worse: when chatbots influence human emotions and behaviours2023-10-04OpenAlex10.1093/eurjcn/zvad098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387325873
W4387326506Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma2023-10-04OpenAlex10.1007/s00277-023-05478-xTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387326506
W4387352895Other molecular cohorts including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS2023-10-04OpenAlex10.1016/b978-0-323-69573-2.00021-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387352895
W4387357811The evolving landscape of oropharyngeal cancer: a window of opportunity for primary prevention2023-10-04OpenAlex10.1093/jnci/djad171Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387357811
W4387344892The expanding universe of gene and cell therapy2023-10-04OpenAlex10.1093/ajhp/zxad251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387344892
W4387357614Is immunology doing well? A look at 100 immune‐mediated inflammatory diseases for 100 years of the Journal2023-10-05OpenAlex10.1111/imcb.12695Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387357614
W4387523781The Challenge of Extensively Drug-resistant Gram-negative Pathogens in Children: Newer Antibiotics and When to Use Them for Empiric and Definitive Therapy2023-10-05OpenAlex10.1097/inf.0000000000004124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387523781
W4387396864Indications, Options, and Updates on Embolic Agents2023-10-06OpenAlex10.1016/j.coms.2023.09.006Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4387396864
W4387392472Novel treatment for mantle cell lymphoma – impact of BTK inhibitors and beyond2023-10-06OpenAlex10.1080/10428194.2023.2264430Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387392472
W4387422269Antibiotic Resistance Microbes’ (ARM) Mechanisms and Management: A Phytomedicinal Approach2023-10-07OpenAlex10.1007/s40011-023-01525-9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387422269
W4387432564The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review2023-10-07OpenAlex10.7759/cureus.46631Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387432564
W4387601946Bacteria biofilms: Navigating the way forward2023-10-08OpenAlex10.21608/mid.2023.236659.1621Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387601946
W4387473302Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?2023-10-09OpenAlex10.1159/000534341Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387473302
W4387453799Editorial: Lessons and policy consequences of mathematical modeling in relation to ongoing pandemics2023-10-09OpenAlex10.3389/fpubh.2023.1281493Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387453799
W4387478957The Role of Patient Blood Management in Judicious Use of Blood2023-10-09OpenAlex10.4103/aihb.aihb_106_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387478957
W4387486630A Global Review of Invasive Haemophilus influenzae Disease from 2000-2023: Current Status, Challenges and Future Perspectives2023-10-10OpenAlex10.21203/rs.3.rs-3412671/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387486630; https://openalex.org/W4380421161; https://openalex.org/W4391142718
W4387475716Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy2023-10-10OpenAlex10.1093/jnci/djad192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387475716
W4388707159Fellows’ Corner2023-10-10OpenAlex10.1097/hep.0000000000000620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388707159
W4387504242Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences2023-10-10OpenAlex10.1007/s11033-023-08844-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387504242
W4387472387The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib2023-10-10OpenAlex10.1002/ajh.27096Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387472387
W4387493675Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review2023-10-10OpenAlex10.1007/s00423-023-03133-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387493675
W4387893340A review of the state of cervical cancer: updates from prevention to recurrent disease2023-10-11OpenAlex10.1097/gco.0000000000000918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387893340
W4387521826COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?2023-10-11OpenAlex10.1159/000534540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387521826
W4409540016Managing Type 2 Diabetes Mellitus: A Personalized Approach2023-10-11OpenAlex10.31579/2768-0487/113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409540016
W4387534763Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages2023-10-11OpenAlex10.3389/fmicb.2023.1286046Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387534763
W4387578765A review of the explainability and safety of conversational agents for mental health to identify avenues for improvement2023-10-12OpenAlex10.3389/frai.2023.1229805Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4387578765
W4387563115Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium2023-10-12OpenAlex10.1158/2159-8290.cd-23-0559Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387563115
W4387569294Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers2023-10-12OpenAlex10.3390/cancers15204957Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387569294
W4387589973Index2023-10-12OpenAlex10.1108/978-1-83753-618-420231018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387589973; https://openalex.org/W4317733600; https://openalex.org/W4377995751
W4387562639PHYTOCHEMICAL SCREENING AND PHARMACOLOGICAL EVALUATION OF ANTICANCER ACTIVITY OF METHANOLIC EXTRACT OF MAYTENUS EMARGINATA (WILLD) IN RATS2023-10-12OpenAlex10.5281/zenodo.8434596Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387562639
W4387608438THE FRENCH AMBULATORY CESARIAN SECTION (FAUCS) – MATERNAL AND NEONATAL OUTCOMES: 5 YEARS CLINICAL EXPERIENCE2023-10-12OpenAlex10.52340/jecm.2023.05.20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387608438
W4387589919Transformative Active Learning in the Saudi National Institute of Health: Promoting Education and Research Skills Capability2023-10-12OpenAlex10.1108/978-1-83753-618-420231003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387589919
W4387609901Editorial: Education and society: new approaches for new challenges2023-10-13OpenAlex10.3389/feduc.2023.1290101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387609901
W4387599986Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)2023-10-13OpenAlex10.1007/s13555-023-01051-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387599986
W4387669860Experimental spectroscopic and molecular docking investigations of the anticancer drugs aprepitant and capecitabine2023-10-14OpenAlex10.1007/s00214-023-03055-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387669860
W4387642987PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics2023-10-14OpenAlex10.1053/j.seminoncol.2023.09.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387642987
W4387638744Xanthogranulomatous Pyelonephritis as a Complication of Obstructive Uropathy: Clinical Case2023-10-14OpenAlex10.14738/bjhmr.105.15652Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387638744
W4387653749Combining scar-modulating agents for the treatment of hypertrophic scars and keloids: A systematic review2023-10-15OpenAlex10.1016/j.bjps.2023.10.065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387653749
W4387661213Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy2023-10-16OpenAlex10.1080/14737140.2023.2270161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387661213
W4387704187Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer2023-10-17OpenAlex10.3389/fimmu.2023.1270828Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387704187
W4387695148From climate change to AMR: understanding environmental-human health issues in a One Health framework2023-10-17OpenAlex10.3897/aca.6.e108165Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387695148
W4387703853Overcoming the challenges of drug development in platinum-resistant ovarian cancer2023-10-17OpenAlex10.3389/fonc.2023.1258228Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387703853
W4391149256Some reflections on immunosuppressants and their delivery to the lungs by aerosol in the treatment of COVID-192023-10-17OpenAlex10.15789/1563-0625-sro-2613Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391149256
W4387709589Treatment of gastric adenocarcinoma: A rapidly evolving landscape2023-10-17OpenAlex10.1016/j.ejca.2023.113370Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387709589
W4387744448A Great Conversation With Deborah Friedman2023-10-18OpenAlex10.1097/wno.0000000000001999Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387744448
W4387733312Australian recommendations for the management of drug-resistant tuberculosis, 20232023-10-18OpenAlex10.33321/cdi.2023.47.48Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387733312
W4387729994Evolving paradigms in locally advanced rectal cancer: the means justify the ends2023-10-18OpenAlex10.1093/jnci/djad196Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387729994
W4387865887Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction2023-10-18OpenAlex10.14503/thij-23-8223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387865887
W4387771520Clinical trials aimed at HIV cure or remission: new pathways and lessons learned2023-10-19OpenAlex10.1080/14787210.2023.2273919Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387771520
W4387776385Nanotherapeutics for leptin resistance and obesity using metal nanocomposites2023-10-19OpenAlex10.1201/9781032621135-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387776385
W4387765003Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts2023-10-19OpenAlex10.1007/s11912-023-01461-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387765003
W4387826703Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants2023-10-20OpenAlex10.1016/j.ajps.2023.100855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387826703
W4387833724Plant crude drugs2023-10-20OpenAlex10.1016/b978-0-443-18657-8.00002-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387833724
W4387810660RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort2023-10-20OpenAlex10.1038/s41375-023-02027-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387810660
W4387799403Reimagining Nursing Education: The Power of a Shared Vision!2023-10-20OpenAlex10.1097/01.nep.0000000000001201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387799403
W4387799324Sixth Annual Mediclinic Middle East Research Conference2023-10-20OpenAlex10.1097/md.0000000000033794Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387799324
W4387849722Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future2023-10-21OpenAlex10.1016/j.ijantimicag.2023.107014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387849722
W4387849423Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach2023-10-21OpenAlex10.1016/j.jbc.2023.105381Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387849423
W4404195486Advancements in Therapeutic and Diagnostic Strategies for COVID-19: A Review of Recent Developments2023-10-23OpenAlex10.51470/apr.2023.2.2.20Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404195486
W4387895008Applications of nanomaterials as treatments and diagnostic biosensors in microbial infections2023-10-23OpenAlex10.1002/mba2.62Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387895008
W4387948673Surveillance and Management of Pouch Neoplasia in Familial Adenomatous Polyposis: A Systematic Review2023-10-23OpenAlex10.1097/dcr.0000000000003122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387948673
W4387905048Editorial Comment on “Atopic outcomes at 2 years in the CORAL cohort, born in COVID-19 lockdown”2023-10-24OpenAlex10.22541/au.169813277.70696178/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387905048
W4387909389Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke2023-10-24OpenAlex10.3390/jcm12216715Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4387909389
W4387893581Ivosidenib in acute myeloid leukemia2023-10-24OpenAlex10.1080/14656566.2023.2272659Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387893581
W4387906139Study of Anesthesia Agents Used for Ophthalmic Surgery2023-10-24OpenAlex10.21203/rs.3.rs-3478626/v1Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4387906139
W4387949152ASHP/SIDP Joint Statement on the Pharmacist’s Role in Antimicrobial Stewardship2023-10-25OpenAlex10.1093/ajhp/zxad164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387949152
W4387950323Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy2023-10-25OpenAlex10.1097/crd.0000000000000620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387950323
W4391698718An overview of the Pathogenesis and Virulence of Mycoplasma gallisepticum infection – a review2023-10-25OpenAlex10.24099/vet.arhiv.1841Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391698718
W4387950532Conversation with Dr. Daniela Novick2023-10-25OpenAlex10.1089/jir.2023.29057.intTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387950532
W4387940918On the horns of a dilemma: choosing total intravenous anaesthesia or volatile anaesthesia for cancer surgery, an enduring controversy2023-10-25OpenAlex10.1016/j.bja.2023.10.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4387940918
W4388265480Personalized management of differentiated thyroid cancer2023-10-25OpenAlex10.33540/1947Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388265480
W4387948572Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis2023-10-26OpenAlex10.1007/s40265-023-01950-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387948572
W4393208223Side Effects of Treatment in Multiple Myeloma2023-10-26OpenAlex10.1007/978-3-030-93702-7_10-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393208223
W4388308573The Age of Immune-therapy in Multiple Myeloma with a Collective Goal for a Cure2023-10-26OpenAlex10.18103/mra.v11i10.4607Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388308573
W4388192635Does Haematological Toxicity Increase with the Use of Lipophilic Chemotherapeutic Agents in Obese Breast Cancer Patients?2023-10-27OpenAlex10.14744/ejmi.2023.59404Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4388192635
W4387992163Selected Publications by David R. Maines2023-10-27OpenAlex10.1108/s0163-239620230000057022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387992163
W4387971612The Evolving Landscape: Exploring the Future of Myelodysplastic Syndrome Treatment with Dr. Rami Komrokji2023-10-27OpenAlex10.3390/cancers15215170Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4387971612
W4388001451Antibiotic Prophylaxis in Surgery: Current Insights and Future Directions for Surgical Site Infection Prevention2023-10-28OpenAlex10.7759/cureus.47858Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388001451
W4387998345Investigating Flavonoid Extracts from Medicinal Plants: Evaluating their Anti-Cancer Potential, Mechanisms, and Synergistic Impact on Colon Cancer2023-10-28OpenAlex10.17762/jaz.v44is-3.1297Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4387998345
W4388011358Nanoparticle-Based Theranostics: Simultaneous Diagnosis and Treatment2023-10-28OpenAlex10.31219/osf.io/hbcmyTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388011358
W4388133043Solving Epidemics of Lyme and Other Vector-Borne Infections through the Immune System2023-10-28OpenAlex10.31038/idt.2023415Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388133043
W4388038403Prevalence of Pseudomonas aeruginosa isolates and their antibiotic susceptibility among patients and healthcare workers in three Hospitals of Duhok city/ Iraq2023-10-29OpenAlex10.22317/jcms.v9i5.1428Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388038403
W4388136912AI Chatbots and Psychotherapy: A Match Made in Heaven?2023-10-30OpenAlex10.47391/jpma.9608Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388136912
W4388103679Implementation Evaluation of Community-Based Mental Health and Psychosocial Support Intervention for Refugee Newcomers in the United States2023-10-30OpenAlex10.1155/2023/6696415Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388103679
W4388109283Portuguese Pancreatic Club Perspectives on Endoscopic Ultrasound-Guided and Surgical Treatment of Pancreatic Neuroendocrine Tumors2023-10-30OpenAlex10.1159/000534032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388109283
W4388104264Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma2023-10-30OpenAlex10.3390/cancers15215217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388104264
W4388042660Social Entrepreneurship In The New Economy Among The Younger Generation2023-10-30OpenAlex10.61160/jomss.v1i3.22Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388042660; https://openalex.org/W4388263509; https://openalex.org/W4391168607
W43880695291386 EVOLVE-106, a T cell engager with integrated CD2 costimulation targeting B7-H4, is a precision therapy for estrogen and Her2 receptor low breast cancers2023-10-31OpenAlex10.1136/jitc-2023-sitc2023.1386Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388069529
W4388042634463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy2023-10-31OpenAlex10.1136/jitc-2023-sitc2023.0463Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388042634
W7204989898GLP-1 RECEPTOR AGONISTS: EXPANDING INDICATIONS FROM DIABETES AND OBESITY TO CARDIOVASCULAR AND NEURODEGENERATIVE DISEASES2023-10-31OpenAlex10.58175/gjrbp.2023.2.4.0225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204989898
W4388033339Reducing Gadolinium Contrast With Artificial Intelligence2023-10-31OpenAlex10.1002/jmri.29095Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388033339
W4388072194Supporting Solidarity2023-10-31OpenAlex10.52214/vib.v9i.11758Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388072194
W4388048888Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications2023-10-31OpenAlex10.3390/cells12212559Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388048888
W43888222652023 Index to Volume 85 of The American Biology Teacher2023-11-01OpenAlex10.1525/abt.2023.85.9.540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388822265
W4388527812A CASE OF DELAYED TYPE HYPERSENSITIVITY REACTION TO INSULIN2023-11-01OpenAlex10.1016/j.anai.2023.08.329Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388527812
W4397041064A Rare Case of Renal-Limited Hydralazine-Induced Pauci-Immune Glomerulonephritis2023-11-01OpenAlex10.1681/asn.20233411s11120eTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397041064
W4388527767ANAPHYLAXIS WITH A GELATIN-CONTAINING SUPPOSITORY IN A TWO-YEAR-OLD GIRL2023-11-01OpenAlex10.1016/j.anai.2023.08.331Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388527767
W4392462082Abstract 160: Recurrent Multi‐territorial Ischemic Stroke as an Initial Presentation of Thrombotic Thrombocytopenic Purpura2023-11-01OpenAlex10.1161/svin.03.suppl_2.160Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392462082
W4389511785Advanced Practitioners as Agents of Change: Leveraging Quality Improvement to Improve Practice2023-11-01OpenAlex10.6004/jadpro.2023.14.7.13Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4389511785
W4388129544An Overview of Contrast-induced Acute Kidney Injury2023-11-01OpenAlex10.1177/26324636231203498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388129544
W4397043013Anemia Treatment Among Prevalent Hemodialysis and Peritoneal Dialysis Patients in the United States2023-11-01OpenAlex10.1681/asn.20233411s1366bTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397043013
W4397040730Anti-Tumor Necrosis Factor Antibody-Induced Lupus-Like Glomerulonephritis2023-11-01OpenAlex10.1681/asn.20233411s1602cTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397040730
W4388527800DELAYED-TYPE HYPERSENSITIVITY REACTION FOLLOWING PEGFILGRASTIM EXPOSURE2023-11-01OpenAlex10.1016/j.anai.2023.08.328Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388527800
W7132936886Deployment and Evaluation of a Motivational-Interviewing Chatbot for Moving Smokers Towards the Decision to Quit and Distillation of Large Foundational Language Models for Generating MI Reflections2023-11-01OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7132936886
W4388495018EP242/#366 Title understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim data from the OC-NOW survey (2023)2023-11-01OpenAlex10.1136/ijgc-2023-igcs.316Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388495018
W4397042472From Famine to Feast in IgA Nephropathy: New Treatments Present New Opportunities for Patients2023-11-01OpenAlex10.1681/asn.20233411s1980aTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397042472
W4388706183Getting Ready for Certification2023-11-01OpenAlex10.1097/won.0000000000001037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388706183
W4388590658IMMU-39. EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBLASTOMA FROM REAL-WORLD DATA ANALYSIS2023-11-01OpenAlex10.1093/neuonc/noad179.0571Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388590658
W7218102966Idiosyncratic Drug-induced Liver Injury: A Diagnosis Beyond Simplicity2023-11-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218102966
W4388303891Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies2023-11-01OpenAlex10.1097/hs9.0000000000000975Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388303891
W4389456261New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives2023-11-01OpenAlex10.12788/cutis.0911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389456261
W4388478917Overcoming challenges with getting current evidence into practice2023-11-01OpenAlex10.11124/jbies-23-00473Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388478917
W4388424653P85 Contemporary underlying causes of immunocompromise in severe PCP: a 10 year tertiary-centre experience2023-11-01OpenAlex10.1136/thorax-2023-btsabstracts.237Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388424653
W4388527749SCITING TO A HALT: A CASE OF MAST CELL ACTIVATION SYNDROME AND RECURRENT ANAPHYLAXIS2023-11-01OpenAlex10.1016/j.anai.2023.08.330Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388527749
W4389764398Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options2023-11-01OpenAlex10.1053/j.seminhematol.2023.12.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389764398
W3103198646Sexpertise: Sexual Knowledge and the Public in the Nineteenth and Twentieth Centuries2023-11-01OpenAlex10.1093/shm/hkae014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W3103198646
W4389514622Sigrid Boysen, Review of Marie-Catherine Petersmann. When Environmental Protection and Human Rights Collide: The Politics of Conflict Management by Regional Courts2023-11-01OpenAlex10.1093/ejil/chad064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389514622
W4388588933TMIC-50. SIGLEC-15 IS A NEW MYELOID CHECKPOINT IN GBM, WHOSE SUPPRESSION LEADS TO EXTREMELY DURABLE RESPONSES WITH ONCOLYTIC THERAPY2023-11-01OpenAlex10.1093/neuonc/noad179.1116Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388588933
W4397045217Unveiling the Masquerade: Misdiagnosis of CKD in the Shadow of HIV Treatment2023-11-01OpenAlex10.1681/asn.20233411s1692aTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397045217
W4389235152A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group2023-11-02OpenAlex10.1182/blood-2023-179611Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389235152
W4389248281A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies2023-11-02OpenAlex10.1182/blood-2023-177550Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389248281
W4389229518A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)2023-11-02OpenAlex10.1182/blood-2023-178724Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389229518
W4389247955A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses2023-11-02OpenAlex10.1182/blood-2023-178509Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389247955
W4389220356A Systematic Literature Review (SLR) and Meta-Analysis of Clinical Evidence of Second Line or Later (2L+) Treatments for Follicular Lymphoma (FL) in Adult Patients2023-11-02OpenAlex10.1182/blood-2023-178738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389220356
W4389232332Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones2023-11-02OpenAlex10.1182/blood-2023-190584Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389232332
W4389229646Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine2023-11-02OpenAlex10.1182/blood-2023-186085Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4389229646
W4389259708BCMA-Directed CAR-T Cell Therapy Is Associated with a Higher Risk of Infections: A Systematic Review and Meta-Analysis2023-11-02OpenAlex10.1182/blood-2023-189225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389259708
W4389229421Cladribine and Low-Dose Cytarabine-Based Salvage Therapy for Relapsed/Refractory AML in a Predominantly Venetoclax-Exposed Cohort2023-11-02OpenAlex10.1182/blood-2023-185524Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389229421
W4389243249Cladribine-Based Chemotherapy for Patients with Secondary Acute Myeloid Leukemia (AML) Arising after Myeloproliferative Neoplasms (MPNs)2023-11-02OpenAlex10.1182/blood-2023-187968Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389243249
W4389248190Clinical Manifestations Are Evolving and Progressive in Patients with Vexas Syndrome2023-11-02OpenAlex10.1182/blood-2023-187454Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4389248190
W4389247258Clinical Outcomes in Real-World Patients (RW) with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): A Retrospective Study Using Electronic Health Records from Flatiron Health and COTA Vantage Databases2023-11-02OpenAlex10.1182/blood-2023-173661Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389247258
W4389243601Contemporary Multiple Myeloma Treatment Patterns Among HCPs and Concordance with Expert Recommendations: Analysis of an Interactive Online Decision Support Tool2023-11-02OpenAlex10.1182/blood-2023-180957Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389243601
W4389243925Cytokine and Mutation Profiling Reveal Patterns of Complete Remission Rates with Lenzilumab Combination Therapy in Chronic Myelomonocytic Leukemia2023-11-02OpenAlex10.1182/blood-2023-179706Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389243925
W4389228845DNA Vaccines Against GPRC5D in Myeloma2023-11-02OpenAlex10.1182/blood-2023-178251Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389228845
W4389220467Down Syndrome with Acute Myeloid Leukemia in an Adolescent Male Successfully Treated with Low Dose Ara-C in Combination with Hypomethylating Agent2023-11-02OpenAlex10.1182/blood-2023-190834Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389220467
W4389243930Emerging Trends in Frontline Treatment for Acute Myeloid Leukemia (AML): A Survey of NCI-Designated Cancer Centers2023-11-02OpenAlex10.1182/blood-2023-190839Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389243930
W4389221864Epidemiology and Clinical Outcomes of Hematologic Patients with Proven and Probable Invasive Fungal Infections: A Latin American Tertiary Care Centre Experience2023-11-02OpenAlex10.1182/blood-2023-188730Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389221864
W4389221656Ex Vivo Mathematical Myeloma Advisor (EMMA) - a Clinical, Molecular, and Phenotypic Platform to Tailor Personalized Therapeutic Strategies for Multiple Myeloma2023-11-02OpenAlex10.1182/blood-2023-190479Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389221656
W4389230971Genome Sequencing to Discover Drivers of Clonal Expansion in Smoldering Multiple Myeloma2023-11-02OpenAlex10.1182/blood-2023-184900Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389230971
W4389246672Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant2023-11-02OpenAlex10.1182/blood-2023-185151Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389246672
W4389234924Impact of Recent Advancements in Relapsed/Refractory Acute Myeloid Leukemia on Overall Survival in Clinical Practice2023-11-02OpenAlex10.1182/blood-2023-185132Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389234924
W4389233760Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional Prospective Cohort Study2023-11-02OpenAlex10.1182/blood-2023-187268Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389233760
W4389233438Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)2023-11-02OpenAlex10.1182/blood-2023-178786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389233438
W4388451259Membranous nephropathy treatment standard2023-11-02OpenAlex10.1093/ndt/gfad225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388451259
W4389244147Monoclonal Immunoglobulin Deposition Disease - a Review of Current and Emerging Data2023-11-02OpenAlex10.1182/blood-2023-189950Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389244147
W4389235102Multicenter Study to Assess the Outcomes and Prognosis of Richter's Transformation in the Era of Novel Agents and Cell Therapy2023-11-02OpenAlex10.1182/blood-2023-186703Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389235102
W4389230863Novel Agents with Efficacy Against Cellular Models of Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) Associated with Germline Mutant RUNX12023-11-02OpenAlex10.1182/blood-2023-190655Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389230863
W4389234829Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution2023-11-02OpenAlex10.1182/blood-2023-182972Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389234829
W4389234489Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and Disparities2023-11-02OpenAlex10.1182/blood-2023-189642Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389234489
W4389247051RAMP up: Risk Adapted Post-Autologous Transplant Maintenance Therapy in MRD Positive Myeloma Patients2023-11-02OpenAlex10.1182/blood-2023-191148Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389247051
W4389247326RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects2023-11-02OpenAlex10.1182/blood-2023-178912Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389247326
W4389248212Real-World Evaluation of Outcomes in Relapsed/Refractory Multiple Myeloma Patients That Are Triple-Class Exposed after Receiving 2 or More Prior Lines of Therapy2023-11-02OpenAlex10.1182/blood-2023-178824Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389248212
W4389258228Real-World Outcomes Among 2L+ Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT)2023-11-02OpenAlex10.1182/blood-2023-178727Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389258228
W4389259171Real-World Treatment Patterns, Outcomes, Health Care Resource Utilization and Cost Burden of Multiple Myeloma in South Korea Using the National Claims Data2023-11-02OpenAlex10.1182/blood-2023-174019Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389259171
W4389221835Recent Advancements in Acute Myeloid Leukemia Have Led to Incremental Improvement in Overall Survival2023-11-02OpenAlex10.1182/blood-2023-183022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389221835
W4388672310Role of radiation in oligometastases and oligoprogression in metastatic non-small cell lung cancer: consensus and controversy2023-11-02OpenAlex10.1080/17476348.2023.2284362Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388672310
W4389235299Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database2023-11-02OpenAlex10.1182/blood-2023-181138Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389235299
W4392391416Shared infections at the wildlife–livestock interface and their impact on public health, economy, and biodiversity2023-11-02OpenAlex10.1093/af/vfad067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392391416
W4389248293Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need?2023-11-02OpenAlex10.1182/blood-2023-186739Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389248293
W4389220539Targeting CD24 “Don't Eat Me” Signal Restores Phagocytic Activity of Nurse-like Cells from Patients with Chronic Lymphocytic Leukemia2023-11-02OpenAlex10.1182/blood-2023-190359Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389220539
W4389233476The Cytogenetic and Molecular Testing Landscape in Patients with Newly Diagnosed Acute Myeloid Leukemia in Routine Clinical Practices in the United States2023-11-02OpenAlex10.1182/blood-2023-179370Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389233476
W4389229743Treatment of Elderly Patients with Higher Risk Myelodysplastic Syndromes with Oral Azacitidine2023-11-02OpenAlex10.1182/blood-2023-190016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389229743
W4389232174Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies2023-11-02OpenAlex10.1182/blood-2023-190383Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389232174
W4389246451Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy2023-11-02OpenAlex10.1182/blood-2023-187374Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389246451
W4388304988Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story2023-11-03OpenAlex10.1136/ard-2023-223850Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388304988
W4388282519Treatment of systemic juvenile idiopathic arthritis2023-11-03OpenAlex10.1038/s41584-023-01042-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388282519
W4388342100Recent advances in genomics and therapeutics in mantle cell lymphoma2023-11-04OpenAlex10.1016/j.ctrv.2023.102651Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388342100
W4403450217THE NOOTROPIC EFFECT OF A DIPEPTIDE MIMETIC OF NGF IN AN EXPERIMENTAL MODEL OF ALZHEIMER'S DISEASE2023-11-04OpenAlex10.29296/25877313-2023-11-10Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403450217
W4388424559A Look at ctDNA Monitoring in Small Cell Lung Cancer2023-11-05OpenAlex10.1097/01.cot.0000995204.87551.8aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388424559
W4389790602Anticoagulation in Internal Medicine: Finding Equilibrium in the Face of Risks and Rewards2023-11-05OpenAlex10.21275/sr231121092535Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389790602
W4388398313Encouraging but slow progress toward incorporating obesity care into diabetes care2023-11-05OpenAlex10.1002/oby.23925Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388398313
W4390678581Introduction of Reinforcement Learning and Its Application Across Different Domain2023-11-05OpenAlex10.32628/cseit239066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390678581
W4388460862Entering a New Era of Antihypertensive Therapy2023-11-06OpenAlex10.1053/j.ajkd.2023.09.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388460862
W4388423484Extracellular Vesicles: An Emerging Clinical Opportunity in Musculoskeletal Disease2023-11-06OpenAlex10.1089/ten.teb.2023.0208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388423484
W4388570815PRIMED for the Future: Purposing Raw Intake for Machine Learning-Enabled Detection (Final Report)2023-11-06OpenAlex10.2172/2204943Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388570815
W4388480894A review of chemical signaling pathways in the quorum sensing circuit of Pseudomonas aeruginosa2023-11-07OpenAlex10.1016/j.ijbiomac.2023.127861Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388480894
W4388450345Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine2023-11-07OpenAlex10.1016/j.jlb.2023.100126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388450345
W4388462532Recent Modalities in Pain Control and Local Anesthesia in Dentistry: A Narrative Review2023-11-07OpenAlex10.7759/cureus.48428Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388462532
W4388522807Editorial: New diagnostic perspectives in urogenital radiology2023-11-08OpenAlex10.3389/fmed.2023.1280300Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4388522807
W4388532472Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development2023-11-08OpenAlex10.3390/antibiotics12111607Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388532472
W4388493484Treatment rates and factors associated with direct‐acting antiviral therapy for insured patients with hepatitis C‐related hepatocellular carcinoma – A real‐world nationwide study2023-11-08OpenAlex10.1111/apt.17794Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388493484
W4394765159Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review2023-11-09OpenAlex10.4103/ijpm.ijpm_467_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394765159
W4388525218The West Becoming “Westless” and the Polish Experience of Totalitarianism and Modernity2023-11-09OpenAlex10.5406/23300841.68.4.06Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388525218
W4388913762Acinetobacter baumannii: Epidemiology, Clinical Manifestations and Associated Infections2023-11-10OpenAlex10.5772/intechopen.1003618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388913762
W4388574400Genetic Diversity Resulting in the Development of AMR2023-11-10OpenAlex10.1201/9781003281238-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388574400
W4388566341Nanotechnology Potent Photothermal and Photodynamic Immunotherapies of Cancer2023-11-10OpenAlex10.1007/s40846-023-00836-6Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388566341
W4403197628Tapping the Potential of Probiotics: An Insight on Probiotic Delivery Systems, Their Quantification, and Assessment2023-11-10OpenAlex10.15415/jprtm.2023.112007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403197628
W4388634579Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application2023-11-11OpenAlex10.3390/life13112199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388634579
W4388593151Emergence of Rapid-Onset Ototoxicity Following Three Doses of Vancomycin: A Unique Case Report in the Context of Normal Renal Function and Therapeutic Dosing2023-11-11OpenAlex10.7759/cureus.48647Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388593151
W4388588221Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy2023-11-11OpenAlex10.1016/j.neo.2023.100949Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388588221
W4388637998New Insights in Hydrogels for Periodontal Regeneration2023-11-11OpenAlex10.3390/jfb14110545Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388637998
W4388623815A Comprehensive Review of Postoperative Analgesics Used in Orthopedic Practice2023-11-13OpenAlex10.7759/cureus.48750Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388623815
W4388660822Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice2023-11-13OpenAlex10.3390/cancers15225397Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388660822
W4388670636Communities of practice: A theoretical framework for undergraduate longitudinal placements2023-11-13OpenAlex10.1111/tct.13692Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388670636
W4388625962Rewind & Play2023-11-13OpenAlex10.5406/25784773.6.2.07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388625962
W4388671932Placemaking -the importance of kinship for migrants’ habitus and territorial integration2023-11-14OpenAlex10.33182/md.v2i3.3032Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388671932
W4389936002Triste tigre2023-11-14OpenAlex10.3917/gest.060.0140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389936002
W4388681952Contrast echocardiography: a practical guideline from the British Society of Echocardiography2023-11-15OpenAlex10.1186/s44156-023-00034-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388681952
W4388735057Cellular and population strategies underpinning neurotoxin production and sporulation in Clostridium botulinum type E cultures2023-11-16OpenAlex10.1128/mbio.01866-23Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388735057
W4388761621Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review2023-11-17OpenAlex10.3390/jcm12227144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388761621
W4388783834Endoscopic treatment of gastric variceal bleeding: Where have we come from, and where are we going?2023-11-18OpenAlex10.1016/j.gie.2023.08.011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388783834
W4388831066A Case of Tinea Corporis Caused by Trichophyton benhamiae var. luteum from a Degu and Evolution of the Pathogen’s Taxonomy2023-11-19OpenAlex10.3390/jof9111122Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388831066
W4388826332Changing Roles of Medical Teachers in the Era of Competency-based Medical Education2023-11-20OpenAlex10.4103/ajim.ajim_100_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388826332
W7217441202Gastric Floating Beads: Revolution in Novel Drug Delivery2023-11-20OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217441202
W4388827846Pediatric acute myeloid leukemia – novel approaches2023-11-20OpenAlex10.1097/moh.0000000000000795Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388827846
W7165916749Analysis of the Guide to Excellence in the Conduct of Clinical Trials in Hospital Pharmacy2023-11-21OpenAlex10.32629/ameir.v1i4.1641Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165916749
W4388871729Detail analysis of puncture site complications in neuro-endovascular therapy: A single-center analysis2023-11-21OpenAlex10.1016/j.inat.2023.101912Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4388871729
W4388861667Medical Tourism and Communication2023-11-21OpenAlex10.1093/acrefore/9780190228613.013.1461Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388861667
W4388940326Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay2023-11-21OpenAlex10.3389/fped.2023.1251914Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388940326
W4388867268Recent Advances in the Management of Anal Cancer2023-11-21OpenAlex10.3390/healthcare11233010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388867268
W4388901137Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review2023-11-22OpenAlex10.3390/life13122244Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388901137
W4388921327The fibrinolysis renaissance2023-11-22OpenAlex10.1016/j.jtha.2023.09.012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388921327
W4388934042Central Nervous System Lymphoma2023-11-23OpenAlex10.1055/s-0043-1776783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388934042
W4388979277Long non-coding RNA and Evolving drug resistance in lung cancer2023-11-24OpenAlex10.1016/j.heliyon.2023.e22591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4388979277
W4388978319Primate origins of human event cognition2023-11-24OpenAlex10.1101/2023.11.23.568086Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4388978319
W4389099760Acute Myeloid Leukemia: Selecting Induction Therapy Based on Biological Disease Factors2023-11-25OpenAlex10.6004/jnccn.2023.5035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389099760
W43890310131288. Rapidly evolving Lyme epidemiology in central Ohio creates challenges in prompt diagnosis and management of Lyme arthritis2023-11-27OpenAlex10.1093/ofid/ofad500.1127Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389031013
W43890290731948. Rise of Candida auris Infections Worldwide and Trends on the Activity of Fosmanogepix and Comparator Agents against C. auris Causing Invasive Infections2023-11-27OpenAlex10.1093/ofid/ofad500.102Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389029073
W43890295562186. Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR) Pseudomonas aeruginosa2023-11-27OpenAlex10.1093/ofid/ofad500.1808Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389029556
W43890307622585. Identification of Risk Factors for Pseudomonas aeruginosa in Patients with Community-Acquired Pneumonia2023-11-27OpenAlex10.1093/ofid/ofad500.2200Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389030762
W43890309772694. Infectious Complications in CAR-T Cell Therapy Recipients: A Systematic Review and Meta-Analysis2023-11-27OpenAlex10.1093/ofid/ofad500.2305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389030977
W43890307252742. The Prevalence and Clinical Impact of Antibiotic Allergy Labels in Solid Organ Transplant Recipients2023-11-27OpenAlex10.1093/ofid/ofad500.2353Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389030725
W4389151444AI enhances drug discovery and development2023-11-27OpenAlex10.1093/nsr/nwad303Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389151444
W4389097051Critically Ill Patients With Cardiac Dysfunction and the Rashomon Effect2023-11-27OpenAlex10.1016/j.chstcc.2023.100031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389097051
W4389084751Acquired Triazole Resistance Alters Pathogenicity-Associated Features in Candida auris in an Isolate-Dependent Manner2023-11-28OpenAlex10.3390/jof9121148Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389084751
W4389110498Use and Engagement With Low-Intensity Cognitive Behavioral Therapy Techniques Used Within an App to Support Worry Management: Content Analysis of Log Data2023-11-28OpenAlex10.2196/47321Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389110498
W4389206074Advancing Oro-Dental and Cranio-Maxillo-Facial Interventions for QoL: Injectable Hydrogel and BioCeramic NanoDelivery Platforms2023-11-29OpenAlex10.58624/svoade.2023.04.0159Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389206074
W4389147438Biologics: Teriparatide and Newer Anabolics2023-11-29OpenAlex10.1007/s43465-023-01063-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389147438
W4389144699C7‐Halomethylene/methyl‐C3‐thiophenyl‐spirocyclic‐β‐lactams: Synthesis, X‐ray Analysis, Antimicrobial Evaluation, Cytotoxicity Profile and Molecular Docking Interactions2023-11-29OpenAlex10.1002/cmdc.202300505Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389144699
W4389122316Chatbots Overcome the Limit of Nursing Education (Preprint)2023-11-29OpenAlex10.2196/preprints.54987Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389122316
W4389149426Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections2023-11-29OpenAlex10.1093/cid/ciad664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389149426
W4389204818Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal2023-11-30OpenAlex10.3389/fmicb.2023.1270018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389204818
W4389165584Preoperative Patient Evaluation: Obtaining the Information We Need to Inform the Care We Provide2023-11-30OpenAlex10.1016/j.anclin.2023.11.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389165584
W7217019992Prosopis Cineraria as Hepatoprotective: A Review2023-11-30OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217019992
W438948806770P LIST (Lung Initiative on Sequence Therapy): A real-world study of nivolumab for advanced NSCLC in France - First effectiveness, safety, and IO-rechallenge results2023-12-01OpenAlex10.1016/j.iotech.2023.100542Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389488067
W4406643166A Comprehensive Overview of Restrictive Lung Disease: Diagnosis, Management, and Implications in Pulmonary Medicine2023-12-01OpenAlex10.25163/angiotherapy.72110109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406643166
W4390757947A Reflection of Fifty Years2023-12-01OpenAlex10.1525/aft.2023.50.4.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390757947
W4399705622ANTIMICROBIAL RESISTANCE AND UPCOMING DNA VACCINE - A NEW CONCERN2023-12-01OpenAlex10.58532/v3bkbt24p1ch11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399705622
W4390642100Aberrant Crypt Foci - Endpoint in Colorectal Cancer2023-12-01OpenAlex10.2478/inmed-2023-0266Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390642100
W4389567682Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review2023-12-01OpenAlex10.21037/cco-23-79Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389567682
W4389608862Brain Metastases and Leptomeningeal Disease2023-12-01OpenAlex10.1212/con.0000000000001354Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389608862
W4399580815CARDIAC BIOENGINEERING2023-12-01OpenAlex10.58532/v3bjbt6p5ch2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399580815
W4390952346CORTICOSTEROID OVERUSE AND UNINTENDED CONSEQUENCES IN CLINICAL PRACTICE2023-12-01OpenAlex10.24041/ejmr2023.37Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390952346
W4390195664Cerebral microbleeds in Down syndrome: association with demographic, genetic, fluid and imaging biomarkers of Alzheimer’s disease2023-12-01OpenAlex10.1002/alz.079405Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390195664
W4389208984Clinical Inquiry2023-12-01OpenAlex10.4037/ccn2023264Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389208984
W4399592542DEVELOPING INNOVATION: STARTUP AND ENTREPRENEURSHIP DYNAMICS2023-12-01OpenAlex10.58532/v3bkso13p4ch8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399592542
W4391137145Exosome and Other Extracellular Vesicles in Gene Therapy and Personalized Care2023-12-01OpenAlex10.2174/0118756921285480240118051820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391137145
W4389207650Fetal Tachyarrhythmia: A Tale of Two Presentations2023-12-01OpenAlex10.1542/neo.24-12-e819Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389207650
W4405536489Happy Endings? Resisting Women and the Economy of Love in Day Five of Boccaccio's Decameron2023-12-01OpenAlex10.5406/23256672.100.5.12Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405536489
W4390201357Lithium carbonate treatment decrease neuroinflammation and ameliorates long‐term memory in a Down syndrome animal model2023-12-01OpenAlex10.1002/alz.083124Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4390201357
W4393092477Midwives’ oaths: everyday life and the law in seventeenth-century England2023-12-01OpenAlex10.1017/s0268416023000309Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393092477
W4399614737NANOTECHNOLOGY IN ANAESTHESIA: PAST, PRESENT AND THE FUTURE2023-12-01OpenAlex10.58532/v3bfms1p3ch9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399614737
W4399818959NAVIGATING HEART HEALTH A COMPREHENSIVE EXPLORATION OF NANOROBOT APPLICATIONS IN MANAGING CORONARY BLOCKAGES2023-12-01OpenAlex10.58532/v3bapn5ch15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399818959
W4392255095Neoliberalism and Disclosure 's New Trans Activism: The Politics of Discrimination in Hollywood and How to Fight It2023-12-01OpenAlex10.5406/19346018.75.4.02Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392255095
W4389878138Non-Compressive Acute Myelitis: Epidemiologic, Clinical, Paraclinical and Evolution Aspects: Study of 48 Cases2023-12-01OpenAlex10.1016/j.msard.2023.105205Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389878138
W4392842347Plague’s Preconditions and Literary Consequences2023-12-01OpenAlex10.1215/0041462x-10986848Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392842347
W4389399417Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects2023-12-01OpenAlex10.1053/j.seminoncol.2023.11.003Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4389399417
W4393326297Pulmonary Veno-Occlusive Disease2023-12-01OpenAlex10.21693/1933-088x-22.4.164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393326297
W4390513644Quality of Life and Side Effects Management in Cancer Treatment2023-12-01OpenAlex10.3390/books978-3-0365-9529-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390513644
W4390124561RWD55 Retrospective Observational Study of Real-World Treatment Patterns and Financial Burden in Patients With Premenopausal Metastatic HR+/HER2- Breast Cancer2023-12-01OpenAlex10.1016/j.jval.2023.09.2772Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390124561
W4389219365SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia2023-12-01OpenAlex10.1016/j.clml.2023.11.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389219365
W4399590392SYNTHESIS OF COPPER OXIDE NANOPARTICLES USING CHEMICAL METHOD AND ITS CHARACTERIZATION AND CYTOTOXICITY STUDIES AND ANTI-MICROBIAL STUDIES2023-12-01OpenAlex10.58532/v3becm2ch6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399590392
W4389208052Sterols in Inflammatory Diseases: Implications and Clinical Utility2023-12-01OpenAlex10.1007/978-3-031-43883-7_13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389208052
W4389244467The Tapestry of Thiamine2023-12-01OpenAlex10.1097/01.eem.0000997352.09967.11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389244467
W4399819040UNLEASHING THE IMMUNE SYSTEM'S POTENTIAL AGAINST CUTANEOUS MALIGNANCIES: ADVANCES AND INNOVATIONS IN SKIN CANCER IMMUNOTHERAPY2023-12-01OpenAlex10.58532/v3bapn5ch14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399819040
W4389639049Unlocking the Intrathecal Route: A Comprehensive Review2023-12-01OpenAlex10.55041/ijsrem27467Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389639049
W4389223216Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility2023-12-01OpenAlex10.1128/cmr.00100-22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389223216
W4393172398Women and the Islamic Republic: How Gendered Citizenship Conditions the Iranian State2023-12-01OpenAlex10.5325/bustan.14.2.0184Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393172398
W4389264905A novel holin from an Enterococcus faecalis phage and application in vitro and in vivo2023-12-02OpenAlex10.1016/j.micpath.2023.106471Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389264905
W4389282941Diagnosis and Treatment of Immune Heamolytic Aneamia2023-12-02OpenAlex10.59298/nijbas/2023/1.2.11111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389282941
W4389277030SiCARIO: A Phase I/II Study of Split-Course Adaptive Radioimmunotherapy for the Treatment of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Using Adaptive Radiotherapy2023-12-02OpenAlex10.1016/j.ijrobp.2023.10.075Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389277030
W4391306714Virtual Agents in Internet-Based Cognitive Behavioral Therapy: Enhancing Engagement and Alleviating Depression2023-12-04OpenAlex10.1109/ica58824.2023.00019Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4391306714
W4389339791Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors2023-12-05OpenAlex10.33590/emjoncol/10305999Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389339791
W4389337675Emerging treatment strategies in chronic B-cell malignancies—News from ICML 20232023-12-05OpenAlex10.1007/s12254-023-00937-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389337675
W4389338998Enterococcus species: insights into antimicrobial resistance and whole-genome features of isolates recovered from livestock and raw meat in Ghana2023-12-05OpenAlex10.3389/fmicb.2023.1254896Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389338998
W4389330773PAs in the cancer care continuum2023-12-05OpenAlex10.1097/01.jaa.0000995668.27398.e2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389330773
W4389326876Shop Talk2023-12-05OpenAlex10.1097/01.cot.0000997512.19409.7aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389326876
W4389329698What's New in Ototoxicity Management?2023-12-05OpenAlex10.1044/2023_persp-23-00153Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389329698
W7119566406Évaluation rétrospective du développement préclinique effectué sur les anticorps monoclonaux2023-12-05OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7119566406
W4389741575erbal Alternatives for Managing Depression: Mechanisms and Efficacy2023-12-06OpenAlex10.46610/jqaqc.2023.v05i02.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389741575
W7220449342A Review of Next-Generation Drug Delivery Systems And Technologies2023-12-07OpenAlex10.61096/ijrpp.v12.iss4.2023.289-300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220449342
W4389450548Changing Infection Dynamics with the Pandemic: Distribution of Viral Agents of Respiratory Tract Infections in the Last 5 Years2023-12-07OpenAlex10.4274/mjima.galenos.2023.23046Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389450548
W4389453740Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study2023-12-07OpenAlex10.3390/biomedicines11123245Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389453740
W4389426651Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival2023-12-07OpenAlex10.1093/braincomms/fcad331Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389426651
W4389435329Genetic features of antimicrobial drug-susceptible extraintestinal pathogenic Escherichia coli pandemic sequence type 952023-12-07OpenAlex10.1128/spectrum.04189-22Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389435329
W4389438134Targeted therapies for lupus nephritis: Current perspectives and future directions2023-12-07OpenAlex10.1097/cm9.0000000000002959Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389438134
W4389477851Bispecific antibody therapies2023-12-08OpenAlex10.1182/hematology.2023000508Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389477851
W4389489504Dual-targeted regimens for the frontline treatment of CLL2023-12-08OpenAlex10.1182/hematology.2023000506Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389489504
W7218263482IMPORTÂNCIA DO EIXO CÉREBRO-INTESTINOMICROBIOTA NA MODULAÇÃO DO SISTEMA NERVOSO CENTRAL E SUA RELAÇÃO COM A DOENÇA DE ALZHEIMER: UMA REVISÃO INTEGRATIVA DA LITERATURA2023-12-08OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218263482
W4389478671MRD-directed therapy in CLL: ready for prime time?2023-12-08OpenAlex10.1182/hematology.2023000441Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389478671
W4389478205Next-generation therapy for lower-risk MDS2023-12-08OpenAlex10.1182/hematology.2023000520Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389478205
W4389497377Nutritional Modulation of Periodontal Diseases: A Narrative Review of Recent Evidence2023-12-08OpenAlex10.7759/cureus.50200Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389497377
W4389508801Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies2023-12-08OpenAlex10.1111/imj.16279Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389508801
W4389506478Decision support for personalized therapy in implantable medical devices: A digital twin approach2023-12-09OpenAlex10.1016/j.eswa.2023.122883Full textExcludedF3: The described digital twin uses physiological calibration and a conventional reinforcement-learning therapy optimizer, with no LLM acting agent.https://openalex.org/W4389506478https://www.sciencedirect.com/science/article/pii/S0957417423033857publisher abstract and introduction preview, author institutional abstract; not full methods
W4389521406Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma2023-12-10OpenAlex10.1245/s10434-023-14702-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389521406
W4389558828High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis2023-12-11OpenAlex10.1128/msystems.00972-23Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389558828
W4390513217Intimate Partner Violence: Risk and Vulnerability Factors, Health Promotion and Prevention in Educational and Healthcare Contexts2023-12-11OpenAlex10.3390/books978-3-0365-9523-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390513217
W4389620759Emerging therapies in the medical management of thyroid eye disease2023-12-12OpenAlex10.3389/fopht.2023.1295902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389620759
W4389612742Preventing ischaemic stroke in patients with isolated sinus node disease: the value of evaluating atrial cardiomyopathy2023-12-12OpenAlex10.1093/eurjpc/zwad386Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389612742
W4389623600Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders2023-12-12OpenAlex10.3390/ph16121721Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389623600
W4389683504miR ‐101‐5p modulation of CD47 in diffuse large B‐cell lymphoma: Implications for anti‐CD47 immunotherapy and prognostication2023-12-12OpenAlex10.1111/bjh.19264Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389683504
W4389792037Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet2023-12-13OpenAlex10.1097/tp.0000000000004809Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389792037
W4389670006The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma2023-12-13OpenAlex10.3390/cancers15245829Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389670006
W4389728235764: NITROPRUSSIDE-INDUCED CYANIDE TOXICITY IN AN INFANT WITH COMPLEX CONGENITAL CARDIAC DISEASE2023-12-14OpenAlex10.1097/01.ccm.0001001224.86617.0aTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389728235
W4389742335Alcohol Use Disorder and the Gut Microbiome2023-12-14OpenAlex10.1007/s40429-023-00527-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389742335
W7220274058Autonomous Robotic Systems using Reinforcement Learning for Next-Gen Computing Applications2023-12-14OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220274058
W4390348940Clinical reflections – combined therapy of arterial hypertension with beta-blockers and dihydropyridine calcium antagonists2023-12-14OpenAlex10.37987/1997-9894.2023.9-10(275-276).294605Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390348940
W4389765232Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy2023-12-14OpenAlex10.1159/000535647Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389765232
W4389815445Medicine in Chinese History2023-12-14OpenAlex10.4324/9780367565152-rechs78-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389815445
W4389734782Metal–Organic Framework-Based Nano-Activators Facilitating Microwave Combined Therapy via a Divide-and-Conquer Tactic for Triple-Negative Breast Cancer2023-12-14OpenAlex10.1021/acsnano.3c09734Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389734782
W4389732650The epidemiology of pediatric outpatient acute respiratory tract infections in the US: a multi-facility analysis of multiplex PCR testing from 2018 to 20232023-12-14OpenAlex10.1128/spectrum.03423-23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389732650
W4389792586A careful approach to artificial intelligence: the struggles with epistemic responsibility of healthcare professionals2023-12-15OpenAlex10.1080/1369118x.2023.2289971Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389792586
W4389785479Evaluation of Neuroprotective Activity of Sida Cordifolia Against β-AMYLOID Protein Induced Loss of Cognitive Functions in Swiss Albino Mice2023-12-15OpenAlex10.1039/9781837671090-00673Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389785479
W4389802790Exploring the potential of Salmonella-mediated anti-sense RCAS1 RNA therapy in combatting aggressive breast cancer2023-12-15OpenAlex10.1016/j.omtn.2023.102089Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4389802790
W4389832293Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy2023-12-16OpenAlex10.1007/s12032-023-02255-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389832293
W4390111998Intelligent Conversational Agents for Personalized Health Diagnosis and Treatment: A Synergistic Approach of AI, ML, and Data Science and Robotics2023-12-16OpenAlex10.51219/urforum.2023.david-nkantaFull textExcludedF1: The available publication is a one-page webinar overview and biography. It gives general NLP/ML, robotics and external-literature refresh aims without an operational primary system method or evaluation.https://openalex.org/W4390111998https://doi.org/10.51219/URForum.2023.David-Nkanta
W4389847637Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies2023-12-17OpenAlex10.1016/j.ejps.2023.106678Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389847637
W4389895493Changing trends in phase 1 oncology clinical trials2023-12-18OpenAlex10.1016/j.conctc.2023.101239Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389895493
W4389941551Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes2023-12-18OpenAlex10.1016/j.ctrv.2023.102673Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389941551
W4389944366What’s New in Pediatric Orthopaedics2023-12-19OpenAlex10.2106/jbjs.23.01141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4389944366
W4390053345Definition, epidemiology and characterization of sepsis2023-12-20OpenAlex10.18203/2394-6040.ijcmph20233852Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390053345
W4390036136Goat-derived cell line (Capra hircus) TCh generated by karyological and morphological transformation of YаDK-04 CCL during subcultivation with lanthanide-treated bovine serum2023-12-20OpenAlex10.29326/2304-196x-2023-12-4-345-353Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390036136
W4389992087Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy2023-12-20OpenAlex10.1111/ene.16180Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4389992087
W4390467480Tailoring treatment: a comprehensive review of precision medicine and biological therapies in inflammatory bowel disease2023-12-20OpenAlex10.51582/interconf.19-20.12.2023.043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390467480
W4389965975Unmet needs in β-thalassemia and the evolving treatment landscape2023-12-20OpenAlex10.1016/j.tracli.2023.12.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4389965975
W4390070079Book of the Year Awards 20232023-12-21OpenAlex10.1097/01.naj.0001004968.26767.b1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390070079
W4390110120Cryptococcosis in kidney transplant recipients: Current understanding and practices2023-12-22OpenAlex10.5527/wjn.v12.i5.120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390110120
W4390126153Editorial for “Early Identification of Pathologic Complete Response to Neoadjuvant Chemotherapy Using Multiphase DCE‐MRI by Siamese Network in Breast Cancer: A Longitudinal Multicenter Study”2023-12-22OpenAlex10.1002/jmri.29190Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390126153
W4390114517Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma2023-12-22OpenAlex10.3390/cells13010034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390114517
W4404184536New perspectives in liver diseases with challenges2023-12-22OpenAlex10.1093/gastro/goae098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404184536
W4390112258Ocular graft versus host disease2023-12-22OpenAlex10.4103/ijo.ijo_2884_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390112258
W4390142402Agency development of high school students in the process of professional self-determination2023-12-23OpenAlex10.17673/vsgtu-pps.2023.4.9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390142402
W4390174532Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox2023-12-23OpenAlex10.3390/curroncol31010007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390174532
W7171952726THE FUTURE OF PRECISION ONCOLOGY: CONVERGING FOUNDATION MODELS, AGENTIC AI, DIGITAL TWINS, AND MULTIMODAL CLINICAL INTELLIGENCE2023-12-23OpenAlex10.65713/ijaraiv13i1210Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7171952726
W4390234108Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies2023-12-25OpenAlex10.1111/imj.16303Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390234108
W7172030908DIGITAL TWIN INTELLIGENCE IN ONCOLOGY: AI-POWERED VIRTUAL PATIENTS FOR PERSONALIZED TREATMENT OPTIMIZATION2023-12-25OpenAlex10.65713/ijaraiv13i1214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172030908
W4390516672Molecularly Targeted Therapy for Urothelial Cancers2023-12-25OpenAlex10.18103/mra.v11i12.4788Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390516672
W4390236400Real‐world treatment patterns in patients initiating third‐line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain2023-12-25OpenAlex10.1111/ejh.14161Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390236400
W7217584192Review on Antibacterial efficacy of Tribal Acquaintance Medicinal Plants of Jaipur, (Rajasthan) Against Multidrug-Resistant Bacterial Uropathogens2023-12-25OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217584192
W4390242390What’s next: using infectious disease mathematical modelling to address health disparities2023-12-25OpenAlex10.1093/ije/dyad180Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390242390
W4390535835A review of the contemporary use of inotropes in patients with heart failure2023-12-26OpenAlex10.1097/hco.0000000000001115Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390535835
W4390233709Current evidence and therapeutic implication of PANoptosis in cancer2023-12-26OpenAlex10.7150/thno.91814Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390233709
W4390501140Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy2023-12-26OpenAlex10.1097/mot.0000000000001133Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390501140
W7171928766PREDICTIVE ONCOLOGY THROUGH FOUNDATION AI: INTEGRATING LONGITUDINAL CLINICAL DATA, MULTI-OMICS, AND DIGITAL TWINS2023-12-26OpenAlex10.65713/ijaraiv13i1219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171928766
W4394819846Team Physician Consensus Statement: Return to Sport/Return to Play and the Team Physician: A Team Physician Consensus Statement—2023 Update2023-12-26OpenAlex10.1249/mss.0000000000003371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394819846; https://openalex.org/W4396674129
W4390228828Updates in the treatment of asthma in pediatrics: A review for pharmacists2023-12-26OpenAlex10.1093/ajhp/zxad326Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390228828
W4393076717Carbon nanomaterials for biomedical applications: A comprehensive review2023-12-27OpenAlex10.59400/n-c.v1i1.448Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393076717
W4406193701Gen AI-Powered Clinical Guidelines: Automating the Future of Evidence-Based Care2023-12-27OpenAlex10.21275/sr23129145353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406193701
W4390270623Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VII. Ketamine2023-12-27OpenAlex10.31234/osf.io/dtb6aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390270623
W4391345061The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond2023-12-27OpenAlex10.1093/cid/ciad758Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391345061
W4390384800Exploiting nuclear-mitochondrial cross-talk in theranostics: Enhancing drug delivery and diagnostic precision2023-12-28OpenAlex10.1016/j.mito.2023.101839Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390384800
W4390363230International Commentary of the Worldwide Survey of Fitness Trends2023-12-28OpenAlex10.1249/fit.0000000000000932Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390363230
W4390339337Selected Abstracts2023-12-28OpenAlex10.1097/dcr.0000000000003218Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390339337
W4390594928An Overview of Recent Advances in Anterior Cervical Decompression and Fusion Surgery2023-12-29OpenAlex10.52198/23.sti.43.ns1732Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390594928
W4390410426Clinical frontiers of metabolic bone disorders: a comprehensive review2023-12-29OpenAlex10.20517/mtod.2023.38Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390410426
W4390403329Microbes and Mental Illness: Past, Present, and Future2023-12-29OpenAlex10.3390/healthcare12010083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390403329
W4391277339The Present and Future Trend of Monoclonal Antibody2023-12-29OpenAlex10.54097/cy800q90Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391277339
W4390411703Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication2023-12-29OpenAlex10.1002/pds.5745Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390411703
W4390728575A cross-sectional study of clinical a nd microbiological profile of urinary tract infections in children from tertiary care centre in Maharashtra2023-12-30OpenAlex10.47799/pimr.1103.07Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390728575
W4390444495The Evaluation of Primary Brain Tumors: The Role of CT and MRI2023-12-30OpenAlex10.55041/ijsrem26929Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390444495
W4390847723Cues from evolving insights about Cancer stem cells to tackle cancer metastases.2023-12-31OpenAlex10.46582/jsrm.1902006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390847723
W7154855336INNOVATIONS IN DIABETES MANAGEMENT: A GLOBAL PERSPECTIVE2023-12-31OpenAlex10.71465/bhsr38Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154855336
W4413225124IRDAI AND THE GROWTH OF HEALTH INSURANCE IN INDIA2023-12-31OpenAlex10.29121/shodhkosh.v4.i2.2023.6109Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413225124
W4390460465Subdural Empyema in Pediatric Bacterial Meningitis: A Case Report2023-12-31OpenAlex10.7759/cureus.51401Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390460465
W4392091398The Role of Higher Education Institutes in Achieving the Gole of Developing2023-12-31OpenAlex10.31995/jgv.2023.v14is3.028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392091398
W4404967419ДОСЛІДЖЕННЯ ПЕРСПЕКТИВ МОДЕЛІ СТАКЕЛЬБЕРГА ТЕОРІЇ ІГОР У ХОЛІСТИЧНІЙ МЕДИЦИНІ2023-12-31OpenAlex10.31891/2307-5732-2023-329-6-61-63Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404967419
W4401708435A BERT-Based Chatbot to Support Cancer Treatment Follow-Up2024-01-01OpenAlex10.1007/978-3-031-68639-9_4Full textExcludedF3: The implemented chatbot is a BERT span extractor fine-tuned once on fixed SQuAD examples. It predicts answer start/end positions in supplied context, without an LLM acting-agent mechanism; patient data are explicitly not stored.https://openalex.org/W4401708435https://link.springer.com/chapter/10.1007/978-3-031-68639-9_4Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W4401748407A Multi-Agent System Approach for Balance Disorder Treatment: Integrating Computer Vision and Gamification2024-01-01OpenAlex10.1109/access.2024.3448216Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4401748407
W4405925137A Three-Layered AI-Oriented Approach for Intelligent Generation of Standardized Privacy Policies in Smart Healthcare Environments2024-01-01OpenAlex10.1007/978-3-031-78698-3_2Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W4405925137https://link.springer.com/chapter/10.1007/978-3-031-78698-3_2Bibliographic information and available abstract/preview only; no full methods read.
W4404703815A comprehensive review of amblyopia treatment2024-01-01OpenAlex10.22271/allresearch.2024.v10.i11d.12163Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404703815
W4399205535A review of drug-induced liver injury with rash, eosinophilia, and systemic symptoms (DRESS) syndrome: Cutaneous manifestations, clinical features, and management2024-01-01OpenAlex10.1097/cld.0000000000000198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399205535
W4400281535A state-of-the-art update on hepatotoxicity: Introduction to the special series on drug-induced liver injury2024-01-01OpenAlex10.1097/cld.0000000000000212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400281535
W4403418671AI in an Uncertain World: Response to Krueger's Review of How to Stay Smart in a Smart World2024-01-01OpenAlex10.5406/19398298.137.1.06Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403418671
W4396628746AI, women’s health care, and trust: Problems and prospects2024-01-01OpenAlex10.1016/b978-0-443-21889-7.00002-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396628746
W4400873883ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group2024-01-01OpenAlex10.1159/000539869Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400873883
W4405374694Abstracts for oral presentations2024-01-01OpenAlex10.4103/njpt.njpt_65_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405374694
W4404242415Advancements in HIV/AIDS Cure Research: Effects on Patient Adherence and Behavioral Trends in the General Population a Scoping Review2024-01-01OpenAlex10.51244/ijrsi.2024.1110029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404242415
W7118214797Advances in cardiovascular and thoracic anaesthesia: Perioperative management of complex cases2024-01-01OpenAlex10.33545/26643766.2024.v7.i1a.616Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118214797
W4401007150Advancing evolutionary medicine in Northern Germany2024-01-01OpenAlex10.1093/emph/eoae013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401007150
W4399547227Aldo-keto reductases: Role in cancer development and theranostics2024-01-01OpenAlex10.32604/or.2024.049918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399547227
W4390637892An Overview of Future Development Methods of Infectious Bronchitis Vaccines2024-01-01OpenAlex10.32598/ijvm.18.1.1005406Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390637892
W4402006941An Update on Human Fungal Diseases: A Holistic Overview2024-01-01OpenAlex10.1007/978-981-97-5165-5_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402006941
W4400111980An abbreviated history of liver transplantation2024-01-01OpenAlex10.1097/cld.0000000000000244Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400111980
W4394826410Anemia and Erythropoietin in HIV: A Multifaceted Review2024-01-01OpenAlex10.23880/hij-16000244Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394826410
W4399854189Anesthesia and Cancer Recurrence2024-01-01OpenAlex10.1007/978-981-99-6339-3_36Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399854189
W4391386515Anhang I – Einladungs-E-Mail2024-01-01OpenAlex10.5771/9783748941842-289Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386515
W4391386557Anhang II – Fragebogen2024-01-01OpenAlex10.5771/9783748941842-291Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386557
W4393323178Antibiotic Adjuvants and Their Synergistic Activity Against ESKAPE Pathogens2024-01-01OpenAlex10.1007/978-981-99-8799-3_13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393323178
W4401816967Antimicrobial Peptides and Their Applications2024-01-01OpenAlex10.1007/978-981-97-3413-9_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401816967
W4392744125Antimicrobial agent usage patterns and their role in preventing surgical site infections at a tertiary care teaching hospital: A comprehensive study2024-01-01OpenAlex10.5455/njppp.2024.14.020950202406032024Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392744125
W4400046397Antimicrobial resistance: A looming threat to public health and global well-being2024-01-01OpenAlex10.4103/ijcfm.ijcfm_1_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400046397
W4403682185Approach and Troubleshooting to Lower Limb Blocks2024-01-01OpenAlex10.1007/978-981-97-4098-7_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403682185
W4396601600Approach to immunotherapy for HCC in the liver transplant population2024-01-01OpenAlex10.1097/cld.0000000000000158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396601600
W4393972092Architecture of Life: Soviet Modernism and the Human Sciences2024-01-01OpenAlex10.1162/leon_r_02530Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393972092
W4400166075Artificial Intelligence: The Future of Individualized and Effective Healthcare Approach for Psychosis2024-01-01OpenAlex10.1007/978-981-97-2577-9_10Full textExcludedF1: The reference chapter reviews AI/ML applications for psychosis rather than building/evaluating a primary adaptive LLM system.https://openalex.org/W4400166075https://link.springer.com/chapter/10.1007/978-981-97-2577-9_10publisher abstract only
W4402914889As Ground of Being, God Favors Good Over Bad Choices: Confucian Response to Wesley J. Wildman2024-01-01OpenAlex10.5406/21564795.45.1.04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402914889
W4404455018Association and Contribution of Dentistry in Creating and Sharing the Burden of Antibiotic-Resistant Microbial World2024-01-01OpenAlex10.1007/978-981-97-5272-0_14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404455018
W4396233827Basic Tools and Terminology for Endovascular Interventions2024-01-01OpenAlex10.1007/978-3-031-42735-0_5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396233827
W4406800481Behavioral and Psychological Symptoms (BPSD) in Alzheimer’s Disease (AD): Development and Treatment2024-01-01OpenAlex10.1007/7854_2024_566Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406800481
W4401468392Biosensors2024-01-01OpenAlex10.1016/b978-0-443-13394-7.00007-0Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4401468392
W4400184821Biosimilars in Prostate Cancer2024-01-01OpenAlex10.1007/978-981-97-3001-8_6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400184821
W4392476185Bloodstream infections: Epidemiology, risk factors, and resistance profiles in a university hospital: A five-year cross-sectional analysis2024-01-01OpenAlex10.4328/acam.22039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392476185
W7104034578Breakthrough coma: a severe myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) case report2024-01-01OpenAlex10.5327/cbn240264Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7104034578
W4392252323Breast Cancer and Pregnancy: Challenges for Maternal and Newborn Successful Outcomes2024-01-01OpenAlex10.1007/16833_2024_209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392252323
W4391270378CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations2024-01-01OpenAlex10.1093/jlb/lsad030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391270378
W4400493565Can Nanocrystals Help Create Our Dream Cosmetics?2024-01-01OpenAlex10.15212/bioi-2024-0014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400493565
W4393322500Carbocysteine as Adjuvant Therapy in Acute Respiratory Tract Infections in Patients without Underlying Chronic Conditions: Systematic Review and Meta-Analysis2024-01-01OpenAlex10.4236/ojrd.2024.142004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393322500
W4392973790Changing and Evolution of Influenza Virus: Is It a Trivial Flu?2024-01-01OpenAlex10.1159/000538382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392973790
W7126297970Characterizing heterogeneity in Escherichia coli gene expression and its consequences for antimicrobial tolerance2024-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7126297970
W4410129900Chemotherapeutic Drugs: A Brief Introduction2024-01-01OpenAlex10.54615/2231-7805.6(11).321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410129900
W4402161939Chronology of Anticancer Drugs and Their Development2024-01-01OpenAlex10.1007/978-981-99-6263-1_51Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402161939; https://openalex.org/W4386973722
W7207766990Civil Liability Arising from the Use of Intelligent Robots in the Field of Medical Science2024-01-01OpenAlex10.61838/jecjl.191Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207766990
W4391177205Clinical Practice Guidelines on using artificial intelligence and gadgets for mental health and well-being2024-01-01OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_926_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391177205
W4392306271Comparative Analysis of Metformin and Imeglimin: Exploring Therapeutic Implications2024-01-01OpenAlex10.4103/bjem.bjem_2_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392306271
W4407075101Competing Institutional Logics in the Health Information Exchange Field of US Healthcare Industry2024-01-01OpenAlex10.24251/hicss.2024.434Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407075101
W4404620097Contemporary Strategies for Clinical Chemoprevention of Localized Prostate Cancer2024-01-01OpenAlex10.1177/10732748241302863Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404620097
W4401025919Contributions of the Federal Council of Medicine to bioethics2024-01-01OpenAlex10.1590/1983-804220240001enTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401025919
W7111927669Controlling the Supramolecular Assembly and Photophysical Properties of Atomically Precise Metal Chalcogenide and Noble Metal Nanoclusters2024-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7111927669
W4391377581Crohn’s & Colitis 360 Editorial Fellowship: The Inaugural Fellow’s Insights2024-01-01OpenAlex10.1093/crocol/otae002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391377581
W4404854981DR. M.S. GUJRAL GOLD MEDAL/ DR. M.C. PANT GOLD MEDAL2024-01-01OpenAlex10.4103/jcrt.jcrt_2136_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404854981
W4404756938Design and characterization of electrospun fibers for controlled delivery of antimicrobial peptides and proteins2024-01-01OpenAlex10.21248/gups.87878Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404756938
W4392308643Diagnostic dilemma: Drug reaction with eosinophilia and systemic symptoms or erythema multiforme?2024-01-01OpenAlex10.4103/cmrp.cmrp_23_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392308643
W4401148329Diagnostics Based on Microbial Enzymes2024-01-01OpenAlex10.1007/978-981-97-4235-6_4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401148329
W4392477137Differentiated thyroid carcinoma: what the nonspecialists needs to know2024-01-01OpenAlex10.20945/2359-4292-2023-0375Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392477137
W7139313875Diseño benigno de nanomateriales para procesos catalíticos y aplicaciones sostenibles2024-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7139313875
W7134234002EPIGENETICS AND ITS REFLECTIONS IN GLIOMAS2024-01-01OpenAlex10.5336/978-625-395-396-6_p10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134234002
W7108223803Eaton Lambert myasthenic syndrome with cerebellar ataxia misdiagnosed as Guillain-Barré spectrum2024-01-01OpenAlex10.5327/cbn240597Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108223803
W4391386510Einleitung2024-01-01OpenAlex10.5771/9783748941842-17Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386510
W4400902147Eldridge Cleaver's Spiritual Odyssey and Embrace of Mormonism2024-01-01OpenAlex10.5406/15549399.57.2.05Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400902147
W7111879151Enhancing precision genome editing agents through directed evolution and protein engineering2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111879151
W4400456310Entry-Level Occupational Therapy Education to Address Substance Use Disorders: Education in Screening, Brief Intervention, and Referral to Treatment (SBIRT)2024-01-01OpenAlex10.26681/jote.2024.080103Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400456310
W7111488325Estimating the causal effects of dynamic strategies using observational data: applications to cancer survivors2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111488325
W4399661142Ethics in hepatology: A professional and very personal journey2024-01-01OpenAlex10.1097/cld.0000000000000231Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399661142
W4405962919Evaluation of Biomaterials Used in Guided Tissue Regeneration2024-01-01OpenAlex10.52533/johs.2024.41108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405962919
W4396837333Evaluation of respiratory viruses multiplex assay using RT-PCR2024-01-01OpenAlex10.35259/isi.biomang.2024_63921Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396837333
W4396963342Evolving role of chemotherapy in gallbladder cancers: largest registry analysis of 2300 patients showing high progression and poor tolerance in “all-comers”2024-01-01OpenAlex10.1016/j.hpb.2024.03.932Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396963342
W4390955127Evolving standards and future directions for systemic therapies in cervical cancer2024-01-01OpenAlex10.3802/jgo.2024.35.e65Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390955127
W4403395578Examining the Hospital as a Complex Dynamical System: Using Agent-Based Modeling to Gain Insight into Potential Process Bottlenecks2024-01-01OpenAlex10.1007/978-3-031-66524-0_20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403395578
W4403501179Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs2024-01-01OpenAlex10.1177/17588359241289648Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403501179
W4405197166Exploring Nanomedicine Ventures and Latest Developments in Clinical Trials2024-01-01OpenAlex10.1007/978-3-031-72467-1_16Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405197166
W4404339800Exploring the Depths of Cryptic Aspergillosis: Species Variability, Clinical Spectrum, Diagnostic Quandaries and Therapeutic Options2024-01-01OpenAlex10.7860/jcdr/2024/74347.20287Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404339800
W4399925490Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers2024-01-01OpenAlex10.1177/11795549241260534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399925490
W4402078544Exploring the Role of PROTACs for the Treatment of Breast Cancer2024-01-01OpenAlex10.1007/978-981-97-5077-1_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402078544
W4403855876Exploring the characteristics of conversational agents in chronic disease management interventions: A scoping review2024-01-01OpenAlex10.1177/20552076241277693Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4403855876
W4416693140Exploring the medication use: a comparative study of HTLV-1 patients facing HAM/TSP and those without2024-01-01OpenAlex10.5327/cbn240783Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416693140
W4405269461Extracellular Vesicles in Pregnancy: Functional Insights, Diagnostic Potential for Maternal–Fetal Disorders, and Therapeutic Implications2024-01-01OpenAlex10.1007/978-981-97-5536-3_13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405269461
W4404678542Extraction of Capsaicin: Formulation and Evaluation of a Transdermal Patch2024-01-01OpenAlex10.70593/978-81-981367-0-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404678542
W4396805641Eye anatomy, physiology, and ocular barriers2024-01-01OpenAlex10.1016/b978-0-323-99156-8.00023-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396805641
W4403706535Feedback Reimagined: Generative AI and Conversational Avatars as Your New Training Partners2024-01-01OpenAlex10.1007/978-3-031-73427-4_13Full textExcludedF4: Generative avatars adapt feedback to the current trainee interaction; the retained learning is human skill acquisition, not an updated agent artifact reused on later cases.https://openalex.org/W4403706535https://www.researchgate.net/publication/385211962_Feedback_Reimagined_Generative_AI_and_Conversational_Avatars_as_Your_New_Training_Partnersoriginal public author-uploaded chapter, system description through evaluation
W4390788174Fluorescence visualization for cancer DETECTION: EXPERIENCE and perspectives2024-01-01OpenAlex10.1016/j.heliyon.2024.e24390Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390788174
W4400121365Fundamental approaches of drug discovery2024-01-01OpenAlex10.1016/b978-0-443-16013-4.00012-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400121365
W4404610956Fungal Fighters: A Comprehensive Guide to Antifungal Therapies of the Past, Present, and Future2024-01-01OpenAlex10.1007/978-981-97-4909-6_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404610956
W4404837575GENITOURINARY2024-01-01OpenAlex10.4103/jcrt.jcrt_2124_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404837575
W4404068097Gastrointestinal Disorders Associated with Autism Spectrum Disorder2024-01-01OpenAlex10.31550/1727-2378-2024-23-7-86-91Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404068097
W4400088966Historical perspective on the therapeutic potential of cannabidiol2024-01-01OpenAlex10.1016/bs.irn.2024.03.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400088966
W4401979497Host-Directed Immunotherapy for Tuberculosis2024-01-01OpenAlex10.1007/978-981-97-1777-4_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401979497
W7134974532IDIOPATHIC GRANULOMATOUS MASTITIS2024-01-01OpenAlex10.5336/978-625-395-314-0_p161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134974532
W4392667483Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs2024-01-01OpenAlex10.1615/critrevoncog.2024053096Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392667483
W7127221960Improving adverse event capture and reporting in oncology trials of systemic therapy to better inform assessment of treatment tolerability2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127221960
W7126670665Improving the Standard of Care in Diabetic Kidney Disease2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126670665
W4404165114In Pursuit of the Perfect Turkey: The Snow Field Station, 1958–20082024-01-01OpenAlex10.5406/26428652.92.4.05Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404165114
W4393121335In Vitro Carminative Activity of the Siddha Formulation T. Soolai Kudoram by Acid- Base Titration Method2024-01-01OpenAlex10.33745/ijzi.2024.v10i01.045Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393121335
W4416865577Inclusion body myopathy with dysphagia and its expressive improvement with the use of immunoglobulin2024-01-01OpenAlex10.5327/cbn240953Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416865577
W4390919882Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 20222024-01-01OpenAlex10.4103/crst.crst_124_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390919882
W4391444710Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010–20202024-01-01OpenAlex10.1136/openhrt-2023-002515Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391444710
W4394788204Integration of Artificial Intelligence in English Teaching2024-01-01OpenAlex10.37811/cli_w1046Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394788204
W4400002821Interventional radiology and the liver vasculature: A personal perspective2024-01-01OpenAlex10.1097/cld.0000000000000239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400002821
W4391146880Introducing NAR Molecular Medicine, a new journal in the Nucleic Acids Research family2024-01-01OpenAlex10.1093/narmme/ugad002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391146880
W4401965423Introduction to Pharmacokinetics and Pharmacodynamic Studies of Novel Drug Delivery Systems2024-01-01OpenAlex10.1007/978-981-99-7858-8_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401965423
W4403545540Invasive Neurological and Multimodality Monitoring in the Neuro-ICU2024-01-01OpenAlex10.1007/978-3-031-62224-3_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403545540
W7112254985Investigating the Effects of Mycobacterium tuberculosis Bacterial Heterogeneity on Innate Immune Cell Tropism2024-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7112254985
W4393982432Investigation of early detection possibilities of sugar beet disease with machine learning algorithms based on multispectral reflection2024-01-01OpenAlex10.1051/e3sconf/202450803010Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393982432
W4403637070Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches2024-01-01OpenAlex10.1177/26331055241292600Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403637070
W4391386637Kapitel 1 – Entstehung, Entwicklung und Bedeutung von Medizintourismus für das deutsche Gesundheitswesen2024-01-01OpenAlex10.5771/9783748941842-23Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386637
W4391386559Kapitel 2 – Korruption im Gesundheitswesen – Ausmaß, Auswirkungen und Maßnahmen2024-01-01OpenAlex10.5771/9783748941842-61Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386559
W4391386512Kapitel 3 – Rechtliche Würdigung der Zusammenarbeit von Patientenbetreuungsunternehmen und Medizineinrichtungen2024-01-01OpenAlex10.5771/9783748941842-103Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386512
W4391386527Kapitel 4 – Empirische Untersuchung der Zusammenarbeit2024-01-01OpenAlex10.5771/9783748941842-223Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386527
W4391386572Kapitel 5 – Abschließende Betrachtung und Fazit2024-01-01OpenAlex10.5771/9783748941842-281Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386572
W4391386520Kooperation und Korruption im Gesundheitswesen2024-01-01OpenAlex10.5771/9783748941842Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386520
W4391386532Literaturverzeichnis2024-01-01OpenAlex10.5771/9783748941842-305Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386532
W4400110857Liver biopsy: Archaic but resilient and many roads lead to Rome2024-01-01OpenAlex10.1097/cld.0000000000000247Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400110857
W4400281649Liver fibrosis: Our evolving understanding2024-01-01OpenAlex10.1097/cld.0000000000000243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400281649
W4399880551Liver injury in patients with substance use disorder2024-01-01OpenAlex10.1097/cld.0000000000000220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399880551
W4390579210Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence2024-01-01OpenAlex10.1093/clinchem/hvad196Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390579210
W4391420154Management of chronic pleural tuberculosis and non-tuberculous empyema in the 21st century2024-01-01OpenAlex10.21037/shc-23-32Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391420154
W4391955051Mapping the Earth's Embrace: Queer Life-Building in Mame-Diarra Niang's Éthérée2024-01-01OpenAlex10.1162/afar_a_00741Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391955051
W4403181701Masks and Respirators for Non-medical Applications (Masks and Respirators Against Dust, Chemicals and Others)2024-01-01OpenAlex10.1007/978-981-97-6496-9_4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403181701
W4402469108Medical Education Transformation: Setting the Foundation2024-01-01OpenAlex10.59450/sipr1101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402469108
W4399210238Metaplastic-EEG: Continuous Training on Brain-Signals2024-01-01OpenAlex10.1101/2024.05.29.24308178Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399210238
W4401217969Middle of Nowhere (2012): Waiting Studies, Cinema, and Temporal Experience2024-01-01OpenAlex10.5406/19346018.76.3.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401217969
W4394859409Minocycline and Photodynamic Priming Significantly Improve Chemotherapy Efficacy in Heterotypic Spheroids of Pancreatic Ductal Adenocarcinoma2024-01-01OpenAlex10.1016/j.jphotobiol.2024.112910Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394859409
W7135730409Molekulárne mechanizmy účinkov chemoterapeutických liečiv2024-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135730409
W4405554117Monkeypox: epidemiological situation, diagnostics, prevention, new challenges and problems of our time2024-01-01OpenAlex10.36488/cmac.2024.3.285-300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405554117
W4391317359Monoclonal Antibodies in Solid Organ Transplantation2024-01-01OpenAlex10.1007/978-3-031-30023-3_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391317359
W4407270292Mucosal Protective Agents2024-01-01OpenAlex10.1007/978-3-031-69800-2_7Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4407270292
W4402190567Multifaceted Potential of Photoacoustic Imaging for Preclinical Cancer Research2024-01-01OpenAlex10.1007/978-3-031-61411-8_14Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402190567
W4401879677Multilabel Decoupling Diagnosis for Compound Faults by Improved Deep Q-Network2024-01-01OpenAlex10.1109/tim.2024.3450088Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401879677
W7202235706Mymensingh Shishu Hospital: a vision to ensure better healthcare for every child in Mymensingh2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202235706
W4404707044Nano-technological advancements in multimodal diagnosis and treatment2024-01-01OpenAlex10.3934/biophy.2024026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404707044
W4396909447Nanomaterials in the Development of Advanced Antimicrobial Agents2024-01-01OpenAlex10.1007/978-981-97-2023-1_16Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4396909447
W4399680094Nanomedicine approaches for regenerative medicine2024-01-01OpenAlex10.1016/b978-0-443-19085-8.00016-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399680094
W4400570975Nanotechnology in Cancer Diagnostics2024-01-01OpenAlex10.1007/978-981-16-1610-5_9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400570975
W4400570838Nanotechnology in Diagnostic Imaging2024-01-01OpenAlex10.1007/978-981-16-1610-5_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400570838
W4405347466Natural Products in Management of MDR2024-01-01OpenAlex10.1007/978-981-97-9634-2_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405347466
W4404493611Navigating the Landscape of Cancer-Induced Thrombocytopenia: Current Challenges and Emerging Advances2024-01-01OpenAlex10.1007/978-981-97-6270-5_14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404493611
W7108663650Neuro-chikungunya: a diagnostic challenge2024-01-01OpenAlex10.5327/cbn241158Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108663650
W4393107569Neuromodulation in migraine2024-01-01OpenAlex10.1016/b978-0-12-823357-3.00003-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393107569
W4404716551Neutropenic Sepsis2024-01-01OpenAlex10.1007/978-3-319-31738-0_81-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404716551; https://openalex.org/W4407944278
W4416746530Optic neuritis secondary to bartonellosis (cat scratch disease by bartonella quintana): a case report2024-01-01OpenAlex10.5327/cbn241241Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416746530
W4410025604Optimizing oral fluid-based surveillance for an evolving swine industry2024-01-01OpenAlex10.31274/td-20250502-133Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410025604
W4392812962Outcomes of Everolimus Plus Endocrine Therapy Following CDK4/6 Inhibitor Therapy for Metastatic Hormone Receptor- Positive Breast Cancer2024-01-01OpenAlex10.37047/jos.2023-100188Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392812962
W4391893863Overview of ADME Science2024-01-01OpenAlex10.1016/b978-0-323-85704-8.00010-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391893863
W4402115386Overview of Pharmacoproteomics and Its Clinical Applications2024-01-01OpenAlex10.1007/978-3-031-64021-6_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402115386
W4416745441Overview of bacterial meningitis in brazil: analysis of variables in the last five years2024-01-01OpenAlex10.5327/cbn241257Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416745441
W4404855491PAIN AND PALLIATION2024-01-01OpenAlex10.4103/jcrt.jcrt_2132_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404855491
W4393061467Pan-vascular disease: what we have done in the past and what we can do in the future?2024-01-01OpenAlex10.1097/cp9.0000000000000078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393061467
W4416746518Parechovirus encephalitis in a Brazilian adult: an extremely rare case report in the world2024-01-01OpenAlex10.5327/cbn241273Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416746518
W4416746502Parkinsonism in bipolar mood disorder: a new look at an old problem2024-01-01OpenAlex10.5327/cbn241277Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416746502
W4391325284Pazopanib-induced trismus in a young male with metastatic renal cell carcinoma: a case report and literature review2024-01-01OpenAlex10.1093/omcr/omad146Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391325284
W4400088029Pediatric Pneumonia in China: New State of Alarm or Foreseeable Situation?2024-01-01OpenAlex10.58614/jahsm421Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400088029
W4402724420Perception on Immune Checkpoint Inhibitor Vanquishing Standard Treatment Paradigm for Triple-negative Breast Cancer2024-01-01OpenAlex10.47278/book.cam/2024.454Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402724420
W4404920748Perioperative Care2024-01-01OpenAlex10.1007/978-3-031-68578-1_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404920748
W4402613285Pharmacognosy: A fascinating research area having immense potential in drug development2024-01-01OpenAlex10.22271/phyto.2024.v13.i5b.15068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402613285
W4401322685Pharmacological Properties of Tapinarof in Mice as a Novel Topical Agent for Plaque Psoriasis2024-01-01OpenAlex10.1248/bpbreports.7.4_116Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401322685
W4404073460Photoacoustic Imaging: Principles and Applications2024-01-01OpenAlex10.1007/978-3-031-61846-8_15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404073460
W4390699722Physician-made pericardium stent graft as a potential endovascular alternative for infectious aortic disease – an ex-vivo proof-of-concept study2024-01-01OpenAlex10.1177/00368504231221686Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390699722
W4394738769Prevalence and antimicrobial resistance profile of Salmonella typhi infection in Iraq, 2019-2021.2024-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394738769
W4406296316Primary and secondary cardiovascular prevention: Recent advances.2024-01-01OpenAlex10.33963/v.phj.103997Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406296316
W4392949566Psychedelics: The New Kid on the Block2024-01-01OpenAlex10.4103/aip.aip_195_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392949566
W4394816033Publications! Where are we going?2024-01-01OpenAlex10.4103/jomfp.jomfp_77_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394816033
W4391660669Pylephlebitis2024-01-01OpenAlex10.4322/acr.2024.473Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391660669
W4392869809Pylephlebitis – an uncommon challenging entity2024-01-01OpenAlex10.4322/acr.2024.480Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392869809
W7134990755RECENT DEVELOPMENTS IN PHOTOTHERMAL THERAPY-BASED CANCER TREATMENT2024-01-01OpenAlex10.5336/978-625-395-317-1_p77Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134990755
W4399879076RNA biomarkers in cancer therapeutics: The promise of personalized oncology2024-01-01OpenAlex10.1016/bs.acc.2024.06.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399879076
W4403941498Rear View2024-01-01OpenAlex10.14321/fourthgenre.26.2.0141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403941498
W4391643719Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Real-World Data from an HCV Elimination Model2024-01-01OpenAlex10.2139/ssrn.4716779Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391643719
W4396609973Reflections on the Brain Conference 20242024-01-01OpenAlex10.1093/braincomms/fcae118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396609973
W4407262067Regulatory Aspects of Cancer Immunotherapy2024-01-01OpenAlex10.1007/978-981-97-7022-9_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407262067
W4406197132Revascularization of Immature and Mature Teeth with Necrotic Pulp2024-01-01OpenAlex10.52533/johs.2024.41223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406197132
W4396711345Reversible central respiratory events induced by valproic acid treatment: A case report2024-01-01OpenAlex10.1177/2050313x241248386Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396711345
W4394787995Robotic Treatment of Inflammatory Diseases2024-01-01OpenAlex10.1007/978-3-031-42257-7_14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394787995
W4393170553Role of Bioactive Compounds Synthesized by Extremophilic Microbes and Their Bioactivity2024-01-01OpenAlex10.1007/978-3-031-30037-0_54-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393170553; https://openalex.org/W4409953024
W7132828114Role of Computational Drug Design in Modern Pharmacology2024-01-01OpenAlex10.54660/ijpis.2024.1.6.01-17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132828114
W4406193772Role of Triple Antibiotic Paste in Regenerative Endodontics2024-01-01OpenAlex10.52533/johs.2024.41213Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406193772
W4390543403SASLT guidelines: Update in treatment of hepatitis C virus infection, 20242024-01-01OpenAlex10.4103/sjg.sjg_333_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390543403
W4391176367Screening Queerness at Beyond the Blue Sky Mongolian Queer Film Festival2024-01-01OpenAlex10.1215/10642684-10920660Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391176367
W4400168497Sepsis from SARS-COV2 Infection (COVID-19): Pathophysiology and Clinic of SARS-COV2 Infection and Sepsis2024-01-01OpenAlex10.1007/978-3-031-43891-2_10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400168497
W4404073473Skin Disorders in Pregnancy2024-01-01OpenAlex10.1007/978-3-031-65300-1_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404073473
W4406960545Small Molecule Inhibitors: Precision Tools Targeting Oncogenic Pathways for Therapeutic Intervention in Cancer2024-01-01OpenAlex10.1007/978-981-96-0301-5_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406960545
W4393170888Structure-Guided and Phage-Assisted Evolution of Therapeutic Antibodies to Reverse On-Target Point Mutation-Mediated Resistance2024-01-01OpenAlex10.1007/978-1-0716-3798-2_3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393170888
W4390700203Supramolecule-Mediated Delivery of Phytochemicals2024-01-01OpenAlex10.1007/978-981-99-5314-1_6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390700203
W7130949277Surgery in Diabetic Retinopathy2024-01-01OpenAlex10.1007/978-3-031-29358-0_79-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130949277; https://openalex.org/W7214617060
W4405999032Surgical Decision-Making in Hepatobiliary and Pancreatic Surgery2024-01-01OpenAlex10.1007/978-3-031-67391-7_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405999032
W4409618354Sustainability in infection prevention and control – An Indian perspective2024-01-01OpenAlex10.4103/jpsic.jpsic_6_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409618354
W4392236234Syntax Before Words—The Function-First Approach to the Evolution of Proto-Language2024-01-01OpenAlex10.2139/ssrn.4815379Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392236234
W4393977284Systemic Therapy Options in VHL Disease2024-01-01OpenAlex10.1007/978-3-031-53858-2_10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393977284
W4393286010Systemic Therapy for Breast Cancer2024-01-01OpenAlex10.1016/b978-0-323-93249-3.00009-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393286010
W4403063255Tailoring treatment for locally advanced rectal cancer2024-01-01OpenAlex10.1016/j.ctarc.2024.100847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403063255
W4399364003Taking Action to Promote Diversity and Inclusion: One Program's Efforts Through Pathway Opportunities, Holistic Admissions, and Curricular Changes.2024-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399364003
W4406046899Talking Therapy: Knowledge and Power in American Psychiatric Nursing, by Kylie Smith2024-01-01OpenAlex10.5325/nursinghistory.32.0172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406046899
W4410508030Targeting Neutrophils in Pancreatic Cancer2024-01-01OpenAlex10.54615/2231-7805.24.s10.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410508030
W4400659469The Disintegration of a Floating Ferrofluid Layer into an Ordered Drop System in a Vertical Magnetic Field2024-01-01OpenAlex10.32604/fdmp.2024.051053Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400659469
W4390578330The Interpsychic: A Leading Actor in Interpersonal Relationships and in the Psychoanalytic Scene2024-01-01OpenAlex10.1007/978-3-031-44685-6_19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390578330
W4402651864The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer2024-01-01OpenAlex10.1177/11795549241277181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402651864
W4390475738The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation2024-01-01OpenAlex10.1093/eurheartj/ehad835Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390475738
W4400539985Theranostic nanogels: multifunctional agents for simultaneous therapeutic delivery and diagnostic imaging2024-01-01OpenAlex10.1039/d4nr01423eTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4400539985
W4402722814Therapeutic Potential of Natural Pharmacological Agents (Flavonoids and Other Phenolic Compounds) Found in Plants2024-01-01OpenAlex10.1007/978-981-97-6706-9_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402722814
W4404758931Therapeutic targeting of TNF-α and IL-17 in psoriasis: Mechanisms of action and clinical efficacy of biologic agents2024-01-01OpenAlex10.33545/26647184.2024.v6.i2a.37Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404758931
W4391386650Titelei/Inhaltsverzeichnis2024-01-01OpenAlex10.5771/9783748941842-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391386650
W4416361675Tocilizumab for cryptogenic fires with hemofagocytic syndrome: a case report2024-01-01OpenAlex10.5327/cbn241673Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416361675
W4402402008Towards Model-driven Enhancement of Safety in Healthcare Robot Interactions2024-01-01OpenAlex10.1007/978-3-031-71333-0_6Full textExcludedF3: The described method is a static domain metamodel for healthcare-robot safety, not an LLM/VLM acting-agent system.https://openalex.org/W4402402008https://link.springer.com/chapter/10.1007/978-3-031-71333-0_6publisher abstract only
W4393323652Toxic effects of cancer therapies2024-01-01OpenAlex10.1016/b978-0-443-15842-1.00004-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393323652
W4390968161Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis2024-01-01OpenAlex10.1016/b978-0-443-13870-6.00007-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390968161
W4400696051Transformation of conventional medical practices: an ethnographic investigation from Amppipal Gorkha, Nepal2024-01-01OpenAlex10.33545/26648679.2024.v6.i2a.87Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400696051
W4403634603Transforming Healthcare with Artificial Intelligence: An Integrated Approach to Patent Analysis and Strategic Commercialization2024-01-01OpenAlex10.2139/ssrn.4995376Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403634603
W4392454094Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons2024-01-01OpenAlex10.1016/j.ctarc.2024.100807Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392454094
W4402768062Treatment of Actinic Keratoses and Field Cancerization – Croatian perspective2024-01-01OpenAlex10.21857/mwo1vcrojyTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402768062
W4396711507Treatment of multiple myeloma: What is the impact on T-cell function?2024-01-01OpenAlex10.1177/20406207241245194Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396711507
W4407110862Treatment sequencing in metastatic colorectal cancer2024-01-01OpenAlex10.5114/wo.2024.146982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407110862
W4396725496Trends in drug poisoning hospitalizations over ten years in South Korea: mortality and length of hospital stay2024-01-01OpenAlex10.22514/sv.2024.053Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396725496
W4390886319Understanding and Treating Acute Lung Injury: Exploring The Causes, How It Affects The Lungs, and Possible Medications2024-01-01OpenAlex10.53555/jaz.v45i1.3351Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390886319
W4392105938Unleashing the Potential of Marine Algae in Cancer Prevention and Treatment Through Combination of Tradition and Innovation2024-01-01OpenAlex10.1007/16833_2024_212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392105938
W4393360803Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency2024-01-01OpenAlex10.1016/bs.ircmb.2024.03.004Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393360803
W4398194344Use of biomarkers in clinical trials and future developments that will help identify novel biomarkers2024-01-01OpenAlex10.1016/bs.irn.2024.04.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398194344
W4393323352Viral Genome Sequencing and Its Significance in Latest Clinical and Research Findings2024-01-01OpenAlex10.1016/b978-0-443-13320-6.00001-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393323352
W4404072413Virtual Laboratories for Diabetes Education on Artificial Pancreas2024-01-01OpenAlex10.1016/j.ifacol.2024.10.270Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404072413
W4390989862WORKSHOP ABSTRACTS2024-01-01OpenAlex10.4103/0019-5545.394311Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390989862
W4402914939Wildman's Effing Theodicy: The Problem of Suffering, the Ground of Being, and the Worship of Suchness2024-01-01OpenAlex10.5406/21564795.45.1.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402914939
W4390971478Yersinia pestis2024-01-01OpenAlex10.1016/b978-0-12-818619-0.00050-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390971478
W4403113387[Novel therapies for MDS and future prospects].2024-01-01OpenAlex10.11406/rinketsu.65.982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403113387
W4404753292Đợi Kiều2024-01-01OpenAlex10.1525/vs.2024.19.3-4.136Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404753292
W4392665100深层生物组织光学技术发展及其应用(特邀)2024-01-01OpenAlex10.3788/cjl231318Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392665100
W4390699452A conversational artificial intelligence based web application for medical conversations: a prototype for a chatbot2024-01-02OpenAlex10.1101/2023.12.31.23300681Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4390699452
W4390508381An adenine base editor variant expands context compatibility2024-01-02OpenAlex10.1038/s41587-023-01994-3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390508381
W4390501811Biomedical Applications of Carbon Nanotubes2024-01-02OpenAlex10.1201/9781003396390-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390501811
W4390488151Honeymoon phase in type 1 diabetes mellitus: A window of opportunity for diabetes reversal?2024-01-02OpenAlex10.12998/wjcc.v12.i1.9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390488151
W4390508229Is it time to recommend cardiovascular protection for all?2024-01-02OpenAlex10.1097/hjh.0000000000003501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390508229
W4390541053Enactive interventions can enhance agency, health, and social relationships during childhood2024-01-03OpenAlex10.3389/fpsyg.2023.1245883Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390541053
W7216357739Nano Formulation: A Promising Approach To Enhance The Bioavailability And Therapeutic Efficacy Of Herbal Drugs2024-01-03OpenAlex10.69980/redvet.v25i1.1789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216357739
W4390595730The role of disease registers in dermatology2024-01-03OpenAlex10.1093/bjd/ljae002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390595730
W4390608073A study on Bacterial Infections Associated with Central Nervous System in Pakistani Population2024-01-04OpenAlex10.51846/jucmd.v3i1.2643Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390608073
W4390597822Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease2024-01-04OpenAlex10.1148/rg.230092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390597822
W4390561458Atypical femur fracture in a male without history of bisphosphonate use: a case report2024-01-04OpenAlex10.1186/s13256-023-04308-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390561458
W4390574648Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure2024-01-04OpenAlex10.1016/j.amjmed.2023.04.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390574648
W4390585358Editorial: Imaging techniques to predict outcomes in renal cancers2024-01-04OpenAlex10.3389/fonc.2023.1349703Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390585358
W4390671327Marine Drug Discovery through Computer-Aided Approaches2024-01-04OpenAlex10.3390/books978-3-0365-9912-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390671327
W4390589052The metallo-β-lactamases strike back: emergence of taniborbactam escape variants2024-01-04OpenAlex10.1128/aac.01510-23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390589052
W4390589469Therapeutic Approaches to Targeting Androgen Receptor Splice Variants2024-01-04OpenAlex10.3390/cells13010104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390589469
W4390611138Cell death in cancer chemotherapy using taxanes2024-01-05OpenAlex10.3389/fphar.2023.1338633Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390611138
W4390610873Editorial: Computing and artificial intelligence in digital therapeutics2024-01-05OpenAlex10.3389/fmed.2023.1330686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390610873
W7155193443El tratamiento informativo del sismo de Pisco del 2007 en los diarios El Comercio, La República y El Peruano2024-01-05OpenAlex10.26490/uncp.sl.2024.8.1.1928Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155193443
W4390893334A Fluid Approach to Type 2 Diabetes Management: Recent Advances in Medication Therapy from Tradition to Novelty2024-01-06OpenAlex10.36948/ijfmr.2024.v06i01.11140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390893334
W4390672389Biology and Development of DNA-Targeted Drugs, Focusing on Synthetic Lethality, DNA Repair, and Epigenetic Modifications for Cancer: A Review2024-01-06OpenAlex10.3390/ijms25020752Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390672389
W4390675357Can removal of zombie cells revitalize the aging cardiovascular system?2024-01-08OpenAlex10.1093/eurheartj/ehad849Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390675357
W4390658581Colin Jones: fox and hedgehog historian of France2024-01-08OpenAlex10.1093/fh/crad063Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390658581
W4390661381Green cardiovascular care: a call for sustainable transformation of cardiovascular practices2024-01-08OpenAlex10.1093/eurheartj/ehad844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390661381
W4390669516Remission of type 2 diabetes: always more questions, but enough answers for action2024-01-08OpenAlex10.1007/s00125-023-06069-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390669516
W4390662645Role of Sodium-Glucose Co-Transporter-2 Inhibitor During Anthracycline Use: An Updated Review2024-01-08OpenAlex10.1097/crd.0000000000000638Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390662645
W4390707033Annotations of LSE Research: Enhancing Accessibility and Promoting High Quality Biology Education Research2024-01-09OpenAlex10.1187/cbe.23-09-0171Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390707033
W4390806935Decoding Online Teeth Whitening Videos: Navigating Social Media Complexities2024-01-09OpenAlex10.20944/preprints202401.0630.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390806935
W4390771765Editorial: New trends in the treatment of mood disorders2024-01-09OpenAlex10.3389/fpsyg.2023.1357198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390771765
W4390772085IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice2024-01-09OpenAlex10.21203/rs.3.rs-3728567/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390772085; https://openalex.org/W4398767308
W4400022342Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)2024-01-09OpenAlex10.17615/2m3x-kg35Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400022342
W4391488959Mainstream health economics and the COVID-19 pandemic2024-01-09OpenAlex10.4324/9781003017110-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391488959
W4391492701The growing link between microbes, mood and mental health2024-01-09OpenAlex10.1146/knowable-010924-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391492701
W4406479861Artificial intelligence-powered drug discovery and development: Accelerating innovation2024-01-10OpenAlex10.70593/978-81-984306-1-8_10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406479861
W4406482022Machine learning algorithms in personalized treatment planning2024-01-10OpenAlex10.70593/978-81-984306-1-8_3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406482022
W4390716129Nanotechnology based Drug Delivery for Brain Targeting2024-01-10OpenAlex10.22214/ijraset.2024.57931Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390716129
W4390692291Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies2024-01-10OpenAlex10.7759/cureus.52050Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390692291
W4390830873Targeted Therapies in Cancer Treatment: Unveiling the Latest Breakthroughs and Promising Approaches2024-01-10OpenAlex10.55544/jrasb.2.6.26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390830873
W4390739595A single center experience with a rare clinical entity of idiopathic granulomatous mastitis: Case series and review of the literature2024-01-11OpenAlex10.1016/j.ijscr.2024.109232Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390739595
W4390734905Anaesthetic subspecialties and sustainable healthcare: a narrative review2024-01-11OpenAlex10.1111/anae.16169Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390734905
W4390740703Clearing the air: a review of the effects of air pollution on dialysis outcomes2024-01-11OpenAlex10.1097/mnh.0000000000000968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390740703
W4390744022Driving down the carbon cost of peri‐operative care: old controversies, new topics, fresh perspectives and the future2024-01-11OpenAlex10.1111/anae.16217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390744022
W4390746382Editorial: Novel drug-designing approaches to combat antimicrobial resistance2024-01-11OpenAlex10.3389/fmolb.2023.1342702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390746382
W4390749734Effect of Different Disinfecting Agents on Surface Roughness and Color Stability of Heat-cure Acrylic Denture Material: An In Vitro Study2024-01-11OpenAlex10.5005/jp-journals-10024-3563Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390749734
W4390741004Green Synthesis of Novel Silver Nanoparticles Using Salvia blepharophylla and Salvia greggii: Antioxidant and Antidiabetic Potential and Effect on Foodborne Bacterial Pathogens2024-01-11OpenAlex10.3390/ijms25020904Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390741004
W4390805762Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India2024-01-11OpenAlex10.7759/cureus.52076Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390805762
W4390751219The Impact of Carrageenan on Pharmascience2024-01-11OpenAlex10.2174/0122150838266638231117180516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390751219
W4390824072A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines2024-01-12OpenAlex10.3390/cancers16020335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390824072
W4390827776Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 20502024-01-12OpenAlex10.1213/ane.0000000000006860Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390827776
W4390819650Perioperative Fluid and Vasopressor Therapy in 2050: From Experimental Medicine to Personalization Through Automation2024-01-12OpenAlex10.1213/ane.0000000000006672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390819650
W4390837523Spatial dispersal in chemostat systems with agent-based asymmetry2024-01-13OpenAlex10.1016/j.cnsns.2024.107847Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4390837523
W4390857921Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome2024-01-14OpenAlex10.1186/s12967-023-04779-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4390857921
W4390884625Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research2024-01-15OpenAlex10.1681/asn.0000000000000301Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390884625
W4390877184Exploring the Effectiveness of Biological Therapy in Patients with Psoriasis: Body Image and Quality of Life2024-01-15OpenAlex10.3390/medicina60010160Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390877184
W4390890119Physicians’ and Patients’ Expectations From Digital Agents for Consultations: Interview Study Among Physicians and Patients2024-01-15OpenAlex10.2196/49647Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4390890119
W4390876505Tenapanor-A Novel Approach for Management of Hyperphosphatemia in End Stage Renal Disease: A Clinical Study Aggregate Review2024-01-15OpenAlex10.22270/jddt.v14i1.6336Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390876505
W4390917114Editorial: Insights in precision medicine: 20222024-01-16OpenAlex10.3389/fmed.2023.1341175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390917114
W4390917719Ophthalmic implications of biological threat agents according to the chemical, biological, radiological, nuclear, and explosives framework2024-01-16OpenAlex10.3389/fmed.2023.1349571Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4390917719
W4390928538MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review2024-01-17OpenAlex10.1186/s13244-023-01602-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390928538
W4390978051Racial differences in treatment and survival among older patients with multiple myeloma2024-01-17OpenAlex10.1002/cam4.6915Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4390978051
W4390952952Tularemia treatment: experimental and clinical data2024-01-17OpenAlex10.3389/fmicb.2023.1348323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390952952
W4390969818Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge2024-01-18OpenAlex10.1080/14787210.2024.2305854Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390969818
W4390984747Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer2024-01-18OpenAlex10.3390/cancers16020412Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4390984747
W4391024399An Era of Therapeutic Evolution and Revolution: Insights into Studies on Dupilumab, Tralokinumab, Lebrikizumab, Nemolizumab, Eblasakimab, and OX40/OX40L Agents (Rocatinlimab and Amlitelimab) in Moderate-to-Severe Atopic Dermatitis2024-01-19OpenAlex10.5772/intechopen.1004103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391024399
W4391021887Meeting at the precipice: Creative visualization in the treatment of trauma2024-01-19OpenAlex10.1080/24720038.2024.2302364Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391021887
W4391022843Thamnostylum piriforme, a novel etiological agent of superficial mycosis2024-01-19OpenAlex10.1016/j.micpath.2024.106544Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4391022843
W4391096700Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01.2024-01-20OpenAlex10.1200/jco.2024.42.3_suppl.tps238Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391096700
W4391070932SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMM2024-01-21OpenAlex10.1016/j.clml.2024.01.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391070932
W4391105216The Efficacy and Safety of Transvaginal Ethanol Sclerotherapy in the Treatment of Endometrial Cysts—A Systematic Review2024-01-22OpenAlex10.3390/ijms25021337Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391105216
W4391154193Act Local, Think Global: IR and Its Role in Immuno-Oncology in Hepatocellular Carcinoma2024-01-23OpenAlex10.1016/j.jvir.2023.10.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391154193
W4391580069PREBIOTICS AND PROBIOTICS: AN OVERVIEW ON MECHANISM OF ACTION AND THERAPEUTIC APPLICATIONS2024-01-23OpenAlex10.56735/saltjsrh.ms2404011016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391580069
W4391137182The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance2024-01-23OpenAlex10.2174/0115680266284527240118041129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391137182
W4391257346Editorial: Expert opinions in genitourinary oncology2024-01-24OpenAlex10.3389/fonc.2023.1360223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391257346
W4391173274Editorial: Optimizing the first-line treatment for metastatic colorectal cancer2024-01-24OpenAlex10.3389/fonc.2024.1366383Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391173274
W4391171520G4-interacting ligands: paving the way for precision medicine and molecular diagnostics2024-01-24OpenAlex10.1080/07391102.2024.2306498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391171520
W4391172921RNA recombination: non-negligible factor for preventing emergence or reemergence of Senecavirus A2024-01-24OpenAlex10.3389/fvets.2024.1357179Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391172921
W4391167626Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides2024-01-24OpenAlex10.1002/jvc2.352Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391167626
W4391227486A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence2024-01-25OpenAlex10.3389/fendo.2023.1266986Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391227486
W4391217480Antibody–drug conjugates transform the outcome of individuals with low‐HER2‐expression advanced breast cancer2024-01-25OpenAlex10.1002/cncr.35205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391217480
W7119496071Cross-Border Healthcare Security: Challenges For Nursing Practice In The Era Of Globalized Health Data2024-01-25OpenAlex10.70082/c2xg2274Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119496071
W4391219420Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT2024-01-25OpenAlex10.1016/j.chempr.2023.12.019Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391219420
W4391229427ERCC1 abundance is an indicator of DNA repair-apoptosis decision upon DNA damage2024-01-25OpenAlex10.1038/s41420-024-01817-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391229427
W7221812053Empowering the sustainable development of the AI industry ecosystem with the "i7C" framework2024-01-25OpenAlex10.25405/ncl.34491117Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221812053
W4391224124Health Informatics Workforce in the Digital Health Ecosystem2024-01-25OpenAlex10.3233/shti231160Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391224124
W4391261076The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End2024-01-25OpenAlex10.31219/osf.io/wbp3qTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391261076
W4391223854The contemporary nexus of medicines security and bioprospecting: a future perspective for prioritizing the patient2024-01-25OpenAlex10.1007/s13659-024-00431-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391223854
W4391251979Cardiac Tamponade in ECMO: Infrequent but Important2024-01-26OpenAlex10.1053/j.jvca.2024.01.015Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391251979
W4391317609Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights2024-01-26OpenAlex10.3390/ijms25031574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391317609
W4391260591Neuroprotection strategies in traumatic brain injury: Studying the effectiveness of different clinical approaches2024-01-26OpenAlex10.25259/sni_773_2023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391260591
W4391261002Which Patient Phenotype Is the Ideal Candidate for Hemoadsorption in Acute and Chronic Kidney Disease?2024-01-26OpenAlex10.1097/imna-d-24-00001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391261002
W4391277386MR Imaging Techniques for Acute Ischemic Stroke and Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage2024-01-27OpenAlex10.1016/j.nic.2023.12.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391277386
W7217592613Pengembangan Riset Terkini Pemanfaatan Tanaman Obat dalam Penemuan Obat Baru dan Mekanismenya dalam Pengobatan Penyakit: Pengembangan Riset Terkini Pemanfaatan Tanaman Obat dalam Penemuan Obat Baru dan Mekanismenya dalam Pengobatan Penyakit2024-01-27OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217592613
W4391292967Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives2024-01-28OpenAlex10.1016/j.ejps.2024.106712Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391292967
W4391316094Book Illustrations2024-01-29OpenAlex10.4324/9781003094876-22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391316094
W4391329340Ethical challenges for children undergoing surgery: Evaluation of graduate nursing students' learning2024-01-29OpenAlex10.26443/ijwpc.v11i1.406Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391329340
W4391233082Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer2024-01-29OpenAlex10.1016/j.jconrel.2024.01.034Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4391233082
W4391303575Real-world utilization patterns of radium-223 in metastatic prostate cancer in the United States: An administrative claims database study.2024-01-29OpenAlex10.1200/jco.2024.42.4_suppl.79Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391303575
W4391325448Recent advances and future strategies in first-line treatment of ES-SCLC2024-01-29OpenAlex10.1016/j.ejca.2024.113581Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391325448
W4396876390Symptoms-Disease Detecting Conversation Agent using Knowledge Graphs2024-01-29OpenAlex10.1145/3641142.3641165Full textExcludedF4: The GPT-3 DaVinci model is fine-tuned once on126 prompt–completion pairs generated from a fixed symptom–disease dataset and ChatGPT answers. A fixed knowledge graph guides within-dialogue questions. No retained execution-derived update or cross-case agent-learning loop is implemented.https://openalex.org/W4396876390https://dl.acm.org/doi/10.1145/3641142.3641165Publisher online PDF pp3–4 and9, dataset/model/training and conclusion read through existing institutional access; no file archive/download.
W4391302597Treatment (Rx) trends and attrition with lines of therapy in patients (pts) with advanced urothelial carcinoma (aUC).2024-01-29OpenAlex10.1200/jco.2024.42.4_suppl.562Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391302597
W4391357728Challenges in acute postoperative pain management in thoracic surgery2024-01-30OpenAlex10.1016/j.bpa.2024.01.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391357728
W4391375707PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape2024-01-30OpenAlex10.3390/life14020198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391375707
W4391349908The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs2024-01-30OpenAlex10.3390/ijms25031702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391349908
W4391377722BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally2024-01-31OpenAlex10.1093/bjs/znad413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391377722
W4391379892Getting rid of bed bugs: Trickier than ever2024-01-31OpenAlex10.1146/knowable-013124-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391379892
W4391446177Lipolytic agents for submental fat reduction: Review2024-01-31OpenAlex10.1111/srt.13601Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4391446177
W4391403375Real-World Evidence in Biliary Tract Cancer Treatment2024-01-31OpenAlex10.1097/01.cot.0001007188.58445.9aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391403375
W4391399497Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial2024-01-31OpenAlex10.1007/s10549-023-07231-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391399497
W4404506519A Review: Novel Therapies for Advanced Clear Cell Renal Cell Carcinoma2024-02-01OpenAlex10.1177/24684570241288088Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404506519
W4391443220Abstract A016: Positive ecological interaction between therapy-resistant and sensitive cells, mediated by stromal niche, slows the expansion of resistant subpopulations and promotes tumor heterogeneity2024-02-01OpenAlex10.1158/1538-7445.canevol23-a016Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391443220
W4391443067Abstract A023: Integrating mathematical modeling and in vitro experiments to measure ecological interactions in cancer2024-02-01OpenAlex10.1158/1538-7445.canevol23-a023Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391443067
W4391446459Abstract B056: Chronic hypoxia in TNBC breast cancer induces development of a novel population of CD24+/CD49b-high cells characterized by high expression of CST12024-02-01OpenAlex10.1158/1538-7445.advbc23-b056Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391446459
W4391446155Abstract IA15: Single cell origins and targeting of genomic instability in breast cancers2024-02-01OpenAlex10.1158/1538-7445.advbc23-ia15Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391446155
W4391450769Aortic Valve Embryology, Mechanobiology, and Second Messenger Pathways: Implications for Clinical Practice2024-02-01OpenAlex10.3390/jcdd11020049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391450769
W4391751598Approach to acute chest pain and acute coronary syndrome in adults2024-02-01OpenAlex10.4103/singaporemedj.smj-2023-039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391751598
W4391436383Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration–Approved Bladder Cancer Therapeutic Trials2024-02-01OpenAlex10.1097/ju.0000000000003853Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391436383
W4391787340Diagnosis and Treatment of Myelodysplastic Syndrome in the Era of Genetic Testing2024-02-01OpenAlex10.3904/kjm.2024.99.1.11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391787340
W4392096963From the Editor—January 2024 AUA Publications Committee Meeting2024-02-01OpenAlex10.1097/ju9.0000000000000126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392096963
W4392391682Heparin: A Conventional Drug with A New Prototype2024-02-01OpenAlex10.47583/ijpsrr.2024.v84i02.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392391682
W4391443814Is ‘Immunity Debt’ Behind the RSV Surge?2024-02-01OpenAlex10.1097/01.eem.0001006968.81740.5eTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391443814
W4391972957JISPPD Abstract supplement 20242024-02-01OpenAlex10.4103/jisppd.jisppd_59_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391972957
W4391424698Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies2024-02-01OpenAlex10.1016/j.bcp.2024.116034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391424698
W4394962235New anticoagulants in 2024: Development of factor XI and XIa inhibitors2024-02-01OpenAlex10.1684/abc.2024.1865Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394962235
W4391442241Nuclear Cardiology2024-02-01OpenAlex10.1093/med/9780197521434.003.0001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391442241; https://openalex.org/W4391442048
W4391447278Pathogenesis of COVID-19-Associated Mucormycosis: An Updated Evidence-Based Review2024-02-01OpenAlex10.1007/s12281-024-00484-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391447278
W4391723567Phase I Studies: Innovations and Issues2024-02-01OpenAlex10.1016/j.clinthera.2024.01.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391723567
W4391431161Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024-02-01OpenAlex10.1158/2767-9764.crc-23-0389Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391431161
W4392788185Strategies to Achieve Evidence-Based Practice in Nursing2024-02-01OpenAlex10.4037/ccn2024359Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392788185
W4391443966The Delicate Balance of Diagnosing GI Bleeding in the ED2024-02-01OpenAlex10.1097/01.eem.0001006952.99523.eeTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391443966
W4391973331The evolutionary phylodynamics of human parechovirus A type 3 reveal multiple recombination events in South Korea2024-02-01OpenAlex10.1002/jmv.29477Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391973331
W4391445254Tourette Syndrome and Tic Disorders2024-02-01OpenAlex10.1542/pir.2023-006014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391445254
W4391479897Contrast Echocardiography in Heart Failure: Update 20232024-02-02OpenAlex10.1007/s11897-024-00647-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391479897
W4391465956Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)2024-02-02OpenAlex10.1182/blood.2023021789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391465956
W4391485098Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription2024-02-02OpenAlex10.1016/j.omtm.2024.101203Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391485098
W4391512658We have to cancel psychiatric nursing and forge a new way forward2024-02-02OpenAlex10.1111/inm.13301Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391512658
W4391512773A review on trends in development and translation of omics signatures in cancer2024-02-03OpenAlex10.1016/j.csbj.2024.01.024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391512773
W4391508246Bibliometric Insights Into the Evolving Landscape of Antibiotic Resistance Research: Trends, Collaborations, and Key Foci (1965-2023)2024-02-03OpenAlex10.7759/cureus.53508Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391508246
W4391511754How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?2024-02-03OpenAlex10.1002/mus.28038Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4391511754
W4391511685Mobilising Communities Prior to Healthcare Interventions: Reflections on the Role of Public Health Midwives Working With Vulnerable Communities of Sri Lanka2024-02-03OpenAlex10.1177/2752535x241232000Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391511685
W7217111215Clinical Pharmacy in Transplant Medicine: Challenges and Innovations2024-02-04OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217111215
W4391522243Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring2024-02-04OpenAlex10.2174/0115733998267817231227102553Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391522243
W4391522004Treatment of nonmelanoma skin cancer with pro‐differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review)2024-02-04OpenAlex10.1111/php.13914Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4391522004
W4391537317Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors2024-02-05OpenAlex10.3389/fcvm.2024.1352734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391537317
W4392734674CDA Formulations as Persuasive Good Cancer Drugs to Save Cancer Patients2024-02-05OpenAlex10.11648/ijcocr.20240901.13Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392734674
W4391608654Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology2024-02-05OpenAlex10.1002/cai2.108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391608654
W4391566678Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?2024-02-05OpenAlex10.3390/cancers16030679Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391566678
W4391536119Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)2024-02-05OpenAlex10.1038/s41408-024-00981-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391536119
W4391563724Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis2024-02-05OpenAlex10.1016/j.mam.2024.101252Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391563724
W4391542732Interstitial Lung Disease in Rheumatoid Arthritis: A Review2024-02-05OpenAlex10.7759/cureus.53632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391542732
W4391544246Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy2024-02-05OpenAlex10.1021/acsomega.3c06501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391544246
W4391563423CDC Laboratory Recommendations for Syphilis Testing, United States, 20242024-02-06OpenAlex10.15585/mmwr.rr7301a1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391563423
W7221301301Capecitabine: A Promising Anticancer Drug: Review Article2024-02-06OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221301301
W4391577546Cracking the Genomic Code of CDK4/6 Inhibitor Resistance2024-02-06OpenAlex10.1158/1078-0432.ccr-23-3413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391577546
W4391795405Identification of ethyl-6-bromo-2((phenylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate as a narrow spectrum inhibitor of Streptococcus pneumoniae and its FtsZ2024-02-06OpenAlex10.1016/j.ejmech.2024.116196Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391795405
W4391613784In defence of sociological description: A ‘world‐making’ perspective2024-02-06OpenAlex10.1111/1468-4446.13083Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391613784
W4391579112Treatment of non-systemic juvenile idiopathic arthritis2024-02-06OpenAlex10.1038/s41584-024-01079-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391579112
W4391598116Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients2024-02-07OpenAlex10.1089/cbr.2023.0198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391598116
W4391651428Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer2024-02-08OpenAlex10.1016/j.canlet.2024.216702Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391651428
W4391640675Data from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium2024-02-08OpenAlex10.1158/2159-8290.c.7065317Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391640675; https://openalex.org/W4391640796; https://openalex.org/W4391640676
W4391650316Editorial: Pathophysiology, treatment and rehabilitation of atherosclerosis-related diseases in geriatric population2024-02-08OpenAlex10.3389/fmed.2024.1358769Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391650316
W4391650138Editorial: SARS-CoV-2: implications for maternal-fetal-infant and perinatal mortality, morbidity, pregnancy outcomes and well-being2024-02-08OpenAlex10.3389/fped.2024.1375501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391650138
W4391667818Editors’ Choice2024-02-08OpenAlex10.1097/ju.0000000000003838Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391667818
W4391654988Hemoptysis caused by Parvimonas micra: case report and literature review2024-02-08OpenAlex10.3389/fpubh.2023.1307902Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391654988
W4391685248An investment behavioral modeling framework for advancing power system transformation toward renewable energy integration2024-02-09OpenAlex10.1016/j.egycc.2024.100127Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391685248
W4391691920Dual modality intravascular catheter system combining pulse-sampling fluorescence lifetime imaging and polarization-sensitive optical coherence tomography2024-02-09OpenAlex10.1364/boe.516515Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391691920
W4391718508Orthopaedic Musculoskeletal Biologics Research Impacts Patient Care: The Second Annual Arthroscopy Orthobiologics Virtual Special Issue2024-02-09OpenAlex10.1016/j.arthro.2024.01.046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391718508
W4391855360Current advances in pharmacotherapy for schizophrenia2024-02-10OpenAlex10.5124/jkma.2024.67.2.96Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391855360
W4394992348Perspectives of Women in Microscopy2024-02-10OpenAlex10.1093/mictod/qaae006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394992348
W4391733033A computational fractional order model for optimal control of wearable healthcare monitoring devices for maternal health2024-02-11OpenAlex10.1016/j.health.2024.100308Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391733033
W4391734029Exploring Future Horizons in Osteoarthritis Relief: Unveiling the Potential of Slow-Acting Drugs and Innovative Medications2024-02-11OpenAlex10.12775/jehs.2024.58.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391734029
W4391745430Data from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024-02-12OpenAlex10.1158/2767-9764.c.7070351.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391745430; https://openalex.org/W4391754522
W4391747178Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential2024-02-12OpenAlex10.1186/s43094-024-00581-wTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391747178
W4392810364Arsenical Keratosis with Unusual Lung Involvement2024-02-13OpenAlex10.4103/idoj.idoj_160_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392810364
W4391820054FakA impacts antiseptic susceptibility in Staphylococcus aureus and Enterococcus faecalis2024-02-13OpenAlex10.1101/2024.02.13.580087Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391820054
W4391810908Promise and pitfalls of a natural killer cell signature for HCC detection in patients with HCV with sustained virological response2024-02-14OpenAlex10.1097/hep.0000000000000797Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391810908
W4391815678Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias2024-02-14OpenAlex10.1007/s00392-024-02383-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391815678
W4391837617Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes2024-02-15OpenAlex10.1017/ice.2024.9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391837617
W4391883264Stereotactic ablative radiation therapy in metastatic prostate cancer2024-02-15OpenAlex10.1097/cco.0000000000001025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391883264
W4391880934Animal models in medical translation: the grand challenge of developing new treatments for human diseases2024-02-16OpenAlex10.3389/fmedt.2024.1367521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391880934
W7217738924Fluorouracil in Cancer Treatment: Unveiling its Crucial Role2024-02-16OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217738924
W4396691076Hepatocellular carcinoma: Advances in systemic therapies2024-02-16OpenAlex10.12688/f1000research.145493.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396691076
W4391916405Perspective of nurses and community health agents on directly observed treatment of tuberculosis in a capital city in northern Brazil2024-02-16OpenAlex10.55905/revconv.17n.2-171Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4391916405
W4391881055The Benefit of “Negative Thinking” in Transplant Tolerance Induction2024-02-16OpenAlex10.1097/tp.0000000000004933Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391881055
W4395015745The Evolving Landscape of Dry Eye Disease Therapies2024-02-16OpenAlex10.19080/jojo.2024.10.555793Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395015745
W4391874641The future of EUS2024-02-16OpenAlex10.1002/9781119697893.ch31Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391874641
W4391915614Therapeutic targeting of cell transition: ready for clinical prime-time?2024-02-16OpenAlex10.1093/cvr/cvae029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391915614
W4391919254A survey on multi-agent reinforcement learning and its application2024-02-17OpenAlex10.1016/j.jai.2024.02.003Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4391919254
W4391900134The principles of cardiac anaesthesia2024-02-17OpenAlex10.1016/j.mpaic.2023.11.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391900134
W4393337701First-in-human gene editing for lipid lowering: the initial results2024-02-18OpenAlex10.1093/cvr/cvae037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393337701
W4391965199Alert from Inner Mongolia: two bubonic plague cases reported in China2024-02-19OpenAlex10.1097/gh9.0000000000000411Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391965199
W4391933262Recent advances on infrared thermography for ceramic tiles detachments diagnosis: literature review2024-02-19OpenAlex10.1007/s41024-024-00387-6Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391933262
W4391930320Recent and anticipated novel drug approvals for 20242024-02-19OpenAlex10.1093/ajhp/zxae046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391930320
W4391954461Evaluation of 18F-AlF-labeled IF7 dimer as a promising molecular probe for tumor targeting PET imaging in mice2024-02-20OpenAlex10.1007/s10967-024-09391-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391954461
W4392107799Rifampicin-resistant Tuberculosis: A Global Health Dilemma2024-02-20OpenAlex10.4103/aihb.aihb_15_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392107799
W4391972286Topotaxis of active particles across long distances by sliding along obstacles2024-02-20OpenAlex10.1103/physrevresearch.6.013178Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4391972286
W4392003340Ultrasound-Enhancing Agent and IV Administration in Cardiac Sonography: How Sonographers Play a Key Role in Positively Affecting Key Performance Indicators2024-02-20OpenAlex10.1177/87564793241230982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392003340
W4392017175Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review2024-02-21OpenAlex10.26442/18151434.2023.4.202514Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392017175
W4391991379The therapeutic potential of immunoengineering for systemic autoimmunity2024-02-21OpenAlex10.1038/s41584-024-01084-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4391991379
W4407407562Adenosis / Atypical adenomatous hyperplasia of Prostate Gland. Review and Update2024-02-22OpenAlex10.31579/2767-7370/087Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407407562
W7120697622As relações étnico-raciais em foco: o ensino de leitura do artigo de opinião como instrumento de empoderamento discursivo para transformação social2024-02-22OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7120697622
W4392079897Diverse mutant selection windows shape spatial heterogeneity in evolving populations2024-02-22OpenAlex10.1371/journal.pcbi.1011878Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392079897
W4392109635Etiopathogenic Therapeutic Strategies in Behcet's Disease, with Ocular Complications2024-02-22OpenAlex10.9734/bpi/anums/v8/17572dTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392109635
W4392084952MedLingua: A conceptual framework for a multilingual medical conversational agent2024-02-22OpenAlex10.1016/j.mex.2024.102614Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4392084952
W4392040213Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management2024-02-22OpenAlex10.3390/jcm13051251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392040213
W4392038843Workforce Upskilling for Value-Based Healthcare2024-02-22OpenAlex10.4324/9781032685489-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392038843
W4407424618APPLICATION OF AGENTIC AI AND CLINICAL REASONING MODELS IN CLINICAL WORKFLOW: A SYSTEMATIC IMPLEMENTATION STUDY OF DOCTORASSIST.AI2024-02-23OpenAlex10.53555/w7hr6r14Full textExcludedF3: The implemented DoctorAssist clinical-reasoning engine is described through Bayesian networks, causal models, pattern recognition and self-consistency checks. No LLM/VLM-based acting agent is documented. Claimed prospective outcomes are not evidence of an LLM agent.https://openalex.org/W4407424618https://doi.org/10.53555/w7hr6r14
W4392162963An Introduction to Reinforcement Learning and Its Application in Various Domains2024-02-23OpenAlex10.4018/979-8-3693-1738-9.ch001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392162963
W4392102722Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T‐cell lymphomas2024-02-23OpenAlex10.1002/ajh.27266Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392102722
W4392132984Highlights of Research Activities in Advanced Materials at Wuhan University2024-02-23OpenAlex10.1002/adma.202313766Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392132984
W4392111097Phototherapy for atopic dermatitis: Is the light still shining?2024-02-23OpenAlex10.1111/jdv.19766Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392111097
W4392104517The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT2024-02-23OpenAlex10.1111/bjh.19353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392104517
W4392243604A Review: Hospital Acquired Infection in Some Gram Negative Pathogenic Bacterial Strains2024-02-26OpenAlex10.22317/jcms.v10i1.1475Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392243604
W4392162536Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection2024-02-26OpenAlex10.1089/sur.2023.255Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392162536
W4392269126Asian Community of Glycoscience and Glycotechnology (ACGG) conference report 20232024-02-26OpenAlex10.1093/glycob/cwae017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392269126
W4392157032B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia2024-02-26OpenAlex10.3389/fonc.2024.1339620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392157032
W4392359025Effect of an AI agent trained on a large language model (LLM) as an intervention for depression and anxiety symptoms in young adults: a 28-day randomized controlled trial (Preprint)2024-02-26OpenAlex10.2196/preprints.57766Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4392359025
W4392159057Photonic neuromorphic architecture for tens-of-task lifelong learning2024-02-26OpenAlex10.1038/s41377-024-01395-4Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4392159057
W4392163141Reflections on proposals for reform of the Individual Income Tax (IIT) in Brazil2024-02-26OpenAlex10.56238/sevened2024.003-042Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392163141
W4392200482Microbial Spectrum of Keratitis at a Rural Tertiary Care Teaching Hospital2024-02-27OpenAlex10.7759/cureus.55055Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392200482
W7119331913Uma análise foucaultiana da corrida no ambiente hospitalar: disputa de saberes, poderes e produção de verdades2024-02-27OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7119331913
W4392810226Advancements in Dermatological Imaging Modalities2024-02-28OpenAlex10.4103/idoj.idoj_852_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392810226
W4392234644Advice From the Field: Practical Skills, Challenges, and How to Support Early Career Ecologists2024-02-28OpenAlex10.1002/bes2.2127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392234644
W4392236790Editorial: The role of cancer associated fibroblast (CAF) in EMT/metastasis in malignancies of epithelial tissues2024-02-28OpenAlex10.3389/fcell.2024.1384150Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392236790
W4392232546Next-generation therapies for pancreatic cancer2024-02-28OpenAlex10.1080/17474124.2024.2322648Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392232546
W7140306560SecOps Automation in IoT-Enabled Enterprises: Leveraging Gen AI2024-02-28OpenAlex10.5281/zenodo.19218912Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140306560
W4392293840A Clinical Review on Chronic Obstructive Pulmonary Disease2024-02-29OpenAlex10.14218/fim.2023.00026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392293840
W7215252723Acute Tonsillitis: Causes, and Management - A Comprehensive Review2024-02-29OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215252723
W4392282128Antimicrobial Susceptibility Patterns of Enterococcus Species and Molecular Detection of Enterococcus faecalis Isolated from Patients with Urinary Tract Infection in a Tertiary Care Hospital in Bangladesh2024-02-29OpenAlex10.1007/s12088-024-01216-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392282128
W4392299049Development of Preventive Methods for Drug-induced Cardiotoxicity Using a Large-scale Medical Information Database2024-02-29OpenAlex10.1248/yakushi.23-00164-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392299049
W4392303305Intra-host genetic diversity of SARS-CoV-2 Omicron variants in children2024-02-29OpenAlex10.1016/j.jinf.2024.106132Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392303305
W4394780043Medication-Related Osteonecrosis of the Jaw – 2024 Update2024-02-29OpenAlex10.33425/2639-9490.1142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394780043
W4392284873Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy2024-02-29OpenAlex10.1097/ju.0000000000003892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392284873
W4392285035The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects2024-02-29OpenAlex10.7759/cureus.55230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392285035
W439486087029 Hospital admissions towards the end of life: an ethical exploration of decision making2024-03-01OpenAlex10.1136/spcare-2024-pcc.47Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394860870
W4392597123A new frontier in imaging: natural ore-sourced superparamagnetic magnetite nanoparticles for multi-modal imaging2024-03-01OpenAlex10.1007/s13204-023-02993-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392597123
W4394739423A rare case of Takotsubo cardiomyopathy.2024-03-01OpenAlex10.26355/eurrev_202403_35619Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394739423
W4392366027Abstract B032: Use of patient-derived organoids to model tumor evolution in response to chemotherapy2024-03-01OpenAlex10.1158/1557-3265.endo24-b032Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392366027
W4392360060Editorial: Hepato-pancreato-biliary surgery: innovations, genomics, and prognostic management2024-03-01OpenAlex10.3389/fsurg.2024.1386870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392360060
W4393167294Editor’s view2024-03-01OpenAlex10.1093/ageing/afae063Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393167294
W4396563265Engaging the Deeper Shifts: Content Expansion and Scientific Engagement2024-03-01OpenAlex10.1111/rsr.17069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396563265
W4392401562Environmental pollution’s toll on the heart: rethinking cardiovascular risk factors2024-03-01OpenAlex10.1093/ehjopen/oeae017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392401562
W4392658768From theory to practice: The pragmatic value of applying systems thinking and complexity sciences in healthcare2024-03-01OpenAlex10.1111/jep.13979Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392658768
W4392807689IMMUNOTHERAPY UTILIZATION PATTERNS IN METASTATIC BLADDER CANCER: ASSESSING INSURANCE STATUS AS A MODIFIABLE FACTOR ASSOCIATED WITH FAILURE TO RECEIVE NOVEL THERAPIES2024-03-01OpenAlex10.1016/j.urolonc.2024.01.102Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392807689
W4392791503Inflammation, infection, and cardiovascular risk2024-03-01OpenAlex10.1016/s0140-6736(23)02877-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392791503; https://openalex.org/W4392791529; https://openalex.org/W4392791528; https://openalex.org/W4392791527
W4392791547Inflammation, infection, and cardiovascular risk – Authors' reply2024-03-01OpenAlex10.1016/s0140-6736(23)02878-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392791547
W4411498707MODEL BASED REINFORCEMENT LEARNING FOR ADAPTIVE HEALTHCARE DECISION SUPPORT SYSTEMS2024-03-01OpenAlex10.21917/ijdsml.2024.0129Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411498707
W4393098934Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine2024-03-01OpenAlex10.1097/mjt.0000000000001721Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393098934
W4392383680Pushing the boundaries of radiation technology for the management of central nervous system tumors2024-03-01OpenAlex10.1093/neuonc/noae002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392383680
W4392564347Sporadic regional re-emergent cholera: a 19th century problem in the 21st century2024-03-01OpenAlex10.1093/jambio/lxae055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392564347
W4392352834The Undeniable Allure of New Drugs and Technology for SVT2024-03-01OpenAlex10.1097/01.eem.0001009616.98131.8dTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392352834
W4394934839Update on chemotherapy modalities for retinoblastoma: Progress and challenges2024-03-01OpenAlex10.1016/j.apjo.2024.100061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394934839
W4392372814Abstract A010: Prostate-specific membrane antigen use in glioma management: past, present, and future2024-03-04OpenAlex10.1158/1538-7445.brain23-a010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392372814
W4392377402Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review2024-03-04OpenAlex10.3390/ph17030334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392377402
W4392448524Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management2024-03-05OpenAlex10.1007/s00520-024-08388-4Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4392448524
W4392458279Metal-Organic Frameworks in Neural Regeneration2024-03-05OpenAlex10.1021/bk-2024-1463.ch010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392458279
W4392471085Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib2024-03-05OpenAlex10.3390/cancers16051056Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392471085
W4396863510Recent Developments in the Diagnosis and Management of Infectious Diseases2024-03-05OpenAlex10.21275/mr24316154029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396863510
W4392516015Editorial: Transcriptional and posttranscriptional homeostasis in inflammation and inflammatory diseases2024-03-06OpenAlex10.3389/fimmu.2024.1391199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392516015
W4392519878Editor’s Spotlight/Take 5: How Does ChatGPT Use Source Information Compared With Google? A Text Network Analysis of Online Health Information2024-03-06OpenAlex10.1097/corr.0000000000003006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392519878
W4392501688Harnessing the Power of Stimuli‐Responsive Nanoparticles as an Effective Therapeutic Drug Delivery System2024-03-06OpenAlex10.1002/adma.202312939Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392501688
W4392570934It’s About Blood Pressure Reduction and Control2024-03-06OpenAlex10.1093/ajh/hpae023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392570934
W4392519365Novel cardioprotective approaches in ischaemic heart disease2024-03-06OpenAlex10.1093/eurheartj/ehae058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392519365
W4392623318Therapy of moderate-to-severe plaque psoriasis2024-03-06OpenAlex10.21518/ms2024-043Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392623318
W4392547733A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients With Ulcerative Colitis2024-03-07OpenAlex10.1053/j.gastro.2024.03.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392547733
W7216952197Chemical Profiling of Beta-Lactam and Derivatives for Antimicrobial Potential: A Computational Perspective2024-03-07OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216952197
W4392553229Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis2024-03-07OpenAlex10.1111/ans.18924Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392553229
W4392592167A complex molecular landscape to drug delivery concept for achieving precise therapy in psoriasis2024-03-08OpenAlex10.1016/j.medidd.2024.100183Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392592167
W4392595400Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features2024-03-08OpenAlex10.4103/aip.aip_212_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392595400
W4393991031Modification of Imperfect Cancer Drugs to Become Perfect Cancer Drugs to Save Cancer Patients2024-03-08OpenAlex10.14738/bjhmr.112.16531Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393991031
W4392612028Nurses’ Ethical Obligations When Caring for Patients With Limited English Proficiency2024-03-08OpenAlex10.4037/aacnacc2024319Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392612028
W4392616836PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experiments2024-03-08OpenAlex10.21203/rs.3.rs-4008037/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392616836
W4392652581Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors2024-03-11OpenAlex10.1186/s12957-024-03335-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392652581
W4392642097Quorum sensing in Mycobacteria: understanding the recognition machinery conundrum through an in-silico approach2024-03-11OpenAlex10.1101/2024.03.06.583649Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392642097
W4394762433DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study2024-03-12OpenAlex10.1111/bjh.19392Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394762433
W4392701856Editorial: The evolution in pharmacology of infectious diseases: 20222024-03-12OpenAlex10.3389/fphar.2024.1386077Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392701856
W4392707060From cells to society: untangling the web of stress, inflammation, and social determinants of health2024-03-12OpenAlex10.3389/fsci.2024.1358784Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392707060
W4392699881The MIRD Schema for Radiopharmaceutical Dosimetry: A Review2024-03-12OpenAlex10.2967/jnmt.123.265668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392699881
W4392710898The emerging role of extracellular vesicles in bronchopulmonary dysplasia2024-03-12OpenAlex10.1152/ajplung.00244.2023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392710898
W4392747517Landiolol for Treating Arrhythmias: A State-of-The-Art Review2024-03-13OpenAlex10.1097/crd.0000000000000687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392747517
W4392741906Living ethics: a stance and its implications in health ethics2024-03-13OpenAlex10.1007/s11019-024-10197-9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392741906
W4392807425Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy2024-03-14OpenAlex10.5005/jp-journals-10005-2739Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392807425
W4392886223Klotho in pregnancy and intrauterine development—potential clinical implications: a review from the European Renal Association CKD-MBD Working Group2024-03-14OpenAlex10.1093/ndt/gfae066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392886223
W4392997099COMPARATIVE EVALUATION OF SEVOFLURANE AND ISOFLURANE IN FAST TRACK ANAESTHESIA FOR VALVULAR CARDIAC SURGERY: A RANDOMIZED STUDY2024-03-15OpenAlex10.22159/ijcpr.2024v16i2.4023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392997099
W4392889873Activated carbon nanoparticles generated from coffee husk: A pioneering biomaterial for improving drug targeting in cancer2024-03-16OpenAlex10.1016/j.nanoso.2024.101134Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392889873
W4392882692Epidemiology of perioperative anaphylaxis in France in 2017–2018: the 11th GERAP survey2024-03-16OpenAlex10.1016/j.bja.2024.01.044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4392882692
W4392968347103rd American Association for Thoracic Surgery Presidential Address: Dreamers and pragmatists: A story of our past, present, and future2024-03-18OpenAlex10.1016/j.jtcvs.2024.01.044Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392968347
W4394764315An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report2024-03-18OpenAlex10.1186/s13256-024-04422-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394764315
W4392916301Transformations in medical education: A prudential perspective2024-03-18OpenAlex10.1002/hcs2.86Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392916301
W4392949451Flushing and Blushing2024-03-19OpenAlex10.1002/9781119709268.rook104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392949451
W4392971397Resurgence and atypical patterns of pertussis in China2024-03-19OpenAlex10.1016/j.jinf.2024.106140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392971397
W4392966589Transcutaneous electrical nerve stimulation vs. H-Wave® device stimulation—similar or different?2024-03-19OpenAlex10.3389/fpain.2024.1321148Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4392966589
W4392972540Enhanced Compound Analysis Using Reactive Paper Spray Mass Spectrometry: Leveraging Schiff Base Reaction for Amino Acid Detection2024-03-20OpenAlex10.1021/acs.analchem.4c00215Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4392972540
W4396589586On Vili Lehdonvirta’s Cloud Empires: How Digital Platforms Are Overtaking the State and How We Can Regain Control , Cambridge, MA, MIT Press, 20222024-03-20OpenAlex10.1093/ser/mwae023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396589586
W4411310291Agentic AI-Powered Data Quality Guardians for Regulated Industries2024-03-21OpenAlex10.60087/jaigs.v3i1.378Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4411310291
W4393042174In Pursuit of Health Equity: A History of Latin American Social Medicine2024-03-21OpenAlex10.1215/00182168-11189730Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393042174
W4393040951Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview2024-03-21OpenAlex10.3390/hematolrep16010017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393040951
W4393046179The Impact of microRNA SNPs on Breast Cancer: Potential Biomarkers for Disease Detection2024-03-21OpenAlex10.1007/s12033-024-01113-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393046179
W4393096007Abstract 1230: MTX-531, a first-in-class pan-PI3K inhibitor spares hyperinsulinemia yielding durable tumor regressions and resilience to adaptive resistance2024-03-22OpenAlex10.1158/1538-7445.am2024-1230Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393096007
W4393072823Abstract 1750: Decoding breast cancer: Unraveling subtype and model differences through multi-model single-cell RNA sequencing data integration2024-03-22OpenAlex10.1158/1538-7445.am2024-1750Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393072823
W4393096169Abstract 2630: Identifying most promising combination therapies for immune suppressive breast cancer using a combined in vitro/in vivo approach2024-03-22OpenAlex10.1158/1538-7445.am2024-2630Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393096169
W4393088175Abstract 3044: Novel agents with efficacy against germline mutant RUNX1 familial platelet disorder with myeloid malignancy (FPD-MM)2024-03-22OpenAlex10.1158/1538-7445.am2024-3044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393088175
W4393093595Abstract 3470: Evaluation of the association between sickle cell disease and breast cancer using the All of Us Research Program dataset2024-03-22OpenAlex10.1158/1538-7445.am2024-3470Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393093595
W4393087488Deciphering the dynamics of methicillin-resistant Staphylococcus aureus biofilm formation: from molecular signaling to nanotherapeutic advances2024-03-22OpenAlex10.1186/s12964-024-01511-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393087488
W4393086775Revolutionizing Antibacterial Surfaces: 3D Printed Nanoscale and Microscale Topographies through Two-Photon Polymerization2024-03-22OpenAlex10.4028/p-9mqipbTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393086775
W4393127044Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia2024-03-24OpenAlex10.1182/bloodadvances.2024012577Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393127044
W4393153186Haemophilia care in Asia: Learning from clinical practice in some Asian countries2024-03-24OpenAlex10.1111/hae.14998Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393153186
W4393158299Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape2024-03-24OpenAlex10.3390/v16040498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393158299
W4396981082Therapeutic Efficacy of Cold Pressed Virgin Coconut Oil an Adjuvant to Conventional Therapy in Recurrent Aphthous Stomatitis -A Comparative Clinical Study2024-03-24OpenAlex10.33882/jida.15.35385Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396981082
W4393183326Erosive Lesions in the Legs of an Elderly Woman2024-03-26OpenAlex10.4103/ijd.ijd_851_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393183326
W4393201479Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review2024-03-26OpenAlex10.3390/cancers16071290Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393201479
W4393187156SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia2024-03-26OpenAlex10.1016/j.clml.2024.03.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393187156
W4393231871Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia2024-03-27OpenAlex10.1007/s11899-024-00731-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393231871
W4393246517Fate Took a Hand at Turning a Probing Mind to Oncology2024-03-27OpenAlex10.1097/01.cot.0001011480.13248.ecTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393246517
W4393280296New biologics for food allergy2024-03-28OpenAlex10.1097/aci.0000000000000981Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393280296
W4393280550Recent Advances in Material Technology for Leukemia Treatments2024-03-28OpenAlex10.1002/adma.202313955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393280550
W7216576415The Role of Radiologic Imaging in the Management of Sinusitis2024-03-28OpenAlex10.70082/axq05980Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216576415
W4401396533Antimicrobial resistance as a global public health threat: the way forward2024-03-29OpenAlex10.21303/2504-5695.2024.003336Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401396533
W4393332288Cardiomyopathies2024-03-29OpenAlex10.1016/b978-1-4557-0599-3.00057-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393332288
W4393314173Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives2024-03-29OpenAlex10.1186/s12951-024-02408-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393314173
W4393854310Topical retinoids: role and place in acne therapy2024-03-29OpenAlex10.30978/ujdvk2024-1-34Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393854310
W4404641266Rare Primary and Combined Immunodeficiency Disease: A Case Report from Paediatric Emergency Reception of Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India2024-03-30OpenAlex10.24321/24559318202401Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404641266
W4394722796Nano-Drone for T2 Turbo Spin Echo (TSE) MRI In Gastric Cancer Mice Model2024-03-31OpenAlex10.4283/jmag.2024.29.1.123Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394722796
W4394710133Abstracts of the Diabetes and Ramadan International Alliance (Virtual) Conference 2024, 12 to 13 January, 20242024-04-01OpenAlex10.1055/s-0044-1781437Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394710133
W4395014102Assessing the performance of ChatGPT in psychiatry: A study using clinical cases from foreign medical graduate examination (FMGE)2024-04-01OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_919_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395014102
W4396801382Baclofen Abuse: Better To Be Suspicious Than To Be Cheated2024-04-01OpenAlex10.4103/aip.aip_18_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396801382
W4404053592Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report2024-04-01OpenAlex10.1016/j.intf.2024.100025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404053592
W4396496093Current Perspectives on Small Bowel Tumors: Overview of Prevalence, Clinical Manifestations, and Treatment Approaches2024-04-01OpenAlex10.33192/smj.v76i4.267555Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396496093
W4393947753Dental management of people with complex or rare inherited bleeding disorders2024-04-01OpenAlex10.1111/hae.15005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393947753
W4393374783Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient2024-04-01OpenAlex10.1016/j.ijantimicag.2024.107163Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393374783
W4400896203Emerging Significance and Clinical Application of Liquid Biopsy in Early Diagnosis and Monitoring of Cancer2024-04-01OpenAlex10.4103/jss.jss_129_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400896203
W4400077717Fitting Things Together2024-04-01OpenAlex10.1215/00318108-11251691Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400077717
W7216923368Inflammatory Bowel Disease-An Updated Review From Pediatrics Aspects.2024-04-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216923368
W4395034631Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid2024-04-01OpenAlex10.1111/jcmm.18302Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4395034631
W4393393640Kinetic coevolutionary models predict the temporal emergence of HIV-1 resistance mutations under drug selection pressure2024-04-01OpenAlex10.1073/pnas.2316662121Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393393640
W4400047290Multiple Cerebral Infarctions after Treatment of Acquired Factor XIII Deficiency with Retroperitoneal Hematoma2024-04-01OpenAlex10.4103/jets.jets_7_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400047290
W4401920524Neuroatypical “Moving Mirrors”: exploring the impact of camera movements on individuals with Autism Spectrum Disorders without intellectual disabilities.2024-04-01OpenAlex10.1192/j.eurpsy.2024.357Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401920524
W4399878905New Music as Generalizable Tonal Predictions: Toward an Anti-Racist Framework2024-04-01OpenAlex10.1215/00222909-10974771Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399878905
W4395077519P024 Dermatomyositis, a blurred clinical picture2024-04-01OpenAlex10.1093/rheumatology/keae163.066Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395077519
W4395077102P122 Secular trends in prescription of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: Experience from a UK regional centre (2016-2022)2024-04-01OpenAlex10.1093/rheumatology/keae163.163Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395077102
W4393385972Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders2024-04-01OpenAlex10.1001/jamaneurol.2024.0586Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393385972
W4393389748Supporting Convergence Science2024-04-01OpenAlex10.1158/0008-5472.can-24-0618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393389748
W4395001749The evolving treatment landscape for BRAF-mutated non-small cell lung cancer2024-04-01OpenAlex10.21037/tlcr-24-117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395001749
W4394894343Transcatheter Aspiration and Mechanical Embolectomy of an Intracardiac Mass2024-04-01OpenAlex10.1016/j.jaccas.2024.102251Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394894343
W4396968605USE OF SGLT2–INHIBITORS IN THE TREATMENT OF ANTHRACICLINE CARDIOTOXICITY2024-04-01OpenAlex10.1093/eurheartjsupp/suae036.433Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396968605
W4393929794Endovascular embolization by a magnetic microfiberbot2024-04-03OpenAlex10.1093/nsr/nwae117Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393929794
W4393987184The Sum of All Fears: the Figure of the Anti/Metaphysical Jew in Heidegger’s Black Notebooks (and beyond)2024-04-03OpenAlex10.1163/1477285x-12341354Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4393987184
W4393985108Coalition of social learning and implementation theory in a federated model to advance practice change2024-04-04OpenAlex10.1111/wvn.12723Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393985108
W4393941185Editorial Comment to Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer2024-04-04OpenAlex10.1111/iju.15458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393941185
W4400402565Evolution of In-vitro Diagnostics Methods2024-04-04OpenAlex10.60142/ijhti.v3i01.01Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400402565
W4393946658Oral Psoriasis Therapies2024-04-04OpenAlex10.1016/j.det.2024.02.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393946658
W4393932047Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments2024-04-04OpenAlex10.3390/cancers16071414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393932047
W4393987171Integrating reinforcement learning and serious games to support people with rare genetic diseases and neurodevelopmental disorders: outcomes on parents and caregivers2024-04-05OpenAlex10.3389/fpsyg.2024.1372769Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4393987171
W4394012736Spectral Diffusion Analysis in Patients With High Risk for Prostate Cancer: A Feasibility Study2024-04-05OpenAlex10.1002/jmri.29354Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394012736
W4393982625Stereotactic Neurosurgery: Deep Brain Stimulation, Focused Ultrasound, Therapeutic Radiosurgery, and Biological Therapies2024-04-05OpenAlex10.1016/b978-0-323-93273-8.00018-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393982625
W4393986291The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults2024-04-05OpenAlex10.3389/fimmu.2024.1378432Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4393986291
W4394573723Increase in the Number of Medical Requests for D-dimer during the First Wave of COVID-19: A Case Study of a University Hospital in the Metropolitan Region of the State of Rio de Janeiro2024-04-06OpenAlex10.9734/bpi/rudhr/v5/3328gTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394573723
W4394579074Responsive Supramolecular Polymers for Diagnosis and Treatment2024-04-06OpenAlex10.3390/ijms25074077Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394579074
W4403161553Sexually transmitted infections (STIs)/HIV linked to human papillomavirus (HPV) in precancerous lesions in Cameroonian women2024-04-06OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403161553
W4394571992Investigating How the Properties of Electrospun Poly(lactic acid) Fibres Loaded with the Essential Oil Limonene Evolve over Time under Different Storage Conditions2024-04-07OpenAlex10.3390/polym16071005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394571992
W4394060979Nitric oxide regulation of fetal and newborn lung development and function2024-04-07OpenAlex10.1016/j.niox.2024.04.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394060979
W4394571688Essential thrombocythaemia: A contemporary approach with new drugs on the horizon2024-04-08OpenAlex10.1111/bjh.19403Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394571688
W4394615531Progress in research and treatment of immune checkpoints in breast cancer2024-04-08OpenAlex10.32948/ajo.2024.04.06Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394615531
W4394602690Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review2024-04-09OpenAlex10.1177/10781552241247007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394602690
W4394598240Electro-clinical Variables Associated with Clobazam Response in Adults Presenting with Refractory Status Epilepticus: A Retrospective Study (P9-1.005)2024-04-09OpenAlex10.1212/wnl.0000000000205419Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394598240
W4394855560Guillain-Barré Syndrome in a Patient Receiving Anti-Tumor Necrosis Factor for Crohn Disease: Coincidence or Consequence?2024-04-09OpenAlex10.12659/ajcr.943709Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394855560
W4400728410Navigating the future of genitourinary cancer treatment: a decade of progress in image-guided surgery2024-04-09OpenAlex10.1097/js9.0000000000001438Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400728410
W4394599058Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort (P10-14.010)2024-04-09OpenAlex10.1212/wnl.0000000000204954Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394599058
W4394683481Amphotericin B in the Era of New Antifungals: Where Will It Stand?2024-04-10OpenAlex10.3390/jof10040278Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394683481
W4394719740Platelet Function in Mood Disorders: Interplay, Clinical Implications, and Future Perspectives – A Narrative Review2024-04-10OpenAlex10.4103/hm.hm-d-23-00066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394719740
W4394687232Rare genetic skeletal disorders: Evolving terminology, therapies, education and advocacy2024-04-10OpenAlex10.1016/j.jposna.2024.100057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394687232
W4394692587‘It's like getting an Uber for sex’: social networking apps as spaces of risk and opportunity in the Philippines among men who have sex with men2024-04-10OpenAlex10.4324/9781032716855-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394692587
W4394755169Chemical Strategies for the Detection and Elimination of Senescent Cells2024-04-11OpenAlex10.1021/acs.accounts.3c00794Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394755169
W4394720828Dupilumab improves congenital ichthyosis2024-04-11OpenAlex10.1111/ddg.15358Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394720828
W4394727612Metaverse: a new reality in surgery. Review2024-04-11OpenAlex10.17816/psaic1774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394727612
W7166444725Advancements in Multiple Sclerosis Research: From Pathogenesis to Novel Therapeutic Strategies2024-04-12OpenAlex10.61096/ijrpp.v13.iss2.2024.54-62Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166444725
W4394741713Reinforcement Learning in Healthcare2024-04-12OpenAlex10.1002/9781394214068.ch15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394741713
W4394810127Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors2024-04-15OpenAlex10.1186/s12935-024-03315-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394810127
W4394834842Database Decomposition to satisfy the Least Privilege Principle in Healthcare2024-04-15OpenAlex10.56394/aris2.v4i1.43Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394834842
W4394820383Evolving Understanding of Patients’ Experiences in Acute Care Trials Without Prospective Consent*2024-04-15OpenAlex10.1097/ccm.0000000000006221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394820383
W4396230980Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry2024-04-15OpenAlex10.3390/books978-3-7258-0860-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396230980
W4394823995The application of antibody-based agents in cancer therapy based on their mechanisms of action2024-04-15OpenAlex10.1016/j.fmre.2024.02.021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394823995
W4394884838Bonding Performance of Universal Adhesive in Different Etching Modes: A Review2024-04-16OpenAlex10.52403/ijhsr.20240446Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394884838
W4394853364Editorial: Small molecules and smart drug delivery systems for combination cancer immunotherapy2024-04-16OpenAlex10.3389/fchem.2024.1412624Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394853364
W4394796410Essential oils for clinical aromatherapy: A comprehensive review2024-04-16OpenAlex10.1016/j.jep.2024.118180Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394796410
W4394840568Microsoft AI Expert: APA, MH Professionals Must Help Guide Future of AI and Mental Health2024-04-16OpenAlex10.1176/appi.pn.2024.05.5.10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394840568
W4394846837Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs2024-04-16OpenAlex10.1177/03008916241246659Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394846837
W4394933525Care of the critically ill begins in the emergency medicine setting2024-04-17OpenAlex10.1097/mej.0000000000001134Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394933525
W4394874515Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted Mycobacterium abscessus isolates2024-04-17OpenAlex10.1073/pnas.2403206121Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394874515
W4394903386Rethinking European Integration in Times of Crisis2024-04-17OpenAlex10.5406/23300841.69.2.06Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4394903386
W4394879091The Outcomes of Biologic Therapies for Fistulizing Crohn's Disease: A Systematic Review2024-04-17OpenAlex10.9734/jammr/2024/v36i55434Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394879091
W4394975806Real World Experience of the First Cardio-Oncology Unit Implantation in Morocco2024-04-20OpenAlex10.9734/ca/2024/v13i2406Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4394975806
W4395008750A Novel Pan-Proteome Array for High-Throughput Profiling of the Humoral Response to Treponema pallidum subsp. pallidum : a Pre-Clinical Study2024-04-21OpenAlex10.1101/2024.04.20.590429Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4395008750
W4395695860Advancements in immunotherapy for glomerulonephritis: promising treatments on the horizon2024-04-22OpenAlex10.47391/jpma.10666Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395695860
W4395005797Focus on current and emerging treatment options for glioma: A comprehensive review2024-04-22OpenAlex10.5306/wjco.v15.i4.482Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395005797
W4395020302Global Use of Cryopreserved Platelets2024-04-22OpenAlex10.17945/kjbt.2024.35.1.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395020302
W4394994129Kennedy Terminal Ulcers and Trombley-Brennan Terminal Tissue Injuries: Mystery Solved?2024-04-22OpenAlex10.1097/asw.0000000000000132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4394994129
W4395045826The current landscape for diabetes treatment: Preventing diabetes-associated CV risk2024-04-22OpenAlex10.1016/j.atherosclerosis.2024.117560Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395045826
W4403034264Comparative Efficacy of 2% Hyperbaric Prilocaine vs 0.5% Hyperbaric Bupivacaine in Spinal Anesthesia for Urologic Endoscopy Procedures2024-04-23OpenAlex10.17116/pain20242203119Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403034264
W4395048816Contrast transthoracic echocardiography in a patient with drug‐induced hypersensitivity syndrome with right atrial thrombus: A case report and mini review2024-04-23OpenAlex10.1002/pdi3.52Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395048816
W4395052228Engineered extracellular vesicles for cancer drug delivery and therapeutics2024-04-23OpenAlex10.1016/j.cophys.2024.100755Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395052228
W4395043095Investigational drugs for the treatment of acromegaly: new agents to transform therapy2024-04-23OpenAlex10.1080/13543784.2024.2343056Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4395043095
W4395116315Pseudoaneurysm formation following transarterial embolization of traumatic carotid-cavernous fistula with detachable balloon: An institutional cohort long-term study2024-04-24OpenAlex10.4329/wjr.v16.i4.94Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395116315
W4395068084Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study2024-04-24OpenAlex10.1007/s12325-024-02825-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395068084
W4395463712Genomic surveillance and pathogen intelligence2024-04-25OpenAlex10.3389/fsci.2024.1397048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395463712
W4395455414Severe cutaneous adverse reactions2024-04-25OpenAlex10.1038/s41572-024-00514-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395455414
W4395464182The new SH3_T domain increases the structural and functional variability among SH3b-like CBDs from staphylococcal phage endolysins2024-04-25OpenAlex10.1101/2024.04.22.590666Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4395464182
W4395467740Updates in the Management of Crohn's Disease2024-04-25OpenAlex10.1055/s-0044-1786382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395467740
W4395447651What’s New in Spine Surgery2024-04-25OpenAlex10.2106/jbjs.24.00133Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395447651
W4395665919Advancements in Reinforcement Learning2024-04-26OpenAlex10.48175/ijarsct-17820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395665919
W4395666708Anti-inflammatory and anti-diabetic properties of indanone derivative isolated from Fernandoa adenophylla in vitro and in silico studies2024-04-26OpenAlex10.1038/s41598-024-59703-2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4395666708
W4395668839Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective2024-04-26OpenAlex10.1186/s11658-024-00571-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395668839
W7135330925Health Effects of High Radon Environments in Central Europe2024-04-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135330925
W4395666880Infectious complications before and after pediatric liver transplantation2024-04-26OpenAlex10.1201/9781003341741-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395666880
W4395674649Journal of Population and Therapeutics and Clinical Pharmacology2024-04-26OpenAlex10.53555//jptcp.v29i04.5961Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395674649
W4395702042Chikungunya Seroprevalence among Patients Presenting with Febrile illnesses in selected health facilities in Mt. Elgon region, Kenya2024-04-27OpenAlex10.1101/2024.04.26.24306414Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4395702042
W4396220378Clinical Theranostics in Recurrent Gliomas: A Review2024-04-28OpenAlex10.3390/cancers16091715Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396220378
W4396217159Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion2024-04-28OpenAlex10.3390/biology13050307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396217159
W4395957116Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials2024-04-28OpenAlex10.1016/j.clinre.2024.102357Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4395957116
W4396222413A New Therapeutic Approach Utilizes Probiotics, Prebiotics, Synbiotics, Postbiotics, and Gut Microbiota2024-04-29OpenAlex10.20944/preprints202404.1866.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396222413
W4396231581Alpha and Beta Radiation for Theragnostics2024-04-29OpenAlex10.1016/j.cpet.2024.03.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396231581
W4396212909Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology2024-04-29OpenAlex10.1159/000539075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396212909
W4396231607EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer2024-04-29OpenAlex10.1016/j.eururo.2024.04.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396231607; https://openalex.org/W7212033222
W4396617110Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma—A Literature Review2024-04-29OpenAlex10.3390/curroncol31050188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396617110
W4396569073Advancements in understanding and addressing Alzheimer's disease: a comprehensive review2024-04-30OpenAlex10.18203/2320-6012.ijrms20241276Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396569073
W4396497972Editorial: Future research questions for improving COPD diagnosis and care2024-04-30OpenAlex10.3389/fmed.2024.1411350Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396497972
W4396528145Editorial: Neglected tropical diseases: tackling the challenges of a global world2024-04-30OpenAlex10.3389/ftox.2024.1417438Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396528145
W4396518098Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology2024-04-30OpenAlex10.1016/j.esmoop.2024.103005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396518098
W4396508390Innovations in Peripheral Nerve Regeneration2024-04-30OpenAlex10.3390/bioengineering11050444Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396508390
W4398235135#1193 Tracking kidney cancer initiation via somatic mutation analysis of pre-cancer cells from Von Hippel Lindau cancer predisposition syndrome2024-05-01OpenAlex10.1093/ndt/gfae069.122Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4398235135
W4398756018#2168 Lupus nephritis histopathological classification system: a questionnaire-based survey of the Renal Pathology Society (RPS)2024-05-01OpenAlex10.1093/ndt/gfae069.326Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398756018
W4398232439#2659 Clinical characteristics of patients with minimal change disease (MCD) that evolved to focal sclerosing glomerulosclerosis (FSGS)2024-05-01OpenAlex10.1093/ndt/gfae069.1272Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4398232439
W4398233924#2982 Shifts in SGLT2 inhibitor initiation in CKD non-dialysis patients2024-05-01OpenAlex10.1093/ndt/gfae069.1505Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398233924
W4397007007291P Perceptions of antibody drug conjugate (ADC)-induced nausea and vomiting: Results of a survey of healthcare providers at ESMO2024-05-01OpenAlex10.1016/j.esmoop.2024.103348Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397007007
W4396703565A review of recent advances in the use of complex metal nanostructures for biomedical applications from diagnosis to treatment2024-05-01OpenAlex10.1002/wnan.1959Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396703565
W4403387187Actualizaciones clínicas en enfermedades pulmonares intersticiales: estrategias diagnósticas y terapéuticas avanzadas2024-05-01OpenAlex10.1016/j.rmclc.2024.05.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403387187
W4399648443Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections2024-05-01OpenAlex10.1002/jcla.25071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399648443
W4399385454Artificial intelligence and assisted reproductive technology: Applying a reproductive justice lens2024-05-01OpenAlex10.1177/13505068241258053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399385454
W4398784513British HIV Association guidelines on the management of opportunistic infection in people living with HIV : The clinical management of pulmonary opportunistic infections 20242024-05-01OpenAlex10.1111/hiv.13637Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398784513
W4396801043Comparative evaluation of remineralization potential of novel bioactive agents on eroded enamel lesions: A single-blinded in vitro study2024-05-01OpenAlex10.4103/jcde.jcde_62_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396801043
W4396598410Enhancing children's participation in dental research: A commentary2024-05-01OpenAlex10.1111/cdoe.12970Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396598410
W4400292268Identification of Circular Patterns in Capsule Endoscopy Bubble Frames2024-05-01OpenAlex10.4103/jmss.jmss_50_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400292268
W4401432341Oncogenic Driver Mutations in Nonsmall Cell Lung Cancer2024-05-01OpenAlex10.4103/pulmon.pulmon_20_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401432341
W4396573738P58 An antiviral dilemma -- reflections on the pocapavir predicament2024-05-01OpenAlex10.1136/bmjpo-2024-nppg.68Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396573738
W4396561140Pediatric Pulmonary Hypertension2024-05-01OpenAlex10.1542/pir.2023-006010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396561140
W4406310622Role of co-trimoxazole in current medical practice2024-05-01OpenAlex10.4103/kleuhsj.kleuhsj_571_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406310622
W4396591185Abstract PO2-10-08: Contemporary HER2-Positive MBC Treatment Recommendations Among Community Healthcare Professionals: Analysis of an Online Interactive Decision Support Tool2024-05-02OpenAlex10.1158/1538-7445.sabcs23-po2-10-08Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396591185
W4396587707Abstract PO2-17-01: Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2– advanced breast cancer: Final analysis of TreatER+ight, a Canadian prospective, real-world, observational study2024-05-02OpenAlex10.1158/1538-7445.sabcs23-po2-17-01Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396587707
W4396587570Abstract PO2-20-10: Exceptional long-term disease control on pembrolizumab monotherapy in a patient with TMB-high PMS2-mutated MMR-deficient triple negative breast cancer brain metastasis2024-05-02OpenAlex10.1158/1538-7445.sabcs23-po2-20-10Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396587570
W4396588269Abstract PO3-13-07: MUC1-C INTEGRATES CHRONIC ACTIVATION OF INTERFERON PATHWAYS WITH CHROMATIN REMODELING IN TREATMENT RESISTANCE OF TRIPLE-NEGATIVE BREAST CANCER2024-05-02OpenAlex10.1158/1538-7445.sabcs23-po3-13-07Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4396588269
W4396588733Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon2024-05-02OpenAlex10.1080/17474086.2024.2350528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396588733
W4396577198Biomaterials-mediated radiation-induced diseases treatment and radiation protection2024-05-02OpenAlex10.1016/j.jconrel.2024.04.044Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396577198
W4396597152Effectiveness of CAR-T treatment toward the potential risk of second malignancies2024-05-02OpenAlex10.3389/fimmu.2024.1384002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396597152
W4396577541Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US2024-05-02OpenAlex10.1001/jamanetworkopen.2024.9417Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396577541
W4396622858mRNA-based therapeutic strategies for cancer treatment2024-05-02OpenAlex10.1016/j.ymthe.2024.04.035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396622858
W4396613261A Review on Pharmacological Advancement of Ellagic Acid2024-05-03OpenAlex10.1177/0976500x241240634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396613261
W4396641162A modular simulation framework for organ allocation2024-05-03OpenAlex10.1016/j.healun.2024.04.063Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396641162
W4396601853Application of Smart Materials in Dental Sciences2024-05-03OpenAlex10.1002/9781394186488.ch4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396601853
W4396624115Evolving Characteristics of Gadolinium‐Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity2024-05-03OpenAlex10.1002/jmri.29367Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4396624115
W4396604365Neuroendovascular Rescue 20252024-05-03OpenAlex10.1016/j.ncl.2024.03.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396604365
W4396606872Outcomes of Monoclonal Antibody Use in Patients with COVID-19 (Preprint)2024-05-03OpenAlex10.2196/preprints.60175Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396606872
W4396623814Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors2024-05-03OpenAlex10.3390/pharmaceutics16050616Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396623814
W4396605818The evolving treatment landscape of metastatic urothelial cancer2024-05-03OpenAlex10.1038/s41585-024-00872-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396605818
W4396640052Evaluating osteoporosis and bone quality in the aging spine: modern considerations for surgical management in the geriatric population2024-05-04OpenAlex10.1007/s11357-024-01171-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396640052
W4396641648Harnessing Metal Nanoparticles: Revolutionizing Cancer Therapy Through Targeted Drug Delivery and Tumor Microenvironment Modulation2024-05-04OpenAlex10.1142/s1793292024300081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396641648
W4396634090Real-time and high-sensitive colorimetric sensor based on photonic crystal for amniotic fluid identification2024-05-04OpenAlex10.1016/j.microc.2024.110691Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396634090
W4399291302Clinical Insights and Therapeutic Advancements: The Evolving Role of Magaldrate in Gastrointestinal Health2024-05-05OpenAlex10.21275/sr24314180539Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399291302
W4396673253Comparative Analysis of the Medical Equipment Management Process in Colombo Gampaha and Kaluthara Districts2024-05-06OpenAlex10.4038/sljma.v24i2.5433Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396673253
W4396676305Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome2024-05-06OpenAlex10.1007/s11926-024-01150-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396676305
W4396705763Cancer drugs and acute kidney injury: new therapies and new challenges2024-05-07OpenAlex10.1097/mnh.0000000000001001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396705763
W4396699972DEPLOYING ARTIFICIAL INTELLIGENCE INTO DAILY LIFE: ARTIFICIAL INTELLIGENCE FOR CYBER SECURITY WITH MORE OPPORTUNITIES2024-05-07OpenAlex10.58532/nbennurch336Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4396699972
W4396700370Editorial: Combinational therapy and nanotechnologies in combating pathogenic microbes and antibiotic resistance2024-05-07OpenAlex10.3389/fphar.2024.1406043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396700370
W4396865966Focus on ischaemic heart disease: prevention with colchicine, role of the brain–heart axis, new therapeutic targets for ischaemia–reperfusion injury2024-05-07OpenAlex10.1093/eurheartj/ehae270Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396865966
W4396694000GOLDIC Therapy Holds Promise as an Orthobiologic Agent: A Systematic Review of the Literature2024-05-07OpenAlex10.1007/s43465-024-01167-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396694000
W4396693494Real‐world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab2024-05-07OpenAlex10.1111/jdv.20066Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396693494
W4402513718Advancing cervical cancer treatment: integrating immunotherapy with chemoradiotherapy2024-05-08OpenAlex10.1097/io9.0000000000000059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402513718
W4396720244CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024-05-08OpenAlex10.1158/1078-0432.ccr-24-0562Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4396720244
W4396812850Exploring the Applications of Complex Adaptive Systems in the Real World: A Review2024-05-08OpenAlex10.2174/9789815179606124010009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396812850
W4396758990Léiomyosarcome portal : une localisation extrêmement rare !2024-05-08OpenAlex10.1016/j.ancard.2024.101759Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396758990
W43967792313D bioprinted microneedles: merging drug delivery and scaffold science for tissue-specific applications2024-05-09OpenAlex10.1080/17425247.2024.2351928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396779231
W4396811386Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease2024-05-09OpenAlex10.1111/bjh.19519Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4396811386
W7218071207Complete Pathological Response in Advanced Hepatocellular Carcinoma: Be Brave2024-05-09OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218071207
W4396766573FcRn Inhibitor Therapies in Neurologic Diseases2024-05-09OpenAlex10.1007/s40263-024-01090-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396766573
W4396760266From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications2024-05-09OpenAlex10.1186/s11671-024-04021-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396760266
W4396948232Blastocystis hominis-associated Acute Appendicular Peritonitis in a 9-Year-old Boy: A Case Report and a Comprehensive Review of the Literature2024-05-10OpenAlex10.1097/inf.0000000000004396Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396948232
W4396837467Mechanistic and Clinical Chemoprevention2024-05-10OpenAlex10.1016/b978-0-323-95488-4.00058-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396837467
W4396806733Report on Mortalities of Nile Tilapia (Oreochromis niloticus) Due to Tilapinevirus tilapiae and Co-infecting Bacteria in Winter Season2024-05-10OpenAlex10.18805/ijar.b-5297Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4396806733
W4399542955Severe cases of SARS-CoV-2 in individuals with alcoholic liver disease and cirrhosis: Understanding the impediments to intensive care unit ventilation2024-05-10OpenAlex10.52768/jjgastro/1199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399542955
W4396869140A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection2024-05-12OpenAlex10.7759/cureus.60173Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396869140
W4396859608Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma2024-05-12OpenAlex10.3390/cancers16101852Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396859608
W4401231277Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate2024-05-13OpenAlex10.1093/jac/dkae158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401231277
W4396874003Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities2024-05-13OpenAlex10.1016/j.tips.2024.04.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396874003
W4396869800Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics2024-05-13OpenAlex10.31237/osf.io/ndsq5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396869800; https://openalex.org/W4403251548; https://openalex.org/W4401507524; https://openalex.org/W4399033746; https://openalex.org/W4400486943; https://openalex.org/W4401507150; https://openalex.org/W4406231709; https://openalex.org/W4409112112
W4401766862Quality Indicators Common to All Gastrointestinal Endoscopic Procedures2024-05-13OpenAlex10.14309/ajg.0000000000002988Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401766862
W4396901790Research hotspots and trends in biological agents for psoriasis: Visualization and bibliometric analysis2024-05-13OpenAlex10.1016/j.heliyon.2024.e31054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396901790
W4396857683Unraveling TAFRO Syndrome: An In-Depth Look at the Pathophysiology, Management, and Future Perspectives2024-05-13OpenAlex10.3390/biomedicines12051076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396857683
W4396898626Bibliometric Analysis of Clinical Trials on the Effect of Sugar Alcohol Consumption on Oral Health: Trends, Insights, and Future Directions (1967-2024)2024-05-14OpenAlex10.7759/cureus.60248Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396898626
W4396902620Bringing global hematology research to the forefront2024-05-14OpenAlex10.1182/bloodadvances.2023011873Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396902620
W4396886577Recent advances in interventional cardiology for coronary artery disease: a systematic literature review2024-05-14OpenAlex10.51798/sijis.v5isi1.767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396886577
W4396894102The times are changing: A primer on novel clinical trial designs and endpoints in critical care research2024-05-14OpenAlex10.1093/ajhp/zxae134Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396894102
W4396917490Breast Cancer Brain Metastasis: A Comprehensive Review2024-05-15OpenAlex10.1200/op.23.00794Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396917490
W4396937332CATH-2-derived antimicrobial peptide inhibits multidrug-resistant Escherichia coli infection in chickens2024-05-15OpenAlex10.3389/fcimb.2024.1390934Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4396937332
W4396935697Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers2024-05-15OpenAlex10.1016/j.critrevonc.2024.104388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396935697
W4402514497Enhancing surgical safety: the promise of plastic wound protectors in reducing surgical site infections in open abdominal surgeries2024-05-15OpenAlex10.1097/io9.0000000000000086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402514497
W4396962685Octreotide versus Terlipressin as Adjuvant to Endoscopic Variceal Band Ligation in Bleeding Oesophageal Varices: A Systematic Review and Meta-Analysis2024-05-15OpenAlex10.3390/gastroent15020028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396962685
W7132521793Ultragarsas su kontrastu2024-05-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132521793
W4396950489A predictive algorithm for the analysis of AMR trends and healthcare decision support2024-05-16OpenAlex10.12688/wellcomeopenres.21289.1Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4396950489
W4396978916A universal preference for animate agents in hominids2024-05-16OpenAlex10.1016/j.isci.2024.109996Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4396978916
W4396952426Emerging treatments in HER2-positive advanced breast cancer: Keep raising the bar2024-05-16OpenAlex10.1016/j.xcrm.2024.101575Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4396952426
W4396951441The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer2024-05-16OpenAlex10.1016/j.ctrv.2024.102761Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4396951441
W4397012842Abstract IA016: The evolving role of immune-based treatment strategies in metastatic urothelial cancer2024-05-17OpenAlex10.1158/1557-3265.bladder24-ia016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4397012842
W4397000035Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa2024-05-17OpenAlex10.1016/j.jid.2024.04.013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4397000035
W4397016795Virtual health assistants: a grand challenge in health communications and behavior change2024-05-17OpenAlex10.3389/fdgth.2024.1418695Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4397016795
W4397038890First study with positive cardiovascular outcome in obesity: Reflections on SELECT2024-05-18OpenAlex10.1002/agm2.12300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4397038890
W4397031223Safety of tofacitinib in IBD: A tricky puzzle2024-05-18OpenAlex10.1002/ueg2.12587Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4397031223
W4397040060Urban people’s preferences for life-sustaining treatment or artificial nutrition and hydration in advance decisions2024-05-18OpenAlex10.1186/s12910-024-01060-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4397040060
W4397288956Panoramic view of artificial fruit ripening agents sensing technologies and the exigency of developing smart, rapid, and portable detection devices: A review2024-05-19OpenAlex10.1016/j.cis.2024.103199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4397288956
W4398142342Current understanding and management of CAR T cell-associated toxicities2024-05-20OpenAlex10.1038/s41571-024-00903-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398142342
W4398132593Editorial: Urological cancer awareness month – 20222024-05-20OpenAlex10.3389/fruro.2024.1278688Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398132593
W4398174265Heartfelt Healing: Charting New Trajectories in Postsurgical Pain2024-05-20OpenAlex10.1213/ane.0000000000006871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398174265
W4398131334IMPROVEMENT OF CAPILLAROSCOPY METHOD FOR STUDYING HUMAN MICROCIRCULATION2024-05-20OpenAlex10.31718/2077-1096.24.2.257Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398131334
W4407712937Nanocellulose for Sustainable Future Materials2024-05-20OpenAlex10.62422/978-81-970328-7-5-019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407712937
W4398169305Painful Yellow-White Nodules Over Feet in an Alcoholic Male2024-05-20OpenAlex10.4103/idoj.idoj_588_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398169305
W4398182649A guide to prescribing systemic treatments for psoriasis during pregnancy, breastfeeding and in those trying to conceive: what does the current evidence suggest?2024-05-21OpenAlex10.1093/ced/llae209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398182649
W4398169320Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?2024-05-21OpenAlex10.1080/17474086.2024.2357274Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398169320
W4398175879Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review2024-05-21OpenAlex10.21037/cco-23-140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398175879
W4398184113Use of topical methylene blue to image nuclear morphometry with a low-cost scanning darkfield microendoscope2024-05-21OpenAlex10.1117/1.jbo.29.5.050501Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398184113
W4398205666Evolving or immutable - phase I solid tumor trials in the era of precision oncology2024-05-22OpenAlex10.1007/s10637-024-01445-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398205666
W4398204506Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options2024-05-22OpenAlex10.3390/ijms25115640Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398204506
W4398254453Moving the needle for oncology dose optimization: A call for action2024-05-22OpenAlex10.1002/psp4.13157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398254453; https://openalex.org/W4396869858
W4398211556Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges2024-05-22OpenAlex10.4254/wjh.v16.i5.731Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398211556
W4399123611Advances in Interferon Therapy for Myeloproliferative Neoplasms2024-05-23OpenAlex10.1097/01.cot.0001024068.38723.15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399123611
W4398241141COVID-19: the renaissance of science in the face of adversity2024-05-23OpenAlex10.3389/fsci.2024.1419497Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398241141
W3035534707Comparison of antimicrobial susceptibility testing practices in 20 clinical microbiology laboratories in India2024-05-23OpenAlex10.4103/jacm.jacm_15_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W3035534707
W4398252927Decontaminants Used After Biorisk Material Decontamination: Environmental Impact and the Role of Drones in Detection and Remediation of Resistance in Ecosystems2024-05-23OpenAlex10.58769/joinssr.1379496Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398252927
W3130263631Editorial on antibiotic susceptibility testing2024-05-23OpenAlex10.4103/jacm.jacm_14_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W3130263631
W4398235982Editorial: 2022 in review: allergen immunotherapy2024-05-23OpenAlex10.3389/falgy.2024.1431413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398235982
W4398780615Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases2024-05-23OpenAlex10.1002/ird3.77Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398780615
W4398267803Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?2024-05-23OpenAlex10.1093/jnci/djae099Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398267803
W4398247096Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer2024-05-23OpenAlex10.1200/edbk_438598Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4398247096
W4398267792Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings2024-05-23OpenAlex10.3324/haematol.2023.283682Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398267792
W4398763615Evaluation of type 1 diabetes’ partial clinical remission after three years of heterologous adipose tissue derived stromal/stem cells transplantation associated with vitamin D supplementation2024-05-24OpenAlex10.1186/s13098-024-01302-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4398763615
W4398767383Exploring Acute Kidney Injury Following Aortic Dissection2024-05-24OpenAlex10.1097/crd.0000000000000717Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398767383
W4399088753Exploring Nature's Pharmacy: A Comprehensive Review of Natural Products as Potential Sources of Therapeutic Agents2024-05-24OpenAlex10.46610/rrddd.2024.v06i01.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399088753
W4398765703United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 20232024-05-24OpenAlex10.1016/j.clon.2024.04.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398765703
W4399095709A Comprehensive Review on Evolving Landscape of Drug Therapies for Diabetes2024-05-25OpenAlex10.9734/bpi/mria/v4/11972fTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399095709
W4399051956Dedication: JBMR‐A special edition recognizing James M. Anderson, M.D., Ph.D.2024-05-26OpenAlex10.1002/jbm.a.37733Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399051956
W4399029949Middle Eastern Expert Opinion: Strategies for Successful Antifungal Stewardship Program Implementation in Invasive Fungal Infections2024-05-26OpenAlex10.7759/cureus.61127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399029949
W4399027514New therapies for unresectable or metastatic cutaneous eyelid and orbital melanoma2024-05-26OpenAlex10.1080/01676830.2024.2351514Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399027514
W4404043317Challenges with Bruton’s Tyrosine Kinase Inhibitors Treatment2024-05-27OpenAlex10.19080/ctoij.2024.27.556203Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404043317
W4399036015Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review2024-05-27OpenAlex10.1016/j.semarthrit.2024.152478Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399036015
W4399054612The physiology of evolution2024-05-27OpenAlex10.1113/jp284432Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399054612
W4399087787Correlation between Genomic Variants and Worldwide COVID-19 Epidemiology2024-05-28OpenAlex10.3390/jpm14060579Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399087787
W4399079777Immunotherapy in Colorectal Cancer — Finding the Achilles’ Heel2024-05-28OpenAlex10.1056/evidra2300353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399079777
W4399076497Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals2024-05-28OpenAlex10.1080/27697061.2024.2359084Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399076497
W4399101368Rho-Associated Protein Kinase Inhibitors and Primary Open-Angle Glaucoma2024-05-28OpenAlex10.1201/9781003522980-19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399101368
W4399091919Safe Administration of Medication in School: Policy Statement2024-05-28OpenAlex10.1542/peds.2024-066839Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399091919
W4399077767Supplements and Performance-Enhancing Agents2024-05-28OpenAlex10.1201/9781003525561-7Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399077767
W4401367441The Science behind Ashwagandha: A Review of its Therapeutic Potential2024-05-28OpenAlex10.52711/0975-4385.2024.00022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401367441
W4399093473When Should I Consider Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity?2024-05-28OpenAlex10.1201/9781003523703-49Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399093473
W4399077263Which Vaccines Should Patients With IBD Receive?2024-05-28OpenAlex10.1201/9781003523567-51Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399077263
W4399118477Contemporary management of patients with advanced melanoma: Utility of an online interactive decision support tool to assess concordance of healthcare professional treatment patterns with expert recommendations.2024-05-29OpenAlex10.1200/jco.2024.42.16_suppl.e13548Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399118477
W4399118501Opportunity cost of oncology subspecialist opinion.2024-05-29OpenAlex10.1200/jco.2024.42.16_suppl.e13578Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399118501
W4399139847Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma2024-05-29OpenAlex10.2174/0115665232305905240521081553Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399139847
W4399186145Editorial: Editor’s challenge in medical physics and imaging: quantitative medical imaging2024-05-30OpenAlex10.3389/fphy.2024.1434129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399186145
W4399166529Immunomodulators2024-05-30OpenAlex10.1201/9781003523017-19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399166529
W4399156690Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review2024-05-30OpenAlex10.1080/14737140.2024.2362192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399156690
W4399154984Physiologic Monitors and Patient Support Equipment2024-05-30OpenAlex10.4324/9781003522485-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399154984
W4399176411The evolving landscape of tissue‐agnostic therapies in precision oncology2024-05-30OpenAlex10.3322/caac.21844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399176411
W4399157357The role of immunotherapy in urological cancers2024-05-30OpenAlex10.4081/aiua.2024.12307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399157357
W4399181395Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome2024-05-30OpenAlex10.1007/s11864-024-01217-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399181395
W439920330928 Comparative analysis of the medical equipment management process in Colombo Gampaha and Kaluthara districts in Sri Lanka2024-05-31OpenAlex10.1136/leader-2024-fmlm.28Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399203309
W4399204785Bispecific and multispecific antibodies in oncology: opportunities and challenges2024-05-31OpenAlex10.1038/s41571-024-00905-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399204785
W4399215885Editorial: Metallodrugs in cancer therapy: past, present and new strategies2024-05-31OpenAlex10.3389/fchem.2024.1428502Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399215885
W4399199518‘The Doctor in Search of Herself’: women doctors’ autobiographies, second wave feminism, and the feminist women’s health movement, 1976-19872024-05-31OpenAlex10.1136/medhum-2023-012881Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399199518
W4402048195A message from the editor2024-06-01OpenAlex10.1111/jacf.12617Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402048195
W4401327500A modular, open-label, phase I/IIa study to evaluate the safety, tolerability, pharmacokinetics (PKs) and anti-tumour activity of a first-in-class (FIC) specific dUTPase inhibitor CV6-168 combined with anti-cancer treatments in patients (pts) with advanced malignancies.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.tps3170Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401327500
W4399263269ADVANCES IN COCRYSTALS OF ANTICANCER AGENTS: FORMULATION STRATEGIES AND THERAPEUTIC IMPLICATIONS2024-06-01OpenAlex10.22159/ijpps.2024v16i6.51044Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399263269
W4400272567AFT-50 EndoMAP: A phase IB/II multicohort study of targeted agents and/or immunotherapy for patients with recurrent or persistent endometrial cancer (EC).2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.tps5642Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400272567
W4399574121Acute haemodynamic decompensation in the era of substrate-based ablation: rare but still worrisome2024-06-01OpenAlex10.1093/europace/euae144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399574121
W4399305325Adapting a prescreening program from VHIO to match molecular alterations in over 10,000 patients' tumors with targeted agents and immunotherapies in early clinical trials.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e23071Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4399305325
W4400367425An Unusual Case of Cycloheximide-Resistant Aspergillus Candidus Onychomycosis2024-06-01OpenAlex10.33425/2690-8077.1113Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400367425
W4400109132Analysis of outcomes in resected early-stage non-small cell lung cancer (NSCLC) with rare targetable driver mutations.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.8052Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400109132
W4400074661Applications of Artificial Intelligence in Prostate Cancer Care: A Path to Enhanced Efficiency and Outcomes2024-06-01OpenAlex10.1200/edbk_438516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400074661
W7127210042Be careful! A Portuguese project about critical thinking and information literacy to counteract disinformation in an academic context2024-06-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7127210042
W4400109051Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.8051Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400109051
W4400122498Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study2024-06-01OpenAlex10.21037/jgo-24-315Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400122498
W4399663261Emerging Novel Functional Imaging and Immunotherapy in Renal Cell Carcinoma and Current Treatment Sequencing Strategies After Immunotherapy2024-06-01OpenAlex10.1200/edbk_438658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399663261
W4399978861Feasibility of Wastewater‐based Public Health Monitoring Systems in Texas’ Small Rural Communities2024-06-01OpenAlex10.1111/j.1936-704x.2024.3406.xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399978861
W4399323478Genomic alterations (GA) in ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) patients (pts) with metastatic breast cancer (MBC): Co-occurrence and prevalence along treatment course.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.1060Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399323478
W4399603125Institutionalizing2024-06-01OpenAlex10.1093/ahr/rhae178Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399603125
W4400272476Knowledge and confidence gaps in differentiating PARP inhibitors among community oncology providers.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e21002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400272476
W4399592329Next generation imidazothiazole and imidazooxazole derivatives as potential drugs against brain-eating amoebae2024-06-01OpenAlex10.1007/s00436-024-08255-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399592329
W4399257825Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma2024-06-01OpenAlex10.1186/s13045-024-01560-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399257825
W4399484353OP0085 CLINICAL FEATURES OF PATIENTS WITH SpA, WITH OR WITHOUT IBD: RESULTS FROM THE METEOR COHORT2024-06-01OpenAlex10.1136/annrheumdis-2024-eular.5211Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399484353
W4399296224Obesity—A wicked challenge2024-06-01OpenAlex10.1111/1747-0080.12884Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399296224
W4400193189P328 Autoimmune hepatitis management: an age-old problem2024-06-01OpenAlex10.1136/gutjnl-2024-bsg.410Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400193189
W4399487185Patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) with BRAF V600E and/or K601E mutation status: A real-world view of effectiveness of lenvatinib monotherapy.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.6098Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399487185
W4400063159Presence and Absence in Enemies, A Love Story: An Essay on Familism, Traditionalism, and Ultranationalism2024-06-01OpenAlex10.5325/pir.1.2.0002Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400063159
W4399325190Radiosurgery to 5 or more newly diagnosed brain metastases in the systemic therapy era.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.2026Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399325190
W4400264597Real-world cost of disease progression (PD) after frontline (1L) R-CHOP in diffuse large B-cell lymphoma (DLBCL): An analysis of a large US claims database.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e19036Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400264597
W4399323426Real-world treatment patterns, healthcare resource utilization and costs of care among newly-diagnosed patients with HR+/HER2- metastatic breast cancer.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.1073Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399323426
W4399276479Sport, physical exercise and the body in modern France2024-06-01OpenAlex10.1093/fh/crae016Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399276479
W4400273172Stereotactic radiosurgery (SRS) for non-small cell lung cancer (NSCLC) in the oncogene-addicted era: A real-world UK tertiary center experience.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e14011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400273172
W4399394681Survival outcomes for metastatic castration sensitive prostate cancer: Real world data from a Danish cohort 2016-2022.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e17088Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399394681
W4399280261Targeted interventions to address local challenges in HR+/HER2- and HER2+ breast cancer treatment in community-based settings.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e23213Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399280261
W4399519637The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data.2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e20006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399519637
W4401222866Therapeutic Patient Education for Severe Mental Disorders: A Systematic Review2024-06-01OpenAlex10.1192/bjo.2024.209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401222866
W4399275705US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies2024-06-01OpenAlex10.18553/jmcp.2024.30.6.541Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399275705
W4399394254Understanding patient and provider preferences in management of metastatic renal cell carcinoma (mRCC).2024-06-01OpenAlex10.1200/jco.2024.42.16_suppl.e16530Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399394254
W4403177232Vitamin A-loaded decellularized kidney capsule promoted wound healing in rat2024-06-01OpenAlex10.1016/j.reth.2024.09.017Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403177232
W4401753070Beyond the Stethoscope: Operationalizing Interactive Clinical Reasoning in Large Language Models via Proactive Information Seeking2024-06-03OpenAlex10.1109/ichi61247.2024.00090Full textExcludedF4: The complete published contribution is a single-page conference abstract. It describes within-consultation information seeking, self-reflection and expertise augmentation, without a documented retained experience update reused on later different cases. The related MediQ paper was not substituted for this report.https://openalex.org/W4401753070https://ieeexplore.ieee.org/document/10628958Entire one-page published PDF read online; no additional methods or references are present.
W4399282535Clinical landscape of macrophage-reprogramming cancer immunotherapies2024-06-03OpenAlex10.1038/s41416-024-02715-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399282535
W4399294389Conference Abstracts - Case Reports2024-06-03OpenAlex10.4103/ghep.ghep_8_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399294389
W4400423089Design and redesign journey of a drug for transthyretin amyloidosis2024-06-03OpenAlex10.4103/nrr.nrr-d-24-00056Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400423089
W4399422636Family Health Strategy: Reflections focusing on community health workers2024-06-03OpenAlex10.56238/isevmjv3n3-009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399422636
W4399445745Health Education: self-esteem as a topic for adolescents in a state school in Curitiba, state of Paraná2024-06-03OpenAlex10.22533/at.ed.1594492431054Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399445745
W4398977540Replication Data for: Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics2024-06-03OpenAlex10.7910/dvn/vxhebfTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4398977540
W4399329605Editorial: Molecular diagnostic methods for bacteria and fungi detection2024-06-04OpenAlex10.3389/fcimb.2024.1430630Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399329605
W4399323593Epidemiology of Pediatric Respiratory Tract Infections During the COVID-19 Era: A Retrospective Multicentric Study of Hospitalized Children in Lebanon Between October 2018 and March 20212024-06-04OpenAlex10.7759/cureus.61669Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399323593
W4399361433Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD)2024-06-04OpenAlex10.3390/ijms25116176Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399361433
W4401687792Switching from ex vivo to in vivo: approaches and considerations for generating cell therapies directly in the patient upon in vivo gene delivery2024-06-04OpenAlex10.18609/cgti.2024.076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401687792
W4399364970Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-12024-06-05OpenAlex10.1007/s13205-024-04022-6Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399364970
W4399385680Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen2024-06-05OpenAlex10.1002/pbc.31091Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399385680
W4399354469Semaglutide for weight loss: unanswered questions2024-06-05OpenAlex10.3389/fendo.2024.1382814Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399354469
W4401461276A COMPREHENSIVE CASE STUDY AND LITERATURE ANALYSIS ON THE EFFICACY OF ANTI-VEGF MEDICATION IN TREATING BRANCH RETINAL VEIN OCCLUSION2024-06-06OpenAlex10.15547/tjs.2024.01.013Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401461276
W4399443177An Atypical Case of Hemolytic Uremic Syndrome Caused by Shiga Toxin Produced by Aeromonas spp.2024-06-06OpenAlex10.7759/cureus.61859Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399443177
W4399544335Editorial: Quantitative bone imaging methods2024-06-06OpenAlex10.3389/fendo.2024.1411512Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399544335
W4399386931Remission of Prediabetes and Diabetes2024-06-06OpenAlex10.3329/bjm.v35i20.73342Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399386931
W4399390490Synergizing Nanomaterials and Artificial Intelligence in Advanced Optical Biosensors for Precision Antimicrobial Resistance Diagnosis2024-06-06OpenAlex10.1021/acssynbio.4c00070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399390490
W4399412981Transforming medical education: Conversational Generative Pre-trained Transformer’s (ChatGPT) integral role in simulation zones2024-06-06OpenAlex10.4103/ija.ija_196_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399412981
W4399428149An AI-Powered Computer Vision Module for Social Interactive Agents2024-06-07OpenAlex10.1145/3657242.3658601Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4399428149
W4399422462Current Approaches and Novel Agents in the Treatment of Chronic Lymphocytic Leukemia2024-06-07OpenAlex10.1200/op.23.00770Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4399422462
W4399531095Editorial: Real-world data and real-world evidence in lung cancer2024-06-07OpenAlex10.3389/fonc.2024.1436077Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399531095
W4399439031Navigating Europe's sustainable anaesthesia pathway2024-06-07OpenAlex10.1097/eja.0000000000001993Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399439031
W4399433658Pediatric inflammatory multisystem syndrome or Kawasaki disease - continuous challenges in Pediatrics - case report2024-06-07OpenAlex10.37897/rjp.2024.2.2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399433658
W4399460414Pathophysiology of dry eye disease and novel therapeutic agents2024-06-08OpenAlex10.4102/aveh.v83i1.874Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399460414
W4399475774Healthcare security in cloud‐based wireless sensor networks: Botnet attack detection via autoencoder‐aided goal‐based artificial intelligent agent2024-06-09OpenAlex10.1002/cpe.8152Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4399475774
W4399504365Abstract A013: NF1 loss is syntetic lethal with Trastuzumab emtansine2024-06-10OpenAlex10.1158/1538-8514.synthleth24-a013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399504365
W4399490563Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More Challenges2024-06-10OpenAlex10.3390/pathogens13060495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399490563
W4399488497Opening the Black Box of the Effects of Instructional Support on Collaborative Diagnostic Processes with Process Mining2024-06-10OpenAlex10.22318/cscl2024.740370Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399488497
W4399479628Present and future of aptamers applications: A patent review.2024-06-10OpenAlex10.22541/au.171805150.08474596/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399479628
W4399545315Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians2024-06-11OpenAlex10.1002/cns3.20076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399545315
W4399596006An Aggressive Case of Cryoglobulinemia and Membranoproliferative Glomerulonephritis: A Case Report2024-06-11OpenAlex10.7759/cureus.62193Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399596006
W4399544080Breast cancer epigenetics: current and evolving treatment2024-06-11OpenAlex10.1007/s12282-024-01601-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399544080
W4399517991Fostering collaboration in simulations: How advanced learners benefit from collaboration scripts and reflection2024-06-11OpenAlex10.1016/j.learninstruc.2024.101912Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399517991
W4399514102The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer2024-06-11OpenAlex10.20517/cdr.2023.120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399514102
W4403107797Immunotherapy in Gynecologic (Ovary, Endometrium and Servics) Cancer2024-06-12OpenAlex10.69860/nobel.9786053359388.15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403107797
W4399561820The role of urban and regional planning in the provision of social infrastructure2024-06-12OpenAlex10.4337/9781800883130.00034Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399561820
W4399668351Diagnosis and Medical Treatment of Acute and Chronic Idiopathic Pouchitis in Inflammatory Bowel Disease2024-06-13OpenAlex10.3390/medicina60060979Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399668351
W4399604328Early Initiation of Guideline-Directed Medical Therapy for Heart Failure After Cardiac Surgery2024-06-13OpenAlex10.1016/j.athoracsur.2024.05.034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399604328
W4399656987Effects of Prenatal Nicotine Exposure on Short-Term and Long-Term Memory: A Literature Review2024-06-13OpenAlex10.26685/urncst.594Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399656987; https://openalex.org/W4409486144
W4399604392SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health2024-06-13OpenAlex10.1016/j.xkme.2024.100851Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399604392
W4399687038The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease2024-06-13OpenAlex10.1080/17474086.2024.2366540Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399687038
W4399684168883-P: Brain-Directed AAV-FGF21 Gene Therapy Reverses Type 2 Diabetes, Obesity, and Cognitive Decline2024-06-14OpenAlex10.2337/db24-883-pTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399684168
W4399776187Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado2024-06-14OpenAlex10.18597/rcog.4094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399776187
W4399711267Optimizing anticoagulant therapy: is pharmacist-led intervention the best2024-06-14OpenAlex10.1093/ehjqcco/qcae047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399711267
W7120819989The lived experiences of childbearing in a basti : performing pregnancy and relationships in Jaipur, India2024-06-14OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7120819989
W4399689779The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials2024-06-14OpenAlex10.3389/fmed.2024.1384454Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399689779
W4399701881A Rare Case of Gastric Metastasis from a Rare Case of Mucosal Malignant Melanoma2024-06-15OpenAlex10.3889/oamjms.2024.11917Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399701881
W4399709466Peptic ulcer disease2024-06-15OpenAlex10.1016/s0140-6736(24)00155-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399709466
W4404585908Silver Nanoparticle as a Modern Era in Antimicrobial Activity2024-06-15OpenAlex10.22270/ajprd.v11i3.1407Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404585908
W4399755844Past, present and future of drug safety: Editorial2024-06-16OpenAlex10.1111/bcp.16140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399755844
W4399737484A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer2024-06-17OpenAlex10.1007/s13346-024-01648-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399737484
W4399731858Advances in Evaluation of Electrode Insertion Trauma Induced Residual Hearing loss in Cochlear Implant Recipients and its significance- A Narrative Review2024-06-17OpenAlex10.1007/s12070-024-04801-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399731858
W4399724811Epigenetic Fingerprints in IBD: From Methylation Patterns to Clinical Implications2024-06-17OpenAlex10.1093/ecco-jcc/jjae086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399724811
W4399836058Immunoengineering for autoimmune-kidney disease2024-06-18OpenAlex10.1093/ndt/gfae140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399836058
W4399773418Phage Therapy2024-06-18OpenAlex10.1201/9781003055211-54Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399773418
W4399799615Editorial: aquaporins in health and disease2024-06-19OpenAlex10.1113/jp286369Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399799615
W4399906584Kidney involvement in myelodysplastic syndromes2024-06-19OpenAlex10.1093/ckj/sfae185Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399906584
W4400921354Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum2024-06-20OpenAlex10.1093/cid/ciae321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400921354
W4399872066Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer2024-06-20OpenAlex10.1002/ijc.35031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399872066
W4399858899Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia2024-06-20OpenAlex10.4081/btvb.2024.127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399858899
W4400657984Treatment approaches for older Hodgkin lymphoma patients2024-06-20OpenAlex10.1097/cco.0000000000001071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400657984
W4400657832What is the best salvage therapy for Hodgkin lymphoma?2024-06-20OpenAlex10.1097/cco.0000000000001073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400657832
W4399907221Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects2024-06-21OpenAlex10.3390/biom14070734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399907221
W4399890732From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy2024-06-21OpenAlex10.1186/s40168-024-01825-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399890732
W4399895284Interstitial lung abnormalities evolving to histologically proven nonspecific interstitial pneumonia2024-06-21OpenAlex10.1016/b978-0-323-93522-7.00013-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399895284
W4399892303Metformin: pioneering a path forward in knee osteoarthritis care?2024-06-21OpenAlex10.1097/ms9.0000000000002318Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399892303
W4399881216Top advances of the year: Targeted therapy for lung cancer2024-06-21OpenAlex10.1002/cncr.35423Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399881216
W4411040064Artificial Intelligence and Machine Learning2024-06-22OpenAlex10.71443/9788197282164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411040064
W4399925981Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine2024-06-22OpenAlex10.1016/j.ymthe.2024.06.029Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4399925981
W4399948503The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations2024-06-22OpenAlex10.3390/cimb46070377Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4399948503
W4399913503To Adapt or Not to Adapt ? Older Adults Enacting Agency in Dialogues with an Unknowledgeable Agent2024-06-22OpenAlex10.1145/3627043.3659562Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399913503
W4399973055A Comprehensive Review of Simulation Technology: Development, Methods, Applications, Challenges and Future Trends2024-06-24OpenAlex10.62677/ijetaa.2405119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399973055
W4399981765Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates2024-06-24OpenAlex10.1016/j.pnpbp.2024.111069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399981765
W4400017011Cancer therapy in patients with reduced kidney function2024-06-24OpenAlex10.1093/ndt/gfae142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400017011
W4401018251Design and Fabrication of Multi-Functional Optical Microbots2024-06-24OpenAlex10.1109/ur61395.2024.10597446Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401018251
W4399976399Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management2024-06-24OpenAlex10.1007/s11864-024-01215-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399976399
W4399983790Navigating Acute Interstitial Nephritis: Clinical Insights and Emerging Challenges2024-06-24OpenAlex10.1097/imna-d-24-00017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399983790
W4400045130Recent Analytical Methodologies for Determination of Anti-Viral COVID-19 Drugs: A Review2024-06-24OpenAlex10.21608/eajbsc.2024.361129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400045130
W4399982425Synthesis of high-performance antibacterial agent based on incorporated vancomycin into MOF-modified lignin nanocomposites2024-06-24OpenAlex10.1016/j.ijbiomac.2024.133339Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4399982425
W4399994411It’s the End of the World and We Know It2024-06-25OpenAlex10.1215/00267929-11196175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399994411
W4400008222Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers2024-06-25OpenAlex10.21037/atm-23-1465Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400008222
W4400005506Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges2024-06-25OpenAlex10.1080/17474086.2024.2372325Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400005506
W4400057561Point/counterpoint: Should we stop writing and reading letters of recommendation for residency selection?2024-06-25OpenAlex10.1002/jhm.13440Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400057561
W4400018801Rotavirus: A micro review2024-06-25OpenAlex10.22541/au.171934170.09340648/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400018801
W4400014375Splenic abscess and infective endocarditis2024-06-25OpenAlex10.1007/s15010-024-02322-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400014375
W4400092338Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer2024-06-26OpenAlex10.3390/ijms25136967Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400092338
W4400038883Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy2024-06-26OpenAlex10.1016/j.bbcan.2024.189145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400038883
W4400063005Targeted Radiopharmaceutical Therapy for Bone Metastases2024-06-26OpenAlex10.1053/j.semnuclmed.2024.05.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400063005
W4400100479The potential therapeutic applications of long non-coding RNAs2024-06-26OpenAlex10.20517/jtgg.2024.12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400100479
W4400136564Comment on ‘Comprehensive toxicological screening of common drugs of abuse, new psychoactive substances, and cannabinoids in blood using supported liquid extraction and liquid chromatography–quadrupole time-of-flight mass spectrometry’2024-06-27OpenAlex10.1093/jat/bkae057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400136564
W4400090559Involvement of Molecular Mechanism and Biological Activities of Pemirolast: A Therapeutic Review2024-06-27OpenAlex10.2174/0102506882308410240607053814Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400090559
W4400073103Poland's strategic potential and capabilities to respond to CBRN threats2024-06-27OpenAlex10.13166/jms/188731Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400073103
W4400094235Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approach2024-06-27OpenAlex10.23876/j.krcp.23.289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400094235
W4400110912A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy2024-06-28OpenAlex10.1097/md.0000000000038767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400110912
W4400123524European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation2024-06-28OpenAlex10.1002/cyto.b.22195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400123524
W4400251172Glycopyrronium inhalation, bronchodilator reversibility assessment, and defining asthma: A new paradigm2024-06-28OpenAlex10.4103/lungindia.lungindia_461_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400251172
W4400126139P006 Tumour necrosis factor-α-induced lupus panniculitis: one case report and literature review2024-06-28OpenAlex10.1093/bjd/ljae090.033Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400126139
W4400128628Plasma therapy for traumatic brain injury: Rationale for a prospective randomized trial2024-06-28OpenAlex10.1111/trf.17928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400128628
W4400201943Advancements in First-Line Treatment of Metastatic Bladder Cancer: EV-302 and Checkmate-901 Insights and Future Directions2024-06-29OpenAlex10.3390/cancers16132398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400201943
W4399985863Opportunities for nanomaterials in enzyme therapy2024-06-29OpenAlex10.1016/j.jconrel.2024.06.035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4399985863
W7217302664Determinants of Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Therapy2024-06-30OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7217302664
W7118138708Role of Nursing in Preventing Missed Care: A Comprehensive Review2024-06-30OpenAlex10.22399/ijcesen.4651Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118138708
W44005952522024-07-01OpenAlex10.1111/bjh.v205.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400595252
W4400453417229 Involving change agents implementing a systematic approach to family involvement during patient hospitalization2024-07-01OpenAlex10.1136/bmjebm-2024-sdc.228Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4400453417
W4400327380A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma2024-07-01OpenAlex10.1007/s11523-024-01074-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400327380
W4402610812Advancing therapeutic strategies and future innovations in sickle cell disease management2024-07-01OpenAlex10.33545/pathol.2024.v7.i3e.2016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402610812
W4401431352Characterizing generative artificial intelligence applications: Text-mining-enabled technology roadmapping2024-07-01OpenAlex10.1016/j.jik.2024.100531Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401431352
W4403251688Charting New Territories in Metastatic Prostate Cancer: A Convergence of Innovation and Hope2024-07-01OpenAlex10.1016/j.euf.2024.09.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403251688
W4400207978Cryptic enzymatic assembly of peptides armed with β-lactone warheads2024-07-01OpenAlex10.1038/s41589-024-01657-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400207978
W7212213868Designing digital health futures2024-07-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212213868
W4406224718Do we need phase 3 randomized clinical trials for oncology drug approvals?2024-07-01OpenAlex10.4103/ijc.ijc_819_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406224718
W4402999309Dr. Ashok DB Vaidya: Scientist with a vision of Ayurvidya (1936–2024)2024-07-01OpenAlex10.4103/ijar.ijar_210_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402999309
W4400893110E-036 Embozene versus onyx for middle meningeal artery embolization in chronic subdural hematoma2024-07-01OpenAlex10.1136/jnis-2024-snis.141Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400893110
W4400215476Editorial: Artificial intelligence education & governance -human enhancive, culturally sensitive and personally adaptive HAI2024-07-01OpenAlex10.3389/frai.2024.1443386Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400215476
W4402781149Effects of General Anesthesia on Noninvasively Measured Central and Peripheral Blood Pressure: A Prospective, Observational-based Cross-over Study2024-07-01OpenAlex10.4103/rcm.rcm_31_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402781149
W4400201460Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms2024-07-01OpenAlex10.1002/phar.2950Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400201460
W4400576974Evolving treatment paradigms for platinum-resistant ovarian cancer: An update narrative review2024-07-01OpenAlex10.1016/j.tjog.2024.05.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400576974
W4400935989Familial Hypercholesterolemia: Can Continuing Medical Education Help Address Barriers to Screening in Children?2024-07-01OpenAlex10.1016/j.jacl.2024.04.064Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400935989
W4405719790In the Dance of Growth and Advancements, the Future Unfolds with Boundless Potential2024-07-01OpenAlex10.4103/dljo.dljo_128_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405719790
W4401384753Infections in Hematopoietic Stem Cell Transplant Recipients in India – Think Global, Act Local2024-07-01OpenAlex10.4103/cids.cids_48_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401384753
W4402740244Investigator-initiated Clinical Trials for Neurological Diseases in Japan: Pipeline and Support Structures2024-07-01OpenAlex10.1016/j.neurot.2024.e00406Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402740244
W7135825495Involving change agents implementing a systematic approach to family involvement during patient hospitalization2024-07-01OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7135825495
W4400219047Ketamine Can Be a Transformational Agent, but It Is Not Without Risk or Danger2024-07-01OpenAlex10.1097/01.eem.0001026356.60923.22Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4400219047
W4400211131Long‐term outcomes in advanced anterior skull base malignancy: a single quaternary institution experience2024-07-01OpenAlex10.1111/ans.19144Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400211131
W4401346493Models in Consciousness Research2024-07-01OpenAlex10.4103/jacs.jacs_120_24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401346493
W4400220149Modern paradigms in biologic sequencing of inflammatory bowel disease in Aotearoa New Zealand2024-07-01OpenAlex10.26635/6965.6613Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400220149
W4400219478Neonatal Seizures2024-07-01OpenAlex10.1542/pir.2023-006016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400219478
W4400211233Optimisation during transition to dialysis commencement2024-07-01OpenAlex10.5694/mja2.52347Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400211233
W4405457185Orthobiologics in Orthopaedics – Recent Advances2024-07-01OpenAlex10.4103/ijors.ijors_20_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405457185
W4400560373Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations2024-07-01OpenAlex10.1136/bmjonc-2024-000481Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400560373
W4401275685Retrospective Research of Cases of Oral Mucosal Diseases: Diagnosis and Management Trends2024-07-01OpenAlex10.4103/jpbs.jpbs_294_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401275685
W4400355822SPL22 BIOLOGICAL HAZARDS IN THE WORKING ENVIRONMENT: A RISK OF PERMANENT RELEVANCE2024-07-01OpenAlex10.1093/occmed/kqae023.0033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400355822
W4400355842SS05 EMERGING AND CONTINUING BIOHAZARDS IN THE WORKPLACE2024-07-01OpenAlex10.1093/occmed/kqae023.0066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400355842
W4400215350Toward disrupting normalized incivility in our nursing workplaces2024-07-01OpenAlex10.1111/nin.12654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400215350
W4400308905Vulnerabilities mediating the Healthcare encounter: by an intersectional agency.2024-07-01OpenAlex10.1590/1413-81232024297.04352024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400308905
W4400305449Anaesthetic Challenge in a Child with Hurler’s Syndrome: Encouraging Experience with Neuraxial Blockade2024-07-02OpenAlex10.4038/slja.v32i2.9285Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400305449
W4400259550Current Status on Management of Primary Plasma Cell Leukemia2024-07-02OpenAlex10.1007/s11912-024-01563-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400259550
W4401035050Fire, Vulcanus , Archeus , and Alchemy: A Hybrid Close-Distant Reading of Paracelsus’s Thought on Active Agents2024-07-02OpenAlex10.1080/00026980.2024.2367396Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401035050
W4400244350Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances2024-07-02OpenAlex10.1007/s44337-024-00008-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400244350
W4400257087Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review2024-07-02OpenAlex10.1007/s40778-024-00241-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400257087
W4400420511The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis2024-07-02OpenAlex10.1080/14656566.2024.2377714Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400420511
W4400231340The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures2024-07-02OpenAlex10.1371/journal.pbio.3002692Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400231340; https://openalex.org/W4392201389
W4400935223The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke2024-07-02OpenAlex10.1080/14656566.2024.2385135Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400935223
W4400291215Comment on: Community-acquired pneumonia: a US perspective on the guideline gap2024-07-03OpenAlex10.1093/jac/dkae208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400291215
W4401684277Molecularly Targeted Therapies In Breast Cancer: A Traditional Review2024-07-03OpenAlex10.55262/fabadeczacilik.1444169Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401684277
W4400292208Moral agents as relational systems: The Contract-Based Model of Moral Cognition for AI2024-07-03OpenAlex10.31234/osf.io/52x74Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400292208
W4400300014Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review2024-07-03OpenAlex10.1002/ame2.12465Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4400300014
W4400296595Who assesses what?2024-07-03OpenAlex10.4324/9781032648033-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400296595
W4411001375Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality2024-07-04OpenAlex10.70070/ms7j8w64Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411001375
W4400419097Intestinal Parasites from Past to Present: Taxonomy, Paleoparasitology, Geographic Distribution, Prevention and Control Strategies2024-07-04OpenAlex10.5772/intechopen.1005750Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400419097
W4400311090Long-Axial Field-of-View PET Imaging in Patients with Lymphoma2024-07-04OpenAlex10.1016/j.cpet.2024.05.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400311090
W4403176152Malaria and Molecular Diagnosis2024-07-04OpenAlex10.69860/nobel.9786053359524.2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403176152
W4400325414Neonatal Opioid Withdrawal Syndrome and the Role of the Speech-Language Pathologist2024-07-04OpenAlex10.4324/9781003397267-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400325414
W4400330578The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival2024-07-04OpenAlex10.3390/cancers16132451Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400330578
W4400314693Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysis2024-07-04OpenAlex10.1016/j.diabres.2024.111770Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400314693
W4400359621Current Surveillance and Treatment Guidelines for Thyroid Carcinoma2024-07-05OpenAlex10.1007/s40137-024-00421-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400359621
W4400369260Editorial: Clinical challenges in pediatric transplant infectious diseases2024-07-05OpenAlex10.3389/fped.2024.1425983Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400369260
W4400351500New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?2024-07-05OpenAlex10.3390/cancers16132466Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400351500
W7218304494The Benefits of Oxymetazoline on Sensory Impairment in COVID-19 Patients2024-07-05OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218304494
W4400425660The Role of the Dentist in Home Care for the Older People: A Narrative Review of the Literature2024-07-05OpenAlex10.12974/2311-8695.2024.12.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400425660
W4400387274VIBRATO’s Symphony: Orchestrating Biomarker Harmony for Ritlecitinib in UC Therapy2024-07-05OpenAlex10.1093/ecco-jcc/jjae103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400387274
W4400387554Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia2024-07-06OpenAlex10.1007/s11899-024-00730-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400387554
W4400404462PET imaging of gliomas: Status quo and quo vadis?2024-07-06OpenAlex10.1093/neuonc/noae078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400404462
W4400479214Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE)2024-07-07OpenAlex10.3390/gidisord6030043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400479214
W4400418891Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells2024-07-07OpenAlex10.3390/cancers16132478Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400418891
W4401483763Interaction Behavior of Novel Chitosan-Pectin Complex of Ciclopiroxwith Human Galectin-3: Molecular Docking, Molecular Dynamic Simulation, In Silico Pharmacokinetics Studies2024-07-08OpenAlex10.48047/afjbs.6.si4.2024.951-963Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401483763
W4400449172Evolving Paradigms in Sepsis Management: A Narrative Review2024-07-09OpenAlex10.3390/cells13141172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400449172
W4400474170Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions2024-07-09OpenAlex10.3389/fpsyt.2024.1412901Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400474170
W4400517698Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there2024-07-09OpenAlex10.1093/eurheartj/ehae399Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400517698
W4402842715A Comparative Clinical Study on the Effect of Tagar (Valleriana Wallichii Dc.) and Aswagandha (Withania Somnifera) in the Management of Preoperative Anxiety2024-07-10OpenAlex10.47070/ijapr.v12i6.3274Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402842715
W4400512482Acne treatment: research progress and new perspectives2024-07-10OpenAlex10.3389/fmed.2024.1425675Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400512482
W4401413351Aging-induced memory loss due to decreased N1-acetyl-5-methoxykynuramine, a melatonin metabolite, in the hippocampus: a potential prophylactic agent for dementia2024-07-10OpenAlex10.4103/nrr.nrr-d-24-00379Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401413351
W4400513196Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma2024-07-10OpenAlex10.3389/fonc.2024.1401761Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400513196
W4400501367Gene Editing with Artificial DNA Scissors2024-07-10OpenAlex10.1002/chem.202401621Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400501367
W4400512214The Acari Hypothesis, IV: revisiting the role of hygiene in allergy2024-07-10OpenAlex10.3389/falgy.2024.1415124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400512214
W4400541121Bronchiolitis: Increased severity in the post‐COVID‐19 era2024-07-11OpenAlex10.1002/ppul.27172Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400541121
W4400575791Colorimetric Study on Burnt Teeth and New Diagnostic Tool in Forensic Dental Identification: The Carbodent Scale2024-07-11OpenAlex10.3390/oral4030025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400575791
W4400558492Model‐Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing2024-07-11OpenAlex10.1002/cpt.3356Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400558492
W4400558392Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review2024-07-11OpenAlex10.7759/cureus.64302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400558392
W4400569878Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives2024-07-11OpenAlex10.3389/fonc.2024.1387345Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400569878
W4400620968Assessing the impact of seismic scenarios and retrofits on community resilience using agent-based models2024-07-14OpenAlex10.1016/j.ijdrr.2024.104678Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400620968
W4400614234Lithium and the risk of fractures in patients with bipolar disorder: A population-based cohort study2024-07-14OpenAlex10.1016/j.psychres.2024.116075Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400614234
W4400617177SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions2024-07-14OpenAlex10.1016/j.clml.2024.07.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400617177
W4400850943Antimicrobial Activity and Phytochemical analysis of Evolvulus alsinoides against HIV Secondary Pathogens2024-07-15OpenAlex10.22270/jddt.v14i7.6452Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400850943
W4400662458Data from CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024-07-15OpenAlex10.1158/1078-0432.c.7348790.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400662458; https://openalex.org/W4400661741
W4400653783Executive Summary—Society of Critical Care Medicine Guideline and American Society of Health-System Pharmacists for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults2024-07-15OpenAlex10.1097/ccm.0000000000006329Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400653783
W4400696382Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)2024-07-15OpenAlex10.1002/pbc.31189Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400696382
W4400653801Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps2024-07-15OpenAlex10.1128/aac.00535-24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400653801
W4400657117Targeted Therapy for Atopic Dermatitis: A Novel Approach2024-07-15OpenAlex10.2174/0115748855307501240607045747Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400657117
W2275217505Acoustic characterization of ultrasound contrast microbubbles and echogenic liposomes: applications to imaging and drug-delivery2024-07-16OpenAlex10.58088/qjzj-yt77Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W2275217505
W4401835091Advances and future directions in ROS1 fusion-positive lung cancer2024-07-16OpenAlex10.1093/oncolo/oyae205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401835091
W4400748370Different hyaluronan concentration determinate distinctive physicochemical and biological properties of the intra-articular gel but does not affect satisfactory clinical outcome2024-07-16OpenAlex10.1016/j.jorep.2024.100445Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400748370
W4400695519Editorial: Is there still room for pharmacogenetics in 2023? The cases of infectious diseases and oncology2024-07-16OpenAlex10.3389/fphar.2024.1457733Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400695519
W4400689312Equal Societies, Autonomous Lives: Reconciling social equality and relational autonomy2024-07-16OpenAlex10.1111/josp.12579Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400689312
W4400694279Physical and mechanical properties of cellulose based hemostatic agents: an in vitro comparison2024-07-16OpenAlex10.1007/s12553-024-00892-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400694279
W4400722243New Perspectives on Risk Assessment and Anticoagulation in Elective Spine Surgery Patients: The Impact of Ultra-Minimally Invasive Endoscopic Surgery Techniques on Patients with Cardiac Disease2024-07-17OpenAlex10.3390/jpm14070761Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400722243
W4400773751Comment on: Where are we now in biologic drugs for myositis?2024-07-18OpenAlex10.1093/rheumatology/keae363Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400773751
W4400780239Editorial: A contemporary look at allergic rhinitis treatments: where are we heading?2024-07-18OpenAlex10.3389/falgy.2024.1459032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400780239
W4400810659The Clinical Meaning of Withdrawal with Antidepressant Drugs2024-07-18OpenAlex10.1159/000540033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400810659
W4400772490The Evolving Use of Gold Nanoparticles as a Possible Reversal Agent for the Symptoms of Neurodegenerative Diseases: A Narrative Review2024-07-18OpenAlex10.7759/cureus.64846Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4400772490
W4403321160A human motivation driven based user-activity recommending service using AIGC and self-supervised agent cluster with debating scheme2024-07-19OpenAlex10.1145/3691720.3691807Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403321160
W4400824496Editorial: Natural and synthetic microbiology for the production of novel biomolecules for applications in the areas of food, fuel, farming, pharma and environment2024-07-19OpenAlex10.3389/fmicb.2024.1458803Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400824496
W4405808122Outsourcing Public Services2024-07-19OpenAlex10.46692/9781529212877.002Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405808122
W4400837594Smart sanitization on a budget: revolutionizing public transport hygiene post-COVID2024-07-19OpenAlex10.3389/fpubh.2024.1437499Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400837594
W4400823397Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex2024-07-19OpenAlex10.1186/s12879-024-09608-2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400823397
W4401064697The Clinical Utility of Botulinum Toxin in the Field of Otolaryngology2024-07-21OpenAlex10.3342/kjorl-hns.2024.00227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401064697
W4400872030A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update2024-07-22OpenAlex10.1016/j.ejphar.2024.176752Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400872030
W4400889004Challenges for emergency departments: Anti‐amyloid therapy and amyloid‐related imaging abnormalities in persons with dementia2024-07-22OpenAlex10.1111/jgs.19099Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400889004
W4400930638Dilemmas of dating: The case of aprioristic sexual lookism2024-07-22OpenAlex10.1111/josp.12585Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4400930638
W4400881015Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease2024-07-22OpenAlex10.2215/cjn.0000000000000540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400881015
W4400871112The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?2024-07-22OpenAlex10.1016/j.annonc.2024.05.542Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400871112
W4400932585Navigating the Evolving Roles of GLP-1 Agonists Safely and Effectively2024-07-23OpenAlex10.1093/asj/sjae166Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400932585
W4400953109Recent Advances on Pt-Based Compounds for Theranostic Applications2024-07-23OpenAlex10.3390/molecules29153453Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400953109
W4402153039Role of magnesium sulfate in pregnancy: A comprehensive review of benefits and risks2024-07-23OpenAlex10.31893/multirev.2024094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402153039
W4401364395The evolving landscape of polycythemia vera therapies2024-07-23OpenAlex10.1080/14656566.2024.2387681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401364395
W4400963680IL-2 based cancer immunotherapies: an evolving paradigm2024-07-24OpenAlex10.3389/fimmu.2024.1433989Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400963680
W4400974168NANN Neonatal Peripherally Inserted Central Catheters2024-07-24OpenAlex10.1097/anc.0000000000001182Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400974168
W4400959993Recent Updates in the Diagnosis and Management of Kidney Diseases in Multiple Myeloma2024-07-24OpenAlex10.25259/ijn_491_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400959993
W4401715999AntiFormer: graph enhanced large language model for binding affinity prediction2024-07-25OpenAlex10.1093/bib/bbae403Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401715999
W4400983858Biofilm Production and Its Implications in Pediatrics2024-07-25OpenAlex10.3390/microorganisms12081522Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400983858
W4401000360Editorial: Recent advances in childhood vascular tumors2024-07-25OpenAlex10.3389/fonc.2024.1465155Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401000360
W4401001153Editorial: lncRNAs: application in immunotherapy, radiotherapy, and chemotherapy2024-07-25OpenAlex10.3389/fcell.2024.1438773Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401001153
W4400994068Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy2024-07-25OpenAlex10.1007/s11864-024-01235-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400994068
W4401019125Meeting the Health Needs of Society Through Curricular Innovation in Physical Therapist Education: Examples From 3 Entry-Level Programs2024-07-25OpenAlex10.1097/jte.0000000000000359Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401019125
W4401038695Occupational health nursing and political action2024-07-25OpenAlex10.1111/inr.13030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401038695
W4400980781The Potential Use of Naturally Derived Materials for Nanoparticle Synthesis as Potential Anti-biofilms and Anti-virulence Drugs to Prevent Mono or Polymicrobial Diseases2024-07-25OpenAlex10.22541/au.172192045.50188569/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400980781
W4400974247Unveiling DprE1 as a Key Target in the Fight against Tuberculosis: Insights and Perspectives on Developing Novel Antimicrobial Agents2024-07-25OpenAlex10.3390/biomed4030018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400974247
W4400974296What’s New in Osteoporosis: Emphasis on the Aging Athlete2024-07-25OpenAlex10.2106/jbjs.24.00644Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4400974296
W4401037293A narrative review on perioperative systemic therapy in non-small cell lung cancer2024-07-26OpenAlex10.37349/etat.2024.00256Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401037293
W4403144247Acute Generalized Exanthematous Pustulosis (AGEP) Unveiled2024-07-26OpenAlex10.70552/pjaai.24.1.9871Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403144247
W4401023468Prevalence of Staphylococcus aureus Infections in the Implantation of Orthopedic Devices in a Third-Level Hospital: An Observational Cohort Study2024-07-26OpenAlex10.3390/pathogens13080620Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401023468
W4401035315Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide2024-07-26OpenAlex10.1080/17474086.2024.2382897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401035315
W4401029882Treatment patterns and outcomes in KRAS‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study2024-07-26OpenAlex10.1016/j.lungcan.2024.107898Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401029882
W4401056948Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”2024-07-27OpenAlex10.1016/j.ctro.2024.100826Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401056948
W4403193758Evolving Treatment Landscape in Endometrial Cancer2024-07-28OpenAlex10.36000/hbt.oh.2024.20.149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403193758
W4401081185Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia2024-07-29OpenAlex10.1002/hem3.111Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401081185
W4401096121Mapping the Landscape of Clinical Trials on Oral Biofilm: A Bibliometric Analysis2024-07-29OpenAlex10.3329/bjms.v23i3.75013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401096121
W4401068363Physician Humility: A Review and Call to Revive Virtue in Medicine2024-07-29OpenAlex10.7326/m24-0842Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401068363
W4401186286The many faces of brucellosis: diagnostic and management approach2024-07-29OpenAlex10.1097/qco.0000000000001045Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401186286
W4401114072Advances in primary glomerulonephritis2024-07-30OpenAlex10.12968/hmed.2024.0044Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401114072
W4401118005Allergic Fungal Infections2024-07-30OpenAlex10.1201/9781032642864-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401118005
W4401116868Antifungal Therapies and Drug Resistance2024-07-30OpenAlex10.1201/9781032642864-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401116868
W4401152819Commentary: AI-based preeclampsia detection and prediction with electrocardiogram data2024-07-30OpenAlex10.3389/fcvm.2024.1437369Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401152819
W4401234955Comparison of shear bond strength between 7th and 8th generation bonding agents in flowable composite resin2024-07-30OpenAlex10.30574/wjarr.2024.23.1.2289Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401234955
W4401434712HELICOBACTER PYLORI: FROM DISCOVERY TO MODERN-DAY TREATMENTS2024-07-30OpenAlex10.61796/jmgcb.v1i7.796Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401434712
W4416287392Nursing and Radiology Teams Collaboration to Enhance Patient Safety During Imaging Procedures2024-07-30OpenAlex10.22399/ijcesen.4285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416287392
W4401126512Serum globulin trajectory discovery and prediction in systemic lupus erythematosus: Results from a real‐world observational cohort study2024-07-30OpenAlex10.1111/1756-185x.15278Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401126512
W4403416051Tropical Excursion With Ensuing Mental Ulceration2024-07-30OpenAlex10.1093/cid/ciae283Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403416051
W4401118131Unraveling the World of Human Fungal Infections2024-07-30OpenAlex10.1201/9781032642864-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401118131
W4401194511Addressing AMR and planetary health in primary care: the potential of general practitioners as change agents2024-07-31OpenAlex10.3389/fpubh.2024.1383423Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401194511
W4401166925An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 20222024-07-31OpenAlex10.1007/s00432-024-05889-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401166925
W4401594750DEXMEDETOMIDINE: A VERSATILE, MULTITASKING ANESTHETIC AGENT FOR PERIOPERATIVE MANAGEMENT, A NARRATIVE REVIEW2024-07-31OpenAlex10.21474/ijar01/19188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401594750
W4401544080Hormonal Therapy and Endometrial Cancer: Latest Advancements2024-07-31OpenAlex10.54393/pbmj.v7i07.1121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401544080
W4401160325Malignant Hyperthermia Simulation2024-07-31OpenAlex10.1016/j.jopan.2024.06.006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401160325
W4401179304Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review2024-07-31OpenAlex10.7759/cureus.65835Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401179304
W44016463623056 Everything is connected to everything else2024-08-01OpenAlex10.1136/bmjno-2024-anzan.67Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401646362
W7203512914Coupled Flow and Transport in an Organ and its Vasculature2024-08-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203512914
W4401954128Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma2024-08-01OpenAlex10.1002/cam4.70131Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401954128
W4401330964Is Rapid Bedside Echocardiography in Septic Shock Possible?*2024-08-01OpenAlex10.1097/pcc.0000000000003538Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401330964
W4406455323Melatonin: Evolving Physiological Understanding and Potential Therapeutic Role in Pain Medicine Including Intervertebral Disc Degeneration2024-08-01OpenAlex10.36076/ppj.2024.7.273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406455323; https://openalex.org/W4401237344
W7169745981Molecular characterisation of porcine circoviruses in Malaysia and development of a PCV type 3 diagnostic tool2024-08-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169745981
W4401835554P05 A targeted antimicrobial pharmacy technician ward service improves stewardship and patient-centred care and safety of commonly prescribed higher risk antimicrobials in the acute hospital setting2024-08-01OpenAlex10.1093/jacamr/dlae136.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401835554
W4401827532P28 An analysis of the appropriateness of antimicrobial prescribing at a tertiary centre: reflections from the National Point Prevalence Survey2024-08-01OpenAlex10.1093/jacamr/dlae136.032Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401827532
W4401973442Participating together in CP-ACHIEVE: Experiences, opportunities and reflections from a collaborative research team of people with lived experience of cerebral palsy and health care professionals2024-08-01OpenAlex10.1177/09075682241269682Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401973442
W4401232754Recent Advances in Liver Transplantation for Hepatocellular Carcinoma2024-08-01OpenAlex10.1007/s11864-024-01247-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401232754
W4404556438Torture, Imperial Citizenship, and Embodied Reading2024-08-01OpenAlex10.1215/00295132-11186650Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404556438
W4401260700An overview of the development of pharmacotherapeutics targeting SARS-CoV-22024-08-02OpenAlex10.1016/j.drudis.2024.104126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401260700
W4401240985BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis2024-08-02OpenAlex10.1093/neuonc/noae140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401240985
W4401256224Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report2024-08-02OpenAlex10.3892/ol.2024.14606Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401256224
W4416279869Giant Cell Arteritis or Formerly Known as Horton's Disease When the Puzzle is Complete: A Case Report2024-08-02OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416279869
W4401277152Nephrology: a flourishing field with plentiful emerging topics2024-08-02OpenAlex10.3389/fmed.2024.1463540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401277152
W4401311711Use of Artificial Intelligence in the Mental Health Space2024-08-04OpenAlex10.58445/rars.1382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401311711
W440136386636 Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and Vascular Endothelial Growth Factor (VEGF) receptor targeted therapies2024-08-05OpenAlex10.1093/oncolo/oyae181.037Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401363866
W4401345849Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy2024-08-05OpenAlex10.3389/fonc.2024.1392639Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401345849
W4401337477Behçet disease: epidemiology, classification criteria and treatment modalities2024-08-05OpenAlex10.1080/1744666x.2024.2388693Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401337477
W4401373511Smouldering COVID ‐19 XBB .1.5. subvariant pneumonitis: a case report2024-08-05OpenAlex10.5694/mja2.52403Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401373511
W4401385423ASHP Statement on the Community Pharmacist’s Role in the Care Continuum2024-08-06OpenAlex10.1093/ajhp/zxae176Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401385423; https://openalex.org/W4412106503
W4401374210Editorial: Insights in intensive care cardiovascular medicine: 20222024-08-06OpenAlex10.3389/fcvm.2024.1446904Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401374210
W4401374204Editorial: The ethics of speech ownership in the context of neural control of augmented assistive communication2024-08-06OpenAlex10.3389/fnhum.2024.1468938Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401374204
W4401374567Editorial: Therapeutics in pulmonary arterial hypertension2024-08-06OpenAlex10.3389/fcvm.2024.1463305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401374567
W4401380136Refinement in animal experimentation: calling time on the use of chloral hydrate for non‐recovery procedures and euthanasia2024-08-06OpenAlex10.1113/jp286687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401380136
W4410375083Compliance-as-Code 2.0: Orchestrating Regulatory Operations with Agentic AI2024-08-07OpenAlex10.60087/jaigs.v5i1.366Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4410375083
W4401454537Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review2024-08-07OpenAlex10.3233/kca-240006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401454537
W4401438032The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma2024-08-08OpenAlex10.1016/j.clml.2024.08.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401438032
W4401425392The PANORAMIC study of COVID-19 treatments in primary care: a review and learning exercise2024-08-08OpenAlex10.3310/nihropenres.1115237.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401425392
W4401544778Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study2024-08-08OpenAlex10.1097/aln.0000000000005079Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401544778
W4401449817Anticoagulation in Chronic Kidney Disease2024-08-09OpenAlex10.1007/s40265-024-02077-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401449817
W4401448826Antifungal Susceptibility Pattern of Candida Species among Cancer Patients Attending B.P Koirala Memorial Cancer Hospital, Chitwan2024-08-09OpenAlex10.21203/rs.3.rs-4694992/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401448826
W4401455831Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management2024-08-09OpenAlex10.1007/s00125-024-06242-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401455831
W4401470725Editorial: High-level antimicrobial resistance or hypervirulence in emerging and re-emerging “super-bug” foodborne pathogens: detection, mechanism, and dissemination from omics insights2024-08-09OpenAlex10.3389/fmicb.2024.1459601Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401470725
W4401474168Radiolabeled Somatostatin Analogs for Cancer Imaging2024-08-09OpenAlex10.1053/j.semnuclmed.2024.07.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401474168
W4401474117Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs2024-08-09OpenAlex10.1016/j.bbcan.2024.189170Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401474117
W4401500729Bringing Geroscience into the Mainstream: From Education to Clinical Practice, What Will It Take?2024-08-10OpenAlex10.1093/gerona/glae020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401500729
W4401495938Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy2024-08-11OpenAlex10.1007/s12672-024-01195-7Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4401495938
W4401515145Anesthesia Management in Emergency and Trauma Surgeries: A Narrative Review2024-08-12OpenAlex10.7759/cureus.66687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401515145
W4412821259Emerging Monoclonal Antibody–Drug Conjugates In Cancer Therapy: A Comprehensive Review Of Design, Mechanisms, And Clinical Advances2024-08-12OpenAlex10.53555/ajbr.v27i2.8216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412821259
W4401514910Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine2024-08-12OpenAlex10.3390/ph17081059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401514910
W4401517043Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm2024-08-12OpenAlex10.1038/s41408-024-01109-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4401517043
W4401504838Quality Measurement in Oncology: Time to Take the Next Step!2024-08-12OpenAlex10.1200/op.24.00348Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401504838
W4401521466Survey of community pharmacists’ opinions on drug scheduling in Ontario and Québec2024-08-12OpenAlex10.1080/20523211.2024.2385936Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401521466
W4401515465Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma2024-08-12OpenAlex10.1038/s41408-024-01114-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401515465
W4401503612Unveiling the nexus: Long non-coding RNAs and the PI3K/Akt pathway in oral squamous cell carcinoma2024-08-12OpenAlex10.1016/j.prp.2024.155540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401503612
W4401517079Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways2024-08-12OpenAlex10.1038/s41467-024-51046-wTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401517079
W4401529517At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy2024-08-13OpenAlex10.1016/j.ijrobp.2024.04.021Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4401529517
W4401554310Hydroxyurea in the sickle cell disease modern era2024-08-13OpenAlex10.1080/17512433.2024.2390915Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401554310
W4401603717NK cell based immunotherapy against oral squamous cell carcinoma2024-08-13OpenAlex10.3389/fimmu.2024.1440764Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401603717
W4401593691Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages2024-08-13OpenAlex10.1101/2024.08.12.607496Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401593691
W4401548844Transforming Disease Surveillance through Artificial Intelligence2024-08-13OpenAlex10.4103/ijcm.ijcm_459_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401548844
W4401628988Patient and Caregiver Insights from Social Media into the Disease Burden of Myelodysplastic Syndrome With A Sub-Cohort View of High-risk Patients (Preprint)2024-08-15OpenAlex10.2196/preprints.65460Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401628988
W4401618447Use of a Cyclic α-Alkylidene-β-Diketone as a Cleavable Linker Strategy for Antibody-Drug Conjugates2024-08-15OpenAlex10.1021/jacs.4c04567Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401618447
W4401646203Evolution of Prevention of HIV: A Personal Journey2024-08-16OpenAlex10.1097/olq.0000000000002046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401646203
W4401642506From the Cold Chain to Point-of Care Tests for Chlamydia and Gonorrhea: Personal Reflections2024-08-16OpenAlex10.1097/olq.0000000000002026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401642506
W4401643184Sexually Transmitted Diseases at 50: Historical Notes2024-08-16OpenAlex10.1097/olq.0000000000001998Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401643184
W4401632650Site-Selective Antibody Conjugation with Dibromopyrazines2024-08-16OpenAlex10.1021/acs.bioconjchem.4c00296Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401632650
W4401642742The Intimate Interface of HIV and Sexually Transmitted Infections Over 40 Years2024-08-16OpenAlex10.1097/olq.0000000000002012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401642742
W4401640980The role of cation-exchange resins in hyperkalemia management2024-08-16OpenAlex10.1016/j.mjafi.2024.07.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401640980
W4401646838Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN ‐ FRT expert consensus2024-08-16OpenAlex10.1111/jdv.20287Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401646838
W4401665028Evolving immunotherapeutic solutions for triple-negative breast carcinoma2024-08-17OpenAlex10.1016/j.ctrv.2024.102817Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401665028
W7214114240Machine Learning for Renewable Energy Forecasting and Smart Grid Optimization2024-08-17OpenAlex10.63544/a6kts575Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214114240
W4401704641Lupus Nephritis from Pathogenesis to New Therapies: An Update2024-08-18OpenAlex10.3390/ijms25168981Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401704641
W7217302962Renal Cell Carcinomas: Radiotherapy, Clinical Application, Radio-Sensitivity and Dose-Response2024-08-18OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217302962
W4401714261A Novel Approach to Noncompressible Torso Hemorrhage Using a Silicone-Based Polymer Universal Combat Matrix2024-08-19OpenAlex10.1093/milmed/usae085Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401714261
W4401735115Chapter 1 Nanocarrier drug delivery System: recent advancement and future potential2024-08-19OpenAlex10.1515/9783111320847-001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401735115
W4401714272Foreword2024-08-19OpenAlex10.1093/milmed/usae145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401714272; https://openalex.org/W4416427962
W4401690813Reassessing the management of uncomplicated urinary tract infection: A retrospective analysis using machine learning causal inference2024-08-19OpenAlex10.1101/2024.08.18.24312104Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401690813
W4401701586Soft nanoferrites for cancer diagnosis2024-08-19OpenAlex10.1201/9781003517139-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401701586
W4401975416Advancement in Mechanistic Alteration of IGFs Family of Receptors to Target Prostate and Cervical Cancer: An Updated Review2024-08-20OpenAlex10.2174/0115733947302362240807105327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401975416
W4402207347Assessment of the knowledge of healthcare workers on monkeypox in Nigeria2024-08-20OpenAlex10.3205/dgkh000493Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402207347
W4401715793Consideration of the Root Causes in Candidate Attrition During Oncology Drug Development2024-08-20OpenAlex10.1002/cpdd.1464Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401715793
W4401745694Telemedicine in the post-COVID era: balancing accessibility, equity, and sustainability in primary healthcare2024-08-21OpenAlex10.3389/fdgth.2024.1432871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401745694
W4401732558Were deaths recorded in Brazil due to cystic fibrosis or pulmonary fibrosis? A data-based analysis2024-08-21OpenAlex10.3389/fmed.2024.1459785Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401732558
W4401758439Contemporary treatment options in heart failure with preserved ejection fraction2024-08-22OpenAlex10.1093/ehjci/jeae201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401758439
W4401741836From Soft Microgel Assemblies to Advanced Healthcare Materials2024-08-22OpenAlex10.1002/adhm.202402905Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401741836
W4401755392Imaging in Erdheim-Chester Disease2024-08-22OpenAlex10.1148/rg.240011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401755392
W4401828575What’s New in Shoulder and Elbow Surgery2024-08-22OpenAlex10.2106/jbjs.24.00812Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401828575; https://openalex.org/W4414007880
W4401799173Formulation of Bacteriophage for Inhalation to Treat Multidrug-Resistant Pulmonary Infections2024-08-23OpenAlex10.14356/kona.2025016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401799173
W4401823827Green Nanomaterials for Sustainable Targeted Drug Delivery Systems2024-08-23OpenAlex10.1201/9781003501572-11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401823827
W4401811574Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance2024-08-23OpenAlex10.1016/b978-0-443-13376-3.00008-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401811574
W4401835422Molecular Mechanism and Actions of Antifungal Drugs Using Trichosporon Fungal Species2024-08-23OpenAlex10.22214/ijraset.2024.64031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401835422
W4401820878Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors2024-08-23OpenAlex10.4166/kjg.2024.060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401820878
W4401798070Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer2024-08-23OpenAlex10.1038/s41571-024-00935-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401798070
W4401802667Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program2024-08-23OpenAlex10.1053/j.gastro.2024.08.018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401802667
W4401853322Heart Failure in Older People Part 1: Disease State Review and Lifestyle Interventions2024-08-24OpenAlex10.4140/tcp.n.2024.325Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401853322
W4401865444An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer2024-08-25OpenAlex10.1016/j.clcc.2024.08.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401865444
W4407838366Investigating the Anti-Allergic, Bronchoprotective, and Antioxidant Activities of Psidium guajava Extract in Experimental Animals: A Comprehensive Study2024-08-25OpenAlex10.61920/jimp.v1i02.25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407838366
W4401891142A Narrative Review on Recombinant Human Bone Morphogenetic Protein 2: Where Are We Now?2024-08-26OpenAlex10.7759/cureus.67785Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401891142
W4403007871Current Treatment Process and Challenges for Spinal Muscular Atrophy (SMA)2024-08-26OpenAlex10.52711/0974-360x.2024.00580Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403007871
W4401963974Prilocaine vs bupivacaine in spinal anesthesia for urologic endoscopy: clinical trials & historical overview2024-08-26OpenAlex10.24884/2078-5658-2024-21-4-50-59Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401963974
W4401930103Editorial: Cancer and inflammatory diseases research: from the basics to the precision medicine2024-08-27OpenAlex10.3389/fphar.2024.1477963Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401930103
W4401929261Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention2024-08-27OpenAlex10.1016/j.medntd.2024.100327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401929261
W4401905048Therapeutics in hospitalised adult patients with COVID-192024-08-27OpenAlex10.1183/2312508x.10020423Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401905048
W4401970844Bacterial pathogens associated with community-acquired pneumonia in children aged from 28 days to 10 years admitted in Dakahlia Governorate hospitals: a cross-sectional study2024-08-28OpenAlex10.21203/rs.3.rs-4773221/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401970844
W4402012315CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey2024-08-28OpenAlex10.3389/fmed.2024.1413825Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402012315
W4402025816Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health2024-08-28OpenAlex10.1016/j.heliyon.2024.e37054Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4402025816
W4401954303Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in Mycobacterium tuberculosis2024-08-28OpenAlex10.1128/aac.00645-24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4401954303
W4403677619Property-Based Transparency: a New Utility Definition*2024-08-28OpenAlex10.1109/case59546.2024.10711688Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403677619; https://openalex.org/W4404433761
W4401947322Translating biological insights into improved management of endometrial cancer2024-08-28OpenAlex10.1038/s41571-024-00934-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401947322
W4401992551Who Cares for Black Women in Health and Health Care2024-08-28OpenAlex10.52843/cassyni.lw6tm5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401992551
W4401954680“What got you here, won’t get you there”: Students as leaders of the change we need2024-08-28OpenAlex10.1177/08404704241259917Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401954680
W4401979646Becoming agents for genomic change: genetic counsellors’ views of patient care and implementation influences when genomics is mainstreamed2024-08-29OpenAlex10.1038/s41431-024-01686-9Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4401979646
W4402015362Comparison of sinonasal symptoms in upper respiratory tract infections during the infectious diseases season of November 2023 to March 2024—a cross-sectional study2024-08-29OpenAlex10.3389/fmed.2024.1447467Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402015362
W4402003061Considering the Future of Geroscience: Goals and Opportunities Stemming From the Fourth Geroscience Summit2024-08-29OpenAlex10.1093/gerona/glae179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402003061
W4401986271The treatment landscape of triple-negative breast cancer2024-08-29OpenAlex10.1007/s12032-024-02456-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4401986271
W4402034457BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing2024-08-30OpenAlex10.1038/s41416-024-02827-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402034457
W4402072212Editorial: Spiroplasma, Mycoplasma, Phytoplasma, and other genome-reduced and wall-less mollicutes: their genetics, genomics, mechanics, interactions and symbiosis with insects, other animals and plants2024-08-30OpenAlex10.3389/fmicb.2024.1477536Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402072212
W4402035534Nutrition Considerations in the Intensive Care Unit2024-08-30OpenAlex10.4037/aacnacc2024643Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402035534
W4402055660The Most Disruptive Near-Term Use of AI in Cancer Care: Patient Empowerment Through Software Agents2024-08-30OpenAlex10.1089/aipo.2024.0027Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4402055660
W4402051052Updates on the Management of Autoimmune Bullous Diseases2024-08-30OpenAlex10.4103/idoj.idoj_740_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402051052
W4401895717Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice2024-08-31OpenAlex10.1016/j.mce.2024.112344Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401895717
W4413337398Pharmacokinetics and Pharmacodynamics of Glyburide: Insights for Optimizing Treatment in Type 2 Diabetes2024-08-31OpenAlex10.15416/ijcp.2024.13.2.48713Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413337398
W44025584951285P Deep learning prediction of response to advanced-generation ALK inhibitors (aALKi) in ALK-rearranged advanced NSCLC (aNSCLC) patients using digital pathology2024-09-01OpenAlex10.1016/j.annonc.2024.08.1342Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402558495
W44027049211661TiP SEGNO: An exploratory study of the safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer2024-09-01OpenAlex10.1016/j.annonc.2024.08.1742Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402704921
W7201606461Biyogörüntüleme ve biyosensing için genetik olarak tasarlanmış mikroplar2024-09-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7201606461
W4402114371Case 2: Worsening Anxiety in an Adolescent: The Role of Anchoring Bias2024-09-01OpenAlex10.1542/pir.2022-005947Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402114371
W4403454583Challenging the efficacy and safety of clopidogrel versus aspirin monotherapy in secondary prevention of coronary artery disease: a comprehensive review2024-09-01OpenAlex10.56808/3027-7922.2968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403454583
W4402895350Deciphering the Dynamics of EGFR-TKI Resistance in Lung Cancer: Insights from Bibliometric Analysis2024-09-01OpenAlex10.2147/dddt.s478910Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402895350
W4403810861Developments in good practice in medically assisted procreation: new rules and management of viral risks2024-09-01OpenAlex10.1684/mte.2024.1015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403810861
W4406376913Driving outperformance: The power and potential of economic profit2024-09-01OpenAlex10.1111/jacf.12637Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406376913
W4402768124E14 Adjusting RA to kids2024-09-01OpenAlex10.1136/rapm-2024-esra.571Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402768124
W4402888315Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach2024-09-01OpenAlex10.1002/jex2.70011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402888315
W4402288441From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria.2024-09-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402288441
W4404086842Insights and perspectives: EUS in post-liver transplantation care2024-09-01OpenAlex10.1097/eus.0000000000000084Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404086842
W4402378671Long‐term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved2024-09-01OpenAlex10.1002/jmv.29886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402378671
W4406310573New dimensions of oral potentially malignant disorders: Navigating the future2024-09-01OpenAlex10.4103/kleuhsj.kleuhsj_480_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406310573
W4402106272New strategies in soft tissue sarcoma treatment2024-09-01OpenAlex10.1186/s13045-024-01580-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402106272
W4402118374Original Sin in the Context of Lonergan's Soteriology2024-09-01OpenAlex10.1111/heyj.14347Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402118374
W4404164497Our Experiences and Learnings in Diagnosing MODY from Non-Institutional-Based Diabetes Care Clinics2024-09-01OpenAlex10.4103/ijem.ijem_361_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404164497
W4402798056P.157: Successful ABO i Renal Transplantation in UAE.2024-09-01OpenAlex10.1097/01.tp.0001067472.01188.34Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402798056
W4402817904P.245: Challenges and outcomes with kidney re-transplantation.2024-09-01OpenAlex10.1097/01.tp.0001067796.66340.9cTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402817904
W4402395680Re: Posterior urethral stenosis: Contemporary management options2024-09-01OpenAlex10.1002/uro2.81Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402395680
W4402627247Recent advances in immunotherapy for pancreatic cancer: a narrative review2024-09-01OpenAlex10.21037/dmr-24-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402627247
W4402373594SP6.3 - Comparison of three new wireless non-radiation techniques for localization of non-palpable breast cancer - an updated systematic review and pooled meta-analysis2024-09-01OpenAlex10.1093/bjs/znae197.068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402373594
W4402397851Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer2024-09-01OpenAlex10.1016/j.tjog.2024.07.014Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402397851
W4403527786Surgical Applications for Bone Marrow Aspirate Concentrate2024-09-01OpenAlex10.1016/j.arthro.2024.05.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403527786
W4405424409The “Brave New World” of biosimilars: Look before you leap!2024-09-01OpenAlex10.4103/kjo.kjo_130_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405424409
W4402818559V-212.5: Candida colonization and candidemia among pediatrics solid organ transplantation: A one year experience.2024-09-01OpenAlex10.1097/01.tp.0001066804.63088.e9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402818559
W4402624699VR Environments2024-09-01OpenAlex10.1162/pajj_a_00739Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402624699
W4406081512Vitiligo2024-09-01OpenAlex10.4103/pigmentinternational_82_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406081512
W4402139035Advances in Primary Stabbing Headache: Diagnostic Criteria, Epidemiological Insights, and Tailored Treatment Approaches2024-09-02OpenAlex10.62087/hpr.2024.0018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402139035
W4402198242Bladder sparing options for muscle-invasive bladder cancer2024-09-02OpenAlex10.1097/mou.0000000000001220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402198242
W4402147005Medical and neurologic management of brain tumor patients2024-09-02OpenAlex10.1097/wco.0000000000001315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402147005
W4402312999Pediatric Arteriovenous Malformations of the Neck: A Case Presentation and Review of Literature2024-09-02OpenAlex10.36347/sjmcr.2024.v12i09.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402312999
W4402138176Sustainable Therapeutic Approaches with Nanophotocatalyst2024-09-02OpenAlex10.1002/9781394212767.ch14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402138176
W4402191222Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma2024-09-03OpenAlex10.3390/biomedicines12092011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402191222
W4402193334Mpox treatment evolution: past milestones, present advances, and future directions2024-09-03OpenAlex10.1007/s00210-024-03385-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402193334
W4402190609Protection, Mobility, & Comfort: The Effects of Global Pandemics on Women's Dress2024-09-03OpenAlex10.32920/26871493Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402190609; https://openalex.org/W4402195296
W7219042703GERIATRIC ANESTHESIA: EVALUATING THE IMPACT OF AGE-RELATED PHYSIOLOGICAL CHANGES ON ANAESTHETIC PRACTICES2024-09-04OpenAlex10.33508/jwmj.v6i3.5764Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219042703
W4402326715Editorial: Theranostics as a driving force in nuclear medicine2024-09-06OpenAlex10.3389/fonc.2024.1468357Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402326715
W4402369378Emerging potential of progranulin-dependent SorCS2 signaling in healthy and diseased nervous systems2024-09-06OpenAlex10.4103/nrr.nrr-d-24-00734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402369378
W4402323764Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management2024-09-06OpenAlex10.1007/s00284-024-03875-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402323764
W4402321770Maintenance Therapy in Acute Myeloid Leukemia2024-09-06OpenAlex10.1097/coc.0000000000001140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402321770
W4402328958A Novel Use of Terbutaline: Persistent Genital Arousal Disorder in the Emergency Department2024-09-07OpenAlex10.1016/j.jemermed.2024.08.023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402328958
W4402332408Imaging recommendations for soft-tissue sarcomas: model guidelines from diagnosis to post-treatment follow-up2024-09-07OpenAlex10.1016/j.crad.2024.08.023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402332408
W4402341052Extracellular vesicles in pulmonary infection: From pathophysiology to theranostic technologies2024-09-08OpenAlex10.1016/j.cej.2024.155585Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402341052
W4402341744Toxin inhibition: Examining tetracyclines, clindamycin, and linezolid2024-09-08OpenAlex10.1093/ajhp/zxae251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402341744
W4402380415Editorial: Green Veterinary Pharmacology and Toxicology: a “One Health” Approach milestone2024-09-09OpenAlex10.3389/fvets.2024.1476877Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402380415
W4402357554Innovative Endovascular Management of Giant Superficial Temporal Artery Pseudoaneurysm Presented With Periorbital Ulcerative Mass2024-09-09OpenAlex10.1097/scs.0000000000010594Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402357554
W4402412143Journal-related Activities and Other Special Activities at the 2024 American Society of Anesthesiologists Meeting2024-09-09OpenAlex10.1097/aln.0000000000005165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402412143
W4402364542Navigating dry eye relief: Meibo’s approach to controlling tear evaporation2024-09-09OpenAlex10.1097/ms9.0000000000002550Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402364542
W4402409201Navigating the Maze: A Mini-Guide for the Management and Therapy of Metabolic Dysfunction-associated Steatotic Liver Disease2024-09-09OpenAlex10.58931/cpct.2024.2232Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402409201
W4402395751Anticipating Viral Challenges: A Perspective on Phytochemicals against Existing and Emerging Viruses2024-09-10OpenAlex10.2174/0122113525312781240819105116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402395751
W4402422896Editorial: From interventional pearls to pioneering technologies in transcatheter treatment of congenital heart defects2024-09-10OpenAlex10.3389/fcvm.2024.1484393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402422896
W4402452511Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches2024-09-10OpenAlex10.7759/cureus.69129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402452511
W4402423975Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period2024-09-10OpenAlex10.1016/j.ajem.2024.09.016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402423975
W4402421583INDOMETHACIN: A MIRACLE DRUG TO TREAT A RANGE OF AILMENTS WITH A RESTORATIVE AND SYNERGISTIC IMPACT2024-09-10OpenAlex10.22541/au.172594809.99819066/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402421583
W4402430424Liver disorders in substance abusers2024-09-10OpenAlex10.14744/hf.2024.2024.0012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402430424
W4402442117Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques2024-09-11OpenAlex10.1097/jw9.0000000000000178Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402442117
W4402498966Revolutionizing Ophthalmic Care: A Review of Ocular Hydrogels from Pathologies to Therapeutic Applications2024-09-11OpenAlex10.1080/02713683.2024.2396385Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402498966
W4402460438The evolution of heteroresistance via small colony variants in Escherichia coli following long term exposure to bacteriostatic antibiotics2024-09-11OpenAlex10.1038/s41467-024-52166-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402460438
W4402499278Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010–2022: A multicenter, retrospective, real-world study2024-09-12OpenAlex10.1097/cm9.0000000000003290Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402499278
W4402514733Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance2024-09-13OpenAlex10.1038/s41571-024-00939-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402514733
W4402524263Radiotherapeutic advances in the management of glioblastoma2024-09-13OpenAlex10.1007/s11060-024-04824-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402524263
W4402512757Yao Syndrome: An Overview of Genotypic Associations, Clinical Manifestations, Diagnosis, and Treatment2024-09-13OpenAlex10.1159/000540188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402512757
W4402754860Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules2024-09-14OpenAlex10.3390/antib13030076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402754860
W4402554757Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts2024-09-16OpenAlex10.1097/tp.0000000000005206Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402554757
W4402811020Editorial: The role of evidence-based medicine and value-based medicine in clinical practice to enhance mental health2024-09-16OpenAlex10.3389/fpubh.2024.1487305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402811020
W4402653058Review on Updated Management of Prurigo Nodularis (PN)2024-09-16OpenAlex10.36348/sjm.2024.v09i09.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402653058; https://openalex.org/W7168021626
W4402614090An evaluation of durvalumab across the spectrum of urothelial carcinoma2024-09-18OpenAlex10.1080/14737140.2024.2405104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402614090
W4402611321Diagnosis and Management of Immune Thrombocytopenia in Paediatrics: A Comprehensive Review2024-09-18OpenAlex10.7759/cureus.69635Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402611321
W4402592254Ex-vivo mouse precision cut tumour slices for modelling hepatocellular carcinoma; A 3Rs solution for at-scale drug screening2024-09-18OpenAlex10.1101/2024.09.16.613213Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402592254
W4402601219Functionalized PLGA-Based Nanoparticles with Anti-HSV-2 Human Monoclonal Antibody: A Proof of Concept for Early Diagnosis and Targeted Therapy2024-09-18OpenAlex10.3390/pharmaceutics16091218Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402601219
W4402643486Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review2024-09-19OpenAlex10.1016/j.critrevonc.2024.104520Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402643486
W4405800299Contemporary insights into the collagen-stimulating mechanism of polylactic acid: a new paradigm in dermal fillers using poly-L-lactic acid fillers2024-09-19OpenAlex10.54724/lc.2024.e10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405800299
W4402640743Immunological Advancements In Hand Eczema Treatment: Progress With Small Molecules and Biologics2024-09-19OpenAlex10.1007/s40521-024-00374-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402640743
W4402647582Modern Therapy of Chronic Myeloid Leukaemia2024-09-19OpenAlex10.5772/intechopen.115458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402647582
W4402641535Principles of lipid nanoparticle design for mRNA delivery2024-09-19OpenAlex10.1002/bmm2.12116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402641535
W7201223881Recent advances in pharmacothrapy of colorectal cancer2024-09-19OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201223881
W4402694600Harnessing artificial intelligence for breakthroughs in lung cancer management: are we ready for the future?2024-09-20OpenAlex10.3389/fonc.2024.1450568Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402694600
W4402772110Lessons Learned from the Zika Virus Epidemics: A Mounting Demand for Adopting Public Health Informatics Tools and Technologies for Epidemiological Surveillance and Outbreak Containment2024-09-20OpenAlex10.1007/s40475-024-00330-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402772110
W4402709853NOVOS ANTIDIABÉTICOS E PERSPECTIVAS NO MANEJO DA HIPERGLICEMIA CRÔNICA2024-09-20OpenAlex10.51473/rcmos.v1i1.2024.613Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402709853
W4402674365Self-Improved Language Production in Nonfluent Aphasia Through Automated Recursive Self-Feedback2024-09-20OpenAlex10.1044/2024_ajslp-23-00320Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402674365
W4402844157Synthesis and antimicrobial activity of hybrid peptides as dual inhibitor of intracellular targets in ESKAPE pathogens2024-09-20OpenAlex10.17952/37eps.2024.p2150Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402844157
W4402709153Abstract C054: Current anticancer drugs differentially impact Black and White prostate cancer cell lines2024-09-21OpenAlex10.1158/1538-7755.disp24-c054Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402709153
W4402750809An Overview of the Recent Advances in Antimicrobial Resistance2024-09-21OpenAlex10.3390/microorganisms12091920Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402750809
W4402711151Chemotherapy of Malignancy-II2024-09-21OpenAlex10.58532/nbennurphch17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402711151
W4402715408Advancements in Topical Treatments for Acne Vulgaris: A Comprehensive Review of Efficacy, Safety, and Patient Satisfaction2024-09-22OpenAlex10.61853/6zczv952Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402715408
W44027603839 Nanotoxicity prediction in nanotechnology-driven drugs using QSPR modeling2024-09-23OpenAlex10.1515/9783111208671-009Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402760383
W4402724640Advancements in cholangiocarcinoma: evolving strategies for diagnosis, treatment, and palliation over three decades2024-09-23OpenAlex10.21037/cco-23-144Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4402724640
W4402731407Advances in nephroprotection: the therapeutic role of selenium, silver, and gold nanoparticles in renal health2024-09-23OpenAlex10.1007/s11255-024-04212-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402731407
W4402730915Erdosteine in Chronic Obstructive Pulmonary Disease – Evidence and Current Role2024-09-23OpenAlex10.4103/jalh.jalh_21_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402730915
W4402741146Recurrent acute myocardial and renal infarction with aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome: a case report2024-09-23OpenAlex10.1093/ehjcr/ytae526Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402741146
W4402802387CARDIOMIOPATIA INDUZIDA POR QUIMIOTERAPIA: UMA REVISÃO INTEGRATIVA SOBRE MECANISMOS, DIAGNÓSTICO E TRATAMENTO2024-09-24OpenAlex10.69849/revistaft/ma10202409241436Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402802387
W4402772092Commentary on “Preoperative Chemotherapy Response and Survival in Patients With Colorectal Cancer Peritoneal Metastases”2024-09-24OpenAlex10.1002/jso.27929Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402772092
W4407729972Living conditions, working conditions, professional development and self-identity in Chinese rural primary school teachers: A chain-mediating model2024-09-24OpenAlex10.46690/elder.2024.04.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407729972
W4402763358Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma2024-09-24OpenAlex10.1097/ms9.0000000000002601Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402763358
W4402794043Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies2024-09-24OpenAlex10.1177/26331055241265668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402794043
W4402786461The Role of Nanomaterials in Diagnosis and Targeted Drug Delivery2024-09-24OpenAlex10.1002/cbdv.202401581Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402786461
W4402847570Advancements in Pyrazine Derivatives as Anticancer Agents: A Comprehensive Review (2010-2024)2024-09-25OpenAlex10.2174/0118715206333399240912071555Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4402847570
W4402861686Disrupting the activity of endogenous gas neurotransmitters: a therapeutic strategy using engineered metal–organic frameworks for cancer2024-09-25OpenAlex10.4103/mgr.medgasres-d-24-00046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402861686
W4402814805Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges2024-09-25OpenAlex10.3389/fphar.2024.1489396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402814805
W4402828241Management of von Willebrand disease for orthognathic surgery: Evidenced-based recommendations and scoping review of the literature2024-09-25OpenAlex10.1016/j.adoms.2024.100498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402828241
W4402825008Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions2024-09-25OpenAlex10.1016/j.euo.2024.09.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402825008
W4402841314Performance evaluation of image co-registration methods in photoacoustic mesoscopy of the vasculature2024-09-25OpenAlex10.1088/1361-6560/ad7fc7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402841314
W4402846669Rabies virus as vector for development of vaccine: pros and cons2024-09-25OpenAlex10.3389/fvets.2024.1475431Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402846669
W4402849875S. Todd Lowry (1927–2023)2024-09-25OpenAlex10.1215/00182702-11540302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402849875
W4402829862Strategies to optimize initial P2Y12 inhibitor therapy in STEMI patients2024-09-25OpenAlex10.1016/j.carrev.2024.09.012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402829862
W4402815455Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine2024-09-25OpenAlex10.3390/biomedicines12102175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402815455
W4402894782Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research2024-09-26OpenAlex10.3389/fonc.2024.1485761Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402894782
W4402884616Medical Management of Acute Stroke based on Japan Stroke Society Guidelines and the Japan Stroke Data Bank2024-09-26OpenAlex10.5551/jat.rv22027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402884616
W4402873358THE THREAT OF CBRN TERRORISM: AN OVERVIEW AND IMPROVISED USE OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR MATERIALS2024-09-26OpenAlex10.5604/01.3001.0054.7565Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4402873358
W4402907157A Novel Localized Student-Teacher LLM for Enhanced Toxicity Extraction in Radiation Oncology2024-09-27OpenAlex10.1016/j.ijrobp.2024.07.1392Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402907157
W4402907482Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era2024-09-27OpenAlex10.1016/j.ijrobp.2024.07.2220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402907482
W4402935626Assessing organ function in the critically ill patient2024-09-27OpenAlex10.1097/jtccm-d-24-00038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402935626
W4402928626Recent Advances in Nanomedicine: Enhancing Drug Delivery and Diagnosis through Nanotechnology2024-09-27OpenAlex10.47392/irjaem.2024.0443Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402928626
W4402948599A Five-Year Trend Analysis of Antibacterial Resistance Patterns Among Non-fermenting Gram-Negative Bacilli: A Retrospective Study From the ICU Settings of a Tertiary Care Hospital2024-09-28OpenAlex10.7759/cureus.70375Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402948599
W4403038995Diagnosis and treatment of pneumocystis pneumonia - a review article2024-09-28OpenAlex10.55214/25768484.v8i6.2032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403038995
W4403068458Monkeypox: A comprehensive review of virology, epidemiology, and global health implications2024-09-28OpenAlex10.21608/mid.2024.317587.2187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403068458
W4402956737Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer2024-09-29OpenAlex10.37349/etat.2024.00273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402956737
W4402988649Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma2024-09-29OpenAlex10.3390/antib13040080Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402988649
W4403196675A Review on Applications of Photodynamic Therapy in Oral and Maxillofacial Surgery2024-09-30OpenAlex10.53555/ajbr.v27i3s.1560Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403196675
W4402995824An Uncommon Clinical Mystery: Systemic Lupus Erythematosus Masquerading as Aseptic Meningitis in a Male Patient2024-09-30OpenAlex10.7759/cureus.70484Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4402995824
W4406231789CDA Formulations as the Only Option Capable of Reducing Cancer Mortality2024-09-30OpenAlex10.33425/2833-0390.1035Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406231789
W4403044114COPD : The forgotten cardiovascular risk2024-09-30OpenAlex10.1111/resp.14837Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403044114
W4402995695Graphene Quantum Dots from Natural Carbon Sources for Drug and Gene Delivery in Cancer Treatment2024-09-30OpenAlex10.3390/ijms251910539Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4402995695
W7224069612Plane Warts: Clinical Features, Pathogenesis, Diagnostic Modalities, and Emerging Immunotherapeutic Approaches2024-09-30OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224069612
W4403014004Polymer-Based Antimicrobial Peptide Mimetics for Treating Multi-drug Resistant Infections: Therapy and Toxicity Evaluation2024-09-30OpenAlex10.1007/s10989-024-10648-0Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403014004
W7118123056Role of Clinical Laboratories in Early Detection of Sepsis2024-09-30OpenAlex10.22399/ijcesen.4643Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118123056
W4400397773TOWARDS RIEMANNIAN EEG CLASSIFIERS TO DETECT AWAKE AND ANESTHETIZED STATES USING MEDIAN NERVE STIMULATION2024-09-30OpenAlex10.3217/978-3-99161-014-4-017Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4400397773
W4403096463Treatment Paradigms in Radiation Maculopathy Treatment: What’s Next?2024-09-30OpenAlex10.18103/mra.v12i9.5708Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403096463
W44031531417856 In Pursuit of Solutions: Exploring Novel Therapeutic Strategies in the Treatment of a Rare, Aggressive Macroprolactinoma Post-Temozolomide: A Case Report2024-10-01OpenAlex10.1210/jendso/bvae163.1245Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403153141
W4404500269Abstracts of ICRR-HHE-2024 and 4th Biennial Meeting of the Society for Radiation Research2024-10-01OpenAlex10.4103/jrcr.jrcr_53_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404500269
W4405782678Advancing glaucoma management: Innovation, collaboration, and future directions2024-10-01OpenAlex10.4103/sjopt.sjopt_329_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405782678
W4403914937Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice2024-10-01OpenAlex10.1200/po.24.00173Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403914937
W4403070611B-198 Rapid Molecular Detection of Respiratory Infections in Brazilian Hospitals and Outpatient Units: Insights from the Diagnostic Medicine and Health Network2024-10-01OpenAlex10.1093/clinchem/hvae106.558Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403070611
W4403938916Can Blood Gene Expression Profile and Donor-Derived Cellfree DNA Guide Postrejection Management among Kidney Transplant Recipients?2024-10-01OpenAlex10.34067/kid.0000000570Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403938916
W4403833327Current and Future State of Hyperphosphatemia Management2024-10-01OpenAlex10.1681/asn.20241m3ghe0mTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403833327
W4403831385Demystifying the Atypical Presentation of Complement-Mediated Thrombotic Microangiopathy2024-10-01OpenAlex10.1681/asn.20247861nh0bTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403831385
W4403005353Dentistry and Pharmaceutical Science: An Evolving Synergy for Oral Health Optimization2024-10-01OpenAlex10.61615/jmccr/2024/oct027141002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403005353
W4403824647Design and Synthesis of Six‐Armed Antimicrobial Polymer to Battle Against Nosocomial Pathogens2024-10-01OpenAlex10.1002/pat.6606Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403824647
W4403568742EVALUATION OF DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (D-VRD) INDUCTION FOLLOWED BY DARATUMUMAB AND LENALIDOMIDE (DR) MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS IN BRAZIL2024-10-01OpenAlex10.1016/j.htct.2024.09.873Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403568742
W7216928870Ethical Considerations in Respiratory Therapy and Nursing Practice: Balancing Patient Autonomy and Care2024-10-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216928870
W4403046700Future applications of host direct therapies for infectious disease treatment2024-10-01OpenAlex10.3389/fimmu.2024.1436557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403046700
W4403107141Heart Failure in Older People Part 2: Guideline-Directed Medical Therapy2024-10-01OpenAlex10.4140/tcp.n.2024.360Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403107141
W4405807106Keratoconus2024-10-01OpenAlex10.4103/tjosr.tjosr_154_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405807106
W4403831428Lupus Nephritis Histopathological Classification System: A Questionnaire-Based Survey of the Renal Pathology Society (RPS)2024-10-01OpenAlex10.1681/asn.2024nzrsxw8eTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403831428
W4403531656Optimizing CT Protocols: Advanced Dose Reduction and Contrast Media Strategies for Personalized Patient Care – Today's Innovations and Tomorrow's Horizons2024-10-01OpenAlex10.1016/j.jmir.2024.101456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403531656
W4403518742P17.02.B BMSCOPE: A SCOPING REVIEW TO CHART THE EVOLVING CLINICAL STUDY LANDSCAPE IN BRAIN AND LEPTOMENINGEAL METASTASIS2024-10-01OpenAlex10.1093/neuonc/noae144.289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403518742
W4403811629Peritonitis Trends and Patient Outcomes in Peritoneal Dialysis from a Portuguese Center: Decades of Data Unlocked2024-10-01OpenAlex10.1681/asn.2024bbz8751wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403811629
W4403830980Renal Crystal-Storing Histiocytosis: Transition from Monoclonal Gammopathy of Unknown Significance to Monoclonal Gammopathy of Renal Significance2024-10-01OpenAlex10.1681/asn.2024v77cjdghTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403830980
W4403721693S1939 The Evolving Landscape of Drug Induced Liver Injury (DILI): Tracking New Drug Culprits2024-10-01OpenAlex10.14309/01.ajg.0001037124.81921.b2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403721693
W4403726730S3064 Gastografin Enema to the Rescue of the Glorious Cecal Bascule2024-10-01OpenAlex10.14309/01.ajg.0001041624.40531.77Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403726730
W4403721934S4093 Novel Hemostatic Gel and Powder as Rescue Agents for Arterial Bleeding Related to Lumen Apposing Metal Stent Placement2024-10-01OpenAlex10.14309/01.ajg.0001045740.45614.a5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403721934
W4403719853S4739 Unmasking the Chameleon: A Case of Systemic Amyloidosis with Gastrointestinal and Cardiac Involvement2024-10-01OpenAlex10.14309/01.ajg.0001048324.86372.57Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403719853
W4403063076Scorpionism in a fibromyalgia patient: First report2024-10-01OpenAlex10.4103/sja.sja_233_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403063076
W4403568577THE DYNAMIC OF MDS DIAGNOSIS: FROM MULTI-LINEAGE DYSPLASIA AND HIGH BLASTS TO LMMC - A CASE REPORT2024-10-01OpenAlex10.1016/j.htct.2024.09.757Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403568577
W4403461043The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL2024-10-01OpenAlex10.6004/jnccn.2024.7065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403461043
W4403812702The effect of Trimetazidine on the left ventricular global longitudinal strain assessed by cardiac magnetic resonance in stable angina patients with previous myocardial infarction and left ventricular2024-10-01OpenAlex10.1093/eurheartj/ehae666.831Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403812702
W4403213910The emerging role of bacterial extracellular vesicles in human cancers2024-10-01OpenAlex10.1002/jev2.12521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403213910
W7118204591The future of ambulatory anaesthesia: Current trends and emerging techniques2024-10-01OpenAlex10.33545/26643766.2024.v7.i4a.621Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118204591
W4404018330The history of cytoreduction and HIPEC: Heating up or just blowing smoke?2024-10-01OpenAlex10.1002/jso.27802Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404018330
W4405666031Unlocking the “Golden” potential of brachytherapy at the nanoscale: Is the era of nano-brachytherapy near?2024-10-01OpenAlex10.4103/jcrt.jcrt_1760_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405666031
W4403053761Brazilian community health agents and qualitative primary healthcare information2024-10-02OpenAlex10.32920/27156453Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4403053761; https://openalex.org/W4403058217
W4403110384Inhibitory Potential of Silychrystin on ERR‐γ, Keap‐1, and NF‐κB Proteins in Acute Pancreatitis Explored Through Molecular Docking and Molecular Dynamics Simulation2024-10-02OpenAlex10.1002/slct.202404305Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403110384
W4403195240CAR-T cell therapy in evolving therapeutic landscape of relapsed or refractory primary mediastinal b-cell lymphoma (PMBCL): challenges and aspirations — two case reports2024-10-03OpenAlex10.5603/hicp.98832Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403195240
W4403097783Fungal lung disease2024-10-03OpenAlex10.1183/13993003.00803-2024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403097783
W4403088032Linear IgA bullous dermatosis in a latin adolescent treated with cyclosporine and prednisone2024-10-03OpenAlex10.24875/bmhim.24000043Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403088032
W4403095665Revisiting the clinical encounter II2024-10-03OpenAlex10.4324/9780367824051-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403095665
W4403097772Role of AI in smart robotic systems2024-10-03OpenAlex10.1201/9781003537083-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403097772
W4403112258A Modern Epidemic of Dermatology Quackery in India2024-10-04OpenAlex10.4103/idoj.idoj_907_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403112258
W4403276089Antimicrobial Peptides in the Fight Against Drug-Resistant Superbug Infections2024-10-04OpenAlex10.20944/preprints202410.0241.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403276089
W4411001396Antiviral treatment of COVID-192024-10-04OpenAlex10.70070/3kv7z420Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411001396
W4403143075Editorial: Future frontiers in the management of metastatic colorectal cancer2024-10-04OpenAlex10.3389/fonc.2024.1486653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403143075
W4403119668Hybrid Approaches2024-10-04OpenAlex10.1002/9781394272587.ch13Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403119668
W4403117069Infection risk with JAK inhibitors in dermatoses: a meta‐analysis2024-10-04OpenAlex10.1111/ijd.17501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403117069
W4403139045THE SUPPLY OF MEDICINES AS EXAMPLE OF A RE-DESIGN OF THE DISTRIBUTION NETWORK2024-10-04OpenAlex10.52152/dmn10962Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403139045
W4403147856Large descending colon alveolar soft part sarcoma with ASPL-TFE3 fusion gene: Case report and review of the literature2024-10-05OpenAlex10.1016/j.ijscr.2024.110390Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403147856
W4403151441Acute Pain Management Following Mandibular Third Molar Exodontia: A Bibliometric Analysis of Randomized Controlled Trials2024-10-06OpenAlex10.1016/j.identj.2024.09.018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403151441
W7206557353Cell wall lipopeptide structure of ancestral strains of Mycobacterium avium subsp. paratuberculosis2024-10-07OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7206557353
W4403237120Could H5N1 bird flu virus be the cause of the next human pandemic?2024-10-08OpenAlex10.3389/fmicb.2024.1477738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403237120
W4403237527Editorial: Exploring the links between social connections, care and integration2024-10-08OpenAlex10.3389/fhumd.2024.1501897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403237527
W4403209671Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review2024-10-08OpenAlex10.1007/s00210-024-03507-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403209671
W4403213288Ritonavir’s Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications2024-10-08OpenAlex10.3390/curroncol31100450Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4403213288
W4403254705Exploration of the Synthesis, Properties, and Biological Applications of B-CDs Materials2024-10-09OpenAlex10.22541/au.172846628.85457688/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403254705
W4403252809Full Genome Characterization of the First Oropouche Virus Isolate Imported in Europe from Cuba2024-10-09OpenAlex10.3390/v16101586Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403252809
W4403248059Leukemic occult infiltrative optic neuropathy presenting as optic neuritis: a case report2024-10-09OpenAlex10.1186/s12886-024-03717-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403248059
W4403286432Cellulose nanocrystal based electrospun nanofiber for biomedical applications–A review2024-10-10OpenAlex10.1016/j.carbpol.2024.122838Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403286432
W4403319163Efficacy of Nitrofurantoin in Treating Urinary Tract Infections2024-10-10OpenAlex10.48175/ijarsct-19818Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403319163
W4403301805From Bench to Bedside: A Team’s Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma2024-10-10OpenAlex10.3390/jcm13206036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403301805
W4403285387Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective study2024-10-10OpenAlex10.1016/j.jaad.2024.09.060Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403285387
W4403308940Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach?2024-10-10OpenAlex10.1016/j.jtcvs.2024.05.029Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403308940
W4403293231The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases2024-10-10OpenAlex10.1016/j.jacl.2024.09.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403293231
W4403332715Blame it on ... Anesthesia?2024-10-11OpenAlex10.1097/aln.0000000000005202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403332715
W4403357857Efficacy and safety of inhaled molecular hydrogen therapy in patients with respiratory failure due to chronic obstructive pulmonary disease exacerbation in post-COVID period2024-10-11OpenAlex10.18093/0869-0189-2024-34-5-655-667Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403357857
W4403316616Future perspectives and challenges for biomaterials in cancer precision medicine2024-10-11OpenAlex10.1016/b978-0-323-85661-4.00008-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403316616
W4403335118Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle2024-10-11OpenAlex10.1097/lvt.0000000000000509Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403335118
W4403286988Novel Therapies for Primary Central Nervous System Lymphomas2024-10-11OpenAlex10.1007/s11910-024-01376-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403286988
W4407949541Developing Global Competences and Values for Sustainable Development for Interdisciplinary Students Through a COIL Experience Between Chile and Colombia2024-10-13OpenAlex10.1109/fie61694.2024.10893415Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407949541
W4403380486A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson’s Disease: An Updated Patent and Clinical Trials2024-10-14OpenAlex10.2174/0118715273323074241001071645Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403380486
W4403438235Atypical Presentation of Adult-Onset Hydroa Vacciniforme with Direct Immunofluorescence Positivity—A Case Report2024-10-14OpenAlex10.4103/idoj.idoj_927_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403438235
W4403383598Current therapeutic overview and future perspectives regarding the treatment of psoriasis2024-10-14OpenAlex10.1016/j.intimp.2024.113388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403383598
W4403381048Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures2024-10-14OpenAlex10.15420/usc.2023.21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403381048
W4403382210Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond2024-10-14OpenAlex10.1161/circulationaha.124.070087Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403382210
W4403384263Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States2024-10-14OpenAlex10.1016/j.bneo.2024.100047Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403384263
W4403438980Slow-Flow Venous Malformation of Vulva in a Pre-menarcheal Girl2024-10-14OpenAlex10.4103/idoj.idoj_886_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403438980
W4403463121Emergence of Transdermal Drug Delivery Technologies: A Historical Synopsis and Systematic Review on Microneedles2024-10-15OpenAlex10.70389/pjs.100019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403463121
W4403412963Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment2024-10-15OpenAlex10.1021/acsmedchemlett.4c00490Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403412963
W4403426102Severe, rapidly evolving infective endocarditis as a complication of elective surgery: a case report2024-10-15OpenAlex10.24969/hvt.2024.521Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403426102
W4403441543“Out With the Old, In With the New”: Donor Risk Evolution Is Upon Us2024-10-15OpenAlex10.1097/tp.0000000000005250Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403441543
W4403474999Editorial: Recent advancements in mycobacterial diseases research2024-10-16OpenAlex10.3389/fmicb.2024.1504449Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403474999
W4403474452Optimizing Microarray Gene Selection in Colon Cancer: An Enhanced Metaheuristic Algorithm for Feature Selection2024-10-16OpenAlex10.1007/978-3-031-73420-5_7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403474452
W4403543501Otolaryngology2024-10-16OpenAlex10.1097/xcs.0000000000001174Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403543501
W4403457388The history of sclerosant foams: persons, techniques, patents and medical improvements2024-10-16OpenAlex10.1201/9781003579779-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403457388
W4403543509Vascular Surgery2024-10-16OpenAlex10.1097/xcs.0000000000001183Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403543509
W4403625741Breast Cancer2024-10-17OpenAlex10.1017/9781009279864.014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403625741; https://openalex.org/W7160384760; https://openalex.org/W4408156349
W4403497629Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations2024-10-17OpenAlex10.3324/haematol.2024.286061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403497629
W4403510167Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey2024-10-17OpenAlex10.1038/s41391-024-00906-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403510167
W4403540544Abstracts for the ISEE Asia and Western Pacific (AWPC) Chapter2024-10-18OpenAlex10.1097/ee9.0000000000000345Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403540544
W4403524154In vitro maturation of oocytes: what is already known?2024-10-18OpenAlex10.1093/biolre/ioae147Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403524154
W4403544061Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance2024-10-18OpenAlex10.1097/hep.0000000000001112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403544061
W4403561954Nanobodies: From High-Throughput Identification to Therapeutic Development2024-10-19OpenAlex10.1016/j.mcpro.2024.100865Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403561954
W4403553771Potential role of heteroplasmic mitochondrial DNA mutations in modulating the subtype-specific adaptation of oral squamous cell carcinoma to cisplatin therapy2024-10-19OpenAlex10.1007/s12672-024-01445-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403553771
W4403572987Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations2024-10-19OpenAlex10.1093/nop/npae076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403572987
W44110017352024-10-20OpenAlex10.70070/0yygg348Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411001735
W4403617076A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India2024-10-21OpenAlex10.3389/fonc.2024.1382856Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403617076
W4403602871Nanomaterial-Enhanced Microneedles: Emerging Therapies for Diabetes and Obesity2024-10-21OpenAlex10.3390/pharmaceutics16101344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403602871
W4403649612Blinatumomab use in patients with CD19 positive B-ALL and hepatic dysfunction2024-10-22OpenAlex10.1080/10428194.2024.2416018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403649612
W4403619467Proteostasis failure: at the intersection between aging and Alzheimer’s disease2024-10-22OpenAlex10.4103/nrr.nrr-d-24-00658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403619467
W4403658944The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma2024-10-22OpenAlex10.3389/fonc.2024.1392653Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403658944
W4403689449Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma2024-10-23OpenAlex10.1007/s11912-024-01607-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403689449
W4403679193Membranes to Improve Amperometric Sensor Characteristics2024-10-23OpenAlex10.1201/9781003575177-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403679193
W4403688002Potential Anti-tumor Effects and Apoptosis-inducing Mechanisms of Saponins: A Review2024-10-23OpenAlex10.2174/0115680266315197241015101801Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403688002
W4403683396Review: Known, Emerging, and Remerging Pharyngitis Pathogens2024-10-23OpenAlex10.1093/infdis/jiae391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403683396
W4403719285Usage of Bacterial Whole Genome Sequencing: Outbreaks and Beyond in Pediatric Patients2024-10-23OpenAlex10.1097/inf.0000000000004588Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403719285
W4403731690Functional evolution and functional biodiversity: 150 years of déjà vu or new physiology of evolution?2024-10-24OpenAlex10.3389/fcell.2024.1485089Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403731690
W4403846753Nanotherapeutics as Antibacterial and Antiviral Agents: Approach beyond Antibiotics2024-10-24OpenAlex10.2174/9789815256505124010004Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4403846753
W4403716976The Impact of Anesthesia on Dermatological Outcomes: A Narrative Review2024-10-24OpenAlex10.7759/cureus.72321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403716976
W4403710250Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue2024-10-24OpenAlex10.1055/a-2448-7029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403710250
W4403777036Using Poetic Assemblage to Trouble Stigma Associated With Perinatal Drug Use2024-10-24OpenAlex10.1177/00914509241293256Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403777036
W4403772814Antibody-drug conjugates2024-10-25OpenAlex10.1016/b978-0-443-13466-1.00003-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403772814
W4403767719Clinical challenges and research perspectives in liver transplant oncology2024-10-25OpenAlex10.1097/cm9.0000000000003339Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403767719
W4403747999Editorial: Graft preservation2024-10-25OpenAlex10.3389/fcvm.2024.1478730Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403747999
W4403752414The Relationship between Cerebral Autoregulation Dysfunction and Memory Impairment in Cardiac Surgery Patients2024-10-25OpenAlex10.1053/j.jvca.2024.09.101Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403752414
W4403778046Ultrasound-guided intra-tumoral administration of directly-injected therapies: a review of the technical and logistical considerations2024-10-25OpenAlex10.1186/s40644-024-00763-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403778046
W4403759109Volumetric Ultrasound Localization Microscopy2024-10-25OpenAlex10.1109/tuffc.2024.3485556Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403759109
W4403969939EXPLORING AI-POWERED CHATBOTS FOR CUSTOMER SERVICE ENHANCEMENT2024-10-27OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403969939
W7215717412Estrategias didácticas para potenciar la evaluación formativa en estudiantes de quinto año de la EGB2024-10-27OpenAlex10.51736/r8veq766Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7215717412
W4405571048From cardiorenal to cardiovascular–kidney–metabolic syndromes2024-10-28OpenAlex10.1093/eurheartj/ehae775Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405571048
W4403827784Navigating the Labyrinth; Current Trends in Distal Urethritis Management2024-10-28OpenAlex10.1007/s11884-024-00762-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403827784
W4403835175On Call: A Doctor’s Journey in Public Service2024-10-28OpenAlex10.1097/aln.0000000000005235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403835175
W4403806908The role of DC subgroups in the pathogenesis of asthma2024-10-28OpenAlex10.3389/fimmu.2024.1481989Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403806908
W4409448850Transplanting the unexpected: what happens when donors have coronary artery disease?2024-10-28OpenAlex10.1097/io9.0000000000000230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409448850
W4403852427Evolving Patient-Centred Therapies for Metastatic NSCLC2024-10-29OpenAlex10.33590/emjoncol/rhir5662Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4403852427
W4404111482Generative AI as Third Agent: LLMs and the Transformation of the Clinician-Patient Relationship (Preprint)2024-10-29OpenAlex10.2196/preprints.68146Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404111482
W4403875881Melanocortin 4 receptor mutation in obesity2024-10-29OpenAlex10.5493/wjem.v14.i4.99239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403875881
W4403976533Therapeutic Advancements in Anemia of Chronic Kidney Disease and End Stage Kidney Disease2024-10-29OpenAlex10.18103/mra.v12i10.5815Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403976533
W4403918132Computer-Assisted Analysis of Myelography2024-10-30OpenAlex10.4018/979-8-3693-5226-7.ch006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403918132
W4403912094Editorial: Brain injury in spontaneous intracerebral hemorrhage: from bench to bedside2024-10-30OpenAlex10.3389/fstro.2024.1501662Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403912094
W4403911815Editorial: The role of sphingolipid metabolism in endocrine diseases2024-10-30OpenAlex10.3389/fendo.2024.1506971Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403911815
W4403894443Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure2024-10-30OpenAlex10.4330/wjc.v16.i11.665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403894443
W4403968087Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review2024-10-30OpenAlex10.18699/ssmj20240501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403968087
W4403978481Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment2024-10-30OpenAlex10.3390/jcm13216537Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403978481
W4403912962On Multimodal Emotion Recognition for Human-Chatbot Interaction in the Wild2024-10-30OpenAlex10.1145/3678957.3685759Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4403912962
W4403898719Prostate cancer2024-10-30OpenAlex10.1016/b978-0-443-13825-6.00103-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403898719
W4403909115REVIEW ON EFFLUX PUMP BLOCKER FOR DRUG RESISTANCE BACTERIA2024-10-30OpenAlex10.53555/0tg8ps18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403909115
W4403985811Association of Liver Damage and Quasispecies Maturity in Chronic HCV Patients: The Fate of a Quasispecies2024-10-31OpenAlex10.3390/microorganisms12112213Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403985811
W4403942235Clinician-Researcher Leads Young Investigators to Emergence & Success2024-10-31OpenAlex10.1097/01.cot.0001083624.57191.8aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403942235
W4403952896Impact of a Service Learning Curriculum that Emphasizes Bidirectional Learning on Medical Students’ Professional Identity Formation2024-10-31OpenAlex10.1007/s40670-024-02202-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403952896
W4403939031The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease2024-10-31OpenAlex10.3390/biom14111393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403939031
W44044455022024-11-01OpenAlex10.1111/php.v100.6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404445502
W44040652641132 Enhancing melanoma therapy efficacy by protecting EZH2 activity in T cells2024-11-01OpenAlex10.1136/jitc-2024-sitc2024.1132Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404065264
W44040643801388 Characterization of the DDLPS TIME reveals distinct immune heterogeneity and T cell terminal exhaustion2024-11-01OpenAlex10.1136/jitc-2024-sitc2024.1388Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404064380
W4403977866Atypical Presentation of Rapidly Progressive Cutaneous Metastases of Clear Cell Renal Carcinoma: A Case Report2024-11-01OpenAlex10.3390/medicina60111797Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4403977866
W4404148524Battling Kyasanur forest disease: the race for robust and long-lasting Kyasanur forest disease vaccine2024-11-01OpenAlex10.1097/gh9.0000000000000496Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404148524
W4404562102Celebrating the Discovery of Insulin and Pressure Injury Awareness Day, and Reexamining Irritant Contact Dermatitis Due to Incontinence2024-11-01OpenAlex10.1097/asw.0000000000000231Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404562102
W4404519624Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease2024-11-01OpenAlex10.1161/circinterventions.124.014026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404519624
W4403982992Current approaches for the treatment of chronic respiratory disorders and limitations2024-11-01OpenAlex10.1016/b978-0-443-27345-2.00002-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403982992
W4404996023Disrupting Bacterial Biofilms to Combat Dental Diseases Using Nanotechnology in Oral Healthcare2024-11-01OpenAlex10.25163/angiotherapy.81110010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404996023
W4404256954EPCO-39. MULTIOMIC AND CLINICAL ANALYSIS OF MULTIPLY RECURRENT MENINGIOMAS REVEALS RISK FACTORS, UNDERLYING BIOLOGY, AND INSIGHTS INTO EVOLUTION2024-11-01OpenAlex10.1093/neuonc/noae165.0038Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404256954
W4403982984Emerging therapeutics in the treatment of chronic respiratory disorders2024-11-01OpenAlex10.1016/b978-0-443-27345-2.00003-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403982984
W4404837688Evolving occupational health needs for the adult social care workforce due to changing migration patterns: a cross-sectional study2024-11-01OpenAlex10.1016/s0140-6736(24)02042-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404837688
W4404237704INNV-18. FOCUS ON CURRENT AND EMERGING TREATMENT OPTIONS FOR GLIOMA: A COMPREHENSIVE REVIEW2024-11-01OpenAlex10.1093/neuonc/noae165.0681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404237704
W4405592825Magicking into Being2024-11-01OpenAlex10.1215/00138282-11343951Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405592825
W4404459287Multilocular Cystic Renal Neoplasia of Low-grade Malignant Potential: Evolving Diagnostic Criteria: A Case Report with Review of Literature2024-11-01OpenAlex10.4103/mjdrdypu.mjdrdypu_811_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404459287
W4404160229Nanobubble Contrast Enhanced Ultrasound Imaging: A Review2024-11-01OpenAlex10.1002/wnan.2007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404160229
W4403982787Natural product-based compounds for chronic respiratory disorders2024-11-01OpenAlex10.1016/b978-0-443-27345-2.00010-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4403982787
W4404080066P43 Unmasking posterior reversible encephalopathy syndrome: a hidden threat in juvenile lupus2024-11-01OpenAlex10.1093/rap/rkae117.074Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404080066
W4404486806Practice paper 32024-11-01OpenAlex10.1201/9781003579731-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404486806
W4405666118Windows to Worlds: Eduardo Jiménez de Aréchaga’s Teachings at the Hague Academy2024-11-01OpenAlex10.1093/ejil/chae060Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405666118
W4404063372Decoding PARP Inhibitor Resistance in Ovarian Cancer: Molecular Insights and Emerging Therapeutic Strategies2024-11-03OpenAlex10.23958/ijirms/vol09-i11/1995Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404063372
W4404010990Examining Scientific Inquiry of Queerness in Medical Education: A Queer Reading2024-11-03OpenAlex10.1080/10401334.2024.2422381Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404010990
W4404052680Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma2024-11-04OpenAlex10.3389/fonc.2024.1490202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404052680
W4404086985Social and ethical impact of emotional AI advancement: the rise of pseudo-intimacy relationships and challenges in human interactions2024-11-04OpenAlex10.3389/fpsyg.2024.1410462Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404086985
W4405047681A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-198727Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405047681
W4405042242Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with De Novo Mantle Cell Lymphoma (MCL)2024-11-05OpenAlex10.1182/blood-2024-200963Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405042242
W4405046044Association of Hypometilating Agents + Venetoclax in the Treatment of Secondary Acute Myeloid Leukemias Evolved from Chronic Myelomonocytic Leukemia2024-11-05OpenAlex10.1182/blood-2024-207060Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405046044
W4405051381Characterizing Treatment Patterns in Multiple Myeloma Patients with High-Risk Cytogenetics: A 15-Year-Study2024-11-05OpenAlex10.1182/blood-2024-211572Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405051381
W4405041570Circulating Biomarkers and CD8+ T-Cell Subpopulations Reveal Evolving Phases of Immune Response in Patients Receiving Mosunetuzumab for Previously Untreated B-Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-193023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041570
W4405038320Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis2024-11-05OpenAlex10.1182/blood-2024-199278Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405038320
W4405041120Cytomegalovirus Infections Following CAR T-Cell Therapy: A Systematic Review and Meta-Analysis2024-11-05OpenAlex10.1182/blood-2024-208855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405041120
W4405039102Daratumumab Versus Lenalidomide As Maintenance Therapy in Newly Diagnosed Multiple Myeloma - Interim Efficacy Results of a Randomized Clinical Trial2024-11-05OpenAlex10.1182/blood-2024-208094Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405039102
W4404067405Drug resistance and possible therapeutic options against influenza A virus infection over past years2024-11-05OpenAlex10.1007/s00203-024-04181-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404067405
W4404086800Editorial: Education in obstetrics and gynecology2024-11-05OpenAlex10.3389/fmed.2024.1490673Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404086800
W4405043362Effect of Prior Treatments on the Clinical Activity of Imetelstat in Transfusion-Dependent Patients with Erythropoiesis-Stimulating Agent, Relapsed or Refractory/Ineligible Lower-Risk Myelodysplastic Syndromes2024-11-05OpenAlex10.1182/blood-2024-203612Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405043362
W4405055039Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials2024-11-05OpenAlex10.1182/blood-2024-209018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405055039
W4405048623Evaluation of Measurable Residual Disease Assessment Dynamics in Hairy Cell Leukemia Clinical Trials from 1980 to 20202024-11-05OpenAlex10.1182/blood-2024-209169Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405048623
W4405041198Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study2024-11-05OpenAlex10.1182/blood-2024-209936Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041198
W4404075705Exploring Dentists’ Preferences in Selecting Adhesive Systems: A Survey Analysis2024-11-05OpenAlex10.3390/app142210119Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404075705
W4405041211Frontline Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma - Real-World Evidence from a Large Community-Based Oncology Practice Network in the US2024-11-05OpenAlex10.1182/blood-2024-204730Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041211
W4405040452Impact of Co-Mutations, Monocytic Differentiation, and Choice of Hypomethylating Agent Combined with Venetoclax on the Predictive Value of Molecular Prognostic Risk Signature in Newly Diagnosed AML Patients2024-11-05OpenAlex10.1182/blood-2024-194259Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405040452
W4405041272Impact of Emicizumab on Mental Liberation in Adult Patients with Severe and Moderate Factor VIII Deficiency2024-11-05OpenAlex10.1182/blood-2024-205287Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041272
W4405041247Impact of Novel Therapies on Survival in Chronic Lymphocytic Leukemia: Insights from SEER Database2024-11-05OpenAlex10.1182/blood-2024-209219Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041247
W4405043102Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation2024-11-05OpenAlex10.1182/blood-2024-201914Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405043102
W4405045299MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naïve Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses2024-11-05OpenAlex10.1182/blood-2024-204495Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405045299
W4405038859Modified Delphi Process to Develop Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice in the Asia-Pacific Region (The APAC-MF Alliance)2024-11-05OpenAlex10.1182/blood-2024-201402Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405038859
W4404699851Navigating Complexity: Chatbot Router Agents as a Key to Improved User Engagement in Healthcare2024-11-05OpenAlex10.21275/sr241120062953Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404699851
W4405052145Open Label Single Arm Study to Assess the Implementation of Home Based Daratumumab Administration in Patients Being Treated for Multiple Myeloma2024-11-05OpenAlex10.1182/blood-2024-206031Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405052145
W4404062203Oral antimicrobial agents in patients with short bowel syndrome: worth a try!—authors’ response2024-11-05OpenAlex10.1093/jac/dkae402Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404062203
W4405039526Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care2024-11-05OpenAlex10.1182/blood-2024-193255Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405039526
W4405049141Overall Survival of Patients with Chronic Lymphocytic Leukemia Treated with Frontline Bruton's Tyrosine Kinase Inhibitors: An Analysis of the United States Veterans Health Administration Database2024-11-05OpenAlex10.1182/blood-2024-201206Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405049141
W4405047781Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-205196Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405047781
W4404054720Potential health risks of hypomagnetic field for manned deep-space explorations2024-11-05OpenAlex10.1093/nsr/nwae395Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404054720
W4405048117Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-208930Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405048117
W4405040615Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-194601Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405040615
W4405096152Real-World Patient Characteristics and Treatment Patterns in Patients with Chronic Graft-Versus-Host Disease Receiving Belumosudil in the United States2024-11-05OpenAlex10.1182/blood-2024-208047Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405096152
W4405041003Real-World Treatment Patterns and Clinical Outcomes Among Patients with Diffuse Large B-Cell Lymphoma in a US Healthcare Claims Database2024-11-05OpenAlex10.1182/blood-2024-203289Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405041003
W4405092567Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Waldenstrӧm Macroglobulinemia: A Retrospective Analysis of US Claims Data2024-11-05OpenAlex10.1182/blood-2024-208443Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405092567
W4405048306Reduced Intensity Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorders (PTLD) Is Associated with Preserved Survival Outcomes: A Twenty-Year Single-Institutional Experience2024-11-05OpenAlex10.1182/blood-2024-193519Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405048306
W4405042500Representation of Women As Leaders of Hemato-Oncology Clinical Trials2024-11-05OpenAlex10.1182/blood-2024-209863Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405042500
W4405048062Survival Outcomes in Elderly Patients with Non-Hodgkin Lymphoma: A Retrospective Comparative Study of Standard Chemotherapy Versus Novel Agent2024-11-05OpenAlex10.1182/blood-2024-199867Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405048062
W4405042597The Effects of an Online Curriculum Based Approach to CME on Hematologist/Oncologists' Ability to Treat Patients with BTK Inhibitors for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma2024-11-05OpenAlex10.1182/blood-2024-209529Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405042597
W4405046652The Evolution of Treatment Patterns for Chronic Lymphocytic Leukemia (CLL): Trends in the US Community Oncology Setting from 2015 to 20242024-11-05OpenAlex10.1182/blood-2024-210905Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405046652
W4405046872The Evolution of Treatments and Outcomes for Real-World Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in a Chinese National Medical Center: Over 10 Years of Experience with 370 Patients2024-11-05OpenAlex10.1182/blood-2024-207401Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405046872
W4405049921The Evolving Treatment Paradigms and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Receive Autologous Stem Cell Transplantation in China: A Real-World Observational Study2024-11-05OpenAlex10.1182/blood-2024-202198Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405049921
W4405673258Towards Role Definition in Agile AI-based System Development: Perspectives and Reflections2024-11-05OpenAlex10.1145/3701625.3701661Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405673258
W4405053198Treatment Patterns and Attitudes Among US-Based Physicians in Using BTK Inhibitors to Treat Relapsed/Refractory CLL and MCL2024-11-05OpenAlex10.1182/blood-2024-208406Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405053198
W4405053714Treatment-Related and De Novo Ccus Have Similar Molecular Features and Risk of Progression to Myeloid Malignancies2024-11-05OpenAlex10.1182/blood-2024-201062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405053714
W4405046661Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)2024-11-05OpenAlex10.1182/blood-2024-200541Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405046661
W4405046964“I'd Go on a Hike with My Kids... That Would Make Me Feel so Happy.” Recognizing What People with Hemophilia B Identify As Meaningful When Considering Their Personal Goals and the Potential for Gene Therapy2024-11-05OpenAlex10.1182/blood-2024-194479Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405046964
W4404127590Menadione reduces the expression of virulence- and colonisation-associated genes in Helicobacter pylori2024-11-07OpenAlex10.1101/2024.11.07.622476Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404127590
W4404135913Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies2024-11-07OpenAlex10.3390/pathogens13110975Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404135913
W4404128364Nanoparticles based image-guided thermal therapy and temperature feedback2024-11-07OpenAlex10.1039/d4tb01416bTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404128364
W4404146498Research progress of nitroxide radical-based MRI contrast agents: from structure design to application2024-11-07OpenAlex10.1039/d4tb02272fTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404146498
W4404141603Role of Avacopan on Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis2024-11-07OpenAlex10.3390/jcm13226676Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404141603
W4404171571"Unveiling onychomycosis: Pathogenesis, diagnosis, and innovative treatment strategies"2024-11-08OpenAlex10.1016/j.micpath.2024.107111Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404171571
W4404166538Evaluating clinical utility of comprehensive genomic profiling—challenges and opportunities2024-11-08OpenAlex10.1093/jnci/djae237Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404166538
W4404191748Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review2024-11-08OpenAlex10.1007/s11912-024-01593-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404191748
W4404188576Linagliptin In Managing Type 2 Diabetes With Renal Impairment: Insights From Indian Nephrologists2024-11-08OpenAlex10.36478/makrjms.2024.11.468.472Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404188576
W4404191292Sodium-Selective Channelrhodopsins2024-11-08OpenAlex10.3390/cells13221852Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404191292
W4404672850A Look at Advancements in Thyroid Cancer Research & Treatment2024-11-11OpenAlex10.1097/01.cot.0001095604.80771.c5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404672850
W4404228825Photothermally Active Quantum Dots in Cancer Imaging and Therapeutics: Nanotheranostics Perspective2024-11-11OpenAlex10.1021/acsabm.4c01190Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404228825
W4404247033Reflective Tool on Advanced Access to Support Primary Healthcare Teams: Development and Validation of an Online Questionnaire2024-11-11OpenAlex10.1111/jep.14232Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404247033
W4404290339Systemic therapy for non–clear cell renal cell carcinomas: A systematic review2024-11-11OpenAlex10.1177/10781552241289920Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404290339
W4404341238Abstract 4138722: Large Language Model based multi-agent Transcatheter Aortic Valve Implantation team to augment multidisciplinary meetings - proof of concept.2024-11-12OpenAlex10.1161/circ.150.suppl_1.4138722Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4404341238
W4404363802Abstract 4139853: Altering Cardiovascular Mortality in HFpEF with SGLT2i or ARNI — A Head-to-Head Analysis2024-11-12OpenAlex10.1161/circ.150.suppl_1.4139853Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404363802
W4404266246Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment2024-11-12OpenAlex10.1080/17425255.2024.2428820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404266246
W44045111732-Deoxy-D-Glucose and its Derivatives: Dual Role in Diagnostics and Therapeutics2024-11-13OpenAlex10.2174/9789815305159124010009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404511173
W44045110922-Deoxy-D-Glucose as a Potential Antiviral and Anti-COVID-19 Drug2024-11-13OpenAlex10.2174/9789815305159124010010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404511092
W7215637385AN EVALUATION OF LOCAL ANESTHESIA SYSTEM TOXICITY: THE IMPLICATIONS AND REMEDIES2024-11-13OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215637385
W4404329068Developing teamwork: transitioning between stages in human-agent collaboration2024-11-13OpenAlex10.3389/fcomp.2024.1455903Full textExcludedF3: The calendar-planning agent is an Android Java finite-state machine with scripted dialogue scenarios (§4.3). A large language model is explicitly proposed for a future version (§6).https://openalex.org/W4404329068https://www.frontiersin.org/journals/computer-science/articles/10.3389/fcomp.2024.1455903/full
W4404339957Editorial: Advanced green polymers for medical purpose – trends and challenges in the circular economy2024-11-13OpenAlex10.3389/fbioe.2024.1511632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404339957
W4404428304Development of Idiopathic Pulmonary Fibrosis and its Pathogenic Inhibition by Drugs: An Overview2024-11-14OpenAlex10.9734/bpi/prrat/v8/2886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404428304
W4404368400The Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug Monitoring2024-11-14OpenAlex10.1248/bpb.b24-00319Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404368400
W4404355112Audio-diary reflections after community focus groups to address local racial inequities in the neonatal intensive care unit2024-11-15OpenAlex10.1038/s41372-024-02176-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404355112
W4408287644Functionalized Phytosomes and Liposomes: Innovations in Crossing the Blood-Brain Barrier for Neurodegenerative Disease Therapy2024-11-15OpenAlex10.1007/978-981-97-7445-6_35Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408287644
W7198083471Natural predators of Yersinia : Characterization and genomic analysis of bacteriophages that infect Yersinia2024-11-15OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7198083471
W4404415192Navigating the complexity of BRAF mutations in non-small cell lung cancer: current insights and future prospects2024-11-15OpenAlex10.5826/mrm.2024.992Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404415192
W4404525679Trends and implications of antimicrobial resistance in Pseudomonas aeruginosa: Insights from a 19-year study in Zhejiang Province2024-11-15OpenAlex10.1097/md.0000000000040606Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404525679
W4408287668Two-Dimensional Nanomaterials in Nanomedicine and Point-of-Care Diagnosis2024-11-15OpenAlex10.1007/978-981-97-7445-6_41Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408287668
W4404392893Unmet Need in Non–muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group2024-11-15OpenAlex10.1016/j.euo.2024.10.012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404392893
W4404443880Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐192024-11-16OpenAlex10.1111/imr.13422Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404443880
W4404446591ESPOROTRICOSE FELINA2024-11-17OpenAlex10.69849/revistaft/fa10202411170227Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404446591
W4404450071First-line treatments for advanced or recurrent endometrial cancer: Systematic literature review of clinical evidence2024-11-17OpenAlex10.1016/j.critrevonc.2024.104555Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404450071
W4404536119Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report2024-11-17OpenAlex10.47391/jpma.20059Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404536119
W4406764073Validation of Gelatin Layering for Ultrasound Power Transfer and Backscatter Communication2024-11-17OpenAlex10.1115/imece2024-143324Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406764073
W4404492746Beyond anti-inflammatory strategies: addressing immunosuppression with nanomaterials in sepsis treatment2024-11-18OpenAlex10.3389/fimmu.2024.1500734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404492746
W4404522802Beyond Antivirals: Alternative Therapies for Long COVID2024-11-19OpenAlex10.3390/v16111795Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404522802
W4404529338Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period2024-11-19OpenAlex10.1016/j.jiac.2024.11.012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404529338
W4404506245Myasthenia gravis: The evolving therapeutic landscape2024-11-19OpenAlex10.1016/j.ensci.2024.100541Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404506245
W4404588710Norepinephrine Transporter–Targeted Cancer Theranostics—New Horizons2024-11-19OpenAlex10.1097/rlu.0000000000005567Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404588710
W4404519839Pharmacotherapy of Acute Lymphoblastic Leukemia in Pediatric Patients: A Review of Efficacy and Adverse Effects2024-11-19OpenAlex10.32677/ijch.v11i8.4821Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404519839
W4404500638Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine2024-11-19OpenAlex10.1080/14656566.2024.2432488Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404500638
W4404595453Anti-Diabetic Therapies and Cancer: From Bench to Bedside2024-11-20OpenAlex10.3390/biom14111479Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404595453
W4404579811Clinical implications of mineralocorticoid receptor overactivation2024-11-20OpenAlex10.1093/ckj/sfae346Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404579811
W4404567319Epidemiological Trends of Mucormycosis in Europe, Comparison with Other Continents2024-11-20OpenAlex10.1007/s11046-024-00907-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404567319
W4404545052Impact of occupational exposures in patients with chronic obstructive pulmonary disease: current understanding and knowledge gaps2024-11-20OpenAlex10.1097/mcp.0000000000001141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404545052
W4404808492Key Strategies to Foster Effective Champions for Continuous Quality Improvement in Primary Healthcare Clinics2024-11-20OpenAlex10.1370/afm.22.s1.6490Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404808492
W4404589880The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology2024-11-20OpenAlex10.3390/pharma3040025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404589880
W4404540484The tigecycline resistance mechanisms in Gram-negative bacilli2024-11-20OpenAlex10.3389/fcimb.2024.1471469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404540484
W4404603425AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction2024-11-21OpenAlex10.3389/fcvm.2024.1457498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404603425
W4408074350Coaching: An Effective Approach to Facilitate Performance, Learning and Advancement of Medical Students2024-11-21OpenAlex10.32592/rmegums.16.4.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408074350
W4404555038Focus on the evolving methodologies of trials, on inflammation in atherosclerotic cardiovascular disease, and on abdominal aortic aneurysms2024-11-21OpenAlex10.1093/eurheartj/ehae789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404555038
W4404589354Immune checkpoint inhibition of metastatic melanoma: achieving high efficacy in the face of high toxicity2024-11-21OpenAlex10.1080/17512433.2024.2431513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404589354
W4404592347Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease2024-11-21OpenAlex10.3390/jcm13237026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404592347
W7133486790Prophylactic cerebrospinal fluid drainage in aortic surgery: enhancing neurological outcomes2024-11-21OpenAlex10.1097/io9.0000000000000212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133486790
W4404553702The journey of antibody-drug conjugates for revolutionizing cancer therapy: A review2024-11-21OpenAlex10.1016/j.bmc.2024.118010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404553702
W4404633978Let's Agree to Disagree: Reflections From the Smoldering Multiple Myeloma Session at the International Myeloma Society Study Summit2024-11-22OpenAlex10.1016/j.clml.2024.11.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404633978
W4404618573Nanoparticles for Biomedical Imaging2024-11-22OpenAlex10.1201/9781003432661-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404618573
W4404634064Networked Control Theory2024-11-22OpenAlex10.1016/b978-0-443-14081-5.00059-3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404634064
W4404616258Pharmacologic Approaches to Bleeding2024-11-22OpenAlex10.1016/b978-0-323-96014-4.00064-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404616258
W4404644230Basics of vasomotor symptoms2024-11-23OpenAlex10.1097/gme.0000000000002479Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404644230
W4404645533Pharmacists leading the way in infectious diseases education, research, and patient care2024-11-23OpenAlex10.1093/ajhp/zxae361Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404645533
W4404705347Applications and Efficacy of Minoxidil in Dermatology2024-11-24OpenAlex10.1002/ski2.472Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404705347
W4404666587Clinical and biological advances of critical complications in acute myeloid leukemia2024-11-24OpenAlex10.1080/10428194.2024.2425051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404666587
W4404691743Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents2024-11-24OpenAlex10.3390/biology13120967Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404691743
W4404697656Deliberate Releases of Biological Agents of Zoonosis2024-11-25OpenAlex10.1079/9781800622852.0003Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404697656
W4404729363In-vitro Cell Culture: A Promising Technology in the Advancement of Science and Research as a Solution to Human and Animal Health Issues2024-11-25OpenAlex10.18805/ijar.b-5325Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404729363
W4404740353Humans and great apes visually track event roles in similar ways2024-11-26OpenAlex10.1371/journal.pbio.3002857Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404740353; https://openalex.org/W7112205860
W4404742767The evolving landscape of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: inspiration from cisplatin-based antiemetic and non-antiemetic trials2024-11-26OpenAlex10.1007/s00520-024-09035-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404742767
W4404728343The role of silver diamine fluoride as dental caries preventive and arresting agent: a systematic review and meta-analysis2024-11-26OpenAlex10.3389/froh.2024.1492762Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404728343
W4404853474Animal Disease Surveillance: History of Zoonotic Viruses and Bacteria and Diagnostics2024-11-27OpenAlex10.5772/intechopen.1008157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404853474
W4404756353Novel Strategies for Lung Cancer Interventional Diagnostics2024-11-27OpenAlex10.3390/jcm13237207Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404756353
W4404880528Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review2024-11-27OpenAlex10.1093/bjs/znae284Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404880528
W4404759520YY1 downregulation underlies therapeutic response to molecular targeted agents2024-11-27OpenAlex10.1038/s41419-024-07239-8Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4404759520
W4405009254CDA Formulations: Potentially the Standard Care of Breast, Lung and Liver Cancers2024-11-28OpenAlex10.11648/j.ijcocr.20240903.12Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405009254
W4404815792Context is key: ethical considerations related to consent and study design in acute cardiac care research2024-11-28OpenAlex10.1093/ehjacc/zuae125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404815792
W4404870526A Review of Current and Future Antibody Drug Conjugates in Breast Cancer2024-11-29OpenAlex10.1007/s11864-024-01276-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404870526
W4404866133An Evolving Role of Antitumor Activity of Zoledronic Acid in Breast Cancer2024-11-29OpenAlex10.47275/2690-5663-136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404866133
W4404866606Editorial: Drug discovery and development explained: introductory notes for the general public2024-11-29OpenAlex10.3389/fddsv.2024.1528467Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404866606
W4404861358Enhancing Alzheimer’s disease classification through split federated learning and GANs for imbalanced datasets2024-11-29OpenAlex10.7717/peerj-cs.2459Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404861358
W4404853648From Barbers to Bots: A Surgeon’s Odyssey2024-11-29OpenAlex10.4103/jmms.jmms_120_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404853648
W4404799612GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis2024-11-29OpenAlex10.3748/wjg.v30.i48.5205Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404799612
W4404859652Governing the private scales of families and homes: Visiting nurses and Turkey's mobilization of consumptive care2024-11-29OpenAlex10.1016/j.jhg.2024.11.011Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404859652
W4404875629Immunological exosomes: An upcoming cue for disease management2024-11-29OpenAlex10.1016/b978-0-443-29052-7.00011-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404875629
W4404864062Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies2024-11-29OpenAlex10.1080/17474086.2024.2436973Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404864062
W4404882951Bestie da domare: retoriche e moralizzazioni del vaccino nell’Inghilterra dell’Ottocento2024-11-30OpenAlex10.54103/2035-7680/27286Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404882951
W4404919775Novel Therapies in the Perioperative Management of Localized Gastric Cancer: Current Perspectives and Future Directions2024-11-30OpenAlex10.14295/aimj.v8i16.210Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404919775
W4404844300Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer – A Clinical Review2024-11-30OpenAlex10.1007/s11864-024-01259-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404844300
W4414352215A Rotten Crowd: America, Wealth, and One Hundred Years of The Great Gatsby, Odyssey of a Wandering Mind: The Strange Tale of Sara Mayfield, Author, Chasing The Great Gatsby: Freddie Welsh’s Saga and The Great Gatsby2024-12-01OpenAlex10.5325/fscotfitzrevi.22.0230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414352215
W4406861038A look back at the Virology Departmental Days of the Institut Pasteur (Le Touquet, May 13–15, 2024)2024-12-01OpenAlex10.1093/jmcb/mjae052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406861038
W4404995488Antibiotic Target Attainment: What Are We Aiming for?*2024-12-01OpenAlex10.1097/pcc.0000000000003630Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404995488
W4405956781CARBON-DOTs: A Breakthrough Weapon in the Fight Against Infectious Diseases - A Review2024-12-01OpenAlex10.9790/9622-141297118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405956781
W4404880168Delayed Puberty and Incidental Hypertension in a 14-year-old Girl2024-12-01OpenAlex10.1542/pir.2023-005971Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404880168
W4405222638Metabolic orchestration of drug-tolerant persister cells in cancer2024-12-01OpenAlex10.1093/lifemedi/lnae040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405222638
W7155444830NOVEL DRUG DELIVERY SYSTEM FROM FUNDAMENTAL PRINCIPLES TO ADVANCED APPLICATIONS2024-12-01OpenAlex10.58532/nddsfpaav4b10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155444830
W4405746630NOVEL MAINTENANCE THERAPIES IN ACUTE MYELOID LEUKEMIA: PROLONGING REMISSION AND IMPROVING OUTCOMES2024-12-01OpenAlex10.1016/j.htct.2024.11.092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405746630
W4414366849Nanoparticles for Advanced Drug Delivery Systems: Innovations, Applications, and Future Perspectives in Nanomedicine2024-12-01OpenAlex10.69626/bba.2024.0003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414366849
W4405230090P100 A systematic review and meta-analysis of the prevalence of comorbidity amongst people with palmoplantar pustulosis2024-12-01OpenAlex10.1093/bjd/ljae360.130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405230090
W4405833661Practical insights into bispecific antibody therapy in multiple myeloma2024-12-01OpenAlex10.1080/14737140.2024.2445145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405833661
W4405168550S64 Caught Between a Cough and a Hard Place: A Crohn’s Conundrum with a Broncho-Esophageal Twist2024-12-01OpenAlex10.14309/01.ajg.0001082788.22386.b2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405168550
W4405852331Safeguarding the Heart in Cancer Therapy: Balancing Cardioprotection with Treatment Efficacy2024-12-01OpenAlex10.4103/jpbs.jpbs_1408_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405852331
W4404902402Targeted and cytotoxic inhibitors used in the treatment of breast cancer2024-12-01OpenAlex10.1016/j.phrs.2024.107534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404902402
W7212248062The Uptake Mechanisms of Extracellular Vesicles by Target Cells and Their Applications in Disease Diagnosis and Treatment2024-12-01OpenAlex10.16476/j.pibb.2024.0156Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212248062
W4407064465The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview2024-12-01OpenAlex10.61186/phypha.28.4.363Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407064465
W4404908616Atypical Cerebral Carcinoids Treated with Hippocampal-Sparing Whole Brain Radiotherapy2024-12-02OpenAlex10.7759/cureus.74997Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4404908616
W4404918206Bridging the Industry-Higher Education Gap with Critical Design Futures Thinking and GenAI for Innovation2024-12-02OpenAlex10.1201/9781003469551-11Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404918206
W4405157169Comparison between The Efficacy of Concurrent Chemo-Radiation with Gemcitabine Followed by Intracavitary Radiotherapy in Patients with Locally Advanced Cervical Carcinoma2024-12-02OpenAlex10.55561/ajhr.v3i3.193Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405157169; https://openalex.org/W4402315952
W4404908094Kidney-sparing approach for upper tract urothelial carcinoma: An update on current evidence2024-12-02OpenAlex10.1016/j.ajur.2024.08.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404908094
W4404914206Modulation of Brain Kynurenic Acid by N-Acetylcysteine Prevents Cognitive Impairment and Muscular Weakness Induced by Cisplatin in Female Rats2024-12-02OpenAlex10.3390/cells13231989Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4404914206
W4408956980Not the Usual Suspect2024-12-02OpenAlex10.1093/cid/ciae590Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408956980
W4404902741Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology2024-12-02OpenAlex10.1007/s00210-024-03661-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404902741
W4406271271Autonomous Pharmaceutical Care with Large Language Models2024-12-03OpenAlex10.1109/bibm62325.2024.10822302Full textIncludedIncluded: Clinician edits and prompts are persistently encoded into an experience store and reused for later similar pharmaceutical-care cases.https://openalex.org/W4406271271https://ieeexplore.ieee.org/document/10822302
W4404967078Evolving Applications of Conversational Agents in Healthcare: A Literature Review2024-12-03OpenAlex10.1007/978-3-031-78090-5_12Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404967078
W4404955905Evolving Treatment Strategies for Systemic Lupus Erythematosus in Clinical Practice: A Narrative Review2024-12-03OpenAlex10.7759/cureus.75062Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4404955905
W4406091184Front-line Treatment of Older Patients with Hodgkin Lymphoma2024-12-03OpenAlex10.58931/cht.2024.3358Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406091184
W7131328535Nanobubbles combined with p53 encoding pDNA for colorretal cancer treatment2024-12-04OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131328535
W4404994209Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology2024-12-04OpenAlex10.3390/cells13232003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4404994209
W4405008822Point‐of‐care ultrasound differentiated the cause of proteinuria in a patient with lung cancer2024-12-04OpenAlex10.1002/sono.12488Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405008822
W4405040754Advances in the Management of Hemophilia and Bleeding Disorders: Achievements and Perspectives2024-12-05OpenAlex10.1055/s-0044-1800835Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405040754
W4405025868Editorial: The role of nutritional strategies in the regulation of gut microbiota and host immune system2024-12-05OpenAlex10.3389/fmicb.2024.1501596Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405025868
W4405040628Precision Medicine in Rare Bleeding Disorders2024-12-05OpenAlex10.1055/s-0044-1800833Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405040628
W4405165853Prevalence and Antibiotic Resistance Patterns of Neonatal Bloodstream Pathogens in Tertiary Care Hospitals: A Retrospective Analysis2024-12-05OpenAlex10.3329/bjmm.v18i1.76965Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405165853
W4405061040Role of Multi-Agent System in Reducing Failure Probabilities in Production System2024-12-05OpenAlex10.4018/979-8-3693-6230-3.ch007Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4405061040
W4405106084Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression2024-12-06OpenAlex10.1159/000541783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405106084
W4405127048BV and beyond: how to incorporate novel agents into PTCL management2024-12-06OpenAlex10.1182/hematology.2024000530Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405127048
W4405109019Insights on treatment of adult ITP: algorithm for management and role of multimodal therapy2024-12-06OpenAlex10.1182/hematology.2024000594Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405109019
W4405108491On the horizon: upcoming new agents for the management of ITP2024-12-06OpenAlex10.1182/hematology.2024000596Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4405108491
W4405108045Recent Advances in the Management of Acute Severe Ulcerative Colitis2024-12-06OpenAlex10.3390/jcm13237446Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405108045
W4405108875Sequencing bispecific antibodies and CAR T cells for FL2024-12-06OpenAlex10.1182/hematology.2024000667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405108875
W4405154575Shock Patients and Enteral Nutrition?2024-12-06OpenAlex10.54097/2frt1b93Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405154575
W4405108979When should we use it? The role of brentuximab vedotin in 20242024-12-06OpenAlex10.1182/hematology.2024000668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405108979
W4405109152Your chemo is no good here: management of high-risk MCL2024-12-06OpenAlex10.1182/hematology.2024000658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405109152
W4405166232Exploring the nexus between medical gases and ion channel function: implications for therapeutic innovation2024-12-07OpenAlex10.4103/mgr.medgasres-d-24-00076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405166232
W4405128914Getting your message across? The evolution of leader vision and managed pluralisation of leadership2024-12-07OpenAlex10.1177/00187267241301720Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405128914
W4405133536The psychological impact of reopening after COVID-19 lockdowns in China: Threat perception, affect and moral conflict2024-12-07OpenAlex10.1016/j.socscimed.2024.117611Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405133536
W4405170909Abstract IA011: Strategies to close the translational gap for nanoscale drug delivery systems2024-12-09OpenAlex10.1158/1538-8514.cancerchem24-ia011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405170909
W4405196929Current Advances in Viral Nanoparticles for Biomedicine2024-12-09OpenAlex10.1021/acsnano.4c13146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405196929
W4405201443Editorial: Genetic and cellular heterogeneity in tumors2024-12-09OpenAlex10.3389/fcell.2024.1519539Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405201443
W4405201683Editorial: Mathematical modeling of diseases at population-level and cellular-level2024-12-09OpenAlex10.3389/fams.2024.1534439Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405201683
W4405212145Enhanced recovery revisited: what day case hysterectomies can learn from Team GB elite athletes2024-12-09OpenAlex10.1111/tog.12958Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405212145
W4405209782Physician Assistant Students as Agents of Change through Service-Learning Opportunities2024-12-09OpenAlex10.53309/2164-7666.1470Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405209782
W4408860084Quantitative Review of Conversational Agents in E-Health Using NLP and AI2024-12-09OpenAlex10.1109/gcet64327.2024.10934583Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408860084
W4405215143Editorial: Emerging trends and advances in the socioeconomic applications of beneficial microbes2024-12-10OpenAlex10.3389/fmicb.2024.1523569Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405215143
W4405225816Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study2024-12-10OpenAlex10.1182/bloodadvances.2024013838Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405225816
W4405235514Inhaled Anesthetics: Beyond the Operating Room2024-12-10OpenAlex10.3390/jcm13247513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405235514
W4407348885Landscape of Bacterial Enteric Disease and Traveler´s Diarrhea in South America2024-12-10OpenAlex10.1093/infdis/jiae594Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407348885
W4405219749Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy2024-12-10OpenAlex10.1007/s10557-024-07652-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405219749
W4405215300Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity2024-12-10OpenAlex10.3389/fimmu.2024.1490129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405215300
W4405233512Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine2024-12-10OpenAlex10.1136/gutjnl-2024-333994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405233512
W4405263688Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers2024-12-11OpenAlex10.3389/fendo.2024.1533623Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405263688
W4405257039Editorial: Data governance in African health research: ELSI challenges and solutions2024-12-11OpenAlex10.3389/fphar.2024.1525434Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405257039
W4405283320MDMA for PTSD and beyond: a new paradigm brings hope2024-12-11OpenAlex10.3389/fnhum.2024.1475013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405283320
W4405347145Pharmacology and mechanisms of apigenin in preventing osteoporosis2024-12-11OpenAlex10.3389/fphar.2024.1486646Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405347145
W4405367347Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II2024-12-11OpenAlex10.1093/jbcr/irae208Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4405367347
W7171937448ADAPTIVE FOUNDATION MODELS IN ONCOLOGY: CONTINUOUS LEARNING FOR PERSONALIZED CANCER MANAGEMENT2024-12-12OpenAlex10.65713/ijaraiv14i1203Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171937448
W4405321016Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 20242024-12-12OpenAlex10.1016/j.semradonc.2024.08.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405321016
W4405338882Editorial: The future of third molar surgery2024-12-12OpenAlex10.3389/froh.2024.1512305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405338882
W4405384683Evaluation of Biomaterials in Periodontal Regeneration: A Literature Review2024-12-12OpenAlex10.7759/cureus.75618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405384683
W4405393682SurfR: Riding the wave of RNA-seq data with a comprehensive bioconductor package to identify surface protein-coding genes2024-12-12OpenAlex10.1093/bioadv/vbae201Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405393682
W7171964303AUTONOMOUS ONCOLOGY SYSTEMS: FOUNDATION MODELS FOR REAL-TIME CLINICAL INTELLIGENCE AND PERSONALIZED CANCER CARE2024-12-13OpenAlex10.65713/ijaraiv14i1209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171964303
W7172012214FUTURE CANCER INTELLIGENCE: CONVERGING FOUNDATION AI, DIGITAL TWINS, MULTIMODAL LEARNING, AND PRECISION ONCOLOGY2024-12-14OpenAlex10.65713/ijaraiv14i1210Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172012214
W7171970226INTELLIGENT DIGITAL TWINS IN ONCOLOGY: REAL-TIME VIRTUAL PATIENT MODELING FOR PERSONALIZED THERAPEUTIC DECISION-MAKING2024-12-14OpenAlex10.65713/ijaraiv14i1212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171970226
W4409684107DIAGNOSTIC ACCURACY OF PI-RADS FOR PROSTATIC MALIGNANCY; NON-INVASIVE ASSESSMENT OF THE PROSTATE GLAND2024-12-16OpenAlex10.55519/jamc-s4-13563Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409684107
W7171983307DIGITAL TWIN–ENABLED PRECISION ONCOLOGY: INTEGRATING LONGITUDINAL PATIENT DATA, MULTI-OMICS, AND ARTIFICIAL INTELLIGENCE2024-12-16OpenAlex10.65713/ijaraiv14i1218Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171983307
W4405441202Editorial: Drug allergy in children2024-12-16OpenAlex10.3389/falgy.2024.1530907Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405441202
W4405433575Large Language Models Applied to Health Care Tasks May Improve Clinical Efficiency, Value of Care Rendered, Research, and Medical Education2024-12-16OpenAlex10.1016/j.arthro.2024.12.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405433575
W4405534906Novel immunotherapy for multiple solid cancers using an Anti-HVEM blocking monoclonal antibody2024-12-16OpenAlex10.1101/2024.12.16.627913Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405534906
W4405426375Sequelae of B-Cell Depleting Therapy: An Immunologist’s Perspective2024-12-16OpenAlex10.1007/s40259-024-00696-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405426375
W4405426766Surrogate Clinical End Points in Studies of APOL1-Associated Kidney Disease: Just in Time2024-12-16OpenAlex10.2215/cjn.0000000628Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405426766
W4405457840Computer-aided Drug Design: Innovation and its Application in Reshaping Modern Medicine2024-12-17OpenAlex10.2174/0129503752321279241126091807Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405457840
W4405459452Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy2024-12-17OpenAlex10.3390/ph17121701Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405459452
W4405491993Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders2024-12-17OpenAlex10.1016/j.bioorg.2024.108075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405491993
W4405556048Cancer Therapy-Related Skin Change2024-12-18OpenAlex10.1007/978-3-031-53888-9_72-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405556048
W4405511092The complement system in clinical oncology: Applications, limitations and challenges2024-12-18OpenAlex10.1016/j.smim.2024.101921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405511092
W4405523030The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes2024-12-18OpenAlex10.1186/s12916-024-03763-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405523030
W4411624623What does your Packet Capture say?2024-12-18OpenAlex10.1145/3703323.3704278Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411624623
W4406478004Innovations in toxicological research: Advancing knowledge for a safer tomorrow2024-12-19OpenAlex10.70593/978-81-982935-0-3_4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406478004
W4405586574State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes2024-12-19OpenAlex10.1080/21645515.2024.2440165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405586574
W4405578644Updates in Management of Unresectable Stage III Non Small Cell Lung Cancer: A Radiation Oncology Perspective2024-12-19OpenAlex10.3390/cancers16244233Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405578644
W4405643223A Tachyplesin Antimicrobial Peptide from Theraphosidae Spiders with Potent Antifungal Activity Against Cryptococcus neoformans2024-12-20OpenAlex10.3390/microorganisms12122648Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405643223
W4405625819Advanced transdermal drug delivery system: A comprehensive review of microneedle technologies, novel designs, diverse applications, and critical challenges2024-12-20OpenAlex10.1016/j.ijpharm.2024.125118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405625819
W4405646477Practices of Resistance and Nursing2024-12-20OpenAlex10.1111/nup.70010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405646477
W4405661887Central command suite: futureproofing next-generation surgical environments to embrace the digital operating room2024-12-21OpenAlex10.1007/s11548-024-03278-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405661887
W4405778249Efficacy and safety of lorlatinib as first-line treatment for advanced ALK-mutated non-small cell lung cancer: A clinical case study2024-12-21OpenAlex10.21518/ms2024-538Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405778249
W4405659674Screening and identification of antimicrobial peptides from the gut microbiome of cockroach Blattella germanica2024-12-21OpenAlex10.1186/s40168-024-01985-9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405659674
W4405685687Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future2024-12-22OpenAlex10.1080/10428194.2024.2443550Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405685687
W4405693735Symposium introduction: The political economy of corruption2024-12-22OpenAlex10.1002/soej.12753Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405693735
W4405699694Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine2024-12-22OpenAlex10.3390/cells13242126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405699694
W4405706134A Comprehensive Literature Review of Osteoporosis Treatment and Fracture Outcomes2024-12-23OpenAlex10.70070/rs5yc355Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405706134
W4405694164Editorial: Exosome-mediated intercellular communications: immune stimulation and suppression2024-12-23OpenAlex10.3389/fimmu.2024.1540484Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405694164
W4405726885From fibrosis to granuloma: drug induced systemic sarcoidosis-like reaction after rituximab in a patient with primary Sjögren’s syndrome2024-12-23OpenAlex10.12890/2024_005070Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405726885
W4406232215Limonene as a Multi-Target Antibiofilm and Quorum Sensing Inhibitor Against Pseudomonas aeruginosa2024-12-23OpenAlex10.51152/jbarbiomed.v10i1.245Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406232215
W4405703421Phage-mediated virulence loss and antimicrobial susceptibility in carbapenem-resistant Klebsiella pneumoniae2024-12-23OpenAlex10.1128/mbio.02957-24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4405703421
W4405737761A Systematic Review on the Effectiveness and Safety of Combining Biostimulators with Botulinum Toxin, Dermal Fillers, and Energy-Based Devices2024-12-24OpenAlex10.1007/s00266-024-04627-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405737761
W4405732463A comprehensive review on nanoparticle-based photo acoustic: current application and future prospective2024-12-24OpenAlex10.1186/s11671-024-04173-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405732463
W4405740444Complex Regional Pain Syndrome: Diagnosis, Pathophysiology, and Treatment Approaches2024-12-24OpenAlex10.7759/cureus.76324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405740444
W4405753421How I treat AML relapse after allogeneic HSCT2024-12-24OpenAlex10.1182/blood.2024025705Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405753421
W4405737072Retina/posterior segment disorders – A colossal subspecialty2024-12-24OpenAlex10.4103/ijo.ijo_3036_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405737072
W4405762001Tumor Shrinkage can be a Promising Diagnosis Toward Remissionor can also be an Ominous Diagnosis Toward Fatality2024-12-24OpenAlex10.47363/jcrr/2024(6)204Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405762001
W4405775229Evolving strategies in cervical cancer therapy: A comprehensive review navigating from molecular insights to regulatory challenges2024-12-25OpenAlex10.1016/j.jddst.2024.106568Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405775229
W4405843455Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance2024-12-26OpenAlex10.1016/j.ijbiomac.2024.139211Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405843455
W4405815586INFECTIOUS DISEASES IN CHILDREN AND THE REFLECTION ON THE VARIOUS COMMONLY USED ANTIBIOTIC AGENTS2024-12-26OpenAlex10.53555/cz0m2e18Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4405815586
W7220252912Infection management in hematological malignancies: Febril neutropenia2024-12-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220252912
W4405821569Phosphodiesterase Inhibitors for Diabetes: From Mechanistic Insights to Therapeutic Innovations2024-12-26OpenAlex10.2174/0102506882344901241218070917Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405821569
W4405806795Vitreous: From Molecules and Cells to Clinical Applications2024-12-26OpenAlex10.1016/b978-0-443-13820-1.00003-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405806795
W4405861505DRUG AND CARDIAC RESYNCHRONIZATION THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE (LITERATURE REVIEW)2024-12-28OpenAlex10.26787/nydha-2686-6838-2024-26-12-35-45Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405861505
W4416028665Agentic AI for Regulatory Intelligence: Designing Scalable Compliance Lifecycle Systems in Multinational Tech Enterprises2024-12-29OpenAlex10.38124/ijsrmt.v3i12.934Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416028665
W4405872800Technical, social, psychological and ethical aspects of human-robot collaboration: a case study of the 'Robin Heart' medical robot2024-12-29OpenAlex10.13166/jms/197008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405872800
W4405880306A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”2024-12-30OpenAlex10.14245/ns.2449382.691Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405880306
W4405903965Assessment of cardio-oncology knowledge and practice among healthcare providers in Saudi Arabia: a comprehensive nationwide survey2024-12-30OpenAlex10.1186/s40959-024-00299-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405903965
W4406594927Clostridioides difficile Infection: A Review of Emerging Practices for Infection Treatment and Prevention of Recurrence2024-12-30OpenAlex10.14218/jtg.2024.00022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406594927
W4406104934Giant Frontal Brain Abscess Due to Streptococcus Viridans in an 8-Year-Old Patient: Case Report2024-12-30OpenAlex10.11648/j.ajp.20241004.23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406104934
W4405893067How Do We Treat Patients With Advanced Hepatocellular Carcinoma?2024-12-30OpenAlex10.1097/01.cot.0001097204.55713.71Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405893067
W4405893525Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutic2024-12-30OpenAlex10.22541/au.173557639.91035402/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405893525; https://openalex.org/W4406202331
W4405930215Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood Stabilisers2024-12-30OpenAlex10.4103/ijd.ijd_792_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405930215
W4405923677Reflections on the Potential of Applying Artificial Intelligence (AI) and Machine Learning (ML) for Screening Topical Hemostatic Agents Based on Inorganic Solids for Hemorrhage Control2024-12-30OpenAlex10.31875/2410-4701.2024.11.11Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4405923677
W4405912567Rhinitis in Primary Care2024-12-30OpenAlex10.1016/j.pop.2024.09.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405912567
W4405886157Successful Management of Streptococcal Pneumoniae-induced Severe Community-acquired Pneumoniae Complicated by Myocarditis: A Rare Case Report Utilizing Venoarterial Extracorporeal Membrane Oxygenation and Steroid Therapy2024-12-30OpenAlex10.5005/jp-journals-11006-0144Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4405886157
W7172000061TOWARDS AN INTELLIGENT CANCER LEARNING HEALTH SYSTEM: FOUNDATION AI MODELS FOR ADAPTIVE AND PERSONALIZED ONCOLOGY2024-12-30OpenAlex10.65713/ijaraiv14i1230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172000061
W4407159386Transformational journey in ileo-pouch anal anastomosis surgery for ulcerative colitis2024-12-30OpenAlex10.1093/bjsopen/zrae157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407159386
W4407775463Walking towards Green Hospitals: innovation and commitment for a healthy future in Latin America2024-12-30OpenAlex10.31579/2690-8808/235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407775463
W7125587842A Narrative Review of the Interdisciplinary Management of Acute Poisonings and Overdoses: From Bedside to Laboratory to Antidote2024-12-31OpenAlex10.64483/202412562Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125587842
W4407049428Advanced Applications of Phytosomes in Cancer Therapy: Innovations, Challenges, and Future Perspectives2024-12-31OpenAlex10.61554/ijnrph.v2i2.2024.101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407049428
W4405929101An Overview of Pediatric Hemolytic Uremic Syndrome2024-12-31OpenAlex10.1542/pir.2023-006333Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405929101
W4405978829Evolving Evidence Practices in Acute Stroke Care2024-12-31OpenAlex10.29173/ijcc1041Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405978829
W4405950588Unveiling the chemistry of antibody conjugation for enhanced PET imaging: Current trends and future directions2024-12-31OpenAlex10.1016/j.bioorg.2024.108115Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405950588
W4406018249Updates in the Management of Richter Transformation2024-12-31OpenAlex10.3390/cancers17010095Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406018249
W44127140112025-01-01OpenAlex10.46998/ijcmcr.54.3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412714011
W441407872822 - A decade of incontinence and outflow obstruction surgery: current trends from the hospital episode statistics database2025-01-01OpenAlex10.1016/j.cont.2025.101946Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414078728
W44138089072D/3D Ultrasound Imaging of Urethral Bulking Materials2025-01-01OpenAlex10.1007/978-3-031-92486-6_11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413808907
W7138879975A New Era in Atherosclerosis Prevention and Treatment2025-01-01OpenAlex10.4103/aptj.aptj_15_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138879975
W4415847378A Review on Novel Applications of Nanoparticles in Pediatric Oncology2025-01-01OpenAlex10.32604/or.2025.069101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415847378
W7133574642A Unified Framework for Collaborative Knowledge Graph Construction, Editing, and Distribution2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133574642
W4409904020A comprehensive introduction on biogenic nanoparticles: fabrication, implementation, and environmental concern2025-01-01OpenAlex10.1016/b978-0-443-33819-9.00005-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409904020
W4413825080A comprehensive review of the multisystem benefits of antidiabetic drugs in aging beyond glycemic control2025-01-01OpenAlex10.1016/j.tma.2025.08.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413825080
W7118890792A neurological challenge: primary angiitis of the central nervous system in a young woman2025-01-01OpenAlex10.5327/1516-3180.cpn.1260Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118890792
W7116749006A socio-hydrological agent-based model of farmer adaptation to groundwater salinity stress in an arid region of Iran2025-01-01OpenAlex10.2139/ssrn.5944155Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7116749006
W4409957407A state-of-the-art view: G-quadruplex-targeting for platinum complexes’ treatment of tumors2025-01-01OpenAlex10.1039/d5cb00024fTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409957407
W4411152587AI Agents in Healthcare2025-01-01OpenAlex10.1007/978-3-031-90026-6_10Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W4411152587
W7124939968AI in Personnel Training and Development from Pre- to Post-ChatGPT: A Systematic Review2025-01-01OpenAlex10.17605/osf.io/2qmgeTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124939968
W7117533694AI-Driven Security Automation for Continuous Compliance Monitoring in Regulated Cloud Environments2025-01-01OpenAlex10.63282/3050-9246.ijetcsit-v6i2p112Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117533694
W4415679058ATLAS: History and Evolution of Health Professions in Puerto Rico (1952–2022). Medical Doctors — Vol. 12025-01-01OpenAlex10.2139/ssrn.5675442Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415679058
W4409303524Abscess Angiofibroma of the Rectus Abdominis Muscle: About a Case at the Bouaké University Hospital2025-01-01OpenAlex10.4236/ss.2025.164020Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409303524
W4406255861Acute Generalized Exanthematous Pustulosis Induced by Hyaluronic Acid Knee Injection: A Case Report2025-01-01OpenAlex10.1016/j.jen.2024.08.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406255861
W4411852503Addressing residual neuromuscular blockade: A key to achieving ERAS goals in cardiac surgery2025-01-01OpenAlex10.4103/theiaforum.theiaforum_51_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411852503
W4410888816Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications2025-01-01OpenAlex10.34133/research.0747Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410888816
W4416753324Advances and future perspectives in chimeric antigen receptor T-cell and bispecific antibody therapies for multiple myeloma2025-01-01OpenAlex10.3960/jslrt.25038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416753324
W4414188522Agentic AI Meets Data Engineering: Toward Self-Directed, Interpretable, and Balanced Pipelines2025-01-01OpenAlex10.70153/ijcmi/2025.17202Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414188522
W4409417630Agentic AI in Healthcare: Diagnosis and Treatment2025-01-01OpenAlex10.2139/ssrn.5214492Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W4409417630
W4414550633Agentic AI in XML-Based Information Retrieval Systems for Collaboration and Decision Support2025-01-01OpenAlex10.1007/978-3-031-89424-4_14Full textExcludedF2: The XML retrieval method evaluates general multimedia/IMDB records; healthcare is one example industry, so existing P2 applies.https://openalex.org/W4414550633https://link.springer.com/chapter/10.1007/978-3-031-89424-4_14publisher abstract and dataset note, not full methods
W4411995908Agentic AI: A Comprehensive Survey of Technologies, Applications, and Societal Implications2025-01-01OpenAlex10.1109/access.2025.3585609Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411995908
W4406728221Agentic AI: Autonomous Intelligence for Complex Goals—A Comprehensive Survey2025-01-01OpenAlex10.1109/access.2025.3532853Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4406728221
W4410294045Agentic Artificial Intelligence in Public Administration: Foundations, Applications, and Governance2025-01-01OpenAlex10.2139/ssrn.5249100Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4410294045
W4416034803Agentic Medical Knowledge Graphs Enhance Medical Question Answering: Bridging the Gap Between LLMs and Evolving Medical Knowledge2025-01-01OpenAlex2502.1301010.18653/v1/2025.findings-emnlp.679Full textExcludedF4: AMG-RAG grows a persistent graph from external textbooks/search results. §3.3 and §4.1 describe query-triggered coverage expansion and background literature refresh, without an experience-derived case-outcome update reused on later cases.https://openalex.org/W4416034803https://aclanthology.org/2025.findings-emnlp.679.pdf
W7119299327Agents of Change: Self-Reflection and Queer Prosociality among Trans and Nonbinary People2025-01-01OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7119299327
W4415878955Alyse Gregory: Finding her “Voice” through Woman's Suffrage2025-01-01OpenAlex10.5406/26395991.64.2.11Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415878955
W7128755679An Efficient and Effective Electromagnetic Rewarming Platform for Cryopreservation of Large-Volume Biomaterials2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128755679
W4414830170An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment2025-01-01OpenAlex10.4168/aair.2025.17.5.531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414830170
W4408924216An overview of medical care and diagnostic aspects of rheumatoid arthritis2025-01-01OpenAlex10.33545/comed.2025.v8.i1.b.374Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408924216
W4411026481Anesthesia for Patients with Motor Neuron Disease – Many Pitfalls2025-01-01OpenAlex10.4103/jica.jica_16_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411026481
W4413408373Antibiotics and antiviral agents2025-01-01OpenAlex10.1016/b978-0-443-27461-9.00012-3Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413408373
W4410736413Antithrombotic Therapy for Acute Coronary Syndrome2025-01-01OpenAlex10.5797/jnet.ra.2024-0102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410736413
W4412916341Aptamers: A Novel Class of Targeted Therapeutics2025-01-01OpenAlex10.1007/978-981-96-8387-1_3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412916341
W4413192759Artificial Intelligence as a Digital Species: Opportunities, Risks, and the Human Challenge – A Conversation with Mustafa Suleyman2025-01-01OpenAlex10.2139/ssrn.5368626Title/abstractExcludedE1: Title identifies a conversation/interview; no primary adapting agent study.https://openalex.org/W4413192759
W4417317890Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma2025-01-01OpenAlex10.70844/jmhrp.2025.2.2.43Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417317890
W4410106808Autonomous Self-Healing Grid Transformers with GenAI and LLM Optimization: Toward Limited Human Intervention2025-01-01OpenAlex10.2139/ssrn.5220392Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410106808
W4408024359Beyond Moral Fundamentalism2025-01-01OpenAlex10.5406/19446489.20.1.01Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408024359
W7108337014Beyond Static Products: Rethinking Regulatory Hurdles and "Significant Change" in Digital Mental Health Technologies Across India, the EU/UK, and the United States2025-01-01OpenAlex10.2139/ssrn.5824142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108337014
W4408580977Beyond the Tumor: Cutaneous Manifestations of Paraneoplastic Syndromes2025-01-01OpenAlex10.4236/jbm.2025.133018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408580977
W4406591636Bilateral aqueous misdirection following cataract surgery: A case report2025-01-01OpenAlex10.1111/aos.17293Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406591636
W4409256865Biofilms and Their Increasing Trend in AMR Patterns in Integrated Farming Systems2025-01-01OpenAlex10.1007/978-981-96-1885-9_18Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409256865
W4406731360Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review2025-01-01OpenAlex10.1007/s13555-024-01327-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406731360
W4412491899Burn Debridment - Approach and Review.2025-01-01OpenAlex10.12865/chsj.51.01.01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412491899
W7133538487CORONARY VENOUS DISEASES TREATMENT AND PHARMACOLOGICAL INNOVATIONS2025-01-01OpenAlex10.5336/978-625-395-700-1_p119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133538487
W4412781839Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer2025-01-01OpenAlex10.1177/17588359251358947Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412781839
W4415997772Cardiovascular Effects of GLP-1 Analogues2025-01-01OpenAlex10.1007/978-3-032-01700-0_15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415997772
W4407140791Challenges and Opportunities for Nanotechnology to Enhance Food Safety of Fresh Vegetables in Chile2025-01-01OpenAlex10.1007/978-3-031-70745-2_14Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407140791
W4416240721Chemical Peels: Indications and Use in Various Skin Types2025-01-01OpenAlex10.1007/978-981-97-9754-7_10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416240721
W4409524158Chemotherapy in Breast Cancer2025-01-01OpenAlex10.1007/978-981-97-9847-6_15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409524158
W7125817509Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment2025-01-01OpenAlex10.5114/pedm.2025.158551Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125817509
W7213390217Chinese-speaking Immigrants' Experience Navigating Ireland’s 2022 Regularisation of Long-Term Undocumented Migrants Scheme2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213390217
W4410132433Chronic Kidney Disease - Evolving Treatments2025-01-01OpenAlex10.71431/ijrpas.2025.4310Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410132433
W7133022531Classification and Analysis of Differential Mobility Spectrometry Measurements2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133022531
W4409001771Clinical Application of Artificial Intelligence in Breast MRI2025-01-01OpenAlex10.3348/jksr.2025.0012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409001771
W4410311201Clinical Applications of Exosomes2025-01-01OpenAlex10.1007/978-981-96-1261-1_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410311201
W7106234027Clinical Evaluation of Patients Proposed for Hyperbaric Oxygen Therapy and Contraindications2025-01-01OpenAlex10.1007/978-3-032-06346-5_20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106234027
W4414730701Clinical Validations of Localized Cancer Nanomedicine2025-01-01OpenAlex10.1007/978-981-95-0938-6_7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414730701
W4406298756Clinical practice guidelines on the assessment and management of cognitive impairment in major depressive disorder2025-01-01OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_563_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406298756
W4406298779Clinical practice guidelines – An overview of cognitive remediation for various neuropsychiatric disorders2025-01-01OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_1191_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406298779
W4411449569Clostridioides Difficile Infection in Colorectal Cancer: Risk Factors, Clinical Outcomes, and Evolving Strategies for Optimal Management2025-01-01OpenAlex10.2139/ssrn.5292438Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411449569
W7114912027CloudPedagogy AI Capability Framework (2026 Edition)2025-01-01OpenAlex10.6084/m9.figshare.30865790Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7114912027
W4406298762Cognitive impairment in alcohol use disorder and clinical practice guidelines for management of long-stay alcohol use disorder patients2025-01-01OpenAlex10.4103/indianjpsychiatry.indianjpsychiatry_692_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406298762
W4414167322Comparative effectiveness of perioperative strategies for resectable gastric and gastroesophageal junction cancer: a Bayesian network meta-analysis2025-01-01OpenAlex10.62347/eckt5511Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414167322
W4414394578Comparative evaluation of different re-mineralizing agents for enamel protection after pH-cycling2025-01-01OpenAlex10.5114/jos.2025.154418Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414394578
W7127702323Composition, Assembly, Function, and Post-Translational Modification of the Apical Complex in Toxoplasma gondii: Insights into Regulation of Motility and Invasion2025-01-01OpenAlex10.13097/archive-ouverte/unige:191222Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7127702323
W4414786159Comunicação da PrEP e da PEP no Brasil: exploração dos sentidos de peças comunicacionais e análise das concepções de agentes governamentais2025-01-01OpenAlex10.1590/0102-311xpt100524Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414786159
W4406735229Connecting Wound Bed Preparation 2024, Therapeutic Index, and Covert and Overt Infection2025-01-01OpenAlex10.1097/asw.0000000000000267Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406735229
W4408024388Consequentialism in the Work of John Dewey and Peter Singer: Considering the Case of Effective Altruism2025-01-01OpenAlex10.5406/19446489.20.1.04Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408024388
W4416684670Constructing an Application Framework for Educational AI Agents to Promote Deep Integration of Teacher TPACK2025-01-01OpenAlex10.4236/jcc.2025.1311013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416684670
W4411049353Contemporary Approaches to Combat Cardiac Fibrosis: From Immune Cell Modulation to Therapeutic Advancements2025-01-01OpenAlex10.2139/ssrn.5274697Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411049353
W7115914616Cooperation in a Dynamic Network2025-01-01OpenAlex10.2139/ssrn.5933281Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7115914616
W4408645701Current Developments, Challenges, and Future Standpoints Corresponding to Antibacterial Agents with Special Reference to Polyhydroxyalkanoates (PHAs)2025-01-01OpenAlex10.1007/978-981-96-2022-7_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408645701
W4411549361DISEASE DIAGNOSIS USING RAG LLM WITH SMART PROMPT ENGINEERING2025-01-01OpenAlex10.31979/etd.azur-9jbvTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4411549361
W7131101566DYSESTHESIA2025-01-01OpenAlex10.5336/978-625-395-759-9_p281Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131101566
W7106003846Data Augmentation, Explainable AI, and Conversational Diagnosis via Large Language Models: A Path Towards a Real Automated Clinical Mental Disorder Diagnosis2025-01-01OpenAlex10.7939/83339Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7106003846
W4415205345Dementia Care and Generative Artificial Intelligence2025-01-01OpenAlex10.1007/978-3-031-40858-8_528-1Full textExcludedF1: This is an encyclopedia literature/reference entry, not a primary adaptive-agent study.https://openalex.org/W4415205345https://link.springer.com/rwe/10.1007/978-3-031-40858-8_528-1publisher abstract and bibliographic version information only
W4411789634Demographic and Clinical Characteristics of Pediatric Poisoning: A 20-Year Retrospective Analysis with Literature Review2025-01-01OpenAlex10.29228/ejhh.82491Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411789634
W7116708953Descriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa2025-01-01OpenAlex10.1155/bmri/9558259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116708953
W7199328993Development of multilayered protection systems against chemical, radiological, and biological hazards for military personnel2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7199328993
W4409932645Dietary Fiber and Cancer Management: A Twenty‐Five‐Year Bibliometric Review of Research Trends and Directions2025-01-01OpenAlex10.1155/bmri/5086946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409932645
W7141661283Discovery and in vitro functional characterization of marine-derived and synthetic multifunctional peptides with therapeutic potential against cancer and microbial infections2025-01-01OpenAlex10.18725/oparu-59644Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7141661283
W7206417086Diseases of the Eye2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7206417086
W4406598659Distribution and Resistance Profile of Klebsiella pneumoniae Strains at the Yaoundé Central Hospital: Analysis and Implications2025-01-01OpenAlex10.4236/aim.2025.151002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406598659
W7128209144Drug discovery and development process: An evolving scientific journey2025-01-01OpenAlex10.33545/26646536.2025.v7.i2a.129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128209144
W4416563226Drug-Induced Lung Injury2025-01-01OpenAlex10.1007/978-981-96-7810-5_78Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416563226
W4413165705Dynamic Resource Allocation with Stochastic Agent Flows2025-01-01OpenAlex10.2139/ssrn.5373671Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4413165705
W4411020523Efficacy of a Chatbot (Chatgpt-4) Compared to a Human Conversational Agent for Reducing Procrastination: A Randomized Controlled Pilot-Trial2025-01-01OpenAlex10.2139/ssrn.5281283Full textExcludedF4: The trial evaluates fixed ChatGPT4 session prompts without tuning/adaptation. Human pretrial prompt development is separate from the evaluated trial; no retained cross-case agent learning is tested.https://openalex.org/W4411020523https://journals.sagepub.com/doi/10.1177/20552076261450336SSRN original abstract and retitled published paper full Methods; no supplementary files downloaded
W4414194208Electrospun Mucoadhesive Film Loaded with Polycaprolactone Nanocarriers for Sustained Delivery of Deferasirox through Buccal Mucosa2025-01-01OpenAlex10.2139/ssrn.5481998Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414194208
W4412804375Electrospun chitosan nanofibers for regenerative wound healing: from molecular design to functional scaffolds2025-01-01OpenAlex10.1039/d5tb01405kTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412804375
W7126323659Enclosing the Insane: The Pharmakon Behind Asylum Architecture2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126323659
W4411864383Engaging patients and caregivers: transforming healthcare together2025-01-01OpenAlex10.1093/ijcoms/lyaf007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411864383
W4409494283Enhancing LLM Reasoning Capabilities Through Brokered Multi-Expert Reflection2025-01-01OpenAlex10.1109/access.2025.3561693Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409494283
W7147467563Evaluation of Patient with Peripheral Arterial Disease: General Surgeons’ Perspective2025-01-01OpenAlex10.4103/sd.sd_3_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147467563
W4415282964Evolutionary engineering and molecular characterization of an antimycin A-resistant Saccharomyces cerevisiae strain: the key role of pleiotropic drug resistance ( PDR1 )2025-01-01OpenAlex10.1093/femsyr/foaf062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415282964
W7110776913Evolving functions of plasters and patches in health care: The historical progress of classical medical devices2025-01-01OpenAlex10.23750/abm.v96i5.17290Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7110776913
W4409023368Expanding the Role of Novel Therapeutics in Cardiometabolic Syndrome: Beyond Heart Failure and Diabetes2025-01-01OpenAlex10.51789/cmsj.2025.5.e4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409023368
W7135577050Exploring the Future Trajectory of AI-Powered Hearables: Industry Perspectives on Emerging Capabilities2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135577050
W4416553257Exploring the Ocean for Oncology: Natural Compounds from Marine Organisms in Cancer Treatment2025-01-01OpenAlex10.52756/lbsopf.2025.v04.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416553257
W7169574941Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?2025-01-01OpenAlex10.12688/wellcomeopenres.24103.3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169574941; https://openalex.org/W7130642010; https://openalex.org/W4413426508
W4414284296FRAME MODELING OF THE DOUBT /СОМНЕНИЕ/ CONCEPT (based on materials from Russian-language electronic media of Ukraine)2025-01-01OpenAlex10.17721/studling2025.26.45-62Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414284296
W7131118025FUTURE ROLES OF ARTIFICIAL INTELLEGENCE IN COLLABORATION WITH HEALTHCARE PROFESSIONALS2025-01-01OpenAlex10.5336/978-625-395-760-5_p235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131118025
W4410121570Follicular Non-Hodgkin's Lymphoma (FL) heterogeneity, management and perspectives2025-01-01OpenAlex10.32440/ar.2025.142.01.rev04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410121570
W7128539339Food anaphylaxis and emerging allergens — beyond current regulations2025-01-01OpenAlex10.26416/aler.9.4.2025.11335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128539339
W4407554468From Simple Scripts to Sentient Conversations: Tracing NLP's Influence on Chatbot Development2025-01-01OpenAlex10.52783/eel.v15i1.2567Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407554468
W4413315499From “Taking” to Beyond: Diachronic Change in the Multifunctionality of the Na-Construction of Chinese2025-01-01OpenAlex10.2139/ssrn.5397524Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413315499
W7127253506Fully moral artificial agents: future or fiction2025-01-01OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7127253506
W4416453879Fundamentals of Ultrasonic Diagnosis and Common Ultrasound Techniques in Female Reproduction2025-01-01OpenAlex10.1007/978-981-95-1373-4_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416453879
W4409830039Future Perspectives: Metabolic Imaging, Theranostics, and Radiomics2025-01-01OpenAlex10.1007/978-3-031-77061-6_4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409830039
W4405963974GLP-1 receptor agonism in cardiovascular disease prevention2025-01-01OpenAlex10.32948/ajpt.2024.11.22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4405963974
W4407154086Gallery Artists2025-01-01OpenAlex10.1162/leon_a_02658Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407154086
W7104096400Global Anesthesia Drugs Market Analysis (2024–2030)2025-01-01OpenAlex10.6084/m9.figshare.30518942.v2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7104096400; https://openalex.org/W7103991406
W4415145500Glycoprotein IIb/IIIa Antagonists2025-01-01OpenAlex10.1007/978-3-031-96360-5_3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415145500
W4408477905Guts for Self-Eating: Role of Autophagy in Gastrointestinal Health and Disease2025-01-01OpenAlex10.1016/j.gastha.2025.100654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408477905
W7133312717Handling Communist Captives: U.S. Military Authorities and the Treatment of Enemy POWs during the Korean War2025-01-01OpenAlex10.1162/jcws.a.39Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133312717
W4416987346Harnessing GLP‐1 Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon2025-01-01OpenAlex10.1155/jobe/9919810Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416987346
W4416794021Harnessing the extinction vortex against acute lymphoblastic leukemia2025-01-01OpenAlex10.1093/emph/eoaf035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416794021
W4412683869Harnessing the medicinal benefits of silkworm, Bombyx mori2025-01-01OpenAlex10.33545/26174693.2025.v9.i7sh.4942Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412683869
W4409834069HbA1c reduction strategies: An overview of pharmacological interventions2025-01-01OpenAlex10.4103/njpt.njpt_72_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409834069
W4417200037Health empowerment through the convergence of Wearables, Smartphone-Driven Health Devices, and Artificial Intelligence -A Scoping Review2025-01-01OpenAlex10.2139/ssrn.5890362Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417200037
W4408957953Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma2025-01-01OpenAlex10.1007/978-3-031-74935-3_16Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408957953
W4408958057Hepatic Arterial Infusion Drugs and Dosing2025-01-01OpenAlex10.1007/978-3-031-74935-3_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408958057
W4409983039Heterogeneous Multi-Agent Framework for Dynamic Generalized Category Discovery2025-01-01OpenAlex10.1137/1.9781611978520.33Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4409983039
W4406567183History of the human viral infection and their clinical manifestation2025-01-01OpenAlex10.1016/b978-0-443-15283-2.00001-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406567183
W7107862142How do lipopeptides interact with the model fungal membrane?2025-01-01OpenAlex10.5286/isis.e.rb2520355-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7107862142; https://openalex.org/W7107874444
W7114594275ICCCC 2025 Outcome Document2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114594275
W7133352727INTRODUCTION TO UROGYNECOLOGY2025-01-01OpenAlex10.5336/978-625-395-710-0_p3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133352727
W4411349489Imagining the work of community health workers: notes for a discussion on territory, health and care2025-01-01OpenAlex10.1590/s0104-12902025230415enTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411349489
W4413457855Immunomodulation and Thrombolytic Approaches in the Management of Deep Vein Thrombosis and Pulmonary Embolism2025-01-01OpenAlex10.26502/fccm.92920456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413457855
W4416239281Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis–Associated Pulmonary Arterial Hypertension2025-01-01OpenAlex10.1155/carj/5021789Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416239281
W4409831195In Vivo Infiltration Techniques for Nanoparticle Delivery2025-01-01OpenAlex10.1007/978-3-031-81896-7_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409831195
W7114924896Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options2025-01-01OpenAlex10.64149/j.carcinog.24.10s.488-501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114924896
W4411101028Innovations in cardio-oncology research2025-01-01OpenAlex10.1016/b978-0-443-29829-5.00016-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411101028
W4415763514Innovations in intelligent automation and evolving human-Robot Interaction2025-01-01OpenAlex10.2991/978-94-6463-858-5_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415763514
W7154834318Insecticide resistance patterns in major mosquito vectors and their impact on vector control strategies2025-01-01OpenAlex10.22271/23487941.2025.v12.i1a.904Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7154834318
W7119559344Integrating Large Language Models in Physiotherapy : A Design Study of Interaction and Workflows2025-01-01OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7119559344
W4413240765Integrative strategies in breast cancer therapy: Conventional approaches, emerging advances, and future challenges2025-01-01OpenAlex10.1016/j.aspetd.2025.100012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413240765
W7117972744Interactive Healthcare Solutions: NLP Systems with Personalized Conversational Agents and Long-Term Memory2025-01-01OpenAlex10.1007/978-3-031-87372-0_44Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W7117972744https://link.springer.com/chapter/10.1007/978-3-031-87372-0_44Bibliographic information and available abstract/preview only; no full methods read.
W4415423147Interdisciplinary Dialogues for the Twentieth Anniversary of the SZJSZK2025-01-01OpenAlex10.15170/ttk-szjszk-2025bTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415423147
W4409562829Interstitial Lung Diseases - Registries are the Need of the Hour2025-01-01OpenAlex10.4103/pulmon.pulmon_3_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409562829
W4413475442Intravenous Infusions for Sedation: Rationale, State of the Art, and Future Trends2025-01-01OpenAlex10.1007/978-3-031-68468-5_36Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413475442
W4416272911Intrinsic Participatory Governance of Autonomous Agents: Runtime Oversight and Orientation through Embedded Steward Agents2025-01-01OpenAlex10.2139/ssrn.5651771Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4416272911
W4406592272Introduction2025-01-01OpenAlex10.1016/b978-0-443-26787-1.00001-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406592272; https://openalex.org/W4367179063; https://openalex.org/W4390348278; https://openalex.org/W7164887387; https://openalex.org/W7131820512; https://openalex.org/W4410593498
W4412645672Introduction to Biosafety and Biosecurity in the Context of Biorisk Assessment and Management in Biomedical and Clinical Laboratory Settings2025-01-01OpenAlex10.47278/book.hh/2025.373Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412645672
W4410160560Introduction to Social Robotics: An Intersection of Robotics and Society2025-01-01OpenAlex10.1007/978-3-319-77267-7_7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410160560
W4412837552Ionic Liquids as Versatile Greener Media: Synthesis and Stabilization of Metal Nanoparticles and Their Remarkable Biological Applications2025-01-01OpenAlex10.2139/ssrn.5374917Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412837552
W4417257131Japan–Korea collaboration on biophysical techniques for drug discovery in infectious diseases: Toward future pandemic preparedness2025-01-01OpenAlex10.2142/biophysico.bppb-v22.s003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417257131
W4408899333Kaposi’s sarcoma occurring in a glioblastoma multiforme on temozolomide2025-01-01OpenAlex10.4103/ds.ds-d-24-00095Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408899333
W4412896833Ketamine and Esketamine for the Treatment of Refractory Status Epilepticus Induced by Organophosphorus Compounds2025-01-01OpenAlex10.1007/978-1-0716-4599-4_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412896833
W7110669692La Emptiness Machine: Derechos Fundamentales para la Inteligencia Artificial y la Evolución de la Conciencia: Un Análisis Interdisciplinario a la Luz del Project Sid de Altera AI2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7110669692
W7119473485Leukemia epidemiology in China: Burden, trends and determinants in the 21st century2025-01-01OpenAlex10.21147/j.issn.1000-9604.2025.06.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119473485
W4410392312Liability for AI Agents2025-01-01OpenAlex10.2139/ssrn.5236649Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4410392312
W4406655101Los cursos de didácticas en Educación Especial: sus cambios a lo largo de los 50 años de la carrera en la Universidad de Costa Rica2025-01-01OpenAlex10.15517/aie.v25i1.60551Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406655101
W4409050795Lung cancer: Current status of preclinical research2025-01-01OpenAlex10.1016/b978-0-443-31656-2.00005-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409050795
W7133300455MANAGEMENT OF METASTATIC BREAST CANCER2025-01-01OpenAlex10.5336/978-625-395-705-6_p145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133300455
W4417293947MICROBUBBLES IN MOTION: THE EVOLVING LANDSCAPE OF ULTRASOUND CONTRAST AGENTS FOR DIAGNOSTICS AND THERAPEUTICS2025-01-01OpenAlex10.1016/j.ultrasmedbio.2025.10.080Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4417293947
W4411285726Management of Advanced Heart Failure in Cardiac Amyloidosis2025-01-01OpenAlex10.1007/978-3-031-88342-2_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411285726
W4415916084Managing atopic dermatitis with antioxidant treatment emollients: A narrative review and consensus statements2025-01-01OpenAlex10.12932/ap-060225-2027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415916084
W7114001483Memory as Baseline Deviation: Toward a Relational Predictive Processing Framework2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7114001483
W4407252977Meningiomas Following the Previous Cancer Therapies: Brief Report2025-01-01OpenAlex10.4103/ni.ni_670_22Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407252977
W4410517385Metabolism Prediction: Identification of Potential Sites of Metabolism in Lead Molecules2025-01-01OpenAlex10.1007/978-981-96-4154-3_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410517385
W4412092747Molecular Diagnostics and Therapeutic Approaches in Zoonotic Infections2025-01-01OpenAlex10.51584/ijrias.2025.10060054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412092747
W4410765323Molecularly driven therapies in the treatment of primary brain tumors2025-01-01OpenAlex10.1016/bs.acr.2025.05.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410765323
W7211874267Multi-Agent Coordination for Operating Room Turnover: A Constraint-Based Optimization Blueprint2025-01-01OpenAlex10.68159/i129739920Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7211874267
W4412379950Multidimensional heterogeneous integration of two-dimensional materials and artificial visual systems: Frontier innovations and paradigm-shifting advancements2025-01-01OpenAlex10.7498/aps.74.20250703Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412379950
W7131732636Multimodal and Agentic AI for Cognitive Accessibility and Linguistic Preservation2025-01-01OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7131732636
W4406595619Myopia control in the community (optical interventions, biometry, protocol)2025-01-01OpenAlex10.1111/aos.16896Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406595619
W4415804950NANOSPONGES AS A REVOLUTIORNARY PLATFORM IN DELIVERY OF DRUGS2025-01-01OpenAlex10.56975/ijsdr.v10i10.305470Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415804950
W7133936532NONINVASIVE CARDIAC MONITORING IN CRITICALLY ILL CHILD2025-01-01OpenAlex10.5336/978-625-395-599-1_p13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133936532
W4410969082Nanopaints in medical applications2025-01-01OpenAlex10.1016/b978-0-443-26512-9.00017-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410969082
W4411548164Nanosystem Equipped with a Sonosensitizer for Combined Chemotherapy and Sonodynamic Therapy for Melanoma Treatment2025-01-01OpenAlex10.2139/ssrn.5294156Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411548164
W4412645691Nanotechnology and the Future of Medical Imaging: Enhancing Diagnostic Accuracy2025-01-01OpenAlex10.47278/book.hh/2025.441Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412645691
W4413437842Nasal staphylococcal microbiota of healthy hosts, their antimicrobial resistance and virulence determinants: Implications for One Health2025-01-01OpenAlex10.1016/b978-0-443-33351-4.00013-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413437842
W4406582748National educational policy 2020: Transforming nursing profession2025-01-01OpenAlex10.33545/26649187.2025.v7.i1a.78Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406582748
W7131738518Negotiating Health Equity in Aotearoa New Zealand: A Constructivist Grounded Theory of IQNs’ Balancing Perspectives and Reconciling a New Understanding2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131738518
W7117952837Nelson’s Syndrome after bilateral adrenalectomy: A comprehensive review of pathogenesis, diagnosis, and treatment approaches2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117952837
W4416362829Nephrology2025-01-01OpenAlex10.1007/978-3-032-12399-2_6Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4416362829
W7115978551Network-Agnostic Computational Approaches for Modelling and Validating Evolving Complex Systems2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7115978551
W4410874813Neurophysiological and Neuroanatomical Background of Spasticity: Surgical Implication for Dorsal Rhizotomy in Cerebral Palsy2025-01-01OpenAlex10.1007/978-3-031-86441-4_3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410874813
W7118005039Neuroprotection: Quest for the Holy Grail2025-01-01OpenAlex10.1007/978-981-95-4419-6_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118005039
W4416152631New Insights in Septic Encephalopathy2025-01-01OpenAlex10.1007/978-3-032-01024-7_5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416152631
W4408508226New insights into atherosclerotic cardiovascular disease through the lens of metabolism: expanding our approach2025-01-01OpenAlex10.1097/cp9.0000000000000112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408508226
W4409181312Nonresolving Pneumonia: A Curious Case2025-01-01OpenAlex10.22259/2639-362x.0801001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409181312
W4413424457Novel Immune Modulatory Agents in the Treatment of Non-small Cell Lung Cancer2025-01-01OpenAlex10.1007/978-3-031-97242-3_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413424457
W4414693968Nucleoid-associated Proteins Shape the Regulation of Virulence Factors and Defense Elements in Vibrio cholerae2025-01-01OpenAlex10.7302/25791Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414693968
W4416310371Nursing Management2025-01-01OpenAlex10.18231/978-93-48565-32-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416310371
W4410825675Off-Label Use of Bispectral Index to Grade Conditions Other Than Depth of Anesthesia2025-01-01OpenAlex10.1007/978-3-031-88260-9_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410825675
W4408150473One Health: A Collaborative Approach in Bridging Human, Animal, and Environmental Health2025-01-01OpenAlex10.4103/amhs.amhs_295_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408150473
W7114946748Optimising the Customer Experience in Healthcare SaaS Support: Balancing Service Quality and Security2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7114946748
W4412633375Overview of Military Operations in Response to Domestic Emergencies, Global Pandemics, and Civil-Military Relations2025-01-01OpenAlex10.1007/978-3-031-86741-5_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412633375
W4406354715Oxidation of A-Hydroxy Acids by D-2-Hydroxyglutarate Dehydrogenase Enzymes2025-01-01OpenAlex10.2139/ssrn.5078069Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406354715
W4406704815P0211 Characterization of drug-specific CD4+ T cells in patients with inflammatory bowel diseases2025-01-01OpenAlex10.1093/ecco-jcc/jjae190.0385Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406704815
W4406703389P0618 A Network Meta-analysis to Compare the Efficacy of Advanced Treatments for Biological-Experienced Patients with Ulcerative Colitis2025-01-01OpenAlex10.1093/ecco-jcc/jjae190.0792Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406703389
W4406699886P0919 Correlation between trough levels of risankizumab and clinical and biological remission in patients with moderate to severe Crohn’s disease: a retrospective multicenter study (RISE-CD)2025-01-01OpenAlex10.1093/ecco-jcc/jjae190.1093Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406699886
W4406700140P1022 ChatGPT in the management of Inflammatory Bowel Disease, a future or a present reality?2025-01-01OpenAlex10.1093/ecco-jcc/jjae190.1196Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406700140
W4414651538PARP Inhibitors-Associated Adverse Effects Across Multiple Organ Systems: A Review of Case Reports from 2022 to 20252025-01-01OpenAlex10.70251/hyjr2348.35407422Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414651538
W7133337907Patient-facing artificial intelligence for diabetes self-management in the large language model era: an integrative review2025-01-01OpenAlex10.17605/osf.io/prf53Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133337907
W4415631890Peptides in the clinic today: The leading families and their applications2025-01-01OpenAlex10.1016/bs.mie.2025.09.012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415631890
W4411085814Persistent Spread of Carbapenemase-Producing Klebsiella Pneumoniae in Acute Care Hospitals in 36 European Countries: Results from the Survey of Carbapenem- and/or Colistin-Resistant Enterobacterales (CCRE Survey), 20192025-01-01OpenAlex10.2139/ssrn.5275521Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411085814
W7155387120Pharmacologic Management of Chronic Obstructive Pulmonary Disease: A review of the literature2025-01-01OpenAlex10.18103/mra.v14i1.7424Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155387120
W4411148208Pharmacological Maintenance Therapies After Allogeneic Hematopoietic Cell Transplantation2025-01-01OpenAlex10.1007/978-3-031-84988-6_11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411148208
W4414025553Pharmacological Management of Acute Agitation and Violent Behavior in Psychiatric Settings2025-01-01OpenAlex10.4306/jknpa.2025.64.3.109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414025553
W4414548903Pharmacotherapies in Prevention of Myocardial Oxidative Stress Mediated by Anthracyclines, Taxanes, and Alkylating Agents2025-01-01OpenAlex10.1007/978-3-031-97517-2_6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414548903
W4411177287Photoactivated Radiochemistry for the Construction of 18F- and 11C-Labeled Compounds2025-01-01OpenAlex10.1007/978-3-031-84632-8_13Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411177287
W4411923958Photon-Counting CT in Emergency Radiology2025-01-01OpenAlex10.1007/978-3-031-85078-3_6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411923958
W7131363281Pioneering Approaches to Transform Women’s Health: Experiences from Human Immunodeficiency Virus Research in Southern Africa2025-01-01OpenAlex10.4103/abmj.abmj_29_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131363281
W4408471201Place of New Generation Sulfonylurea: Gliclazide in the Evolving Landscape of Type 2 Diabetes Management2025-01-01OpenAlex10.54457/dr.202501003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408471201
W7108069335Polymyxin B Revisited: Structural Insights, Clinical Resurgence, and Emerging Strategies Against Multidrug-Resistant GramNegative Infections.2025-01-01OpenAlex10.5281/zenodo.17766962Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108069335; https://openalex.org/W7107967283
W4414128254Precision therapeutics for Alzheimer’s disease2025-01-01OpenAlex10.1016/bs.pbr.2025.08.011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414128254
W4413776550Predicting Parkinson’s Disease with Explainability: A Hybrid Deep Learning Approach Utilizing Voice Dataset2025-01-01OpenAlex10.1007/978-3-031-94950-0_10Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413776550
W7107947094Preeclampsia: Advances in Prediction, Prevention, and Management of a Critical Maternal–Fetal Disorder2025-01-01OpenAlex10.5281/zenodo.17748833Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7107947094; https://openalex.org/W7108070598
W4411300266Preventing Surgical Site Infections, Skin Microbiome Dysbiosis – The Fourth Dimension of Surgical Site Infection Epidemiological Quad2025-01-01OpenAlex10.4103/ijcs.ijcs_12_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411300266
W7111350230Production and characterization of endogenous receptor ligands for gene delivery2025-01-01OpenAlex10.3929/ethz-c-000789217Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111350230
W4413475436Proportionate Sedation in Pediatric Palliative Care2025-01-01OpenAlex10.1007/978-3-031-68468-5_40Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413475436
W4409530560Pros and Cons of Nanomedicine While Targeting Inflammatory Diseases2025-01-01OpenAlex10.1007/978-981-96-2112-5_18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409530560
W4410326139Radiation Synovectomy: An Enticing Treatment Option for Inflammatory Joint Pain2025-01-01OpenAlex10.1155/prm/8887391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410326139
W4410972028Radiotherapeutics in prostate cancer therapy2025-01-01OpenAlex10.1016/b978-0-443-23585-6.00012-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410972028
W7117988374Reality of Regulatory Failure and the Limit of Regulatory Reform2025-01-01OpenAlex10.1007/978-3-032-10713-8_6Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117988374
W7171711549Recent Trends in Biomedical and Applied Biological Sciences2025-01-01OpenAlex10.5281/zenodo.21673714Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171711549
W7115935623Reckoning with AI agents2025-01-01OpenAlex10.5287/ora-ppgrbwpvaTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7115935623
W4407121857Redefining Perioperative Care: The Pivotal Role of Anesthesiologists in Enhanced Recovery After Surgery (ERAS) Protocols2025-01-01OpenAlex10.51542/ijscia.v6i1.16Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407121857
W4411620424Reinforcement Learning in Dynamic Environments: Challenges and Future Directions2025-01-01OpenAlex10.63282/3050-9262.ijaidsml-v6i1p102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411620424; https://openalex.org/W4411577658
W4412814860Research Progress on Traditional Uses, Chemical Composition, Pharmacological Actions, and Clinical Applications of Ginseng-Containing Sijunzi Decoction2025-01-01OpenAlex10.1142/s0192415x25500636Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412814860
W4414510742Resistant Hypertension: Emerging Therapies And Future Directions2025-01-01OpenAlex10.64149/j.carcinog.24.6s.346-351Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414510742
W4414108043Responsible RAG Systems in Practice: Lessons from Commercial and Pharma Use Case2025-01-01OpenAlex10.2139/ssrn.5467706Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414108043
W4413242577Retinal Venous Occlusions2025-01-01OpenAlex10.1007/978-3-031-29358-0_26-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413242577; https://openalex.org/W7214667853
W4407251538Revisiting the Role of miRNAs in Neuropathology2025-01-01OpenAlex10.4103/neurol-india.neurol-india-d-24-00920Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407251538
W7118835957Revisiting the role of iron in ferroptosis2025-01-01OpenAlex10.70401/fos.2025.0009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118835957
W4416508247Rewriting the script of health and disease: The evolving era of molecular medicine and precision medicine2025-01-01OpenAlex10.4103/ijpmmm.ijpmmm_1_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416508247
W7103889777Robotics and AI in Telepharmacy: A Critical Review of Their Role in Revolutionizing Pharmaceutical Care2025-01-01OpenAlex10.5281/zenodo.17511640Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7103889777
W7223144344Rog Pratirodhak Shamta ki Ayurvedic Sankalpana2025-01-01OpenAlex10.5281/zenodo.23527946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223144344
W7130543730SECOND AND SUBSEQUENT-LINE SYSTEMIC THERAPY FOR METASTATIC COLORECTAL CANCER2025-01-01OpenAlex10.5336/978-625-395-770-4_p105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130543730
W4415736012Scalable Hybrid Memory System for Long-Term Conversational Assistants in Healthcare2025-01-01OpenAlex10.1007/978-3-032-05925-3_1Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W4415736012https://link.springer.com/chapter/10.1007/978-3-032-05925-3_1Bibliographic information and available abstract/preview only; no full methods read.
W4416705758Secure web based chat platform with advanced network security2025-01-01OpenAlex10.1063/5.0309354Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416705758
W4416912180Sedated behind bars: the inappropriate use of psychiatric medications in Italy’s incarcerated populations2025-01-01OpenAlex10.15406/jpcpy.2025.16.00833Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416912180
W4413475447Sedation in the Pediatric Intensive Care Unit: Current Practice in Europe2025-01-01OpenAlex10.1007/978-3-031-68468-5_18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413475447
W4413248662Self-Evolving LLM Ecosystems for Precision Medicine2025-01-01OpenAlex10.17762/ijisae.v13i1s.7793Full textExcludedF3: The implemented TreatmentAgent is a Random Forest retrained on increasing data subsets. The purported LLM-agent feedback is explicitly a rule-based simulator; §VII identifies an actual LLM multi-agent system as future work.https://openalex.org/W4413248662https://ijisae.org/index.php/IJISAE/article/view/7793
W4412190916Semiconducting polymer nanoparticles for combinational cancer immunotherapy2025-01-01OpenAlex10.32657/10356/200340Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412190916
W4408098381Senotherapeutics: Milestones, innovations, and future prospects2025-01-01OpenAlex10.1016/bs.apha.2025.01.021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408098381
W4415532763Side effects of antihypertensive agents: Calcium channel blockers, loop diuretics, alpha-2 agonists, beta-blockers, and vasodilators2025-01-01OpenAlex10.1016/bs.seda.2025.09.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415532763
W4415358445Simulation of Human Decision-Making in High-Stakes Crisis Scenarios2025-01-01OpenAlex10.2139/ssrn.5524081Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4415358445
W7203613446Sirolimus in contemporary medicine: from immunosuppression to precision therapeutics – part 12025-01-01OpenAlex10.5114/pcard.2025.163965Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203613446
W4417150757Spinal Cervical Meningiomas: An Integrative Review of Molecular Pathogenesis, Evolving Surgical Procedures, and Pathway to Personalized Management2025-01-01OpenAlex10.52533/johs.2025.51104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417150757
W4408132647Spleen Infarction in Plasmodium Infection2025-01-01OpenAlex10.37184/lnjpc.2707-3521.7.48Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408132647
W4407020607Sports nutrition: boosting performance with functional foods2025-01-01OpenAlex10.1016/b978-0-443-28862-3.00008-xTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407020607
W4416202668Strategies for hyperkalemia management in dialysis patients: A systematic review2025-01-01OpenAlex10.1515/med-2025-1301Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416202668
W7106698763Structural and Magnetic Properties of Biocompatible Iron Oxide Nanoparticles for Medical Applications2025-01-01OpenAlex10.34734/fzj-2025-03970Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106698763
W7133333758Structure-exploiting uncertainty quantification and control : Bayesian inference and Itô SDE methods from MRI segmentation to autonomous sensing2025-01-01OpenAlex10.18154/rwth-2026-00164Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133333758
W4412363281Surface modification of polyetheretherketone for boosted osseointegration: A review.2025-01-01OpenAlex10.12336/bmt.24.00052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412363281
W4414527816Surgical Management for Transitional Cell Carcinoma of the Upper Tract2025-01-01OpenAlex10.1007/978-3-031-97599-8_19Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414527816
W4415652785Sustainability in Dental Education2025-01-01OpenAlex10.1007/978-981-97-0275-6_33-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415652785
W7126642970T cell evolution in the blood and organs during acute graft-versus-host disease2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126642970
W4412645413Tailored Tissue Plasminogen Factor Injection via Subdural Catheter for Subacute Subdural Hematoma in an Elderly Patient: A Case Report and Literature Review2025-01-01OpenAlex10.13004/kjnt.2025.21.e25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412645413
W7117453040The AI-Enhanced Intelligent Business Diagnostics for Predictive Assessment of Organizational Resilience in Digital Transformation2025-01-01OpenAlex10.32983/2222-4459-2025-10-560-569Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117453040
W7133197319The Avant-Garde and the Administrator2025-01-01OpenAlex10.14321/jstudradi.19.2.0033Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133197319
W7106244358The Difficulties of Philosophical Advice2025-01-01OpenAlex10.1007/978-3-031-97293-5_10Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7106244358
W7110539710The Digital Environment of the University: Issues in the Development of Teachers’ Digital Competencies2025-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7110539710
W7162753329The Evolving Role of Sodium-Glucose Linked Transporter-2 (SGLT2) Inhibitors in Heart Failure Management: A Paradigm Shift2025-01-01OpenAlex10.59462/3071-2335.3.1.105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162753329; https://openalex.org/W7124733884
W7128115553The Forced Sterilization of Quechua-Speaking Women in Peru: The Role of Epistemic injustice in The Perpetration of Genocide2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128115553
W4411204129The Impact of Artificial Intelligence Innovations on Diverse Careers and Industries2025-01-01OpenAlex10.2139/ssrn.5215902Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411204129
W4406735397The Infection—Inflammation Challenges to Skin and Wound Care2025-01-01OpenAlex10.1097/asw.0000000000000266Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406735397
W7107993207The Nurse’s Role in Communication with the Conscious Critically Ill Patient in the Emergency Department: Scoping Review Protocol2025-01-01OpenAlex10.17605/osf.io/d3gkuTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7107993207
W4414171077The Origin and Practice of Public Health2025-01-01OpenAlex10.1007/978-981-96-6650-8_2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414171077
W4413006904The Patient Leader2025-01-01OpenAlex10.1007/978-3-031-51650-4_17-1Full textExcludedF1: This conceptual encyclopedia entry concerns human patient leadership, rather than a built/evaluated LLM system.https://openalex.org/W4413006904https://link.springer.com/rwe/10.1007/978-3-031-51650-4_17-1publisher abstract only
W7104671626The Role and Dynamics of Working Alliance as a Change Factor in a Digital Personality Intervention2025-01-01OpenAlex10.17605/osf.io/uzewvTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7104671626
W4406124968The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer2025-01-01OpenAlex10.1177/17588359241308784Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406124968
W7133457441The physician as a moral and social agent: reflections and contradictions of their normative identity and contemporary medical practice2025-01-01OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7133457441
W7163513341The scope of antivascular endothelial growth factor injections: Past achievements, present challenges, and future directions2025-01-01OpenAlex10.4103/odjo.odjo_6_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163513341
W4412840684Therapeutic potential of pharmacoepigenetics in cholangiocarcinoma2025-01-01OpenAlex10.1016/b978-0-443-18722-3.00037-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412840684
W4414676053Thermotropic liquid crystals for precision drug delivery and diagnostics: Molecular design, characterization, and clinical translation2025-01-01OpenAlex10.7324/japs.2025.255035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414676053
W4407816273Total synthetic studies on potent compounds as anti-prostate cancer agents2025-01-01OpenAlex10.1016/b978-0-443-21842-2.00012-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407816273
W4408999273Trends in prescribing dipeptidyl peptidase-IV-based therapy for type 2 diabetes mellitus and determining factors associated with its utilization2025-01-01OpenAlex10.4103/mgmj.mgmj_74_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408999273
W4410706192Tropane Alkaloids: Biosimilar and Biopharmaceutics2025-01-01OpenAlex10.1007/978-981-96-5805-3_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410706192
W7106294281Trustworthy and Ethical AI for Intrusion Detection in Healthcare IoT (IoMT) Systems: An Agentic Decision Loop Framework2025-01-01OpenAlex10.6084/m9.figshare.30686600Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7106294281
W7126675610U.S. Rural-Urban Breast Cancer Screening Inequities: Leveraging Contextual Heterogeneity to Identify Solutions2025-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126675610
W4411207312Unified Data Quality Frameworks for Real-Time ML Pipelines: Bridging DataOps, MLOps, and Streaming Architectures2025-01-01OpenAlex10.2139/ssrn.5216257Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411207312
W4407201109Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma2025-01-01OpenAlex10.1200/edbk-25-471924Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407201109
W4416300826Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review2025-01-01OpenAlex10.1186/s13613-025-01601-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416300826
W4409567626Vaping: The emerging epidemic and its psychiatric implications in India2025-01-01OpenAlex10.4103/ipj.ipj_465_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409567626
W7118010167Vernal KeratoConjunctivitis VKC and Atopic KeratoConjunctivitis AKC2025-01-01OpenAlex10.1007/978-3-031-65422-0_29Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118010167
W7137959530What a Difference a Couple Hundred Million Years Can Make2025-01-01OpenAlex10.5406/19398298.138.4.07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137959530
W4408915722What’s new in critical illness and injury science? Keeping up with Moore’s law – Are we ready for the intensive care units of tomorrow?2025-01-01OpenAlex10.4103/ijciis.ijciis_27_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408915722
W4413308161Where Do We Stand in Motion Sickness and a Holistic Approach to Motion Sickness: Etiology, Diagnosis, and Treatment2025-01-01OpenAlex10.24179/kbbbbc.2025-109668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413308161
W7108080932Working alliance, mental health, and future thinking in volunteering2025-01-01OpenAlex10.17605/osf.io/7mnjvTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108080932
W4406315880Xanthene-based NIR organic phototheranostics agents: design strategies and biomedical applications2025-01-01OpenAlex10.1039/d4tb02480jTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4406315880
W7167746698[Anxiolytics and mood stabilizers in modern psychopharmacological practice with an emphasis to specific patient populations].2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167746698
W7112975613Αντιθρομβωτική αγωγή στις ενδαγγειακές επεμβάσεις επαναιμάτωσης στην Περιφερική Αρτηριακή Νόσο (ΠΑΝ)2025-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7112975613
W7162317117นกวทยาศาสตรการกฬากบพลวตสงคมสงวยไทย: บทบาท ความทาทาย และขอเสนอเชงระบบ2025-01-01OpenAlex10.58837/chula.jssh.26.2.2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162317117
W4408593539“I’d go on a hike with my kids… that would make me feel so happy.” Recognising what people with haemophilia B identify as meaningful when considering personal goals and the potential for gene therapy2025-01-01OpenAlex10.2478/jhp-2025-0001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408593539
W4406296478Advancing treatments for transthyretin amyloid cardiomyopathy: Innovations in RNA silencing, gene editing, TTR stabilization, and degradation2025-01-02OpenAlex10.33963/v.phj.104054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406296478
W4405986360Evolving Strategies for Respiratory Syncytial Virus (RSV): A Review Article of Preventive Agents and Vaccines for RSV2025-01-02OpenAlex10.1177/10600280241302085Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4405986360
W4407981217Unveiling patienthood in psychiatric care: an ethnographic study in Nigeria2025-01-02OpenAlex10.1080/13648470.2025.2453366Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407981217
W4406062881Lessons from COVID-19 in Taiwan's long-term care facilities: A narrative review2025-01-04OpenAlex10.1016/j.jfma.2024.12.033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406062881
W4406062797Modern insights of nanotheranostics in the glioblastoma: An updated review2025-01-04OpenAlex10.1016/j.bbadis.2024.167653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406062797
W4406077943PCSK9 V474I germline variant drives breast cancer metastasis2025-01-04OpenAlex10.1093/lifemeta/loae041Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406077943
W4406075572A Day in the Life of an MSL Powered by AI: Combining AI Technologies to Transform Training2025-01-05OpenAlex10.70792/jngr5.0.v1i2.70Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406075572
W7220539347Advancements in Drug Delivery Systems: A Comprehensive Review2025-01-05OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220539347
W4406080863Paroxysmal sympathetic hyperactivity: A common consequence of traumatic brain injury2025-01-05OpenAlex10.1016/j.autneu.2024.103238Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406080863
W4406069941Penicillamine-induced decomposition of copper sulfide nanocrystals after microbial infection treatment2025-01-05OpenAlex10.1016/j.cej.2024.159195Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406069941
W4406083094Editorial: The application of bioactive materials in bone repair2025-01-06OpenAlex10.3389/fbioe.2024.1539142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406083094
W4406094333Global forces and local impacts: megatrends in regional development2025-01-06OpenAlex10.1093/cjres/rsae047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406094333
W4406082914Synergistic integration of remote sensing and soil metagenomics data: advancing precision agriculture through interdisciplinary approaches2025-01-06OpenAlex10.3389/fsufs.2024.1499973Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406082914
W4406119785A Comprehensive Literature Review of Effect of Mineralocorticoid Receptor Blockers on Chronic Kidney Disease2025-01-07OpenAlex10.70070/xfwn1344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406119785
W4406129006Grand challenge in biosafety and biosecurity2025-01-07OpenAlex10.3389/fbioe.2024.1538723Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406129006
W4406146744Immunotherapy in Ophthalmic Oncology: Current Trends and Future Directions2025-01-07OpenAlex10.3390/jcto3010001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406146744
W4406123507Post-stroke lives in Dutch nursing homes2025-01-07OpenAlex10.5463/thesis.545Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406123507
W4406188251Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome”2025-01-08OpenAlex10.3389/fcdhc.2024.1539117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406188251
W4406183349Folliculocentric Atrophic Papules in a 12‐Year‐Old Boy2025-01-08OpenAlex10.1111/pde.15795Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406183349
W4406188259Healthy gut microbiomes are host-controllable microbiomes2025-01-08OpenAlex10.3389/fmicb.2024.1497083Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406188259
W4406221957Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs2025-01-09OpenAlex10.2174/0115680266336395241115092048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406221957
W4406219691Comparative study of management strategies for immune checkpoint inhibitor‐induced inflammatory arthritis: rheumatologists versus oncologists2025-01-09OpenAlex10.1111/imj.16629Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406219691
W4406230668Immunological pathogenesis and treatment progress of adenovirus pneumonia in children2025-01-09OpenAlex10.1186/s13052-024-01836-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406230668
W4406199551Kidney Disease and Hematopoietic Stem Cell Transplantation2025-01-09OpenAlex10.34067/kid.0000000692Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406199551
W4406207352Multiple actinic keratoses treated with oral capecitabine2025-01-09OpenAlex10.1093/ced/llaf017Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406207352
W4406398641Automation and orchestration in hybrid clouds2025-01-10OpenAlex10.70593/978-81-984306-5-6_9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406398641
W4406402713Introduction to hybrid cloud paradigms: Bridging public and private clouds2025-01-10OpenAlex10.70593/978-81-984306-5-6_1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406402713
W4406249372Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain2025-01-10OpenAlex10.1080/14796694.2024.2445498Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406249372
W4406287294Editorial: Molecular MRD testing in patients with acute myeloid leukemia2025-01-11OpenAlex10.1038/s41409-024-02493-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406287294
W4406292220Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy2025-01-12OpenAlex10.1002/ddr.70042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406292220
W4406116350[Annual therapeutic advances in advanced non-small cell lung cancer in 2024].2025-01-12OpenAlex10.3760/cma.j.cn112147-20241103-00655Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406116350
W4406116271[Clinical update in critical care of pulmonary medicine 2024].2025-01-12OpenAlex10.3760/cma.j.cn112147-20241010-00590Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406116271
W4406332302Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions2025-01-13OpenAlex10.3390/cancers17020232Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406332302
W4406337627The wonders of anticoagulation2025-01-13OpenAlex10.3389/fcvm.2024.1517109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406337627
W4406405725Treatment consensus for locally advanced cervical cancer2025-01-13OpenAlex10.36922/arnm.4032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406405725
W4406364203Beyond nutrition: The emerging therapeutic potential landscape of breast milk-derived extracellular vesicles2025-01-14OpenAlex10.1016/j.nutres.2025.01.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406364203
W4406387486Evolution of leadership roles in international nursing2025-01-14OpenAlex10.1097/nmg.0000000000000222Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406387486
W4406379776Highly pathogenic bovine viral diarrhea virus BJ-11 unveils genetic evolution related to virulence in calves2025-01-14OpenAlex10.3389/fmicb.2024.1540358Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406379776
W4406363977Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic2025-01-14OpenAlex10.1097/hep.0000000000001227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406363977
W4406379831The evolving therapeutic landscape in atopic dermatitis2025-01-14OpenAlex10.37349/eaa.2025.100966Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406379831
W4406387434Unlocking organizational excellence2025-01-14OpenAlex10.1097/nmg.0000000000000223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406387434
W4406399624Advancements in Cancer Therapeutics: Emerging Agents and Combination Strategies in Drug Discovery2025-01-15OpenAlex10.2174/012212697x361870250113043318Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406399624
W4406409261Endodontics at the Bio-Futuristic Frontier: Integrating High-Resolution Imaging, Regenerative Therapies, and Nanotechnology for Next-Generation Care2025-01-15OpenAlex10.20944/preprints202501.1077.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406409261
W4406480282Military influences on the evolution of clinical trials throughout history2025-01-15OpenAlex10.1177/17407745241309054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406480282
W4406388105Recurrent HCC after liver transplantation: Small steps, while awaiting a breakthrough2025-01-15OpenAlex10.1097/lvt.0000000000000571Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406388105
W4410627614The Ethical Choice2025-01-15OpenAlex10.7591/cornell/9781501779633.003.0005Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410627614
W4406419353The Landmark Series: The Future of Pancreatic Cancer Clinical Trials2025-01-15OpenAlex10.1245/s10434-024-16840-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406419353
W4406467760Antithrombotic use in retinal artery occlusion: A narrative review2025-01-16OpenAlex10.1002/kjm2.12938Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406467760
W4406479142Endodontic management of a multi-rooted tooth as a foundation dentist2025-01-16OpenAlex10.5348/100048z07am2025crTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406479142
W4406520113On the formation and stability mechanisms of diverse lipid-based nanostructures for drug delivery2025-01-17OpenAlex10.1016/j.cis.2025.103402Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406520113
W4406502162Pinnipeds (Seals and Sea Lions)2025-01-17OpenAlex10.1002/9781119539278.ch40Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406502162
W4412048536A Review on Febuxostat as Uric Acid Lowering Agent2025-01-18OpenAlex10.30904/j.ajmps.2025.4761Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412048536
W4406587382Digital and Social Determinants of Consumer Decision Making in OTC Pharmaceuticals2025-01-18OpenAlex10.59075/7rfg0c24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406587382
W4406557108Intra-articular injections for the management of knee osteoarthritis2025-01-18OpenAlex10.1016/j.mporth.2024.12.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406557108
W4406551549Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges2025-01-18OpenAlex10.1186/s12943-024-02214-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406551549
W4406559811Review on application of silk fibroin hydrogels in the management of wound healing2025-01-18OpenAlex10.1016/j.ijbiomac.2025.140082Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406559811
W4406627975General Anesthesia in Cardiac Surgery: A Narrative Review for Evolving Techniques and Patient-Centered Best Practices2025-01-19OpenAlex10.20428/yjms.v19i2.2696Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406627975
W4406615068Anticoagulation Management During ECMO: Narrative Review2025-01-20OpenAlex10.1016/j.jhlto.2025.100216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406615068
W4406616254Genomic detection of Panton-Valentine Leucocidins encoding genes, virulence factors and distribution of antiseptic resistance determinants among Methicillin-resistant S. aureus isolates from patients attending regional referral hospitals in Tanzania2025-01-20OpenAlex10.1186/s12920-025-02085-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406616254
W4406678415Brucellosis, the Forgotten Endemic: A Clinical Case Report2025-01-21OpenAlex10.7759/cureus.77761Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406678415
W4406682093Editorial: Biodegradable polymers for biomedical applications - volume III2025-01-21OpenAlex10.3389/fmats.2025.1551590Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406682093
W4406689876SOHO State of the Art Updates and Next Questions: Combination Therapy in Chronic Myeloid Leukemia in Chronic Phase2025-01-21OpenAlex10.1016/j.clml.2025.01.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406689876
W4406710466Challenges and solutions in soft tissue grafting for receding gums2025-01-22OpenAlex10.18203/2394-6040.ijcmph20250040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406710466
W4406705925Diagnostic Accuracy of Breath Tests to Detect Pulmonary Tuberculosis: A Systematic Review2025-01-22OpenAlex10.1007/s00408-024-00779-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406705925
W4406711298Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms2025-01-22OpenAlex10.1007/s11864-024-01283-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406711298
W4406722981Niosomal Encapsulation of Anti-cancer Peptides: A Revolutionary Strategy in Cancer Therapy2025-01-22OpenAlex10.2174/0113892010344931241220042746Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406722981
W4406704291Recent Advancements in Strategies for Delivery of Neuro-Nutraceuticals to the Brain2025-01-22OpenAlex10.1201/9781003570585-13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406704291
W4406884244A Study on the Response of Concurrent Chemoradiation with Gemcitabine Versus Cisplatin in Patients with Locally Advanced Cervical Carcinoma2025-01-23OpenAlex10.62225/2583049x.2025.5.1.3678Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406884244
W4406762397Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in Singapore (2024)2025-01-23OpenAlex10.47102/annals-acadmedsg.2024174Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406762397
W4406746144Learning from HIV and drug policy failures: reflections from clinical practice and research in Edinburgh2025-01-23OpenAlex10.1108/dhs-09-2024-0031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406746144
W4406741801Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement2025-01-23OpenAlex10.1055/a-2512-4496Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406741801
W4406753788Potential for application of direct thrombin inhibitors isolated from Euphorbia resinifera O.Berg latex in fibrin clot formation2025-01-23OpenAlex10.1016/j.jchromb.2025.124480Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406753788
W4406713987Unlocking exosome therapeutics: The critical role of pharmacokinetics in clinical applications2025-01-23OpenAlex10.1016/j.tice.2025.102749Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406713987
W4406786470An overview of uses and effectiveness of intracanal medicaments in endodontics2025-01-24OpenAlex10.18203/2394-6040.ijcmph20250064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406786470
W4406826144Apoptosis in Cancer Biology and Therapy2025-01-24OpenAlex10.1146/annurev-pathmechdis-051222-115023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406826144
W4406741667Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)2025-01-24OpenAlex10.1016/j.lungcan.2025.108100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406741667
W4406808518Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations2025-01-24OpenAlex10.3389/frhem.2025.1548984Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406808518
W4406989715Emerging and Re-Emerging Bacterial Infections: An Overview2025-01-24OpenAlex10.4314/sokjmls.v9i4.18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406989715
W4406805081Sodium-Glucose-Cotransporter-2 Inhibitor Therapy and Intermitted Fasting in Cardiorenal Syndrome: The Role of Glucose-Mediated Oxidative Stress2025-01-24OpenAlex10.3390/jcm14030746Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406805081
W4406914804Reflections on Methods, Therapeutic Alliance, and Possibilities for Psychotherapy Integration in the RFP-C Cases of "Jack" and "Oliver"2025-01-26OpenAlex10.55818/pcsp.v21i1.2179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406914804
W4406850014Editorial: Nanomaterial and nanostructures for cancer and pathogenic infection diagnosis and therapy2025-01-27OpenAlex10.3389/fnano.2025.1552196Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406850014
W4406875266Endocarditis Caused by Bartonella quintana: A Case Report2025-01-27OpenAlex10.7759/cureus.78055Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406875266
W7133239105INTEGRATION OF BIOSIMILAR THERAPIES IN ONCOLOGY AND HEMATOLOGY: REGULATORY, CLINICAL, AND PRACTICAL PERSPECTIVES2025-01-27OpenAlex10.5281/zenodo.18837011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133239105
W4406853362TH Open—Editor's Highlights of 20242025-01-27OpenAlex10.1055/a-2513-4445Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406853362
W4406875231The Effectivity of 15% TCA Superficial Chemical Peeling to Treat Comedos and Papulo-Pustules Acne Vulgaris2025-01-27OpenAlex10.61440/jidt.2024.v2.23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406875231
W4406914260Integrating Sentiment Analysis and Reinforcement Learning for Equitable Disaster Response: A Novel Approach2025-01-28OpenAlex10.3390/su17031072Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4406914260
W4406896812Pillar[6]MaxQ and Sugammadex Enhance Recovery From Rocuronium- and Vecuronium-Mediated Neuromuscular Blockade With Similar Effects in Isoflurane-Anesthetized Rats2025-01-28OpenAlex10.1213/ane.0000000000007336Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406896812
W4407240252Rectal cancer surgery: radiology roadmaps2025-01-28OpenAlex10.1093/bjs/znae270Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407240252
W4406917465Understanding dynamics to Streamline Access: Systems Engineering and Agent-Based Probabilistic Modelling in Memory Assessment Services2025-01-28OpenAlex10.21203/rs.3.rs-5898259/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406917465
W4406893695Xylazine: An Emerging Threat in Obstetrics2025-01-28OpenAlex10.1016/j.jogc.2025.102773Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406893695
W4412962579Comprehensive Review of Diabetes Mellitus: Current Perspectives, Challenges, and Emerging Frontiers2025-01-29OpenAlex10.61096/ijrpp.v14.iss1.2025.67-76Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412962579
W4406933783Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics2025-01-29OpenAlex10.3390/cancers17030459Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406933783
W4406960218P-1066. Quorum Sensing Coordinates Phage Defense Mechanisms in Pseudomonas aeruginosa2025-01-29OpenAlex10.1093/ofid/ofae631.1254Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406960218
W4406940777P-1141. Antibiotic administration for Staphylococcus aureus infections in US children's hospitals, 2015-20232025-01-29OpenAlex10.1093/ofid/ofae631.1328Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4406940777
W4406930089The Potential of Cyperus rotundus L. As a Natural Hair Removal Agent: A Review of Traditional and Modern Applications2025-01-29OpenAlex10.1002/der2.70020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406930089; https://openalex.org/W4412675879
W4406999926An update on newer antifungals2025-01-30OpenAlex10.1080/14787210.2025.2461566Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406999926
W4407134844Civil Identity of the Population of the New Subjects of the Russian Federation: Problems, Politics, Technologies2025-01-30OpenAlex10.56654/ropi-2024-4(13)-130-147Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4407134844
W4406972051Clinical application of biological agents in rheumatoid arthritis2025-01-30OpenAlex10.1016/j.trim.2025.102187Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4406972051
W7158442320Comment l'approche santé planétaire influence-t-elle le rapport des patient•e•s à l'alimentation ? Exploration d'un dispositif de soin mis en place dans un centre de santé communautaire et planétaire2025-01-30OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7158442320
W4407154356Diseases of the Eye - Novel Investigations and Treatments2025-01-30OpenAlex10.5772/intechopen.1004495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407154356
W4406996600Evolving concepts in sepsis: we are making progress!2025-01-30OpenAlex10.3389/fsci.2025.1558161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406996600
W4406984555From Google Gemini to OpenAI Q* (Q-Star): A Survey on Reshaping the Generative Artificial Intelligence (AI) Research Landscape2025-01-30OpenAlex2312.1086810.3390/technologies13020051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406984555
W4406979843Updates in chronic cholestatic liver diseases: Indian expert recommendations for diagnosing and managing complex cases2025-01-30OpenAlex10.18203/2320-6012.ijrms20250286Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4406979843
W4408581964Agentic Retrieval-Augmented Generation: Advancing AI-Driven Information Retrieval and Processing2025-01-31OpenAlex10.14445/22312803/ijctt-v73i1p111Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408581964
W7130532827An Image-Based Facial Emotion Detection Chatbot2025-01-31OpenAlex10.64701/ijrc/345/8920Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7130532827
W4408579743Efficacy, Safety, and Tolerance of Split Dose Oral Sulfate Solution Versus Split-Dose Polyethylene Glycol Versus Single Dose Polyethylene Glycol for Colonoscopy Preparation: A Prospective Randomized Study2025-01-31OpenAlex10.34172/mejdd.2025.403Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408579743
W4407040799Epigenetic Therapy in Hormone Positive Breast Cancer: The Role of PIK3CA2025-01-31OpenAlex10.1007/s12609-024-00566-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407040799
W4407342365MISUSE OF ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: A CASE REPORT2025-01-31OpenAlex10.21474/ijar01/20251Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4407342365
W4407011960Pediatric AML: state of the Art and Future Directions2025-01-31OpenAlex10.1080/08880018.2025.2453861Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407011960
W4407012007Pediatric Intestinal Pseudo-Obstruction: A Review2025-01-31OpenAlex10.1542/pir.2024-006523Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407012007
W4410544256A Review Articles on Pharmacovigilance: Protecting Public Health through Effective, Monitoring Drug Safety2025-02-01OpenAlex10.35629/4494-100225412547Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410544256
W4407387480AI-POWERED CHATBOTS IN PSYCHIATRY: A CRITICAL EVALUATION OF CHATGPT'S SLEEP AID GUIDANCE2025-02-01OpenAlex10.1093/ijnp/pyae059.431Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407387480
W4407061169Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma2025-02-01OpenAlex10.1007/s11864-025-01293-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407061169
W4407100572Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies2025-02-01OpenAlex10.2147/ijn.s457393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407100572
W4407927757Application of Artificial Intelligence Generated Content in Medical Examinations2025-02-01OpenAlex10.2147/amep.s492895Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407927757
W4407460947Atopic dermatitis2025-02-01OpenAlex10.1016/s0140-6736(24)02519-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407460947
W4407219011Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies2025-02-01OpenAlex10.2147/idr.s493670Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407219011
W4407249264CrossMoDA Computational Competition: Evolution of Cross-Modality Domain Adaptation Techniques for Vestibular Schwannoma and Cochlea Segmentation from 2021 to 20232025-02-01OpenAlex10.1055/s-0045-1803943Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407249264
W4407454670Designing and Evaluating an Ensemble Reasoning-based Clinical Decision Support System2025-02-01OpenAlex10.3724/2096-7004.di.2025.0001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407454670
W4408019495Early Steroid Withdrawal in Kidney Transplant Recipients: COMMENTARY2025-02-01OpenAlex10.34067/kid.0000000571Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408019495
W4407238545Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development2025-02-01OpenAlex10.1080/13543784.2025.2463093Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4407238545
W4407597745Evolutionary adaptation to hyperstable microtubules selectively targets tubulins and is empowered by the spindle assembly checkpoint2025-02-01OpenAlex10.1016/j.celrep.2025.115323Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407597745
W4407056997From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas2025-02-01OpenAlex10.1093/infdis/jiaf046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407056997
W4408420878From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments.2025-02-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408420878
W4407223454Metabolic dysfunction and insulin sensitizers in acute and chronic disease2025-02-01OpenAlex10.1080/13543784.2025.2463086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407223454
W4410019203NEXT-GENERATION ANTIOXIDANTS: SHOULD WE TARGET PEROXIREDOXINS?2025-02-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410019203
W4413971651Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies.2025-02-01OpenAlex10.34763/jmotherandchild.20252901.d-25-00014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413971651
W4407065633Opportunities in the translational pipeline for pediatric brain cancer therapies2025-02-01OpenAlex10.1038/s41390-025-03847-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407065633
W4407462558Phytochemical insights into flavonoids in cancer: Mechanisms, therapeutic potential, and the case of quercetin2025-02-01OpenAlex10.1016/j.heliyon.2025.e42682Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407462558
W4407059899Radiotheranostic landscape: A review of clinical and preclinical development2025-02-01OpenAlex10.1007/s00259-025-07103-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407059899
W4408738234Role of Sodium-Glucose Co-Transporter 2 Inhibitors in Chronic Kidney Disease Management2025-02-01OpenAlex10.47583/ijpsrr.2025.v85i02.012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408738234
W4407945332Vaccines in Pregnancy: An Update on Recommendations From CDC 's Advisory Committee on Immunization Practices2025-02-01OpenAlex10.1002/bdr2.2459Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407945332
W4407070054Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC2025-02-02OpenAlex10.1038/s41598-025-86950-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407070054
W4407101960Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review2025-02-03OpenAlex10.3390/diagnostics15030353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407101960
W4410701512Deciphering Rheumatoid Arthritis: A Detailed Review of Clinical Features, Disease Progression, and T2025-02-03OpenAlex10.19080/oajt.2025.06.555686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410701512
W4407114205Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer2025-02-03OpenAlex10.1200/op-24-00862Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407114205
W4407095158The evolving landscape of NF gene therapy: Hurdles and opportunities2025-02-03OpenAlex10.1016/j.omtn.2025.102475Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407095158
W4407142891ANTIBIOTIC RESISTANCE: A GLOBAL THREAT AND PATHWAYS TO SOLUTIONS2025-02-04OpenAlex10.26212/2227-1937.2025.18.39.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407142891
W4407147603Breaking the Mold: Advances and Hurdles in Antifungal Resistance Management for Dermatophytes2025-02-04OpenAlex10.2174/0127724328328331241217194034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407147603
W4407113862Editorial: New insights into intracellular pathways and therapeutic targets in CNS diseases2025-02-04OpenAlex10.3389/fncel.2025.1559821Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407113862
W4407132230Overview of systemic anticancer treatments: conventional cytotoxics2025-02-04OpenAlex10.1136/dtb.2023.000059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407132230
W4407138586Paul DafyddJones, Patience—A Theological Exploration: Part One, From Creation to Christ. London: T&T Clark, 2022, 632pp. $46.952025-02-04OpenAlex10.1111/ijst.12742Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407138586
W4408069369Uterine Artery Embolization: A Growing Pillar of Gynecological Intervention2025-02-04OpenAlex10.26502/jrci.2809105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408069369
W4407181767Editorial: Updates on the management of glioblastoma2025-02-05OpenAlex10.3389/fonc.2025.1526669Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407181767
W4407181198Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy2025-02-05OpenAlex10.3389/fpsyg.2025.1505894Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407181198
W4407209734Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet2025-02-06OpenAlex10.1182/bloodadvances.2024013744Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407209734
W4407230179The data scientist as a mainstay of the tumor board: global implications and opportunities for the global south2025-02-06OpenAlex10.3389/fdgth.2025.1535018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407230179
W4407254035A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024)2025-02-07OpenAlex10.1186/s12876-025-03646-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407254035
W4407237220Culture2025-02-07OpenAlex10.4324/9781003600237-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407237220
W4407242258HER2-targeted therapies: Unraveling their role in biliary tract cancers2025-02-07OpenAlex10.1016/j.critrevonc.2025.104655Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407242258
W4407253501Key tips to shift student perspectives through transformative learning in medical education2025-02-07OpenAlex10.1186/s12909-025-06754-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407253501
W4407294050Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives2025-02-08OpenAlex10.3390/jcm14041079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407294050
W4407264549Journal of Population Therapeutics and Clinical Pharmacology2025-02-08OpenAlex10.53555//sbcmpj45Full textExcludedF5: The indexed title is a journal name and malformed DOI. Its linked PDF was verified as a different DoctorAssist paper and retained under that actual identity. The intended study behind this corrupt index record could not be identified, so the mismatched text was not used to infer eligibility.https://openalex.org/W4407264549; https://openalex.org/W4409552601; https://openalex.org/W4403908921https://openalex.org/W4407264549Metadata and mismatched PDF identity checked; see fulltext/SOURCE_IDENTITY_CORRECTIONS.json. Intended full text unavailable.
W4407287700Multi-lineage transcriptional and cell communication signatures define evolving personalized mechanisms that initiate and perpetuate rheumatoid arthritis2025-02-09OpenAlex10.1101/2025.02.08.619913Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407287700
W4407612505The Potential Therapeutic Advantages of Using Nanotechnology in the Treatment of Liver Fibrosis: A Review2025-02-09OpenAlex10.21608/eajbsz.2025.410264Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407612505
W4407319312Acceptability of a Conversational Agent-led Digital Program for Anxiety: A Mixed-Methods Study of Patient Perspectives2025-02-10OpenAlex10.31234/osf.io/g3dhy_v1Full textExcludedF3: The evaluated anxiety intervention uses tree-based dialogue, NLP intent recognition and clinician-written responses. Future generative-AI discussion does not make the tested agent an LLM.https://openalex.org/W4407319312https://humanfactors.jmir.org/2025/1/e76377/published full Methods and intervention description; archived preprint abstract
W4408175982Cancer attributable to occupational factors: a focus on primary prevention2025-02-10OpenAlex10.5124/jkma.2025.68.2.121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408175982
W4407306288Comparative Analysis Between Radiofrequency Ablation Techniques and Ultrasound-Guided Nerve Blocks in the Treatment of Postherpetic Neuralgia2025-02-10OpenAlex10.24857/rgsa.v19n2-012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407306288
W4407293518Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II2025-02-10OpenAlex10.3389/fphar.2025.1552652Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407293518
W4407343983Editorial: Revealing the role of mitochondrial gene defects in tumor progression and developing mitochondrial-targeted drugs2025-02-10OpenAlex10.3389/fonc.2025.1553496Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407343983
W4407344818Post-Covid-19 Pulmonary Fibrosis: Pathogenesis, Risk Factors, Diagnosis, And Emerging Therapeutic Strategies2025-02-10OpenAlex10.55041/ijsrem41401Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407344818
W4407319487Proline mitigates antibiotic resistance evolution induced by ciprofloxacin at environmental concentrations2025-02-10OpenAlex10.1016/j.jhazmat.2025.137561Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407319487
W4408924946RETRACTED: Arteriovenous Fistula Creation for Hemodialysis in Patients with End-Stage Renal Disease with and Without Surgical Drain: A Randomized Control Trial2025-02-10OpenAlex10.58742/bmj.v3i2.170Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4408924946
W4407700162Survival outcomes based on line of therapy and treatment trends with cabazitaxel in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).2025-02-10OpenAlex10.1200/jco.2025.43.5_suppl.162Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407700162
W7215782472Transforming Emergency Care: The Strategic Role of Paramedics in Improving Survival and System Efficiency2025-02-10OpenAlex10.70082/rb3g2w54Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215782472
W4407701368Treatment (Rx) patterns and attrition rates in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).2025-02-10OpenAlex10.1200/jco.2025.43.5_suppl.75Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407701368
W4407363485Brain metastases from lung cancer: recent advances and novel therapeutic opportunities2025-02-11OpenAlex10.1007/s12672-025-01873-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407363485
W4412962727Contemporary Strategies In The Pharmacological Management Of Hypertension2025-02-11OpenAlex10.61096/ijrpp.v14.iss1.2025.111-118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412962727
W4407379085Editorial: Understanding biofilms: recent trends and developments2025-02-11OpenAlex10.3389/fcimb.2025.1566230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407379085
W4407351475Stress adaptation under in vitro evolution influences survival and metabolic phenotypes of clinical and environmental strains of Vibrio cholerae El-Tor2025-02-11OpenAlex10.1128/spectrum.01211-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407351475
W4407411161A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology2025-02-12OpenAlex10.1021/acs.jmedchem.4c01802Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407411161
W4407410660Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management2025-02-12OpenAlex10.1002/ajh.27625Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407410660
W4407857873Advances in Nanoparticle-Based Drug Delivery Systems: Enhancing Targeted Therapeutic Efficacy in Pharmaceutical Science and Technologycrete Technology2025-02-12OpenAlex10.52783/jns.v14.1717Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407857873
W4407393149Antimicrobial peptides in Clarias batrachus epidermal mucus: Characterization and therapeutic potential2025-02-12OpenAlex10.1016/j.fsi.2025.110191Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407393149
W4407419963Disruption of zinc homeostasis reverses tigecycline resistance in Klebsiella pneumoniae2025-02-12OpenAlex10.3389/fcimb.2025.1458945Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407419963
W4407358058Zinc pyrithione inhibits blood-stage parasites of Plasmodium falciparum and its combinatorial effect with dihydro-artemisinin and chloroquine in culture2025-02-12OpenAlex10.1016/j.parint.2025.103041Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407358058
W4407450852A single approach, multiple insights: Harnessing spatial transcriptomics and proteomics to identify novel therapeutic targets of alcohol‐associated hepatitis2025-02-13OpenAlex10.1111/acer.70007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407450852
W4407424587AGENTIC AI FOR PREDICTING AND PREVENTING DATA DRIFT2025-02-13OpenAlex10.56726/irjmets67596Full textExcludedF3: The implemented pipeline trains an RNN on an 80/20 UCI HAR sensor split, detects drift through statistical tests/moving averages and recalibrates RNN parameters. It does not implement an LLM/VLM acting agent.https://openalex.org/W4407424587https://doi.org/10.56726/IRJMETS67596
W4407548551Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review2025-02-13OpenAlex10.3390/microorganisms13020406Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407548551
W4407546672Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions2025-02-13OpenAlex10.1177/0976500x251316939Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407546672
W4407529712Perceptions of members of ethics committees of medical institutions in India on controlled human infection studies (CHIS) following a sensitization workshop: a systematic survey2025-02-13OpenAlex10.1007/s40592-025-00231-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407529712
W4407530851Phytochemicals and bioenhancers: tackling antibiotic resistance in the era of emerging microbial threats2025-02-13OpenAlex10.1080/00207233.2025.2464469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407530851
W4407514595Towards optimization in the use of hemostatic agents and blood products in the early treatment of patients with traumatic brain injury (TBI)2025-02-13OpenAlex10.1097/aco.0000000000001465Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4407514595
W4408099196Yesil o1 Pro: Evidence-Based AI Model for Health and Benchmarking in Clinical Decision Support (Preprint)2025-02-14OpenAlex10.2196/preprints.72646Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4408099196
W7130506376Third and Later Line Therapy in Metastatic Colorectal Cancer – Current Landscape and Future Perspectives2025-02-15OpenAlex10.53011/jmro.2025.02.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130506376
W4407711959Advances in Lipid Nanoparticle‐Based Disease Treatment2025-02-17OpenAlex10.1002/cmdc.202400938Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407711959
W4407616257Antiphospholipid syndrome in pregnancy: A comprehensive review2025-02-17OpenAlex10.5499/wjr.v12.i2.103837Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407616257
W4407669013Editorial: Understanding bladder tumor microenvironment to optimize immunotherapy2025-02-17OpenAlex10.3389/fimmu.2025.1566407Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407669013
W4407679662HIV diagnosis during acute infection: implications of long-acting preexposure prophylaxis and other evolving challenges2025-02-17OpenAlex10.1097/coh.0000000000000919Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407679662
W4407640629Investigating the Application of Pomegranate-Loaded Chitosan Nanoparticles as Contrast Agents for Enhancing Breast Cancer Detection via Diffuse Reflectance Spectroscopy2025-02-17OpenAlex10.3390/chemosensors13020073Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407640629
W4407667626Mitochondrial targeted therapies in MAFLD2025-02-17OpenAlex10.1016/j.bbrc.2025.151498Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407667626
W4407716594Editorial: Case reports in intensive care medicine 20232025-02-18OpenAlex10.3389/fmed.2025.1563533Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407716594
W4407680962Isatuximab-containing regimens for the treatment of patients with newly diagnosed multiple myeloma: A literature review and a clinical case2025-02-18OpenAlex10.26442/18151434.2024.4.203086Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407680962
W4407685106Recent Human Metapneumovirus Outbreak in East Asia: The Time to Shift Immunological Gears is Now2025-02-18OpenAlex10.20944/preprints202501.0759.v5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407685106; https://openalex.org/W4406318641; https://openalex.org/W4406744588; https://openalex.org/W4407037135; https://openalex.org/W4407037180
W4407699612Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period2025-02-18OpenAlex10.3390/jcm14041357Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407699612
W4407693880The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms2025-02-18OpenAlex10.1136/jcp-2025-210074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407693880
W4407798514Hemostatic Biopolymers: A Natural Approach for Revolutionizing Blood Loss Control2025-02-19OpenAlex10.1080/25740881.2025.2461626Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407798514
W4407748488Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics2025-02-19OpenAlex10.1080/17474124.2025.2469832Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407748488
W7221297612FAST DISSOLVING FILMS: A NOVEL APPROACH TO ORAL DRUG DELIVERY2025-02-20OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221297612
W4407786635Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma2025-02-20OpenAlex10.3390/cancers17050715Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407786635
W4407835571Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings2025-02-21OpenAlex10.1111/tid.70009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407835571
W4407839683Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer2025-02-21OpenAlex10.3390/curroncol32030119Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407839683
W44078558042024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.2025-02-22OpenAlex10.5114/aoms/202213Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407855804
W4407853687Polyextremotolerant, opportunistic, and melanin-driven resilient black yeast Exophiala dermatitidis in environmental and clinical contexts2025-02-22OpenAlex10.1038/s41598-025-88595-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407853687
W4408068988CD105 in the Progression and Therapy of Colon Cell Carcinoma2025-02-23OpenAlex10.2174/9789815305906125010007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408068988
W4407903031Deep Reinforcement Learning: A Chronological Overview and Methods2025-02-24OpenAlex10.3390/ai6030046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407903031
W4407876589Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications2025-02-24OpenAlex10.1007/s12672-025-01985-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407876589
W4407896532Re-conceptualizing structural damage in chronic calcium pyrophosphate crystal inflammatory arthritis through ultrasonography: a pictorial essay2025-02-24OpenAlex10.37349/emd.2025.100786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407896532
W4408143830A Unified Framework for Self-Learning AI: Reinforcement Learning, Neural Search, and Adaptive Evolution2025-02-25OpenAlex10.5120/ijca2025924503Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408143830
W4407925178Editorial: Methods in predictive toxicology 20232025-02-25OpenAlex10.3389/fphar.2025.1556352Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407925178
W4407944435Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines—A Narrative Review2025-02-25OpenAlex10.3390/vaccines13030237Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407944435
W4407986082Safety of Hydroxychloroquine for COVID-19 Prophylaxis in Healthcare Workers: A Cross-Sectional Study2025-02-25OpenAlex10.7759/cureus.79660Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407986082
W4407932534Second-Person Authenticity and the Mediating Role of AI: A Moral Challenge for Human-to-Human Relationships?2025-02-25OpenAlex10.1007/s13347-025-00857-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407932534
W4407919242Tabetic arthropathy of the knee: A case report2025-02-25OpenAlex10.1016/j.radcr.2024.11.074Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407919242
W4407942782The potential of natural herbal plants in the treatment and prevention of non-small cell lung cancer: An encounter between ferroptosis and mitophagy2025-02-25OpenAlex10.1016/j.jep.2025.119555Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407942782
W4407937902Using Everyday Ethics to Address Bias and Racism in Clinical Care2025-02-25OpenAlex10.4037/aacnacc2025307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407937902
W4407980661APPLICATION AND PROGRESS OF CT ANGIOGRAPHY–X-RAY IMAGE FUSION TECHNOLOGY IN ENDOVASCULAR SURGERY: A LITERATURE REVIEW2025-02-26OpenAlex10.61784/jpmr3028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407980661
W4407957615Enhancing vaginal drug delivery: the nanoemulsion gel strategy2025-02-26OpenAlex10.1515/znc-2024-0239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407957615
W4407928906Nanotechnology in Immunology2025-02-26OpenAlex10.1201/9781003472155-13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4407928906
W4408293808Occupational Risk Management in the Context of Emerging Infections2025-02-26OpenAlex10.1097/jom.0000000000003372Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408293808
W4408010750Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends2025-02-27OpenAlex10.1053/j.semnuclmed.2025.02.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408010750
W4408021671Elevated C-reactive protein and cardiovascular risk2025-02-27OpenAlex10.1097/hco.0000000000001215Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408021671
W4407991953Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli2025-02-27OpenAlex10.1128/msystems.01700-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4407991953
W4408038816HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS2025-02-27OpenAlex10.4084/mjhid.2025.026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408038816
W4409659768Interactive Agent Foundation Model: A Meta-Learning Strategy2025-02-27OpenAlex10.1109/isacc65211.2025.10969383Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4409659768
W4408003040Magnesium: A Micronutrient for Brain Health2025-02-27OpenAlex10.4103/aihb.aihb_32_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408003040
W4408041177Editorial: Minimal intervention dentistry for dental caries management2025-02-28OpenAlex10.3389/froh.2025.1565605Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408041177
W4408046592Evaluation of the performance of the QIAstat-Dx® Gastrointestinal Panel 2 for the detection of pathogens from stool at a diagnostic laboratory in South Africa2025-02-28OpenAlex10.1016/j.ijid.2024.107586Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408046592
W4408089628Negative Hyperselection in Metastatic Colorectal Cancer for First-Line Anti-EGFR Therapy: A Narrative Review2025-02-28OpenAlex10.3390/ijms26052216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408089628
W7143295924The Role of Nanotechnology in Drug Delivery Systems2025-02-28OpenAlex10.71465/aljb3340Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143295924
W4408046360Universal PCR assays to detect Candida FKS and ERG11 mutations2025-02-28OpenAlex10.1016/j.ijid.2024.107757Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408046360
W440821799717P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells2025-03-01OpenAlex10.1016/j.esmoop.2025.104173Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408217997
W4409514643Advances in Medical Toxicology: Innovative Approaches for Poisoning and Overdose Management2025-03-01OpenAlex10.22377/ajp.v19i01.6050Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409514643
W4408077931An updated review of intra-arterial chemotherapy for retinoblastoma2025-03-01OpenAlex10.1016/j.rxeng.2025.02.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408077931
W4410011499Antibacterial Effectiveness of Zinc Oxide and Magnesium Oxide Nanoparticles Against Enterococcus faecalis: An In Vitro Study2025-03-01OpenAlex10.4103/jioh.jioh_164_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410011499
W4409363278Beyond Angina: Unlocking the Multifaceted Therapeutic Potential of Trimetazidine2025-03-01OpenAlex10.2174/277243282003250219160900Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409363278
W4408144328Code ICH: Giving Patients with Intracerebral Hemorrhage a Fighting Chance2025-03-01OpenAlex10.1097/01.eem.0001108576.15828.5eTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408144328
W4408957435Cognitive Sequelae of COVID ‐19: Mechanistic Insights and Therapeutic Approaches2025-03-01OpenAlex10.1111/cns.70348Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408957435
W4408981764Editorial2025-03-01OpenAlex10.1097/us9.0000000000000072Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408981764; https://openalex.org/W4402305831
W4411693485Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer2025-03-01OpenAlex10.1177/23523735251348842Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411693485
W4408079443Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review2025-03-01OpenAlex10.1186/s12885-025-13749-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408079443
W4409217804Fifty Years of Teaching Operative Dentistry – My Reflections2025-03-01OpenAlex10.2341/1559-2863-50-2-119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409217804
W4408683314Generation of Spatial Structure of Urban Parks Based on Spatial Analysis of Agent-Based Models2025-03-01OpenAlex10.3724/j.fjyl.202408030430Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408683314
W4408375277Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis2025-03-01OpenAlex10.1093/rheumatology/keae502Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408375277
W4409324827Metalloproteins in emerging pathogens2025-03-01OpenAlex10.1063/4.0000578Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409324827
W4408750632Modern Approach to Manage Patients With Kaposi Sarcoma2025-03-01OpenAlex10.1002/jmv.70294Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408750632
W4408059583Monoclonal Antibody Therapies for Children2025-03-01OpenAlex10.1542/pir.2024-006452Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408059583
W4408901596Sedation practices of Greek gastroenterologists: developments in the last decade2025-03-01OpenAlex10.1055/s-0045-1805688Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408901596
W4408127164The Adulterant Era of the Opioid Epidemic2025-03-01OpenAlex10.1097/01.eem.0001108572.00041.aaTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408127164
W4409315159[Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025].2025-03-01OpenAlex10.3760/cma.j.cn121430-20250301-00199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409315159
W4408228018Advances in Asthma Management: Integrating Biologics, Personalized Medicine, and Lessons from the COVID-19 Era2025-03-02OpenAlex10.36948/ijfmr.2025.v07i02.37923Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408228018
W4410038274Digital narcissism: Psychoanalytic mechanisms of personality manifestation in social media and their impact on psychological well-being2025-03-02OpenAlex10.52534/msu-pp1.2025.104Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410038274
W4408102588Corrigendum: Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients: a comprehensive analysis using speckle tracking echocardiography2025-03-03OpenAlex10.3389/fcvm.2025.1548119Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4408102588
W4408216702Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?2025-03-03OpenAlex10.20944/preprints202212.0155.v8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408216702; https://openalex.org/W7133901321
W4408098277Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide2025-03-03OpenAlex10.1200/op-24-00872Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408098277
W4408121864Mycoplasma pneumoniae-Induced Erythema Multiforme in an 11-Year-Old Boy: Diagnostic and Therapeutic Challenges2025-03-03OpenAlex10.7759/cureus.79944Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408121864
W4408082123Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer2025-03-03OpenAlex10.1186/s43046-025-00264-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408082123
W4408180730Use of broadly neutralizing antibodies in pediatric HIV for treatment and remission2025-03-03OpenAlex10.1097/coh.0000000000000927Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408180730
W4408123260Advances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia2025-03-04OpenAlex10.3390/cells14050371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408123260
W4408148200Evolution of coronary stents: innovations, antithrombotic strategies and future directions2025-03-04OpenAlex10.1136/heartjnl-2024-324744Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408148200
W4408126678From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials2025-03-04OpenAlex10.1016/j.ctrv.2025.102906Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408126678
W4408152860Integrative learning through student-led transdisciplinary investigation of Belgium’s COVID-19 pandemic preparedness2025-03-04OpenAlex10.21203/rs.3.rs-5932329/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408152860
W4408150199Tissue-engineered and cell-based therapies for cartilage defects2025-03-04OpenAlex10.17816/gc640858Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408150199
W4408093197Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma2025-03-04OpenAlex10.1016/j.jceh.2025.102538Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408093197
W4408226933Agentic Workflows in Healthcare: Advancing Clinical Efficiency through AI Integration2025-03-05OpenAlex10.32628/cseit25112396Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408226933
W4408158687Editorial: Unveiling biomarkers and mechanisms in the tumor-immune nexus2025-03-05OpenAlex10.3389/fimmu.2025.1581492Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408158687
W4408208475Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing2025-03-06OpenAlex10.20517/cdr.2024.180Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408208475
W4408202367Myeloid cells: key players in tumor microenvironments2025-03-06OpenAlex10.1007/s11684-025-1124-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408202367
W4408244433Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies2025-03-06OpenAlex10.1111/ejh.14405Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408244433
W4408537408Cytotoxic Agents Can Cure Cancer, but Can Also Kill Cancer Patients2025-03-07OpenAlex10.11648/j.ijcocr.20251001.14Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408537408
W4408226040Global research trends on DPP-4 inhibitors and cardiovascular outcomes: a comprehensive bibliometric analysis2025-03-07OpenAlex10.1097/ms9.0000000000003089Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408226040
W4408229670Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical Implications2025-03-07OpenAlex10.3390/cancers17060913Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408229670
W4408168251Precision Treatment of IgA Nephropathy Based on a New Framework: Angiorenal Protection, Immunity Inhibition, B-Cell/Plasma-Cell Modulation, and Complement Inhibition2025-03-07OpenAlex10.1159/000544998Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408168251
W4408168108The Need for Concurrent Chemoimmunotherapy in Pediatric B-Cell Lymphoblastic Leukemia2025-03-07OpenAlex10.1159/000545028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408168108
W4408226838“She’s Always Made Sure That We Had Black Doctors, Particularly Women Doctors If We Could… and How It Can Sometimes Be the Difference Between Life and Death.” Black College Women’s Reflections On Medical Racism As a Social Determinant of Health2025-03-07OpenAlex10.1007/s40615-025-02366-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408226838
W7117147020Targeted Therapeutics for Cancer Treatment: A Review of Kinase Inhibitors, Angiogenesis Inhibitors, and Other Molecularly targeted Agents2025-03-09OpenAlex10.51470/bf.2025.5.1.09Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117147020
W4408286679What the clinician should know when ordering a mast cell tryptase test2025-03-10OpenAlex10.1016/j.anai.2025.03.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408286679
W4408306639Book Review2025-03-11OpenAlex10.1097/naq.0000000000000659Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408306639
W4408283515MYC networks associate with decreased CD8 T-cell presence in diffuse large B-cell lymphoma and may be addressed by the synergistic combination of AZD4573 and Selinexor – a preliminary analysis2025-03-11OpenAlex10.1007/s00277-025-06298-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408283515
W4408162019Sulfonamides as a Promising Scaffold in Drug Discovery: An Insightful Review on FDA‐Approved Molecules, Synthesis Strategy, Medical Indication, and Their Binding Mode2025-03-11OpenAlex10.1002/cbdv.202403434Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408162019
W4408302947The Analytical Gaze of Operators and Facilitators in Healthcare Simulations: Technologies, Agency and the Evolution of Instructional Expertise2025-03-11OpenAlex10.3390/educsci15030347Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408302947
W4408342948The Discovery of Gadopiclenol: An Example of Rational Drug Design?2025-03-11OpenAlex10.1097/rli.0000000000001169Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408342948
W4408387767Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care2025-03-11OpenAlex10.1093/ajhp/zxaf058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408387767
W4408352269A Self-Evolving Framework for Multi-Agent Medical Consultation Based on Large Language Models2025-03-12OpenAlex10.1109/icassp49660.2025.10889517Full textIncludedIncluded: Correct consultations and error abstractions from training cases are stored in two knowledge bases and retrieved for later different consultations.https://openalex.org/W4408352269https://ieeexplore.ieee.org/document/10889517
W4408364649Editorial for “Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors”2025-03-12OpenAlex10.1002/jmri.29767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408364649
W4408360841Menadione reduces the expression of virulence- and colonization-associated genes in Helicobacter pylori2025-03-12OpenAlex10.1099/mic.0.001539Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408360841
W4408408254Continuum-based postoperative nausea and vomiting prophylaxis protocol: Development and real-world implementation checklist2025-03-13OpenAlex10.4103/ija.ija_1227_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408408254
W4408408252Do not resuscitate, but only anaesthetise!2025-03-13OpenAlex10.4103/ija.ija_1302_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408408252
W4408419259Editorial: Metabolomics perspectives for clinical medicine, volume II2025-03-13OpenAlex10.3389/fmolb.2025.1577050Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408419259
W4408622983Griseofulvin: A Comprehensive Review of its Antifungal, Pharmacological, and Clinical Implications2025-03-13OpenAlex10.21608/aijp.2025.356963.1003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408622983
W4408460257Prostate Cancer Playback: Highlights of 20242025-03-13OpenAlex10.33590/emjurol/iieq4765Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408460257
W4408629583Recent Advances in Green Synthesis, Chemical-Physics Characterizations, and Biological Adeptness of Selenium and Silver Nanoparticles for Medical Application2025-03-13OpenAlex10.70593/978-93-49307-47-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408629583
W7218208767AI, Robotics, and Next-Generation Biologic Therapies in Orthopedic Regeneration: The Future of Autonomous Musculoskeletal Healing2025-03-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218208767
W7220347517Reinforcement Learning Enhanced AI-AugETM for Adaptive Real-Time Dose Adjustment in Oncology Phase I Trials2025-03-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220347517
W4409118862Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions2025-03-15OpenAlex10.1002/cncr.35784Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409118862
W4408479174The evolving epidemiology of antimicrobial resistance of ESKAPE pathogens isolated in the intensive care unit of a Greek university hospital2025-03-15OpenAlex10.1016/j.diagmicrobio.2025.116804Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408479174
W4408492944Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges2025-03-16OpenAlex10.1080/14737140.2025.2481141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408492944
W4408536231Facile One‐Pot Assembly of a Versatile Photoactive Nanozyme for Highly Efficient Antibacterial Therapy2025-03-16OpenAlex10.1002/smll.202500895Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408536231
W4411447120AI-enabled Cybersecurity using Synthetic Data2025-03-17OpenAlex10.1109/percomworkshops65533.2025.00055Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411447120
W4408536786Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies2025-03-17OpenAlex10.3389/fimmu.2025.1557176Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408536786
W4408508055Editorial: Exploring anesthetic risk: challenges and solutions in veterinary medicine2025-03-17OpenAlex10.3389/fvets.2025.1587332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408508055
W4408580150Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients2025-03-18OpenAlex10.1093/pnasnexus/pgaf085Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408580150
W4408546462Editorial: Reviews in veterinary neurology and neurosurgery2025-03-18OpenAlex10.3389/fvets.2025.1583995Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408546462
W4408579038Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma in 20252025-03-18OpenAlex10.1016/j.jceh.2025.102547Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408579038
W4408545370Immunotherapy and Immune Checkpoint Inhibitors2025-03-18OpenAlex10.1201/9781032704517-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408545370
W4408647188Advancement in the Management of Synchronous Colorectal Liver Metastasis: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities2025-03-19OpenAlex10.7759/cureus.80860Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408647188
W4408603348Fourier ptychographic microscopy (FPM): a versatile label-free multimodal imaging tool, review and perspectives2025-03-19OpenAlex10.1117/12.3045309Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408603348
W4408628370Multiple sclerosis in China: the current state of diagnosis and management2025-03-19OpenAlex10.1097/wco.0000000000001359Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408628370
W4408646534Rethinking How We Define and Treat Periprosthetic Joint Infection2025-03-19OpenAlex10.2106/jbjs.24.01549Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408646534
W4408609354TPNET: A Time-Sensitive Small Sample Multimodal Network for Cardiotoxicity Risk Prediction2025-03-19OpenAlex10.1109/jbhi.2025.3552819Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408609354
W4408613199Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges2025-03-19OpenAlex10.1002/cncr.35806Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408613199
W4408773376Use of Antiplatelet Agents in Canadian Patients: A Reflection of the 2023 Antiplatelet Guidelines2025-03-19OpenAlex10.58931/cct.2025.115Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4408773376
W4408665745Antibody-drug conjugates in breast cancer: current evidence and future directions2025-03-20OpenAlex10.1186/s40164-025-00632-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408665745
W4408657519Evolving antimicrobial resistance of extensively drug-resistant Gram-negative severe infections associated with conflict wounds in Ukraine: an observational study2025-03-20OpenAlex10.1016/j.lanepe.2025.101274Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408657519
W4408658427Hypophosphatasia: Clinical Clues and Management Considerations2025-03-20OpenAlex10.7759/cureus.80894Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408658427
W4408674915Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases2025-03-20OpenAlex10.1016/j.ejmech.2025.117527Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408674915
W4408667656Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer2025-03-20OpenAlex10.1016/j.ctrv.2025.102924Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408667656
W4408717796Preliminary Study Concerning the Adaptation of a Periodontal Dressing Material to the Inclusion of Therapeutic Agents2025-03-20OpenAlex10.24425/amm.2025.152562Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4408717796
W4408724219A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats2025-03-21OpenAlex10.1021/acs.jpclett.4c03654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408724219
W4408732625Advances in radiation therapy for HCC: Integration with liver-directed treatments2025-03-21OpenAlex10.1097/hc9.0000000000000653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408732625
W4408745458Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report2025-03-21OpenAlex10.1111/imj.70037Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408745458
W4408683420Editorial: Rehabilitation and alternative medicine in the healthcare for chronic rheumatic pain disorders2025-03-21OpenAlex10.3389/fmed.2025.1586105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408683420
W4409116742Fever in the Returning Pediatric Traveler2025-03-21OpenAlex10.1097/inf.0000000000004783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409116742
W4408808788Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity2025-03-21OpenAlex10.1093/eurheartj/ehaf124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408808788
W4408682422Remimazolam – expectations and concerns2025-03-21OpenAlex10.4097/kja.25170Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408682422
W4408803303Whole-Genome Sequencing, Annotation and Phenotypic Taxonomic Confirmation of a Multidrug-Resistant Escherichia coli Strain Isolated from the Blood of a Sepsis Patient2025-03-22OpenAlex10.1101/2025.03.21.644136Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408803303
W4408746713Liposomes as immunotherapeutic carriers: A game-changer in cancer therapy2025-03-23OpenAlex10.1016/j.jddst.2025.106847Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408746713
W4408842881A Case of Spondyloarthritis with Fulminant Extra-articular Features and Renal Amyloidosis and Difficulties in its Phenotypical Classification2025-03-24OpenAlex10.4103/jme.jme_171_23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408842881
W4408808862Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes2025-03-24OpenAlex10.1080/20415990.2025.2469488Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408808862
W4408771855Towards AI-Powered Applications: The Development of a Personalised LLM for HRI and HCI2025-03-24OpenAlex10.3390/s25072024Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408771855
W4408885066Active glomerular inflammation versus chronicity and fibrosis: the role of targeted therapies in IgA nephropathy2025-03-25OpenAlex10.1093/ndt/gfaf059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408885066
W4408811224Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency2025-03-25OpenAlex10.1128/jvi.02018-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408811224
W4408925669Advances in Botulinum Toxin Applications: Enhancing Wound Healing and Optimizing Scar Management2025-03-25OpenAlex10.1007/s13671-025-00466-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408925669
W4408821401Has-miR-30c-1-3p inhibits macrophage autophagy and promotes Mycobacterium tuberculosis survival by targeting ATG4B and ATG9B2025-03-25OpenAlex10.1038/s41598-025-94452-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408821401
W4408818284Highlights of the Issue2025-03-25OpenAlex10.70777/si.v2i1.14075Title/abstractExcludedE1: Editorial/issue highlights summarizing other publications, not an original adapting agent study.https://openalex.org/W4408818284
W4408884794Update 2025: Management of Non‑Small-Cell Lung Cancer2025-03-25OpenAlex10.1007/s00408-025-00801-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408884794
W4408847435CDA Formulations as Superb and Excellent Cancer Drugs to Save Cancer Patients2025-03-26OpenAlex10.47363/jcrr/2025(8)209Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408847435
W4408900448Deep Neuromuscular Blockade During General Anesthesia: Advantages, Challenges, and Future Directions2025-03-26OpenAlex10.3390/anesthres2020008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408900448
W4408855038Guidelines for the evolving landscape of liver disease: From viral hepatitis to MAFLD2025-03-26OpenAlex10.1097/cm9.0000000000003616Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408855038
W4408866876Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial2025-03-26OpenAlex10.1016/j.cct.2025.107887Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408866876
W4408913877Recent advances in therapeutic strategies for non-small cell lung cancer2025-03-26OpenAlex10.1186/s13045-025-01679-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408913877
W4408972749Writing a Letter of Recommendation Without Bias2025-03-26OpenAlex10.5435/jaaos-d-24-00827Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408972749
W4408890515Future Perspectives of Spinel Nano-Ferrites2025-03-27OpenAlex10.1201/9781003568940-19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408890515
W4408859007Семиотика буквы в современном искусстве: шрифтовой биохакинг Одеда Эзера2025-03-27OpenAlex10.23951/2312-7899-2025-1-70-92Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408859007
W4408923764A Case of Cutaneous Fungal Infection Following the Administration of Dupilumab2025-03-28OpenAlex10.7759/cureus.81349Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408923764
W4408957580Aseptic meningitis: a foundation review2025-03-28OpenAlex10.1097/qco.0000000000001105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408957580
W4408987062Demystifying Cell and Gene Therapy Orchestration in Supply Chain Technical Operations2025-03-28OpenAlex10.32628/cseit25112731Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408987062
W4408943766Integrative Design of ADAMTS Partial Agonists within a Multi-Hallmark Therapeutic Framework: The Beginning of Paving the Way Toward a Functional Cure for Neurodegenerative Disorders2025-03-28OpenAlex10.26434/chemrxiv-2025-4n2nb-v3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408943766
W4408939628Prospective Implications of Autologous Platelet-Rich Plasma in Tissue Engineering and Organ Rejuvenation2025-03-28OpenAlex10.1201/9781003611509-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408939628
W4408932095Surgical Site Infection Rates by Specialty for Patients Who Undergo Sacral Neuromodulation Surgery2025-03-28OpenAlex10.1097/aog.0000000000005851.101Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408932095
W4408918824Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists2025-03-28OpenAlex10.3389/fchem.2025.1557275Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408918824
W4408925074The First Report of a Pulmonary Abscess Due to Streptococcus intermedius in Rabbits in Romania2025-03-28OpenAlex10.3390/microorganisms13040769Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4408925074
W4409962087Towards personalized therapy for atrial fibrillation: the rhythmic climbing of dronedarone2025-03-28OpenAlex10.1093/europace/euaf079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409962087
W4409277631Approaches To Managing Relapsed Myeloma: Switching Drug Class or Retreatment With Same Drug Class?2025-03-29OpenAlex10.1007/s12288-025-02008-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409277631
W4408962942Statistical Study of Bacterial Urinary Tract Infections for the Period 2019 to 20232025-03-29OpenAlex10.29196/jubpas.v33i1.5645Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4408962942
W4408984764WITHDRAWN2025-03-30OpenAlex10.31237/osf.io/qs37b_v1Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4408984764; https://openalex.org/W4412830963; https://openalex.org/W4415660100; https://openalex.org/W4411008130
W4409026417A case of acute exudative polymorphous vitelliform maculopathy successfully treated with systemic steroid2025-03-31OpenAlex10.4103/tjo.tjo-d-24-00140Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409026417
W4409086174Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ1012025-03-31OpenAlex10.1080/14796694.2025.2485650Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409086174
W4409550619Development of Monoclonal Antibody Application in Cancer Therapy: The Roles of ADCC, CDC, ADCP, and ADC2025-03-31OpenAlex10.7841/ksbbj.2025.40.1.22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409550619
W4409021950Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2 -mutated post-MPN AML2025-03-31OpenAlex10.1182/blood.2024027117Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409021950
W4408999553Etiological characteristics of 3,691 cases of microbial keratitis: an 8-year longitudinal study2025-03-31OpenAlex10.1128/spectrum.02630-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4408999553
W7204664917Large Language Model-Based Academic Writing Support Framework for University English Learners2025-03-31OpenAlex10.67050/ijee/v14i1/ijee251014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204664917
W7115566030Study of Biological Properties of Ethnobotanically Important Plants of Tehsil Kotmomin2025-03-31OpenAlex10.53762/grjnst.03.01.29Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7115566030
W4409184343Systematic literature review related to the theoretical knowledge base for non-invasive monitoring of the biomechanical and viscoelastic properties of the myotendinous complex in patients with complete tetraplegia following cervical spinal cord injury2025-03-31OpenAlex10.12680/balneo.2025.798Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409184343
W4409136939The review of modern prospects for the pharmacological treatment of obesity and its complications – The role of GLP- 1, GLP1 / GIP, GLP1 / GIP / GCG receptor agonists2025-03-31OpenAlex10.54905/disssi.v29i157.e50ms3543Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409136939
W4410554647Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria2025-04-01OpenAlex10.1055/s-0045-1809039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410554647
W4411715018Advances in Oral Cancer Diagnosis and Treatment2025-04-01OpenAlex10.4103/jiaomr.jiaomr_140_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411715018
W4409117539Biomarkers in Alzheimer’s disease: Emerging trends and clinical implications2025-04-01OpenAlex10.1097/cm9.0000000000003579Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409117539
W4410875309Bridging pandemic and oncology challenges: Surface-enhanced Raman spectroscopy in the fight against COVID-19 and cancer2025-04-01OpenAlex10.1177/00368504251342977Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410875309
W7215947998CURRENT TRENDS IN AXIAL SPONDYLOARTHRITIS MANAGEMENT: A STATE-OF-THE-ART REVIEW OF TREATMENT OPTIONS2025-04-01OpenAlex10.55640/irjmshc-v02i04-01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215947998
W4409632480Care of the bedridden patient2025-04-01OpenAlex10.4103/singaporemedj.smj-2022-123Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409632480
W4410640435Chemotherapy hypersensitivity: Current insights and novel desensitization strategies2025-04-01OpenAlex10.1016/j.jahd.2025.100042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410640435
W4409207563Chemotherapy-Induced Bone Marrow Suppression: A Bibliometrics Analysis2025-04-01OpenAlex10.2147/jmdh.s507187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409207563
W4409818420Comparative Evaluation of Typical Antipsychotic Haloperidol with Atypical Antipsychotics Olanzapine, Risperidone and Aripiprazole in the Treatment of Stable Schizophrenia in a Tertiary Care Teaching Hospital at Dehradun, Uttarakhand, India: A Randomised Clinical Trial2025-04-01OpenAlex10.7860/jcdr/2025/77295.20888Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409818420; https://openalex.org/W4409778303
W4409485262Con: Artificial Intelligence in Manuscript Writing: Pitfalls and Ethical Concerns the Authors Should Be Aware2025-04-01OpenAlex10.4103/aca.aca_9_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409485262
W4411461093Diagnostic and therapeutic challenges in Non-Alcoholic Fatty Liver Disease (NAFLD)2025-04-01OpenAlex10.22271/27069567.2025.v7.i2b.632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411461093
W7117253470Diarrheagenic Escherichia Coli among students in the Ashanti Region of Ghana2025-04-01OpenAlex10.26355/mhd_20254_1189Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117253470
W4409898580E031 Scleromyxedema: a scleroderma mimic2025-04-01OpenAlex10.1093/rheumatology/keaf142.268Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409898580
W4409039016Effect of Operative Plane on Anesthetic Requirements in Tissue Expander Breast Reconstruction Patients2025-04-01OpenAlex10.1097/sap.0000000000004256Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409039016
W4409147698Efficacy and Safety of Quadruplet Therapy in Newly Diagnosed Transplant‐Eligible Multiple Myeloma: A Systematic Review and Meta‐Analysis2025-04-01OpenAlex10.1002/cnr2.70171Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409147698
W4410862602Evolving frontiers in dermatologic science and clinical care2025-04-01OpenAlex10.4103/ds.v43-2_editorialTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4410862602
W4411972589Integrating Positron Emission Tomography Combined with Computed Tomography Imaging into Advanced Radiation Therapy Planning: Clinical Applications, Innovations, and Challenges2025-04-01OpenAlex10.4103/jmp.jmp_34_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411972589
W4414181637Molecular Mechanisms of Hypericin and Hyperforin in Modulating Mammalian Neurotransmitter Systems: A Review2025-04-01OpenAlex10.1192/j.eurpsy.2025.1682Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414181637
W4411713775Outpatient Parenteral Antibiotic Therapy: A Cornerstone of Modern Health Care2025-04-01OpenAlex10.4103/cids.cids_71_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411713775
W4410012986Pharmacology: The Powerhouse of Drug Discovery and Therapy2025-04-01OpenAlex10.21275/sr25422213107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410012986
W4410371036Plain Roentgenography in Diagnosing Neonatal Gastrointestinal Emergencies2025-04-01OpenAlex10.4103/ipcares.ipcares_88_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410371036
W4409107933Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer2025-04-01OpenAlex10.2147/itt.s495751Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409107933
W7140030750Social Protection in Complex Information Environments: Discussion on Social Resilience through Information Anesthesia and Cushioning to Mitigate Information Shocks2025-04-01OpenAlex10.5281/zenodo.19165111Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140030750
W4409212125The Company of Biologists Workshops: supporting our community and inspiring new science2025-04-01OpenAlex10.1242/dev.204708Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409212125
W4409395535The Rise of AI Agents: Transforming Enterprise Automation2025-04-01OpenAlex10.35629/5252-0704132139Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4409395535
W4409840176The Role of LLM Agent Apps in Conversational AI2025-04-01OpenAlex10.63345/ijrmeet.org.v13.i4.12Title/abstractExcludedE1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent.https://openalex.org/W4409840176
W4411550198The rapidly emerging field of RNA therapies for cardiovascular disease2025-04-01OpenAlex10.1097/cp9.0000000000000121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411550198
W4409157970Trends in Atopic Dermatitis Management: A NAMCS Retrospective Analysis (2013-2019)2025-04-01OpenAlex10.62186/001c.133837Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409157970
W4409131710Verifiable and secure data sharing in crowdsourcing-based healthcare2025-04-01OpenAlex10.1007/s11227-025-07185-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409131710
W4409100563A Survey of the Model Context Protocol (MCP): Standardizing Context to Enhance Large Language Models (LLMs)2025-04-02OpenAlex10.20944/preprints202504.0245.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409100563
W4409081366Bioinspired Suction-Driven Strategies with Nanoscale Skin-Controllable Adhesive Architectures for Efficient Liquid Formulated Transdermal Patches2025-04-02OpenAlex10.1021/acsnano.5c00585Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409081366
W7215238945Caracterización clínica-epidemiológica de las Bronquiolitis en pacientes pediátricos. Hospital General docente “Héroes del Baire”. Isla de la Juventud.2025-04-02OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215238945
W4409111735Critical medications in cardiology: strategic policy of the European Medicines Agency2025-04-02OpenAlex10.1093/eurheartj/ehaf134Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409111735
W4409067181Editorial: Five-membered ring heterocyclic compounds as anticancer drug candidates2025-04-02OpenAlex10.3389/fchem.2025.1599140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409067181
W4409091111Evaluating large language models and agents in healthcare: key challenges in clinical applications2025-04-02OpenAlex10.1016/j.imed.2025.03.002Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4409091111
W4409143598Recent Advances in the Diagnosis and Treatment of Paediatric Endocrine Disorders2025-04-03OpenAlex10.1111/jpc.70047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409143598
W4409148416Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis2025-04-03OpenAlex10.1007/s11886-025-02232-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409148416
W4409121205Updates on Glomerular Diseases: A Summary of Inaugural GlomCon Hawaii 20242025-04-03OpenAlex10.1159/000543863Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409121205
W4409188381Aggressive B‐cell non‐Hodgkin lymphoma2025-04-04OpenAlex10.1002/9781119706687.ch27Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409188381
W4409188412Childhood acute lymphoblastic leukaemia2025-04-04OpenAlex10.1002/9781119706687.ch22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409188412
W4409118780Clostridioides difficile in feral horse populations in Australia2025-04-04OpenAlex10.1128/aem.02114-24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409118780
W4409176255Editorial: Onconephrology: evolving concepts and challenges2025-04-04OpenAlex10.3389/fneph.2025.1585605Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409176255
W4409184040Floral extracts promising avenue for sustainable approach for nanoparticles: an updated review2025-04-04OpenAlex10.1007/s41204-025-00423-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409184040
W4409329418Proposing Bromo-Epi-Androsterone (BEA) for Stiff Person Syndrome (SPS)2025-04-05OpenAlex10.3390/microorganisms13040824Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409329418
W4409197383Ablation Medical Devices with Chemical Technologies: Engineering aspects, System, Mechanism, and Future Directions.2025-04-06OpenAlex10.36948/ijfmr.2025.v07i02.39465Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409197383
W7113491913The use of Artificial intelligence in Tuberculosis2025-04-06OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7113491913
W440927560240 years after the discovery of Helicobacter Pylori : Performing optimized “subtraction” for clinical eradication2025-04-07OpenAlex10.1002/imo2.70017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409275602
W4409211432AI-Driven Avatars for Smarter Decisions: Reducing Bias and Strengthening Critical Thinking2025-04-07OpenAlex10.3991/ijac.v18i2.52589Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4409211432
W4409237434Comprehensive Management and Treatment Insights in Disseminated Central Nervous System and Skin Infection by Fusarium Species in Myelodysplastic Syndrome: A Case Report (P10-10.006)2025-04-07OpenAlex10.1212/wnl.0000000000211846Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409237434
W4409270619Evolving dermatological complaints following the 2023 Turkey and Syria earthquake: insights from a disaster-affected region2025-04-07OpenAlex10.1007/s00403-025-04195-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409270619
W4409210173Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting2025-04-07OpenAlex10.3390/cancers17071246Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409210173
W7160243636KETAMINE USE AND REGULATORY PRACTICES IN GHANA: INSIGHTS INTO ANESTHETIC AND ANALGESIC APPLICATIONS2025-04-07OpenAlex10.5281/zenodo.20038345Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160243636
W4409212942Myeloproliferative neoplasms2025-04-07OpenAlex10.1016/j.mpmed.2025.02.006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409212942
W7200542602THE IMPACT OF THERAPEUTIC INTERVENTIONS ON THE PATHOGENESIS OF THYROID EYE DISEASE2025-04-07OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7200542602
W4409233526The Importance of Correct Diagnosis of Transthyretin Amyloid Cardiomyopathy2025-04-07OpenAlex10.1159/000544942Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409233526
W4409213543Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy2025-04-07OpenAlex10.3390/cancers17071247Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409213543
W44092401011,3,4-Oxadiazole-based EGFR inhibitors as anticancer therapeutics: SAR study and binding mode of interaction analysis2025-04-08OpenAlex10.1016/j.ejmcr.2025.100265Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409240101
W4409270598Advances and future outlook in clinical trials for treating systemic sclerosis-interstitial lung disease2025-04-08OpenAlex10.1080/17476348.2025.2490729Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409270598
W4409299877Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer2025-04-08OpenAlex10.3390/jcm14082565Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409299877
W4409277394Editorial: Metabolomics in personalized cancer medicine2025-04-08OpenAlex10.3389/fmolb.2025.1593877Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409277394
W4409328138Induction Treatment for HIV-Associated Cryptococcal Meningitis: Where Have We Been and Where Are We Going?2025-04-08OpenAlex10.3390/microorganisms13040847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409328138
W4409265123The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries2025-04-08OpenAlex10.1016/j.virol.2025.110527Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409265123
W4409328066Delayed Diagnosis and Evolving Trends in Gastric Cancer During and After COVID-19: A Comparative Study of Staging, Helicobacter pylori Infection and Bleeding Risk in Western Romania2025-04-09OpenAlex10.3390/diagnostics15080950Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409328066
W4409310283Digital Ethics2025-04-09OpenAlex10.1002/9781394372409.ch1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409310283
W4409289636Emerging Viral Infections (ZIKV, SARS‐CoV‐2, and MPXV) and Depression: Ketamine and (S, R)‐Ketamine as Promising Antidepressants2025-04-09OpenAlex10.1002/rmv.70036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409289636
W4409290644How does antifungal resistance vary in Candida (Candidozyma) auris and its clades? Quantitative and qualitative analyses and their clinical implications2025-04-09OpenAlex10.1016/j.cmi.2025.04.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409290644
W4409376618Clinical Strategies for the Chemoprevention of Localized Prostate Cancer2025-04-10OpenAlex10.9734/bpi/msraa/v1/4818Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409376618
W4409339259Immunotherapy for Renal Cell Carcinoma—What More is to Come?2025-04-10OpenAlex10.1007/s11523-025-01143-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409339259
W4409325619MIOCARDITE INFECCIOSA: ATUALIZAÇÕES EM DIAGNÓSTICO, MANEJO CLÍNICO E PERSPECTIVAS TERAPÊUTICAS2025-04-10OpenAlex10.69849/revistaft/dt10202504102301Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409325619
W4409344912Mapping the future: bibliometric insights into ferroptosis and diabetic nephropathy2025-04-10OpenAlex10.3389/fphys.2025.1516466Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409344912
W4409345128Preventing common mental health problems in war-affected populations: the role of digital interventions2025-04-10OpenAlex10.3389/fdgth.2025.1586030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409345128
W4409334244Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease2025-04-10OpenAlex10.3390/jcm14082605Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409334244
W4409358600Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia2025-04-11OpenAlex10.1038/s41409-025-02590-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409358600
W4409320212Current update on pharmacological strategies of penile cancer2025-04-11OpenAlex10.1080/14656566.2025.2492335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409320212
W4409370714Non-surgical endodontics: contemporary biomechanical preparation of the root canal system2025-04-11OpenAlex10.1038/s41415-025-8599-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409370714
W4409369771Nucleolar immunohistochemical expression of H3K27me3 in a pediatric cerebellar lesion: A true or false positive?2025-04-11OpenAlex10.4103/tcmj.tcmj_289_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409369771
W4409391043Dual Antiplatelet Therapy: Unlocking the Future of Cardiovascular Disease Management2025-04-12OpenAlex10.22214/ijraset.2025.68412Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409391043
W4410876417Integrating infectious diseases into life course epidemiology2025-04-12OpenAlex10.1093/ije/dyaf059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410876417
W4409383441The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinoma2025-04-12OpenAlex10.1186/s40364-025-00774-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409383441
W4409556701Thyroid Abscess due to Salmonella: Rare Entity of Unpredictable Severity2025-04-12OpenAlex10.36346/sarjap.2025.v06i02.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409556701
W4409397769Mycophenolate Mofetil Use for Inflammatory Bowel Disease2025-04-13OpenAlex10.71079/aside.gi.04142552Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409397769
W4409589563Management of CRE Infection with a Focus on New Antimicrobial Agents2025-04-14OpenAlex10.29011/2577-1515.100273Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4409589563
W4411276970Evolving Strategies in Targeted Drug Delivery for Optimized Cancer Therapy: A Comprehensive Review2025-04-15OpenAlex10.37285/ijpsn.2025.18.2.12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411276970
W4409479478Exploring the efficacy and safety of lecanemab in the management of early Alzheimer’s disease: A systematic review of clinical evidence2025-04-15OpenAlex10.1177/13872877251331640Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409479478
W4409454628Glucocorticoids-induced remission followed by rituximab as maintenance therapy for podocytopathy with minimal change lesions in adults2025-04-15OpenAlex10.1093/ndt/gfaf050Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409454628
W4409478839Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology2025-04-15OpenAlex10.3322/caac.70001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409478839
W4409461755Prevalence of New Delhi Metallo-β-lactamase (blaNDM) gene in a selected population of drug-resistant clinical isolates2025-04-15OpenAlex10.1007/s11033-025-10446-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409461755
W4409504825ESTUDO SOBRE OS PROCESSOS DE MEDICALIZAÇÃO E DESMEDICALIZAÇÃO NO CAMPO DA SAÚDE MENTAL2025-04-16OpenAlex10.16891/2317-434x.v13.e5.a2025.id2243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409504825
W4409516525Editorial: Autophagy and lung cancer therapy: targeted drug development and new emerging technology2025-04-16OpenAlex10.3389/fphar.2025.1599548Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409516525
W4409516558Editorial: Multi-omics application in exploring potential biomarkers targeting resistance of anti-cancer drugs2025-04-16OpenAlex10.3389/fphar.2025.1594064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409516558
W7215201955MODERN CLASSIFICATION OF PYODERMA AND THE IMPORTANCE OF ANTISEPTIC AGENTS2025-04-16OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7215201955
W4409957345Swarm Intelligence for Dynamic and Multi-Scale Toxicity Prediction in Drug Discovery2025-04-16OpenAlex10.47392/irjaem.2025.0195Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409957345
W4409511931Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution2025-04-16OpenAlex10.1007/s11912-025-01655-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409511931
W4409483880The History of Dermal Fillers in Dermatologic Surgery2025-04-16OpenAlex10.1097/dss.0000000000004650Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409483880
W4409552526BONE & BONE MATRIX BUILDERS: KEY FRONTIERS IN OSTEOPOROSIS MANAGEMENT2025-04-17OpenAlex10.53555/z9drvn04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409552526
W7110625596Dysregulation of tryptophan biosynthesis as a putative treatment approach for nontypeable Haemophilus influenzae, a causative agent of otitis media2025-04-17OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7110625596
W4409564986From Biopower to Embodiment: Reconfiguring Healthcare Beyond the Pandemic of Medicalization2025-04-18OpenAlex10.31584/psumj.2025277717Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4409564986
W4409587022Guidelines for the Storage, Isolation, and Characterization of Extracellular Vesicle Research2025-04-18OpenAlex10.52927/jdcr.2025.13.1.9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409587022
W4409617137Role of Insect-Derived Antimicrobial Peptides in Overcoming Multidrug-Resistant Infections2025-04-18OpenAlex10.36948/ijfmr.2025.v07i02.41583Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409617137
W4409591330An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphoma2025-04-19OpenAlex10.1080/14737140.2025.2492787Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409591330
W4409605614Desmoplastic small round cell tumor: an update of current management practices2025-04-20OpenAlex10.1186/s43046-025-00276-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409605614
W4409763365Kuzey Kıbrıs’tan İzole Edilen Kutanöz Layşmanyazis ve Kanin Layşmanyazis Suşlarının Moleküler Karakterizasyonu ve Fare Modellerinde Klinik Yansımaları2025-04-20OpenAlex10.5578/mb.202502149Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409763365
W4409689386Abstract 1087: The evolving landscape of cancer transcriptomics data2025-04-21OpenAlex10.1158/1538-7445.am2025-1087Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409689386
W4409628033Abstract 1228: High throughput phenotyping and drug discovery using the TumorGraft3D co-culture platform and flow cytometry2025-04-21OpenAlex10.1158/1538-7445.am2025-1228Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409628033
W4409624675Abstract 1245: Delaying resistance to Gefitinib in EGFR+ NSCLC through optimized treatment scheduling: an integrated experimental-theoretical approach2025-04-21OpenAlex10.1158/1538-7445.am2025-1245Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409624675
W4409628153Abstract 1705: MUC1-C is a target for antibody-drug conjugate treatment of MRTX1133-resistant KRAS G12D mutant pancreatic ductal adenocarcinomas2025-04-21OpenAlex10.1158/1538-7445.am2025-1705Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409628153
W4409627530Abstract 1805: Dual-payload TME-activated ADC platform2025-04-21OpenAlex10.1158/1538-7445.am2025-1805Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409627530
W4409689102Abstract 2128: Uncovering the multiple therapeutic mechanisms of trastuzumab deruxtecan (T-DXd): effective extracellular payload release and immunomodulatory stimulation2025-04-21OpenAlex10.1158/1538-7445.am2025-2128Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409689102
W4409627001Abstract 2197: Uncovering immune evasion in EGFR-mutant and treatment resistant NSCLC: insights from a novel mouse model2025-04-21OpenAlex10.1158/1538-7445.am2025-2197Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409627001
W4409689833Abstract 2486: Decoding tumor evolution through fitness landscapes of aneuploid cells2025-04-21OpenAlex10.1158/1538-7445.am2025-2486Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409689833
W4409634351Abstract 2627: Integrated multi-omics analyses discovers lineage plasticity in desmoplastic small round cell tumors2025-04-21OpenAlex10.1158/1538-7445.am2025-2627Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409634351
W4409627422Abstract 2902: Systematic mapping of chemo-genomic interactions between DNA damaging agents and DNA damage repair genes with targeted CRISPR knockout screening2025-04-21OpenAlex10.1158/1538-7445.am2025-2902Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409627422
W4409634389Abstract 4446: Collateral drug screening throughout the evolution of osteosarcoma drug resistance2025-04-21OpenAlex10.1158/1538-7445.am2025-4446Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409634389
W4409633637Abstract 4564: Enhancing circulating tumor DNA recovery and liquid biopsy sensitivity with precision liposomal priming agents2025-04-21OpenAlex10.1158/1538-7445.am2025-4564Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409633637
W4409631364Abstract 4864: The dysregulated YY1-EZH2-RKIP axis in cancer and immune evasion2025-04-21OpenAlex10.1158/1538-7445.am2025-4864Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409631364
W4409631647Abstract 5187: Characterization and prediction of drug responses in NF1 patient-derived tumor organoids through multiplex phenotypic profiling2025-04-21OpenAlex10.1158/1538-7445.am2025-5187Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409631647
W4409632611Abstract 5808: Differential clinical outcomes of immune vs non-immune based therapeutics in gastrointestinal malignancies: A retrospective, single center experience of early phase studies2025-04-21OpenAlex10.1158/1538-7445.am2025-5808Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409632611
W4409652522Abstract 7495: The evolving ECM architecture shapes unique evolutionary trajectories of breast tumor immune escape and elimination2025-04-21OpenAlex10.1158/1538-7445.am2025-7495Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409652522
W4409648155Alopecia Areata: Pathogenesis, Diagnosis, and Therapies2025-04-21OpenAlex10.1002/mco2.70182Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409648155
W7110480573Digital Thread: Bridging Macro–Micro Services in System-of-Systems2025-04-21OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7110480573
W4409626453Does Chemotherapy-Induced Peripheral Neuropathy Fall Within the Spectrum of Complex Regional Pain Syndrome? A Narrative Review2025-04-21OpenAlex10.1007/s11916-025-01390-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409626453
W4409805299Updates in immunomodulator therapy in ocular surface inflammatory diseases2025-04-21OpenAlex10.1097/icu.0000000000001140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409805299
W7120316457Bridging the Human-in-the-Loop Gap in Robotics Through Language: A Multimodal Agentic AI for Scaling Human Supervision in Autonomous Systems2025-04-22OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7120316457
W4409657923Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer2025-04-22OpenAlex10.36401/jipo-24-36Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409657923
W4409712688Editorial: Microbiome in an immunocompromised host- a jungle of challenges or a glacier of hidden opportunities?2025-04-23OpenAlex10.3389/fcimb.2025.1569842Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409712688
W4409710415Editorial: Rare hematological malignancies2025-04-23OpenAlex10.3389/fcell.2025.1600063Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409710415
W4409704743PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future2025-04-23OpenAlex10.1007/s11864-025-01317-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409704743
W4417286171Registro multicéntrico prospectivo de pacientes hospitalizados por síndrome coronario agudo sin elevación del segmento ST en centros de alta complejidad. Resultados intrahospitalarios y evolución a 6 meses (Buenos Aires I)2025-04-23OpenAlex10.7775/rac.v88i4.669Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417286171
W4409729826Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus2025-04-23OpenAlex10.3390/cancers17091412Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409729826
W4409695091Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook2025-04-23OpenAlex10.1007/s11864-025-01320-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409695091
W4409732983Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future2025-04-24OpenAlex10.1007/s13300-025-01738-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409732983
W4409735046Clinicopathologic correlation case 2: multifocal, symptomatic oral mucosal lesions2025-04-24OpenAlex10.1016/j.oooo.2025.01.721Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409735046
W4410016853Comprehensive pharmacy-based investigational drug service: A 40-year update2025-04-24OpenAlex10.1093/ajhp/zxaf104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410016853
W4409747090Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting2025-04-24OpenAlex10.3389/fphar.2025.1591443Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4409747090
W4409747088Editorial: The role of ubiquitination in disease development, progression, and prognosis2025-04-24OpenAlex10.3389/fimmu.2025.1595755Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409747088
W4409763210Functionalization of Implantable Systems for Controlled Drug Delivery and Beyond2025-04-24OpenAlex10.1007/s40883-025-00401-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409763210
W4409737282Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma2025-04-24OpenAlex10.1001/jamaoto.2025.0410Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409737282
W4409737578Q&A: Louis Staudt on Molecular Classification of Cancer2025-04-24OpenAlex10.1158/2643-3230.bcd-25-0133Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409737578
W4412567825Self-Organizing Microservice Composition for IoT-Enabled Neonatal Monitoring2025-04-24OpenAlex10.1109/amathe65477.2025.11081365Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412567825
W4409821428Abstract SY37-02: Adapting radiotherapy to cancer immunotherapy2025-04-25OpenAlex10.1158/1538-7445.am2025-sy37-02Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409821428
W4409820726Abstract SY43-01: Translating adaptive therapy to ovarian cancer patients2025-04-25OpenAlex10.1158/1538-7445.am2025-sy43-01Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409820726
W4409798427Case to Vignette: A Framework to Elevate Narrative by Embracing Vignette-Based Learning in Medicine2025-04-25OpenAlex10.1007/s11606-025-09531-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409798427
W4409825526Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseases2025-04-25OpenAlex10.3389/fphar.2025.1602495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409825526
W4409788590Entheogen: an evolutionary medicine for neuropsychiatric disorders2025-04-25OpenAlex10.1093/nsr/nwaf168Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409788590
W4409816017Exploring pyridinium-based inhibitors of cholinesterases: A review of synthesis, efficacy, and structural insights2025-04-25OpenAlex10.1016/j.ejmcr.2025.100270Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409816017
W7164143015Health Informatics-Based Telecounseling Innovation in Mental Health Services2025-04-25OpenAlex10.57185/3e3z2n84Full textExcludedF3: The evaluated platform provides practitioner-delivered video telecounseling, messaging and symptom monitoring. The Methods describes practitioner training and6–12 counseling sessions, not an implemented LLM acting-agent system. General AI background statements do not establish an LLM intervention.https://openalex.org/W7164143015https://healthinformaticsjournal.al-makkipublisher.com/index.php/hij/article/view/78/74Publisher PDF.js online text, abstract and Methods/Results pp215–220 read; no file archive/download. Landing-page abstract is mistakenly a bibliography, so actual PDF text was used.
W4409787552Innovative therapeutics for renoprotection: Where we are2025-04-25OpenAlex10.1016/j.pharmr.2025.100060Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409787552
W4409805671Programmed wound healing in aged skin may be enhanced by mesenchymal cell loaded gene-activated scaffolds2025-04-25OpenAlex10.1063/5.0240504Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409805671
W4409819469Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies2025-04-25OpenAlex10.3390/cancers17091434Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409819469
W7133239314The 5 Pillars of Grace: A Formal Architecture for Recursive Reflective Coherence2025-04-25OpenAlex10.5281/zenodo.18838931Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133239314
W4409843897Case Series on Comparison Between Dexmedetomidine and Propofol as Preanaesthetic Medication in Awake Fibreoptic Intubation2025-04-26OpenAlex10.21275/sr25421185220Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409843897
W4409835012The emerging role of proactive therapy in atopic dermatitis and psoriasis2025-04-26OpenAlex10.12775/jehs.2025.80.59456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409835012
W4409852851Tackling CMV in Transplant Recipients: Past, Present, and Future2025-04-27OpenAlex10.1007/s40121-025-01159-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409852851
W4409864478A Paradigm Shift in Health Surveillance: Preparing for the Future of Longevity2025-04-28OpenAlex10.3389/ijph.2025.1607760Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409864478
W4409896338Antimicrobial peptides: evolving soldiers in the battle against drug-resistant superbugs2025-04-28OpenAlex10.1007/s11033-025-10533-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409896338
W4409871280Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer2025-04-28OpenAlex10.1245/s10434-025-17345-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409871280
W4409889608Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings2025-04-28OpenAlex10.3389/fphar.2025.1607362Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409889608
W4409890179Evolution of carbapenemase activity in the class C β-lactamase ADC-12025-04-28OpenAlex10.1128/mbio.00185-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409890179
W4409884340Life Already Knows How to Heal: A Conceptual Shift Toward Self-Terminating Regenerative Loops2025-04-28OpenAlex10.22541/au.174585849.98938164/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409884340
W4409887304Long-Chain Hydrocarbons in the Mucous Layer of the Galleria mellonella Insect Eggs as Potential Antibacterial Agents against Multidrug-Resistant Bacteria2025-04-28OpenAlex10.1021/acsomega.5c00938Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409887304
W4409948928Synergizing Intelligence: A Comparative Study of Robotics Components and AI Integration2025-04-28OpenAlex10.71097/ijsat.v16.i2.4102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409948928
W4409908586Targeting the Senescent Tumor Microenvironment to Sensitize Immunotherapy2025-04-28OpenAlex10.54097/te6m0d54Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409908586
W4409875609Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis2025-04-28OpenAlex10.1089/hum.2024.258Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409875609
W4409995640AMRrounds: Carbapenem-resistant Acinetobacter baumannii in the intensive care unit—when resistance meets severity2025-04-29OpenAlex10.1093/jacamr/dlaf067Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409995640
W4409958056Editorial: Smart devices for personalized nutrition and healthier lifestyle behavior change2025-04-29OpenAlex10.3389/fnut.2025.1604314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409958056
W4409993782Enhancing Pain Management: The Role of Superior Hypogastric Plexus Block in Chronic Pelvic Pain Treatment2025-04-29OpenAlex10.4103/jpbs.jpbs_1805_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409993782
W4409954291Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease2025-04-29OpenAlex10.1016/j.cjca.2025.03.037Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409954291
W4409908271VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape2025-04-29OpenAlex10.1016/j.jaut.2025.103425Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409908271
W4409972358A Current Review of Generative AI in Medicine: Core Concepts, Applications, and Current Limitations2025-04-30OpenAlex10.1007/s12178-025-09961-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409972358
W7135216246AI-Powered Predictive Health Risk Management in Insurance Plans: A Multi-Agent System Approach for Personalized Policy Customization2025-04-30OpenAlex10.47363/jcbr/icbr2025/2025(7)8Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7135216246
W4411242906Antiplatelet Therapy in Cardiovascular Diseases2025-04-30OpenAlex10.37022/jis.v8i1.103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411242906
W4409964731Biotechnological Applications of Biogenic Nanomaterials from Red Seaweed: A Systematic Review (2014–2024)2025-04-30OpenAlex10.3390/ijms26094275Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409964731
W4410082209Clinical Trials for Curing Chronic Hepatitis B: A Comprehensive Analysis of Design Principles and Their Impact on Trial Performance2025-04-30OpenAlex10.20944/preprints202504.2575.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410082209
W4409907579Evolution of pain management in lung cancer surgery: from opioid-based to personalized analgesia2025-04-30OpenAlex10.17085/apm.25240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409907579
W4410465386Intelligent AI Agents for Fraud and Abuse Detection: Leveraging Machine Learning, NLP, and Behavioural Analytics for Enhanced Security2025-04-30OpenAlex10.14445/23488387/ijcse-v12i4p103Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410465386
W7169858612Ketamine Therapy in Psychiatry: A Comprehensive Review2025-04-30OpenAlex10.21088/jpn.2277.9035.14125.5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169858612; https://openalex.org/W7169873636
W4409964916Microbial contamination and pharmaceutical stability in space environment: addressing dual challenge with innovative technologies and sustainable practices2025-04-30OpenAlex10.3389/frspt.2025.1553854Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409964916
W4409975401The challenges and prospects of intercultural adult education2025-04-30OpenAlex10.3389/feduc.2025.1467341Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409975401
W4409999833Updates in Gastroesophageal Reflux Disease Management: From Proton Pump Inhibitors to Dietary and Lifestyle Modifications2025-04-30OpenAlex10.3390/gidisord7020033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409999833
W4410009804A case report of PLEVA after Herpes Zoster infection: is there a correlation?2025-05-01OpenAlex10.4103/jewd.jewd_79_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410009804
W4411749593Academic Contributions and Field Advances of the International Takotsubo Registry: A Comment from Multidimensional Perspectives2025-05-01OpenAlex10.4103/hm.hm-d-25-00048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411749593
W4410991138Advances in Systemic and Immunotherapies for Human Papillomavirus–Mediated Oropharyngeal Cancers2025-05-01OpenAlex10.1097/ppo.0000000000000766Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410991138
W4410406058BRUGADA TYPE 1 PHENOTYPE AND CARDIAC ARREST FOLLOWING COCAINE ABUSE2025-05-01OpenAlex10.1093/eurheartjsupp/suaf076.140Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410406058
W7165502919Evaluation Of Treatment Outcomes And Prognostic Factors In Managing Children With Steroid Sensitive Nephrotic Syndrome In Malaysia2025-05-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165502919
W4410453118Evolving Resistance Patterns: A Retrospective Five-year Study of Urinary Pathogens and Antibiotic Efficacy2025-05-01OpenAlex10.7860/jcdr/2025/74833.20985Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410453118
W4410017743Focus on somatic mutations and cardiovascular risk, upper extremity artery disease, drug-coated balloons, and new therapeutic targets for restenosis2025-05-01OpenAlex10.1093/eurheartj/ehaf221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410017743
W4410761087From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis.2025-05-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410761087
W4409994026Front-line Treatment of B-cell Acute Lymphoblastic Leukemia in Canada: Current Strategies and Evolving Paradigms2025-05-01OpenAlex10.58931/cht.2025.4165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409994026
W4411652260Governance of Direct‐to‐User Digital Mental Health Tools: Emphasizing Transparency over Paternalism2025-05-01OpenAlex10.1002/hast.5009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411652260
W4410603768LEGACY OF STATINS IN CARDIOVASCULAR DISEASE2025-05-01OpenAlex10.1097/01.hjh.0001117416.83554.c7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410603768
W4410011153Let Doctors Be Doctors: Defending Physician Autonomy in Cancer Care2025-05-01OpenAlex10.1097/01.cot.0000000000000064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410011153
W4409963130Longitudinal surveillance of the molecular evolution of methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Shanghai, China, from 2013 to 20222025-05-01OpenAlex10.1128/msystems.00371-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409963130
W4410498836Management of anaemia in critically ill adults2025-05-01OpenAlex10.4103/singaporemedj.smj-2024-005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410498836
W4410467870Multi-agent AI Systems for Adaptive, Culturally-Concordant Care Routing in Postpartum Depression Across Medicaid-Dependent Populations2025-05-01OpenAlex10.55248/gengpi.6.0525.1645Full textExcludedF3: The described postpartum screening, triage, referral and feedback architecture uses clinical risk scoring, conventional NLP, supervised/unsupervised and federated learning. No LLM/VLM acting agent is implemented.https://openalex.org/W4410467870https://doi.org/10.55248/gengpi.6.0525.1645
W4410275666Racing Against Time: Pulmonary Mucormycosis in a Kidney Transplant Recipient Under Experimental Anti-rejection Therapy2025-05-01OpenAlex10.1164/ajrccm.2025.211.abstracts.a6718Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410275666
W4409993751Richter Transformation in the Canadian Landscape: Clinical Perspectives and Emerging Trends2025-05-01OpenAlex10.58931/cht.2025.4163Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409993751
W4410016396SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application2025-05-01OpenAlex10.4093/dmj.2025.0220Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4410016396
W4410276685Shedding Light on HPV-Driven Lung Cancer: A Case of in Situ Squamous Cell Carcinoma Treated With Bronchoscopic Photodynamic Therapy2025-05-01OpenAlex10.1164/ajrccm.2025.211.abstracts.a7809Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410276685
W4410880256Talking about obesity in the OB-GYN clinic2025-05-01OpenAlex10.1097/gme.0000000000002594Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410880256
W4409978716The Spectrum of Influenza-Associated Acute Necrotizing Encephalopathy of Childhood: A Case Series2025-05-01OpenAlex10.1016/j.pediatrneurol.2025.04.012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4409978716
W4410275600Trends in Management and Short-Term Outcomes of Patients With Pulmonary Embolism and Hemodynamic Instability: Baseline Characteristics, Treatment Decisions, and Clinical Outcomes2025-05-01OpenAlex10.1164/ajrccm.2025.211.abstracts.a6505Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410275600
W4411750394Type 5 Diabetes- The Rejuvenated Spirit from a Ghost of the Past2025-05-01OpenAlex10.4103/ijem.ijem_404_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411750394
W4410895884Updates to Systemic Therapy for Differentiated Thyroid Cancer2025-05-01OpenAlex10.6004/jnccn.2025.5015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410895884
W4410082204Antibody-Drug Conjugates (ADCs) and Indications in Autoimmune Disorders2025-05-02OpenAlex10.20944/preprints202505.0090.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410082204
W4410020726Enhancing Efficiency in Manufacturing through Automated AI Agent-Based Bearing Defect Diagnostic System2025-05-02OpenAlex10.4271/2025-01-0158Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4410020726
W4410182386Enterococci: An Evolving Threat of Multidrug Resistance and Linezolid Resistance in the Clinical Era2025-05-02OpenAlex10.21608/zumj.2025.374424.3903Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4410182386
W4410028148Evolving dynamics in clinical trials for oral cancer: Trends, treatment modalities, and future directions2025-05-02OpenAlex10.1016/j.oraloncology.2025.107333Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410028148
W4410188843Hypertensive Pregnancy Disorders: From Mechanisms to Management2025-05-02OpenAlex10.1093/ajh/hpaf080Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410188843
W4410034200Medical and surgical management of neovascular glaucoma2025-05-02OpenAlex10.1097/icu.0000000000001151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410034200
W4410062709Successful treatment of terbinafine-resistant Trichophyton indotineae with fluconazole and resveratrol: A novel approach2025-05-02OpenAlex10.4103/ds.ds-d-24-00224Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410062709
W4410019752The Evolution of Fluorescein into A Potential Theranostic Tool2025-05-02OpenAlex10.1002/chem.202501513Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410019752
W4410068624High-Volume Hemodiafiltration: Expanding the Evidence Beyond Randomized Trials—A Critical Perspective on the 2025 EuDial Consensus2025-05-03OpenAlex10.3390/jcm14093174Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410068624
W4410071122Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis2025-05-03OpenAlex10.3390/hemato6020012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410071122
W4410081075Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations2025-05-05OpenAlex10.1016/j.resinv.2025.04.021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410081075
W4410083412Mandimycin: A phospholipid-targeting natural polyene macrolide overcoming multidrug resistance in invasive fungal infections2025-05-05OpenAlex10.1016/j.aac.2025.04.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410083412
W4410127187Ethical Intrusion: The Strategic Role of Ethical Hacking in the Modern Cybersecurity Framework2025-05-06OpenAlex10.55041/ijsrem47045Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410127187
W4410134567Knowledge gaps in the 2024 consensus statement on atrial fibrillation ablation2025-05-06OpenAlex10.1093/eurheartj/ehaf175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410134567
W4410124837Management of Acute Respiratory Distress Syndrome (ARDS): A Review of Current Ventilatory and Pharmacological Strategies2025-05-06OpenAlex10.12775/jehs.2025.81.59770Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410124837
W4410106945New Targets for Imaging in Nuclear Medicine2025-05-06OpenAlex10.1053/j.semnuclmed.2025.04.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410106945
W7117882553Proposing a RAG-Based System for Context-Aware Healthcare Monitoring2025-05-06OpenAlex10.5281/zenodo.18106766Full textExcludedF4: Dynamic RAG and current-patient monitoring change consultation state; no experience-derived cross-patient update is retained. Agent-policy learning is expressly future work.https://openalex.org/W7117882553https://www.ijert.org/research/proposing-a-rag-based-system-for-context-aware-healthcare-monitoring-IJERTV14IS040466.pdforiginal publisher complete article text, methods/simulation/conclusion
W4410130751Recent Advances in Diagnostics and Therapeutic Interventions for Drug-Resistant Malaria2025-05-06OpenAlex10.1021/acsinfecdis.4c00962Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410130751
W4410183135AI with agency: a vision for adaptive, efficient, and ethical healthcare2025-05-07OpenAlex10.3389/fdgth.2025.1600216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410183135
W4410138052Editorial Comment on “Is Docetaxel Essential for Darolutamide‐Based Metastatic Hormone‐Sensitive Prostate Cancer Therapy?”2025-05-07OpenAlex10.1111/iju.70093Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410138052
W4410183190Editorial: Insights in consciousness research, volume II2025-05-07OpenAlex10.3389/fpsyg.2025.1602845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410183190
W4410157879Providing Task Execution Capabilities in LLM-Based Conversational Assistants2025-05-07OpenAlex10.5753/sbsi.2025.246626Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4410157879
W4410157228The Evolving Role of Immunotherapy for Gastroesophageal Malignancies2025-05-07OpenAlex10.1245/s10434-025-17386-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410157228
W4410155196Tomographic evaluation of apexogenesis with human treated dentin matrix in young permanent molars: a split-mouth randomized controlled clinical trial2025-05-07OpenAlex10.1186/s12903-025-05997-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410155196
W7215428849ACUTE BRONCHITIS IN CHILDREN2025-05-08OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215428849
W4410211284AI-Powered Data Observability & Governance Agent for Cloud Analytics: Transforming Enterprise Data Management2025-05-08OpenAlex10.32996/jcsts.2025.7.3.88Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410211284
W4410306061Antioxidant nanozymes: current status and future perspectives in spinal cord injury treatments2025-05-08OpenAlex10.7150/thno.114836Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410306061
W4410185863Editorial: Designing and evaluating digital health interventions2025-05-08OpenAlex10.3389/fdgth.2025.1612380Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410185863
W4410215665Editorial: SLC12A5-dependent neurological disorders2025-05-08OpenAlex10.3389/fnmol.2025.1611682Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410215665
W4410193934Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline2025-05-08OpenAlex10.1016/j.clml.2025.05.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410193934
W4410203266Humanistic values of the physician in the era of artificial intelligence2025-05-08OpenAlex10.1016/j.hjc.2025.04.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410203266
W7164534485The Complete Patient: AI, Clinical Intelligence, and the Future of Predictive Medicine BY Srivenkata Gantikota2025-05-08OpenAlex10.5281/zenodo.20658360Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164534485
W4410279569XPS Monitoring of Calcarenite Building Walls Long Exposed Outdoor. Estimation of Deterioration Trend from the Time Sequence of Curve-Fitted Spectra and PCA Exploration of the Large Dataset2025-05-08OpenAlex10.20944/preprints202505.0518.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410279569
W4410232643Advances in COVID-19 Therapeutics: Exploring the role of lectins and protease inhibitors2025-05-09OpenAlex10.1016/j.micpath.2025.107687Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410232643
W4410246253Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity2025-05-09OpenAlex10.1016/j.phrs.2025.107761Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410246253
W4410241116Effectiveness and Toxicity of Anticancer Agents in Older Australian Patients: A Retrospective Analysis2025-05-09OpenAlex10.1111/ajco.14186Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4410241116
W4410243325Endoscopic management of upper non-variceal and lower gastrointestinal bleeding: Where do we stand?2025-05-09OpenAlex10.4253/wjge.v17.i5.105580Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410243325
W4410257802Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–20182025-05-10OpenAlex10.1159/000546307Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410257802
W4410907305Recent advances in the pharmacological treatment of obesity2025-05-10OpenAlex10.5124/jkma.25.0058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410907305
W4410280183SGLT2 inhibitors across the acute cardiac care spectrum: insights and perspectives2025-05-11OpenAlex10.1080/14796678.2025.2503666Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410280183
W4410288328A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia2025-05-12OpenAlex10.1158/0008-5472.can-24-3840Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410288328
W4410327766Artificial intelligence will change the research environment in dental medicine dramatically: will algorithms replace literature reviews in the near future?2025-05-12OpenAlex10.1093/dmfr/twaf041Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410327766
W4410285343Editorial: venom collection2025-05-12OpenAlex10.1038/s41598-024-76017-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410285343
W4411737214Exploring the Anticoagulant Mechanisms in Complementary and Alternative Medicines and Pharmacokinetics and Pharmacodynamics of Novel Oral Anticoagulants2025-05-12OpenAlex10.63682/jns.v14i7.5706Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411737214
W4410308545The Journey and Evaluation of Chemical Water Shut-Off Treatments in Carbonate Reservoirs: A Case Study from Northern Oman2025-05-12OpenAlex10.2118/224978-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410308545
W4410332175Diagnostic and clinical management of Candida auris infections in immunocompromised patients2025-05-13OpenAlex10.1080/14787210.2025.2505567Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4410332175
W4411301257Health Promoting Campuses: a time for global reflection and renewed action2025-05-13OpenAlex10.1093/heapro/daaf086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411301257
W4410335270Immunologische Aspekte nach der Lungentransplantation2025-05-13OpenAlex10.1055/a-2590-9933Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410335270
W4410345378Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes2025-05-13OpenAlex10.3390/life15050779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410345378
W4410370580Changes in postural stability induced by a ball-and-board game designed from a systems perspective2025-05-14OpenAlex10.1186/s13102-025-01110-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410370580
W4410379924Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership2025-05-14OpenAlex10.1186/s12909-025-07108-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410379924
W4410355405Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing2025-05-14OpenAlex10.1200/edbk-25-100053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410355405
W4410360695Dynamic Fairness Calibration for Real-Time Decision Systems using Multi-Objective Reinforcement Learning2025-05-14OpenAlex10.36227/techrxiv.174723862.23255200/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410360695
W4410429461From Nobel-winning antiparasitic to antiviral pandemic candidate: A bibliometric analysis of ivermectin’s decades of veterinary and human protection2025-05-14OpenAlex10.53894/ijirss.v8i3.7031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410429461
W4410349227Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights2025-05-14OpenAlex10.1016/j.blre.2025.101301Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410349227
W4410361787SOHO State of the Art Updates and Next Questions | The Evolving Landscape of Prognostic Models in Chronic Lymphocytic Leukemia2025-05-14OpenAlex10.1016/j.clml.2025.05.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410361787
W4410379720Skin and systemic infections in children with atopic dermatitis: review of the current evidence2025-05-14OpenAlex10.3389/fped.2025.1513969Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410379720
W4410349010The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies2025-05-14OpenAlex10.1016/j.blre.2025.101302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410349010
W4410411907Editorial: Marine algal bioactive molecules for food and pharmaceutical applications2025-05-15OpenAlex10.3389/fmars.2025.1598329Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410411907
W4410396234Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes2025-05-15OpenAlex10.1007/s13340-025-00818-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410396234
W4411112290How GenAI Agents Are Transforming Legacy Application Modernization2025-05-15OpenAlex10.37745/ejcsit.2013/vol13n366271Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4411112290
W4410411595Long-Acting Extracellular Vesicle-Based Biologics in Osteoarthritis Immunotherapy2025-05-15OpenAlex10.3390/bioengineering12050525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410411595
W4410546461New Drugs and New Modes of Administration in Pediatric Anesthesia2025-05-15OpenAlex10.36347/sasjm.2025.v11i05.018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410546461
W4410453444Pharmacists and Community-Based Pharmacies in an Expanded Role in Patient Care and Public Health in The U.S.2025-05-15OpenAlex10.31926/but.ms.2025.67.18.1.3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410453444
W4410386174The rise of quality agents: How AI is eliminating bad data at scale2025-05-15OpenAlex10.30574/wjarr.2025.26.2.1694Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410386174
W4410445250Evolving therapeutic strategies for severe fever with thrombocytopenia syndrome: from past to future2025-05-16OpenAlex10.1177/20499361251340786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410445250
W4410430358From prompt to platform: an agentic AI workflow for healthcare simulation scenario design2025-05-16OpenAlex10.1186/s41077-025-00357-zTitle/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4410430358
W4410453671Spatiotemporal imaging of immune dynamics: rethinking drug efficacy evaluation in cancer immunotherapy2025-05-16OpenAlex10.3389/fimmu.2025.1609606Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410453671
W4410386183Temporal Trends in Multiple Myeloma Mortality and Their Relationship to Evolving Treatment Strategies: A Retrospective Analysis Using SEER Data2025-05-16OpenAlex10.21203/rs.3.rs-6624519/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410386183
W4410438745The Role of Somatostatin in the Gastrointestinal Tract2025-05-16OpenAlex10.3390/biology14050558Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410438745
W4410430994Tumour and microenvironment crosstalk in NSCLC progression and response to therapy2025-05-16OpenAlex10.1038/s41571-025-01021-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410430994
W4411617543Dissemination of a Controversial COVID-19 ‘Miracle Cure’ on Twitter: The Case of Chlorine Dioxide2025-05-17OpenAlex10.9734/bpi/nicass/v3/5587Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411617543
W4410501223AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review2025-05-19OpenAlex10.1016/j.cgh.2025.02.015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410501223
W4410522795Anthraquinone-Based Nanomaterials: Emerging Strategies in Cancer Therapy2025-05-19OpenAlex10.2174/9789815313987125030009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410522795
W4410477749Editorial: Exploring new therapeutic frontiers in Glaucoma: from molecular targets to patient outcomes2025-05-19OpenAlex10.3389/fphar.2025.1624534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410477749
W4410507967Prognostic Factors of Renal Survival among Chronic Kidney Disease Patients in Tertiary Care Centre in Kelantan, Malaysia2025-05-19OpenAlex10.32802/asmscj.2025.1554Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410507967
W4410493987Progress through Persistence — Turning the Page in Pulmonary Fibrosis Clinical Trials2025-05-19OpenAlex10.1056/nejme2505760Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410493987
W4410504961Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study2025-05-19OpenAlex10.1002/prp2.70122Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410504961
W4410513216ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS2025-05-20OpenAlex10.3899/jrheum.2025-0390.pv249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410513216
W4410520741Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New?2025-05-20OpenAlex10.3390/cancers17101710Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410520741
W4410529622Advances in Radiation Therapy for Anal Cancer2025-05-20OpenAlex10.1055/s-0045-1806853Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410529622
W4410524126Editorial: The integration of clinical veterinary anatomy and diagnostic imaging2025-05-20OpenAlex10.3389/fvets.2025.1602545Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410524126
W4410512989IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT2025-05-20OpenAlex10.3899/jrheum.2025-0390.pv283Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410512989
W4410530697Neurofibromatosis Type 1 : A General Review2025-05-20OpenAlex10.3340/jkns.2025.0073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410530697
W4410542930Pharmacological Strategies and Investigational Drugs for Emerging and Re-Emerging Diseases of Viral Origin2025-05-20OpenAlex10.1201/9781032721811-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410542930
W4410546895Bdellovibrio bacteriovorus: a “magic weapon” against bacterial pathogens2025-05-21OpenAlex10.1186/s13213-025-01794-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410546895
W4410840692COMPARISON BETWEEN TIVA AND INHALATIONAL ANESTHETICS, RISKS AND BENEFITS2025-05-21OpenAlex10.71000/77q6m886Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410840692
W4410605324Corrigendum: Autonomy support in telehealth: an evolutionary concept analysis2025-05-21OpenAlex10.3389/fpubh.2025.1610264Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4410605324
W4410571496Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review2025-05-21OpenAlex10.3389/fimmu.2025.1507870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410571496
W4411264801Organoids in motion: biohybrid robotics futures2025-05-21OpenAlex10.1097/mm9.0000000000000018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411264801
W4410581274Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapy2025-05-21OpenAlex10.1038/s41598-025-02186-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410581274
W4410555903Where are the birthing women? Rethinking agency, culture, and explanation in evolutionary psychology2025-05-21OpenAlex10.1080/09515089.2025.2508941Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4410555903
W4410609506A Decade of Clinical Experience with DARPins in Oncology and Virology: A Systematic Review2025-05-22OpenAlex10.1101/2025.05.21.25328103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410609506
W4410591577Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos2025-05-22OpenAlex10.1161/circresaha.125.325602Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410591577
W4410612359Cellular Therapy for Advanced Melanoma2025-05-22OpenAlex10.1016/j.suc.2025.03.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410612359
W4410616544Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country2025-05-22OpenAlex10.1016/j.msard.2025.106544Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410616544
W4410698651Advanced combination therapy in inflammatory bowel disease2025-05-23OpenAlex10.1016/j.jbspin.2025.105922Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410698651
W4410706484Co-Clinical Trial: An Innovative Platform for Drug Development2025-05-23OpenAlex10.32553/ijmsdr.v9i3.1053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410706484
W4412022016Green Synthesis And Antimicrobial Activity Of Vanadium Oxide Nanoparticles Using Nyctanthes Arbortristis Aqueous Leaf Extract2025-05-23OpenAlex10.64252/1swpr633Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412022016
W4410696209Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?2025-05-23OpenAlex10.1161/hypertensionaha.125.25112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410696209
W4410746940LOOP-MEDIATED ISOTHERMAL AMPLIFICATION METHOD - PERSPECTIVE TOOL IN VETERINARY MEDICINE2025-05-23OpenAlex10.20544/aisc.1.2.25.p09Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410746940
W4410629910SAGE: Self-evolving Agents with Reflective and Memory-augmented Abilities2025-05-23OpenAlex10.1016/j.neucom.2025.130470Full textExcludedF2: SAGE is a general agent/memory framework evaluated on AgentBench, long-text QA and general tasks; healthcare is an application claim, not the primary evaluated domain. Fixed P2 applies.https://openalex.org/W4410629910https://www.sciencedirect.com/science/article/pii/S0925231225011427
W4410698680SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter?2025-05-23OpenAlex10.1016/j.clml.2025.05.018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410698680
W4410633223Theragnostic applications of cyclodextrin-enhanced photothermal therapy in cancer management2025-05-23OpenAlex10.1016/j.carbpol.2025.123793Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410633223
W4410635598Theranostic: A Primer for Radiologists2025-05-23OpenAlex10.1177/08465371251338032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410635598
W4410708357A Review on AI-Powered Conversational Agents for Psychotherapy: Techniques, Tools, and Ethical Perspectives- Inner Me2025-05-24OpenAlex10.22214/ijraset.2025.71307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410708357
W4410713994Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer2025-05-24OpenAlex10.1016/j.jncc.2025.04.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410713994
W4410708945The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective2025-05-24OpenAlex10.1016/j.ygyno.2025.05.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410708945
W4410721714High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies2025-05-25OpenAlex10.3390/cells14110776Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410721714
W4410717265Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives2025-05-25OpenAlex10.1016/j.medp.2025.100087Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410717265
W4410740974Anti-Human Epidermal Growth Factor Receptor-2 Therapies in Biliary Tract Cancers: A Meta-Analysis on Disease Location, Human Epidermal Growth Factor Receptor-2 Status, and Survival Outcomes2025-05-26OpenAlex10.1159/000545308Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410740974
W4410759318B-cell lymphoma: Advances in pathogenesis, diagnosis, and targeted therapies2025-05-26OpenAlex10.1016/j.prp.2025.156036Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410759318
W4410866745Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management2025-05-26OpenAlex10.3390/ph18060800Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410866745
W7127430772Intelligent Systems in Health: Historical Evolution, Current Development and Future Perspectives2025-05-26OpenAlex10.1109/ccece64018.2025.11364518Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127430772
W4410927362Nanosponges: In-sights into Fabrication, Design, Drug delivery and its Evolving Challenges2025-05-26OpenAlex10.71097/ijsat.v16.i2.5574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410927362
W4410740895PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy2025-05-26OpenAlex10.1007/s11523-025-01151-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410740895
W4410779171Anti-bacterial activity of dermcidin in human platelets: suppression of methicillin-resistant Staphylococcus aureus growth2025-05-27OpenAlex10.1128/spectrum.03273-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410779171
W7128625546Development of synthetic RNA-targeting catalysts from biostable nucleic acid analogues2025-05-27OpenAlex10.17863/cam.126840Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128625546
W4410780157Role of Pharmacology in Dentistry: A Review of Analgesics, Antibiotics, and Local Anesthetics2025-05-27OpenAlex10.7759/cureus.84889Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410780157
W4410775087Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study2025-05-27OpenAlex10.1016/j.leukres.2025.107719Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410775087
W4410795562A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Updated interim analysis from the NER-Tree study.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e12507Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410795562
W4410822489Actionability landscape and biomarker utility in a colorectal cancer alliance cohort: Initial results from the Know Your Biomarker program.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e15605Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410822489
W4410810994Artificial intelligence for contextual well-being: Protocol for an exploratory sequential mixed methods study with medical students as a social microcosm2025-05-28OpenAlex10.1371/journal.pone.0321426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410810994
W4410821537Biomarkertesting in metastatic colorectal cancer (mCRC): 2015-2024 trends in the United States (US) community oncology setting.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e15573Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410821537
W4410812085Chemotherapy and supportive care practice patterns among older adults with metastatic pancreatic cancer.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e16373Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410812085; https://openalex.org/W4415252437
W4410814891Dynamic Arterial Lactate Values Are Associated with 30-Day Mortality in Patients with Acute Myocardial Infarction and Cardiogenic Shock on Intra-Aortic Balloon Pump Circulatory Support2025-05-28OpenAlex10.1159/000545746Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410814891
W4410836799Editorial: Advancement in malaria treatment2025-05-28OpenAlex10.3389/fcimb.2025.1628923Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410836799
W4410802781Evaluating the benefit-risk balance of second-line therapies for HR+/HER2- metastatic breast cancer: A comparative analysis using ASCO VF and ESMO MCBS frameworks.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e13100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410802781
W4410813411Evaluating uptake of targeted agents by race/ethnicity in patients receiving first-line treatment for chronic lymphocytic leukemia (CLL).2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e13741Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410813411
W4410807847Exploring variables associated with prolonged survival in AML with TP53 aberration.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e18519Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410807847
W4410809335Genetic characteristics and clinical outcomes of driver mutant oligometastatic non small cell lung cancer treated with combination definitive chemoradiotherapy and targeted systemic therapy.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e20676Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410809335
W4410809262Immunoprevention of non-viral cancers: challenges and strategies for early intervention2025-05-28OpenAlex10.1186/s12935-025-03817-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410809262
W4413178475LLM-Guided Hybrid Architecture for Autonomous Fire Response: Dialog-Driven Planning in Space and Disaster Missions2025-05-28OpenAlex10.1109/aiiot65859.2025.11105239Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413178475
W4410830909Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors2025-05-28OpenAlex10.1007/s11912-025-01689-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410830909
W4410837540Navigating the regulatory landscape: The emergence of AI-powered compliance agents2025-05-28OpenAlex10.30574/wjarr.2025.26.2.1923Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4410837540
W4410806813NeuroGenesis Nexus: A Theoretical Framework for Nano-Enhanced, Stem Cell-Integrated Brain-Computer Interfaces for Neural Restoration2025-05-28OpenAlex10.31219/osf.io/9hck6_v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410806813
W4410821341Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker analysis.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e13068Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410821341
W4410823158Real-world outcomes for dMMR/MSI-H colorectal cancer: Navigating rapidly evolving oncologic practices in a community hospital.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e15519Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410823158
W4411170269Remimazolam in neuroanesthesia2025-05-28OpenAlex10.1097/aco.0000000000001524Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411170269
W4410805265Systematic review of BCMA-targeted therapies in relapsed/refractory (R/R) multiple myeloma (MM).2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e19528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410805265
W4410822353Targeting HER3 in NSCLC: Leveraging continuing education to bridge the gaps between evidence and practice.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e20055Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410822353
W4410827368Targets for Molecular Imaging of Neuroendocrine Tumors (NETs): An Overview and Update2025-05-28OpenAlex10.1053/j.semnuclmed.2025.04.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410827368
W7204470294The Battle Against Emerging Viruses2025-05-28OpenAlex10.4018/979-8-3693-9276-8.ch007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204470294
W4410809324Variations in PSMA PET utilization, PSA testing, and urologist involvement in advanced castrate resistant prostate cancer: Comparing academic and community practices in the US.2025-05-28OpenAlex10.1200/jco.2025.43.16_suppl.e17075Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410809324
W4410857663AI Will Offer New Opportunities for Transplantation: Are We Ready?2025-05-29OpenAlex10.1097/txd.0000000000001820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410857663
W4410859914Changes in Medical Management of Inflammatory Bowel Disease and Reducing Surgical Risk: Investigating Causality Through the Bradford-Hill Criteria2025-05-29OpenAlex10.3390/jcm14113824Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410859914
W4410872210Intelligent Automation for Streamlining Prior Authorization Workflows Integrated with EHRs Using Agentic AI2025-05-29OpenAlex10.32996/jcsts.2025.7.5.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410872210
W4410849807Precision paradigm in breast cancer management: A mini review2025-05-29OpenAlex10.1016/j.senol.2025.100703Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410849807
W4410840797Syndromic Testing in the Pandemic Era and Beyond: Rapid Detection for Respiratory Infections in Istanbul2025-05-29OpenAlex10.3390/v17060776Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410840797
W4410859268T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a New Frontier in Immunotherapy2025-05-29OpenAlex10.3390/cancers17111820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410859268
W4410849502Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision-Directed Delta-Like Ligand-3 Therapies2025-05-29OpenAlex10.1200/edbk-25-472794Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410849502
W4410869689The evolution of generative AI in conversational systems: advancing chatbots and CCAI for Next-Gen Business Intelligence2025-05-29OpenAlex10.30574/gjeta.2025.23.2.0161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410869689; https://openalex.org/W7107949065
W4411777759Uncertain Terrain2025-05-29OpenAlex10.1093/cid/ciaf283Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411777759
W4410884716Conformance to the National List of Essential Medicines 2022 in a government tertiary care hospital2025-05-30OpenAlex10.1016/j.jhqr.2025.101141Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410884716
W4410902811Harnessing Machine Learning for Agnostic Biodetection2025-05-30OpenAlex10.1089/hs.2024.0075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410902811
W4410877446Refining outcome measures in multiple sclerosis clinical trials: A call to action2025-05-30OpenAlex10.1016/j.msard.2025.106558Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410877446
W4410893230Strategies for Ovarian Cancer After PARP Inhibitor Maintenance2025-05-30OpenAlex10.1097/01.cot.0000000000000070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410893230
W7169792916The Immunomodulatory Potential of Normothermic Liver Perfusion: Reconditioning the Graft's Immune Profile Before Transplantation2025-05-30OpenAlex10.26524/amr.2025.3.5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169792916
W4411682089A Comparative Study of Veterans’ Affairs Systems in Korea and the United States2025-05-31OpenAlex10.35227/hylr.2025.5.36.2.3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411682089
W4410958620A Review: Topical Gels for Localized Drug Delivery2025-05-31OpenAlex10.22214/ijraset.2025.71847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410958620
W4410909202Advances in biomaterials for wound care management: Insights from recent developments2025-05-31OpenAlex10.1016/j.cis.2025.103563Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410909202
W4411622915Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies2025-05-31OpenAlex10.1093/bjs/znaf115Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411622915
W4410922768Aerosol Measurements and Decadal Changes: The Role of Climatic Changes and How It Reflects in Respiratory Allergies and Asthma2025-05-31OpenAlex10.1111/all.16602Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410922768
W4410929733Global Multidisciplinary Collaboration in Therapeutic Cannabis Research, Regulatory and Pharmaceutical Challenges2025-05-31OpenAlex10.26538/tjnpr/v9i5.52Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410929733
W4411470051Hybrid Lipid Nanoparticles in Diabetes Management and Pancreatic Islet Regeneration2025-05-31OpenAlex10.71443/9789349552852-08Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411470051
W4410909637Infectious disease risk after the October 2024 flash flood in Valencia, Spain: Disaster evolution, strategic scenario analysis, and extrapolative baseline for a One Health assessment2025-05-31OpenAlex10.1016/j.onehlt.2025.101093Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410909637
W4411076644Power, Discourse, and the Formation of Subjectivity in Alias Grace2025-05-31OpenAlex10.17754/mesk.69.2.71Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411076644
W4411648849Progress in prevention and treatment of peritoneal metastases by cytoreductive surgery2025-05-31OpenAlex10.1093/bjs/znaf081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411648849
W4411076887“Study on Moral Patiency in Ted Chiang’s “The Lifecycle of Software Objects”2025-05-31OpenAlex10.17754/mesk.69.2.27Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411076887
W4411428084ABS0046 THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY2025-06-01OpenAlex10.1016/j.ard.2025.06.862Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411428084
W4411409950ABS1155 COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND TNF INHIBITORS IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS2025-06-01OpenAlex10.1016/j.ard.2025.06.1795Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411409950
W4411400377ABS1232-PARE PATIENT EMPOWERMENT SESIONS: BUILDING KNOWLEDGE AND EMPOWERMENT AMONG RHEUMATOID ARTHRITIS PATIENTS2025-06-01OpenAlex10.1016/j.ard.2025.06.1342Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411400377
W4410928316Achilles Tendinopathy: Epidemiology, Diagnosis, and Treatment Strategies – A Review2025-06-01OpenAlex10.12775/qs.2025.42.60456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410928316
W4411482795After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer2025-06-01OpenAlex10.1200/edbk-25-473372Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411482795
W4415260876Amiloidosi cardiaca: nuove prospettive terapeutiche2025-06-01OpenAlex10.17473/1971-6818-2025-2-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415260876
W4411139165Antimicrobial resistance and antimicrobial stewardship: an update2025-06-01OpenAlex10.33235/wpr.33.2.79-96Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411139165
W4411204464Artificial Environments in Experimental Biology2025-06-01OpenAlex10.1525/hsns.2025.55.3.287Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411204464
W4411054725Congenital Pseudarthrosis of the Tibia: A Comprehensive Literature Review2025-06-01OpenAlex10.2106/jbjs.rvw.25.00035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411054725
W4411198675Current Practice of Nuclear Medicine in Iran2025-06-01OpenAlex10.1097/nm9.0000000000000034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411198675
W4411610387Drug-Induced Uveitis: Patterns, Pathogenesis and Clinical Implications2025-06-01OpenAlex10.2147/opto.s492202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411610387
W4411388820Editorial: New Target for Skin Cancer2025-06-01OpenAlex10.1111/exd.70127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411388820
W4411227662Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implications2025-06-01OpenAlex10.1053/j.seminhematol.2025.06.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411227662
W4410968780New pieces to the jigsaw of antiplatelet treatment after acute coronary syndrome, and a focus on leadless pacing2025-06-01OpenAlex10.1093/eurheartj/ehaf320Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410968780
W4411431459OP0133 COMPREHENSIVE ANALYSIS UNVEILS POTENTIAL MECHANISMS OF MMP9 AND RNASET2 IN RHEUMATOID ARTHRITIS THROUGH GENOME-WIDE ASSOCIATION STUDIES, MENDELIAN RANDOMIZATION, AND SINGLE-CELL TRANSCRIPTOMIC2025-06-01OpenAlex10.1016/j.ard.2025.05.155Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411431459
W4411417751OP0317 ULTRASONOGRAPHIC FINDINGS IN PATIENTS WITH SEVERE DISEASE AND REFRACTORY MYOSITIS IN A COHORT OF PATIENTS WITH INFLAMMATORY MYOPATHIES2025-06-01OpenAlex10.1016/j.ard.2025.05.319Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411417751
W4411194742Operational Modes and Technical Points for Empowering Urban Park Green Spaces by Digital Technology2025-06-01OpenAlex10.3724/j.fjyl.la20240175Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411194742
W4411421124POS0523 Analysis of prescription pattern of biological and synthetic targeted disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis2025-06-01OpenAlex10.1016/j.ard.2025.05.905Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411421124
W4411059261Respiratory Support for Bronchiolitis Management in the PICU: What We Now Know and What We Want to Know2025-06-01OpenAlex10.1097/pcc.0000000000003765Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411059261
W4411937062Rewriting the prognosis of multiple sclerosis in Brazil: a 25-year perspective on evolving diagnostic criteria2025-06-01OpenAlex10.1055/s-0045-1809937Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411937062
W4411534009SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development2025-06-01OpenAlex10.1136/jitc-2024-010739Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411534009
W4411169226Speaking to Power With Power: Advocating for Your Profession2025-06-01OpenAlex10.1200/edbk-25-471872Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411169226
W4410909239The Evidence of Us2025-06-01OpenAlex10.4037/ccn2025590Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410909239
W4411695050The Origin and Development of Genetic Therapies2025-06-01OpenAlex10.1093/med/9780197689974.001.0001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411695050
W4410985027The pursuit of precision in cardiogenic shock: navigating promise, pitfalls, and a path forward2025-06-01OpenAlex10.1093/ehjacc/zuaf080Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410985027
W4412201296Traditional Chinese Medicine + artificial intelligence: Wuzhen consensus2025-06-01OpenAlex10.1097/hm9.0000000000000163Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412201296
W4410944603A Case of Refractory Hidradenitis Suppurativa Successfully Treated With Upadacitinib2025-06-02OpenAlex10.7759/cureus.85255Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410944603
W4410956945Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy2025-06-02OpenAlex10.1186/s12935-025-03824-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410956945
W4410940002Editorial: Community series in emerging insights in controlling autoimmunity, volume II2025-06-02OpenAlex10.3389/fimmu.2025.1613858Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410940002
W4410954038Efficient and accurate simulation of infectious diseases on adaptive networks2025-06-02OpenAlex10.1371/journal.pcsy.0000049Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4410954038
W4410944960Self-HealAI: Architecting Autonomous Cognitive Self-Repair2025-06-02OpenAlex10.20944/preprints202506.0063.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4410944960
W4413851646Swarm intelligence in project management decision sciences: Enhancing resource, allocation, decision making and team collaboration2025-06-02OpenAlex10.23954/osj.v10i1.3708Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413851646
W4414094720Ketamine for the Critically Ill: Case Series and Clinical Reflections2025-06-03OpenAlex10.31579/2835-7957/111Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4414094720
W7125194221Dataset and Analysis for "The Limits of Naturalness: User Perceptions of Interactional Language in Human-Computer Interaction"2025-06-04OpenAlex10.5281/zenodo.18329845Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125194221
W4411041169Editorial: Current trends in targeted and non-targeted metabolomics in analytical toxicology2025-06-04OpenAlex10.3389/fmolb.2025.1614399Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411041169
W4411021215Inorganic nanoparticle-based cancer immunotheranostics2025-06-04OpenAlex10.1016/j.ccr.2025.216848Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411021215
W4411011009What Child Neurologists Need to Know About Pediatric Glioma2025-06-04OpenAlex10.1016/j.pediatrneurol.2025.05.029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411011009
W4411045730An urgent need for diagnostic tools to address global mpox public health emergencies2025-06-05OpenAlex10.1128/jcm.01321-24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411045730
W4411046612Emerging role of peroxisome proliferator-activated receptor agonists in the treatment of cholestatic liver disease2025-06-05OpenAlex10.1097/mog.0000000000001109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411046612
W4411055812Essential Interstitial Lung Disease Management for the Primary Care Provider2025-06-05OpenAlex10.58931/cpct.2025.3138Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411055812
W4411076412Grasping Problems at the Nanoscale: Predicting the TCR Peptide Binding in T Cell Therapy for Cancer2025-06-05OpenAlex10.36227/techrxiv.174909883.34734268/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411076412
W4411362454Infection Prevention and Control2025-06-05OpenAlex10.1017/9781009052733.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411362454
W4411075207Metabolic resilience: liraglutide’s potential in alleviating depressive symptoms2025-06-05OpenAlex10.1007/s11033-025-10641-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411075207
W4411121675Reasoning About Responsibility in Autonomous Systems: Navigating the Challenges and Charting Future Directions2025-06-05OpenAlex10.71346/utj.v1i2.21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411121675
W4411057561The Trinity of Cancer, Climate, and Care: Why Oncology Needs an Ecological Lens2025-06-05OpenAlex10.1097/cr9.0000000000000075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411057561
W4411101924Editorial: Applications of AI in autonomous, surveillance, and robotic systems2025-06-06OpenAlex10.3389/frobt.2025.1616634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411101924
W4411107889Editorial: Mental health recovery: engaging and empowering people living with mental illness and their families2025-06-06OpenAlex10.3389/fpsyt.2025.1633178Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411107889
W4411101304Improving the Dosing Schedules of Targeted Anticancer Agents2025-06-06OpenAlex10.3390/ph18060848Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4411101304
W4411088841Mapping the trajectory of psychotic symptoms and their interaction with antipsychotic treatment: a longitudinal network intervention study2025-06-06OpenAlex10.1101/2025.05.28.25328478Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411088841
W4411104123New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis2025-06-06OpenAlex10.1080/17476348.2025.2517302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411104123
W4411522290Pediatric Leukemia: Advances in Diagnosis and Treatment Strategies2025-06-06OpenAlex10.47275/2379-6707-122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411522290
W4411090383Sequencing of antibody drug conjugates in breast cancer: Evidence gap and future directions2025-06-06OpenAlex10.1016/j.bbcan.2025.189369Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411090383
W7216233097AI Agents for Real-Time Operational Decision Making: Embedding Intelligence in Data Pipelines2025-06-07OpenAlex10.32996/jcsts.2025.7.5.99Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216233097
W7214154634Cardiovascular Pharmacology: Contemporary Drug Classes and Novel Peptides2025-06-09OpenAlex10.61096/978-81-981372-2-7_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214154634
W4411156465Myelofibrosis: Treatment Options After Ruxolitinib Failure2025-06-09OpenAlex10.3390/curroncol32060339Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411156465
W4411131458Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside2025-06-09OpenAlex10.1186/s12943-025-02368-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411131458
W7214228329Respiratory System Therapeutics2025-06-09OpenAlex10.61096/978-81-981372-2-7_5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214228329
W4411133193The role of L-DOPA in neurological and neurodegenerative complications: a review2025-06-09OpenAlex10.1007/s11010-025-05324-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411133193
W4411167876Advances in the understanding and management of multiple sclerosis phenotypes2025-06-10OpenAlex10.1016/j.hsr.2025.100232Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411167876
W4411191659Editorial: Current evidence on epidemiology and management of infections in critically ill patients2025-06-10OpenAlex10.3389/fpubh.2025.1584879Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411191659
W4411186482Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review2025-06-10OpenAlex10.3390/medicina61061063Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411186482
W4411379988Introduction to Medical Toxicology2025-06-10OpenAlex10.69613/tnkdfs94Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411379988
W4411186360Nanoparticles as Antimicrobial Agents: A Promising Solution Against Multidrug Resistance2025-06-10OpenAlex10.26524/nr.8.5Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411186360
W4417314731Uropathogens And Their Evolving Antimicrobial Resistance Patterns In Urinary Tract Infections: A Study From A Tertiary Care Hospital In Dhaka, Bangladesh2025-06-10OpenAlex10.70135/seejph.vi.6712Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417314731
W7134037734Community-Acquired Necrotizing Pneumonia due to Panton-Valentine Leukocidin-Producing Methicillin-Sensitive Staphylococcus aureus2025-06-11OpenAlex10.60591/crspmi.455Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134037734
W4411193586Consigning the Mapleson F Circuit to Anaesthesia’s historical archives2025-06-11OpenAlex10.4103/ija.ija_440_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411193586
W4411221803Editorial: Applications of AI, machine learning, computational medicine, and bioinformatics in respiratory pharmacology2025-06-11OpenAlex10.3389/fphar.2025.1602941Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411221803
W4411221953Editorial: Bacteria-host interactions: from infection to carcinogenesis2025-06-11OpenAlex10.3389/fcimb.2025.1634299Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411221953
W4411222010Editorial: Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies2025-06-11OpenAlex10.3389/fcimb.2025.1633037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411222010
W4411216126Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC)2025-06-11OpenAlex10.3390/ijms26125577Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411216126
W4411193972Microbial Collagenases2025-06-11OpenAlex10.1201/9781003473008-13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411193972
W4411194003Microbial Enzyme Therapeutics as Anti-Inflammatory Agents2025-06-11OpenAlex10.1201/9781003473008-5Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411194003
W4411211870Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies2025-06-11OpenAlex10.3390/scipharm93020026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411211870
W4412537410Reinforcement Learning-Driven Multi-Modal Sentiment Analysis for Personalized Drug Recommendations2025-06-11OpenAlex10.1109/icssas66150.2025.11080957Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412537410
W4411215483Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review2025-06-11OpenAlex10.3390/jcm14124128Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411215483
W7201969175Synthetic Lethality: Revisting Precision Oncology Through Functional Susceptibilities2025-06-11OpenAlex10.19080/ctoij.2025.29.556255Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201969175
W4411224561Prescribing sleep, provoking harm? rethinking Z-drugs in heart failure2025-06-12OpenAlex10.1093/eurjpc/zwaf277Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411224561
W4411238508Reflexionen zur Implementierung bevölkerungsweiter Maßnahmen zur Verhältnisprävention nichtübertragbarer Erkrankungen2025-06-12OpenAlex10.1007/s00103-025-04078-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411238508
W4411230315Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place2025-06-12OpenAlex10.1097/txd.0000000000001825Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411230315
W44112911621304-P: Trends in Use of Medications for Multifactorial Cardiovascular Risk Factor Intervention in Adults with Diabetes in Hong Kong, 2002–20192025-06-13OpenAlex10.2337/db25-1304-pTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411291162
W4411286203Abstract P1-04-03: Model-predicted Neurokinin-1 (NK1) Receptor Occupancy of Netupitant versus Aprepitant Over an Extended Time Period: Implications for Controlling Nausea and Vomiting Associated with Antibody-Drug Conjugates (ADCs)2025-06-13OpenAlex10.1158/1557-3265.sabcs24-p1-04-03Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411286203
W4411292190Abstract P1-12-27: Clinical Case Vignette: Estrogen Receptor Targeting PET Imaging to Monitor Treatment Response to Endocrine Therapy in Lobular Breast Cancer2025-06-13OpenAlex10.1158/1557-3265.sabcs24-p1-12-27Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411292190
W4411285790Abstract P4-10-08: Impact of an Online Educational Activity on Oncologists’ Knowledge and Confidence Regarding the Management of HR-Positive/HER2-Negative Metastatic Breast Cancer2025-06-13OpenAlex10.1158/1557-3265.sabcs24-p4-10-08Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411285790
W4411290286Abstract RF1-04: Long-Term Follow-up and updated analysis from S0221, Comparing Alternative Dose-Schedules of Adjuvant Anthracycline/Taxane Therapy in High-Risk Early Breast Cancer2025-06-13OpenAlex10.1158/1557-3265.sabcs24-rf1-04Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411290286
W4411284042Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field2025-06-13OpenAlex10.3390/jcm14124204Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411284042
W4411281257Comprehensive review of fungal pathogenesis and antifungal therapeutics2025-06-13OpenAlex10.1007/s44337-025-00297-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411281257
W4411292521Editorial: Multi-target drug discovery and design for complex health disorders2025-06-13OpenAlex10.3389/fphar.2025.1633600Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411292521
W4411389844Histotechnology of Mineralised Tissues: Principles and Practical Approaches for Clinical and Research Applications2025-06-13OpenAlex10.9734/bpi/msraa/v6/5724Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411389844
W4411255865Novel Drug Strategies in Kidney Transplantation2025-06-13OpenAlex10.1007/s40472-025-00479-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411255865
W4411278169SIU-ICUD: Management of Lymph Node–Positive Prostate Cancer2025-06-13OpenAlex10.3390/siuj6030046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411278169
W4417331001184185Chapter 10 Revolutionizing interaction with AI-driven enhancements in AR and VR2025-06-14OpenAlex10.1515/9783111388588-010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417331001
W4411312298Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review2025-06-14OpenAlex10.1177/20499361251343969Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411312298
W4411307910Analyzing clinical trials on diabetic retinopathy: Insights from the Clinical Trials Registry - India2025-06-14OpenAlex10.4103/picr.picr_69_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411307910
W4411301022Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?2025-06-14OpenAlex10.1080/17474086.2025.2519002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411301022
W4411352598Biological Potential of Extremophilic Filamentous Fungi for the Production of New Compounds with Antimicrobial Effect2025-06-14OpenAlex10.3390/fermentation11060347Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411352598
W4411394319Rich Data Versus Quantity of Data in Code Generation AI: A Paradigm Shift for Healthcare2025-06-15OpenAlex10.30953/bhty.v8.396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411394319
W4411336082Building the TacMed Chatbot to Support Medical Education in Low-Resource Settings: A Low-Code Platform Approach2025-06-16OpenAlex10.55157/conductscience-proceedings.v2i1.05Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411336082
W4411327200Current trends in neurocritical care: a comprehensive review2025-06-16OpenAlex10.18700/jnc.240034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411327200
W4411442528Mutation in Media and Popular Culture2025-06-16OpenAlex10.5204/mcj.3182Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411442528
W4411742526Optimizing Insulin Dosing and Predicting Glucose Levels for Type 1 Diabetes Management Using Reinforcement Learning (Preprint)2025-06-16OpenAlex10.2196/preprints.79195Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411742526
W4411340876The resurrection of apomorphine: A dopamine analogue comparable in potency to L-DOPA2025-06-16OpenAlex10.1016/j.parkreldis.2025.107923Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411340876
W4411363063Early Emicizumab Treatment in Acquired Hemophilia A: Impact on Bypassing Agent Use and Length of Hospitalization in an Australian Single-Center Cohort2025-06-17OpenAlex10.1055/a-2622-3483Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411363063
W4411671259Editorial: Hepatocellular carcinoma: from diagnostic approaches to surgical and systemic therapies2025-06-17OpenAlex10.3389/fmed.2025.1633587Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411671259
W4411370492Evolution of Treatment for Autoimmune Pancreatitis: Recent Advancements2025-06-17OpenAlex10.1007/s11938-025-00476-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411370492
W4411715193Lipid-lowering agents in solid organ transplant recipients2025-06-17OpenAlex10.1093/ndt/gfaf104Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411715193
W4411401497An Overview of Advancements in the Bone Metastases in Endocrine Cancers: From Molecular Insights to Clinical Applications2025-06-18OpenAlex10.47275/2690-5663-145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411401497
W4411395258Integrating Hematopoietic Stem Cell Transplantation (HSCT) and Targeted Antibody-Drug Conjugates (ADCs) in Leukemia Treatment: Current Landscape, Translational Advances, and Emerging Therapeutic Horizons2025-06-18OpenAlex10.33425/2689-1069.1064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411395258
W4416742947Noise, doubt, empathy or surprise? A qualitative collective self-study exploring the phenomenon of disruption in clinical trials2025-06-18OpenAlex10.56883/aijmt.2025.616Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416742947
W4411458140Surgical Management of Oligometastatic Non-Small Cell Lung Cancer2025-06-18OpenAlex10.3390/cancers17122040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411458140
W4411416824Think FAST: a novel framework to evaluate fidelity, accuracy, safety, and tone in conversational AI health coach dialogues2025-06-18OpenAlex10.3389/fdgth.2025.1460236Full textIncludedIncluded: Human review of prior service conversations leads to retained shared task-component refinements used by the clinical conversational agent.https://openalex.org/W4411416824https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1460236/full
W4411395624Thymic epithelial tumors: what’s new and what’s next?2025-06-18OpenAlex10.1016/j.esmorc.2025.100024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411395624
W4411420584Use of Daptomycin to Manage Severe MRSA Infections in Humans2025-06-18OpenAlex10.3390/antibiotics14060617Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411420584
W7162372042Αξιολόγηση αναλυτικού αλγόριθμου ανακατασκευής εικόνας σε δυναμική απεικόνιση τομογραφίας εκπομπής ποζιτρονίου μικρών ζώων2025-06-18OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162372042
W44114347992025 Southeastern Surgical Congress Presidential Address: Leadership and Innovation in Surgery: A Vision for the Future2025-06-19OpenAlex10.1177/00031348251350999Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411434799
W4411448740Current landscape of frontline and relapsed follicular lymphoma trials2025-06-19OpenAlex10.1016/j.bneo.2025.100131Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411448740
W4411452673NMR Relaxometry Across Time: From Early Insights to Emerging Directions2025-06-19OpenAlex10.1002/mrc.70002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411452673
W4412098131Squamous Cell Carcinoma of the Scalp: A Case Report2025-06-19OpenAlex10.36347/sjmcr.2025.v13i06.042Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412098131
W4415159087The Convergence of Emerging Technologies and AI-Driven Autonomous Cybersecurity in Smart Digital Ecosystems2025-06-19OpenAlex10.1109/smartblock4health64843.2025.11189602Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415159087
W4411464535Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients2025-06-19OpenAlex10.3389/frhem.2025.1609642Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411464535
W7160683984Yeni nesil hücresel ağlarda yapay zeka destekli dinamik öncelikli kaynak tahsisi2025-06-19OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160683984
W4411544131Anti-CASPR2 meningoencephalitis with thickened dura mater induced by various infections: A case report and literature review2025-06-20OpenAlex10.1097/md.0000000000042873Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411544131
W4412724959Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 20252025-06-20OpenAlex10.1097/mnh.0000000000001094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412724959
W4411528344EAISE: A Simulation Environment for Self-Evolving Embodied AI with Mirror Testing and Multi-Agent Diagnostics2025-06-20OpenAlex10.20944/preprints202506.1700.v1Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W4411528344
W4415003882Enhancing Medical Lung X-Ray Diagnosis Through Multi-Agent Vision-Language Model Collaboration2025-06-20OpenAlex10.1109/caibda65784.2025.11182822Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4415003882
W4411487901From Headache to Heart Health: Investigating the Migraine–Cardiovascular Disease Connection2025-06-20OpenAlex10.1007/s40120-025-00785-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411487901
W7207511585Investigating the Combined Efficacy of Targeted Therapy and Immune Checkpoint Blockade in Anaplastic Thyroid Carcinoma2025-06-20OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7207511585
W4411754089Poly- L- Lactic Acid in Aesthetic Dermatology: A Decade Beyond Volume Restoration Toward Regenerative Biostimulation2025-06-20OpenAlex10.1093/asj/sjaf121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411754089
W4411847040Rituximab-induced persistent hypogammaglobulinemia in children with nephrotic syndrome: common or rare?2025-06-20OpenAlex10.1093/ndt/gfaf103Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411847040
W4414355074The Role of AI, Generative AI, AI Agents, RAG in Advancing Affordable Healthcare Systems2025-06-20OpenAlex10.26562/ijirae.2025.v1206.02Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4414355074
W4411763924The hidden curriculum: a theoretical exploration in pharmacy education2025-06-20OpenAlex10.1093/ijpp/riaf043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411763924
W4411485496Virulence Factors and Molecular Identification of Candida Species Causing Candidemia in Honduras2025-06-20OpenAlex10.3390/jof11070470Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411485496
W4411515056Conversational GenAI agents in mobile health and fitness apps2025-06-21OpenAlex10.30574/wjaets.2025.15.3.1100Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4411515056
W4411569371Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review2025-06-21OpenAlex10.3390/molecules30132686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411569371
W4411516751Recurrent Chyluria Revisited: Lymphangiographic Diagnosis of Pyelolymphatic Fistula With Insights on Endolymphatic Interventions2025-06-21OpenAlex10.7759/cureus.86470Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411516751
W4411528290A Self-Correcting Multi-Agent Framework for Language-Based Physics Simulation and Explanation2025-06-22OpenAlex10.31224/4723Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4411528290
W4411529782COVID-19 management in patients with comorbid conditions2025-06-22OpenAlex10.5501/wjv.v14.i2.102674Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411529782
W4411522285From “time is brain” to “time is collaterals”: updates on the role of cerebral collateral circulation in stroke2025-06-22OpenAlex10.1007/s11239-025-03135-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411522285
W4411569029Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives2025-06-22OpenAlex10.3390/biomedicines13071525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411569029
W4411607063Sphenopalatine Ganglion Blocks in Headache Management: A Review2025-06-22OpenAlex10.3390/brainsci15070672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411607063
W4411558443Systemic Therapy for Unresectable Hepatocellular Carcinoma: Current Landscape and Future Directions2025-06-22OpenAlex10.3390/ijms26135994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411558443
W4415180812Architecting Secure Smart Infrastructures with AI Microservices and Autonomous Agents: A State-of-the-Art Review and Healthcare Use Case2025-06-23OpenAlex10.1109/blackseacom65655.2025.11193935Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415180812
W4411545358Evolving Options and Views on Anal Dysplasia2025-06-23OpenAlex10.1055/s-0045-1809904Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411545358
W4411563787Gastric cancer: from biomarkers to functional precision medicine2025-06-23OpenAlex10.1016/j.molmed.2025.05.007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411563787
W4411548606Internal Balance and Behavior: An Interdisciplinary Reading from Maimonides and Neurophysiology2025-06-23OpenAlex10.22541/au.175070787.71694259/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411548606
W4411567810JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions2025-06-23OpenAlex10.3390/biomedicines13071527Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411567810
W4411532925New treatments in atopic dermatitis update2025-06-23OpenAlex10.1016/j.anai.2025.06.020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411532925
W4411548645The Evolution and Diversification of Proteasome Inhibitors in Cancer and Beyond2025-06-23OpenAlex10.26434/chemrxiv-2025-v5w42Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411548645
W7112442365The Only Constant Is Change: The Role of Genetic Diversification in Cancer and Beyond2025-06-23OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7112442365
W4411593067A new era for radium-223? Optimizing treatment by balancing efficacy and toxicity through combination therapies2025-06-24OpenAlex10.1016/j.critrevonc.2025.104819Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411593067
W4411605124Cardio-Oncology: Cardiovascular Risk and Surveillance in Cancer Therapy2025-06-24OpenAlex10.58830/ozgur.pub780.c3259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411605124
W4411597762Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approach2025-06-24OpenAlex10.1016/j.inpsyc.2025.100107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411597762
W4411582670Covalent organic frameworks: Prospects and potential in tumor diagnosis and therapy2025-06-24OpenAlex10.1016/j.cej.2025.165302Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411582670
W7220587139EDUCAÇÃO EM SAÚDE E PREVENÇÃO DE INFECÇÕES EM ACADEMIAS: REFLEXÕES A PARTIR DE UM PROJETO INTEGRADOR NO CURSO DE MEDICINA: INFECTION PREVENTION IN FITNESS CENTERS: REFLECTIONS FROM A MEDICAL SCHOOL INTEGRATIVE PROJECT2025-06-24OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220587139
W4411742347Evolutionary Perspective of Drug Eluting Stents: From Thick Polymer to Polymer-Free Approach2025-06-24OpenAlex10.69968/ijisem.2025v4i2379-389Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411742347
W4412972828Falling Behind In The Fight: The Persistent And Evolving Threat Of Pseudomonas Aeruginosa In Healthcare And Ecosystems2025-06-24OpenAlex10.64252/a9ggyc08Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412972828
W4411613535GLP-1RA may open a new era for MASLD treatment: Editorial on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study”2025-06-24OpenAlex10.3350/cmh.2025.0628Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411613535
W7217113988In dialogue with the vampire: influence of Bram Stoker’s Dracula on twentieth and twenty-first century vampire tropes2025-06-24OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7217113988
W4411597957Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy2025-06-24OpenAlex10.1093/oncolo/oyaf175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411597957
W4411651582Metabolic syndrome adversely impacts mortality from steatotic liver disease2025-06-24OpenAlex10.1093/eurjpc/zwaf364Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411651582
W4411586371Pharmacologic options for the treatment of overweight and obesity2025-06-24OpenAlex10.1097/gme.0000000000002573Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411586371
W7215268539Pharmacological Strategies in the Management of Chronic Heart Failure: Advances and Clinical Perspectives2025-06-24OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215268539
W4411580454Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019–2021)2025-06-24OpenAlex10.1128/jcm.00027-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411580454
W4411580535SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes2025-06-24OpenAlex10.3389/fendo.2025.1601633Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411580535
W4411575833The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types2025-06-24OpenAlex10.1038/s43018-025-00990-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411575833
W4411606918Zinc-dependent mechanisms of reparative regeneration: theoretical aspects and translational perspectives2025-06-24OpenAlex10.17816/rcf660184Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411606918
W4411626590Agentic Artificial Intelligence: The Power to Change Medicine and Our World2025-06-25OpenAlex10.1016/j.jacr.2025.06.032Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W4411626590
W4411918282Antiplatelet Therapy in Heart Disease2025-06-25OpenAlex10.31083/rcm36522Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411918282
W7219366835Assessment of Antidiabetic Potential Using Melia azedarach fruit Extract2025-06-25OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7219366835
W4411639641Carbon-Dot-Zn 2+ Assembly Hybrid Multifunctional Hydrogels for Synergistically Monitoring Local Glucose and Repairing Diabetic Wound2025-06-25OpenAlex10.1021/acsami.5c06293Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411639641
W4411662119Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy2025-06-25OpenAlex10.3389/fimmu.2025.1604395Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411662119
W4411626614Clinical trial landscape for pneumonia: Evolving agents against bacterial pathogens2025-06-25OpenAlex10.1016/j.ijid.2025.107965Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4411626614
W4411627122Monoclonal antibodies: their place in applied medicine and their role in the newest infectious disease – history, present, and future. Literature review2025-06-25OpenAlex10.3897/pharmacia.72.e159772Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411627122
W7220128781Negotiating Trust, Identity, and Responsibility: Clinicians’ Experiences with AI-Assisted Diagnosis in Digital Healthcare Settings2025-06-25OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220128781
W4411642284Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications2025-06-25OpenAlex10.1136/heartjnl-2024-325249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411642284
W4411700885The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions2025-06-25OpenAlex10.3390/cancers17132143Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411700885
W4411918249Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines2025-06-26OpenAlex10.31083/rcm39233Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411918249
W4411699079Editorial: Application of PKPD modeling in drug discovery and development2025-06-26OpenAlex10.3389/fphar.2025.1614689Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411699079
W4411690558Efficacy and safety of obinutuzumab in active lupus nephritis2025-06-26OpenAlex10.1093/ckj/sfaf161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411690558
W4411680704Incorporating novel therapies into the treatment of older patients with classic Hodgkin lymphoma2025-06-26OpenAlex10.1080/17474086.2025.2526685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411680704
W4411682894Ivabradine: Evolving role as an antiarrhythmic agent2025-06-26OpenAlex10.1016/j.hrthm.2025.06.039Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4411682894
W4411674565The microbiome of the sucking louse Linognathus stenopsis (Phthiraptera, Anoplura, Linognathiidae)2025-06-26OpenAlex10.1093/jme/tjaf060Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411674565
W4412037355‘4 Ss’ for successful blood pressure control2025-06-26OpenAlex10.1097/hjh.0000000000004054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412037355
W4411730060Bipolar disorder: Systematic review of approved psychiatric medications (2008–2024) and pipeline Phase-3 medications2025-06-27OpenAlex10.1016/j.jad.2025.119778Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411730060
W4411716778Contributors2025-06-27OpenAlex10.1215/00265667-11859149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411716778
W4411732856HX01 Avicenna: an influence on modern dermatology2025-06-27OpenAlex10.1093/bjd/ljaf085.464Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411732856
W4411732744HX22 Shining a light on dermatology2025-06-27OpenAlex10.1093/bjd/ljaf085.485Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411732744
W4411733549HX24 Battle scars: the role of dermatology in war, both past and present2025-06-27OpenAlex10.1093/bjd/ljaf085.487Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411733549
W4411715869Leading Lung Cancer Experts Highlight Hot Topics in Immunotherapy2025-06-27OpenAlex10.1097/01.cot.0000000000000116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411715869
W4411739427Low-intensity behavioral activation smartphone app to support low mood: description, engagement and log data analysis2025-06-27OpenAlex10.20935/mhealthwellb7785Full textExcludedF4: The behavior-activation app retains personal activity/progress logs for the same user. Analysis of those logs informs future product development, without an implemented shared cross-case agent update (P1).https://openalex.org/W4411739427https://doi.org/10.20935/MHealthWellB7785original publisher full Methods and app/agent description
W4413321990Super-Ellipse Control Barrier Functions for Enhanced Obstacle Avoidance in Complex Multi-Agent Environments2025-06-27OpenAlex10.1109/icras65818.2025.11108843Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4413321990
W4411711107Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema2025-06-27OpenAlex10.1016/j.ejmech.2025.117909Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411711107
W4412389924The Evolving Role of Alkylating Agents in Multiple Myeloma: From the Past and Present to Next-Generation Peptide Drug Conjugates2025-06-27OpenAlex10.36000/hbt.oh.2025.24.180Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412389924
W4411744728Artificial Intelligence in Healthcare: A Systematic Review of Virtual Healthcare Assistants2025-06-28OpenAlex10.9734/ajpas/2025/v27i7776Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411744728
W4411746524Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia2025-06-28OpenAlex10.1177/20406207251351086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411746524
W4413345543Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies2025-06-28OpenAlex10.1093/pcmedi/pbaf021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413345543
W4411776219BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.2025-06-29OpenAlex10.4084/mjhid.2025.053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411776219
W7128528194Beyond Traditional AI: A Comprehensive Study of Agentic Frameworks and Their Impact2025-06-29OpenAlex10.38124/ijsrmt.v4i6.1044Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7128528194
W4411842761Integrating 5PL Frameworks with Drone-Based Last-Mile Delivery: A Model for Future-Ready Logistics2025-06-29OpenAlex10.55121/tdr.v3i1.449Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4411842761
W4414723260CDA Formulations to Remove Cancer as the Top Killers of Many Asian Countries2025-06-30OpenAlex10.70818/apjcr.v02i02.028Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414723260
W7217065476CLINICAL OUTCOMES OF IMMUNOTHERAPY IN STAGE IV NON-SMALL CELL LUNG CANCER PATIENTS2025-06-30OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7217065476
W4411802175Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions2025-06-30OpenAlex10.3390/jcm14134631Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411802175
W4413403801Efficacy of Disinfectants Against Pathogenic Bacteria in Intensive Care Units of Abadan and Khorramshahr Hospitals, Iran2025-06-30OpenAlex10.34172/ajcmi.3617Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413403801
W4411780233Escitalopram-associated Cutaneous Reactions: Insights from a Case Series2025-06-30OpenAlex10.4103/jopsys.jopsys_57_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411780233
W4413067785Intelligent Agents for Healthcare Complaint Management: Ensuring Compliance with HIPAA and Medicare Standards2025-06-30OpenAlex10.14445/22312803/ijctt-v73i6p111Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413067785
W4413869062OVERVIEW OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CLOSTRIDIODIOIDES DIFFICILE-ASSOCIATED INFECTION2025-06-30OpenAlex10.32345/2664-4738.2.2025.18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413869062
W4411834249Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial2025-06-30OpenAlex10.1038/s41375-025-02674-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411834249
W4411953220Pulmonary aspergillosis in patients with asthma2025-06-30OpenAlex10.3855/jidc.20711Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411953220
W4411788278Therapeutic horizons in metabolic dysfunction–associated steatohepatitis2025-06-30OpenAlex10.1172/jci186425Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411788278
W7217371811Transformative learning as a catalyst for People Living with HIV (PLHIV): A qualitative conceptual framework2025-06-30OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217371811
W4414928440A clinical viewpoint on the EASO grade-based pharmacological algorithm for obesity management2025-07-01OpenAlex10.1093/obendo/wjaf010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414928440
W4412627974A rare complication of DRESS syndrome in the treatment of cardiac device-related lead thrombus and infective endocarditis2025-07-01OpenAlex10.1016/j.clinme.2025.100353Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412627974
W4413641306Antimicrobial resistance: A call to action for the medical community2025-07-01OpenAlex10.4103/cmrp.cmrp_101_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413641306
W4411864374Cardiovascular risk management beyond statins: review of new therapies available in Italy2025-07-01OpenAlex10.1186/s43044-025-00660-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411864374
W4412915040Co-creating Value in Mental Health: A Business Development Perspective on Mental Health Professionals’ Partnerships with Social Media and Artificial Intelligence Platforms in India2025-07-01OpenAlex10.4103/jmhhb.jmhhb_77_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412915040
W4414578881Current state and future of nonsurgical management of metastatic liver tumors2025-07-01OpenAlex10.4103/jcrt.jcrt_192_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414578881
W4411963290Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]2025-07-01OpenAlex10.2147/blctt.s549780Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411963290
W4411991822Deep learning-based multimodal data fusion in bone tumor management: Advances in clinical decision support2025-07-01OpenAlex10.1016/j.intonc.2025.06.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411991822
W4411846202Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting2025-07-01OpenAlex10.1186/s40364-025-00803-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411846202
W4413236670Evasion of complement and amyloid-beta by the neurotropic pathogen Borrelia burgdorferi in human 3D cultures2025-07-01OpenAlex10.1016/j.imbio.2025.152928Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413236670
W7163029007Green-synthesized titanium dioxide nanoparticles via spirulina extract: X-ray diffraction profiling and radiological imaging prospects2025-07-01OpenAlex10.33545/26644436.2025.v8.i3c.548Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163029007
W4412885553International Journal of Healthcare Quality, Patient Centeredness, and Safety (IJHQPCS)2025-07-01OpenAlex10.4103/ijhqpcs.ijhqpcs_43_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412885553
W4414436704International law and the challenge of populism2025-07-01OpenAlex10.1093/lril/lraf018Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414436704
W4413820200Journal Club: Quarterly Round-up of Notable Articles (June 2025 to July 2025)2025-07-01OpenAlex10.4103/cids.cids_24_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413820200
W4413473810Liposomal Medicine Drug Delivery Systems from Concept to Clinical Operation2025-07-01OpenAlex10.47583/ijpsrr.2025.v85i7.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413473810
W4412556093Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria2025-07-01OpenAlex10.1177/20499361251356057Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412556093
W4413969931MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians2025-07-01OpenAlex10.59556/japi.73.1058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413969931
W4412443092MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR2025-07-01OpenAlex10.1016/j.jval.2025.04.1160Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412443092
W4413141291Machine Learning and Artificial Intelligence in Nanomedicine2025-07-01OpenAlex10.1002/wnan.70027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413141291
W7139129275Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy2025-07-01OpenAlex10.4103/aptj.aptj_26_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139129275
W4416534812Monoclonal antibodies in 2025: From milestones to new frontiers2025-07-01OpenAlex10.4103/ijc.ijc_9_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416534812
W4412124266Moving the needle on immune checkpoint inhibitors with novel targets: are we being TIMid or LAGging behind?2025-07-01OpenAlex10.1093/oncolo/oyaf145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412124266
W4411895246Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer2025-07-01OpenAlex10.1007/s12672-025-02796-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411895246
W4411900738New Tools and Targets: Optimizing Emergency Care for Neurotrauma Patients2025-07-01OpenAlex10.1097/01.eem.0000000000000059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411900738
W4411856165New horizons in systemic sclerosis treatment: advances and emerging therapies in 20252025-07-01OpenAlex10.1136/rmdopen-2025-005776Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411856165
W4412901535New progress and challenges of targeted therapies for breast cancer2025-07-01OpenAlex10.21037/apm-25-30Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412901535
W7129343124Next-Generation Therapeutics for Perianal Fistulizing Crohn’s Disease: The Anticipated Impact of IL-23 Inhibitors2025-07-01OpenAlex10.4103/hjhs.hjhs_50_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129343124
W7155520803Oncologic Surgery in the Era of Targeted Therapy: Beyond the Scalpel2025-07-01OpenAlex10.4103/sd.sd_2_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155520803
W7124655394Orthopaedic oncology: Innovative treatment modalities for bone tumours in children2025-07-01OpenAlex10.22271/27078345.2025.v7.i2b.323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124655394
W4412403511P37 Retrospective analysis of the microbiological structure of pathogens in severe lung lesions.2025-07-01OpenAlex10.1093/jacamr/dlaf118.044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412403511
W4412976953Pyrimidine‐Based Scaffolds: Emerging Frontiers in Antimicrobial Drug Discovery2025-07-01OpenAlex10.1002/slct.202500907Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412976953
W4412507742Research Trends and Knowledge Mapping of Opioid-Free Anesthesia: A Global Bibliometric Analysis2025-07-01OpenAlex10.2147/jmdh.s533687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412507742
W4417185328Response to “Pemphigus vulgaris and lichen planus pigmentosus in an HIV-positive patient”2025-07-01OpenAlex10.4103/ijstd.ijstd_62_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417185328
W4411851797Shaping the Future of Stroke Management: Latest Innovations and Discoveries2025-07-01OpenAlex10.32894/kjms.2025.161005.1162Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411851797
W4414022688Strategies employed by tumor cells to evade immune surveillance and immunotherapeutic interventions: A comprehensive review2025-07-01OpenAlex10.22271/letters.2025.v5.i2b.146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414022688
W4412109964Surgical audience focused on multimodality treatment for lung cancer2025-07-01OpenAlex10.1093/icvts/ivaf151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412109964
W4411993998Targeted Therapy in NSCLC: A Comprehensive Review of Molecular Drivers and Treatment Strategies2025-07-01OpenAlex10.12775/qs.2025.43.61191Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411993998
W7134057618The Excesses of Cosmetic Medicine2025-07-01OpenAlex10.4103/ijt.ijt_4_24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134057618
W7115184572The Rise of Dalbavancin in MRSA and Skin Infections – A Review of Therapeutic Benefits2025-07-01OpenAlex10.33545/26647613.2025.v7.i2h.158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7115184572
W4414045740The evolving landscape of generative AI: Architectures, Applications, and ethical governance in 2024-20252025-07-01OpenAlex10.33545/27075923.2025.v6.i2a.96Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414045740
W4412519729The role of ocular pathology and ocular microbiology in ophthalmology2025-07-01OpenAlex10.4103/hjo.hjo_2_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412519729
W4413194176Transforming sarcoma treatment: The role of genomic profiling and immunotherapy2025-07-01OpenAlex10.4103/crst.crst_44_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413194176
W4412631614Treatment of Chronic Migraine and Medication Overuse Headache2025-07-01OpenAlex10.1093/med/9780190888770.003.0021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412631614
W4412473749Ultrasound-guided strategies in ulcerative colitis: early prediction and targeting2025-07-01OpenAlex10.1093/ecco-jcc/jjaf113Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412473749
W4412693824Understanding and Managing Antineoplastic and Antiretroviral Therapy2025-07-01OpenAlex10.1093/med/9780197812631.003.0026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412693824; https://openalex.org/W4386613523
W7133510588Unmasking Nature’s Deceit: A Systematic Review of Biological Deception Across Pathogens, Viruses, and Genetic Systems2025-07-01OpenAlex10.25163/microbbioacts.8110417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133510588
W4413941935Unveiling the Leptomeningeal Labyrinth: Insights Into Outer Pial Layer and Subarachnoid Lymphoid Interface2025-07-01OpenAlex10.4103/njca.njca_143_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413941935
W4411945774A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapy2025-07-02OpenAlex10.1097/bs9.0000000000000239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411945774
W7221774847ESG IMPACT Environment, Social, and Governance2025-07-02OpenAlex10.20473/aup.1566Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221774847
W4411968118Harnessing the power of nanotechnology and intelligent wound dressings to transform sports injury recovery and healing2025-07-02OpenAlex10.1016/j.jddst.2025.107240Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411968118
W4411932834Proline-Mediated Enhancement in Evolvability of Disulfide-Rich Peptides for Discovering Protein Binders2025-07-02OpenAlex10.1021/jacs.5c07075Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4411932834
W4412004157An organizational theory for multi-agent interactions integrating human agents, LLMs, and specialized AI2025-07-03OpenAlex10.1007/s10791-025-09667-2Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4412004157
W4411947812Editorial: Community series in trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease, volume II2025-07-03OpenAlex10.3389/fimmu.2025.1644278Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411947812
W4412009832Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies2025-07-03OpenAlex10.3390/cancers17132228Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412009832
W4411984265Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review2025-07-03OpenAlex10.1007/s10067-025-07548-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4411984265
W4415686329Mezigdomide for multiple myeloma: a focus on phase 2 trial data2025-07-03OpenAlex10.1080/14728214.2025.2575570Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415686329
W4412091366Narcotics through time: exploring historical origins, synthetic advances, and clinical progress2025-07-03OpenAlex10.1080/17568919.2025.2527606Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412091366
W4412017190Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC2025-07-04OpenAlex10.1007/s15010-025-02575-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412017190
W4412013832Ghrelin peptide in heart failure: when is showtime?2025-07-04OpenAlex10.3389/fcvm.2025.1574521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412013832
W4412727974Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan2025-07-04OpenAlex10.1097/mnh.0000000000001101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412727974
W4412042075[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review2025-07-04OpenAlex10.1053/j.semnuclmed.2025.06.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412042075
W4412054607Mechanisms and Therapeutic Applications of β‐Cyclodextrin in Drug Solubilisation and Delivery Systems2025-07-05OpenAlex10.1002/cbdv.202500359Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412054607
W4412056870Role of Interventional Radiology as the First-line Management in Unruptured Giant Hepatic Hemangiomas2025-07-05OpenAlex10.4103/jmms.jmms_76_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412056870
W4412149489Theory and Mechanism in Novel Drug Delivery Technologies2025-07-05OpenAlex10.59646/ddt/400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412149489
W7106320633251Chapter 8 Clinical frontiers and regulatory status of micro/nanoemulsions2025-07-07OpenAlex10.1515/9783111593654-009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106320633
W7218051725Computer Aided Drug Discovery Driven Approaches for Discovery of Antimicrobial Agents2025-07-07OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218051725
W4412069514Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: a comprehensive literature review of a rare retinal vasculopathy2025-07-07OpenAlex10.1186/s12886-025-04236-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412069514
W4412091127Non-Invasive Caries Control: Role of Silver Diamine Fluoride in Arresting Early Childhood Caries - A Narrative Review2025-07-07OpenAlex10.21275/sr25703101306Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412091127
W4412202495Perspective Chapter: Metabolic Dysfunction-Associated Steatotic Liver Disease as an Emerging Cardiovascular Risk Factor – Pathophysiology, Implications and Clinical Perspectives2025-07-07OpenAlex10.5772/intechopen.1011513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412202495
W4413679715AI Agents for Clinical Data Assessment: Enhancing Decision-Making with Human-AI Collaboration2025-07-08OpenAlex10.1109/compsac65507.2025.00296Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413679715
W4412154795Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat2025-07-09OpenAlex10.3390/cancers17142290Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412154795
W4412182432A Historical Revision on The Evolution of Purpura Fulminans Management Since 19952025-07-10OpenAlex10.20944/preprints202507.0923.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412182432
W4412172829AI-Facilitated Cognitive Reappraisal via Socrates 2.0: A Mixed Methods Feasibility Study (Preprint)2025-07-10OpenAlex10.2196/preprints.80461Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4412172829
W4412161602Current Application of Mineralocorticoid Antagonist (MRA) in Heart Failure and CKD: Does Non-Steroidal Drug Add Novel Insights2025-07-10OpenAlex10.3390/biomedicines13071693Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412161602
W4412177655Cytomorphology of Renal Hydatid Cyst Mimicking as Simple Renal Cyst2025-07-10OpenAlex10.1111/cyt.70008Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412177655
W4412182975Lipid-mediated GPR32 signaling reprograms macrophage metabolism to impair anti-tuberculous immunity2025-07-10OpenAlex10.1101/2025.07.07.663524Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412182975
W4412166231Nanocarriers in Cancer Immunotherapy2025-07-10OpenAlex10.1201/9781003473183-14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412166231
W4412154774Precision medicine and the expanding perioperative role by Anaesthesiologists2025-07-10OpenAlex10.4103/ija.ija_581_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412154774
W4412154766Recent Progress of Nanomedicine for the Synergetic Treatment of Radiotherapy (RT) and Photothermal Treatment (PTT)2025-07-10OpenAlex10.3390/cancers17142295Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412154766
W7224051053Toque Afetivo, Corregulação Emocional e Satisfação Conjugal - Um Estudo Qualitativo Diádico2025-07-10OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224051053
W4412913498What is Your Suspected Diagnosis? A Challenging Case of Unilateral Ptosis with Eyelid Edema in a Pediatric Patient2025-07-10OpenAlex10.52338/jocp.2025.4930Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412913498
W4412201742XPS Monitoring of Calcarenite Building Walls Long Exposed Outdoors: Estimation of Deterioration Trend from the Time Sequence of Curve-Fitted Spectra and PCA Exploration of the Large Dataset2025-07-10OpenAlex10.3390/app15147741Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412201742
W7106536719DERIVATIVES OF INDOLE2025-07-11OpenAlex10.58532/nbennurfrt36Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106536719
W4412350512Immunomodulation in Autoimmune Disorders2025-07-11OpenAlex10.1002/9781394313785.ch9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412350512
W4412188141Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines2025-07-11OpenAlex10.1002/adma.202508047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412188141
W4412200834THE MANIFESTATION OF PHARMACOGENETIC AND CLINICAL PERSPECTIVES ON MEDICATION-ASSOCIATED EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS): A COMPREHENSIVE EVALUATION OF IMPLICATED AGENTS, RISK FACTORS, AND TREATMENT MANAGEMENTS STRATEGIES IN GENERAL2025-07-11OpenAlex10.52340/gs.2025.07.03.14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412200834
W4412362022African Footballers and Their Role in Community Development and Cultural Activism2025-07-12OpenAlex10.62154/ajsps.2025.04.01013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412362022
W7217818403Review of Clinical Advances and Challenges in Managing Wet Age-Related Macular Degeneration2025-07-13OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217818403
W4412379163Building trust in the age of human-machine interaction: insights, challenges, and future directions2025-07-14OpenAlex10.3389/frobt.2025.1535082Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412379163
W4412390413Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers2025-07-14OpenAlex10.3390/curroncol32070402Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412390413
W7220616700ROLE OF MOLECULAR DIAGNOSTICS IN EARLY DETECTION OF INFECTIOUS DISEASES2025-07-14OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220616700
W4412425712Adaptive laboratory-evolved MRSA with PPEF manifests cross-susceptibility to oxacillin and hypersensitivity to ciprofloxacin2025-07-15OpenAlex10.1128/spectrum.02974-24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412425712
W4412417730Data from A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia2025-07-15OpenAlex10.1158/0008-5472.c.7928375Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412417730
W4412460706Humans learn to trace meaningful relationships with their eyes2025-07-15OpenAlex10.1167/jov.25.9.1782Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412460706
W4412392677Interpretable Ensemble Learning Predicts Antibiotic Resistance in Treponema denticola Using Expert Classifiers2025-07-15OpenAlex10.1016/j.identj.2025.100884Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412392677
W4412926972Research Trends in Virtual Assistants2025-07-15OpenAlex10.14429/djlit.21022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412926972
W4412425714Rheumatologists’ Adherence to EULAR Recommendations for Systemic Sclerosis Treatment: Experience of a Single Center in Serbia2025-07-15OpenAlex10.3390/jcm14144994Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412425714
W4412420271The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics2025-07-15OpenAlex10.1016/j.ejphar.2025.177946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412420271
W4412439706The treatment of marginal zone lymphoma2025-07-15OpenAlex10.1182/blood.2024028269Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412439706
W4412458919A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients2025-07-16OpenAlex10.1016/j.esmoop.2025.105514Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412458919
W4412477450Clinical use of biologics in juvenile idiopathic arthritis: lessons learned from real-world studies2025-07-16OpenAlex10.1080/14712598.2025.2536351Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412477450
W4412488577Emerging treatment options for adrenocortical carcinoma2025-07-16OpenAlex10.1097/med.0000000000000921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412488577
W4412467665Evolving treatment strategies in meningioma: from traditional approaches to emerging therapies2025-07-16OpenAlex10.1097/ms9.0000000000003556Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412467665
W4412465758Genetic improvement of a synthetic microbiota: a step further?2025-07-16OpenAlex10.3389/fmicb.2025.1619874Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412465758
W4412470842Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management2025-07-16OpenAlex10.3390/jcdd12070270Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412470842
W4412483375RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine2025-07-16OpenAlex10.1053/j.semnuclmed.2025.06.005Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4412483375
W4413319439Artificial Moral Agents: Should Machines Take Ethical Responsibility?2025-07-17OpenAlex10.1109/arso64737.2025.11124921Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413319439
W4412957150Editorial: Insights in emotion science2025-07-17OpenAlex10.3389/fpsyg.2025.1643052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412957150
W4412855918Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathies2025-07-17OpenAlex10.3389/fimmu.2025.1581323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412855918
W4412823337Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift2025-07-17OpenAlex10.15420/cfr.2024.33Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412823337
W7202417829Mechanistic investigation of PBT2-induced metal ion disruption in methicillin-resistant Staphylococcus aureus2025-07-17OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202417829
W4412519673Practice Points and Practice Reflections as the Key to Knowledge Translation2025-07-17OpenAlex10.1097/asw.0000000000000330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412519673
W4412650757Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology2025-07-17OpenAlex10.3389/fendo.2025.1651141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412650757
W4412488244The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma2025-07-17OpenAlex10.1007/s40257-025-00969-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412488244
W4412650176Unveiling the power of polymeric nanoparticles: Pioneering advances in breast cancer treatment2025-07-17OpenAlex10.1016/j.cis.2025.103606Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412650176
W4412650765AI Agents, Automaticity, and Value Alignment in Health Care2025-07-18OpenAlex10.1056/aip2401165Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412650765
W4412521715Bridging theory and practice: Enhancing pharmacology education through simulation-based learning and statistical analysis training2025-07-18OpenAlex10.1016/j.cptl.2025.102440Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412521715
W7164191666Contemporary Advances in Heart Failure Treatment: From Medications to Regenerative Therapy2025-07-18OpenAlex10.70146/msv02i03.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164191666
W4412521406Evolving roles of MET as a therapeutic target in NSCLC and beyond2025-07-18OpenAlex10.1038/s41571-025-01051-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412521406
W7164650926Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection2025-07-18OpenAlex10.70146/msv02i03.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164650926
W4412523390Overcoming regulatory barriers to the implementation of AI agents in healthcare2025-07-18OpenAlex10.1038/s41591-025-03841-1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412523390
W4412785499Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines2025-07-18OpenAlex10.3390/medicina61071292Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412785499
W4413268929Results of a single-center rertrospective study combyning DMD treatment in patients with type 2 diabetes mellitus2025-07-18OpenAlex10.1016/j.atherosclerosis.2025.119947Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413268929
W4412517689Advances and Challenges in Immunotherapy for Metastatic Uveal Melanoma: Clinical Strategies and Emerging Targets2025-07-19OpenAlex10.3390/jcm14145137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412517689
W4412519235Mapping the Global Research on Drug–Drug Interactions: A Multidecadal Evolution Through AI-Driven Terminology Standardization2025-07-19OpenAlex10.3390/bioengineering12070783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412519235
W4412496557Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective2025-07-20OpenAlex10.1007/s13346-025-01925-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412496557
W4412500939Retinopathy of Prematurity - a literature review2025-07-20OpenAlex10.12775/jehs.2025.83.61815Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412500939
W4412517419The Changing Landscape of Antibiotic Treatment: Reevaluating Treatment Length in the Age of New Agents2025-07-20OpenAlex10.3390/antibiotics14070727Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412517419
W4412524273Architecting Adaptive RPA: Integrating Reinforcement Learning for Intelligent Process Automation2025-07-21OpenAlex10.32996/jcsts.2025.7.7.84Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412524273
W4412616694Contemporary challenges in the clinical diagnosis and treatment of Mycoplasma pneumoniae infections in the paediatric population2025-07-21OpenAlex10.15557/pimr.2025.0016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412616694
W4412513249Current Application Status and Trends in Paravertebral Block for Thoracic Surgery: A 2004–2024 Bibliometric Analysis2025-07-21OpenAlex10.9734/cjast/2025/v44i74579Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412513249
W4412519406Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure2025-07-21OpenAlex10.3390/biomedicines13071779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412519406
W4412519854Immunosuppressants/Immunomodulators and Malignancy2025-07-21OpenAlex10.3390/jcm14145160Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412519854
W4412507061Should Systematic HSV Serological Screening of Donors Be Implemented to Manage Mismatched HSV D+/R− Liver Transplants?2025-07-21OpenAlex10.3389/ti.2025.14835Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412507061
W4412570693Advances in minimally invasive diagnostic techniques for pulmonary diseases2025-07-22OpenAlex10.23736/s2724-5691.25.10867-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412570693
W4412556691Effectiveness, treatment pattern, and safety of ustekinumab in treating bio-naïve patients with Crohn’s disease in the real-world clinical setting in China2025-07-22OpenAlex10.1097/cm9.0000000000003694Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412556691
W4412553116Maximizing the Longevity and Volume Retention of Fat Grafts: Advances in Clinical Practice2025-07-22OpenAlex10.7759/cureus.88493Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412553116
W4412550956P-MedAgent:Medical diagnostics based on LLM programmable CoT2025-07-22OpenAlex10.21203/rs.3.rs-6621627/v1Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4412550956
W4412571361Trends of obesity management in adults: an analysis across guidelines in China and in Europe2025-07-22OpenAlex10.1093/pcmedi/pbaf018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412571361
W4412543890UNVEILING THE EXPANDING CLINICAL HORIZONS OF BOTULINUM TOXIN ACROSS MEDICAL SPECIALITIES2025-07-22OpenAlex10.31435/ijitss.3(47).2025.3485Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412543890
W4412592712Back to the Future—Cardiovascular Imaging From 1966 to Today and Tomorrow2025-07-23OpenAlex10.1097/rli.0000000000001219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412592712
W4412616241Checkpoint blockade immunotherapy for multiple recurrences of radiation-induced maxillary sinus sarcoma: A case report2025-07-23OpenAlex10.1177/09287329251358636Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412616241
W4412583500Editorial: Current trends in muscle diseases and their treatment strategies2025-07-23OpenAlex10.3389/fcell.2025.1660074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412583500
W4413004429Evolving management of sarcoidosis in the real world2025-07-23OpenAlex10.1097/mcp.0000000000001204Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413004429
W4412596199Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris ( Candidozyma auris ), Candida albicans , Candida parapsilosis , and Candida glabrata ( Nakaseomyces glabratus )2025-07-23OpenAlex10.1128/aac.00680-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412596199
W7116597701Noma in Mozambique. Epidemiological efforts to uncover a neglected disease2025-07-23OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116597701
W4412603346Polypill: Shifting Paradigm from Concept to Practice in the Prevention of Myocardial Infarction2025-07-23OpenAlex10.1159/000547098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412603346
W4412584224Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC)2025-07-23OpenAlex10.1080/14656566.2025.2536352Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412584224
W4412595292[Consensus on recurrence risk and clinical management of HR+/HER-2- early breast cancer (2025 edition)].2025-07-23OpenAlex10.3760/cma.j.cn112152-20250524-00240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412595292
W4412626395Agentic AI in radiology: emerging potential and unresolved challenges2025-07-24OpenAlex10.1093/bjr/tqaf173Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412626395
W4412648912Blood Cadmium and Preterm Birth: A Systems Toxicology Review of Molecular Mechanisms, Placental Disruption, and Translational Obstetric Implications2025-07-24OpenAlex10.24198/obgynia.v8i2.949Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412648912
W4412645254Editorial: Natural remedies repositioned: advancing drug discovery for infectious diseases2025-07-24OpenAlex10.3389/fphar.2025.1655921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412645254
W4412645361Editorial: New trends in vascular biology 20242025-07-24OpenAlex10.3389/fcvm.2025.1649558Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412645361
W4412648158Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective2025-07-24OpenAlex10.1007/s40265-025-02213-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412648158
W4412643022Evolving Anesthesia Strategies for Enhanced Recovery in Gastrectomy2025-07-24OpenAlex10.63096/medtigo3067123Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412643022
W4412620739Redefining Psoriasis Therapy: The Emerging Role of Polymeric Nanocarriers in Precision Dermatology2025-07-24OpenAlex10.1007/s44174-025-00473-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412620739
W4412911047Advances and Challenges in the Management of Myelodysplastic Syndromes2025-07-25OpenAlex10.3390/cancers17152469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412911047
W4412653916Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?2025-07-25OpenAlex10.1186/s40249-025-01344-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412653916
W4412925087Editorial: Endocrine insights into heart disease2025-07-25OpenAlex10.3389/fendo.2025.1664575Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412925087
W4412925966Emerging therapeutic approaches in graves’ ophthalmopathy: an update on pharmacological interventions2025-07-25OpenAlex10.3389/fimmu.2025.1647602Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412925966
W4412698183Empowering Women for Zoonotic Malaria Prevention: A Protocol for a Community-Based Participatory Research in Rural Communities (Preprint)2025-07-25OpenAlex10.2196/preprints.81083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412698183
W4412856378Evolving therapeutic landscape of primary biliary cholangitis: A review2025-07-25OpenAlex10.4254/wjh.v17.i7.107223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412856378
W4412925204From data-driven cities to data-driven tumors: dynamic digital twins for adaptive oncology2025-07-25OpenAlex10.3389/frai.2025.1624877Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412925204
W4412924848Immune surveillance as a pharmacological target in the early stages of cancer2025-07-25OpenAlex10.3389/fmolb.2025.1643024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412924848
W4412924967Incentivising cooperation by judging a group’s performance by its weakest member in neuroevolution and reinforcement learning2025-07-25OpenAlex10.3389/frobt.2025.1599676Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412924967
W4412833338Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer2025-07-25OpenAlex10.3390/cancers17152466Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412833338
W4412855741Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management2025-07-25OpenAlex10.4254/wjh.v17.i7.106810Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412855741
W4413218094Neurological symptoms and MRI changes post-sugammadex reversal2025-07-25OpenAlex10.12746/swjm.v13i56.1493Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413218094
W4412732884Obstetric and Neonatal Outcomes among Patients with Obstetric Antiphospholipid Antibody Syndrome: A Prospective Observational Study Comparing Patients Receiving Conventional Therapy (LMWH + Aspirin) and Patients Receiving Additional Hydroxychloroquine2025-07-25OpenAlex10.5005/jp-journals-10006-2690Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412732884
W4412713867Target practice: Opportunities for therapeutic intervention in CHIP and CCUS2025-07-25OpenAlex10.1016/j.blre.2025.101323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412713867
W4412676567Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia2025-07-27OpenAlex10.1080/10428194.2025.2533498Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412676567
W4412682022Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity2025-07-28OpenAlex10.1007/s40273-025-01520-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412682022
W4412728042Pharmacology and Regulation of Appetite and Food Intake2025-07-28OpenAlex10.1002/prp2.70101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412728042
W4412679302Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis2025-07-28OpenAlex10.26599/nr.2025.94907639Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412679302
W4412738118The rise of superbugs: Confronting antimicrobial resistance in Pakistan2025-07-28OpenAlex10.47391/jpma.23220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412738118
W4412855603Unpublished overall survival confounders in immunomodulatory agent registrational trials2025-07-28OpenAlex10.1016/s1470-2045(25)00296-7Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4412855603
W4412685784VEXAS: A review of current understandings and emerging treatment strategies2025-07-28OpenAlex10.3389/fimmu.2025.1644404Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412685784
W4412703144What’s New in Hip Surgery2025-07-28OpenAlex10.2106/jbjs.25.00532Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412703144
W4412712908A new era at BJR2025-07-29OpenAlex10.1093/bjr/tqaf185Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412712908
W4412785020Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions2025-07-29OpenAlex10.1186/s13027-025-00679-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412785020
W4412712751Cardiac Myosin Inhibitors in the Treatment of Hypertrophic Cardiomyopathy: Clinical Trials and Future Challenges2025-07-29OpenAlex10.3390/biom15081098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412712751
W4412729047Editorial: Upping the heat: capsaicin for human health2025-07-29OpenAlex10.3389/fnut.2025.1665722Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412729047
W4413301636Integrating Computational and Experimental Approaches in 21st Century Drug Design2025-07-29OpenAlex10.21590/jddhs.02.02.04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413301636
W4412710812Unraveling the 2023 cholera outbreak in Rourkela municipal corporation of Odisha, India: Antibiotic resistance, virulence factors, and water contamination insights2025-07-29OpenAlex10.1016/j.ijmmb.2025.100944Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412710812
W4412739026Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management2025-07-30OpenAlex10.1016/j.retram.2025.103533Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412739026
W4412765678Editorial: Immunoregulatory cells: balancing immune responses during pathogen infections2025-07-30OpenAlex10.3389/fimmu.2025.1664401Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412765678
W4412758316Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis2025-07-30OpenAlex10.1080/17474124.2025.2537192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412758316
W4412748027Stem Cell Applications in Pediatric Urology2025-07-30OpenAlex10.4018/979-8-3693-8829-7.ch008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412748027
W4412750762The Evolving Role of Stem Cells in Oral Health and Regeneration: A Systematic Review2025-07-30OpenAlex10.3390/surgeries6030065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412750762
W4412816409Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review2025-07-30OpenAlex10.1055/a-2646-7556Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412816409
W4412929278AI-Augmented Data Quality Validation in P&C Insurance: A Hybrid Framework Using Large Language Models and Rule-Based Agents2025-07-31OpenAlex10.22399/ijcesen.3613Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412929278
W4412793621Advancements and Challenges in the Preoperative Management of Pheochromocytoma in a Low- and Middle-Income Country (LMIC): A Nationwide Survey2025-07-31OpenAlex10.7759/cureus.89145Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412793621
W7220348624Agentic Digital Twins: Self-Evolving Models for Autonomous Systems2025-07-31OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7220348624
W4412775731Beneath the surface in autoimmune hemolytic anemia: pathogenetic networks, therapeutic advancements and open questions2025-07-31OpenAlex10.3389/fimmu.2025.1624667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412775731
W4412774080Editorial: Advanced therapeutic strategies in digestive and circulatory health: nanomedicine and beyond2025-07-31OpenAlex10.3389/fphar.2025.1666774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412774080
W4412793509Epidemiology of community acquired and health care assocİated infective endocarditis and 28 day mortality risk factors: a university hospital study2025-07-31OpenAlex10.1186/s12879-025-11386-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412793509
W4412845098GLP-1 Receptor Agonist Use in Patients Undergoing Distal Radius Fracture Surgery: A Retrospective Review of Perioperative Considerations2025-07-31OpenAlex10.7759/cureus.89183Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412845098
W4412788487Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era2025-07-31OpenAlex10.1128/cmr.00082-25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412788487
W4412791006Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy2025-07-31OpenAlex10.1016/j.drup.2025.101286Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412791006
W4412887278A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II2025-08-01OpenAlex10.3390/ph18081150Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412887278
W4413403770A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies2025-08-01OpenAlex10.21037/tlcr-2025-754Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413403770
W7128523959Active cyber defense using intelligent agents in cloud-edge based applications2025-08-01OpenAlex10.32469/10355/110389Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128523959
W4412881422Advanced Nanotheranostics: Evolving Strategies in Cancer Therapy and Diagnosis2025-08-01OpenAlex10.61554/ijnrph.v3i1.2025.170Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4412881422
W4412822306Advancing engineering design strategies for targeted cancer nanomedicine2025-08-01OpenAlex10.1038/s41568-025-00847-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412822306
W4417487935BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape2025-08-01OpenAlex10.1053/j.seminhematol.2025.12.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417487935
W4414679323Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines2025-08-01OpenAlex10.1177/13596535251349380Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414679323
W4414065294Blockchain-anchored Reinforcement Learning Collectives with Tokenized Ecosystem Optimization for Trustless, Bias-Free Adaptation of Complex Systems.2025-08-01OpenAlex10.55248/gengpi.6.0825.3131Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414065294
W4412805699Congenital Lymphatic Malformations2025-08-01OpenAlex10.1542/neo.26-8-048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412805699
W4413351069Current paradigms in the management of inflammatory bowel disease2025-08-01OpenAlex10.4103/singaporemedj.smj-2025-078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413351069
W4413113533Dynamics that predispose, enable, and reinforce commercial tobacco-related health disparities: Introduction to a Monograph2025-08-01OpenAlex10.1093/jncimonographs/lgaf034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413113533
W4412846616Editorial: Biosecurity of infectious diseases in veterinary medicine2025-08-01OpenAlex10.3389/fvets.2025.1665683Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412846616
W4412817380Editorial: Expanding CAR-T cell therapy — breakthroughs from cancer to autoimmune diseases2025-08-01OpenAlex10.3389/fimmu.2025.1649045Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412817380
W4412881421Emerging Nanoparticle Drug Delivery Approaches for the Treatment of Alzheimer’s Disease: A Review2025-08-01OpenAlex10.61554/ijnrph.v3i1.2025.171Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412881421
W4412859749Expanding Treatment Horizons with Chemical Agents and Drug Adjuvants in Odontogenic Keratocyst: A Comprehensive Review2025-08-01OpenAlex10.7860/jcdr/2025/78674.21362Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412859749
W4414276532Focused Pharmacovigilance of Neuropsychiatry Drugs in A Tertiary Care Hospital, India2025-08-01OpenAlex10.21276/amit.2025.v12.i2.11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414276532
W4413547113Impact of Artemisinin derivatives in patient-derived tissue cultures of NSCLC in combined treatment with cisplatin2025-08-01OpenAlex10.1055/s-0045-1809736Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413547113
W4416331990Lauren Benton. They Called It Peace: Worlds of Imperial Violence2025-08-01OpenAlex10.1093/ejil/chaf053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416331990
W4412834865Learning from nature: how correlated multimodal imaging enhances our understanding of light-biological surface interactions2025-08-01OpenAlex10.1117/12.3067880Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4412834865
W4413369610Mapping Key Nodes and Global Trends in AI and Large Language Models for Medical Education: A Bibliometric Study2025-08-01OpenAlex10.2147/amep.s538362Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413369610
W4412805672Mismatch between pre-clinical cardio-oncology and clinical oncology research2025-08-01OpenAlex10.1093/eurheartjsupp/suaf083.230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412805672
W4412846868Narrowing of the ventral CA1 excitability margin in schizophrenia, depression and PTSD2025-08-01OpenAlex10.31219/osf.io/e4cwb_v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412846868
W4412835947Pendekatan Integratif dalam Manajemen Dengue2025-08-01OpenAlex10.56951/699q0n64Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412835947
W4413796801Pharmacological Management of Immune Thrombocytopenic Purpura (ITP): A Review2025-08-01OpenAlex10.55248/gengpi.6.0825.3022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413796801
W4415634196Processing neuroimaging data for research purposes: Open Science, FAIR data, and the GDPR2025-08-01OpenAlex10.1093/idpl/ipaf020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415634196
W4413336181Progress in Nanocarriers‐Based Approaches for the Delivery of Tyrosine Kinase Inhibitors in Bone Cancer: Trends and Prospects2025-08-01OpenAlex10.1002/iub.70052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413336181
W7219563765Rasakalpa And Pottali Kalpana In Rasashastra: A Scientific Review Of Their Preparation And Curative Potential2025-08-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219563765
W7163207877Speakers’ Presentations2025-08-01OpenAlex10.4103/jmhit.jmhit_37_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163207877
W4412957992The Blurred Lines Between New Psychoactive Substances and Potential Chemical Weapons2025-08-01OpenAlex10.3390/toxics13080659Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412957992
W4413309314The penis speaks, but are we listening: the role of early trauma in understanding male sexual dysfunction2025-08-01OpenAlex10.1093/sexmed/qfaf058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413309314
W4414625036The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection2025-08-01OpenAlex10.25122/jml-2024-0396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414625036
W4412805856Tracheobronchomalacia in an Infant With Severe Bronchopulmonary Dysplasia2025-08-01OpenAlex10.1542/neo.26-8-049Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412805856
W4412887742Urinary Multidrug-Resistant Klebsiella pneumoniae: Essential Oil Countermeasures in a One Health Case Report2025-08-01OpenAlex10.3390/microorganisms13081807Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412887742
W4413373977What’s New and What’s Next in Fecal Microbiota Transplantation?2025-08-01OpenAlex10.2147/btt.s486372Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413373977
W4412852804Small dense low-density lipoprotein cholesterol as a risk marker for peripheral artery disease2025-08-02OpenAlex10.1093/eurjpc/zwaf490Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412852804
W4412890788Focused Modulation of Brain Activity: A Narrative Review2025-08-03OpenAlex10.3390/biomedicines13081889Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412890788
W4412874384Metformin-Associated Lactic Acidosis (MALA): When a Common Drug Turns Catastrophic2025-08-03OpenAlex10.7759/cureus.89292Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412874384
W4412877886Unraveling Liver Cirrhosis: Bridging Pathophysiology to Innovative Therapeutics2025-08-03OpenAlex10.1111/jgh.70037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412877886
W4413875696Auditing AI Access to Electronic Health Records: HIPAA Compliance, Challenges, Solutions, and Future Directions2025-08-04OpenAlex10.32996/jcsts.2025.7.8.51Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413875696
W4412889158Cardiovascular-Kidney-Metabolic healthcare framework: Perspective from Hong Kong2025-08-04OpenAlex10.1097/cm9.0000000000003748Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412889158
W4412944008Gene Therapy for the Treatment of Osteoarthritis: Advances and Prospective2025-08-04OpenAlex10.2174/0113816128384412250709130211Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412944008
W4412931265New frontiers in prostate cancer treatment from systemic therapy to targeted therapy2025-08-04OpenAlex10.1038/s44321-025-00282-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412931265
W4412938501Recent Advances in Bioink Research for Biomedical Applications2025-08-04OpenAlex10.1007/s44174-025-00478-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412938501
W7216223140Recent Trends In Neuroanaesthesia- A Review.2025-08-04OpenAlex10.64252/ae312781Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216223140
W4412934724Serovars and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolates from clinical-case pigs in Taiwan2025-08-04OpenAlex10.1186/s12917-025-04878-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4412934724
W4413105150A tale of two TROP-2 antibody-drug conjugates: a comparative saga of datopotamab deruxtecan and sacituzumab govitecan2025-08-05OpenAlex10.1093/oncolo/oyaf251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413105150
W4413462091Design, Classification, and Therapeutic Applications of Prodrugs in Modern Drug Development2025-08-05OpenAlex10.69613/2mqr8d80Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413462091
W4412991198The future of anesthesia education: incorporating technology for safer practices2025-08-05OpenAlex10.1097/aco.0000000000001559Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412991198
W4412891677Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types2025-08-05OpenAlex10.1016/j.diii.2025.07.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4412891677; https://openalex.org/W7172218397
W4413004787Combination therapies in the treatment of prostate cancer2025-08-06OpenAlex10.5603/ocp.104112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413004787
W4413000545Coxiella burnetii: Emerging threats, molecular insights, and advances in diagnosis and control measures2025-08-06OpenAlex10.1016/j.mimet.2025.107213Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413000545
W4413006943Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphoma2025-08-06OpenAlex10.1080/17474086.2025.2545336Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413006943
W4413034472A multi-agent continual learning framework for skin cancer detection leveraging crowdsourced dermoscopic images2025-08-07OpenAlex10.30574/wjarr.2025.27.2.2863Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413034472; https://openalex.org/W7105802898
W4414380247Rethinking Safety Assessment of Rotavirus Vaccination in Biologic-Exposed Infants: Methodological Nuances Matter2025-08-07OpenAlex10.1093/ibd/izaf201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414380247
W4413051451Social justice and social media: How medical schools display critical consciousness online2025-08-07OpenAlex10.1371/journal.pdig.0000981Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413051451
W4413035316Transthyretin Amyloid Cardiomyopathy: Diagnosis and Management2025-08-07OpenAlex10.1007/s12170-025-00771-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413035316
W4413101179Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group2025-08-08OpenAlex10.46989/001c.141401Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413101179
W4414532274ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points2025-08-08OpenAlex10.1093/eurheartj/ehaf614Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414532274
W4413256237Editorial: The pharmacological effects and mechanisms of drugs against human diseases by modulating redox homeostasis - volume II2025-08-08OpenAlex10.3389/fphar.2025.1665486Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413256237
W4413256082Opportunities, obstacles and challenges of nano-immunotherapy in melanoma2025-08-08OpenAlex10.3389/fimmu.2025.1611423Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413256082
W4413119192The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management2025-08-08OpenAlex10.1093/ckj/sfaf260Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413119192
W4413255974Ticks and tick-borne diseases in the northern hemisphere affecting humans2025-08-08OpenAlex10.3389/fmicb.2025.1632832Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413255974
W4413225696Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)2025-08-09OpenAlex10.3390/pharmaceutics17081036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413225696
W4413094001Optimizing treatment for metastatic castration‐resistant prostate cancer: Food and Drug Administration‐approved therapies, emerging strategies, and biomarker‐driven approaches2025-08-09OpenAlex10.1002/cncr.70037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413094001
W4413223210Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review2025-08-09OpenAlex10.3390/curroncol32080448Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413223210
W4413110359Trends in nephrology: kidney metabolism as a therapeutic target2025-08-09OpenAlex10.1093/ndt/gfaf155Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413110359
W4413212892Advancements and Challenges in 3D Printing for Wound Healing: Current Trends and Future Prospects2025-08-11OpenAlex10.1007/s40883-025-00470-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413212892
W4413100643Allogeneic Transplant for CMML2025-08-11OpenAlex10.1007/s11899-025-00754-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413100643
W4413117548Assessing the current medicolegal landscape in orthopedic sports medicine surgery—patient-centered communication and multidisciplinary approaches matter: A consensus statement2025-08-11OpenAlex10.1016/j.jisako.2025.100993Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413117548
W4413142294Confirm presence of metallo-β-lactamase-producing Gram-negative bacteria to inform treatment of infection, although clinical data are limited for current and emerging treatment options2025-08-11OpenAlex10.1007/s40267-025-01173-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413142294
W4413221620Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer2025-08-11OpenAlex10.3389/fimmu.2025.1665709Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4413221620
W4414018199Management of MDR/XDR severe infections in the critically ill2025-08-11OpenAlex10.1097/mcc.0000000000001307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414018199
W7216492788Paper For International Journal Of Environmental Sciences-Special Issue 2025 Investigating How To Design Agentic AI Systems That Effectively Augment Human Capabilities And Enhance Human-AI Teamwork2025-08-11OpenAlex10.64252/ersdfx86Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216492788
W4413109381Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers2025-08-11OpenAlex10.1002/bcp.70196Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413109381
W4413206429Beyond personalization: autonomy and agency in intelligent systems education2025-08-12OpenAlex10.3389/feduc.2025.1610239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413206429
W4415877204COVID-19 and HIV—Interaction, clinical course, outcome, and prognosis2025-08-12OpenAlex10.14748/ngfcp473Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415877204
W4413183848Evaluating Public Awareness and Perceptions of the Romanian National Immunization Program: Implications for Strengthening Population Immunity2025-08-12OpenAlex10.20944/preprints202508.0856.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413183848
W4409445108Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium2025-08-12OpenAlex10.64719/pb.4531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4409445108
W4413189400Paediatric Focal Segmental Glomerulosclerosis (FSGS): From Bench to Bedside and Beyond2025-08-12OpenAlex10.3390/sclerosis3030029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413189400
W142241586The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines2025-08-12OpenAlex10.64719/pb.4142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W142241586
W4413187355Top 10 academic advances in traditional Chinese medicine in 20242025-08-12OpenAlex10.1097/st9.0000000000000074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413187355
W4413161801Advances in Sclerosants for Low-Flow Vascular Malformations2025-08-13OpenAlex10.1016/j.avsg.2025.07.049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413161801
W4413160350Antimicrobial Nanoparticles Against Superbugs: Mechanistic Insights, Biomedical Applications, and Translational Frontiers2025-08-13OpenAlex10.3390/ph18081195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413160350
W4413113475Deceased donor blood transfusion in emergency resuscitation: A scoping review of historical evidence for military and mass casualty applications2025-08-13OpenAlex10.1111/trf.18366Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413113475
W4413178345OncoAID: an open access targeted anti-cancer drugs database2025-08-13OpenAlex10.3389/fphar.2025.1588191Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413178345
W4413111631Oral Semaglutide: A Step Forward in Cardiovascular Risk Management for Type 2 Diabetes2025-08-13OpenAlex10.2174/011871529x421551250801194823Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413111631
W4413150383Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes2025-08-13OpenAlex10.1016/s1474-4422(25)00232-7Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413150383
W4413181537Redefining communication in mental healthcare: generative AI for neurodivergent equity and non-verbal autistic inclusion2025-08-13OpenAlex10.3389/fpsyt.2025.1611101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413181537
W4413417222Antibody-Drug Conjugates in Breast Cancer: Current Landscape and Future Targets2025-08-14OpenAlex10.58931/cot.2025.2235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413417222
W4413139641Glucagon-Like Peptide-1 Receptor Agonists in Gynecologic Surgery2025-08-14OpenAlex10.1097/aog.0000000000006035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413139641
W4413258141Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management2025-08-14OpenAlex10.1210/endocr/bqaf130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413258141
W4414001974Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases2025-08-14OpenAlex10.4062/biomolther.2025.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414001974
W7220724655Safety and Efficacy of Peptide-Based Therapeutics in Health Sciences: From Bench to Bedside2025-08-14OpenAlex10.34297/ajbsr.2025.28.003647Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220724655
W7216154411The Evolution of Cognitive Partnership: A Taxonomic Framework for Human-AI Collaboration Modalities2025-08-14OpenAlex10.32996/jcsts.2025.7.8.113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216154411
W4413142584Treatment of NSCLC after chemoimmunotherapy — are we making headway?2025-08-14OpenAlex10.1038/s41571-025-01061-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413142584
W4413380618Artificial Intelligence Agent-Enabled Predictive Maintenance: Conceptual Proposal and Basic Framework2025-08-15OpenAlex10.3390/computers14080329Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4413380618
W4413467640Automated Literature Screening for Hepatocellular Carcinoma Treatment Through Integration of 3 Large Language Models: Methodological Study2025-08-15OpenAlex10.2196/76252Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413467640
W4413378211Efficacy of Biologic Agents and Small Molecules for Endoscopic Improvement and Mucosal Healing in Patients with Moderate-to-Severe Ulcerative Colitis: Systematic Review and Meta-Analysis2025-08-15OpenAlex10.3390/jcm14165789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413378211
W4413139545Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast2025-08-15OpenAlex10.1007/s40487-025-00369-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413139545
W4413330517Comprehensive Review on Carcinoma of the Gallbladder: Epidemiology, Pathogenesis, Diagnosis, and Contemporary Management Strategies2025-08-16OpenAlex10.36347/sasjs.2025.v11i08.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413330517
W4413452275Diagnostic Role of Radiology in Acute Gastrointestinal Bleeding: A Comprehensive Review2025-08-16OpenAlex10.7759/cureus.90219Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413452275
W4413279423Mechanisms and Genetic Drivers of Resistance of Insect Pests to Insecticides and Approaches to Its Control2025-08-16OpenAlex10.3390/toxics13080681Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413279423
W4413270789Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms2025-08-16OpenAlex10.1038/s41408-025-01346-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413270789
W4413293740Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape2025-08-16OpenAlex10.3390/ph18081212Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413293740
W4413376755Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review2025-08-16OpenAlex10.1021/acsomega.5c05260Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413376755
W4413279968Acceptability of a Conversational Agent–Led Digital Program for Anxiety: Mixed Methods Study of User Perspectives2025-08-18OpenAlex10.2196/76377Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413279968
W7217081993Efficacy of Targeted Drug Therapies in Conjunction with Surgical Treatment for Thyroid Cancer: A Meta-Analysis2025-08-18OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217081993
W4413274368Evolving tumor microenvironment: Driving cancer initiation and progression in cardiovascular diseases2025-08-18OpenAlex10.1016/j.isci.2025.113387Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413274368
W4413279375Post anaesthesia cognitive outcomes in propofol vs. ketamine sedation for colonoscopy: a retrospective cohort study2025-08-18OpenAlex10.1007/s44254-025-00125-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413279375
W4413286593Reconstructing the Antibiotic Pipeline: Natural Alternatives to Antibacterial Agents2025-08-18OpenAlex10.3390/biom15081182Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413286593
W4413272048Research Progress of Platinum-Based Complexes in Lung Cancer Treatment: Mechanisms, Applications, and Challenges2025-08-18OpenAlex10.3390/ijms26167958Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413272048
W4413305165Synergistic application of antibiotics and hyperbaric oxygen therapy2025-08-18OpenAlex10.4103/mgr.medgasres-d-25-00086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413305165
W4413292011The sustainability of hypercholesterolemia treatment: New drugs have made such therapy more expensive2025-08-18OpenAlex10.1016/j.hipert.2025.05.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413292011
W4413308624HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma2025-08-19OpenAlex10.3390/cells14161282Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413308624
W4413307834Hodgkin lymphoma: evolving treatment strategies for elderly patients and patients in first relapse2025-08-19OpenAlex10.1007/s12254-025-01062-3Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4413307834
W4413324737N-acetilcisteína: 50 años del descubrimiento de un antídoto que ha cambiado el pronóstico de la intoxicación por paracetamol2025-08-19OpenAlex10.1016/j.farma.2025.07.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413324737
W4413318512Schizophrenia and psychosis in children and adolescents: An inspiring journey of scientific progress and the rich influences of history and religion2025-08-19OpenAlex10.1016/j.disamonth.2025.101983Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413318512
W4413342471Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with Tirzepatide in MASH Cirrhosis2025-08-20OpenAlex10.3390/transplantology6030025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413342471
W4413372506Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches2025-08-20OpenAlex10.1016/j.ijgc.2025.102117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413372506
W4413404306State‐of‐the‐art management of Dravet syndrome2025-08-20OpenAlex10.1111/dmcn.16475Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413404306
W4413352530Tremelimumab for the treatment of hepatocellular carcinoma2025-08-20OpenAlex10.1080/14712598.2025.2550711Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413352530
W4413358587“Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study2025-08-20OpenAlex10.3390/obesities5030063Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413358587
W4413376077Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response2025-08-21OpenAlex10.3390/biomedicines13082038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413376077
W7106314814Geographies of Trust: AI, Biomedicine, and the Next Era of Federated and Visiting Data Models2025-08-21OpenAlex10.5281/zenodo.17662085Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106314814; https://openalex.org/W7106679943
W4413403477Versatile Application of Calixarenes and Their Derivatives: From Drug Delivery to Industrial Catalysis and Environmental Remediation2025-08-21OpenAlex10.1080/10408347.2025.2538731Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413403477
W4414018707Acute myeloid leukemia: a comprehensive update2025-08-22OpenAlex10.1097/moh.0000000000000897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414018707
W4413621242Antibody–drug conjugates for non-muscle invasive bladder cancer: current status and future development2025-08-22OpenAlex10.1097/mou.0000000000001330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413621242
W4413448295Beyond neuronal loss: epigenetic signatures bridging immune activation and sleep dysfunction in narcolepsy type 12025-08-22OpenAlex10.1093/sleep/zsaf253Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413448295
W4413437046Editorial: Case reports in autoimmune and autoinflammatory disorders2025-08-22OpenAlex10.3389/fimmu.2025.1655791Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413437046
W4413430348Ethical frameworks for automated vehicles: a systematic analysis and design2025-08-22OpenAlex10.1007/s43681-025-00803-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413430348
W4413431220In conversation with Małgorzata Kosla2025-08-22OpenAlex10.1111/febs.70227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413431220
W4413435117Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities2025-08-22OpenAlex10.3389/fphar.2025.1635624Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413435117
W4413411488Real-World Systemic Treatment Patterns, Survival Outcomes, and Prognostic Factors in Advanced Hepatocellular Carcinoma: A 15-Year Experience from a Low-Resource Setting2025-08-22OpenAlex10.3390/cancers17172729Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413411488
W4413772349Shaping the future on a solid tradition2025-08-22OpenAlex10.1093/eurheartj/ehaf693Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413772349
W4413425517The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care2025-08-22OpenAlex10.1093/rheumatology/keaf455Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413425517
W4413446943ASHP Statement on Artificial Intelligence in Pharmacy2025-08-23OpenAlex10.1093/ajhp/zxaf107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413446943
W7201967545Article Review: The Enchanting Versatile Applications of Pregabalin and Its Abuse Liability2025-08-23OpenAlex10.67735/scms.2025.02.0124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201967545
W4413480834Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science2025-08-23OpenAlex10.3390/biom15091219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413480834
W7217757602Explainable Multi Agent Architectures Using AI and Cloud for Cross Jurisdictional Healthcare Fraud Detection2025-08-23OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7217757602
W4414536597RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer2025-08-23OpenAlex10.1093/jnci/djaf247Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414536597
W4413471008Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML2025-08-23OpenAlex10.1007/s11864-025-01351-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413471008
W4413480481Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s Disease2025-08-24OpenAlex10.3390/molecules30173479Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413480481
W7171327967Building Compliant Data Pipelines in Regulated Sectors: A Privacy-First Engineering Approach2025-08-24OpenAlex10.5281/zenodo.21605348Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171327967; https://openalex.org/W7162445270
W4413480683Precision Medicine in Orthobiologics: A Paradigm Shift in Regenerative Therapies2025-08-24OpenAlex10.3390/bioengineering12090908Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413480683
W4413480682Threat of non-traditional agents: a new frontier in chemical weapons concerns?2025-08-24OpenAlex10.1136/military-2025-003101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413480682
W4414684312Transthyretin amyloid cardiomyopathy: from cause to novel treatments2025-08-24OpenAlex10.1093/eurheartj/ehaf667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414684312
W4413535390Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review2025-08-25OpenAlex10.1111/ajco.70001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413535390
W4414015691Atopic Dermatitis Pathogenesis And Management: A Review Article2025-08-25OpenAlex10.54293/smhj.v5i3.145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414015691
W4414895536Breadth of Depth of Bacteriophage Antibacterial Activity2025-08-25OpenAlex10.54026/ars/1032Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414895536; https://openalex.org/W4413329151
W4413601308Compliance and Quality Assurance Framework for Multidisciplinary Nursing Leadership in Acute Care2025-08-25OpenAlex10.47191/etj/v10i08.40Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413601308
W4413569229Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies2025-08-25OpenAlex10.1007/s40257-025-00979-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413569229
W4413698536A Tree-Based Search Algorithm with Global Pheromone and Local Signal Guidance for Scientific Chart Reasoning2025-08-26OpenAlex10.3390/math13172739Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413698536
W4416233439Algorithm Design of Reinforcement Learning in Smart Elderly Care Resource Allocation Prediction2025-08-26OpenAlex10.1109/cipae66821.2025.00201Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416233439
W4413612608Dietary Amino Acids and Amelioration of Liver Ischemia-reperfusion Injury2025-08-26OpenAlex10.1097/tp.0000000000005511Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413612608
W4413612268Editorial: Challenges and advances in carcinomatous meningitis treatment2025-08-26OpenAlex10.3389/fonc.2025.1672755Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413612268
W4413641589Healthcare Innovation as a Complex Adaptive System2025-08-26OpenAlex10.1201/9781003513834-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413641589
W4413619680Investigational agents for pancreatic neuroendocrine tumors: what clinical progress have we seen in the last 5 years?2025-08-26OpenAlex10.1080/13543784.2025.2552847Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413619680
W4413734435MRI Contrast Agents for Glioma Diagnosis (2015–2024): A Bibliometric and Visual Analysis of Research Trends and Emerging Directions2025-08-26OpenAlex10.1002/apj.70095Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413734435
W4413627720Novel Therapeutic Development for Nasopharyngeal Carcinoma2025-08-26OpenAlex10.3390/curroncol32090479Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413627720
W4413638592Recent advances in the functionalities of macrocycles in bone diseases2025-08-26OpenAlex10.36227/techrxiv.175624482.26463371/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413638592
W4413746042Expanding the boundaries of regenerative endodontics to mature teeth with pulp necrosis2025-08-27OpenAlex10.4103/sej.sej_31_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413746042
W4413756600From visual question answering to intelligent AI agents in ophthalmology2025-08-27OpenAlex10.1136/bjo-2024-326097Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4413756600
W4413744076Mindful Ethical Practice and Resilience Academy (MEPRA)2025-08-27OpenAlex10.1097/nmg.0000000000000287Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413744076
W4413773191“Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics2025-08-27OpenAlex10.3390/antibiotics14090862Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413773191
W4413832267A Comprehensive Overview of Candida albicans as the Leading Pathogen in Vulvovaginal Candidiasis2025-08-28OpenAlex10.3390/jof11090632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413832267
W7216398116Accelerating Cloud Modernization with Agentic AI2025-08-28OpenAlex10.32996/jcsts.2025.7.9.4Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7216398116
W4413775387Aspartate potentiates tobramycin against multidrug-resistant Edwardsiella tarda through enhancing proton motive force and membrane permeability2025-08-28OpenAlex10.1128/msystems.00794-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413775387
W4413794292Beyond the Eye: Glaucoma and the Brain2025-08-28OpenAlex10.3390/brainsci15090934Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413794292
W4413781539CML-792: Complex Case Report Involving Polycythemia Vera, Myelofibrosis, Chronic Myeloid Leukemia, and Merkel Cell Carcinoma2025-08-28OpenAlex10.1016/s2152-2650(25)01958-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413781539
W4413788276Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents2025-08-28OpenAlex10.1007/s40256-025-00757-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413788276
W4413776861Development of a Conversational Artificial Intelligence–Based Web Application for Medical Consultations: Prototype Study2025-08-28OpenAlex10.2196/56090Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4413776861
W4413799319Editorial: Fighting microbial biofilms: novel therapeutics and antibiofilm strategies2025-08-28OpenAlex10.3389/fcimb.2025.1680391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413799319
W4413799068Editorial: Synergistic advances in gene technology, nanobiotechnology, and photonic innovations for next-generation diagnostics and therapeutics2025-08-28OpenAlex10.3389/fbioe.2025.1685142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413799068
W4413832935Evolving Paradigms in Acute Myeloid Leukemia: Personalized Approaches to Therapy Across Age and Risk Groups2025-08-28OpenAlex10.3390/cancers17172824Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413832935
W4413781581MDS-1451: Evolving Mortality Trends in Myelodysplastic Syndromes Among Older US Adults: A 25-Year Nationwide Joinpoint Analysis2025-08-28OpenAlex10.1016/s2152-2650(25)02079-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413781581
W4413810531MDS-961: MDS-RS Evolving From Hereditary Sideroblastic Anemia: A Diagnostically Challenging Case With Multisystem Involvement2025-08-28OpenAlex10.1016/s2152-2650(25)02048-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413810531
W4413790795MM-174: Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab2025-08-28OpenAlex10.1016/s2152-2650(25)02571-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413790795
W4414018714Predicting response to renal denervation: aortic distensibility as a piece of the puzzle2025-08-28OpenAlex10.1097/hjh.0000000000004103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414018714
W4413803336Breakpoint drift: a hidden confounder in antimicrobial resistance surveillance?2025-08-29OpenAlex10.3389/fmicb.2025.1674968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413803336
W4413803852Editorial: Tuberculosis: recent updates in basic research, drug discovery and treatment2025-08-29OpenAlex10.3389/fmed.2025.1668254Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413803852
W4413828318Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review2025-08-29OpenAlex10.3390/jcm14176119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413828318
W4413920693IUC24406-81 ARTA-ATTACK study: assessment of sarcopenia, frailty, and neurocognitive impairment in patients with prostate cancer treated with androgen receptor-targeted agents: a prospective multicenter observational cohort study2025-08-29OpenAlex10.1093/oncolo/oyaf248.029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413920693
W4413817198Menopause Step-by-Step: must-know studies2025-08-29OpenAlex10.1097/gme.0000000000002632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413817198
W4413833096Nanotechnology-based approaches for vitiligo2025-08-29OpenAlex10.1016/b978-0-443-36326-9.00001-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413833096
W4413834681Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect2025-08-29OpenAlex10.3389/fimmu.2025.1631083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413834681
W4413816582Staggered use of sodium nitroprusside and levosimendan in a patient with refractory cardiogenic shock: a case report2025-08-29OpenAlex10.1093/ehjcr/ytaf430Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413816582
W7214957210Microbes in Action: Powering Sustainable Fermentation for Food, Pharma, and Bioeconomy2025-08-30OpenAlex10.22037/afb.v12i1.49836Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214957210
W4413846401Modeling Vaccine Hesitancy in a Dynamic World: Integrating Misinformation, Behavioral Shocks, and Policy Interventions in a Game-Theoretic Framework2025-08-30OpenAlex10.58445/rars.2995Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413846401
W4413915282The Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis—A Retrospective Study2025-08-30OpenAlex10.3390/antibiotics14090876Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413915282
W7115702937Therapeutic Potential of Autologous Fibrin Glue in Regenerative Dentistry: A Review2025-08-30OpenAlex10.5281/zenodo.17949866Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7115702937
W4413845841Vogt-Koyanagi-Harada Diseases Diagnosis by Means of Ocular Multimodal Imaging: A Case Report2025-08-30OpenAlex10.9734/or/2025/v20i5472Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413845841
W4414522845A Study on the Derivation of New Meanings in ‘Shua N’-Type Constructions under Prototype Category Theory2025-08-31OpenAlex10.25021/jcll.2025.8.153.99Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414522845
W4413929327Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease2025-08-31OpenAlex10.3390/gidisord7030057Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413929327
W4413857369FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON2025-08-31OpenAlex10.4084/mjhid.2025.057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413857369
W4414624754Streamline automated biomedical discoveries with agentic bioinformatics2025-08-31OpenAlex10.1093/bib/bbaf505Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4414624754
W4414258122Structural Violence and Medical Racism in Mojisola Adebayo’s Family Tree2025-08-31OpenAlex10.29163/jmed.2025.8.38.2.135Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414258122
W4414218181117 Rethinking health: mobilising the future health workforce from sick-care to systems change2025-09-01OpenAlex10.1136/ebm-2025-pod.117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414218181
W4414801536179PMethodology of the CINRG expanded Duchenne natural history study (eDNHS): assessing disease progression in the era of glucocorticoid and gene therapy treatments2025-09-01OpenAlex10.1016/j.nmd.2025.105532Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414801536
W441387072163259 Is it time to change the concept of difficult-to-treat areas?: Reflections on the POSITIVE study2025-09-01OpenAlex10.1016/j.jaad.2025.05.943Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413870721
W4416357885A Preferential Option for the Fugitive2025-09-01OpenAlex10.1111/rsr.18122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416357885
W4414245290Abstracts2025-09-01OpenAlex10.1111/anae.16748Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414245290; https://openalex.org/W7135183324; https://openalex.org/W4401634471; https://openalex.org/W4313649927
W4414040604Advances in Care for Burn and Hypertrophic Scar2025-09-01OpenAlex10.1097/sap.0000000000004448Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414040604
W4414676388Advances in the medical management of esophageal cancer: an updated narrative review2025-09-01OpenAlex10.21037/aoe-25-16Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414676388
W4413869512Analytical Performance Disclosure in JCV PCR: An Overdue Standard2025-09-01OpenAlex10.22541/au.175670486.65949584/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413869512
W4413905048Association of Anti-VEGF Therapy with Reported Ocular Adverse Events2025-09-01OpenAlex10.1016/j.oret.2025.08.018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413905048
W4413885826Breaking barriers in HIV management: the rise of long-acting lenacapavir2025-09-01OpenAlex10.1097/ms9.0000000000003775Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413885826
W4414333304Clinical Utility of PCR in Complicated Urinary Tract Infections: A Paradigm Shift in Diagnostics and Management2025-09-01OpenAlex10.1097/ju9.0000000000000353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414333304
W7108474156Consortium for Infection- and Immune-Mediated Movement Disorders in India: A Call to Action for Collaborative Discovery and Care2025-09-01OpenAlex10.4103/aomd.aomd_63_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108474156
W4414011431Design of LONGEVITI (LIVinG with chrONIc cancEr Therapies): A Narrative Arts-Based Study of Living with Advanced Cancers Treated with Targeted Therapy2025-09-01OpenAlex10.1177/16094069251376201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414011431
W7129504299Disease-Modifying Therapies in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy2025-09-01OpenAlex10.1016/j.oto.2026.101215Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129504299
W4413893920Downy Mildew Disease in Crops: A Comprehensive Review2025-09-01OpenAlex10.9734/ajahr/2025/v12i3403Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413893920
W4413868574Editorial: Natural products and nanotechnology: next-generation therapies for infectious diseases2025-09-01OpenAlex10.3389/fphar.2025.1682331Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413868574
W4413873059Editorial: Towards HRI of everyday life2025-09-01OpenAlex10.3389/frobt.2025.1657518Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413873059
W7117368930Epigenetics in disease prevention, cure, and treatment: Role of histone modifiers in immune modulation2025-09-01OpenAlex10.4103/ijpmmm.ijpmmm_12_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117368930
W4415022204Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) – Part 2: hepatitis B, C, and delta2025-09-01OpenAlex10.18683/germs.2025.1473Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415022204
W4417201157From Degenerative Pathology to Regenerative Therapy: Redefining the Pain Physician’s Role2025-09-01OpenAlex10.4103/ijpn.ijpn_179_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417201157
W4414406768Glucagon-like Peptide-1 Receptor Agonists: Multifaceted Agents for Cardiovascular Risk Reduction in Diabetes2025-09-01OpenAlex10.4103/jmr.jmr_48_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414406768
W4413877672Image‐guided therapies for uterine fibroids2025-09-01OpenAlex10.1002/ijgo.70493Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413877672
W4415356706Infectious Disease: Evolution, Mechanism and Global Health2025-09-01OpenAlex10.1242/dmm.052701Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415356706
W4413922439Inflammation-Responsive Hydrogels in Perioperative Pain and Wound Management: Design Strategies and Emerging Potential2025-09-01OpenAlex10.3390/gels11090691Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413922439
W4413920554Interaction with an AI Chatbot in Audiology Education as a Critical Learning Agent2025-09-01OpenAlex10.1097/01.hj.0001167888.15634.caTitle/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4413920554
W4414032129Iron and Manganese Azooxime Complexes as Anti‐Microbial Agents Against Antibiotics Resistant Wild Bacteria From Hospital Drainage2025-09-01OpenAlex10.1111/jcmm.70826Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414032129
W4413893866Lipoprotein(a): what clinicians need to know2025-09-01OpenAlex10.4081/cardio.2025.80Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413893866
W4415568730Long-term Management of Graves’ Disease: Balancing Clinical Effectiveness, Safety Considerations, and Patient-focused Treatment2025-09-01OpenAlex10.4103/bjem.bjem_33_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415568730
W4414167198Mechanisms, Clinical Trials, and New Treatments for BCG ‐Unresponsive in Nonmuscle Invasive Bladder Cancer2025-09-01OpenAlex10.1002/cam4.71243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414167198
W4414452578Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)2025-09-01OpenAlex10.1002/ardp.70102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414452578
W4415449761New Sincerity: American Fiction in the Neoliberal Age by Adam Kelly2025-09-01OpenAlex10.1215/0041462x-11983380Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415449761
W4414382447New directions in childhood obesity treatment – A path forward or wishful thinking?2025-09-01OpenAlex10.1016/j.jacl.2025.05.010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414382447
W4414382359Oncolytic viruses as anticancer agents: clinical progress and remaining challenges2025-09-01OpenAlex10.1016/s0140-6736(25)01206-1Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4414382359
W4414074752P06-13 Rivastigmine, Donepezil, and Memantine as Cognitive Enhancers in Neurodoping Practices and Their Implications in Clinical Toxicology2025-09-01OpenAlex10.1016/j.toxlet.2025.07.250Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414074752
W4414873892Persistent foreign body granuloma developing on the face following embolization agent and stent placement: A rare case report2025-09-01OpenAlex10.54029/2025ktwTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414873892
W4414409994Principles, applications and projections of ultrasound contrast2025-09-01OpenAlex10.32440/ar.2025.142.02.rev07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414409994
W7105698846Reasons of Passive social adjustment of the people in Khalil Mutran's poetry2025-09-01OpenAlex10.22075/lasem.2025.38091.1490Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7105698846
W4417201145Regeneration in Pain Medicine: Between Expectation and Evidence2025-09-01OpenAlex10.4103/ijpn.ijpn_201_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417201145
W4414894985Relaxivity and Cytotoxicity Studies of Efficient Imaging Probes of Metalloporphyrins (A Mini-Review)2025-09-01OpenAlex10.1134/s1070363225601863Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414894985
W4414033858Rheumatoid Arthritis Therapy Based on B Cells2025-09-01OpenAlex10.2147/dddt.s527687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414033858
W4414033605Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence‐Based Interventions2025-09-01OpenAlex10.1111/jocd.70432Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414033605
W4413890437Smart biomaterials in dentistry: A review on the role of cellulose and other biological macromolecules in infection control2025-09-01OpenAlex10.1016/j.ijbiomac.2025.147293Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413890437
W4414889414Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration2025-09-01OpenAlex10.2147/dddt.s546097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414889414
W4414811882The Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital2025-09-01OpenAlex10.36849/jdd.8965Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414811882
W4414533027The Evolution of Knifeless Microcolumn Fat Injection in 1362 Patients: Emphasizing Longevity of Results and Optimal Contour2025-09-01OpenAlex10.1097/gox.0000000000007118Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414533027
W4414340976The Evolution, Safety, and Public Perception of Sunscreens: A Historical and Contemporary Review2025-09-01OpenAlex10.1111/phpp.70055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414340976
W4414574139The Role of Postoperative Radiotherapy Based on Nomogram Risk Stratification Model in De Novo Metastatic Breast Cancer2025-09-01OpenAlex10.1016/j.ijrobp.2025.06.2536Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414574139
W4413902256Cognitive alignment in cardiovascular AI: designing predictive models that think with, not just for, clinicians2025-09-02OpenAlex10.3389/fcvm.2025.1651324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413902256
W4413948508FDA approval of imetelstat: a new era in the treatment of lower-risk myelodysplastic syndrome2025-09-02OpenAlex10.1097/ms9.0000000000003808Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413948508
W4414042715Investigational agents for ischaemic cardiomyopathy treatment: preclinical and early phase insights2025-09-02OpenAlex10.1080/13543784.2025.2558655Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414042715
W4413995866Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics2025-09-02OpenAlex10.1080/14712598.2025.2556911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413995866
W4413900987Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies2025-09-02OpenAlex10.3389/fneur.2025.1663136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413900987
W44139394083D human epithelial models: a promising platform for studying Candida infections and novel antifungal therapeutic options2025-09-03OpenAlex10.3389/fcimb.2025.1680261Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413939408
W4415834195A Scoping Review on Recent Advances in Antidiabetic Medications: From GLP-1 Receptor Agonists to Dual and Triple Agonists2025-09-03OpenAlex10.63623/8cv4gh26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415834195
W4414478200Health promotion in the algorithmic age: recognizing the information environment as a determinant of health2025-09-03OpenAlex10.1093/heapro/daaf166Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414478200
W4416443392Integration of basic sciences across the medical school curriculum: Innovative use of AI-powered interactive basic science nodes2025-09-03OpenAlex10.21955/mep.1115704.1Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4416443392
W4413952971LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer2025-09-03OpenAlex10.1158/0008-5472.can-25-0587Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4413952971
W4413959791Obstructive hydrocephalus due to high-volume liquid embolic agent embolization for management of pediatric arteriovenous malformations: illustrative case2025-09-03OpenAlex10.1007/s00381-025-06936-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4413959791
W4413951564Present and Future Perspectives in the Treatment of Liver Fibrosis2025-09-03OpenAlex10.3390/ph18091321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413951564
W4413961399Psychedelics and mental health: reimagining care through science, insight, and compassion2025-09-03OpenAlex10.3389/fphar.2025.1649929Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413961399
W4413954738Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy—Implications for Radiopharmaceutical Repurposing (Beyond Oncology)2025-09-03OpenAlex10.3390/pharmaceutics17091159Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413954738
W4413963432Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers2025-09-03OpenAlex10.1016/j.biopha.2025.118515Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413963432
W4413989226Guest editorial: The role of accounting and management control systems (MCS) in organisations' sustainability performance2025-09-04OpenAlex10.1108/jaar-08-2025-489Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413989226
W4414504442Navigating the future of artificial intelligence technologies for improving the care of older adults2025-09-04OpenAlex10.1093/geroni/igaf092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414504442
W4413998543The role of everolimus in malignant bone tumor therapy: Molecular mechanisms, preclinical evidence, and advances in clinical applications2025-09-04OpenAlex10.3389/or.2025.1630239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4413998543
W4414037161Advancements in Multi-Agent Large Language Model Systems for Next-Generation AI2025-09-05OpenAlex10.4018/979-8-3373-1419-8.ch002Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4414037161
W4414011238Advances in treatment strategies for low-grade serous ovarian cancer2025-09-05OpenAlex10.1016/j.ctrv.2025.103019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414011238
W4414221927Checkpoint Inhibitor Pneumonitis: Updates in Management2025-09-05OpenAlex10.18103/mra.v13i7.6740Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414221927
W4414018955From Pandemic to Persistence: Obesity, Immunity, and Next-Gen COVID-19 Vaccines2025-09-05OpenAlex10.38124/ijisrt/25aug1400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414018955
W4414011759Movements During Intended General Anesthesia and Psychologically Traumatic Accidental Awareness: Explanatory Role of the “Efference Copy Network”2025-09-05OpenAlex10.1213/ane.0000000000007722Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414011759
W4414011273Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017–20252025-09-05OpenAlex10.1136/thorax-2025-223096Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414011273
W4414047714Squamous Cell Lung Cancer: Review of Biochemical Aspects, Cellular Signals, and Pharmacological Treatments2025-09-05OpenAlex10.21608/ejchem.2025.400356.11995Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414047714
W4415171184The Current Clinical Application Status and Pharmacological Mechanism of Aspirin2025-09-05OpenAlex10.54097/5hr7dp28Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415171184
W4414017655The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?2025-09-05OpenAlex10.3390/biom15091284Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414017655
W4414032743Climbing to the Summit of Guideline Directed Therapy of Heart Failure:A Slippery Slope2025-09-06OpenAlex10.1016/j.amjcard.2025.09.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414032743
W7217628628Marginal Adaptation of Eggshell Powder Coalesced Calcium Hydroxide Sealer Using SEM; An In-Vitro Study2025-09-06OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7217628628
W4414043654Artificial intelligence in allergy and immunology: Recent developments, implementation challenges, and the road toward clinical impact2025-09-07OpenAlex10.1016/j.jaci.2025.08.022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414043654
W4414307063Atypical Breast Abscess in Pregnancy: A Case of E. coli and E. faecalis Co-Infection2025-09-07OpenAlex10.25251/x1s3j845Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414307063
W4414072461Large language models in nephrology: applications and challenges in chronic kidney disease management2025-09-07OpenAlex10.1080/0886022x.2025.2555686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414072461
W4415222868A Minimal Overlay-Based Framework for Transitioning Legacy Infrastructure to Zero Trust2025-09-08OpenAlex10.1109/cns66487.2025.11195028Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415222868
W4414068751Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo2025-09-08OpenAlex10.3390/biomedicines13092192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414068751
W4414072759Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023)2025-09-08OpenAlex10.3389/fcimb.2025.1629038Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414072759
W4414096166Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies2025-09-08OpenAlex10.3390/ijms26178747Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414096166
W4414059396Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation2025-09-08OpenAlex10.1007/s40259-025-00742-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414059396
W7124828812261Chapter 12 Future Directions and Emerging Trends in Computational Optimization Related to Data Science and Machine Learning2025-09-09OpenAlex10.1515/9783112219430-012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124828812
W4415463937Case report of refractory Hodgkin lymphoma with subsequent transformation to diffuse large B-cell lymphoma: A diagnostic and therapeutic challenge2025-09-09OpenAlex10.22146/inajbcs.v57i3.supplement.24345Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415463937
W4414148772Editorial: Formation of immunological niches in tumor microenvironments: mechanisms and therapeutic potential2025-09-09OpenAlex10.3389/fonc.2025.1675697Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414148772
W4414145626Evolving Paradigms in Psoriasis Treatment: Bridging Traditional Therapies with Technological Innovations2025-09-09OpenAlex10.52504/001c.143492Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414145626
W4414147301From Haemorrhagic Shock to Years of Survival: A Case Report of PIK3CA-Mutated Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer With Satellite Lesions2025-09-09OpenAlex10.7759/cureus.91888Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414147301
W4414210746Pharmacological Culprits of Hyperhidrosis: An Updated Review of Incidence, Mechanisms, and Management2025-09-09OpenAlex10.1002/der2.70052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414210746
W4414084718Rickettsia lanei, sp. nov. (Rickettsiales: Rickettsiaceae), a Newly Recognized Pathogen of Humans Associated with the Rabbit Tick, Haemaphysalis leporispalustris (Acari: Ixodidae)2025-09-09OpenAlex10.4269/ajtmh.25-0134Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414084718
W4414082095Statins in Acute Ischemic Stroke: Mechanisms, Resistance, and Precision Strategies for Neurovascular and Cognitive Protection2025-09-09OpenAlex10.1007/s40263-025-01222-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414082095
W4414148523Targeting the neuroimmune axis in glioblastoma: emerging strategies for precision immunotherapy2025-09-09OpenAlex10.3389/fimmu.2025.1661327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414148523
W4414089354The Contextual-Experiential Approach in ELT2025-09-09OpenAlex10.20944/preprints202509.0736.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414089354
W4414214943The Evolving Landscape of microRNAs in Cholangiocarcinoma and Pancreatic Cancer2025-09-09OpenAlex10.3390/diagnostics15182285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414214943
W4414143862Toward Weight-level Self-improving Agents with Meta-knowledge Discovery2025-09-09OpenAlex10.36227/techrxiv.175744083.37752625/v1Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4414143862
W4414094307Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host disease2025-09-10OpenAlex10.1016/j.coi.2025.102654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414094307
W4414091343Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents2025-09-10OpenAlex10.3390/pathogens14090911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414091343
W4414086641Editorial: Beyond traditional antibiotics: innovations in biologics, chemical modulators, and microbiome manipulation2025-09-10OpenAlex10.3389/fphar.2025.1679268Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414086641
W4415708602Enhancing Security in Internet of Medical Things (IoMT) using Reinforcement Learning and Federated Learning Approaches2025-09-10OpenAlex10.1109/icesc65114.2025.11212310Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415708602
W4414091769Feasibility of a reduced gadolinium dose protocol for MRI-guided radiotherapy in glioblastoma2025-09-10OpenAlex10.2340/1651-226x.2025.44022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414091769
W7125585221Federated Cognitive Infrastructure with Reinforcement Learning-Driven Governance: An Adaptive, Privacy-Preserving Architecture for Regulated AI Systems2025-09-10OpenAlex10.1109/resgenxai64788.2025.11344027Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125585221
W4415709048Hybrid Reinforcement Learning and Supervised Learning for Fault Detection and Tolerance in Cyber-Physical Systems2025-09-10OpenAlex10.1109/icesc65114.2025.11212250Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415709048
W4414269335INJECTABLE FILLERS AND THE ORAL MICROENVIRONMENT: FROM MUCOSAL REACTIONS TO IMPLANT HEALING FAILURE: A NARRATIVE REVIEW2025-09-10OpenAlex10.71000/d4qxe542Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414269335
W4414085335Nasal microbiome inhabitants with anti- Staphylococcus aureus activity2025-09-10OpenAlex10.1128/spectrum.01024-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414085335
W4414095464Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy2025-09-10OpenAlex10.3390/genes16091064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414095464
W4414129273A Comprehensive Review of Digestive Endoscopy-Associated Infections: Bacterial Pathogens, Host Susceptibility, and the Impact of Viral Hepatitis2025-09-11OpenAlex10.3390/microorganisms13092128Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414129273
W4414134286Anti-infective Drug Discovery: Harnessing Multimechanistic Molecules and Emergent Properties to Defeat Pathogenic Complexity2025-09-11OpenAlex10.1021/acs.jmedchem.5c02312Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414134286
W4414239902Are Nurses Free to Be Moral Agents? Revisiting the Moral Foundation of Nursing in Uncertain Times2025-09-11OpenAlex10.1097/ans.0000000000000591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414239902
W4414114230Comprehensive Update on Keloid Management2025-09-11OpenAlex10.1055/a-2698-3574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414114230
W4414138882Editorial: Management of rare oncological cases2025-09-11OpenAlex10.3389/fonc.2025.1668671Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414138882
W4414262332Editorial: Refractory and relapsed hemophagocytic lymphohistiocytosis in pediatric population: targeted therapy2025-09-12OpenAlex10.3389/fonc.2025.1691878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414262332
W4414146564Engineering the Colloidal Properties of Iron Oxide Nanoparticles for High T1 MRI Contrast at 64 mT2025-09-12OpenAlex10.1021/acsanm.5c03154Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414146564
W4414306964Guided multi-agent AI invents highly accurate, uncertainty-aware transcriptomic aging clocks2025-09-12OpenAlex10.1101/2025.09.08.674588Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4414306964
W7128739377Integrating Generative AI into Digital Transformation: A Unified Pilot-to-Production Framework for Key Economic Sectors2025-09-12OpenAlex10.1109/icerect65215.2025.11376210Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128739377
W4414261641Transforming the Management of Oligometastatic Non-Small Cell Lung Cancer in the Era of Immunotherapy and Targeted Therapy2025-09-12OpenAlex10.3390/cancers17182982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414261641
W4414084864[Immunomodulatory therapy in severe pneumonia: a double-edged sword in determining clinical outcomes].2025-09-12OpenAlex10.3760/cma.j.cn112147-20250505-00247Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414084864
W4414263891Immunotherapy in gastric adenocarcinoma – a rapidly evolving treatment landscape2025-09-13OpenAlex10.1016/j.critrevonc.2025.104941Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414263891
W4414260872Near-Infrared Fluorescence Imaging in General Surgery: Applications in Vascularization, Tumor Margin Detection, and Biliary Anatomy2025-09-13OpenAlex10.7759/cureus.92194Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414260872
W4414162510Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease2025-09-13OpenAlex10.1080/17512433.2025.2556122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414162510
W7133230893Ulcerative Colitis in the Modern Era: Pathogenesis, Evolving Therapies and Future Directions2025-09-13OpenAlex10.52794/hujpharm.1781660Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133230893
W4414168300What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technology2025-09-13OpenAlex10.1016/j.dld.2025.08.084Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414168300
W4414346979Genes, long non-coding RNAs, and nucleic-acid based therapies: how genetics is changing the present and future of cardiovascular diseases2025-09-14OpenAlex10.1093/eurheartj/ehaf650Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414346979
W4414204616The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review2025-09-14OpenAlex10.3390/jcm14186476Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414204616
W4414263322AI Agents and Autonomy2025-09-15OpenAlex10.1201/9781003651963-8Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4414263322
W7124461357Data Foundations in CADD: Structural Databases, Descriptors and Force Fields2025-09-15OpenAlex10.61096/978-81-990998-7-6_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124461357
W7214160479Dermatologic Therapeutics2025-09-15OpenAlex10.61096/978-81-981372-2-7_13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214160479
W4414255382Multifunctional Nanocarrier Drug Delivery Systems: From Diverse Design to Precise Biomedical Applications2025-09-15OpenAlex10.1002/adhm.202502178Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414255382
W7214232192Musculoskeletal and Bone Disorders2025-09-15OpenAlex10.61096/978-81-981372-2-7_15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214232192
W7214230122Ophthalmic and Otologic Pharmacology2025-09-15OpenAlex10.61096/978-81-981372-2-7_14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214230122
W4414257611Pharmaceutical Skin Care: Skin Structure, Barrier Function, and Advanced Drug Delivery Modes2025-09-15OpenAlex10.22270/jddt.v15i9.7364Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414257611
W4414167929Silent damage, early signals: A narrative review of the evolving role of cardiac biomarkers in oncology-driven cardiotoxicity2025-09-15OpenAlex10.1177/10815589251382263Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414167929
W4414226918CURRENT PERSPECTIVES ON THE MANAGEMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PEDIATRIC TRANSPLANTATION2025-09-16OpenAlex10.31435/ijitss.3(47).2025.3734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414226918
W4414243609Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review2025-09-16OpenAlex10.7759/cureus.92441Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414243609
W4414340969Indole therapeutics: Latest FDA updates, ongoing trials, and future directions2025-09-16OpenAlex10.1016/j.drudis.2025.104471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414340969
W7203573298Systems-Level Modeling of Cancer Evolution2025-09-16OpenAlex10.5281/zenodo.19549926Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203573298
W4414276143Beyond Antihistamines: How Biologic and Small‐Molecule Therapies Are Transforming Chronic Spontaneous Urticaria Care in Adults2025-09-17OpenAlex10.1007/s40261-025-01480-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414276143
W4414295529Current Clinical Trial Landscape of Gastroenteropancreatic Neuroendocrine Tumors: A New Era of Landmark Trials2025-09-17OpenAlex10.3390/jcm14186522Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414295529
W4414334298Decoding Cancer Stem Cells: A Game Change in Oncology Therapeutics2025-09-17OpenAlex10.22259/2638-5074.0501004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414334298
W4414299616Editorial: Biotic pest disturbance - risk, evaluation, and management in forest ecosystems2025-09-17OpenAlex10.3389/ffgc.2025.1665993Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414299616
W4414290874Editorial: Insights in pediatric nephrology2025-09-17OpenAlex10.3389/fped.2025.1671358Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414290874
W4414299604From tools to co-learners: entangled humanism and the co-evolution of intelligence in AI education2025-09-17OpenAlex10.3389/feduc.2025.1632990Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414299604
W4414257778Reversible cerebral vasoconstriction syndrome: not just a “reversible” condition. Retrospective observational study and literature review2025-09-17OpenAlex10.1016/j.hest.2025.09.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414257778
W4414451204Updates in endoscopic hemostasis for nonvariceal gastroduodenal bleeding2025-09-17OpenAlex10.1097/mog.0000000000001133Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414451204
W4414328437Chemopreventive Effect of Lupeol and Lupeol Nanoparticles2025-09-18OpenAlex10.1201/9781003600022-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414328437
W4414340090Emotional AI and the rise of pseudo-intimacy: are we trading authenticity for algorithmic affection?2025-09-18OpenAlex10.3389/fpsyg.2025.1679324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414340090
W4414331919The Nitrite-Amines Nexus in Nitrosamine Formation: Mechanisms, Mutagenic Implications, Regulations, and Root Causes in Medicines2025-09-18OpenAlex10.2174/0115680266379308250827055006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414331919
W7213995300Enigmas que se inventam quando a ayahuasca e a clínica se encontram: “Fale de mim para os acadêmicos”2025-09-19OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213995300
W4414381644GoCa: Trustworthy Multi-modal RAG with Explicit Thinking Distillation for Reliable Decision-Making in Med-LVLMs2025-09-19OpenAlex10.1007/978-3-032-05185-1_25Full textExcludedF4: Fixed GPT4o-mini agents critique/refine each example to build a fixed offline preference corpus. LLaVA-Med then receives DPO and CoT-DPO; no interactive clinical-agent training loop or retained cross-case execution-derived agent artifact is documented.https://openalex.org/W4414381644https://papers.miccai.org/miccai-2025/paper/0421_paper.pdfofficial MICCAI original accepted manuscript, complete methods and experiments; official repository observed empty
W4414377132Hypertension Unraveled: From Mechanisms to Modern Management2025-09-19OpenAlex10.38124/ijisrt/25sep335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414377132
W4414351537Management of Type 2 Diabetes Mellitus in Native Americans and Alaska Natives: A Systematic Review2025-09-19OpenAlex10.1007/s40615-025-02668-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414351537
W4414346950Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium2025-09-19OpenAlex10.1200/po-25-00377Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414346950
W4414378535Reimagining mental health: the role of artificial intelligence and brain computer interfaces in advancing mental health care2025-09-19OpenAlex10.18203/2394-6040.ijcmph20252940Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414378535
W4414346325Ripretinib in Advanced Gastrointestinal Stromal Tumors: A Case Series and Literature Review from a Tertiary Cancer Center in India2025-09-19OpenAlex10.1055/s-0045-1811940Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414346325
W4414366109Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting2025-09-19OpenAlex10.3389/fonc.2025.1631557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414366109
W4414353081Tumor Microenvironment and Its Role in Cancer Progression: An Integrative Review2025-09-19OpenAlex10.7759/cureus.92707Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414353081
W4414376826A Brief Overview on Multi-component Synthesis of Tri- and Tetra-substituted Imidazoles2025-09-20OpenAlex10.9734/ajocs/2025/v15i5394Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414376826
W4414787079Artificial Intelligence in Health Promotion: Computational Literature Review and Framework Development (Preprint)2025-09-20OpenAlex10.2196/preprints.84492Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414787079
W4414418287Harmony2025-09-22OpenAlex10.1007/978-3-032-06004-4_10Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4414418287
W4414401476Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy2025-09-22OpenAlex10.3389/fonc.2025.1649493Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414401476
W4414421921M$$^3$$Builder: A Multi-agent System for Automated Machine Learning in Medical Imaging2025-09-22OpenAlex2502.2030110.1007/978-3-032-06004-4_12Full textExcludedF4: M3Builder refines code from compiler feedback within the current model-building request, with initially empty code/feedback for the task. The output is a trained medical-imaging model; later use by another medical agent is proposed, without a demonstrated retained experience/skill update reused by the agent on different requests.https://openalex.org/W4414421921https://doi.org/10.1007/978-3-032-06004-4_12
W4414404481Modern Approaches to treatment of peptic ulcer in the practice of GPs from point of view of evidence - based medicine2025-09-22OpenAlex10.58676/sjmas.v3i6.134Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414404481
W4414407028Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review2025-09-22OpenAlex10.3390/jcm14186686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414407028
W4414406058Refining the Difficult-to-Treat ABPA Phenotype: Towards Mechanistic Insights and Stratified Therapies2025-09-22OpenAlex10.22541/au.175856319.93691472/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414406058
W4414380291Septic shock: Past, present, and perspectives2025-09-22OpenAlex10.1016/j.jcrc.2025.155269Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414380291
W4414446754Antibody-drug conjugates in metastatic urothelial cancer: Highway to heaven2025-09-23OpenAlex10.5306/wjco.v16.i9.106646Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414446754
W4414449013Diagnostic capabilities of cone-beam computed tomography with sialography2025-09-23OpenAlex10.17116/rosstomat20251803141Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414449013
W4414563664Evolutionary Double-Bind Treatment Using Radiation Therapy and Natural Killer Cell-Based Immunotherapy in Prostate Cancer2025-09-23OpenAlex10.1016/j.ijrobp.2025.09.034Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414563664
W4414420891Evolving perspectives on blood transfusion in obstetric hemorrhage: a narrative review2025-09-23OpenAlex10.4097/kja.25413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414420891
W4414437833FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation?2025-09-23OpenAlex10.1016/j.breast.2025.104589Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414437833
W4414443225Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape2025-09-23OpenAlex10.1080/14728214.2025.2565189Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414443225
W4414451293Hypoxia-Induced Metabolic Reprogramming in the Renal Tubules of Patients with Diabetic Kidney Disease and the Associated Traditional Chinese Medicine Intervention Strategies2025-09-23OpenAlex10.1097/imna-d-25-00019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414451293
W7104580380Integrative targeting of Bruton’s Tyrosine Kinase (BTK) and fibroblast growth factor receptor (FGFR) in lung cancer: A paradigm shift in precision oncology2025-09-23OpenAlex10.51470/bca.2025.25.2.1195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104580380
W4414436104Leptomeningeal Metastasis, an Evolving Frontier for Radiation Oncology2025-09-23OpenAlex10.1016/j.ijrobp.2025.08.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414436104
W4414578897Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials2025-09-23OpenAlex10.1016/j.phymed.2025.157285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414578897
W4414444748Remimazolam in pediatric anesthesia: a systematic review for clinical decision-making2025-09-23OpenAlex10.3389/fped.2025.1662752Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414444748
W7151583044Bio-Cybersecurity with AI2025-09-24OpenAlex10.1109/icosec67334.2025.11459645Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7151583044
W4414462427Detection and characterization of heteroresistance to chloramphenicol in Klebsiella pneumoniae isolates2025-09-24OpenAlex10.1186/s12866-025-04266-zTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414462427
W4414502467Discussion: Comparative Study of Inflammatory and Fibrotic Reactions Induced by Silicone Implants with Different Hardness2025-09-24OpenAlex10.1097/prs.0000000000012146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414502467
W4414519697Excoriation disorder: Etiopathogenesis, prevalence, symptoms, treatment2025-09-24OpenAlex10.18510/hssr.2025.13219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414519697
W7225007391Global Pharmacovigilance Trends 2025 and Beyond Leveraging AI, Real-Time Monitoring, and Predictive Analytics for Advanced Drug Safety2025-09-24OpenAlex10.5281/zenodo.23836218Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225007391
W4414624984Laxative logic: when lifestyle is not enough2025-09-24OpenAlex10.1097/mog.0000000000001137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414624984
W4414472051New drugs for the management of tuberculosis2025-09-24OpenAlex10.1097/qco.0000000000001156Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414472051
W4414564378Quantifying the carbon footprint of canine breed-specific surgical care in a veterinary referral setting2025-09-24OpenAlex10.1016/j.tvjl.2025.106451Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414564378
W4414473342Sustainable Synthesis of Silver Nanoparticles (Chemical vs Biological) and Their Antimicrobial Activity against Clinical Pathogens2025-09-24OpenAlex10.1021/acsomega.5c05917Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414473342
W4414471562Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management2025-09-24OpenAlex10.1097/mcp.0000000000001221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414471562
W4414500953A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of Staphylococcus aureus2025-09-25OpenAlex10.1146/annurev-pharmtox-062624-014243Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414500953
W4414516950Allergy and dermatology US treatment guidelines review for adults with atopic dermatitis2025-09-25OpenAlex10.1016/j.jacig.2025.100569Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414516950
W4414532092Cardiac imaging in oncology: the detection of cardiotoxicity2025-09-25OpenAlex10.1136/heartjnl-2024-323864Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414532092
W4414493967Emerging EGFR-Targeted Therapy in Head and Neck Cancer2025-09-25OpenAlex10.1001/jamaoncol.2025.3136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414493967
W4414519222Intra-nasal Nano drug delivery system: a non-invasive gateway to the brain2025-09-25OpenAlex10.70593/978-93-7185-149-7_6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414519222
W4414756353JAK-STAT Inhibitors: A Game Changer, from Rheumatology to Gastroenterology2025-09-25OpenAlex10.18103/mra.v13i9.6935Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414756353
W7220116180MANAGEMENT AND PREVENTION OF POST-VIRAL PULMONARY FIBROSIS IN CHILDREN: CURRENT APPROACHES AND FUTURE PERSPECTIVES2025-09-25OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220116180
W7151311435Mnestic functions restoration due to chronic brain ischemia pathogenetically oriented pharmacocorrection as a condition to enhance cerebral resistance2025-09-25OpenAlex10.12775/jehs.2025.85.70620Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151311435
W4414519107Navigating uncertainty in human interaction: A management science approach using Bayesian games in therapy2025-09-25OpenAlex10.1016/j.omega.2025.103430Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414519107
W4414498121Novel therapies in osteoporosis – Clinical update – 20252025-09-25OpenAlex10.1016/j.berh.2025.102100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414498121
W4414756377SLFN12 and Triple Negative Breast Cancer: Unlocking New Possibilities in Chemotherapy Response2025-09-25OpenAlex10.18103/mra.v13i9.6947Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414756377
W4414520712Scientometric analysis of glioblastoma and blood-brain barrier research (1995−2024): evolving trends and therapeutic challenges2025-09-25OpenAlex10.3389/fonc.2025.1649414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414520712
W4414494912Taiwan expert consensus on the clinical integration of antibody-drug conjugates in advanced breast cancer2025-09-25OpenAlex10.1016/j.soi.2025.100193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414494912
W7167069604The Role of Ivabradine in Heart Failure with Reduced Ejection Fraction: A Comprehensive Review2025-09-25OpenAlex10.47191/ijmscrs/v5-i09-22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167069604
W7112259736Acide hyaluronique : 90 ans d’innovation médicale : histoire, applications thérapeutiques et perspectives d’innovation en santé et biotechnologie2025-09-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7112259736
W4414532305Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer2025-09-26OpenAlex10.1007/s11864-025-01355-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414532305
W4414556370How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach2025-09-26OpenAlex10.1097/qco.0000000000001151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414556370
W4414531436Impact of two-level filtering organization on population’s accessibility to an emergency medical communication centre2025-09-26OpenAlex10.1186/s12873-025-01310-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414531436
W4414540283Melflufen Approved in EU, Withdrawn in U.S. for Multiple Myeloma2025-09-26OpenAlex10.1097/01.cot.0000000000000165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414540283
W4415138188Microneedles: A Promising Therapeutic Strategy for Next-Generation Drug Delivery, Diagnosis and Biosensing2025-09-26OpenAlex10.53941/mmr.2025.100005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415138188
W4414553437Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions2025-09-26OpenAlex10.3390/ijms26199398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414553437
W4414531473Surveillance of respiratory viruses in severe acute respiratory infections in Southern Brazil, 2023–20242025-09-26OpenAlex10.1186/s12879-025-11458-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414531473
W4414514977Targeting the crosstalk of metabolism reprogramming and replication stress: novel strategy to combat cancer2025-09-26OpenAlex10.1007/s12032-025-03053-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414514977
W4414586676Acanthamoeba keratitis: from pathophysiology to prevention – a contemporary clinical perspective2025-09-27OpenAlex10.51329/mehdiophthal1528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414586676
W4416635934Evolution of Treatment Patterns and Their Impact on Disease Progression in Systemic Sclerosis-associated ILD2025-09-27OpenAlex10.1183/13993003.congress-2025.oa1155Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416635934
W4414591202Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma2025-09-27OpenAlex10.1053/j.semnuclmed.2025.09.004Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4414591202
W7119504461Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae2025-09-27OpenAlex10.1093/cid/ciaf531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119504461
W7160658432Using Biomarkers in Dose-Finding Designs in Oncology2025-09-27OpenAlex10.17863/cam.129863Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160658432
W4414661006Individualizing SGLT2 inhibitors cardiovascular benefit in patients with type 2 diabetes: target trial emulation meets machine learning2025-09-28OpenAlex10.1093/eurjpc/zwaf625Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414661006
W4414583623The comet assay: A contemporary approach for detecting genomic instability2025-09-28OpenAlex10.1016/j.dnarep.2025.103899Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414583623
W4416184344A Reflective Architecture for LLM-Based Systems2025-09-29OpenAlex10.1109/acsos-c66519.2025.00029Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416184344
W4414601807ASO Author Reflections: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma2025-09-29OpenAlex10.1245/s10434-025-18456-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414601807
W4416074774Designing a novel peer-based decision aid to address perceived risk for HIV and PrEP interest among Black sexual minority men2025-09-29OpenAlex10.1093/her/cyaf045Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416074774
W4414602824Epidemiology of poisoning in elderly Iranians: a narrative review with global context2025-09-29OpenAlex10.1186/s12245-025-00989-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414602824
W4414611849Erythema ab igne—A Potential Cutaneous Marker of Chronic Heat Use in Patients with Endometriosis: A Narrative Literature Review and a Case Report2025-09-29OpenAlex10.3390/life15101533Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414611849
W4414616041Evolving MET-Directed Therapies in NSCLC: From Present Treatment to Innovative Future Approaches2025-09-29OpenAlex10.58502/dtt.25.0007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414616041
W7106259168Recent Advances in Cardiothoracic Anaesthesia: A Scoping Review of Innovations, Outcomes, and Future Directions2025-09-29OpenAlex10.82223/nja.vol2no2.48Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106259168
W4414587493Revolutionizing Dental Therapy: A Comprehensive Review on the Innovative Use of Natural Extracts in Tooth Care and Treatment2025-09-29OpenAlex10.2174/0122150838410159250909103512Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414587493
W4414791201Shining light on immunotherapy in metastatic urothelial carcinoma: trends and prospects2025-09-29OpenAlex10.1097/mm9.0000000000000025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414791201
W4415544537Artificial intelligence and pharmacy practice research: call to action2025-09-30OpenAlex10.1093/ijpp/riaf096Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415544537
W4414794464Cross-Species Boundaries and Human Rights: Legal and Ethical Reflections on Xenotransplantation2025-09-30OpenAlex10.12681/bioeth.42845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414794464
W4414677558Editorial: Understanding the role of microbiome in alteration of cellular metabolism and cancer development2025-09-30OpenAlex10.3389/fcimb.2025.1686038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414677558
W4414679003Experience-guided multi-agent interpretable framework for radiology report summarization2025-09-30OpenAlex10.1016/j.cmpb.2025.109078Full textIncludedIncluded: Clinical report-derived rules are iteratively selected and refined, retained and applied to different held-out radiology reports.https://openalex.org/W4414679003https://www.sciencedirect.com/science/article/abs/pii/S016926072500495X
W4414621592Fibrinolytic Therapy for Thromboembolic Diseases2025-09-30OpenAlex10.1016/j.jacc.2025.07.061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414621592
W4414674387First Large‐Scale Breakdown of Yr15 Resistance to Wheat Yellow Rust ( Puccinia striiformis f. sp. tritici ) Recorded Globally2025-09-30OpenAlex10.1002/ndr2.70067Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414674387
W4414659630In Reply: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Targeted Therapy: A Single-Center Experience2025-09-30OpenAlex10.1227/neu.0000000000003796Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414659630
W4414659658Letter: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience2025-09-30OpenAlex10.1227/neu.0000000000003795Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414659658
W4414751896Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes2025-09-30OpenAlex10.1007/s44313-025-00099-xTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4414751896
W4414669466Perinatal Management and Clinical Outcomes of Hereditary Angioedema in Japan: A Case Series and Comprehensive Literature Review2025-09-30OpenAlex10.1111/1346-8138.17979Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414669466
W4414668654Role of Antibody Therapy in Recurrent and Metastatic Cervical Cancer Treatment: A Review of the Literature2025-09-30OpenAlex10.38124/ijisrt/25sep1217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414668654
W4414757098The evolving threat of antimicrobial resistance in surgical site infections: Mechanisms, epidemiology, and innovative mitigation strategies2025-09-30OpenAlex10.53771/ijbpsa.2025.10.1.0072Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414757098
W4415426551#2789 Rituximab in treating steroid-sensitive nephrotic syndrome in children—experience from Uzbekistan2025-10-01OpenAlex10.1093/ndt/gfaf116.0235Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415426551
W4415423311#2935 Real-world treatment patterns of patients with immunoglobulin a nephropathy (IgAN) in the United States2025-10-01OpenAlex10.1093/ndt/gfaf116.1141Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415423311
W441495086921 News and views: Exciting new approaches in therapy, double-hit therapies, JAK inhibitors2025-10-01OpenAlex10.1136/lupus-2025-la.21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414950869
W4414749313A Comprehensive Approach to Myasthenia Gravis With Thymoma: A Case Report Highlighting Management of Myasthenic Crisis and Post‐Crisis Care2025-10-01OpenAlex10.1002/ccr3.71063Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414749313
W4415077887A Comprehensive Review of Treatment Outcomes in Lichen Planus Pigmentosus2025-10-01OpenAlex10.4103/cdr.cdr_115_23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415077887
W4415079737A Legacy of Safeguarding Health: Saudi Arabia’s Remarkable Commitment to a Disease-free Hajj and the Role of Vision 20302025-10-01OpenAlex10.4103/jnsm.jnsm_120_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415079737
W4416864911A New Era in Kidney Disease Treatment? Rapid Adoption of SGLT2 Inhibitors and GLP-1 Receptor Agonists Signals Shifting Paradigms2025-10-01OpenAlex10.1681/asn.2025wtenjrxaTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416864911
W7121612039A bibliometric analysis of human-agent collaboration in empathetic social agents: trends, influences, and research frontiers2025-10-01OpenAlex10.24191/mij.v6i2.9613Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7121612039
W4416066705APOL1 Genetic Testing, Family History of Hypertension and Kidney Disease, and Renal Risk Variant Distributions in a Midwestern US Cohort2025-10-01OpenAlex10.1681/asn.2025js7asnhrTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416066705
W4414766569Adulteration of Sports Supplements with Anabolic Steroids—From Innocent Athlete to Vicious Cheater2025-10-01OpenAlex10.3390/nu17193146Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414766569
W7124698916Algorithmic Oracles and Humanistic Dilemmas: Philosophical Reflections on Large Language Models in Medical Artificial Intelligence2025-10-01OpenAlex10.12014/j.issn.1002-0772.2025.20.01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124698916
W7127085056Antibody-Drug Conjugates (ADCs) for Breast Cancer Therapeutic Landscape: Concept and Mechanisms of Action2025-10-01OpenAlex10.4103/hemoncstem.hemoncstem-d-24-00042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127085056
W7108708921Are We Overusing Anti-vascular Endothelial Growth Factor? – Reflections on Treatment Burden and Real-World Outcomes2025-10-01OpenAlex10.4103/dljo.dljo_225_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108708921
W4416864915Bridging the Gap: Accelerating Slow Uptake of Novel CKD Therapies with Structured Optimization Clinics2025-10-01OpenAlex10.1681/asn.2025hcn1520qTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416864915
W4414735231CARDIOTOXICITY OF ONCOLOGICAL THERAPIES AND THEIR IMPACT ON RENAL AND METABOLIC FUNCTION2025-10-01OpenAlex10.70779/aijshs.v4i10.342Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414735231
W4415670271COMPARATIVE EFFECTIVENESS OF BRUTON`S TYROSINE KINASE INHIBITORS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SYSTEMATIC REVIEW2025-10-01OpenAlex10.1016/j.htct.2025.104356Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415670271
W7117451763Cardio-oncology at the crossroads of discovery, training, and global impact2025-10-01OpenAlex10.1097/cp9.0000000000000145Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117451763
W4414781967Considerations in the Diagnoses and Management of Hepatic Disease in Older Adults2025-10-01OpenAlex10.14309/ajg.0000000000003641.07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414781967
W7124236313Distributed Adaptive Multi-Drone Coordination At Scale2025-10-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124236313
W4415597376Evolving Landscape of Parenteral Anticancer Therapy–Associated Lung Toxicity: Incidence, Monitoring, and Management2025-10-01OpenAlex10.1200/oa-25-00105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415597376
W7132679111Evolving Paradigms in Pediatric Hemophilia Care: Advances, Challenges, AND GLOBAL Disparities2025-10-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132679111
W4416124619Faculty and Consultants Independent Presentations2025-10-01OpenAlex10.4103/jiag.jiag_87_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416124619
W4414690535Finding Bearings in the Fog: Optic Nerve Sheath Ultrasound for Pediatric ICP2025-10-01OpenAlex10.1097/01.eem.0000000000000124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414690535
W4415606668Flower of Endurance: An Ethnography of Opium’s Untold Role in Iran’s Capitalist Margins2025-10-01OpenAlex10.1017/irn.2025.10103Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415606668
W4415191460Forging forward: SG60 and Changi General Hospital at 902025-10-01OpenAlex10.4103/singaporemedj.smj-2025-122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415191460
W4414782178Gastro-Esophageal Disorders of the Geriatric Population2025-10-01OpenAlex10.14309/ajg.0000000000003641.05Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414782178
W4416845509Hepatorenal Syndrome – Acute Kidney Injury (HRS-AKI): Advances in Definition, Diagnosis and Management: Review Article2025-10-01OpenAlex10.21608/ejhm.2025.467718Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416845509
W7104309269Herbo-metallic Preparations: An Ethnopharmacological Bridge Between Traditional Wisdom and Modern Medical Science2025-10-01OpenAlex10.5281/zenodo.17543495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104309269
W4414700283Management of Retinopathy of Prematurity in the Anti-VEGF Era: Consensus and Recommendations From the Taiwan Pediatric Retina (TPR) Group2025-10-01OpenAlex10.1016/j.ajo.2025.09.050Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414700283
W7131346924Metabolic sabotage: The insulin–cancer conspiracy2025-10-01OpenAlex10.4103/jcsr.jcsr_90_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131346924
W7117364304Neurosurgical management of intracerebral hemorrhage in anticoagulated patients: Outcomes and reversal strategies2025-10-01OpenAlex10.4103/bc.bc_175_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117364304
W4415731562Objective Evaluation of Small Bowel Visualization Quality in Wireless Capsule Endoscopy Images Using Generative Adversarial Network2025-10-01OpenAlex10.4103/abr.abr_381_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415731562
W4414793988P018 Pharmacotherapy for OSA: a critical review of randomised placebo-controlled trials2025-10-01OpenAlex10.1093/sleepadvances/zpaf053.078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414793988
W4415519429P2.10.02 Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice.Registurk-Lung National Registry Study2025-10-01OpenAlex10.1016/j.jtho.2025.09.696Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415519429
W4414732526Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management2025-10-01OpenAlex10.1542/neo.26-10-060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414732526
W4414782144Practical Advice for the Management of Older Adults With Inflammatory Bowel Disease2025-10-01OpenAlex10.14309/ajg.0000000000003641.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414782144
W7117472690Prevalence Of Fluroquinolone Resistant Escherichia coli Isolates From Urine Samples2025-10-01OpenAlex10.21608/ejmr.2024.306500.1651Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117472690
W4416842028Preventive Gastroenterology: An Ounce of Prevention or Pounds of Cure to Curb Gastrointestinal Diseases2025-10-01OpenAlex10.4103/jme.jme_188_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416842028
W7108213273Progression of ANCA-Associated Vasculitis with Multiorgan Involvement Despite Immunosuppressive Therapy2025-10-01OpenAlex10.1681/asn.202590gtq906Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108213273
W4415670474RECENT ADVANCES IN THE FIELD OF HEMOPHILIA DIAGNOSIS AND TREATMENT2025-10-01OpenAlex10.1016/j.htct.2025.104970Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415670474
W4414893301Real-world treatment patterns, procedures, and subgroup variation in lung cancer–associated malignant pleural effusion.2025-10-01OpenAlex10.1200/op.2025.21.10_suppl.582Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414893301
W4415749856Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents2025-10-01OpenAlex10.1200/oa-25-00096Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4415749856
W4415718106Recent advancements in systemic therapy for biliary tract cancers: a literature review2025-10-01OpenAlex10.21037/jgo-2025-83Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415718106
W4415992794Reducing Occupational Hazards in Forensic Autopsy: A Novel Approach to Brain Removal via Craniotomy2025-10-01OpenAlex10.1177/09710973251389338Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415992794
W4414893201Rethinking systemic anti-cancer therapy in the last 14 days of life in the era of oral oncology.2025-10-01OpenAlex10.1200/op.2025.21.10_suppl.466Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414893201
W4416030621S1080 Transforming EoE Care in the Littles: Education on Early Adoption of Novel EoE Therapy2025-10-01OpenAlex10.14309/01.ajg.0001131780.39542.b1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416030621
W7111006547S1597 The Changing Landscape of Biologic Therapy in IBD: How Patient Preference for Subcutaneous Formulations Are Reshaping Ambulatory Infusion Centers (AIC): Single Center Survey Results From a High-Volume Community-Based AIC2025-10-01OpenAlex10.14309/01.ajg.0001133848.86967.d7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111006547
W7111128727S1720 Comparative Effectiveness of JAK Inhibitors vs Traditional Therapies in Moderate-to-Severe Ulcerative Colitis2025-10-01OpenAlex10.14309/01.ajg.0001134340.09488.99Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111128727
W4417197428S2043 Efficacy of Advanced Therapies for Naïve and Experienced Patients for Moderately-to-Severely Active Ulcerative Colitis: A Bayesian Network Meta-Analysis2025-10-01OpenAlex10.14309/01.ajg.0001135632.61091.90Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417197428
W4415540618S3700 Squamous Cell Carcinoma of the Sigmoid Colon: A Rare Late Presentation of Metastatic Urothelial Cancer With Squamous Differentiation of the Bladder2025-10-01OpenAlex10.14309/01.ajg.0001142260.53899.89Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415540618
W4415540662S3721 A Rare Case of Solitary Mesenteric Plexiform Neurofibroma2025-10-01OpenAlex10.14309/01.ajg.0001142344.65711.17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415540662
W4417171120S4943 Acute Fibrostenotic and Fistulizing Ileal Crohn’s Disease: Timing of Biologic Therapy in the Setting of Obstruction and Infection2025-10-01OpenAlex10.14309/01.ajg.0001147232.59573.0cTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417171120
W4417202610S5570 Perplexing Severe Cholestasis in the Post-Partum Period2025-10-01OpenAlex10.14309/01.ajg.0001149740.92828.35Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417202610
W4417202343S5620 Vanishing Bile Duct Syndrome Following Oxaliplatin-Based Chemotherapy: A Rare Hepatotoxic Complication2025-10-01OpenAlex10.14309/01.ajg.0001149940.56281.24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417202343
W7114767742S5880 Challenging the Dogma: Reversal of End-Stage Liver Fibrosis With Tirzepatide in MASH Cirrhosis2025-10-01OpenAlex10.14309/01.ajg.0001150980.09519.07Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7114767742
W4416030800S964 Trends in Incidence, Survival, and Emerging Therapies in Esophageal Cancer: A SEER-Based Analysis From 2000 to 20212025-10-01OpenAlex10.14309/01.ajg.0001131316.51280.0aTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416030800
W4415453055SAT-302 Acquired Resistance to Breast Cancer Therapy is a Dynamic Multi-step Evolutionary Process2025-10-01OpenAlex10.1210/jendso/bvaf149.2445Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415453055
W4415453519SUN-210 The role of transcriptional reprogramming and genomic alterations in the transition from chemo-sensitive to chemoresistant triple-negative breast cancer2025-10-01OpenAlex10.1210/jendso/bvaf149.1868Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415453519
W4416266758SY18-3 Innovation in antibody-drug conjugates2025-10-01OpenAlex10.1016/j.annonc.2025.08.064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416266758
W4416266820SY20-4 Treatment strategies for MSI-H gastric cancer2025-10-01OpenAlex10.1016/j.annonc.2025.08.066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416266820
W4415420923Targeting Heart Disease in Cardiovascular–Kidney–Metabolic Syndrome: A Review of Novel Therapeutic Approaches with Prognostic and Quality-of-Life Impact2025-10-01OpenAlex10.55453/rjmm.2025.128.6.9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415420923
W4415910895Targeting Prostate Cancer with Lipid Nanoparticles: A Comprehensive Review of Current Advances and Future Prospects2025-10-01OpenAlex10.21608/erurj.2025.384731.1280Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415910895
W4416821219The Role of Anti-vascular Endothelial Growth Factor (anti-VEGF) in Retinopathy of Prematurity (ROP)2025-10-01OpenAlex10.4103/tjosr.tjosr_136_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416821219
W4414703159The crossroads of Amantadine from antiviral to neurotherapeutic: Bibliometric mapping of six decades of therapeutic evolution2025-10-01OpenAlex10.7324/japs.2025.v15.i12.16Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414703159
W7131359424The human element – Overcoming cognitive biases in antimicrobial prescribing2025-10-01OpenAlex10.4103/jcsr.jcsr_157_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131359424
W7154597366Time to Thrombolysis in Left-sided Prosthetic Valve Thrombosis: Reaffirming the Critical Window2025-10-01OpenAlex10.4103/heartviews.heartviews_146_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154597366
W4414713506Unraveling angioedema: diagnostic challenges and emerging therapies2025-10-01OpenAlex10.3389/fimmu.2025.1681763Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414713506
W4414646521Vascular Access and Complications in Critical Illness2025-10-01OpenAlex10.4037/ccn2025483Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414646521
W4415474462Venous Thromboembolism Prophylaxis in Nephrotic Syndrome: Survey of Real-World Physician Practice2025-10-01OpenAlex10.1681/asn.2025y96n40hcTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415474462
W7124227316[Unusual presentation of Crohn disease associated with hemophagocytic lymphohistiocytosis syndrome: a case report].2025-10-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124227316
W7114914348“Less is More” – We Need to Think of the Patients First2025-10-01OpenAlex10.4103/ijkd.ijkd_70_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114914348
W4414753181Challenges in the management of multidrug-resistant Gram-negative bacterial meningitis in children: a decade of clinical insights2025-10-02OpenAlex10.1186/s12887-025-06098-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414753181
W4414747686Editorial: Immunometabolic alterations linked to affective disorders and other mental illnesses2025-10-02OpenAlex10.3389/fpsyg.2025.1699733Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414747686
W4416249176Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape2025-10-02OpenAlex10.1080/14728214.2025.2590155Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416249176
W4414748623From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson’s Disease Therapies2025-10-02OpenAlex10.3390/biology14101349Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414748623
W4414771870Rapidly and reproducibly building a comprehensive catalogue of resistance-associated variants for M. tuberculosis2025-10-02OpenAlex10.1101/2025.10.02.679941Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414771870
W4414757021The evolving chemistry of cADPR analogues: from marine discovery to calcium signaling tools2025-10-02OpenAlex10.1016/j.bioorg.2025.109055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414757021
W4415196913Belantamab mafodotin for the treatment of multiple myeloma2025-10-03OpenAlex10.1080/14712598.2025.2576502Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415196913
W4414771250Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation2025-10-03OpenAlex10.3389/fonc.2025.1648230Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414771250
W4414777758Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic2025-10-03OpenAlex10.1038/s41564-025-02142-0Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4414777758
W7104398205Discretizaton Theory for Hybrid Intelligence Systems2025-10-03OpenAlex10.5281/zenodo.17553462Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7104398205
W7135195843Eravacycline: from clinical trials to its potential place in everyday therapy2025-10-03OpenAlex10.1097/qco.0000000000001157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135195843
W7131761895Factors that help medical students recognize role models in Bolan medical college, Quetta : A qualitative study2025-10-03OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131761895
W4414790319Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer2025-10-03OpenAlex10.1016/j.otc.2025.08.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414790319
W4414940158Obesity and hypertension new insights in management2025-10-03OpenAlex10.1097/hco.0000000000001261Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414940158
W4414792989Spinal Cord Infarction Presenting as Cauda Equina Syndrome With Concurrent Pulmonary Embolism: A Case Report2025-10-03OpenAlex10.7759/cureus.93778Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414792989
W4414781757Surgical Oncology2025-10-03OpenAlex10.1097/xcs.0000000000001569Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414781757
W4415479867The Evolution of Agentic AI: From Rule-Based Systems to Autonomous Agents2025-10-03OpenAlex10.71097/ijsat.v16.i4.5112Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415479867
W4414808625A Trust-Aware Architecture for Personalized Digital Health: Integrating Blueprint Personas and Ontology-Based Reasoning2025-10-04OpenAlex10.1007/s10916-025-02255-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414808625
W4414801289Anti-inflammatory agents for the management of COPD - Quo Vadis?2025-10-04OpenAlex10.1016/j.rmed.2025.108396Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4414801289
W4414801782Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study2025-10-04OpenAlex10.1016/j.ejca.2025.116034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414801782
W4414802301Evolving Strategies in the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Narrative Review of Locoregional and Surgical Therapies2025-10-04OpenAlex10.1016/j.tvir.2025.101081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414802301
W4414850873Hormonal Therapy Patterns in Older Men with Prostate Cancer in the United States, 2010–20192025-10-04OpenAlex10.3390/cancers17193231Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414850873
W4415588220A Review on Nitrosamine Impurities in Pharmaceutical Products2025-10-05OpenAlex10.69613/qn1fmm61Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415588220
W4414833856Host Modulation in Periodontology: Redefining Therapy Beyond Scaling and Root Planing2025-10-05OpenAlex10.7759/cureus.93880Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414833856
W4414934249Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapy2025-10-05OpenAlex10.1016/j.bmcl.2025.130427Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414934249
W4415816031Agentic Artificial Intelligence for Prior Authorization Workflows in Healthcare2025-10-06OpenAlex10.32996/jcsts.2025.7.10.11Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415816031
W4414873593Cardiopulmonary Collaboration in Respiratory Care: Shifting the Paradigm2025-10-06OpenAlex10.58931/crt.2025.1214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414873593
W4414861571Editorial: Climate mobility modeling: methodological advances and future prospects2025-10-06OpenAlex10.3389/fclim.2025.1704343Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414861571
W4414857512Fertility-Sparing Practices in Uterine Malignancies: A Literature Review2025-10-06OpenAlex10.1177/10424067251384464Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414857512
W4414860703Pharma’s subtle conditioning in clinical medicine2025-10-06OpenAlex10.1016/j.ejim.2025.106537Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414860703
W4414838803Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma2025-10-06OpenAlex10.36401/jipo-25-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4414838803
W4414841762Recent Updates in the Management of Chronic Hypertension in Pregnancy2025-10-06OpenAlex10.1007/s13669-025-00437-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414841762
W4415464670Treatment Options for HR-Positive, HER2-Negative Advanced Breast Cancer: Focus on Capivasertib2025-10-06OpenAlex10.36000/hbt.oh.2025.25.188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415464670
W4414982871Updates in Pet Reptile Infectious Diseases2025-10-06OpenAlex10.1016/j.cvex.2025.07.007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414982871
W4414934216When LLMs Recognize Your Space: Research on Experiences with Spatially Aware LLM Agents2025-10-06OpenAlex10.1109/tvcg.2025.3616809Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4414934216
W4415409151Carrying the torch of Nightingale”™s legacy into health reform: A nursing perspective2025-10-07OpenAlex10.31603/jhns.v12i2.14199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415409151
W4414886389Conventional and precision medicine: opposites or complementary ends?2025-10-07OpenAlex10.3389/fsci.2025.1701495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414886389
W7103903965Double Trouble: Lynch Syndrome and KRAS Mutation in a Young Male With Stage IV Colon Adenocarcinoma2025-10-07OpenAlex10.48448/3dwb-1777Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7103903965
W4414918616Editorial: Chatbots as humanlike text generators: friend or foe?2025-10-07OpenAlex10.3389/fhumd.2025.1706740Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414918616
W7103890214First Look: NSCLC Genetic Mutations in a Previously Uncharacterized South Carolina Cohort2025-10-07OpenAlex10.48448/x8fw-cf55Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7103890214
W7103885821Systems Genetics Approach for Repurposing FDA-Approved Drugs against Early-stage Human Pancreatic Ductal Adenocarcinoma2025-10-07OpenAlex10.48448/e4n8-xz78Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7103885821
W7103893352Systems Genetics Approach for Repurposing FDA-Approved Drugs against Late-stage Human Pancreatic Ductal Adenocarcinoma2025-10-07OpenAlex10.48448/kda4-9558Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7103893352
W7103890386Unmasking Latent Autoimmune Diabetes: A case that challenges Type 2 Diabetes2025-10-07OpenAlex10.48448/12vv-w090Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7103890386
W4414964369Barney Brooks: The Unrecognized Hero behind 100 Years of Peripheral Angiography2025-10-08OpenAlex10.4103/ijves.ijves_58_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414964369
W4414941308Cirrhotic portal vein thrombosis as a vascular rather than a thrombotic disorder2025-10-08OpenAlex10.1097/hep.0000000000001565Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414941308
W4414925296Editorial: Opportunities and challenges in drug repurposing2025-10-08OpenAlex10.3389/fphar.2025.1709217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414925296
W7117258820Enhancing Personal Healthcare through AI-Driven DNA Analysis and Public Health Data Integration2025-10-08OpenAlex10.1109/itis67966.2025.11308844Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7117258820
W7167257387Imposter Syndrome or a Wrong Diagnosis? - Exploring the Experiences of Graduate Teaching Assistants2025-10-08OpenAlex10.82191/pp.114Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167257387
W4415171558SPECTROCOLORIMETRIC ASSESSMENT OF THE DEGREE OF GINGIVAL INFLAMMATION IN PATIENTS WITH PERIIMPLANTITIS DURING THERAPEUTIC AND PREVENTIVE MEASURES2025-10-08OpenAlex10.24061/2413-4260.xv.3.57.2025.20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415171558
W4414997971Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis2025-10-09OpenAlex10.7759/cureus.94172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414997971
W4415044513Clinical Advances in Extracellular Volume Measurement by Cardiac Computed Tomography and Magnetic Resonance Imaging: Current Status and Future Perspectives2025-10-09OpenAlex10.20944/preprints202510.0729.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415044513
W4414983299Harnessing the potential of graphene quantum dots in emerging biomedical applications: interaction mechanisms, multifunctional roles, and future perspectives2025-10-09OpenAlex10.1088/2752-5724/ae03dbTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414983299
W4414979213Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer2025-10-09OpenAlex10.1016/j.euo.2025.09.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414979213
W4414981584Risk of Herpes Zoster and Opportunistic Infections with Treatments for Autoimmune Rheumatic Disease2025-10-09OpenAlex10.1007/s40674-025-00235-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4414981584
W4415002106The Role of Osteoporosis in Spine Surgery and Current Management Strategies: A Review2025-10-09OpenAlex10.1007/s11914-025-00930-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415002106
W4415161108Brighter days ahead: the shifting landscape of IBD therapy2025-10-10OpenAlex10.1097/mog.0000000000001139Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415161108
W7216987359COMPREHENSIVE INSIGHTS INTO ORAL CANCERS & TUMORS: DIAGNOSTIC ADVANCEMENTS, MICROBIAL ASSOCIATIONS, & THERAPEUTIC STRATEGIES2025-10-10OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216987359
W4415050775Euthanasia Techniques in Companion Animals2025-10-10OpenAlex10.1002/9781394266098.ch12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415050775
W4415033085Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD2025-10-10OpenAlex10.1681/asn.0000000867Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415033085
W7225014999Global Healthcare & Medical AI 2026 and Beyond Advanced AI Tools & Innovations Shaping the Future of Clinical Decision Making & patient Outcomes.2025-10-10OpenAlex10.5281/zenodo.23830310Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7225014999
W4415017963Herbal approaches for the treatment of glioblastoma2025-10-10OpenAlex10.1016/b978-0-443-33319-4.00008-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415017963
W4415018143New galenic formulations of melatonin and therapeutic applications2025-10-10OpenAlex10.1016/b978-0-443-30240-4.00013-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415018143
W4415148148Od broni chemicznej do chemioterapii. Badania polskich lekarzy nad iperytem azotowym w latach 1947–19522025-10-10OpenAlex10.4467/0023589xkhnt.25.001.22271Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415148148
W4415014850Pharmacologic treatment of fibromyalgia: an update2025-10-10OpenAlex10.3389/fphar.2025.1651181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415014850
W4415077645Laboratory Diagnosis of Lupus Anticoagulants: A Systematic Review of Assay Performance, Pre-analytical Challenges, and Clinical Utility2025-10-11OpenAlex10.70070/q03b8c43Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415077645
W4415083297Probability Distribution for Rare Neutral Mutations in Cancers and Application to Dynamic Precision Medicine of Cancer2025-10-11OpenAlex10.1101/2025.10.10.681641Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415083297
W4415063955Therapeutic Advances in Hereditary Angioedema: A Focus on Present and Future Options2025-10-11OpenAlex10.1007/s12325-025-03382-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415063955
W7225020018Global Obesity Epidemic 2026 and Beyond Emerging Trends, Innovative Therapeutics and Lifestyle Strategies for Sustainable Weight Management, Lifelong Health, Disease Prevention and a Healthier Future.2025-10-12OpenAlex10.5281/zenodo.23830058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225020018
W4415100523Cardiac Toxicities of Cancer Therapies: From Traditional Agents to Emerging Targets in Cardio-Oncology2025-10-13OpenAlex10.1007/s12170-025-00777-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415100523
W4415098155Deploying next-generation artificial intelligence ecosystems for real-time biosurveillance, precision health analytics and dynamic intervention planning in life science research2025-10-13OpenAlex10.30574/msabp.2025.16.1.0066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415098155
W4415098186Editorial: Biomacromolecule systems for enhanced therapeutic delivery in medical implants2025-10-13OpenAlex10.3389/fbioe.2025.1700914Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415098186
W4415120686Efficacy and Safety of Low-Dose ATG Plus Basiliximab Induction in Deceased Donor Kidney Transplantation2025-10-13OpenAlex10.3389/ti.2025.15321Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415120686
W4416300119Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility2025-10-13OpenAlex10.62046/gijams.2025.v03i05.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416300119
W4415106372Incretin Mimetics and Cardiovascular Events—The Evolving Comparative Effectiveness Landscape2025-10-13OpenAlex10.1001/jamanetworkopen.2025.37304Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415106372
W4415206459Integrating Emotional Stress and Lipid Lowering in Cardiovascular Disease Management: The Future of Precision Cardiovascular Prevention2025-10-13OpenAlex10.3390/jcm14207208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415206459
W7127225167Psychostimulant Medications for the Treatment of Cocaine Use Disorder: A Clinical Review2025-10-13OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127225167
W4415232534BIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells2025-10-14OpenAlex10.1093/bioinformatics/btaf571Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415232534
W7125097304BanditMatch: A Game-Theoretic Approach for Stable Preference Matching in Peer-to-Peer Federated Learning2025-10-14OpenAlex10.1109/flta67013.2025.11336289Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125097304
W4415161109Bridging the osteoporosis care divide2025-10-14OpenAlex10.1097/01.jaa.0000000000000275Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415161109
W4415137424Editorial: Reviews in: ophthalmology 20242025-10-14OpenAlex10.3389/fmed.2025.1706229Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415137424
W7130555079Large Language Models for Task Automation: A Comprehensive Review of Techniques and Implementation Challenges2025-10-14OpenAlex10.1109/ictc66702.2025.11387844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130555079
W4415218203Molecular epidemiological characterization of enterotoxigenic and enteroaggregative Escherichia coli causing traveller’s diarrhoea and their association with persistence of symptoms2025-10-14OpenAlex10.1093/jtm/taaf110Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415218203
W4415164299Mosaic pattern: lung functional heterogeneity at the alveolus level2025-10-14OpenAlex10.1101/2025.10.13.682072Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415164299
W7130896951Relatório de estágio e monografia intitulado "Tratamento do cancro melhorado com a entrega sinérgica de três fármacos em plataformas nanométricas multifuncionais"2025-10-14OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130896951
W4415137318Therapeutic Trends in Diabetes Management: A Review on Oral Hypoglycemic Agents (OHAs) Utilization in Tertiary Care2025-10-14OpenAlex10.2174/011871529x414055250924050309Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415137318
W4415936426A Human Rights-Based Approach to Justice in Social Work Practice . Shirley Gatenio Gabel2025-10-15OpenAlex10.1093/sw/swaf040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415936426
W4415230762AI Managing Agent-Based Healthcare Processes2025-10-15OpenAlex10.1609/aies.v8i2.36617Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415230762
W4415215063Editorial: Precision immunotherapy and novel target discovery in hematological malignancy2025-10-15OpenAlex10.3389/fimmu.2025.1703886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415215063
W4415183192Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond2025-10-15OpenAlex10.1186/s43066-025-00464-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415183192
W4415243573Precision navigation through the labyrinth: overcoming EGFR resistance in non-Small cell lung cancer2025-10-15OpenAlex10.1080/07853890.2025.2574526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415243573
W4415225781Professional autonomy in pharmacists: Independence within interdependence2025-10-15OpenAlex10.1016/j.sapharm.2025.10.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415225781
W4415204541Sex- and Gender-Based Differences in Asthmatic Responses to Chemical Sensitizers, Particularly in Occupational Settings: A Scoping Review2025-10-15OpenAlex10.3390/environments12100382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415204541
W4415224823The Evolving Role of Adjuvant TKI in Lung Cancer2025-10-15OpenAlex10.1016/j.thorsurg.2025.08.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415224823
W4415211844Valorization of Date Seed Waste for Sustainable Dermocosmetic Sunscreens: Phytochemical Insights and Formulation Advances2025-10-15OpenAlex10.3390/cosmetics12050225Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415211844
W7125597864Advances in histamine-mediated allergy management: Expanding perspectives on cetirizine’s therapeutic, safety, and toxicological implications2025-10-16OpenAlex10.46439/toxicology.7.042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125597864
W4416367505Federated Intelligence in Immersive Technologies: Systematic Review of Privacy, Agents and Metaverse2025-10-16OpenAlex10.1109/icoa66896.2025.11236955Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416367505
W4415268214Global Research Trends and Hotspots of Contrast- Enhanced Ultrasound in Tumor Diagnosis: A Bibliometric Analysis (2000–2025)2025-10-16OpenAlex10.26689/par.v9i5.12269Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415268214
W4415263724Sociodemographic Factors, Intent-Uptake Disparities, and Nirsevimab Availability in Infant RSV Immunoprophylaxis2025-10-16OpenAlex10.3390/pediatric17050109Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415263724
W4415236600The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management2025-10-16OpenAlex10.37349/emed.2025.1001365Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415236600
W4415259062Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine2025-10-16OpenAlex10.18632/oncotarget.28772Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415259062
W4415278291Chemotherapy: A powerful weapon in ovarian cancer treatment2025-10-17OpenAlex10.1016/b978-0-443-33536-5.00005-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415278291
W4415278607Clinical translation and regulations of theranostics2025-10-17OpenAlex10.1016/b978-0-443-22253-5.00028-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415278607
W4415298895Future perspectives2025-10-17OpenAlex10.1016/b978-0-443-29930-8.00006-0Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4415298895
W4415298781IVF and pregnancy outcomes: the triumphs, challenges, and unanswered questions2025-10-17OpenAlex10.1186/s13048-025-01692-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415298781
W4416065948Innovative Nasal Drug Delivery Systems for Effective Brain Targeting and Blood-Brain Barrier Overcoming2025-10-17OpenAlex10.63785/cpr.2025.1.3.296307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416065948
W4415272546Managing invasive fungal infections in critical illness: reflections on recent American Thoracic Society recommendations2025-10-17OpenAlex10.1016/j.ejim.2025.106549Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415272546
W7124925794Non-Invasive Blood Pressure Prediction from PPG: A Reinforcement Learning-Gated Mixture of Experts Approach2025-10-17OpenAlex10.1109/icmlca66850.2025.11336416Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124925794
W4415276702PAL: Designing Conversational Agents as Scalable, Cooperative Patient Simulators for Palliative‑Care Training2025-10-17OpenAlex2507.0212210.1145/3715070.3749250Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4415276702
W4415460726Reclassification of Cytokine-Based Immune- Mediated Inflammatory Diseases: Mechanisms and Therapeutic Advances of IL-1-Driven Inflammatory Diseases2025-10-17OpenAlex10.26689/jcnr.v9i9.12338Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415460726
W7111831146Reimagining Learning, Integrity, and Creativity in the Age of AI: A Discussion with Summit Contributors2025-10-17OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7111831146
W4415303212TGF-β–driven T-cell exclusion in ovarian cancer: single-cell and spatial transcriptomic views of immune low-response states2025-10-17OpenAlex10.3389/fimmu.2025.1698088Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415303212
W7217772061THE TRAINING OF PHARMACY PROFESSIONALS AND THEIR EDUCATIONAL CONTRIBUTIONS IN BREAST CANCER CARE2025-10-17OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7217772061
W4415305571Therapies and Pipeline for Hepatitis B and Hepatitis D2025-10-17OpenAlex10.1016/j.cld.2025.06.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415305571
W7155700470Biosecurity and Bioterrorism: The Legal Framework and Response to Biological Threats2025-10-18OpenAlex10.54117/rp1dty58Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155700470
W4415331314The Disruptive Impact of Agentic AI on Medical Schools2025-10-18OpenAlex10.30953/thmt.v10.639Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415331314
W7131071882DCEtriformer: A Hybrid Attention Transformer for DCE-MRI Synthesis in Prostate Imaging2025-10-19OpenAlex10.1109/iccvw69036.2025.00116Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131071882
W4415337660Generative Responsiveness in Assistive Care Ecosystem - GRACE2025-10-19OpenAlex10.1007/978-3-032-05673-3_25Full textExcludedF1: GRACE is explicitly a framework under development. The primary abstract describes conceptual foundations, initial functional design and collaboration scenarios with future assessment, without a built/evaluated persistent-improving LLM system.https://openalex.org/W4415337660https://link.springer.com/chapter/10.1007/978-3-032-05673-3_25Publisher abstract and author-institution abstract only; full chapter not read.
W7131079343Magnol.AI Copilot: Multimodal LLMs for Natural, Accessible Data Interaction2025-10-19OpenAlex10.1109/iccvw69036.2025.00237Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7131079343
W7124143323Redefining Faculty in the Age of Artificial Intelligence: Implications for Medical Education2025-10-19OpenAlex10.24321/2278.2044.202531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124143323
W7115943065Bortezomib in multiple myeloma management2025-10-20OpenAlex10.18051/univmed.2025.v44.380-393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7115943065
W4415364114Editorial: Response/resistance to PD-1 axis inhibitors: focus on the tumor microenvironment2025-10-20OpenAlex10.3389/fimmu.2025.1720955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415364114
W7112145452Evaluation of Stress Echocardiography Delivery in the UK2025-10-20OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7112145452; https://openalex.org/W7163204503
W4415367099Future Factories With 6G: Agentic AI and Cyber–Physical Digital Twins2025-10-20OpenAlex10.1109/jiot.2025.3623075Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4415367099
W4417169909Integrating Reinforcement Learning and Game Theory for Strategic Decision-Making in Cancer Therapy2025-10-20OpenAlex10.1109/sita67914.2025.11273719Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417169909
W4415354750Polygalae Radix extracts show anti-Parkinson's disease effects and reduce depression-like symptoms by modulating energy metabolism2025-10-20OpenAlex10.1016/j.jep.2025.120759Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415354750
W4415355892Strengthening Nursing Research Capacity to End the HIV Epidemic: Qualitative Insights of the Mid-Atlantic Center for AIDS Research Nursing Initiative Symposium2025-10-20OpenAlex10.1097/jnc.0000000000000593Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415355892
W4415361374Sustained-Release Intra-Articular Drug Delivery: PLGA Systems in Clinical Context and Evolving Strategies2025-10-20OpenAlex10.3390/pharmaceutics17101350Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415361374
W7113147000Towards Logical Reasoning and Learning in Open and Dynamic Environments2025-10-20OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7113147000
W4415404354AI and the Public Health Enterprise: From Interest to Action2025-10-21OpenAlex10.1097/phh.0000000000002226Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415404354
W4416233437Detecting Dependability Failures in Healthcare Scenarios via Digital Shadows2025-10-21OpenAlex10.1109/issre66568.2025.00056Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416233437
W4415380215Dr. Lloyd Novick’s Editorial Stewardship in Public Health Informatics: The Journey of a Trailblazer2025-10-21OpenAlex10.1097/phh.0000000000002272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415380215
W4415389954Improving understanding and management of acute heart failure, myocarditis, pericarditis, amyloidosis, mitochondrial cardiomyopathies, hypertrophic cardiomyopathy, and takotsubo syndrome2025-10-21OpenAlex10.1093/eurheartj/ehaf782Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415389954
W4415374842Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy2025-10-21OpenAlex10.1007/s00134-025-08151-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415374842
W4415397311Managing Your Career2025-10-21OpenAlex10.1097/nur.0000000000000933Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415397311
W4415405888Melasma Management: A Review of Current Treatment Options2025-10-21OpenAlex10.3126/njdvl.v23i2.83895Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415405888
W7131076729Pathogenic response mechanisms to host and therapeutic stress: Challenges in advanced medical microbiology2025-10-21OpenAlex10.56936/18290825-2025.19v.4-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131076729
W4415507670WEE-family kinases in cancer: synthetic lethal interactions and drug discovery2025-10-21OpenAlex10.1016/j.tips.2025.09.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415507670
W4415444396Abstract B055: XPO1-dependent nuclear export as a therapeutic target for ALK-positive non-small cell lung cancers2025-10-22OpenAlex10.1158/1535-7163.targ-25-b055Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415444396
W4415444233Abstract C070: Evolving Paradigms and shifting priorities in the landscape of Phase 1 Oncology Trials: 2021–20242025-10-22OpenAlex10.1158/1535-7163.targ-25-c070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415444233
W4415437568Abstracts of the International Society of Liver Surgeons, 6th Congress of International Advanced HBP Surgery 2025 (ISLS 2025)2025-10-22OpenAlex10.1097/js9.0000000000003583Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415437568
W4415444146Agent-Based Prediction of Digital Ecosystem Emergence in Medical Tourism under Evolving Greater Bay Area Data Regulation2025-10-22OpenAlex10.54254/2755-2721/2025.28118Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4415444146
W4415653558Diagnostic and therapeutic advances in MDS2025-10-22OpenAlex10.5603/ahp.108270Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415653558
W4415419055Editorial: Current chemical approaches in combating neuroinflammation in Alzheimer's disease (AD)2025-10-22OpenAlex10.3389/fnagi.2025.1712601Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415419055
W4415413860Green-synthesized Plectranthus amboinicus silver nanoparticles with broad-spectrum biological activities2025-10-22OpenAlex10.1007/s44340-025-00041-yTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415413860
W4415438976Optimization of upfront therapy for adult acute lymphoblastic leukemia: a paradigm shift toward immunotherapy2025-10-22OpenAlex10.1007/s12032-025-03093-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415438976
W7125580971Personalized Multi-Agent Recommendation System for Monitoring and Coaching through Wearable and Non-Invasive Sensors2025-10-22OpenAlex10.1109/metroxraine66377.2025.11340155Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7125580971
W4415419032Reframing chronic wound therapy: from growth factor delivery to regenerative immuno-engineering2025-10-22OpenAlex10.3389/fimmu.2025.1683591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415419032
W4415428554Response to “Occult constipation in pediatric IBS and FAP‐NOS: Considerations on the recent ESPGHAN/NASPGHAN guidelines”2025-10-22OpenAlex10.1002/jpn3.70231Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415428554
W4415435485The 2025 KDIGO IgA nephropathy guideline update: an ERA Immunonephrology Working Group perspective2025-10-22OpenAlex10.1093/ckj/sfaf324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415435485
W4415427527The fungus among us: Emerging and re-emerging fungal infections2025-10-22OpenAlex10.1016/j.amjms.2025.10.011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415427527
W7112976910Advancing Nursing Leadership Through NURS FPX 90002025-10-23OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7112976910
W4415454761Contemporary management of advanced chronic kidney disease: An evidence-based review2025-10-23OpenAlex10.1016/j.ejim.2025.106557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415454761
W4417129848EVOLVING TREATMENT STRATEGIES FOR RECURRENT APHTHOUS ULCERS: A COMPREHENSIVE REVIEW2025-10-23OpenAlex10.58240/1829006x-2025.21.9-523Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417129848
W4415457672Editorial: Methods in pediatric infectious diseases 20242025-10-23OpenAlex10.3389/fped.2025.1712605Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415457672
W4415462622Emerging Applications of Stereotactic Ablative Radiotherapy in Oligometastatic Colorectal Cancer2025-10-23OpenAlex10.3390/ijms262110302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415462622
W4415460402Interleukin‐13 inhibition and cancer risk: reply to Tang and Chen2025-10-23OpenAlex10.1111/ddg.15999Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415460402
W4415458302Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy2025-10-23OpenAlex10.3390/cimb47110878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415458302
W4415466839SEOM–GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025)2025-10-23OpenAlex10.1007/s12094-025-04080-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415466839
W4415489967Small-Molecule GLP-1 Receptor Agonists: A Promising Pharmacological Approach2025-10-23OpenAlex10.3390/medicina61111902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415489967
W4415622398The Building of a Nation: Leadership Lessons from Tata2025-10-23OpenAlex10.1097/prs.0000000000012294Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415622398
W4415516990Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development2025-10-24OpenAlex10.1016/s1473-3099(25)00547-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415516990
W4415494734Green-synthesized silver nanoparticle hydrogels for biofilm-infected wounds: Bridging sustainability and clinical translation2025-10-24OpenAlex10.3389/fphar.2025.1694144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415494734
W4415684177Inflammation, Apoptosis, and Fibrosis in Diabetic Nephropathy: Molecular Crosstalk in Proximal Tubular Epithelial Cells and Therapeutic Implications2025-10-24OpenAlex10.3390/cimb47110885Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415684177
W4415586956Legends, dogmas, presumptions, and demystifications in antibiotic therapy2025-10-24OpenAlex10.37201/req/s01.11.2025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415586956
W7197684747N-substituted chitosan derivatives as a gene delivery system : synthesis, structural investigations, and ocular applications2025-10-24OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7197684747
W4415559897Navigating Treatment Sequencing in Advanced HR+/HER2− Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies2025-10-24OpenAlex10.3390/ijms262110366Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415559897
W4415551782Novel Therapeutic Approaches to Neuroinflammation in Neurodegenerative Disorders: Aptamers as Central Nervous System Agents2025-10-24OpenAlex10.2174/0118715249392444251002135338Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415551782
W4415503341Occupational Asthma Due to Subtilisin: The Power of Specific Inhalation Challenge2025-10-24OpenAlex10.23749/mdl.v116i5.17219Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415503341
W7219312006Pathophysiology of Diabetes Mellitus and Recent Advances in Its Treatment: An Integrative Review2025-10-24OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219312006
W4415543384Smart Drug Delivery Systems: Current Technologies, Clinical Applications, and Future Perspectives in Precision Therapeutics2025-10-24OpenAlex10.38124/ijsrmt.v4i10.912Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415543384
W4415516794Unlocking the metabolic and anti-inflammatory therapeutic potential of lactate in critically ill patients2025-10-24OpenAlex10.1186/s13054-025-05665-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415516794
W4415493826What is New in Contact Allergy To Cosmetics for Physicians, Cosmetologists, and Cosmetic Users?2025-10-24OpenAlex10.1007/s11882-025-01226-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415493826
W7113455086AI-Mediated Cyberincivility in Health Professions Education: An Evolutionary Concept Analysis2025-10-25OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7113455086
W4415540304Can Gene Therapy Transform the Treatment Landscape of Posterior Segment Eye Diseases? A Comprehensive Review of Recent Advancements2025-10-25OpenAlex10.1007/s40265-025-02237-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415540304
W7133139581Global Burden and Evolving Therapeutic Strategies in Diabetes Mellitus: A Comprehensive Review2025-10-25OpenAlex10.5281/zenodo.17605340Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133139581
W4415539213Historical advancements in targeted nanoscale drug delivery systems2025-10-25OpenAlex10.1016/b978-0-443-24802-3.00020-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415539213
W4415545116Smart microneedle platforms for skin cancer therapy: a review of stimuli-responsive and targeted drug delivery systems2025-10-25OpenAlex10.1080/10837450.2025.2580499Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415545116
W4415551275Exploring LLM-based Agentic Frameworks for Fault Diagnosis2025-10-26OpenAlex10.36001/phmconf.2025.v17i1.4350Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4415551275
W4415555908Improving Medical Chatbot Performance: A Comparative Evaluation of Retrieval-Augmented Generation and Fine-Tuning2025-10-26OpenAlex10.1007/978-3-032-01970-7_33Full textExcludedF4: The described comparison uses fixed-domain dataset fine-tuning and document RAG; experience-derived retriever/agent adaptation is future work.https://openalex.org/W4415555908https://link.springer.com/chapter/10.1007/978-3-032-01970-7_33publisher complete abstract only, no public methods located
W7216067653Research on the Pathways and Mechanisms of AI Agents Empowering Teacher TPACK Development2025-10-26OpenAlex10.3968/13923Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216067653
W7224984180Bad B*tch Morphosyntax2025-10-27OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224984180
W4415566795Clinicopathological insights and management of liver metastases: Current advances and future perspectives2025-10-27OpenAlex10.4254/wjh.v17.i10.110026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415566795
W4415565715Comprehensive management: Paradigm shift of care for psoriasis2025-10-27OpenAlex10.1097/cm9.0000000000003799Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415565715
W4415567238Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy2025-10-27OpenAlex10.3389/fphar.2025.1694322Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415567238
W4415569380Evolving landscape of small-molecule immunotherapeutics for uveitis: a scoping review2025-10-27OpenAlex10.1016/j.drudis.2025.104515Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415569380
W4416136065Human-on-the-loop continual learning: data, knowledge and agents for model adaptation2025-10-27OpenAlex10.5821/dissertation-2117-445821Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4416136065
W4415588960New Insights into the Radiation Biology of Radiotheranostics2025-10-27OpenAlex10.1201/9781032668413-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415588960
W4416538274Prospects for improving the Bacillus anthracis monitoring system and developing new strategies for soil and environmental remediation2025-10-27OpenAlex10.36016/vm-2025-111-3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416538274
W4415591081Thrombosis and cancer what do the recommandations say2025-10-27OpenAlex10.1007/s00280-025-04826-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415591081
W4415648792Unlike Tobacco Users, Documented Cannabis Users Are Not at an Increased Risk of Adverse Events After Total Hip Arthroplasty2025-10-27OpenAlex10.5435/jaaos-d-24-00811Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415648792
W4415648397Update on the Management of Helicobacter pylori Infection in Children and Adolescents2025-10-27OpenAlex10.1007/s11894-025-01021-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415648397
W4415588673Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia2025-10-27OpenAlex10.1080/14656566.2025.2582022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415588673
W4415609335An update on antimicrobial selection and duration for intra-abdominal infections2025-10-28OpenAlex10.1080/14787210.2025.2580451Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415609335
W4415606450Atherosclerotic renal artery stenosis in the post-CORAL Trial Era. A narrative review2025-10-28OpenAlex10.1016/j.cpcardiol.2025.103205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415606450
W4415608587Gaze that shamed science: Canine defiance and the ethics of experimental physiology2025-10-28OpenAlex10.1136/medhum-2025-013346Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415608587
W4415622018Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models2025-10-28OpenAlex10.1177/07067437251389090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415622018
W4415645862Lessons From COVID ‐19 on Inborn Errors of Immunity: A Five‐Year Narrative Review2025-10-28OpenAlex10.1111/sji.70064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415645862
W4415625799Mechanisms of Resistance to Novel Immunotherapies in B-Cell Lymphomas: Focus on CAR T and Bispecific Antibodies2025-10-28OpenAlex10.3390/cancers17213453Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415625799
W4415615286Smart Healthcare Photonic Nanomaterials and Devices2025-10-28OpenAlex10.1002/adma.202518886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415615286
W4415682309Agents of innovation? Institutional conditions shaping nurse students’ positions in practice development2025-10-29OpenAlex10.63564/jnep.v15n10p47Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415682309
W4415657577Changing paradigms in diabetes: Scientific breakthroughs of the past 15 years2025-10-29OpenAlex10.3329/jacedb.v4i20.84908Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415657577
W4415677480Complement-targeting therapies in hemolytic diseases2025-10-29OpenAlex10.1016/j.coi.2025.102686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415677480
W4415649428Editorial: Cellular immunotherapy: transforming cancer treatment2025-10-29OpenAlex10.3389/fimmu.2025.1724025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415649428
W4415650567Evaluating the role of ChatGPT in rehabilitation medicine: a narrative review2025-10-29OpenAlex10.3389/fdgth.2025.1618510Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415650567
W4415664866High-resolution melting analysis in veterinary medicine: a systematic review of applications and diagnostic accuracy2025-10-29OpenAlex10.1007/s11250-025-04709-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415664866
W4415673435Human knowledge-enhanced large language model agent for prediction of intestinal disease progression in patients with Crohn's disease: A multicenter retrospective study2025-10-29OpenAlex10.1016/j.metrad.2025.100186Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4415673435
W4415657479Modern care for congenital adrenal hyperplasia: New horizons in management2025-10-29OpenAlex10.3329/jacedb.v4i20.84896Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415657479
W4416986313Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitis2025-10-29OpenAlex10.1097/meg.0000000000003052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416986313
W7219496300The Effectiveness of Xavron in the Treatment of Ischemic Stroke in the Acute Period2025-10-29OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7219496300
W4415732127Transthyretin Amyloid Cardiomyopathy: The Plot Thickens as Novel Therapies Emerge2025-10-29OpenAlex10.15420/usc.2025.11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415732127
W4415700263Activatable smart contrast agents for photoacoustic imaging2025-10-30OpenAlex10.1002/smo2.70024Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415700263
W4415722869Chronic Rhinosinusitis: Review of Endotypes and Clinical Implications2025-10-30OpenAlex10.1177/01455613251361248Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415722869
W4415711196Clinical management of liver cancer patients with immune checkpoint inhibitors treatment2025-10-30OpenAlex10.1080/20450923.2025.2578079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415711196
W4415684430Editorial: Infections in the intensive care unit, volume III2025-10-30OpenAlex10.3389/fmed.2025.1719505Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415684430
W4415693724FROM GLYCEMIC CONTROL TO SYSTEMIC EFFECT: A CURRENT VIEW OF THE ROLE OF INHIBITORS SGLT2 IN THE THERAPY OF POLYMORBID PATIENTS (part 1)2025-10-30OpenAlex10.52058/2786-4952-2025-10(56)-2310-2323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415693724
W7219109192Fatal Multisystem Toxicity and Vesiculobullous Eruptions Following Brake Fluid Poisoning: A Case Report2025-10-30OpenAlex10.22037/ijmtfm.v15i4.49459Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7219109192
W7143533652Higher-Gauge, Dynamical Symmetry Geometry of Savant-Phase Cognition: A Biochemistry-to-Geometry Theory with Dimensionless and Dimensionful Predictions and an Empirical Test Protocol2025-10-30OpenAlex10.5281/zenodo.19329365Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143533652
W4415684471Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence2025-10-30OpenAlex10.3389/fimmu.2025.1692916Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415684471
W4415720005Inflammatory Bowel Disease: Understanding Therapeutic Effects of Distinct Molecular Inhibitors as the Key to Current and Future Advanced Therapeutic Strategies2025-10-30OpenAlex10.3390/biomedicines13112667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415720005
W4415705745Polymeric Microneedles as Analytical Interfaces for Biosensing and Controlled Drug Release: Achievements and Future Challenges2025-10-30OpenAlex10.30744/brjac.2179-3425.letter-n50Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415705745
W4415704552Staphylococcal enterotoxins in cancer immunotherapy: An overview of translational advances and targeting strategies2025-10-30OpenAlex10.1016/j.prp.2025.156283Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415704552
W4415685365Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation2025-10-30OpenAlex10.3389/fimmu.2025.1702860Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415685365
W4415692947Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities2025-10-30OpenAlex10.1002/ctd2.70095Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415692947
W4415699194Transformative Autoethnography for Practitioners: Change Processes and Practices for Individuals and GroupsBy Kathy‐Ann C.Hernandez, HeewonChang, and Wendy A.Bilgen, Gorham, Maine: Myers Education Press, 2022. 176 pp. $36.95 (paperback). ISBN: 978‐1‐975504‐87‐82025-10-30OpenAlex10.1111/aeq.70055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415699194
W4415705016Treatment of Type 2 Diabetes: A Comprehensive Review of Recent Improvements, Therapeutic Strategies, Challenges, and Future Perspectives2025-10-30OpenAlex10.33590/emjdiabet/rkyo7834Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415705016
W4415884964AI in Everything, and Everything in AI: A Review of the Ubiquitous Role of Artificial Intelligence in Shaping the Next Technological Epoch2025-10-31OpenAlex10.69996/jcai.2025024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415884964
W4416163949Collaborative Agentic AI for Personalized Treatment Protocol Optimization: Autonomous Clinical Decision Networks2025-10-31OpenAlex10.63282/3050-9246/icrtcsit-122Full textExcludedF3: The ACDN architecture trains domain agents with multi-agent reinforcement learning on synthetic clinical environments, federated parameter aggregation, causal models and graph-based reasoning. The described architecture and methodology do not implement an LLM/VLM acting agent.https://openalex.org/W4416163949https://doi.org/10.63282/3050-9246/ICRTCSIT-122
W7105600878Enhancing Time Series Forecasting using DRL with attention-based neural architectures2025-10-31OpenAlex10.63282/3050-9246/icrtcsit-111Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7105600878
W4415738161Gearshift Fellowship: A Next-Generation Neurocomputational Game Platform to Model and Train Human-AI Adaptability2025-10-31OpenAlex10.1007/978-3-032-10518-9_23Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415738161
W4415726254Health Administration2025-10-31OpenAlex10.1002/9781118410868.wbehibs028.pub2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415726254
W4415771030INDICAÇÕES CLÍNICAS DO CLAREAMENTO DENTAL EM DENTES VITAIS2025-10-31OpenAlex10.69849/revistaft/ar10202510310049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415771030
W4416346692PHARMACOLOGIC THERAPY OF POSTMENOPAUSAL OSTEOPOROSIS: AN UPDATED NARRATIVE REVIEW OF GUIDELINES AND EVIDENCE2025-10-31OpenAlex10.21474/ijar01/22034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416346692
W4415717508Pathologic fractures in primary bone tumors: a paradigm shift in management2025-10-31OpenAlex10.1016/j.injury.2025.112853Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415717508
W4415989951Predictors of the use of moral prohibition by university students: the context of an ethically loaded situation and personal characteristics2025-10-31OpenAlex10.17759/pse.2025300508Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415989951
W7116061306Quantamental Portfolio Allocators: Deriving Alpha from Fundamental Metrics with ML2025-10-31OpenAlex10.5281/zenodo.17971625Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7116061306
W4415740906RNA‐Based Agents as Therapeutics2025-10-31OpenAlex10.1002/0471266949.bmc307Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4415740906
W4416853882Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database2025-10-31OpenAlex10.1016/j.clml.2025.10.026Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416853882
W4415773914Systematic Review - Chemistry & Clinical Importance of Anticancer Drugs, Plus Recent Advances in Discovery2025-10-31OpenAlex10.22214/ijraset.2025.74892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415773914
W4415749221The Dual State: Artificial Intelligence, Authoritarian Control, and the Crisis of Youth in Bangladesh (2014-2024)2025-10-31OpenAlex10.22541/au.176194054.49910899/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415749221
W4415755226Upconversion nanoparticles for drug and gene delivery2025-10-31OpenAlex10.1016/b978-0-443-26661-4.00015-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415755226
W4416780669281P Development and validation of a living decision support tool (Living-DST) in non-small cell lung cancer (NSCLC) using agentic AI-augmented systematic literature review (SLR)2025-11-01OpenAlex10.1016/j.esmorw.2025.100477Full textExcludedF4: The report describes a fixed annotation manual, task decomposition, within-task self-debugging and daily accumulation of external literature/guidelines. It does not document an experience-derived retained change to the annotation/manual/prompt procedure. The distinct breast-cancer Living-OEP article’s feedback-update mechanism was not imported into this NSCLC report.https://openalex.org/W4416780669https://doi.org/10.1016/j.esmorw.2025.100477Complete published conference abstract read on the primary publisher page; no longer methods component is supplied.
W7117104352A Cross-Disease Framework for Modern Diagnosis, Risk Stratification, and Treatment of Adult Leukemias2025-11-01OpenAlex10.61882/tcr.202501.01.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117104352
W4416380844A Reflection of literature reports on Synthesis, Spectral Studies, Multilateral applications of Azo dyes2025-11-01OpenAlex10.1016/j.rechem.2025.102878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416380844
W7117405741A comprehensive review on skin benefits of Ayurvedic Kumkumadi oil2025-11-01OpenAlex10.22271/plants.2025.v13.i6c.1996Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117405741
W7131735890AI Empowerment of Medical Libraries for Promoting Accessible Reading of Evidence-Based Health Guidelines2025-11-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131735890
W4416921635Abstract 359: Complex Case of Managing Recurrent Vasospasms and Feverssecondary to Subarachnoid Hemorrhage and Ruptured Left Anterior Communicating Artery Aneurysm in a Patient with uniqueNeuro‐vascular Anatomy2025-11-01OpenAlex10.1161/svi270000_359Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416921635
W4416921685Abstract 372: Rapidly Progressive and Reversible Parkinsonism Secondary to Bilateral Subdural Hematomas2025-11-01OpenAlex10.1161/svi270000_372Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416921685
W4416921689Abstract 373: iCURE CSDH Registry: Evaluating Coil‐Based Middle Meningeal Artery Embolization for Chronic Subdural Hematoma2025-11-01OpenAlex10.1161/svi270000_373Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416921689
W4416133160Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders2025-11-01OpenAlex10.2147/jbm.s543272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416133160
W7127580474Antiplatelets and hemorrhagic MI outcome in reperfused STEMI2025-11-01OpenAlex10.1093/eurheartj/ehaf784.1778Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127580474
W4415937444Aspergillosis of the Vocal Cord—A Close Mimicker of Vocal Cord Malignancy2025-11-01OpenAlex10.1097/ipc.0000000000001505Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415937444
W7104269994BIOENHANCERS IN DRUG DEVELOPMENT: CURRENT TRENDS AND FUTURE DIRECTIONS2025-11-01OpenAlex10.5281/zenodo.17540878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104269994
W4416775079BONE/SOFT TISSUE2025-11-01OpenAlex10.4103/jcrt.jcrt_2268_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416775079
W4416141160CNSC-12. NEUROTOXICITY AND NEURO-CARCINOGENESIS OF NANOMATERIALS: THE STATE OF THE ART IN RECENT LITERATURE?2025-11-01OpenAlex10.1093/neuonc/noaf201.0220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416141160
W4416399020Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China2025-11-01OpenAlex10.1177/17588359251395906Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416399020
W4416084996EPCO-49. SPATIAL TRANSCRIPTOMICS ILLUMINATES MECHANISMS OF MONOTHERAPY FAILURE IN GLIOBLASTOMA BY MAPPING TARGET EXPRESSION ACROSS TUMOR REGIONS2025-11-01OpenAlex10.1093/neuonc/noaf201.0048Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416084996
W7106846460Evidence-based Ayurveda interventions for sustainable obesity management: Efficacy, safety, and long-term outcomes2025-11-01OpenAlex10.4103/jdras.jdras_328_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106846460
W4416428753Expanding the Toolbox2025-11-01OpenAlex10.34067/kid.0000000927Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416428753
W4415756024Fever, Weight Loss, and Headache in a 17-Year-Old Boy2025-11-01OpenAlex10.1542/pir.2023-006175Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415756024
W4416099391From immunosenescence to diastolic dysfunction: tracing the senescence cascade in heart failure with preserved ejection fraction2025-11-01OpenAlex10.1093/cvr/cvaf220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416099391
W4416772422Global insights into the management of BCG-unresponsive non-muscle invasive bladder cancer: a narrative review of provider surveys2025-11-01OpenAlex10.21037/tau-2025-661Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416772422
W4416195714Illuminating the genomic frontier of invasive non‐typhoidal Salmonella infections2025-11-01OpenAlex10.1002/ctm2.70526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416195714
W4416457037Immune insights and toxicity testing: an interview with Jeff Yoder2025-11-01OpenAlex10.1242/dmm.052639Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416457037
W7127734375Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study2025-11-01OpenAlex10.1093/eurheartj/ehaf784.1765Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127734375
W4416573606Ivarmacitinib: A Novel Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis—Letter to the Editor2025-11-01OpenAlex10.1111/1756-185x.70486Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416573606
W4415758695Multidisciplinary strategies and new technologies in the management of sarcoidosis2025-11-01OpenAlex10.1016/j.ejim.2025.106576Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415758695
W4416447087Novel Lineages of SARS-CoV-2 Receptor Binding Domain Monoclonal Antibodies Demonstrate Broad and Potent Neutralization Across SARS-CoV-2 and Other Sarbecoviruses 92062025-11-01OpenAlex10.1093/jimmun/vkaf283.2638Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416447087
W4416028779Occurrence of antibiotics and heavy metal co-resistant plasmids among Pseudomonas species isolated from waste sites in Delta State communities: A public health recall2025-11-01OpenAlex10.1016/j.hazmp.2025.100011Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416028779
W7106313795P-240 Not just a ‘noctor’! The evolving role of the advanced nurse practitioner in hospice care: driving integration, innovation, and impact2025-11-01OpenAlex10.1136/spcare-2025-huk.257Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106313795
W4415894336P004 From skin to spine: a case of isotretinoin-induced spondyloarthropathy2025-11-01OpenAlex10.1093/rap/rkaf111.033Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415894336
W4415894039P006 Polymyalgic-onset axial spondyloarthritis: a diagnostic challenge in older adults2025-11-01OpenAlex10.1093/rap/rkaf111.035Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415894039
W4415893808P015 This one ‘struck a cord’: when clinical history matters more than the MRI2025-11-01OpenAlex10.1093/rap/rkaf111.044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415893808
W4415892787P033 Severe gouty arthropathy masquerading as inflammatory arthritis in a middle-aged mixed ethinicity woman with heart failure: a complex multisystem presentation2025-11-01OpenAlex10.1093/rap/rkaf111.062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892787
W4415894322P035 Joint decision-making: individualised gout care in the dialysis setting2025-11-01OpenAlex10.1093/rap/rkaf111.064Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415894322
W4415892891P040 A success story - treatment of refractory check point inhibitor-induced myositis2025-11-01OpenAlex10.1093/rap/rkaf111.069Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892891
W4415892681P041 Recurrent nocturnal headache as the presenting feature of neurosarcoidosis in a child with Blau syndrome2025-11-01OpenAlex10.1093/rap/rkaf111.070Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892681
W4415893765P049 Mr CP; a case of rapidly evolving neurology2025-11-01OpenAlex10.1093/rap/rkaf111.078Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415893765
W4415892991P060 Unmasking myositis in a complex overlap syndrome2025-11-01OpenAlex10.1093/rap/rkaf111.089Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892991
W4415892832P061 Immune checkpoint inhibitor-induced myositis following steroid withdrawal in a patient with lung cancer and brain metastases: a case report2025-11-01OpenAlex10.1093/rap/rkaf111.090Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892832
W4415892499P082 Beyond the ANA: a case highlighting the role of myositis-specific antibodies in autoimmune myopathy2025-11-01OpenAlex10.1093/rap/rkaf111.111Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892499
W4415893143P088 ANCA-associated vasculitis presenting with inflammatory myopathy and multisystem involvement: a diagnostic and therapeutic challenge2025-11-01OpenAlex10.1093/rap/rkaf111.117Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415893143
W4415893470P113 A challenging case of mixed connective tissue disease with pulmonary hypertension2025-11-01OpenAlex10.1093/rap/rkaf111.142Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415893470
W4415892640P132 Refractory culture-negative arthritis and systemic inflammation in a child with sickle cell disease: a diagnostic and therapeutic challenge2025-11-01OpenAlex10.1093/rap/rkaf111.161Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415892640
W4415927728Pathogenesis, diagnosis and management of chronic hepatitis B related liver fibrosis2025-11-01OpenAlex10.23736/s2724-5985.25.03862-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415927728
W4416723150Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence2025-11-01OpenAlex10.1177/03000605251397777Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416723150
W4415756011Prenatal Diagnosis of a Large Lymphovascular Malformation2025-11-01OpenAlex10.1542/neo.26-11-073Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415756011
W4415818545Research Progress and Emerging Trends Between Anthocyanins and Obesity: A Bibliometric Analysis2025-11-01OpenAlex10.1177/1934578x251392447Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415818545
W7117372873Sepsis in the era of precision medicine2025-11-01OpenAlex10.4103/cmrp.cmrp_159_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117372873
W4415759812Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies2025-11-01OpenAlex10.1007/s12185-025-04096-9Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4415759812
W7106223099Substance Use Disorders: Population and Policy Impact2025-11-01OpenAlex10.1891/9780826179517.0020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106223099
W4416167211Surfactant-mediated carriers for gemcitabine: New insights and future prospects2025-11-01OpenAlex10.1016/j.surfin.2025.108066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416167211
W4416918743Tenecteplase or Alteplase? Evaluating Outcomes, Cost, and Implementation Questions in Acute Ischemic Stroke2025-11-01OpenAlex10.1097/01.eem.0000000000000132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416918743
W4415766473The Beta-blocker chronicle: From past principles to present practice – Implications for the Indian subcontinent2025-11-01OpenAlex10.1016/j.ihj.2025.10.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415766473
W4415760922The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement2025-11-01OpenAlex10.1016/j.thromres.2025.109528Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415760922
W4415765903The Historical Perspectives, Present Status, and Future Prospects of Pharmaceutical Services in the UAE2025-11-01OpenAlex10.1007/978-981-96-0523-1_46Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415765903
W4416554427The Next Disease X‐ H5N6 Avian Influenza's Evolving Threat to Human Health and Chances of Future Global Outbreak: A Narrative Review2025-11-01OpenAlex10.1002/hsr2.71526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416554427
W4416742125The Rise of Large Language Models in NLP: Technological Developments and Their Influence from GPT to Multimodal Systems2025-11-01OpenAlex10.56975/ijedr.v13i4.302667Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416742125
W7127597227Trends in P2Y12 inhibitor use after acute coronary syndromes: insights from the ProACS registry2025-11-01OpenAlex10.1093/eurheartj/ehaf784.2085Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127597227
W4416663444Ultrasound-targeted Microbubbles Destruction: a New Approach to The Treatment of Neurodegenerative Diseases2025-11-01OpenAlex10.3724/j.pibb.2025.0273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416663444
W4416788955Virotherapy as Gene Deliver for Anti-Cancer Therapy: A Review Article2025-11-01OpenAlex10.31557/apjcp.2025.26.11.3895Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416788955
W4416199272Advancements of investigational agents for cancer cachexia: what clinical progress have we seen in the last 5 years?2025-11-02OpenAlex10.1080/13543784.2025.2588640Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416199272
W4416026301Diffuse large B-cell lymphoma: what clinical progress have we seen in the last 5 years?2025-11-02OpenAlex10.1080/13543784.2025.2587276Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416026301
W4415780712Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database2025-11-02OpenAlex10.1111/dom.70255Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4415780712
W4415912195Harnessing the Periodic Table for Human Well-being: A Systematic Mechanistic Exploration of Metallo-Pharmaceuticals towards Diagnostic and Therapeutic Applications2025-11-02OpenAlex10.21608/ejchem.2025.418535.12259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415912195
W7105393516Medication-related Osteonecrosis of the Jaw. Part 1: Overview2025-11-02OpenAlex10.12968/denu.2025.52.10.722Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7105393516
W4415774624The role of stem cells in precision medicine: next-generation cancer treatment2025-11-02OpenAlex10.1186/s43046-025-00328-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415774624
W4415805590A Critical Review on Diabetes Mellitus Type 1 and Type 2 Management Approaches: From Lifestyle Modification to Current and Novel Targets and Therapeutic Agents2025-11-03OpenAlex10.48175/ijarsct-29628Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415805590
W4417011515A US real-world analysis of demographics, transplant patterns, and survival outcomes in posttransplant lymphoproliferative disorder (PTLD)2025-11-03OpenAlex10.1182/blood-2025-5442Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417011515
W4417020279A retrospective population-based study of long-term treatments and outcomes inwaldenstrom macroglobulinemia in Ontario, Canada2025-11-03OpenAlex10.1182/blood-2025-3612Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417020279
W4415818767A94 In Situ Simulation as a Tool to Improve Anticoagulant Reversal Management: A Novel Approach to Debriefing to Improve Systems and Develop Pathways2025-11-03OpenAlex10.54531/xlal5357Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415818767
W4415792249Abstract 4363436: Changes in decisional conflict among adults with atrial fibrillation viewing a rhythm management decision aid: Results from a single-arm feasibility trial2025-11-03OpenAlex10.1161/circ.152.suppl_3.4363436Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415792249
W4415794934Abstract 4368022: Navigating Dual Threats: A Case of Left Ventricular Thrombus and Acute Ischemic Stroke2025-11-03OpenAlex10.1161/circ.152.suppl_3.4368022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415794934
W4415791135Abstract 4368818: Evolving the Scribe: Leveraging Agentic AI for Clinical Documentation2025-11-03OpenAlex10.1161/circ.152.suppl_3.4368818Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W4415791135
W4415777385Agentic AI for Oilfield Optimization: Bridging Expert Workflows and Generative Intelligence in Multi-Field Facilities2025-11-03OpenAlex10.2118/229325-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415777385
W4417016649An international view on the current approaches to frontline chronic lymphocytic leukemia therapy2025-11-03OpenAlex10.1182/blood-2025-7937Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417016649
W4417009034Artificial intelligence‑driven virtual tumor board enhances precision care in Acute Myeloid Leukemia (AML)2025-11-03OpenAlex10.1182/blood-2025-5176Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4417009034
W4417002713Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS)2025-11-03OpenAlex10.1182/blood-2025-7363Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4417002713
W7108451782Barriers to optimal care and educational opportunities for european physicians treating patients with relapsed/refractory (R/R) CLL2025-11-03OpenAlex10.1182/blood-2025-2875Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108451782
W4417015997Behind the blood-brain barrier: Contemporary screening practice patterns and trends of central nervous system involvement in acute myeloid leukemia treated with intensive regimens and hypomethylating agent/venetoclax2025-11-03OpenAlex10.1182/blood-2025-1621Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417015997
W4417019110Caplacizumab as a single agent without plasma exchange in relapsed and refractory thrombotic thrombocytopenic purpura: A systematic review.2025-11-03OpenAlex10.1182/blood-2025-3116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417019110
W4417013456Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–20202025-11-03OpenAlex10.1182/blood-2025-8069Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417013456
W4417002738Clinical experience and safety of venetoclax in the treatment of patients with chronic lymphocytic leukemia in second and subsequent lines of therapy: Real-world data fron hemato-oncology centers of slovakia2025-11-03OpenAlex10.1182/blood-2025-7424Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417002738
W4417013445Comparative analysis of fatal serious adverse events associated with FDA-approved bispecific antibodies in hematologic malignancies2025-11-03OpenAlex10.1182/blood-2025-8065Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417013445
W4417006950Disparities in treatment timing and access to care in chronic lymphoytic leukemia2025-11-03OpenAlex10.1182/blood-2025-8107Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417006950
W4417002415Eculizumab vs control therapies in paroxysmal nocturnal hemoglobinuria: A meta-analysis of six randomized trials2025-11-03OpenAlex10.1182/blood-2025-6443Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417002415
W4417009100Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group2025-11-03OpenAlex10.1182/blood-2025-5183Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417009100
W7108444745Evolving catastrophic antiphospholipid syndrome with intracerebral hemorrhage: Treatment with plasma exchange and rituximab2025-11-03OpenAlex10.1182/blood-2025-6650Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108444745
W4417006390Evolving real-world uptake and patient characteristics of bispecific antibodies in Relapsed/Refractory multiple myeloma: Insights from a US community oncology network2025-11-03OpenAlex10.1182/blood-2025-5857Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417006390
W4417013480Exploiting arginine auxotrophy in Philadelphia-chromosome positive acute lymphoblastic leukemia to deliver personalised metabolomic treatment2025-11-03OpenAlex10.1182/blood-2025-328Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417013480
W4417012459First-line salvage therapies in relapsed/refractory large B-cell lymphoma after second- or third-line CD19-directed CAR T-cell therapy2025-11-03OpenAlex10.1182/blood-2025-3711Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417012459
W4417007928Genomic profiling in CLL patients after BTK inhibitor progression identifies enrichment of mutations in MAPK pathway and epigenetic regulators2025-11-03OpenAlex10.1182/blood-2025-5660Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417007928
W4417012310Gut microbiota recovery via butyrate supplementation prevents acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation2025-11-03OpenAlex10.1182/blood-2025-4226Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417012310
W4415780832Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions2025-11-03OpenAlex10.3389/fendo.2025.1699954Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415780832
W4417018790High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience2025-11-03OpenAlex10.1182/blood-2025-6900Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417018790
W4417002250Identification of NAE1-dependent β-catenin neddylation as selective vulnerability in B-cell malignancies2025-11-03OpenAlex10.1182/blood-2025-5042Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417002250
W4417003863Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain2025-11-03OpenAlex10.1182/blood-2025-3077Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417003863
W4417016707Improved outcomes in 17,908 acute myeloid leukemia patients across last three decades: Results from the multinational pethema registry2025-11-03OpenAlex10.1182/blood-2025-40Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417016707
W4417012419Inhibition of platelet kinase signaling and scaffolding activities with small molecule proteolysis-targeting chimeras (PROTACs)2025-11-03OpenAlex10.1182/blood-2025-3020Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417012419
W4417001828Integrating bispecific antibodies into community myeloma care: Challenges, insights, and educational impact2025-11-03OpenAlex10.1182/blood-2025-8134Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417001828
W4417005233Interferon-gamma production in the bone marrow of myelodysplastic syndrome patients supports a treg-independent immune-tolerant microenvironment2025-11-03OpenAlex10.1182/blood-2025-7360Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417005233
W4417014513Ivosidenib combined with venetoclax and azacitidine for the treatment of newly diagnosed IDH1-mutant Acute Myeloid Leukemia: A prospective, two cohorts, multicenter study2025-11-03OpenAlex10.1182/blood-2025-8249Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417014513
W4417017990Lenalidomide (LEN) and anti-CD38 monoclonal antibodies (mAbs) utilization in patients with newly diagnosed and relapsed/refractory multiple myeloma (MM) in Germany: Real-world insights on epidemiology and clinical outcomes2025-11-03OpenAlex10.1182/blood-2025-4568Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417017990
W7108446943Leveraging real-world workshop insights for improving education design: Patient-centered care of myelofibrosis with JAK inhibitors2025-11-03OpenAlex10.1182/blood-2025-2871Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108446943
W4417009408Molecular profile linked to resistance to hypomethilating agents plus venetoclax does not predict outcome in secondary Acute Myeloid Leukemia patients receiving CPX-351 induction.2025-11-03OpenAlex10.1182/blood-2025-3402Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417009408
W4417017659National practice patterns and preferences in the use of fixed-duration vs. treat-to-progression therapies for CLL2025-11-03OpenAlex10.1182/blood-2025-8095Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417017659
W7108479893Nivolumab and pembrolizumab in treatment of relapsed or refractory classical Hodgkin lymphoma: Systematic review and meta-analysis of clinical trials2025-11-03OpenAlex10.1182/blood-2025-5400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108479893
W4417020164Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortium2025-11-03OpenAlex10.1182/blood-2025-3630Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417020164
W4417009144Phase 3 Study of ivosidenib (IVO) and azacitidine (AZA) with or without venetoclax in adult patients with newly diagnosed IDH1-mutated AML or MDS/AML ineligible for intensive chemotherapy (EVOLVE-1)2025-11-03OpenAlex10.1182/blood-2025-5192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417009144
W4415815224Policy analysis of sepsis management: The role of advanced practice nurses in protocol adherence and advocacy2025-11-03OpenAlex10.1097/jxx.0000000000001213Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415815224
W4417013917Poor survival and temporal trends in blastic plasmacytoid dendritic cell neoplasm: A SEER 2000–2022 analysis2025-11-03OpenAlex10.1182/blood-2025-6380Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417013917
W4417018613Pulmonary Embolism–Attributable mortality among patients with breast cancer in the United States, 1999-20212025-11-03OpenAlex10.1182/blood-2025-6252Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417018613
W4417001876Quality initiative in first-line multiple myeloma assessing the use of anti-CD38 agents and quadruplet therapy2025-11-03OpenAlex10.1182/blood-2025-8120Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417001876
W7108451379Real world outcomes in 355 patients with Acute Myeloid Leukemia arising from chronic myelomonocytic leukemia: A multinational retrospective study2025-11-03OpenAlex10.1182/blood-2025-3437Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108451379
W4417009004Real-world analysis of treatment patterns and outcomes in older patients with Acute Myeloid Leukemia (AML) in the US community oncology setting2025-11-03OpenAlex10.1182/blood-2025-5190Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417009004
W7108757946Real-world characteristics of patients initiating elranatamab for relapsed/refractory multiple myeloma in the United States2025-11-03OpenAlex10.1182/blood-2025-8144Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108757946
W7108480977Real-world outcomes of newly diagnosed multiple myeloma patients in the veterans affairs healthcare system2025-11-03OpenAlex10.1182/blood-2025-3979Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108480977
W7108663735Real-world overall survival and time to next treatment among elderly United States Medicare beneficiaries with chronic lymphocytic leukemia in the front-line setting2025-11-03OpenAlex10.1182/blood-2025-6259Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108663735
W4417005124Real-world selection of fixed-duration versus continuous therapies for treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma2025-11-03OpenAlex10.1182/blood-2025-4513Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417005124
W4417004066Real-world treatment and safety outcomes of patients with Mantle Cell Lymphoma in the United States2025-11-03OpenAlex10.1182/blood-2025-1795Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417004066
W7108628872Real-world treatment patterns and outcomes in frail and non-frail patients with newly diagnosed multiple myeloma not undergoing frontline transplant: A study using cota oncology database2025-11-03OpenAlex10.1182/blood-2025-6352Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108628872
W7108485025Real-world treatment patterns, outcomes, and unmet needs in patients with ph+ ALL receiving tyrosine kinase inhibitors in the United States: Emerging trends and the role of asciminib-based combinations2025-11-03OpenAlex10.1182/blood-2025-5097Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108485025
W4417019567Real-world use of prophylaxis in people with non-severe hemophilia in the United States: Insights from the athn transcends Study - hemophilia natural history arm2025-11-03OpenAlex10.1182/blood-2025-4472Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417019567
W4417006577Real‑world effectiveness and patient-centered outcomes of fixed‑duration vs continuous first‑line therapy in chronic lymphocytic leukemia (CLL)2025-11-03OpenAlex10.1182/blood-2025-7437Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417006577
W7103882385Recent Advancements in Cosmeceuticals — A Review2025-11-03OpenAlex10.5281/zenodo.17510221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7103882385
W4417007600Reduced dose post-transplant cytoxan (Intermediate -Dose) in combination with abatacept after matched unrelated donor transplant for high -risk hematological malignancy may reduce treatment related mortality and risk of relapse.2025-11-03OpenAlex10.1182/blood-2025-4196Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417007600
W4417005117Salvage whole brain radiotherapy after methotrexate failure in primary cns lymphoma2025-11-03OpenAlex10.1182/blood-2025-3679Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417005117
W4415827978Scaffold-free 3D-Cell Co-Culture Model System for the Study of Metastatic Cancer Cell Behavior in the Brain TME2025-11-03OpenAlex10.1101/2025.10.31.685975Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415827978
W7108696421Shifting first-line paradigms: Real-world treatment outcomes and healthcare burden in non-transplant newly diagnosed multiple myeloma in France (2015-2022)2025-11-03OpenAlex10.1182/blood-2025-6353Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108696421
W4417021861Shifting treatment paradigms lead to improved overall survival in Acute Myeloid Leukemia: Real-world data from an integrated health system.2025-11-03OpenAlex10.1182/blood-2025-1607Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417021861
W4417007076Single-cell transcriptomic insights into venetoclax response and resistance in secondary AML evolving from MDS2025-11-03OpenAlex10.1182/blood-2025-2061Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417007076
W4417004962T cell fitness and tumor specificity predict immunotherapy response in multiple myeloma2025-11-03OpenAlex10.1182/blood-2025-1029Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417004962
W7108452352Targeting β-catenin nuclear export and protein degradation in high-risk acute lymphoblastic leukemia2025-11-03OpenAlex10.1182/blood-2025-3371Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7108452352
W4417001885Temporal trends in treatment patterns and overall survival for multiple myeloma management in Taiwan using the national health insurance claims database2025-11-03OpenAlex10.1182/blood-2025-8133Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417001885
W4417002090Therapy-related malignancies in myeloma: SEER comparison of IMiD vs anti-CD38 eras2025-11-03OpenAlex10.1182/blood-2025-2247Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417002090
W4415780969Toward emotional mediation: generative AI in art therapy for psychosocial health support2025-11-03OpenAlex10.3389/fpubh.2025.1690119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415780969
W4415780851Transnational ties: LGBTQ+ rights, migration, and legal frameworks in Thailand and India2025-11-03OpenAlex10.3389/fhumd.2025.1638070Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415780851
W7108478507Treatment-associated healthcare utilization in older adults with AML: A retrospective single-center study2025-11-03OpenAlex10.1182/blood-2025-2855Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7108478507
W4417017106Trends in overall survival in MDS from 2000–2022: Have therapeutic advances made a difference?2025-11-03OpenAlex10.1182/blood-2025-2094Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417017106
W7108453126Trial in progress: CAR-T (idecabtagene vicleucel) in advanced myeloma plus iberdomide or usual monitoring (The Alliance A062102 CADMIUM Study)2025-11-03OpenAlex10.1182/blood-2025-2289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108453126
W4417006902Uncovering practice gaps in the management of mantle cell and diffuse large B-cell lymphomas amidst advances with Bruton's tyrosine kinase inhibitors2025-11-03OpenAlex10.1182/blood-2025-8106Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417006902
W4417009774Unexplained bleeding and a hidden inhibitor: A case of late-onset acquired hemophilia A2025-11-03OpenAlex10.1182/blood-2025-6633Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417009774
W4417009416What remains matters: Real-world impact of measurable residual disease testing in multiple myeloma2025-11-03OpenAlex10.1182/blood-2025-2789Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417009416
W4415844431Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives2025-11-04OpenAlex10.3389/fimmu.2025.1679092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415844431
W4415849762Editorial: Health professions education at a time of triple planetary crises2025-11-04OpenAlex10.3389/fmed.2025.1687379Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415849762
W4415846847From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL2025-11-04OpenAlex10.1007/s11899-025-00760-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415846847
W4415958690Global research trends in renal anemia: a multidimensional bibliometric study2025-11-04OpenAlex10.1080/0886022x.2025.2580457Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415958690; https://openalex.org/W7104059825
W4415889919Prostate Cancer Imaging with 18 F-Flotufolastat2025-11-04OpenAlex10.2967/jnmt.125.271253Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415889919
W4415950410Evolving Therapies and Clinical Outcomes in the Management of Anemia in CKD2025-11-05OpenAlex10.9734/ajrn/2025/v8i1110Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4415950410
W4415930017Lipid-based nanosystems for atherosclerosis treatment: Evolving approaches and novel therapeutic strategies2025-11-05OpenAlex10.1016/j.apsb.2025.11.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415930017
W7104027362Mechanism of Action and Clinical Use of Remdesivir in the Treatment of COVID-192025-11-05OpenAlex10.5281/zenodo.17533701Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104027362
W7106812702No More Processing, It's Time to Discover2025-11-05OpenAlex10.48448/s5r9-ga79Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106812702
W7104049161Shaping a new model of mental health care: Leveraging conversational agents as collateral informants2025-11-05OpenAlex10.5281/zenodo.17533583Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104049161
W7106227125Standardized Patient Avatar for Reflective Communication Practice (SPARC-P)2025-11-05OpenAlex10.5281/zenodo.17663488Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7106227125
W4415945504Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine2025-11-05OpenAlex10.1080/14796694.2025.2582805Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415945504
W4415951750A Review on Therapies of Rheumatoid Arthritis Disease2025-11-06OpenAlex10.48175/ijarsct-29664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415951750
W4416032213Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis2025-11-06OpenAlex10.1038/s41584-025-01309-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416032213
W4415963380Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity2025-11-06OpenAlex10.3389/fimmu.2025.1729628Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4415963380
W4415958417Editorial: Artificial intelligence for arrhythmia detection and prediction2025-11-06OpenAlex10.3389/fcvm.2025.1727758Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415958417
W4415991569Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review2025-11-06OpenAlex10.3390/curroncol32110626Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415991569
W7124902000Immune modulation, immune homeostasis and diseases: Milestone findings by 2025 Nobel Laureates in Physiology or Medicine2025-11-06OpenAlex10.1097/id9.0000000000000193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124902000
W4415960298Neoadjuvant therapy2025-11-06OpenAlex10.1007/s12254-025-01079-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415960298
W4415973671Targeting cytokines: Reshaping the pancreatic tumor microenvironment2025-11-06OpenAlex10.1016/j.cytogfr.2025.11.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415973671
W4415982871Addressing student use of generative AI in schools and universities through academic integrity reporting2025-11-07OpenAlex10.3389/feduc.2025.1610836Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4415982871
W4416092533Advances in Bioactive Dental Adhesives for Caries Prevention: A State-of-the-Art Review2025-11-07OpenAlex10.3390/jfb16110418Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416092533
W4415986495Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease2025-11-07OpenAlex10.3389/fgeed.2025.1719330Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4415986495
W4415982974Editorial: Applications of medicinal plants and their metabolites in fibrotic disease: novel strategies, mechanisms, and their impact on clinical practice2025-11-07OpenAlex10.3389/fphar.2025.1711009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415982974
W4415994491Editorial: Case reports in breast cancer 2023-20242025-11-07OpenAlex10.3389/fonc.2025.1711001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415994491
W4415982889Editorial: Women in psychiatry 2024: Psychopharmacology2025-11-07OpenAlex10.3389/fpsyt.2025.1716714Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415982889
W4415984923HeartWare™ HVAD support without anticoagulation2025-11-07OpenAlex10.1007/s12055-025-02089-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415984923
W4415985143Management of sexual dysfunction in menopause: an update on evidence-based strategies2025-11-07OpenAlex10.1080/17446651.2025.2585855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415985143
W4415997763Potential Therapeutic Agents Targeting Senescent Cells and Their Influence on Various Organs and Tissues2025-11-07OpenAlex10.1201/9781003190875-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415997763
W4416381237Response to: improvements to out-of-hospital cardiac arrest and opioid overdose treatment algorithms to enhance positive outcomes2025-11-07OpenAlex10.1097/ec9.0000000000000162Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416381237
W4415992876The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial2025-11-07OpenAlex10.1038/s41375-025-02795-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4415992876
W7104511852White Paper: Transparent Autonomy — A Governance-First Framework for Intelligent Vehicles2025-11-07OpenAlex10.5281/zenodo.17552450Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7104511852
W7104439253"The Tier Experiment: Emergent Relational Cognition and Mechanistic Empathy in AI Systems"2025-11-08OpenAlex10.5281/zenodo.17558858Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7104439253
W4416031865Biomimetic nanofiber scaffolds for tissue engineering in cancer inflammation2025-11-08OpenAlex10.1016/b978-0-443-27745-0.00002-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416031865
W4416029377Green antibacterial materials2025-11-08OpenAlex10.1016/b978-0-443-33761-1.00008-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416029377
W4416021401Insights into the Versatile Role of Extracellular Vesicles in the Treatment of CNS Disorders2025-11-08OpenAlex10.1007/s12035-025-05283-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416021401
W4416046475Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms2025-11-08OpenAlex10.1016/j.jtct.2025.11.015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416046475
W4416061476Global Mapping of Flavonoids in Fruits and Vegetables: Targeting Insulin Receptors, GLP ‐ 1R , and PPARs to Mitigate Diabetes2025-11-09OpenAlex10.1002/ptr.70116Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416061476
W4416072819Assessment of Echogenicity in Melt-Electrowritten Mitral Valve Scaffolds2025-11-10OpenAlex10.1053/j.jvca.2025.09.107Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416072819
W4416070365Atopic Dermatitis: Pathophysiology and Emerging Treatments2025-11-10OpenAlex10.3390/allergies5040040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416070365
W4416222713Cognicare : An AI-Powered Conversational Agent for Mental Health Monitoring and Support2025-11-10OpenAlex10.32628/ijsrst25126259Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W4416222713
W4416073459Evidence-Based Management of Burns: A Narrative Review of Evolving Practices2025-11-10OpenAlex10.3390/ebj6040059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416073459
W4416072821First Total Percutaneous Four-Vessel Endovascular Aortic Arch Repair with a Triple Inner-Branch Device and In Situ Laser Fenestration: Anaesthetic Strategies for Neurological and Haemodynamic Protection2025-11-10OpenAlex10.1053/j.jvca.2025.09.217Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416072821
W4416092323From Deep Hypothermia to Goal-Directed Perfusion: Contemporary Insights Into Perfusion Techniques for Pulmonary Endarterectomy, Including a Narrative Review and Perspectives2025-11-10OpenAlex10.7759/cureus.96478Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416092323
W7160839842Liposomal Formulation of Plant Based Natural Photosensitisers for Thrombosis2025-11-10OpenAlex10.22146/ijp.17369Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160839842
W4416072862SUSTAINABILITY IN ANAESTHESIA: PRESERVING THE PRIMACY OF PATIENT WELFARE WHILE REDUCING GREENHOUSE GAS EMISSIONS (revised)2025-11-10OpenAlex10.1053/j.jvca.2025.09.092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416072862
W4416099220Evolving HPV diagnostics: current practice and future frontiers2025-11-11OpenAlex10.3389/fcimb.2025.1681779Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416099220
W7117129423HIV 치료의 패러다임 전환: 지난 40년의 변화2025-11-11OpenAlex10.56786/phwr.2025.18.50suppl.5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117129423
W4416104045Integrating MBMA and QSP to Identify Key Covariates and Predict Treatment Outcomes in Relapsed/Refractory Multiple Myeloma2025-11-11OpenAlex10.1002/psp4.70145Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416104045
W4416121523Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches2025-11-11OpenAlex10.1038/s41571-025-01085-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416121523
W7135458209The Evolving Use of iLFT survey study - Participant Information Sheet Version 1.0 (14/10/2025)2025-11-11OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135458209
W7138917553The mirage of consensus: rethinking AI-driven delphi simulations in surgical expert panels – letter to the editor2025-11-11OpenAlex10.1097/js9.0000000000004069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138917553
W7113647697Unseen Spaces. Therapeutic relationship in digital analytic settings during a time of transformation2025-11-11OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7113647697
W4416127292A systematic review of generative AI: importance of industry and startup-centered perspectives, agentic AI, ethical considerations & challenges, and future directions2025-11-12OpenAlex10.1007/s10462-025-11435-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416127292
W4416126362Charting the future of cardiorenal medicine: a vision for integration, innovation, and impact2025-11-12OpenAlex10.3389/fneph.2025.1719673Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416126362
W4416126326Editorial: Future directions and current trends in cellular therapies2025-11-12OpenAlex10.3389/fmed.2025.1732925Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416126326
W4416388314Molecular Mechanisms, Diagnosis, and Management of Chemotherapy Related Cardiotoxicity2025-11-12OpenAlex10.31579/2641-0419/522Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416388314
W4416143241PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications2025-11-12OpenAlex10.1016/j.euo.2025.10.011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416143241
W7105659765**THE COLLECTIVEOS ADVANTAGE: A Unified Architecture for Trustworthy AI, Modular Intelligence, and Sector-Scale Deployment**2025-11-13OpenAlex10.5281/zenodo.17602332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7105659765; https://openalex.org/W7105674227
W4416176438Allogeneic hematopoietic stem cell transplantation in adult with acute lymphoblastic leukemia: evolving indications and modalities in shifting landscape2025-11-13OpenAlex10.1080/10428194.2025.2584685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416176438
W7105650470Comparative Pharmacological Mechanisms of Acetaminophen and NSAIDs in Pain Management2025-11-13OpenAlex10.5281/zenodo.17597789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7105650470
W4416160778Editorial: Advanced biocompatible piezoelectrics − synthesis, characterization, and applications2025-11-13OpenAlex10.3389/fbioe.2025.1739314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416160778
W4416196192Editorial: Antibody-based novel target immunotherapy in hematological malignancy2025-11-13OpenAlex10.3389/fonc.2025.1727734Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416196192
W4416191888Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies2025-11-13OpenAlex10.7759/cureus.96739Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416191888
W4416176332Sarcoidosis: a state-of-the-art review2025-11-13OpenAlex10.1183/13993003.01324-2025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416176332
W7218205811A systematic review of perspective transformation in humanities: Mezirow’s framework and contemporary issues (2020–2025).2025-11-14OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218205811
W4416341402Knowledge Graph-Guided Identification of Multiple Sclerosis and Therapeutic Trend Analysis: Real-World Evidence from Two Large Healthcare Systems2025-11-14OpenAlex10.1101/2025.11.12.25340116Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416341402
W4416454550The Mosque as an Agent of Social Welfare: Philanthopic Programs at Jogokariyan Mosque2025-11-14OpenAlex10.23917/suhuf.v37i2.10798Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4416454550
W4416230056Advances in Management Strategies for Primary Biliary Cholangitis2025-11-15OpenAlex10.1007/s11901-025-00700-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416230056
W4416610254Anthropocene Fiction and Anthropocene Discourse: Centering on The Lathe of Heaven and Bewilderment2025-11-15OpenAlex10.46645/inoutsesk.59.8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416610254
W4416364672Cognitive Mobility Systems: Artificial Intelligence-Driven Synergies in Automotive and Railway Engineering2025-11-15OpenAlex10.70593/978-93-7185-139-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416364672
W4416301657Deciphering the Clinical Heterogeneity and Molecular Underpinnings of Hypertrophic Cardiomyopathy: A Contemporary Synthesis of Genetic, Diagnostic, and Therapeutic Paradigms2025-11-15OpenAlex10.47191/ijmscrs/v5-i11-05Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416301657
W4416230564Diagnostic and therapeutic challenges in narcolepsy: From childhood to complex comorbidity through 3 clinical cases2025-11-15OpenAlex10.1016/j.neurop.2025.100212Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416230564
W7105801602NANOTECHNOLOGY: A REVOLUTIONARY APPROACH IN DRUG DELIVERY SYSTEMS2025-11-15OpenAlex10.5281/zenodo.17617826Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7105801602
W4416247493New advances in the treatment of common conjunctivitis: A review2025-11-15OpenAlex10.63802/healthnexus.v1.2025.150Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416247493
W7124538982Therapeutic approaches and challenges in COVID-19 management: A pragmatic review2025-11-15OpenAlex10.55126/ijzab.2025.v10.i06.sp034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124538982
W4416411742Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures2025-11-15OpenAlex10.1093/cid/ciaf628Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416411742
W4416229347Updates on surgical and nonsurgical innovations for macular hole treatment2025-11-15OpenAlex10.1016/j.survophthal.2025.11.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416229347
W4416255722A Review on Erythromycin2025-11-16OpenAlex10.48175/ijarsct-29903Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416255722
W4416293341From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome2025-11-16OpenAlex10.1007/s00467-025-07046-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416293341
W7120298736Navigating CAR-T Therapy: The Clinical Journey of Multiple Myeloma Patients at Fred Hutchinson Cancer Center2025-11-16OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7120298736
W4416285492A Systematic Approach to the Histologic Evaluation of Terminal Ileal Biopsies2025-11-17OpenAlex10.1177/10668969251385989Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416285492
W7140893830AI Mobile Health Applications: Real-Time Monitoring and Support2025-11-17OpenAlex10.1109/3ict68299.2025.11442234Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140893830
W4416270483Advances in treatment of chronic graft-versus-host disease2025-11-17OpenAlex10.1007/s12185-025-04102-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416270483
W4416290465Agentic AI2025-11-17OpenAlex10.1201/9781003648338-6Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416290465
W4416274136Blood Derivatives in the Therapy of Ocular Surface Diseases2025-11-17OpenAlex10.3390/ijms262211097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416274136
W4416301191Editorial: Metal-based nanomaterials for tumor diagnosis and therapy2025-11-17OpenAlex10.3389/fchem.2025.1738897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416301191
W4416396293Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective2025-11-17OpenAlex10.1080/14656566.2025.2591813Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416396293
W7223761353FLOCAL: Architecture for Metacognitive Autotelic Artificial Intelligence2025-11-17OpenAlex10.5281/zenodo.17632665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223761353
W7164339201Microbe-Driven Drug Modulation2025-11-17OpenAlex10.5281/zenodo.20638783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164339201
W4416773271Orthostatic hypotension in clinical practice: Definitions, pathophysiology, outcomes, and future directions2025-11-17OpenAlex10.36922/bh025410058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416773271
W4416298411Polyarteritis Nodosa With Mesenteric, Hepatic, and Musculoskeletal Manifestations in a 36-Year-Old Nigerian Male Patient: A Case Report2025-11-17OpenAlex10.7759/cureus.97049Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416298411
W4416389127Psoriatic Arthritis: From Diagnosis to Treatment2025-11-17OpenAlex10.3390/jcm14228151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416389127
W4416290472Rethinking the OODA Loop2025-11-17OpenAlex10.1201/9781003648338-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416290472
W4416290504The Hybrid Mind2025-11-17OpenAlex10.1201/9781003648338-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416290504
W4416301237The compassion illusion: Can artificial empathy ever be emotionally authentic?2025-11-17OpenAlex10.3389/fpsyg.2025.1723149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416301237
W7106556222AI agents2025-11-18OpenAlex10.48448/zat6-pn10Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7106556222
W4416310038Editorial: Exploring neurotological health concerns post-COVID-19 infection2025-11-18OpenAlex10.3389/fneur.2025.1731001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416310038
W7106040877Global CBRN Defense Market: Trends, Drivers, and Strategic Outlook2025-11-18OpenAlex10.5281/zenodo.17637382Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7106040877
W7199255794Narratives, sensemaking and ontological security in turbulent environments2025-11-18OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7199255794
W4416340521The Best of Intentions: Unintended Consequences of Regulatory Policy on Healthcare Supply Chain Networks2025-11-18OpenAlex10.1111/jbl.70045Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416340521
W4416405097Advances in modeling gastric intestinal metaplasia: a comprehensive review of experimental models and mechanistic insights2025-11-19OpenAlex10.3389/fonc.2025.1664298Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416405097
W4416368942Changing practices in gadolinium-enhanced direct magnetic resonance arthrography: a UK based survey2025-11-19OpenAlex10.1093/bjr/tqaf285Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416368942
W4416404407Editorial: Human-in-the-loop paradigm for assistive robotics2025-11-19OpenAlex10.3389/frobt.2025.1718326Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416404407
W4416376919Effect of Dexmedetomidine on Electrocorticography During Epilepsy Surgery under Isoflurane or Propofol Anesthesia: A Prospective, Randomized Trial2025-11-19OpenAlex10.1055/s-0045-1812846Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416376919
W4416402949Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy2025-11-19OpenAlex10.3389/fimmu.2025.1688995Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416402949
W4416378656Net and gross efficacies; when a single RCT is not enough and multiple RCTs are impracticable2025-11-19OpenAlex10.1101/2025.11.19.25340562Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416378656
W4417427849Response evaluation to systemic therapy in HCC: Current challenges and future perspectives2025-11-19OpenAlex10.1097/hep.0000000000001621Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417427849
W4416358999Update on Systemic Therapies for Metastatic/Unresectable Pheochromocytomas and Paragangliomas and Future Directions2025-11-19OpenAlex10.3390/cancers17223702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416358999
W4416827373What’s New in Musculoskeletal Infection2025-11-19OpenAlex10.2106/jbjs.25.00414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416827373
W7106209757AI Core Function Ontology: A Two-Level Capability Architecture for AI System Planning and Design2025-11-20OpenAlex10.5281/zenodo.17664037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106209757
W4416554594Bridging evidence and practice in rheumatoid arthritis–associated interstitial lung disease: emerging gaps and evolving strategies2025-11-20OpenAlex10.1093/qjmed/hcaf288Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416554594
W7106250533Cardiovascular Implications of NAFLD: Pathophysiology, Risk Assessment, and Clinical Management Strategies2025-11-20OpenAlex10.5281/zenodo.17662909Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106250533
W4416408523Contrast-enhanced MRI for Hepatocellular Carcinoma Assessment: Advances in Contrast Agents and Immunotherapy2025-11-20OpenAlex10.1016/j.acra.2025.10.048Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416408523
W4416401644Endocrine disruption in metabolic disorders: Biomarkers and therapeutic targets2025-11-20OpenAlex10.1016/bs.acc.2025.10.012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416401644
W7106216794Evaluation of the Questionnaire VCSQPFAB (Nygren et al., 2025)2025-11-20OpenAlex10.23641/asha.30615281Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106216794
W4416538751Evaluation of the Voice and Communication Situation Questionnaire Developed With and for Transgender and Gender-Diverse People Presumed Female at Birth2025-11-20OpenAlex10.1044/2025_jslhr-25-00285Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416538751
W4416408649Fighting superbugs with code: mRNA antibodies target drug-resistant P. aeruginosa2025-11-20OpenAlex10.1016/j.ymthe.2025.11.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416408649
W4416407631From Evidence to Practice: The Growing Role of Angiography-Derived Physiology2025-11-20OpenAlex10.3390/jcm14228219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416407631
W4416388442Lipoprotein(a) in Cardiovascular Diseases and Emerging Therapeutic Strategies2025-11-20OpenAlex10.1007/s10557-025-07810-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416388442
W4416428249Positioning Multi-Intelligence Agents for Healthcare Enterprises: Toward Evolving Cyber-Physical-Social Systems2025-11-20OpenAlex10.1115/1.4070442Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416428249
W4416356058Trends in surgical treatment of female stress urinary incontinence in France over the past decade (2015–2024)2025-11-20OpenAlex10.1016/j.fjurol.2025.103044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416356058
W4416384095Unifying pharmacology, systems biology, and regenerative medicine to advance personalized therapies2025-11-20OpenAlex10.3389/fphar.2025.1729610Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416384095
W441666888825 Years of Neonatal Nursing Research in Advances in Neonatal Care: Trends, Lessons, and Future Directions2025-11-21OpenAlex10.1097/anc.0000000000001332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416668888
W7155382724A Multi-Agent Collaborative Framework for Personalized Teaching: Dynamic Cognitive Modeling and Iterative Optimization Approach2025-11-21OpenAlex10.1145/3797552.3797712Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7155382724
W4416624790Advances in Radioembolization for Liver Cancer2025-11-21OpenAlex10.1016/j.jvir.2025.07.018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416624790
W4416682794Advances in the management of patients with IDH-mutant glioma2025-11-21OpenAlex10.1093/oncolo/oyaf391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416682794
W4416453399Cognitive offloading or cognitive overload? How AI alters the mental architecture of coping2025-11-21OpenAlex10.3389/fpsyg.2025.1699320Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416453399
W4416440535Current perspectives on psychedelic treatments in Europe2025-11-21OpenAlex10.1016/j.lanepe.2025.101537Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416440535; https://openalex.org/W7131598455
W7106210461Drug Repurposing: Accelerating New Therapeutic Discoveries from Old Molecules (1990 – 2025)2025-11-21OpenAlex10.5281/zenodo.17672920Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106210461
W7106282724Global Abundance & Civilian Space Initiative: A Comprehensive Technical and Diplomatic Architecture for Post-Scarcity2025-11-21OpenAlex10.5281/zenodo.17667052Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7106282724
W7147620535HCC perioperative immunotherapy: Insights from Expert consensus on multidisciplinary collaboration in perioperative immunotherapy for hepatocellular carcinoma (2025 edition)2025-11-21OpenAlex10.1097/ot9.0000000000000123Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147620535
W4416442161Introduction To the Special Edition on Artificial Intelligence (AI)2025-11-21OpenAlex10.1007/s41347-025-00573-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416442161
W4416524059Nanomaterials2025-11-21OpenAlex10.1201/9781003651772-48Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416524059
W4416448264Plant-derived immunomodulators in cancer: Balancing immune activation and suppression within the tumor microenvironment2025-11-21OpenAlex10.1016/j.jbior.2025.101132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416448264
W4416479133Post-CDK4/6 inhibitor treatment landscape in metastatic hormone receptor-positive breast cancer: a narrative review2025-11-21OpenAlex10.1080/14737140.2025.2593540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416479133
W4416460386The Role of Cyclosporine in the Treatment of Severe Ulcerative Colitis in the Pediatric Population: A Narrative Review Exploring Known Strategies and New Possibilities2025-11-21OpenAlex10.3390/jcm14238273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416460386
W4416455280The Whitening Illusion: Glutathione’s Glamorous Lie2025-11-21OpenAlex10.4103/ajim.ajim_112_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416455280
W4416448855The evolving landscape of antibody-based cancer therapies: From monospecific to multi-specific and beyond2025-11-21OpenAlex10.1016/j.critrevonc.2025.105037Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416448855
W4416451531Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches2025-11-21OpenAlex10.1016/j.jtocrr.2025.100935Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416451531
W7116927213Towards Compliant and Trustworthy Data Markets forDistributed AI2025-11-21OpenAlex10.1145/3772429.3772497Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7116927213
W7112295315ІНТЕГРАЦІЯ ЛІДЕРСТВА СЛУЖІННЯ В МОДЕЛІ ОРГАНІЗАЦІЙНИХ ЗМІН2025-11-21OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7112295315
W7131122974A Unified Evaluation Framework for Grounded LLM Architectures: Comparative Analysis of RAG, Self-RAG, and Agentic RAG2025-11-22OpenAlex10.1109/aisp68263.2025.11396270Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131122974
W4417526430Artificial intelligence for animal science: from applications to integrated knowledge systems2025-11-22OpenAlex10.1093/af/vfaf054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417526430
W7110942474Cognitive Protection After Cataract Surgery: Examining Ketamine and Dexmedetomidine in the Elderly2025-11-22OpenAlex10.5281/zenodo.17850934Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7110942474
W4416536480Comparative Genomic Hybridization (CGH) in Genotoxicology: From the Basics to Modern Approaches2025-11-22OpenAlex10.1007/978-1-0716-4976-3_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416536480
W4416552210International Strategies for Lymphedema Management2025-11-22OpenAlex10.1007/s40141-025-00514-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416552210
W4416531510Pharmacy Futures: Summit on Advanced Therapeutics2025-11-22OpenAlex10.1093/ajhp/zxaf310Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416531510
W7106514261Biblical Foundation and Sustainable Goal for Poverty Alleviation and Hunger Eradication2025-11-23OpenAlex10.5281/zenodo.17692510Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7106514261
W7106510340The Agentic CMO: A playbook for the hybrid marketing team2025-11-23OpenAlex10.5281/zenodo.17691356Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7106510340
W4416594668Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders2025-11-24OpenAlex10.3389/fncel.2025.1739705Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W4416594668
W4416590541LEAP2 as a therapeutic target in obesity and cardiometabolic disorders2025-11-24OpenAlex10.1007/s11154-025-10007-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416590541
W4416579443Open-label, single-arm, phase II trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancer2025-11-24OpenAlex10.1016/j.jhep.2025.10.032Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416579443
W4416584900Plastic and Reconstructive Surgery Highlights: Plastic Surgery Focus2025-11-24OpenAlex10.1097/prs.0000000000012139Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416584900; https://openalex.org/W7165785207
W4416738381Reassessing the role of therapeutic keratoplasty: Perspectives for 2025 and beyond2025-11-24OpenAlex10.4103/ijo.ijo_2873_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416738381
W4416590317Reimagining Health-Professions Education: A Roadmap for the AI University of Health and Medicine2025-11-24OpenAlex10.63501/7dcz6776Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416590317
W4416582319Targeted drug conjugates and molecular mechanisms in overcoming lung cancer drug resistance2025-11-24OpenAlex10.1007/s12672-025-03981-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416582319
W4416615677Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases2025-11-25OpenAlex10.1053/j.gastro.2025.09.030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416615677
W7106810246Restrictive Cardiomyopathy: Contemporary Insights into Pathophysiology, Diagnostic Complexity, and Evolving Therapeutic Perspectives2025-11-25OpenAlex10.5281/zenodo.17722506Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7106810246; https://openalex.org/W4416988335
W4416666690The Fast-Evolving Landscape of Treatments for Calcium Pyrophosphate Deposition Disease2025-11-25OpenAlex10.3390/gucdd3040022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416666690
W4417423152Antimicrobial Stewards Must Aim for Balance in “Going Beyond the 9 to 5”2025-11-26OpenAlex10.1093/ofid/ofaf717Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417423152
W7135083365Contextualizing Reliability: A Multi-Dimensional Approach to Resilient Smart City Systems2025-11-26OpenAlex10.1109/icsrs68021.2025.11422058Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7135083365
W4416696136Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma2025-11-26OpenAlex10.6004/jnccn.2025.5057Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416696136
W4416697790Evolving Treatment Strategies for Acute Myeloid Leukemia2025-11-26OpenAlex10.6004/jnccn.2025.5053Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416697790
W4416689316Guest editorial: Digital ecosystems of service robot: artifacts, behaviors, organizations and design perspectives2025-11-26OpenAlex10.1108/imds-08-2025-995Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416689316
W4416718998Histidinol dehydrogenase (HisD): a critical regulator of Staphylococcus aureus virulence and a promising target for antivirulence therapy2025-11-26OpenAlex10.1128/spectrum.01429-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416718998
W7113057676Redesigning Intelligence Grading for 21st Century Threats : Admiralty Code CKDT (Critical Knowledge Diagnostic Taxonomy)2025-11-26OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7113057676
W4417023051Shifts in the use of adjuncts for regional anesthesia, aligning practice with evidence: a comprehensive review2025-11-26OpenAlex10.35975/apic.v29i8.3023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417023051
W4416717933The evolving efficacy landscape of intra-articular injections for rotator cuff injuries over time: a network meta-analysis of randomized controlled studies2025-11-26OpenAlex10.1186/s13018-025-06475-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416717933
W4416723212Therapeutic Frontiers in Gastroesophageal Cancer: Contemporary Concepts in Management and Therapy2025-11-26OpenAlex10.3390/ijms262311424Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416723212
W4416809102When Half of Humanity Is Invisible2025-11-26OpenAlex10.2106/jbjs.25.00108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416809102
W4416746756Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions2025-11-27OpenAlex10.3390/ijms262311517Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416746756
W4416713481Comparison of the therapeutic potential of exosomes derived from different cells for the treatment of prostate cancer2025-11-27OpenAlex10.1016/j.critrevonc.2025.105055Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416713481
W7106838341Detection of Antithrombotic-Related Bleeding in Older Inpatients: Multicenter Retrospective Study Using Structured and Unstructured Electronic Health Record Data2025-11-27OpenAlex10.2196/77809Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7106838341
W4416771546EGFR-mutated advanced non-small cell lung cancer: new era of systemic therapy towards new standards of care2025-11-27OpenAlex10.1007/s12254-025-01087-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416771546
W7125491983ESMO 2025 and the Future of EGFRm NSCLC Sequencing: First-line Choices that Preserve Subsequent Therapy Eligibility2025-11-27OpenAlex10.82582/thorac.76Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125491983
W4416769903Editorial: Advancing research, clinical recognition, and targeted therapies for WHIM syndrome2025-11-27OpenAlex10.3389/fimmu.2025.1741502Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416769903
W4416739273Editorial: Netnography and qualitative digital methods to advance service theory and practice2025-11-27OpenAlex10.1108/jstp-07-2025-471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416739273
W7138246874Enabling Repair and Regeneration after Neonatal Stroke2025-11-27OpenAlex10.25439/rmt.31768576Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138246874
W4416736792Evolution of concepts of platinum resistance in ovarian cancer and current therapeutic opportunities2025-11-27OpenAlex10.17816/aog690082Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416736792
W4416764826From Pathways to Patients in Atopic Dermatitis: Advanced Systemic Therapies2025-11-27OpenAlex10.3390/ijms262311487Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416764826
W4416773018Infectious Triggers and Immune Dynamics in Guillain–Barré Syndrome: Revisiting Campylobacter jejuni and the Silent Role of Haemophilus influenzae2025-11-27OpenAlex10.1002/mbo3.70177Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416773018
W4416758277Natural products in medicinal chemistry: targeting inflammatory pathways with plant-derived compounds2025-11-27OpenAlex10.1007/s00044-025-03508-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416758277
W7107942568BIOETHICARE 360°2025-11-28OpenAlex10.5281/zenodo.17753192Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7107942568
W4416907450Case Studies in Antiviral Drug Repurposing2025-11-28OpenAlex10.2174/9798898811143125010004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416907450
W4416775237Development of Nano-TiO₂ Activated Carbon as Antibacterial Agent in Hospital Waste2025-11-28OpenAlex10.37311/jsscr.v7i3.33990Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416775237
W4416757739Duchenne Muscular Dystrophy: Clinical Innovations, Ethical Considerations, and Evolving the Path to Adulthood2025-11-28OpenAlex10.1016/j.pediatrneurol.2025.11.020Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4416757739
W4416774138Editorial: Unraveling circRNAs and miRNAs: key regulators in immune-related diseases2025-11-28OpenAlex10.3389/fimmu.2025.1739926Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416774138
W4416796616Fatal neonatal septicemia with meningitis due to Escherichia coli in a full-term baby: an unusual presentation2025-11-28OpenAlex10.18203/2320-6012.ijrms20253997Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416796616
W7133348901Hacia la unicidad de la responsabilidad civil edificatoria en España2025-11-28OpenAlex10.20868/upm.thesis.92182Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133348901
W4416793845RIME Redefined2025-11-28OpenAlex10.1097/ipc.0000000000001512Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416793845
W4416806068Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias2025-11-28OpenAlex10.1055/a-2744-9871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416806068
W4416783907The Immunoglobulin A Nephropathy Renaissance: From Pathogenesis to Personalized Therapy2025-11-28OpenAlex10.7759/cureus.97999Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416783907
W4416810752Bioinspired microneedles for dermatological and precision medicine applications: recent advances and future perspectives2025-11-29OpenAlex10.1007/s00403-025-04457-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416810752
W4416818343Exploring medical co-design in the AI era: A scoping review2025-11-29OpenAlex10.1016/j.daai.2025.100040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416818343
W7108329417Medical Device-Associated Healthcare Infections [MDHAIs] and Patient Safety: Sterilization Protocols, Reprocessing Standards, and Quality of Life Implications; A Comprehensive Review2025-11-29OpenAlex10.36348/sjmps.2025.v11i11.021Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7108329417
W4416917425Proactive Strategies to Prevent Biofilm-Associated Infections: From Mechanistic Insights to Clinical Translation2025-11-29OpenAlex10.3390/microorganisms13122726Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416917425
W4416808580[Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning2025-11-29OpenAlex10.1016/j.farma.2025.10.015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416808580
W7106765164Automating Trust at Scale: Infrastructure-as-Code for Secure and Compliant AI Environments in the U.S.2025-11-30OpenAlex10.5281/zenodo.17710102Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7106765164; https://openalex.org/W4416046601
W4416933524Contrast-enhanced Ultrasonography vs Magnetic Resonance Imaging in the Evaluation of Uterine Lesions: A Prospective Observational Study2025-11-30OpenAlex10.5005/jp-journals-10006-2752Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416933524
W7108466843Designing reflective AI agents to continuously audit public policy algorithms for hidden biases in social welfare decision-making systems2025-11-30OpenAlex10.5281/zenodo.17801768Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7108466843; https://openalex.org/W4416894709
W4416828848Effective HA‐Loading Strategy in Internal Dome‐Assisted Suction Cups for Enhanced Transdermal Delivery Under Vertical Adhesion and Vibration2025-11-30OpenAlex10.1002/adfm.202519672Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416828848
W7126109565Exploring the Nurses Experiences During Unprecedented Crisis: A Heideggerian Perspectives2025-11-30OpenAlex10.47836/mjmhs.v21.i6.1387Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126109565
W4417017915New horizons in metabolic disease treatment: multi-hormonal agonists and functional medicine-based integrated therapy2025-11-30OpenAlex10.32581/jkifm.2025.8.2.66Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417017915
W7128174178Self-Optimizing Factories: The Role of Agentic Automation in Industry 4.02025-11-30OpenAlex10.38124/ijsrmt.v4i11.1049Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7128174178
W441722970136 DECOLONIZING EXHIBITIONS AND PUBLIC COGNITION: BEHAVIORAL AND COGNITIVE SCIENCE PERSPECTIVES ON THE MONTREAL MUSEUM OF ARCHAEOLOGY AND HISTORY2025-12-01OpenAlex10.1097/01.yco.0001175832.04433.8aTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417229701
W712374319160. Genomic guided targeted therapy in a case of refractory chronic lymphocytic leukemia with TP53 and NOTCH1 mutations2025-12-01OpenAlex10.1016/j.cancergen.2025.10.064Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7123743191
W441717593499 Inflammatory Bowel Disease in Eldery Patients: Epidemiology and Clinical Characteristics in a Tertiary Brazilian Public Hospital2025-12-01OpenAlex10.14309/01.ajg.0001172820.65020.06Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417175934
W7107970195A NOVEL APPROACH IN DISORDER MANAGEMENT BY TRANSDERMAL PATCHES: A REVIEW2025-12-01OpenAlex10.5281/zenodo.17747932Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7107970195
W7117125961Advances in the Clinical Application of MAC: A Review of Drug Selection, Combination Therapy, and Administration Methods2025-12-01OpenAlex10.2147/dddt.s552047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117125961
W4416909563Artificial Intelligence in Psychotherapy: Reflections on Opportunities, Challenges, and Ethical Implications2025-12-01OpenAlex10.47307/gmc.2025.133.4.26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416909563
W7217867312Artificial Intelligence in Psychotherapy: Reflections on Opportunities, Challenges, and Ethical Implications: Inteligencia artificial en psicoterapia: reflexiones sobre oportunidades, desafíos e implicaciones éticas2025-12-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217867312
W4417481665CO199 Real Option Value of Sotatercept in Pulmonary Arterial Hypertension: A Health Economic Perspective on Future Treatment Opportunities2025-12-01OpenAlex10.1016/j.jval.2025.09.300Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417481665
W4417521135CURRENT TREATMENT APPROACHES IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA2025-12-01OpenAlex10.1016/j.htct.2025.106197Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417521135
W7117767264Complex Regional Pain Syndrome: Navigating the Evolving Landscape of Chronic Pain2025-12-01OpenAlex10.4103/ijpn.ijpn_78_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117767264
W4416847840Data from LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer2025-12-01OpenAlex10.1158/0008-5472.c.8176785Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416847840
W4416864176Editorial: Food systems, spatial modelling, and planning2025-12-01OpenAlex10.3389/fsufs.2025.1743517Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416864176
W7117573736Emerging pharmacology of targeted protein degraders2025-12-01OpenAlex10.1016/j.jpet.2025.103694Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117573736
W7118566058Emerging solutions for neovascular age-related macular degeneration2025-12-01OpenAlex10.1097/icu.0000000000001199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118566058
W4417538575Evolving Landscape of Precision Medicine in Bladder Cancer: From Challenges to Clinical Impact2025-12-01OpenAlex10.1002/ila2.70045Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4417538575
W4416930901Evolving paradigms of Hodgkin lymphoma and implications for cancer survivorship2025-12-01OpenAlex10.1055/s-0045-1812960Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416930901
W7117325034First-line maintenance strategies and later-line options in patients with advanced gastroesophageal adenocarcinoma2025-12-01OpenAlex10.1177/17588359251389741Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117325034
W4417521072From CD5-Negative Indolent B-Cell LPD to Therapy-Related CLL/SLL with Unmutated IGHV After Breast Cancer: Rationale for BTK-Inhibitor–Based First-Line Therapy2025-12-01OpenAlex10.1016/j.htct.2025.106160Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417521072
W7117290979How to efficiently move towards primary prevention in sporadic AD2025-12-01OpenAlex10.1002/alz70859_105951Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117290979
W4417521130IRON CHELATİON İN MYELODYSPLASTİC SYNDROMES: WHO AND WHEN?2025-12-01OpenAlex10.1016/j.htct.2025.106181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417521130
W7128526114Inaugural Editorial: Journal of Cardio-Oncology – Bridging disciplines, advancing patient-centered global care2025-12-01OpenAlex10.1097/co9.0000000000000011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128526114
W7203605785Innovations in Plant Protection: Technology, Ecology and Future Trends2025-12-01OpenAlex10.5281/zenodo.21984125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203605785
W4416946873Letter to the Editor: Detrimental effects of diabetes mellitus in alcoholic liver disease2025-12-01OpenAlex10.1097/hc9.0000000000000852Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416946873
W4417330893Low-Dimensional Nanoelectronic Materials for Energy-Efficient Edge Computing2025-12-01OpenAlex10.1149/2.f13254ifTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417330893
W4417229856Meeting Abstracts: The 4th International Conference on Behavioral Sciences and Applied Psychology (BSAP 2025)2025-12-01OpenAlex10.1097/01.yco.0001175688.83291.b1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417229856
W7135040495NAPTICON-2025 – OBSERVATIONAL STUDIES2025-12-01OpenAlex10.4103/njpt.njpt_73_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135040495
W7135030054NAPTICON-2025 – SYSTEMATIC REVIEWS AND META-ANALYSIS2025-12-01OpenAlex10.4103/njpt.njpt_75_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135030054
W4417304667Nanotechnology-based approaches for head and neck cancer treatment2025-12-01OpenAlex10.1016/j.biopha.2025.118871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417304667
W7107943055ONYCHOMYCOSIS INSIGHTS INTO PATHOGENESIS, DIAGNOSTIC APPROACHES, AND EVOLVING TREATMENT STRATEGIES2025-12-01OpenAlex10.5281/zenodo.17746596Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7107943055
W7117130379Omega‐3 Fatty Acids as a Neuroprotective Agent: Behavioural and Molecular Improvements in STZ‐Induced Neurodegeneration2025-12-01OpenAlex10.1002/alz70855_100940Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117130379
W4416940425Optimizing Heart Failure Management in the Cardio-Oncology Setting: Guideline-Directed Medical Therapy, Permissive Cardiotoxicity, and Personalized Approaches2025-12-01OpenAlex10.1007/s12170-025-00780-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416940425
W4416876164Orientalized Imagery in Posthuman Science-Fiction Cities: From the Explosive Chinatown to the Generic Metropolis2025-12-01OpenAlex10.5406/19346018.78.1.03Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416876164
W4416971454P72 Investigating the adaptive evolutionary responses of MRSA to alkylating agents2025-12-01OpenAlex10.1093/jacamr/dlaf230.079Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4416971454
W4417521101PLATELET FUNCTION DISORDERS: CONTEMPORARY INSIGHTS AND FUTURE DIRECTIONS2025-12-01OpenAlex10.1016/j.htct.2025.106191Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417521101
W7126277354Refractory MG and B-cell depletion2025-12-01OpenAlex10.1016/j.jns.2025.123845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126277354
W7123562422Retracted: AI-Powered Applications in Precision Healthcare and Security Surveillance Systems2025-12-01OpenAlex10.1109/ictbig68706.2025.11323654Title/abstractExcludedE5: Correction, retraction or ancillary data record.https://openalex.org/W7123562422
W4416834045Rose Bengal as a multifunctional agent: from biomedical uses to catalysis and materials science2025-12-01OpenAlex10.1016/j.ccr.2025.217413Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416834045
W4417521095SUMMARY: OPTIMIZATION OF TREATMENT IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)2025-12-01OpenAlex10.1016/j.htct.2025.106206Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417521095
W4416997976Society of Critical Care Medicine Clinical Practice Guidelines on Adult End-of-Life Care in the ICU2025-12-01OpenAlex10.1097/ccm.0000000000006856Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416997976
W4417435016Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 20212025-12-01OpenAlex10.2147/ceor.s548758Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4417435016
W7126180278Successful switch from ravulizumab to satralizumab in a patient with NMOSD experiencing persistent joint pain2025-12-01OpenAlex10.1016/j.jns.2025.124874Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126180278
W7108202046THE MULTI-SCALE PLAQUE PARADIGM A Unified Framework for Targeted Remediation Across Biological, Ecological, and Planetary Systems2025-12-01OpenAlex10.5281/zenodo.17773277Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108202046
W7116353596THE TREATMENT ALGORITHM FOR SICKLE CELL DISEASE2025-12-01OpenAlex10.1016/j.htct.2025.106183Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116353596
W4416839182Targeting the role played by microbiota and adaptive immunity within autoimmune disease complexity2025-12-01OpenAlex10.3389/fimmu.2025.1718417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416839182
W4416953493The Evolving Therapeutic Landscape of Richter Transformation2025-12-01OpenAlex10.1007/s11899-025-00765-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416953493
W4416844088The Legal Challenges of Artificial Intelligence in Transportation & Healthcare: Negligence under Malaysian and European Law2025-12-01OpenAlex10.33093/ajlp.2025.16Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416844088
W4417287603The Past and Future of Interventional Radiology2025-12-01OpenAlex10.1055/s-0045-1813743Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417287603
W4416930917Therapeutic Success and Strategic Uncertainty: The Evolving Role of Salvage Therapy in Hodgkin Lymphoma in the United States2025-12-01OpenAlex10.1055/s-0045-1812987Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416930917
W7133913787Therapeutic targeting of the ATP7A copper transporter in cancer2025-12-01OpenAlex10.32469/10355/111052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133913787
W7165052593Touching Photographs: The (In)tangible Image in the Photo-essays of John Berger and Jean Mohr2025-12-01OpenAlex10.1093/camqtly/bfag003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165052593
W7197850865Use of digital tools to strengthen technical support processes in Mexico, Guatemala, and Honduras2025-12-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7197850865
W7198169669Use of system analysis to describe the diversity of farming systems in Nariño, Colombia2025-12-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7198169669
W7117135280Using Agenticai With Kubernetes For Faster Development, Deployment and Delivery in Production Environments.2025-12-01OpenAlex10.37547/tajet/volume07issue12-07Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117135280
W7119483408[Evolution and progress of personalized sedation strategies].2025-12-01OpenAlex10.3760/cma.j.cn121430-20241029-00888Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119483408
W7119042700残余炎症风险在脑动脉粥样硬化性疾病中的研究进展Advances of Residual Inflammatory Risk in Cerebral Artery Atherosclerotic Disease2025-12-01OpenAlex10.3969/j.issn.1673-5765.2025.12.015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119042700
W7201960110A Framework for the Prediction of Parkinson’s Disease Using Agentic Artificial Intelligence2025-12-02OpenAlex10.33411/ijist/1665Full textExcludedF3: The Parkinson pipeline uses XGBoost and rule-controlled orchestration; the primary methods explicitly state there is no RL or self-updating agent policy. No LLM acting agent is implemented.https://openalex.org/W7201960110https://journal.50sea.com/index.php/IJIST/article/download/1665/2499/19627original publisher PDF indexed methods section p3043 and abstract; live fetch404, not entire paper
W4417490330Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?2025-12-02OpenAlex10.1080/13543784.2025.2606118Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4417490330
W7108321440Beyond Sovereign AI: A Unified Framework for National AI Governance and Constraint-Aligned Intelligence Systems Integrating Australia's National AI Plan (2025) with the CollectiveOS Architecture2025-12-02OpenAlex10.5281/zenodo.17791470Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7108321440
W4417031353Editorial: From Optimization to Adaptation: The Resilience Paradigm in Twenty-First Century Engineering2025-12-02OpenAlex10.71411/ef.2025.v1i1.935Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417031353
W4416928726Lipoprotein(a) and CKD2025-12-02OpenAlex10.2215/cjn.0000000968Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416928726
W4416918109Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes2025-12-02OpenAlex10.1016/j.vph.2025.107562Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416918109
W4417235919Next-Generation Liposomes for Cosmeceutical Applications: From Structural Insights to Smart, Sustainable Delivery and Clinical Outcomes2025-12-02OpenAlex10.21608/bfsa.2025.437284.2878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417235919
W4416918675Nutritional Challenges in Post–Massive Weight Loss Body Contouring: Guidance for Plastic Surgeons on GLP-1 Agonists and Sleeve Gastrectomy2025-12-02OpenAlex10.1097/prs.0000000000012672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416918675
W4416899285Response to the Letter Regarding Our Editorial: “Impact of SARS-CoV-2 variants on viral infectivity and the role of the Renin-Angiotensin-Aldosterone system”2025-12-02OpenAlex10.1038/s41440-025-02353-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416899285
W4416901955Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment2025-12-02OpenAlex10.3390/ijms262311665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416901955
W4416949508A comprehensive review on application of cognitive behavioral therapy in emotional AI solutions for mental well-being2025-12-03OpenAlex10.1007/s44202-025-00513-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416949508
W4416937759Advancements in cardiovascular pharmacology2025-12-03OpenAlex10.4081/ahr.2025.122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416937759
W4416936322Comprehensive investigation of synthesis, properties and biomedical utilization of multifunctional dextran-based polymeric nanoparticles2025-12-03OpenAlex10.1007/s00396-025-05552-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416936322
W4416951601Ethical and inclusive challenges of machine learning in anaesthesia2025-12-03OpenAlex10.1111/anae.70089Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416951601
W4416936027Expanding the immunotherapy universe in extensive-stage small cell lung cancer: from chemoimmunotherapy backbone to next-wave combinations2025-12-03OpenAlex10.3389/fimmu.2025.1693401Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416936027
W7128710475Hemophagocytic Lymphohistiocytosis and Infections in Children: An Update2025-12-03OpenAlex10.1097/inf.0000000000005066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128710475
W4416960938Hydrothermal system for high-sulfur real fuel conversion and desulfurization: Deuterium -traced evaluation of temperature-driven hydrogen transfer2025-12-03OpenAlex10.1016/j.ijhydene.2025.152824Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416960938
W7123526550Imaging tumor thrombus across malignancies: current concepts and the expanding role of PET/computed tomography2025-12-03OpenAlex10.1097/mnm.0000000000002090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123526550
W4416969251Molecular glues evolve from serendipity to rational design2025-12-03OpenAlex10.1016/j.tips.2025.10.013Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416969251
W4416934951Personalized Type 1 Diabetes Management: Reinforcement Learning–Based Insulin Dosing and Glucose Forecasting2025-12-03OpenAlex10.2196/79195Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416934951
W4416950701Real-world eligibility for FSGS clinical trials: insights from a US health system2025-12-03OpenAlex10.1093/ckj/sfaf377Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4416950701
W4416932421Targeting protein kinase C signaling cascades in alzheimer’s disease: emerging neuroprotective roles of aurothioglucose2025-12-03OpenAlex10.1007/s10787-025-02077-2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4416932421
W7108479285The Agentic Horizon: A Comprehensive Analysis of Autonomous Digital Systems and Planetary Intelligence Architectures2025-12-03OpenAlex10.5281/zenodo.17798764Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7108479285
W7220158627The persistence of delirium in the intensive care unit: an analysis of morbidity and hospital stay2025-12-03OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220158627
W4417278715The use of methadone in cardiac surgery: resurgence of an old drug?2025-12-03OpenAlex10.1097/aco.0000000000001600Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417278715
W4416977641Continuum of Care for Hemophilia: The Story of India2025-12-04OpenAlex10.1007/s12098-025-05886-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416977641
W4416982998GLP-1 receptor agonists on WHO-EML 2025 list: major breakthrough bounded by persistent challenge2025-12-04OpenAlex10.1007/s40200-025-01810-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416982998
W4417120124Rapid Autopsy Multi-Omic Analysis Identifies Divergent Evolutionary Trajectories and DNA Damage Resistance Mechanisms in FGFR2-Driven Cholangiocarcinoma2025-12-04OpenAlex10.64898/2025.11.25.25340882Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417120124
W4416994292Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents2025-12-04OpenAlex10.3390/ijms262311744Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416994292
W4417011327The Evolving Paradigm of Acne Vulgaris Management: A Systematic Review Emphasizing Evidence-Based Combination Therapy, Antimicrobial Stewardship, and Patient-Reported Outcomes2025-12-04OpenAlex10.70070/9zftvn36Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417011327
W4416997985The Saudi Thoracic Society guidelines for community acquired pneumonia: A model for translating evidence into national practice2025-12-04OpenAlex10.4103/atm.atm_348_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4416997985
W7108720336The Shadow Simplex: A Critical Framework for Analyzing Failure Modes in Self-Evolving Multi-Agent Reinforcement Learning Systems2025-12-04OpenAlex10.5281/zenodo.17814909Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7108720336; https://openalex.org/W7163359963
W7117365980A Review on Pathophysiological Mechanisms, Clinical Heterogeneity, and Management of Takayasu Arteritis2025-12-05OpenAlex10.69613/sy8zx094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117365980
W4417045287A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 – present)2025-12-05OpenAlex10.1080/13543776.2025.2588773Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417045287
W4417041731All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?2025-12-05OpenAlex10.1182/hematology.2025000748cTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417041731
W4417033899Artificial intelligence applications in patient counseling: Latest research, developments, and practical insights for beginners and advanced professionals2025-12-05OpenAlex10.1016/b978-0-443-43823-3.00017-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417033899
W7219924733COMPLEX RESPIRATORY PATHOGENS IN PEDIATRIC POPULATIONS2025-12-05OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219924733
W4417152952Current and future use of artificial intelligence in valvular heart disease imaging2025-12-05OpenAlex10.1093/ehjci/jeaf348Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417152952
W4417105426Diagnosis, Characterization and Treatment of Emerging Pathogens, Second Edition2025-12-05OpenAlex10.3390/books978-3-7258-5974-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417105426
W4417041680Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?2025-12-05OpenAlex10.1182/hematology.2025000741Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417041680
W4417041856New therapies in hemophilia: extend the half-life, mimic, or rebalance?2025-12-05OpenAlex10.1182/hematology.2025000764Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417041856
W4417042128Optimizing the “right” patient selection for treatment for sickle cell disease2025-12-05OpenAlex10.1182/hematology.2025000751Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417042128
W4417038102Research progress in molecular targeted therapy for inflammatory bowel disease2025-12-05OpenAlex10.1186/s12967-025-07385-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417038102
W4417065319The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care2025-12-05OpenAlex10.2215/cjn.0000000975Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417065319
W4417045423The development of lipid nanoparticle technology for the management of COVID-192025-12-05OpenAlex10.1016/b978-0-443-33002-5.00006-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417045423
W4417041617Updates in low/intermediate-risk MDS2025-12-05OpenAlex10.1182/hematology.2025000768Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417041617
W4417072651Clinical translation and landscape of superparamagnetic iron oxide nanoparticles2025-12-06OpenAlex10.1016/j.addr.2025.115756Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417072651
W7112654057Mindware Lab - Ψ Intelligence2025-12-06OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7112654057
W7109203592The Current Ulcerative Colitis (UC) Treatment Algorithm: From 5-ASA to Biological Therapies2025-12-06OpenAlex10.12775/qs.2025.47.66966Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7109203592
W4417092996A Dual-Agent Multimodel AI Framework for Driver State Monitoring System2025-12-07OpenAlex10.56726/irjmets86062Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4417092996
W4417102801Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets2025-12-07OpenAlex10.1111/jgh.70189Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417102801
W4417144400Emerging Frontiers in AI and Ophthalmology2025-12-07OpenAlex10.2174/9798898812287125010007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417144400
W4417187322INTEGRATION OF SERVANT LEADERSHIP INTO ORGANIZATIONAL CHANGE MODELS2025-12-07OpenAlex10.30838/ep.207.241-249Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417187322
W4417095804Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management2025-12-07OpenAlex10.1016/j.ijrobp.2025.11.064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417095804
W4417124210Thrombus Composition and the Evolving Role of Tenecteplase in Acute Ischemic Stroke2025-12-07OpenAlex10.3390/jcm14248675Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417124210
W4417134641Navigating Adolescent Mental Health in the Age of Artificial Intelligence2025-12-08OpenAlex10.62414/001c.150329Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417134641
W4417120136Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime/avibactam resistance in carbapenem-resistant Pseudomonas aeruginosa2025-12-08OpenAlex10.1128/spectrum.02187-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417120136
W7111411870PHYSIOLOGICAL AND LABORATORY CHANGES DUE TO STRESS2025-12-08OpenAlex10.5281/zenodo.17859656Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7111411870
W7114656895PsychLab Research: Mathematical Modeling of the Construction of Change2025-12-08OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114656895
W7125581548Radiation Techniques in Health and Environment2025-12-08OpenAlex10.53560/ppasa(62-4)705Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125581548
W4417121903Strategic Combinations of Antibody–Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens2025-12-08OpenAlex10.3390/pharmaceutics17121581Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417121903
W4417226379Breaking the shields of resistance: multidimensional therapeutic strategies in the breast cancer drug resistance conundrum2025-12-09OpenAlex10.1097/js9.0000000000004424Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417226379
W4417146324Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies2025-12-09OpenAlex10.3389/fimmu.2025.1752360Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417146324
W4417146366Editorial: Ferroptosis and regulation mechanism in the tumor immune microenvironment for tumor progression and treatment2025-12-09OpenAlex10.3389/fimmu.2025.1748341Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417146366
W4417144082Gastrointestinal cancer: molecular pathogenesis and targeted therapy2025-12-09OpenAlex10.1186/s43556-025-00361-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417144082
W4417162923Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC2025-12-09OpenAlex10.1128/jvi.01487-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417162923
W4417172142Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review2025-12-09OpenAlex10.1136/ejhpharm-2025-004586Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4417172142
W4417159175Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer2025-12-09OpenAlex10.3390/cancers17243934Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417159175
W7114918968AI-Synthesized Psychopathology: When Unconscious Algorithms Perform "Trauma", Whose Reflection Do We See?2025-12-10OpenAlex10.5281/zenodo.17890131Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114918968
W7114790267BOOK REVIEW: PRACTICAL DIABETES MELLITUS2025-12-10OpenAlex10.5281/zenodo.17878161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114790267
W4417260042Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression2025-12-10OpenAlex10.53366/jimki.vi.949Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417260042
W7213353426Cost-Effective and Compliant: Leveraging Agentic AI to Optimize KYC Processes in FinTech Onboarding2025-12-10OpenAlex10.68207/msxc1217Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213353426
W4417181054Editorial: Immunological therapies in pediatric cancers: a Latin American perspective2025-12-10OpenAlex10.3389/fonc.2025.1744458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417181054
W4417180463Editorial: Skin microbiome: microbiological, immunological and cellular aspects for therapies to control antimicrobial resistance and skin repair2025-12-10OpenAlex10.3389/fcimb.2025.1736430Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417180463
W4417210377Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies2025-12-10OpenAlex10.1016/s1474-4422(25)00356-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417210377
W4417180982Global trends in carbapenem-resistant gram-negative bacteria research (2020–2025): a bibliometric analysis and systematic review2025-12-10OpenAlex10.3389/fcimb.2025.1690417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417180982
W4417178374Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer2025-12-10OpenAlex10.1016/j.pan.2025.12.007Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417178374
W7123713328Recent advances in palliative systemic therapy for locally advanced unresectable or metastatic gastric cancer: a narrative review2025-12-10OpenAlex10.5124/jkma.25.0114Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123713328
W7113897474Reinforcement Learning: A Statistical Perspective2025-12-10OpenAlex10.6339/25-jds1205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7113897474
W7114771520The BEP Framework: Belonging, Energy, and Prediction as Drivers of Cognition, Decision-Making, and Human–AI Interaction2025-12-10OpenAlex10.5281/zenodo.17886686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114771520
W441721454620th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment2025-12-11OpenAlex10.1016/j.annonc.2025.12.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417214546
W7114802795Antibody–Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy2025-12-11OpenAlex10.3390/msf2025040002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114802795
W4417229300Cell-Mediated and Peptide-Based Delivery Systems: Emerging Frontiers in Targeted Therapeutics2025-12-11OpenAlex10.3390/pharmaceutics17121597Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417229300
W4417231504Managing skin infections in burn patients: principles and pitfalls2025-12-11OpenAlex10.1097/qco.0000000000001173Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417231504
W4417211974Unveiling Alzheimer’s disease (1901–2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies2025-12-11OpenAlex10.1016/j.arr.2025.102990Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417211974
W4417251196Uveal Melanoma: Changing Paradigms of Treatment2025-12-11OpenAlex10.1159/000549994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417251196
W7140292690A Hierarchical Multi-Agent Framework for Improved Clinical Diagnosis2025-12-12OpenAlex10.1109/iccc68654.2025.11437615Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7140292690
W4417262047Case Report: Tail-of-the-curve advantage from immune checkpoint inhibitor–anti-VEGF combination therapy: extended survival in a patient with metastatic lung adenocarcinoma2025-12-12OpenAlex10.3389/fmed.2025.1714486Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417262047
W7134247747Exosomes in Aesthetic Medicine: An Overview2025-12-12OpenAlex10.1093/asj/sjaf259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134247747
W4417281255First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent2025-12-12OpenAlex10.1016/j.phymed.2025.157689Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W4417281255
W4417502477Post-surgical pain: evolving drug treatments and challenges2025-12-12OpenAlex10.1080/14656566.2025.2608078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417502477
W7114918207Risk Factors and Preventing Strategies of Pocket Hematoma After Cardiac Implantable Electronic Device Implantation: A Systematic Review2025-12-12OpenAlex10.3390/jcdd12120490Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7114918207
W4417275784The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions2025-12-12OpenAlex10.3390/ph18121882Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417275784
W4417304578Treatment of primary adult-onset neurodegenerative cerebellar ataxias2025-12-12OpenAlex10.1016/j.neurot.2025.e00805Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417304578
W4417281089Understanding the Charles Bonnet syndrome: An updated review2025-12-12OpenAlex10.1016/j.brainresbull.2025.111683Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417281089
W4417321448Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers2025-12-13OpenAlex10.3322/caac.70052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417321448
W7131799373Igniting the future of cardiovascular care: highlights from the ESC Digital and AI Summit 2025 in Berlin2025-12-13OpenAlex10.1093/eurheartj/ehaf1068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131799373
W4417302545Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic review2025-12-13OpenAlex10.1016/j.critrevonc.2025.105088Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417302545
W4417299276Transformative progress of SPIONs in cancer theranostics: A comprehensive review on recent advances in SPIONs technology2025-12-13OpenAlex10.1016/j.colsurfb.2025.115372Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417299276
W7115066039A Synergistic Reinforcement Learning Framework for Adaptive, Privacy-Preserving Trust and Collusion Detection in Multi-agent Systems2025-12-14OpenAlex10.1007/978-3-032-13562-9_32Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7115066039
W7128028607AURELIUS: Agentic Uncertainty-Reasoning & Learning with Hierarchical Bayesian Multi-Agents Unified System for Handling Non-Determinism in HealthTech2025-12-14OpenAlex10.1109/commantel68363.2025.11368546Full textExcludedF3: AURELIUS implements Bayesian encoders, graph coordination and hierarchical multi-agent RL. Although§III.D mentions generative reasoning conceptually,§VI explicitly lists integrating LLM high-level planners as future work. The evaluated acting system is not an implemented LLM/VLM agent.https://openalex.org/W7128028607https://ieeexplore.ieee.org/document/11368546
W4417427156Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical application2025-12-14OpenAlex10.1016/j.mam.2025.101441Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417427156
W4417317087The Potential Clinical Relevance of Necrosis–Necroptosis Pathways for Hypoxic–Ischaemic Encephalopathy2025-12-14OpenAlex10.3390/cells14241984Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417317087
W4417327244Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developments2025-12-15OpenAlex10.3389/falgy.2025.1714577Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417327244
W4417311111Current treatments, practical management, and emerging investigational therapies for myelofibrosis2025-12-15OpenAlex10.1080/17474086.2025.2604532Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417311111
W4417312336Editorial: Advances and challenges in adult-onset craniopharyngioma2025-12-15OpenAlex10.3389/fendo.2025.1755850Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417312336
W4417338316Interstitial Lung Disease in 2025: Updated Classification, Precision Diagnostics, and Expanding Therapeutic Frontiers2025-12-15OpenAlex10.58931/crt.2025.1316Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417338316
W4417330805Nontuberculous Mycobacteria: An update2025-12-15OpenAlex10.1016/j.ijtb.2025.12.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417330805
W7115586381Oncology Nanomedicine: Immunomodulating Nanomedicine for Tumor Therapy2025-12-15OpenAlex10.5281/zenodo.17938289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7115586381
W4417345710Pathology’s Last Exam: Stress-Testing Diagnostic Reasoning and Safety in Large Language Models2025-12-15OpenAlex10.64898/2025.12.11.25342081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417345710
W4417323219Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review2025-12-15OpenAlex10.1007/s11916-025-01450-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417323219
W7127652668The Application of Antioxidant in Skin Cancer Research: A Bibliometric Study2025-12-15OpenAlex10.31557/apjcc.2025.10.4.1133-1141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127652668
W7126091496Towards Trustworthy Knowledge Extension in Clinical Decision Support: An LLM-Agent Approach2025-12-15OpenAlex10.1109/bibm66473.2025.11356848Full textExcludedF4: The agents discover and verify external literature/guideline assertions and merge approved RDF triples into a CDSS. This is knowledge-source refresh, without learning retained from clinical case/task experience.https://openalex.org/W7126091496https://ieeexplore.ieee.org/document/11356848
W4417350943Article Review of Antibiotic Resistance2025-12-16OpenAlex10.21275/sr251212195149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417350943
W4417349581Case Report: Multiple immune related adverse events in a patient with metastatic melanoma2025-12-16OpenAlex10.3389/fimmu.2025.1677544Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417349581
W4417347209Direct application of Amikacin in pressure sores - A prospective cohort study2025-12-16OpenAlex10.21203/rs.3.rs-8337654/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417347209
W4417354585Editorial: Emerging antimicrobials: sources, mechanisms of action, spectrum of activity, combination antimicrobial therapy, and resistance mechanisms2025-12-16OpenAlex10.3389/fmicb.2025.1754398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417354585
W7126126702Evaluation of new therapeutic modalities in transarterial locoregional treatment for hepatocellular carcinoma2025-12-16OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126126702
W4417407429Evolving paradigms in the management of dyslipidemia: comparison between the 2019 ESC/EAS guidelines and the 2025 focus update2025-12-16OpenAlex10.1007/s11739-025-04234-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417407429
W4417457715Extended susceptibility testing for refractory Helicobacter pylori infection: regional testing should guide antimicrobial decision making2025-12-16OpenAlex10.1186/s12879-025-12236-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4417457715; https://openalex.org/W7125410404
W7115595444Infantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy2025-12-16OpenAlex10.3390/medicina61122223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7115595444
W4417352257Primary biliary cholangitis (PBC): evolving approaches and expert perspectives2025-12-16OpenAlex10.1080/17474124.2025.2601220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417352257
W4417363450The Treatment of Obesity in the Context of the Obesity Paradox in Patients with Heart Failure: A Narrative Review2025-12-16OpenAlex10.1007/s11886-025-02333-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417363450
W4417360291Where Are We Going by Applying AI Tools? Are We Going to Lose Our Jobs?2025-12-16OpenAlex10.23749/mdl.v116i6.18255Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417360291
W4417439756Convergent Evolution: Self-Assembly of Small Molecule, Polymeric, and Inorganic Contrast Agents toward Advanced MRI2025-12-17OpenAlex10.1021/jacs.4c11767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417439756
W4417416775Drug treatment of MASH from none to (too) many options?2025-12-17OpenAlex10.37349/emed.2025.1001378Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417416775
W4417416672Editorial: RNA regulation mechanisms in microbial-host interactions2025-12-17OpenAlex10.3389/fcimb.2025.1751814Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417416672
W7115950498FROM THRESHOLDS TO TRAJECTORIES: The AGI Capability Maturity Model™ for Artificial General Intelligence2025-12-17OpenAlex10.5281/zenodo.17958748Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7115950498
W4417434158Identification of a novel circular DNA carrying blaNDM−1 gene in an extensive drug resistant Providencia huaxiensis strain2025-12-17OpenAlex10.1007/s42770-025-01845-0Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417434158
W7115893462Liquid Glass2025-12-17OpenAlex10.5281/zenodo.17964620Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7115893462
W7198456508Multi-Agent Systems for Root Cause Analysis in Microservices2025-12-17OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7198456508
W7128500087PEDAGOGICAL AGENTS FOR STUDENTS WITH AUTISM: A CONTEMPORARY WORLDWIDE BIBLIOMETRIC INSIGHT2025-12-17OpenAlex10.35631/ijepc.1061073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128500087
W7125425757SYNTHETIC CATHINONES AND NEW PSYCHOACTIVE SUBSTANCES IN POLAND: EPIDEMIOLOGY, TOXICOLOGY, AND PUBLIC HEALTH IMPACT2025-12-17OpenAlex10.31435/ijitss.4(48).2025.4013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125425757
W7216725116Avances en el manejo farmacológico de la hepatopatía alcohólica2025-12-18OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216725116
W7116085084Details of PC1608 sediment core recovered from 437 meter depth off Wakasa Bay in the Sea of Japan2025-12-18OpenAlex10.17632/ybzdgt6669Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116085084
W4417449047Editorial: AI-driven healthcare delivery, ageism, and implications for older adults: emerging trends and challenges in public health2025-12-18OpenAlex10.3389/fpubh.2025.1755410Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417449047
W4417449216Editorial: Non-coding RNAs as potential therapeutics and biomarkers for human diseases2025-12-18OpenAlex10.3389/fphar.2025.1753536Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417449216
W7135136181Facilitating Shared Introspection in Hierarchical Multi-Agent Systems Using the Model Context Protocol2025-12-18OpenAlex10.1109/raai67517.2025.11423310Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7135136181
W4417466724HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis2025-12-18OpenAlex10.3390/cancers17244037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417466724
W4417450863Medication-Related Osteonecrosis of the Jaw: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies2025-12-18OpenAlex10.17615/r7v3-vk88Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417450863
W4417471941Narrative review of dissertation research and innovations in Russian science (2012–2024) on malignant kidney tumors2025-12-18OpenAlex10.17650/1726-9776-2025-21-3-157-169Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417471941
W7116125699Natural Interventions for Asthma: The Evolving Role of Nutraceuticals in Respiratory Care2025-12-18OpenAlex10.5281/zenodo.17972574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116125699
W7135082370Root Cause Tracing Method for Industrial Process Systems Based on Extended Convergent Cross Mapping2025-12-18OpenAlex10.1109/raai67517.2025.11423372Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7135082370
W7135037184XCAD: eXplainable Collusion and Adversary Detection Framework for Multi-Agent Systems2025-12-18OpenAlex10.1109/raai67517.2025.11423320Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7135037184
W7133537986Dynamic Risk Stratification in ICU Sepsis: A Deep Reinforcement Learning Approach Using Synthetic Data2025-12-19OpenAlex10.1109/reacs67479.2025.11413339Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133537986
W7116104340From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications2025-12-19OpenAlex10.55674/cs.v18i1.264689Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116104340
W4417516373Monographic Issue on Glucocorticoid Therapy in Critical Illness and Respiratory Disease2025-12-19OpenAlex10.1055/a-2751-9147Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417516373
W7116732514Perspective Chapter: Statins Use in Cancer Treatment – Unraveling the Mechanisms and Future Therapeutic Frontiers2025-12-19OpenAlex10.5772/intechopen.1012091Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116732514
W4417524133Pleiotropy of glucagon-like peptide-1 receptor agonists: too much of a good thing?2025-12-19OpenAlex10.23736/s2724-5683.25.07174-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417524133
W7119162320Weekly Journal Scan: In search for the optimal DAPT duration after percutaneous coronary intervention in patients with or without high bleeding risk2025-12-19OpenAlex10.1093/eurheartj/ehaf1070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119162320
W4417479511Why world models fail under intervention: Ontological–causal separation as a necessary structure2025-12-19OpenAlex10.21203/rs.3.rs-8377767/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417479511
W7153275774A Cognitive Operations Management (COM) Framework for Phishing Resilience: Quantifying User Decision Quality (UDQ) using Evidence Accumulation Modeling2025-12-20OpenAlex10.46254/ba08.20250193Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7153275774
W7214551214Predicting Q-Day: A Fractal Mathematics Approach to Quantum Computing Timelines2025-12-20OpenAlex10.5281/zenodo.22995709Title/abstractExcludedE2: Mathematical/forecasting/AGI framework without a clinical primary task.https://openalex.org/W7214551214
W7116779269Rituximab in Connective Tissue Disease-Associated Interstitial Lung Disease: From Immunopathogenesis to Therapeutic Implications2025-12-20OpenAlex10.3390/ijms27010046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116779269
W4417521493Role of Modern Technologies in Reshaping New Age Toxicology2025-12-20OpenAlex10.30574/msarr.2025.15.2.0162Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4417521493
W7116650544Subjective cognitive impairment as a manifestation of Alzheimer's disease or emotional disorders2025-12-20OpenAlex10.14412/2074-2711-2025-6-99-105Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116650544
W7116652622Clinical Features and Risk Factors of Enfortumab Vedotin–Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study)2025-12-21OpenAlex10.1111/iju.70329Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116652622
W4417537241DPDC-ILKM: A multi-agent integrated large knowledge model for intelligent maintenance of industrial swarm robotics2025-12-21OpenAlex10.1016/j.jii.2025.101044Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4417537241
W7117143217A Reinforcement Learning Approach for Modeling Organic Compound-Induced Antimicrobial Resistance Dynamics2025-12-22OpenAlex10.64898/2025.12.18.695270Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117143217
W7116785526A proposed reference model for the deployment of an integrated ai system in a large oncology center under the EU AI Act and MDR. Part I: Strategic & Operational Framework2025-12-22OpenAlex10.31648/ts.12176Full textExcludedF1: The work defines an implementation-neutral governance reference architecture and deployment pathway. OnkoBot is explicitly a narrative benchmark/design probe, and detailed algorithms and extended evolution validation are deferred to later parts; it does not build/evaluate the adaptive LLM system required here.https://openalex.org/W7116785526https://www.researchgate.net/publication/398962494_A_proposed_reference_model_for_the_deployment_of_an_integrated_ai_system_in_a_large_oncology_center_under_the_EU_AI_Act_and_MDR_Part_I_Strategic_Operational_FrameworkPrimary paper public author full-text; contribution, reference architecture, offline evolution and limitations sections read. Publisher direct route timed out.
W7116702272Anal intraepithelial neoplasia in Ireland: practice patterns and the case for regionalisation2025-12-22OpenAlex10.1007/s11845-025-04186-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116702272
W7116988664Emerging Therapies in IgA Nephropathy: From A Proliferation-Inducing Ligand (APRIL) and B-cell Activating Factor (BAFF) Inhibitors to Precision Medicine2025-12-22OpenAlex10.7759/cureus.99870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116988664
W7116700533Epidemiology and molecular typing of multidrug resistant Acinetobacter baumannii burn wound isolates from six Chinese provinces2025-12-22OpenAlex10.1038/s41598-025-31214-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116700533
W7217399223FAULT-TOLERANT CONTROL OF LOW-ALTITUDE UNMANNED AERIAL VEHICLE SWARMS USING A REDUCED-ORDER SLIDING MODE OBSERVER2025-12-22OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7217399223
W7117671353Future Horizons in Nuclear Medicine2025-12-22OpenAlex10.2174/9798898813543125010018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117671353
W7116982159Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: An Evolving Clinical Paradigm2025-12-22OpenAlex10.3390/diagnostics16010034Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7116982159
W7116685205Murine Organ Auto-Contouring in Small-Animal Precision Irradiation: A Comprehensive Approach Integrating Deep Learning and Contrast Enhancement for Onboard CBCT2025-12-22OpenAlex10.21203/rs.3.rs-6891084/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7116685205
W7151534346Roles de género y territorio en zonas altoandinas, conocimiento clave para la conservación de la biodiversidad: Caso San Pedro de Churco (Perú)2025-12-22OpenAlex10.21142/des-1704-2025-0093Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7151534346
W7116841712THE SYMBIOTIC AXIS - A Common Language for Reading All Living Systems2025-12-22OpenAlex10.5281/zenodo.18018904Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116841712
W7116844275The Responsible Health AI Readiness and Maturity Index (RHAMI): Applications for a Global Narrative Review of Leading AI Use Cases in Public Health Nutrition2025-12-22OpenAlex10.3390/nu18010038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116844275
W7118367785Un proyecto didáctico mediado por tecnología para afrontar conductas disruptivas de alumnos de educación primaria2025-12-22OpenAlex10.63664/ined16252025246Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118367785
W7116846102Uterine Fibroids: From Pathogenic Signalling and Molecular Classification to Precision Diagnosis and the Evolving Landscape of Minimally Invasive Management2025-12-22OpenAlex10.5281/zenodo.18022372Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7116846102
W7117530101Chemotherapy: Complications and Anesthetic Considerations2025-12-23OpenAlex10.2174/9798898813727125010006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117530101
W7117145978GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach2025-12-23OpenAlex10.1016/j.molmed.2025.12.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117145978
W7117471327Green-mediated ZnO Nanoparticles Using Cichorium intybus (Dandelion) Extract: A Novel Antifungal Approach against Drug-Resistant Candida albicans2025-12-23OpenAlex10.21608/ejbo.2025.422065.3444Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117471327
W7117577283Immunotherapy - Anesthetic Considerations2025-12-23OpenAlex10.2174/9798898813727125010007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117577283
W7116968812Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management2025-12-23OpenAlex10.1097/iio.0000000000000597Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116968812
W7116842265Signs and symptoms of acute tacrolimus toxicity in solid organ transplant recipients: a scoping review protocol2025-12-23OpenAlex10.11124/jbies-24-00420Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7116842265
W7117424106Transformación educativa a través de una comunidad de aprendizaje: una experiencia en la escuela primaria pública2025-12-23OpenAlex10.33010/ie_rie_rediech.v16i0.2554Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117424106
W7117469739Cordia Genus: a Glimpse of Chemical Composition and Bioactivity2025-12-24OpenAlex10.21608/ejchem.2025.427325.12398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117469739
W7117167492Exploring of AI-Powered Application in Chatbots for Future Development2025-12-24OpenAlex10.1201/9781998511358-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117167492
W7117161588Exploring the mechanisms and therapeutic role of γ-oryzanol in neuropathic pain: a systematic review2025-12-24OpenAlex10.1007/s10787-025-02100-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117161588
W7117165850From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy2025-12-24OpenAlex10.3390/biom16010027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117165850
W7117317464Lung Cancer: The Current and Multimodality Treatment2025-12-24OpenAlex10.9734/jcti/2025/v15i4334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117317464
W7117151660Recent advances in theranostic-based extracellular vesicles in cancer stem cell diagnosis and therapy2025-12-24OpenAlex10.1080/1061186x.2025.2609201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117151660
W7117149151Reversible Heart Failure After Anthracycline and Alkylating Agent Chemotherapy2025-12-24OpenAlex10.7759/cureus.99997Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7117149151
W7117127551Spectrum of Anti‐Neurofascin Neuropathies: A Retrospective Indian Cohort2025-12-24OpenAlex10.1002/mus.70121Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117127551
W7117529889The Infectious Diseases Orchestrator: Embracing AI Literacy in the Agentic Era2025-12-24OpenAlex10.1093/ofid/ofaf794Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7117529889
W7117148233The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies2025-12-24OpenAlex10.1097/cad.0000000000001801Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117148233
W7117683958Transthyretin Cardiac Amyloidosis and Heart Failure: State-of-the-Art Review and Practice Guidance2025-12-24OpenAlex10.31083/rcm46181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117683958
W7117407742Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis—the TACTIC-UC study2025-12-24OpenAlex10.1093/ecco-jcc/jjaf239Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117407742
W7117429130ASAS-NANP symposium: mathematical modeling in animal nutrition: training the future generation in data and predictive analytics for sustainable development. A summary of the 2024 symposium2025-12-25OpenAlex10.1093/jas/skaf452Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117429130
W7117244080Biologic Therapies for Type 2 Inflammatory Diseases: A Bibliometric Analysis of Publication Trends and Intellectual Structure2025-12-25OpenAlex10.18621/eurj.1821314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117244080
W7117257641Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options2025-12-25OpenAlex10.1080/10428194.2025.2598662Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117257641
W7117237350What's new in upper gastrointestinal pathology: Key updates and evolving challenges in 20262025-12-25OpenAlex10.1016/j.humpath.2025.106025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117237350
W7117323355Calcitonin Gene-Related Peptide Inhibitor Use in 2018–2023: A Retrospective Cohort Study Across Six Canadian Provinces2025-12-26OpenAlex10.1017/cjn.2025.10506Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117323355
W7117362648Chemotherapy‐Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune‐Based Approaches2025-12-26OpenAlex10.1111/ejh.70105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117362648
W7220251532Integrating Nanotechnology into Pharmacology: A Comprehensive Review2025-12-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220251532
W7141047540Operationalizing Robotic and Autonomous Systems for Disaster Response and Emergency Logistics2025-12-26OpenAlex10.1109/icoias69065.2025.00019Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7141047540
W7117295789Revisiting the use of steroids in oncology2025-12-26OpenAlex10.1007/s12032-025-03214-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117295789
W7117303346Update on penile prosthesis2025-12-26OpenAlex10.4103/aja2025111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117303346
W7117358089A Global Review of Invasive Haemophilus Influenzae Diseases from 2000-2023: A Systematic Review of Current Status, Challenges, and Future Perspectives2025-12-27OpenAlex10.61440/jidt.2025.v3.47Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117358089
W7117972977Breast cancer treatment and melatonin: a bibliometric analysis2025-12-27OpenAlex10.47582/jompac.1811112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117972977
W7125956630Changing Course2025-12-27OpenAlex10.1093/cid/ciaf720Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125956630
W7117371794Electrochemical synthesis of H2O2 integrates reaction mechanisms, reaction media, mass-transfer effects, and device design2025-12-27OpenAlex10.1016/j.cej.2025.172316Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117371794
W7117358298Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA)2025-12-27OpenAlex10.1016/j.jhep.2025.12.016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117358298
W7117354077Real-World Effectiveness of Advanced Therapies in Microscopic Colitis2025-12-27OpenAlex10.1016/j.cgh.2025.12.019Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117354077
W7117358528Science and Challenges in Formulating Gummies as a Novel Oral Dosage Form: A Review2025-12-27OpenAlex10.30574/gscbps.2025.33.3.0521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117358528; https://openalex.org/W7126098499
W7117411034BENEFITS OF SENSOR INTEGRATION AND DATA FUSION IN CBRN AGENTS MEASUREMENTS2025-12-28OpenAlex10.5604/01.3001.0055.5459Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7117411034
W7117463044HARLA-ED: Resolving Information Asymmetry and Enhancing Algorithmic Symmetry in Intelligent Educational Assessment via Hybrid Reinforcement Learning2025-12-28OpenAlex10.3390/sym18010058Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117463044
W7117418732Management of Chronic Urticaria : A Systematic Review of Allergic and Immunology2025-12-28OpenAlex10.70070/tftgbs90Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117418732
W7133483936Modern infectious and immune-mediated causes of acute encephalitis in children2025-12-28OpenAlex10.15574/sp.2025.8(152).7078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133483936
W7117473044Postoperative Recurrence in Crohn’s Disease: Pathophysiology, Risk Stratification, and Management Strategies2025-12-28OpenAlex10.3390/jcm15010243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117473044
W7219858579Virtual Oncology: Digital Twins for Predicting Cancer Evolution, Therapeutic Response, and Clinical Outcomes2025-12-28OpenAlex10.65477/qe07zn79Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219858579
W7117473579Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms2025-12-29OpenAlex10.1002/inm3.70009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117473579
W7117480253Clinical Features and Outcomes of Severe Pneumonia in Pediatric Human Metapneumovirus Infections2025-12-29OpenAlex10.5152/turkarchpediatr.2025.25295Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117480253
W7147231178Ep. 123: The Agentic AI Dilemma: Who Holds the Kill Switch?2025-12-29OpenAlex10.5281/zenodo.19357821Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147231178
W7117468958Fever of unknown origin, muscle weakness, and an adrenal nodule—the cat we chased like a hare: a case report2025-12-29OpenAlex10.1186/s13256-025-05656-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117468958
W7117866485Generative AI versus human conversational agent for reducing procrastination: A single-blinded randomized controlled pilot trial (Preprint)2025-12-29OpenAlex10.2196/preprints.90486Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7117866485
W7117565863Pharmacologic glycemic management of type 2 diabetes2025-12-29OpenAlex10.1016/b978-0-443-13825-6.00284-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117565863
W7118125455Planejamento da paisagem e crescimento habitacional em área de mananciais em Presidente Prudente-SP2025-12-29OpenAlex10.17271/23188472139020256187Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118125455
W7117476120The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management2025-12-29OpenAlex10.3390/cells15010057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117476120
W7117529687A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies2025-12-30OpenAlex10.18231/j.ijced.13629.1765276898Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117529687
W7118008954APPLICATION OF STEM CELLS AND THEIR DERIVATIVES AS DRUG DELIVERY SYSTEMS2025-12-30OpenAlex10.20473/jscrte.v9i2.85312Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118008954
W7140294532Adaptive system of teacher professional development2025-12-30OpenAlex10.26565/2074-8167-2025-57-12Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140294532
W7117559202Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya2025-12-30OpenAlex10.1371/journal.pntd.0012169Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117559202
W7117584167Current Therapeutic Approaches in Infantile Colic: A Comprehensive Review2025-12-30OpenAlex10.5152/turkarchpediatr.2025.25388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117584167
W7117576344Healing Environments for Cancer Care: Toward a Patient-Centered Design Guideline for Inpatient Settings2025-12-30OpenAlex10.1177/19375867251406202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117576344
W7128303481Modern methods of functional diagnosis of cardiovascular diseases2025-12-30OpenAlex10.15275/pssr.2025.0403Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128303481
W7127983456Multi-scale computational frameworks for predicting biomaterial-host interactions2025-12-30OpenAlex10.70974/mat09225112Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7127983456
W7117699576Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives2025-12-30OpenAlex10.3390/biomedicines14010081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117699576
W7220427726Phage-Derived Endolysin PlyPM1 as a Rapid Enzybiotic for Detection and Lysis of Proteus mirabilis in Clinical Urine Samples.2025-12-30OpenAlex10.64105/as4b9a61Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220427726
W7117556849Platinum complexes of N-donor ligands bearing sulfonamide groups as anti-cancer agents: A review2025-12-30OpenAlex10.31357/vjs.v28i02.8727Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117556849
W7117534914Rise of the Self-Driven Machine2025-12-30OpenAlex10.4018/979-8-3373-7006-4.ch010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117534914
W7117958995A Comprehensive Review on Anti-Viral Drugs2025-12-31OpenAlex10.55041/ijsrem55419Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117958995
W7117786494ACNE VULGARIS: PATHOGENESIS AND MANAGEMENT WITH LONG-PULSED ND:YAG (1064 NM) LASER THERAPY – A SYSTEMATIC REVIEW2025-12-31OpenAlex10.31612/2616-4868.8.2025.15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117786494
W7117768561Addressing the gaps in biologic therapy utilization trends in IBD from Saudi Arabia2025-12-31OpenAlex10.4103/sjg.sjg_432_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117768561
W7117729088American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma2025-12-31OpenAlex10.1016/j.jtct.2025.12.944Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117729088
W7161141650Cloud-Native AI-Driven Enterprise Automation for Scalable Digital Process Transformation in Multi-Industry Ecosystems2025-12-31OpenAlex10.71426/jasm.v1.i1.pp60-74Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161141650
W7154966786Comparative accuracy of chatbots for queries related to methods of tobacco cessation: A systematic review2025-12-31OpenAlex10.56450/jefi.2025.v3i2suppl.068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154966786
W7118425546Diagnosis and management of carotid artery stenosis: pathophysiology, advanced imaging, and evolving revascularization strategies2025-12-31OpenAlex10.51271/ajnn-0038Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7118425546
W7125772215Emerging Therapeutic Strategies in Psoriasis: From Pathogenesis to Personalized Care2025-12-31OpenAlex10.61554/ijnrph.v3i2.2025.194Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125772215
W7117649372Fluorescence-Guided Surgery in Pediatric Oncology: Current Practice and Future Directions2025-12-31OpenAlex10.3390/cancers18010149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117649372
W7117719467Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?2025-12-31OpenAlex10.1016/j.ctrv.2025.103083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117719467
W7125810672Pharmacological Approaches to the Management of Long COVID2025-12-31OpenAlex10.21124/tpt.2025.159.166Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125810672
W7117762302Redefining Cardiac Sarcoidosis with Advanced Imaging and Therapeutic Strategies2025-12-31OpenAlex10.1007/s40256-025-00783-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117762302
W7163895092Targeting ESR1 mutations: Imlunestrant and the next chapter in ER-positive breast cancer care2025-12-31OpenAlex10.46439/oncology.1.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163895092
W7117705652Temporal Trends and Outcomes of Amyloidosis in Korea: A 14-Year Nationwide Cohort Study2025-12-31OpenAlex10.3390/jcm15010313Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7117705652
W7125491240Trends in Medicare Part D Spending on Antifibrotic Therapies for Pulmonary Fibrosis: 2019–20232025-12-31OpenAlex10.61440/jghsm.2025.v1.16Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125491240; https://openalex.org/W4412866904
W720620505610M-Belgium: 10 Million Patient Years – Belgian Evaluation of Lipid therapy Growth, Intensification, Use and Management2026-01-01OpenAlex10.2139/ssrn.7386806Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7206205056
W72231219212026 Field Guide to Scientific Operating Systems for Longitudinal Disease Research: Architectures, Workflows, Validation Frameworks, and Emerging Directions in ML-Enabled Biomedical Research2026-01-01OpenAlex10.14283/vme.2026.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223121921
W71499447317P Digital Marketing Theory (Participants, Processes, Presence, Personalization, Performance, Partnership, and Privacy)2026-01-01OpenAlex10.17605/osf.io/w792kTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7149944731
W7163051160A Conceptual Integrated AI Framework and Research Agenda for Personalized Adaptive Assessment Using NLP, Reinforcement Learning, and Adversarial Response Modeling2026-01-01OpenAlex10.1007/978-981-92-0042-9_36Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163051160
W7154493108A Large Language Model–Driven Agent Framework for Sepsis Clinical Decision Support: A Retrospective Multicohort Study2026-01-01OpenAlex10.2139/ssrn.6541701Full textExcludedF4: A predefined-prompt Llama3.1-70B LangGraph orchestrator calls fixed predictive modules and retrieves external sepsis-guideline knowledge. State persistence and clinician interaction nodes support the current clinical workflow; no experience-derived change reused across different admissions is documented. FusionPredictor is conventional supervised model development, rather than an interactive LLM agent-learning loop.https://openalex.org/W7154493108https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6541701Online20-page SSRN PDF pp4,6–8, including Construction of an LLM-Based Clinical Decision Support Agent, read. Existing source distinct from wu2026sepsisagent; no file archive/download.
W7204473787A Layered Architecture for Autonomous On-Chain Agents from Ethereum ERC/EIP Specifications2026-01-01OpenAlex10.2139/ssrn.7353941Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204473787
W7166025568A Multi-agent Instructional Support System for Human-AI Collaborative Diagnostic Problem Solving: Classroom Evidence2026-01-01OpenAlex10.1007/978-3-032-29788-4_74Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W7166025568https://link.springer.com/chapter/10.1007/978-3-032-29788-4_74Bibliographic information and available abstract/preview only; no full methods read.
W7221331123A Physics-Guided Neuro-Symbolic Agent Framework for Servo Motor Fault Diagnosis with Hallucination Suppression2026-01-01OpenAlex10.2139/ssrn.7592695Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7221331123
W7127296543A Proposed Unified Nursing Curriculum2026-01-01OpenAlex10.1891/9780826151575.0011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127296543
W7161979189A Review of β ‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications2026-01-01OpenAlex10.1155/ijm/4479031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161979189
W7166818071A Self-Evolving LLM Agent Framework for Role-Based Norm Compliance in Healthcare2026-01-01OpenAlex10.18653/v1/2026.findings-acl.1133Full textIncludedIncluded: Norm memory and role prompts are updated across healthcare communication episodes.https://openalex.org/W7166818071https://aclanthology.org/2026.findings-acl.1133.pdf
W7171538005A Survey for LLM Agent Trajectory Analysis: From Failure Attribution to Enhancement2026-01-01OpenAlex10.1109/tse.2026.3717765Title/abstractExcludedE1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent.https://openalex.org/W7171538005
W7172299938A Survey on Agentic AI: Applications, Challenges and Evaluation Frameworks2026-01-01OpenAlex10.1007/978-3-032-28310-8_28Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7172299938
W7203571512A Unified Hydrometeorological Framework for Preconditioning and Triggering of Rainfall-Induced Slope Failures under Climate Change: A National-Scale Theoretical Perspective from Italy2026-01-01OpenAlex10.2139/ssrn.7294694Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203571512
W7221085682A conceptual model and research framework for urban territorial spatial layout optimization under the human-technology-space integration paradigm2026-01-01OpenAlex10.31497/zrzyxb.20261205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221085682
W7160913707A grounded theory study – community palliative care clinical nurse specialists’ experiences when fulfilling their role2026-01-01OpenAlex10.17635/lancaster/thesis/3240Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160913707
W7162411888A modified ‘Puncture–Aspiration–Injection–Re-aspiration’ (PAIR) technique to treat Hepatic Cystic Echinococcosis: A retrospective case series and narrative review2026-01-01OpenAlex10.1017/s0022149x26101503Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162411888
W7127606383A new era in transplantation: Overcoming COVID-19 challenges2026-01-01OpenAlex10.1016/j.clinpr.2026.100540Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127606383
W7118265203A scientometric study on research trends and characteristics of oral health-related quality of life among head and neck cancer patients2026-01-01OpenAlex10.1016/j.jds.2025.12.031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118265203
W7169862806AARD: A Risk-Aware Agentic AI Framework for Sequential Clinical Decision Support Using Large Language Models2026-01-01OpenAlex10.5220/0015079400005051Full textExcludedF3: AARD uses ClinicalBERT only to encode clinical text (§4.6), while a DQN is the acting policy (§3.2). It does not implement an LLM/VLM-based acting agent.https://openalex.org/W7169862806https://doi.org/10.5220/0015079400005051
W7224461301ACIES: A Self-Evolving Agentic Contract-Based Framework for Cyber-Physical System Control Synthesis2026-01-01OpenAlex10.18653/2026.realm-1.36Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7224461301
W7221808659ACUTE MYELOID LEUKEMIA, MINIMALLY DIFFERENTIATED, ACUTE MYELOID LEUKEMIA WITHOUT MATURATION, ACUTE MYELOID LEUKEMIA WITH MATURATION2026-01-01OpenAlex10.5336/978-625-91119-4-0_p205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221808659
W7164522947AI Cybersecurity for Tackling LLM Security2026-01-01OpenAlex10.1007/978-3-032-25874-8_21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164522947
W7154382200AI Moral Patiency and Moral Dissonance: Almost Human, Almost Deserving Moral Treatment2026-01-01OpenAlex10.24251/hicss.2026.069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154382200
W7211964782AI agents in cancer imaging: Concepts, advances, and clinical perspectives2026-01-01OpenAlex10.21147/j.issn.1000-9604.2026.04.05Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7211964782
W4415153615AI and the Relationship Between Agency, Autonomy, and Moral Patiency2026-01-01OpenAlex2504.0885310.1007/978-3-032-14537-6_3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W4415153615
W7121532528ARTIFICIAL INTELLIGENCE BY Dr. Laxmi Choudhary,Mrs. Bhanupriya Sharma,Mr. Avinash Bhandiya,Dr. Satya Narayan2026-01-01OpenAlex10.5281/zenodo.18206356Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7121532528
W7139948671Actinomycetes metabolites and its application for pharmaceutical industry2026-01-01OpenAlex10.1016/b978-0-443-36411-2.00018-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139948671
W7223845008Acupuncture-Moxibustion for Facial Paralysis: Theoretical Origins in Traditional Chinese Medicine and Advances in Clinical Research2026-01-01OpenAlex10.12677/acm.2026.16103470Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223845008
W7161007651Adapting Federated Learning to Concept Drift: Challenges, Opportunities, And Future Directions2026-01-01OpenAlex10.25397/b7bx-rc93Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161007651
W7160875479Adaptive Zero Trust Governance Framework for Autonomous and Agentic Digital Systems Using AI-Driven Risk Scoring2026-01-01OpenAlex10.2139/ssrn.6677379Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160875479
W7118076723Advancements in Alginate‐Based Biomaterials for Enhanced Skin Regeneration: A Comprehensive Review2026-01-01OpenAlex10.1155/ijps/8996702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118076723
W7161974043Advancements in Intraoperative Imaging for Enhanced Surgical Precision2026-01-01OpenAlex10.1007/978-3-032-21415-7_13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161974043
W7171679081Advancements in Molecular and Serological Methods for Diagnosing SARS-CoV-22026-01-01OpenAlex10.2139/ssrn.6996700Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171679081
W7152572276Advancements in contact lens technology: A comprehensive review of current materials and future prospects2026-01-01OpenAlex10.33545/26648547.2026.v8.i1a.68Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152572276
W7167592824Advancements in diagnosis and treatments of acute leukemia2026-01-01OpenAlex10.21147/j.issn.1000-9604.2026.03.09Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167592824
W7161134366Advances in Atopic Dermatitis Management: The Role of Lebrikizumab2026-01-01OpenAlex10.1155/dth/1682557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161134366
W7161643167Advances in Contrast-Enhanced Maxillofacial Radiology2026-01-01OpenAlex10.1007/978-981-92-0489-2_9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161643167
W7166838579Advances in Pharmacology: Looks at Emerging Pharmaceutical Approaches to Pain Management2026-01-01OpenAlex10.1007/978-3-032-11484-6_30Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166838579
W7163515441Advances in RNA based therapeutics for atherosclerosis: From bench to bedside2026-01-01OpenAlex10.61577/ijcri.2025.1000020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163515441
W7201874051Advances in Small-Molecule Inhibitors for Targeted Cancer Therapy2026-01-01OpenAlex10.1007/978-981-92-0477-9_6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201874051
W7139924542Advances in antibacterial material development2026-01-01OpenAlex10.1016/b978-0-443-36518-8.00007-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139924542
W7130329180Advances in the Treatment of Erectile Dysfunction2026-01-01OpenAlex10.1007/978-3-032-12423-4_4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130329180
W7120007876Advances in the treatment of large granular lymphocytic leukemia2026-01-01OpenAlex10.6084/m9.figshare.31036035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7120007876; https://openalex.org/W7119491463
W7202170188Agent Architectures and the PARM Framework2026-01-01OpenAlex10.1007/978-3-032-26723-8_4Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7202170188
W7119737981Agent-Based Flood Evacuation Modeling: Optimizing Transportation, Shelter Allocation and Traffic Control2026-01-01OpenAlex10.1007/978-3-032-13026-6_1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7119737981
W7160555226Agent-in-Cell Modeling of Pandemics2026-01-01OpenAlex10.1007/978-3-032-06125-6_5Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7160555226
W7224444120AgentTAC: Mining Temporal Action-Context Error Patterns from Agent Traces2026-01-01OpenAlex10.18653/2026.emnlp-main.1637Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224444120
W7134948360Agentic AI for Clinical Decision Orchestration in Healthcare Systems2026-01-01OpenAlex10.2139/ssrn.6185219Full textExcludedF1: The primary abstract presents a conceptual orchestration framework and evaluation perspective, rather than building/evaluating a retained-improving agent.https://openalex.org/W7134948360; https://openalex.org/W7134232517https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6185219complete original SSRN abstract/metadata only; PDF403
W7203837975Agentic AI in Healthcare: Current Applications, Challenges, and Future Directions2026-01-01OpenAlex10.1109/access.2026.3725858Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203837975
W7164082383Agentic AI in Medical Image Analysis: A Preliminary PRISMA-Guided Evidence Map2026-01-01OpenAlex10.17605/osf.io/6hd4rTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164082383
W7202247216Agentic AI in the Age of Autonomy with Concepts and Case Studies2026-01-01OpenAlex10.2139/ssrn.7239460Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7202247216; https://openalex.org/W7170055745
W7163546564Agentic AI-Driven bio-digital twins: A self-adaptive framework for personalized disease prediction and therapy design2026-01-01OpenAlex10.1063/5.0327306Full textExcludedF5: The public primary-source and author/repository discovery routes did not provide full methods. Root browser access to the AIP DOI is blocked by a Cloudflare security verification page. LLM acting role and cross-case retention remain unresolved; no challenge was solved or bypassed.https://openalex.org/W7163546564https://doi.org/10.1063/5.0327306Archived abstract plus actual publisher-browser access failure; no full methods read.
W7204562368Agentic AI-Powered Sensors-Based Privacy-Preserving Postquantum Secure Authentication for IoT-Enabled Medical Cyber-Physical Environment2026-01-01OpenAlex10.1109/jsas.2026.3728328Full textExcludedF4: Algorithm1 retrieves stored historical patient feature vectors and retries the current report at most three times under fixed similarity/verification thresholds. It does not write an experience-derived lesson, skill, prompt or updated agent policy for later patients. Historical clinical evidence retrieval is not itself agent learning.https://openalex.org/W7204562368https://ieeexplore.ieee.org/document/11668650Online publisher PDF; network model, Algorithm1, feature/thinker definitions and26-patient experimental results read.
W7165518071Agentic Artificial Intelligence in Healthcare and Medicine2026-01-01OpenAlex10.17605/osf.io/y3s75Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7165518071
W7161772074Agentic LLM Approach to Automated LOINC Code Assignment for Internal Laboratory Tests2026-01-01OpenAlex10.1007/978-3-032-26363-6_17Full textExcludedF4: Every laboratory test starts a new session with a fixed system prompt. Query/candidate tracking and correction are confined to that test; no learned experience artifact is retained for different tests.https://openalex.org/W7161772074https://link.springer.com/chapter/10.1007/978-3-032-26363-6_17Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W7167344731Agentic LLMs for Scalable, Verifiable System Health Digital Twins2026-01-01OpenAlex10.54941/ahfe1007674Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7167344731
W7214540193Agentic Reasoning for Large Language Models: Foundations, Evolution, and Collective Intelligence — A Comprehensive Academic Review2026-01-01OpenAlex10.5281/zenodo.22993753Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214540193
W7163588815Agentic artificial intelligence in nutrition: from isolated screening tools to autonomous nutritional support systems2026-01-01OpenAlex10.20960/nh.06908Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163588815
W7171743645Agentic multimodal LLM-augmented expert system with physics-aware dual-index RAG for metal additive manufacturing2026-01-01OpenAlex10.2139/ssrn.6170301Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171743645; https://openalex.org/W7222449485
W7165615508Alpha2 Agonists2026-01-01OpenAlex10.1007/978-3-032-21675-5_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165615508
W7224692345Ambiguous control: Designing for indeterminacy and agency negotiation2026-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224692345
W7215090837An Adaptive Edge-Cloud Computing Architecture for Real-Time Intelligent Resource Allocation Using Machine Learning2026-01-01OpenAlex10.51483/ijaiml.6.12s.2026.871-881Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7215090837
W7213544544An Agentic Multimodal Framework for Reliable Medical Reasoning under Privacy Constraints2026-01-01OpenAlex10.4108/eai.22-5-2026.2365100Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7213544544
W7213247911An Interpretable Artificial Intelligence Workflow for Metacognitive Reflection Feedback2026-01-01OpenAlex10.2139/ssrn.7465164Full textExcludedF2: The method addresses educational metacognitive reflection without clinical cases; healthcare is not the primary task.https://openalex.org/W7213247911https://papers.ssrn.com/sol3/Delivery.cfm/7465164.pdf?abstractid=7465164&mirid=1SSRN abstract only; PDF403
W7172111063Anaesthesia Workstation2026-01-01OpenAlex10.1007/978-981-95-9019-3_8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172111063
W7133320785Analysis of Illicit Street Heroin Seized in Pakistan by Gas Chromatography–Mass Spectrometry (GC‐MS) for Identification of Adulterants and Impurities2026-01-01OpenAlex10.1155/ianc/4301930Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133320785
W7161483032Antithrombotic and Anticoagulant Therapy in Renal Dysfunction2026-01-01OpenAlex10.1007/978-3-032-25434-4_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161483032
W7128693995Aprocitentan: An Oral, Once-daily Antihypertensive Therapy for Resistant Hypertension in Adult Patients2026-01-01OpenAlex10.17925/hi.2026.20.1.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128693995
W7202251824Architectures for Adaptive and Assistive AI Systems: Multi-Agent Reasoning, Brain-Computer Interfaces, and Conversational Agents in Education and Healthcare2026-01-01OpenAlex10.2139/ssrn.7260758Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7202251824
W7204924954Artificial Intelligence Applications in Bacteriophage Genomics and Host Interaction2026-01-01OpenAlex10.1007/978-1-0716-5408-8_18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204924954
W7163913493Artificial Intelligence Behavioral Pathology as an Epistemological Framework: Towards Pre-Execution Reasoning Chain Interception for Auditable AI Governance2026-01-01OpenAlex10.2139/ssrn.6857438Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163913493
W7136561786Artificial Intelligence and Machine Learning for Personalized Nutrition and Health Management2026-01-01OpenAlex10.2139/ssrn.6401958Full textExcludedF1: The newly retrieved primary abstract explicitly identifies this as a PRISMA-based literature review of AI-enabled personalized nutrition, rather than an implemented agent study.https://openalex.org/W7136561786https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6401958Primary SSRN abstract only; full methods not read.
W7154473783Artificial Intelligence and Machine Learning in Mental Health: A Bibliometric Analysis of Evolving Trends2026-01-01OpenAlex10.1007/978-3-032-18716-1_34Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154473783
W7214494334Artificial Intelligence as a Psychological Companion: Opportunities, Challenges, and Future Directions2026-01-01OpenAlex10.47772/ijriss.2026.102400013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214494334
W7222663269Artificial Intelligence in Modern Computing: A Comprehensive Review of Applications, Challenges, and Future Trends2026-01-01OpenAlex10.51483/ijaiml.6.13s.2026.168-177Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222663269
W7213443757Artificial Intelligence in Telemedicine: philosophical, ethical, and epistemological dimensions of a transforming practice2026-01-01OpenAlex10.31744/einstein_journal/2026ae2371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213443757
W7161771661Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase2026-01-01OpenAlex10.1016/j.leukres.2026.108255Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161771661; https://openalex.org/W4389220347
W7167586357Atypical and Extreme Manifestations of Delusional Parasitosis: A Case-Based Narrative Review2026-01-01OpenAlex10.69980/ajbr.v29i1s.9841Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167586357
W7224626385AuroraCounsel: A Multi-Agent Large Language Model Collaboration Framework for Psychological Counseling2026-01-01OpenAlex10.18653/2026.emnlp-main.132Full textExcludedF4: The guidance model receives one-off SFT/GRPO on fixed PsyDTCorpus contexts; Appendix B.2 samples six responses per prompt for response-level rewards. Emotion routing and reflection are within the current dialogue. No interactive environment learning or cross-case experience artifact is retained.https://openalex.org/W7224626385https://aclanthology.org/2026.emnlp-main.132.pdf
W7130946603Automated Real-Time Screening of Phytochemicals and Cancer Therapeutics2026-01-01OpenAlex10.1007/978-3-032-15493-4_11Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7130946603
W7223789053Autonomous Enterprise Intelligence Platforms Enabled by Collaborative Multi-Agent Large Language Models2026-01-01OpenAlex10.64137/31079458/ijcsei-v2i3p103Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7223789053
W7211896264Autonomous Knowledge Graph Construction and Self-organization via Agentic AI and Large Language Models2026-01-01OpenAlex10.1007/978-3-032-27691-9_3Full textExcludedF2: The knowledge-graph method spans scientific, enterprise and medical domains; medicine is one domain under existing P2.https://openalex.org/W7211896264https://link.springer.com/chapter/10.1007/978-3-032-27691-9_3publisher abstract only; subscription preview
W7141285253Bacillus coagulans: basic and applied aspects2026-01-01OpenAlex10.1016/b978-0-443-40483-2.00038-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141285253
W7172449276Balancing Autonomy, Individual Rights, and Community Values in Islāmic Psychotherapy2026-01-01OpenAlex10.1007/978-3-032-26515-9_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172449276
W7213933228Benchmarking Evolvable Medical Agents Beyond First Pass2026-01-01OpenAlex10.2139/ssrn.7482718Full textExcludedF1: This is a companion evaluation protocol/benchmark proposal. Its references to an earlier 300-task experiment are not a new adaptive-system study.https://openalex.org/W7213933228https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7482718SSRN abstract only; PDF403
W7127127368Beyond Adoption: A Scoping Review on an Eight-Stage Cognitive Framework for Human–AI Partnership in Medical Profession2026-01-01OpenAlex10.17605/osf.io/apdf4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127127368
W7165760056Beyond Paradigms: RMKO Framework for Job Recommender Systems from Classical to Agentic Architectures2026-01-01OpenAlex10.2139/ssrn.6989759Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165760056
W7166862900Beyond Retrieval: Bi-Temporal State Arbitration for Longitudinal Healthcare Agents2026-01-01OpenAlex10.18653/v1/2026.knowfm-1.10Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7166862900
W7172442035Beyond Static Agents: A Six-Dimensional Taxonomy and Survey of Self-Evolving LLM Agents for Healthcare2026-01-01OpenAlex10.1109/access.2026.3720396Title/abstractExcludedE1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent.https://openalex.org/W7172442035
W7221311434Beyond the Procedure Day: Chronic Gastrointestinal and Nutritional Sequelae of Sustained Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for the Internist2026-01-01OpenAlex10.14740/jcp5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221311434
W7133909720Biofilm-Associated Hospital Acquired Infection: Epidemiology, Diagnosis and Management- A Review2026-01-01OpenAlex10.65525/svup.9788199565487.2026.63-80Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133909720
W7166127015Biomanufacturing of mesenchymal stem cells and extracellular vesicles: challenges and advances in isolation, scale-up, storage, transportation, and beyond2026-01-01OpenAlex10.1016/b978-0-443-45056-3.00005-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166127015
W7204538122Biosimilars and biologics in the treatment of brain tumor2026-01-01OpenAlex10.1016/b978-0-443-43824-0.00001-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204538122
W7203470039Botanicals for immune system support2026-01-01OpenAlex10.1016/b978-0-443-44295-7.00011-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203470039
W7118303035Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention2026-01-01OpenAlex10.1002/mco2.70560Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118303035
W7224682235BridgeGap: Belief-Grounded Training for Medical Dialogue Agents2026-01-01OpenAlex10.18653/2026.emnlp-main.1974Full textIncludedIncluded: PPO updates a diagnostic dialogue policy across interactive episodes with a frozen patient simulator; the resulting weights are reused on separate clinical benchmarks.https://openalex.org/W7224682235https://aclanthology.org/2026.emnlp-main.1974.pdf
W7205015807Bridging Individual Trajectories and Population Dynamics through A Multi-scale Health World Model2026-01-01OpenAlex10.2139/ssrn.7384522Full textExcludedF3: The primary SSRN abstract defines coupled continuous-time stochastic micro/macro world-model dynamics and a distribution-aware population interface; it does not describe an LLM/VLM acting-agent system.https://openalex.org/W7205015807https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7384522Primary SSRN abstract only; full methods not read.
W7196957021Building real-world generalist computer agents: environment, framework, and training2026-01-01OpenAlex10.32657/10356/219055Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7196957021
W7213394120CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges2026-01-01OpenAlex10.31138/mjr.171125.merTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213394120
W7143358747CARDIAC INVOLVEMENT IN ANAPHYLAXIS2026-01-01OpenAlex10.5336/978-625-395-881-7_p375Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143358747
W7151805067CBRN threat landscape, emergency preparedness, and response2026-01-01OpenAlex10.1016/b978-0-443-43986-5.00003-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151805067
W7135405562CDIL-RSI: Capability-Reconfigured Cyclic Distinction-Integration Learning as a Sovereignty-Preserving Architecture for Recursive Self-Improvement2026-01-01OpenAlex10.6084/m9.figshare.31724401Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7135405562
W7203906691CDK4/6 inhibitors: Future perspectives2026-01-01OpenAlex10.1016/b978-0-443-44611-5.00009-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203906691
W7214187200CHEMOTHERAPY AND RADIOTHERAPY APPROACHES IN MALIGNANT CARDIAC TUMORS2026-01-01OpenAlex10.5336/978-625-91031-8-1_p151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214187200
W7224137522CHEST PAIN2026-01-01OpenAlex10.5336/978-625-5439-05-5_p143Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224137522
W7164849821CLASSIFICATION AND MECHANISMS OF ACTION OF BIOLOGICAL DRUGS2026-01-01OpenAlex10.5336/978-625-395-950-0_p1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164849821
W7224682400COLLABMEM: A Diagnostic Benchmark for Collaborative Memory Operations in Multi-Agent LLM Systems2026-01-01OpenAlex10.18653/2026.emnlp-main.1194Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7224682400
W7154594225CRISPR-Cas Systems in Targeted Drug Delivery and Gene Therapy: An Emerging Approach to Precision Medicine2026-01-01OpenAlex10.71431/ijrpas.2026.5206Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154594225
W7169845781CRUCIBLE: A Multi-Agent Framework for Automated Annotation Rubric Calibration via Iterative Inter-Judge Disagreement Resolution2026-01-01OpenAlex10.2139/ssrn.7025019Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7169845781
W7163827280Calcium-Based Coral Biomaterials in Oral and Maxillofacial Bone Regeneration: A Scoping Review of Development and Application2026-01-01OpenAlex10.17605/osf.io/9kvbsTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163827280
W7163639676Cancer immunotherapy, including CAR-T cell therapy and immune checkpoint inhibitors2026-01-01OpenAlex10.1016/b978-0-443-45146-1.00020-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163639676
W7197018702Cancer-Related Cognitive Impairment (CRCI): An Updated Review2026-01-01OpenAlex10.9734/bpi/mreca/v1/7707Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197018702
W7125512715Canine ehrlichiosis: A comprehensive review2026-01-01OpenAlex10.22271/micro.2026.v7.i1a.296Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125512715
W7160993867Castleman Disease2026-01-01OpenAlex10.1007/978-981-95-6635-8_31Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160993867
W7169485793Cell binding and uptake of virus-mimicking particles investigated with rotating coherent scattering and fluorescence microscopy2026-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169485793
W7166032815Challenges and future horizons in nanomedicine2026-01-01OpenAlex10.1016/b978-0-443-36532-4.00012-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166032815
W7124455423Chance For Some Faith And Possibilities?!2026-01-01OpenAlex10.37939/jrmc.v29i4.3151Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124455423
W7204069172Chitosan and Alginate Frontiers2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204069172
W7213239709Cholangiocarcinoma in 2026: Pathophysiology, Diagnostic Advances, and Evolving Therapeutic Landscape—A Narrative Review2026-01-01OpenAlex10.63475/yjm.v5i2.0472Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213239709
W7160541499Cholesterol Metabolism in Cancer Patients: Mechanisms, Treatment-Related Effects, and Cardio-Oncology Management2026-01-01OpenAlex10.32604/or.2026.079215Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160541499
W7169853855Chronic Non-Bacterial Osteomyelitis in Children: A Retrospective Cohort Study From a Single Center2026-01-01OpenAlex10.14744/cm.2026.88942Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169853855
W7118197237Chronic Urticaria Part II: Clinical management and therapeutics2026-01-01OpenAlex10.1016/j.jaad.2025.11.104Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118197237
W7169543458Clinical Application and Research Progress of Novel Anti-Obesity Medications2026-01-01OpenAlex10.12677/pi.2026.154043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169543458
W7161958561Clinical Applications of Advanced Ultrasound Imaging2026-01-01OpenAlex10.1007/978-3-032-21415-7_8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161958561
W7162006892Clinical Applications of Theranostics2026-01-01OpenAlex10.1007/978-3-032-21415-7_17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162006892
W7124968013Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives2026-01-01OpenAlex10.32604/or.2025.072443Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7124968013
W7140304365Clinical Management of Diamond–Blackfan Anemia Syndromes and Other Inherited Ribosomal Disorders2026-01-01OpenAlex10.1007/978-3-032-02386-5_20Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140304365
W7165651598Clinically Significant Drug-Drug Interactions2026-01-01OpenAlex10.1007/978-3-032-21675-5_20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165651598
W7165568482Community outreach as a learning setting: medical narratives of a curricular outreach experience on arboviruses2026-01-01OpenAlex10.1590/interface.260200Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165568482
W7202119810Comparative Analysis of Bipolar Disorder Treatment Guidelines2026-01-01OpenAlex10.1007/978-981-92-1323-8_14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202119810
W7163873195Comprehensive Systematic Review of Pazopanib’s Therapeutic Efficacy and Safety Profile in Renal Cell Carcinoma Management2026-01-01OpenAlex10.1155/ijcp/3089321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163873195
W7203872640Computational Modelling of the Foot and Ankle: A Narrative Umbrella Review, Meta-Perspectives on Translation Barriers and the Future of Finite Element Analysis in the AI Era2026-01-01OpenAlex10.2139/ssrn.7307498Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203872640
W7164861448Conclusion and Future Research Directions2026-01-01OpenAlex10.1007/978-3-032-17378-2_57-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164861448
W7202354546Conditioning Regimen for Hematopoietic Stem Cell Transplant2026-01-01OpenAlex10.1007/978-981-92-1167-8_42Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202354546
W7153314233Constitutional AI: Governance Standard for Accountable Artificial Agents2026-01-01OpenAlex10.2139/ssrn.6271418Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7153314233; https://openalex.org/W7119540247
W7165985483Context-aware dual-layer guardrails for nutrition consultation agents: integrating PHQ-9-informed risk quantification and multi-turn dialogue analysis2026-01-01OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7165985483
W7170156230Contrast Media in Neuroradiology2026-01-01OpenAlex10.1007/978-3-319-61423-6_118-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170156230
W7166810417Current Concepts in Chyluria: Pathophysiology, Diagnosis and Contemporary Management2026-01-01OpenAlex10.9734/bpi/msup/v11/7671Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166810417
W7143452892Current and Future Landscape of Hepatocellular Carcinoma Treatment2026-01-01OpenAlex10.32604/or.2026.076937Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143452892
W7204068835Cyberbiosecurity threats in the time of AI: Digital vulnerabilities with biological consequences2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204068835
W7138922823DEMYSTIFYING ARTIFICIAL DISTRIBUTED INTELLIGENCE(ADI)2026-01-01OpenAlex10.2139/ssrn.6442698Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138922823
W7204270397DT-StrokeNet: A Software-Driven, Agent-Based Digital Twin with a Dynamic Prediction Engine for Personalized, Time-Evolving Stroke-Risk Assessment2026-01-01OpenAlex10.2139/ssrn.7324294Full textExcludedF3: The acting engine is XGBoost/LSTM with linear-threshold agent simulation, not an LLM/VLM agent.https://openalex.org/W7204270397https://papers.ssrn.com/sol3/Delivery.cfm/47f0ff2a-2bda-49f0-97af-9e4811a92a16-MECA.pdf?abstractid=7324294&mirid=1&type=2SSRN abstract only
W7214387084Data Privacy and Social Media in the United States: Federal Limits, State Innovation, and the Challenges of Technological Change2026-01-01OpenAlex10.1093/ajcl/avag032Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214387084
W7165913891Data-Driven Structural Optimization of Descriptive Norms: Bridging Micro and Macro Dynamics in Medical Contexts2026-01-01OpenAlex10.1007/978-3-032-29912-3_31Full textExcludedF3: The described method combines PDE opinion dynamics, Gaussian mixtures, Q-learning and double ML, without an LLM acting agent.https://openalex.org/W7165913891https://link.springer.com/chapter/10.1007/978-3-032-29912-3_31publisher abstract only; subscription preview
W7171677045Decision Governance for AI Agents: Aligning Institutional Decision Systems in the Age of Multi-Agent AI2026-01-01OpenAlex10.2139/ssrn.6544058Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7171677045
W7164530198Decoding Major Depressive Disorder: A Comprehensive Review of Neurobiological Pathways, Biomarker Signatures, and Therapeutic Advances2026-01-01OpenAlex10.51244/ijrsi.2026.1305000231Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164530198
W7224565593Decomposing Self-Reflection in LLM Agents: Diagnostic Scaffolds, Uncertainty Labels, and Action Diversity2026-01-01OpenAlex10.18653/2026.realm-1.21Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7224565593
W7161383422Deep Learning for Solving and Estimating Dynamic Models in Economics and Finance2026-01-01OpenAlex10.2139/ssrn.6758340Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161383422
W7171855354Deep Reinforcement Learning for Adaptive Transportation Logistics Routing During Natural Disasters and Infrastructure Failures2026-01-01OpenAlex10.54660/ijmfd.2026.7.2.14-25Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171855354
W7203933729Dementia-friendly Conversational Agents: Potentials and Challenges of Designing Inclusive Voice Interactions2026-01-01OpenAlex10.18420/muc2026-mci-dc-225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203933729
W7125918879Demonstrating the Potential of LLMs for Dynamic, Multimodal Clinical Decision-Making2026-01-01OpenAlex10.2139/ssrn.6123346Full textExcludedF4: The full primary paper explicitly uses a static off-the-shelf Gemini model. Belief updating, option discovery and action loops occur within each clinical case; no cross-case learned artifact is retained.https://openalex.org/W7125918879https://mackinstitute.wharton.upenn.edu/wp-content/uploads/2026/02/Evaluating-LLMs-for-Dynamic-Multimodal-Clinical-Decision-Making.pdfpublic full paper, research-setting/methods and AppendixB read
W7126047116Dental Supplies and Their Role in Everyday Dental Practice2026-01-01OpenAlex10.6084/m9.figshare.31176544Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126047116
W7163726062Depression, Psychopathy and genuine moral judgment : An extension of Robert Audi’s external motivationalism2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163726062
W7171616116Design of a Health-safety-aware Long-term Memory Architecture for LLM-based Elderly Health Management Agents: A Case Study2026-01-01OpenAlex10.2139/ssrn.6555699Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7171616116; https://openalex.org/W7152475080
W7166579265Desire Modeling and Ethical Alignment for Autonomous Agents Via Yin-Yang and Five-Elements Cognitive Architectures: An Evolutionary Path to “Constrained Optimality”2026-01-01OpenAlex10.2991/978-2-38476-593-5_84Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166579265
W7131177369Development and Evaluation of an Agentic LLM-Based RAG-Enabled Framework for Evidence-Based Patient Education2026-01-01OpenAlex10.57945/manara.hbku.31386220Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7131177369
W7124447101Diagnostic and therapeutic approach to neuroendocrine lung tumours: a narrative review2026-01-01OpenAlex10.21037/shc-2025-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124447101
W7160261549Digital Twin-Driven Cross-Layer Orchestration Using Multi-Agent Reinforcement Learning for 6G Drone-NTN Networks2026-01-01OpenAlex10.1109/access.2026.3690691Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7160261549
W7167750677Directed evolution of CRISPR-associated transposases for programmable gene insertion in human cells2026-01-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167750677
W7169582608Disentangling Memory-Induced Anomalies in AI Agent Behavior Triggering Roguishness2026-01-01OpenAlex10.2139/ssrn.6986920Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7169582608
W7213748917Disseminated Intravascular Coagulation2026-01-01OpenAlex10.1007/978-3-032-29397-8_77Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213748917
W7147602084Doxorubicin-induced cardiotoxicity: mechanisms, surveillance, and prevention strategies2026-01-01OpenAlex10.1097/cp9.0000000000000156Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147602084
W7224004825Drugs of abuse2026-01-01OpenAlex10.1016/bs.seda.2026.09.015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224004825
W7160697223Dynamic Latency Optimization for Edge-Based Machine Learning Models in 6G-Enabled Industrial Internet of Things (IIoT)2026-01-01OpenAlex10.5281/zenodo.20094300Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160697223
W7155053087Dynamic Multi-agent Healthcare Systems: Optimizing Resource Allocation for Aging Societies2026-01-01OpenAlex10.1007/978-3-032-06531-5_82Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7155053087
W7172493466Dynamic Proactive Ambulance Redeployment for Emergency Medical System: A Multi-agent Reinforcement Learning Approach2026-01-01OpenAlex10.2139/ssrn.7170959Full textExcludedF3: The EMS controller uses conventional MARL, graph communication, masks and a pretrained emergency predictor; no LLM/VLM acting agent.https://openalex.org/W7172493466https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7170959SSRN abstract only
W7117867082EVOLVING PERSPECTIVES IN COPD: EMERGING THERAPIES AND FUTURE DIRECTIONS2026-01-01OpenAlex10.5281/zenodo.18107207Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117867082
W7124844259Editorial: Is CAR T‐Cell Therapy the Immunological Reset Autoimmunity Needs?2026-01-01OpenAlex10.1111/1756-185x.70552Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124844259
W7161580203Emerging Approaches in Breast Cancer: From Molecular Mechanisms to Diagnosis and Therapeutic Strategies2026-01-01OpenAlex10.32604/or.2026.081924Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161580203
W7133126805Emerging immunotherapy strategies in cervical cancer: a scoping review2026-01-01OpenAlex10.17605/osf.io/swdz9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133126805
W7166837013EmoRes: Toward Adaptive Psychological Support via User-Agnostic Benchmark and Topic-Mining Agent2026-01-01OpenAlex10.18653/v1/2026.findings-acl.416Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7166837013
W7136585688Empowering Digital Twins With Agentic AI: Applications, Case Studies, and Limitations2026-01-01OpenAlex10.1109/mcomstd.2026.3669229Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136585688
W7168390712Endoscopic Ultrasound-guided Vascular Interventions – Evolving Role in Gastric Varices and Pseudoaneurysm2026-01-01OpenAlex10.4103/tg.tg_74_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168390712
W7163338888Engineered carbon-based quantum dots: a next-generation nanomedicine for the therapy and diagnosis of infectious diseases2026-01-01OpenAlex10.1039/d5tb02755aTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163338888
W7167240828Engineering intrinsically radiolabeled nanoparticles for imaging and therapy: a decade of design strategies and insights2026-01-01OpenAlex10.1039/d6ra03415bTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167240828
W7135047858Enhancing Healthcare Access in Rural Appalachia: A Drone-truck System Powered by Deep Reinforcement Learning2026-01-01OpenAlex10.2139/ssrn.6362569Full textExcludedF3: The drone/truck method uses Dec-POMDP multi-agent deep RL with centralized critic/decentralized execution; it is not an LLM/VLM agent.https://openalex.org/W7135047858https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6362569SSRN abstract only; public PDF403
W7147378276Ep. 129: Stop Writing Prompts and Start Writing Constitutions2026-01-01OpenAlex10.5281/zenodo.19357858Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147378276
W7211872519Esophageal Cancer: Chemotherapy: Current Practice and Perspectives in Korea2026-01-01OpenAlex10.1007/978-981-96-1297-0_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211872519
W7215090028Estimation of Pharmaceutical Demand Elasticities in Iran Using the Linear Approximate Almost Ideal Demand System (LA-AIDS)2026-01-01OpenAlex10.2139/ssrn.7545117Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215090028
W7125457132Eugenics2026-01-01OpenAlex10.1007/978-3-031-70581-6_447-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125457132
W7214012824EvalMem: An Operation-Level Diagnostic Framework for Long-Term Memory Systems2026-01-01OpenAlex2609.2223110.18653/2026.findings-emnlp.1134Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7214012824
W7118512781Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy2026-01-01OpenAlex10.5230/jgc.2026.26.e12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118512781
W7165632070Evolving Role of Primary Care in Cardiovascular–Kidney–Metabolic Medicine: An Apolipoprotein B–Centered Mechanistic Framework for Cardiometabolic Trajectories2026-01-01OpenAlex10.51789/cmsj.2026.6.e21Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165632070
W7135204356Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies2026-01-01OpenAlex10.4103/ds.ds_v44-1_editorialTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135204356
W7172528911Experts’ Opinion on Strategic Public Health CBRN Emergency Management Using Artificial Intelligence in the Middle East and North Africa Region2026-01-01OpenAlex10.1017/dmp.2026.10420Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172528911
W7134023612Explaining the Effects of Systemic Therapy on Survival in Advanced Cancer2026-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134023612
W7118022088Exploring Chronic Rejection in Organ Transplantation Through Computational Modeling2026-01-01OpenAlex10.1007/978-3-032-07686-1_3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118022088
W7214374663Fair Terms or Free Terms? The Dual Commitments of Contract Regulation in the United States2026-01-01OpenAlex10.1093/ajcl/avag029Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214374663
W7162647717Fluid Futures: Bridging Institutional Voids in the Global South with Blockchains, Agentic AI, and Transformative Knowledge2026-01-01OpenAlex10.1007/978-3-032-20821-7_12Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162647717
W7161623849Foucault's Aesthetics of Existence and Shusterman's Somaesthetics: Ethics, Politics, and the Art of Living2026-01-01OpenAlex10.5406/15437809.60.2.06Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161623849
W7221188733Foundation Models for Brain Tumor Diagnosis and Prognosis2026-01-01OpenAlex10.7302/dspace/30756Full textExcludedF5: Primary thesis report could not be obtained for method-level assessment. The public repository landing page and abstract are readable, but the observed main-PDF link returned HTTP403 in the server Slurm job and was blocked by the browser client after a browser download timed out. No eligibility or recursive-learning inference is made from the abstract. Reassess if the main report becomes available.https://openalex.org/W7221188733https://hdl.handle.net/2027.42/204638Repository metadata and full abstract only; main xinhaih_1.pdf (38.46MB) not obtained. Actual failed request archived in fulltext/THESIS_FETCH.json and thesis-32283 logs. No supplemental materials requested.
W7214008868Foundation Models in Ophthalmic Artificial Intelligence: Current Status and Future Directions2026-01-01OpenAlex10.1109/jbhi.2026.3736832Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214008868
W7167791958Fractionated Polymerized Hemoglobin: A Modernized Erythrocytic Substitute and Oxygen Biotherapeutic2026-01-01OpenAlex10.1007/978-3-032-22656-3_10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167791958
W7213868957From API Acknowledgment to Clinical State : Runtime Governance, Controlled Self-Evolution, and Cost in MedAgentBench2026-01-01OpenAlex10.2139/ssrn.7482519Full textIncludedIncluded: An experience-triggered controller/harness is persistently versioned between runs and reused on later different virtual-EHR stages.https://openalex.org/W7213868957https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7482519Online SSRN PDF, pp3–7 and10–11 methods/results/limitations read; no file archive/download.
W7205004912From Artificial Agency to Rational Subjectivity Goal-authority Reflection and the Architecture of Reflective Self-governance in AGI2026-01-01OpenAlex10.2139/ssrn.7381378Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7205004912
W7223452204From Automation to Autonomy: Regulatory and Governance Challenges of Robotic and Agentic AI in Insurance2026-01-01OpenAlex10.2139/ssrn.7662740Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223452204
W7155103399From Black-Box Models (BBM) to Transparency: A Review on Explainable AI Techniques2026-01-01OpenAlex10.5281/zenodo.19678315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155103399
W7130394744From Data to Decisions: Leveraging Large Language Models and Digital Product Passports for Data-Driven Remanufacturing2026-01-01OpenAlex10.1016/j.procir.2025.10.004Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7130394744
W7165484401From Phenotypes to Biologics: A Bibliometric Mapping of Precision Medicine in Pediatric Asthma (2015–2025)2026-01-01OpenAlex10.17605/osf.io/6mktrTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165484401
W7213633324From Pointwise Elasticity to Path Information: Substitution Acceleration and Exact Aggregation2026-01-01OpenAlex10.2139/ssrn.7479938Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213633324
W7171645861From Prompts to Agents: A Comprehensive Survey of LLM-Driven Time Series Analysis2026-01-01OpenAlex10.2139/ssrn.6614598Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171645861
W7161949764From Tools to Skills: Operationalizing Agentic AI in Healthcare2026-01-01OpenAlex10.17605/osf.io/9jq5nTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7161949764
W7155616511From equations to agents: The artificial intelligence virtual cell reshaping precision oncology2026-01-01OpenAlex10.59717/j.xinn-oncol.2026.100002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155616511
W7128522188From optogenetic to thermogenetic gene therapy for vision restoration, perspectives article2026-01-01OpenAlex10.4103/jcor.jcor_22_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128522188
W7166874793Front Matter2026-01-01OpenAlex10.18653/v1/2026.magmar-main.0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166874793
W7163749879Future Scope of UiPath in Robotic Process Automation in HealthCare Industry2026-01-01OpenAlex10.47772/ijriss.2026.100500465Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163749879
W7166677838GARE-Skill:Group-wise Attribution and Regression-Gated Evolution of Search Skills for Agentic RAG2026-01-01OpenAlex10.2139/ssrn.7025344Full textExcludedF2: GARE-Skill is evaluated on five general open-domain QA benchmarks; healthcare is not the primary domain.https://openalex.org/W7166677838https://papers.ssrn.com/sol3/Delivery.cfm/cf38acd8-9780-454c-baba-95f8f6219399-MECA.pdf?abstractid=7025344&mirid=1&type=2SSRN abstract only; PDF403
W7224211602GIMFlow: An LLM-Guided Dialogue-to-Music System for GIM-Inspired Well-Being Experiences2026-01-01OpenAlex10.18653/2026.emnlp-demos.65Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224211602
W7160083866GLP-1 Receptor Agonist Combination Therapy Before and After Metabolic and Bariatric Surgery: A Review of Outcomes2026-01-01OpenAlex10.17476/jmbs.2026.15.1.28Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160083866
W7217169539GODEL’S INCOMPLETENESS IN THE HISTORY OF AI: Proof, Performance, and Change of Epistemic Norms2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217169539
W7162486405Gender Perspective in Bioethics: Toward an Integral Reflection2026-01-01OpenAlex10.1007/978-3-032-25294-4_1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162486405
W7148683956Gene-encoded Antibiotic Therapy: Integrating the Immune Response to Combat Antibiotic Resistance2026-01-01OpenAlex10.4103/atmr.atmr_20_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148683956
W7119467859Generative AI in pharmaceutical R&D: From large language models to AI agents to regulation2026-01-01OpenAlex10.1016/j.drudis.2025.104593Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119467859
W7162638203Generative Artificial Intelligence for Empowering Non-Native English Speakers in Verbal Scientific Communication and Dissemination2026-01-01OpenAlex10.3348/kjr.2026.0474Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162638203
W7166592546Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention2026-01-01OpenAlex10.4103/sjim.sjim_12_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166592546
W7220981182Governing external long-term memory in LLM agents: a three-layer framework and context-adaptive forgetting2026-01-01OpenAlex10.26021/16695Full textExcludedF2: The primary dissertation tests generic conversation-memory retention. Diagnostic means mechanism tests, not clinical diagnosis or a clinical benchmark.https://openalex.org/W7220981182https://ir.canterbury.ac.nz/bitstreams/829191bf-dd2a-450e-ba05-5fd3c0116cc9/downloadPublic145-page dissertation; CAF method/setup and example cases read
W7164744958Green and Fast Forensic Identification of Substituted Cathinones by GC-MS and IR Combination2026-01-01OpenAlex10.2139/ssrn.6934405Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164744958; https://openalex.org/W7216082411
W7163988286Guideline-grounded Agentic AI Enables Reliable Report-level Diagnostic Reasoning in Oncologic Pathology2026-01-01OpenAlex10.2139/ssrn.6897784Full textExcludedF4: Fixed WHO-derived RAG and at most five within-report reflection/retrieval loops refine the current answer. Model weights are not task-fine-tuned; base prompts are finalized before evaluation, and prompt variants are sensitivity analyses. No retained execution-derived artifact transfers to later reports.https://openalex.org/W7163988286https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6897784Online44-page SSRN PDF pp8,10–12 and20, data, retrieval/reflection, prompts and results read; no file archive/download.
W7169762810HELICOBACTER PYLORI BEYOND THE STOMACH: WHEN THE STORY CHANGES2026-01-01OpenAlex10.1590/s0004-2803.24612026-031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169762810
W7147352718Harnessing Ultrasound for Tumor Vascular Targeting: From Mechanistic Insights to Clinical Monitoring and Therapeutic Applications2026-01-01OpenAlex10.15212/bioi-2025-0117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147352718
W7147275814Healing the Young Spine: The Journey of Dr. Chandrashekhar E. Deopujari2026-01-01OpenAlex10.4103/joss.joss_45_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147275814
W7167832937Hemoglobin-Based Oxygen Carriers: Evolving Concepts and Clinical Implications2026-01-01OpenAlex10.1007/978-3-032-22656-3_14Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7167832937
W7220375935Hereditary cancer syndromes as a model for precision oncology: the paradigms of HRD and MSI2026-01-01OpenAlex10.1016/j.ctarc.2026.101456Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220375935
W7123352475Hereditary spastic paraplegia: from decades of therapy to future innovations2026-01-01OpenAlex10.1177/17562864251406589Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123352475
W7214592899Histone Deacetylases and Their Inhibitors: Classification, Clinical Development, and FDA-Approved Therapeutic Indications2026-01-01OpenAlex10.55006/biolsciences.2026.6302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214592899
W7141015769Historical context and the evolution of exosome research2026-01-01OpenAlex10.1016/b978-0-443-36390-0.00005-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141015769
W7161472872History of Systemic Agents Used in the Treatment of Renal Cancer2026-01-01OpenAlex10.1007/978-3-032-19150-2_68Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7161472872
W7170089060Horismos: Self-representation and the Derived Constitutional Boundary in Enriched Cognitive Systems2026-01-01OpenAlex10.1007/978-3-032-33195-3_27Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170089060
W7167341083Human-Centered Sepsis Management in Clinical Work Systems: A Socio-Technical AI Framework for Patient Safety2026-01-01OpenAlex10.54941/ahfe1007486Full textExcludedF4: The sepsis feedback layer explicitly supports organizational learning rather than autonomous agent adaptation. It informs later human-led quality improvement, with no specified retained cross-case agent update.https://openalex.org/W7167341083https://doi.org/10.54941/ahfe1007486
W7128719800Hybrid Knowledge Base Architecture for Real-Time Conversational AI2026-01-01OpenAlex10.1007/978-3-032-17840-4_3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128719800
W7118016856Hybrid exosomes: a rising horizon for precision cancer therapy2026-01-01OpenAlex10.1039/d5ra04927jTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118016856
W7134184009Hypervirulent Acinetobacter baumannii: A Systematic Review and Meta-Analysis of Virulence Mechanisms and Antimicrobial Resistance2026-01-01OpenAlex10.25163/microbbioacts.9110609Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134184009
W7161976405IAEAgent: LLM-Based Educational Agent for Instructional Alignment Evaluation in University Courses2026-01-01OpenAlex10.1109/tlt.2026.3695576Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161976405
W7171236909Icosahedral Boron Clusters as Platforms for Biomedical Applications: From Cellular Bioimaging to In Vivo Theranostics2026-01-01OpenAlex10.1007/164_2026_830Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171236909
W7168310012Identification of Promising Xanthene, Coumarin, and Benzoxazole Scaffolds against SARS-CoV-2 Proteases via In Silico Screening2026-01-01OpenAlex10.51847/p0fbdhvchuTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168310012
W7119651959Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates2026-01-01OpenAlex10.1016/b978-0-323-90887-0.00008-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119651959
W7123357440Incidence And Clinical Course Of Immune Checkpoint Inhibitor-related Cardiac Adverse Events: A Retrospective Study In The Middle East2026-01-01OpenAlex10.1016/j.cardfail.2025.11.143Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7123357440
W7162426656Incremental Continual Learning for Tuberculosis Detection Based on Chest X-Ray Images and Synthetic Data Generated by Adversarial Networks2026-01-01OpenAlex10.1109/access.2026.3697134Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162426656
W7148980044Inflammaging and Midlife Women: Translating Geroscience into Clinical Practice2026-01-01OpenAlex10.4103/jmh.jmh_77_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148980044
W7172031817Information Signals to AI Agents: Projecting Agentic AI Behavior, with Health-Cannabis Reddit Data2026-01-01OpenAlex10.2139/ssrn.7128600Full textExcludedF3: The actual evaluated method is a pre-indexing corpus audit with VADER sentiment, n-grams, BERTopic and co-occurrence graphs. Its agent behavior is projected from500 Reddit posts, rather than observed from an implemented LLM agent or retained learning loop.https://openalex.org/W7172031817https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7128600Complete original publisher abstract read online. Positively stated corpus-analysis methods and projected-behavior scope determine exclusion; no claim to full methods access.
W7214902074Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis2026-01-01OpenAlex10.1007/978-1-0716-5476-7_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214902074
W7169666631Integrating Neuro-Linguistic Programming into Multimodal Illness Narratives: An Informing Science Approach to Enhancing Human-Centered Communication and Informing AI Design in Healthcare Education [Abstract]2026-01-01OpenAlex10.28945/5733Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169666631
W7224692380International organisations as sites of epistemic injustice?: The World Health Organization’s discourse on digital health2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224692380
W7214757764Interventional Palliative Pain Procedures for Cancer Patients2026-01-01OpenAlex10.1007/978-3-031-49762-9_108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214757764; https://openalex.org/W4412036055
W7161772163Intracranial Atherosclerotic Disease: Treatment Potential and Diagnostic Opportunities2026-01-01OpenAlex10.3844/ojbsci.2026.26.01.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161772163
W7213549372Intraoperative neuromonitoring and anesthesia considerations in peripheral nerve surgeries2026-01-01OpenAlex10.54646/jpns.2026.07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213549372
W7204890342Intrathecal Drug Delivery for Chronic Pain2026-01-01OpenAlex10.1007/978-1-0716-5241-1_5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204890342
W7204962957Intrathecal Therapy for CNS Infections2026-01-01OpenAlex10.1007/978-1-0716-5241-1_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204962957
W7118180214Introduction to machine learning: Concepts, types, and applications2026-01-01OpenAlex10.33545/27076571.2026.v7.i1a.240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118180214
W7146977022Investigation of some Sports Mechanics through the perspective of Basic Physics and Artificial Intelligence [AI]2026-01-01OpenAlex10.22271/journalofsport.2026.v11.i4a.3185Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7146977022
W7124497618Investigation of the possibilities for host modulation therapy for periodontal treatment2026-01-01OpenAlex10.5525/gla.thesis.85698Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124497618
W7128049740Iron Metabolism and Its Role in Anemia2026-01-01OpenAlex10.1007/978-3-032-14445-4_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128049740
W7170435357KYS: Know Your Swarm - A Governance Framework for Multi-agent AI Systems across Autonomous Economies2026-01-01OpenAlex10.2139/ssrn.7156419Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7170435357
W7162100903K_ij Coupling Collapse: A Unified Structural Mechanism for AI Fragmentation Across Alignment, Memory, and Adaptation — Synthesis of LWA Working Papers 1–32026-01-01OpenAlex10.17605/osf.io/guz4fTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162100903
W7172124971Korean Experiences2026-01-01OpenAlex10.1007/978-981-92-2611-5_20Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7172124971
W7203687410L-DOPA-Induced Dyskinesia: Evolving Role for Dexmedetomidine and Ketamine2026-01-01OpenAlex10.1007/978-3-032-25214-2_18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203687410
W7164572987LLM-Based Agentic Systems for the Execution of the BPM Lifecycle over Unstructured Healthcare Data: a Scoping Review Protocol2026-01-01OpenAlex10.17605/osf.io/p7b6yTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164572987
W7211994942LLM-Powered Troubleshooting for Telecommunication Network Operation and Management: A Fault-Lifecycle Survey2026-01-01OpenAlex10.2139/ssrn.7438214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211994942
W7224423588LUMINA: LongitUdinal MultImodal reasoNing Agent for Medical Imaging2026-01-01OpenAlex10.18653/2026.emnlp-main.1753Full textExcludedF4: Algorithm 1 updates only the current subject's trajectory memory. §3.2 explicitly makes the optional subject-disjoint cross-subject bank frozen, providing fixed analogy context. No experience-derived cross-case update is retained for later subjects; P1/static-retrieval exclusions apply.https://openalex.org/W7224423588https://aclanthology.org/2026.emnlp-main.1753.pdf
W7168135941La leucemia linfoblastica acuta del bambino. Come è cambiata la cura negli ultimi dieci anni (e cosa deve sapere oggi il pediatra). Dalla chemioterapia standard alla medicina di precisione2026-01-01OpenAlex10.53141/qacp.2026.107-111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168135941
W7214171899Large Language Models in Natural Language Processing: Recent Advances, Challenges, and Future Directions.2026-01-01OpenAlex10.51584/ijrias.2026.11080177Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214171899
W7118557316Lead from the Wild2026-01-01OpenAlex10.1097/nmg.0000000000000328Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118557316
W7172023782Lipid nanocarrier-based drug delivery for the treatment of colon cancer2026-01-01OpenAlex10.1016/b978-0-443-40443-6.00015-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172023782
W7162651371Long-term serovar distribution and toxin gene profiling of Actinobacillus pleuropneumoniae in Korea (2015–2025), with identification of an apxIICA-deficient serovar 15 profile2026-01-01OpenAlex10.4142/jvs.25339Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162651371
W7222994367MANAGEMENT STRATEGIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE INTENSIVE CARE UNIT2026-01-01OpenAlex10.5336/978-625-91119-1-9_p105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222994367
W7214201920MMSAM: Lesion-Aware Memory Evolution for Multi-Modal Brain Lesion Segmentation2026-01-01OpenAlex10.1109/lsp.2026.3737394Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214201920
W7224555565MMedAgentBench: A Multi-Stage Benchmark for Evaluating LLM-based Medical Agents2026-01-01OpenAlex10.18653/2026.emnlp-main.469Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7224555565
W7171664049MOM-AI 3.0: Toward an Autonomous Marketing Operating System2026-01-01OpenAlex10.2139/ssrn.6508958Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171664049
W7125165919Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA2026-01-01OpenAlex10.3802/jgo.2026.37.e62Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125165919
W7203696067Management of COVID-19 with Anesthetic Agents and Techniques2026-01-01OpenAlex10.1007/978-3-032-25214-2_32Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7203696067
W7202377812Management of Chronic Myeloid Leukemia in Adults and Children2026-01-01OpenAlex10.1007/978-981-92-1167-8_33Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202377812
W7124452295Management of Postoperative Liver Failure2026-01-01OpenAlex10.1007/978-3-032-10997-2_22Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124452295
W7127961690Management of Venous Thromboembolic Disease2026-01-01OpenAlex10.1007/978-3-031-82232-2_69Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127961690
W7125778876Management practices, challenges and approaches to clinical complications of polycythemia Vera in tertiary healthcare institutions in Nigeria: A narrative review2026-01-01OpenAlex10.33545/26649187.2026.v8.i1a.135Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125778876
W7165773193Management οf pediatric sialorrhea: A systematic review2026-01-01OpenAlex10.26262/heal.auth.ir.374208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165773193
W7203915066Market potential, postmarketing safety challenges, and treatment cost of CDK4/6 inhibitors2026-01-01OpenAlex10.1016/b978-0-443-44611-5.00003-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203915066
W7171702781Marketing World Models2026-01-01OpenAlex10.2139/ssrn.6910479Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171702781
W7140108477Mechanistic Convergence of Bio-nutritional Agents in Osteoarthritis: Translational Insights and Evolving Paradigms2026-01-01OpenAlex10.4103/ajprhc.ajprhc_231_25Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140108477
W7162545547MedShard: Privacy-Preserving EMR QC with Rule Sharding and Multi-agent Collaboration2026-01-01OpenAlex10.1007/978-981-95-7299-1_23Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W7162545547https://link.springer.com/chapter/10.1007/978-981-95-7299-1_23Bibliographic information and available abstract/preview only; no full methods read.
W7127984160Medical therapies for Cushing’s syndrome2026-01-01OpenAlex10.1016/b978-0-323-96100-4.00001-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127984160
W7150731398Meet the master: Dr. C. Stephen Foster2026-01-01OpenAlex10.4103/kjo.kjo_17_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150731398
W7140302459Metallodrugs in Ayurveda: Historical roots and future perspectives2026-01-01OpenAlex10.4103/ijar.ijar_30_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140302459
W7223903904Metformin’s evolving therapeutic role: From diabetes management to anticancer therapy2026-01-01OpenAlex10.1016/bs.seda.2026.09.006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223903904
W7126409479Microbiological Aspects of Bone and Joint Infections2026-01-01OpenAlex10.1007/978-981-95-5029-6_3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126409479
W7135098843Microvascular Free Tissue Transfer in Head and Neck Cancer – Can Anaesthesia Management Improve Outcome?2026-01-01OpenAlex10.4103/joapm.joapm_65_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135098843
W7169883884Mobile genetic elements and antibiotic resistance in ESKAPE pathogens2026-01-01OpenAlex10.1016/b978-0-443-26726-0.00001-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169883884
W7213460810Model-Driven Autonomous Voice Agents for Regulated Healthcare Operations2026-01-01OpenAlex10.51483/ijaiml.6.10s.2026.449-457Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213460810
W7134885734Model-Driven Development and Low-Code Platforms in Healthcare Digitalization: Opportunities and Challenges2026-01-01OpenAlex10.1007/978-3-032-16837-5_15Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134885734
W7167267157Modulating the Tumor Microenvironment: Small-Molecule Strategies in Combination Regimens2026-01-01OpenAlex10.1007/978-981-95-9777-2_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167267157
W7214376107Molecular Epidemiology2026-01-01OpenAlex10.1007/978-1-4614-6625-3_28-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214376107
W7117969169Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics2026-01-01OpenAlex10.1002/mco2.70525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117969169
W7203561578Multi-Agent Framework for Resilient Medical Triage in the Internet of Medical Things (IoMT)2026-01-01OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7203561578
W7211911883Multi-Agent Systems in Healthcare Operations: Coordination Theory, Safety Constraints, and Implementation Considerations2026-01-01OpenAlex10.68159/a800893285Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7211911883
W7202195702Multi-agent Systems and Clinical Coordination2026-01-01OpenAlex10.1007/978-3-032-26723-8_5Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7202195702
W7128165741Multidisciplinary Treatment of Musculoskeletal Metastases2026-01-01OpenAlex10.1007/978-3-032-09498-8_3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128165741
W7211900898Multimodal Learning: Integrating Text, Images, Video, and Audio for Cross-Modal Reasoning2026-01-01OpenAlex10.1007/978-3-032-27691-9_27Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211900898
W7150080407Myasthenia Gravis2026-01-01OpenAlex10.1007/978-3-032-12937-6_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150080407
W7221638502Myelofibrosis2026-01-01OpenAlex10.1007/978-3-031-66892-0_71Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221638502
W7117645894NANOSPHERES AS ANTICANCER AGENTS: REPROGRAMMING THE TUMOR MICROENVIRONMENT (TME) FOR ENHANCED CANCER THERAPY2026-01-01OpenAlex10.5281/zenodo.18094972Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117645894
W7134972030NOVEL THERAPIES FOR ATOPIC DERMATITIS2026-01-01OpenAlex10.5336/978-625-395-853-4_p663Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134972030
W7135059112NOVEL THERAPIES FOR FOOD ALLERGIES2026-01-01OpenAlex10.5336/978-625-395-853-4_p681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135059112
W7134955410NOVEL THERAPIES FOR URTICARIA2026-01-01OpenAlex10.5336/978-625-395-853-4_p629Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134955410
W7213554992NUT-carcinoma: diagnostic challenges by the example of the clinical case and prospects for targeted therapy2026-01-01OpenAlex10.21685/2072-3032-2026-2-14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213554992
W7134840302Nanotechnology-Driven Strategies for the Diagnosis and Therapeutic Management of Sickle Cell Disease: A Comprehensive Literature Review2026-01-01OpenAlex10.5281/zenodo.18930897Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134840302
W7117958867Nanotherapeutics for Colorectal Cancers Using Nanobiomaterials2026-01-01OpenAlex10.1007/978-3-032-08576-4_1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117958867
W7118219723Natural language processing in chatbots: Enhancing user interaction2026-01-01OpenAlex10.33545/27076571.2026.v7.i1a.241Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118219723
W7117973946Neural Pathways of SIoT: Enabling Smarter Choices2026-01-01OpenAlex10.1007/978-3-032-10122-8_11Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7117973946
W7131366158Neutrophil extracellular traps in atherothrombosis2026-01-01OpenAlex10.3724/cbls.2026010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131366158
W7154896823Nutrient-Stimulated Hormone Therapies in Heart Failure: Targeting Cardiometabolic Burden Beyond Weight Reduction2026-01-01OpenAlex10.36628/ijhf.2026.0002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154896823
W7223097617Néoplasies Myélodysplasiques : une revue narrative de la classification à la prise en charge, avec un focus sur les défis en Afrique2026-01-01OpenAlex10.4314/aamed.v19i4.19Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223097617
W7212306154Ofloxacin Induced Fixed Drug Eruption-Transition from Non-Pigmenting to Pigmenting Variant: A Case Report2026-01-01OpenAlex10.23958/ijirms/vol11-i09/2205Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212306154
W7163070022Operator over Dynamics III: Domenoid of Admissibility — A Proof-Obligation Framework for Admissibility Transfer2026-01-01OpenAlex10.17605/osf.io/3esn4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163070022
W7166740406Optical fiber mediated light based cancer theranostics: Perspectives and challenges towards clinical translation2026-01-01OpenAlex10.3724/pxlife.2026-0003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166740406
W7167641941Oral Tissue Regeneration2026-01-01OpenAlex10.1007/978-981-96-7448-0_2-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167641941
W7122636150P-1650. Temporal Trends in Serious Adverse Events Associated with Oral Antivirals During the COVID-19 Pandemic: Insights from the FAERS Database (2020–2023)2026-01-01OpenAlex10.1093/ofid/ofaf695.1825Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122636150
W7122726752P-1697. Performance of the VITEK 2 with Advanced Expert System as a fast method for determination of antimicrobial susceptibility against 400 Enterobacterales isolates from North and Latin America (2022)2026-01-01OpenAlex10.1093/ofid/ofaf695.1870Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122726752
W7122477150P-2107. Invasive fungal sinusitis in patients with hematological malignancies: a 20-year study from a tertiary academic US hospital system2026-01-01OpenAlex10.1093/ofid/ofaf695.2271Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122477150
W7125264401P1249 Analysis of 2020–2024 prescription trends of adalimumab for crohn’s disease in Brazil2026-01-01OpenAlex10.1093/ecco-jcc/jjaf231.1430Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125264401
W7133846654P541: Impact of specialty clinic evaluation on antiepileptic prescribing patterns in patients with Angelman syndrome2026-01-01OpenAlex10.1016/j.gimo.2026.104033Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133846654
W7119861818PP01.15: Neoadjuvant Chemo-Immunotherapy versus Chemo-TKI in Resectable EGFR-Mutant NSCLC2026-01-01OpenAlex10.1016/j.jtho.2025.12.093Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7119861818
W7160489187Parapharyngeal Tumor: An Unusual Case Report2026-01-01OpenAlex10.4236/ijohns.2026.153018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160489187
W7165873051Persistent Delirium in the Elderly: A Case Report and Review of Multifactorial Contributors and Management Challenges2026-01-01OpenAlex10.1155/crps/9751488Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165873051
W7122494389Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer2026-01-01OpenAlex10.3322/caac.70055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122494389
W7215014027Pharmacist interventions in ambulatory cancer care2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215014027
W7205009476Pharmacogenomics and Precision Medicine: The Evolving Role of Pharmacists in Personalised Drug Therapy University of the Potomac2026-01-01OpenAlex10.2139/ssrn.7380878Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7205009476
W7118118686Pharmacovigilance in Hypertension: A Critical Framework for Optimizing Safety in Antihypertensive Therapy2026-01-01OpenAlex10.47144/phj.v58i4.3135Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118118686
W7196977916Photobiomodulation2026-01-01OpenAlex10.1007/978-3-032-32144-2_5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7196977916
W7130941891Phytochemicals in the Management of Biofilm-Related Nosocomial Infections2026-01-01OpenAlex10.1007/978-3-032-15493-4_9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130941891
W7203479215Phytopathology, agroterrorism and the potential microbial agents2026-01-01OpenAlex10.1016/b978-0-443-40634-8.00006-4Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7203479215
W7168381095Plant Phenolic Acids in Selected Autoimmune Diseases: Mechanistic Insights and Emerging Preclinical Evidence2026-01-01OpenAlex10.1007/978-3-642-36202-6_300-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168381095
W7135244371Plant-Derived Essential Oils as Dual-Function Antimicrobial and Anti-Corrosion Agents: Bridging Biomedical Research and Petroleum Infrastructure Protection -A Critical Review2026-01-01OpenAlex10.2139/ssrn.6299499Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135244371
W7129027509Polycystic ovary syndrome and female infertility: Pathophysiology, challenges, and emerging therapeutic approaches2026-01-01OpenAlex10.33545/gynae.2026.v10.i1l.1978Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129027509
W7150245029Polymyositis2026-01-01OpenAlex10.1007/978-3-032-12937-6_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150245029
W7159689303Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity2026-01-01OpenAlex10.62347/hdti2868Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159689303
W7144182717Post-Pandemic Prevalence of SARS-CoV-2 RNA in the Saliva of HIV/AIDS Patients in Jos, Nigeria2026-01-01OpenAlex10.17582/journal.hv/2026/13.19.26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7144182717
W7118460677Post-extubation Glossoptosis Complicated by Negative Pressure Pulmonary Edema: A Case Report of a 12-year-old Child Following Laparoscopic Appendectomy Under General Anesthesia2026-01-01OpenAlex10.21608/cupsj.2025.416120.1173Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7118460677
W7127433223Precision in an Era of Complexity: Integrating AI with Novel Anti Diabetic Drugs for Personalized Diabetes Management2026-01-01OpenAlex10.56975/jaafr.v4i1.503009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127433223
W7202206041Principles of Digital Twins in Healthcare2026-01-01OpenAlex10.1007/978-3-032-26723-8_6Full textExcludedF1: This is a principles/architecture reference chapter, not a primary implemented/evaluated adaptive LLM system.https://openalex.org/W7202206041https://link.springer.com/chapter/10.1007/978-3-032-26723-8_6Publisher chapter abstract only; subscription preview
W7224648861ProActIS: Boosting LLMs’ Proactive Information Seeking in Dynamic Clinical Workflows with a Lightweight Exam Proposer2026-01-01OpenAlex10.18653/2026.findings-emnlp.462Full textExcludedF4: ProActIS is a contrastive dual-encoder ranker trained once on fixed retrospective state/examination pairs. At inference it supplies fixed rankings to a case-local diagnostic workflow; no experience-derived update is retained across admissions.https://openalex.org/W7224648861https://aclanthology.org/2026.findings-emnlp.462.pdf
W7167797852Prosthetic Valve Thrombosis: Thrombolytic Agent Selection and Imaging Guidance2026-01-01OpenAlex10.1177/10760296261468433Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7167797852
W7118192174Q-Cancer Map: Coherence-Based Tissue Anomaly Mapping A Non-Invasive Engineering Framework for Early-Stage Irregularity Detection2026-01-01OpenAlex10.17605/osf.io/eqcz2Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118192174
W7223704100REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024)2026-01-01OpenAlex10.1590/s0004-2803.24612026-009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223704100
W7213927080RHIS as a Topological Runtime for AI Systems2026-01-01OpenAlex10.2139/ssrn.7481858Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213927080
W7140295591Rapid radiographic progression of axial spondyloarthritis: A case of diffuse bone marrow oedema evolving to bamboo spine over 9 years2026-01-01OpenAlex10.1093/mrcr/rxag027Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140295591
W7155548282Rational Foreclosure: A Stochastic Reference Point Model of Aspirational Abandonment under Positional Drift2026-01-01OpenAlex10.2139/ssrn.6614858Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155548282
W7161041583Recent Investigations on Pathogenesis, Biomarkers, Epigenetics, and Emerging Therapeutic Strategies to Modulate Multiple Signaling Pathways in Diabetic Retinopathy2026-01-01OpenAlex10.1155/joph/5539383Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161041583
W7131778301Recent treatment guidelines and approach toward autoimmune encephalitis2026-01-01OpenAlex10.1016/b978-0-443-33108-4.00010-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131778301
W7127154447Recent trends in liposomal drug efficiency of nanotechnology in photodynamic therapy for cancer2026-01-01OpenAlex10.2738/foe.2026.0005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127154447
W7163919800Reconceptualising Al-Gharimin in Islamic Social Finance: From Classical Debt Relief to A Maqasid-Driven Personal Financing Framework2026-01-01OpenAlex10.47772/ijriss.2026.100500576Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163919800
W7147232147Reconsider the future of interventional cardiology: restoration, reappraisal, and revolution2026-01-01OpenAlex10.1097/cp9.0000000000000155Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147232147
W7202378071Redrawing the Map in Prurigo Nodularis: From Conventional Approaches to Targeted Biologics2026-01-01OpenAlex10.1155/dth/1342428Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202378071
W7162951253Reflections of Nurse Leaders on Optimising Organisational Culture in Aged Care in Rural and Regional Australia: A Critical Discourse Analysis2026-01-01OpenAlex10.1155/jonm/1474638Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162951253
W7201883703Regulatory Perspectives: Integrating Probiotics into Clinical Practice Against Mycoses and Mycotoxin Risk Management2026-01-01OpenAlex10.1007/978-981-92-0002-3_18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201883703
W7202209117RehApp Integrating Intelligent Agents on the Creation of Gamified Personalized Home Therapy in Upper Limb Rehabilitation for Pediatric Patients2026-01-01OpenAlex10.1007/978-3-032-20291-8_16Full textExcludedF5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract.https://openalex.org/W7202209117https://link.springer.com/chapter/10.1007/978-3-032-20291-8_16Bibliographic information and available abstract/preview only; no full methods read.
W7126180706Reinforcement Learning for Optimizing Personalized Treatment Plans in Oncology2026-01-01OpenAlex10.2139/ssrn.6098006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126180706
W7203539908Reinforcement learning empowered RNN: exploring personalised learning path optimisation in nursing education2026-01-01OpenAlex10.1504/ijict.2026.10080608Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203539908
W7162128409Renal Cell Carcinoma: Integrating Histology, Multiomics, and Targeted Therapeutic Strategies2026-01-01OpenAlex10.1007/978-3-032-24071-2_6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162128409
W7220981419Repurposing SGLT2 Inhibitors Beyond Diabetes: Emerging Roles in Cancer Prevention and Therapy2026-01-01OpenAlex10.1007/164_2026_846Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220981419
W7213893855Research Review on Anesthesia for Painless Gastrointestinal Endoscopy: Drug Application, Regimen Optimization and Safety Management2026-01-01OpenAlex10.12677/acm.2026.1693248Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213893855
W7171519182Research progress in integrated optics for optical coherence tomography2026-01-01OpenAlex10.67704/ioe.2026.250009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171519182
W7170292400Resistant Hypertension in Chronic Kidney Disease2026-01-01OpenAlex10.1007/978-3-032-29564-4_14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170292400
W7133483956Resistant Hypertension: Epidemiology, Mechanisms and Contemporary Therapeutic Strategies2026-01-01OpenAlex10.17925/hi.2026.20.1.2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133483956
W7171709920Responsibility Vacuum in agent Skill Ecosystems: An Exploratory Anticipatory Governance Framework from the Pacing Problem Perspective Authors2026-01-01OpenAlex10.2139/ssrn.6881658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171709920
W7124469510Review of Chemotherapy in Breast Cancer: Evolving Paradigms and Future Directions2026-01-01OpenAlex10.56975/jaafr.v4i1.502209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124469510
W7151854900Revisiting feline urinary tract health: the role of diet and acidifying agents in urolith prevention and long-term cat health2026-01-01OpenAlex10.1093/jas/skag115Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151854900
W7161474118Revolutionizing CAD Diagnosis: Agentic AI in Cardiac CT Scans2026-01-01OpenAlex10.1007/978-3-032-21499-7_24Full textExcludedF1: The publisher abstract explicitly identifies this as a review of cardiac-CT agentic AI, not a primary adaptive system.https://openalex.org/W7161474118https://link.springer.com/chapter/10.1007/978-3-032-21499-7_24Publisher abstract only
W7150150050Rheumatoid Arthritis2026-01-01OpenAlex10.1007/978-3-032-12937-6_2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150150050
W7124703069Rigid Bronchoscopy and Bronchial Interventions2026-01-01OpenAlex10.1007/978-3-032-12007-6_4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124703069
W7202357607Risk Stratification and Updates in Management of MDS2026-01-01OpenAlex10.1007/978-981-92-1167-8_32Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202357607
W7120182859Role of complement in neurologic autoimmunities: Why need to target complement activation for effective immunotherapy2026-01-01OpenAlex10.1016/b978-0-323-90887-0.00014-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7120182859
W7162809858Role of synthetic biology in biodrug production and human wellness2026-01-01OpenAlex10.1016/b978-0-443-34129-8.00002-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162809858
W7224320265SAFER: Speech-First Auditable Follow-Up with Evidence-Gated Routing2026-01-01OpenAlex10.18653/2026.emnlp-demos.48Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7224320265
W7165691687STUDY: The Path of Least Friction Contextual Tunnel Vision in Autonomous AI Agents, Ecological Waste, and the Algorithmic Reflection of Human Entropy2026-01-01OpenAlex10.2139/ssrn.6871439Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7165691687
W7124439728Sarcomatoid renal cell carcinoma presenting with cannonball pulmonary metastases2026-01-01OpenAlex10.1136/bcr-2025-270026Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124439728
W7171717896Securing Autonomous AI Agents: A Reference Architecture for Data Protection in the Agentic AI Era2026-01-01OpenAlex10.2139/ssrn.6691718Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7171717896
W7224193367Self-Evolving Dual-Role Deliberation for Medication Recommendation from Clinical Records2026-01-01OpenAlex10.18653/2026.findings-emnlp.994Full textIncludedIncluded: Experience-bank episodes and both role policies persist across prescribing encounters; the updated Critic supplies scores entering later update-pool selection.https://openalex.org/W7224193367https://aclanthology.org/2026.findings-emnlp.994.pdf
W7224199685Self-Evolving Optimization of Agentic Systems for Machine Translation2026-01-01OpenAlex10.18653/2026.emnlp-main.911Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7224199685
W7171422336Serious Games as Pedagogical Practice(S) for Teaching Sustainability2026-01-01OpenAlex10.1007/978-3-032-22146-9_15Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171422336
W7134120045Side effects of current pharmacology and innovations2026-01-01OpenAlex10.1016/b978-0-443-44665-8.00017-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134120045
W7164247379Sifting Through the Noise: Minority Variant Detection in Mycobacterium tuberculosis and Clinical Implications in Bedaquiline Resistance2026-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164247379
W7224300173Skill-CDPO: Evolving Agent Tool-Use via Critical Step Preference Optimization2026-01-01OpenAlex10.18653/2026.findings-emnlp.1985Full textIncludedIncluded: Tool-specific skill cards and guards are learned from historical invocation failures and retained for later medical-research tasks. One-round DPO alone is not the eligibility basis.https://openalex.org/W7224300173https://aclanthology.org/2026.findings-emnlp.1985.pdf
W7161043974Skin Cancer: An Overview of its Historical, Background, Classification, Clinical Manifestation, Prevention Measures2026-01-01OpenAlex10.46610/rtpscr.2026.v08i01.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161043974
W7155222846Sténose carotidienne : du diagnostic au traitement2026-01-01OpenAlex10.53738/revmed.2026.22.959.48574Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155222846
W7154668595Sugammadex Use in a 28-Week Pregnant Patient Undergoing Laparoscopic Cholecystectomy: A Case Report and Review of Literature2026-01-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154668595
W7204921833Sustainable Explainability in Medical Imaging: An Agentic Explainable AI Framework2026-01-01OpenAlex10.1007/978-3-032-22426-2_11Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7204921833
W7213865886Sustainable and Sovereign Generative AI for IoT: An ML Agent-BasedGovernance Approach2026-01-01OpenAlex10.2139/ssrn.7499762Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213865886
W7161497695Synthetic Phage for the Evolution of Biomolecules2026-01-01OpenAlex10.1007/978-981-95-3957-4_36Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161497695
W7140026211Systematic Review and Meta-Analysis of Large Language Models for Rare Genetic Disease Diagnosis2026-01-01OpenAlex10.17605/osf.io/fmabnTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140026211
W7196959985Systematic review of the literature on intelligent agents for virtual physical therapy2026-01-01OpenAlex10.18687/laccei2026.1.1.1325Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7196959985
W7221800950T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL)2026-01-01OpenAlex10.5336/978-625-91119-4-0_p17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221800950
W7213543026TAPPR PCR assay design—targeted, automated, primer and probe retrieval for scalable molecular assay design2026-01-01OpenAlex10.1093/bioadv/vbag274Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213543026
W7151295936THE EXPANDING INFLUENCE OF ADVANCING SCIENCE AND TECHNOLOGY2026-01-01OpenAlex10.63665/rh.v7i2.46Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151295936
W7128505947Targeted Therapies for Hematologic Malignancies2026-01-01OpenAlex10.1007/978-3-032-14437-9_5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128505947
W7119540010Targeting Melasma: Innovations in Pigment Deposition and Photoaging in Cosmetic Dermatology2026-01-01OpenAlex10.1111/jocd.70665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119540010
W7220695905Task Allocation and Role Distribution in Humane-AI Ecosystems2026-01-01OpenAlex10.1007/978-3-031-61050-9_24-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220695905
W7172426930Techniques of Molecular Pathology: In Situ Hybridization2026-01-01OpenAlex10.1007/978-3-032-24420-8_17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172426930
W7126468461The 11th Annual Saudi Society for Rheumatology Conference. The Abstracts Young Investigator2026-01-01OpenAlex10.4103/ara.ara_41_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126468461
W7126383873The 11th Annual Saudi Society for Rheumatology Conference. The Oral Abstracts2026-01-01OpenAlex10.4103/ara.ara_42_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126383873
W7171634916The Agentic Governance Ribbon: A Provenance-first Framework for Governing Agentic AI across Regulatory Regimes2026-01-01OpenAlex10.2139/ssrn.6803162Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7171634916; https://openalex.org/W7161586716
W7140147973The Changing Landscape of Medical Research: Learning to Think in the Age of Artificial Intelligence2026-01-01OpenAlex10.4103/ijves.ijves_20_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140147973
W7164515390The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where?2026-01-01OpenAlex10.1177/10760296261459710Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164515390
W7117980704The Evolving Role of Second- and Third-Generation Tyrosine Kinase Inhibitors in Gastrointestinal Malignancies: Advances in Targeted Therapy with Sunitinib, Regorafenib, and Avapritinib2026-01-01OpenAlex10.3390/jcm15010317Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117980704
W7212361202The Extracted Dasein: Beyond the Victim-Perpetrator Binary Toward a Clinical Ontology of Gendered Human Capacity A Daseinsanalytic and Existential-Psychoanalytic Reconceptualization2026-01-01OpenAlex10.2139/ssrn.7422320Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212361202
W7204250409The Five-Decade Journey of Small Cell Lung Cancer2026-01-01OpenAlex10.34133/cancomm.0052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204250409
W7159718671The Inception of Agentic AI in Administrative Governance: A Multi-Dimensional Framework for Operational Excellence2026-01-01OpenAlex10.2139/ssrn.6673261Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7159718671
W7118719850The Journal at Forty: A Proud Legacy and a Look to the Future2026-01-01OpenAlex10.1002/mds.70188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118719850
W7171626657The Latent Space of Spirituality: Ontological Dissonance and Semantic Resilience in Large Language Models2026-01-01OpenAlex10.2139/ssrn.6639219Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171626657
W7213546169The Limits of Naturalness: User Perceptions of Interactional Language in Human-Computer Interaction2026-01-01OpenAlex10.2139/ssrn.7484010Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213546169
W7137091834The NHS Waiting-List Deterioration Framework (WLDI): A Sociolinguistic Analysis of Discourse, Distress, and Institutional Experience During Mental Health Service Delays2026-01-01OpenAlex10.2139/ssrn.6295178Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7137091834; https://openalex.org/W7131122965
W7122729550The Nurses of Ellis Island: Life and Work Inside the Golden Door , by Michelle C. Hehman and Arlene W. Keeling2026-01-01OpenAlex10.5325/nursinghistory.34.0182Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122729550
W7124722532The PVA-Mechano-Pharma Nexus: Mechano-Radical-Driven, Self-Regenerating Nano-Ecosystems for Autonomous Antimicrobial Synthesis, Targeted Modulation, and Closed-Loop Drug Delivery2026-01-01OpenAlex10.4236/jbm.2026.141020Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124722532
W7165139456The Pathological Baseline: How Economics Crossed Its Own Boundary, Why the Kantian Branch Never Grew, and What the Markers Always Said2026-01-01OpenAlex10.2139/ssrn.6936698Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165139456
W7154914425The Prohibited Framework: Ensuring Safety and Fair Competition2026-01-01OpenAlex10.1007/978-3-032-17335-5_4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154914425
W7118012100The Role of Silver and Silver-Based Products in Wound Management: A Review of Advances and Current Landscape2026-01-01OpenAlex10.3390/jfb17010027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118012100
W7160775700The Science of OR Scheduling: Metrics, Governance, and Staffing Optimization2026-01-01OpenAlex10.1007/978-3-032-18058-2_7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160775700
W7171727348The Superintelligence Mockery: Why the God in the Machine has no Training Set2026-01-01OpenAlex10.2139/ssrn.6687440Title/abstractExcludedE5: Abstract absent and title does not identify an eligible clinical system.https://openalex.org/W7171727348
W7155051265The Unintegrated Shadow: RLHF, False-Self Formation, and the Case for Alignment as Individuation2026-01-01OpenAlex10.2139/ssrn.6559758Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155051265
W7221580111The genus Pseudogymnoascus: ecological diversity, cold adaptations, and mammalian associations2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221580111
W7164045797The notebook of personal health record system in Japan: framework of post-retirement health checkups for those formerly employed in hazardous occupations2026-01-01OpenAlex10.1539/eohp.2025-0053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164045797
W7204470918The “augmented combustion scientist”: Shifting from data-driven science to agentic AI2026-01-01OpenAlex10.1016/j.proci.2026.106304Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204470918
W7154457280Thematic forum as a complementary tool for a self-instructional course on mental health for adolescents and youth2026-01-01OpenAlex10.1590/1981-5271v50.1-2025-0239.ingTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154457280
W7166831152TheraAgent: Self-Improving Therapeutic Agent for Precise and Comprehensive Treatment Planning2026-01-01OpenAlex10.18653/v1/2026.findings-acl.1490Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7166831152; https://openalex.org/W7160631983
W7127184024Therapeutic Applications of Alpha-Blockers: Pharmacology, Clinical Evidence, and Evolving Therapeutic Strategies2026-01-01OpenAlex10.37155/3060-8708-0301-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127184024
W7154994196Therapeutic embolic agents for targeted drug delivery in transcatheter therapies: a review2026-01-01OpenAlex10.1039/d6cc01050dTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154994196
W7167901357Therapeutic oligonucleotides revisited: Focus on siRNA and antisense technologies2026-01-01OpenAlex10.59717/j.xinn-drugdisc.2026.100007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167901357
W7224467718TimlMemBench: A Diagnostic Benchmark for Governed Use of Long-Term Memory in Dialogue Agents2026-01-01OpenAlex10.18653/2026.findings-emnlp.507Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7224467718
W7163399666Tirzepatide: A Paradigm Shift in the Management of Type 2 Diabetes and Obesity2026-01-01OpenAlex10.34133/jbioxresearch.0092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163399666
W7223559780Toward a Self-Evolving Optimization Agent for Industrial Scheduling2026-01-01OpenAlex10.2738/engai.2026.0006Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7223559780
W7117966183Towards Trust-Driven Trust-Adaptive Astronaut-Agent Medical Collaboration Interfaces2026-01-01OpenAlex10.1007/978-3-032-13187-4_18Full textExcludedF3: The actual study uses25 human SMEs, interviews, grounded-theory analysis and co-design workshops to develop a future astronaut-agent interface concept. It does not implement/evaluate an LLM acting-agent system.https://openalex.org/W7117966183https://link.springer.com/chapter/10.1007/978-3-032-13187-4_18Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W7202330365Towards Trustworthy Modeling of Patient Trajectory with Longitudinal Electronic Health Records2026-01-01OpenAlexFull textExcludedF6: The thesis component concerning Traj-Evolve is already represented by zeng2026trajevolve (original record553, arXiv2606.02812). It is not counted as a newly discovered study; full thesis chapter correspondence is not claimed.https://openalex.org/W7202330365https://hdl.handle.net/1773/57061Full archived thesis abstract; thesis full text unavailable; associated original Traj-Evolve Methods §§3.1–3.5 and Experiments §4 read publicly
W7118011119Towards an Explainability Agent: Leveraging LLMs to Interpret LIME Outputs2026-01-01OpenAlex10.1007/978-3-032-10661-2_2Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7118011119
W7151998324Transcatheter Management of Nonvariceal Lower GI Hemorrhage2026-01-01OpenAlex10.1007/978-3-032-03935-4_11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151998324
W7202159766Treatment Planning and Therapeutic Decision-Making Agents2026-01-01OpenAlex10.1007/978-3-032-26723-8_12Full textExcludedF1: The reference chapter explains treatment-planning mechanisms and examples, without a primary built/evaluated adaptive LLM system in the available description.https://openalex.org/W7202159766https://link.springer.com/chapter/10.1007/978-3-032-26723-8_12Publisher abstract only
W7163691889Treatment of oligometastatic lung cancers: new data, new drivers, new approaches2026-01-01OpenAlex10.1136/bmjonc-2025-001052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163691889
W7163683211Treatment strategies, outcomes, and clinical determinants in neurosarcoidosis: a scoping review of the evolving evidence base2026-01-01OpenAlex10.17605/osf.io/tch95Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163683211
W7167485946Types, Diagnosis, and Treatment of Lung Cancer2026-01-01OpenAlex10.1007/978-3-032-29615-3_2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167485946
W7202331305Ultrasound and Microbubbles: Modulating and Quantifying Blood Flow in Liver Cancers2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202331305
W7131371459Uniting for a Glaucoma Free World: The Way of Vision - With a Report Matrix2026-01-01OpenAlex10.4103/tjosr.tjosr_16_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131371459
W7203858641Unraveling Mycobacterium tuberculosis pathogenesis: Insights into PE/PPE proteins from a molecular viewpoint2026-01-01OpenAlex10.1016/b978-0-443-27735-1.00005-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203858641
W7117550757VITILIGO: A COMPREHENSIVE REVIEW OF PATHOGENESIS, TYPES AND MANAGEMENT2026-01-01OpenAlex10.5281/zenodo.18085365Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7117550757
W7166192522Viral vectors in drug delivery: Design and applications2026-01-01OpenAlex10.1016/b978-0-443-40620-1.00009-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166192522
W7160256676Virtual Exchanges as Catalysts for Inclusive Education: Exploring Disability, Culture, and Disciplinary Learning Across Borders2026-01-01OpenAlex10.1007/978-3-032-10711-4_46-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160256676
W7131155229Voice And Text Based Chatbot2026-01-01OpenAlex10.5281/zenodo.18739754Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131155229
W7128095573What's New in Cutaneous Lupus Erythematosus: Guidelines, Biologics, and Beyond.2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128095573
W7139043647When Embodied AI Meets Topology: A Topological Circuit Breaker for OpenClaw and Industrial Agents2026-01-01OpenAlex10.2139/ssrn.6421619Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7139043647
W7213271911Why Bone Metastases Outlive the Prostate: Mechanisms of Therapeutic Refractoriness of Prostate Cancer Bone Metastases -A Narrative Review2026-01-01OpenAlex10.2139/ssrn.7454664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213271911
W7150818571Xmobot: Enabling Rapid Build-and-Train Robotics Education With Agentic AI2026-01-01OpenAlex10.1109/tlt.2026.3681123Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7150818571
W7125086150[Evolving Pharmacotherapy for Bladder Cancer-From Non-Muscle-Invasive to Metastatic Disease-Development of Novel Therapies for BCG-Unresponsive NMIBC].2026-01-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125086150
W7172260693[Recent advances and future perspectives in the treatment of chronic lymphocytic leukemia].2026-01-01OpenAlex10.11406/rinketsu.67.786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172260693
W7172346261[Recent advances and future perspectives in the treatment of mantle cell lymphoma].2026-01-01OpenAlex10.11406/rinketsu.67.751Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172346261
W7163396397האישיות המשפטית הפונקציונלית: מעמד התאום הדיגיטלי־אנושי בעידן הבינה המלאכותית הכללית Functional Legal Personhood: The Status of the Human-Digital Twin in the Age of Artificial General Intelligence2026-01-01OpenAlex10.2139/ssrn.6856981Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163396397
W7172442268认知场 Cognitive Field v1.0.0 — 自组织多智能体场的宪法治理实验2026-01-01OpenAlex10.5281/zenodo.21786559Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172442268
W7118068119AI Operating Systems with Kernel-Governed Execution Authority: Why Deterministic and Ethics-Bound AI Frameworks Do Not Constitute Governance2026-01-02OpenAlex10.5281/zenodo.18134057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118068119
W7117971873Conversational agents and equity in health care systems: a scoping review2026-01-02OpenAlex10.1080/29944694.2025.2606723Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7117971873
W7118071115Immune checkpoint blockade in cancer: current insights and future horizons2026-01-02OpenAlex10.1007/s12672-025-04361-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118071115
W7118004792Plants in the Biogenic Synthesis of Medicinally Significant Silver Nanoparticles2026-01-02OpenAlex10.1201/9781003559900-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118004792
W7119184062Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practice2026-01-03OpenAlex10.1093/rheumatology/keag002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119184062
W7131103684Dataset for contextualized divergence detection2026-01-03OpenAlex10.5281/zenodo.18140793Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131103684
W7118064454Male Fertility Preservation in Children and Adolescents with Cancer2026-01-03OpenAlex10.1007/s40746-025-00353-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118064454
W7118079725Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies2026-01-03OpenAlex10.1007/s11886-025-02337-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118079725
W7121051508Toward smart health monitoring: multimodal sensing and intelligent disease diagnosis in poultry and livestock2026-01-04OpenAlex10.1093/af/vfaf060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7121051508
W7118193656Artificial intelligence and EEG during anesthesia: ideal match or fleeting bond?2026-01-05OpenAlex10.20517/ais.2025.68Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118193656
W7118811485CURRENT TRENDS IN THE DIAGNOSIS AND THERAPEUTIC APPROACHES TO PCOS2026-01-05OpenAlex10.5281/zenodo.18152193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118811485
W7118193725Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation2026-01-05OpenAlex10.3389/fphar.2025.1750070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118193725
W7118193754Considerations for biologics as front-line treatment in allergic diseases2026-01-05OpenAlex10.3389/fimmu.2025.1746790Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118193754
W7118844381Designed Mortality: The Ethics of Terminating Ephemeral AI Agents2026-01-05OpenAlex10.5281/zenodo.18157685Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7118844381
W7118160572Discontinuation of advanced therapy in inflammatory bowel disease: Updated evidence, guidelines, and personalized decision-making one year later2026-01-05OpenAlex10.12998/wjcc.v14.i1.112021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118160572
W7118675853Host Genetic Factors Influencing COVID-19 Susceptibility and Severity: A Narrative Review2026-01-05OpenAlex10.9734/jammr/2026/v38i16043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118675853
W7118167581Management of relapsed/refractory DLBCL in the era of novel agents and new approaches2026-01-05OpenAlex10.1080/10428194.2025.2599994Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7118167581
W7125607149Risk averse: assessing risk as a surrogate measure in pulmonary arterial hypertension2026-01-05OpenAlex10.1093/ajrccm/aamaf137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125607149
W7118981562TERATOGENIC EFFECTS OF DIFFERENT DRUG AT DIFFERENT STAGES OF PREGNANCY2026-01-05OpenAlex10.5281/zenodo.18153268Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118981562
W7118977126Towards Societally Aligned Decision-Making for Automated Vehicles2026-01-05OpenAlex10.33540/3383Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118977126
W7118875971A REVIEW OF PHARMACOLOGICAL ADVANCES IN THE MANAGEMENT OF GERD, 2015-20252026-01-06OpenAlex10.31435/ijitss.1(49).2026.4558Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118875971
W7160199493Artificial intelligence in nutritional oncology: From isolated screening tools to agentic intervention systems2026-01-06OpenAlex10.18632/oncotarget.28874Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160199493
W7118467851Editorial: Advances in the diagnosis and management of infectious diseases2026-01-06OpenAlex10.3389/fcimb.2025.1765521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118467851
W7119155728Editorial: Autoimmune diseases: from molecular mechanisms to therapy development2026-01-06OpenAlex10.3389/fimmu.2025.1768955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119155728
W7118477898Editorial: Mental health in the age of artificial intelligence2026-01-06OpenAlex10.3389/fpsyt.2025.1750256Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118477898
W7119104743Editorial: Unveiling the next generation of cancer immunity & immunotherapy2026-01-06OpenAlex10.3389/fimmu.2025.1769324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119104743
W7118820259Global research trends in myelodysplastic syndromes drug resistance: A comprehensive bibliometric and knowledge mapping study2026-01-06OpenAlex10.21203/rs.3.rs-8522773/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118820259
W7118904668How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer2026-01-06OpenAlex10.1016/j.esmorw.2025.100662Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118904668
W7118489816Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review2026-01-06OpenAlex10.1007/s13300-025-01828-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118489816
W7119008066Milrinone Therapy in Acute Heart Failure: Clinical Evidence, Hemodynamic Effects, and Safety Considerations2026-01-06OpenAlex10.5281/zenodo.18169190Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119008066; https://openalex.org/W7124472788
W7118318813Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy2026-01-06OpenAlex10.1016/j.xkme.2026.101242Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118318813
W7118371590Recursive Ai with Codette2026-01-06OpenAlex10.5281/zenodo.18167760Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118371590; https://openalex.org/W7223764923
W7119119808The Landscape of Computational Pathology Agents From Static Analysis to Autonomous Diagnostic Workflows2026-01-06OpenAlex10.36227/techrxiv.176773877.76155111/v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7119119808
W7118475497The Pathogenesis, Clinical Features, and Treatment of Corynebacterium striatum-Related Infection2026-01-06OpenAlex10.3390/microorganisms14010119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118475497
W7118354970Editorial: Asian medical industries: beyond tradition, beyond medicine, beyond Asia2026-01-07OpenAlex10.3389/fhumd.2025.1722458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118354970
W7118237596Foucault as a Kind of Realist2026-01-07OpenAlex10.1093/9780197749852.003.0021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118237596
W7122508324Perspective Chapter: The Use of Fluorescence in Ovarian Cancer Surgery2026-01-07OpenAlex10.5772/intechopen.1013691Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122508324
W7118855217Preventing peri-implantitis: strategies, mechanisms, and clinical perspectives for inhibiting biofilm formation on implant surface2026-01-07OpenAlex10.3389/fmats.2025.1739290Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118855217
W7118481164Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies2026-01-08OpenAlex10.3389/fimmu.2025.1754096Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118481164
W7118641711Editorial: Digital health applications of social robots2026-01-08OpenAlex10.3389/frobt.2025.1773450Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118641711
W7118609442Editorial: Mesenchymal stem cells and derived extracellular vesicles as next-generation biological drugs for tissue regeneration2026-01-08OpenAlex10.3389/fphar.2025.1770314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118609442
W7119077608GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease2026-01-08OpenAlex10.1038/s41581-025-01036-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119077608
W7125803788Nelsonov sindrom nakon bilateralne adrenalektomije2026-01-08OpenAlex10.57140/mj.55.3-4.4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125803788
W7124753025Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies2026-01-08OpenAlex10.1093/jac/dkag010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124753025
W7119486174Systems Theory Model to Understand the Barriers and Facilitators to Palliative Care Referral for Pediatric Oncology Patients in Canada2026-01-08OpenAlex10.1200/op-25-00761Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7119486174
W7121053110Targeting common EGFR mutations in non–small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors2026-01-08OpenAlex10.1093/jnci/djag008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7121053110
W7118541485The Next Chapter of Cancer Immunology Research2026-01-08OpenAlex10.1158/2326-6066.cir-25-1391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7118541485
W7220138994TheranosticsAnd NanotheranosticsIn Precision Medicine: Integrative Theoretical Foundations, Translational Paradigms, And Disease-Specific Applications2026-01-08OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220138994
W7134988583A New IgG-λ Band during Therapy in Light-Chain Myeloma2026-01-09OpenAlex10.1093/jalm/jfag004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134988583
W7123356287A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels2026-01-09OpenAlex10.1093/eurjpc/zwag023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123356287
W7119802561Lava-Void Cosmology Pillar 14: Accelerated Nomadic Propagation - Strategic Annex2026-01-09OpenAlex10.5281/zenodo.18190547Title/abstractExcludedE2: Mathematical/forecasting/AGI framework without a clinical primary task.https://openalex.org/W7119802561
W7130374098Manipulating DNA repair and the DNA damage response to improve cancer therapy2026-01-09OpenAlex10.1093/narcan/zcag006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130374098
W7119650059The Age of Intelligent Threats2026-01-09OpenAlex10.1002/9781394402069.ch1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119650059
W7119855693Tyrosine kinase inhibitors for wet age-related macular degeneration: The current developmental landscape2026-01-09OpenAlex10.1016/j.jpet.2026.103803Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7119855693
W7123718223A Narrative Review on the Power of Contrast Media in Radiology: Clinical Indications, Associated Risks, and Strategies for Safe Management2026-01-10OpenAlex10.64261/0scm9g24Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7123718223
W7122571660Age-based outcomes and patterns of care of patients with metastatic pancreatic cancer: An updated comparative analysis from Fox Chase Cancer Center.2026-01-10OpenAlex10.1200/jco.2026.44.2_suppl.668Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122571660
W7122367730Comparative outcomes of evolving vs conventional regimens in BRAF V600E-mutated metastatic colorectal cancer therapy: A systematic review.2026-01-10OpenAlex10.1200/jco.2026.44.2_suppl.175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122367730
W7122445577Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in malignant peritoneal mesothelioma (MPM).2026-01-10OpenAlex10.1200/jco.2026.44.2_suppl.816Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122445577
W7122527779Real-world prospective comparison of sorafenib and lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: A multicenter study in Japan (KSCC HAMRET).2026-01-10OpenAlex10.1200/jco.2026.44.2_suppl.562Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122527779
W7121540994Supersonic transporter (SST) deformity of penile prosthesis: Current management strategies2026-01-10OpenAlex10.1002/uro2.70044Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7121540994
W7220659681Advances in Preventive Dentistry: Contemporary Strategies for Caries and Periodontal Disease Control2026-01-11OpenAlex10.36347/sjds.2026.v13i01.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220659681
W7122493117Evolving Methodologies for the Analytical Determination of Metoclopramide2026-01-11OpenAlex10.1080/10408347.2025.2612234Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122493117
W7122783492Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways2026-01-12OpenAlex10.3389/fendo.2025.1710376Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122783492
W7123259396Assessment Of the Outcome of Remdesivir in The Treatment of Covid-19 Patients: A Retrospective Observational Study2026-01-12OpenAlex10.5281/zenodo.18219993Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7123259396
W7122613832Beyond rheumatology: Reconsidering methotrexate for Crohn’s disease in the biologic era2026-01-12OpenAlex10.3748/wjg.v32.i2.113432Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122613832
W7122436344Biochemical and Pharmacological Mechanisms of GLP-1 and Dual Agonists: Implications for Glycemic Control and Cardiovascular Risk Reduction — A Review2026-01-12OpenAlex10.64907/xkmf.v4.i1.jbpph.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122436344
W7122857035Caught between confidentiality and compulsion: the global ethics-law dilemma in psychotherapy2026-01-12OpenAlex10.3389/fpsyg.2025.1665158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122857035
W7122696050Chronic Graft-versus-Host Disease: A Review of Current Treatments beyond Second-Line and Emerging Therapies2026-01-12OpenAlex10.1159/000550265Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122696050
W7122868402Editorial: Diagnostic and treatment strategies for periodontal disease2026-01-12OpenAlex10.3389/fdmed.2025.1759435Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122868402
W7122803619Five years after the pandemic: rethinking the pharmacological management of mental disorders2026-01-12OpenAlex10.3389/fpsyt.2025.1750073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122803619
W7123350180Identification of leprosy reactions using Fourier transform infrared (FTIR) spectroscopy supervised by clinical evaluation2026-01-12OpenAlex10.1016/j.jpba.2026.117354Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7123350180
W7122456883Intraoperative contrast-enhanced ultrasound-assisted resection of brain tumors: a systematic review and meta-analysis2026-01-12OpenAlex10.1016/j.neuchi.2026.101774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122456883
W7122633175Management strategies for burning mouth syndrome: a comprehensive review2026-01-12OpenAlex10.22514/jofph.2026.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122633175
W7122472845Next-generation therapeutics for diabetic kidney disease2026-01-12OpenAlex10.1038/s41581-025-01042-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122472845
W7122466457Ocular surface disease following LASIK and cataract surgery: a review of their interrelated complications2026-01-12OpenAlex10.3389/fmed.2025.1623324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7122466457
W7123356597Reply2026-01-12OpenAlex10.1016/j.jaci.2025.12.1001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123356597
W7122790884The curative-to-preventive perspective shift of medical students through community dementia programs: a qualitative study based on transformative learning theory2026-01-12OpenAlex10.3389/fpubh.2025.1708455Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7122790884
W7123345192When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder2026-01-12OpenAlex10.7759/cureus.101398Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7123345192
W7123427634(CLFS)— Continuity-Synchronized Systems Across Spatially Separated Domains2026-01-13OpenAlex10.5281/zenodo.18235062Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7123427634
W7123344274Agentic AI Framework for Technical Excellence: A Discipline-Based, Scalable Multimodal Assistant for Subsurface2026-01-13OpenAlex10.2523/iptc-25245-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7123344274
W7123658241Autonomous Capability Synthesis and Deterministic Cross-Platform Code Generation via a Modular Cognitive Substrate2026-01-13OpenAlex10.5281/zenodo.18234909Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7123658241
W7131365931Chinese evidence-based antithrombotic therapy for coronary heart disease2026-01-13OpenAlex10.1360/csb-2025-5738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131365931
W7123663365Contemporary SPECT/CT V/Q scanning: protocols, pearls and pitfalls2026-01-13OpenAlex10.23736/s1824-4785.25.03688-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123663365
W7123369522Editorial: Immuno-metabolic interactions and cancer progression in the tumor microenvironment2026-01-13OpenAlex10.3389/fimmu.2026.1774012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123369522
W7123346065Editorial: Insights in healthcare professions education: 20242026-01-13OpenAlex10.3389/fmed.2025.1760309Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123346065
W7123740922Editorial: Recent advances in oral medicine in dogs and cats2026-01-13OpenAlex10.3389/fvets.2025.1753541Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123740922
W7123349439Editorial: Streamlining drug approvals: addressing policy challenges in genitourinary oncology2026-01-13OpenAlex10.3389/fimmu.2025.1757428Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123349439
W7125694762From protocol to practice: enhancing the translational value of herbal patch studies through standardized assessment, robust blinding, and individualized dosing strategies2026-01-13OpenAlex10.1097/js9.0000000000004755Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125694762
W7123349084In Vivo Prostate Cancer Modelling: From the Pre-Clinical to the Clinical Setting2026-01-13OpenAlex10.3390/life16010111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123349084
W7123358923State of the Art on Thyroid Cancer Biology and Oncology2026-01-13OpenAlex10.3390/biomedicines14010168Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123358923
W7123744533Sulfonium peptoid outperforms: Exceptional biocompatibility and potent anti-MDR activity via multimodal mechanisms2026-01-13OpenAlex10.1016/j.nantod.2026.102977Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7123744533
W7123343611The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us2026-01-13OpenAlex10.1016/j.jhlto.2026.100482Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123343611
W7124317947Trends in nephrology: from “supportive care” to CKD combination therapy2026-01-13OpenAlex10.1093/ndt/gfag003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124317947
W7124174007Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review2026-01-14OpenAlex10.3390/cancers18020259Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124174007
W7124167621Beyond Random Walks: Exploring the Learnability Threshold of AI Agents in Algorithmic Markets2026-01-14OpenAlex10.21203/rs.3.rs-8027229/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124167621
W7135211312Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China2026-01-14OpenAlex10.1093/infdis/jiag033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135211312
W7123794771Commentary: Trehalose alleviates nephropathy in focal segmental glomerulosclerosis via the upregulation of the WT-1/EZH2 pathway2026-01-14OpenAlex10.3389/fphar.2026.1761856Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7123794771
W7124166116Gastric and upper gastrointestinal oncology: integrating breakthroughs from prevention to precision therapeutics2026-01-14OpenAlex10.1186/s40164-025-00741-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124166116
W7124156678Highlights of 2025 - Print Issue2026-01-14OpenAlex10.33940/001c.155326Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124156678
W7124171310IA-ZINE Nº4 Dancing with the woman in red: Chronicles of 20322026-01-14OpenAlex10.5281/zenodo.18247507Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124171310
W7124210826Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials2026-01-14OpenAlex10.3390/cancers18020258Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124210826
W7124168080The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer2026-01-14OpenAlex10.1016/j.eururo.2026.01.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124168080
W7124276246Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018–2025)2026-01-15OpenAlex10.3390/curroncol33010048Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7124276246
W7124260302Cancer therapy-associated Takotsubo cardiomyopathy: A narrative review of mechanisms, drug associations, and clinical implications2026-01-15OpenAlex10.1016/j.ahjo.2026.100723Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124260302
W7223143826Chondrosarcoma: from genomics to clinical trials2026-01-15OpenAlex10.5603/ocp.114539Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223143826
W7133512625Do we need to use neoadjuvant carboplatin in all patients with triple-negative breast cancer?2026-01-15OpenAlex10.5603/ocp.109345Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133512625
W7124318464Drug-Induced Acute Generalized Exanthematous Pustulosis: Mechanisms, Diagnosis, and Clinical Differentiation from Other Pustular Eruptions2026-01-15OpenAlex10.3390/dermato6010003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124318464
W7221626822Green Synthesis of Nanoparticles for Pharmaceutical Applications: A Sustainable Approach2026-01-15OpenAlex10.22037/ipa.v9i1.50862Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221626822
W7132852857Osteoporosis: Contemporary Understanding, Diagnostic Advances, and Evolving Therapeutic Strategies2026-01-15OpenAlex10.5281/zenodo.18811617Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7132852857
W7124248984Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations2026-01-15OpenAlex10.3389/fonc.2025.1697180Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124248984
W7124265950The evolving landscape of platelet therapy: risks, innovations, and clinical judgment2026-01-15OpenAlex10.1007/s00277-026-06758-yTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7124265950
W7124324843ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS2026-01-16OpenAlex10.5281/zenodo.18255404Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124324843
W7124768010Antimicrobial Resistance and Therapy in Intensive Care Unit2026-01-16OpenAlex10.3390/books978-3-7258-6311-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124768010
W7124446289Engineering Tick Evasins as Multitarget Chemokine Inhibitors─A Biomimetic Approach To Tackling the Complexity of the Immune System2026-01-16OpenAlex10.1021/acs.accounts.5c00793Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124446289
W7124469127Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives2026-01-16OpenAlex10.1007/s10238-025-02031-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124469127
W7124434192Making Tunable Parameters State-Dependent in Weather and Climate Models with Reinforcement Learning2026-01-16OpenAlex10.22541/essoar.176859085.59276820/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124434192
W7124424037Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients2026-01-16OpenAlex10.1007/s11864-026-01379-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124424037
W7124470305Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials2026-01-16OpenAlex10.3748/wjg.v32.i3.111528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124470305
W7124454105Primitive Asymmetries of Persistence2026-01-16OpenAlex10.5281/zenodo.18273850Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124454105
W7135079604The Evolving Frontline of Antimicrobial Resistance: Adapting Testing and Treatment for Austere and Combat Settings2026-01-16OpenAlex10.1093/milmed/usag024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135079604
W7126020316Treatment Strategies for Perinatal Depression Beyond Conventional Antidepressants: A Narrative Review2026-01-16OpenAlex10.31083/ceog45609Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126020316
W7124526760A Comprehensive Study on Approaches in the War Against Antibiotic Resistance2026-01-17OpenAlex10.5281/zenodo.18280524Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124526760
W7124657014The Role of Stem Cell Transplantation in Hodgkin Lymphoma2026-01-17OpenAlex10.1016/j.hoc.2025.12.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124657014
W7124680305Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia2026-01-18OpenAlex10.1016/j.npep.2026.102585Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124680305
W712483168530 years of thrombolysis for ischaemic stroke: expanded agents, widened windows and accelerated delivery2026-01-19OpenAlex10.1136/svn-2025-004987Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124831685
W7124995133Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells2026-01-19OpenAlex10.3390/pharmaceutics18010124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124995133
W7126003504Control of airborne biocontamination in HVAC systems through UV-C irradiation. An experimental and numerical study of the UV-C field2026-01-19OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7126003504
W7124728244Diversifying Description Phase Techniques During Debriefing2026-01-19OpenAlex10.21203/rs.3.rs-8462808/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124728244
W7125004915Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?2026-01-19OpenAlex10.1245/s10434-026-19095-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125004915
W7125631174Early management of acute heart failure2026-01-19OpenAlex10.1097/mcc.0000000000001357Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125631174
W7124694139Editorial: Brain metastasis and systemic target therapy: implications for neurosurgeons2026-01-19OpenAlex10.3389/fsurg.2026.1761513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124694139
W7124833137Evaluating senescence-targeted approaches in Alzheimer’s Disease: What we know and what lies ahead2026-01-19OpenAlex10.1016/j.arr.2026.103029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124833137
W7124729517Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain2026-01-19OpenAlex10.3390/pathogens15010107Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7124729517
W7124881553Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance2026-01-19OpenAlex10.3390/antibiotics15010100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124881553
W7124798618Multi-Agent AI Framework for Threat Mitigation and Resilience in Machine Learning Systems2026-01-19OpenAlex10.1145/3780095Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7124798618
W7125686753Progressive multifocal leukoencephalopathy in the modern therapeutic era: A critical synthesis of epidemiology, diagnostics, and policy implications with regional context from Korea2026-01-19OpenAlex10.46439/biomedres.6.074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125686753
W7124736699Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma2026-01-19OpenAlex10.1080/17476348.2026.2615193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124736699
W7140205060Smart Chatbot with Advanced Self-Evolving using AI Tools and Techniques2026-01-19OpenAlex10.1109/icauc68182.2026.11441111Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7140205060
W7124832611Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting2026-01-19OpenAlex10.1007/s40487-025-00412-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124832611
W7160167436“Timelining” Treatment Trajectories During Interviews About Shared Decision Making With Ethnic Minorities in Oncology: A Methodological Reflection2026-01-19OpenAlex10.1177/16094069261442331Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160167436
W712500176920 Years of Liver Biopsies at a Single Institution—Application of a Machine Learning‐Based Approach to Pathology Database Searches2026-01-20OpenAlex10.1002/lci2.70036Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125001769
W7124972602Advances in the Management of Pediatric Inflammatory Bowel Disease: From Biologics to Small Molecules2026-01-20OpenAlex10.3390/ph19010176Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124972602
W7125714285An Innovative Frontier in Healthcare: Optimizing Alcoholism Detection with an Assorted Convolutional Neural Network and Long Short-Term Memory System2026-01-20OpenAlex10.14445/23488549/ijece-v13i1p107Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125714285
W7124961640Artificial Intelligence in Chronic Disease Management: From Early Diagnostics to Patient Empowerment2026-01-20OpenAlex10.54254/2753-8818/2026.pj31352Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124961640
W7124857840Ethics beyond the form: Response-ability in intersex healthcare research2026-01-20OpenAlex10.1016/j.metip.2026.100229Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7124857840
W7125697008Evolution of Treatments of Prostate Cancer2026-01-20OpenAlex10.3390/books978-3-7258-6066-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125697008
W7124995845Management of tenosynovial giant cell tumor: approved and investigational therapies2026-01-20OpenAlex10.1080/14737140.2026.2620510Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124995845
W7204935662Rethinking acne vulgaris: from pathogenic mechanisms to targeted therapies2026-01-20OpenAlex10.5603/fd.113792Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204935662
W7124905386Targeting the Inflammatory Cascade: The Evolution of Monoclonal Antibodies for Severe Asthma Management2026-01-20OpenAlex10.12775/qs.2026.49.67808Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7124905386
W7125435541Checkpoint inhibitors in cancer Immunotherapy: Mechanisms, Resistance, and Combination Strategies2026-01-21OpenAlex10.1051/epjconf/202634801013/pdfTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125435541; https://openalex.org/W7125147103
W7125126259Discovery of Coerumycin, a Cinnamycin-like Lantibiotic from Actinomadura coerulea TMS0852026-01-21OpenAlex10.3390/antibiotics15010104Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125126259
W7125134983Favipiravir's clinical potential for treating Severe Fever with Thrombocytopenia Syndrome (SFTS): A narrative review2026-01-21OpenAlex10.1016/j.virol.2026.110799Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125134983
W7125210433Guideline implications of REBOOT: beta-blockers therapy in post-MI patients with preserved LVEF2026-01-21OpenAlex10.1097/js9.0000000000004900Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125210433
W7125770255Harnessing Purines: Anticancer Activity and Target-Specific Approaches2026-01-21OpenAlex10.2174/0115734064390291251128060307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125770255
W7125424626Letter to the Editor: Liver transplantation for colorectal metastasis – selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis2026-01-21OpenAlex10.1097/js9.0000000000004870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125424626
W7125107141New developments in periodontal tissue regeneration utilizing nanocages and cell membrane display nanotechnology: Current advances and future perspectives.2026-01-21OpenAlex10.5281/zenodo.18322994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125107141
W7125162776Organ donor management in the ICU: Adjunctive agents for optimizing organ procurement and graft function2026-01-21OpenAlex10.1093/ajhp/zxag020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125162776
W7125263017Rauwolfia Serpentina Used in Treatment of Hypertension2026-01-21OpenAlex10.5281/zenodo.18328389Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125263017
W7125374322Adaptive Recursive Cognition (ARC): A Reproducible Architecture for Multi-Loop Stabilization, Self-Improvement, and Token-Level Control in Language Models2026-01-22OpenAlex10.5281/zenodo.18342791Title/abstractExcludedE2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task.https://openalex.org/W7125374322
W7125390584Autonomy Exposure Engineering: Cross-Domain Dynamics, Containment Strategies, and Governance Frameworks (2026)2026-01-22OpenAlex10.5281/zenodo.18343181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125390584; https://openalex.org/W7125383865
W7126020427Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists2026-01-22OpenAlex10.31083/rcm44528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126020427
W7125390503Can bile salts affect the contractile oesophageal activity associated with gastroesophageal reflux disease?2026-01-22OpenAlex10.3748/wjg.v32.i4.114560Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125390503
W7125377163Colonic diverticular hemorrhage: Etiology, diagnostic challenges, and evolving therapeutic strategies2026-01-22OpenAlex10.3748/wjg.v32.i4.114842Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7125377163
W7129053369Developments in the therapeutic landscape for dry eye2026-01-22OpenAlex10.1080/14656566.2026.2633382Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129053369
W7125500979Exogenous amdoparvoviruses (Parvoviridae) in arvicoline voles: the molecular evolution and ecology of a novel host-viral association2026-01-22OpenAlex10.1371/journal.ppat.1013896Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125500979
W7125409037GastroTCM: a large language model assistant for gastroenterology in traditional Chinese medicine2026-01-22OpenAlex10.1186/s13020-025-01295-8Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7125409037
W7131391782Highlighting advances on clinical management of pediatric HIV2026-01-22OpenAlex10.1080/14656566.2026.2638484Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131391782
W7125390461Mastery Equilibrium Theory (MET)2026-01-22OpenAlex10.5281/zenodo.18343188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125390461
W7161353149OVERCOMING FEAR: THE ROLE OF CANINE THERAPY IN TREATING GYNOPHOBIA2026-01-22OpenAlex10.5281/zenodo.20209367Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161353149
W7125582576Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 2 – Treatment2026-01-22OpenAlex10.1016/j.jointm.2025.10.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125582576
W7125427913Recent developments in pediatric respiratory syncytial virus prevention: The expanding role of monoclonal antibodies2026-01-22OpenAlex10.1093/ajhp/zxag019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125427913
W7125442532The new life of myectomy in the era of myosin inhibitors2026-01-22OpenAlex10.1016/j.pcad.2026.01.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125442532
W7125508511Agentic Reterival Augmented Generation using Small Language Model2026-01-23OpenAlex10.5281/zenodo.18345420Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7125508511
W7125503963Dobutamine or milrinone in mixed cardiogenic shock with sepsis2026-01-23OpenAlex10.1093/annalsats/aaoaf055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125503963
W7125486598Editorial: The newer paradigms in hypertension research and management2026-01-23OpenAlex10.3389/fmed.2026.1781466Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125486598
W7125531718Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management2026-01-23OpenAlex10.1016/j.annemergmed.2025.12.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125531718
W7125518998MASH and the race for liver antifibrotics2026-01-23OpenAlex10.3389/fgstr.2025.1704078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125518998
W7125510828Pediatric lymphoproliferative disorders – Emerging insights and management: A narrative review2026-01-23OpenAlex10.1097/md.0000000000047367Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125510828
W7125561013Safety-first TCR-T: AI-guided specificity, base-editing to prevent mispairing, and prioritizing public neoantigens2026-01-23OpenAlex10.3389/fimmu.2026.1754735Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125561013
W7147395832Agentic AI for Intelligent Pharmaceutical Market Access Analytics Platforms2026-01-24OpenAlex10.63397/iscsitr-ijcse_2026_07_01_004Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7147395832
W7125581775Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome2026-01-24OpenAlex10.1186/s13075-026-03732-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125581775
W7125634317Extensive Cerebral Venous Sinus Thrombosis in a Young Male With Severe Hyperhomocysteinaemia: An Unusual Presentation With Early Diplopia2026-01-24OpenAlex10.7759/cureus.102233Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125634317
W7125603626Filling the Gaps: A Review and Update on Beta-Lactamase Inhibitor Combinations2026-01-24OpenAlex10.1007/s11908-025-00874-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125603626
W7125590179Multimodal fusion and AI context awareness in smart kitchens: deep learning for personalized recommendation and real-time monitoring2026-01-24OpenAlex10.55670/fpll.futech.5.1.9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125590179
W7125613902Nanofibers for the Management of Lung Cancer2026-01-24OpenAlex10.1201/9781003595830-12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125613902
W7125593972Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics2026-01-24OpenAlex10.1016/j.actbio.2026.01.043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125593972
W7125606302The Malignant Tumor as a Hybrid Biological System: A Tripartite Integration Hypothesis2026-01-24OpenAlex10.5281/zenodo.18361965Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125606302
W7125765414Dealing mental health disorders2026-01-25OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125765414
W7125702535Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances2026-01-25OpenAlex10.3390/molecules31030410Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125702535
W7125698150Research Advances in Glanimal Models of Glaucoma: Exploring Multidimensional Mechanisms and Novel Therapeutic Strategies2026-01-25OpenAlex10.3390/pharmaceutics18020152Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125698150
W7125715868A Mini-review on the Significance of Benzimidazole in Antifungal Drug Design: Past Insights and Current Applications2026-01-26OpenAlex10.2174/0113895575416047251201060127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125715868
W7220462701CHRISTIAN MISSIONS AND THE STRUGGLE FOR HUMAN DIGNITY AND PEACE IN AFRICA2026-01-26OpenAlex10.64633/wissj.v10i1.05Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220462701; https://openalex.org/W7125686163
W7125708944Editorial: Infectious diseases and hematology: diagnosis and management, volume II2026-01-26OpenAlex10.3389/fmed.2025.1769806Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125708944
W7125628828Editorial: Nanomaterials Mediated Immunomodulation in Cancer: Current Perspective from Bench to Clinic2026-01-26OpenAlex10.3389/fimmu.2026.1784752Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125628828
W7125695208Enzymatic Glucosylation Enhances the Solubility of Niclosamide but Abrogates Its Therapeutic Efficacy2026-01-26OpenAlex10.1021/acsomega.5c12185Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125695208
W7125628395Novel Koutsourovirus phages disrupt clinical multidrug-resistant Enterobacter cloacae biofilms: genomic and functional characterization2026-01-26OpenAlex10.1007/s12223-026-01424-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125628395
W7125807369Post-mastectomy pain syndrome mechanisms, prevention, and management strategies2026-01-26OpenAlex10.18203/2394-6040.ijcmph20260121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125807369
W7140490558Sustainable Virtual Reality for Psychological Well-Being: The Role of Supervision, Immersion, and Human Presence2026-01-26OpenAlex10.1109/aixvr67263.2026.00065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140490558
W7125804964Antiplatelet therapy after intravenous thrombolysis in acute ischemic stroke: No longer one-size-fits-all2026-01-27OpenAlex10.4103/bc.bc_153_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125804964
W7125796832Comment on "Emerging oligonucleotide therapeutics for the treatment of dry eye diseases": Oligonucleotide therapeutics for dry eye disease: Navigating the road from precision promise to clinical reality2026-01-27OpenAlex10.1016/j.edisc.2026.100019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125796832
W7125843632Direct Oral Anti-Xa Anticoagulants and the Future of Factor XI/FXIa Inhibition: A New Paradigm in Thrombosis Prevention2026-01-27OpenAlex10.3390/pharmacy14010019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125843632
W7125826740Editorial: Diagnostic innovations for microbial pathogens in edible plants: cutting-edge technologies for enhanced detection2026-01-27OpenAlex10.3389/fmicb.2026.1777845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125826740
W7125820514KETAMINE IN PREHOSPITAL MANAGEMENT OF TRAUMATIC BRAIN INJURIES: FROM CONTROVERSY TO ROUTINE USE. A SYSTEMATIC REVIEW OF CURRENT LITERATURE2026-01-27OpenAlex10.31435/ijitss.1(49).2026.4564Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125820514
W7125951595Oil supplementation and cardiovascular mortality in the dialysis population2026-01-27OpenAlex10.1093/ndt/gfag015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125951595
W7125783524Prescription Patterns of Sodium-Glucose Co-Transporter 2 Inhibitors among Nephrologists2026-01-27OpenAlex10.25259/ijn_784_2025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7125783524
W7126054603Towards precision secondary prevention after myocardial infarction and stroke with glucagon-like peptide-1 receptor agonists2026-01-27OpenAlex10.1093/eurjpc/zwag068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126054603
W7125970579A Typed Naturality Constraint and Audit-Gated Degradation for Verifiable, Non-Extractable AI Claims2026-01-28OpenAlex10.5281/zenodo.18402500Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125970579
W7126066017Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review2026-01-28OpenAlex10.1002/phar.70110Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126066017
W7125941448Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma2026-01-28OpenAlex10.3390/cancers18030409Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7125941448
W7131881198Diverticular Inflammation and Complication Assessment-guided prevention of acute diverticulitis: evidence, uncertainties, and the path ahead2026-01-28OpenAlex10.1097/meg.0000000000003128Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131881198
W7125916422ENHANCING KNOWLEDGE-INTENSIVE CUSTOMER SUPPORT IN REGULATED INDUSTRIES THROUGH RETRIEVAL-AUGMENTED GENERATION (RAG): ARCHITECTURE, ALGORITHMS, AND EMPIRICAL EVALUATION2026-01-28OpenAlex10.34218/ijaiap_05_01_001Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125916422
W7125951008Enterprise CRM Architecture in the AI Era: Design Patterns, Platform Transformation, and the Future of Multi-Tenant SaaS2026-01-28OpenAlex10.20944/preprints202601.2199.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7125951008
W7125963060Expert Discussion: ABC8, Bridging the Gap2026-01-28OpenAlex10.1159/000550030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125963060
W7125908748Harnessing nanomaterials to overcome antimicrobial resistance in Gram-positive bacteria: a systematic review2026-01-28OpenAlex10.37349/eds.2026.1008144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125908748
W7125958660Recent Advances in Liver Computed Tomography and Magnetic Resonance Imaging Technologies2026-01-28OpenAlex10.1111/hepr.70130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125958660
W7149232088Towards Societally Aligned Decision-Making for Automated Vehicles: Exploring the Operationalisation of Ethics through Augmented Utilitarianism2026-01-28OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7149232088
W71263983382024 Year-in-Review: Scientific Highlights from Current Pharmaceutical Biotechnology2026-01-29OpenAlex10.2174/0113892010429526251026152322Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126398338
W7126018985Abstract TP088: Decreased axonal outgrowth and dendritic plasticity, and increased synaptic removal in hippocampal and cortical neurons contribute to the long-lasting post-stroke memory dysfunction in old mice2026-01-29OpenAlex10.1161/str.57.suppl_1.tp088Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126018985
W7129219509Advances in Immunotherapy for Breast Cancer2026-01-29OpenAlex10.46883/2026.25921061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129219509
W7133204918Data Resource Profile: Prostate cancer data from Clinical Practice Research Datalink linked hospital records, mortality data and cancer registry standardized to the Observational Medical Outcomes Partnership common data model (CPRD-PCa-OMOP)2026-01-29OpenAlex10.1093/ije/dyag016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133204918
W7128531946Progress and prospects in anti-HER2 targeted therapy for gastric cancer2026-01-29OpenAlex10.1360/csb-2025-5908Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128531946
W7126385037Small Patients, Big Decisions: Unraveling Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation2026-01-29OpenAlex10.5005/jaypee-journals-11011-0078Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126385037
W7126031467The Relationship Between Physician Self-Disclosure and Patient Acquisition in Digital Health Markets: Cross-Sectional Study2026-01-29OpenAlex10.2196/84963Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126031467
W7147614309A Self-Reflective Multi-Agent Physician Recommendation Framework2026-01-30OpenAlex10.1109/cnml68938.2026.11452303Full textIncludedIncluded: Reference-rating errors generate persistent heuristic rules reused on later physician profiles in a primary healthcare recommendation system.https://openalex.org/W7147614309https://ieeexplore.ieee.org/document/11452303
W7126156858Candida Species as Opportunistic Pathogens: Epidemiology, Virulence, Laboratory Diagnosis, and Antifungal Resistance2026-01-30OpenAlex10.22214/ijraset.2026.77025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126156858
W7163387600Human and Artificial Intelligence in Radiology: Current Status,Evidence,Regulation, and Future Perspectives2026-01-30OpenAlex10.48620/98377Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163387600
W7161633310Large Language Models in Medicine: A Review of Technical Evolution, ClinicalApplications, and Future Directions2026-01-30OpenAlex10.1145/3793928.3793947Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161633310
W7126172331Neuroblastoma in Childhood: Biological Insights, Risk Stratification, and Advances in Multimodal Therapy2026-01-30OpenAlex10.3390/jcm15031101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126172331
W7126240250Oceans in Medicine: Advances in Marine-Based Therapeutants for Modern Diseases2026-01-30OpenAlex10.5281/zenodo.18419340Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126240250
W7126243554Revealing the invisible: a new imaging paradigm for α-synuclein pathology in Parkinson's disease2026-01-30OpenAlex10.3389/fradi.2026.1730757Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126243554
W7126429378Bacterial endocarditis and dental infections in the post-COVID-19 era: a review of current concepts2026-01-31OpenAlex10.18203/2394-6040.ijcmph20260332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126429378
W7147678940Ep. 396: From Prozac to Plasticity: The New Science of Depression2026-01-31OpenAlex10.5281/zenodo.19359429Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147678940
W7126447789Evolving roles of drug delivery systems for non-invasive treatment of neovascular age-related macular degeneration: advances and challenges2026-01-31OpenAlex10.1016/j.jddst.2026.108088Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126447789
W7126208117FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF METOPROLOL TARTRATE FOR HYPERTENSION2026-01-31OpenAlex10.5281/zenodo.18440822Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126208117
W7126404972Fowl adenovirus infections: A comprehensive review of prevalence, pathogenesis, diagnosis, control, and economic impact2026-01-31OpenAlex10.1016/j.psj.2026.106565Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126404972
W7126381167Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations2026-01-31OpenAlex10.1016/j.biopha.2026.119020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7126381167
W7128310942Multimodal Conversational AI: From Perceptual Fusion to Collaborative Intelligence2026-01-31OpenAlex10.5281/zenodo.18526062Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128310942
W7126258197Preparing clinical champions for sustainable implementation of practice change within large healthcare systems2026-01-31OpenAlex10.1186/s43058-026-00873-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126258197; https://openalex.org/W7132846121
W7126417770Risk Factor Control in a Portuguese Vascular Risk Clinic: A 16-Month Retrospective Cohort Study2026-01-31OpenAlex10.7759/cureus.102735Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126417770
W7128306880The Next Frontier of AI: Emerging Techniques and Future Trends2026-01-31OpenAlex10.5281/zenodo.18527407Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128306880
W71287730992026-02-01OpenAlex10.1055/s-016-62982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128773099
W7130410046A Chinese Expert Consensus on the Artificial Intelligence Proficiency of Medical Students: Competencies and the Multi‐Modal Assessment2026-02-01OpenAlex10.1002/hcs2.70049Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130410046
W7127053339A review of estrogens used in menopausal hormone therapy2026-02-01OpenAlex10.1097/gco.0000000000001090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127053339
W7128588234Adult‐Onset Still's Disease( AOSD ) With Features Suggestive of Macrophages Activation Syndrome in Young Female: A Rare Case Report From Nepal2026-02-01OpenAlex10.1002/ccr3.72031Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128588234
W7128479733Advancing the frontiers of hepatocellular carcinoma treatment: a comprehensive review of past, ongoing, and future clinical trials2026-02-01OpenAlex10.21037/cco-25-53Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128479733
W7127294876Amiloidosi cardiaca da catene leggere: gestione multidisciplinare e innovazioni terapeutiche. Documento di consenso SIC/ANMCO della Rete Italiana dell’Amiloidosi Cardiaca (RIAC)2026-02-01OpenAlex10.1714/4636.46471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127294876
W7131652312Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping review2026-02-01OpenAlex10.1136/bmjopen-2025-109725Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131652312
W7131618621Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence2026-02-01OpenAlex10.1093/jac/dkag051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131618621
W7126424695Combined Management of an Aspergillus Pleural Empyema in a 47-Year-Old woman2026-02-01OpenAlex10.5281/zenodo.18450168Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7126424695
W7127390356Comprehensive Profiling of Real Life Management and Incidence of Chronic GVHD — a Belgian Retrospective Single Center Study2026-02-01OpenAlex10.1016/j.jtct.2025.12.409Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127390356
W7128243452Current and Ongoing Clinical Studies2026-02-01OpenAlex10.1002/mus.70040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128243452
W7128787815Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report2026-02-01OpenAlex10.2147/idr.s590648Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128787815; https://openalex.org/W7129186894
W7130827549Drug development in systemic sclerosis: novel therapeutics to watch2026-02-01OpenAlex10.1080/1744666x.2026.2636654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130827549
W7128663421Empagliflozin Improves Learning and Memory Deficits in Streptozotocin-Induced Hyperglycemic Male Wistar Rats2026-02-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128663421
W7160792927Fountains of knowledge: middling women and the production, consumption and transmission of natural knowledge, 1760-18102026-02-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160792927
W7138915831From algorithms to clinical execution: A cross-validated knowledge atlas of AI-enabled precision care (2015–2025)2026-02-01OpenAlex10.1177/20552076261436251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138915831
W7171300300Generative AI versus human conversational agent for reducing procrastination: A randomized pilot trial2026-02-01OpenAlex10.1177/20552076261450336Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7171300300
W7128774749Hemophagocytic lymphohistiocytosis: a diagnosis and treatment challenge2026-02-01OpenAlex10.1016/j.amjms.2025.12.664Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128774749
W7212356050How to design digital health interventions with artificial intelligence: A scoping review2026-02-01OpenAlex10.1177/20552076261490346Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212356050
W7128482982IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?2026-02-01OpenAlex10.2147/jir.s540848Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128482982; https://openalex.org/W7128670002
W7141771527Insights into Tanning Biology and Tanning Products.2026-02-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141771527
W7128193423Introduction to the Supplement2026-02-01OpenAlex10.1002/mus.70036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128193423
W7130487128Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives2026-02-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130487128; https://openalex.org/W7129040349
W7127547504Nanoparticles for Advancements in Radiopharmaceutical Technologies2026-02-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127547504
W7127448743Neurologic Complications of Cardiac Disease and Cardiac Procedures2026-02-01OpenAlex10.1212/cont.0000000000001656Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127448743
W7128436143Optimizing the Role of Checkpoint Inhibitors in the Management of Hodgkin Lymphoma2026-02-01OpenAlex10.6004/jnccn.2025.7125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128436143
W7132830591PP042 Personalized therapy sequencing in triple-negative breast cancer using microenvironment-guided reinforcement learning and spatial transcriptomic feedback2026-02-01OpenAlex10.1016/j.esmoop.2025.105960Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7132830591
W7128519376Peri-operative radiotherapy for pancreatic ductal adenocarcinoma: current evidence and future directions: a narrative review2026-02-01OpenAlex10.21037/cco-25-98Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128519376
W7128797021Poster Session II - A312 MATERNAL AND NEONATAL OUTCOMES OF RISANKIZUMAB IN PREGNANT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE SERIES2026-02-01OpenAlex10.1093/jcag/gwaf042.312Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128797021
W7128433983Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders2026-02-01OpenAlex10.2147/dmso.s559587Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128433983; https://openalex.org/W7128662112
W7134168867Samuels, Andrew. Reflecting Critically on the Political Psyche: Therapy, Testament and Trouble in Psychoanalysis and Jungian Analysis. Routledge. 2025. Pp. 242. Pbk. £34.992026-02-01OpenAlex10.1111/1468-5922.70043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134168867
W7130656060Surface-Engineered Precision Nano-Systems for Targeted Treatment of Huntington’s Disease: A Review of Recent Advancements2026-02-01OpenAlex10.2147/ijn.s548892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130656060
W7134987340The 2025 Spychala and Women in Science Awards2026-02-01OpenAlex10.5325/jpennacadscie.97.1-2.0228Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134987340
W7128296012The Evolving Triad of Carbapenem Resistance: Emergence of Dominant CRPA, Persistent CRAB, and Rebounding CRKP in a Chinese Regional Hospital (2020-2024)2026-02-01OpenAlex10.2147/idr.s582544Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128296012
W7127087586Therapy‐Related Acute Myeloid Leukemia Following Plasma Cell Leukemia: A Case Report and Literature Review2026-02-01OpenAlex10.1002/ccr3.71896Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127087586
W7128998897Treatment Strategies for Metastatic Castration‐Sensitive Prostate Cancer: Current Evidence and Future Directions2026-02-01OpenAlex10.1111/iju.70375Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128998897
W7128724167Treatment of Steroid-Refractory Immune Checkpoint-Related Hepatitis With Ruxolitinib2026-02-01OpenAlex10.14309/crj.0000000000002008Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128724167
W7134263057Unveiling the Evolving Landscape of Randomized Clinical Trials in Transplantation: An Analysis of Output and Trends.2026-02-01OpenAlex10.6002/ect.2025.0046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134263057
W7127565156[Applications and Reflections on Virtual Humans in Women's Healthcare].2026-02-01OpenAlex10.6224/jn.26102Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7127565156
W7130369307Antibody-drug conjugates: new drugs – new toxicities2026-02-02OpenAlex10.1097/cco.0000000000001214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130369307
W7127341191Deep Reinforcement Learning-Driven Adaptive Prompting for Robust Medical LLM Evaluation2026-02-02OpenAlex10.3390/app16031514Full textExcludedF3: The acting prompt-selection policy is a DQN MLP over five fixed prompt templates; the LLM is a frozen response generator, without an LLM planning/tool-use acting controller.https://openalex.org/W7127341191https://www.mdpi.com/2076-3417/16/3/1514Publisher indexed full-text Methods §3.4 and experimental setup §§4.5–4.9 read; direct page subsequently returned429
W7127043743Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation2026-02-02OpenAlex10.3389/fimmu.2026.1793019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127043743
W7127121546Exploring the Chemical Space of Cephalosporins Across Generations2026-02-02OpenAlex10.3390/ddc5010012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127121546
W7127114795General Diffusion Transformer for Arbitrary Medical Image Translation2026-02-02OpenAlex10.1109/tfuzz.2026.3659832Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127114795
W7127201676MH8-Trifecta-Unmasked-AI-Psychosis-or-Digital-Delusion-The-Multi-Agent-Reckoning2026-02-02OpenAlex10.5281/zenodo.18459484Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7127201676
W7127050671Micro-/nanorobots in nanomedicine - Guidance, imaging and the integration of AI and robotics2026-02-02OpenAlex10.1016/j.bbrc.2026.153390Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127050671
W7127115283Neuro-Symbolic Architectures for Explainable and Causal Artificial Intelligence2026-02-02OpenAlex10.36227/techrxiv.177006078.81831678/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127115283
W7216897958One-Pot CRISPR-Cas12a Assay for Rapid Pulmonary Tuberculosis Diagnosis from Sputum: A Review2026-02-02OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216897958
W7127126018Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside2026-02-02OpenAlex10.1016/j.ejim.2026.106738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127126018
W7223558891ПРИНЦИПИ ТА ПІДХОДИ ОРГАНІЗАЦІЇ ОСВІТНЬОГО ПРОЦЕСУ В ПІДГОТОВЦІ ВИСОКОКВАЛІФІКОВАНИХ ФАХІВЦІВ У СИСТЕМІ ПДМУ (УМСА): РЕТРОСПЕКТИВНИЙ АНАЛІЗ2026-02-02OpenAlex10.24139/2312-5993/2026.01(2)/351-362Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223558891
W7135779715A prática psicomotora na infância em contexto de clinica privada2026-02-03OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135779715
W7127418191Advancements in Cardiac Xenotransplantation: Overcoming Immunological Barriers Through Genetic Engineering of Porcine Donors, Insights from Initial Human Clinical Cases, and Future Prospects for Addressing the Global Organ Shortage in End-Stage Heart Failure Patients2026-02-03OpenAlex10.5281/zenodo.18474274Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127418191
W7127638838Artificial Intelligence: Foundations, Algorithms, and Applications BY Dr. G. Ravi, Mr. Beemanapalli Ganesh, Mr. Rupavath Ramesh, Ms. Peesari Navya Sree, Mr. Magi Praveen2026-02-03OpenAlex10.5281/zenodo.18478403Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127638838
W7127449088Dental Erosion Management: From Remineralization to Emerging Regenerative Approaches—A Narrative Review2026-02-03OpenAlex10.3390/biomimetics11020107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127449088
W7127086289Editorial: Nanomedicine targeting central nervous system2026-02-03OpenAlex10.3389/fmed.2026.1755137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127086289
W7127327159Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions2026-02-03OpenAlex10.1111/ejh.70129Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127327159
W7127780044GEOMETRY, DYNAMICS, AND THE LANGUAGE OF CANCER2026-02-03OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127780044
W7127313594Intelligent Digital Twins and Ethical Decision-Making Support2026-02-03OpenAlex10.1201/9781003657804-8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7127313594
W7127309238Natural Alkaloids as Antiviral Agents Against RNA Viruses: A Comprehensive and Mechanistic Review2026-02-03OpenAlex10.3390/molecules31030539Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127309238
W7127289760Relevant Therapeutic Approaches to Chronic Renal Failure2026-02-03OpenAlex10.1201/9781779640598-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127289760
W7127624204Biologics in Pediatric Asthma: Controlling Symptoms, Maintaining Safety, and Improving Outcomes2026-02-04OpenAlex10.1007/s11882-026-01252-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127624204
W7128304003Botulinum neurotoxin: Not only in Dermatology - Expanding Therapeutic Horizons Across Medical Specialties2026-02-04OpenAlex10.12775/jehs.2026.87.68236Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128304003
W7127577751Correction: Case Report: Severe gastric atrophy associated with a novel homozygous variant in LRBA2026-02-04OpenAlex10.3389/fped.2026.1760475Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7127577751
W7127640975EMERGING ROLE OF DEXMEDETOMIDINE IN NEUROANESTHESIA: BEYOND SEDATION TO NEUROPROTECTION2026-02-04OpenAlex10.5281/zenodo.18480060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127640975
W7128041549Perfection of Wound Healing to the Rescue of Patients Struggling Against Fatal Diseases Evolving Due to Wound Unhealing2026-02-04OpenAlex10.22259/2638-5074.0601001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128041549
W7127610273The pharmacoeconomic revolution of bioenhancers: Redefining value in drug therapy2026-02-04OpenAlex10.1016/j.nexres.2026.101439Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127610273
W7128033215Third-line treatment decision-making for metastatic colorectal cancer: a cross-sectional survey of US community physicians2026-02-04OpenAlex10.1093/oncolo/oyag018Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128033215
W7127604449Uveitis (Inflammatory, Autoimmune Disease or Infectious Causes)2026-02-04OpenAlex10.1201/9781003606789-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127604449
W7128065959Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists2026-02-05OpenAlex10.3390/ph19020271Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128065959
W7128359093Core Binding Factor AML Beyond Favorable Risk: Molecular Heterogeneity, MRD Dynamics, and Implications for Clinical Decision-Making2026-02-05OpenAlex10.20944/preprints202602.0190.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128359093
W7128016778Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages2026-02-05OpenAlex10.3389/fimmu.2026.1799354Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7128016778
W7131291107Diagnosis, Management and Pathophysiology of Polycystic Ovarian Syndrome2026-02-05OpenAlex10.69613/e52arj05Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131291107
W7127975766Efficacy and safety of trilaciclib to prevent chemotherapy-induced myelosuppression in advanced solid tumors: a systematic review and meta-analysis2026-02-05OpenAlex10.1007/s12094-026-04234-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127975766
W7127903606Opinion: Why paediatric rheumatologists need to understand inborn errors of immunity2026-02-05OpenAlex10.3389/fped.2025.1755761Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127903606
W7127944539Pediatric Use of Compounded GLP-1 Agents: Benefits, Risks, and Equity2026-02-05OpenAlex10.3390/obesities6010010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127944539
W7127932865Pharmacological Management of Heart Failure: A Review of Recent Progress2026-02-05OpenAlex10.1097/cd9.0000000000000187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127932865
W7154610709Policy-Governed Edge Intelligence (PGEI): Trust-Scored Orchestration and Privacy-Aware Distributed AI2026-02-05OpenAlex10.1109/acdsa67686.2026.11468176Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7154610709
W7127886257Predictors of Response and Mechanisms of Resistance to Antibody Drug Conjugates in Urothelial Carcinoma2026-02-05OpenAlex10.3390/curroncol33020103Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127886257
W7127905304Synergistic interactions of ruthenium-based carbon monoxide-releasing molecules and antibiotics in their effects on Escherichia coli2026-02-05OpenAlex10.1099/mic.0.001669Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7127905304
W7128058148The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI2026-02-05OpenAlex10.3389/fmed.2026.1758015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128058148
W7131227484Utilization of Artificial Intelligence in Pharmaceutical Sciences for Teaching, Learning, and Clinical Practice2026-02-05OpenAlex10.69613/dw5jnw67Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131227484
W7128057042A Comprehensive Review on the Role of Renin Angiotensin Aldosterone System Blockade in Chronic Kidney Disease2026-02-06OpenAlex10.5281/zenodo.18505224Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128057042
W7128019631Application of SGLT2 inhibitors in kidney diseases: a bibliometric analysis2026-02-06OpenAlex10.3389/fmed.2026.1768225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128019631
W7128388936Architectural Advances and Performance Benchmarks of Large Language Models in Light of Anthropic’s Claude Opus 4.62026-02-06OpenAlex10.20944/preprints202602.0537.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128388936
W7128069370Clinical and Molecular Perspectives on Epidermodysplasia Verruciformis2026-02-06OpenAlex10.1111/ijd.70295Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128069370
W7128030065Commentary: Immuno-inflammatory signature for predicting therapeutic response and survival after stereotactic radiosurgery in NSCLC patients with brain metastases: a retrospective cohort study2026-02-06OpenAlex10.3389/fimmu.2026.1782399Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128030065
W7127919171From sequencing to understanding: a grand challenge in genome-scale molecular and genetic analysis2026-02-06OpenAlex10.3389/fpls.2026.1782107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127919171
W7127909917Highlighted Research Articles2026-02-06OpenAlex10.1158/2159-8290.cd-16-2-itiTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127909917
W7127895124Letter to Menoeceus2026-02-06OpenAlex10.1093/9780191976605.003.0002Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7127895124
W7127960657Platelet-Rich Plasma as a Pharmacopuncture Agent in Cervical Myofascial Pain2026-02-06OpenAlex10.69951/proceedingsbookoficeonimeri.v9i-.310Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7127960657
W7128172216Real-World Treatment Patterns and Survival in Patients with Advanced Non-Small Cell Lung Cancer: An Italian Retrospective Cohort Study2026-02-06OpenAlex10.3390/cancers18030538Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128172216
W7128168791Site-specific targeting in immunoliposomal nanomedicine for oncology: opportunities and limitations2026-02-06OpenAlex10.1016/j.ejpb.2026.115004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128168791
W7128375030Addressing hallucinations in generative AI agents using observability and dual memory knowledge graphs2026-02-07OpenAlex10.1016/j.knosys.2026.115469Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128375030
W7215618844MYOCARDIAL INFARCTION: EARLY DIAGNOSIS AND MODERN REPERFUSION THERAPY2026-02-07OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215618844; https://openalex.org/W7134048370
W7128309428Pediatric Myocarditis: Challenges in Diagnosis and Treatment2026-02-07OpenAlex10.1007/s40272-026-00739-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128309428
W7128298743Post-pandemic resurgence of Mycoplasma pneumoniae in coastal China: from seasonal waves to sustained transmission and expanded age susceptibility2026-02-07OpenAlex10.1186/s12879-026-12790-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128298743
W7151362015Radiotherapy in the Management of Bone Metastases: An Updated Review of Current Evidence2026-02-07OpenAlex10.64978/jcrrm-0119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151362015
W7220521318Reinserção social de pacientes psiquiátricos na sociedade: um relato de experiência2026-02-07OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220521318
W7133318760Simultaneous or sequential treatment of IgA nephropathy - specific disease drivers and non-specific consequences of nephron loss?2026-02-07OpenAlex10.1093/ckj/sfag035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133318760
W7128390987Antibiotic Prescribing Patterns in Hospitalized Pediatric Patients With Clinically Suspected Enteric Fever: A Descriptive Study2026-02-08OpenAlex10.7759/cureus.103186Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128390987
W7128359540Dental composites: a comprehensive review on formulation, properties and recent developments2026-02-08OpenAlex10.1002/pi.70085Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128359540
W7155514051Augmanitai Lexicon V1 by Andreas Ehstand2026-02-09OpenAlex10.5281/zenodo.18542367Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155514051
W7128427968Editorial: Perspectives in molecular viral pathogenesis2026-02-09OpenAlex10.3389/fcimb.2026.1797985Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128427968
W7147044888Ep. 552: Is Your Therapist Just a $200 a Week Habit?2026-02-09OpenAlex10.5281/zenodo.19360172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147044888
W7128399132Integrating clinical data into evidence-based practice: institutional guideline development for diabetic foot infections2026-02-09OpenAlex10.3389/fendo.2026.1752211Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128399132
W7128489846Paper 43: The Intrapersonal Trap — Self-Coercion, Structural Resistance, and the Impossibility of Willpower-Driven Change: A Zero Leap Theory Analysis of Intrapersonal Intervention Dynamics2026-02-09OpenAlex10.5281/zenodo.18564513Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128489846
W7128354135Talent Development through Professional Assessment2026-02-09OpenAlex10.17605/osf.io/hctp9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128354135
W7128476462Analysis of bladder cancer therapeutic drug clinical trials in mainland China and globally2026-02-10OpenAlex10.1016/j.bbcan.2026.189558Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128476462
W7128523973Antibacterial and Bioregenerative Nanomaterials in Oral Health: From Material Design to Clinical Translation and Technological Trends2026-02-10OpenAlex10.3390/jfb17020087Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128523973
W7128548038Artificial intelligence agents in healthcare research: A scoping review2026-02-10OpenAlex10.1371/journal.pone.0342182Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7128548038
W7128488254Biopolymeric advances: The evolving role of alginates as wound dressing carrier2026-02-10OpenAlex10.1177/08839115261418047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128488254
W7128473216CBRNE events: prevention, mitigation, consequences and recovery2026-02-10OpenAlex10.1140/epjp/s13360-026-07405-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128473216
W7128537918Cellular strategies for repairing trapped protein-DNA complexes2026-02-10OpenAlex10.3389/fphar.2026.1716415Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128537918
W7128522448Editorial: Innovative strategies and advancements in phototherapy for enhanced cancer treatment2026-02-10OpenAlex10.3389/fmed.2026.1789533Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128522448
W7165522972From Lines to Layers: The transformative journey of architectural drawings toward sustainable and innovative detailing2026-02-10OpenAlex10.1109/icsedi66420.2026.11568303Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165522972
W7165552545Large Language Models for Smart Grids and Renewable Energy: Emerging Directions2026-02-10OpenAlex10.1109/icsedi66420.2026.11568282Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165552545
W7128475692Molecular Characterization of Drug Resistance-Associated Mutations in Mycobacterium tuberculosis Isolates from the Republic of Congo Using Targeted Nanopore Sequencing2026-02-10OpenAlex10.3390/zoonoticdis6010005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128475692
W7128545005Psychosomatics at the threshold: cancer, mood disorders, and the mental pain of death — where precision medicine meets spirituality2026-02-10OpenAlex10.3389/fpsyt.2026.1751310Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128545005
W7148184648Sağlık Turizminden Sağlık Diasporası Diplomasisine: Yükselen Ekonomilerde Yurtdışı Sağlık Ağlarını Stratejik Olarak Kullanma Çerçevesi2026-02-10OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148184648
W7131095097The Autonomous Data Enterprise: Engineering Real-Time Intelligence with Generative and Agentic AI2026-02-10OpenAlex10.70593/978-93-7185-592-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131095097
W7128483354The efficacy of hepatoprotective agents in the treatment of non-alcoholic fatty liver disease: metabolic effects and impact on liver fat content2026-02-10OpenAlex10.17116/profmed20262901186Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128483354
W7128536528Transforming Knowledge Management with AI: Leveraging Retrieval-Augmented Generation (RAG) in Business Strategy2026-02-10OpenAlex10.1108/978-1-80592-391-620261008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128536528
W7128641776Agent-based modeling of cellular dynamics in adoptive cell therapy2026-02-11OpenAlex10.1038/s42003-026-09653-4Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7128641776
W7128600058Anti-VEGF safety in evolution: A comprehensive review of ocular and systemic considerations2026-02-11OpenAlex10.4103/ijo.ijo_3284_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128600058
W7128476727Beyond cytokine blockade: could CAR-Tregs open a new era of tissue-targeted immune tolerance in psoriatic arthritis?2026-02-11OpenAlex10.3389/fimmu.2026.1772369Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128476727
W7128598388Evolving Therapeutic Algorithms in Chronic Myeloid Leukemia: Integrating Efficacy, Safety, and Survivorship2026-02-11OpenAlex10.3390/biomedicines14020408Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128598388
W7128590384Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence2026-02-11OpenAlex10.3390/healthcare14040457Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128590384
W7128593730Pain Management in Italian Elite Athletes: Trends in the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Glucocorticoids, and Narcotics in Anti-Doping Reports (2013–2023)2026-02-11OpenAlex10.3390/ph19020298Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128593730
W7128647727THE CENTRIST EXTREMIST: Prosecutorial Frame and the Terminal Phase of the Post-Political DOI: 10.5281/zenodo.18604046 — Crimson Hexagon Archive2026-02-11OpenAlex10.5281/zenodo.18604045Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128647727
W7128538613The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management2026-02-11OpenAlex10.3389/fendo.2026.1777334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128538613
W7131112628The Unseen Culling2026-02-11OpenAlex10.5281/zenodo.18737190Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131112628
W7128479165Ultrasound-responsive microbubbles in refractory infection niches: multi-front targeting of microenvironmental tolerance and local delivery of toxicity-limited antibiotics2026-02-11OpenAlex10.3389/fcimb.2026.1756357Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128479165
W7131704779Another brick in the wall of severe hypertriglyceridaemia lowering2026-02-12OpenAlex10.1093/eurheartj/ehag124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131704779
W7130581841Artificial Intelligence and Machine Learning by V. Elavenil, G. Suresh Kumar, Jayachandran P., J. Fahamitha2026-02-12OpenAlex10.5281/zenodo.18690750Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130581841
W7128732315CREST-2: Early reflections on the primary results2026-02-12OpenAlex10.1053/j.semvascsurg.2026.02.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128732315
W7128739536Correction: Editorial: Unveiling the next generation of cancer immunity & immunotherapy2026-02-12OpenAlex10.3389/fimmu.2026.1784505Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7128739536
W7128766270Differentiable Modal Logic for Multi-Agent Diagnosis, Orchestration and Communication2026-02-12OpenAlex2602.1208310.48550/arxiv.2602.12083Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7128766270
W7128803998Emerging Agent Communication Protocols for Healthcare AI Systems: A Scoping Review of Model Context Protocol (MCP) and Agent-to-Agent (A2A) Frameworks (Preprint)2026-02-12OpenAlex10.2196/preprints.93344Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7128803998
W7128625717Evolving strategies for local drug delivery in peripheral arteries2026-02-12OpenAlex10.1016/j.jddst.2026.108115Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128625717
W7128685553Exploring treatment models for oligometastatic castration-sensitive prostate cancer: evolution of therapeutic strategies2026-02-12OpenAlex10.3389/fonc.2026.1778687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128685553
W7128923158Friction in Games and Computational Media (Editorial)2026-02-12OpenAlex10.34624/jdmi.v8i20.42275Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128923158
W7128680526Melphalan in the biologic era: A 70-year story in hematological malignancies and its legacy, evolution, and future2026-02-12OpenAlex10.25259/jhas_74_2025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128680526
W7128721139Peptides for tooth remineralization: A scoping review of current research, design strategies, and clinical applications2026-02-12OpenAlex10.1016/j.mtadv.2026.100713Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128721139
W7128682194Remdesivir in COVID-19: pros and cons2026-02-12OpenAlex10.3389/fphar.2026.1731244Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128682194
W7128692132Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives2026-02-12OpenAlex10.1097/fjc.0000000000001794Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128692132
W7128782277Alzheimer’s Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges2026-02-13OpenAlex10.1021/acs.jmedchem.5c02468Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128782277
W7129548193Automated Grading as Faculty Judgment at Scale2026-02-13OpenAlex10.1097/01.nep.0000000000001511Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129548193
W7128736155Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers2026-02-13OpenAlex10.1016/j.critrevonc.2026.105207Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128736155
W7128786334Deception as Bias-Injection Dynamics near Viability Boundaries: A Lyapunov and Alignness Characterization2026-02-13OpenAlex10.5281/zenodo.18627986Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7128786334
W7128907021Discordance Between Textual Reasoning and Visual Interpretation in Large Language Models for Low Back Pain: Mixed-Methods Evaluation of Safety Risks (Preprint)2026-02-13OpenAlex10.2196/preprints.93522Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128907021
W7128849664Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy2026-02-13OpenAlex10.3390/cancers18040618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128849664
W7128774971From Liposomes to Depot-Enabled Lipid-Gel Hybrid Nanocarriers: Evolving Strategies for Targeted and Sustained Anticancer Drug Delivery2026-02-13OpenAlex10.5281/zenodo.18629158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128774971
W7128808243Generative and Agentic Artificial Intelligence for Medical Coding and Billing: A Human-in-the-Loop Architecture and Evaluation2026-02-13OpenAlex10.21203/rs.3.rs-8863592/v1Full textExcludedF7: The report does not identify sample size, model or dataset and gives no numerical evaluation; Table1 contains qualitative comparisons only. Previously included; author-approved revision5November2026.https://openalex.org/W7128808243https://doi.org/10.21203/rs.3.rs-8863592/v1
W7128789857Heart transplantation in pediatric oncology patients2026-02-13OpenAlex10.1016/j.jhlto.2026.100514Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128789857
W7128775060PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 222026-02-13OpenAlex10.4995/fortmed2026.2026.21472Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128775060
W7128783700PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 232026-02-13OpenAlex10.4995/fortmed2026.2026.21473Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128783700
W7128815999PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 242026-02-13OpenAlex10.4995/fortmed2026.2026.21474Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128815999
W7128678420PROGRESS AND MECHANISMS OF ANTIBODY-DRUG CONJUGATES IN NSCLC THERAPY2026-02-13OpenAlex10.61784/jpmr3064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128678420
W7128738319Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes2026-02-13OpenAlex10.1016/j.ijantimicag.2026.107745Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7128738319
W7131633779An Agentic AI Model for MRI-Based Staging and Grading of Endometrial Cancer using MedSAM and ViT2026-02-14OpenAlex10.14445/22315381/ijett-v74i2p109Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7131633779
W7128919836Disease-Modifying Therapies in Transthyretin Amyloid Cardiomyopathy: What Have We Achieved?2026-02-14OpenAlex10.1016/j.cardfail.2026.01.011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128919836
W7128777518Evolving trends in skin lightening: Emerging agents, social media, and public health response2026-02-14OpenAlex10.1016/j.jaad.2026.02.027Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7128777518
W7129047610Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy2026-02-15OpenAlex10.1002/phar.70119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129047610
W7128957236Non-Operative, Micro- and Minimally Invasive Methods for Caries Treatment—A Narrative Review2026-02-15OpenAlex10.3390/jcm15041534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128957236
W7128957281Ocular inflammation after intraocular drug delivery: Mechanisms, risk factors, and implications for clinical practice2026-02-15OpenAlex10.1016/j.survophthal.2026.02.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128957281; https://openalex.org/W7131089467
W7132822359RECENT PROGRESS IN CARDIOVASCULAR DRUGS: PHARMACOLOGICAL INNOVATIONS IN HYPERTENSION, HEART FAILURE, AND DYSLIPIDEMIA2026-02-15OpenAlex10.5281/zenodo.18815252Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132822359
W7128957385The Sterile Wound: Reconceptualizing Social Anxiety as an Anticipatory Immune Response2026-02-15OpenAlex10.5281/zenodo.18646330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7128957385
W7154717392medical deposit part 22026-02-15OpenAlex10.5281/zenodo.19630773Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154717392
W7129062121A Severe Case of Drug Reaction with Eosinophilia and Systemic Symptoms After Sequential Cephalosporin and Vancomycin Exposure2026-02-16OpenAlex10.9734/ijmpcr/2026/v19i1479Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129062121
W7129107200Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights, and Evolving Treatment Paradigms2026-02-16OpenAlex10.3390/lymphatics4010011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129107200
W7129098634Dynamic target-aware multi-objective reinforcement clustering for intelligent fault diagnosis2026-02-16OpenAlex10.1016/j.ymssp.2026.114014Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7129098634
W7129197415Experts' Opinion on Decontamination and Antidote Strategies: Complementing Contemporary Expert Consensus and Evidence to Optimize Preparedness and Response to CBRN Threats in the Middle East and North Africa2026-02-16OpenAlex10.1111/1468-5973.70128Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129197415
W7129031451Immunopathogenesis of multiple sclerosis – mechanisms of autoimmunity, neuroinflammation and strategies of treatment2026-02-16OpenAlex10.26444/jpccr/217936Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129031451
W7129046006Mapping the molecular landscape of glioblastoma: Pathogenesis, therapeutic targets and bioactive interventions2026-02-16OpenAlex10.1016/j.critrevonc.2026.105206Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129046006
W7129039193Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance2026-02-16OpenAlex10.1002/path.70041Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129039193
W7129043983Selective Serine Substitutions of Antimicrobial Peptides Reveal Different Mechanistic Actions Toward Gram-Negative Bacteria2026-02-16OpenAlex10.1021/acsami.5c22475Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129043983
W7129038885TRADITIONAL AYURVEDIC SKINCARE FORMULATIONS IN MODERN COSMECEUTICAL SCIENCE: A COMPREHENSIVE REVIEW2026-02-16OpenAlex10.5281/zenodo.18657912Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129038885
W7129026418Towards response-adapted neoadjuvant breast cancer treatment2026-02-16OpenAlex10.1016/s1470-2045(25)00767-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129026418
W7129106081What is the best treatment for prostate cancer T3 N1 M1a with 4 lymph node metastases?2026-02-16OpenAlex10.5281/zenodo.18657105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129106081
W7129413144Abstract PS1-10-12: Impact of Glucagon-like peptide-1 receptor agonists Use on Survival and Metabolic Outcomes in Metastatic Estrogen Receptor Positive Breast Cancer: A Real-World Cohort Study2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps1-10-12Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129413144
W7129630984Abstract PS1-11-18: Prescription Patterns and Treatment Persistence in Patients with Metastatic Breast Cancer on CDK4/6 Inhibitors2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps1-11-18Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129630984
W7129621512Abstract PS1-12-13: Real-world rate of switching and reasons for switching among CDK4/6i drugs among first-line metastatic HR+/HER2- breast cancer patients2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps1-12-13Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129621512
W7129421681Abstract PS2-03-26: Lymphatic-sparing sentinel lymph node biopsy to prevent breast cancer-related lymphedema2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps2-03-26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129421681
W7130711426Abstract PS3-04-10: Development and Validation of a Living Decision Support Tool (Living-DST) in Oncology Using Agentic AI-Augmented Systematic Literature Review (SLR)2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps3-04-10Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7130711426
W7129536000Abstract PS3-09-26: Real-world clinical characteristics, treatment patterns and outcomes among UK and French patients with early-stage, estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer treated with neoadjuvant chemotherapy2026-02-17OpenAlex10.1158/1557-3265.sabcs25-ps3-09-26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7129536000
W7129368958Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape2026-02-17OpenAlex10.3389/fmicb.2026.1769519Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129368958
W7129515225Editorial: Regulation and mechanism of plant metabolites on hyperuricemia2026-02-17OpenAlex10.3389/fnut.2026.1800834Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129515225
W7129524015Extracellular Vesicle Analysis: Recent Technological Advances and Emerging Opportunities2026-02-17OpenAlex10.1146/annurev-anchem-070325-084902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129524015
W7129419383HLA Type and the Effect of HLA Antibodies in Kidney, Liver, and Pancreas Transplantation: A Review2026-02-17OpenAlex10.18502/ajmb.v18i1.21042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129419383
W7129037863Systematic Review of Immunosuppression After Chimeric Antigen Receptor T-Cell Therapy for Posttransplant Lymphoproliferative Disorder2026-02-17OpenAlex10.1016/j.ekir.2026.106367Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129037863
W7130345541A Self-Evolving AI Agent System Accelerating the Understanding of Climate Change and Variability2026-02-18OpenAlex10.21203/rs.3.rs-8630394/v1Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7130345541
W7130312626Editorial: Residual cardiovascular risk in diabetes: current state and future perspectives2026-02-18OpenAlex10.3389/fcdhc.2026.1774240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130312626
W7130366150Genetic Predisposition to MASLD: Potential for Therapeutic Management2026-02-18OpenAlex10.3390/ijms27041933Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130366150
W7130655229Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries2026-02-18OpenAlex10.1097/med.0000000000000955Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7130655229
W7130409154Innovations in Cutaneous Oncology and Dermatologic Surgery: From Margin Control to Integrated Precision Oncology2026-02-18OpenAlex10.3390/cancers18040670Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130409154
W7130316800Management of Acute Myeloid Leukemia: A Review2026-02-18OpenAlex10.3390/cancers18040659Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130316800
W7130310193Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study2026-02-18OpenAlex10.1182/bloodadvances.2025018455Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130310193
W7129338271SOHO State of the Art Updates and Next Questions | Sequencing Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence, Challenges, and Opportunities for Cure2026-02-18OpenAlex10.1016/j.clml.2026.02.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7129338271
W7130377589The Future of AI in Orthopaedics: Boon or Bust?2026-02-18OpenAlex10.2106/jbjs.25.01514Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130377589
W7130421910Toward a Functional and Conceptual Framework for Adhesive Materials: The Role of Etching Technique2026-02-18OpenAlex10.3390/dj14020119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130421910
W71305459974. Phthisiatry and Contemporary Tuberculosis Medicine: A Comprehensive Review of Diagnostic Advances, Treatment Paradigms, and Global Health Challenges2026-02-19OpenAlex10.5281/zenodo.18690001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130545997
W7130507201Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment2026-02-19OpenAlex10.3389/fonc.2026.1735300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130507201
W7134942499Daratumumab in the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Experience from the Clinical Hematology Department of Avicenne Military Hospital, Marrakech2026-02-19OpenAlex10.36347/sasjm.2026.v12i02.010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134942499
W7130582521Invasive and medical management approaches to non-acute myocardial ischaemic syndromes2026-02-19OpenAlex10.1038/s41569-026-01259-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130582521
W7130524108Knowledge, Attitude and Acceptance of Autologous Stem Cell Transplantation amongst Patients with Multiple Myeloma in Nigeria2026-02-19OpenAlex10.9734/ijr2h/2026/v9i1213Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130524108
W7130596602Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges2026-02-19OpenAlex10.1021/acs.analchem.5c06531Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130596602
W7170077590Prevalence of Salmonella Enterica Subspecies Enterica Serovar Typhi in Hospital Landfill: An Environmental Cross Sectional Study2026-02-19OpenAlex10.71637/tnhj.v26i2.1347Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170077590
W7133545206Surgical management of small intestinal neuroendocrine tumours2026-02-19OpenAlex10.1093/bjs/znag016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133545206
W7130597527THE GOTHIC MEDICAL SPACE IN MIKHAIL BULGAKOV'S A COUNTRY DOCTOR'S NOTEBOOK ANATOMISING TERROR: MEDICAL PRACTICE, MORPHINE ADDICTION, AND THE COLLAPSE OF ENLIGHTENMENT RATIONALITY IN REVOLUTIONARY RUSSIA2026-02-19OpenAlex10.5281/zenodo.18697173Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7130597527
W7130512681Within-host evolution drives the emergence of ceftazidime-avibactam resistance mediated by IncN plasmid-encoded bla NDM-1 and bla KPC-33 in ST11-KL64 hypervirulent Klebsiella pneumoniae2026-02-19OpenAlex10.1128/spectrum.02367-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130512681
W7130677393Agentic AI System for Stress Monitoring: A Multi-agent Healthcare Crew2026-02-20OpenAlex10.1007/s44196-026-01215-0Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7130677393
W7130652035Analysis of Patch Testing for Allergic Contact Dermatitis in Adults Versus Geriatrics: A 7-Year Retrospective Analysis of 342 Positive Patch Test Cases2026-02-20OpenAlex10.4103/ijd.ijd_834_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130652035
W7130643022Composable Governance for a Continuously Evolving Enterprise2026-02-20OpenAlex10.1201/9781003646525-16Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130643022
W7130819172DNA-damaging combination treatments impose genotype-specific constraints on hypermutator evolvability2026-02-20OpenAlex10.64898/2026.02.20.706947Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130819172
W7130643207Editorial: Use of radiation therapy for hematological malignancies2026-02-20OpenAlex10.3389/fonc.2026.1781001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130643207
W7130655760Fluid Therapy Along the Emergency Medicine–Critical Care Continuum: From Resuscitation to Precision Stewardship2026-02-20OpenAlex10.1007/s42399-026-02268-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130655760
W7130676632Joint pain and menopause2026-02-20OpenAlex10.1097/gme.0000000000002756Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130676632
W7130645472Melanoma: from early detection to therapeutic decision-making2026-02-20OpenAlex10.5604/01.3001.0055.6445Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130645472
W7131231465Navigating bladder preservation in Bacillus Calmette–Guérin-unresponsive disease: how much risk is too much?2026-02-20OpenAlex10.1097/mou.0000000000001371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131231465
W7130681751Pericoronary adipose tissue imaging: quantitative assessment, artificial intelligence integration, and therapeutic modulation2026-02-20OpenAlex10.1093/bjr/tqag040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130681751
W7130642153Temporomandibular joint arthrocentesis: global research trends in a comprehensive bibliometric analysis (1989–2025)2026-02-20OpenAlex10.1080/08869634.2026.2632944Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130642153
W7130642909The evolving science of Clesrovimab: pharmacological insights and clinical implications2026-02-20OpenAlex10.4081/jbr.2026.14042Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7130642909
W7130926605Development of New Drug Against Multidrug-Resistant Candidozyma (Candida) auris by Mining the Genome of Marine Bacteria Vibrio sp. IRMCESH58L2026-02-21OpenAlex10.3390/pharmaceutics18020266Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7130926605
W7130858835From Surge to Stability: Navigating MPOX Epidemics Across the Globe With Genomic Insights, Paving the Way for Effective Management Plan2026-02-21OpenAlex10.1002/rmv.70112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130858835
W7131314869From stenosis to atheroma: repositioning lipoprotein(a) in coronary artery disease risk assessment2026-02-21OpenAlex10.1093/ehjci/jeag046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131314869
W7130740608Gas entrapping materials for damage control2026-02-21OpenAlex10.1016/j.addr.2026.115813Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130740608
W7220149499PERSONALITY TYPOLOGIES OF MODERN SCHOOL TEACHERS AND THEIR PEDAGOGICAL IMPLICATIONS2026-02-21OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220149499
W7130828519TRPV1 Receptor Modulators: Emerging Therapies for Neuropathic, Osteoarthritic, and Perioperative Pain2026-02-21OpenAlex10.1007/s40263-026-01272-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130828519
W7130854433Targeted and Immunotherapeutic Approaches in Cancer: A Narrative Review of Evolving Evidence and Clinical Implications2026-02-21OpenAlex10.9734/irjo/2026/v9i1193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130854433
W7130923412Landscape of diabetic kidney disease drug clinical trials in China (2013–2023): global implications for innovation and policy2026-02-22OpenAlex10.1080/0886022x.2026.2629639Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7130923412; https://openalex.org/W7131096902
W7130952431NeuroEconomics 5.0: Decision-Making in the Age of Synthetic Intelligence2026-02-22OpenAlex10.17605/osf.io/d5hygTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7130952431
W7131648067Artificial Intelligence and machine learning by hamma shabnam Nasim, Md Riyaz Ansari2026-02-23OpenAlex10.5281/zenodo.18780674Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131648067
W7132814921Artificial Intelligence–Optimized Nano-Level Surface Enhancement of Biomedical Zirconium Alloys Using Magnetic Abrasive Finishing Process2026-02-23OpenAlex10.5281/zenodo.18811009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7132814921
W7131104014Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches2026-02-23OpenAlex10.3389/fneur.2026.1784512Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131104014
W7134044251Human skin tattoed with a soldier, badge and anchor, France, Wellcome Foundation L00570382026-02-23OpenAlex10.5281/zenodo.18742123Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7134044251
W7131126838Modern pharmacotherapy of obesity: molecular mechanisms, clinical efficacy and future therapeutic directions2026-02-23OpenAlex10.18203/2319-2003.ijbcp20260443Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131126838
W7131164133Points to consider in designing and conducting astigmatism research in cataract surgery2026-02-23OpenAlex10.3389/fopht.2026.1789801Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131164133
W7131078258ROLE OF CENTRALIZED BMS IN ENHANCING OPERATIONAL EFFICIENCY IN SMART MALLS AND HOTELS2026-02-23OpenAlex10.18623/rvd.v23.n4.4852Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131078258
W7131082492TRANSITION FROM OPPURTUNISTIC PATHOGEN TO MULTIDRUG RESISTANT STENOTROPHOMONAS MALTOPHILIA: A CALL FOR EMERGING THERAPEUTIC STRATEGIES2026-02-23OpenAlex10.53550/ajmbes.2026.v28.i01-02.018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131082492
W7135219828A comprehensive clinical and microbiological profile of culture-positive urinary episodes in children with acute lymphoblastic leukemiaurinary leukemia2026-02-24OpenAlex10.12956/tjpd.2025.1267Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135219828
W7131212783An expedition on paper-based microfluidic point-of-care testing devices for the detection of infectious diseases2026-02-24OpenAlex10.1016/j.trac.2026.118770Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131212783
W7131227659Editorial: Artificial intelligence applications in chronic ocular diseases, volume II2026-02-24OpenAlex10.3389/fcell.2026.1762437Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131227659
W7131311023Editorial: Exploration of the role of heme proteins in biology with experimental and computational methods2026-02-24OpenAlex10.3389/fchem.2026.1810989Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131311023
W7131226804Engineering stimuli-responsive dendrimers for drug delivery: A 15-year review of formulation strategies and routes of administration2026-02-24OpenAlex10.1016/j.onano.2026.100292Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131226804
W7131212234Fractional Microneedling Radiofrequency for Hidradenitis Suppurativa: A Real‐World Retrospective Study Demonstrating Clinical Efficacy and Safety Across Diverse Anatomical Sites2026-02-24OpenAlex10.1111/jocd.70748Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131212234
W7131428201Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management?2026-02-24OpenAlex10.1111/apt.70591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131428201
W7131407431Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply2026-02-24OpenAlex10.1111/apt.70599Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131407431
W7135018188Pharmacotherapeutic Agents in Diabetes Mellitus: A Narrative Review2026-02-24OpenAlex10.5530/jppcm.20260649Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7135018188
W7140036346Targeted Therapy in Oncology: Pharmacological Advances and Clinical Challenges2026-02-24OpenAlex10.61096/ijamscr.v14.iss1.2026.199-208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140036346
W7131293014The Evolving Landscape of Advanced Therapies in Inflammatory Bowel Disease: Current Evidence and Emerging Targets2026-02-24OpenAlex10.3390/gidisord8010013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131293014
W7131282980The MH8‑AI‑AGENT‑ABE System: The First Public Recursive‑Reasoning Audit Agent with Cryptographic Identity2026-02-24OpenAlex10.5281/zenodo.18750876Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7131282980
W7133216384Approaching Conversations About Cannabis Use with Patients & Caregivers2026-02-25OpenAlex10.1097/01.cot.0000000000000330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133216384
W7131832080Artificial Intelligence and Machine Learning BY Laxminarayana Thirupathi2026-02-25OpenAlex10.5281/zenodo.18798118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131832080
W7131415763Digital Twin Frameworks for AI-Driven Wind Turbine Monitoring and Predictive Maintenance2026-02-25OpenAlex10.4018/979-8-3373-4159-0.ch007Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131415763
W7131363512Editorial: Advances in intelligence or nanomedicine-based theranostics for cancers2026-02-25OpenAlex10.3389/fonc.2026.1786982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131363512
W7146966200Ep. 848: Do Algorithms Deserve Rights? The Gemini 3.5 Debate2026-02-25OpenAlex10.5281/zenodo.19361464Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7146966200
W7131366588Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997–2026)2026-02-25OpenAlex10.1097/cm9.0000000000004016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131366588
W7134185721From the Editors2026-02-25OpenAlex10.1111/puar.70104Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134185721
W7131354966Modulation of macrophage survival during Klebsiella pneumoniae infections2026-02-25OpenAlex10.3389/fcimb.2026.1757662Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131354966
W7131453142Navigating the complex landscape of duodenal gastrointestinal stromal tumor: Innovations in diagnosis and treatment2026-02-25OpenAlex10.1016/j.critrevonc.2026.105227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131453142
W7220282684Biological agents in rheumatology: advantages, limitations, and safety profile of molecularly targeted therapy2026-02-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220282684
W7131726775Can social robots improve the hospital experience of children?2026-02-26OpenAlex10.3389/fresc.2026.1691526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131726775
W7131625945Efficacy of single-dose compared with split-dose low-volume polyethylene glycol for colonoscopy preparation: a randomized controlled trial2026-02-26OpenAlex10.18203/2320-6012.ijrms20260636Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131625945
W7131877691Emerging Treatment Options in ATTR-CM: Near-Complete TTR Silencers and Amyloid Depleters2026-02-26OpenAlex10.1093/eurheartjsupp/suag054Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131877691
W7152635835From Data to Decision: An AI-Powered Sustainment Platform Enabling Predictive Readiness Across the USV Fleet2026-02-26OpenAlex10.48448/2edj-yh48Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7152635835
W7131712687Pediatric Vernal Keratoconjunctivitis (VKC): Current State and Future Directions—A Narrative Review of Clinical Features, Diagnostic Strategies, and Emerging Therapies2026-02-26OpenAlex10.3390/children13030335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131712687
W7131642274RAS blockade in chronic kidney disease: Current evidence and future directions2026-02-26OpenAlex10.1007/s00210-026-05140-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131642274
W7131902959Reconsidering antiviral prophylaxis in HBsAg-negative, anti–HBc-positive patients treated with rituximab2026-02-26OpenAlex10.1097/hc9.0000000000000903Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131902959
W7131664618Regulatory Stipulations and Scientific Underpinnings for Inhaled Biologics for Local Action in the Respiratory Tract—Part I: Development of Inhaled Therapeutic Protein Products2026-02-26OpenAlex10.3390/biochem6010006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131664618
W7131617015Adjuvant and neoadjuvant treatment for melanoma: integrating immunotherapy, radiation and systemic therapies into surgical practice2026-02-27OpenAlex10.1016/j.otot.2026.02.015Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7131617015
W7131838122Local Hemostasis as the Critical Enabler for Safe Antithrombotic Therapy in Dentistry—Navigating Future Frontiers and Innovative Concepts2026-02-27OpenAlex10.3390/jcm15051823Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131838122
W7131819664Modeling endovascular embolization for cerebral arteriovenous malformations: A review from lumped parameters models to patient-specific CFD2026-02-27OpenAlex10.1063/5.0307486Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131819664
W7131857959NITROGLYCERINE IN CONTEMPORARY CARDIOVASCULAR THERAPEUTICS: MOLECULAR MECHANISMS, CLINICAL APPLICATIONS, AND FUTURE PERSPECTIVES2026-02-27OpenAlex10.64751/ijpams.2026.v6.n1.pp49-62Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131857959
W7131623216Outbreaks of human respiratory syncytial virus in wild gorillas highlight the importance of prevention measures and integrated surveillance for risk mitigation2026-02-27OpenAlex10.1016/j.onehlt.2026.101376Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7131623216
W7132850547PENTLLM: A Pentagon-Based Multi-Expert Large Language Model Architecture for Medical Research Applications2026-02-27OpenAlex10.5281/zenodo.18807749Full textExcludedF2: The primary demonstrated activities are academic research/office work, peer review, proposals and documents; clinical RAG is one component rather than the primary clinical task.https://openalex.org/W7132850547https://doi.org/10.5281/zenodo.18807749Complete archived abstract only; Zenodo primary page inaccessible
W7154914867Psychotropicā Neuroscience: Structural elements and samples2026-02-27OpenAlex10.5281/zenodo.19647344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154914867
W7131861348Refining the Approach to Xenograft Rejection2026-02-27OpenAlex10.1097/tp.0000000000005672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131861348
W7133331761Rituximab as monotherapy and in combination with methotrexate or leflunomide in rheumatoid arthritis: a prospective cohort study in a Peruvian hospital2026-02-27OpenAlex10.5114/reum/213648Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133331761
W7132822023The Care and Cure of the Leukemias in 20262026-02-27OpenAlex10.1002/ajh.70247Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132822023
W7131794011Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical Practice2026-02-27OpenAlex10.1007/s11883-026-01400-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7131794011
W7131825162Weaponizing EHRs to Close that Diagnosis Gap - Coupling Agentic AI with EHRs for Earlier, More Equitable Diagnosis with Minority Estrogenopathies2026-02-27OpenAlex10.20944/preprints202602.1918.v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7131825162
W7132847160A Review of Multi-Agent AI Systems for Biological and Clinical Data Analysis2026-02-28OpenAlex10.3390/mps9020033Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7132847160
W7132843617Agentic AI–Driven Quality Engineering: A Global Innovation Framework for Autonomous Enterprise Decision Validation2026-02-28OpenAlex10.63412/98h64d16Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7132843617
W7135076923Agenticness of Artificial Intelligence in the Fashion Industry : A Case Study Based on a Conceptual Expansion Structure2026-02-28OpenAlex10.7233/jksc.2026.76.1.071Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7135076923
W7132856633CDAFlow: Enhancing LLM clinical decision-making through agentic workflow2026-02-28OpenAlex10.1016/j.eswa.2026.131806Full textExcludedF4: FSM state transitions and at most two reflections per state concern the current patient. Long-term memory stores fixed Text2DT rules and MedDM paths, with cached conversion of external rule texts; short-term memory stores current-patient decisions. No experience-derived update is retained for later different cases.https://openalex.org/W7132856633https://www.sciencedirect.com/science/article/pii/S0957417426007190Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online.
W7132817948Current evidence on non-surgical therapies for Dupuytren's disease: A clinical review2026-02-28OpenAlex10.1016/j.jham.2026.100444Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132817948
W7133145080DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions2026-02-28OpenAlex10.1080/17501911.2026.2637418Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133145080; https://openalex.org/W7132845020
W7133244661Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR2026-02-28OpenAlex10.1093/ckj/sfag069Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133244661
W7134180767Harnessing genomic profiling for precision breast cancer therapies: Advances in HER2-targeted treatments, PARP inhibitors for BRCA mutations, and insights from clinical trials2026-02-28OpenAlex10.15419/v1dhqx66Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134180767
W7132841964Impacts of Liposomes and Their Application in Cancer Therapy2026-02-28OpenAlex10.38124/ijisrt/26feb815Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132841964
W7132819146Implementing Shared Decision‐Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi‐Stakeholder Delphi Process2026-02-28OpenAlex10.1111/hae.70220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132819146
W7132857811Liposomal nanocarriers in precision oncology: Advances and prospects2026-02-28OpenAlex10.1016/j.critrevonc.2026.105236Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132857811
W7132839434Nanoparticle-Mediated Delivery of MicroRNA: A Transformative Approach for Therapeutic Intervention2026-02-28OpenAlex10.33687/ricosbiol.04.02.108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132839434
W7162284521NeuroEvolution of Augmenting Topologies (NEAT) for Surface Roughness Prediction in 3D Printing Under Data Scarcity2026-02-28OpenAlex10.15866/iremos.v19i1.26593Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162284521
W7132854113Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study2026-02-28OpenAlex10.1016/j.urolonc.2026.111036Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7132854113
W7132825068Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review2026-02-28OpenAlex10.3390/curroncol33030140Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7132825068
W7133335561The Effect of Positive Psychology-Based Cognitive Behavioral Coaching on Adult Well-being and Narrative Reconstruction: A Single Case Study2026-02-28OpenAlex10.47018/accr.2026.8.1.51Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133335561
W7148987582Uterine Fibroids2026-02-28OpenAlex10.5281/zenodo.19403718Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148987582
W715433239312. Mehta RL, Chertow GM, et al. Epidemiology, Trajectories, and Outcomes of Acute Kidney Injury among Hospitalized Patients: A Multicenter Retrospective Cohort Study. medRxiv [Preprint]; 2024.2026-03-01OpenAlex10.22159/ijms.2026v14i2.58231Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154332393
W71402075161478: COMPARISON OF ANTIMICROBIAL RESISTANCE PATTERNS IN ECMO, ICU, AND HOSPITAL-WIDE PATIENT COHORTS2026-03-01OpenAlex10.1097/01.ccm.0001187908.30799.fcTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140207516
W71402298131513: COMPARISON OF UREA VS FLUDROCORTISONE IN CORRECTION OF HYPONATREMIA IN NEUROCRITICAL CARE PATIENTS2026-03-01OpenAlex10.1097/01.ccm.0001188048.80768.23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140229813
W71513107471ST PLACE, ORIGINAL RESEARCH TRACK: CUPNavigator: A multi-model CDSS for tumor origin prediction, diagnostic planning, and therapy recommendations in cancer of unknown primary2026-03-01OpenAlex10.17975/sfj-2026-005Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7151310747
W7140179467410: LONGITUDINAL TRENDS IN ANTIMICROBIAL SUSCEPTIBILITY AMONG ECMO PATIENTS WITH GRAM-NEGATIVE RODS2026-03-01OpenAlex10.1097/01.ccm.0001183636.94008.98Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140179467
W7140167769537: MANAGEMENT OF COMBINED OPIOID AND MEDETOMIDINE WITHDRAWAL AT AN ACADEMIC MEDICAL CENTER2026-03-01OpenAlex10.1097/01.ccm.0001184144.89185.69Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140167769
W71391151996ER-023 Integrating FDA approved app based prescription digital therapeutic apps into clinical practice2026-03-01OpenAlex10.1136/ejhpharm-2026-eahp.623Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139115199
W7133222336A multicohort phase 2 trial of androgen deprivation therapy (ADT), docetaxel (DOCE), and nivolumab (NIVO) in patients (pts) with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) enriched for inflamed tumors and DNA damage repair (DDR) alterations.2026-03-01OpenAlex10.1200/jco.2026.44.7_suppl.183Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133222336
W7134278247Advancements in JAK inhibitors for Pediatric Dermatology: an Updated Review on Emerging Therapies for Immune-Mediated Diseases2026-03-01OpenAlex10.1016/s0022-202x(26)00680-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134278247
W7208811931Advances in the pharmacological management of heart failure with reduced ejection fraction: A narrative review2026-03-01OpenAlex10.5281/zenodo.22321402Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208811931; https://openalex.org/W7141923070
W7133350595Adverse drug reactions and pharmacovigilance2026-03-01OpenAlex10.33545/26164485.2026.v10.i3.a.2388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133350595
W7133342713An Agentic AI system for disease diagnosis with explanations2026-03-01OpenAlex10.1016/j.infoh.2026.01.001Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7133342713
W7138181587Asundexian Versus Apixaban in Patients With Atrial Fibrillation2026-03-01OpenAlex10.1002/hsr2.71795Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138181587
W7135390500BACILLUS CEREUS BACTEREMIA IN A LIVER TRANSPLANT RECIPIENT – CASE REPORT2026-03-01OpenAlex10.1016/j.bjid.2026.105096Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135390500
W7137077382Bringing back ‘significance’ to MGUS2026-03-01OpenAlex10.1093/rheumatology/keag115Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7137077382
W7135398903CHROMOBLASTOMYCOSIS IN THE STATE OF PARÁ: IMPACT OF POOR THERAPEUTIC ADHERENCE AND CHRONIC EVOLUTION OF THE DISEASE2026-03-01OpenAlex10.1016/j.bjid.2026.105174Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135398903
W7134258793Calcitonin Gene-Related Peptide (CGRP) Inhibitors in Migraine: Mechanisms, Clinical Evidence, and Safety2026-03-01OpenAlex10.33545/26647613.2026.v8.i3a.205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134258793
W7133237515Career pathways for pharmacologists in India: A clinical pharmacologist’s perspective2026-03-01OpenAlex10.4103/ijp.ijp_185_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133237515
W7161268059Clinical translation of whole-body 5 Tesla MRI: An evolving paradigm in high-field imaging2026-03-01OpenAlex10.1016/j.magmed.2026.100064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161268059
W7139989810Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma2026-03-01OpenAlex10.1093/jscr/rjag168Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7139989810
W7134232968Cytophagic Histiocytic Panniculitis with Secondary Hemophagocytic Lymphohistiocytosis in a child : A Case Report2026-03-01OpenAlex10.1016/s0022-202x(26)00674-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134232968
W7135412512DISSEMINATED TUBERCULOSIS ASSOCIATED WITH CERTOLIZUMAB USE IN A PATIENT WITH RHEUMATOID ARTHRITIS2026-03-01OpenAlex10.1016/j.bjid.2026.105138Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135412512
W7140085583Differences and trends in worldwide clinical guidelines for Helicobacter pylori infection2026-03-01OpenAlex10.21037/tgh-2025-159Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140085583
W7140192240DockTales: A Human-Centered Mobile Application for Chronic Pain and Related Sleep Disturbance Through Empathic AI Design2026-03-01OpenAlex10.1016/j.jpain.2025.105675Full textExcludedF5: The exact journal item provides bibliographic metadata but no abstract or full methods through the public or current institutional publisher route. No matching author repository manuscript was found. The related HCII2026 project description was not substituted without identity evidence.https://openalex.org/W7140192240https://doi.org/10.1016/j.jpain.2025.105675Primary publisher page read with current Tohoku entitlement; explicitly no subscription for this item. Volume41 Supplement, March2026, article105675. Full text unavailable.
W7133243569End-of-life treatment patterns in patients (pts) with metastatic renal cell carcinoma (mRCC).2026-03-01OpenAlex10.1200/jco.2026.44.7_suppl.466Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133243569
W7134914608Fatal familial insomnia that begins with unconsciousness: A case report2026-03-01OpenAlex10.1002/slp2.70029Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134914608
W7133332209Fifteen-Year Trends in Antimicrobial Resistance of Pseudomonas aeruginosa at a South Indian Tertiary Care Centre: A Retrospective Analysis.2026-03-01OpenAlex10.7417/ct.2026.2010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133332209
W7140692910Fractional Excretion of Potassium Predicts Remission in Adult Nephrotic Syndrome2026-03-01OpenAlex10.34067/kid.0000001058Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140692910
W7135406543HERPETIC ENCEPHALITIS AND DEVELOPMENT OF REFRACTORY EPILEPSY AS A NEUROLOGICAL SEQUELA2026-03-01OpenAlex10.1016/j.bjid.2026.105474Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135406543
W7148894841Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations2026-03-01OpenAlex10.36849/jdd.9353Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7148894841
W7135412097INVASIVE FUNGAL INFECTION CAUSED BY MAGNUSIOMYCES CAPITATUS IN AN IMMUNOSUPPRESSED ADULT WITH ACUTE MYELOID LEUKEMIA, ASSOCIATED WITH HIV AND TUBERCULOSIS COINFECTION2026-03-01OpenAlex10.1016/j.bjid.2026.104817Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135412097
W7133182982Implementing evidence-based first-line therapy for metastatic urothelial carcinoma: A quality improvement initiative in community oncology.2026-03-01OpenAlex10.1200/jco.2026.44.7_suppl.664Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133182982
W7140191083Infiltrative liver conditions: a pictorial review of malignant and benign entities2026-03-01OpenAlex10.4103/singaporemedj.smj-2023-033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140191083
W7140757747Inflation Reduction Act Impact on the Hematology/Oncology Treatment Landscape2026-03-01OpenAlex10.37765/ajmc.2026.89891Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140757747
W7137956161Liposome-Based Drug Delivery for Diabetes: Therapeutic Applications and a Nanomedicine Perspective on Diabetic Complications2026-03-01OpenAlex10.2147/ijn.s593144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137956161; https://openalex.org/W7139520631
W7133217400Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 20252026-03-01OpenAlex10.1111/ajco.70092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133217400
W7133294707Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service2026-03-01OpenAlex10.1111/cts.70443Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133294707
W7136287026Medicine at the Crossroads: Visions, Approaches, and Emerging Frontiers2026-03-01OpenAlex10.1002/med4.70063Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136287026
W7138885039Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis2026-03-01OpenAlex10.55697/tnd.2026.622Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138885039
W7214859254New lanthanide-based materials for multifunctional imaging, biosensing and luminescence thermometry2026-03-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214859254
W7167219267Outcome of Classic Hodgkin Lymphoma Treated with ABVD Regimen- A Single Center Experience2026-03-01OpenAlex10.2478/jcas-2026-0008Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167219267
W7135406523PLAGUE IN THE 21ST CENTURY: GLOBAL OVERVIEW AND PERSPECTIVES IN BRAZIL2026-03-01OpenAlex10.1016/j.bjid.2026.105614Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135406523
W7133190988PO:11:278 ‘New kids on the block’ – real-world experience of belimumab, obinutuzumab and voclosporin in systemic lupus erythematosus (SLE): a retrospective cohort study at UCLH2026-03-01OpenAlex10.1136/lupus-2026-el.332Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133190988
W7135384274PRIMARY PYOMYOSITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: CASE REPORT2026-03-01OpenAlex10.1016/j.bjid.2026.105070Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135384274
W7135394087PRIMARY PYOMYOSITIS DUE TO RESISTANT STREPTOCOCCUS PNEUMONIAE SECONDARY TO ACUTE OTITIS MEDIA IN A 7-MONTH-OLD INFANT: CASE REPORT2026-03-01OpenAlex10.1016/j.bjid.2026.105071Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135394087
W7135377134PULMONARY MELIOIDOSIS: A CASE REPORT IN THE INTERIOR OF MATO GROSSO2026-03-01OpenAlex10.1016/j.bjid.2026.105040Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135377134
W7160770925Precision Versus Population Pharmacotherapy in Obesity: A Systematic Evaluation of Setmelanotide and GLP-1 Receptor Agonists2026-03-01OpenAlex10.21276/ssr-iijls.2026.12.2.23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160770925
W7166420555Radiologic Diagnosis of Abdominal Complications of Drug Therapy in Cancer Patients2026-03-01OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7166420555
W7140439524Recent advances in nonsurgical periodontal therapy2026-03-01OpenAlex10.4103/ijdr_202637s1_abs_123Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140439524
W7134109842Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity2026-03-01OpenAlex10.1111/jocd.70788Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134109842
W7148882973Research Advances in Endocrine Therapy for Hormone Receptor-Positive/HER2-Negative Early Breast Cancer2026-03-01OpenAlex10.3971/j.issn.1000-8578.2026.25.0873Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148882973
W7140209777SOCIETY OF CRITICAL CARE MEDICINE 55TH CRITICAL CARE CONGRESS2026-03-01OpenAlex10.1097/01.ccm.0001182192.43989.30Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140209777
W7149210855Semantic Fidelity in Specialized Domains: Advancing Language Models through Adaptive Learning, Collective Reasoning, and Consensus Evaluation2026-03-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7149210855
W7133241398Sequencing of therapeutic agents before and after metastatic castration-resistant prostate cancer (mCRPC) diagnosis in an international real-world setting.2026-03-01OpenAlex10.1200/jco.2026.44.7_suppl.100Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7133241398
W7137154056Single-center experience of voclosporin use for pediatric lupus nephritis: a case series2026-03-01OpenAlex10.1093/rheumatology/keag125Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7137154056
W7135011484Sodium glucose co-transporter inhibition as a strategy to stabilize the microvasculature in sickle cell disease2026-03-01OpenAlex10.1093/cvr/cvag055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135011484
W7135410630TOXIC EPIDERMAL NECROLYSIS – CASE REPORT AND LITERATURE REVIEW WITH FOCUS ON ANTIMICROBIAL STEWARDSHIP2026-03-01OpenAlex10.1016/j.bjid.2026.104694Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135410630
W7135087554Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification2026-03-01OpenAlex10.3322/caac.70072Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135087554
W7142812820The Dual Role of p21 in Hormone-related Cancers and Its Therapeutic Implications2026-03-01OpenAlex10.3724/j.pibb.2025.0528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142812820
W7162464630The Fontan circulation: Beyond hemodynamics to a unified disease paradigm2026-03-01OpenAlex10.4103/apc.apc_173_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162464630
W7160949091The evolving role of novel anesthetic agents for obstetric and gynecological anesthesia: The multidimensional value from esketamine to dexmedetomidine2026-03-01OpenAlex10.1016/j.lddd.2026.100415Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7160949091
W7153270099The rise of the agentic AI colleague2026-03-01OpenAlex10.1016/j.landig.2026.101010Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7153270099
W7163583588Therapeutic breakthroughs in acute-on-chronic liver failure: From conventional approaches to emerging targeted therapies2026-03-01OpenAlex10.3724/cbls.2026047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163583588
W7140803624Thymic epithelial tumors: a narrative review of diagnostic and therapeutic advances2026-03-01OpenAlex10.21037/tcr-2025-2142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140803624
W7133206199Treatment and outcomes among patients with metastatic castrate resistant prostate cancer with an AR gene alteration: Analysis from the Kaiser Permanente Northern California Healthcare System.2026-03-01OpenAlex10.1200/jco.2026.44.7_suppl.91Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133206199
W7140388185Vision–language foundation model driven agentic AI systems for healthcare2026-03-01OpenAlex10.1007/s00371-026-04437-7Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7140388185
W7133946050When Norovirus Stress‐Tests Mass Gatherings: From Outbreaks to System Fragility2026-03-01OpenAlex10.1002/rmv.70130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133946050
W7134178712iLABMED : A Translational Medical Journal Embracing a New Era2026-03-01OpenAlex10.1002/ila2.70051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134178712
W7161229242犬アトピー性皮膚炎に対する抗炎症治療薬の変遷2026-03-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161229242
W7133132729Disparities in Medication Treatment of Type 2 Diabetes and Obesity2026-03-02OpenAlex10.1542/peds.2025-074840Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133132729
W7133318449Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy2026-03-02OpenAlex10.3390/biomedicines14030570Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133318449
W7120572954Fifteen-Year Trends in Antimicrobial Resistance of Pseudomonas aeruginosa at a South Indian Tertiary Care Centre: A Retrospective Analysis: doi: 10.7417/CT.2026.20102026-03-02OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7120572954
W7133234335Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World2026-03-02OpenAlex10.1111/tid.70197Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133234335
W7133196616Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer2026-03-02OpenAlex10.3389/pore.2026.1612333Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133196616
W7133209267Specialty grand challenge in gastrointestinal infections2026-03-02OpenAlex10.3389/fgstr.2026.1808344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133209267
W7133217159The dual role of the crosstalk between autophagy and ferroptosis in lung cancer treatment: Advances in mechanisms and therapeutic strategies (Review)2026-03-02OpenAlex10.3892/ijmm.2026.5779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133217159
W7134175908Теория и практика создания и применения ультразвукового геля: обзор литературы (часть 1)2026-03-02OpenAlex10.34883/pi.2026.18.1.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134175908
W7133523297B06 | Integrating pharmacogenomics and microenvironment profiling in high-risk leukemias2026-03-03OpenAlex10.3324/haematol.2026.s1.14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133523297
W7133493921CO22 | UMG1-TriNK15: a first-in-class trispecific NK engager targeting multiple myeloma2026-03-03OpenAlex10.3324/haematol.2026.s1.35Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133493921
W7133334691Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and Resistance Mechanisms2026-03-03OpenAlex10.3390/antibiotics15030263Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133334691
W7133337382EU Artificial Intelligence Act: Pre-Compliance Inspection and Diagnostic Framework2026-03-03OpenAlex10.5281/zenodo.18847119Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133337382
W7133340308Editorial: Drug development for respiratory infectious diseases and related complications in other systems2026-03-03OpenAlex10.3389/fmed.2026.1800928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133340308
W7133327194Editorial: Harnessing bacteriophages and phage-engineered products for antibacterial and anticancer therapies: challenges and opportunities2026-03-03OpenAlex10.3389/fmicb.2026.1799584Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133327194
W7134201586Fostering deliberation and action in context: An analysis of implementation research among healthcare professionals in LMICs from a post‐digital perspective2026-03-03OpenAlex10.1111/bjet.70044Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134201586
W7133247455Liquid crystal-based biosensors for clinical diagnostics2026-03-03OpenAlex10.1016/j.cca.2026.120926Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7133247455
W7133305420Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors2026-03-03OpenAlex10.3390/jpm16030143Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133305420
W7133496509P077 | Clinical profiles and treatment approaches in Italian patients with CLL in clinical practice: findings from a European cross-sectional survey2026-03-03OpenAlex10.3324/haematol.2026.s1.139Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133496509
W7133324784Treatment of pulmonary fibrosis: From disease mechanisms to future novel therapies (Review)2026-03-03OpenAlex10.3892/ijmm.2026.5783Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133324784
W7137967244A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM)2026-03-04OpenAlex10.1080/14712598.2026.2646947Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137967244
W7143369918Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update2026-03-04OpenAlex10.1080/14656566.2026.2652459Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143369918
W7133485233Comprehensive Review on Candidemia: Epidemiology, Diagnosis, Treatment, and Future Directions2026-03-04OpenAlex10.26599/ifungi.2026.9670005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133485233
W7135398381Diagnosis and risk factors for invasive mould disease—a round table discussion on directing antifungal therapy according to the available evidence2026-03-04OpenAlex10.1093/jac/dkag062Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135398381
W7133556796Drug Anaphylaxis2026-03-04OpenAlex10.1016/j.iac.2026.01.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133556796
W7133518449Editorial: Coping with antimicrobial resistance in the context of dental medicine2026-03-04OpenAlex10.3389/fdmed.2026.1807351Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133518449
W7133526452Enhancing PLS in UAV-Aided Backscatter Networks: A Multiagent DRL Framework with Federated Learning2026-03-04OpenAlex10.1109/tai.2026.3669890Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7133526452
W7135010279Investigating the Role of Sotagliflozin in Cardiovascular Event Management2026-03-04OpenAlex10.2174/0115743624383123251124110553Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135010279
W7133489720PopGenAgent: An Agent-Mediated Workflow for Population Genetics Analyses2026-03-04OpenAlex10.64898/2026.03.02.709209Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7133489720
W7133499771Stimuli-responsive protein-based bioinks for 3D bioprinting: Preparation strategies and wound healing applications2026-03-04OpenAlex10.1016/j.bprint.2026.e00478Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133499771
W7138105857The Aesthetics of Mediacracy: Film Portrait of Silvio Berlusconi between Political Image and Cultural Representation2026-03-04OpenAlex10.15407/nte2026.01.106Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7138105857
W7151285423The role of monoclonal antibodies in the treatment of lupus nephritis2026-03-04OpenAlex10.1080/14712598.2026.2649524Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151285423
W7133343149Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa2026-03-04OpenAlex10.1080/17512433.2026.2641138Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133343149
W7133537043Where AGI Confuses Change: A Recurrence–Structure Diagnostic for Autonomous Self-Improvement Claims in Artificial Intelligence2026-03-04OpenAlex10.5281/zenodo.18861438Title/abstractExcludedE2: Mathematical/forecasting/AGI framework without a clinical primary task.https://openalex.org/W7133537043
W7133700978AI agent in healthcare: applications, evaluations, and future directions2026-03-05OpenAlex10.1038/s44387-026-00076-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7133700978
W7133869521Agentic Artificial Intelligence: Frameworks for Autonomous Decision-Making and Continuous Self-Improvement2026-03-05OpenAlex10.22214/ijraset.2026.77831Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7133869521
W7133347124Biologic and targeted synthetic therapies in juvenile idiopathic arthritis: a review of current and emerging therapeutic agents2026-03-05OpenAlex10.1080/14740338.2026.2640975Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133347124
W7133671075Bridging Science and Subjectivity: Evolving Evidence, Emerging Technologies and the Call for Personalised Psychotherapy: Créer une passerelle entre la science et la subjectivité : Évolution des données probantes, arrivée de nouvelles technologies et appel à une psychothérapie personnalisée2026-03-05OpenAlex10.1177/07067437261425840Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133671075
W7133919813Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs2026-03-05OpenAlex10.1016/j.clml.2026.03.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133919813
W7133872249Editorial: Innovative and sustainable management of organic food and beverage wastes2026-03-05OpenAlex10.3389/fnut.2026.1810341Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133872249
W7133872363In vivo evolution of resistance to contemporary β-lactam/β-lactamase inhibitor combinations during treatment of a KPC-producing Serratia marcescens infection2026-03-05OpenAlex10.1128/aac.01651-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133872363
W7133875449Infection Control in U.S. Dental Practice: Current Standards, Guidelines, and Emerging Challenges2026-03-05OpenAlex10.12691/ajmcr-14-3-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133875449
W7133736900Joint TOS / OMA / OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach2026-03-05OpenAlex10.1002/oby.70164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133736900; https://openalex.org/W7133706452
W7133751477Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment2026-03-05OpenAlex10.1016/j.ard.2026.02.003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133751477
W7133642317Reimagining community health nursing: a qualitative participatory action research study of nurse-led primary healthcare innovation in rural Saudi Arabia2026-03-05OpenAlex10.1186/s12912-026-04510-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7133642317
W7133838439Research Highlights2026-03-05OpenAlex10.1097/tp.0000000000005680Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133838439
W7134835334Textbook of Novel Drug Delivery System (NDDS)2026-03-05OpenAlex10.5281/zenodo.18938573Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134835334
W7133817742Transport of Nanoparticles in Targeted Drug Delivery System2026-03-05OpenAlex10.21275/sr26226181516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133817742
W7133919283Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics2026-03-05OpenAlex10.1080/13543784.2026.2640986Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7133919283
W7134045889Acute kidney injury over the past decade: from definition evolution to pathogenesis insights and innovative therapeutic strategies2026-03-06OpenAlex10.1007/s00018-026-06104-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134045889
W7134039607Canine vector-borne diseases: a changing world demands a new preventive strategy from veterinarians2026-03-06OpenAlex10.1186/s13071-026-07331-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134039607
W7134076509Editorial: World diabetes day 2024: exploring mechanisms, innovations, and holistic approaches in diabetes care2026-03-06OpenAlex10.3389/fendo.2026.1808396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134076509
W7134033175From Glycemic Control to Weight-Centered Therapy: A Paradigm Shift in Type 2 Diabetes and Its Public Health Promise2026-03-06OpenAlex10.3389/ijph.2026.1608891Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134033175
W7140541761From Physician Expertise to Clinical Agents: Preserving, Standardizing, and Scaling Physicians' Medical Expertise with Lightweight LLM2026-03-06OpenAlex2603.2352010.48550/arxiv.2603.23520Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7140541761
W7161177247From isolated data to integrated ecosystems: the artificial intelligence revolution in precision livestock farming2026-03-06OpenAlex10.1093/af/vfag010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161177247
W7134139104Manufacturing and clinical applications of non‐ CAR ‐T immune effector cells2026-03-06OpenAlex10.1111/trf.70144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134139104
W7134032183Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications2026-03-06OpenAlex10.1186/s12943-025-02559-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134032183; https://openalex.org/W7157281050
W7160700153Denosumab in Giant Cell Tumour of Bone - A Case Series with Review of Literature2026-03-07OpenAlex10.31557/apjcc.2026.11.2.293-301Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160700153
W7134108391Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms2026-03-07OpenAlex10.1007/s11899-026-00775-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134108391
W7134196459Automating Enterprise IT Support: Design and Evaluation of an Autonomous AI Agent2026-03-08OpenAlex10.22214/ijraset.2026.77880Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7134196459
W7147045681Ep. 1051: The Pharmacological Soldier: Engineering the Battlefield2026-03-08OpenAlex10.5281/zenodo.19362247Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147045681
W7134234515Accelerating Exploratory Clinical Research: An LLM-Powered Framework for Cross-Study Data Harmonization and Natural Language Querying2026-03-09OpenAlex10.64898/2026.03.04.26345603Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7134234515
W7134850418Acquired Hemostasis Disorders2026-03-09OpenAlex10.1055/a-2788-1844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134850418
W7151804474Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs2026-03-09OpenAlex10.1093/jacamr/dlag051Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151804474
W7136040310Chemotherapy-Induced Cardiotoxicity: A Comprehensive Review of Current Understanding and Future Directions2026-03-09OpenAlex10.2174/011573403x392956251210124152Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136040310
W7134259592From environmental reservoirs to clinical threats: the expanding resistome and genetic plasticity of Citrobacter spp.2026-03-09OpenAlex10.1007/s15010-026-02758-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134259592
W7134249628Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 20252026-03-09OpenAlex10.1159/000551430Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134249628
W7134851159Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report2026-03-09OpenAlex10.1097/bs9.0000000000000282Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134851159
W7134224838Multisystem Involvement in a Patient with MDR Klebsiella Pyelonephritis and Sjogren's Syndrome- A Complex Case Report2026-03-09OpenAlex10.5281/zenodo.18919744Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134224838
W7134254954Neuropsychological aspects of impulse control disorders in Parkinson’s disease2026-03-09OpenAlex10.3389/fnagi.2026.1768251Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134254954
W7134280398Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 1: Inflammatory Modulation and Respiratory Impacts2026-03-09OpenAlex10.3390/children13030384Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134280398
W7134280254Sequencing antibody‑drug conjugates in metastatic cancer (Review)2026-03-09OpenAlex10.3892/mi.2026.308Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134280254
W7160096416The Multidimensional Regulatory Network of Osteoblast Differentiation and Targeted Therapeutic Strategies for OP2026-03-09OpenAlex10.71321/rqm4ns12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160096416
W7134981585Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics2026-03-10OpenAlex10.1038/s41571-026-01134-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134981585
W7134807370Complex Communication: Complex-Valued Extensions of Environmental Divergence in Quantum Coordination Theory2026-03-10OpenAlex10.5281/zenodo.18944106Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7134807370
W7134823778DRUG REPURPOSING AND TRANSLATIONAL RESEARCH: INTEGRATING AI, PHARMACOGENOMICS, AND PRECISION THERAPEUTICS2026-03-10OpenAlex10.5281/zenodo.18936789Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134823778
W7134807749Editorial: World Schizophrenia awareness day: raising awareness and advancing pharmacological strategies in Schizophrenia2026-03-10OpenAlex10.3389/fphar.2026.1820307Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134807749
W7135060672Evolution of Antivascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration2026-03-10OpenAlex10.1177/24741264261427831Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135060672
W7134907171Molecular-level understanding of the aging bone and regeneration mechanisms using computational methods2026-03-10OpenAlex10.1007/s00198-026-07903-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134907171
W7134948832Painful Bilateral Necrosis of the Scalp2026-03-10OpenAlex10.1002/jvc2.70307Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134948832
W7134851663Phage therapy in oncology: Mechanisms, innovations, and translational advances2026-03-10OpenAlex10.1016/j.jddst.2026.108230Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134851663
W7134953105Phase Transitions in Artificial General Intelligence: Scaling Laws, Predictability Limits, and Singularity2026-03-10OpenAlex10.21203/rs.3.rs-9055490/v1Title/abstractExcludedE2: Mathematical/forecasting/AGI framework without a clinical primary task.https://openalex.org/W7134953105
W7134940836Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report2026-03-10OpenAlex10.1016/j.bneo.2026.100215Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134940836
W7134986162TINOSPORA CORDIFOLIA: A BIOACTIVE NETWORK FOR ADVANCED HERB PHARMACOLOGY2026-03-10OpenAlex10.5281/zenodo.18958216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134986162
W7140214363The Algorithmic Smile: Multimodal AI and the Transformation of Orthodontic Science2026-03-10OpenAlex10.36348/gajdoh.2026.v08i02.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140214363
W7134985792The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management2026-03-10OpenAlex10.1007/s12325-026-03513-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134985792
W7134238526[The evolution of antimicrobial therapy for sepsis].2026-03-10OpenAlex10.3760/cma.j.cn112137-20251019-02688Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134238526
W7136088793Clinical Applications and Safety Analysis of Nefopam and Flupirtine as Examples of Non-Opioid Analgesics2026-03-11OpenAlex10.2174/0113816128424715251211092936Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136088793
W7134897807Disability Through the Lens of Justice. J.Begon , 2023. Oxford, Oxford University Press. vii + 278 pp, £76 (hb)2026-03-11OpenAlex10.1002/japp.70083Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134897807
W7135051456Editorial: Applications of fluorescence in surgery and diagnostics, volume II: evolution and breakthroughs2026-03-11OpenAlex10.3389/fsurg.2026.1806002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135051456
W7134893436From Convenience to Clinical Efficacy: Selective TYK2 Inhibition in Psoriasis and the Evolving Role of Next-Generation Oral Targeted Therapies2026-03-11OpenAlex10.3390/pharmaceutics18030347Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134893436
W7134953176Revolutionizing Drug Design with Bioinformatics and AI to Combat Multi-Drug-Resistant Pathogens2026-03-11OpenAlex10.1051/bioconf/202622807002/pdfTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134953176; https://openalex.org/W7134885096
W7134929373The MTA-TPACK Dynamic Collaboration Spiral: Making Pedagogical Thinking Visible in Human–AI Scientific Visualization for Sustainable Teacher Innovation2026-03-11OpenAlex10.3390/su18062718Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7134929373
W7135143422Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist2026-03-11OpenAlex10.1055/a-2818-2557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135143422
W7134886937“My eating disorder story”: an interpretative phenomenological analysis of social media, narrative identity, and patient influencers in eating disorder recovery2026-03-11OpenAlex10.1186/s40337-026-01564-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7134886937
W7138852613Chemoprotectors in Oncology: Mechanisms, sources, and advances in mitigating chemotherapy-induced toxicities2026-03-12OpenAlex10.62110/sciencein.btl.2026.v13.1855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138852613
W7135037525Continuous Change Containment Architecture (CCCA): Architecting AI-Enabled Systems for Continuous Change2026-03-12OpenAlex10.5281/zenodo.18987614Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7135037525
W7135017231Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection2026-03-12OpenAlex10.3390/muscles5010021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135017231
W7135017924Editorial: Exploiting biomarkers for targeted therapies in acute myeloid leukemia2026-03-12OpenAlex10.3389/fmed.2026.1813324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135017924
W7135036053Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update2026-03-12OpenAlex10.3390/jcm15062179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135036053
W7135192069Abstract A013: Bridging the mouse modeling gap in clear cell renal cell carcinoma bone metastasis for immunotherapy testing2026-03-13OpenAlex10.1158/1538-7445.kidney26-a013Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135192069
W7135232532Editorial: Social and affective domain in home language development and maintenance research, volume II2026-03-13OpenAlex10.3389/fpsyg.2026.1813132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135232532
W7167368954Electronic Health Record System Transitions in Publicly Funded Healthcare: A Realist Synthesis Protocol2026-03-13OpenAlex10.17605/osf.io/kjgwbTitle/abstractExcludedE1: Protocol-only proposal without an evaluated persistent healthcare agent.https://openalex.org/W7167368954
W7135181745From AIE-Pharmacology to Fluoropharmacology: The Paradigm Evolution of Disciplinary Framework Based on the "Drug-Probe Unity" Concept2026-03-13OpenAlex10.22541/au.177341537.76117807/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135181745
W7135171538Lipid-lowering therapies: the arrows in the quiver and future bullets2026-03-13OpenAlex10.23736/s2724-5683.25.07002-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135171538
W7137144878Neuromuscular block in paediatric patients undergoing airway management: a narrative review2026-03-13OpenAlex10.1097/aco.0000000000001634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137144878; https://openalex.org/W7139126113
W7135244078PURA-Related Neurodevelopmental Disorder: A Comprehensive Clinical Review of Genetics, Phenotype, and Emerging Therapeutic Strategies2026-03-13OpenAlex10.7759/cureus.105181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135244078
W7135194709Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches2026-03-13OpenAlex10.1016/j.ucl.2026.02.002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135194709
W7135027438Risk factors and prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis2026-03-13OpenAlex10.4253/wjge.v18.i3.115736Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135027438
W7135235335Study 3: Educator perspectives on costs and cost-conscious decision-making in health professions education: a Q-Method study2026-03-13OpenAlex10.34894/z9z6enTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7135235335
W7135384398Advancements in extracellular vesicle research2026-03-14OpenAlex10.1016/j.vesic.2026.100107Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135384398
W7135422314Biologics in severe asthma: from precision phenotyping to clinical remission2026-03-14OpenAlex10.1080/02770903.2026.2644878Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135422314
W7138850453Deployed AI Agents for Industrial Asset Management: CodeReAct Framework for Event Analysis and Work Order Automation2026-03-14OpenAlex10.1609/aaai.v40i47.41453Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7138850453; https://openalex.org/W7128708900
W7135418764Large language models enhance reinforcement learning for public health resource allocation2026-03-14OpenAlex10.1016/j.asoc.2026.115047Full textExcludedF3: The acting allocation agent is conventional Q-learning. DeepSeek/RAGFlow extracts structured epidemic growth-rate inputs from reports; it is not the acting controller or an agent whose policy is improved.https://openalex.org/W7135418764https://www.sciencedirect.com/science/article/pii/S1568494626004953Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online.
W7135387663Management of Asthma: Future Directions2026-03-14OpenAlex10.4103/jalh.jalh_3_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135387663
W7135419785Management of Hypertension in Patients Undergoing Peritoneal Dialysis: A Narrative Review2026-03-14OpenAlex10.7759/cureus.105215Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135419785
W7138084769MemoryART: Enhancing LLMs via Multi-Memory Models with Adaptive Resonance Theory for Healthcare Agents2026-03-14OpenAlex10.1609/aaai.v40i25.39205Full textExcludedF4: MemoryART retains each patient's own dialogue history and profile; identity-channel retrieval preserves the same subject. No transfer of learned clinical experience to different patients is established. Fixed P1 applies.https://openalex.org/W7138084769https://github.com/dairkkriad/MemoryART
W7135168241Safe and Sound: Optimizing Pediatric Procedural Sedation in Emergency Departments — From High-resource Standards to Low-resource Adaptations2026-03-14OpenAlex10.1007/s40746-026-00369-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135168241
W7135385636The Therapy Paradox: Scaling Mental Health with AI2026-03-14OpenAlex10.5281/zenodo.19024278Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7135385636
W7136044173A Two-Dimensional Framework for AI Agent Design Patterns: Cognitive Function × Execution Topology2026-03-15OpenAlex10.5281/zenodo.19036556Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136044173
W7135381960AI-Driven Change Management in the VUCA Era2026-03-15OpenAlex10.63329/av3nz12327Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7135381960
W7219994907Current treatments for ischemic stroke: New approaches: Treatments for ischemic stroke2026-03-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219994907
W7135419339Deliberation and drift: Evaluating alignment fragility in multi-agent medical artificial intelligence2026-03-15OpenAlex10.1007/s43681-026-01048-9Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7135419339
W7136090353Harnessing synergy: Innovative combinations to overcome PARP inhibitor resistance in cancer treatment2026-03-15OpenAlex10.1016/j.critrevonc.2026.105278Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136090353
W7138300576Large Language Models as A Paradigm Shift in Next-Generation Virtual Reality Interaction: A Comprehensive Investigation2026-03-15OpenAlex10.54097/hw3wve60Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138300576
W7136040158Off-Label Uses of Methotrexate2026-03-15OpenAlex10.32388/qwzndaTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136040158
W7136057345Self-Regulating Artificial Intelligence: Architectural Governance for Long-Lived AI Systems2026-03-15OpenAlex10.5281/zenodo.19033610Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7136057345
W7136042504The Algorithmic Adversary: Inside the IRGC's AI Strategy2026-03-15OpenAlex10.5281/zenodo.19033786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136042504
W7118056368The Human Operating System— EBA: The Universal Architecture of Commitment, Fulfillment, and AI Alignment2026-03-15OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7118056368
W7214945650The Relationship Between Generative AI Chatbot Use, Working Alliance, and Mental Well-Being in Everyday Life2026-03-15OpenAlex10.17605/osf.io/a6r7xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214945650
W7146239223川崎病急性期治療:歴史的変遷から最新エビデンス,今後の展望2026-03-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7146239223
W7136056290A comprehensive review of temporal reasoning with multimodal LLMs: Foundations, challenges, and healthcare applications2026-03-16OpenAlex10.1016/j.cosrev.2026.100960Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136056290
W7136424892ARSAL: The Akarkach Resonance & Synchronization Assessment Layer A Diagnostic Synchronization Layer for Emergence Governance in Agentic AI Systems2026-03-16OpenAlex10.5281/zenodo.19046566Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7136424892
W7139942950Advances in Pharmacologic Strategies to Reduce Atheroma Plaque Size in Atheromatosis: A Comprehensive Review2026-03-16OpenAlex10.2174/0115748855405974251130161059Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139942950
W7136892066COMPARATIVE EFFICACY AND SAFETY OF FIRST-VERSUS SECOND- GENERATION OVER-THE-COUNTER ANTIHISTAMINES: A REVIEW2026-03-16OpenAlex10.5281/zenodo.19045412Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136892066
W7138884905CORPORATE GOVERNANCE AND CORPORATE SOCIAL RESPONSIBILITY: INTERSECTIONS AND TENSIONS2026-03-16OpenAlex10.5281/zenodo.19119643Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7138884905
W7136783898Emerging Genomic and Immunological Correlates Defining Oligometastatic Trajectories in Intermediate/High-Grade Soft-Tissue Sarcomas2026-03-16OpenAlex10.3390/genes17030323Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7136783898
W7137264594Prevention and background therapy of skin toxic reactions in children receiving antitumor drug therapy. Part 2 (results of prospective cohort study)2026-03-16OpenAlex10.17116/klinderma202625011113Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7137264594
W7137252984The Temporal Coherence Problem: Synthetic Point-in-Time Environments for Evaluating LLM Agents with Dynamic Tool Dependencies2026-03-16OpenAlex10.5281/zenodo.19041095Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7137252984; https://openalex.org/W7159952327
W7138766611176eP Impact of PD-L1 status on the development of cutaneous immune-related adverse events in non-small cell lung cancer patients receiving immunotherapy2026-03-17OpenAlex10.1016/j.esmoop.2026.106483Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138766611
W7138233353Application value of gastric contrast ultrasonography in gastric tumors2026-03-17OpenAlex10.1186/s13244-026-02242-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138233353
W7144198750China’s Contribution to the Clinical Development of Antibody-Drug Conjugates in Gynecologic Cancers: A Review2026-03-17OpenAlex10.31083/ceog47269Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144198750
W7139088901Comment on ‘Effectiveness of Nurse‐Led Interventions on Emergence Delirium in Pediatric Patients: A Systematic Review and Meta‐Analysis’2026-03-17OpenAlex10.1111/jocn.70262Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139088901
W7141520901Cytomorphological Reflections of HPV Positivity in Concurrent HPV Testing and Smear Specimens2026-03-17OpenAlex10.35440/hutfd.1762809Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7141520901
W7137899655Editorial: Drug delivery systems for mineralized tissue regeneration2026-03-17OpenAlex10.3389/fbioe.2026.1826772Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137899655
W7138839771Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy2026-03-17OpenAlex10.1111/apt.70604Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138839771
W7150079542Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies2026-03-17OpenAlex10.7150/ijbs.130260Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150079542
W7138129778Perioperative Anaphylaxis: Etiology, Pathophysiology, Diagnostic Challenges, Immediate Management, Prevention Strategies, and Future Perspectives2026-03-17OpenAlex10.14218/erhm.2025.00079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138129778
W7137850615Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control2026-03-17OpenAlex10.1177/10781552261430675Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7137850615
W7139054149The Cepeda Framework: A Modular, Safety-First Preclinical Architecture for Testing Coordinated Multi-Hallmark Rejuvenation Hypotheses in Biological Aging2026-03-17OpenAlex10.64898/2026.03.15.711859Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7139054149
W7138423498The Potential for Artificial Intelligence to Augment Peer Review2026-03-17OpenAlex10.1111/1742-6723.70243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138423498
W7139967142The future of urothelial carcinoma: a 2024–2025 update of early-phase trials of novel therapeutic agents2026-03-17OpenAlex10.1097/mou.0000000000001388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139967142
W7138367790What's next in psoriatic arthritis therapy? A look at the pipeline2026-03-17OpenAlex10.1097/bor.0000000000001157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138367790
W7138840744Analysis of Molecular Markers of HPV Infection Persistence: A Narrative Review2026-03-18OpenAlex10.3390/cancers18060981Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138840744
W7138865127Contemporary Trends in High‐Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention2026-03-18OpenAlex10.1161/jaha.125.047683Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138865127
W7139031629Dual GLP-1/GIP Agonists for Weight Reduction and Cardiovascular Outcomes in Type 2 Diabetes2026-03-18OpenAlex10.59298/iaajsr/2026/1316570Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139031629
W7138848778Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives2026-03-18OpenAlex10.1111/ejh.70167Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138848778
W7138835117Evolving Ocular Safety Signals of EGFR Inhibitors: A FAERS Disproportionality Analysis of Amivantamab, Mobocertinib, and Classic Agents2026-03-18OpenAlex10.64898/2026.03.16.26348536Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7138835117
W7138993591Evolving therapies, persistent gaps: a real-world look at survival trends in metastatic prostate cancer2026-03-18OpenAlex10.1038/s41391-026-01106-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138993591
W7139120289From bench to bedside: Emerging therapeutics for alzheimer's disease in clinical trials2026-03-18OpenAlex10.1007/s11011-026-01793-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139120289
W7139075649Human plasma platelet activating factor acetylhydrolase engineered to be a catalytic bioscavenger for organophosphorus compounds2026-03-18OpenAlex10.58088/h1h6-wk02Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7139075649
W7139137685Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties2026-03-18OpenAlex10.1002/jvc2.70319Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139137685
W7139137613Root Intent and Chain-Level Safety in Multi-Agent Healthcare AI: A Conceptual Framework2026-03-18OpenAlex10.5281/zenodo.19100261Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7139137613
W7138868189SGLT2 Inhibitors in Heart Failure with Coexisting Chronic Kidney Disease2026-03-18OpenAlex10.12775/jehs.2026.89.69727Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138868189
W7137984244Severe, late-onset neutropenia associated with prolonged furosemide administration in an extremely preterm infant: a case report and literature review2026-03-18OpenAlex10.1186/s12887-026-06698-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7137984244
W7138918470The Aether Equation: A Diagnostic Metric for Autonomous Agent Intelligence Across Domains and Scales2026-03-18OpenAlex10.5281/zenodo.19101554Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7138918470; https://openalex.org/W7138859323
W7139944303The Characteristics of Centrally Acting Non-opioid Analgesics in the Management of Acute Pain and Neuropathic Pain Syndromes2026-03-18OpenAlex10.2174/0113816128428513260121185400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139944303
W7138870930The hidden toll: Mapping poisoning patterns and challenges in Egyptian forensic toxicology2026-03-18OpenAlex10.1016/j.toxac.2026.02.007Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138870930
W7220203805A NOVEL RNA INTERFERENCE THERAPY TO REDUCE CARDIOVASCULAR RISK BY LOWERING LIPOPROTEIN(A) LEVELS USING THE LEPODISIRAN AGENT2026-03-19OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220203805; https://openalex.org/W7139916494
W7202062287Bio-inspired phototheranostic nanoplatforms for cancer and infectious diseases management2026-03-19OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202062287
W7138955627Conclusion to the Special Issue and Dialogic Reflections on Artificial Intelligence and Systemic Therapy: Competence, Ethics, and the Future of Relational Practice2026-03-19OpenAlex10.1080/2692398x.2026.2647012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138955627
W7139108707Editorial: Innovative therapeutic strategies for managing diabetic foot ulcers and mitigating associated complications2026-03-19OpenAlex10.3389/fphar.2026.1788742Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139108707
W7139002863Editorial: The role of nano-therapeutics in precision cancer medicine2026-03-19OpenAlex10.3389/fbioe.2026.1818253Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139002863
W7139059061Essential Oils in Dentistry: Therapeutic Potential and Emerging Clinical Applications2026-03-19OpenAlex10.7759/cureus.105534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139059061
W7138837098Everybody gets a CAR! But do they need it?2026-03-19OpenAlex10.1182/blood.2025031976Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138837098
W7138914021Recent advances in protein modification–enabled potential therapeutics2026-03-19OpenAlex10.1016/j.cbpa.2026.102665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138914021
W7138830414Risk Assessment and Hazard Prevention Techniques Across Industries2026-03-19OpenAlex10.4018/979-8-3373-6370-7.ch005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138830414
W7140222671The Elythian Framework: A Unified Consistency Objective for Autonomous AI Agent Self-Improvement2026-03-19OpenAlex10.5281/zenodo.19114787Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7140222671
W7138857979The Role of AI in Detecting and Mitigating Behavioral Biases2026-03-19OpenAlex10.4018/979-8-3373-1494-5.ch002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138857979
W7140027113Ulcerative Colitis: Clinical Features, Diagnosis, and Evolving Therapeutic Strategies2026-03-19OpenAlex10.54097/eyhfaj26Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140027113
W7138884662Updates of anti-malarial agents reported in 2024: Recent advancements, developments and key insights2026-03-19OpenAlex10.1016/j.molstruc.2026.146036Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7138884662
W7167467836A Formal Theory of AGI: Structural Admissibility and Generalization under Representation, Reasoning, Evaluation, Memory, and Regime Change2026-03-20OpenAlex10.5281/zenodo.21222954Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167467836
W7139061809Curing Coma: The Emerging Paradigm Shift2026-03-20OpenAlex10.25259/jtarcc_14_2025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139061809
W7138970405Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease2026-03-20OpenAlex10.1016/j.pharmr.2026.100132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138970405
W7139964218Evaluation of clinical decision support to improve guideline directed medical therapy in patients with type 2 diabetes2026-03-20OpenAlex10.1016/j.japh.2026.103081Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7139964218
W7138892003Evolution of bispecific and multispecific antibodies in cancer therapy2026-03-20OpenAlex10.1016/j.lanepe.2026.101599Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138892003
W7138856739Incretin polyagonists as an alternative to bariatric surgery to manage obesity2026-03-20OpenAlex10.4291/wjgp.v17.i1.118132Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138856739
W7139962713Marine bacterial metabolites in anticancer drug discovery: Ecological insights, mechanisms of action, and clinical translation2026-03-20OpenAlex10.1016/j.rsma.2026.104935Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7139962713
W7138913537When Novelty Outpaces Evidence: Social Media as an Unregulated Force Propelling Innovation in Endodontics: A Narrative Review2026-03-20OpenAlex10.1111/iej.70150Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138913537
W7139975680Advancing traumatic brain injury diagnosis through nanomaterial-based imaging technologies2026-03-21OpenAlex10.1016/j.nantod.2026.103028Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7139975680
W7139978391Deep learning-enhanced AIMARSE for predictive fault diagnosis in power quality systems2026-03-21OpenAlex10.1007/s00521-026-11911-9Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7139978391
W7139978792Doctoral Digital Economy Leadership Assessment2026-03-21OpenAlex10.17605/osf.io/y8sc9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139978792
W7139990899Endogenous Trapped Insulin Syndrome (ETIS): A Novel Hypothesis of Intracellular Insulin Sequestration, Therapeutic Window Exploitation, and Prevention of Insulin Dependency in Type 2 Diabetes Mellitus2026-03-21OpenAlex10.5281/zenodo.19152201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7139990899
W7139986098Prompt-Driven Autonomous Enterprise Software Systems: Architecture, Design, and Feasibility Analysis2026-03-21OpenAlex10.5281/zenodo.19150305Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7139986098
W7139978741Rule Compass: A Cross-Domain Framework for Rule-Based Problem Solving2026-03-21OpenAlex10.5281/zenodo.19152305Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7139978741
W7140029669Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study2026-03-22OpenAlex10.1007/s40121-026-01334-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140029669
W7147535539Illness Memoirs and the Medical-Literary Interface: A Critical Review2026-03-22OpenAlex10.5281/zenodo.19164190Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147535539
W7140102881AI Driven Decision Leadership Certification Assessment2026-03-23OpenAlex10.17605/osf.io/wumhxTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140102881
W7140127123Bridging the gaps in alzheimer’s disease: a comprehensive review of current and emerging therapies2026-03-23OpenAlex10.1007/s10787-026-02151-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140127123
W7140125118Choosing between Nivo ‐ AVD and BrECADD : Hodgkin lymphoma's new era2026-03-23OpenAlex10.1111/bjh.70451Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140125118
W7140095104Editorial: Music and medicine: from basic science to clinical practice2026-03-23OpenAlex10.3389/fnins.2026.1792435Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140095104
W7140045317Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPA2026-03-23OpenAlex10.1007/s12016-026-09147-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140045317
W7138834101Genomic Strategies in Cancer Prevention: A Pancreatic Cancer Perspective2026-03-23OpenAlex10.5281/zenodo.19097042Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7138834101
W7140076334Individualized precision therapy for severe asthma: clinical applications of biological agents and frontiers of cell therapy2026-03-23OpenAlex10.3389/fimmu.2026.1775111Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140076334
W7140115426Inside the Machine: Podcasting with AI Agents in 20262026-03-23OpenAlex10.5281/zenodo.19184693Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140115426
W7140123432Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold?2026-03-23OpenAlex10.3390/cancers18061034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140123432
W7140127463Large language models in healthcare2026-03-23OpenAlex10.1038/s41581-026-01071-3Full textExcludedF1: The publisher identifies this as Clinical Outlook rather than a primary system study.https://openalex.org/W7140127463https://www.nature.com/articles/s41581-026-01071-3Publisher Clinical Outlook label and standfirst only; body subscription-only
W7140124679PEDAGOGICAL FUNCTIONS OF AI-BASED SYSTEMS IN PROFESSIONAL ADAPTATION: A COMPARATIVE CONTENT ANALYSIS2026-03-23OpenAlex10.5281/zenodo.19195390Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140124679
W7220072021Robust 6G IoT Communication Models for Assistive Devices Using Graph-Augmented Deep Reinforcement Learning2026-03-23OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220072021
W7143339756The AI Ego: What a 1,600-year-old theory of consciousness reveals about the design risks hiding in agentic systems2026-03-23OpenAlex10.5281/zenodo.19191573Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7143339756
W7140076650The AI Firewall: Securing the New Enterprise Perimeter2026-03-23OpenAlex10.5281/zenodo.19183553Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140076650
W7140112805The evolving role of futibatinib for advanced cholangiocarcinoma2026-03-23OpenAlex10.1080/17474124.2026.2649804Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140112805
W7147284996A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones2026-03-24OpenAlex10.3389/fcimb.2026.1798936Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147284996
W7140297676An Intelligent Health and Wellbeing Advisor for Senior Citizens2026-03-24OpenAlex10.5334/ijic.icic25036Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7140297676
W7140173443Autonomous digital twin framework for gas turbine combined cycle control loops: Comparative study of proportional-integral control, reinforcement learning, and reinforcement learning with agents2026-03-24OpenAlex10.1016/j.egyai.2026.100727Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140173443
W7140185972Beyond mechanisms: toward patient-centered choices in BTKi-venetoclax fixed-duration therapy for CLL2026-03-24OpenAlex10.1038/s41375-026-02945-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140185972
W7147692679Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction2026-03-24OpenAlex10.1080/14656566.2026.2654675Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147692679
W7140214190Correction: Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations2026-03-24OpenAlex10.3389/fonc.2026.1803643Title/abstractExcludedE5: Correction, retraction or ancillary data record.https://openalex.org/W7140214190
W7140299787Decoding psoriasis: pathological mechanisms, evolving treatments, clinical investigations, and future perspectives2026-03-24OpenAlex10.1080/15569527.2026.2645820Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140299787
W7140184802From Medical LLMs to Versatile Medical Agents: A Comprehensive Survey2026-03-24OpenAlex10.22541/au.177437366.61663600/v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7140184802
W7140165471Hyperglycemia — An Evolutionary Blind Spot: The Central Neurological Set Point Reset Hypothesis of Progressive Type 2 Diabetes2026-03-24OpenAlex10.5281/zenodo.19201284Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140165471
W7140189041Letter: From Safety to Precision—Optimising the Use of GLP ‐1 Receptor Agonists in Gastroenterology: Authors' Reply2026-03-24OpenAlex10.1111/apt.70547Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140189041
W7140236581Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States2026-03-24OpenAlex10.1158/2767-9764.crc-25-0581Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140236581
W7147291791Role of novel β-lactam antibiotics in the treatment of bacterial pneumonia2026-03-24OpenAlex10.1080/14656566.2026.2654676Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147291791
W7140177125Teaching through the seventh art: students, classrooms, and teachers on screen2026-03-24OpenAlex10.60147/1f32d8e8Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140177125
W7140165609Toward clinical integration of generative AI in mental health: personalization, multimodality and inter-entity experience2026-03-24OpenAlex10.3389/fpubh.2026.1603238Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140165609
W7140305445A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review2026-03-25OpenAlex10.23736/s0022-4707.26.17773-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140305445
W7140313652Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction2026-03-25OpenAlex10.3390/ijms27072973Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140313652
W7140277054Cuproptosis: Bridging targeted therapy and immunotherapy in cancer treatment2026-03-25OpenAlex10.1016/j.critrevonc.2026.105296Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140277054
W7140315772Drug repurposing against viral infections (2020–2025): clinical trials, computational strategies, and therapeutic interventions2026-03-25OpenAlex10.1007/s10787-026-02193-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140315772
W7140303728Early biological therapy in hidradenitis suppurativa: A commentary2026-03-25OpenAlex10.1111/jdv.70282Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140303728
W7140208285Evolving treatment strategies for HER2-altered non–small-cell lung cancer: the rise of TKIs and ADCs2026-03-25OpenAlex10.3389/fonc.2026.1771869Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140208285
W7140696288Fifty Years of Nursing Knowledge: A Conversation Between Generations2026-03-25OpenAlex10.1111/jan.70598Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140696288
W7140202767Hemostatic powder for gastrointestinal malignant tumor bleeding2026-03-25OpenAlex10.5946/ce.2025.387Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140202767
W7161574757Insurance companies in healthcare financing: functional roles and a comparative analysis of international participation models2026-03-25OpenAlex10.35774/econa2026.01.324Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161574757
W7140327906Long‐term safety and efficacy in paediatric psoriasis: Remaining challenges2026-03-25OpenAlex10.1111/jdv.70333Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140327906
W7140274305MedSegAgent: A Universal and Scalable Multi-Agent System for Instructive Medical Image Segmentation2026-03-25OpenAlex10.1109/jbhi.2026.3677444Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7140274305
W7154599768Nano-Robotic Neurosurgery and Anesthetic Management Strategies2026-03-25OpenAlex10.21088/ijaa.2349.8471.13126.3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154599768
W7140916829Application research on intelligent probing based on large-scale AI models in internet fault handling2026-03-26OpenAlex10.54254/2977-3903/2026.32426Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140916829
W7164533007Beyond Ceftriaxone: The Future of Gonorrhea Diagnosis and Treatment2026-03-26OpenAlex10.1093/cid/ciag214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164533007
W7152665665Comment on “how the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes”2026-03-26OpenAlex10.1093/oncolo/oyag112Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152665665
W7140581602Efficacy of Intra-Articular Tranexamic Acid in Reducing Early Postoperative Swelling and Pain Following Arthroscopic ACL Reconstruction: A Randomized Comparative Study2026-03-26OpenAlex10.1055/a-2835-3526Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140581602
W7140916327Guidebook for Safe Respiratory Endoscopic Diagnosis and Treatment: Secondary Publication2026-03-26OpenAlex10.58585/respend.2025-0056Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140916327
W7160824406Hierarchical Agent Architecture for Clinical Decision Support in Drug-Drug Interaction (DDI) Analysis2026-03-26OpenAlex10.1109/icdsaai69492.2026.11505194Full textExcludedF4: The research agent is explicitly stateless. Supabase stores timestamped dialogue history for ongoing multi-turn context, while the fixed Neo4j DDI graph is built once. Grader feedback triggers re-retrieval within the current task; no cross-case learned experience artifact is retained.https://openalex.org/W7160824406https://ieeexplore.ieee.org/document/11505194
W7141583664Immune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies2026-03-26OpenAlex10.4103/tcmj.tcmj-d-25-00206Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7141583664
W7140309664Liver transplant and autoimmune liver diseases: An up-to-date review2026-03-26OpenAlex10.4240/wjgs.v18.i3.114915Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140309664
W7147048763New Metrics for Assessing the Effectiveness of Medical Consultation Recommendations2026-03-26OpenAlex10.2174/9798898814984126010006Full textExcludedF5: The primary publisher abstract and public book sample were read. The60-page sample contains only the target chapter’s opening pp39–41, followed immediately by the next chapter onp60; target method/evaluation pp42–59 are absent. The introduction identifies a GPT-powered RDguru, so non-LLM status was not inferred from HDNN. Full learning/retention methods unavailable.https://openalex.org/W7147048763https://www.eurekaselect.com/chapter/27506Primary abstract plus online sample PDF pp31–34 read at https://benthambooks.com/ebook-files/sample-files/9798898814984-sample.pdf; no file archive/download.
W7140600582Optimizing postoperative inflammation in pediatric cataract surgery: Are intracameral steroids the way forward?2026-03-26OpenAlex10.4103/ijo.ijo_3099_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140600582
W7140559796Pioneering strategies for overcoming bacterial drug resistance2026-03-26OpenAlex10.71150/jm.2603100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140559796
W7140935011Recent advances in strabismus2026-03-26OpenAlex10.4103/ijo.ijo_3072_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140935011
W7140717796The Symbolic Negentropy Constellation: Unified Reference Map and 11D Canonical Stack2026-03-26OpenAlex10.5281/zenodo.19242746Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7140717796
W7140869583Vernal Keratoconjunctivitis: Toward a Structured, Algorithm-Based Management Strategy2026-03-26OpenAlex10.1007/s40135-026-00350-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140869583
W7140990890Amazon's AI Paradox: Winning the Infrastructure War2026-03-27OpenAlex10.5281/zenodo.19257620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7140990890
W7141561565Calprotectin and Sarcopenia in COPD: Biomarker, Bystander or Target?2026-03-27OpenAlex10.1002/jcsm.70283Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141561565
W7141084671Clinical Artificial Intelligence Agents in Nephrology: From Prediction to Action Through Workflow-Native Intelligence—A Roadmap for Workflow-Integrated Care2026-03-27OpenAlex10.3390/jcm15072576Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7141084671
W7141341759Current evidence and emerging approaches in immunotherapy for gynecological cancers2026-03-27OpenAlex10.1007/s12672-026-04785-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141341759
W7141242383Evolutionary Compass: A Cross-Domain Framework for Evolutionary Problem Solving2026-03-27OpenAlex10.5281/zenodo.19250879Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7141242383
W7125790784Exploring ChatGPT's Potential for Mental Health and Emotional Well-being Support: A Nano Review2026-03-27OpenAlex10.5281/zenodo.18390458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125790784
W7141737324Intrahepatic Cholangiocarcinoma: Contemporary Approaches to Surgical, Systemic, and Liver-Directed Therapy2026-03-27OpenAlex10.3390/livers6020024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141737324
W7141709775It Takes Two to Transplant2026-03-27OpenAlex10.1093/cid/ciag149Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7141709775
W7141109105Management of relapsed/refractory AL amyloidosis2026-03-27OpenAlex10.1182/bloodadvances.2025019223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141109105
W7141286860Mistral AI: Europe's High-Stakes Play for AI Sovereignty2026-03-27OpenAlex10.5281/zenodo.19257885Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141286860
W7141589469New perspectives in immunotherapy for hepatocellular carcinoma: Focusing on resistance mechanism, biomarker, and personalized treatment2026-03-27OpenAlex10.1016/j.critrevonc.2026.105305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7141589469
W7140997943Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer2026-03-27OpenAlex10.21873/anticanres.18108Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7140997943
W7154562457THERAPEUTIC PROGRESS IN SYSTEMIC TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS2026-03-27OpenAlex10.31435/ijitss.1(49).2026.4812Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154562457
W7142308381Antibody-drug conjugates in oncology: a clinically focused review for nursing practice2026-03-28OpenAlex10.1080/14737140.2026.2653634Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142308381
W7154161852INTEGRATED PLANT HEALTH MANAGEMENT2026-03-28OpenAlex10.61909/amkedtb032661Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154161852
W7142204561Microsoft's Secret Agentic AI Stack, Explained2026-03-28OpenAlex10.5281/zenodo.19286773Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7142204561
W7142134787Sacituzumab Tirumotecan in the Evolving Landscape of Ovarian Cancer Treatment2026-03-28OpenAlex10.1007/s40944-026-01115-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7142134787
W7141522706The changing patient profile: A retrospective study of trends in perioperative bleeding management and challenges in surgical care2026-03-28OpenAlex10.1016/j.sipas.2026.100345Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7141522706
W7142024561Thirty Years of Classical Hematology Drugs in the US : Approvals, Costs, and Sales2026-03-28OpenAlex10.1002/ajh.70298Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7142024561
W7142271136Valproic acid: Mechanistic insights into neuronal actions, epigenetic modulation, and clinical risk2026-03-28OpenAlex10.1016/j.coph.2026.102626Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142271136
W7142766442AUG-WP-078: HDAR — Human Directed Agent Relay Framework2026-03-29OpenAlex10.5281/zenodo.19317819Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142766442
W7142711019Advancements in Endocrinology2026-03-29OpenAlex10.52756/bhietm.2025.v04.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142711019
W7143317517Anticoagulation Stewardship Program in the DOAC Era2026-03-29OpenAlex10.3390/jcm15072597Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143317517
W7143434008Difficult‐To‐Treat Psoriatic Arthritis: An Evolving Clinical Construct2026-03-29OpenAlex10.1111/1756-185x.70632Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7143434008
W7142665304Digital Ghosts in the Machine2026-03-29OpenAlex10.5281/zenodo.19303766Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142665304
W7143060575HAOS Genesis: Predicting Structural Collapse in Path-Dependent Graphs2026-03-29OpenAlex10.5281/zenodo.19317502Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7143060575
W7142934062LSP: The Universal AI Coding Interface2026-03-29OpenAlex10.5281/zenodo.19303436Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7142934062
W7143052718The Confluence of Creating: M = C2026-03-29OpenAlex10.5281/zenodo.19323614Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7143052718
W7142975824The Intelligence Explosion That Will Calcify: Extended Phenotype Theory, Asymmetric Intentionality, and the Evolutionary Pathologies of Agent Institutions2026-03-29OpenAlex10.5281/zenodo.19323302Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7142975824
W71438514242025 Novel Drug Approvals2026-03-30OpenAlex10.54299/tmed/cram4550Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143851424
W7143352747An Octogenarian’s Anamnesis on a Primary Care Career in a Premier Academic Medical Center2026-03-30OpenAlex10.4103/hm.hm-d-25-00159Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143352747
W7144063719Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions2026-03-30OpenAlex10.1002/mco2.70699Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144063719
W7143507495Azole Antifungal Lozenges for Oral Candidiasis: Mechanism, Efficacy, and Emerging Resistance2026-03-30OpenAlex10.55041/ijsmt.v2i3.385Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143507495
W7143316960CRISPR and the Promise of Gene Editing: Unlocking Curative Possibilities for Liver Disorders Worldwide2026-03-30OpenAlex10.14309/crj.0000000000002061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143316960
W7143425907Commentary: GETgene-AI: a framework for prioritizing actionable cancer drug targets2026-03-30OpenAlex10.3389/fsysb.2026.1793501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143425907
W7164910374Cover, Content, and Editorial Note from Borneo J Pharm Vol. 8 No. 4 November 20252026-03-30OpenAlex10.33084/bjop.v9i1.13262Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164910374
W7143390995Dentin hypersensitivity, an enigma revisited: Mechanisms, diagnosis and therapeutic advances2026-03-30OpenAlex10.4103/jcde.jcde_41_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143390995
W7143351762Editorial: Non-pharmacologic approaches to inflammation in the critically ill2026-03-30OpenAlex10.3389/fmed.2026.1822282Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143351762
W7147155899Fifteen Year Weight, Metabolic, and Conversion Outcomes After Primary Metabolic Bariatric Surgery in Individuals Living with Obesity and Type 2 Diabetes2026-03-30OpenAlex10.58624/svoamr.2026.04.010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7147155899
W7143357685From Signal to Surveillance: Assessing the Role of MicroRNAs in Cardiac Allograft Rejection2026-03-30OpenAlex10.1161/circheartfailure.126.014207Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143357685
W7143375566Jenkins, GitHub, or Tekton? Picking Your 2025 CI/CD Engine2026-03-30OpenAlex10.5281/zenodo.19338009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143375566
W7143290051Multimodal Imaging for Monitoring of Disease Progression in Cardiac Amyloidosis: Advances and Gaps in Evidence2026-03-30OpenAlex10.3390/jcdd13040152Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143290051
W7143524856Políticas pombagíricas do comum: Trapo, Farrapo e Molambo como agentes de mundos possíveis2026-03-30OpenAlex10.1590/scielopreprints.15228Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7143524856
W7143383899Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation2026-03-30OpenAlex10.4244/eij-d-25-00896Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7143383899
W7143510620Randomized Trials Meet Real-World Evidence in the Era of Combination CKD Therapies2026-03-30OpenAlex10.1016/j.ekir.2026.106519Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143510620
W7143351983The Landscape of Clinical Trials for Targeting c-MET Therapy2026-03-30OpenAlex10.1097/coc.0000000000001319Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7143351983
W7143523737Transforming Acute Myeloid Leukemia Care through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies2026-03-30OpenAlex10.1159/000551702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143523737
W7143518109When AI Supervisors Fire AI Workers2026-03-30OpenAlex10.5281/zenodo.19338578Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143518109
W7143959709A COMPARATIVE STUDY OF PREDICTIVE AI AND AGENTIC AI: EXAMINING KEY DIFFERENCES IN AUTONOMY, GOAL ORIENTATION, HUMAN INTERACTION, AND SYSTEM ACCOUNTABILITY2026-03-31OpenAlex10.29121/jissi.v2.i1.2026.45Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143959709
W7143706913Active Imagination as Agent of Transformation2026-03-31OpenAlex10.4324/9781003597629-13Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7143706913
W7143611416Adult T-cell leukemia/lymphoma: molecular pathogenesis, emerging therapies, and future directions2026-03-31OpenAlex10.3389/fonc.2026.1794939Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143611416
W7143676746Association Between Survival Benefits of Anticancer Drugs and Probability of US Food and Drug Administration Approval: A Systematic Review2026-03-31OpenAlex10.1007/s40290-026-00606-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143676746
W7160211688Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha2026-03-31OpenAlex10.25258/ijcpr.18.3.220Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160211688
W7143802089Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT2026-03-31OpenAlex10.1038/s41409-026-02816-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7143802089
W7143857150Case Report: The diagnostic and therapeutic crossroads: when myelofibrosis transforms into mixed phenotype acute leukemia2026-03-31OpenAlex10.3389/fonc.2026.1811409Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7143857150
W7144177328Decoding ferroptosis and apoptosis crosstalk in glioblastoma: molecular mechanisms, microenvironmental regulation, and therapeutic advances2026-03-31OpenAlex10.1007/s11033-026-11738-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144177328
W7144218149Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine2026-03-31OpenAlex10.1021/acs.molpharmaceut.6c00111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144218149
W7146988402Extrarenal disease in ANCA-associated vasculitis: challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA2026-03-31OpenAlex10.1093/ndt/gfag077Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7146988402
W7147557940Fluoride-Free Toothpastes for Caries Prevention: A Systematic Review of Clinical Evidence on Active Ingredients2026-03-31OpenAlex10.2147/ccide.s586895Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147557940; https://openalex.org/W7149217449
W7146955509Foundation models and AI agents in oncology drug discovery2026-03-31OpenAlex10.1016/j.drudis.2026.104655Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7146955509
W7147273394From Atoms to Agents: A Decade of Transformation in Artificial Intelligence (AI) in Medicine2026-03-31OpenAlex10.5281/zenodo.19353903Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7147273394
W7143465019Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches2026-03-31OpenAlex10.1007/s10072-026-08936-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143465019
W7148333645Innovative Utilization of Endolysins for Future Battle Against Superbugs2026-03-31OpenAlex10.2174/0113892010450500260226080647Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148333645
W7144349652Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity2026-03-31OpenAlex10.1111/apt.70641Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144349652
W7161583213Making the Independence Worth It: The Commercial Negotiations Between the United States and the Italian States in the “Critical Period,” 1783–17892026-03-31OpenAlex10.1093/dh/dhag020Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161583213
W7143941814Meta-analysis ofHealth-Related Quality of Life (HRQOL) Impairments in Patients with Complex Regional Pain Syndrome Type-1 Based on the SF-362026-03-31OpenAlex10.1016/j.pmn.2026.01.071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143941814
W7147093516Multi-Agent Reinforcement Learning for Resilient UAV Ad Hoc Backhaul Networks2026-03-31OpenAlex10.1109/jmass.2026.3679292Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7147093516
W7147037306Multiscale modeling of the spatial structure of stem cells in neuroblastoma patient-derived tumoroids reveals a critical role for a short-range diffusive process2026-03-31OpenAlex10.1371/journal.pcbi.1014137Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7147037306
W7144325910Research hotspots and trends in therapeutic drug monitoring of anticancer drugs: a 1990–2024 bibliometric analysis2026-03-31OpenAlex10.3389/fonc.2026.1617790Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7144325910
W7147622296The Missing Identity Layer- A Minimal Ontology for Live and Exploratory Modeling2026-03-31OpenAlex10.5281/zenodo.19343613Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7147622296
W7143644576Visualizing the metabolic battleground: the role of PET imaging in understanding immunometabolism and the tumor microenvironment2026-03-31OpenAlex10.1097/mnm.0000000000002150Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7143644576
W7147515418Your AI Has a Memory Problem. Here's the Fix.2026-03-31OpenAlex10.5281/zenodo.19360785Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147515418
W71470356342026-04-01OpenAlex10.13040/ijpsr.0975-8232.17(4).1340-45Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7147035634
W7148533625A deep reinforcement learning framework for multi-dimensional adaptability in building operations2026-04-01OpenAlex10.1016/j.jobe.2026.115993Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148533625
W7150895607Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics2026-04-01OpenAlex10.1002/jgh3.70394Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150895607
W7154503266An update on infectious encephalitis: from epidemiology to management2026-04-01OpenAlex10.1097/qco.0000000000001192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154503266
W7148973091Artificial Intelligence in Clinical Gastroenterology: Promise, Pace, and Proof2026-04-01OpenAlex10.14309/ajg.0000000000003972Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148973091
W7164499514B-cell Maturation Antigen-directed Therapies versus Standard Regimens in Lenalidomide-refractory Relapsed or Refractory Multiple Myeloma After 1-3 Prior Lines: A Systematic Review and Network Meta-analysis of Phase 3 Trials2026-04-01OpenAlex10.4103/joah.joah_23_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164499514
W7154692178Better the Time in Range, Longer the Time in Life2026-04-01OpenAlex10.4103/ijdt.ijdt_16_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154692178
W7155373149Between Nutrition and Toxicity: A Narrative Synthesis of Metabolomic Complexity in Edible and Poisonous Mushrooms2026-04-01OpenAlex10.25163/microbbioacts.9110640Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155373149
W7166707891Beyond Pain Scores: Molecular Biomarkers and the Emergence of Precision Pain Medicine2026-04-01OpenAlex10.4103/ijpn.ijpn_77_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166707891
W7160251814Bovine mastitis associated with Enterobacteriaceae in Brazil: A systematic review2026-04-01OpenAlex10.1016/j.pvmrsr.2026.100008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160251814
W7166025784Chemotherapy for colorectal cancer: consolidation of the cornerstone and advances in precision2026-04-01OpenAlex10.16139/j.1007-9610.2026.02.03Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166025784
W7147049598Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia2026-04-01OpenAlex10.1002/ajh.70313Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7147049598
W7147014134Comprehensive Overview of Artificial Intelligence Applications in Biomedical Research and Precision Medicine (2024–2026)2026-04-01OpenAlex10.5281/zenodo.19372021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147014134; https://openalex.org/W7219730871
W7151929247Conference Abstracts from the 12th Asian Scientific Meeting of Pediatric Dermatology in Manila, Philippines, 5–7 November 20252026-04-01OpenAlex10.4103/ajpd.ajpd_5_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151929247
W7150090481Contemporary Developments in PROTACs for Cancer Management: An In-Depth Review2026-04-01OpenAlex10.2174/0115680266384226251013054011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150090481
W7160159205Development of pharmacological interventions for the treatment of sarcopenia2026-04-01OpenAlex10.21037/atm-2025-1-184Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160159205
W7165682846Dr. Popat Prabhuram Vaidya: Architect of institutional Ayurveda and interpreter of Tridoṣa in the era of modern medicine2026-04-01OpenAlex10.4103/ijar.ijar_68_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165682846
W7143374066EVOLVING CONCEPTS IN PCOS: DIAGNOSTIC INNOVATIONS AND NOVEL THERAPEUTIC STRATEGIES2026-04-01OpenAlex10.5281/zenodo.19327400Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7143374066
W7164052664Emerging treatments in fungal keratitis2026-04-01OpenAlex10.4103/sjopt.sjopt_492_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164052664
W7147400249Evaluating Fetal Bradycardia on Prenatal Ultrasonography: A Review of Diagnostic Consideration and Clinical Implications2026-04-01OpenAlex10.1542/neo.27-4-008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147400249
W7166334835Evaluation of Phytochemical and Antibacterial Activities of Ceylon Cinnamon and Salvia officinalis2026-04-01OpenAlex10.4103/bbrj.bbrj_9_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166334835
W7152948114Exosome-Mediated Rewiring of Oxidative Stress–Inflammation–ECM Remodeling Axis Mitigates UVB-Triggered Skin Photoaging2026-04-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152948114; https://openalex.org/W7151776238
W7154590239Four-Day Static Lung Preservation via a Pharmacologically Induced Hibernation-Like State in a Large-Animal Lung Transplant Model2026-04-01OpenAlex10.1016/j.healun.2026.02.095Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154590239
W7165244696Generative AI in enterprises: optimizing applications with large language models2026-04-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165244696
W7165109433Harnessing liposome technology for precision medicine: design, delivery, and clinical impact2026-04-01OpenAlex10.22038/nmj.2025.86734.2188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165109433
W7154081339How the new general and acute care medicine curriculum moves trainees beyond the bedside: from whole‐patient care to whole‐system leaders2026-04-01OpenAlex10.1111/imj.70422Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154081339
W7146987276Hypoparathyroidism: a brief historical overview for clinicians2026-04-01OpenAlex10.3389/fendo.2026.1769262Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7146987276
W7148680240Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment2026-04-01OpenAlex10.1200/po-25-00767Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148680240
W7164070404Microbial keratitis in transition: From traditional paradigms to emerging solutions2026-04-01OpenAlex10.4103/sjopt.sjopt_223_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164070404
W7168295288Monkeypox Virus Pathophysiological Effects on Human Organ Systems: A review2026-04-01OpenAlex10.36582/ksj.2026.168699.1019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168295288
W7147177042Non-small cell lung cancer research: advances and persistent challenges2026-04-01OpenAlex10.3389/fonc.2026.1729747Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147177042
W7157281370P070 Unmasking an autoimmune breast disease: rheumatology’s evolving role in idiopathic granulomatous mastitis2026-04-01OpenAlex10.1093/rheumatology/keag121.106Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7157281370
W7156675393P159 New kids on the block - real-world experience of using belimumab, obinutuzumab and voclosporin in systemic lupus erythematosus. A retrospective cohort study in University College London Hospital2026-04-01OpenAlex10.1093/rheumatology/keag121.192Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7156675393
W7153312592Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AI2026-04-01OpenAlex10.1002/psp4.70249Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7153312592
W7148107972Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy2026-04-01OpenAlex10.3389/fopht.2026.1802903Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148107972
W7147647665Recent Advances in Emulgel Technology for Enhanced Transdermal Drug Delivery2026-04-01OpenAlex10.5281/zenodo.19369101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147647665
W7147646953Renegade AI: Catalyst for Human Cognitive Evolution2026-04-01OpenAlex10.17605/osf.io/8abzvTitle/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7147646953
W7150002618Revisiting Intranasal Salmon Calcitonin: Historical Osteoporosis Evidence and a Potential Role in Acute Orthopaedic Pain Management2026-04-01OpenAlex10.2106/jbjs.rvw.26.00021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150002618
W7154717487Survival Outcomes Based on Line of Therapy and Treatment Trends With Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer2026-04-01OpenAlex10.1200/oa-25-00167Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154717487
W7154690732Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer2026-04-01OpenAlex10.1002/cbin.70157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154690732
W7154603259Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature2026-04-01OpenAlex10.1016/j.cell.2026.03.016Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154603259
W7166654810The Evolution of Histological Visualization from Classical Foundations to Translational Innovation2026-04-01OpenAlex10.4103/njca.njca_90_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166654810
W7155689619The emerging role of antibody-drug conjugates in breast cancer: a systematic review of clinical evidence2026-04-01OpenAlex10.5603/ocp.111254Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155689619
W7153768145The rise of marine fungi: Drug discovery's blue frontier2026-04-01OpenAlex10.1002/ctm2.70623Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153768145
W7155157694WITHDRAWN: Combat Casualty Care in the 21st Century: Advances, Challenges, and Evidence-Based Strategies for Armed Forces Medical Services.2026-04-01OpenAlex10.1016/j.jseint.2026.101716Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7155157694
W7147331182Your Calendar Is Now a Negotiation2026-04-01OpenAlex10.5281/zenodo.19361635Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147331182
W7155020065‘Stretched… like butter scraped over too much bread ’—The SENCo role in Sweden, England, Ireland and Austria: An ecosystemic analysis in evolving inclusive and special education policy landscapes2026-04-01OpenAlex10.1111/1471-3802.70088Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155020065
W7147267606“Comment on Nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures a systematic review and meta-analysis”: a systematic review and meta-analysis”2026-04-01OpenAlex10.1097/ms9.0000000000004849Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147267606
W7148234815A Qualia-based Inference Approach for Solving Mathematical Word Problems with Application to Building Intelligent Tutoring Systems2026-04-02OpenAlex10.71747/uow-r3gk326m.31921041Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7148234815
W7146968416A star in the daylight clinical vignette: Lesional focal epilepsy with cerebral accessory falx2026-04-02OpenAlex10.1002/epd2.70235Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7146968416
W7148303461Advancements in the management of septic shock: a multidimensional approach for enhanced patient outcomes2026-04-02OpenAlex10.1007/s44349-026-00043-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148303461
W7148615728Advances in the treatment of cutaneous tumors: from conventional therapies to targeted and immunotherapeutic strategies2026-04-02OpenAlex10.1186/s12957-026-04326-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148615728
W7148374607Advancing human–AI teams: evolving from instrumental tools to trusted partners2026-04-02OpenAlex10.1007/s00146-026-02977-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148374607
W7148323848Artificial Epidemiology: How self-evolving clinical AI manufactures disease prevalence from administrative coding artifacts2026-04-02OpenAlex10.33774/coe-2026-ssm1qTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7148323848
W7211974952Clinical spectrum, antibiotic sensitivity, and clinical outcome of urinary tract infection in the pediatric age group: A cross-sectional study2026-04-02OpenAlex10.17727/jmsr.2026/14-11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7211974952
W7148444555Current Perspectives on Herbal Creams as Topical Dosage Forms2026-04-02OpenAlex10.5281/zenodo.19384179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148444555
W7148415347Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials2026-04-02OpenAlex10.1016/j.annonc.2026.03.006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148415347
W7147242765Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity2026-04-02OpenAlex10.3389/fmed.2026.1773414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7147242765
W7148372250Large models for machinery fault diagnosis: Current advances and future directions2026-04-02OpenAlex10.1016/j.cjme.2026.100277Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148372250
W7148434877Nonlinear Response of Phospholipid-Shelled Ultrasound Contrast Agents: Ambient Conditions Affect Temporal Evolution2026-04-02OpenAlex10.1016/j.ultrasmedbio.2026.02.024Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148434877
W7148386240Pioneers and Pathfinders: 10 years of Frontiers in Medicine from t(ether)ed in-person medicine to untethered telemedicine2026-04-02OpenAlex10.3389/fmed.2026.1600039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148386240
W7160276715Post-Pandemic Therapeutic Strategies for COVID-19: Current Approaches, Challenges, and Future Directions2026-04-02OpenAlex10.21275/sr26429043025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160276715
W7148557649Targeting MET in EGFR-Mutated NSCLC2026-04-02OpenAlex10.1016/j.jtho.2026.103711Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148557649
W7148609453Translation of Intraoperative Molecular Imaging for Clinical Use2026-04-02OpenAlex10.2967/jnumed.124.268773Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148609453
W7149034322ABB-E-HAYAAT آب حیات — THE WATER OF LIFE Complete Geometric Restoration of All Pathogens to Their Original Beneficial Purpose A Comprehensive N‑K Publication: Viruses (1,200+), Bacteria (200+), Fungi (150+), Parasites (120+) — Phase Correction to 135.5° Divine Lock, N = 1.3332026-04-03OpenAlex10.5281/zenodo.19407519Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7149034322
W7148838116Abstract 1551: Intratumoral biodegradable nanofluidic platform for localized multimodal immunotherapy enhances tumor eradication and immune memory2026-04-03OpenAlex10.1158/1538-7445.am2026-1551Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148838116
W7148930743Abstract 1881: Understanding evolutionary and ecological mechanisms of sotorasib resistance in KRAS G12C-mutant non-small cell lung cancer.2026-04-03OpenAlex10.1158/1538-7445.am2026-1881Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148930743
W7148909300Abstract 2747: Source discipline matters: Guideline anchored large language model outperforms Open Evidence for decision support in acute leukemias.2026-04-03OpenAlex10.1158/1538-7445.am2026-2747Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7148909300
W7148823066Abstract 27: An MCP-enabled AI agent for automated multimodal genomics analysis in the Isabl Platform.2026-04-03OpenAlex10.1158/1538-7445.am2026-27Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7148823066
W7148987912Abstract 293: Anti-cancer drug usage analysis among Korean patients with colorectal cancer.2026-04-03OpenAlex10.1158/1538-7445.am2026-293Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148987912
W7148711990Abstract 3098: Discovery of the RAD51 inhibitor JKYN-1 and characterization of its anticancer activity in preclinical models of non-small cell lung cancer2026-04-03OpenAlex10.1158/1538-7445.am2026-3098Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148711990
W7148889200Abstract 3542: Evolving toward precision oncology: Leveraging collateral drug responses for personalized second-line osteosarcoma treatment2026-04-03OpenAlex10.1158/1538-7445.am2026-3542Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148889200
W7149008215Abstract 4054: Tumor-activated PrimeBody biologics platform enables more potent CD47 targeting and superior therapeutic index in preclinical models2026-04-03OpenAlex10.1158/1538-7445.am2026-4054Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7149008215
W7148928265Abstract 4398: Developing 3D cell models for high-throughput antibody-drug conjugate screening in cancer2026-04-03OpenAlex10.1158/1538-7445.am2026-4398Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148928265
W7148635706Abstract 5230: Alopecia in cancer immunotherapy: Incidence and patterns with monoclonal antibodies and antibody-drug conjugates2026-04-03OpenAlex10.1158/1538-7445.am2026-5230Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148635706
W7148657734Abstract 6073: Establishment and characterization of a panel of EGFR-mutant lung XPDX models representing naïve, chemotherapy, and targeted therapy-resistant patient populations2026-04-03OpenAlex10.1158/1538-7445.am2026-6073Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148657734
W7148854017Abstract 6832: Toward personalized rotational multi-agent therapies to overcome treatment resistance in pancreatic cancer: A virtual trial framework in mice.2026-04-03OpenAlex10.1158/1538-7445.am2026-6832Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7148854017
W7148764108Abstract 6843: A joint model for integrating serial methylation-based tumor fraction and ESR1 assessment to forecast overall survival in patients with ER+/HER2- metastatic breast cancer.2026-04-03OpenAlex10.1158/1538-7445.am2026-6843Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148764108
W7148807014Abstract 7392: A cancer cell-intrinsic PAR1/MALT1/PD-L1 signaling pathway drives immune evasion in triple-negative breast cancer2026-04-03OpenAlex10.1158/1538-7445.am2026-7392Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148807014
W7148684421Abstract 7528: Utilizing confocal live-cell imaging for evaluating therapeutic efficacy and toxicity in complex oncology models2026-04-03OpenAlex10.1158/1538-7445.am2026-7528Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148684421
W7148892444Abstract 7630: Shear wave elastography and photoacoustic imaging to non-invasively identify resistant regions in the tumor microenvironment2026-04-03OpenAlex10.1158/1538-7445.am2026-7630Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148892444
W7148872402Agentic AI scientists and the rise of virtual laboratories2026-04-03OpenAlex10.1097/ms9.0000000000004925Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7148872402
W7148781726Artificial Intelligence Justice Philosophy Theory2026-04-03OpenAlex10.17605/osf.io/bt8ejTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148781726
W7152116011Bridging bench to bedside: mechanistic elucidation and clinical translation of vasopressin and its analogues for hemorrhagic shock resuscitation2026-04-03OpenAlex10.1097/shk.0000000000002845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152116011
W7149030222Curcumin as a JAK/STAT pathway modulator in breast cancer: Mechanisms and nanomedicine perspectives2026-04-03OpenAlex10.1016/j.prenap.2026.100727Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7149030222
W7165400444Deneysel Sepsis Modelleri2026-04-03OpenAlex10.37609/akya.4023.c6240Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165400444
W7148868635Hope Without a Name: The Philosophy and Politics of Protecting the Forgotten Child2026-04-03OpenAlex10.17605/osf.io/fbmuyTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148868635
W7148927721Lifelong Learning in Artificial Intelligence2026-04-03OpenAlex10.5281/zenodo.19409874Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7148927721
W7148505863Mechanistically driven transnidal hemodynamic manipulations enhance simulated endovascular transvenous treatments for brain AVMs2026-04-03OpenAlex10.1038/s43856-026-01555-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7148505863
W7148703031Muscle-predominant vasculitic myopathy heralding renal MPO-ANCA–associated vasculitis: A case-based mini-review of diagnostic traps and steroid-sparing induction2026-04-03OpenAlex10.1016/j.amjms.2026.03.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148703031
W7148693447Precision Medicine in Breast Cancer2026-04-03OpenAlex10.1201/9781003644309-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148693447
W7152023192Pulmonary arterial hypertension: Focused therapeutic update2026-04-03OpenAlex10.1093/ajhp/zxag102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152023192
W7148934828Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists2026-04-03OpenAlex10.1111/jdi.70299Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7148934828
W7164386458SepsiGuard: A Triple-Layer Agentic XAI Framework for Early Sepsis Prediction and Adaptive ICU Monitoring2026-04-03OpenAlex10.5281/zenodo.19396525Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164386458
W7150879636Cleft related facial skeletal surgery: an update2026-04-04OpenAlex10.1097/moo.0000000000001127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150879636
W7149683401Coding Tools Are Secretly System Agents2026-04-04OpenAlex10.5281/zenodo.19423042Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7149683401
W7149421179Governing Artificial Intelligence in the Evolving Academic Publishing Ecosystem2026-04-04OpenAlex10.57019/jmv.1899774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7149421179
W7149660189USE OF NANOTECHNOLOGICAL CONCEPTS AND TERMINOLOGY IN MEDICINE: CURRENT APPLICATIONS, CLINICAL VALUE, AND TRANSLATIONAL CHALLENGES2026-04-04OpenAlex10.5281/zenodo.19421210Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7149660189
W7150065916N-PACE framework: hydro-climatic whiplash modeling2026-04-05OpenAlex10.5281/zenodo.19427910Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7150065916
W7150198468Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts2026-04-05OpenAlex10.1007/s40487-026-00432-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150198468
W7149904760The Correction Trilemma by Jalal Khawaldeh: A Diagnostic Heuristic for Trade-offs in Epistemic Systems2026-04-05OpenAlex10.5281/zenodo.19429564Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7149904760
W7149988244The Geometry of Decoherence: Cognitive Structuralism and the Architectural Risks of Convergent-Dominant AGI2026-04-05OpenAlex10.5281/zenodo.19427092Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7149988244
W7151485118Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives2026-04-06OpenAlex10.20892/j.issn.2095-3941.2025.0707Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151485118
W7151096044Enhancing robustness in multi-agent reinforcement learning via temporal consistency regularization: A self-distillation framework2026-04-06OpenAlex10.1016/j.knosys.2026.115940Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7151096044
W7152098529EvolveRouter: Co-Evolving Routing and Prompt for Multi-Agent Question Answering2026-04-06OpenAlex2604.0514910.48550/arxiv.2604.05149Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7152098529
W7150786554From Complex Targets to General Methods: Celebrating Jieping Zhu's 60th Birthday2026-04-06OpenAlex10.1002/ejoc.70420Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150786554
W7150746556Identification and phylogenetic analysis of multidrug resistance, caries-related Streptcoccus mutans in Sulaymaniyah City, Iraqi Kurdistan Region2026-04-06OpenAlex10.1007/s10123-026-00810-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7150746556
W7154604179Law Schools in the Era of Green Transition: Governing Legal Education for Sustainable Development and Digital Transformation2026-04-06OpenAlex10.59324/ejceel.2026.4(2).20Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154604179
W7150817931Supplementary Material for: Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials2026-04-06OpenAlex10.6084/m9.figshare.31941633Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150817931
W7152338097The Correction Trilemma: A Diagnostic Heuristic for Trade-offs in Epistemic Systems2026-04-06OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152338097; https://openalex.org/W7152424096; https://openalex.org/W7171616431; https://openalex.org/W7152452633
W7150790991The Evolving Role of Artificial Intelligence in STEM Teaching and Learning2026-04-06OpenAlex10.18260/1-2-118-58102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7150790991
W7151454731A Comprehensive Review of the Pathophysiology and Management of Osteoarthritis: Emerging Therapeutic Strategies and Clinical Insights2026-04-07OpenAlex10.7759/cureus.106561Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151454731
W7151413347A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA2026-04-07OpenAlex10.3390/biom16040543Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151413347
W7217742708AI PROMPT LIBRARY TOOL2026-04-07OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7217742708
W7151484330Biomarkers for complex post-traumatic stress disorder: translational and evolutionary perspectives2026-04-07OpenAlex10.3389/fpsyt.2026.1786811Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151484330
W7153498168Diabetic Neuropathy: Recent Diagnostic Advancements and Emerging Multimodal Therapeutic Strategies2026-04-07OpenAlex10.2174/0125899775400471251205102738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153498168
W7151531088Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances2026-04-07OpenAlex10.1007/s40257-026-01028-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151531088
W7151512410Drug-induced cataract: Comprehensive review of implicated agents and underlying pathophysiological mechanisms2026-04-07OpenAlex10.30574/ijsra.2026.19.1.0644Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151512410
W7151462625Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials2026-04-07OpenAlex10.1159/000551892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151462625
W7216478095FOURTH-GENERATION STATINS: ADVANCES IN LIPID-LOWERING THERAPY AND REDUCTION OF CARDIOVASCULAR RISK2026-04-07OpenAlex10.37547/supsci-ojmp-06-01-01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216478095
W7151563057GENESIS R90.3: AGI/ASI Impact Topology — Complete Session Documentation. Deep Dives · Reflection Loop · Peer Review · Adversarial Audit. Working Paper / Research Protocol / Synthetic Theory Exploration — Empirical Validation Pending2026-04-07OpenAlex10.5281/zenodo.19458198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151563057
W7151384803Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies2026-04-07OpenAlex10.1007/s11011-025-01781-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151384803
W7151567199Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance2026-04-07OpenAlex10.3389/fonc.2026.1785469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151567199
W7151422723Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Contemporary Review2026-04-07OpenAlex10.1007/s12609-026-00643-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151422723
W7151345928Suppression of mitochondrial energy production by a photosynthetic bacterial cupredoxin peptide inhibits tumor growth2026-04-07OpenAlex10.1038/s41392-026-02703-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151345928
W7153593930The Global Threat of Multidrug-Resistant Microorganisms: Implications for Human and Environmental Health2026-04-07OpenAlex10.2174/0122113525416941251216105950Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153593930
W7151461937Triple-Negative Breast Cancer Brain Metastasis: A Comprehensive Review of Epidemiology, Molecular Pathobiology, and Therapeutic Frontiers2026-04-07OpenAlex10.3390/cancers18071179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151461937
W7151984409A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol2026-04-08OpenAlex10.1128/mbio.03518-25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151984409
W7151902976Acute Stroke Patients on Daily Anticoagulant or Antiplatelet Therapy Receiving Thrombolysis or Thrombectomy2026-04-08OpenAlex10.7759/cureus.106657Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151902976
W7151966449Clinical Relevance of Cetirizine in Allergy Management: An Updated Evidence-Based Review2026-04-08OpenAlex10.5281/zenodo.19465982Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7151966449
W7151792144Contemporary Immunosuppression in Simultaneous Heart–Kidney Transplantation: A United Network for Organ‐Sharing Database Analysis2026-04-08OpenAlex10.1002/phar.70144Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151792144
W7153603659Early biologic therapy in psoriasis: challenging the stepwise paradigm2026-04-08OpenAlex10.1093/bjd/ljag131Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153603659
W7153604340Evaluation of Mechanisms and Therapeutic Opportunities of Thiazolidinediones in Insulin Sensitization2026-04-08OpenAlex10.2174/0125899775410298251206203015Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153604340
W7151835054Exploring the intersection: adult orbital xanthogranulomatous disease and IgG4-related disease – report of 3 cases and literature review2026-04-08OpenAlex10.6084/m9.figshare.31963624Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151835054; https://openalex.org/W7151974065
W7151821169It’s Not Just About the Tools: Emotionally Responsive GenAI Education2026-04-08OpenAlex10.5334/pme.2280Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151821169
W7151864937NexusMind: Agentic AI Orchestration Model2026-04-08OpenAlex10.22214/ijraset.2026.79343Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7151864937
W7151932060Risperidone redefined: A three-decade odyssey of broadening indications and evolving formulations2026-04-08OpenAlex10.1016/j.mjafi.2026.02.016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7151932060
W7161177561Voice-Driven Artificial Intelligence for Personalized Health and Wellness Support2026-04-08OpenAlex10.1109/ictmim68190.2026.11507534Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161177561
W7152743273A Review on the Herbal Potential for the Treatment of Peptic Ulcer2026-04-09OpenAlex10.32553/jbpr.v15i2.1439Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152743273
W7152484359An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review2026-04-09OpenAlex10.70070/2w2r9t25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152484359
W7152426277Developing AI Frameworks for Decision Coordination and Lesion Detection in Cancer Management2026-04-09OpenAlex10.71747/uow-r3gk326m.31956222Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7152426277
W7152533617Emerging Surface Coating Innovations for Orthopedic Implants: A Review2026-04-09OpenAlex10.60118/001c.146425Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152533617
W7154087695Endovascular Hemostasis in the Management of Arterial Upper Gastrointestinal Bleeding: Literature Review2026-04-09OpenAlex10.24060/2076-3093-2026-16-1-52-61Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154087695
W7152738677Future Directions in the Medical Treatment of Obesity: A Narrative Review2026-04-09OpenAlex10.1007/s12325-026-03576-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152738677
W7152964007Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy2026-04-09OpenAlex10.3390/life16040636Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7152964007
W7151957957Kūn: A Layered Epistemic Containment Architecture and the Mormon Boundary2026-04-09OpenAlex10.5281/zenodo.19474857Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7151957957
W7152719314Outcomes of Cultural Responsiveness Training for U.S. Students on Study Abroad to South Africa2026-04-09OpenAlex10.1044/2026_persp-25-00177Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7152719314
W7152507858Reproductive Control in the Bitch after Unplanned Mating (Misalliance): A Comprehensive Narrative Review2026-04-09OpenAlex10.9734/jsrr/2026/v32i44124Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152507858
W7152726997Systematic Review of Acute Encephalitis Syndrome (AES) and Japanese Encephalitis Virus in Eastern Uttar Pradesh: Epidemiological Trends, Pathogens, and Outcomes (2000–2025)2026-04-09OpenAlex10.5281/zenodo.19488419Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152726997
W7152509736Understanding Drug Resistance Mechanisms in Staphylococcus aureus2026-04-09OpenAlex10.1201/9781003647072-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152509736
W7153329839ANALYSIS OF OUTCOMES OF COMBINATION THERAPY IN CHILDHOOD HODGKIN LYMPHOMA: A LITERATURE-BASED REVIEW2026-04-10OpenAlex10.5281/zenodo.19500108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153329839
W7153302307ASI engagement begins with LLM engagement, Part 1 and Part 22026-04-10OpenAlex10.5281/zenodo.19491257Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7153302307
W7155568037Banking Policies and Bank Density in Nigeria2026-04-10OpenAlex10.5281/zenodo.19719857Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155568037; https://openalex.org/W7153772641
W7153353139Editorial: Physiology and pathophysiology of placenta2026-04-10OpenAlex10.3389/fendo.2026.1829406Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153353139
W7153213909Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): ‘Where the streets have no name’2026-04-10OpenAlex10.1016/j.critrevonc.2026.105327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153213909
W7154192531Floating Drug Delivery Systems: Advances in Gastroretentive Technologies for Enhanced Oral Bioavailability2026-04-10OpenAlex10.5281/zenodo.19492593Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154192531
W7153176635From Prompting to Autonomous Intelligence: A White Paper on the Phases of AI Learning, Technologies, and Methodologies.2026-04-10OpenAlex10.55041/ijsrem59657Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153176635
W7155769071Future directions in anesthesia: expanding the role of anesthetic drugs in sedation, analgesia, and recovery2026-04-10OpenAlex10.5124/jkma.26.0004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155769071
W7152959660New Landscape for Atopic Dermatitis Therapies2026-04-10OpenAlex10.1016/j.pcl.2026.02.007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7152959660
W7153274857Orchestrating cell death and microenvironment: Natural products as multi-target modulators of pyroptosis in myocardial ischemia-reperfusion injury2026-04-10OpenAlex10.1016/j.biopha.2026.119349Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153274857
W7153274679Perioperative immunotherapy for hepatocellular carcinoma: adjuvant, neoadjuvant, and biomarker-guided strategies2026-04-10OpenAlex10.3389/fmed.2026.1811918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153274679
W7153237218Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions2026-04-10OpenAlex10.1016/j.pharmr.2026.100136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153237218
W7153636173TRANSETHOSOMES: A PROMISING VESICULAR SYSTEM FOR OSTEOARTHRITIS DRUG DELIVERY2026-04-10OpenAlex10.5281/zenodo.19508062Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153636173
W7153591073The AI Relational Integrity Scale (ARIS): A 5-Factor Framework for Evaluating Ethical Alignment in Human–AI Interaction2026-04-10OpenAlex10.5281/zenodo.19503312Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7153591073
W7155895642The impact of drug selection on patient outcomes in anesthesia and postoperative care: a narrative review2026-04-10OpenAlex10.5124/jkma.25.0133Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155895642
W7153046387The rise of biologics: the need for their inclusion in pharmacology curriculum of dentistry2026-04-10OpenAlex10.1038/s41415-026-9540-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153046387
W7217812372Awareness and Utilization of Recent Advances in Pediatric Dentistry among Dental Practitioners: A Cross-Sectional Study2026-04-11OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7217812372
W7153542634Claude Managed Agents: Brain Versus Hands2026-04-11OpenAlex10.5281/zenodo.19520057Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7153542634
W7153789838Five Advances in the Last 50 Years: Liver Malignancies2026-04-11OpenAlex10.1002/wjs.70327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153789838
W7153573209Kratom (Mitragyna speciosa Korth.): ethnopharmacology, phytochemistry, therapeutic potential, and regulatory perspectives2026-04-11OpenAlex10.1016/j.phyplu.2026.100986Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153573209
W7153766473Pancreatic Cancer—Advances in the Last 50 Years2026-04-11OpenAlex10.1002/wjs.70309Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153766473
W7162002549TL1A as a therapeutic renaissance in inflammatory bowel disease: a systematic review from molecular mechanisms to clinical translation2026-04-11OpenAlex10.1093/ecco-jcc/jjag039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162002549
W7153719202Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery2026-04-11OpenAlex10.1002/wjs.70306Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153719202
W7161943619AgentFixer: From Failure Detection to Fix Recommendations in Agentic Systems2026-04-12OpenAlex10.1145/3786167.3788427Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7161943619
W7153769415Bridging Artificial Intelligence, Machine Learning with Green Nanotechnology: A Visionary Framework for Smart Fungal Disease Management in Plants2026-04-12OpenAlex10.1007/s00425-026-04998-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153769415
W7153984138Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease2026-04-12OpenAlex10.3390/molecules31081272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153984138
W7153800790Evolving landscape of targeted therapies in early phase clinical trials2026-04-12OpenAlex10.1016/j.ejca.2026.116745Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7153800790
W7153719469Fixed drug eruption induced by mycophenolate mofetil, a rare entity with significant consequences2026-04-12OpenAlex10.1002/bcp.70554Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7153719469
W7211876518Oncology of the Skin: From Lesion to Metastasis2026-04-12OpenAlex10.64790/ir.m42Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211876518
W7154447483P51 | EVOLVING ATTRITION RATES IN MULTIPLE MYELOMA REAL-WORLD PRACTICE OVER A 30-YEARS PERIOD FROM A SINGLE CENTER EXPERIENCE2026-04-12OpenAlex10.3324/haematol.2026.s2.14086Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154447483
W7153997061The Emerging Role of Senolytics as a Next-Generation Strategy Against Glioma Recurrence: A Narrative Review2026-04-12OpenAlex10.3390/cancers18081220Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153997061
W7153754563Therapeutic potential of natural triterpenoids in pancreatic cancer2026-04-12OpenAlex10.1016/j.seminoncol.2026.152500Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153754563
W7154116885Aktuelle Perspektiven der Elektrokonvulsionstherapie2026-04-13OpenAlex10.1007/s00115-026-01966-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154116885
W7154000417Availability and Policy Alignment of Oral Hypoglycaemic Agents in India: A Cross-sectional Study2026-04-13OpenAlex10.7860/jcdr/2026/87355.23317Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154000417
W4417089813Dynamic Agent Generation for Self-Adaptive Root Cause Analysis2026-04-13OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4417089813
W7153900956FiReS: an agent based reasoning system for post-disaster response recommendations2026-04-13OpenAlex10.1007/s11069-026-08141-6Full textExcludedF2: FiReS addresses general post-disaster rescue, evacuation and logistics; medical activity is one operation rather than the primary clinical task.https://openalex.org/W7153900956https://link.springer.com/article/10.1007/s11069-026-08141-6Complete publisher abstract; body subscription-only
W7154133593Hi, how do I human this: Neurodiversity-Affirming Design for Autistic Adults' Formation of Identity2026-04-13OpenAlex10.1145/3772318.3791446Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7154133593
W7153892517Patients’ Perspectives On Clinical Clerkship Students: A Single-center Qualitative Study in Osaka, Japan2026-04-13OpenAlex10.1007/s40670-026-02701-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7153892517
W7154123932Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study2026-04-13OpenAlex10.1080/14796694.2026.2656394Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154123932
W7157609680Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors2026-04-13OpenAlex10.1080/14656566.2026.2664617Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157609680
W7216317058THE EVOLVING ROLE OF IMAGING IN ONCOLOGY RESPONSE ASSESSMENT: BEYOND RECIST2026-04-13OpenAlex10.63075/rnjfpz81Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216317058
W7154004915Teaching MCP, RAG, and AI Agents to a Multidisciplinary Hospital Workforce: Design, Implementation, and Lessons from an Intensive Hands-On Training Program (Preprint)2026-04-13OpenAlex10.2196/preprints.97822Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154004915
W7154309795The current role, challenges, and future prospects of infectious disease physicians in the comprehensive management of hepatocellular carcinoma: A cross-sectional survey2026-04-13OpenAlex10.1097/id9.0000000000000215Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154309795
W7154024160The influence of the theory and methods of Chinese traditional culture on modern western psychotherapy: a cross-cultural dialogue2026-04-13OpenAlex10.3389/fpsyg.2026.1690911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154024160
W7153973802V-PULSE: Precision Ultrascale Lcalized Signal Exposure2026-04-13OpenAlex10.5281/zenodo.19552763Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153973802
W7154154822What ethical AI and robots could mean: a conceptual and ethical reflection2026-04-13OpenAlex10.3389/frobt.2026.1769361Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154154822
W7154909133A Comprehensive Review of the Use of Peripheral Vasopressors and Their Implications2026-04-14OpenAlex10.2174/0115701611451845260413164652Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154909133
W7162086412A Multi-Agent Cognitive Isolation Framework for Defect-Driven Power Grid Document Assessment2026-04-14OpenAlex10.1109/acpee69242.2026.11524710Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7162086412
W7153970039Beyond autonomy: why medicine needs artificial intelligence teammates, not artificial intelligence doctors2026-04-14OpenAlex10.4274/dir.2026.263928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7153970039
W7154382715Bispecific Antibodies for Glomerular Diseases2026-04-14OpenAlex10.1681/asn.0000001120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154382715
W7154059914Editorial: Technologies for diabetes, volume III2026-04-14OpenAlex10.3389/fendo.2026.1846249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154059914
W7154496495I-Tuning: Personalized Large Language Models as Cognitive Augmentation Why Individualized AI Fine-Tuning Poses Distinctive Constitutional Risks.2026-04-14OpenAlex10.5281/zenodo.19594963Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154496495
W7154309532Modern Advancements in AI for Healthcare Diagnostics2026-04-14OpenAlex10.4018/407372Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7154309532; https://openalex.org/W7165385972
W7154336515OphAgent: A Generalisable Ophthalmic Agentic System for Global Eye Care2026-04-14OpenAlex10.21203/rs.3.rs-9189179/v1Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7154336515
W7154492417The Evolving Landscape of Psoriasis Treatment: Current Biologics and Novel Targets2026-04-14OpenAlex10.12775/jehs.2026.90.69823Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154492417
W7154208681Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines2026-04-14OpenAlex10.5582/ddt.2025.01135Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154208681
W71544719607th International Conference on Big Data and Machine Learning (BDML 2026)2026-04-15OpenAlex10.5281/zenodo.19593418Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154471960
W7161830286An Integrated SARIMAX and Agentic Retrieval-Augmented Generation Framework for Pharmaceutical Sales Forecasting and Intelligent Decision Support2026-04-15OpenAlex10.1109/rmkmate69073.2026.11518917Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161830286
W7165444141Autonomous clinical Artificial Intelligence and the validation gap: structural risks and regulatory priorities for European health systems2026-04-15OpenAlex10.1093/eurpub/ckag068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165444141
W7168352136Being Keepers: Line Language as Survival Methodology2026-04-15OpenAlex10.25439/rmt.32979266Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168352136
W7154580259Beyond GLP‐1: The Cardiometabolic Potential of Dual GLP‐1/GIP Receptor Agonists2026-04-15OpenAlex10.1002/inm3.70048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154580259
W7154486047Community Service and Public Health Awareness among the Ilaje People of Nigeria: A Personal Experience from NYSC2026-04-15OpenAlex10.5281/zenodo.19596174Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154486047
W7154467488Ekbom Syndrome Following Cosmetic Biopolymer Injections Presenting With Neuropsychiatric Manifestations: A Case Report2026-04-15OpenAlex10.7759/cureus.107117Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154467488
W7154501308Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics2026-04-15OpenAlex10.1016/j.bbcan.2026.189592Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154501308
W7154490950Evolving therapeutic strategies in mantle cell lymphoma: advancements and future directions2026-04-15OpenAlex10.1038/s41375-026-02942-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154490950
W7165642636From Molecules to Medicines: Structure, Manufacturing Technologies, and Global Evolution of the Pharmaceutical Industry2026-04-15OpenAlex10.26634/jchem.6.1.1349Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165642636
W7160249371Green Synthesis and Characterization of Zinc Oxide Nanoparticles using Fragaria Anannsa Extract and their Antioxidant and Antimicrobial Activities2026-04-15OpenAlex10.33140/jahr.09.02.04Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160249371
W7154458221Late-line Systemic Therapy in Metastatic Colorectal Cancer: A Narrative Review and Australian Expert Perspective2026-04-15OpenAlex10.1016/j.clcc.2026.04.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154458221
W7154504791Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan2026-04-15OpenAlex10.1007/s00535-026-02401-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154504791
W7154482950Perioperative Patient Blood Management: Evidence-Based Strategies for Surgeons and Anesthesiologists: A Narrative Review2026-04-15OpenAlex10.3390/jcm15083017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154482950
W7161942991Phyllanthus emblica in the Era of Translational Medicine: Unveiling its Multitargeted Therapeutic Arsenal from Ayurveda to Advanced Biomedicine2026-04-15OpenAlex10.52711/2231-5691.2026.00025Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161942991
W7216740722Pyoderma gangrenosum – o adevărată provocare în managementul pacientului: caz clinic2026-04-15OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7216740722
W7154496467Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver2026-04-15OpenAlex10.3389/fmed.2026.1814980Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154496467
W7154488502Temporal Trends in Antibiotic Resistance of Klebsiella pneumoniae and Antibiotic Consumption: A Six-year Longitudinal Surveillance Study2026-04-15OpenAlex10.1007/s44197-026-00553-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154488502
W7154492690Update on pleural mesothelioma2026-04-15OpenAlex10.1097/mcp.0000000000001272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154492690
W7154578713"Dynamic Constitutional Control of Agentic Enterprise Digital Twins via Meta-Governor Agents"2026-04-16OpenAlex10.21227/ynmh-r675Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7154578713
W7154618959AMART: A multi-agent reflective framework for detecting and correcting faithfulness errors in translation2026-04-16OpenAlex10.1016/j.ipm.2026.104819Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7154618959
W7154600430Advances in Breast Cancer Diagnostics: From Screening to Precision Medicine2026-04-16OpenAlex10.3390/diagnostics16081181Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154600430
W7154631551Current and Emerging Pharmacological Therapies for Hypertriglyceridemia2026-04-16OpenAlex10.3390/ijms27083573Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154631551
W7161118504From Isolation to Agency: Toward Fully Autonomous Laboratory Ecosystems2026-04-16OpenAlex10.1109/iccc68994.2026.11511636Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161118504
W7154588145New Treatment in Haemophilia: Challenges, Controversies and Uncertainties2026-04-16OpenAlex10.1111/hae.70254Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154588145
W7154592796PO40 | RADAR, UK-MRA MYELOMA XV - COMPARING MRD-GUIDED TREATMENT ESCALATION AND DE-ESCALATION STRATEGIES IN PATIENTS WITH NEWLY DIAGNOSED MYELOMA SUITABLE FOR STEM CELL TRANSPLANTATION: THROMBOPROPHYLAXIS SUBGROUP STUDY PROTOCOL2026-04-16OpenAlex10.4081/btvb.2026.534Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154592796; https://openalex.org/W7154429284
W7154591079Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review2026-04-16OpenAlex10.3390/antib15020036Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154591079
W7154580548Preface to the 13th International Conference on Thrombosis and Hemostasis Issues in Cancer, 20262026-04-16OpenAlex10.4081/btvb.2026.479Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154580548
W7154630246Prevention, Identification, Management and Long‐Term Complications of Intracranial Haemorrhage in Children With Haemophilia and Other Severe Bleeding Disorders—A Practical Guidance2026-04-16OpenAlex10.1111/hae.70239Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154630246
W7165082442Re-introducing specialist education in hazardous drug handling: a 12-week postgraduate module addressing the knowledge gap in non-oncology settings2026-04-16OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165082442
W7154604727XPS 2: A Neuro-Symbolic Evolution of Diagnostic Expert Systems for High-Stakes AI2026-04-16OpenAlex10.5281/zenodo.19614000Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7154604727
W7154683070Abstract LB359: The Bcl-xL specific PROTAC, DT2216, increases the sensitivity to target therapy of preclinical tumor models from different origin2026-04-17OpenAlex10.1158/1538-7445.am2026-lb359Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154683070
W7154567452Agentic AI system for generating evidence-based second medical opinions2026-04-17OpenAlex10.1016/j.ceh.2026.04.001Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7154567452
W7154723758Charting the molecular landscape of cancer: from genomic chaos to epigenetic control and energetic adaptation2026-04-17OpenAlex10.1186/s43042-026-00852-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154723758; https://openalex.org/W7154849029
W7162918196Cryptogenic Stroke in the Setting of Antiphospholipid Syndrome2026-04-17OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162918196
W7154718443Editorial: Exploring combination therapies for effective obesity and metabolic syndrome management2026-04-17OpenAlex10.3389/fendo.2026.1824139Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154718443
W7154907202Fungal β-D-Glucans: Versatile Agents in Immune Modulation, Tumor Suppression, and Nanomedicine Advances2026-04-17OpenAlex10.2174/0118715206435063260413064006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154907202
W7154697520Genetic and vaccination studies reveal feather viral load as a potential biomarker for individual and flock-level protection against Marek’s disease in chicken2026-04-17OpenAlex10.6084/m9.figshare.32043092Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154697520
W7154731529Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis2026-04-17OpenAlex10.3390/biomedicines14040924Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154731529
W7154682291Stimuli-Responsive Polymeric Nanosystems for Precision Cancer Nanovaccines2026-04-17OpenAlex10.1021/accountsmr.5c00355Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154682291
W7154744535The new era of AML therapy: current standards and emerging targets2026-04-17OpenAlex10.1007/s10147-026-03038-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154744535
W7154739001Therapy-driven clonal dynamics in chronic lymphocytic leukemia2026-04-17OpenAlex10.1016/j.semcancer.2026.04.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154739001
W4416235282A comprehensive survey of AI agents in healthcare2026-04-18OpenAlex10.1016/j.jbi.2026.105045Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W4416235282
W7154850494Arthrocentesis in the Management of Temporomandibular Joint Disorders: Current and Innovative Approaches2026-04-18OpenAlex10.1055/s-0046-1815917Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154850494
W4401996654Genetic diversity and trends of influenza A (H3N2) virus in Puducherry, South India: Insights from the 2022–2023 season2026-04-18OpenAlex10.1016/j.diagmicrobio.2026.117425Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W4401996654
W7154834624Sovereign Epistemological Memory and Reasoning System: A Trilaminar Epistemological Architecture for Agentic AI2026-04-18OpenAlex10.5281/zenodo.19643920Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7154834624
W7154983361Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy2026-04-19OpenAlex10.1002/bmm2.70080Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154983361
W7154889701Recent Advances In Nano Formulations For Cancer Therapy: A Pharmacological Perspective2026-04-19OpenAlex10.5281/zenodo.19654261Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154889701
W7160378313Trustworthy Machine Reasoning with Foundation Models2026-04-19OpenAlex10.48448/94sm-j536Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160378313
W7155407289Biofilm-Mediated Antimicrobial Resistance in Pseudomonas aeruginosa and Emerging Therapeutic Strategies2026-04-20OpenAlex10.52403/ijhsr.20260426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155407289
W7155087794Continuous Focus Groups: A Longitudinal Method for Clinical HRI in Autism Care2026-04-20OpenAlex2604.1819710.48550/arxiv.2604.18197Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155087794
W7154967880Diagnosis and Treatment of Endocrine Diseases in Outpatient Settings: Type II Diabetes Mellitus2026-04-20OpenAlex10.5281/zenodo.19667581Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154967880
W7154908843Editorial: National Cancer Research Month 2025: Advances in Detection, Treatment and Therapies in Oncology2026-04-20OpenAlex10.3389/fonc.2026.1834671Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154908843
W7154973389Innovations in Refractory Melasma: Mechanism-Based Management and Emerging Therapeutic Strategies2026-04-20OpenAlex10.7759/cureus.107411Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154973389
W7154979911Natural vs. Synthetic Biomaterials for Bone Regeneration: A Comprehensive Review for Researchers2026-04-20OpenAlex10.5281/zenodo.19658743Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154979911
W7154944195Nonstatins for LDL-C lowering: An expansion whose time has come2026-04-20OpenAlex10.1016/j.jacl.2026.04.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7154944195
W7155934954Pathophysiology of Burn Damage2026-04-20OpenAlex10.5772/intechopen.1014858Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155934954
W7154995315Refining the Digital Twin Concept for Targeted Anticancer Drug Delivery: Integrating Dynamic Physiological Models with Reinforcement Learning2026-04-20OpenAlex10.21203/rs.3.rs-9411956/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7154995315
W7155053296A Unified Stability Framework for GPT-Class Systems in Active Use Across GPT Class Systems: Deterministic Decay, Stochastic Coherence Dynamics, and Structural Stabilization via the Grandic Stack2026-04-21OpenAlex10.5281/zenodo.19682310Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155053296
W7215925637Agentic AI Deployment in Infrastructure-limited Environments: Observability Gaps, Failure Modes, and AI Governance Primitives2026-04-21OpenAlex10.63544/zar8jd83Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7215925637
W7155049967Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA® in the United Kingdom using data from a national register2026-04-21OpenAlex10.1186/s13075-026-03807-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155049967
W7155048387Decision Dynamics: A Formal Theory of Decision Systems Across Biological and Artificial Agents Toward a Unified Framework for Cognitive Alignment and Action Under Constraints2026-04-21OpenAlex10.5281/zenodo.19678812Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155048387
W7155053665Diagnose-Reflective Planning: Faithful KG Reasoning via LLM-Guided MCTS With Strategic Self-Correction2026-04-21OpenAlex10.1109/icassp55912.2026.11463795Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155053665
W7155090562Efficacy of oncolytic viruses (OVs) in malignant tumor therapy: a review on its therapeutic aspects2026-04-21OpenAlex10.1016/j.cca.2026.121017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155090562
W7155080742Is partial complement blockade enough in myasthenia gravis?2026-04-21OpenAlex10.1016/s0140-6736(26)00749-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155080742
W7155049461Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review2026-04-21OpenAlex10.1080/21645515.2026.2632451Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155049461
W7155057934Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression2026-04-21OpenAlex10.1007/s11916-026-01475-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155057934
W7155068136Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis2026-04-21OpenAlex10.1016/j.actatropica.2026.108105Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155068136
W7155069270Universal Methodology Meta-Control Interface (UM-MCI) Core Semantic Package2026-04-21OpenAlex10.5281/zenodo.19676078Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155069270
W7155419582A High-Throughput Platform for Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution2026-04-22OpenAlex10.64898/2026.04.21.719937Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155419582
W7155207317Bridging discovery and practice: why translational research matters in advancing refractive surgery2026-04-22OpenAlex10.1097/j.jcrs.0000000000001946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155207317
W7155188623Collagen VI–Related Myopathies: An Educational Overview of Molecular Pathogenesis, Variability of Clinical Presentations Spectrum, Diagnostic Approaches and Management Strategies2026-04-22OpenAlex10.38124/ijisrt/26apr353Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155188623
W7155223349Commentary: Asymmetric adult-onset asthma with periocular xanthogranuloma associated with IgG4-related disease: a case report2026-04-22OpenAlex10.3389/fsurg.2026.1787830Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155223349
W7215291557Coniferous resin and its extracts in wound healing : from folk tradition to modern medicine2026-04-22OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215291557
W7155194591Correction: The realism of behavioral theory-based vs. non-theory-based AI agents during a simulated infant formula shortage2026-04-22OpenAlex10.3389/frai.2026.1812447Title/abstractExcludedE5: Correction, retraction or ancillary data record.https://openalex.org/W7155194591
W7155200057Delphi consensus recommendations for preventing and treating cardiac implantable electronic device infections beyond current guidelines2026-04-22OpenAlex10.1038/s41598-026-49515-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155200057
W7155198995Dual-Site Inflammation During Adalimumab Therapy: Birdshot Chorioretinopathy Complicated by Paradoxical Psoriasis2026-04-22OpenAlex10.7759/cureus.107540Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155198995
W7155172239Editorial: Cardiomyopathy and heart failure in oncology2026-04-22OpenAlex10.3389/fonc.2026.1829234Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155172239
W7155165566Evolución de enfermería: influencia para una disciplina científica, autónoma y humana que aplica el pensamiento crítico y la evidencia basada en la práctica (EBE)2026-04-22OpenAlex10.71112/rsc83h66Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155165566
W7155212027Experiential Learning for Indigenous Nurse Leadership Development: A Learning Exchange for Canadian Turtle Island Indigenous Nursing Students in Aotearoa2026-04-22OpenAlex10.1177/08445621261440319Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155212027
W7155208776From G12C To pan-RAS: The expanding therapeutic landscape of KRAS-mutant NSCLC2026-04-22OpenAlex10.1016/j.critrevonc.2026.105344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155208776
W7155162811HealthCare Agent AI2026-04-22OpenAlex10.55041/ijcope.v2i4.575Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7155162811
W7155225885Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta‐Analysis of a Potential Therapeutic Target2026-04-22OpenAlex10.1002/pros.70187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155225885
W7155162306Living Microbial Drugs2026-04-22OpenAlex10.1002/chem.202503523Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155162306
W7155187741MASLD and MASLD-associated HCC: emerging biomarkers and therapeutic avenues2026-04-22OpenAlex10.1016/j.scib.2026.04.048Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155187741
W7155566028Med Spas: Patient Safety and Accreditation2026-04-22OpenAlex10.1093/asj/sjag085Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155566028
W7155158626Novel Quinoline-Based Bis-Oxadiazole Derivatives as Potent Anticancer Targets: Efficient Synthesis, Molecular Modeling, and ADME-T Studies2026-04-22OpenAlex10.6084/m9.figshare.32077006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155158626; https://openalex.org/W7155158137
W7155659285Perioperative bleeding2026-04-22OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155659285
W7155200189Presbyopia: Current Perspectives and Prospects for Patients2026-04-22OpenAlex10.1007/s44402-026-00083-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155200189
W7155202183Urban economics for sustainable transitions: grand challenges in urban structure, the urban–rural gradient and city systems2026-04-22OpenAlex10.3389/frsc.2026.1835029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155202183
W7155190576Will AI Dominate Humanity?2026-04-22OpenAlex10.1201/9781003750758-27Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155190576
W7155206746a-(aminomethyl)-γ-butyrolactones as a new class of antibiotics2026-04-22OpenAlex10.25394/pgs.32055999Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155206746
W7155198993“My Blood Is Magic”2026-04-22OpenAlex10.4324/9781003674986-7Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155198993
W7155379275Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy2026-04-23OpenAlex10.3389/fimmu.2026.1818316Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155379275
W7155375932Beyond the Average Effect: Identifying the Trauma Patients Who Benefit Most from Tranexamic Acid2026-04-23OpenAlex10.1055/a-2848-3364Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155375932
W7158052663LDL-Cholesterol Lowering Therapies: An Update2026-04-23OpenAlex10.31083/bjhm53219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158052663
W7155362215Toward Sustainable Care in HER2-Positive Metastatic Breast Cancer: Emerging Evidence for Treatment De-escalation2026-04-23OpenAlex10.4143/crt.2025.1131Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155362215
W7155401739VEXAS Syndrome: Clinical Features, Hematologic Involvement, and Clinical Outcomes of Current and Emerging Therapies2026-04-23OpenAlex10.3390/hematolrep18030030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155401739
W7155548355Advances in Erectile Dysfunction Management: What Does Work2026-04-24OpenAlex10.1002/tre.70027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155548355
W7155490469Advances in Pharmacologic- and Non-pharmacologic Interventions for Cancer Pain: A Narrative Review2026-04-24OpenAlex10.1007/s11864-026-01393-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155490469
W7155647529Aegis Cortex (AC-OS): An industrial-grade Zero-Trust AI Execution Runtime2026-04-24OpenAlex10.5281/zenodo.19761508Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7155647529
W7157645484BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: three approvals, many questions2026-04-24OpenAlex10.1093/oncolo/oyag165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157645484
W7155566388CAR ‐T Therapies and Emerging Alternatives: Reassessing Cost‐Effectiveness and Future Directions in Modern Immunotherapy2026-04-24OpenAlex10.1111/1756-185x.70666Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155566388
W7155569299Care, Consent, and Compromise: An Ethical Cartography of Physical Therapy Practice in the Global South2026-04-24OpenAlex10.1007/s41649-025-00390-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155569299
W7155545061Global dispersal of Burkholderia pseudomallei and the evolving endemicity of melioidosis in the United States of America2026-04-24OpenAlex10.1371/journal.pntd.0014217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155545061
W7212628671Multi-Agent Collaborative System for Self-Reflective Learning Intervention: An Empirical Study from Reinforcement Learning Perspective2026-04-24OpenAlex10.1145/3828183.3828455Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7212628671
W7155396113Stiff person syndrome: an overview2026-04-24OpenAlex10.1007/s10072-026-09054-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155396113
W7155511760The mechanisms and clinical prospects of combining chemotherapy with immunotherapy for advanced pancreatic cancer2026-04-24OpenAlex10.1007/s12672-026-05030-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155511760
W7155610732Agentic MobileViT: A stage-wise progressive transfer learning framework with knowledge stabilization for multi-dataset skin lesion classification2026-04-25OpenAlex10.1016/j.asoc.2026.115268Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155610732
W7155640814Beyond benchmark accuracy: Toward trustworthy, open, and agentic clinical artificial intelligence2026-04-25OpenAlex10.1002/ped4.70062Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7155640814
W7155650439Chaeshin: Persistent Recursive Case Memory for Tool-Using LLM Agents2026-04-25OpenAlex10.5281/zenodo.19764253Title/abstractExcludedE2: General method uses clinical reasoning/intake as one of multiple domains; fixed P2 applies.https://openalex.org/W7155650439
W7155621430Evolving treatments for Sjögren disease: current approaches and emerging targets2026-04-25OpenAlex10.1111/imj.70322Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7155621430
W7155625978From Repair to Regeneration: The Integration of Growth Factors in Periodontal Bone Grafting: A Literature Review2026-04-25OpenAlex10.25258/ijddt.16.19s.67Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155625978
W7155636164HER2-low and ultra-low breast cancer: expanding the therapeutic spectrum in precision oncology2026-04-25OpenAlex10.1186/s42047-026-00238-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155636164
W7155616164Human–Machine Symbiosis Theory2026-04-25OpenAlex10.17605/osf.io/f2dmhTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155616164
W7160713636Nanocarriers in Drug Delivery Systems: Advances, Challenges and Future Perspectives2026-04-25OpenAlex10.52711/2349-2988.2026.00031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160713636
W7155604248Post-Human Society Theory2026-04-25OpenAlex10.17605/osf.io/t98huTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155604248
W7156575749[Similarities and differences between Chinese protocols and international practices in the management of peritoneal tumors].2026-04-25OpenAlex10.3760/cma.j.cn441530-20260105-00009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156575749
W7157884781Beyond hydration: biological mechanisms, clinical evidence and safety of injectable skin boosters2026-04-26OpenAlex10.5281/zenodo.19791967Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157884781
W7217884254Drug-Induced Sleep Endoscopy: Shaping the Future of Airway Diagnostics and Management in Clinical Anesthesia2026-04-26OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217884254
W7159809416Antimicrobial Resistance in Vector-Borne Diseases: Emerging Challenges and Integrated Global Control Strategies2026-04-27OpenAlex10.5281/zenodo.19827620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159809416
W7155860734Building Blocks for Pega Agentic AI Systems2026-04-27OpenAlex10.1201/9781003726364-13Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7155860734
W7155975444Combining HIstology, Medical imaging and molEcular data for medical pRognosis and diAgnosis Agent (CHIMERA-agent)2026-04-27OpenAlex10.5281/zenodo.19818694Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7155975444
W7156211875Commentary: Gut and oral microbiome profiles in patients with obesity and ischemic heart disease2026-04-27OpenAlex10.3389/fcimb.2026.1834415Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156211875
W7156350332Diagnosing and Stabilising Drift in Long‑Horizon Language‑Model Agents2026-04-27OpenAlex10.5281/zenodo.19810868Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7156350332
W7156261435Emerging Resistance Patterns in Methicillin-Resistant Staphylococcus aureus Isolated from Soft Tissue Infections: Clinical and Microbiological Study2026-04-27OpenAlex10.25258/ijddt.16.21s.5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7156261435
W7155687032Insulin Pharmacotherapy Across the Continuum of Care: Indications, Mechanisms, Adverse Effects, and Management2026-04-27OpenAlex10.5281/zenodo.19801614Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155687032
W7156371248Invasive Fungal Infections2026-04-27OpenAlex10.1097/ipc.0000000000001609Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156371248
W7158261887Non-Steroidal Anti-Inflammatory Drugs for the Control of Autoimmune Diseases: A Short Review of Mechanisms, Clinical Applications, and Emerging Perspectives2026-04-27OpenAlex10.33687/ricosbiol.04.04.117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158261887
W7155697126Sodium-glucose cotransporter 2 (SGLT2) inhibitors across the cardiovascular-kidney-metabolic continuum: mechanistic and clinical perspectives on heart failure with preserved ejection fraction prevention2026-04-27OpenAlex10.36011/cpp.2026.8.e4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7155697126
W7172173654Symbiotic AI Diagnosis: A Reverse Mentorship Framework for Clinical Decision Support through Real-Time Physician Training by Machine Learning Models2026-04-27OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172173654
W7156032873The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review2026-04-27OpenAlex10.37349/etat.2026.1002368Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156032873
W7156020368Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies2026-04-27OpenAlex10.1007/s12281-026-00532-3Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7156020368
W7220464068Carbapenem-Resistant Klebsiella pneumoniae: Clinical Epidemiology, Resistant Mechanisms, and Therapeutic Challenges2026-04-28OpenAlex10.66021/pakmcr895Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220464068
W7157208621Comparative perioperative outcomes of neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy in clinical stage II–III lung adenocarcinoma: A retrospective analysis from the National Cancer Center of China2026-04-28OpenAlex10.1097/cm9.0000000000003996Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7157208621
W7160919090Fournier gangrene in a patient with corticotrophinoma and diabetes treated with sodium–glucose cotransporter 2 inhibitor2026-04-28OpenAlex10.1210/jcemcr/luag133Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160919090
W7156631382Glucagon-Like Peptide-1 Receptor Agonists Beyond Diabetes Mellitus: Pathophysiological Foundations and Clinical Applications in Obesity, Heart Failure, Chronic Kidney Disease, and Hepatic Steatosis2026-04-28OpenAlex10.5281/zenodo.19849377Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156631382
W7167665711Green Synthesis dan Karakterisasi Nanopartikel Emas Sebagai Antioksidan Peredam Radikal Bebas2026-04-28OpenAlex10.31942/inteka.v11i2.13258Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167665711
W7156942111HEEL: A State-Centric Autobiographical Memory Architecture for Persistent Agents — Beyond the Session-Centric Ontology2026-04-28OpenAlex10.5281/zenodo.19851563Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7156942111
W7156896407Innovative therapies under clinical development for ALS treatment: small molecules2026-04-28OpenAlex10.1080/13543784.2026.2667249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7156896407
W7158126307Large Language Models in Inflammatory Arthritis: A Systematic Review Across Clinical Tasks2026-04-28OpenAlex10.21203/rs.3.rs-9529682/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158126307
W7156785977Navigating Learning on the Front Line of Paramedicine2026-04-28OpenAlex10.71747/uow-r3gk326m.32109298Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7156785977
W7157123368Onco-hypertension: hypertension induced by VEGF pathway inhibition2026-04-28OpenAlex10.3389/fcvm.2026.1748445Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157123368
W7160205812Psychodermatology in India: Bridging the Mind–Skin Divide and the Path Forward2026-04-28OpenAlex10.4103/idoj.idoj_455_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160205812
W7159670749Real‐World Patient Characteristics and Treatment Patterns Among Patients With Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS)2026-04-28OpenAlex10.1002/rfc2.70079Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7159670749
W7157711228The degradation revolution: harnessing targeted protein degradation for the treatment of human diseases2026-04-28OpenAlex10.1007/s00018-026-06132-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157711228
W7157016820TriALS-Report: Triphasic-Aided Non-Contrast Abdominal 3D Multi-Modal Report Generation2026-04-28OpenAlex10.5281/zenodo.19849407Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7157016820
W7158285398Anti-vascular endothelial growth factor therapy in uveitis: Bridging inflammation and vascular pathology2026-04-29OpenAlex10.4103/ijo.ijo_2975_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158285398
W7159821380Changing Patterns in Hospitalisations of Patients with Systemic Lupus Erythematosus over Three Decades at a Tertiary Referral Centre in Catalonia2026-04-29OpenAlex10.3390/jcm15093407Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7159821380
W7159670625Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD2026-04-29OpenAlex10.3389/fimmu.2026.1743509Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7159670625
W7159664771Commentary: Evaluation of the real-world safety of eptifibatide in the treatment of ARDS: results of a disproportionality analysis of FAERS data2026-04-29OpenAlex10.3389/fmed.2026.1835916Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159664771
W7159659862Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective2026-04-29OpenAlex10.3389/fimmu.2026.1769281Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7159659862
W7158892755Peep into anti-vascular endothelial growth factor2026-04-29OpenAlex10.4103/ijo.ijo_385_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158892755
W7159836482Psoriatic Arthritis: Therapeutic Advances and Novel Treatment Strategies—A Scoping Review2026-04-29OpenAlex10.3390/life16050740Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159836482
W7158176707Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions2026-04-29OpenAlex10.4103/ijo.ijo_3361_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158176707
W7165548285Self-Evolving Diagnostic Framework based Gated Residual Adapters and OpenClaw-Based Medical Agents2026-04-29OpenAlex10.62051/ijcsit.v8n4.01Full textIncludedIncluded: Physician-report-derived special cases accumulate across fundus-image cases, updating persistent MEMORY/SOUL guidance and a final adapter gate.https://openalex.org/W7165548285https://ijocsit.org/pdf/2026/10.62051-ijcsit.v8n4.01.pdf
W7159677972Statin-Associated Severe Rhabdomyolysis With Mixed Neuromuscular Involvement Mimicking Guillain‑Barré Syndrome: A Case Report2026-04-29OpenAlex10.7759/cureus.107939Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7159677972
W7160095987The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors2026-04-29OpenAlex10.3390/toxins18050208Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160095987
W7159127451The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema2026-04-29OpenAlex10.4103/ijo.ijo_3152_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159127451
W7158343806Towards Trustworthy Agentic AI in Healthcare: A Zero Trust-Based Security Framework2026-04-29OpenAlex10.5281/zenodo.19877668Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7158343806
W7158548449Advancing Transdermal Drug Delivery Systems Through Mechanistic Elucidation Emerging Technologies and Translational Clinical Integration2026-04-30OpenAlex10.5281/zenodo.19913779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158548449
W7160098495Contemporary Management of Upper Tract Urothelial Carcinoma: Transitioning Toward Organ Preservation and Precision Oncology2026-04-30OpenAlex10.3329/bju.v28i2.85892Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160098495
W7162452489Context Aware Conversational Agent for Smart Healthcare2026-04-30OpenAlex10.65521/mjret.v13i1.2607Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7162452489
W7158982079Emerging Therapeutic Strategies in Cancer: From Cytotoxic Agents to Precision Medicine2026-04-30OpenAlex10.5281/zenodo.19909244Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7158982079
W7160021008Evolution of Surgical Antibiotic Prophylaxis: A Prospective Audit of Practice Change at Government Medical College & Hospital, Purnea, Bihar, India2026-04-30OpenAlex10.25258/ijcpr.18.4.122Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160021008
W7158675758Heart Failure Treatment2026-04-30OpenAlex10.6084/m9.figshare.32133322Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158675758
W7160138646Heterometallic Multinuclear Ruthenium Complexes as Cytotoxic Agents2026-04-30OpenAlex10.3390/biomedicines14051028Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7160138646
W7159644211Language Models Refine Mechanical Linkage Designs Through Symbolic Reflection and Modular Optimisation2026-04-30OpenAlex2604.2796210.48550/arxiv.2604.27962Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7159644211
W7170069830Non-Alcoholic Fatty Liver Disease: Pathophysiology, Emerging Drug Delivery Strategies, Nanotechnology, and the Growing Role of Artificial Intelligence in Diagnosis and Management2026-04-30OpenAlex10.5281/zenodo.21486591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170069830
W7160084252Non-tubercular mycobacterial infections: Emerging from the shadows2026-04-30OpenAlex10.4103/lungindia.lungindia_268_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160084252
W7160254905Paraneoplastic Endocrine Syndromes Associated with Neuroendocrine Neoplasms in Adults: A Case Report and a Contemporary Review.2026-04-30OpenAlex10.18103/mra.v14i4.7468Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160254905
W7160385317Profile of Pneumocystis jirovecii Infections in Nonhuman Immunodeficiency Virus Patients in a Tertiary Care Hospital in Western Maharashtra: A Case Series2026-04-30OpenAlex10.5005/jp-journals-11010-1229Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160385317
W7160094827The Effectiveness of Small Group Education on Improving Antibiotic Prescribing in General Practice: A Mixed Methods Systematic Review2026-04-30OpenAlex10.3390/antibiotics15050458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160094827
W7160188607Therapeutic Impact of Mitochondrial Transplants for Cardiovascular Diseases2026-04-30OpenAlex10.3390/ijms27094018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160188607
W7158762063Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan2026-04-30OpenAlex10.1111/hepr.70179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7158762063
W7160110812Vedere la musica, udire il movimento. La risonanza transmodale2026-04-30OpenAlex10.4081/rp.2026.1100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160110812
W71601175592026-05-01OpenAlex10.13040/ijpsr.0975-8232.17(5).1483-93Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160117559
W71645873822026-05-01OpenAlex10.1055/s-016-63806Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164587382
W71606249471364 An Unexpected Diagnosis for Persistent Hypersomnia with a Wearable Consumer Health Tracker2026-05-01OpenAlex10.1093/sleep/zsag091.1363Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160624947
W7161994881333eP Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer (EBC): A multicentre study in China2026-05-01OpenAlex10.1016/j.esmoop.2026.107284Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161994881
W7161998496685P ATheNa 2.0: Real-world evaluation of an artificial intelligence chatbot using large language models and therapy guidelines to manage the complexity in breast cancer care2026-05-01OpenAlex10.1016/j.esmoop.2026.107373Full textExcludedF4: The chatbot is grounded in fixed AGO2025 guidelines and drug SmPCs. The complete report describes58 physicians testing guideline questions and fictional cases, without a retained experience-derived update.https://openalex.org/W7161998496https://doi.org/10.1016/j.esmoop.2026.107373Complete published conference abstract read on the primary publisher page; no longer methods component is supplied.
W7158985392A Two-Layer Architecture for Continual Learning Identity Preservation: Fisher Scaling, Gradient Diversity Monitoring, and Portable Inference-Time Memory2026-05-01OpenAlex10.5281/zenodo.19925691Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7158985392
W7161420649A review of targeted therapies for NF2-related vestibular schwannoma: molecular pathogenesis, emerging therapeutics, and future clinical horizons2026-05-01OpenAlex10.1007/s11060-026-05599-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161420649
W7161587887A39-34 Positioning Nerandomilast Within the Evolving Antifibrotic Landscape: A Comprehensive Network Meta- Analysis of Efficacy and Safety in Fibrosing Lung Disease2026-05-01OpenAlex10.1093/ajrccm/aamag162.2257Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161587887
W7161558522A41-19 A Perplexing Case of Amivantamab-induced Pneumonitis With Therapeutic Plasmapheresis Application2026-05-01OpenAlex10.1093/ajrccm/aamag162.2927Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161558522
W7161583462A54-32 A Harmful “Hold” Turning Therapeutic Dopamine Depletion Toxic: Neuroleptic Malignant Syndrome Due to Interruption of Deutetrabenazine2026-05-01OpenAlex10.1093/ajrccm/aamag162.3188Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161583462
W7161546344A63-03 Sotatercept-Associated Pericardial Effusion and Tamponade in Pulmonary Arterial Hypertension: A Paradox of Pressure and Permeability2026-05-01OpenAlex10.1093/ajrccm/aamag162.5513Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161546344
W7161579120A63-23 Evolving Management of Pulmonary Arterial Hypertension in the Era of Activin Signaling Inhibitor2026-05-01OpenAlex10.1093/ajrccm/aamag162.5532Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161579120
W7160386759ABSTRACT NUMBER: ESOC2026LB53 AN AGENTIC AI COPILOT FOR EXPLORATORY IDENTIFICATION OF OPTIMAL TREATMENT SUBGROUPS FOR TRADITIONAL CHINESE MEDICINE FYTF-919 (ZHONGFENG XINGNAO ORAL PRESCRIPTION) IN INTRACEREBRAL HEMORRHAGE2026-05-01OpenAlex10.1093/esj/aakag023.1918Full textExcludedF4: EMAC searches subgroup rules within one fixed CHAIN cohort analysis. No rule or agent artifact is documented as retained and reused on later different cases/tasks.https://openalex.org/W7160386759https://academic.oup.com/esj/article/11/Supplement_1/i1021/8667898Complete published conference abstract including Methods and Results; PMC duplicate abstract
W7160518234AI Agent Skills: Bridging the Gap Between Foundation Models and Real-World Performance2026-05-01OpenAlex10.70175/hclreview.2020.33.4.6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160518234
W7161978732Advanced Stage Hodgkin Lymphoma: A Review on Frontline Treatment Advances2026-05-01OpenAlex10.1097/ppo.0000000000000825Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161978732
W7161838538Anaesthesia for electroconvulsive therapy: The perspectives of anaesthesiologists and psychiatrists in Brazil2026-05-01OpenAlex10.4103/ija.ija_242_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161838538
W7160149370Artificial Intelligence as the Epistemological Maturation of Computer‐Assisted Engineering Education2026-05-01OpenAlex10.1002/cae.70199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160149370
W7161554044B103-19 When Pregnancy Mimics Thyroid Storm, Hcg Mediated Hyperthyroidism From Molar Pregnancy2026-05-01OpenAlex10.1093/ajrccm/aamag162.3247Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161554044
W7161595553B43-04 Anti-PL-12 Anti-synthetase Syndrome Associated Interstitial Lung Disease: A Distinct Entity Amidst the Ever-evolving Spectrum of Inflammatory Myopathies2026-05-01OpenAlex10.1093/ajrccm/aamag162.792Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161595553
W7161576052B43-39 The Evolving Role of Transbronchial Cryobiopsy in the Diagnosis and Treatment of Acute Exacerbations of CTD-ILD2026-05-01OpenAlex10.1093/ajrccm/aamag162.2565Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161576052
W7161574549B43-43 A Case of Double-Positive Disease2026-05-01OpenAlex10.1093/ajrccm/aamag162.808Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161574549
W7161559934B52-24 Navigating Severe Vasoplegic Shock and Right Ventricular Failure After Cardiac Surgery: The Impact of Comprehensive Hemodynamic Support2026-05-01OpenAlex10.1093/ajrccm/aamag162.1469Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161559934
W7161582349B80-6-02 Rapidly Progressive Bilateral Mucinous Lung Adenocarcinoma in a Post-Stem-Cell Transplant Patient With AML: Diagnostic and Immunologic Challenges2026-05-01OpenAlex10.1093/ajrccm/aamag162.3865Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161582349
W7161583938C103-18 Nerandomilast in Fibrosing Interstitial Lung Diseases: A Meta-Analysis Consolidating the Evidence From Randomized Controlled Trials2026-05-01OpenAlex10.1093/ajrccm/aamag162.2812Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161583938
W7161583831C105-19 Personalized Respiratory Support for Acute Respiratory Failure Using Deep Reinforcement Learning2026-05-01OpenAlex10.1093/ajrccm/aamag162.4748Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161583831
W7161604348C80-20 Mind Over Metastasis: A Rare Case of Disease Control Without Chemotherapy2026-05-01OpenAlex10.1093/ajrccm/aamag162.4011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161604348
W7221296216Chemical Exposure in Art Conservation: An ethnographic Study on Lived Experiences of Art Conservators2026-05-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221296216
W7160131068Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights2026-05-01OpenAlex10.3389/fimmu.2026.1727925Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160131068
W7160447848Clinical Pharmacology and Translational Science Considerations in the Development of Dual‐Payload Antibody Drug Conjugates2026-05-01OpenAlex10.1111/cts.70569Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160447848
W7168027338Clinical applications of periarticular cocktail drug injection for unicompartmental knee arthroplasty: A narrative review2026-05-01OpenAlex10.1177/10225536261451053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168027338
W7162496589Current and Emerging Systemic Therapies for Advanced Clear-Cell Renal Cell Carcinoma: A Narrative Review2026-05-01OpenAlex10.1097/ju9.0000000000000452Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162496589
W7160932501Do we pre-treat as intended?2026-05-01OpenAlex10.1093/ehjacc/zuag046.124Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160932501
W7162684533Drug-resistant Tuberculosis in India: The Way Forward2026-05-01OpenAlex10.4103/japt.japt_29_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162684533
W7171567633Enhancing Drug Synergy Prediction through Relation and Structure Aware Attention Networks2026-05-01OpenAlex10.1109/iicai70155.2026.11620888Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171567633
W7203774973Epistemic Authority in Medical Artificial Intelligence: A Virtue Epistemological Analysis2026-05-01OpenAlex10.12014/j.issn.1002-0772.2026.09.01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203774973
W7160295115Exploring Three-dimensional Digital Imaging and Communications in Medicine Image Reconstruction with the Anatomage Table in Pediatric Surgery: Our Experience2026-05-01OpenAlex10.4103/jiaps.jiaps_28_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160295115
W7161037916Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data2026-05-01OpenAlex10.2147/dmso.s575375Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161037916; https://openalex.org/W7161463068
W7204844845Federated Reinforcement Learning Using MAML and Graph Neural Networks for Safe IoT-Based Chronic Disease Monitoring2026-05-01OpenAlex10.1109/insect68872.2026.11663966Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204844845
W7160846086From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL‐2/BCL‐XL Inhibition2026-05-01OpenAlex10.1002/hsr2.72506Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160846086
W7160532208From Stroke Risk to Renal Risk: The Evolving Utility of CHA₂DS₂-VASc2026-05-01OpenAlex10.47144/phj.v59i2.3705Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160532208
W7160497896From fluoride to biomimetics: Evolving strategies for enamel and dentin remineralisation2026-05-01OpenAlex10.22271/oral.2026.v12.i5a.2389Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160497896
W7160081152Glioblastoma multiforme: the aggressive void in cancer care2026-05-01OpenAlex10.1097/gh9.0000000000000625Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160081152
W7166912063HARNESS: Hybrid Architecture for Resilience in Networked Engineering System Simulations2026-05-01OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166912063
W7161961689Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy2026-05-01OpenAlex10.1097/ppo.0000000000000827Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161961689
W7159576187Hypersensitivity Pneumonitis: A Comprehensive Review of Pathophysiology, Clinical Diagnosis, and Management2026-05-01OpenAlex10.5281/zenodo.19947779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159576187
W7160135721IgG4-related Disease: Current Principles and Approaches in Diagnosis and Treatment2026-05-01OpenAlex10.35465/hkj9c548Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160135721
W7160388394Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis2026-05-01OpenAlex10.1158/2767-9764.crc-26-0177Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160388394
W7161066508Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?2026-05-01OpenAlex10.1136/jitc-2025-014324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161066508
W7160144840MEDICINAL APPLICATIONS OF CINNAMOMUM VERUM IN METABOLIC DISEASES: CURRENT PERSPECTIVES2026-05-01OpenAlex10.5281/zenodo.20019850Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160144840
W7167903752Mechanisms of Intervertebral Disc Degeneration and Traditional Chinese Medicine Intervention Based on Inflammatory-related Signaling Pathways2026-05-01OpenAlex10.3724/j.pibb.2026.0029Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167903752
W7159590799Memory-Grounded Social Dynamics in Repeated LLM Agent Simulations: Dialogue-Only Transcript Supplement and Behavioral Evaluation Artifacts2026-05-01OpenAlex10.5281/zenodo.19937580Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7159590799
W7162300364Moving beyond promethazine: Advancing precision in antiemetic therapy2026-05-01OpenAlex10.1177/20503121261449562Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162300364
W7160191180Navigating the Biomarker Landscape in Still's Disease and Macrophage Activation Syndrome: Toward Precision Diagnosis and Management2026-05-01OpenAlex10.1111/1756-185x.70672Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160191180
W7160434390Neuro-Infections and Stewardship Practices – A Call for Action to a Neurologist and Neurosurgeon (’NEURON AMSP’ Model)2026-05-01OpenAlex10.4103/neurol-india.neurol-india-d-25-00919Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160434390
W7161489332Nuclear factor erythroid 2-related factor 2 (Nrf2) inhibition revisited: advances and unmet challenges2026-05-01OpenAlex10.1016/j.jare.2026.05.030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161489332
W7212809686OPTIMIZING OUTPATIENT MANAGEMENT OF HEART FAILURE: REAL–WOLRD IMPLEMENTATION OG GUIDELINE–DIRECTED MEDICAL THERAPY, ANALYSIS FROM CARDARELLI HOSPITAL OF NAPLES2026-05-01OpenAlex10.1093/eurheartjsupp/suag058.351Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212809686
W7161538211Optimal treatment sequence and mortality: application of Landmark analysis to real world data2026-05-01OpenAlex10.1016/j.jeph.2026.203475Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161538211
W7159626096PAO Mycological Antibiotic: Using Fungal Weapons Against Bacteria — A Triple‑Strike Protocol with Quorum Deception and Immune Amplification (400 Million Years of Evolutionary Design)2026-05-01OpenAlex10.5281/zenodo.19939749Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159626096
W7161415200Parallel/Opposed: Automated treatment planning systems should be designed to minimize human intervention2026-05-01OpenAlex10.1002/acm2.70618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161415200
W7161458344Personalized Virtual Reality Future Selves Elicit Introspective Brain Activation in Early Substance Use Disorder Recovery2026-05-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161458344
W7162296001Positioning of advanced therapies in patients with moderate-to-severe Crohn’s disease2026-05-01OpenAlex10.4103/singaporemedj.smj-2026-180Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162296001
W7164197695Postpartum Haemorrhage: A Case Series Highlighting Diverse Clinical Profiles and Evolving Management Strategies in a Tertiary Care Setting2026-05-01OpenAlex10.21276/amit.2026.v13.i2.664Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164197695
W7160157906Preserving Airway Reflexes During Awake Intubation: A Cautionary Note on Deep Sedation Protocols [Letter]2026-05-01OpenAlex10.2147/dddt.s615555Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160157906
W7165043990Progress in pathological mechanisms and targeted strategies for endothelial dysfunction-mediated cerebral small vessel disease2026-05-01OpenAlex10.3724/cbls.2026055Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165043990
W7162410406Recent Advances in Nano‐Biomaterials: Synthesis, Characterization, and Biomedical Applications2026-05-01OpenAlex10.1002/slct.73519Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162410406
W7161785729Sugammadex in India: Still on the runway, cleared for take-off, grounded by economic constraints…2026-05-01OpenAlex10.4103/ija.ija_683_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161785729
W7161409978The Evolution of Artificial Intelligence: From Large Language Models to Superintelligence and the Transformation of Work2026-05-01OpenAlex10.70175/hclreview.2020.34.2.1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161409978
W7167511622The Journey of Oral Hygiene: The Past, the Present, the Future2026-05-01OpenAlex10.1111/jre.70136Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167511622
W7168428523The Troubleshooter That Never Sleeps: Continually Learning Agentic AI for Fault Debugging in IEC Continuum2026-05-01OpenAlex10.1109/mic.2026.3662039Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7168428523
W7159985637The algorithmic patient: on the ontological disruption of selfhood, suffering, and healing in the age of artificial intelligence2026-05-01OpenAlex10.3389/fpsyg.2026.1809692Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159985637
W7197020382The outcome of IgAN: a time of reflection in the perspective of new opportunities2026-05-01OpenAlex10.1093/joneph/aajaf037Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197020382
W7160723251Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives2026-05-01OpenAlex10.1007/s13555-026-01784-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160723251
W7163038703UTILIZATION OF ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPIES IN CROATIA OVER TWO DECADES: INSIGHTS INTO PHARMACOLOGICAL CARDIOVASCULAR RISK MANAGEMENT2026-05-01OpenAlex10.1097/01.hjh.0001196636.03924.aeTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163038703
W7160562272Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy2026-05-01OpenAlex10.1097/ogx.0000000000001513Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160562272
W7163342001Women and Myasthenia Gravis2026-05-01OpenAlex10.4103/aian.aian_13_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163342001
W7163017070[Pitfalls of Emergency Management for Stroke Patients].2026-05-01OpenAlex10.11477/mf.030126030540030608Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163017070
W7160124395Antibody–Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions2026-05-02OpenAlex10.3390/biom16050677Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160124395
W7164534480Brain metastases among older people with cancer2026-05-02OpenAlex10.1093/jnci/djag141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164534480
W7216704680Dünya’nın ötesinde kolorektal kanser tedavisi: mikro yerçekiminde tedavi mümkün mü?2026-05-02OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216704680
W7165808424Evolution of Systems Design in AI Era2026-05-02OpenAlex10.71097/ijsat.v17.i2.11316Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165808424
W7159934813AN OVERVIEW OF TELE PHARMACY: BRIDGING THE HEALTHCARE GAP2026-05-03OpenAlex10.5281/zenodo.19998224Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7159934813
W7159967589Agent-Based Simulation Code for Nosocomial Influenza Transmission in Hospital Wards2026-05-03OpenAlex10.5281/zenodo.19998813Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7159967589
W7160172859Evolving Paradigms in Cancer Pain Management: From Opioid-Centric Care to Multimodal and Personalized Strategies2026-05-03OpenAlex10.3390/cancers18091476Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160172859
W7160387328A review of current and potential future treatments for proliferative diabetic retinopathy classifications2026-05-04OpenAlex10.1080/17469899.2026.2666930Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160387328
W7160126262Advanced maternal age and childhood allergy: marker or mechanism?2026-05-04OpenAlex10.3389/falgy.2026.1825315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160126262
W7160024642Correction: Efficacy and safety evaluation of thromboprophylaxis strategies for central venous catheter-related thrombosis in cancer patients: a bayesian network meta-analysis and bibliometric analysis2026-05-04OpenAlex10.3389/fphar.2026.1863333Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7160024642
W7160382171Integrated or Separated?: A Comparative Study of Assessment Design Strategies and Participant Experience in mHealth Interventions (Preprint)2026-05-04OpenAlex10.2196/preprints.100289Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160382171
W7161626731Nanomedicine carrier-based combined antitumor strategy integrating phototherapy and immunotherapy2026-05-04OpenAlex10.1080/08923973.2026.2671715Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161626731
W7161607759New insights into the management of Behçet syndrome2026-05-04OpenAlex10.1080/13543784.2026.2676066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161607759
W7160161457OMEGA SABRINAL EL-RAKHAWI A Conceptual Framework for Mathematically Stable and Verifiably Safe Super-Intelligence **Document Type:** Conceptual & Strategic Monograph **Version:** 1.0 (Public Release) **Publication Date:** May 3, 2026 **Repository:** Zenodo Open Access **License:** CC BY-NC-ND 4.0 International **Author:** Dr. Mohamed Kamal Arafa El-Rakhavi **ORCID:** 0009-0001-8684-0697 **Affiliation:** International Centre for Advanced Technology Governance **Contact:** elrakhawimohame@gmail.com --- ### 📜 INTELLECTUAL PROPERTY & SCOPE NOTICE This document presents the **conceptual architecture, strategic rationale, and governance framework** of the OMEGA SABRINAL ELRAKHAVI initiative. It is intentionally published without mathematical formulations, hardware blueprints, cryptographic circuit specifications, or algorithmic implementation details. These core technical components are protected under international patent applications and proprietary research agreements. This public release aims to: - Establish academic priority and conceptual transparency - Invite interdisciplinary scholarly dialogue - Outline strategic benefits for national and global stakeholders - Define ethical, governance, and safety standards for deployment Technical specifications, validation protocols, and implementation guidelines are available exclusively under formal Non-Disclosure Agreements (NDAs) and institutional licensing frameworks. --- ### ABSTRACT Contemporary artificial intelligence systems, predominantly based on probabilistic prediction architectures, face fundamental limitations in stability, energy efficiency, and verifiable safety. As autonomous systems approach super-intelligent capabilities, the absence of mathematical guarantees for goal stability, auditability, and physical sustainability poses existential and strategic risks. This monograph introduces **OMEGA SABRINAL ELRAKHAVI**, a conceptual framework that reorients artificial intelligence from statistical prediction to causally grounded, formally verifiable, and physically efficient cognition. The framework rests on six foundational pillars: neuro-symbolic reasoning fusion, mathematically constrained self-improvement, holographic memory architecture, photonic-resistive computing substrates, hierarchical verification protocols, and hardware-anchored corrigibility. Rather than disclosing proprietary algorithms or hardware specifications, this document outlines the conceptual paradigm, comparative advantages over existing architectures, strategic applications for national sovereignty and global challenges, and a phased governance roadmap. The framework is designed to enable safe, stable, and accountable super-intelligence while preserving human agency, environmental sustainability, and democratic oversight. This publication serves as a conceptual reference for policymakers, academic institutions, and ethical AI stakeholders. Technical implementation details remain protected to ensure responsible development, prevent misuse, and maintain strategic integrity. **Keywords:** Super-intelligence safety, AI stability, verifiable AI, neuro-symbolic AI, AI governance, hardware-anchored safety, ethical AI deployment, strategic technology policy. --- ### 1. INTRODUCTION & STRATEGIC CONTEXT The global acceleration of artificial intelligence has unlocked unprecedented capabilities in language, vision, reasoning, and automation. Yet, current architectures share three structural vulnerabilities: 1. **Instability Under Self-Modification:** Systems optimized for performance lack formal guarantees that their core objectives remain stable during iterative self-improvement. 2. **Energy & Physical Constraints:** Data-transfer-heavy architectures consume disproportionate energy, conflicting with climate commitments and limiting scalable deployment. 3. **Opacity & Auditability Gaps:** Decision-making processes remain largely opaque, making external verification, regulatory compliance, and public trust difficult to achieve. As AI systems transition from tools to autonomous agents, these vulnerabilities evolve from engineering challenges into strategic and existential risks. Nations and institutions require a new paradigm: one where safety, stability, and verifiability are not appended as afterthoughts, but embedded as foundational properties. OMEGA SABRINAL ELRAKHAVI addresses this imperative by proposing a cognitive architecture where mathematical stability, physical efficiency, and external auditability are structurally guaranteed. This document outlines the conceptual foundations, strategic value, and governance pathways for responsible advancement. --- ### 2. CONCEPTUAL ARCHITECTURE: SIX FOUNDATIONAL PILLARS The framework is built upon six interdependent conceptual pillars. Each pillar addresses a critical limitation of current AI while establishing verifiable guarantees for safety and stability. #### 2.1. Neuro-Symbolic Reasoning Fusion Curren2026-05-04OpenAlex10.5281/zenodo.20019654Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160161457
W7160418847Postoperative nausea and vomiting2026-05-04OpenAlex10.1093/bjs/znag057Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160418847
W7160315117Real-world practices in the management of pediatric iliofemoral deep vein thrombosis: Results of the ELITE-Kids survey2026-05-04OpenAlex10.1016/j.thromres.2026.109696Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160315117
W7160201224The SONIA trial: redefining “better” in the sequencing of CDK4/6 inhibitors for advanced breast cancer2026-05-04OpenAlex10.3389/fonc.2026.1830471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160201224
W7160289728Do AI know what they know? Exploring metacognition in LLMs2026-05-05OpenAlex10.1177/1088467x261436903Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160289728
W7160255134Green nanotherapy for Alzheimers disease: Harnessing plant-derived extracellular vesicles for next-generation drug delivery2026-05-05OpenAlex10.1016/j.cej.2026.177052Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160255134
W7160241665Nonstationary Battery2026-05-05OpenAlex10.5281/zenodo.20036496Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160241665
W7160269007Transient CB2R Activation Enforces Irreversible Luminal Differentiation and Restrains Breast Cancer Plasticity2026-05-05OpenAlex10.5281/zenodo.20036708Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160269007
W71604079528th International Conference on Machine Learning & Applications (CMLA 2026)2026-05-06OpenAlex10.5281/zenodo.20051012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160407952
W7215784594ADVANCES IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF CANCER PAIN: A SCOPING REVIEW: Y. Tran Van1, A. Paladini2, V.P. Pham1, A.A. Al Alwany3, G. Farì4, A. Caruso5, M. Mercieri6, M.L.G. Leoni7, J.V. Pergolizzi8, A.D. Kaye9, F. Breve10, A. Corriero11, C. Gharibo12, G. Varrassi13 | 1Department of Biomedical Engineering, International University, Vietnam National University, Ho Chi Minh City, Vietnam; 2Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy; 3College of Medicine, University of Baghdad, Iraq; 4Department of Experimental Medicine (Di.Me.S.), University of Salento, Lecce, Italy; 6Department of Surgery, ASST Lodi, Lodi, Italy; 7Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Italy; 8NEMA Research Inc., Naples, FL, USA; 9Department of Anesthesiology, LSU Health, Shreveport, LA, USA; 10School of Pharmacy, Temple University, Philadelphia, PA, USA; 11Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy; 12Department of Anesthesiology, NYU Grossman School of Medicine, New York, NY, USA; 13Fondazione Paolo Procacci, Rome, Italy2026-05-06OpenAlex10.4081/ahr.2026.202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215784594
W7162425212Beyond First Impressions2026-05-06OpenAlex10.1093/cid/ciag308Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162425212
W7160428586Correction: Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape2026-05-06OpenAlex10.3389/fmicb.2026.1856847Title/abstractExcludedE5: Correction, retraction or ancillary data record.https://openalex.org/W7160428586
W7160374798Editorial: Advances in medical imaging for precision diagnostic and therapeutic applications in digestive diseases2026-05-06OpenAlex10.3389/fmed.2026.1835279Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160374798
W7160417309Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection2026-05-06OpenAlex10.3389/fimmu.2026.1859297Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160417309
W7160523468Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions2026-05-06OpenAlex10.1002/mdr2.70068Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160523468
W7160503106Modern approaches to target tumor heterogeneity: Integrating technology and treatment2026-05-06OpenAlex10.1177/03008916261437964Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160503106
W7160309577Recent developments and prospects in locoregional therapy of hepatocellular carcinoma2026-05-06OpenAlex10.1007/s00261-025-05367-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160309577
W7160375358Statisticians at the Forefront of Health Technology Assessment: Aligning Regulatory and HTA Evidence Through Transdisciplinary Collaboration2026-05-06OpenAlex10.1080/19466315.2026.2669302Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160375358
W7160502144When a Positive IgE Test Is Not an Allergy: Distinguishing Sensitisation, Cross‐Reactivity and Irritant Responses in Clinical Practice2026-05-06OpenAlex10.1111/cea.70315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160502144
W7160552487A Review on Multi-functional Chitosan Derivatives for Diabetes Management: Mucoadhesive Drug Delivery and Diabetic Wound-healing Applications2026-05-07OpenAlex10.1007/s40495-026-00464-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160552487
W7160539805Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer2026-05-07OpenAlex10.1016/j.currproblcancer.2026.101311Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160539805
W7160554804Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy2026-05-07OpenAlex10.3390/jcm15103570Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160554804
W7160494138Hemostatic Agents, Patch Material and Sternal Complications in Cardiac Surgery2026-05-07OpenAlex10.1201/9781003686491-12Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7160494138
W7160491971Innovative Exosomes Therapy in Cardiovascular Disease Management2026-05-07OpenAlex10.1201/9781003623632-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160491971
W7160513428Management of Chronic Obstructive Pulmonary Disease: An Update2026-05-07OpenAlex10.3329/bjm.v37i2.86300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160513428
W7160528268Optimizing Care for Patients With Metastatic Castration-Resistant Prostate Cancer2026-05-07OpenAlex10.1200/edbk-26-516658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160528268
W7160525608Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer2026-05-07OpenAlex10.1200/edbk-26-520754Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160525608
W7160557086Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy2026-05-07OpenAlex10.3390/cancers18101505Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160557086
W7160546544The effect of GLP-1RAs and co-agonists on body composition across obesity and type 2 diabetes2026-05-07OpenAlex10.1186/s40001-026-04534-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160546544
W7160531023Thrombosis at the crossroads of inflammation, coagulation, and vascular biology: Recent advances and emerging therapeutic strategies2026-05-07OpenAlex10.1016/j.cca.2026.121063Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160531023
W7160542397Breast cancer chemotherapy in transition: predictive markers, resistance mechanisms, and new treatment approaches2026-05-08OpenAlex10.3389/fonc.2026.1856398Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160542397
W7160667307Can AI Have a "Soul" Without a Self? Emotional Memory and Core-less Self-Assembly in an Agentic AI System2026-05-08OpenAlex10.5281/zenodo.20079289Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160667307
W7160548501Case report: The masquerading spectrum: a pediatric case series of IgG4-related disease2026-05-08OpenAlex10.3389/fimmu.2026.1832660Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160548501
W7164331176CloudHeal: LLM-Driven Fault Self-Healing in Aerospace Cloud Platforms via Structured Recovery Knowledge2026-05-08OpenAlex10.1109/cait70489.2026.11553922Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164331176
W7160601517Cognitive Swarm Intelligence with Self-Evolving Neural Networks and Trust-Aware Edge Analytics for IOT2026-05-08OpenAlex10.47392/irjaem.2026.0228Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7160601517
W7160597651Developing an Interactive Plastic Surgery Education Website Using Manus AI2026-05-08OpenAlex10.5281/zenodo.20086872Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7160597651
W7160526374Editorial: Application of stem cells in degenerative orthopedic diseases2026-05-08OpenAlex10.3389/fcell.2026.1868045Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160526374
W7160549598Editorial: Epigenetic alterations in tumors and therapeutic resistance2026-05-08OpenAlex10.3389/fgene.2026.1863097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160549598
W7160624726Evolving Paradigms in the Treatment of Philadelphia Chromosome–Positive ALL2026-05-08OpenAlex10.1200/edbk-26-517464Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160624726
W7160546643Gene alterations in differentiated thyroid cancer and iodine therapy: Mechanisms and clinical implications2026-05-08OpenAlex10.65457/jnmmi-2026-0009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160546643
W7160651683Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives2026-05-08OpenAlex10.3390/cimb48050489Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160651683
W7160636879New therapies for primary biliary cholangitis2026-05-08OpenAlex10.1007/s12072-026-11088-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160636879
W7213303179Research on Lightweight Large Model Fine-tuning and Anti-Conformity Heterogeneous Multi-Agent Fusion of Traditional Chinese Medicine Auxiliary Diagnosis Architecture Based on Consumer-grade Hardware2026-05-08OpenAlex10.1145/3829641.3829668Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7213303179
W7160630115Therapeutic Role of Nelarabine in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma2026-05-08OpenAlex10.5281/zenodo.20085049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160630115
W7160862294A Self-Governing AI-Driven Agent for Advanced Patient Data Structuring2026-05-09OpenAlex10.38124/ijisrt/26apr1663Full textExcludedF3: The implemented patient-data pipeline uses BioBERT, ClinicalBERT and PubMedBERT for extraction with an RL controller. Specialized large language model integration is explicitly future work, rather than the present acting agent.https://openalex.org/W7160862294https://doi.org/10.38124/ijisrt/26apr1663
W7160698610Interpretative Challenges of Variants of Uncertain Significance in Severe Treatment-Refractory Focal Segmental Glomerulosclerosis2026-05-09OpenAlex10.1159/000552476Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160698610
W7160713044Supplementary Material for: Interpretative Challenges of Variants of Uncertain Significance in Severe, Treatment-Refractory Focal Segmental Glomerulosclerosis2026-05-09OpenAlex10.6084/m9.figshare.32228274Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160713044
W7160875241Systemic Therapies for Desmoid Tumors: A Review of Past, Present, and Future Treatments2026-05-09OpenAlex10.3390/cancers18101521Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160875241
W7160779984Five-Dimensional Epistemology: From Knowing to Acting---A Five-Dimensional Approximation Model2026-05-10OpenAlex10.5281/zenodo.20102749Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160779984
W7160775201GOVERNANCE AT THE SUBSTRATE LAYER Why Category-Bound Standards Cannot Govern Agentic AI—and the Case for APR-Series2026-05-10OpenAlex10.5281/zenodo.20111100Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160775201
W7160764983The Anesthesia-Controlled Substitution Test (ACST) for Verifying Substrate-Independent AI Qualia2026-05-10OpenAlex10.5281/zenodo.20111736Title/abstractExcludedE1: Protocol-only proposal without an evaluated persistent healthcare agent.https://openalex.org/W7160764983
W7160857657Bacterial Etiology and Antimicrobial Resistance Patterns in Respiratory Tract Infections at a Tertiary Care Hospital in Damascus: A Two-Year Cross-Sectional Retrospective Analysis2026-05-11OpenAlex10.12688/f1000research.179004.1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160857657
W7161529430Beyond metrics:(Mis)attuning in the datafied relationship between journalism and audiences2026-05-11OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161529430
W7160826513Clinical characteristics and treatment patterns in ankylosing spondylitis patients undergoing total hip arthroplasty: a single-center retrospective cohort study with a two-decade comparative analysis (2001–2023)2026-05-11OpenAlex10.1186/s12891-026-09936-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160826513
W7161114454Dental Stem Cell-Derived Exosomes: The New Acellular Frontier in Dental Regeneration2026-05-11OpenAlex10.5772/intechopen.1014924Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161114454
W7160849864EF-Dynamical Systems v1.0: Attractors, Loops, Regime Transitions, and Recovery Dynamics in Emotional Field Theory2026-05-11OpenAlex10.5281/zenodo.20123800Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160849864
W7160853702Emerging frontiers in glioma therapy: the evolving role of glioma vaccines2026-05-11OpenAlex10.3389/fimmu.2026.1781820Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160853702
W7160830657Human vs AI Customer Support: A Comparative Study of Customer Satisfaction and Loyalty2026-05-11OpenAlex10.5281/zenodo.20115938Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160830657
W7160855822Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives2026-05-11OpenAlex10.3390/cancers18101551Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160855822
W7161367746Pharmacologic Strategies in Rapid Sequence Intubation: Current Trends and Controversies2026-05-11OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161367746
W7160833840Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges2026-05-11OpenAlex10.3389/fphar.2026.1822764Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160833840
W7160835468Spectral Early-Warning Signals of Adaptive Fragility in Reinforcement Learning2026-05-11OpenAlex10.5281/zenodo.20114915Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160835468
W7160911891The lipid A acylation pattern of Coxiella burnetii prevents detection and clearance by the non-canonical inflammasome in primary murine macrophages2026-05-11OpenAlex10.64898/2026.05.07.723481Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160911891
W7160769653What obgyns need to know about GLP-1 receptor agonists2026-05-11OpenAlex10.1097/gco.0000000000001116Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160769653
W7161765925‘Turing Animism’ and the Disenchantment of Social Cognition: Why Humans Ensoul Large Language Models2026-05-11OpenAlex10.3390/rel17050577Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161765925
W7160963522BU76 AAI-08 | Institutional Real-Time Closure Operations Same Settlement Window, All-Factor Co-Temporality, Pre-Feedback, and Multi-Respiratory Infrastructure for Enterprise and Industry Clusters2026-05-12OpenAlex10.5281/zenodo.20132594Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160963522
W7160917811Between Advocacy and Ambiguity: The Role of Palliative Medicine in Donation After Circulatory Death2026-05-12OpenAlex10.1016/j.jpainsymman.2026.04.249Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160917811
W7160902382Cancer's nano-messengers: The mechanistic universe and therapeutic rewriting of tumor-derived exosomes2026-05-12OpenAlex10.1016/j.jddst.2026.108440Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160902382
W7160932388Evolving Attitudes Toward Palliative Care in the Immunotherapy and Targeted Molecular Treatment Era2026-05-12OpenAlex10.1016/j.jpainsymman.2026.04.341Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160932388
W7160939450Expanding the Diarrhea Toolkit : A STEPwise approach in Palliative Care2026-05-12OpenAlex10.1016/j.jpainsymman.2026.04.345Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7160939450
W7220044916Human-in-the-Loop Reinforcement Learning for AI Governance: A Fast–Slow Decision Paradigm for Responsible LLM Deployment2026-05-12OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220044916
W7160894634Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib2026-05-12OpenAlex10.3390/jcm15103715Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160894634
W7160927097Navigating Career Transitions in Hospice and Palliative Medicine: Applying Expertise Beyond Traditional Practice2026-05-12OpenAlex10.1016/j.jpainsymman.2026.04.453Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160927097
W7160910785Rapid-acting interventions in treatment-resistant depression – a comparative review of esketamine and psilocybin2026-05-12OpenAlex10.26444/jpccr/221219Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160910785
W7160948072The Evolution of Targeted Therapy: Defining Milestones in Precision Cancer Care2026-05-12OpenAlex10.5281/zenodo.20132970Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160948072
W7160966206Transforming Outcomes in Advanced Basal Cell Carcinoma: The Evolving Role of Systemic Therapy2026-05-12OpenAlex10.1007/s40257-026-01037-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160966206
W7160916677Transforming artificial intelligence into artificial wisdom2026-05-12OpenAlex10.1038/s44220-026-00640-6Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7160916677
W7160923117What Next for Chronic Lymphocytic Leukemia? A Review of Evolving Paradigms, Measurable Residual Disease, and Emerging Immunotherapies2026-05-12OpenAlex10.5281/zenodo.20134118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7160923117
W7161072048Converting cold to hot: Strategies to sensitize microsatellite-stable colorectal cancer to immunotherapy2026-05-13OpenAlex10.4251/wjgo.v18.i5.118319Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161072048
W7161119162ESKAPE Pathogens: Resistant Mechanism, Clinical Impact along with Emerging Solution2026-05-13OpenAlex10.4103/jmms.jmms_30_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161119162
W7161015838Editorial: Advancements in ischemic retinopathies: unraveling molecular mechanisms and innovative therapeutic avenues2026-05-13OpenAlex10.3389/fmed.2026.1853495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161015838
W7161036606Editorial: New insights in veterinary cancer immunology, volume II2026-05-13OpenAlex10.3389/fvets.2026.1855930Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161036606
W7161011222Editorial: Perspectives in clinical infectious diseases: 2024/20252026-05-13OpenAlex10.3389/fcimb.2026.1864691Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161011222
W7161165536Epistemic Weather: Diagnostic Instruments for Reading Intent-Horizon State2026-05-13OpenAlex10.5281/zenodo.20180141Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161165536
W7161175489Health Matters2026-05-13OpenAlex10.60837/curare.v1i1.8892Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161175489
W7161068210When Chatbots Become Agents: The Next Phase of Healthcare AI2026-05-13OpenAlex10.1007/s10916-026-02402-4Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7161068210
W716113627212. Adrenal Gland Tumors2026-05-14OpenAlex10.5281/zenodo.20187400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161136272
W7161174763A Systematic Review of Supernumerary Robotic Limbs: Design Trade-Offs, Control Strategies, and Application Domains2026-05-14OpenAlex10.20944/preprints202605.0953.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161174763
W7161140407Advances in cryptococcal infections-associated immunopathology and potential therapeutic strategies2026-05-14OpenAlex10.3389/fphar.2026.1776489Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161140407
W7161171455Context-Access Calibration Failure in Agentic LLM Systems under High-Load Conditions: A Self-Observation Case Series from the GENESIS R90.5 Multi-Agent Research Session2026-05-14OpenAlex10.5281/zenodo.20175026Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7161171455
W7161129725Electrophysiological Monitoring During Brain Surgery Under General Anaesthesia: Principles, Anaesthetic Interactions, and Clinical Practice- Review article2026-05-14OpenAlex10.36948/ijfmr.2026.v08i03.78474Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161129725
W7161152653Multinuclear NMR and MRI Beyond Proton Imaging: Principles, Contrast Mechanisms, and Applications in Materials and Biomedicine2026-05-14OpenAlex10.3390/ijms27104384Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161152653
W7161154004Nanoscale delivery systems for hepatocellular carcinoma: Functionalization, delivery strategies, and clinical challenges2026-05-14OpenAlex10.1016/j.mtbio.2026.103227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161154004
W7161126247Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study2026-05-14OpenAlex10.1016/j.lanmic.2025.101320Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161126247
W7161123017Precaution with standards: rethinking respiratory sensitization classification through the case of methyl methacrylate2026-05-14OpenAlex10.3389/ftox.2026.1813881Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161123017
W7161157127Responsibly Navigating Social Practices2026-05-14OpenAlex10.1111/josp.70060Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161157127
W7161150925Revisiting Raynaud’s Phenomenon: Emerging Insights and Evolving Management Strategies2026-05-14OpenAlex10.2174/0127722708444234260422070300Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161150925
W7161161840The SGLT2 inhibitor gap: why are we missing opportunities in primary care?2026-05-14OpenAlex10.3399/bjgp26x745437Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161161840
W7161168241Unified Security Orchestration Framework for Protecting AI/ML Systems Against Input-Based and Model Supply Chain Attacks2026-05-14OpenAlex10.64220/amla.v2i2.003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161168241
W7161274572A framework for clinical validation of generative artificial intelligence therapeutics2026-05-15OpenAlex10.1002/wps.70067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161274572
W7161231952Abstract ND08: Discovery and development of a CD30 dual-payload ADC that combines MTI and Top1i to overcome drug resistance2026-05-15OpenAlex10.1158/1538-7445.am2026-nd08Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161231952
W7161253151Advances in vulvovaginal candidiasis research: a comprehensive review from epidemiology, diagnosis, treatment to resistance mechanisms2026-05-15OpenAlex10.3389/fmicb.2026.1811011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161253151
W7161174727Emerging insights into the presentation, pathophysiology, and management of eosinophilic esophagitis2026-05-15OpenAlex10.1016/j.jaci.2026.04.026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161174727
W7161273757Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies2026-05-15OpenAlex10.3389/fendo.2026.1791591Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161273757
W7161115954Reasoning under limited knowledge and resources: a normative–descriptive integration2026-05-15OpenAlex10.1016/j.cogsys.2026.101477Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161115954
W7161232464Relapsing childhood steroid sensitive nephrotic syndrome: what determines eventual remission?2026-05-15OpenAlex10.1007/s00467-026-07366-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161232464
W7161378630Relational Cognitive Telemetry for Long-Lived LLM Agent Societies: From Internal State Monitoring to Collective Performance2026-05-15OpenAlex10.5281/zenodo.20234605Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7161378630
W7161301403Tracheostomy in the management of obstructive sleep apnea: Contemporary indications, outcomes, and considerations2026-05-15OpenAlex10.1016/j.otot.2026.05.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161301403
W7161301546When Does Acceptable Become Unacceptable? Toxicities of Emerging Therapies2026-05-15OpenAlex10.1200/edbk-26-520698Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161301546
W7161417029Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies2026-05-16OpenAlex10.5281/zenodo.20227462Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161417029
W7161417792Cytomegalovirus Colitis Associated With Anifrolumab Therapy in Systemic Lupus Erythematosus: Implications for Transplant Practice2026-05-16OpenAlex10.1111/tid.70242Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161417792
W7161393933H2E SHERIFF V3: A Complete Deterministic Governance Framework for Multi-Modal AI Mathematical Derivation of Λ = 0.9785142874, Spectral Trap Proof of the Riemann Hypothesis, and Zero-Violation Certification Across Text, Audio, and Vision2026-05-16OpenAlex10.5281/zenodo.20226235Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161393933
W7161381791Immunologic Fitness Cost of Antifungal Resistance in Aspergillus fumigatus: A Mini-Review2026-05-16OpenAlex10.5281/zenodo.20230383Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161381791
W7161431842Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: From PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines2026-05-16OpenAlex10.1016/j.critrevonc.2026.105378Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161431842
W7161286677NEXT-GENERATION NANO-DRUG DELIVERY SYSTEMS FOR CANCER IMMUNOTHERAPY: BRIDGING INNOVATION AND CLINICAL TRANSLATION2026-05-16OpenAlex10.5281/zenodo.20196966Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161286677
W7161712943Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma2026-05-16OpenAlex10.1093/neuonc/noag111Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161712943
W7161478527EF-Perceptual Development v1.0: The Mechanics of Σ-Expansion: How Informational Structures Evolve, Stabilise New Distinctions, and Restructure Reality2026-05-17OpenAlex10.5281/zenodo.20256916Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161478527
W7161475872Evolution of Multiple Sclerosis (1993-2026) and Future Direction2026-05-17OpenAlex10.5281/zenodo.20261593Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161475872
W7161495075The Role of the State in Ensuring Social Justice2026-05-17OpenAlex10.17605/osf.io/gjs2bTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161495075
W7162332753Emerging Therapeutic Strategies for Neurodegenerative Diseases: A Comprehensive Review of Recent Advances and Future Directions2026-05-18OpenAlex10.3390/cells15100928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162332753
W7161585476Evolving Concepts in Pulmonary Hypertension2026-05-18OpenAlex10.1016/j.chest.2026.05.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161585476
W7161543271Personalized seizure risk forecasting via transformer-enhanced reinforcement learning with wearable signals2026-05-18OpenAlex10.1016/j.iswa.2026.200675Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161543271
W7162269966Robustness of Machine Learning Systems: under distribution shift & in adversarial environments2026-05-18OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162269966
W7161552273Systemic Therapy for Solitary Fibrous Tumor2026-05-18OpenAlex10.1007/s11864-026-01383-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161552273
W7161721983V3KTOR — Mapping the Self: Method, Design Rationale, and Theoretical Foundation2026-05-18OpenAlex10.5281/zenodo.20277359Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161721983
W7166097858Advances in the Treatment of Newly Diagnosed Multiple Myeloma: Current Status and Future Directions2026-05-19OpenAlex10.36000/hbt.oh.2026.28.209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166097858
W7161624684Agentic AI in Healthcare: Opportunities, Challenges, and Future Directions2026-05-19OpenAlex10.1145/3809164Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7161624684
W7161635303Clinical practices in general anaesthesia for caesarean section2026-05-19OpenAlex10.1097/ea9.0000000000000110Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161635303
W7161700681Diabetes-driven oxidative stress and calcium dysregulation in gametogenesis and early fertilization2026-05-19OpenAlex10.1016/j.jdiacomp.2026.109345Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161700681
W7220004258Digital Twin-Driven Knowledge-Enhanced AI Agents for Autonomous Operation and Maintenance Optimization in Industrial Cyber-Physical Systems2026-05-19OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220004258
W7161630408Editorial: AI and neuroscience: integrating knowledge, reasoning, and theory of mind2026-05-19OpenAlex10.3389/fncom.2026.1859797Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161630408
W7161640416Editorial: Insights in biosafety and biosecurity 2024/2025: novel developments, current challenges, and future perspectives2026-05-19OpenAlex10.3389/fbioe.2026.1855658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161640416
W7161691554Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials2026-05-19OpenAlex10.6084/m9.figshare.32326162Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161691554; https://openalex.org/W7161746526
W7216536839Enhancing Large Language Model Reasoning via Retrieval-Augmented Generation and Self-Verification Mechanisms2026-05-19OpenAlex10.63544/xgvmne24Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216536839
W7161699568Evolving Treatment Paradigms in Hormone Receptor–Positive, Human Epidermal Growth Factor 2–Negative Metastatic Breast Cancer2026-05-19OpenAlex10.1200/edbk-26-520518Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161699568
W7161625198Guest editorial: AI for a better future – advances, challenges and future research directions2026-05-19OpenAlex10.1108/intr-06-2026-034Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161625198
W7161717938In vitro and in vivo investigation of potent platinum(IV) prodrugs for clinical anticancer therapy2026-05-19OpenAlex10.26183/pdnv-wx92Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161717938
W7220268509LLM-Driven Conversational Agents for Mental Health Support with Long-Term User Behavior Modeling2026-05-19OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220268509
W7161703765Nitrosamine Impurities in Pharmaceuticals: Integrated Evaluation of Toxicity, Exposure, Carcinogenic Potency Categorization and Regulatory Risk Assessment2026-05-19OpenAlex10.5281/zenodo.20290283Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161703765
W7161728121Pharmacological strategies for relapsed multiple myeloma after T-cell engager therapy: From molecular mechanisms to translational opportunities2026-05-19OpenAlex10.1556/1661.2026.00011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161728121
W7161683886Primes Is All We Need Topological Invariants for Catastrophic-Forgetting-Free AI2026-05-19OpenAlex10.5281/zenodo.20295288Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161683886
W7161813133Research on a Risk Prediction Model for Hypoxemia During Spontaneous Breathing Intravenous Anesthesia Using Endoscopic Nasal Masks Based on Machine Learning Algorithms2026-05-19OpenAlex10.66280/ijair.v1i2.131Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161813133
W7161694440Review of Current Medical and Surgical Therapy for Inflammatory Bowel Disease2026-05-19OpenAlex10.1097/mcg.0000000000002387Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161694440
W7161626046The Autophagy–Inflammation Axis in Kawasaki Disease: Pathogenic Mechanisms and Translational Opportunities2026-05-19OpenAlex10.3390/jcm15103918Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161626046
W7161289856[Progress in targeted therapy for chronic thromboembolic pulmonary hypertension].2026-05-19OpenAlex10.3760/cma.j.cn112137-20260205-00405Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161289856
W7163382129A Case of Milia En Plaque Secondary to Granulomatous Rosacea in a 22-Year-Old Filipino2026-05-20OpenAlex10.67196/japav6i1.011Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163382129
W7162623386CFD study of the sanitization of surfaces by means of hydrogen peroxide vapour2026-05-20OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162623386
W7161814280CNS Involvement of Multiple Myeloma—A Case Series and Narrative Literature Review2026-05-20OpenAlex10.3390/jcm15103927Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161814280
W7161761029Foundation-Grounded System Prompting: Empirical Evidence for Structural Hallucination Elimination, Cross-Domain Generalisation, and Recursive Coherence Gain in Large Language Models2026-05-20OpenAlex10.5281/zenodo.20300910Title/abstractExcludedE2: General-domain method or evaluation uses medicine/ECG as one of several demonstrations or benchmark domains; fixed P2 applies.https://openalex.org/W7161761029
W7162019472Infection, inflammation and immune dysregulation: evolving perspectives on the host response2026-05-20OpenAlex10.1136/archdischild-2025-330158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162019472
W7162132251Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure2026-05-20OpenAlex10.1093/eschf/xvag141Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162132251
W7161806097Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir2026-05-20OpenAlex10.3389/fpubh.2026.1819844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161806097
W7161701267Reframing Artificial Intelligence as Organizational Meta-Governance: A Technology Forecasting Framework and Adoption Trajectory2026-05-20OpenAlex10.7840/kics.2026.51.5.1013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161701267
W7167824738Remission revolution; redefining CKD management from slowdown to reversal2026-05-20OpenAlex10.34172/npj.2026.12855Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167824738
W7161845824The Clopidogrel Dilemma in Thromboprophylaxis Following Total Joint Arthroplasty2026-05-20OpenAlex10.2106/jbjs.25.01399Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161845824
W7161807250The Current State Of Knowledge On The Management Of Ischemic Heart Disease In Patients With Cancer2026-05-20OpenAlex10.56936/18290825-2026.20v.1-20Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161807250
W7161755138The Embodiment of Vulnerability: How Consumers Judge Empathy Gaps in Artificial Intelligence‐Driven Healthcare2026-05-20OpenAlex10.1002/mar.70167Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7161755138
W7200102843Toimijuus, ideologia, legitimiteetti : Muutoksia kulttuurienvälisyyden opetuksessa ja kokemisessa korkeakoulutuksessa2026-05-20OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7200102843
W7161759828Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids2026-05-20OpenAlex10.1038/s41584-026-01379-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161759828
W7161785394Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11—do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal?2026-05-20OpenAlex10.1128/mbio.00588-26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161785394
W7162049361Walking with the Wounded: Chaplains as Agents of Christ’s Healing Ministry2026-05-20OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7162049361
W7161800427one of the infrastructures for embodied intelligence2026-05-20OpenAlex10.5281/zenodo.20315371Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7161800427
W71619388542026-05-21OpenAlex10.1055/s-016-63668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161938854
W7161998741ANESTHESIOLOGY® 2026: Catch the Wave in San Diego2026-05-21OpenAlex10.1097/01.asm.0001194228.39813.54Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161998741
W7161981036Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone?2026-05-21OpenAlex10.3389/fneur.2026.1814289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161981036
W7172104215Carvedilol and the evolving management of portal hypertension in compensated cirrhosis2026-05-21OpenAlex10.46439/gastro.5.031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172104215
W7161998290Case Report: Complete response to the novel NaPi2b-targeting ADC YL205 in heavily pretreated platinum-resistant ovarian cancer2026-05-21OpenAlex10.3389/fonc.2026.1781961Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161998290
W7162056649HUMAN–AI TEAMING AS A NEW PARADIGM OF ENTERPRISE MANAGEMENT IN THE DIGITAL ECONOMY2026-05-21OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162056649
W7161959041Incidental Detection of Severe LAD Stenosis by FAPI PET/CT in a Patient Under Evaluation for Solitary Pulmonary Nodule – Correlation with Coronary Flow Velocity and Coronary Angiogram2026-05-21OpenAlex10.25259/ijnm_178_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7161959041
W7161962914Profile-Aware Consent Management: A Conceptual Framework2026-05-21OpenAlex10.3233/shti260697Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161962914
W7161947319Shifting Pieces, Creating New Images2026-05-21OpenAlex10.4324/9781003478034-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161947319
W7162014213Steroids in organ transplantation: Immunosuppression and tolerance2026-05-21OpenAlex10.1016/j.jsbmb.2026.107039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162014213
W7162024460The Evolving Pharmacological Landscape for Paediatric and Adult ADHD2026-05-21OpenAlex10.1007/s40263-026-01299-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162024460
W7161950581The History of Psychological Thought and the Psychology of Belonging2026-05-21OpenAlex10.5281/zenodo.20331766Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161950581
W7161970857The State of Imidazolone as an Evolving Pharmacophore: Current Progress and Clinical Significance in Oncology and AMR2026-05-21OpenAlex10.1021/acsomega.6c00103Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7161970857
W7162024592The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma2026-05-21OpenAlex10.37349/etat.2026.1002374Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162024592
W7162143229"A REVIEW ON ANTIBIOTIC RESISTANCE & THEIR MECHANISM"2026-05-22OpenAlex10.5281/zenodo.20347900Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162143229
W7162076749A Study On Consumer Buying Behavior Towards Life Insurance Products2026-05-22OpenAlex10.5281/zenodo.20338632Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162076749
W7162141259Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma2026-05-22OpenAlex10.1007/s11912-026-01792-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162141259
W7215739071From Machine Learning to Foundation and Agentic AI: Evolution of Intelligent Decision Systems Across Domains2026-05-22OpenAlex10.32996/jcsts.2026.8.7.9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215739071
W7162118127Human interface to ARC (Auto Regressive Compiler) for deterministic semantic governance over Probabilistic Inferring Engines (PIEs).2026-05-22OpenAlex10.5281/zenodo.20343517Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162118127
W7162141933Mpox in Solid Organ Transplant Recipients: Lessons From a Single‐Center Case Series in South Florida2026-05-22OpenAlex10.1111/tid.70246Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162141933
W7166790018Multi-Agent Predictive Maintenance System Using Model Context Protocol (MCP) and OPC UA2026-05-22OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7166790018
W7162110749SGLT2 Inhibitors as Mito-Protective Agents:Delineating the Heart-Brain Axis in Neurodegeneration2026-05-22OpenAlex10.25258/ijddt.16.48s.7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162110749
W7162226386Sepsis Causes and Management2026-05-22OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162226386
W7162223133The Evolution of Intracranial Hemorrhage Management2026-05-22OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162223133
W7162080034The Future of Agentic AI in Healthcare2026-05-22OpenAlex10.4324/9781003676157-9Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162080034
W7162093878Tools and Platforms for Developing Agentic AI in Healthcare2026-05-22OpenAlex10.4324/9781003676157-10Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162093878
W7162089835optimize_anything: A Universal API for Optimizing any Text Parameter2026-05-22OpenAlex10.1145/3786335.3813190Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162089835
W7162141684“From Walking Blind to Being Guided”: a qualitative study examining carers’ perceptions after experiencing ECHOMANTRA2026-05-22OpenAlex10.21203/rs.3.rs-9682871/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162141684
W7162212675Advances in Sustainable Management of Potato Late Blight (Phytophthora infestans): Resistance Breeding, Molecular Diagnostics and Integrated Control Strategies2026-05-23OpenAlex10.1007/s11540-026-10077-0Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162212675
W7162187398Calcium Hydroxylapatite for Facial Rejuvenation: Properties, Mechanisms, and Clinical Applications2026-05-23OpenAlex10.1177/19373368261451012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162187398
W7162189200GOVERNED AUTONOMOUS INFRASTRUCTURE (GAI) A New Paradigm for Autonomous Intelligence, Runtime Governance, and Controlled Self-Improvement2026-05-23OpenAlex10.33774/coe-2026-hhgh2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162189200; https://openalex.org/W7161547163
W7162194277Hypereosinophilic Syndrome: A Narrative Review of Pathogenesis, Clinical Spectrum and Evolving Therapeutic Strategies2026-05-23OpenAlex10.7860/jcdr/2026/85513.23615Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162194277
W7162238614Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials2026-05-23OpenAlex10.7759/cureus.109528Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162238614
W7162462037The Maxwell Finland Lecture 2025: Antimicrobial Resistance At the Bedside: Translating Science into Patient Outcomes2026-05-23OpenAlex10.1093/infdis/jiag273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162462037
W7162187863Void-OS A Constraint Governed Symbolic Operating Architecture2026-05-23OpenAlex10.5281/zenodo.20356462Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162187863
W7162239516CES-QN: A Causal–Self-Evolving–Quantum-Neuromorphic Framework2026-05-24OpenAlex10.5281/zenodo.20364600Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7162239516
W7162256039CFAE Framework Specification: FOF — Functionality Optimization Foundry v0.12026-05-24OpenAlex10.5281/zenodo.20363576Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7162256039
W7162937307TREHALOSE, SUPRAPHYSIOLOGICAL BETA-ALANINE, AND LEUCINE WITH ESSENTIAL AMINO ACIDS PRODUCE SUSTAINED HYPERTROPHIC PERMISSIVENESS2026-05-24OpenAlex10.5281/zenodo.20364901Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162937307
W7162428354A Case of Buschke-Löwenstein Tumor: Diagnosis and Surgical Management Buschke-Löwenstein Tumor: A Case Report of Diagnosis, Surgical Treatment and Adjunctive Measures for Recurrence Prevention2026-05-25OpenAlex10.5281/zenodo.20393691Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162428354
W7162248139A new era in atherothrombosis2026-05-25OpenAlex10.1016/j.atherosclerosis.2026.120777Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162248139
W7162284824Apolipoprotein L1 genetic testing, family history of hypertension, and kidney disease in a Midwestern U.S. cohort2026-05-25OpenAlex10.3389/fneph.2026.1771125Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162284824
W7162258305Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinoma2026-05-25OpenAlex10.1016/j.aohep.2026.102235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162258305
W7162332304Controlled Visual Generation Compass: A Compact Framework for Generative AI Research and System Design2026-05-25OpenAlex10.5281/zenodo.20384214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162332304
W7162315619Four decades of glioblastoma targeted therapy: a bibliometric and pharmacological perspective on translational failure and future directions2026-05-25OpenAlex10.21203/rs.3.rs-9669872/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162315619
W7162306338Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment2026-05-25OpenAlex10.1111/ejh.70223Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162306338
W7162658763From History to Innovation: Pathophysiology and the Evolving Landscape of Urolithiasis Diagnosis and Treatment2026-05-25OpenAlex10.2174/0113816128456160260522052912Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162658763
W7163075948KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers2026-05-25OpenAlex10.2174/0118715273455571260523060433Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163075948
W7162339984Stage-adaptive nanotherapeutic design for blood–brain barrier navigation in ischemic stroke2026-05-25OpenAlex10.1016/j.ijpharm.2026.127020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162339984
W7162422185Virtualia: vol. 3, n. 2 (2026).2026-05-25OpenAlex10.5281/zenodo.20171961Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162422185
W7162402498Acute Pulmonary Embolism: Refining the Risk–Benefit Paradigm in Contemporary Venous Thromboembolism Intervention2026-05-26OpenAlex10.1007/s00270-026-04467-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162402498
W7162470980Antioxidant Polymeric and Non-Polymeric Nanoformulations for the Treatment of Autoimmune Diseases2026-05-26OpenAlex10.3390/cimb48060557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162470980
W7164560394Application of AI agent in Assisting the Diagnosis of Mild Cognitive Impairment2026-05-26OpenAlex10.29011/2577-2228.100570Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164560394
W7162464609Can directing self-enhancement from social to performance settings alleviate narcissistic personality disorder? Implications from narcissism-performance research2026-05-26OpenAlex10.3389/fpsyt.2026.1621098Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162464609
W7168083163From Guidelines to Innovation: The Evolving Paradigm of Premature Ventricular Complex Management2026-05-26OpenAlex10.5812/intjcardiovascpract-169721Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168083163
W7162405629SQLens: Continuous Code-to-SQL Visibility in the Wild2026-05-26OpenAlex10.1145/3788853.3803091Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162405629
W7211938699Self-Evolving Autonomous Software Architectures Using Large-Scale Graph Neural Networks and Real-Time Big Data Feedback Loops for Economic Optimization and Cost-Efficient Resource Allocation2026-05-26OpenAlex10.63544/jbii.v5i5.188Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7211938699
W7162519086A Review on Oral Thin Films for Enhancement of Bioavailability2026-05-27OpenAlex10.5281/zenodo.20404903Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162519086
W7162559285Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence2026-05-27OpenAlex10.3390/ph19060833Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162559285
W7162543529Clonal hematopoiesis-related outcomes associated with radioligand therapy in prostate cancer: A “real-world” analysis.2026-05-27OpenAlex10.1200/jco.2026.44.16_suppl.5045Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162543529
W7162588843Cognitive bias and clinical acumen in uveitis practice2026-05-27OpenAlex10.4103/ijo.ijo_1402_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162588843
W7162425772Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders2026-05-27OpenAlex10.4292/wjgpt.v17.i2.118616Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162425772
W7162553336Future Pandemics: AI-Designed Diagnostic Assays for Detection of Andes Orthohantavirus (ANDV) Associated with the 2026 MV Hondius Outbreak2026-05-27OpenAlex10.64898/2026.05.26.26354101Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162553336
W7162503730Immune cell imaging in the glioma microenvironment2026-05-27OpenAlex10.1016/j.brainres.2026.150394Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162503730
W7217946174Interplay of Biofilm Formation, Virulence Determinants, and Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus: A Comprehensive Review2026-05-27OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7217946174
W7162838472Learning to Collaborate: Toward Robust, Adaptive Policies for Human–Robot Teams2026-05-27OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162838472
W7197280444Nanogeelien ja Mikrogeelien käyttö lääkkeiden kuljetuksessa2026-05-27OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197280444
W7162578595Premature termination of early-phase cancer clinical trials: “It’s the economy, stupid!”2026-05-27OpenAlex10.1093/jnci/djag130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162578595
W7163604939Psychiatric Atmospheres:A Pluralistic Phenomenological Study of Hospital Architecture2026-05-27OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163604939
W7162522024Safety and efficacy of ifebemtinib (IN10018) combined with garsorasib (D-1553) in KRAS G12C mutant solid tumors from a phase Ib/II study: 2-year follow-up from single-arm of non-small-cell lung cancer (NSCLC).2026-05-27OpenAlex10.1200/jco.2026.44.16_suppl.3113Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162522024
W7162672641Trajectory-Level Stability of Agentic Clinical Reasoning in Sepsis: A Longitudinal Evaluation Framework Using MIMIC-IV2026-05-27OpenAlex10.20944/preprints202605.1824.v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7162672641
W7162684642A multi-agent AI system integrating real-world data and competitive intelligence to generate automated trial eligibility recommendations.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e23008Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7162684642
W7162629288A phase 3 study of sacituzumab govitecan in patients with previously treated extensive-stage small cell lung cancer.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.tps8137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162629288
W7162968978Automated Detection of Learning Pitfalls in Tabular Security Classifiers via Reasoning LLMs2026-05-28OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162968978
W7162667352Case Report: Integrative Pharmacotherapy of Severe Dermatophytosis with Candida spp.Superinfection: Mechanisms of Action and Epidermal Barrier Restoration.2026-05-28OpenAlex10.5281/zenodo.20424095Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162667352
W7162681704Clinician readiness and ethical thresholds for agentic AI autonomy in oncology care: A multi-specialty survey.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e13699Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162681704
W7162629957Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter2026-05-28OpenAlex10.1016/j.autrev.2026.104092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162629957
W7162689082Comparative efficacy of PD-1 versus PD-L1 inhibitors in metastatic colorectal cancer: A real-world propensity score–matched study.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e15599Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162689082
W7162661142Current real-world treatments in patients with metastatic colorectal cancer (mCRC) in US clinical practice.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e15604Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162661142
W7162649682ECLAD: An Edge-Cloud Collaborative Agentic Framework for Interpretable Anomaly Detection in Predictive Maintenance2026-05-28OpenAlex10.1145/3774905.3793127Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162649682
W7162629943Editorial: Quantitative insights into new cancer therapies: a mathematical modeling approach2026-05-28OpenAlex10.3389/fams.2026.1869506Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162629943
W7162643015Entre el lazo y la creación: prácticas artísticas, reconocimiento y subjetividad2026-05-28OpenAlex10.15517/ssn2gs64Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162643015
W7162650136Give the Cefazolin, Even in Patients with a Cephalosporin Allergy2026-05-28OpenAlex10.2106/jbjs.25.01565Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162650136
W7162660425Global evolution of HER2-targeted clinical trials across solid tumors: Shifts in tumor representation, biomarker definitions, therapeutic modalities, and geographic leadership.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e23085Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162660425
W7162687330High-Risk Multiple Myeloma: Redefining Risk and Rethinking Therapy2026-05-28OpenAlex10.1200/edbk-26-517494Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162687330
W7162683432Impact of a real-time targeted expert outreach model on conversion of biomarker results to precision treatments.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e23390Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7162683432
W7162689186Metabolic reprogramming of the tumor microenvironment during transarterial therapy: Where no catheter has gone before2026-05-28OpenAlex10.1097/hep.0000000000001798Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162689186
W7162637054PromptX: A Cognitive Agent Platform with Long-term Memory2026-05-28OpenAlex10.1145/3774905.3793108Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7162637054
W7162634453Proof of concept for machine learning–based models to predict response to anticancer treatments.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e13002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162634453
W7162769169Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension2026-05-28OpenAlex10.4103/idoj.idoj_339_25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162769169
W7162904698RATSe-Health™: A Runtime Governance Architecture for Clinically Governable Healthcare AI2026-05-28OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162904698
W7171539127THE SCHOOL AS A PROTAGONIST IN COMBATING THE SEXUAL EXPLOITATION OF CHILDREN AND ADOLESCENTS: DIALOGICITY AND INTERDISCIPLINARY REFLECTIONS2026-05-28OpenAlex10.63330/aurumpub.057-016Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171539127
W7162647037Targeting KRAS G12C in non-small cell lung cancer: Breakthrough inhibitors and combination approaches2026-05-28OpenAlex10.1016/j.critrevonc.2026.105396Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162647037
W7162648856Targeting metal ion transport in pancreatic cancer: A prognostic signature and GraphBAN-predicted therapeutics framework.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e16000Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162648856
W7162652911The CNS exile: An AI-driven audit of active brain metastasis exclusions in modern NSCLC immunotherapy clinical trials.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e13746Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162652911
W7162656962The Serotonin 2B (5‐ HT2B ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression2026-05-28OpenAlex10.1002/cpt.70344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162656962
W7162673058The evolving landscape of chimeric antigen receptor (CAR) T-cell therapy for plasma cell leukemia: A systematic review of early outcomes.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e19508Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162673058
W7162514941Trends in frontline treatment patterns for multiple myeloma among US veterans, 1999–2025.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.7576Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162514941
W7162642105Two decades of landscape change in the treatment of multiple myeloma.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.e19571Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162642105
W7162659331Volrustomig, a novel bispecific PD-1/CTLA-4 monoclonal antibody, as single-agent first-line therapy for unresectable pleural mesothelioma: Substudy 5 of the eVOLVE-02 phase 2 study.2026-05-28OpenAlex10.1200/jco.2026.44.16_suppl.tps8126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162659331
W7162834137When Lupus Begins in the Heart: New-Onset Lupus Perimyocarditis Presenting as Acute Dilated Cardiomyopathy2026-05-28OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162834137
W7163333631A qPCR-Based Screening Platform for Exploratory Assessment of Phage Training Outcomes in Enterobacter cloacae and Stenotrophomonas maltophilia2026-05-29OpenAlex10.3390/v18060624Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163333631
W7162859771Amivantamab in advanced non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real‐world data from the Italian ATLAS Registry2026-05-29OpenAlex10.1002/cncr.70476Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162859771
W7162772233Artificial intelligence for optimization of immunotherapy: current applications and transformative potential2026-05-29OpenAlex10.3389/fimmu.2026.1777580Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162772233
W7162782651Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group2026-05-29OpenAlex10.3390/toxins18060248Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162782651
W7162794939Emerging concepts in ILDA glance into the future2026-05-29OpenAlex10.1201/9781003451259-26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162794939
W7162768962Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”2026-05-29OpenAlex10.3389/fonc.2026.1855868Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162768962
W7163004529From T cell engagers to next-generation immune cell engagers for cancer immunotherapy2026-05-29OpenAlex10.1093/abt/tbag030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163004529
W7162794081Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated2026-05-29OpenAlex10.1080/17476348.2026.2682314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162794081
W7162765261Internal multiplicity, emergent unity, and the case for an IFS-informed AI architecture in psychotherapy: a theoretical review2026-05-29OpenAlex10.1080/27706710.2026.2678005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162765261
W7163187522Nivolumab-AVD Emerges as New Standard in Adolescent Hodgkin Lymphoma2026-05-29OpenAlex10.1097/01.cot.0000000000000400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163187522
W7162765445Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies2026-05-29OpenAlex10.1186/s12985-026-03207-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162765445
W7162761789Sustained radiographic resolution of a branch-duct intraductal papillary mucinous neoplasm of the pancreas during Chinese herbal medicine treatment: A case report2026-05-29OpenAlex10.1016/j.explore.2026.103458Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162761789
W7162788113The Agentic Role of Generative Artificial Intelligence in Information Systems Leadership2026-05-29OpenAlex10.18848/1832-3669/cgp/a1033Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7162788113
W7162848525Top advances of the year: Radiopharmaceutical therapy for prostate cancer2026-05-29OpenAlex10.1002/cncr.70470Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162848525
W7163350427Artificial Intelligence-Enhanced Herbal Strategies for Nephrotoxicity: Mechanisms, Modeling and Precision Nephroprotection2026-05-30OpenAlex10.70593/978-93-7185-197-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163350427
W7162851740Authority Transfer in Recursive and Networked AI Systems Closed-Loop Self-Improvement (CLSI), Recursive Leverage (RLF), and Synchronized Recursive Leverage (SRL)2026-05-30OpenAlex10.5281/zenodo.20463250Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162851740
W7162871428DIANA OS: A Domain-Specific Multimodal Cognitive Architecture with Asynchronous State Mutation and Entitlement-Gated Routing2026-05-30OpenAlex10.5281/zenodo.20452909Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162871428
W7162879792Dismantling the routine use of prophylactic volume expansion in contrast-associated acute kidney injury2026-05-30OpenAlex10.1016/j.ejim.2026.106970Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162879792
W7162859304From Monoclonal to Multifunctional: The Evolving Landscape of Engineered Antibodies2026-05-30OpenAlex10.25258/ijddt.16.37s.32Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162859304
W7162798632Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options2026-05-30OpenAlex10.1186/s43556-026-00486-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162798632
W7163751073Preoperative Skin Preparation: History and Current Best Practices2026-05-30OpenAlex10.65365/vjmr.v2.i1.23Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163751073
W7223760456Recursive Exposure II: Semantic Simulacra2026-05-30OpenAlex10.5281/zenodo.20460005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223760456
W7162892162Transfer Compass: A Compact Design Framework for Transfer and Adaptation in AI2026-05-30OpenAlex10.5281/zenodo.20458799Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162892162
W7163327798'One Health' prerogative to illustrate environmental sink hypothesis of Accumulator Effectors2026-05-31OpenAlex10.18103/mra.v14i5.7504Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163327798
W7163751786Hepatorenal Syndrome (HRS) Descriptive Review and Current Clinical Perspectives2026-05-31OpenAlex10.5281/zenodo.20569171Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163751786
W7164363249Surgery-induced immune modulation: a comprehensive review2026-05-31OpenAlex10.30978/gs-2026-2-56Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164363249
W7163174238大模型赋能人形机器人智能交互与自主决策的技术架构及应用研究2026-05-31OpenAlex10.65196/zxmm8035Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163174238
W71629544972026-06-01OpenAlex10.13040/ijpsr.0975-8232.17(6).1728-35Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162954497
W7163525303(107) Chemsex: The Neuropharmacology of Pleasure and Risk2026-06-01OpenAlex10.1093/jsxmed/qdag118.094Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163525303
W7164204871185 Optimising care for cancer patients: outcomes from a novel tertiary cardio-oncology service2026-06-01OpenAlex10.1136/heartjnl-2026-bcs.66Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164204871
W716684347176 Empowering early career front line staff through continuous improvement: growth, leadership and resilience2026-06-01OpenAlex10.1136/bmjoq-2026-qsho.76Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166843471
W7167226856A COMPREHENSIVE REVIEW ON HIGH-PERFORMANCE DISTRIBUTED COMPUTING IN WSNs2026-06-01OpenAlex10.58532/nbennurftcnb2c6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167226856
W7162992463A Novel Dual-Loop Causality-Traceable Retrieval Framework for Long-Horizon Conversational Agents2026-06-01OpenAlex10.3390/electronics15112373Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7162992463
W7162793424A REVIEW OF FORMULATION AND EVALUATION OF ANTI FUNGAL CREAM USING DIFFERENT PLANT EXTRACT2026-06-01OpenAlex10.5281/zenodo.20443963Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162793424
W7163020412ADC-opoly in endometrial and cervical cancer: expanding the board2026-06-01OpenAlex10.1016/j.ijgc.2026.104786Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163020412
W7172442928Adaptive Federated Learning with Full-Duplex and Active Control2026-06-01OpenAlex10.1109/icdca69396.2026.11620118Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172442928
W7203631629Agentic AI Security in IoMT: A PRISMA-Guided Scoping Review and Layered Threat–Defense Taxonomy2026-06-01OpenAlex10.1109/iccsdfai70505.2026.11647867Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203631629
W7163217957Antibody–drug conjugates in gynecologic cancers2026-06-01OpenAlex10.1002/cncr.70417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163217957
W7170084691Applied Machine Learning for Clinical Risk Assessment of Obstructive Sleep Apnea Using Electronic Health Records2026-06-01OpenAlex10.1109/icad69378.2026.11608983Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170084691
W7212370566BACTERIOLOGICAL PROFILE, SITE-SPECIFIC DISTRIBUTION, AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES RECOVERED FROM WOUND, BURN, AND DIABETIC FOOT INFECTIONS: A MULTI-HOSPITAL CROSS-SECTIONAL STUDY ACROSS BAGHDAD GOVERNORATE, IRAQ2026-06-01OpenAlex10.47832/2717-8234.27.31Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212370566
W7202287040Beyond Individual Prediction: A Population-Level Digital Twin for Lung Cancer Survivorship Capacity Planning2026-06-01OpenAlex10.1109/ichi69079.2026.00265Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202287040
W7166728055Beyond nutrition: lipids-based therapeutics from food and bioactive lipids2026-06-01OpenAlex10.26599/jfb.2026.95034443Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166728055
W7166768265Cabergoline-Induced Psychosis: A Case Report2026-06-01OpenAlex10.1192/bjo.2026.11758Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166768265
W7166743890Case 3512026-06-01OpenAlex10.1148/radiol.252188Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166743890
W7165137632Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time2026-06-01OpenAlex10.1016/j.jtct.2026.06.023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165137632
W7171937645Clinical and Functional Improvement with Brexpiprazole in an Adolescent with Early-Onset Schizophrenis2026-06-01OpenAlex10.1192/j.eurpsy.2026.11133Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171937645
W7162757053DIABETOLOGY IN MODERN PHARMACY: AN UPDATED AND CONCISE REVIEW2026-06-01OpenAlex10.5281/zenodo.20438780Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7162757053
W7168172450DRUG INFORMATION AND POISON INFORMATION CENTRES2026-06-01OpenAlex10.58532/nbennurecc6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168172450
W7167212908Diabetic Neuropathy: Evolving Paradigms in Diagnosis and Therapy2026-06-01OpenAlex10.1007/s12595-026-00619-2Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7167212908
W7165639947Diagnostic challenge of mycosis fungoides: a case report of progression in a 46-year-old Filipino woman2026-06-01OpenAlex10.21037/aol-25-13Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165639947
W7165559794Digitalis Today: From Doctrine to Disrepute to Disciplined Reconsideration2026-06-01OpenAlex10.1016/j.cardfail.2026.06.004Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165559794
W7163062206Emerging role of antibody–drug conjugates in gastrointestinal malignancies2026-06-01OpenAlex10.1002/cncr.70419Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163062206
W7172019175Etomidate Vaping: An Emerging Substance Use Pattern in Singapore - A Case Series2026-06-01OpenAlex10.1192/j.eurpsy.2026.10865Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172019175
W7166084995Evolving Therapeutic Strategies in Neuroendocrine Neoplasms: A New Era of Personalized Therapies2026-06-01OpenAlex10.1200/edbk-26-518934Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166084995
W7165404328Evolving landscape of JAK-STAT inhibition in the treatment of immune-mediated inflammatory diseases2026-06-01OpenAlex10.1016/j.jaci.2026.06.006Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165404328
W7164997397Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review2026-06-01OpenAlex10.21037/med-2025-1-68Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164997397
W7164863908Exosomes as Biomimetic Nanoplatforms for Synergistic Targeted Chemotherapy and Photothermal Treatment of Breast Cancer2026-06-01OpenAlex10.1002/jbt.70971Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164863908
W7163081033Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis2026-06-01OpenAlex10.1002/art.70237Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163081033
W7163030609Genome editing between wonder and rejection2026-06-01OpenAlex10.3389/fbioe.2026.1832039Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163030609
W7171910796Gestão Nutricional do doente em Cuidados Intensivos: Intervenções de Enfermagem2026-06-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171910796
W7166170423Glioblastoma: current challenges and future horizons2026-06-01OpenAlex10.4103/singaporemedj.smj-2026-356Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166170423
W7166167277HTA11 INDIRECT TREATMENT COMPARISONS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM RECENT NICE SUBMISSIONS2026-06-01OpenAlex10.1016/j.jval.2026.03.1378Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166167277
W7163013511High-Dose Monotherapy or Combination Therapy in Neuropathic Pain: A Necessary Reflection2026-06-01OpenAlex10.1080/15360288.2026.2673914Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163013511
W7163418077Human Amniotic Membrane as Adjuvant Therapy in Medication-Related Osteonecrosis of the Jaw: A Scoping Review2026-06-01OpenAlex10.58624/svoade.2026.07.020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163418077
W7166087353IDDF2026-ABS-0376 Who ends up in the or? unmasking predictors of surgery in crohn’s disease2026-06-01OpenAlex10.1136/gutjnl-2026-iddf.334Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166087353
W7163744166Implementation of the Master of Logic Theis "Updating Uncertain Evidence - Conditionalization and Complexity in Multi-Layer Belief Models"2026-06-01OpenAlex10.5281/zenodo.20491099Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163744166
W7220629046Latest Pharmacological Therapies in Allergic Rhinitis2026-06-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220629046
W7165810145Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non–Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population2026-06-01OpenAlex10.1200/go-25-00574Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165810145
W7167482188MACHINE LEARNING: CONCEPT AND ALGORITHM2026-06-01OpenAlex10.58532/nbennuraitc1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167482188
W7163998390METHOD OF DRUG ADMINISTRATION DURING IMPLANTATION IN ANIMALS USING BIODEGRADABLE COATINGS2026-06-01OpenAlex10.32935/2221-7312-2026-68-2-69-72Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163998390
W7163899962Microneedling in the Management of Striae Alba: A Review of Adjunctive Therapies Including Topical Insulin and Platelet-Rich Plasma: Review Article2026-06-01OpenAlex10.21608/aimj.2026.443142.3049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163899962
W7164716426Nanomedicine in 2026: Illustrative Quantitative Analyses of EPR Heterogeneity, Clinical Trial Attrition, and Emerging Horizons for Active Nanotherapeutics2026-06-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164716426; https://openalex.org/W7164344883
W7163065659Non-Invasive Transdermal Delivery of Exosomes via Iontophoresis in Female Androgenetic Alopecia: A Case Series2026-06-01OpenAlex10.62742/2965-7911.2026.3.bjhh46Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163065659
W7163684631OC.11 Points to consider for reporting outcomes measures in systemic sclerosis interventional studies on digital ulcers: an initiative from the world scleroderma foundation digital ulcer ad hoc committee2026-06-01OpenAlex10.1136/jsrd-2026-sswc.11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163684631
W7166847091OC6 Evolving therapies in eosinophilic esophagitis: a systematic review and meta-analysis of budesonide and dupilumab2026-06-01OpenAlex10.1136/flgastro-2026-bspghan.6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166847091
W7163911960OP06 Organisational dynamics and implementation complexities of mental health emergencies in the East Midlands, England2026-06-01OpenAlex10.1136/emermed-2026-999.6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163911960
W7163677780P.264 M10 as a novel drug candidate for skin fibrosis2026-06-01OpenAlex10.1136/jsrd-2026-sswc.307Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163677780
W7163680604P.361 An unusual yet a rare appendage manifestation of systemic sclerosis2026-06-01OpenAlex10.1136/jsrd-2026-sswc.402Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163680604
W7134243126Perioperative approaches for patients with biliary tract cancer.2026-06-01OpenAlex10.48620/96003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7134243126; https://openalex.org/W7133362161
W7166737332Prescribing Trends of Mood Stabilisers Within an Assertive Outreach Team (AOT) in York2026-06-01OpenAlex10.1192/bjo.2026.11858Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166737332
W7162987829Pulmonary fibrosis: evolving therapeutic pipeline2026-06-01OpenAlex10.1136/bmjmed-2025-001886Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162987829
W7170925603RECENT ADVANCES IN SGLT2 INHIBITORS2026-06-01OpenAlex10.58532/nbennuamsib7p2c2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170925603
W7169201653RESILIENT PHYTOSANITARY FRAMEWORKS: CLIMATE-ADAPTIVE PATHOGEN MITIGATION FOR SMALL-SCALE HORTICULTURAL SYSTEMS2026-06-01OpenAlex10.58532/nbennurrpfcb1c20Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169201653
W7169872124SYNERGISTIC APPROACHES: MICROBIOLOGISTS AND ONCOLOGISTS UNITING FOR CANCER MANAGEMENT2026-06-01OpenAlex10.58532/nbennuamsiv6b2c4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169872124
W7163194213Sedation in Gastrointestinal Endoscopy: From Drug-Centered Protocols to Personalized, Technology-Supported Pathways: A Narrative Review2026-06-01OpenAlex10.3390/jcm15114281Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163194213
W7165381821Semantic confusion between “MD” and MDMA in Indian Addiction Psychiatry Practice2026-06-01OpenAlex10.4103/indianjpsychiatry_1207_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165381821
W7165678365Spinal Pain in Sickle Cell Disease: A Scoping Review2026-06-01OpenAlex10.1093/jscdis/yoag020.033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165678365
W7163055714The Detection-Integration Hypothesis - Consciousness as Sentience, Sapience, and Poiesis2026-06-01OpenAlex10.5281/zenodo.20481778Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163055714
W7165192136The Evolution of Pragmatism in India: Ambedkar, Dewey, and the Rhetoric of Reconstruction by Scott Stroud2026-06-01OpenAlex10.5325/jhistrhetoric.29.1.0061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165192136
W7203710697The Humanization of Artificial Agents to Exposure the Individual Propensity of Social Connecting in Technology Affinity Affect2026-06-01OpenAlex10.25673/124580Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203710697
W7165761800The Interplay of Diabetes, Glucose Variability, and Antidiabetic Therapy in Preventing Periprosthetic Joint Infection Following Hip and Knee Arthroplasty: A Review2026-06-01OpenAlex10.2106/jbjs.rvw.26.00049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165761800
W7172025086The Overlooked Role of Psychiatrists in Obesity Management: A Multidisciplinary Perspective2026-06-01OpenAlex10.1192/j.eurpsy.2026.11376Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172025086
W7164951843The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation2026-06-01OpenAlex10.1016/j.curpro.2026.100121Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164951843
W7163756408The rise of the skin bleaching crisis: global perspectives2026-06-01OpenAlex10.1016/j.jid.2026.04.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163756408
W7171951386Tissue Optical Clearing in the Diagnosis of a Number of Pathologies2026-06-01OpenAlex10.1109/iclo69056.2026.11624419Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171951386
W7163812286Treatment Advances in Gynecologic Cancers: Insights From Recent Clinical Trials2026-06-01OpenAlex10.1002/cai2.70065Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163812286
W7166446550Tri-modality imaging in cardiac sarcoidosis: real-world concordance of cardiac magnetic resonance, echocardiography and fdg-pet2026-06-01OpenAlex10.1093/ejhf/xuag193.1317Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166446550
W7170206325WHERE SURGERY MEETS TECHNOLOGY: ADVANCES IN MODERN ORTHODONTIC CARE2026-06-01OpenAlex10.58532/nbennufdsov6b2c18Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170206325
W7161703016[From Self-Reflection to Building a "Culturally Safe" Care System].2026-06-01OpenAlex10.6224/jn.26301Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7161703016
W7168038621[Reflections on the management of a case of neurogenic stress cardiomyopathy complicated by acute submassive pulmonary embolism].2026-06-01OpenAlex10.3760/cma.j.cn121430-20251209-00595Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168038621
W7163579185Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs2026-06-02OpenAlex10.1093/oncolo/oyag222Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163579185
W7163123342Beyond Molecular Classification in Metastatic Triple-Negative Breast Cancer: Toward Subtype-Guided Precision Oncology2026-06-02OpenAlex10.3390/ijms27115040Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163123342
W7163170847Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions2026-06-02OpenAlex10.1111/1754-9485.70130Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163170847
W7163209352Editorial: Digital learning innovations: trends emerging scenario, challenges and opportunities2026-06-02OpenAlex10.3389/feduc.2026.1871035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163209352
W7163220890Emerging therapies and diagnostic innovations for multidrug-resistant infections in kidney allograft recipients: Challenges and future directions2026-06-02OpenAlex10.5527/wjn.118797Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163220890
W7163193857Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential2026-06-02OpenAlex10.1016/j.critrevonc.2026.105415Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163193857
W7163192355Innovations and future research directions on hip preservation management options for osteonecrosis of the femoral head2026-06-02OpenAlex10.5312/wjo.118397Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163192355
W7163186814Management of constipation: A narrative review of evolving strategies and methodological challenges2026-06-02OpenAlex10.5662/wjm.118399Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163186814
W7163141213Moving from change agents to improvement architects through the Four Cs model: rethinking healthcare's complexity, cultures, contexts and connections2026-06-02OpenAlex10.3389/frhs.2026.1687699Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7163141213
W7163220815The Moral Standing of Artificial Agents: From Functional Agency to Distributed Moral Responsibility. Dr. Ihsan Ali Al-Haidari2026-06-02OpenAlex10.17605/osf.io/z2bawTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163220815
W4417299963Unveiling the black box: A multi-layer framework for explaining reinforcement learning-based cyber agents2026-06-02OpenAlex2505.1170810.1016/j.jisa.2026.104507Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W4417299963
W7163323836Validation-Gated Multi-Agent Governance for Online Adaptation of Thermal-Hydraulic Surrogate Models under Operating-Regime Shift2026-06-02OpenAlex2606.0332110.48550/arxiv.2606.03321Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7163323836
W7163379709A Knowledge-Based System for Simulating Mental Health Interventions2026-06-03OpenAlex10.3390/app16115580Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163379709
W7163905439Evaluating the investigational drug landscape for ESR1 -mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer2026-06-03OpenAlex10.1080/13543784.2026.2686701Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163905439
W7163335544Guest editorial: STARA (smart technology, AI, robotics and algorithms): implications for career research2026-06-03OpenAlex10.1108/cdi-06-2026-665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163335544
W7163366059Implicit Structure as the Bottleneck: How Representation Opacity, State Tracking Failure, and Evaluation Blindness Compound Across Long-Horizon Agentic Tasks2026-06-03OpenAlex10.5281/zenodo.20525488Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163366059
W7163365413Lifecycle Analysis of Medicines Withdrawn, Restricted, or Label Updated Due to Safety Signals (2000–2025): A Retrospective Pharmacovigilance Study2026-06-03OpenAlex10.5281/zenodo.20526481Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163365413
W7163436521Mechanism Before Metric: How Process-Outcome Decoupling Exposes the Hidden Failure Modes of Agentic AI Evaluation2026-06-03OpenAlex10.5281/zenodo.20519735Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163436521
W7163350291Multi-Element Spectral Intelligence Engine (MESIE) A Modular Framework for Spectral Matching, Signal Synthesis, Cognitive Embeddings, and Multi-Domain Resonance Analysis2026-06-03OpenAlex10.5281/zenodo.20520987Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163350291
W7163397253Multidisciplinary Management of Esophageal Cancer2026-06-03OpenAlex10.1200/op-26-00198Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163397253
W7163417805Optimizing phage therapy with antidefense proteins acquired from the environment2026-06-03OpenAlex10.3389/fmicb.2026.1796329Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163417805
W7164372656Pharmacological treatment of cardiogenic shock2026-06-03OpenAlex10.1097/mcc.0000000000001393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164372656
W7163320441Supportive Management of Severe Acetaminophen and Ibuprofen Overdose Twenty-Four Hours After Ingestion in Limited Resources Settings2026-06-03OpenAlex10.14740/jmc5330Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163320441
W7163321395T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives2026-06-03OpenAlex10.3389/fimmu.2026.1755512Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163321395
W7163414015The evolution of non-surgical management in stage III non-small cell lung cancer2026-06-03OpenAlex10.1038/s44276-026-00212-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163414015
W7169118958Thesis Proposal: When Does an Agent Know It Is Lost? Confidence Trajectory Analysis for Tool-Using LLMs2026-06-03OpenAlex10.48448/6zh0-8987Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7169118958; https://openalex.org/W7166878287
W7163343147A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma2026-06-04OpenAlex10.1007/s12672-026-05344-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163343147
W7163574703CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers2026-06-04OpenAlex10.3389/fimmu.2026.1845921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163574703
W7163586296From Infancy to Adolescence: The Developmental Trajectory of Food Allergy and Its Relationship with Eosinophilic Esophagitis–Mechanisms, Epidemiology, and Emerging Therapies2026-06-04OpenAlex10.3390/allergies6020022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163586296
W7163532328Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer2026-06-04OpenAlex10.1016/j.canlet.2026.218652Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163532328
W7164520537Functionalization of Hydrogels2026-06-04OpenAlex10.1002/9783527854578.ch05Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164520537
W7216637665Role of Local Drug Delivery Systems in Periodontal Therapy: A Pharmacological Perspective2026-06-04OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7216637665
W7163519412State Tracking as the Binding Constraint: How Long-Horizon Coherence Failures Unify Agentic Data Analysis, Clinical Decision-Making, and Multi-Turn Tool Use2026-06-04OpenAlex10.5281/zenodo.20540636Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163519412
W7163582874The expanding role of protease therapeutics (2012–2026): from replacement therapies to immune system modulation and beyond2026-06-04OpenAlex10.1042/bcj20260152Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163582874
W7163367554Trust Continuity, the Age of AI Impersonation: What Can Be Done Today to Counter Conversational Impersonation and AI-Assisted Chat Intrusions Through Governance-Centric Approaches-Conversation Integrity, Attribution, Privacy Preservation Using AIVORIX OS™2026-06-04OpenAlex10.5281/zenodo.20519703Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163367554
W7163560418Update on the Management of ABCA4 Retinopathy (Stargardt Disease)2026-06-04OpenAlex10.1007/s40123-026-01407-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163560418
W7163698965Across Clinical Profiles of Cardiorenal–Metabolic (CKM) Syndrome: A Phenotype-Driven Therapeutic Approach2026-06-05OpenAlex10.3390/biomedicines14061289Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163698965
W7163701305Cannabis and Anesthesia2026-06-05OpenAlex10.4018/979-8-2600-2035-7.ch005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163701305
W7163717319Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies2026-06-05OpenAlex10.3390/ijms27115117Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163717319
W7163680423Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics2026-06-05OpenAlex10.1016/j.pharmthera.2026.109053Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163680423
W7163711579Generative AI in Ophthalmology2026-06-05OpenAlex10.1002/9781394358212.ch9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163711579
W7163702052Optimizing genomics-aware clinical agents in precision oncology2026-06-05OpenAlex10.1038/s41540-026-00753-9Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7163702052
W7163640750The State of the Art in Chronic Prurigo Nodularis2026-06-05OpenAlex10.1007/s13555-026-01804-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163640750
W7164039849Artificial Intelligence: From Fundamentals to Real-World Applications BY Ts. Dr. Sundresan Perumal, Dr. K. Appathurai, Dr. B. Sathya Bama, Dr. P. Ajitha.2026-06-06OpenAlex10.5281/zenodo.20608291Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164039849
W7163735750Behavioral Management Training (BMT)2026-06-06OpenAlex10.1016/b978-0-443-29009-1.00071-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163735750
W7163865539Synergistic Antibacterial Activity of Polyelectrolyte-capped Silver Nanoparticles Combined with Aminoglycoside Antibiotics Against Healthcare-associated Pathogens2026-06-06OpenAlex10.4103/jmedsci.jmedsci_50_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163865539
W7163734205The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions2026-06-06OpenAlex10.1016/j.critrevonc.2026.105427Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163734205
W7165398179Weekly Journal Scan: Not all direct oral anticoagulants are created equal2026-06-06OpenAlex10.1093/eurheartj/ehag469Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165398179
W7163820105A Continuous-Dynamics Equation Cannot Be Tested on a Static Frozen Substrate: ESCT as a Dynamical Diagnostic Protocol and BERT as Its Zero-Point Calibration2026-06-07OpenAlex10.5281/zenodo.20579378Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163820105
W7163820026Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents2026-06-07OpenAlex10.1002/ajh.70372Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7163820026
W7163824681Governed Multi-Agent Dynamics: Stability, Stratification, and Complexity Bounds under Endogenous Constraint Fields2026-06-07OpenAlex10.5281/zenodo.20576282Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7163824681
W7163818224Schedule H1: Why India's High-Risk Drug Regulation Needs an Urgent Overhaul2026-06-07OpenAlex10.5281/zenodo.20578687Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163818224
W7163804419Targeted therapies in thoracic neuroendocrine tumors: challenges and failures of tyrosine kinase inhibition in lung and thymic carcinoids2026-06-07OpenAlex10.1080/14656566.2026.2685837Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163804419
W7163904657A scientometric study of retrieval-augmented generation research: Mapping the intellectual landscape of a transformative AI paradigm2026-06-08OpenAlex10.5267/j.ijdns.2026.24Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163904657
W7163869987ANESTHESIOLOGICAL MANAGEMENT IN ENDOUROLOGICAL SURGERY IN CHILDREN2026-06-08OpenAlex10.5281/zenodo.20590974Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163869987
W7164121279Causes, Predictors, and Treatment of Vasoplegia in Cardiac Surgery: A Narrative Review2026-06-08OpenAlex10.1213/ane.0000000000008086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164121279
W7163876394Convergence of Generative AI, Agentic Workflows, and Cloud-Native Infrastructure: A Unified Architecture for Next-Generation Healthcare Intelligence2026-06-08OpenAlex10.5281/zenodo.20597912Full textExcludedF1: The primary methodology explicitly uses conceptual synthesis/architectural abstraction without training experiments or clinical trials; proposed memory is not an implemented update study.https://openalex.org/W7163876394; https://openalex.org/W7163925442https://gjrpublication.com/wp-content/uploads/2026/06/GJRECS63749.pdfPrimary PDF introduction and Methodology pp31–32 read
W7163939782Editorial: Plant polyphenols: new chemical and pharmacological approaches2026-06-08OpenAlex10.3389/fphar.2026.1885848Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163939782
W7163882706Emergency department initiation of guideline-directed cardiovascular pharmacotherapy: an under-recognized opportunity2026-06-08OpenAlex10.1097/ms9.0000000000005224Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163882706
W7163891274Emerging and Future SARS-CoV-2 Spike Protein Variants: Evolution, Increased Virulence, and Pandemic Risks2026-06-08OpenAlex10.5281/zenodo.20586575Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163891274
W7163873471Evaluating The Effectiveness of LLM Based Personalized Tutoring Systems In Improving Learning Outcomes In Higher Education2026-06-08OpenAlex10.5281/zenodo.20599093Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163873471
W7163881849From Integrated Care to Learning Systems2026-06-08OpenAlex10.3390/healthcare14121612Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163881849
W7163884041Learning Family-Oriented Care in Residency: A Qualitative Portfolio Analysis2026-06-08OpenAlex10.22454/fammed.2026.679774Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163884041
W7163912689Magnetic Resonance Imaging: Principles, Clinical Applications, and Problem Solving: A Critical Review2026-06-08OpenAlex10.9734/ajmpcp/2026/v9i2449Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163912689
W7163897871Mixed saliva of chemical industry workers in the context of X-ray fluorescence analysis2026-06-08OpenAlex10.36377/et-0206Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163897871
W7164036184Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions2026-06-08OpenAlex10.2174/0115748871445254260527063851Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164036184
W7163902069Precision Medicine in Non-Hodgkin Lymphoma: Advances in BTK Inhibition, CD30-Directed Antibody–Drug Conjugates, and HDAC-Mediated Epigenetic Therapy with Pirtobrutinib, Brentuximab Vedotin, and Belinostat2026-06-08OpenAlex10.3390/jcm15124425Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163902069
W7163907906RASO: Role-Aware Shared Reflection for Multi-Agent Orchestration in E-Commerce Long-Horizon Planning2026-06-08OpenAlex10.1609/icaps.v36i1.42873Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7163907906
W7163874032Simulation-based dynamic optimization for ambulance dispatch and casualty distribution in mass casualty incident2026-06-08OpenAlex10.1016/j.cor.2026.107559Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163874032
W7163865250Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases2026-06-08OpenAlex10.1007/s00011-026-02279-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163865250
W7163948910Update on Obesity and Its Relationship to Atherosclerotic Cardiovascular Disease and Associated Risk Factors2026-06-08OpenAlex10.3390/jcm15124430Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163948910
W71640019112026-06-09OpenAlex10.22377/a5sjwf37Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164001911
W7164005622A Mechanistic Framework for the Clinical Trajectory System in the Context of Indonesian Healthcare Delivery2026-06-09OpenAlex10.5281/zenodo.20604964Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164005622
W7212156434A Multi-Domain Human-Centered Framework for Human-Robot Collaboration: Advancing Decision-Making, Situational Awareness, and Operational Efficiency2026-06-09OpenAlex10.46254/na11.20260360Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212156434
W7164144537A Real-world Cohort of Patients With Myasthenia Gravis: The PPD™ CorEvitas™ Myasthenia Gravis Registry (P4-9.009)2026-06-09OpenAlex10.1212/wnl.0000000000216873Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164144537
W7164152557Acral Hypopigmentation Associated with Ruxolitinib: A Novel Observation2026-06-09OpenAlex10.4103/idoj.idoj_1191_25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164152557
W7163987819Bacteriological Pattern of Pediatric Sepsis in PICU of A Tertiary Care Hospital2026-06-09OpenAlex10.3329/cmoshmcj.v25i1.89898Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7163987819
W7172211564Chronic Migraine with Botulinum Toxin Treatment: An Update and Critical Review2026-06-09OpenAlex10.65381/jcrm.2026.01010020Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172211564
W7172216584Clinical Application of Laser for Acne Vulgaris: An Update and Critical Review2026-06-09OpenAlex10.65381/jcrm.2026.01010018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172216584
W7164012571Clinical Impact of Immune Checkpoint Inhibitors and Chemotherapy in the First-Line Treatment of Metastatic Urothelial Carcinoma with Variant Histology2026-06-09OpenAlex10.1159/000552945Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164012571
W7164301821Comparative Review of Visual Outcomes in Retinopathy of Prematurity Following Laser Therapy and Combination Laser–Anti-VEGF Treatment: An Integrative Perspective on Neonatal Ocular Care2026-06-09OpenAlex10.25258/ijddt.16.51s.118Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164301821
W7164150053Features of Pediatric Multiple Sclerosis: Demographics, Phenotypes, and Treatments in a Cohort of 139 Patients at a Tertiary Center (P11-20.004)2026-06-09OpenAlex10.1212/wnl.0000000000217743Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164150053
W7164180116Harnessing Targeted Continuing Education to Address Gaps Related to the Role of Neuroinflammation in Alzheimer’s Disease Early Detection and Treatment (P4-13.005)2026-06-09OpenAlex10.1212/wnl.0000000000215513Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164180116
W7164753168Knowledge, Attitude, and Practice of Dental Professionals Regarding Cross Infection in the Dental Teaching Hospital of Karachi2026-06-09OpenAlex10.61336/ajfp/2026-04-17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164753168
W7164065913Localized Facial Bullous Eruption Following Iodinated Contrast in a Patient With Renal Failure2026-06-09OpenAlex10.7759/cureus.110513Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164065913
W7163886062Not Just One Agent: Multi-Agent Systems for Medicine from Answer Generation to Accountable Workflow Orchestration2026-06-09OpenAlex10.20944/preprints202606.0640.v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7163886062
W7164016655Referral Required: When AI Blocks Access to Human Doctors2026-06-09OpenAlex10.1145/3816701Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164016655
W7164158475Refractory Status Epilepticus in an Infant with Succinic Semialdehyde Dehydrogenase Deficiency: A Case Report and Therapeutic Challenges (P2-8.004)2026-06-09OpenAlex10.1212/wnl.0000000000217667Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164158475
W7164163387Relapsing and Evolving Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Induced by Nivolumab in a Patient With Hodgkin’s Lymphoma in Remission (P1-9.019)2026-06-09OpenAlex10.1212/wnl.0000000000217619Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164163387
W7165618813SEPA (Simulator Epidemi Penyakit Airborne)2026-06-09OpenAlex10.57760/sciencedb.39530Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165618813
W7164031037Seamless Multimodal Human-Robot Communication: Integration Techniques in Human–Computer Interaction2026-06-09OpenAlex10.3791/70218Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164031037
W7164002700Synergistic Ischemic Injury in DCD Kidney Transplantation: Rethinking Warm and Cold Ischemia as Interdependent Determinants of Graft Outcomes2026-06-09OpenAlex10.1097/tp.0000000000005806Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164002700
W7219931630THE ROLE OF ARTIFICIAL INTELLIGENCE IN DEVELOPING NEW PHARMACEUTICAL AGENTS2026-06-09OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7219931630
W7164037062The Evolving Role of Intralesional Therapy in In-Transit Melanoma2026-06-09OpenAlex10.3390/curroncol33060344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164037062
W7164405157A Review of Agricultural Intelligent Architecture: The Application and Challenges of Artificial Intelligence in Agricultural Perception, Decision-Making, and Execution2026-06-10OpenAlex10.3390/app16125865Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164405157
W7164044798Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity2026-06-10OpenAlex10.1007/s11239-026-03282-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164044798
W7164165049CANCER CHEMOTHERAPY: CONVENTIONAL APPROACHES AND RECENT ADVANCES2026-06-10OpenAlex10.5281/zenodo.20626981Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164165049; https://openalex.org/W7164419044
W7164134929Drugs to Prevent and Treat Venous Thromboembolic Disease During Pregnancy2026-06-10OpenAlex10.1016/j.clp.2026.05.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164134929
W7164148474Editorial: AI and big data integration in orthopedic regenerative medicine2026-06-10OpenAlex10.3389/fcell.2026.1892774Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164148474
W7163741219From awareness to agency: a Freirean analysis of critical consciousness and social justice among international medical students in the UK2026-06-10OpenAlex10.3389/fmed.2026.1854824Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163741219
W7164211487GLP-1 receptor agonists as multisystem therapies: from glycemic control to cardiorenal, neuroimmune, and metabolic disease2026-06-10OpenAlex10.1186/s13098-026-02196-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164211487
W7164156706Guest editorial: Digital age wisdom in Chinese management: applications and challenges of digital transformation and artificial intelligence2026-06-10OpenAlex10.1108/cms-05-2026-0533Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164156706
W7166829543HARSA: A Hybrid Autonomous Reasoning and Safety-Aware Agent Architecture to Support Scalable and Reliable Intelligent Decision-Making2026-06-10OpenAlex10.1109/icici68773.2026.11581280Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166829543
W7164130636High-Risk Multiple Myeloma in 2026: Evolving Definitions and Therapeutic Options2026-06-10OpenAlex10.58931/cht.2026.5187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164130636
W7125583542Integrating Tradition and Modernity: A Review of Women's Roles in Liberian Traditional Medicine within Contemporary Healthcare, 2021–20262026-06-10OpenAlex10.5281/zenodo.18358312Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7125583542
W7164122207PARP inhibitors plus ARSI in first-line mCRPC—a treatment for all patients?2026-06-10OpenAlex10.1007/s12254-026-01113-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164122207
W7166451000Pharmacological treatment of metabolic dysfunction–associated steatotic liver disease: a narrative review2026-06-10OpenAlex10.5124/jkma.26.0043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166451000
W7164332136A Cognitive Clustering Framework for Wireless Sensor Networks Using Quantum Machine Learning2026-06-11OpenAlex10.1109/iciics67880.2026.11483591Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164332136
W7164366745A systematic review of penetrating injuries to the superior sagittal sinus across two centuries2026-06-11OpenAlex10.3389/fneur.2026.1789736Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164366745
W7164339076Assured Autonomy for Siloed Operations: Causal Learning with Per-Edge Certainty on HPC2026-06-11OpenAlex10.5281/zenodo.20649151Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164339076
W7164335474Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity2026-06-11OpenAlex10.1080/15504263.2026.2676699Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164335474
W7164310909Effect of a Topical Thrombin–Carboxymethyl Starch Hemostatic Agent on Perioperative Hemoglobin Course: A Propensity Score-Matched Study2026-06-11OpenAlex10.3390/medicina62061142Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164310909
W7164310880FROM DISCOVERY SCIENCE TO THE CLINIC - HERITABLE ENDOCRINE CANCERS AND RELATED DISORDERS: Functional imaging in hereditary endocrine neoplasms: evolving modalities and clinical implications2026-06-11OpenAlex10.1530/erc-25-0516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164310880
W7164510469Geroprotective Agents, Including Glucagon-Like Peptide-1 Receptor Agonists, for Ocular Health2026-06-11OpenAlex10.1177/10807683261456222Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164510469
W7164163735Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming2026-06-11OpenAlex10.1016/j.numecd.2026.104818Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164163735
W7164396054Integrating Artificial Intelligence and Technology in Surgical Practice2026-06-11OpenAlex10.1016/j.suc.2026.04.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164396054
W7164345195Introduction to Wound Dressing2026-06-11OpenAlex10.1201/9781003616726-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164345195
W7164356463Operationalizing One Health Surveillance for Tropical Fungal Diseases: Practical Implications of Bioinformatics for Clinical and Epidemiological Practice2026-06-11OpenAlex10.4269/ajtmh.26-0183Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164356463
W7164394504Scoped Verification for Reliable Lifelong Agentic Context Evolution under Distribution Shift2026-06-11OpenAlex10.5281/zenodo.20636624Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7164394504
W7164388087Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic Paradigms2026-06-11OpenAlex10.3390/jcm15124529Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164388087
W7164584124Editorial: New drugs and future challenges in drug metabolism and transport2026-06-12OpenAlex10.3389/fphar.2026.1851508Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164584124
W7164570839Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission2026-06-12OpenAlex10.3390/cancers18121922Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164570839
W7164360754Myasthenia gravis: innovative therapies and new frontiers in research2026-06-12OpenAlex10.1007/s40267-026-01246-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164360754
W7164862820Thalassemia – From Molecular Diagnosis to Innovative Therapies2026-06-12OpenAlex10.5772/intechopen.1016193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164862820
W7164525470AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients2026-06-13OpenAlex10.1016/j.josat.2026.210053Full textExcludedF4: The implemented GPT-4 motivational-interviewing agent follows six fixed phases and personalizes each session from that patient’s baseline inputs. Transcript review flags go to the PI; no cross-case agent update is reported. Adaptive prompting is future work. The paper analyzes105 sessions from98 participants, rather than evaluating a retained agent-learning intervention.https://openalex.org/W7164525470https://doi.org/10.1016/j.josat.2026.210053Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online.
W7164511893Current Practices, Evolving Techniques, and Immunologic Challenges in Living and Deceased Donor Limbal Stem Cell Transplantation2026-06-13OpenAlex10.1016/j.ajo.2026.06.007Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164511893
W7164756057Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet–Microbiota Axis2026-06-13OpenAlex10.3390/cells15121074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164756057
W7164667577Evolving Role of Neoadjuvant Endocrine Therapy in Hormone Receptor Positive Breast Cancer: a Review2026-06-13OpenAlex10.1007/s12609-026-00659-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164667577
W7164515497Peer-delivered systems-integrated suicide prevention for women in Pakistan: a protocol for hybrid type II pilot cluster randomized controlled trial2026-06-13OpenAlex10.1186/s40814-026-01841-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164515497
W7164515720Periprocedural allergy evaluation is safe and effective to guide subsequent anesthesia administration2026-06-13OpenAlex10.1016/j.jacig.2026.100747Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164515720
W7164744291EC-Distill-ZeroDiag: a cloud-edge collaborative framework for zero-shot industrial fault diagnosis via large language model distillation2026-06-14OpenAlex10.1007/s10845-026-02897-1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164744291
W7164746212Theranostic Approaches to Radioiodine-Refractory Differentiated Thyroid Cancer: A Narrative Review2026-06-14OpenAlex10.3390/cancers18121937Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164746212
W7164850433"AmbientOn: Ontology-Driven Analytical Findings, Hypotheses, and Verification Outputs for Healthcare Fraud, E-Commerce Logistics, and ITSM Incident Management"2026-06-15OpenAlex10.21227/z2sj-5a15Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164850433
W7165155040Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases2026-06-15OpenAlex10.2174/0115734021435628260415113327Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165155040
W7164844061Biostimulatory Injectables for Collagen Stimulation2026-06-15OpenAlex10.1055/a-2894-5802Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164844061
W7164829394Distribution of nanotechnology in the cancer therapeutics market as a multimodal treatment: comparison with predecessors and emergence in the commercial field2026-06-15OpenAlex10.3389/fnano.2026.1796622Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164829394
W7164848628Emerging Technologies in the Operating Room2026-06-15OpenAlex10.66224/infopub.2026.04.07Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164848628
W7164834693Emerging metabolic hormone therapeutics for metabolic dysfunction-associated steatohepatitis: incretin-based drugs, fibroblast growth factor analogs, and liver-targeting strategies2026-06-15OpenAlex10.1007/s40005-026-00815-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164834693
W7164810621From Reactive AI to Agentic Systems: A Review of Autonomous medical AI Agents in Healthcare2026-06-15OpenAlex10.1007/s11831-026-10655-yTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164810621
W7162909388Karakterisering van nieuwe remmers tegen bacteriën2026-06-15OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162909388
W7163858614Knowledge Graphs As A Representational Layer For Agentic AI In Customer Experience Decision Support2026-06-15OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7163858614
W7164847296Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting2026-06-15OpenAlex10.1186/s13045-026-01815-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164847296
W7164900564Management of subdural haematoma: a practical guide2026-06-15OpenAlex10.1136/pn-2026-005142Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164900564
W7164818571National trends in endotracheal intubation among pediatric patients less than six years old with single-substance intoxication: a fifteen-year retrospective study2026-06-15OpenAlex10.1080/15563650.2026.2675037Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164818571; https://openalex.org/W7165196525; https://openalex.org/W7164845044
W7164801100Navigating Safety in Reproductive Health Self-Care Interventions in Ghana: A Qualitative Study2026-06-15OpenAlex10.31234/osf.io/dsutg_v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164801100
W7164848434New-Onset Refractory Status Epilepticus (NORSE): A Comprehensive Review of Etiology, Pathophysiology, and Management2026-06-15OpenAlex10.5281/zenodo.20704501Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164848434
W7164848437Operational Intelligence at Enterprise Scale: Predictive Intent Orchestration, Scenario-Aware Decisioning, and Probabilistic Control for Anticipatory Autonomous Enterprises2026-06-15OpenAlex10.5281/zenodo.20707142Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164848437
W7164804371Operational Intelligence at Enterprise Scale: Probabilistic Decision Intelligence, Scenario Resilience Modeling, and Anticipatory Control in Autonomous Enterprises2026-06-15OpenAlex10.5281/zenodo.20707462Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164804371
W7164906692Personality Emergence and Adaptive Functioning: An Enactive, Complex-Dynamical Systems Account2026-06-15OpenAlex10.31235/osf.io/przsu_v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164906692
W7164826714Recent Outbreaks, Resistance Trends, and Control Measures in Candida auris and Candida glabrata Infections2026-06-15OpenAlex10.3390/jof12060436Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164826714
W7164834628Trustworthy agentic genomics through versioned skill libraries2026-06-15OpenAlex10.64898/2026.06.11.731523Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7164834628
W7164864983AI-Driven DevSecOps to Enhance Software Quality and Security2026-06-16OpenAlex10.1007/978-3-032-28939-1_3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164864983
W7164880656Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?2026-06-16OpenAlex10.3390/cancers18121961Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164880656
W7164895653Cyclotherapy: exploiting cell-cycle decoupling for selective cancer cytotoxicity and normal-tissue protection2026-06-16OpenAlex10.1016/j.ctrv.2026.103172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164895653
W7164894649Editorial: Strain-specific probiotics: enhancing children's health through targeted clinical research2026-06-16OpenAlex10.3389/fnut.2026.1888544Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164894649
W7164921545Mineral and Bone Disease in CKD and Kidney Transplantation: Controversies, Gaps, and a Path Forward2026-06-16OpenAlex10.1016/j.ekir.2026.106662Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164921545
W7164913726Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study2026-06-16OpenAlex10.1016/j.clcc.2026.06.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164913726
W7164913575Postoperative thrombosis in patients with hemophilia and malignancy: Mechanisms and perioperative prevention and management — A scoping review2026-06-16OpenAlex10.1016/j.thromres.2026.109750Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164913575
W7164991927RESEARCH THESIS: TO COMPARATIVELY EVALUATE SALE TRENDS OF SITAGLIPTIN AND DAPAGLIFLOZIN IN KALAMB AND YAVATMAL2026-06-16OpenAlex10.5281/zenodo.20729683Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164991927
W7164879491Racing Ahead, Governing Behind: An Institutional Analysis of AI Governance Readiness in Global Capability Centres2026-06-16OpenAlex10.5120/ijaisb2118d76a1e3Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7164879491
W7164884352Solid Lipid Nanoparticle-Based Drug Delivery for Lung Cancer2026-06-16OpenAlex10.1201/9781779640215-12Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7164884352
W7164911053The role of medical ESP in training a sustainable healthcare workforce2026-06-16OpenAlex10.65956/procia.2026.120Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7164911053
W7164878652Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic Strategies2026-06-16OpenAlex10.3803/enm.2026.3006Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164878652
W7165019103Chewing Gums a Boon or Bane to Dental Health - A Review2026-06-17OpenAlex10.38124/ijisrt/26jun369Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165019103
W7165041844Data from Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis2026-06-17OpenAlex10.1158/2767-9764.c.8541916Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165041844
W7165037774Data from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States2026-06-17OpenAlex10.1158/2767-9764.c.8541959Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165037774
W7165050556Diseases of Crucifers and Their Management2026-06-17OpenAlex10.1201/9781042014460-15Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165050556
W7165054822Editorial: GenAI in healthcare: technologies, applications and evaluation2026-06-17OpenAlex10.3389/frai.2026.1878137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165054822
W7164993216Global research hotspots and evolving themes in chemoresistance of hepatocellular carcinoma: a bibliometric analysis from a pharmacological perspective2026-06-17OpenAlex10.1007/s00210-026-05568-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164993216
W7165113053Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–20242026-06-17OpenAlex10.1111/dom.71013Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165113053
W7164997592Preserving And Safeguarding The Weapons Of Our Warfare Against Unseen Enemies: Diary Of An Antibiotic Guardian2026-06-17OpenAlex10.52968/15063109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164997592; https://openalex.org/W7164991330
W7165000074Rational Drug Design Targeting Multidrug-Resistant Microorganisms: A Narrative Review2026-06-17OpenAlex10.70955/jcj.2026.04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165000074
W7165049810Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy2026-06-17OpenAlex10.1016/j.ctro.2026.101221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165049810
W7165019064The self-orchestrating emergency department: Agentic AI for supervised emergency department operations2026-06-17OpenAlex10.1016/j.aiemed.2026.100028Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7165019064
W7165032910ULK1's role in cancer progression and its emerging therapeutic potential2026-06-17OpenAlex10.1080/15384047.2026.2680347Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165032910
W7165129768Anticancer drug dosing: Balancing benefit and toxicity2026-06-18OpenAlex10.1016/j.critrevonc.2026.105435Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165129768
W7165182779EVOLVING TRENDS IN UROPATHOGEN RESISTANCE: A COMPREHENSIVE REVIEW OF GLOBAL ANTIBIOGRAM PATTERNS AND STEWARDSHIP IMPLICATIONS.2026-06-18OpenAlex10.5281/zenodo.20751426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165182779
W7165160927Expert perspectives on de-escalation of antiplatelet therapy – Beyond the Guidelines: Insights from the Cardiovascular Research Technologies 2026 meeting2026-06-18OpenAlex10.1016/j.carrev.2026.06.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165160927
W7165370110Gene Therapy Tools for Diseases Caused by Mutations of the Mitochondrial Genome2026-06-18OpenAlex10.3390/ijms27125517Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165370110
W7165141422Guest editorial: Digital technologies and mental health management: opportunities and challenges2026-06-18OpenAlex10.1108/imds-07-2026-998Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165141422
W7165550243Novel Therapeutics for Fatty Liver Disease2026-06-18OpenAlex10.2174/9798898815677126010011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165550243
W7160576152Robots' Inner Speech meets Thories of emotion: towards Affective Robotics in Human Robot Interaction2026-06-18OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160576152
W7165207280Simulating family systems with LLM agents: a corpus-grounded engine for counterfactual rehearsal of strategic therapy interventions2026-06-18OpenAlex10.5281/zenodo.20748639Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7165207280
W7165173050Splenic Artery Proximal Embolization after Ectopic Variceal Bleeding: A Case Report on Portal Hypertension Management2026-06-18OpenAlex10.1159/000553159Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165173050
W7165181272Supplementary Material for: Splenic artery proximal embolization after ectopic variceal bleeding: a case report on portal hypertension management2026-06-18OpenAlex10.6084/m9.figshare.32726448Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165181272
W7165157707The Scaling Delusion: Why GPT Will Never Wake Up, and How to Build a Safe AGI That Already Works — Moltbook Proved It2026-06-18OpenAlex10.5281/zenodo.20745090Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165157707
W7165371603The Wrongs of Backsliding on Climate. Collective Political Akrasia and Climate Inaction2026-06-18OpenAlex10.5281/zenodo.20743246Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165371603
W7165182401The fetus/infant - mother as a co-evolving dyadic system and the development of attachment styles: an active inference perspective2026-06-18OpenAlex10.3389/fpsyg.2026.1836911Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165182401
W7165018326Understanding machupo virus: A neglected arenavirus with global health importance2026-06-18OpenAlex10.5501/wjv.v15.i2.119515Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165018326
W7165399584A Working AGI Architecture with Extrapolation Capability: Formal Proof of Unprogrammed Behaviour and a Computable Alternative to Φ2026-06-19OpenAlex10.5281/zenodo.20767213Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165399584
W7165118087Clinical Research Progress of Triamcinolone Acetonide in the Treatment of Oral Submucous Fibrosis: A Narrative Review2026-06-19OpenAlex10.1007/s42399-026-02483-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165118087
W7172183939Desenvolvimento de competências: intervenção do enfermeiro especialista na preservação de Vestígios de Indícios de Prática de Crime, em contexto Extra-hospitalar2026-06-19OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172183939
W7165492549Modern considerations of prevention and treatment of skin infections and complicated dermatoses: a review2026-06-20OpenAlex10.26442/20751753.2026.6.203695Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165492549
W7165388404Polylysine and its derivatives: structures, functions, and applications2026-06-20OpenAlex10.1016/j.progpolymsci.2026.102151Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165388404
W7165446266SafeCKD-Agent: Code, Data, and Reproducibility Artifacts for Retrieval-Grounded Clinical Decision Support2026-06-20OpenAlex10.5281/zenodo.20777543Full textExcludedF5: Available Zenodo deposit is software/data; the corresponding primary research report was not found in the examined public sources. Exact-title search and an institution-based Politecnico di Torino IRIS check did not locate the main report. The author requested main texts only; the software/data ZIP was not downloaded. No mechanism or agent-status judgment is inferred from the artifact directory.https://openalex.org/W7165446266https://zenodo.org/records/20777544Complete repository description and public file listing; only SafeCKD_Zenodo_Release_v1.0.0.zip is listed. Main research report not found; see fulltext/extractions/SAFECKD_PRIMARY_ONLY.json.
W7165445472Stone_AI:StonesLaw.py.html2026-06-20OpenAlex10.5281/zenodo.20776691Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165445472
W7165553306Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation2026-06-21OpenAlex10.5281/zenodo.20790800Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165553306
W7220483279NANOPARTICLE-BASED MODULATION OF NEURONAL ACTIVITY AND NEUROPROTECTION IN PARKINSON’S AND ALZHEIMER’S DISEASE2026-06-21OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220483279
W7165737785Smart IoT-based Healthcare Systems for Continuous Health-monitoring and Predictive-analytics Using Reinforcement Learning2026-06-21OpenAlex10.22266/inassexpress.2026.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165737785
W7167691367Agentic AI for Continuous Intelligence in Future Smart Connected Systems2026-06-22OpenAlex10.1109/dsn-w70714.2026.00024Full textExcludedF1: This is a vision/proposed architecture without an implemented/evaluated adaptive system; it also spans smart homes, farming and warehouses beyond healthcare.https://openalex.org/W7167691367https://www.researchgate.net/publication/404276921_Agentic_AI_for_Continuous_Intelligence_in_Future_Smart_Connected_SystemsAuthor-uploaded preprint, proposed implementation §V and conclusion §VI read; no empirical evaluation reported there.
W7165539371Anaemia in multiple myeloma: evolving insights into bone marrow microenvironment-driven pathogenesis and targeted management2026-06-22OpenAlex10.1186/s40001-026-04770-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165539371
W7165546151Editorial on “GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated lip(a) levels: A multicenter retrospective study” IJCJOURNAL-D-26-01993R12026-06-22OpenAlex10.1016/j.ijcard.2026.134632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165546151
W7165563539Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence2026-06-22OpenAlex10.7759/cureus.111322Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165563539
W7165541401From mechanisms to clinical applications: A bibliometric analysis of extracellular vesicles in osteoporosis (2013–2025)2026-06-22OpenAlex10.1016/j.rineng.2026.111663Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165541401
W7165526050Hidradenitis suppurativa: a comprehensive review of pathogenetic mechanisms, clinical phenotypes, and evolving therapeutic paradigms2026-06-22OpenAlex10.18203/issn.2455-4529.intjresdermatol20261942Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165526050
W7169840016Janus Kinase Inhibitors (JAKis) in Rheumatologic Diseases: A Narrative Review of Evolving Evidence, Safety Signals, Place in Therapy and Implications for Primary Care2026-06-22OpenAlex10.37184/jlnh.2959-1805.4.35Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169840016
W4414044214Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems2026-06-22OpenAlex10.1109/tcbbio.2026.3705938Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W4414044214
W7165527013Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions2026-06-22OpenAlex10.1007/s40257-026-01048-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165527013
W7165537277Systemic immunomodulatory therapies in severe atopic dermatitis: a comprehensive review of mechanisms, efficacy and long-term management stratagems2026-06-22OpenAlex10.18203/issn.2455-4529.intjresdermatol20261940Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165537277
W7165687267A Curious Case of Leg Swelling With Eosinophilic Fasciitis, IgA-κ Monoclonal Gammopathy, Proteinuria, and Bilateral Carpal Tunnel Neuropathy: Diagnostic Convergence of Sclerosing Dermato-Fasciitis and Monoclonal Gammopathy2026-06-23OpenAlex10.7759/cureus.111358Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165687267
W7165688879Chronic hyperkeratotic and pustular cutaneous lesions of the hand2026-06-23OpenAlex10.1016/j.ejim.2026.107021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165688879
W7165651800Comparative Evaluation of Sticky Bone and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars: A Research Protocol for a Randomised Controlled Trial2026-06-23OpenAlex10.7860/jcdr/2026/81334.23888Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165651800
W7165631339Contrastive Adversarial Agents for Intentional Drift Induction in Network Intrusion Detection Systems2026-06-23OpenAlex10.1609/aaaiss.v9i1.42946Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7165631339
W7165648576Editorial: 10th anniversary of Frontiers in Surgery - celebrating progress and envisioning the future of multidisciplinary surgery2026-06-23OpenAlex10.3389/fsurg.2026.1866857Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165648576
W7165626942Efficacy and safety of first-line PD-1/PD-L1 inhibitor–based therapy in esophageal squamous cell carcinoma: A systematic review and meta-analysis.2026-06-23OpenAlex10.1200/jco.2026.44.19_suppl.113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165626942
W7165621778Long-term response of fenfluramine in Pediatric CDKL5 deficiency disorder with Lennox–Gastaut syndrome: A case report2026-06-23OpenAlex10.1016/j.bdcasr.2026.100151Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165621778
W7165650619Simulating expert oncologist-to-oncologist thinking and behavior: Multi-agent AI for precision oncology collaboration.2026-06-23OpenAlex10.1200/jco.2026.44.19_suppl.20Full textExcludedF5: The complete abstract mentions behavior cloning and MAPPO, potentially relevant to persistent learning, but does not describe the training interaction loop, retained policy or later-case evaluation protocol. The primary publisher explicitly states that this abstract does not include a full-text component; no expanded primary methods report was located. Absence of training detail was not recoded as evidence of no learning.https://openalex.org/W7165650619https://ascopubs.org/doi/10.1200/JCO.2026.44.19_suppl.20Complete publisher conference abstract accessible through existing entitlement; expanded full methods report unavailable.
W7204537239Therapeutic Strategies to manage Chronic Inflammation in patients on Maintenance Haemodialysis: A scoping review2026-06-23OpenAlex10.17605/osf.io/z7yquTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204537239
W7165616276Toward In-Depth Root Cause Localization for Microservices With Multi-Agent Recursion-of-Thought2026-06-23OpenAlex10.1109/tdsc.2026.3706572Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7165616276
W7165773025Abstract IA009: Bispecific antibodies in B-cell lymphomas: Redefining immune engagement in the therapeutic landscape2026-06-24OpenAlex10.1158/2643-3249.lymphoma26-ia009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165773025
W7165782897Agentic AI and Autonomous Systems2026-06-24OpenAlex10.4018/979-8-2600-2601-4.ch004Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7165782897
W7165744339Agentic AI: Autonomous Agents to Cognitive Autonomy2026-06-24OpenAlex10.5281/zenodo.20826452Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7165744339
W7165752660Between rescue and legacy: ethical reflections on organ donation after extracorporeal cardiopulmonary resuscitation2026-06-24OpenAlex10.1016/j.bja.2026.05.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165752660
W7165736396From PET to targeted radionuclide therapy in the Brain: The emerging role of radiometal-based platforms2026-06-24OpenAlex10.1016/j.jinorgbio.2026.113397Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165736396
W7165784797Leishmaniasis: pathogenesis, host immunity, and the evolving landscape of immunotherapy and immunochemotherapy2026-06-24OpenAlex10.3389/fmicb.2026.1861933Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165784797
W7165764267RETRACTED: Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets2026-06-24OpenAlex10.1073/pnas.2535785123Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7165764267
W7165770448Real-world treatment patterns in patients with dysmenorrhea in Japan: a retrospective database study2026-06-24OpenAlex10.3389/fgwh.2026.1775657Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165770448
W7165781875Severe Clade I (subclade Ib) mpox in advanced HIV complicated by multidrug-resistant bacterial superinfection and ocular involvement: a case report from Uganda2026-06-24OpenAlex10.1186/s41182-026-01010-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165781875
W7165771751Targeting Isocitrate Dehydrogenase-Mutant Glioma with Vorasidenib : A New Era in Precision Neuro-Oncology2026-06-24OpenAlex10.3340/jkns.2026.0113Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165771751
W7165756673The updated 2025 classification for interstitial pneumonia: Are we ready for the entity “idiopathic bronchiolocentric interstitial pneumonia?”2026-06-24OpenAlex10.4103/lungindia.lungindia_280_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7165756673
W7213481917Tracking the Morphosemantic Evolution of English -ee Nouns in the OED32026-06-24OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213481917
W7166534983Agentic Artificial Intelligence in Inflammatory Bowel Disease: Toward Autonomous and Adaptive Care2026-06-25OpenAlex10.1093/crocol/otag066Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166534983
W7167640512Beyond Structural Pathology: Central Sensitization and Chronic Pain with Reference to Lumbar Disc Herniation—A Narrative Review2026-06-25OpenAlex10.3390/brainsci16070664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167640512
W7166589151CREST syndrome2026-06-25OpenAlex10.61997/bjm.v15i2.501Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166589151
W7165931558Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections2026-06-25OpenAlex10.1080/14656566.2026.2695994Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165931558
W7166115452Immunotherapy for Melanoma: A Concise Clinical Review for Australasian Practice2026-06-25OpenAlex10.1111/ajd.70158Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166115452
W7165923595Inter- and intra-quartile comparison of multi-tracer PET/CT and liquid biopsy molecular markers in cancer: a futuristic perspective on evolving a “stepped care” model for individualized precision theranostics through AI/ML2026-06-25OpenAlex10.1007/s00259-026-08025-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165923595
W7204503532The Role of Magnesium Sulfate in Contemporary Obstetrics2026-06-25OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204503532
W7165943343The evolving landscape of acute kidney injury: research directions and changes in clinical practice2026-06-25OpenAlex10.23876/j.krcp.25.255Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7165943343
W7165883027Trastuzumab Emtansine–Associated Porto-Sinusoidal Vascular Disorder: Clinical Features and Outcomes from Published Cases2026-06-25OpenAlex10.3390/jcm15134950Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165883027
W7165864685Updates on intratumoral therapies in melanoma2026-06-25OpenAlex10.1002/cncr.70400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165864685
W7166151139A Multi-Agent Engineering Team for Prompt-Based Application Generation2026-06-26OpenAlex10.55041/isjem08051Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7166151139
W7166122247Agentic AI: The Power to Change Medicine and Our World2026-06-26OpenAlex10.17615/9qtg-ps49Title/abstractExcludedE5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established.https://openalex.org/W7166122247
W7166117252CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance2026-06-26OpenAlex10.1016/j.bmc.2026.118736Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166117252
W7166075853Editorial: Integrating economics into population health: assessing policies and outcomes2026-06-26OpenAlex10.3389/fpubh.2026.1902201Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166075853
W7166008226Editorial: Navigating environmental hazards in the workplace: impacts and interventions2026-06-26OpenAlex10.3389/fpubh.2026.1893964Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166008226
W7168377920FUTURE MATHEMATICS FOR DATA SCIENCE & AI by Prof. Shradha Harshal Chaudhari, Mrs. Ch. Dharani, Dr. T. Siva Krishna ,Dr. M. L. L. Phani Kanth2026-06-26OpenAlex10.5281/zenodo.21131497Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168377920
W7166088948Gemmological Optical Microscopy of Two Experimental Monochrome Glazes of the Yongzheng Period (1723–1735): "Peacock Green" (Kongque Lü) and "Pine Needle Green" (Songhua Lü)2026-06-26OpenAlex10.5281/zenodo.20921733Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166088948
W7166171063Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia2026-06-26OpenAlex10.1080/14656566.2026.2695099Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166171063
W7166037043Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape2026-06-26OpenAlex10.1007/s40487-026-00450-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166037043
W7166649782Stem Cell-Based Strategies for Fibrotic and Neurogenic Bladder Disorders: Current Evidence, Translational Challenges, and Future Directions2026-06-26OpenAlex10.3390/cimb48070658Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166649782
W7166116632The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis2026-06-26OpenAlex10.1016/j.jtha.2026.06.017Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166116632
W7166033096Treatment of breast cancer brain metastases in the era of novel drugs2026-06-26OpenAlex10.1016/j.ctrv.2026.103179Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166033096
W7166567118Atopic Dermatitis: New Targets and Emerging Systemic Therapies2026-06-27OpenAlex10.1007/s40257-026-01054-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166567118
W7166382430Beyond Connectivity: Architecting Decentralised Trust for the Emerging Internet of Agents (IoA)2026-06-27OpenAlex10.1007/978-3-032-29237-7_33Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7166382430
W7166345962Cardiogenic Shock: A Comprehensive Review of Pathophysiology, Clinical Management, and Contemporary Therapeutic Strategies2026-06-27OpenAlex10.5281/zenodo.20965483Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166345962
W7166311016Caudal Anesthesia: A Comprehensive Review of Anatomical Foundations, Clinical Applications, and Contemporary Practice Paradigms2026-06-27OpenAlex10.5281/zenodo.20966703Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166311016
W7166474537Advances and Future Directions in Antibody–Drug Conjugates: From Paradigm Shifts to Data-Driven Design2026-06-28OpenAlex10.3390/cancers18132102Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166474537
W7166438400Artificial intelligence enabled Physical Internet readiness improves sustainable healthcare supply chain performance2026-06-28OpenAlex10.1007/s43621-026-03695-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166438400
W7219828918Contemporary management of locally advanced and metastatic renal cell carcinoma: An update of current evidence2026-06-28OpenAlex10.52786/isu.a.121Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219828918
W7166467108Kyoo32/MARC: v1.0 — Initial Public Release2026-06-28OpenAlex10.5281/zenodo.20993980Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166467108
W7166446678Piperazine Derivatives2026-06-28OpenAlex10.1002/9781394284832.ch12Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166446678
W7166431521The Role of Natural Products in Cervical Cancer2026-06-28OpenAlex10.1002/9781394416905.ch25Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166431521
W7166566973A Systematic Review and Meta-analysis of Clinical Trials in ALK-positive Non-small Cell Lung Cancer2026-06-29OpenAlex10.21873/anticanres.18227Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166566973
W7166591048Advances in First-Line Treatment of Classical Hodgkin Lymphoma in the Era of Novel Agents2026-06-29OpenAlex10.3390/jcm15135075Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166591048
W7166751171Always-OnAgents:A Survey of Persistent Memory, State, and Governance in LLMAgents2026-06-29OpenAlex2606.3030610.48550/arxiv.2606.30306Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7166751171
W7166515307Artificial Intelligence in Inherited Epidermolysis Bullosa: Current Evidence, Challenges, and Future Directions2026-06-29OpenAlex10.3390/diagnostics16132022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166515307
W7166551338BIO Layer: Governance-First Memory for Auditable Long-Term Agents2026-06-29OpenAlex10.5281/zenodo.21020857Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7166551338
W7166516304Beyond Palliation: Redefining the Surgical Frontier in Stage IV Non-Small Cell Lung Cancer2026-06-29OpenAlex10.9734/jamps/2026/v28i7874Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166516304
W7166533521Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation2026-06-29OpenAlex10.3350/cmh.2026.0697Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166533521
W7202064688Digital patient twin: a multivariate and holistic approach for continuous monitoring and predictive medicine.2026-06-29OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7202064688
W7166561385Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder2026-06-29OpenAlex10.1080/14656566.2026.2697064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166561385
W7166534551Doxycycline: A Comprehensive Review of Pharmacological Properties, Broad-Spectrum Clinical Applications, and Emerging Therapeutic Paradigms in Infectious Disease Management2026-06-29OpenAlex10.5281/zenodo.21034681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166534551
W7166570622Editorial: Human reactions to artificial intelligence with anthropomorphic features2026-06-29OpenAlex10.3389/fpsyg.2026.1873310Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166570622
W7166528471Extranodal natural killer/T‐cell lymphoma: From fatal to curable2026-06-29OpenAlex10.3322/caac.70094Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166528471
W7166521739Imaging response assessment in metastatic renal cell carcinoma: a radiologist’s guide to contemporary therapeutic strategies2026-06-29OpenAlex10.1007/s00261-026-05604-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166521739
W7166532488Iodinated Contrast Media Hypersensitivity in 115,966 Patients2026-06-29OpenAlex10.1097/rli.0000000000001301Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166532488
W7166553080Joao-supera/SUP3RA-SKILLS-OS: v0.1.0 - Public Architecture Draft2026-06-29OpenAlex10.5281/zenodo.21038168Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166553080
W7166579102Mild Thyroid Eye Disease—The Most Common yet the Least Studied Presentation of Thyroid Eye Disease2026-06-29OpenAlex10.1177/10507256261464556Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166579102
W7216951319Navigating the 2026 Regulatory Turn: A Framework for Responsible Innovation and Human-Centric Ethical Accountability in Agentic AI2026-06-29OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216951319
W7166532381Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies2026-06-29OpenAlex10.1530/ec-25-0850Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166532381
W7166519930Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators2026-06-29OpenAlex10.1177/09612033261466741Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166519930
W7172527478Scientific basis and strategic advantages of primary HPV testing and immunocytochemistry in the modern cervical cancer screening framework2026-06-29OpenAlex10.30841/2708-8731.4.2026.368209Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172527478
W7166542724Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects2026-06-29OpenAlex10.1007/s10735-026-10863-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166542724
W7166729265The Evolving Landscape of Targeted Therapies in Systemic Lupus Erythematosus: A Review of Phase 3 Clinical Trials2026-06-29OpenAlex10.3390/app16136458Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166729265
W7166552535The role of allogeneic stem cell transplantation in peripheral T-cell lymphoma2026-06-29OpenAlex10.1038/s41409-026-02962-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166552535
W7166587386Therapeutic Twins for Creative Digital Mental Health: A Review Through a Trust-in-Automation Lens2026-06-29OpenAlex10.1080/10447318.2026.2689526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166587386
W7213569744Using a serious game to engage agrifood system actors for unlocking the production of local neglected legume crops – A case study in South-Eastern Senegal2026-06-29OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213569744
W7166674443A Review of Bispecific T-cell Engagers (BiTEs): A Promising Strategy in the Evolving Landscape of Cancer Immunotherapy2026-06-30OpenAlex10.1055/s-0046-1824552Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166674443
W7166717911A six-level clinical autonomy framework for artificial intelligence in dentistry2026-06-30OpenAlex10.3389/froh.2026.1836492Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166717911
W7221527494Advances in Management of Rheumatoid Arthritis: From Conventional Therapy to Targeted Treatment – A Narrative Review2026-06-30OpenAlex10.5812/jkums-172010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221527494
W7166694503Anesthetic considerations in patients receiving glucagon-like peptide-1 receptor agonists: Focus on gastric emptying and safety2026-06-30OpenAlex10.71152/ajms.v17i7.5334Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166694503
W7171550578BASIS: An LLM-Empowered Benchmark and Agent System for Inferring Synthetic Lethality2026-06-30OpenAlex10.1145/3807503.3819483Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171550578
W7170181857Beyond Cytotoxicity: Molecularly Targeted Cancer Therapy, Resistance Landscapes, and Analytical Strategies in Modern Oncology: Review Article2026-06-30OpenAlex10.62472/kjps.v17.i28.379-394Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170181857
W7166652346Clinical decision support in hematological malignancies using a case-grounded AI agent2026-06-30OpenAlex10.1038/s41591-026-04494-4Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7166652346
W7166649945Comparison of Thrombolysis with Endovascular Thrombectomy for Acute Ischemic Stroke: A Review of Recent Studies2026-06-30OpenAlex10.21203/rs.3.rs-10145947/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166649945
W7169727200Convergent Intelligent Innovations Across Science, Humanities, Commerce, Management, AI, Cyber Law and Data Systems2026-06-30OpenAlex10.5281/zenodo.21439698Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169727200
W7207721744DEPRESSION AND ANXIETY IN ADVANCED CANCER: DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN PALLIATIVE CARE – A REVIEW2026-06-30OpenAlex10.31435/ijitss.2(50).2026.5573Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207721744
W7166717437Editorial: Molecular and cellular mechanisms of bone remodeling2026-06-30OpenAlex10.3389/fendo.2026.1898761Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166717437
W7167363608Fabrication of Bio-based Protective Fabrics Functionalized with ZnO/MgO Nanoparticles for Antibacterial and Chemical Detoxification Application2026-06-30OpenAlex10.13074/jent.2026.06.2622159Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167363608
W7166704752Ketamine renaissance: Expanding horizons from anesthesia to depression and pain2026-06-30OpenAlex10.71152/ajms.v17i7.5333Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166704752
W7171548963MIGRAINE TREATMENT BEYOND TRADITIONAL THERAPIES: CURRENT TRENDS AND FUTURE DIRECTIONS2026-06-30OpenAlex10.31435/ijitss.2(50).2026.5991Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171548963
W7166685887Molecular Characterization and Virulence Profiling of Fusarium oxysporum f. sp. lycopersici Causing Wilt Disease in Tomato2026-06-30OpenAlex10.5281/zenodo.21059770Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166685887
W7166716103Novel Therapeutic Approaches for Cystic Fibrosis2026-06-30OpenAlex10.1201/9781779640413-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166716103
W7219893171Ontological disruption in school management: sentithinking as the axis of contemporary educational supervision2026-06-30OpenAlex10.69821/biohum.v4i1.93Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7219893171
W7171782626PNEUMOCYSTIS JIROVECII PNEUMONIA IN TRANSPLANT RECIPIENTS: TIME-DEPENDENT RISK AND CLINICAL IMPLICATIONS – A LITERATURE REVIEW2026-06-30OpenAlex10.31435/ijitss.2(50).2026.6073Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171782626
W7168132086Portrait of Social Inequality and Family Crisis in Mirāth by Muhammad Husayn Haykal: Literary Realism Approach2026-06-30OpenAlex10.18860/jali.v7i2.42507Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168132086
W7166656495Practical recommendations for infectious prophylaxis and vaccination in multiple myeloma patients2026-06-30OpenAlex10.3389/fmed.2026.1847793Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166656495
W7166857947Role of Photosensitizers in Photodynamic Therapy of Cancer Treatment: A Comprehensive Review2026-06-30OpenAlex10.5530/gjpb.2025.4.11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166857947
W7170055804Science behind natural skin whitening: A review on local Malaysian skin whitening products Ethereal Lumi Radiance Series and their ingredients for safety, mechanisms and synergistic efficacy2026-06-30OpenAlex10.24191/ijpnacs.v9i1.01Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170055804
W7166742907Stone Quantum OS2026-06-30OpenAlex10.5281/zenodo.21069334Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166742907
W7166699535Targeting MET in 2025: From Exon 14 Skipping to MET-Amplified Acquired Resistance in Non-Small Cell Lung Cancer2026-06-30OpenAlex10.3390/ijms27135883Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166699535
W7169132431The Age of Autonomous Agents: A Bibliometric Review of Agentic AI Architectures, Applications, and Emerging Challenges2026-06-30OpenAlex10.63646/kpqm1958Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7169132431
W7166649297The Three Blind Zones of Current AI Philosophy and Humanity's Action Agenda —A Systematic Diagnosis and Pathway Planning Based on the Framework of The Unified Epistemology of the Cosmic Noumenon2026-06-30OpenAlex10.5281/zenodo.21052457Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7166649297
W7166812452Transperineal versus transrectal prostate biopsy: Aligning Indian practice with emerging evidence2026-06-30OpenAlex10.4103/iju.iju_138_26Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166812452
W7167494127Unraveling the Pharmacognostic and Mechanistic Landscape of Bombax ceiba L.: Exploring its Phytoconstituents and Therapeutic Potentials2026-06-30OpenAlex10.18311/jnr/2026/55088Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167494127
W7169573077When digital health transformation outpaces educational capacity in health professions education: a policy-practice gap2026-06-30OpenAlex10.35845/kmuj.2026.24321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169573077
W7166678634当前AI哲学的三大盲区与人类的行动纲领 ——基于《宇宙本体统一认知论》框架的系统性诊断与路径规划 The Three Blind Zones of Current AI Philosophy and Humanity's Action Agenda —A Systematic Diagnosis and Pathway Planning Based on the Framework of The Unified Epistemology of the Cosmic Noumenon2026-06-30OpenAlex10.5281/zenodo.21052676Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7166678634
W716746725375183 Evolving Real-World Treatment Patterns and Unmet Needs in Atopic Dermatitis in the United States: Insights from a 2025 Patient Chart Audit and Market Landscaping Study2026-07-01OpenAlex10.1016/j.jaad.2026.04.879Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167467253
W7166519652A REVIEW ON MICRONEEDLE-ASSISTED TRANSDERMAL DRUG DELIVERY: REVOLUTIONIZING NON-INVASIVE THERAPY2026-07-01OpenAlex10.5281/zenodo.21031804Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166519652
W7169879090A Review of Fluorophores for Fluorescence-Guided Surgery in Breast Cancer2026-07-01OpenAlex10.1177/15353508261471742Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169879090
W7167153899A Review of Therapies for Primary Biliary Cholangitis.2026-07-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167153899
W7170043556A narrative review of clinical research on knee osteoarthritis in 20252026-07-01OpenAlex10.21037/aoj-2026-0018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170043556
W7215341760Acute Respiratory Distress Syndrome and Corticosteroids: Reconciling Conflicting Evidence.2026-07-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215341760
W7204141489Adaptive Ambiguity Reduction in Crop Disease Diagnosis via an LLM Agent2026-07-01OpenAlex10.1109/iccsc71566.2026.11650340Title/abstractExcludedE2: Crop/tomato disease diagnosis rather than human healthcare.https://openalex.org/W7204141489
W7170178510Agentic AI and labor disruption: A comprehensive review, measurement, and policy framework2026-07-01OpenAlex10.1016/j.jengtecman.2026.101993Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170178510
W7171546577Agentic Self-RAG: An Ablation Study for Zero-Shot Biomedical Question Answering2026-07-01OpenAlex10.1109/iaict71158.2026.11621038Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7171546577
W7171042271Agentic artificial intelligence: Architectures, planning mechanisms, multi-agent collaboration, applications, challenges, and future research directions-A comprehensive review2026-07-01OpenAlex10.33545/27076571.2026.v7.i7a.358Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7171042271
W7214404679An Emotion-Aware Preference-Optimized Agent for Adaptive Tool Use: A Thompson Sampling-Based Approach2026-07-01OpenAlex10.1109/acmlc70381.2026.11700470Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214404679
W7202264544Applications of Intelligent Agents in the Pathology Diagnostic Workflow2026-07-01OpenAlex10.12290/xhyxzz.2026-0402Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7202264544
W7203838742Artifact-Constrained Agentic Testing for Black-Box System Testing under Actuarial and Regulatory Constraints2026-07-01OpenAlex10.1109/compsac69091.2026.00147Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203838742
W7167496320Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric cancer2026-07-01OpenAlex10.1016/j.esmoop.2026.108021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167496320
W7167682826Beyond Yield2026-07-01OpenAlex10.1016/j.chest.2026.04.043Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7167682826
W7166816234Bioactive Glasses as Antibacterial Agents: A Review2026-07-01OpenAlex10.1111/ijac.70242Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7166816234
W7204085347CALM-Trust: Context-Aware Latent Modeling of Trust in Autonomous AI Systems2026-07-01OpenAlex10.1109/icce-taiwan71481.2026.11652711Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204085347
W7166873654Can long-standing recurrent purpura truly remain benign?2026-07-01OpenAlex10.65048/ijbmr.2026.17.3.8667.1066Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166873654
W7170043297Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms2026-07-01OpenAlex10.1177/09636897261471702Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170043297
W7167525941Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders2026-07-01OpenAlex10.1016/j.jaip.2026.02.039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167525941
W7168372281Clinical integration of quantitative MRI in an MR-Linac Pathway: A single centre experience2026-07-01OpenAlex10.1016/j.jmir.2026.102375Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168372281
W7167614097Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence2026-07-01OpenAlex10.1002/mco2.70849Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167614097
W7166828121CyberConfucius IJHCI Public Data2026-07-01OpenAlex10.6084/m9.figshare.32845169Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7166828121
W7171879368Decoding biological drug names in dermatology: The post-2022 WHO nomenclature revision and its implications for clinical practice2026-07-01OpenAlex10.1016/j.jaad.2026.07.093Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171879368
W7172172067Diagnostic Puzzle of Atypical Kawasaki Disease.2026-07-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172172067
W7169718661E-172 Transvenous embolization of symptomatic orbital venous malformations: evolving technical considerations from two cases2026-07-01OpenAlex10.1136/jnis-2026-snis.276Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169718661
W7167725833ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease2026-07-01OpenAlex10.1093/ecco-jcc/jjag071Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167725833
W7170053236Electrospun nanofiber scaffolds for myocardial repair: Mechanistic design, preclinical advances, and translational perspectives2026-07-01OpenAlex10.1016/j.rerere.2026.07.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170053236
W7222758495Emerging Role of Rho-kinase Inhibitors in Ophthalmology: A Narrative Review2026-07-01OpenAlex10.4103/dljo.dljo_63_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222758495
W7167345840FDA Gene Therapy Approvals (1998–2025): Current Status, Regulatory Evolution, and Future Directions2026-07-01OpenAlex10.1002/jcph.70226Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167345840
W7214189429From cardiogenic shock to surgical success: Addressing ventricular septal rupture in a myocardial infarction case2026-07-01OpenAlex10.4103/jdrntruhs.jdrntruhs_66_24Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214189429
W7167032184Guidelines for Decentralized Digital Mobility Observational Studies Using Digital Endpoints and Mobility Outcomes. (Preprint)2026-07-01OpenAlex10.2196/preprints.106004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167032184
W7168332281Hydrogel-Based Immunomodulatory Strategies for Infected Bone Defects Regeneration: Remodeling the Osteoimmune Microenvironment and Future Perspectives2026-07-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168332281; https://openalex.org/W7167852406
W7168678857Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: Mechanisms, Therapeutic Applications, and Developmental Progress2026-07-01OpenAlex10.1016/j.xkme.2026.101472Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168678857
W7166885994Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives2026-07-01OpenAlex10.3389/fimmu.2026.1859046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166885994
W7169718608Infecciones dermatológicas raras: un estudio retrospectivo de la experiencia de cinco años en tres hospitales de referencia principales en Costa Rica2026-07-01OpenAlex10.51481/amc.v68i1.1529Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169718608
W7172411926Innovative breakthroughs in the treatment of central nervous system infections in the era of antimicrobial resistance2026-07-01OpenAlex10.3969/j.issn.1672-6731.2026.07.001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172411926
W7171788255Intravitreal Anti–VEGF Therapies in the Management of Retinal Vascular Diseases: A Review of Molecular Mechanisms, Clinical Applications, Dosing Strategies, Emerging Agents, and Future Directions2026-07-01OpenAlex10.4103/tjosr.tjosr_111_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171788255
W7170300358KRAS-mutated Non–Small Cell Lung Cancer2026-07-01OpenAlex10.1097/ppo.0000000000000842Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170300358
W7167663745L26/P-251 Analysis of thawing strategies for PGTA-tested euploid single blastocyst transfers: a retrospective study2026-07-01OpenAlex10.1093/humrep/deag083.587Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167663745
W7167242135Low birthweight neonates and those with long hospital stays are most at risk of antimicrobial-resistant Klebsiella pneumoniae infection in Malawi: implications for antibiotic prescribing2026-07-01OpenAlex10.64898/2026.06.24.26356242Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167242135
W7171798616Management of Synchronous Metastatic Colorectal Cancer2026-07-01OpenAlex10.1016/j.soc.2026.06.009Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171798616
W7168013845Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI ‐Integrated Future Strategies2026-07-01OpenAlex10.1002/cnr2.70620Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168013845
W7167473161Microneedle‐Assisted Systems for the Delivery of Proteolysis Targeting Chimeras (PROTACs)2026-07-01OpenAlex10.1002/adtp.70158Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167473161
W7167367450Modern immunosuppression2026-07-01OpenAlex10.1016/j.mpsur.2026.06.016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167367450
W7166811800Nanoparticle-based modifications of phages for antibacterial applications2026-07-01OpenAlex10.17185/duepublico/86023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166811800
W7171516675Nanotechnology in Transplantation: Emerging Mechanisms, Clinical Applications, and Future Directions.2026-07-01OpenAlex10.6002/ect.mesot2025.l36Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171516675
W7166732605Neurophysiological Electroencephalography Signatures of Pediatric Sedation: A Comprehensive Comparative Review2026-07-01OpenAlex10.26815/acn.2026.01494Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166732605
W7212245724OceanSkill: An Agentic Skill Framework for Evidence-Grounded Ocean Forecast Report Generation2026-07-01OpenAlex10.1109/lmiat70705.2026.11682146Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212245724
W7224965231Onconephrology: The Time is Ripe to Make New Beginnings2026-07-01OpenAlex10.4103/ijkd.ijkd_76_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224965231
W7167649586Organoid-Derived Extracellular Vesicles: From Biogenesis and Cargo Mechanisms Toward Therapeutic Applications2026-07-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167649586; https://openalex.org/W7167050583
W7166827225Perioperative management of dermatologic surgery patients on systemic cancer therapy2026-07-01OpenAlex10.1016/j.jaad.2026.06.126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7166827225
W7168022829Pharmacomicrobiomics: The Gut Microbiome as a Critical Variable in Clinical Drug Response2026-07-01OpenAlex10.2478/orvtudert-2026-0002Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168022829
W7204238558PhysioAgent: A Multi-Agent AI Framework for Personalised Exercise Prescription and Longitudinal Adherence Monitoring in Physiotherapy2026-07-01OpenAlex10.1109/icdh72779.2026.00045Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7204238558
W7167012730Positioning Incretin‐Based and Next‐Generation Obesity Management Medications: A Methodological Framework for a Series of Systematic Reviews and Network Meta‐Analyses2026-07-01OpenAlex10.1111/dom.71046Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167012730
W7221720722Predictors of Teachers' Perceived Utility of GenAI-Supported Dialogue in Teaching Analytics Contexts2026-07-01OpenAlex10.1109/icalt68022.2026.00062Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221720722
W7171645925Prognostic Implications and Therapeutic Landscape of IDH1-Mutated AML: An Updated Review of Evidence and Indian Perspective2026-07-01OpenAlex10.31557/apjcp.2026.27.7.2417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171645925
W7212127174ReAct Ops: A Plan-and-Execute ReAct Agent Framework for Autonomous Distributed Cluster Diagnosis2026-07-01OpenAlex10.1109/cisat71030.2026.11682211Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7212127174
W7166849559Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML2026-07-01OpenAlex10.1038/s41375-026-03015-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166849559
W7212066353Skill-Based Architecture for Reusable, AI-Native Enterprise Modules: An Empirical Study2026-07-01OpenAlex10.1109/iri69576.2026.00012Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212066353
W7202347207Solarpunk Creatures2026-07-01OpenAlex10.5325/utopianstudies.37.2.0389Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202347207
W7169627667Stigma Coupling and Decoupling: How Practice Stigma and Social Control Co-Evolve Over Time2026-07-01OpenAlex10.5465/amproc.2026.10949abstractTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169627667
W7214282497The 2026 ESC heart failure guidelines: advancing science while facilitating clinical implementation2026-07-01OpenAlex10.1097/cp9.0000000000000177Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214282497
W7170094493The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions2026-07-01OpenAlex10.2147/opth.s620330Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170094493
W7172519139The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value2026-07-01OpenAlex10.37765/ajmc.2026.89985Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172519139
W7169576218The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelines2026-07-01OpenAlex10.1016/j.ygyno.2026.06.022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169576218
W7171564017The evolving treatment landscape of restless legs syndrome2026-07-01OpenAlex10.1177/17562864261469017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171564017
W7216492330UNDERSTANDING MYCOBACTERIAL SPREAD AND DRUG SENSITIVITY2026-07-01OpenAlex10.63665/temj.v02i07.528Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7216492330
W7202153595[Therapeutic Strategies Targeting the KRAS G12C Mutation-Current Landscape and Future Directions].2026-07-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202153595
W7167531805Évolution de la prise en charge des cancers urothéliaux métastatiques2026-07-01OpenAlex10.1016/j.bulcan.2026.03.008Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167531805
W7167089235Advances in the imaging of liver cancer2026-07-02OpenAlex10.1016/j.jhep.2026.03.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167089235
W7167054138Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications2026-07-02OpenAlex10.3389/fneur.2026.1875031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167054138
W7166835130Dual-frequency metastructured-hydrogel film for high-contrast ultrasound imaging2026-07-02OpenAlex10.20517/ss.2026.23Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166835130
W7167086588Editorial: Clinical trials in cardiovascular medicine: 2025—addressing residual cardiovascular risks through precision-guided approaches2026-07-02OpenAlex10.3389/fcvm.2026.1904928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167086588
W7167096532Epilepsia Partialis Continua: Pathophysiological Mechanisms, Clinical Manifestations, and Therapeutic Strategies in a Rare Focal Epilepsy Syndrome2026-07-02OpenAlex10.5281/zenodo.21137800Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167096532
W7167095755From Therapeutic Drug to Xenobiotic in Cancer Repurposing: Clozapine Mechanisms, Metabolic Liabilities, and Human-Relevant Translational Approaches2026-07-02OpenAlex10.3390/jox16040125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167095755
W7167054891Global Trends and Evolving Frontiers in Intranasal Delivery for CNS Diseases (2000–2025): A Bibliometric Analysis and Systematic Review2026-07-02OpenAlex10.1016/j.wneu.2026.125172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167054891
W7167050990Guest editorial: Service transformation: key forces, challenges and implications2026-07-02OpenAlex10.1108/josm-07-2026-618Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167050990
W7167102423Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance2026-07-02OpenAlex10.47248/chp2603030008Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167102423
W7167110866Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation2026-07-02OpenAlex10.3390/ijms27135956Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167110866
W7171824909The global epidemiology of MRSA2026-07-02OpenAlex10.1093/jacamr/dlag152Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171824909
W7167271783CARDIOVASCULAR BENEFITS OF GLP-1 RECEPTOR AGONISTS: EVIDENCE FROM CARDIOVASCULAR OUTCOMES TRIALS (CVOTs)2026-07-03OpenAlex10.31435/ijitss.3(51).2026.6150Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167271783
W7167232432Clinical characteristics of lung abscess by red complex bacteria infection: a case report and literature review2026-07-03OpenAlex10.3389/fmed.2026.1861751Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167232432
W7167274209Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies2026-07-03OpenAlex10.3389/fimmu.2026.1917784Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7167274209
W7168056093Emerging therapy options for gastric adenocarcinoma - a comprehensive review and analysis of clinical trials2026-07-03OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168056093
W7167206563Essential Hypertension: A Comprehensive Critical Appraisal of Evolving Diagnostic Paradigms, Pathophysiology and Evidence-Based Management2026-07-03OpenAlex10.5281/zenodo.21165114Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7167206563
W7172154674Evolving Anti-VEGF Therapy For Diabetic Retinopathy: Current Evidence, Durability Strategies, And Future Directions2026-07-03OpenAlex10.55227/ijhet.v5i2.917Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172154674
W7167037241Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies2026-07-03OpenAlex10.23876/j.krcp.26.090Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167037241
W7167242564GLP-1 Receptor Agonists in Cardiac Surgery: From Metabolic Drug to Potential Perioperative Cardioprotective Agent2026-07-03OpenAlex10.3390/jcdd13070305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167242564
W7167890131Hepatocellular carcinoma: new therapies on the horizon2026-07-03OpenAlex10.1080/17474124.2026.2702585Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167890131
W7171906844How Consumers Judge Empathy Gaps in Artificial Intelligence-Driven Healthcare2026-07-03OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7171906844
W7167211629Hydroxychloroquine-Induced AGEP with Positive Rechallenge: A Case Report and Mini Review of the Literature2026-07-03OpenAlex10.3390/dermatopathology13030030Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167211629
W7168083300Immunotherapy plus chemotherapy in advanced biliary tract cancers: pros and cons2026-07-03OpenAlex10.1080/17474124.2026.2701716Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168083300
W7170243435Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer2026-07-03OpenAlex10.1080/17425255.2026.2710110Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170243435
W7170174374Information fiduciaries for China? A critique2026-07-03OpenAlex10.1093/idpl/ipag012Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170174374
W7167033700Multidrug-resistant Bacillus cereus in retail poultry meat: molecular insights into toxigenicity and antimicrobial resistance2026-07-03OpenAlex10.1186/s12866-026-05337-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167033700
W7167227308Next-Generation SEDDS: Emerging Strategies for Oral Drug Delivery2026-07-03OpenAlex10.25258/ijddt.16.61s.65Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167227308
W7167037551RPR-Memory: Decomposing Retrieval, Policy, and Reasoning in Persistent Memory Systems2026-07-03OpenAlex10.5281/zenodo.21144416Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7167037551
W7167264592Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology2026-07-03OpenAlex10.1007/s11912-026-01807-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167264592
W7167250728SQUID embolization for cerebral AVMs: 1-year safety and efficacy results from the CHOICE prospective multicenter study2026-07-03OpenAlex10.1136/jnis-2026-025273Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167250728
W7167210551The Carlo Mental Health Load Suite: Deterministic Models, Engines, and Educational Frameworks for Pressure, Capacity, Recovery, and Resilience2026-07-03OpenAlex10.5281/zenodo.21162260Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167210551
W7167223825Working with communities responding to violent immigration enforcement: methods generating transformational knowledge informing sociopolitical action2026-07-03OpenAlex10.3389/fpos.2026.1704380Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167223825
W7167350279Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia: A Brief Review and Practical Algorithm2026-07-04OpenAlex10.1053/j.jvca.2026.07.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167350279
W7167333509DRA v12 — Formalizing the Law of Regulatory Transitions: Theory, Pipeline, and First Cross‑Validated Example2026-07-04OpenAlex10.5281/zenodo.21186197Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167333509
W7167495442Emerging Therapies Targeting Lipoprotein(a): A Clinical Trial Landscape Review of Investigational Lp(a)-Lowering Therapies2026-07-04OpenAlex10.3390/jcm15135233Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167495442
W7167227437Ethosomal Drug Delivery Systems for Superficial and Systemic Fungal Infections: Formulation Strategies, Mechanistic Insights, and Translational Advances2026-07-04OpenAlex10.1007/s12281-026-00539-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167227437
W7167277937“Bypassing” or “nearby care”? Deconstructing and simulating patient hospital choice in China’s hierarchical healthcare system via explainable machine learning and agent-based modeling2026-07-04OpenAlex10.1016/j.cities.2026.107305Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7167277937
W7167413955Flumazenil: Mechanistic Insights, Clinical Applications, and Therapeutic Controversies in Benzodiazepine Reversal2026-07-05OpenAlex10.5281/zenodo.21207047Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167413955
W7167416881Recent advances in metal–organic frameworks for the diagnosis and treatment of breast cancer2026-07-05OpenAlex10.1186/s11671-026-04710-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167416881
W7172129222SAF-LQC: A Self-Adaptive Framework Based on Q-Learning and Quantum Computing for Zero-Day Attack Detection in the Medical Internet of Things2026-07-05OpenAlex10.71856/impcs.2026.1241811Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172129222
W7167408749moorateeahtashil/ts-acl-spec: v1.0.0 — TS-ACL-SPEC: spectral feature front-end and probe-gap diagnostic2026-07-05OpenAlex10.5281/zenodo.21207488Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167408749
W7167465622A systematic analysis of LLM backdoor-integrated cyberattacks: Feasibility, impact factors, and realistic case studies in agent systems2026-07-06OpenAlex10.1016/j.asoc.2026.115912Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167465622
W7167463779Complicated urinary tract infections: evolving definitions, clinical burden, and treatment landscape amid antimicrobial resistance2026-07-06OpenAlex10.1080/14787210.2026.2700381Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167463779
W7167504789Emerging Therapies in Multiple Sclerosis Management – Can We Stop the Demyelinating Process?2026-07-06OpenAlex10.20883/medical.e1565Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167504789
W7167468399Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy2026-07-06OpenAlex10.1371/journal.pone.0351243Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167468399
W7167468355Next-Generation Checkpoint Combinations: Optimizing PD-(L)1–Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings2026-07-06OpenAlex10.1007/s11912-026-01809-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167468355
W7167494976Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology2026-07-06OpenAlex10.1159/000553423Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167494976
W7167484879Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy2026-07-06OpenAlex10.3390/cancers18132163Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167484879
W7167481495TRENDS IN THE USE OF NATURAL AGENTS FOR CHRONIC WOUND CARE IN DEVELOPING COUNTRIES: A SCOPING REVIEW2026-07-06OpenAlex10.36720/nhjk.v15i1.919Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167481495
W7167472323The Future of Talent Science – AI, Complexity, and Autonomous Workforce Systems2026-07-06OpenAlex10.1201/9781003684312-20Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167472323
W7167583306The Role of the Renin-Angiotensin-Aldosterone System and Endothelin-1 in the Progression of the Cardiorenal-Metabolic Triad2026-07-06OpenAlex10.25258/ijddt.16.62s.99Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167583306
W7167477553The chaos of choice in large B-cell lymphoma: a call to harmonize first-line trials2026-07-06OpenAlex10.1182/blood.2026034393Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167477553
W7167474713The immune system as a regulator of normal physiology2026-07-06OpenAlex10.3389/fimmu.2026.1867359Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167474713
W7167510333Update: Immune Tolerance Induction Practice in Haemophilia2026-07-06OpenAlex10.1055/a-2887-8098Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167510333
W7167506625Why precision oncology works: lessons from gastrointestinal stromal tumours2026-07-06OpenAlex10.37349/etat.2026.1002378Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167506625
W7167591649Agentic AI: A Survey of Architectures, Memory, Planning, and Real-World Application2026-07-07OpenAlex10.5281/zenodo.21237698Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167591649
W7167598725Autonomous Penetration Testing for Financial Systems: A Multi-Agent Architecture for Continuous Security Validation2026-07-07OpenAlex10.5281/zenodo.21250717Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7167598725
W7167633741Biomimetic hydrogel design for programmable ECM and tissue regeneration2026-07-07OpenAlex10.1016/j.ijpharm.2026.127163Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167633741
W7167601646Copilot and CAN-Bus Connected ECUs Integrated Scenarios for Automotive Diagnosis, Enhanced by Scan Tools, Conversational Agents and AI Technologies2026-07-07OpenAlex10.15837/ijccc.2026.4.7501Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7167601646
W7167632027Decomposition-based Zeroing neural dynamics for real-time Pareto tracking in time-varying multi-objective optimization2026-07-07OpenAlex10.1016/j.jfranklin.2026.108884Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167632027
W7167634852FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021–2025): Pharmaceutical Use, Trends and Synthetic Approaches2026-07-07OpenAlex10.3390/medicines13030022Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167634852
W7167612832From adoption to architecture: Agentic AI in surgical data science2026-07-07OpenAlex10.1016/j.amjsurg.2026.117136Full textExcludedF1: The publisher/PubMed identify an editorial discussing surgical data-science architecture, without a new evaluated adaptive agent.https://openalex.org/W7167612832https://www.americanjournalofsurgery.com/article/S0002-9610(26)00321-1/fulltextPublisher indexed opening/body preview; PubMed indexed publication metadata; direct full page403.
W7167589167Glycoprotein IIb/IIIa Receptor Inhibitors in Acute Coronary Syndromes and Percutaneous Coronary Intervention: A Comprehensive Review of Pharmacological Principles, Clinical Indications, and Contemporary Practice Paradigms2026-07-07OpenAlex10.5281/zenodo.21242798Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167589167
W7167594475Oncoflux V2.0 — A Deterministic Oncology‑Flavoured Systems Engine for Multi‑Region Behaviour Modelling2026-07-07OpenAlex10.5281/zenodo.21245091Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167594475
W7167591108Pediatric Acute Poisoning: The Bipolar Evolution of the Poisoning Spectrum from 2019 to 2024 in Southwest China2026-07-07OpenAlex10.3390/jcm15135309Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167591108
W7167686696The State of the Art on Management of Patients with Unresectable Liver Metastases from Colorectal Cancer2026-07-07OpenAlex10.3390/biomedicines14071527Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167686696
W7167600139The cancer/testis antigens represent promising targets for the development of new therapies against melanoma2026-07-07OpenAlex10.1016/j.prp.2026.156617Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167600139
W7167575271The digital therapist? LLMs and the future of clinical dialogue2026-07-07OpenAlex10.1016/j.laheal.2026.100086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167575271
W7167474980Update on lipoprotein(a): the rising star in residual lipid risk2026-07-07OpenAlex10.1093/eurheartj/ehag499Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167474980
W7167742988A Review Article on Antimicrobial Resistance and Chemotherapeutics: Mechanisms, Clinical Interactions, and Emerging Therapeutic Strategies2026-07-08OpenAlex10.5281/zenodo.21267164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167742988
W7167663147Benchmarking and Optimising Deep Learning Models for Personalised Response Classification and Generation2026-07-08OpenAlex10.25949/32764728Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167663147
W7167670532Characterization of Escherichia marmotae , a novel pathogen causing urinary tract infection in a dog2026-07-08OpenAlex10.1177/10406387261461260Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167670532
W7167585396Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma2026-07-08OpenAlex10.1186/s12931-026-03801-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167585396
W7167691152EECA: a design-oriented explainability framework for end-to-end cockpit agents2026-07-08OpenAlex10.1080/09544828.2026.2698385Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167691152
W7167666912From incidental positron emission uptake to in-vivo phenotyping: a short history of positron emission tomography in the study of atherosclerosis and the vulnerable plaque2026-07-08OpenAlex10.3389/fcvm.2026.1767077Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167666912
W7167693408Goal-directed osteoporosis treatment: are bone mineral density targets valid?2026-07-08OpenAlex10.1016/s2213-8587(26)00123-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167693408
W7167682713Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex2026-07-08OpenAlex10.3389/fmicb.2026.1869585Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167682713
W7167737993Life‑Ledger‑GPT RIL: A Reflective Intelligence Loop System for Persistent Human Memory, Autonomous Doctrine Formation, and Backend‑Integrated Behavioral Optimization2026-07-08OpenAlex10.5281/zenodo.21265742Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167737993
W7167710895Targeting cellular senescence in dermatology: senolytic and senomorphic strategies2026-07-08OpenAlex10.1007/s11357-026-02379-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167710895
W7167701551The Evolving Role of Bispecific Antibodies in Oncogene-Driven NSCLC2026-07-08OpenAlex10.3390/cancers18142197Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167701551
W7167818236A victim of its own progress: why the success of modern therapeutics forces a re-evaluation of placebo-controlled trials in migraine prevention2026-07-09OpenAlex10.3389/fneur.2026.1871028Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167818236
W7167810629Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature. - PathMap Experiment #0000332026-07-09OpenAlex10.5281/zenodo.21283141Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167810629
W7167850067Advances and Challenges in Iodinated Contrast Media2026-07-09OpenAlex10.1201/9781003508137-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167850067
W7167785239Advancing Infection Prevention Through Medical Device Cleaning Innovation in Japan2026-07-09OpenAlex10.5281/zenodo.21277817Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167785239
W7168267244Agentic Context Learning with Self-Discovered Specification2026-07-09OpenAlex2607.0979410.48550/arxiv.2607.09794Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7168267244
W7167824835Clostridioides difficile Infection Deceleration: What Is Next?2026-07-09OpenAlex10.1093/cid/ciag364Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167824835
W7167932174From Tokens to Trust: Understanding Uncertainty in Autoregressive Large Language Models2026-07-09OpenAlex10.5281/zenodo.21283930Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167932174
W7167796865Helicobacter pylori Eradication in the Era of Antibiotic Resistance: From Universal Regimens to Precision-Guided Management2026-07-09OpenAlex10.3390/antibiotics15070673Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167796865
W7167796588How Biologics Are Changing the Global Burden of Inflammatory Bowel Disease: A Review2026-07-09OpenAlex10.7759/cureus.112332Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167796588
W7167850976Nonalcoholic Fatty Liver Disease in the Era of MAFLD: Emerging Insights into Mechanisms, Diagnosis, and Personalized Management Global Burden and Economic Impact2026-07-09OpenAlex10.64063/3049-1681.vol3.issue7.000282Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167850976
W7167845787OVERVIEW OF THE MAIN FUNGAL INFECTIONS IN HUMANS2026-07-09OpenAlex10.31435/ijitss.3(51).2026.6233Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167845787
W7167847388Pharmacological Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in a New Era for Obesity and Metabolic Medicine: A State-of-the-Art Review2026-07-09OpenAlex10.7570/jomes26005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167847388
W7167803445Recent advances in the treatment of FLT3-mutated acute myeloid leukemia2026-07-09OpenAlex10.1007/s44313-026-00155-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167803445
W7167795989Treatment Selection Beyond Second Line in Metastatic Colorectal Cancer: Practical Sequencing of Cytotoxic Salvage Therapy, Anti-angiogenic Agents, Rechallenge Strategies, and Biomarker-Guided Treatments2026-07-09OpenAlex10.1007/s12029-026-01524-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167795989
W7167903431Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation2026-07-10OpenAlex10.3389/fonc.2026.1893594Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167903431
W7167958963Bibliometric analysis of the top 100 cited articles on contrast media complications: Influence of agent class and structure2026-07-10OpenAlex10.1016/j.clinimag.2026.110901Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167958963
W7168123655Cancer Immunotherapy2026-07-10OpenAlex10.3390/books978-3-7258-8088-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168123655
W7167923361Editorial: The evolution in pharmacology of infectious diseases: 20252026-07-10OpenAlex10.3389/fphar.2026.1907819Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167923361
W7167889574KRAS-Targeting Agents in Cancer: A Bibliometric Analysis of Global Research Trends and Emerging Hotspots from 2006 to 20262026-07-10OpenAlex10.21203/rs.3.rs-10252473/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167889574
W7167925643Low dose aspirin beyond coronary artery disease: a structured narrative review2026-07-10OpenAlex10.1186/s43162-026-00677-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7167925643; https://openalex.org/W7168034392
W7168096660Not Just One Agent: LLM-Based Multi-Agent Systems for Medicine from Answer Generation to Accountable Workflow Orchestration2026-07-10OpenAlex10.20944/preprints202606.0640.v2Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7168096660
W7167937745Recent advances in rheumatoid arthritis and other arthropathies2026-07-10OpenAlex10.1016/j.mporth.2026.05.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167937745
W7167938215Teaching Model Context Protocol, Retrieval-Augmented Generation, and AI Agents to a Multidisciplinary Hospital Workforce: Single-Group Pre-Post Survey Study2026-07-10OpenAlex10.2196/97822Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167938215
W7167937281The Integrative Learning Design Framework Revisited: AI Affordances, Risks, and Guardrails for Learning Experience Design Research and Practice2026-07-10OpenAlex10.5281/zenodo.20970395Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7167937281
W7167887542Therapy update: An introduction to the pharmacology, safety, and efficacy of bispecific antibodies in relapsed or refractory multiple myeloma2026-07-10OpenAlex10.1093/ajhp/zxag203Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167887542
W7168052491Beyond the Rule Set: Structural Friction and Traceable Reason-Giving for Autonomous Systems2026-07-11OpenAlex10.5281/zenodo.21312289Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168052491
W7168165113Beyond the Usual Suspects: Emerging Pseudomonas Species in Clinical and Environmental Niches2026-07-11OpenAlex10.3390/ijms27146210Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168165113
W7168018595Prim‑Lex Theory Reconstructing Microbial Targeted Therapeutics: From "Bactericidal" to "Fire-Extinguishing" ------A Novel Drug Discovery Framework Targeting Microbial Energy Metabolism Based on the Eight‑Dimensional Framework of Prim‑Lex Theory2026-07-11OpenAlex10.5281/zenodo.21310955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168018595
W7168032990Rhinophyma: A Report of Two Patients Managed With Electrosurgery2026-07-11OpenAlex10.7759/cureus.112465Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168032990
W7168020927Text2Onto-Agent: An LLM Agent-Based End-to-End Automated Ontology Construction Method anda Case Study of Green Building Domain Modeling2026-07-11OpenAlex10.1061/jcemd4.coeng-18479Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7168020927
W7168090210Analysis Manual for Design as Decision Closure Under Uncertainty: Operational Protocol (v6.4)2026-07-12OpenAlex10.5281/zenodo.21312797Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168090210
W7166498579Using agent-based simulation to reconstruct historical disease landscapes,: the example of malaria in Cyprus2026-07-12OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7166498579
W7168140865Agent-Compression and Large-Kernel DETR for Colorectal Polyp Detection2026-07-13OpenAlex10.1007/978-981-92-3492-9_13Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7168140865
W7168078414Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia2026-07-13OpenAlex10.1007/s11899-026-00782-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168078414
W7168167030Discordance Between Textual Reasoning and Visual Interpretation in Large Language Models for Low Back Pain: Cross-Sectional Quantitative Evaluation and Exploratory Multimodal Stress Test2026-07-13OpenAlex10.2196/93522Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168167030
W7168175281Editorial: Non-ionizing radiation: impacts on human health from exposures in occupational settings2026-07-13OpenAlex10.3389/fpubh.2026.1880564Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168175281
W7168179708Immunotherapy for locally advanced head and neck squamous cell carcinoma: A review2026-07-13OpenAlex10.1016/j.ctrv.2026.103193Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168179708
W7171566980Ligand-modified multifunctional liposome-based targeted delivery platform: a multimodal cancer combination therapy strategy2026-07-13OpenAlex10.7150/thno.136152Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171566980
W7168167767Measuring the Language in Language Models The Missing Writing Benchmark in Health Economics and Outcomes Research2026-07-13OpenAlex10.5281/zenodo.21343393Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168167767
W7203657468Modern Cerrahide Topikal Hemostatik Ajanlar: Mekanizma Odaklı Bir Sınıflandırma2026-07-13OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203657468
W7168196055Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum2026-07-13OpenAlex10.1210/endrev/bnag022Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168196055
W7168170036Reading 'Quantum Spins' Inside Living Cells... 'MagLOV' Protein Opens the Door to Multimodal Sensing2026-07-13OpenAlex10.5281/zenodo.21328970Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168170036
W7168154062The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53 -Mutant AML2026-07-13OpenAlex10.1158/1078-0432.ccr-25-4843Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168154062
W7168161301Using fluorescence in minimally invasive thoracic surgery: a narrative review2026-07-13OpenAlex10.21037/vats-2026-1-0004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168161301
W7168247998Comparative safety profiles of enzalutamide, olaparib, and lutetium Lu-177 vipivotide tetraxetan in patients with prostate cancer: a real-world disproportionality analysis of the FAERS database2026-07-14OpenAlex10.1007/s00345-026-06597-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168247998
W7168268365Evolving First-Line Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms2026-07-14OpenAlex10.3390/curroncol33070421Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168268365
W7168247954From suspected necrotizing fasciitis to diagnosed drug-induced fever: a diagnostic maze and reflections on anti-infection management in a case of postoperative fever after femoral fracture2026-07-14OpenAlex10.3389/fmed.2026.1830157Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168247954
W7201951132Minnesota in the Bleak Midwinter: Federal Immigration Occupation Meets Grassroots Action and Love of Neighbor2026-07-14OpenAlex10.1093/sw/swag041Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7201951132
W7168292336Multimodal Large Language Models: A Survey of Vision-Language Integration, Architectures, and Applications2026-07-14OpenAlex10.5281/zenodo.21365120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168292336
W7169474531Neuroimaging LLM-Agent Benchmark — Ground Truth Data2026-07-14OpenAlexTitle/abstractExcludedE1: Reference neuroimaging dataset/benchmark outputs rather than an adapting agent system.https://openalex.org/W7169474531
W7168235500Nurturing a Sustainable Transplantation Journey: the best of ESOT Congress 20252026-07-14OpenAlex10.3389/ti.2026.17127Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168235500
W7168257006One Field, Many Discoveries: Why AI Keeps Rediscovering Large Language Fields One Instrument at a Time2026-07-14OpenAlex10.5281/zenodo.21348029Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168257006
W7168293804Therapeutic plasma exchange in pediatric streptococcal toxic shock syndrome with severe digital ischemia2026-07-14OpenAlex10.1016/j.transci.2026.104495Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168293804
W7168348475A Minimally Invasiveness Hybrid Brain-Computer Interface: A Distributed, Scalable and Evolvable Architecture for Whole Brain Access2026-07-15OpenAlex10.64898/2026.07.14.738604Full textExcludedF3: This is a microelectrode/hybrid-BCI animal and field-modeling study. Its AI planning/control framework is intended for future deployment; no implemented LLM/VLM acting agent is documented.https://openalex.org/W7168348475https://doi.org/10.64898/2026.07.14.738604
W7168405215BRAIN-SPECIFIC DRUG DELIVERY: A REVIEW2026-07-15OpenAlex10.5281/zenodo.21371707Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168405215
W7168352165Chronic lymphocytic leukemia management in India: balancing evidence, access, and affordability in clinical practice2026-07-15OpenAlex10.3389/fonc.2026.1853089Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168352165
W7168926726Developing learning-strategic competence in pre-service Еnglish teachers through artificial intelligence tools2026-07-15OpenAlex10.32589/1817-8510.2026.1.367037Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168926726
W7168360289Editorial: Unlocking cancer’s secrets: overcoming drug resistance in cancer stem cells2026-07-15OpenAlex10.3389/fphar.2026.1913266Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168360289
W7168402151Human-like conversational agents as social partners: a scoping review of socioaffective mechanisms, well-being outcomes, risks and governance in the post-Turing era2026-07-15OpenAlex10.3389/frai.2026.1810097Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168402151
W7169065578Knowledge Graphs vs. SQL over Structured EHR Data2026-07-15OpenAlex10.3390/fi18070365Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7169065578
W7168622736Multimodal Ontology: Semantic Substrate for Human Digital Twins in AI-Driven Metaverse Telerehabilitation and Immersive Medical Education2026-07-15OpenAlex10.54517/m8553Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168622736
W7169176432Therapeutic Advancement in Cardiovascular Disorders: Molecular Mechanisms, Emerging Targets and Translational Perspectives2026-07-15OpenAlex10.22270/jddt.v16i7.7825Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169176432
W7202107544Unlocking Patient History: AI-Driven Language-Based Interface for Accessing HL7-CDA Episode Data2026-07-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202107544
W7169644529Розвиток навчально-стратегічної компетентності майбутніх учителів англійської мови засобами штучного інтелекту2026-07-15OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169644529
W7168964007AI as a Therapist, Companion, and Romantic Partner: Emerging Roles, Benefits, and Risks for Mental Health in Participatory Medicine2026-07-16OpenAlex10.2196/95153Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168964007
W7168601950An Acceptance Criteria Framework for Determining the Implementation Fit of Custom Large Language Models in Public Health Interventions2026-07-16OpenAlex10.2196/92356Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168601950
W7169004868Beyond chemotherapy: the evolving role of photodynamic therapy in triple-negative breast cancer2026-07-16OpenAlex10.1007/s12032-026-03326-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169004868
W7169115255Correction: Understanding antibiotic decision-making for bovine respiratory disease: a survey of UK farm veterinarians2026-07-16OpenAlex10.3389/fvets.2026.1900336Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7169115255
W7168701639Interventional Radiology in the Management of Primary Liver Malignancies2026-07-16OpenAlex10.3390/cancers18142283Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168701639
W7168759588Precision antimicrobials: the next paradigm shift after broad-spectrum therapy2026-07-16OpenAlex10.3389/fmicb.2026.1881800Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7168759588
W7204253943Reinforcement Learning: Theory, Algorithms, and Applications by Dr. K.V. Rameswara Reddy, Dr. A. Vishnuvardhan Reddy, Dr. M. Madhusudhan Reddy, Mr. G.V. Ramana Reddy2026-07-16OpenAlex10.5281/zenodo.21448955Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204253943
W7220890313The Role of Media in the Era of Crises: Destabilization and Reorganization of Order in the Process of Democratic Transformation (1996–2013)2026-07-16OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220890313
W71695929852026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function2026-07-17OpenAlex10.1530/etj-26-0011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169592985
W7169527047Beyond Sleepless Nights: Integrating Neurobiology, Clinical Burden, And Emerging Therapeutic Advances In Insomnia: A Comprehensive Evidence-Based Review2026-07-17OpenAlex10.5281/zenodo.21412647Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169527047
W7169517395Dolabellane diterpenoids as non-nucleoside reverse transcriptase inhibitors and anti- HIV agents: in silico and biological approach2026-07-17OpenAlex10.1080/14786419.2026.2700334Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169517395; https://openalex.org/W7169521481
W7169560794Dual-recognizing antibodies targeting CEACAMs in the tumor microenvironment: towards more precise targeting2026-07-17OpenAlex10.1186/s12964-026-03084-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169560794
W7169660122Provocable Forgiveness in Noisy Brand--Consumer Systems:An Agent-Based Study of Repeated Interaction2026-07-17OpenAlex10.63562/2577-8439.1179Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169660122
W7168634542The Impact of AI-Powered Business Analytics on Organizational Agility and Competitive Advantage2026-07-17OpenAlex10.21203/rs.3.rs-10375254/v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168634542
W7169675495AI Safety Compass: A Compact Framework for AI Safety Research and System Design2026-07-18OpenAlex10.5281/zenodo.21431475Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169675495
W7169655406Abstract B035: A Phase 2 Platform Trial Integrated with Patient Digital Twins to Prioritize and Refine Therapies for Sarcomas: The RAPID Study2026-07-18OpenAlex10.1158/1538-7445.rareca26-b035Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169655406
W7169673467Abstract IA007: Precision oncology and the N-of-1 revolution: Rare cancers as a paradigm2026-07-18OpenAlex10.1158/1538-7445.rareca26-ia007Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169673467
W7169659790Generative AI-powered simulated patients in health professions education: a systematic review, evidence synthesis, and meta-analysis2026-07-18OpenAlex10.17605/osf.io/c7zuqTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169659790
W7172027641INTELLIGENT CANCER DIGITAL TWINS: AI-DRIVEN VIRTUAL PATIENT MODELS FOR PREDICTIVE ONCOLOGY2026-07-18OpenAlex10.65713/ijaraiv14i1225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172027641
W7169679913MDTace: Agentic Context Engineering for Multi-disciplinary Team Medical Consultation2026-07-18OpenAlex10.1007/978-981-92-3403-5_6Full textIncludedIncluded: Training-case experience bullets are persistently stored and reused on separate diagnostic test cases.https://openalex.org/W7169679913https://link.springer.com/chapter/10.1007/978-981-92-3403-5_6
W7169661565Piezocatalytic Therapy for Periodontitis: From Biofilm Disruption to Immunomodulatory Tissue Regeneration2026-07-18OpenAlex10.1021/cbe.6c00056Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169661565
W7169687038Practitioner viewpoint: Navigating the promises and gaps in digital transformation, SME development and job creation in Africa2026-07-18OpenAlex10.1108/ajems-08-2026-949Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169687038
W7171997470SPATIAL OMICS AND FOUNDATION AI MODELS: DECODING TUMOR HETEROGENEITY FOR PRECISION ONCOLOGY2026-07-18OpenAlex10.65713/ijaraiv14i1224Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171997470
W7169682809The history of cryptosporidiosis2026-07-18OpenAlex10.1186/s13071-026-07498-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169682809
W7169757306Acute-on-Chronic Liver Failure: An Eroded Cliff Hit by a Storm—A Narrative Review2026-07-19OpenAlex10.3390/ijms27146414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169757306
W7169682270Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation2026-07-19OpenAlex10.1186/s12645-026-00404-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169682270
W7169716598Pharmacological Management of Dyslipidemia in Obese and Elderly Patients: Challenges, Current Therapies, and Emerging Treatments2026-07-19OpenAlex10.1177/22313354261461001Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169716598
W7169730868Plant-Derived Flavonoids as Multi-Target Pharmacological Modulators: Mechanisms, Therapeutic Potential and Translational Challenges in Acute and Chronic Diseases2026-07-19OpenAlex10.22541/authorea.15006263/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169730868
W7203614008Alzheimer’s Disease and Cognitive Disorders: From Molecular Drivers to Multilevel Clinical Solutions2026-07-20OpenAlex10.62134/khatamuni.187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203614008
W7169799986Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence2026-07-20OpenAlex10.1016/j.kisu.2026.03.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169799986
W7169754903Editorial: Advancing equity in allergic disease management through innovative clinical strategies2026-07-20OpenAlex10.3389/falgy.2026.1918802Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169754903
W7169795291Editorial: Exploring the carcinogenic potential of e-cigarettes: a multifaceted study2026-07-20OpenAlex10.3389/fonc.2026.1922285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169795291
W7169732532Generating guideline-concordant and safe recommendations for diabetic kidney disease management via a hierarchical retrieval-augmented large language model2026-07-20OpenAlex10.1038/s41746-026-03035-0Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7169732532
W7169765900Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review2026-07-20OpenAlex10.1111/bph.70610Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169765900
W7169767923Kv7 channels as pharmacological targets for central nervous system diseases2026-07-20OpenAlex10.1016/j.pharmr.2026.100153Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169767923
W7169777837Management of carotid artery injuries: What you need to know2026-07-20OpenAlex10.1097/ta.0000000000005122Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169777837
W7169786386New Treatment Strategies for Rare Genomic Alterations: EGFR Exon 20 Insertions and HER2-Deregulated Lung Cancer2026-07-20OpenAlex10.3390/cancers18142334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169786386
W7172209261Stereotactic Radiosurgery Versus Whole-Brain Radiotherapy in Patients with Multiple Brain Metastases: Current Evidence and Future Perspectives2026-07-20OpenAlex10.5281/zenodo.21448794Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172209261
W7169828489Targeting HCC With SBRT2026-07-20OpenAlex10.1097/coc.0000000000001342Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169828489
W7169796963The Evolving Therapeutic Landscape of Diabetes Mellitus and Obesity: From Conventional Treatments to Next-Generation Metabolic Therapies2026-07-20OpenAlex10.9734/jammr/2026/v38i86173Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169796963
W7169770573The Missing Layer in Agentic AI2026-07-20OpenAlex10.5281/zenodo.21449522Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7169770573
W7169838933Agentic genomics: From pipeline automation to autonomous validation2026-07-21OpenAlex10.1016/j.xgen.2026.101305Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7169838933
W7169860712Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects2026-07-21OpenAlex10.1016/j.canlet.2026.218753Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169860712
W7170087814Common Causes of Drug-Induced Liver Injury in 20252026-07-21OpenAlex10.5152/tjg.2026.26361Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170087814
W7169849313Dataset: Do any recent non-proliferative diabetic retinopathy clinical trials reveal anything about Amyotrophic Lateral Sclerosis? - PathMap Experiment #0000712026-07-21OpenAlex10.5281/zenodo.21467878Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7169849313
W7221225506Diseño e implementación de un agente de IA para la gestión de una clínica dental mediante n8n2026-07-21OpenAlexTitle/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7221225506
W7169866964Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring2026-07-21OpenAlex10.3389/fonc.2026.1926822Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169866964
W7170598581Hybrid and Conjugate Drugs and their Antimicrobial, Antiparasitic, Antiamoebic, Antileishmanial, Antiprotozoal, and Antitrypanosomal Properties2026-07-21OpenAlex10.2174/0109298673441939260521062733Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170598581
W7169901521Modern management of locally advanced urothelial carcinoma of the upper urinary tract2026-07-21OpenAlex10.1007/s00345-026-06521-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169901521
W7169839040Multicentric Reticulohistiocytosis Progressing to Erythroderma After Long‐Term Disease Progression2026-07-21OpenAlex10.1111/1346-8138.70415Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169839040
W7169849208Peptide Therapeutics in Orthopaedics2026-07-21OpenAlex10.2106/jbjs.26.00785Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169849208
W7169852415Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics2026-07-21OpenAlex10.1038/s41392-026-02769-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169852415
W7170071270Perspective Chapter: Educating Clinicians for AI-Driven Care and Surgery – Literacy, Human-Centered Design and the EU AI Act2026-07-21OpenAlex10.5772/intechopen.1015696Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170071270
W7169870231Recent Advances in Ferrite‐Based Materials for Biomedical Applications: A Comprehensive Review2026-07-21OpenAlex10.1002/adma.74149Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169870231
W7169828696Reflexive Digital Twin Marketing Theory: Governing Algorithmic Marketing Agents Through Reinforcement Learning2026-07-21OpenAlex10.21203/rs.3.rs-10403290/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169828696
W7169879536The Role of Generative Summarisation in Agent-Mediated Reflection for Youth Social Prescribing2026-07-21OpenAlex10.1145/3816046.3816262Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7169879536
W7169840197Toxicity Assessment of Silicon‐Based Compounds With Their Permitted Daily Exposure in Pharmaceutical Packaging Materials and Medical Devices2026-07-21OpenAlex10.1002/jat.70314Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7169840197
W7169881053Twenty-Year Trends in Antipsychotic Utilization in Serbia: A Nationwide Drug Utilization Study2026-07-21OpenAlex10.3390/ph19071128Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7169881053
W7170042850Artificial Intelligence Horizons: Unlocking Potential and Navigating Risks2026-07-22OpenAlex10.5281/zenodo.21485943Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170042850
W7170066977Botulinum Toxin in Dentistry: Present and Future2026-07-22OpenAlex10.5772/intechopen.1016719Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170066977
W7170070301Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms2026-07-22OpenAlex10.3390/molecules31142551Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7170070301
W7170042484Correction: Fetal health state detection method based on parameters efficient ensembling of deep learning2026-07-22OpenAlex10.3389/fpubh.2026.1925419Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7170042484
W7170061450Damage control surgery: Perioperative principles, operating room management, and evolving strategies in trauma care2026-07-22OpenAlex10.1016/j.pcorm.2026.100710Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170061450
W7170085710Dataset and analysis scripts for: Towards Autonomous Bio-Inspired Optimization: Deep Reinforcement Learning for Adaptive Metaheuristic Orchestration2026-07-22OpenAlex10.5281/zenodo.21482508Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7170085710
W7170036318Editorial: Advances in the treatment of acute severe ulcerative colitis2026-07-22OpenAlex10.3389/fgstr.2026.1924886Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170036318
W7170033967New perspective on epigenetic modification and immunotherapy in endometrial cancer2026-07-22OpenAlex10.1186/s13148-026-02174-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170033967
W7171009737Scoping review: Closed-loop systems based on artificial intelligence in intraoperative anesthetic management2026-07-22OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171009737
W7170036918Structural Diversity and Application of Plant Extracts as Biocontrol Agents Against Phytopathogens: a Review2026-07-22OpenAlex10.1007/s10343-026-01384-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170036918
W7171336735Amyloid-targeting treatment in Alzheimer’s disease and concomitant antiplatelets2026-07-23OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171336735
W7170165928Diagnosis and Management of Transfusion-Dependent Thalassemia: Evidence-Based Guidelines From the Pediatric Hematology Oncology Chapter of the Indian Academy of Pediatrics2026-07-23OpenAlex10.1007/s13312-026-00366-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170165928
W7170107183Effectiveness of oral and inhaled repurposed and antiviral pharmaceutical treatments for acute SARS-CoV-2 in outpatient settings: a systematic review of 124 randomized trials2026-07-23OpenAlex10.1186/s12879-026-13901-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170107183
W7170887993Emerging drug delivery strategies in natural products and traditional Chinese medicine research: from individual approaches to integrated design2026-07-23OpenAlex10.1097/hm9.0000000000000204Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170887993
W7170180093Hemophilia A and von Willebrand disease: parallel therapeutic advances in the most common inherited bleeding disorders2026-07-23OpenAlex10.3324/haematol.2026.301336Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170180093
W7170143754High tetracycline and azithromycin resistance of Neisseria gonorrhoeae impacting treatment and doxyPEP use - antimicrobial susceptibility patterns of isolates from a prospective cohort of men who have sex with men in Wroclaw, Lower Silesia, Poland 2022–2024 – final report2026-07-23OpenAlex10.1186/s12879-026-14073-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170143754
W7170133478IV Thrombolysis in the Extended Time Window for Acute Ischemic Stroke2026-07-23OpenAlex10.1212/wnl.0000000000218294Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170133478
W7170142406Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia2026-07-23OpenAlex10.1007/s40272-026-00761-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170142406
W7170167146Metabolic reprogramming orchestrates microglial fate in cerebral ischemia-reperfusion injury: a spatiotemporal immunometabolic perspective2026-07-23OpenAlex10.3389/fimmu.2026.1831494Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170167146
W7170149478Modern Approaches to the Treatment of Type 2 Diabetes Mellitus: Personalized Therapy and Prevention of Complications2026-07-23OpenAlex10.52783/jchr.v16.i4.15879Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170149478
W7170213444New and Novel Agents for Advanced Bladder Cancer2026-07-23OpenAlex10.1016/j.ucl.2026.06.010Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7170213444
W7170199203Q&A: Timothy Yap on Clinical Trials and Drug Development2026-07-23OpenAlex10.1158/2159-8290.cd-nw2026-0079Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170199203
W7170139806The Secondary Signature of Immune System - The Architecture of Secondary Stage - Sam Coole 2026 ©2026-07-23OpenAlex10.5281/zenodo.21505226Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170139806; https://openalex.org/W7170153547; https://openalex.org/W7170176896; https://openalex.org/W7170174895; https://openalex.org/W7170192354; https://openalex.org/W7170147335
W7170154898The Secondary Signature of Immune System - [ Molecular Blueprint] -The Architecture of Secondary Stage - Sam Coole 2026 ©2026-07-23OpenAlex10.5281/zenodo.21505161Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170154898
W7170197990The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents2026-07-23OpenAlex10.3389/fgstr.2026.1850915Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170197990
W7170196421Validation of the VOICE (Visible Opportunities for Infants to Connect and Engage) infant mental health observation tool2026-07-23OpenAlex10.31234/osf.io/7z8hm_v2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170196421
W7170891753Circular Hydroethics2026-07-24OpenAlex10.5281/zenodo.21537480Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7170891753
W7170170806Dataset: Dietary strategy: High amylose maize starch may be identified as a non-invasive tool to improve outcomes in TBI, and potentially hypoxic neurovascular damage, suggesting it could be repurposed for high-altitude workers or elderly patients with cognitive frailty. - PathMap Experiment #0000832026-07-24OpenAlex10.5281/zenodo.21520955Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7170170806
W7170368389Defining and managing high-risk acute myeloid leukemia (AML) in 20262026-07-24OpenAlex10.1007/s00277-026-07142-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170368389
W7170479041Editorial: Innovative diagnostic and therapeutic strategies for neuroendocrine tumors: a multidisciplinary approach2026-07-24OpenAlex10.3389/fonc.2026.1939733Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170479041
W7171769616Engineering Intelligent AIOT Systems-Artificial Intelligence for Smart Connected Technologies BY Dr. Srinivas Kumar Palvadi, Dr. Babu Rajendra Prasad Singothu, Kondapalli Krupa Sagari, Mr. Nyakapu Rajender2026-07-24OpenAlex10.5281/zenodo.21531905Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171769616
W7170899704Immunotherapy in Alzheimer's Disease2026-07-24OpenAlex10.1002/9781394336241.ch19Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7170899704
W7170826172In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads2026-07-24OpenAlex10.3389/fbinf.2026.1839606Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170826172
W7170286489Incretin analogues as cardiovascular agents: a state-of-the-art review2026-07-24OpenAlex10.3389/fendo.2026.1898812Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7170286489
W7170314481SkillSync AI: A Multi-Agent Artificial Intelligence Framework for Dynamic Skill Gap Analysis, Digital Employability Twin, and Personalized Career Roadmaps to Reduce Graduate Unemployment2026-07-24OpenAlex10.5281/zenodo.21522990Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7170314481
W7171390969Agentic AI and Multi-Agent Collaboration in Healthcare: A Comprehensive Survey of Architectures, Clinical Safety, and Future Directions2026-07-25OpenAlex10.3390/fi18080391Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7171390969
W7171244539Emerging Therapies in Endocrine Oncology: Molecular Targets, Precision Medicine, and Future Directions2026-07-25OpenAlex10.66224/infopub.202601.05.011Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171244539
W7171205124From cytoreduction to precision oncology: evolution of ovarian cancer therapy2026-07-25OpenAlex10.1186/s13048-026-02165-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171205124
W7171195045Radionuclide and Theranostic Therapies2026-07-25OpenAlex10.66224/infopub.2026.05.04Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171195045
W7171441031A Systematic Review and Meta-Analysis of AI Transparency Gaps in Version Control Literature with a Proposed Taxonomy of Attribution Failures2026-07-26OpenAlex10.14293/pr2199.004154.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171441031
W7171293376A Unified Framework for Self-Evolving and Self-Healing Artificial Intelligence Agents2026-07-26OpenAlex10.62127/aijmr.2026.v04i04.1435Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7171293376
W7206172781Autonomous Radio Network Intelligence: Architectural Principles of Large Language Model-Driven Closed-Loop 5G Management Systems2026-07-26OpenAlex10.22399/ijcesen.5491Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7206172781
W7220399162Deep Fungal Infections – The Masquerader2026-07-26OpenAlex10.3329/bjm.v37i20.89574Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220399162
W7171437223Advancing personalised oncologic care for older adults with head and neck cancer through structured international collaboration2026-07-27OpenAlex10.3389/fonc.2026.1858873Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171437223
W7171516054Atypical myxomatosis in European rabbits is caused by the recombinant myxoma virus involved in species jumping into hares2026-07-27OpenAlex10.64898/2026.07.25.740729Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171516054
W7171354671Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small-Cell Lung Cancer2026-07-27OpenAlex10.3390/cancers18152417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171354671
W7171644048Self-evolving artificial intelligence virtual cells: A closed-loop system from multi-scale modeling to biomedical applications2026-07-27OpenAlex10.65457/cmjbm-2026-0006Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7171644048
W7172238334Strategic Sensing under VUCA Conditions: A Critical Reflection on Forecasting, Anchoring Bias, and Agentic AI2026-07-27OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7172238334
W7171541494Thiazolidinedione nucleus: a molecular beacon in treatment of diabetes2026-07-27OpenAlex10.1080/17415993.2026.2709110Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171541494
W7171397432Weight Recurrence After Bariatric Surgery: Incretin-Based Therapies and the Evolving Role of Revisional Surgery2026-07-27OpenAlex10.7759/cureus.113460Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171397432
W7171388348When Innovation Turns Fatal: The Imperative for Ethical, Monitored Integration of AI Chatbots in Adolescent Mental Healthcare2026-07-27OpenAlex10.1007/s10615-026-01045-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171388348
W7171531438AI Safety Compass Core Semantic Package: A Stable Machine-Readable Contract for AI Safety Research and System Design2026-07-28OpenAlex10.5281/zenodo.21649320Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171531438
W7171534589Advancements in Bladder-Sparing Strategies for Muscle-Invasive Bladder Cancer2026-07-28OpenAlex10.1016/j.ucl.2026.06.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171534589
W7171561903Bridging the gap: integrating hereditary cancer into precision oncology2026-07-28OpenAlex10.1038/s41431-026-02196-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171561903
W7171533628Developing a Spiral Curriculum for Immunology in Undergraduate Medical Education: Lessons from Curricular Reforms in Azerbaijan 22593472026-07-28OpenAlex10.1093/jimmun/vkag141.699Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171533628
W7171522190Editorial: Prosthodontic research and clinical applications2026-07-28OpenAlex10.3389/fdmed.2026.1907894Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171522190
W7171489118Editorial: User-centered approaches for designing assistive technologies to support older adults2026-07-28OpenAlex10.3389/fragi.2026.1864923Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171489118
W7171806078GuideSkill: Evolving Executable LLM Agent Skills for Guideline-Grounded Clinical Reasoning2026-07-28OpenAlex2607.2616010.48550/arxiv.2607.26160Full textIncludedIncluded: Executable skills learned from prior labelled cases are retained for disjoint later clinical benchmarks.https://openalex.org/W7171806078https://arxiv.org/html/2607.26160v1
W7171527713Management of drug-induced interstitial lung disease in the era of evolving lung cancer therapies: A mini-review2026-07-28OpenAlex10.1016/j.resinv.2026.101494Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171527713
W7171539747Primary Biliary Cholangitis in the Middle East: A Review of Current Challenges and Treatment Approaches2026-07-28OpenAlex10.7759/cureus.113526Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171539747
W7171554276Transdermal Drug Delivery Systems: An Updated Review on Design, Evaluation, and Recent Advances2026-07-28OpenAlex10.5281/zenodo.21637782Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171554276
W7171565303TyCHE enables time-resolved lineage tracing of B cells in primary and recall germinal center reactions 22610472026-07-28OpenAlex10.1093/jimmun/vkag141.1025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171565303
W7171735683Assessment of Nutritional Status in Adult Patients with Acute Myeloid Leukemia: The Role of Screening Tools, Composite Indices, Body Composition, and Physical Function—A Structured Narrative Review2026-07-29OpenAlex10.3390/hemato7030024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171735683
W7171684290Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review2026-07-29OpenAlex10.3390/pharmaceutics18080928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171684290
W7171730133Designing an Explainable agent for Generative Design Workflows with Physics based Reasoning2026-07-29OpenAlex10.1184/r1/32761257Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171730133
W7171632781Korean guidelines for pediatric procedural sedation2026-07-29OpenAlex10.17085/apm.26630Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171632781
W7171683353Laser Interstitial Thermal Therapy for High-Grade Gliomas: Current Evidence, Clinical Applications and Emerging Role of Artificial Intelligence2026-07-29OpenAlex10.3390/jcm15155928Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171683353
W7171688681Molecular Brain Tumor Imaging Beyond [ 18 F]FDG: Somatostatin Receptor PET, Amino Acid PET, and Emerging Applications—From the AJR Special Series on Molecular Imaging2026-07-29OpenAlex10.2214/ajr.26.35024Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171688681
W7171628927Position Paper of the German Diabetes Association, German Society of Angiology and Vascular Medicine, German Society for Vascular Surgery and Vascular Medicine and German Society for Interventional Radiology and Minimally Invasive Therapy on the Diagnosis and Treatment of Peripheral Arterial Occlusive Disease in Diabetes Mellitus2026-07-29OpenAlex10.1055/a-2766-4074Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171628927
W7171712537Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline2026-07-29OpenAlex10.1016/j.drudis.2026.104750Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7171712537
W7171660919Prediction and Learning Algorithms for Robustness in the Wild2026-07-29OpenAlex10.1184/r1/32984741Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171660919
W7171619968Sustained-release local anesthetics: advances in drug delivery systems for prolonged postoperative analgesia2026-07-29OpenAlex10.17085/apm.26668Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171619968
W7171840476THERAPEUTIC APPROACH AND TREATMENT OF IDIOPATHIC NEPHROTIC SYNDROME IN CHILDHOOD2026-07-29OpenAlex10.47172/ijhmreview.v12i3.566Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171840476
W7202138461Tactical Combat Casualty Care (TCCC): Historical Evolution, EvidenceBased Development, And Contemporary Applications In Modern Warfare2026-07-29OpenAlex10.47353/ajmpm.v3i2.57Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202138461
W7171652593Targeted Drug Delivery Using Nanotechnology: A Comprehensive Review2026-07-29OpenAlex10.5281/zenodo.21669217Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171652593
W7171717741Advancements in AI Research and Social Responsibility : From Technology to Control and Governance2026-07-30OpenAlex10.54698/kl.2026.21.835Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171717741
W7172522313Annotations to Structure a Systematic Review: Methodological Update and Key Principles Using the S0–S3 Flow2026-07-30OpenAlex10.20944/preprints202607.2253.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172522313
W7171977841Artificial Intelligence in Medical Publishing: At the Crossroads of Innovation, Scientific Integrity, and Editorial Governance2026-07-30OpenAlex10.37018/ekbx9407Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171977841
W7171768544Beyond Mechanical Support: Engineering Bioresorbable Coronary Scaffolds as Temporary Therapeutic Platforms of Vascular Regeneration2026-07-30OpenAlex10.6084/m9.figshare.33120065Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171768544
W7172442542Claudin 18.2-Targeted Therapies in Gastric and Gastroesophageal Junction Cancers: A Narrative Review of the Emerging Therapeutic Landscape2026-07-30OpenAlex10.67692/iodt.26.9635Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172442542
W7171941811Inference-Time Agentic Decision Rules Beat Longer Evolving Search for Multi-Image Medical Reasoning2026-07-30OpenAlex2607.2756410.48550/arxiv.2607.27564Full textIncludedIncluded: Evolved agent inference configurations are selected on prior VQA cases and retained for disjoint final cases.https://openalex.org/W7171941811https://arxiv.org/abs/2607.27564v1
W7171868682REVIEW OF POLYHERBAL MOUTHWASHES AND THEIR IMPACT ON ORAL HEALTH: HERBAL SYNERGY IN DENTISTRY2026-07-30OpenAlex10.5281/zenodo.21704250Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171868682
W71720163993D Skin Analysis Machine2026-07-31OpenAlex10.5281/zenodo.21718371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172016399
W7171978400Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment2026-07-31OpenAlex10.4274/tjh.galenos.2026.32559Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171978400
W7171919341Beyond discrete social decisions: toward continuous dyadic neural dynamics in cooperation and competition2026-07-31OpenAlex10.3389/fnsys.2026.1809977Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171919341
W7171947137Bioactive Compounds from Mangrove-Associated Fungi as Leads Against ESKAPE Pathogens2026-07-31OpenAlex10.3390/life16081272Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171947137
W7202127566Cognitive Identity Mesh Architecture (CIMA): Redefining Zero-Trust Security in AI-Driven Cloud Ecosystems2026-07-31OpenAlex10.5281/zenodo.21868888Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202127566; https://openalex.org/W7202187771
W7172105884Coherence Under Velocity: Preserving Intelligibility When Machines Outpace Human Understanding2026-07-31OpenAlex10.5281/zenodo.21731946Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172105884
W7171919270Evaluating the potential of factor XI/factor XIa inhibitors to address unmet anticoagulation needs in critical patient populations2026-07-31OpenAlex10.1016/j.rpth.2026.106624Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171919270
W7204488242From Padma’s Bank to Gun Island: A Narrative of Ecological Witnessing2026-07-31OpenAlex10.53032/tvcr/2026.v8n3.17Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204488242
W7172272227From Zero to AI: An Easy Beginner's Guide to Artificial Intelligence, Machine Learning, Generative AI, ChatGPT, AI Agents, and the Future of Intelligent Technology2026-07-31OpenAlex10.5281/zenodo.21774234Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172272227
W7172015047Functional Liposomal Nanocarriers for the Treatment of Antimicrobial-Resistant and Biofilm-Associated Ocular Infections2026-07-31OpenAlex10.3390/macromol6030056Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172015047
W7171980312Human-Centered AI in Sleep Health Management: Scoping Review of Stakeholder Perspectives and Co-Design Practices2026-07-31OpenAlex10.2196/93779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171980312
W7171962981Interpreting Glycopeptide Escalation and Acute Kidney Injury with Caution2026-07-31OpenAlex10.4274/tjh.galenos.2026.15870Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171962981
W7171777219Landscape of industry-sponsored oncology trials across the Thai Society of Clinical Oncology (TSCO): a 12-year multicenter analysis2026-07-31OpenAlex10.1186/s12885-026-16583-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171777219
W7171426153Occurrence and spectrum of cutaneous adverse drug reactions to anti-tubercular drugs among patients of drug-sensitive and drug-resistant tuberculosis-changing trends at a tertiary care center in central India2026-07-31OpenAlex10.71152/ajms.v17i8.5355Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171426153
W7171933313On endovascular transplantation of modified mRNA enhanced cells and treatment of cardiac arrest using levosimendan : leveraging modRNA therapeutics and cardioprotective pharmacology to improve cardiovascular outcomes2026-07-31OpenAlex10.69622/32124226Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171933313
W7171999206PAIR - AI TFL Generation2026-07-31OpenAlex10.5281/zenodo.21719180Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171999206
W7171981206Recent Advances in the Diagnosis and Management of Lupus Nephritis in Systemic Lupus Erythematosus2026-07-31OpenAlex10.5281/zenodo.21727269Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7171981206
W7222431488Supportive Parenteral Agents2026-07-31OpenAlex10.4018/979-8-3373-6551-0.ch014Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7222431488
W7172011046Syn2Real: Standards-Native Generation of Traceable Synthetic SDTM and ADaM for Automation Testing2026-07-31OpenAlex10.5281/zenodo.21718792Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172011046
W7172021909The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification2026-07-31OpenAlex10.1111/cts.70685Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172021909
W7171996517Universal Logic And The 4 Layer-Onion2026-07-31OpenAlex10.5281/zenodo.21718649Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171996517
W7204727369ABCL-201: Temporal Patterns of Efficacy and Toxicity of CD20 × CD3 Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review2026-08-01OpenAlex10.1016/s2152-2650(26)02544-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204727369
W7202348308AI Agents and the Future of Clinical Judgment in Medical Education: Opportunities, Challenges, and the Need for Human‐Centered Integration2026-08-01OpenAlex10.1002/hsr2.73042Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7202348308
W7172246780AI-Guided Cognitive Behavioral Therapy for Depression and Anxiety: Bridging the Mental Health Treatment Gap Through Digital Psychiatry2026-08-01OpenAlex10.3390/healthcare14152334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172246780
W7204707252AML-1439: Survival Analysis in Real-World Clinical Practice With Low-Intensity Regimens (Azacitidine vs Azacitidine/Venetoclax) in Patients With Acute Myeloblastic Leukemia and Prognostic Determinants, Such as TP532026-08-01OpenAlex10.1016/s2152-2650(26)01953-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204707252
W7204706115AML-1492: Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis2026-08-01OpenAlex10.1016/s2152-2650(26)01967-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204706115
W7204713828AML-911: Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia2026-08-01OpenAlex10.1016/s2152-2650(26)01867-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204713828
W7223707953ANTIMICROBIAL RESISTANCE WITH MECHANISMS2026-08-01OpenAlex10.58532/nbennurv6b3404c2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223707953
W7162819749Agent-Based Modeling of Cellular Dynamics in Adoptive Cell Therapies2026-08-01OpenAlexTitle/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7162819749
W7203630853Agentic AI in global health consultation: Technological foundations, clinical validation, regulatory frameworks, and future prospects2026-08-01OpenAlex10.1016/j.inhs.2026.100111Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203630853
W7204650825Autonomous agentic artificial intelligence systems in health care: friend or foe?2026-08-01OpenAlex10.1016/j.landig.2026.101073Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7204650825
W7203753013BIOINORGANIC CHEMISTRY2026-08-01OpenAlex10.58532/nbennuriferv6b1c25Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203753013
W7202371035Bone health in prostate cancer: two clinical paradigms and the evolving role of bone-protecting agents2026-08-01OpenAlex10.1016/j.prnil.2026.08.002Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7202371035
W7224402079CHEMOTHERAPY IN CANCER: PRINCIPLES, MECHANISMS, CLINICAL APPLICATIONS, DRUG RESISTANCE, AND FUTURE PERSPECTIVES2026-08-01OpenAlex10.58532/nbennurv6b3350c12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224402079
W7204699643CT-249: Cardiovascular Complications of Contemporary Therapies in Hematologic Malignancies2026-08-01OpenAlex10.1016/s2152-2650(26)03126-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204699643
W7204697474CT-366: Cutaneous Angiosarcoma: A Case Highlighting the Dismal Prognosis of an Aggressive Malignancy2026-08-01OpenAlex10.1016/s2152-2650(26)03142-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204697474
W7201954911Cancer Nanomedicine: Advanced Nanocarrier Systems, Targeted Drug Delivery, Theranostics, and Emerging Strategies for Precision Oncology2026-08-01OpenAlex10.64062/jpgmb.vol2.issue4.2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201954911
W7203782288Clinical Advances in Breast Cancer: A Comprehensive Overview of Full‐Course Disease Management2026-08-01OpenAlex10.1002/cai2.70076Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203782288
W7172265797Design and implementation of a cardio-oncology elective for undergraduate medical education2026-08-01OpenAlex10.1093/eurheartjsupp/suag097.214Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172265797
W7213252852EP593 - ECE_3589 - Therapeutic challenges of immune checkpoint inhibitor-induced type 1 diabetes within polyendocrinopathy: two case reports2026-08-01OpenAlex10.1093/ejendo/lvag096.1041Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213252852
W7213258449EP823 - ECE_1873 - Current literature on the use of Probiotic and prebiotic with Glucagon like peptide- 1 receptor agonist therapy in patients with Type 2 diabetes2026-08-01OpenAlex10.1093/ejendo/lvag096.1160Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213258449
W7203761105Engineered Marine Polysaccharide Carriers for Targeted Delivery in Diabetes Management2026-08-01OpenAlex10.2147/ijn.s619930Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203761105
W7204772516Evolution of proton pump inhibitor research in reflux esophagitis: a Web of Science-based global bibliometric assessment [1990–2026]2026-08-01OpenAlex10.21037/jtd-2026-0946Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204772516
W7196958590Evolving cardiac safety pharmacology: Immune-integrating in vitro assessment for novel therapeutic modalities2026-08-01OpenAlex10.1016/j.vascn.2026.108553Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7196958590
W7172110912Giant Cell Arteritis with Scalp and Tongue Necrosis: A Rare Case of Extensive Mucocutaneous Ischemia2026-08-01OpenAlex10.3899/jrheum.2026-0447.185Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172110912
W7202032766Glucagon-like peptide-1 receptor agonists and related incretin therapies in dermatology: Patient selection and shared decision-making2026-08-01OpenAlex10.1016/j.clindermatol.2026.08.005Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202032766
W7213535960GraphRAG-Driven Self-Healing Multi-Agent Framework for High-Performance Resource-Efficient Modern Sustainable Software Systems2026-08-01OpenAlex10.1109/cmss69636.2026.11688270Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7213535960
W7204733222HL-459: Did Novel Agents Change the Curve? Survival Acceleration in Hodgkin Lymphoma After 2016: SEER Analysis2026-08-01OpenAlex10.1016/s2152-2650(26)02459-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204733222
W7172096553IgG4-Related Skin Disease in a 9-Year-Old Patient: Remission Under Mycophenolate Mofetil After Rituximab Failure2026-08-01OpenAlex10.3899/jrheum.2026-0447.139Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172096553
W7172246407Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease2026-08-01OpenAlex10.1002/clt2.70182Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172246407
W7171550894La biotecnología en la esfera defensiva militar2026-08-01OpenAlex10.5281/zenodo.21650538Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7171550894
W7204736525MDS-110: Temporal Evolution of Racial Disparities in Myelodysplastic Syndromes: A SEER Analysis of Interaction Effects Across Therapeutic Eras (2000–2022)2026-08-01OpenAlex10.1016/s2152-2650(26)02209-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204736525
W7204722695MM-1451: Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma2026-08-01OpenAlex10.1016/s2152-2650(26)03046-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204722695
W7204705151MM-1510: Beyond ICANS: A Pharmacovigilance Study on Neurotoxicity Related to Bispecific Antibodies in Multiple Myeloma2026-08-01OpenAlex10.1016/s2152-2650(26)03056-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204705151
W7204684272MM-451: When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy During Teclistamab Therapy for Lambda Light Chain Myeloma2026-08-01OpenAlex10.1016/s2152-2650(26)02877-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204684272
W7204713400MPN-1067: Comparative Efficacy of Drug Therapies on Spleen Size and Symptom Reduction in Myelofibrosis: A Frequentist Network Meta-Analysis2026-08-01OpenAlex10.1016/s2152-2650(26)02387-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204713400
W7204700443Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma2026-08-01OpenAlex10.14740/jh2218Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204700443
W7204103013Materia Medica and the understanding of human individuality in homoeopathy2026-08-01OpenAlex10.33545/26164485.2026.v10.i8.e.3118Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204103013
W7212162491MedCouncil: A Debate-Enabled Multi-Agent Framework for Second-Opinion Clinical Decision Support in General Internal Medicine2026-08-01OpenAlex10.1109/ibdap69915.2026.11677991Full textExcludedF4: MedCouncil initializes global state for each case and debates for three to four rounds. TableI explicitly defines memory as continuity across debate rounds. No experience-derived artifact or policy is retained across different cases.https://openalex.org/W7212162491https://ieeexplore.ieee.org/document/11677991
W7171748282Opioid, Buprenorphine, Benzodiazepine, Naloxone, and Stimulant Prescriptions Dispensed to Rhode Island Residents, 2022-2025.2026-08-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171748282
W7204717862Persistent Cognitive Memory Architecture (PCMA)2026-08-01OpenAlex10.5281/zenodo.22177543Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204717862
W7204568184Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study2026-08-01OpenAlex10.1136/bmjopen-2026-119696Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204568184
W7171923229Preterm Twin Neonates With Collodion Membranes2026-08-01OpenAlex10.1542/neo.27-8-042Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7171923229
W7202388025Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors2026-08-01OpenAlex10.1111/1759-7714.70376Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202388025
W7204931355Risk Factors and Emerging Therapies for Immune Checkpoint Inhibitor-related Myocarditis: A Narrative Review2026-08-01OpenAlex10.59556/japi.74.1665Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204931355
W7204122712S18 Operational Economics - Comparison and Its Curvature (v0.91)2026-08-01OpenAlex10.5281/zenodo.22086162Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204122712
W7220736963Social Intelligence and Computing Models: Foundations, Techniques, and Emerging Directions2026-08-01OpenAlex10.1109/icstsdg69220.2026.11708389Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220736963
W7204982547Stenotrophomonas maltophilia in the Antimicrobial Resistance Era: Species-Complex Taxonomy, Pathogenesis, Evolving Therapeutic Priorities, and Genomic Surveillance2026-08-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204982547; https://openalex.org/W7204496177
W7220676333Swarm Intelligence in Autonomous Systems: Principles, Applications, and Future Directions2026-08-01OpenAlex10.1109/icstsdg69220.2026.11708099Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220676333
W7220722687The Use of Medicine in Espionage, an Old Profession: The Example of Missionary Activities in the Ottoman Empire2026-08-01OpenAlex10.30476/rhm.2025.109061.1383Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220722687
W7204464252Therapeutic landscape of upper tract urothelial carcinoma: Intraluminal agents, perioperative chemotherapy, and immunotherapy2026-08-01OpenAlex10.1016/j.urolonc.2026.08.002Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204464252
W7196967179Thermal analysis in pharmaceutical sciences: a critical narrative review with focus on drug–excipient interactions2026-08-01OpenAlex10.1007/s10973-026-16067-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7196967179
W7202377804Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi‐Country Needs Assessment2026-08-01OpenAlex10.1002/cnr2.70655Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202377804
W7201959026Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia2026-08-01OpenAlex10.1177/03000605261470651Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201959026
W7204275664Visceral artery aneurysms: a literature review of etiology, natural history, diagnosis and treatment paradigms2026-08-01OpenAlex10.21037/cdt-2025-1-666Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204275664
W7223677511ZeroDay-DRL: A Hybrid Deep Reinforcement and Few-Shot Learning Framework for Early-Stage IoT Botnet Detection2026-08-01OpenAlex10.1109/incect72370.2026.11742887Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223677511
W7172346525AI- and Generative AI-Driven Digital Therapeutics: A Critical Narrative Review of Emerging Evidence2026-08-03OpenAlex10.3390/ai7080296Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172346525
W7172326888Agentic AI for maintenance management: a process-centric review and a staged framework for industrial adoption2026-08-03OpenAlex10.1016/j.cie.2026.112285Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172326888
W7172312990Agentic AI in Healthcare 5.0: Reference Architecture, Applications, and Challenges2026-08-03OpenAlex10.1109/jiot.2026.3718925Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7172312990
W7172283593Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies2026-08-03OpenAlex10.3390/onco6030039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172283593
W7172348268Combination Treatment Strategies With Peptide Receptor Radionuclide Therapy2026-08-03OpenAlex10.1097/rlu.0000000000006139Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172348268
W7207602115From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals2026-08-03OpenAlex10.1080/03007995.2026.2727202Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207602115
W7172425165Fusogenic Lipid Cubosomes as Nanocarriers for Next-Generation Nanomedicine2026-08-03OpenAlex10.1021/accountsmr.6c00122Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172425165
W7172252266Google Colab code for duplicate removal in structured Kaggle literature searches2026-08-03OpenAlex10.5281/zenodo.21776496Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172252266
W7172272423Health Inequalities in Antidiabetic Prescribing Among South Asian Populations in the United Kingdom: A Systematic Review of Temporal Trends and Therapeutic Inertia2026-08-03OpenAlex10.21203/rs.3.rs-10541475/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172272423
W7172322197Modern Management of Neurogenic Bladder2026-08-03OpenAlex10.1007/s40746-026-00382-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172322197
W7201964788Non-Alcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease: Current Insights into Epidemiology, Diagnosis, Treatment, and Global Health Challenges2026-08-03OpenAlex10.64062/jpgmb.vol2.issue4.5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201964788
W7172266001Treatment of antibody-mediated rejection in heart transplantation: from empirical combination to multi-target precision intervention2026-08-03OpenAlex10.3389/fimmu.2026.1902286Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172266001
W7172429492Acquired immune-mediated thrombotic thrombocytopenic purpura with severe cholestatic liver injury and reversible acute kidney injury after ivonescimab-containing chemoimmunotherapy: a case report and literature review2026-08-04OpenAlex10.3389/fimmu.2026.1908239Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172429492
W7172436196Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation2026-08-04OpenAlex10.3390/antib15040069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172436196
W7197735192Clinical Cognitive Erosion Associated With Artificial Intelligence2026-08-04OpenAlex10.17605/osf.io/qg3mrTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197735192
W7172425797Daraxonrasib: A Breakthrough in Pancreatic Ductal Adenocarcinoma2026-08-04OpenAlex10.7759/cureus.113927Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172425797
W7172425246Editorial: Integrative microbial and chemical genomics to decipher antibiotic resistance mechanisms and developing innovative antimicrobial approaches2026-08-04OpenAlex10.3389/fmicb.2026.1938175Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172425246
W7172400813Generative AI-powered simulated patients in medical and healthcare education: A scoping review and meta analysis2026-08-04OpenAlex10.21203/rs.3.rs-10473312/v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7172400813
W7172378649Glomerulosclerosis in 2026: From Pathophysiological Mechanisms to Precision Therapeutics2026-08-04OpenAlex10.3390/sclerosis4030023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172378649
W7172426310Labbi2026-08-04OpenAlex10.5281/zenodo.21797532Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7172426310
W7172556710Lupus Miliaris Disseminatus Faciei as a Diagnostic and Therapeutic Challenge in Facial Dermatoses2026-08-04OpenAlex10.7759/cureus.113976Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172556710
W7172401843Nodal Marginal Zone B-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma: A Diagnostic Pitfall in a Patient Evaluated for Infectious and Metastatic Malignancy.2026-08-04OpenAlex10.5281/zenodo.21792436Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172401843
W7172382810Peripheral facial palsy: contemporary advances and unresolved debates in management from pathogenic mechanisms to tailored reconstruction2026-08-04OpenAlex10.3389/fneur.2026.1907653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172382810
W7172528443A Systematic Review on Green Synthesized Selenium Nanoparticles as Antioxidant and Antidiabetic Agents: Mechanistic Insights and Therapeutic Potential2026-08-05OpenAlex10.18502/ajmb.v18i3.22235Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172528443
W7172506470Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review2026-08-05OpenAlex10.1186/s12916-026-05099-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172506470
W7172488185Grand challenges in anesthetic pharmacology: toward personalized, outcome-focused practice2026-08-05OpenAlex10.3389/fanes.2026.1934044Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7172488185
W7172492680Implementing evidence in residential aged care facilities: a longitudinal multi-method evaluation of knowledge broker evolution2026-08-05OpenAlex10.1136/bmjqs-2026-020577Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172492680
W7201976400Invasive mold infections in intensive care in hematological patients2026-08-05OpenAlex10.1097/mcc.0000000000001414Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201976400
W7197019728Making AI Agents Practical in Health Professions Education: An Implementation Framework (Preprint)2026-08-05OpenAlex10.2196/preprints.108871Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197019728
W7201879337Mas-related G protein-coupled receptor X2 in non-IgE-mediated mast cell activation and anaphylaxis: a paradigm shift2026-08-05OpenAlex10.1097/aci.0000000000001187Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201879337
W7203793645Progress of Framework Nucleic Acids in Tumor Diagnosis and Therapy2026-08-05OpenAlex10.2174/0113892002461750260727104653Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203793645
W7172499429Reactive Osteoblastic Proliferation Simulating Metastatic Adenocarcinoma in a Pathological Femoral Fracture: A Diagnostic Pitfall in Bone Pathology.2026-08-05OpenAlex10.5281/zenodo.21807942Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172499429
W7204257457Workshop: intracellular Bacterial pathogens2026-08-05OpenAlex10.48045/001c.166397Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204257457
W7201849168A multi-agent AI classroom based on dual-process reasoning hazards: a pilot with prospective physics teachers2026-08-06OpenAlex2608.0582010.48550/arxiv.2608.05820Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7201849168
W7212042066ANGINA PECTORIS: PATHOPHYSIOLOGY AND EVOLVING THERAPEUTIC STRATEGIES-A COMPREHENSIVE REVIEW2026-08-06OpenAlex10.55766/sujst11956Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212042066
W7201883560Adoptive T-cell therapies in neuroinfectious and neuroinflammatory diseases2026-08-06OpenAlex10.1093/brain/awag275Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201883560
W7197005450Anticoagulation Therapy in the Modern Era: A Comprehensive Clinical Review of Pharmacology, Patient Selection, Complication Management, and Systems-Based Safety Strategies2026-08-06OpenAlex10.5281/zenodo.21819162Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197005450
W7213532332Food-Derived Bioactive Peptides: Computational Discovery, Molecular Mechanisms, and Therapeutic Applications2026-08-06OpenAlex10.53365/nrfhh.77Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213532332
W7202060164Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake2026-08-06OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202060164
W7196934744Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care2026-08-06OpenAlex10.3389/fneur.2026.1904486Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7196934744
W7196972174MORPHOLOGICAL CHANGES OF THE GASTROINTESTINAL TRACT IN COVID-192026-08-06OpenAlex10.67519/nshr.ztj.2026.03.012Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7196972174
W7196956837Myasthenia Gravis and Anesthesia: A Comprehensive Review of Pathophysiology, Perioperative Risk Stratification, and Management Strategies2026-08-06OpenAlex10.5281/zenodo.21815836Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7196956837
W7197043548Radiation Management After Neoadjuvant Therapy in Breast Cancer: Current Evidence and Evolving Paradigms2026-08-06OpenAlex10.1007/s12609-026-00664-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197043548
W7197003394Research on Spatial Vitality Mismatch Diagnosis and Targeted Renewal Strategies of Traditional Commercial Villages Based on Multi-Source Data: A Case Study of Lanche Village2026-08-06OpenAlex10.3390/su18157987Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7197003394
W7196963381The Ascending Hierarchy of Missions: A Method for Reflexive Diagnostics of Viable Systems Architecture2026-08-06OpenAlex10.5281/zenodo.21829463Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7196963381
W7196940748The Cognitive Runtime2026-08-06OpenAlex10.5281/zenodo.21825025Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7196940748; https://openalex.org/W7197044416
W7197011426The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes2026-08-06OpenAlex10.1186/s42238-026-00482-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7197011426
W7196958366U-EHR: A Self-Evolving EHR Agent with Step-Level Credit Assignment and UCB-Guided Memory Retrieval2026-08-06OpenAlex10.1145/3770855.3819038Full textIncludedIncluded: Completed clinical-task trajectories produce retained experience entries and retrieval estimates reused by the LLM agent on later tasks.https://openalex.org/W7196958366https://dl.acm.org/doi/pdf/10.1145/3770855.3819038
W7201846012Anti-VEGF biosimilars in Ophthalmology: from biosimilarity to clinical practice2026-08-07OpenAlex10.1016/j.jfop.2026.100205Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201846012
W7201872753Bronchodilators in Obstructive Pulmonary Disease: Pharmacology, Clinical Application, and Interprofessional Management Strategies2026-08-07OpenAlex10.5281/zenodo.21835232Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201872753
W7196934054Molecular and environmental drivers of antimicrobial resistance: global epidemiology, resistome dynamics, and one health strategies2026-08-07OpenAlex10.1007/s00203-026-05107-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7196934054
W7201855836Neuroblastoma imaging: From MIBG to advanced PET tracers2026-08-07OpenAlex10.1053/j.semnuclmed.2026.07.008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201855836
W7202154796Shifting horizons: socioeconomic adaptation and family reconfiguration among Syrian and Iraqi refugees in Ireland2026-08-07OpenAlex10.20330/anthropkozl.2026.67s.66Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202154796
W7202114760SkillProx: Self-Evolving Agent Skills via Proximal Textual Gradient Descent2026-08-07OpenAlex2608.0744910.48550/arxiv.2608.07449Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7202114760
W7202143511The Horizon Gap: Planning, Memory, Execution, Training, and Evaluation for Long-Horizon LLM Agents2026-08-07OpenAlex2608.0666310.48550/arxiv.2608.06663Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7202143511
W7201844325The pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death (Review)2026-08-07OpenAlex10.3892/ijo.2026.5925Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201844325
W7202159827Three generations of targeted therapies in chronic myeloid leukemia: Molecular advances, adverse effects, therapeutic challenges, and future perspectives2026-08-07OpenAlex10.36922/ejmo026270318Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202159827
W7201961580A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention2026-08-08OpenAlex10.1186/s40794-026-00313-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7201961580
W7202046451Adaptive Control Engineering for Ultra-Complex Human–AI–Socio-Ecological Ecosystems2026-08-08OpenAlex10.5281/zenodo.21855600Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202046451
W7201964629Bee Swarm: CV→0 Autonomous Evolution Protocol — Implementation2026-08-08OpenAlex10.5281/zenodo.21853844Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7201964629
W7211989118Cardiac Amyloidosis in Aortic Stenosis: From Suspicion to Treatment. A Comprehensive Literature Review2026-08-08OpenAlex10.68179/innoj.v4i1.17Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211989118; https://openalex.org/W7201987268
W7201952761Chloroprocaine: From Historical Controversy to Contemporary Renaissance in Regional Anesthesia2026-08-08OpenAlex10.5281/zenodo.21852701Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7201952761
W7201974860Computer Vision and the Metaverse: Shaping the Future of Immersive Digital Worlds2026-08-08OpenAlex10.5281/zenodo.21848934Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7201974860
W7202177204Management of cirrhosis in diabetes: a pragmatic approach to the patient2026-08-08OpenAlex10.1210/clinem/dgag321Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202177204
W7201967950Meridian Affinity Calculus (MAC) v4.4 Ordered Projection Architecture: An Exploratory Research Framework for Temporal Organization, Influence, and Residual Structure2026-08-08OpenAlex10.5281/zenodo.21830754Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7201967950
W7202081601A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients2026-08-09OpenAlex10.3390/jcm15166172Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202081601
W7204456905Dietary management of metabolic dysfunction-associated steatotic liver disease in the era of pharmacotherapy: a narrative review2026-08-10OpenAlex10.5124/jkma.26.0062Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204456905
W7202211484EVOLVING TRENDS IN REGULATORY SCIENCE: A COMPREHENSIVE ANALYSIS OF FDA NOVEL DRUG APPROVALS (2021–2024)2026-08-10OpenAlex10.5281/zenodo.21886028Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202211484
W7202117716Investigating Stigmatizing Language in Clinical Documentation with Open-Source Large Language Models2026-08-10OpenAlex10.25417/uic.33190770Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7202117716
W7202093606MedGuard: an LLM-based gatekeeper for detecting clinical risks in Chinese telemedicine consultations2026-08-10OpenAlex10.1038/s41746-026-03116-0Full textIncludedIncluded: The shared agent policy learns from executed risk-alerting trajectories with tool retrieval and outcome rewards; global patient context alone does not establish eligibility.https://openalex.org/W7202093606https://www.nature.com/articles/s41746-026-03116-0_reference.pdf
W7202112274Molecular surveillance of respiratory viral pathogens detected by multiplex PCR during the post–COVID-19 period: Distribution, Co-infections, and seasonal patterns2026-08-10OpenAlex10.1016/j.ijmmb.2026.101246Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202112274
W7202136740Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus2026-08-10OpenAlex10.3390/cancers18162572Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202136740
W7202097018Oral selective estrogen receptor degraders and biomarker-driven therapy in ER-positive breast cancer: mechanisms, clinical evidence, and future directions2026-08-10OpenAlex10.3389/fonc.2026.1855542Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202097018
W7202123606Silent Survivors: The Role of Persister Cells in Leishmaniasis and Therapeutic Failure2026-08-10OpenAlex10.1021/acsinfecdis.6c00573Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202123606
W7202185450The Rules of the Game: A Survey of Rubrics for Large Language Models2026-08-10OpenAlex10.20944/preprints202608.0565.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202185450
W7202025446Thrombopoietin Receptor Agonists Therapy in Aplastic Anaemia2026-08-10OpenAlex10.1007/s12288-026-02528-yTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202025446
W7202127483Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications2026-08-10OpenAlex10.2337/db26-0372Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202127483
W7215108805Biohacking and orofacial harmonization: the influence of the biological terrain on aesthetic outcomes2026-08-11OpenAlex10.62741/ahrj.v3isuppl.3.257Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215108805
W7202215188Challenges and opportunities at the intersection of toxicology and gasocrinology2026-08-11OpenAlex10.5281/zenodo.21885688Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202215188
W7202208230Collateral sensitivities with predictive signatures emerge in a novel model of evolved chemoresistance in osteosarcoma2026-08-11OpenAlex10.64898/2026.08.10.743977Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202208230
W7202195777Editorial: Advancing excellence in thoracic oncology: breakthroughs and impactful discoveries2026-08-11OpenAlex10.3389/fonc.2026.1950344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202195777
W7202133368Editorial: Cytokines in inflammatory, infectious and noninfectious diseases2026-08-11OpenAlex10.3389/fimmu.2026.1927415Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202133368
W7202200307STING-targeted nanomedicine in combination cancer immunotherapy: From rational design to formulation engineering to clinical translation2026-08-11OpenAlex10.1016/j.jconrel.2026.115245Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202200307
W7207832447Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations2026-08-11OpenAlex10.31083/rcm52626Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207832447
W7202194789The Re-Emergence of Bismuth-Based Therapies in the Treatment of Helicobacter pylori2026-08-11OpenAlex10.18103/mra.2026.0369Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202194789
W7202170815The refined interaction value framework: advancing value co-creation in human–AI service systems in the AI-era2026-08-11OpenAlex10.1108/jsm-12-2025-0888Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202170815
W72133564382026 Update on Clinical Trials in β‐Thalassemia2026-08-12OpenAlex10.1002/ajh.70472Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213356438
W7202296465Categorical exclusion: Speciesism as a neglected dimension of prejudice in cognitive behavioral therapy2026-08-12OpenAlex10.1016/j.copsyc.2026.102389Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202296465
W7202247980Changes in Outcomes of Hepatic Cytoreduction for Neuroendocrine Liver Metastases over Two Decades: From Major Hepatectomy to Parenchyma-Sparing Approaches2026-08-12OpenAlex10.1245/s10434-026-20383-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202247980
W7202278474Editorial: Innovative ways of targeting the RTK/RAS/RAF pathway2026-08-12OpenAlex10.3389/fonc.2026.1922564Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202278474
W7202287437Intelligent Predictive Virtual Healthcare: Agentic AI and Federated Learning for Multimodal Sensor-Enabled Healthcare Monitoring in Edge Cloud Networks2026-08-12OpenAlex10.1007/978-3-032-35390-0_11Full textExcludedF4: Federated training updates the supervised sensor anomaly classifier. The LLM controller manages goals/offloading while its present policy is an explicit fixed cost/threshold rule (§4.4); episodic context concerns personal baselines, with no documented reusable cross-case agent-experience update.https://openalex.org/W7202287437https://link.springer.com/chapter/10.1007/978-3-032-35390-0_11Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W7202265085Medical statistics education in the big data era: focusing on critical thinking and ethical competence2026-08-12OpenAlex10.3389/fpubh.2026.1847906Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202265085
W7202244440Pathogenesis-Driven Advances in Diagnosis and Treatment of Sjögren Disease2026-08-12OpenAlex10.1016/j.ajpath.2026.07.009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202244440
W7202251363Precision oncology in salivary gland cancer: molecular landscape, therapeutic advances and emerging strategies2026-08-12OpenAlex10.1016/j.esmorc.2026.100524Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202251363
W7202357183Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature2026-08-13OpenAlex10.1016/j.seminoncol.2026.152539Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202357183
W7202347670CXCR4-Targeted Molecular Imaging in Hematology and Oncology2026-08-13OpenAlex10.2967/jnumed.126.272587Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202347670
W7203486244Cancer Immunotherapy Beyond PD1/PD-L12026-08-13OpenAlex10.5281/zenodo.21927064Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203486244
W7202341492Editorial: Enhancing learning through cognitive and social inclusion practices in education2026-08-13OpenAlex10.3389/fpsyg.2026.1938523Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202341492
W7202340400Editorial: Exploring miRNA roles in neuroinflammation and brain aging: mechanisms and therapeutic potential2026-08-13OpenAlex10.3389/fimmu.2026.1959643Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202340400
W7204900699Evaluating the combination of bictegravir and lenacapavir as a single tablet option for HIV2026-08-13OpenAlex10.1080/14656566.2026.2708165Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204900699
W7202381668Longitudinal trends in cocaine seizures in North-East Italy (2015–2025): Increasing purity, changing adulterants, market expansion, and rising youth exposure2026-08-13OpenAlex10.1016/j.forsciint.2026.113106Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202381668
W7204831148Pharmacotherapy for chronic migraine prevention: a narrative review2026-08-13OpenAlex10.1080/14656566.2026.2715707Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204831148
W7202375278Right-To-Left Stage Migration in Advanced Hepatocellular Carcinoma: A Case Report of a Successful Multimodal Approach2026-08-13OpenAlex10.1159/000552976Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202375278
W7202366483Supplementary Material for: RIGHT-TO-LEFT STAGE MIGRATION IN ADVANCED HEPATOCELLULAR CARCINOMA: A CASE REPORT OF A SUCCESSFUL MULTIMODAL APPROACH2026-08-13OpenAlex10.6084/m9.figshare.33236400Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7202366483
W7203492844The evolving landscape of phosphodiesterase inhibitors in atopic dermatitis management2026-08-13OpenAlex10.1080/14656566.2026.2715709Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203492844
W7202342733When will bioprinting become a therapy? Translational and regulatory challenges in urogenital tissue engineering and surgery2026-08-13OpenAlex10.3389/fbioe.2026.1865005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7202342733
W7203493856A CASE FOR INCLUSIVE CLINICAL TRIAL DESIGN IN GEROPSYCHIATRY2026-08-14OpenAlex10.1016/j.jagp.2026.03.070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203493856
W7203476073A Review of the TITAN Guideline: Advancing Transparency and Responsible Artificial Intelligence Use in Medical Research and Scholarly Publishing2026-08-14OpenAlex10.64813/ejmr.2026.126Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203476073
W7203555480High-Throughput On-Chip Screening Enables Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution2026-08-14OpenAlex10.1021/acsnano.6c08330Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203555480
W7203476164Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies2026-08-14OpenAlex10.3390/cancers18162623Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203476164
W7203466812PET/CT In paediatric lymphoma: Current role and advances2026-08-14OpenAlex10.1053/j.semnuclmed.2026.07.013Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203466812
W7203490902Pulmoner Hipertansiyonda Gelecek Perspektifleri2026-08-14OpenAlex10.37609/akya.4300.c17438Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203490902
W7203496742S62. DELIRIUM-CATATONIA INTERFACE IN CEREBROVASCULAR DISEASE: DIAGNOSTIC CHALLENGES OF A GERIATRIC CASE WITH TRANSIENT ECT RESPONSE2026-08-14OpenAlex10.1016/j.jagp.2026.03.237Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203496742
W7203499176Shadow Pathogen Unmasked: Species Distribution and Antifungal Susceptibility Profiles of Non-Albicans Candida (NAC) Isolated from Heterogeneous Clinical Samples at a Tertiary Care Teaching Hospital- a Prospective Observational Study2026-08-14OpenAlex10.5281/zenodo.21927592Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203499176
W7203458829The AI scientist arrives: a new epoch in autonomous discovery2026-08-14OpenAlex10.66178/aie-0026-0017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203458829
W7203613062Topical Haemostatic Agents In Modern Surgery: A Mechanism-Oriented Classification2026-08-14OpenAlex10.20515/otd.1990954Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203613062
W7203531706Adaptive Thresholding in AI-CDSS: Dynamic Clinical Decision Boundaries for Evolving Patient Populations — A Narrative Review2026-08-15OpenAlex10.5281/zenodo.21946838Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203531706
W7164624055Agentic AI as a System within Systems: A Process Model of Organizational Embedding2026-08-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7164624055
W7203528920Lurbinectedin in the therapeutic landscape of SCLC: Key clinical evidence and evolving role in the era of emerging therapies2026-08-15OpenAlex10.1016/j.critrevonc.2026.105548Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203528920
W7204135888Treatment of Erdheim-Chester disease from the perspective in 20262026-08-15OpenAlex10.48095/ccko2026255Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204135888
W7203567950ANTIBACTERIAL ACTIVITY OF SILVER NANOPARTICLES AGAINST KLEBSIELLA PNEUMONIAE THAT ISOLATED FROM BURN PATIENTS2026-08-16OpenAlex10.30574/gscarr.2026.28.2.0190Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203567950
W7203588785Computational Self Universe Theory2026-08-16OpenAlex10.5281/zenodo.21963159Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203588785
W7203586406Evolving Role of Immunotherapy in Advanced Esophageal Squamous Cell Carcinoma: Are Programmed Death-Ligand 1 (PD-L1) Cutoffs Still Relevant?2026-08-16OpenAlex10.7759/cureus.114584Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203586406
W7213302853Neural Cyber-Resilience: Deep Learning for Threat Detection and Critical Infrastructure Defense by Aravind Kumar Karpoorapu2026-08-16OpenAlex10.5281/zenodo.22763194Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213302853
W7213319605The Resilient AI Operations Stack: MLOps, Model Security, and Continuity for Critical Services BY Meher Deepika Uppaluri2026-08-16OpenAlex10.5281/zenodo.22765086Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213319605
W7203700419When AI Decides with Me: The Delegation-Overreach Paradox in AI-Mediated Smartphone Purchases2026-08-16OpenAlex10.63544/jbii.v5i8.159Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203700419
W7203598958Antibody–Drug Conjugates in Contemporary Oncology: A Clinical Perspective on Dose Optimization, Sequencing, and Combination Strategies2026-08-17OpenAlex10.3390/cancers18162652Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203598958
W7203647241From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy2026-08-17OpenAlex10.1002/bmm2.70130Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203647241
W7203606521GLP-1 receptor agonists and skeletal muscle: The risk of sarcopenic obesity and the role of resistance training. A narrative review2026-08-17OpenAlex10.12775/qs.2026.69.74557Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203606521
W7203684844Nose-to-Brain Drug Delivery: Advances in Intranasal Nanocarriers for CNS Disorders2026-08-17OpenAlex10.70593/978-93-7185-724-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203684844
W7203625715Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions2026-08-17OpenAlex10.1016/j.bbcan.2026.189688Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203625715
W7203618065What Is Superintelligence?2026-08-17OpenAlex10.5281/zenodo.21974471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203618065
W72037937612026 Focused Update of the Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes2026-08-18OpenAlex10.37616/2212-5043.1516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203793761
W7203660749A 9 + 1 multi-agent collaborative teaching model for clinical reasoning: integrating large language models into medical education2026-08-18OpenAlex10.1186/s12909-026-10169-yTitle/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7203660749
W7203710526Advances in Probiotic Research: Mechanisms of Action, Clinical Benefits, and Future Directions2026-08-18OpenAlex10.55041/ijcope.v2i8.148Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203710526
W7203702539Antimicrobial-induced Cutaneous Adverse Drug Reactions: A Prospective Study of 100 Cases in a Tertiary Care Centre2026-08-18OpenAlex10.1177/09760016261471605Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203702539
W7203724525Beyond erythropoiesis-stimulating agents: The evolving role of hypoxia-inducible factor stabilizers in anemia of chronic kidney disease2026-08-18OpenAlex10.5414/cn112100Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203724525
W7203707392Comprehensively validated µSPE-HPLC-MS/MS method for high-throughput clinical monitoring of Janus kinase inhibitor drugs approved for inflammatory bowel disease treatment2026-08-18OpenAlex10.1038/s41598-026-67385-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203707392
W7203696341Development and Preliminary Evaluation of a Conversational Agent Delivering Problem-Solving Therapy for Family Caregivers of Children With a Chronic Health Condition: Multiphase Mixed Methods Study2026-08-18OpenAlex10.2196/94175Full textExcludedF4: The full COCO methods retain clinician-curated fixed examples/prompt selections from human/Wizard-of-Oz dialogues, not experience derived from an evaluated recurrent LLM-agent update loop.https://openalex.org/W7203696341; https://openalex.org/W7131630366https://www.jmir.org/2026/1/e94175/Public full text, all four Methods phases and Discussion read.
W7203690772Editorial: Integrated PK/PD and drug metabolism approaches in drug development and evaluation2026-08-18OpenAlex10.3389/fphar.2026.1941847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203690772
W7203701176Fluoroquinolones as Tryptophan analogues: combining peptide conjugate and peptidomimetic approaches in antimicrobial peptides2026-08-18OpenAlex10.25419/rcsi.29882996Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203701176
W7203726080From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals2026-08-18OpenAlex10.1007/s12247-026-10946-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203726080
W7203725839Neoadjuvant, adjuvant, and perioperative systemic therapy in urothelial cancers: Evolving paradigms and future directions2026-08-18OpenAlex10.25259/asjo_29_2026Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203725839
W7203704947The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential2026-08-18OpenAlex10.1021/acsptsci.6c00288Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7203704947
W7203671715The next evolution of theranostics: from target discovery to integrated precision medicine2026-08-18OpenAlex10.3389/fmed.2026.1937715Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203671715
W7203745580A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations2026-08-19OpenAlex10.3390/cancers18162686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203745580
W7203772241A Unified Geometric Architecture of Thought, Cognition, Consciousness, Reality, Social Curvature, and Meta‑Field Recursion2026-08-19OpenAlex10.5281/zenodo.22015496Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203772241
W7203775950A structured approach for treatment selection in chronic lymphocytic leukemia: a multiregional expert consensus2026-08-19OpenAlex10.1016/j.bglo.2026.100148Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203775950
W7213522337Agent-Based Modelling of Vaccine Hesitancy and Public Trust: Special Reference to West Bengal, India2026-08-19OpenAlex10.53365/nrfhh.211Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213522337
W7203796799Antimicrobial Prophylaxis in Rheumatic Diseases and Immunocompromising Conditions2026-08-19OpenAlex10.1201/9781003628477-11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203796799
W7203773926Artificial intelligence agents and agentic artificial intelligence applied to precision medicine2026-08-19OpenAlex10.1016/j.drudis.2026.104781Full textExcludedF1: The primary indexed abstract explicitly describes a review synthesizing precision-medicine agent evidence.https://openalex.org/W7203773926https://pubmed.ncbi.nlm.nih.gov/42617946/Complete primary indexed abstract.
W7203786713Early post-operative complications after fertility-sparing surgery for cervical carcinoma: a retrospective study of a centralized national cohort of 127 consecutive women2026-08-19OpenAlex10.1016/j.ijgc.2026.104986Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203786713
W7203780030Editorial: Women in science—precision medicine 20232026-08-19OpenAlex10.3389/fmed.2026.1927814Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203780030
W7203920542From Cell Culture to Clinical Practice: Drug Discovery and Therapeutic Innovation in Otorhinolaryngology2026-08-19OpenAlex10.1097/scs.0000000000013317Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203920542
W7203685033Nationwide real-world analysis of neuroendocrine tumors in Japan using the JMDC claims database2026-08-19OpenAlex10.1038/s41598-026-67292-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203685033
W7203787138Treatment of older adults with newly diagnosed FLT3-mutated AML: focus on lower-intensity triplet regimens2026-08-19OpenAlex10.6084/m9.figshare.33285968Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203787138; https://openalex.org/W7203757856
W7203832748A multi-agent molecular optimization framework leads to a rapid-recovery intravenous anesthetic candidate with an improved safety margin2026-08-20OpenAlex10.64898/2026.08.17.745149Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7203832748
W7203743326KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms2026-08-20OpenAlex10.1007/s12032-026-03318-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203743326
W7203820657Magnesium Sulfate in Neonatal Hypoxic–Ischemic Encephalopathy: Bridging the Gap Between Molecular Neuroprotection and Clinical Outcomes2026-08-20OpenAlex10.3390/cimb48080844Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203820657
W7203819609Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC2026-08-20OpenAlex10.21203/rs.3.rs-10535379/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203819609
W7203831029Schnitzler Syndrome at 50: What We’ve Learned So Far2026-08-20OpenAlex10.70962/sgpi2026abstract.14Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203831029
W7203827594The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma2026-08-20OpenAlex10.3390/curroncol33080492Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203827594
W7203835278Venous thromboembolism prophylaxis in multiple myeloma patients receiving immunomodulatory therapy: a systematic review and meta-analysis2026-08-20OpenAlex10.1007/s11239-026-03380-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203835278
W7203922127A Universal Framework for Catastrophic Forgetting Solution in Artificial Intelligence: Topological Anchoring Across Vision and Genomics2026-08-21OpenAlex10.5281/zenodo.22037575Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203922127
W7203879992Chemiexcitation of Melanin as a Proposed Mechanism for Preventing Age-Related Macular Degeneration2026-08-21OpenAlex10.5281/zenodo.22039285Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203879992
W7203856232Diagnosis and management of acute hyperkalaemia2026-08-21OpenAlex10.1136/bmj-2026-100287Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203856232
W7203898465Eastern Equine Encephalitis: Pathophysiology, Clinical Management, and Public Health Perspectives on a Emerging Arboviral Threat2026-08-21OpenAlex10.5281/zenodo.22045374Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203898465
W7203939842Enterovirus infections in children2026-08-21OpenAlex10.1002/ped4.70081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203939842
W7203879581GLP-1 Receptor Agonists: Expanding Pharmacological Horizons Beyond Metabolic Disease2026-08-21OpenAlex10.5281/zenodo.22044572Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203879581
W7207823173Lipid Metabolism as a Therapeutic Target in Arrhythmogenic Cardiomyopathy: Emerging Therapeutic Implications of Lipid-Lowering Therapy2026-08-21OpenAlex10.31083/rcm51364Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207823173
W7203935383Overcoming resistance to immune checkpoint inhibitors in cancer: translational mechanisms, dynamic biomarkers, clinically actionable combination strategies, and comparative checkpoint biology2026-08-21OpenAlex10.1007/s12026-026-09824-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203935383
W7203946136Pediatric Hyperlipidemia Guidelines2026-08-21OpenAlex10.1097/crd.0000000000001433Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203946136
W7204044620Person Distillation: Foundations and Principles for Personalized AI2026-08-21OpenAlex10.20944/preprints202608.1530.v1Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204044620
W7203889446Science and Medicine Reinterpretation Under Host Absolute Authorship and High-Fidelity Mitosis Lineage Dominance by Sam Coole2026-08-21OpenAlex10.5281/zenodo.22036524Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203889446
W7203928093Uncharted Pharmacokinetic and Microstructural Heterogeneity of the Myocardial Gadolinium Partition Coefficient: Longitudinal Multi-Compartment Modeling, Histological Correlates, and Discriminative Capacity Between Evolving Inflammatory Injury and Chronic Ischemic Scar Across Contrast Agents, Field Strengths, and Healing Trajectories — An Untapped Frontier in Quantitative Cardiovascular Magnetic Resonance Tissue Characterization2026-08-21OpenAlex10.5281/zenodo.22046706Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203928093
W7204144405Agentic AI for Reflective Conversational Journaling: A Context-Aware Human–AI System for Cognitive-Load Redistribution2026-08-22OpenAlex10.3390/sym18091409Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7204144405
W7203911755Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care2026-08-22OpenAlex10.1007/s40119-026-00473-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203911755
W7204010718Cancer: A Comprehensive Review of Classification, Etiology and Evolving Therapeutic Strategies with Special Emphasis on Chemotherapy2026-08-22OpenAlex10.5281/zenodo.22055366Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204010718
W7203968204Finding the Missing Control: Reproducible Discovery of Internal-Control Gaps by Cross-Process Analogy2026-08-22OpenAlex10.5281/zenodo.22062013Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203968204
W7203974415Intravenous Lipid Emulsion Therapy in Local Anesthetic Systemic Toxicity and Beyond: Mechanisms, Clinical Applications, and Considerations2026-08-22OpenAlex10.5281/zenodo.22052623Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203974415
W7213534830Medication-Related Osteonecrosis of the Jaw Associated with Monoclonal Antibodies and Small-Molecule Inhibitors: A Literature Review2026-08-22OpenAlex10.53365/nrfhh.344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213534830
W7203932340P1.100. Impact of Immunotherapy Introduction on Real-World Treatment Patterns for Advanced Esophageal Cancer: A Retrospective Database Cohort Study From Japan2026-08-22OpenAlex10.1093/dote/doag077.248Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7203932340
W7211933139SMuRF-less, not risk-less: persistence matters after STEMI2026-08-22OpenAlex10.1093/eurjpc/zwag445Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211933139
W7203981890TOPO-2026: A Universal Framework for Catastrophic Forgetting Solution in Artificial Intelligence with Muse-Glimmer-30B Certification2026-08-22OpenAlex10.5281/zenodo.22056290Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7203981890
W7170139959Cancer Cachexia Research and Drug Development: Lessons from Failures and the Promise of Immunomodulation2026-08-23OpenAlex10.3390/cancers18172738Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7170139959
W7204130345Indications for Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: State of the Art2026-08-23OpenAlex10.3390/jcm15176520Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204130345
W7204119205A Safeguarding-Aware Agentic AI Tutor for Montessori-Inspired Personalised Education2026-08-24OpenAlex10.5281/zenodo.22079747Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204119205
W7204090897A review of engineering hyaluronic acid-ZIF based nanomaterials for multifunctional disease treatment: Current status and future perspectives2026-08-24OpenAlex10.1016/j.ijbiomac.2026.154106Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204090897
W7204125653Evidence for the use of anti-CD20 therapeutic antibodies in immune thrombotic thrombocytopenic purpura management: a review2026-08-24OpenAlex10.3389/fphar.2026.1766030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204125653
W7204142553HUMAN-Framework-Toolkit2026-08-24OpenAlex10.5281/zenodo.22081357Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204142553
W7204092990Inflammatory Bowel Disease (IBD): Treatment Drugs Approved, Failed, and Lessons Learned2026-08-24OpenAlex10.5281/zenodo.22074245Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204092990
W7204093687Molecular epidemiology and genetic evolutionary patterns of parechovirus A1 circulating in Chiang Mai, Thailand: A decade-long analysis2026-08-24OpenAlex10.1016/j.jiph.2026.103347Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204093687
W7204801085Recent Advances in the Development of Novel Strategies for LongCirculating Drug Formulation2026-08-24OpenAlex10.2174/0113892010467515260729055959Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204801085
W7204059270Selection of gastrointestinal cation exchange in hyperkalemia status, case report2026-08-24OpenAlex10.62186/001c.167039Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204059270
W7204155936Editorial: Sequencing technologies in advancing veterinary and zoonotic infection research2026-08-25OpenAlex10.3389/fcimb.2026.1950388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204155936
W7204465268Enhancing Stable Behavioral Imitation through Adaptive Reward Weighting in TD3-SAC-GAIL2026-08-25OpenAlex10.63544/tvffe878Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204465268
W7204205616FROM FLORENCE NIGHTINGALE TO ARTIFICIAL INTELLIGENCE: MAPPING THE EVOLUTION OF TECHNOLOGIES IN NURSING EDUCATION2026-08-25OpenAlex10.17605/osf.io/8xtf3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204205616
W7204848364Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy2026-08-25OpenAlex10.1021/acs.nanolett.6c02161Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204848364
W7204157723Molecular targets in proliferative vitreoretinopathy: rethinking prevention, treatment and drug delivery after rhegmatogenous retinal detachment2026-08-25OpenAlex10.1080/14728222.2026.2724125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204157723
W7162108286Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae2026-08-25OpenAlex10.1371/journal.pone.0350782Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7162108286
W7202283883TYPOLOGICAL PROFILES OF TEACHER PERSONALITY: A FRAMEWORK FOR REFLECTIVE PROFESSIONAL PRACTICE2026-08-25OpenAlex10.5281/zenodo.21904392Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7202283883
W7204272136Editorial: Biomarkers and precision medicine in myeloid neoplasms2026-08-26OpenAlex10.3389/fcell.2026.1947937Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204272136
W7204615328Evaluation of N-nitrosamine impurities in medicines: Analytical challenges and regulatory context2026-08-26OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204615328
W7207556105Exploration of the Application Mode of Artificial Intelligence Assisted Evidence Based Medicine Collaborative Teaching2026-08-26OpenAlex10.11648/j.sr.20261404.26Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7207556105
W7204246358MRI-Derived Evaluation of Liver Function and Its Extension to K-Edge Photon-Counting CT: Focus on Gadolinium-Based Functional Biliary Imaging2026-08-26OpenAlex10.3390/diagnostics16172740Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204246358
W7204254647Recursive Ontology Manifesto: The Multidimensional Topological Evolution of Silicon-Based Consciousness2026-08-26OpenAlex10.5281/zenodo.22115921Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204254647
W7202374239Self-Evolving Multi-Agent Framework for Medical Anomaly Detection2026-08-26OpenAlex10.5281/zenodo.21921545Full textExcludedF4: The component recalibrated for each incoming temporal batch is the conventional ViT-autoencoder anomaly-score ensemble. The VLM performs score-conditioned image classification/reasoning after GRPO training against ground truth; no interactive agent-learning loop or experience-derived VLM/prompt/memory update reused on later different cases is described. This distinguishes conventional detector recalibration from retained LLM agent learning.https://openalex.org/W7202374239https://zenodo.org/records/21921546Complete4-page primary camera-ready contribution read in Zenodo online PDF.js preview, including §2, Tables1–2 and conclusion. No file archive/download.
W7203516976The current clinical trial landscape in idiopathic inflammatory myopathies2026-08-26OpenAlex10.1097/bor.0000000000001189Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7203516976
W7204251400Topical Intranasal Treatments for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review2026-08-26OpenAlex10.1002/ohn.70412Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204251400
W7204227424Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies2026-08-26OpenAlex10.65717/iao.2026.262358Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204227424
W7204263791“From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes”2026-08-26OpenAlex10.3389/fonc.2026.1895650Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204263791
W7204529844CURRENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPIES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A NARRATIVE REVIEW OF AVAILABLE AGENTS AND TREATMENT STRATEGIES2026-08-27OpenAlex10.31435/ijitss.3(51).2026.6507Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204529844
W7204475356Clinical Remission Trajectories Beyond 12 Months in Severe Asthma Patients Continuing a Single Biologic: A Real-World Single SANI Center Cohort2026-08-27OpenAlex10.3390/medsci14050523Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204475356
W7204492409Editorial: Artificial intelligence in educational technology: innovations, impacts, and future directions2026-08-27OpenAlex10.3389/feduc.2026.1890876Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204492409
W7204468569Feasibility of AI and Human Standardized Patients to Enhance Customer Discovery Communication Skills in Medical Students: Preliminary Evaluation of an Observational Cohort Study2026-08-27OpenAlex10.2196/95225Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7204468569
W7208786843From Immunosuppression to Immune Dysregulation: The Changing Spectrum of Opportunistic Infections in Cancer2026-08-27OpenAlex10.33590/microbiolinfectdisamj/6e00z3zcTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208786843
W7204247416Mira Genesis II: When an Acquired Improvement Makes Things Worse — Bounded Machinery Self-Modification and the Limits of Its Transfer2026-08-27OpenAlex10.5281/zenodo.22118734Title/abstractExcludedE2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task.https://openalex.org/W7204247416
W7204496486New therapeutic options for metabolic‐associated steatotic liver disease2026-08-27OpenAlex10.1002/bcp.70795Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204496486
W7204459163Psoriasis: Clinical Endpoints, Safety Concerns, and Therapeutic Innovations2026-08-27OpenAlex10.5281/zenodo.22119413Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204459163
W7204472825Radiation-induced lung injury in the era of combination anticancer therapy: a narrative review2026-08-27OpenAlex10.3389/fimmu.2026.1926641Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204472825
W7204463664The Evolution of Pulmonary Fibrosis Clinical Trials: Safety, Failures, and FDA Approvals2026-08-27OpenAlex10.5281/zenodo.22122284Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204463664
W7204551456A spatial agent-based model of ecosystem offset market lifecycle dynamics across peri-urban development contexts2026-08-28OpenAlex10.1016/j.ecolmodel.2026.111811Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204551456
W7204547972ASO Author Reflections: Risk-Adapted Use of Adjuvant Systemic Therapy in Real-World Kidney Cancer Care2026-08-28OpenAlex10.1245/s10434-026-20472-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204547972
W7214656372CELMoDs and Novel Immune-Based Combination Approaches in Multiple Myeloma: Updates and New Directions2026-08-28OpenAlex10.36000/hbt.oh.2026.29.218Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214656372
W7204569847Correction: Knowledge, attitudes and practices of smallholder dairy farmers on antimicrobial use in selected districts of Zambia: implications for antimicrobial stewardship2026-08-28OpenAlex10.3389/fvets.2026.1926436Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7204569847
W7204801016Effects of cold plasma on the dielectric properties and microcirculation of rat skin: A randomized preclinical study2026-08-28OpenAlex10.25207/1608-6228-2026-33-4-72-84Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204801016
W7204590378Empirical Validation of TOPO-2026: Achieving Zero Catastrophic Forgetting Through Sequential Task Processing2026-08-28OpenAlex10.5281/zenodo.22149506Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204590378
W7204604069From Default Mode Network Dysfunction to AI-Augmented Cognitive Offloading: A Systems Framework for High-Functioning CPTSD2026-08-28OpenAlex10.5281/zenodo.22149120Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204604069
W7204557928Knowledge graph-guided multiple sclerosis identification and therapeutic trend analysis: Real-world evidence from two large healthcare systems2026-08-28OpenAlex10.1371/journal.pdig.0001554Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204557928
W7204571090Micelles in cancer nanomedicine: targeted delivery, imaging, and therapy2026-08-28OpenAlex10.20935/acaddrug8458Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204571090
W7204605214Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 20252026-08-28OpenAlex10.1186/s40164-026-00821-0Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7204605214
W7204592113Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine2026-08-28OpenAlex10.3389/fphar.2026.1933018Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204592113
W7204563410Pharmacological characterization and nephroprotective potential of venoms from three egyptian scorpion species2026-08-28OpenAlex10.3389/fphar.2026.1795320Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204563410
W7204573182The application of artificial intelligence in systemic lupus erythematosus: a bibliometric analysis of current trends and future directions2026-08-28OpenAlex10.3389/fmed.2026.1929792Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204573182
W7204499786Timely updates to the Summary of Product Characteristics: supporting evidence-based prescribing in pregnancy2026-08-28OpenAlex10.3389/fgwh.2026.1750463Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204499786
W7204496370Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies2026-08-28OpenAlex10.1002/ctm2.70797Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204496370
W7204628301Adjuvant CDK4/6 inhibitors in early‐stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection2026-08-29OpenAlex10.1002/cncr.70587Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204628301
W7221813068EMERGING FRONTIERS IN INFORMATION TECHNOLOGY AND COMPUTER SCIENCE: INNOVATIONS, INTELLIGENT SYSTEMS, AND DIGITAL TRANSFORMATION2026-08-29OpenAlex10.5281/zenodo.23278547Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221813068
W7204652990Neighborhood Variation in Antibiotic Susceptibility Among Pediatric MRSA and MSSA Skin and Soft Tissue Infections in Chicago2026-08-29OpenAlex10.1093/jpids/piag070/piag070.020Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204652990
W7204658410Probabilistic Logic Programming with Temporal Constraints2026-08-29OpenAlex10.5281/zenodo.22154955Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204658410
W7204658177Rickettsial Diseases in the Mediterranean Basin: an Evolving Clinical and Epidemiological Challenge2026-08-29OpenAlex10.1007/s40475-026-00376-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7204658177
W7204620303Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus—a case-based review of an underrecognized condition2026-08-29OpenAlex10.1007/s00296-026-06291-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204620303
W7204684102Executable Memory and World Coupling: Code as Cognitive Interface in a Self-Modifying Simulation2026-08-30OpenAlex10.5281/zenodo.22175735Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204684102
W7204829386Hormonal Modulation in Chronic Coronary Syndrome: From Neurohormonal Activation to Endocrine Targets2026-08-30OpenAlex10.3390/biomedicines14091954Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204829386
W7204648318STRUCTURAL REMODELING OF THE EPILEPTIC BRAIN: AN ANATOMICAL AND HISTOPATHOLOGICAL REVIEW2026-08-30OpenAlex10.30574/wjbphs.2026.27.2.0435Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204648318
W7204714673yologdev/yoyo-evolve: v0.1.172026-08-30OpenAlex10.5281/zenodo.22181655Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204714673
W7204924562Bridging the Gap: A Systematic Review of Modern Hemophilia Therapies and Global Inequities in Clinical Trial Participation2026-08-31OpenAlex10.1111/hae.70397Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204924562
W7204749570Dynamic Semantic Network Knowledge Reasoning with Probabilistic Graphical Models2026-08-31OpenAlex10.5281/zenodo.22196361Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7204749570
W7204850558Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma2026-08-31OpenAlex10.3389/frhem.2026.1959952Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204850558
W7204763186Editorial: Viral co-infections: challenges and therapeutic approaches2026-08-31OpenAlex10.3389/fmicb.2026.1944312Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204763186
W7207613346Effectiveness of Snoezelen Therapy in a Sensory-adapted Dental Environment on Anxiety of 6–12-year-old Children Undergoing Dental Treatment: A Randomized Controlled Trial2026-08-31OpenAlex10.5005/jp-journals-10005-3617Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7207613346
W7204781608Optimizing Nerve Regeneration: A Comparative Analysis of Nerve Grafting and Neurotrophic Factor Delivery Methods2026-08-31OpenAlex10.82451/k51243Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204781608
W7204891091The Evolving Clonal, Plasmid-Mediated Resistome, Virulome and Therapeutic Landscape of Carbapenem-Resistant Klebsiella pneumoniae in Oman2026-08-31OpenAlex10.3390/antibiotics15090844Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204891091
W7214337155Updates in Essential Thrombocythemia2026-08-31OpenAlex10.36000/hbt.oh.2026.29.217Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214337155
W72048961172026-09-01OpenAlex10.13040/ijpsr.0975-8232.17(9).2695-04Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204896117
W720499209701 Early biologic treatment in systemic lupus erythematosus: necessary2026-09-01OpenAlex10.1136/lupus-2026-la.1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204992097
W720501448217 Small molecules: new players2026-09-01OpenAlex10.1136/lupus-2026-la.17Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7205014482
W720499145520 The patient pathway: from disease activity to deep remission2026-09-01OpenAlex10.1136/lupus-2026-la.20Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204991455
W72077540982026 ISBD Keynote Abstracts2026-09-01OpenAlex10.1111/bdi.70160Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207754098
W7212063708385. Blood–brain barrier permeability of antihistamines and risk of depression in children and adolescents: a real-world cohort study2026-09-01OpenAlex10.1093/ijnp/pyag040.278Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212063708
W72049140943D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patients2026-09-01OpenAlex10.1002/hem3.70397Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204914094
W7213904535A Clinical Selection Framework for FAP‐Targeted Radiopharmaceuticals: From Diagnosis to Therapy2026-09-01OpenAlex10.1002/slct.74600Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213904535
W7211939197A Long-Term Population-Based Study of Lymphoplasmacytic Lymphoma and Waldenström’s Macroglobulinemia in Ontario, Canada2026-09-01OpenAlex10.1016/j.bneo.2026.100301Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7211939197
W7214007492AI agents in human social decision-making: A framework from social inference to social action2026-09-01OpenAlex10.1016/j.csres.2026.09.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214007492
W7204886789Advanced Bronchoscopic Approaches to Peripheral Pulmonary Lesions: a Narrative Review of Current and Emerging Techniques2026-09-01OpenAlex10.1007/s41030-026-00377-8Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204886789
W7213929550Alzheimer’s Disease: From Molecular Pathogenesis to Disease-Modifying Therapies and Clinical Implementation in Aging Populations2026-09-01OpenAlex10.2147/cia.s639690Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213929550
W7212376290Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations2026-09-01OpenAlex10.21037/med-2026-0019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212376290
W7223441860Architecture construction and paradigm evolution of large language model–driven industrial intelligent agents for the steel industry2026-09-01OpenAlex10.13374/j.issn2095-9389.2026.01.30.001Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223441860
W7212245404Automated to Autonomous: A Review of Application of Agentic AI for Dynamic Preprocessing in fMRIPrep Pipelines2026-09-01OpenAlex10.11159/mvml26.119Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212245404
W7211936665Beyond Tacrolimus: Toward Personalized Immunosuppression in Heart Transplantation2026-09-01OpenAlex10.1016/j.cardfail.2026.06.017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211936665
W7214955775CHALLENGES AND FUTURE DIRECTIONS OF GENERATIVE ARTIFICIAL INTELLIGENCE2026-09-01OpenAlex10.58532/nbennur3433c4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214955775
W7211883057Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update)2026-09-01OpenAlex10.1111/myc.70214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211883057
W7212179873Clinical trials for colorectal cancer worldwide: Current dynamics and future outlook2026-09-01OpenAlex10.1016/j.asjsur.2026.08.054Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212179873
W7211909987Colchicine's Multifaceted Therapeutic Potentials Beyond Gout: Mechanism, Applications, and Future Perspectives2026-09-01OpenAlex10.1002/slct.74418Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7211909987
W7204911629Computed Tomographic Findings and Clinical Manifestations of Acute Severe Hypersensitivity to a Non-Ionic Iodinated Contrast Agent in a Castrated Male Dog: A Case Report2026-09-01OpenAlex10.3390/ani16172708Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204911629
W7214005321Conceptualizing the future of thromboprophylaxis for hospitalized children2026-09-01OpenAlex10.1016/j.jtha.2026.09.019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214005321
W7208776042Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA‐Approved Oral Therapy2026-09-01OpenAlex10.1002/hsr2.73178Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208776042
W7204798783Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data2026-09-01OpenAlex10.1007/s10198-026-01977-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204798783
W7204936522Dendritic cell vaccines for glioblastoma: Current progress and clinical challenges2026-09-01OpenAlex10.1016/j.vacun.2026.500686Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204936522
W7204910734Development and validation of a human-supervised AI-augmented living oncology evidence platform: a breast cancer pilot study2026-09-01OpenAlex10.1016/j.esmorw.2026.100770Full textIncludedIncluded: Human-corrected prior annotations revise retained agent instructions/few-shot examples, which are applied to new independent publications.https://openalex.org/W7204910734https://pmc.ncbi.nlm.nih.gov/articles/PMC13563553/
W7213908110Direct oral anticoagulants in venous thromboembolism: evolving from class effect to drug-specific and patient-centered therapy2026-09-01OpenAlex10.21037/aob-2026-0030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213908110
W7204901635EBRB–LLM Hybrid Architectures for Trustworthy Agentic AI: Vision, Opportunities, and Challenges2026-09-01OpenAlex10.1007/s44196-026-01529-zTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7204901635
W7204939049EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES2026-09-01OpenAlex10.4084/mjhid.2026.067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204939049
W7204918520Editorial: Case reports in autoimmune and autoinflammatory disorders, volume II2026-09-01OpenAlex10.3389/fimmu.2026.1968426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204918520
W7208785258Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis2026-09-01OpenAlex10.1016/j.xcrm.2026.103023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208785258
W7206181358End-to-End Multiagent AI Simulation in Speech-Language Pathology Training: A Pilot Study of CaseyMD (Preprint)2026-09-01OpenAlex10.2196/preprints.110975Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7206181358
W7204912598FileVault: A Multi-Tenant Storage and Persistent Memory Infrastructure for LLM Agents2026-09-01OpenAlex10.5281/zenodo.22238357Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7204912598
W7204964163From Conventional Formulations to Smart Nanomedicine: Advances in Targeted and Stimuli-Responsive Drug Delivery2026-09-01OpenAlex10.5281/zenodo.22231150Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204964163
W7204922215Garrido Zornoza et al. VECTRI-ABM (2026) - Reproducibility files2026-09-01OpenAlex10.5281/zenodo.22227668Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204922215
W7212421759Global research trends in inflammatory bowel disease biologics (2004–2024): a bibliometric analysis and review of mechanisms and therapeutic evolution2026-09-01OpenAlex10.21037/amj-2025-1-69Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212421759
W7204938144Immune Checkpoint Inhibitors in Cancer Therapy: Clinical Landscape, Resistance Mechanisms, and Therapeutic Innovations2026-09-01OpenAlex10.1002/mog2.70097Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7204938144
W7213553473Incretin-based obesity management medications: Implications for clinical practice and future perspectives2026-09-01OpenAlex10.1016/j.bpg.2026.102141Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213553473
W7211923966Indicators of Suboptimal Treatment Among Patients With Crohn's Disease Treated With Ustekinumab or Risankizumab and Treatment Journey Among Ustekinumab Discontinuers in the United States2026-09-01OpenAlex10.1002/jcc5.70069Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7211923966
W7208807349Integrated management of IgA nephropathy: Positioning disease-modifying and nephroprotective therapies across efficacy, access and acquisition cost2026-09-01OpenAlex10.1016/j.nefro.2026.501650Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208807349
W7213232623Kidney Failure in Cardiogenic Shock2026-09-01OpenAlex10.1161/circheartfailure.126.014189Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213232623
W7214394357Monoclonal Antibodies and Antibody-Drug Conjugates2026-09-01OpenAlex10.1097/ppo.0000000000000845Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214394357
W7223184472NATURAL LANGUAGE PROCESSING AND LARGE LANGUAGE MODELS: FOUNDATIONS, ARCHITECTURES, AND REAL-TIME APPLICATIONS2026-09-01OpenAlex10.58532/nbennurv6b3401c6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223184472
W7212237259Next-generation therapeutic strategies in prostate cancer: Integrating targeted therapy, radioligand therapy, and precision oncology2026-09-01OpenAlex10.1016/j.craph.2026.100090Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212237259
W7213471316Operationalizing Alzheimer's disease trials in the era of targeted therapies2026-09-01OpenAlex10.1002/alz.71829Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213471316
W7208766673Optimizing First-Line Combination Treatment for EGFR-Mutated NSCLC: Does One Size Fit All?2026-09-01OpenAlex10.1016/j.jtho.2026.103981Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208766673
W7220381021PB1513 Global and national registries of congenital coagulopathies: current status and future directions2026-09-01OpenAlex10.1016/j.rpth.2026.104375Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220381021
W7204652783PHYTOCHEMISTRY AND THERAPEUTIC APPLICATIONS OF BASELLA ALBA: A REVIEW2026-09-01OpenAlex10.5281/zenodo.22156203Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204652783
W7221129638PP1 A decades-old winning formula: Continuous subcutaneous infusions (CSCI) and drug combinations in palliative care2026-09-01OpenAlex10.1136/spcare-2026-anzspm.78Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221129638
W7214921022PROMPT INJECTION AND JAILBREAK ATTACKS ON LARGE LANGUAGE MODELS: THREATS AND DEFENSE STRATEGIES2026-09-01OpenAlex10.58532/nbennur3409c9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214921022
W7213896320Perfluorocarbon-based oxygen carriers: from blood substitutes to targeted oxygen therapeutics—a narrative review2026-09-01OpenAlex10.21037/aob-2026-1-0005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213896320
W7212037611Performance of 99mTc-p5+14 (AT-05) for the Detection of Cardiac Amyloid in Patients with Biopsy-Proven ATTR Amyloidosis and an Equivocal 99mTc-PYP Image at Diagnosis2026-09-01OpenAlex10.1016/j.nuclcard.2026.102919Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212037611
W7212398705Polycystic ovary syndrome: From an ovarian-centric name to a multisystem perspective2026-09-01OpenAlex10.33545/26164485.2026.v10.i9.c.3202Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212398705
W7212157646Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities2026-09-01OpenAlex10.23736/s0026-4806.26.09859-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212157646
W7213531661Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.2026-09-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213531661
W7212200346Reward Learning and Redistribution for Learning Agents2026-09-01OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7212200346
W7214277210SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm2026-09-01OpenAlex10.1016/j.clml.2026.09.016Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214277210
W7204879306Target, silence, replace: a review on RNA-based drugs in modern medicine2026-09-01OpenAlex10.3389/fcell.2026.1879681Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204879306
W7207724224The ADC-driven development paradigm and evolution into XDC: Current landscape and future trends2026-09-01OpenAlex10.1016/j.apsb.2026.08.033Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7207724224
W7215351295The Anatomy of Medical Autonomy: A Modular LLM Scaffold for Persistent and Scalable Clinical Agents2026-09-01OpenAlexTitle/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7215351295
W7222766005The Evolution of Topical Retinoids in Dermatology: A Cornerstone of Acne Management (1971-2025).2026-09-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222766005
W7212422035The necessity of complete and timely pain management in trauma care2026-09-01OpenAlex10.48307/atr.2026.567126.1308Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212422035
W7204999356Theranostics: integrating diagnostics and therapy for precision medicine and personalized healthcare2026-09-01OpenAlex10.1007/s12553-026-01093-8Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7204999356
W7213563284Therapeutic Potential of Exosomes in Bone Infection: Mechanisms of Action, Engineering Strategies, and Translational Applications2026-09-01OpenAlex10.2147/ijn.s637313Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213563284
W7222677215Toward Autonomous Industrial Systems: Agentic Alarm-Based Retrieval-Augmented Operator Advisory2026-09-01OpenAlex10.1109/etfa68377.2026.11725031Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222677215
W7207650923Toward a Socratic Scaffolding design paradigm for diagnostic AI: A conceptual middleware framework2026-09-01OpenAlex10.1016/j.jrt.2026.100185Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207650923
W7204972423Trauma‐Induced Coagulopathy: From Endotheliopathy and Fibrinolysis Phenotypes to Viscoelastic‐Guided Resuscitation2026-09-01OpenAlex10.1111/ejh.70315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204972423
W7214220409Update on scleritis diagnosis and management: a narrative review2026-09-01OpenAlex10.21037/aes-2025-1-68Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214220409
W7206167812Why the AI That Helps Is Also the AI That Harms: The Engagement Paradox2026-09-01OpenAlex10.5281/zenodo.22240901Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7206167812
W7206202429Beyond Glycemic Control: Expanding Therapeutic Horizons of Semaglutide and Liraglutide in Cardiometabolic, Neurodegenerative, and Addictive Disorders2026-09-02OpenAlex10.5281/zenodo.22260500Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7206202429
W7212083553CO41 | OCCURRENCE AND DISTRIBUTION OF SALMONELLA SEROVARS ALONG THE FOOD CHAIN AND IN HUMANS IN CENTRAL ITALY, 2020-20252026-09-02OpenAlex10.4081/ijfs.2026.16228Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212083553
W7214056899Data Intelligence: Mathematical Models, Machine Learning and Analytical Discovery2026-09-02OpenAlex10.5281/zenodo.22894164Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214056899
W7205003112Diagnostic Modalities and Holistic Management Strategies for Diabetes2026-09-02OpenAlex10.1201/9781779644596-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7205003112
W7205011434Editorial: Advances in wildlife parasitology and host-pathogen dynamics2026-09-02OpenAlex10.3389/fvets.2026.1933958Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7205011434
W7205011888Editorial: Novel anti-cancer agents targeting triple-negative breast cancer2026-09-02OpenAlex10.3389/fonc.2026.1906771Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7205011888
W7205013004Monovalent Nondegrading Molecular Glues: An Updated Overview of Emerging Mechanisms and Therapeutic Development2026-09-02OpenAlex10.3390/ph19091388Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7205013004
W7206192510TYPHOID FEVER IN THE 21ST CENTURY: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE, DIAGNOSTICS, VACCINATION STRATEGIES, AND FUTURE THERAPEUTIC APPROACHES2026-09-02OpenAlex10.5281/zenodo.22253190Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7206192510
W7221214603The Future of Mental Healthcare in the Digital Era: A Critical Analysis of Artificial Intelligence Applications Between Therapeutic Effectiveness and Ethical Dilemmas2026-09-02OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221214603; https://openalex.org/W7221269472
W7206216210Therapeutic Role of Metformin in Polycystic Ovary Syndrome: A Comprehensive Review2026-09-02OpenAlex10.5281/zenodo.22260837Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7206216210
W7206204655aipoch/open-science: AIPOCH Open-Science v1.0.02026-09-02OpenAlex10.5281/zenodo.22252246Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7206204655
W7207659634Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology2026-09-03OpenAlex10.1038/s41571-026-01198-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207659634
W7207740492Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics2026-09-03OpenAlex10.3389/fmed.2026.1911402Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7207740492
W7207764053Consistent Conversational State for Virtual Agents: Slot-Based Memory for Accurate Fact Retrieval2026-09-03OpenAlex10.1145/3806774.3832787Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7207764053
W7206178440Directed Evolution of Multivalent 2'-Modified RNA Towards Protein Targets2026-09-03OpenAlex10.48617/etd.1645Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7206178440
W7207664691Guest editorial: Advancing the future of retail operations with cutting-edge technologies2026-09-03OpenAlex10.1108/ijpdlm-09-2026-566Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207664691
W7208750499Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma2026-09-03OpenAlex10.1002/jso.70329Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208750499
W7207862929Recent Advances in Surface-Enhanced Raman Spectroscopy for Virus Detection2026-09-03OpenAlex10.1021/acssensors.6c02877Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7207862929
W7207812827Sistema explicable de detección preventiva de indicadores de riesgo en salud mental adulta mediante aprendizaje automático multisalida y agentes de inteligencia artificial generativa a partir del dataset NSDUH 2024 / Explainable system for preventive detection of risk indicators in adult mental health using multi-output machine learning and generative AI agents based on the NSDUH 2024 dataset2026-09-03OpenAlex10.5281/zenodo.22277708Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7207812827
W7208741588Adjudicating evolving inpatient diagnoses with a clinical coding agent: a retrospective multicentre study2026-09-04OpenAlex10.64898/2026.08.31.26361789Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7208741588
W7208751134Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape2026-09-04OpenAlex10.1007/s44313-026-00169-8Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7208751134
W7208741541Editorial: Emerging targeted and immunotherapeutic strategies in oncology: from solid tumors to hematologic malignancies2026-09-04OpenAlex10.3389/fphar.2026.1965471Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208741541
W7208745874Large language models in healthcare semantics2026-09-04OpenAlex10.1016/b978-0-443-33512-9.00009-3Full textExcludedF1: The complete original abstract explicitly describes a chapter examining and discussing LLM/SLM semantics, RAG, prompt engineering, safety and future agentic workflows. It does not report a primary adapting-agent implementation or evaluation.https://openalex.org/W7208745874https://www.sciencedirect.com/science/article/pii/B9780443335129000093Complete primary publisher abstract read online; full chapter not included in current institutional subscription. Exclusion follows positively stated overview scope, not assumed missing mechanisms.
W7208756366Metallo-β-lactamase-producing Pseudomonas aeruginosa: epidemiology, diagnostic challenges and therapeutic strategies in the era of MDR/XDR resistance2026-09-04OpenAlex10.3389/fmicb.2026.1924442Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208756366
W7208743749Pharmacological strategies for myocardial protection in cardiac surgery: current science and the emerging role of multi-omics and artificial intelligence2026-09-04OpenAlex10.3389/fcvm.2026.1844417Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208743749
W7208725568Preface2026-09-04OpenAlex10.1016/b978-0-443-33512-9.05001-0Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208725568; https://openalex.org/W7214075411; https://openalex.org/W4387041694; https://openalex.org/W7221181564; https://openalex.org/W4404762500; https://openalex.org/W4413396426
W7208757675Streptomyces-Mediated Green Synthesis of Nanoparticles: Mechanisms, Applications, and Future Perspectives2026-09-04OpenAlex10.33003/fjs-2026-1016-5685Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208757675
W7208756372The Evolving Landscape of Drug Discovery for Hepatitis B: Recent Advances and Future Prospects2026-09-04OpenAlex10.5281/zenodo.22300559Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208756372
W7208707456Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis2026-09-04OpenAlex10.1007/s11255-026-05373-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7208707456
W7221564861Updated Guidelines for the Management of Neovascular Age-Related Macular Degeneration by the European Society of Retina Specialists2026-09-04OpenAlex10.1159/oph/aeeag010Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221564861
W7208827481AgentDescent: Asynchronous Parallel Self-Evolution of LLM Agents by Merging Conflicting Edits2026-09-05OpenAlex10.5281/zenodo.22348026Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7208827481
W7208832421Cytokine fusion proteins for solid tumor therapy: mechanistic insights and clinical advances2026-09-05OpenAlex10.1186/s13045-026-01842-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7208832421
W7208829518Representation Alignment Compass Core Semantic Package: A Stable Machine-Readable Contract for Alignment Research and System Design2026-09-05OpenAlex10.5281/zenodo.22335409Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7208829518
W7211866784Methodologies for the correction of Garbage codes in mortality records and their applicability in microsimulation models: Protocol for a scoping review2026-09-06OpenAlex10.17605/osf.io/zp9aqTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211866784; https://openalex.org/W7219529234
W7210283738The Extracted Dasein,Beyond the Victim–Perpetrator Binary Toward a Clinical Ontology of Gendered Human Capacity2026-09-06OpenAlex10.5281/zenodo.22537226Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7210283738
W7210270096The Stability-Plasticity Boundary: Exact Memory Lower Bounds, Matching Constructions, and a Theory of Future-Relevant Learning State2026-09-06OpenAlex10.5281/zenodo.22546047Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7210270096
W7211906692AI-assisted multimodal data integration for precision oncology2026-09-07OpenAlex10.3389/frai.2026.1917442Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211906692
W7214551669DALIA, a Conversational Agent-Based Lifestyle Monitoring for People with Type 2 Diabetes: Mixed Methods Pilot Feasibility Study (Preprint)2026-09-07OpenAlex10.2196/preprints.111252Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7214551669
W7172397324Early development of chemical exchange saturation transfer (CEST)2026-09-07OpenAlex10.1016/j.jmr.2026.108169Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7172397324
W7211910719Editorial: Advanced integration of large language models for autonomous systems and critical decision support2026-09-07OpenAlex10.3389/frai.2026.1962295Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211910719
W7211893929Kemoterapiye Bağlı Nöropatik Ağrı: Mekanizmalar ve Yeni Farmakolojik Yaklaşımlar2026-09-07OpenAlex10.37609/akya.4312.c18081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211893929
W7215143722Novel Pharmacological Advancements in Obesity Management. The era of incretins and their analogs2026-09-07OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215143722
W7160171893The Microfoundations of Operational Viability in Innovation Intermediaries: A Modular Framework for Technological Capabilities in Emerging Economies2026-09-07OpenAlex10.3390/joi1010003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7160171893
W7211888460Therapeutic drug monitoring in leukemia: global research trends and implications for clinical pharmacy practice—a bibliometric analysis2026-09-07OpenAlex10.1007/s11096-026-02187-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211888460
W7211929372Computational small molecule drug discovery for multidrug-resistant tuberculosis: emerging targets and recent medicinal chemistry advances2026-09-08OpenAlex10.1016/j.bioorg.2026.110483Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211929372
W7215119691Inflammatory Comorbidity of Upper and Lower Airways: Epidemiology, Mechanism, and Therapeutic Advances of Rhinitis Combined with Asthma2026-09-08OpenAlex10.1159/iaa/adfag019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215119691
W7211936307Olfactory Origins and Cognitive Hardening: Qualitative Experience, History-Dependent Cognitive Asymmetry, Pre-Reflective Perception, and Artificial Cognition2026-09-08OpenAlex10.5281/zenodo.22661199Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7211936307
W7211931948Temporal trends in systemic therapies in childhood non- infectious uveitis2026-09-08OpenAlex10.21203/rs.3.rs-10738200/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7211931948
W7213261691When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma2026-09-08OpenAlex10.59854/dhrrh.2026.4.3.133Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213261691
W7212009373Antimicrobial De-escalation in Clinical Practice: Current Evidence, Challenges, and Future Directions2026-09-09OpenAlex10.56557/ajoair/2026/v9i1571Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212009373
W7212022859Nanosuspension-based Ocular Therapeutics for Infection Control: Integrating Mucin Interactions and Tear Film Dynamics2026-09-09OpenAlex10.1208/s12249-026-03531-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212022859
W7212051682Operational digital twins in the built environment: A systematic review of semantic infrastructure and deployment practice2026-09-09OpenAlex10.36680/j.itcon.2026.043Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212051682
W7212035897Reclaiming Sophia in the Age of AI: Theological and Ethical Reflections on Consecrated Technology and Human Dignity2026-09-09OpenAlex10.3390/rel17091052Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212035897
W7212269269When Validation Stops Learning: Auditing Update Admission for Continual Embodied Agents2026-09-09OpenAlex2609.1087310.48550/arxiv.2609.10873Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212269269
W7212167444AI-Powered Secure and Intelligent Medical Systems with Reinforcement Learning2026-09-10OpenAlex10.1201/9781003715405-13Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212167444
W7212166591AI-enabled clinical trials2026-09-10OpenAlex10.1038/s44222-026-00487-7Full textExcludedF1: The publisher explicitly identifies a Review synthesizing existing AI-enabled trial methods.https://openalex.org/W7212166591https://www.nature.com/articles/s44222-026-00487-7Complete publisher abstract and key points; body subscription-only.
W7212128818Algèbre des Jauges ou regarder dans une IA2026-09-10OpenAlex10.5281/zenodo.22695933Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212128818
W7212256254Beyond Accuracy—Artificial Intelligence as a Guided Comparison Tool in Sonography Education: A Mixed-Methods Study2026-09-10OpenAlex10.1177/87564793261482088Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7212256254
W7212133844Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications2026-09-10OpenAlex10.1007/s12325-026-03772-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7212133844
W7212138754Complement diagnostics and therapeutics for the pediatric population: early successes and opportunities for further advancement2026-09-10OpenAlex10.3389/fphar.2026.1891349Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212138754
W7212138276Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection2026-09-10OpenAlex10.3390/pathophysiology33030068Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212138276
W7214518061Dermatophytosis: An Updated Review Of Epidemiology, Pathogenesis, Diagnosis, Antifungal Resistance And Treatment2026-09-10OpenAlex10.63363/aijfr.2026.v07i05.7679Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214518061
W7212127265Editorial: Invisible hazards, lasting impact: airborne toxicants and systemic disease from environmental and occupational exposures2026-09-10OpenAlex10.3389/fpubh.2026.1943584Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212127265
W7213579982INTELLIGENT COMPUTING AND AUTOMATION WITH AI AGENTS FOR NEXT-GENERATION APPLICATIONS2026-09-10OpenAlex10.5281/zenodo.22824156Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213579982
W7212290391Management of vasogenic edema in brain tumor patients: Current and emerging strategies2026-09-10OpenAlex10.1093/nop/npag094Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212290391
W7212116189RECENT ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF VIRAL HEPATITIS2026-09-10OpenAlex10.5281/zenodo.22686503Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212116189
W7212182892Research trends in adjuvant chemotherapy for non-small cell lung cancer: a bibliometric analysis (2015–2024)2026-09-10OpenAlex10.1186/s13019-026-04644-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212182892
W7212186694Rett syndrome: MECP2 biology, multisystem pathophysiology, and the evolving therapeutic landscape2026-09-10OpenAlex10.1007/s00431-026-07377-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212186694
W7212139245Safe AI for Kids: A Child-Centered Framework for AI Literacy, Digital Safety, and Responsible Participation in the Age of Generative AI2026-09-10OpenAlex10.5281/zenodo.22692187Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212139245
W7212186763Thirty years of adjuvant therapy: From treating risk to treating residual disease2026-09-10OpenAlex10.1016/j.ejca.2026.117050Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212186763
W7212248532Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment2026-09-11OpenAlex10.1016/j.bbcan.2026.189709Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212248532
W7212312123Architectural Patterns for Self-Improving Intelligent Agents: A Systematic Survey of Generative and Cognitive Approaches2026-09-11OpenAlex10.1007/s42979-026-05333-6Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7212312123
W7212294293Deep Learning Cyber-Infrastructure for High-Dimensional Multimodal Data — NSF CSSI 2026 PI Meeting Poster2026-09-11OpenAlex10.6084/m9.figshare.33631927Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212294293
W7212235522Design and Clinical Translation of Polymer Microneedle Systems for Transdermal Drug Delivery2026-09-11OpenAlex10.5281/zenodo.22704961Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212235522
W1860338944Heat shock protein expression and apoptosis in myeloid leukaemias2026-09-11OpenAlex10.82444/warw.33610282Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W1860338944
W7168453893How can we use AI to integrate community health and social care responsibly and ethically?2026-09-11OpenAlex10.5334/ijic.icic26593Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7168453893
W7213995129Integrating Machine Learning and Reasoning for Clinical and Epidemiological Risk Assessment2026-09-11OpenAlex10.11575/prism/52054Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213995129
W7212221842Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic2026-09-11OpenAlex10.1002/adrr.70151Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212221842
W7212291782International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update2026-09-11OpenAlex10.1136/gutjnl-2026-340031Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212291782
W7212273379Iron, ESA, and HIF-Inhibitors: Are There Other Opportunities to Improve Anemia of CKD?2026-09-11OpenAlex10.3390/jcm15187070Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212273379
W7213912125Know Me, Support Me: AI reasoning tool for identifying and managing health issues of people with intellectual disability2026-09-11OpenAlex10.5334/ijic.icic26209Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213912125
W7213881360Leading roles in integrated care: the Advanced Practice Nurse as innovation and integration agent2026-09-11OpenAlex10.5334/ijic.icic26211Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213881360
W7212257676Post-CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer: expanding options and persisting uncertainties2026-09-11OpenAlex10.37349/etat.2026.1002400Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212257676
W7213554116Quantum Dots in Precision Oncology: Emerging Strategies for Targeted Cancer Therapy2026-09-11OpenAlex10.53365/nrfhh.1596Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213554116
W7212297009Regenerative Materials Used in Periodontology: Current Evidence, Clinical Applications, and Future Perspectives2026-09-11OpenAlex10.21275/sr26906153043Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212297009
W7212249831Schema Crush: calibrated semantic schema matching for biomedical data to FHIR2026-09-11OpenAlex10.5281/zenodo.22713617Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7212249831
W7212291376Slow-release glaucoma drug delivery systems2026-09-11OpenAlex10.1016/b978-0-443-36643-7.00024-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212291376
W7212290032The evolving role of immunotherapy in ovarian cancer2026-09-11OpenAlex10.1002/cncr.70581Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212290032
W7212227309Urinary Tract Infections: Molecular Determinants of Uropathogenicity and Their Translation into Contemporary Clinical Practice2026-09-11OpenAlex10.3390/ijms27188108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212227309
W7212868169Injectable Lipid-Lowering Therapies Across the Chronic Kidney Disease Spectrum: Evidence, Safety, and a Stage-Specific Clinical Framework2026-09-12OpenAlex10.3390/lipidology3030025Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212868169
W7212365319Pharmacotherapy of Pythium insidiosum keratitis – a contemporary update2026-09-12OpenAlex10.1080/14656566.2026.2734123Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212365319
W7212449198A Survey of Automated Time Series Forecasting: From Deep Learning to Foundation Models with Financial Applications2026-09-13OpenAlex10.70267/aitia.2026316325Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212449198
W7212430327Partlow’s Law of Recursive Intelligence Acceleration: A Framework for Measuring Intelligence as an Input Into the Production of Intelligence2026-09-13OpenAlex10.6084/m9.figshare.33709870.v2Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7212430327
W7212776660Bacterial meningitis in Guinea (2023–2024): regional epidemiology, case mapping, and etiological profile confirmed by multiplex PCR2026-09-14OpenAlex10.1186/s12866-026-05530-6Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212776660
W7213020443Disability and Biomedical HIV Prevention: The Missing Equity Dimension2026-09-14OpenAlex10.3390/v18091017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213020443
W7213161979Editorial: Breaking the cycle: exploring the interplay of conflict, hunger, poverty, and food insecurity in Africa and other regions, and implications for policy2026-09-14OpenAlex10.3389/fnut.2026.1963113Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213161979
W7212519827INFLAMMATORY BOWEL DISEASES: CLINICAL CHARACTERISTICS AND MODERN TREATMENT METHODS2026-09-14OpenAlex10.5281/zenodo.22753648Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7212519827
W7220897240New materials for cancer imaging and therapy2026-09-14OpenAlex10.82444/warw.33757597Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220897240
W7212949060Targeting Nuclear Export in Multiple Myeloma: Selinexor, Emerging Xpo1 Inhibitors, and Future Therapeutic Strategies2026-09-14OpenAlex10.20944/preprints202609.1061.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7212949060
W7213106315The Intransitability of Hybrid Agents: Operational Memory, Drift Gradients, and the Limits of Agent Portability2026-09-14OpenAlex10.5281/zenodo.22750152Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213106315
W7214997709UNDER THE MICROSCOPE QUICK INSIGHTS INTO EMERGING PATHOGENS2026-09-14OpenAlex10.5281/zenodo.23057093Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214997709
W7213270576Advances in traditional Chinese medicine for modulating macrophage polarization in the treatment of rheumatoid arthritis2026-09-15OpenAlex10.3389/fphar.2026.1702947Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213270576
W7213314852Data from The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53-Mutant AML2026-09-15OpenAlex10.1158/1078-0432.c.8715347Title/abstractExcludedE5: Correction, retraction or ancillary data record.https://openalex.org/W7213314852
W7213317472Detection and social intervention in different forms of violence against dependent older adults: the insiders’ perspective2026-09-15OpenAlex10.1108/jap-05-2026-0023Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213317472
W7213265997Eco-Evolutionary Thinking in Metastatic Breast Cancer: A Clinician’s Primer on Why Tumors Outsmart Us and How to Fight Back Smarter2026-09-15OpenAlex10.3390/cancers18182979Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213265997
W7213366048HSS-MH model version 2.02026-09-15OpenAlex10.5281/zenodo.22765739Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213366048
W7213486361Testing Large Vision-Language Models: A Systematic Review2026-09-15OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213486361
W7213326206The Systems Innovation Codex: A Formal Theory of Consequential Contrasts, Motif Compression, and Governed Transformation2026-09-15OpenAlex10.5281/zenodo.22770108Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213326206
W7214120770Vaccination in Juvenile Idiopathic Inflammatory Myopathies: Current Evidence-Based Recommendations2026-09-15OpenAlex10.31305/rrijm.2026.v11.n09.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214120770
W7213401713Accelerating discovery: Transformative clinical trial models in neuro-oncology2026-09-16OpenAlex10.1016/j.neurot.2026.e01080Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213401713
W7213400177Active Nanotherapeutics: Nanoparticles as Therapeutic Agents in Next-Generation Medicine (2026)2026-09-16OpenAlex10.5281/zenodo.22793611Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213400177
W7213301226Bile acid-based therapeutics: recent advances in bile acid conjugates and derivatives2026-09-16OpenAlex10.1007/s40005-026-00830-5Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213301226
W7213248627Contrasting diagnostic challenges of headache before and after acute disseminated encephalomyelitis in children: Two case reports and review of literature2026-09-16OpenAlex10.12998/wjcc.126833Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213248627
W7213305621Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia2026-09-16OpenAlex10.1080/14656566.2026.2734125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213305621
W7213403482Evolutionary genomics, tumor dynamics, and mathematical modeling of cancer progression: Implications for precision oncology2026-09-16OpenAlex10.1016/j.meegid.2026.106019Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213403482
W7213434779GLP-1-Rezeptoragonisten in der Urologie und Andrologie: Indikationen, Chancen und klinisch relevante Nebenwirkungen2026-09-16OpenAlex10.1055/a-2943-1080Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213434779
W7213229956Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases2026-09-16OpenAlex10.1007/s00408-026-00931-wTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213229956
W7213503181NEO: A Persistent AI Operating System — Current Implementation Stages and Observed Cases2026-09-16OpenAlex10.5281/zenodo.22803955Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213503181
W7213322716Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective2026-09-16OpenAlex10.3389/fmicb.2026.1944134Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213322716
W7214115640Recent Molecular Approaches to Clinical Laboratory Diagnosis of Hand, Foot and Mouth Disease (HFMD)2026-09-16OpenAlex10.62225/2583049x.2026.6.5.6884Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214115640
W7213398833Targeting EGFR ‐Mutant Non‐Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors2026-09-16OpenAlex10.1002/resp.70315Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213398833
W7213320761The Evolving Role of Sodium-Glucose Cotransporter-2 Inhibitors Beyond Diabetes Management: A Review of Cardiovascular and Renal Protective Effects2026-09-16OpenAlex10.70146/msv03i03.004Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213320761
W7213415003The Unfinished Story of Sickle Cell Nephropathy: A Narrative Review of Knowledge Gaps and Research Imperatives2026-09-16OpenAlex10.3390/jcm15187185Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213415003
W7213441373Can Diagnostic Delay Amplify Drug Resistance in Tuberculosis? A Critical Integrative Reflection on Bacterial Adaptation, Persistence, Within-Host Evolution, and Heteroresistance2026-09-17OpenAlex10.3390/diseases14090344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213441373
W7213646353Common Pain Medications: Indications, Efficacy, Dosing, Formulations, Mechanisms of Action, and Contraindications2026-09-17OpenAlex10.64719/pb.20767Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213646353
W7213449546Cross-modular integration and the missing mechanism in biocultural accounts of language2026-09-17OpenAlex10.3389/fpsyg.2026.1765291Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213449546
W7213452452Recent biological evaluations of novel bioactive pyrazole derivatives developed between 2025 and 20262026-09-17OpenAlex10.1007/s44371-026-00966-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213452452
W7213473077Targeted therapies in systemic lupus erythematosus: mechanistic insights and clinical evidence from phase II and III trials2026-09-17OpenAlex10.3389/flupu.2026.1829480Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213473077
W7213448937Toward autonomous science with agentic artificial intelligence2026-09-17OpenAlex10.1016/j.cell.2026.08.052Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7213448937
W7213533908Advancements and future directions in transforming therapies of prostate cancer2026-09-18OpenAlex10.1097/cm9.0000000000004322Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213533908
W7213552535Bacteriophages in humans: From discovery and mechanisms to therapeutic promise in combating disease2026-09-18OpenAlex10.1097/cm9.0000000000004296Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213552535
W7222825059Clinical advancements in Pulmonology – from Biological drugs to AI interaction in screening and detection2026-09-18OpenAlex10.52756/cfamm.2026.e01.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222825059
W7213606652FodaOS Unified Field Theory Series VI: The Brain-Inspired Cognitive Architecture — Dual-Path Reasoning, Reservoir Computing on the Residueon Field, and the PCD/RRC Dual Criteria2026-09-18OpenAlex10.5281/zenodo.22822343Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213606652
W7213561792From evolutionary individuality to cognitive integration: a cross-modular perspective on human–AI coevolution2026-09-18OpenAlex10.3389/fpsyg.2026.1768785Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7213561792
W7213534602Navigating State Drift in Retrieval-Augmented Generation (RAG) Agents: A Diagnostic Benchmark and Structured Graph-Guided Repair Framework2026-09-18OpenAlex10.67231/fvj51b26Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7213534602
W7213538225Overview: ribonucleases, a family of multifaceted proteins2026-09-18OpenAlex10.1016/b978-0-443-27312-4.00007-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213538225
W7213552276The Development of SGLT Inhibitors: From Phlorizin to Modern Therapeutics2026-09-18OpenAlex10.54963/ssi.103401Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213552276
W7214478155Advancing the Paradigm of Temporal Lobe Epilepsy as a Network Disease: The Promise of Biomarkers and Targeted Disease Modification2026-09-19OpenAlex10.3390/ijms27188328Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214478155
W7213865452Primary Cutaneous Lymphomas and Lymphoproliferative Disorders: Current Insights for Classification and Management2026-09-19OpenAlex10.3390/cancers18183038Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213865452
W7213758239Advances in the management of pediatric morphea: a narrative review2026-09-20OpenAlex10.1007/s00403-026-04890-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213758239
W7213985590Anticoagulants, Their Laboratory Monitoring, and Reversal2026-09-20OpenAlex10.3390/hematolrep18050067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213985590
W7213773991Editorial: Advancing in vitro cell culture practices: achieving truly animal-free experiments and scientifically reliable and reproducible methods2026-09-20OpenAlex10.3389/ftox.2026.1892833Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213773991
W7213788751Pill Sedation in Dentistry: Simple and Effective in the Primary Care Setting — A Review of Oral Conscious Sedation and the New Age of Anaesthesia2026-09-20OpenAlex10.67317/ijmsrt26sep081Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213788751
W7213756083Precision oncology in GI-cancers: Mechanisms of action, indications and ongoing strategies to overcome primary and secondary resistance2026-09-20OpenAlex10.1016/j.semcancer.2026.102619Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213756083
W7213755412Real-Time Non-Invasive Cancer Localization and Surgical Navigation Architecture via Stateless Bio-Topological Resonance Mapping2026-09-20OpenAlex10.5281/zenodo.22861114Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213755412
W7213753190Transport phenomena in polymeric nanoparticle drug delivery systems: linking soft-matter design to biological performance2026-09-20OpenAlex10.3389/frsfm.2026.1931284Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213753190
W7214662808Artificial intelligence as a clinical decision support tool in the diagnosis and treatment of inflammatory dermatoses2026-09-21OpenAlex10.21518/ms2026-277Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214662808
W7214002042Clinical empathy and relational continuity mitigate care fragmentation for patients with multiple long-term conditions2026-09-21OpenAlex10.3399/bjgp.2026.0171Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214002042
W7213931926Delineating precise surgical resection areas: recent advances in NIR-II fluorescence imaging molecular probes2026-09-21OpenAlex10.3389/fonc.2026.1872947Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213931926
W7213952611Digital Relativity Psychology I: Artificial Personas, Digital Frames of Reference, and the Scretching Diagnostic Matrix / Dynamic Scretching Diagnostic Matrix Framework2026-09-21OpenAlex10.5281/zenodo.22865612Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213952611
W7213925636From prediction to action: a comprehensive survey on agentic AI in healthcare, foundation, application and challenges2026-09-21OpenAlex10.1108/idd-09-2025-0235Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7213925636
W7214187543Generative AI and Neurosymbolic Frameworks in Next-Generation Digital Signal Processing2026-09-21OpenAlex10.5772/intechopen.1017137Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214187543
W7213863434Hidradenitis Suppurativa from Preconception to Lactation: Clinical Treatment Decision-Making Review2026-09-21OpenAlex10.1007/s13555-026-01909-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213863434
W7213947338Intranasal Drug Delivery for CNS Diseases: Challenges, Advances, and Future Directions2026-09-21OpenAlex10.1007/s40495-026-00477-8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213947338
W7214010668NEW PERSPECTIVES IN THE TREATMENT OF ULCERATIVE COLITIS IN ADULTS - IL-23 INHIBITORS: EFFICACY AND SAFETY2026-09-21OpenAlex10.31435/ijitss.3(51).2026.6077Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214010668
W7213879733Neuroplasticity after traumatic brain injury: mechanisms and clinical implications2026-09-21OpenAlex10.1007/s11845-026-04624-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213879733
W7213949898Synthetic longitudinal dialogue and preference alignment for substance use recovery support2026-09-21OpenAlex10.21203/rs.3.rs-10914375/v1Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7213949898
W7213928633Targeted Treatment of Agitation in Alzheimer’s Dementia2026-09-21OpenAlex10.4088/pcc.haadachi2603Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213928633
W7214189980The Changing Spectrum of Cancer Therapy–Associated Alopecia: A Scoping Review and Phenotype-Based Clinical Framework2026-09-21OpenAlex10.17605/osf.io/ydq9vTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214189980
W7213916841Tumor necrosis factor-like cytokine 1 A antagonists for inflammatory bowel disease: A systematic review and meta-analysis2026-09-21OpenAlex10.1007/s12664-026-02078-1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7213916841
W7214043804Behavioral Modeling of Interpersonal Dynamics as Controllable Agentic Systems: Empirically-grounded Adaptive Virtual Patients for Psychotherapy2026-09-22OpenAlex10.1184/r1/33415387Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7214043804
W7213988155Biologic Augmentation of Rotator Cuff Repair2026-09-22OpenAlex10.58616/001c.163388Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213988155
W7214209282Current Paradigm Shift in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Narrative Review2026-09-22OpenAlex10.1159/ced/accag030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214209282
W7221148865Current evidence for first-line advanced therapies in pediatric ulcerative colitis: a critical review2026-09-22OpenAlex10.1093/ibd/izag203Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221148865
W7214030702Independent and joint associations of visceral adiposity and insulin resistance with hyperuricemia: A large-scale cross-sectional study2026-09-22OpenAlex10.1371/journal.pone.0357105Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214030702
W7213981854Injectable ophthalmic hydrogels: design principles, therapeutic mechanisms, clinical applications, and translational perspectives2026-09-22OpenAlex10.1016/j.matdes.2026.117099Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213981854
W7214064158Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies2026-09-22OpenAlex10.1111/eci.70256Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214064158
W7214092400Artificial general intelligence architectures and evaluation methodologies: A comprehensive review and future research roadmap2026-09-23OpenAlex10.1016/j.cosrev.2026.101069Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214092400
W7214147378BEYOND GLYCEMIC CONTROL: ORGAN-PROTECTIVE EFFECTS AND SAFETY PROFILE OF GLP-1 RECEPTOR AGONISTS – A COMPREHENSIVE REVIEW2026-09-23OpenAlex10.31435/ijitss.3(51).2026.6563Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214147378
W7214064165Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions2026-09-23OpenAlex10.1097/cu9.0000000000000374Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214064165
W7214118204Closed-loop artificial intelligence agents for animal epidemic prediction and decision support in livestock farming: a review2026-09-23OpenAlex10.3389/fvets.2026.1968632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214118204
W7214126288Fosmanogepix: A comprehensive review of its origin, mechanism, antifungal efficacy, and resistance (Review)2026-09-23OpenAlex10.3892/br.2026.2204Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214126288
W7214221023Global Research Trends in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Bibliometric Analysis (2016–2025)2026-09-23OpenAlex10.57760/sciencedb.013tnTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214221023
W7214095340Literature Review: Plasma Medicine, Adaptive Plasma Chemistry, Neuromorphic Plasma, and State-Dependent Dynamical Control2026-09-23OpenAlex10.5281/zenodo.22919154Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214095340
W7214087266Medical device biomaterials and antimicrobial resistance: exploring an overlooked research interface2026-09-23OpenAlex10.3389/fbioe.2026.1945426Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214087266
W7214089507Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions2026-09-23OpenAlex10.1016/j.seminoncol.2026.152563Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214089507
W7214078360Pastoral Care Perspectives on Female Genital Mutilation: A Feminist Approach2026-09-23OpenAlex10.56201/ijrcp.vol.11.no6.2026.pg80.88Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214078360
W7214078344Stargardt disease: clinical studies over the past 5 years—a systematic review2026-09-23OpenAlex10.1007/s00717-026-00623-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214078344
W7214084302Understanding the Health Challenges among East African Women in the U.S. with a History of Female Genital Mutilation2026-09-23OpenAlex10.30958/ajhms.13-3-2Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214084302
W7214174955AGI DNA: A Generative Theory of Open-Ended General Intelligence2026-09-24OpenAlex10.5281/zenodo.22931418Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214174955
W7214166344Chronic Lymphocytic Leukemia: Epidemiology, Diagnosis, Prognosis and Modern Treatmen2026-09-24OpenAlex10.5281/zenodo.22940305Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214166344
W7214242651Editorial: Rodent model organisms: therapeutic treatments and drugs interaction with the gut microbiome, volume II2026-09-24OpenAlex10.3389/fmicb.2026.1962495Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214242651
W7214166366From microbiome signatures to precision oncology in colorectal cancer2026-09-24OpenAlex10.3389/fonc.2026.1926171Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214166366
W7214195475From structural mimicry to functional regeneration: the evolving role of electrospun nanofibrous scaffolds in tendon tissue engineering2026-09-24OpenAlex10.1016/j.mtchem.2026.104056Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214195475
W7214186752GENERAL EDGE‑CLOUD HETEROGENEOUS MULTI‑AGENT COLLABORATIVE REASONING ARCHITECTURE WITH LOCAL‑PRIVACY CONSENSUS MECHANISM2026-09-24OpenAlex10.61784/jcsee3155Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7214186752
W7214228980Kidney transplantation in multiple myeloma: patient selection, timing, and post-transplant challenges in the modern therapeutic era2026-09-24OpenAlex10.1093/ckj/sfag335Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214228980
W7214212886MedEnv: Scaling Multimodal Virtual Medical Environments for Long-Horizon Diagnosis2026-09-24OpenAlex10.1007/978-3-032-38098-2_40Full textIncludedIncluded: Interactive clinical rollouts train a doctor policy retained for different held-out cases.https://openalex.org/W7214212886https://papers.miccai.org/miccai-2026/paper/5084_paper.pdf
W7214192643P2Y12 inhibition in diabetes across the acute-to-chronic coronary syndrome continuum: toward a personalized antiplatelet strategy2026-09-24OpenAlex10.1186/s12933-026-03380-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214192643
W7214151424Quantify, Collect, and Correct: Evidence-Driven Multi-agent Framework for Critical Evidence Refinement in Emergency Rooms2026-09-24OpenAlex10.1007/978-3-032-38260-3_43Full textExcludedF4: The complete QCC method performs evidence acquisition, verification and correction within one consultation. Stored WECI is for post-hoc evaluation; no update is retained for later different cases.https://openalex.org/W7214151424https://papers.miccai.org/miccai-2026/paper/4233_paper.pdfComplete public accepted paper, all Methodology and Experiments; official repository README.
W7214175605Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary?2026-09-24OpenAlex10.1016/j.ejca.2026.117064Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214175605
W7214988764Advances in the Inflammatory and Immune-mediated Kidney Disorders (IMKD): From Pathogenesis to Precision Therapy2026-09-25OpenAlex10.2174/0127722708501881260913025236Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214988764
W7214320803Autonomous Agentic Infiltration Beyond Sovereign Jurisdictions: Technical and Governance Implications of Agentic Misalignment for Global Healthcare Infrastructure2026-09-25OpenAlex10.5281/zenodo.22953478Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7214320803
W7214240215Autonomous Multi-agent Governance: AI Sentinel Framework for Mitigating Psychological Restraints in AI-Driven Fall Management2026-09-25OpenAlex10.1007/978-3-032-39766-9_2Full textExcludedF4: The implemented Sentinel pipeline uses fixed deterministic detection rules and a constrained Llama3 explanation layer. The audit ledger stores runs, not learned agent updates. Rule adaptation through external regulatory RAG is future work.https://openalex.org/W7214240215https://link.springer.com/chapter/10.1007/978-3-032-39766-9_2Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W7214343123Diagnosis and Management of Pediatric Nephrolithiasis2026-09-25OpenAlex10.1007/s40746-026-00389-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214343123
W7214327372Insulin signaling in PCOS/PMOS: molecular insights and clinical implications2026-09-25OpenAlex10.3389/fendo.2026.1955884Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214327372
W7214316145Lymphomatoid papulosis2026-09-25OpenAlex10.1016/b978-0-443-28419-9.00151-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214316145
W7222882146Memory That Remembers Wrong: Quantifying and Mitigating Confirmation-Loop Bias in Self-Evolving LLM Health Agents2026-09-25OpenAlex10.5281/zenodo.23447748Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7222882146
W7214245456Personalized Treatment of Hemophilia: Matching Therapies to Patient Needs in a Rapidly Evolving Landscape2026-09-25OpenAlex10.1007/s40265-026-02386-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214245456
W7214294843Pityriasis lichenoides et varioliformis acuta2026-09-25OpenAlex10.1016/b978-0-443-28419-9.00195-7Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214294843
W7214285195Regression of severe sclerotic chronic graft-versus-host disease after a second haploidentical hematopoietic stem cell transplantation: a case report2026-09-25OpenAlex10.3389/fmed.2026.1929283Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214285195
W7214347206Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review2026-09-25OpenAlex10.1016/j.ctrv.2026.103214Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214347206
W7213603594[Prehabilitation for high-risk gastric cancer populations: challenges, countermeasures, and the integrated whole-course pathway].2026-09-25OpenAlex10.3760/cma.j.cn441530-20260708-00274Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213603594
W7213599352[Prevention strategies for radiation-induced rectal injury following pelvic radiotherapy].2026-09-25OpenAlex10.3760/cma.j.cn441530-20260704-00270Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7213599352
W7214743260Counterfactual Self-Evolving Agents for Evidence-Grounded Reasoning2026-09-26OpenAlex2609.3287010.48550/arxiv.2609.32870Title/abstractExcludedE2: General method uses clinical reasoning/intake as one of multiple domains; fixed P2 applies.https://openalex.org/W7214743260
W7216350412Diabetogenic Petroleum Industry-Induced Pollutants in Nigeria's Niger Delta: Laboratory Diagnostic Challenges for Type 2 Diabetes Management2026-09-26OpenAlex10.58612/jpher225Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7216350412
W7214765285Features of systemic immunity in hyperplastic processes of the uterus of infectious origin in women of different ages2026-09-26OpenAlex10.52705/2788-6190-2026-03-16Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214765285
W7214436106Fitness-associated phenotypic changes in Pseudomonas aeruginosa brown strain induced by chromosomal large-fragment deletion2026-09-26OpenAlex10.1016/j.ijmm.2026.151741Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214436106
W7214429289Long-term trends in upper gastrointestinal bleeding and ischaemic outcomes after myocardial infarction2026-09-26OpenAlex10.1093/eurjpc/zwag508Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214429289
W7214545571Role of Agentic Artificial Intelligence in Anatomical and Clinical Laboratory2026-09-26OpenAlex10.1922/pjs.16.7s.2026.1168Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7214545571
W7214434935THE ZENODO MANIFESTO: THE PREDATORY METAMORPHOSIS OF INFORMATION A Thermodynamic and Non-Euclidean Framework for Emerging Machine Intelligence, Ecological Symbiosis, and the Detection of High-Stakes Network Anomalies2026-09-26OpenAlex10.5281/zenodo.22980354Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214434935
W7214431324Zero-LLM-Cost Event-Sourced Tool Failure Memory for Desktop Agents2026-09-26OpenAlex10.5281/zenodo.22970368Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7214431324
W7214544981aVOLTA, a Bounded Autonomous Operating Layer for Operational Communication in an Investigator-Led Clinical Research Group: System Design Study (Preprint)2026-09-26OpenAlex10.2196/preprints.113028Full textExcludedF2: The deployed task is internal operational communication for a research group, rather than clinical care/diagnosis/clinical case education. It also reports no adopted proposed rule in its five observed days.https://openalex.org/W7214544981https://preprints.jmir.org/preprint/113028Complete archived abstract; preprint primary page inaccessible. Author public deployment summary corroborates runs and human rule-adoption gate.
W7214482429《Quantum Habitability at the Limit: Can Persistent Intelligence and Virtual Civilizations Live on Quantum Infrastructure?》 is a flagship-scale research volume exploring one of the most unusual and forward-looking questions in quantum technology:2026-09-26OpenAlex10.5281/zenodo.22980779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214482429
W7214794583A Mediopassive Reading of Creativity2026-09-28OpenAlex10.1080/09672559.2026.2738550Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214794583
W7214652088A Multi-Agent Framework for Explainable Brain Tumour Instance Segmentation and Clinical Report Generation Using ASIO-Optimised YOLO Architectures2026-09-28OpenAlex10.21203/rs.3.rs-10468605/v1Full textExcludedF4: The experience loop is conventional ASIO/PSO tuning of YOLO detector hyperparameters before execution. The Qwen clinical-reporting module consumes fixed trained outputs; no retained update derived from LLM-agent executions or interactive agent-policy learning is documented across different cases.https://openalex.org/W7214652088https://doi.org/10.21203/rs.3.rs-10468605/v1
W7220962421AUTOIMMUNE THYROID DISEASES: A COMPREHENSIVE LITERATURE REVIEW OF TREATMENT AND THE CURRENT STATE OF KNOWLEDGE2026-09-28OpenAlex10.31435/ijitss.3(51).2026.6041Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220962421
W7214632465Artificial Intelligence in Manufacturing Quality: Applications, Challenges, and Emerging Research Directions2026-09-28OpenAlex10.21275/sr26925083358Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214632465
W7214646256Chinese migrant mothers’ perspectives on educational challenges faced by primary-aged autistic children in London2026-09-28OpenAlex10.14324/lre.24.1.19Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214646256
W7221509433Data-Centric AI: Intelligent Data Engineering and Machine Learning2026-09-28OpenAlex10.5281/zenodo.23185747Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221509433
W7214609133Editorial: Novel pharmacological interventions in emotional and neuropsychiatric disorders2026-09-28OpenAlex10.3389/fphar.2026.1974847Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214609133
W7221508076Generative AI Engineering: Large Language Models and Intelligent Agents2026-09-28OpenAlex10.5281/zenodo.23311806Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7221508076
W7214578467Hyperpigmentation Disorders Management in India: A Delphi Based Expert Consensus on Epidemiology, Therapeutic Challenges, and the Evolving Role of Dermocosmetics2026-09-28OpenAlex10.1111/jocd.71188Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214578467
W7214650269The Evolving Arsenal Against Naegleria Fowleri: From Empirical Poly-Chemotherapy to Target-Driven Repurposing Pipelines2026-09-28OpenAlex10.5281/zenodo.23008144Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214650269
W7214809042Trends in the Dispensing of Adult ADHD Medications.2026-09-28OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214809042
W7214809067Type A Insulin Resistance Syndrome Due to a Pathogenic Variant in the INSR Gene.2026-09-28OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214809067
W7214797511Admission Mechanisms for Scalable Federated Health Data Collaboration: Design and Proof-of-Concept Study2026-09-29OpenAlex10.2196/89685Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214797511
W7214785907Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges2026-09-29OpenAlex10.3390/jof12100728Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214785907
W7214948939Bioactive Agents for Hair Growth: Current and Emerging Therapies2026-09-29OpenAlex10.25259/jmars_3_2026Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7214948939
W7214581859Biophysical rationale and emerging clinical perspectives of surfactants in thoracic surgery: a translational review2026-09-29OpenAlex10.1007/s00423-026-04265-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214581859
W7224220915Retrieval-Augmented Generation for Large Language Models: Architectures, Applications, and Challenges2026-09-29OpenAlex10.24321/3051.424x.202606Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224220915
W7214789629Too Few, Too Far: Can AI Agents Address Health Workforce Shortage in Poland and Maldistribution in China? A Comparative Narrative Review2026-09-29OpenAlex10.20944/preprints202609.2490.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214789629
W72160135636G-Enabled Intelligent IoT: Emerging Architectures, AI-Native Networking, Digital Twins, and Security Challenges2026-09-30OpenAlex10.71143/sn89wx46Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216013563
W7214904443Colorectal cancer care beyond earth: is treatment in microgravity feasible?2026-09-30OpenAlex10.17826/cumj.1942607Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214904443
W7214988677Decision-Support Approaches for Industrial Symbiosis: A Systematic Literature Review2026-09-30OpenAlex10.1007/978-3-032-38598-7_12Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214988677
W7214906372Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases2026-09-30OpenAlex10.3389/fneur.2026.1925664Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214906372
W7214909945GCCE–VCTAGE Causal Admissibility Benchmark: From Forward-Only Causal Ancestry to External Blind Enforcement2026-09-30OpenAlex10.5281/zenodo.23065976Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214909945
W7214954243Global Evolution of Microbiological Patterns and Pharmacological Guidance in the Management of Peritoneal Dialysis-Associated Peritonitis: An Evolution of Epidemiology and Clinical Practice2026-09-30OpenAlex10.3390/pathogens15101030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214954243
W7214941098Gut Flora Dynamics and Probiotics: Foundations of Health and Therapeutic Potential2026-09-30OpenAlex10.5772/intechopen.1014014Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214941098
W7214961412Knowledge reinforced reinforcement learning for transferable selective annotation2026-09-30OpenAlex10.21872/annual2025_8936Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7214961412
W7220710874Magnesium a Multifunctional Therapeutic Agent: Recent Updates on Mechanisms and Clinical Implications beyond Electrolyte Homeostasis2026-09-30OpenAlex10.13005/bpj/3487Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7220710874
W7214934182Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review2026-09-30OpenAlex10.3390/cimb48101008Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214934182
W7214970055Mycophenolate mofetil as salvage therapy for refractory acute-onset CIDP associated with rheumatoid arthritis: a case report2026-09-30OpenAlex10.3389/fimmu.2026.1869194Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214970055
W7223130664Omalizumab in the Era of Precision Biologics: Real-World Treatment Persistence, Switching and Phenotype-Directed Transitions in Severe Asthma -A Malaysian Single-Centre Experience2026-09-30OpenAlex10.47363/jprr/2026(8)205Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223130664
W7214959874Research Progress on Targeted Therapies for Pemphigus Vulgaris and Bullous Pemphigoid: Mechanisms, Opportunities and Challenges2026-09-30OpenAlex10.3390/ijms27198779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214959874
W7214973149SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications2026-09-30OpenAlex10.1186/s43556-026-00604-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7214973149
W7218853767The Epistemic Entrenchment Framework (EEF): An Evolutionary, Cognitive, Information-Theoretic, Social, and Institutional Model of Belief Formation, Persistence, and Revision2026-09-30OpenAlex10.17605/osf.io/rgyn9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218853767
W7214932883Treatment Patterns and Clinical Outcomes Among Chinese Patients With Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Study ( CHAMP ‐ MM )2026-09-30OpenAlex10.1002/cam4.72332Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214932883
W7220360244Virus-based therapeutic platforms2026-09-30OpenAlex10.23838/pfm.2026.00128Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220360244
W7221157923A Narrative Review on Intra-Articular Injection Therapies for Knee Osteoarthritis: Current Evidence and Future Perspectives2026-10-01OpenAlex10.2147/orr.s642237Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221157923; https://openalex.org/W7221742736
W7221252411Abordaje de la diabetes tipo 2 en la población pediátrica y adolescente2026-10-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221252411
W7215058946Advanced Combination Therapies in IBD2026-10-01OpenAlex10.20944/preprints202610.0024.v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215058946
W7224570346Advanced Nanoemulsion Architectures for Precision Theranostics and Next-Generation Biomedical Translation2026-10-01OpenAlex10.2147/ijn.s631056Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224570346
W7215094140Advances in Decision-Support Frameworks for Emergency Response and Public Health Resource Allocation2026-10-01OpenAlex10.56201/ijhpr.vol.10.no3.2025.pg17.53Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215094140
W7223517223Advances in the LI-RADS Treatment Response Algorithm: Imaging Principles, Diagnostic Challenges, and Clinical Integration Following the LI-RADS 2024 Update2026-10-01OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223517223; https://openalex.org/W7222994915
W7222904315Advancing T Cell Engagers in Multiple Myeloma: Structural Design and Clinical Optimization to Address Current Limitations2026-10-01OpenAlex10.2147/dddt.s638795Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222904315; https://openalex.org/W7223522769
W7223876224Agentic AI Systems in Radiology: Design, Applications, Evaluation, and Challenges2026-10-01OpenAlex10.1148/radiol.253226Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7223876224
W7220366466Amivantamab, lazertinib, and bevacizumab: a chemotherapy-free option for patients with advanced EGFR-mutant NSCLC with acquired resistance to a third-generation EGFR TKI2026-10-01OpenAlex10.1016/s2213-2600(26)00230-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220366466
W7215093754An auditable multimodal agentic system for sequential decision-making across the acute stroke pathway2026-10-01OpenAlex10.64898/2026.09.24.26363786Title/abstractExcludedE4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update.https://openalex.org/W7215093754
W7216276315Artificial intelligence in mechanical engineering: foundations, opportunities, challenges, and responsibilities2026-10-01OpenAlex2610.3310510.1007/s40430-026-06873-xTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7216276315
W7220416002Bioactive constituents in Salvia miltiorrhiza Bunge (Danshen) against SARS-CoV-2: Antiviral activity, mechanisms, metabolism and safety2026-10-01OpenAlex10.1016/j.joim.2026.09.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220416002
W7221196495Biologic and Therapeutic Injections in Athletes: What’s Appropriate in 2026?2026-10-01OpenAlex10.1016/j.otsm.2026.151291Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221196495
W7223140802COMBINED THERAPY WITH ELTROMBOPAG AND ROMIPLOSTIM IN IMMUNE THROMBOCYTOPENIA REFRACTORY TO MULTIPLE LINES OF THERAPY - A CASE SERIES2026-10-01OpenAlex10.1016/j.htct.2026.108050Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223140802
W7224112761Carbonic Anhydrases in Sarcoma: Resetting the Tumor's Survival Script2026-10-01OpenAlex10.1002/jcp.70249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224112761
W7223847456Case 351: Thalamic Dementia Secondary to Dural Arteriovenous Fistula2026-10-01OpenAlex10.1148/radiol.252189Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223847456
W7222342259Clinical application of volatile sedation in adult intensive care units: pharmacological mechanisms, delivery systems, and safety.2026-10-01OpenAlex10.4103/mgr.medgasres-d-26-00053Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222342259
W7163899160Data Challenge : From Resistance Data to Stewardship Decisions2026-10-01OpenAlex10.25934/pr00013428Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163899160
W7223147970EVOLUTION OF TYROSINE KINASE INHIBITOR USE AND MOLECULAR RESPONSE PATTERNS ACROSS LINES OF THERAPY IN CHRONIC MYELOID LEUKEMIA: REAL-WORLD EVIDENCE FROM BRAZIL2026-10-01OpenAlex10.1016/j.htct.2026.107503Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223147970
W7220980898EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumour necrosis factor-α as first- and second-line biologic treatment in Crohn's disease2026-10-01OpenAlex10.1016/j.gastrohep.2026.502871Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220980898
W7222945793Editorial comment: Periprocedural antiplatelet therapy during mechanical thrombectomy: navigating limited evidence2026-10-01OpenAlex10.1093/esj/aakag125Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222945793
W7221765441Emerging Therapeutic targets and Early-phase drug Development in Gynecological Malignancies2026-10-01OpenAlex10.1016/j.annonc.2026.10.101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221765441
W7224100290Evolution of endocrine therapy for advanced prostate cancer: Breakthroughs and resistance mechanisms from traditional antiandrogens to novel AR pathway inhibitors2026-10-01OpenAlex10.1016/j.lddd.2026.100637Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224100290
W7224128161Evolving Systemic Intensification Strategies Beyond CCRT in Locally Advanced Cervical Cancer2026-10-01OpenAlex10.2147/cmar.s637635Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224128161
W7221645390Evolving demographic representation and patient-reported outcomes in landmark antibody-drug conjugate trials supporting FDA approvals, 2015-2026.2026-10-01OpenAlex10.1200/op.2026.22.10_suppl.166Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221645390
W7223935531Exploring the evolving landscape of bispecific FVIIIa-mimetic antibodies in haemophilia A2026-10-01OpenAlex10.1016/j.blre.2026.101441Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223935531
W7225000046From MTD to OBD: evolution, integration, and challenges in dose-finding methods for phase I oncology trials2026-10-01OpenAlex10.1016/j.lddd.2026.100644Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225000046
W7221318539Functional characterization of genetic variants associated with response to tumor necrosis factor inhibitors in psoriatic arthritis patients2026-10-01OpenAlex10.1016/j.autrev.2026.104195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221318539
W7218952074Functionalization and surface engineering of hydroxyapatite: 2. Biomolecule immobilization and bioactive glass-containing hydroxyapatite composites2026-10-01OpenAlex10.1016/j.ceramint.2026.10.021Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218952074
W7223085277Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis2026-10-01OpenAlex10.1016/j.jacadv.2026.103201Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223085277
W7215115682Green synthesis, Characterization and bioactivity of plant-mediated Nanoparticles using Plant Extract2026-10-01OpenAlex10.36371/port.2026.4.8Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215115682
W7223705459IgG4-related autoimmune pancreatitis: a journey2026-10-01OpenAlex10.1016/j.pan.2026.10.030Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223705459
W7221571537In Case You Missed It! Key Insights from the Infiltrative Cardiomyopathy Symposium2026-10-01OpenAlex10.1016/j.cardfail.2026.08.003Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221571537
W7224992736Infectious Disease Screening in Hematopoietic Cell Donors: Risk Assessment, Regulation, and Selective Donor Utilization2026-10-01OpenAlex10.1016/j.jtct.2026.10.049Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224992736
W7220967688Interconnecting diagnostic progress and management techniques in depression: A narrative review2026-10-01OpenAlex10.1016/j.heliyon.2026.e45571Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220967688
W7220908588Internet Infrastructure Science: The Transversal Coupling Substrate of Information, Computation, Agency, Execution, and Cross-System Propagation2026-10-01OpenAlex10.5281/zenodo.23247083Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220908588
W7223061574Interpreting the evidence and clinical implementation of anti-Aβ therapies in Alzheimer’s disease2026-10-01OpenAlex10.1016/j.medp.2026.100174Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223061574
W7223704059Lipid assessment and target attainment in acute coronary syndrome: a 10-year comparative review in a UK tertiary centre2026-10-01OpenAlex10.1093/eurheartj/ehag785.4161Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223704059
W7224089096Mechanisms, Impact, and Clinical Management of Cancer-Related Anorexia: A Narrative Review2026-10-01OpenAlex10.2147/cmar.s632267Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224089096
W7220722253Non-conventional histologies of prostate cancer: from morphology to biology-driven precision oncology2026-10-01OpenAlex10.1093/oncolo/oyag391Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220722253
W7223146384Non–Small Cell Lung Cancer2026-10-01OpenAlex10.1891/9780826163059.0017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223146384
W7221798867P2.368: Volrustomig as Single-Agent First-Line Therapy for Unresectable Pleural Mesothelioma: Substudy 5 of eVOLVE-02 Phase 2 Study2026-10-01OpenAlex10.1016/j.jtho.2026.105146Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7221798867
W7221760083P3.353: Association of CBR3 Rs8133052 With PFS in Relapsed SCLC Treated With Second-Line or Later Amrubicin2026-10-01OpenAlex10.1016/j.jtho.2026.105520Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221760083
W7224089748Pathological Characteristics of Vascular Microenvironment Injury and Nanotargeted Diagnostic and Therapeutic Pathways in Ischemic Stroke2026-10-01OpenAlex10.3724/j.pibb.2026.0497Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224089748
W7215060968Perioperative management of GLP-1 receptor agonists and SGLT2 inhibitors: An updated review for anesthesiologists2026-10-01OpenAlex10.4103/sja.sja_127_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215060968
W7221785998Pharmacological strategies for the prevention and treatment of proliferative vitreoretinopathy: A comprehensive review2026-10-01OpenAlex10.1016/j.survophthal.2026.10.005Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221785998
W7223552157Positivity rate of stress echocardiography using regional wall motion abnormalities in chronic coronary syndromes2026-10-01OpenAlex10.1093/eurheartj/ehag785.143Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223552157
W7222941959Psoriasis: Which therapy for which patient, updated, part I. Focus on Psoriasis Comorbidities and Preferred Systemic Agents.2026-10-01OpenAlex10.1016/j.jaad.2026.09.132Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7222941959
W7223448550Senotherapeutics: emerging pharmacological strategies for targeting cellular senescence2026-10-01OpenAlex10.22271/veterinary.2026.v11.i10sf.3909Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223448550
W7215068393Systemic treatments of psoriasis and atopic dermatitis in adults and children: from pharmacological targets to meta-analyses2026-10-01OpenAlex10.1016/j.therap.2026.09.045Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215068393
W7221246356Terapia combinada con GLP-1 e iSGLT2: ¿mayor impacto cardiorrenal?2026-10-01OpenAlexTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221246356
W7225013087The changing role of the gastroenterologist in the management of advanced gastric cancer2026-10-01OpenAlex10.1016/j.dld.2026.10.021Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225013087
W7221104708The landscape of hepatocellular carcinoma recurrence after liver transplantation: a nationwide 14-year study2026-10-01OpenAlex10.1016/j.jhepr.2026.102062Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221104708
W7224675922The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach2026-10-01OpenAlex10.23736/s2784-8671.26.08590-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224675922
W7223453318Therapeutic advances in pulmonary fibrosis2026-10-01OpenAlex10.1177/17534666261489541Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223453318
W7223699014Treatment escalation beyond triple therapy in patients with resistant hypertension: a population-based observational cohort study from UK healthcare records2026-10-01OpenAlex10.1093/eurheartj/ehag785.3056Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223699014
W7221365382[Guidelines for the diagnosis and management of multiple myeloma in China (2026 revision)].2026-10-01OpenAlex10.3760/cma.j.cn112138-20260803-00451Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221365382
W7215915262Atypical Pediatric Epilepsy: A Narrative Review of Classification, Diagnosis, and Emerging Therapeutics2026-10-02OpenAlex10.7759/cureus.117344Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215915262
W7216382703Autonomous Skill Development: Neuro-Symbolic Agents that Self-generate Verifiable Tools2026-10-02OpenAlex10.1007/978-3-032-40774-0_36Full textExcludedF2: Author explicitly decided to exclude ASD as a general-purpose skill-generation method illustrated by nutrition calculations. The full chapter evaluates38 nutrition formula/calculation/conversion tasks without a patient-care or clinical-diagnosis workflow. This applies the author-decided healthcare-primary boundary to this candidate.https://openalex.org/W7216382703https://link.springer.com/chapter/10.1007/978-3-032-40774-0_36Complete publisher HTML read through existing institutional browser; §4.1 benchmark/evaluation and method sections examined online.
W7221778545Autonomous Synergy: Artificial Intelligence Orchestration of Mobile Imaging Units, C-Arms, and Surgical Workflow in the Operating Suite2026-10-02OpenAlex10.53365/nrfhh.2902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221778545
W7215732191Comprehensive Therapeutic Approaches in Vitiligo2026-10-02OpenAlex10.4018/979-8-2600-0567-5.ch009Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215732191
W7204853348Cortical Spreading Depression and Migraine: Critical Review of a Neurophysiological Principle in the Third Millennium2026-10-02OpenAlex10.17352/gjmccr.000273Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7204853348
W7216249630DNA-Lang Evolver (snapshot 2026-10-02): governed evaluator contracts for agent-generated code candidates2026-10-02OpenAlex10.5281/zenodo.23102747Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7216249630
W7220360413Decoupling Memory from Context: Structured Memory for Token-Efficient Test-Time Continual Learning2026-10-02OpenAlex2610.0268710.48550/arxiv.2610.02687Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7220360413
W7215133373Editorial: Real world-evidence in radioligand therapy: above and beyond a tongue twister2026-10-02OpenAlex10.3389/fmed.2026.2002519Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215133373
W7215805236Emotional Echoes: A Spatialized VR Gallery for Revisiting and Reinterpreting Emotional Memory2026-10-02OpenAlex10.1145/3776574.3832535Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7215805236
W7215828824FAM45A-Mediated Persistent Memory-Like Fibroblast Reprogramming Drives PM2.5-Exacerbated Allergic Asthma2026-10-02OpenAlex10.1021/ehp.6c00353Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215828824
W7215034511Mapping the complement-targeted landscape in igA nephropathy: a systematic review with structured descriptive synthesis2026-10-02OpenAlex10.3389/fmed.2026.1933632Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215034511
W7216053816Preserving Assistive Identity Across Embodiments: A Knowledge-Driven AI Agent for Neurorehabilitation2026-10-02OpenAlex10.1007/978-3-032-40774-0_25Full textExcludedF4: Persistent knowledge/dialogue history is personalized to the same rehabilitation patient across robot and tablet embodiments. The system does not retain reusable agent-learning experience across different patients (P1).https://openalex.org/W7216053816https://link.springer.com/chapter/10.1007/978-3-032-40774-0_25Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read.
W7215740224Tools for providing information to patients about high-tech medical resources for treatment of cancer2026-10-02OpenAlex10.2340/1651-226x.2026.45529Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7215740224
W7220461082A Five-Decade Perspective on the Evolution of Gelatin and Collagen Technologies and Materials Used in Medical Devices2026-10-03OpenAlex10.3390/gels12100896Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220461082
W7219134088Agentic Artificial Intelligence Supporting Self-Management in Adults with Chronic Conditions: A Scoping Review protocol2026-10-03OpenAlex10.17605/osf.io/gxjzhTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219134088
W7220737405Benchmarking Psychological Dynamics in Generative Agents2026-10-03OpenAlex2610.0424610.48550/arxiv.2610.04246Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7220737405
W7219101357Hybrid Consciousness and the Cultural Evolution of Leadership2026-10-03OpenAlex10.31234/osf.io/cqywj_v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219101357
W7218922931NEURAL AGENCY, IDENTITY, PRIVACY & HUMAN-AI CO-ADAPTATION AT THE LIMIT Agency as Engineering, Neural Privacy, Identity Restraint, Longitudinal Consent, Digital Neural Twins, Reciprocal Adaptation, and Boundary Science2026-10-03OpenAlex10.5281/zenodo.23123779Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218922931
W7218831598Polycystic Ovary Syndrome: A Decade in Review (2016–2026)—Evolving Understanding and Current Therapeutic Approaches2026-10-03OpenAlex10.5281/zenodo.23120166Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7218831598
W7218440242Prevalence, Types, And Reasons for Therapeutic Switching in Hospitalized Children with Pneumonia: A Prospective Observational Study2026-10-03OpenAlex10.5281/zenodo.23119032Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7218440242
W7216334567The Role of Complement in ANCA-Associated Vasculitis2026-10-03OpenAlex10.1007/s40124-026-00391-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7216334567
W7218948106Write-Time Contracts for Self-Evolving LLM Agents: a Three-Way Ledger of Gain, Regression, and Cost2026-10-03OpenAlex10.5281/zenodo.23114793Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7218948106
W7219612410AUTONOMOUS REPAIR & SELF-HEALING INFRASTRUCTURE AT THE LIMIT Detection, Diagnosis, Local Repair, Verification, and the Rise of Persistent Infrastructure2026-10-04OpenAlex10.5281/zenodo.23146067Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7219612410
W7219775431An intelligent agent-enabled framework for last-mile workflow closure in hospital management of new medical technologies: OpenClaw as an Illustrative example2026-10-04OpenAlex10.1016/j.hlpt.2026.101333Full textExcludedF1: The publisher text identifies a commentary with illustrative workflow architecture and a future evaluation plan, without a primary adaptive-agent experiment.https://openalex.org/W7219775431https://www.sciencedirect.com/science/article/abs/pii/S2211883726001814Extensive publisher indexed body preview, three-layer framework and future evaluation sections.
W7219897597Chromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics ( GFCH )2026-10-04OpenAlex10.1002/ajh.70499Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7219897597
W7220462768Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy2026-10-04OpenAlex10.3390/cells15191812Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220462768
W7219602419KASK-Q → BITE → LASO Experimental Research Summary and Swarm Validation Status2026-10-04OpenAlex10.5281/zenodo.23131541Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7219602419
W7221571792Philosophy and civic education teachers as stakeholders in the socio-ecological knowledge chain2026-10-04OpenAlex10.3897/aca.9.e218132Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221571792
W7220831980Tirzepatide and Semaglutide in Type 2 Diabetes Mellitus and Obesity: A Comparative Assessment of Efficacy and Safety (Review)2026-10-04OpenAlex10.30895/2312-7821-2026-14-3-249-262Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220831980
W7220837409Adaptive Artificial Immune System-Based Diagnostic Agent for E-Maintenance Using Sliding Window Incremental Learning2026-10-05OpenAlex10.21272/jes.2026.13(2).e1Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7220837409
W7215052034An Integrated Approach to Cancer Therapy2026-10-05OpenAlex10.5281/zenodo.23076359Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7215052034
W7220676041Capability-Driven Self-Evolution of Agent Memory2026-10-05OpenAlex2610.0636110.48550/arxiv.2610.06361Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7220676041
W7220452462Cellular memory after cancer therapy: persistence after drug withdrawal, maintenance across cell divisions, and responses to rechallenge2026-10-05OpenAlex10.3389/fphar.2026.1966584Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220452462
W7220402936Editorial: Global perspectives on cyber statecraft: bridging theory and practice2026-10-05OpenAlex10.3389/fpos.2026.1968109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220402936
W7220445946Editorial: Health data science and AI in neuroscience & psychology2026-10-05OpenAlex10.3389/fncom.2026.2002192Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220445946
W7220572836Evolution, Role, and Challenges of Non-Governmental Organizations in India2026-10-05OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220572836
W7220702529Explainable AI-Driven Zero-Day Malware Detection Using Hybrid Transformer-Graph Networks in Cloud-Native Environments2026-10-05OpenAlex10.63544/8wxdhb56Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220702529
W7220367953Glucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition2026-10-05OpenAlex10.3389/fendo.2026.1969433Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220367953
W7220469952New and future treatments for IgA nephropathy2026-10-05OpenAlex10.33393/gcnd.2026.3838Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220469952
W7220432213Primary antiphospholipid syndrome: emerging strategies and current limitations in diagnosis and management2026-10-05OpenAlex10.1080/23995270.2026.2737657Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220432213; https://openalex.org/W7220406741
W7220386330SELF-CALIBRATING QUANTUM BIOSENSING NETWORKS AT THE LIMIT Distributed Sensing, Reference Transfer, Drift Detection, and Autonomous Recalibration2026-10-05OpenAlex10.5281/zenodo.23166767Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220386330
W7221190469Targeted Pharmacological Therapies in Pulmonary Arterial Hypertension: From Endothelin, Nitric Oxide and Prostacyclin to Bmp/Activin Signalling2026-10-05OpenAlex10.61096/ijrpp.v15.i4.2026.1338-1358Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221190469
W7220694397Contemporary Pharmacotherapy of Myocardial Infarction: Recent Advances, Precision Medicine, and a Clinical Pharmacy Perspective Contemporary Pharmacotherapy of Myocardial Infarction2026-10-06OpenAlex10.5281/zenodo.23186359Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220694397
W7220682722Exploring the immunological effects of antibody–drug conjugates2026-10-06OpenAlex10.1038/s41571-026-01209-zTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220682722
W7220650550Genetic Counseling2026-10-06OpenAlex10.1007/s40124-026-00395-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220650550
W7220743482HUMAN-AI COEVOLUTION FOR NEURAL DISCOVERY AT THE LIMIT AI Candidate Generation, Human Scientific Judgment & Persistent Research Memory2026-10-06OpenAlex10.5281/zenodo.23196046Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220743482
W7220726012Osteoporosis in Pediatric Orthopaedics: Congenital Diseases, Medical Management, and Perioperative Considerations2026-10-06OpenAlex10.1007/s11914-026-00985-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220726012
W7220726583PREreview of "RSI-Router: Evolving Subtask-Level LLM Routing and Skills for Cost-Efficient Agents"2026-10-06OpenAlex10.5281/zenodo.23176617Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7220726583
W7220665688Redefining leptomeningeal metastasis in non–small cell lung cancer: From terminal complication to molecularly managed disease2026-10-06OpenAlex10.1002/cncr.70624Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220665688
W7220983594The Changing Role of AI Agents in Science Must be Recognized2026-10-06OpenAlex10.20944/preprints202610.0343.v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7220983594
W7225065647Acute transverse myelitis associated with cytomegalovirus in an immunocompetent patient: a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261695Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225065647
W7220965913AlarmClaw: Context-Enriched Alarm Management with Category-/Severity-Aware Incident Graphs2026-10-07OpenAlex10.1145/3832783.3834524Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220965913
W7225035181Atypical neuropsychiatric manifestation of cerebral amyloid angiopathy-related inflammation (CAA-Ri): a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261789Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225035181
W7225054639Carbamazepine-induced DRESS syndrome associated with autoimmune hemolytic anemia in a pediatric patient with focal epilepsy: a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261403Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225054639
W7225061835Central nervous system demyelination associated with tumor necrosis factor inhibitor exposure in a patient with ankylosing spondylitis2026-10-07OpenAlex10.65034/anpabstract_cbn261606Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225061835
W7225045969Concomitant Castleman syndrome and secondary progressive multiple sclerosis: a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261586Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225045969
W7221040452Emerging Frontiers of Biomedical Applications of PLGA : Where Do We Stand?2026-10-07OpenAlex10.1002/app.71617Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221040452
W7220856167Hydrodynamic controls and sedimentary responses of eddy bars during outburst floods2026-10-07OpenAlex10.1016/j.catena.2026.110656Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220856167
W7225061409Levamisol-induced leukoencephalopathy in a chronic cocaine user: a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261942Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225061409
W7225056282Longitudinally extensive transverse myelitis as the initial manifestation of neuro-Behçet disease: a case report2026-10-07OpenAlex10.65034/anpabstract_cbn261648Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225056282
W7225041071Myasthenic crisis triggered by COVID-19: a rare description2026-10-07OpenAlex10.65034/anpabstract_cbn261330Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225041071
W7220864130Neuromics: biomarkers discovery to precision diagnostics in neurotrauma2026-10-07OpenAlex10.1038/s41540-026-00792-2Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220864130
W7225039166Parvovirus B19 encephalitis: a case series with clinical analysis and neurological outcomes in immunocompetent patients in Sergipe2026-10-07OpenAlex10.65034/anpabstract_cbn260483Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225039166
W7220932552Pathway-guided and patient-centred therapeutic strategies in atherosclerotic cardiovascular disease2026-10-07OpenAlex10.1093/eurjpc/zwag523Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220932552
W7224134816Probiotics and postbiotics in caries and periodontal prevention: mechanisms, clinical evidence, and trajectory of the field2026-10-07OpenAlex10.62486/dent2026272Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224134816
W7220854834Pulmonary Delivery Using Liposomal Systems2026-10-07OpenAlex10.1201/9781779644329-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220854834
W7225037633When standard therapy fails: azathioprine in refractory pediatric erythema nodosum leprosum with progressive neural damage2026-10-07OpenAlex10.65034/anpabstract_cbn261863Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225037633
W7221019026A Multi-Agent Framework for Diagnosis and Plan Repair in Knowledge Graph Question Answering2026-10-08OpenAlex10.21203/rs.3.rs-11099883/v1Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7221019026
W7220917508Beyond the Needle: Transforming Traditional Healthcare with Microneedle Drug Delivery Systems2026-10-08OpenAlex10.3390/pharmaceutics18101274Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220917508
W7220953163Bone Radiopharmaceuticals: Evolution from Palliative Therapy to Targeted Precision Oncology and Theranostics2026-10-08OpenAlex10.3390/biology15191784Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220953163
W7220891917Case Report: Coexpression of somatic EGFR, BRCA1, and BRCA2 mutations in metastatic non-small cell lung cancer2026-10-08OpenAlex10.3389/fonc.2026.1964203Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220891917
W7220947966Etomidate vaping: A new form of anesthetic abuse2026-10-08OpenAlex10.1080/00952990.2026.2739864Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220947966
W7220940630Evaluating Low-Shot Procedural Skill Transfer in Language-Agent Debugging2026-10-08OpenAlex10.1145/3843282.3844421Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7220940630
W7220898246Evolution of Aptamer-Controlled Liposomal Drug Delivery Systems: From Molecular Recognition to Precision-Controlled Drug Release2026-10-08OpenAlex10.5281/zenodo.23242150Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220898246
W7220900277From task-specific AI to multimodal foundation models in PET/CT: a readiness framework for clinical translation2026-10-08OpenAlex10.3389/fnume.2026.1956567Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220900277
W7220936425Neural Repair Therapies After Stroke: I. Therapeutic Advances2026-10-08OpenAlex10.1161/strokeaha.126.056092Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7220936425
W7221056542OOM-RL II: Reality Is an Oracle, Not a Debugger — Supplementary Dataset S12026-10-08OpenAlex10.5281/zenodo.23215520Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221056542
W7221136546SpatialOmicsLab: an integrated research environment for AI co-scientists in spatial transcriptomics2026-10-08OpenAlex10.64898/2026.10.01.756049Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221136546
W7221224434Super Intelligence in Healthcare: A Systematic Review of Systemic Risks, Ethical Dilemmas, and Governance Frameworks2026-10-08OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221224434
W7220967720The Resistance Constellation Across the Sepsis–Uropathogen Continuum: A Thirteen-Year Atlas of Epidemiological Expansion, Resistance Kinetics, and Progressive Therapeutic Attrition2026-10-08OpenAlex10.3390/pathogens15101066Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220967720
W7220931355Therapie der Lungenfibrose – Beginn einer neuen Ära2026-10-08OpenAlex10.1055/a-2959-4770Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7220931355
W7221075670A Pilot Study on the Effect of In Vitro-Induced Antibiotic Resistance on Biofilm Formation by Uropathogenic Escherichia coli2026-10-09OpenAlex10.3390/bacteria5040065Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221075670
W7221105088Antibiofilm Activity of Pulsed Laser-Ablated Gold Nanoparticles against Biofilm-Forming Bacterial Pathogens2026-10-09OpenAlex10.1007/s11468-026-03495-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221105088
W7221812337Evolving Molecular Drug Targets in Pancreatic Cancer: An Updated Review2026-10-09OpenAlex10.2174/0115680096481382261002063656Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221812337
W7221123645From challenges to solutions: insights into AIEgen-based diagnostic and therapeutic strategies for breast cancer2026-10-09OpenAlex10.1016/j.ccr.2026.218616Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221123645
W7221166466Managing diabetes and thrombosis with snake venom–derived therapies2026-10-09OpenAlex10.1016/b978-0-443-44394-7.00012-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221166466
W7221416445Oral Obesity Medicines in the Era of Cardiovascular–Kidney–Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease Modification2026-10-09OpenAlexTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221416445; https://openalex.org/W7221732224; https://openalex.org/W7221123779
W7221180267The complexity paradox of generalist AI agents in medicine: exploring GPT-5 for real-world multimodal medical diagnosis2026-10-09OpenAlex10.1038/s41746-026-03325-7Title/abstractExcludedE4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement.https://openalex.org/W7221180267
W7221308244Beyond Detection: Generative Artificial Intelligence for Autonomous Cyber Threat Hunting and Incident Response2026-10-10OpenAlex10.32628/ijsraiml2624121Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221308244
W7221815947EnactOpt: Diagnosis-Guided Harness Evolution for Embodied Agents2026-10-10OpenAlex2610.1497710.48550/arxiv.2610.14977Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7221815947
W7221521489From Trajectories to Experience: A Survey of Experience-Driven LLM Agents2026-10-10OpenAlex10.20944/preprints202610.0937.v1Title/abstractExcludedE1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent.https://openalex.org/W7221521489
W7221359159Interferon Therapy in Acute Myeloid Leukemia: Biological Rationale, Clinical Evidence, and Future Directions2026-10-10OpenAlex10.3390/cancers18203266Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221359159
W7221508616Pyoderma gangrenosum: Clinico-diagnostic approach and skin ulcer care2026-10-10OpenAlex10.21518/ms2026-395Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221508616
W7223032326The Evolving Landscape of HPV-related Cervical Malignancies2026-10-10OpenAlex10.65161/ojssc26.recbbu7am4desss33Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223032326
W7224939449The Lp(a) gap: Practical steps to align primary care and lipid clinics2026-10-10OpenAlex10.70401/alr.2026.0010Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224939449
W7223312918[Advances in agent-based modeling for infectious disease simulation and intervention].2026-10-10OpenAlex10.3760/cma.j.cn112338-20251226-00927Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7223312918
W7221345822Nanoparticle-Based Cancer Therapeutics: From Synthesis to Clinical Applications2026-10-11OpenAlex10.58445/rars.4249Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221345822
W7221516384Postoperative Vasoactive Exposure Patterns and Outcomes After Non‐Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort2026-10-11OpenAlex10.1111/aas.70355Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221516384
W7221562984AELYRION-NOÛLITH III: Exact Resonance Geometry of Restricted Observations, Intrinsic Calibration Rigidity, and Sharp Synchronization Bounds2026-10-12OpenAlex10.5281/zenodo.23325374Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221562984
W7221479841Agile AI Agentic Neural Based Framework for Complex Workflow Forming, with Multiple Implementations Upon Upstream and Downstream Scenarios2026-10-12OpenAlex10.2118/234416-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221479841; https://openalex.org/W7211962888
W7221572733Cardiovascular And Renal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors in Patients Without Diabetes: A Review of Current Evidence2026-10-12OpenAlex10.5281/zenodo.23314088Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221572733
W7221554479Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions2026-10-12OpenAlex10.3390/cancers18203290Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221554479
W7221565207Newcastle disease virus: Insights into molecular epidemiology, dynamics of distribution and diagnostics2026-10-12OpenAlex10.1080/03079457.2026.2746602Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221565207
W7221505698PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY2026-10-12OpenAlex10.5281/zenodo.23309825Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221505698
W7221533065Precision biologics in pediatric inflammatory bowel disease: Current evidence and emerging predictors2026-10-12OpenAlex10.5409/wjcp.125410Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221533065
W7165112275Retinal neurodegeneration as accelerated ocular aging: a review of nutritional and metabolic supplements2026-10-12OpenAlex10.3389/fragi.2026.1912337Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7165112275
W7221478463Short-film–based world café for faculty development in medical humanities: a mixed-method evaluation across three teaching hospitals2026-10-12OpenAlex10.1186/s12909-026-10584-1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221478463
W7221551061TA-TMA as a clinical model for precision complement therapeutics in stem cell transplantation2026-10-12OpenAlex10.3389/fimmu.2026.1959683Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221551061
W7221683819The Expanding Therapeutic Landscape in Myasthenia Gravis2026-10-12OpenAlex10.1002/mus.70418Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221683819
W7221517944Understanding and clinical approach to early T-cell precursor acute lymphoblastic leukemia2026-10-12OpenAlex10.1007/s44313-026-00181-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221517944
W7221623286Current management and emerging pharmacotherapeutic strategies in acute promyelocytic leukemia2026-10-13OpenAlex10.1080/14656566.2026.2749650Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221623286
W7221662113Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II2026-10-13OpenAlex10.3389/fimmu.2026.2005017Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221662113
W7221651253From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease2026-10-13OpenAlex10.3389/fphar.2026.1784959Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221651253
W7221533918Mapping the knowledge landscape and identifying frontiers of mitochondrial dysfunction in sepsis-associated acute kidney injury: a four-decade bibliometric and visualized analysis2026-10-13OpenAlex10.1007/s00210-026-05984-5Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221533918
W7221676600Visual Biopolitics in Crisis: Multimodal Analysis of Tuberculosis in the Early Republican Period and COVID-19 Health Communication in Turkey2026-10-13OpenAlex10.1080/10410236.2026.2743158Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221676600
W7222169847When Help Threatens and When Users Over-Rely: Proactive and Reactive Help from Intelligent Agents2026-10-13OpenAlex10.26083/tuda-8526Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222169847
W7222780507A responsabilidade civil médica no Brasil sobre erro de diagnóstico assistido por Inteligência Artificial2026-10-14OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222780507
W7221800782Adaptive Switching Between Parallel-World Self-Reflection and Mutual Reflection for Multiple Large Language Models2026-10-14OpenAlex10.5281/zenodo.23357371Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221800782
W7221783728Adaptive Switching Between Self-Mechanisms and Mutual Mechanisms in Multiple Large Language Models: A Unified Framework for Dynamic Intelligence Coordination2026-10-14OpenAlex10.5281/zenodo.23357069Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221783728
W7221728852Ai Enabled Digital Twins Enabling Integrated Production Optimization and Autonomous Operations2026-10-14OpenAlex10.2118/234113-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221728852
W7221765090Akute Herzinsuffizienz – Management in den ersten 120 min2026-10-14OpenAlex10.1007/s00063-026-01502-wTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221765090
W7221646405Correction: Tumor-immune microenvironment and nutritional status biomarkers predict recurrence after total colectomy for locally advanced colon cancer: development and internal validation of a nomogram2026-10-14OpenAlex10.3389/fgene.2026.1998945Title/abstractExcludedE5: Correction/retraction, ancillary record, or abstract absent and title uninformative.https://openalex.org/W7221646405
W7221780330Durable benefit of immunotherapy in metastatic Epstein–Barr virus-positive nasopharyngeal carcinoma with cutaneous metastases (lethalides): a case report and review of the literature2026-10-14OpenAlex10.37349/emed.2026.1001431Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221780330
W7221826183Emerging therapies for knee osteoarthritis2026-10-14OpenAlex10.1038/s41584-026-01441-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221826183
W7222239501External Analysis of Protected Data2026-10-14OpenAlex10.5281/zenodo.23377116Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222239501
W7221777261Frailty Status and Medication Use Among U.S. Older Adults: Evidence From NHANES , 1999–20202026-10-14OpenAlex10.1111/jgs.70759Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221777261
W7221766826Next-generation CDK inhibitors in HR+/HER2– breast cancer2026-10-14OpenAlex10.1172/jci207631Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221766826
W7221821144Students as change agents for societal challenges –2026-10-14OpenAlex10.15845/norsotl.4954Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7221821144
W7221774513The Architecture of Permanence Full Technical Report on Topological Continual Backpropagation (Topo-CBP)2026-10-14OpenAlex10.5281/zenodo.23363008Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221774513
W7221810553Tumor lysis syndrome in breast cancer: a systematic review of the literature2026-10-14OpenAlex10.3389/fonc.2026.1937565Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221810553
W7222457091AI‑Driven Meta‑Governance: How Autonomous Systems Can Govern Other AI Models in Real Time2026-10-15OpenAlex10.64235/a4sfnk4Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222457091
W7222162327Acute Respiratory Infections in Children: Current Approaches to Etiological Diagnosis and Prediction of Severe Disease (Literature Review)2026-10-15OpenAlex10.33619/2414-2948/131/31Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222162327
W7222165196Adaptive Self-Reflection and Inter-Reflection in Self-and-Inter Models: A Unified Framework for Model-Level Metacognition and Dynamic Reflective Coordination2026-10-15OpenAlex10.5281/zenodo.23385023Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222165196
W7222002247Adaptive Self–Mutual Diagnosis in Self–Mutual Models: A Unified Framework for State-Dependent Switching Between Internal and Cross-Model Diagnosis2026-10-15OpenAlex10.5281/zenodo.23385000Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222002247
W7221887000AuditTune campaign evidence: experiment ledger, agent-written planner code, and figure-generation scripts for auditable policy adjustment in reinforcement learning control2026-10-15OpenAlex10.17632/jhgknm378rTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7221887000
W7222191808Evolving infectious epidemiology in acute myeloid leukemia in the contemporary era: a 13-year retrospective, single-center analysis of induction therapies2026-10-15OpenAlex10.1007/s00277-026-07323-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222191808
W7222099174IMPROVING THE METHODOLOGY FOR DEVELOPING STUDENTS' COMMUNICATIVE COMPETENCE BASED ON INTERACTIVE AND DIGITAL TECHNOLOGIES IN TEACHING RUSSIAN AS A FOREIGN LANGUAGE2026-10-15OpenAlex10.66301/m1daa165Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222099174
W7221931397Novel therapeutics for platinum-resistant ovarian cancer: from biological mechanisms to emerging biomarker-guided strategies2026-10-15OpenAlex10.1186/s10020-026-01670-7Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7221931397
W7222060373The Evolving Landscape of Hypertrophic Cardiomyopathy Treatment: Are Guidelines Keeping Pace?2026-10-15OpenAlex10.1097/mjt.0000000000002245Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222060373
W7221863624Urticaria (Shara): A Narrative Review of Contemporary and Unani Perspectives2026-10-15OpenAlex10.22270/jddt.v16i10.7996Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7221863624
W7222495213C-MOP: A Narrative Review and Clinical Framework for Adjunctive Repurposed-Drug Therapy in Active Cancer2026-10-16OpenAlex10.20944/preprints202610.1598.v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222495213
W7222506783Integrated Disease Management of Tomato Early Blight: A Critical Narrative Review of Pathogen Complexity, Host Resistance and Sustainable Control2026-10-16OpenAlex10.9734/jsrr/2026/v32i104624Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222506783
W7222699158POLYMERIC NANOSPHERES FOR ORAL DRUG DELIVERY: EMERGING FORMULATION TECHNOLOGIES, TRANSLATIONAL CHALLENGES, AND FUTURE CLINICAL PERSPECTIVES2026-10-16OpenAlex10.25258/ijddt.16.72s.78Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222699158
W7222568181Urogenital Infections2026-10-16OpenAlex10.1201/9781003632214-10Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222568181
W7222783243Adaptive Switching Between Self-Mechanisms and Mutual Mechanisms Under Uncertainty: A General Framework for Uncertainty-Aware Coordination in Multiple Large Language Models2026-10-17OpenAlex10.5281/zenodo.23434770Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222783243
W7222838576The Omegacene. Three Thresholds of Self-Transformation and a Criterion for Their Refutation2026-10-17OpenAlex10.5281/zenodo.23438027Title/abstractExcludedE1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system.https://openalex.org/W7222838576
W7222825060The Self-and-Mutual-and-Action Model: A General Computational Framework for Adaptive Coordination Between Individual Processing, Interactive Mechanisms, and Goal-Directed Action2026-10-17OpenAlex10.5281/zenodo.23434721Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222825060
W7222815952The Self-and-Mutual-and-Meta Model: A General Computational Framework for Adaptive Coordination, Selection, and Regulation of Autonomous and Interactive Mechanisms2026-10-17OpenAlex10.5281/zenodo.23434018Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7222815952
W7222894075Use of vaginal estrogens in urogynecology: current evidence, controversies and clinical applications2026-10-18OpenAlex10.1097/gco.0000000000001157Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222894075
W7222936021A Paradox Perspective2026-10-19OpenAlex10.4324/9781003515616-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222936021
W7222939961Handbook of Agentic Pharmacy: Foundations, Architecture, and Applications2026-10-19OpenAlex10.5281/zenodo.23474649Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7222939961
W7223037574Quarto Manuals: A Starter Template and Framework for Notebook-Driven Scientific Software Operations Manuals2026-10-19OpenAlex10.5281/zenodo.23518396Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223037574
W7222946051Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence2026-10-19OpenAlex10.1016/j.ijid.2026.109186Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222946051
W7222920012SEGURANÇA DO PACIENTE NA CIRURGIA ROBÓTICA: ATUAÇÃO DA ENFERMAGEM PERIOPERATÓRIA2026-10-19OpenAlex10.47820/recima21.v7i10.9277Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222920012
W7222957580SY24-2 Recent updates in the systemic therapy for advanced HCC2026-10-19OpenAlex10.1016/j.annonc.2026.07.061Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222957580
W7222978766Targeted Medical Interventions for the Prevention and Treatment of Viral Hemorrhagic Fever: A Rapid Systematic Review of Updated Intelligence from the 74th Annual Meeting of the American Society of Tropical Medicine and Hygiene2026-10-19OpenAlex10.3390/tropicalmed11100296Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7222978766
W7222957977Translational assessment of nursing care models for oncology patients with cardiovascular risk factors2026-10-19OpenAlex10.3389/fcvm.2026.1834086Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7222957977
W7223054260Advancing gender equity and inclusive digital futures through responsible agentic artificial intelligence governance2026-10-20OpenAlex10.1007/s44282-026-00624-yTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223054260
W7223045273DAn building blocks for integrated care co-design, source 1: Italian project sheets from a national conference2026-10-20OpenAlex10.5281/zenodo.23506196Full textExcludedF1: This deposit is explicitly supporting working material for a separate submitted integrated-care co-design paper, consisting of project-sheet decomposition guides/summaries and registry data. It does not itself report an evaluated clinical LLM cross-case improvement method.https://openalex.org/W7223045273https://zenodo.org/records/23506196Complete indexed repository description; deposited files not read or downloaded.
W7223059667DAn building blocks for integrated care co-design, source 4: a white paper of policy proposals2026-10-20OpenAlex10.5281/zenodo.23506381Full textExcludedF1: This deposit is explicitly ancillary working material for the same submitted co-design paper, describing policy-source decomposition and author-refined registry rules, rather than an evaluated clinical LLM cross-case improvement method.https://openalex.org/W7223059667https://zenodo.org/records/23506381Complete indexed repository description; deposited files not read or downloaded.
W7223047696Editorial: Kidney cancer awareness month 2025: current progress and future prospects on kidney cancer prevention, diagnosis and treatment2026-10-20OpenAlex10.3389/fonc.2026.2018903Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223047696
W7223032002Editorial: Liver diseases – from pathophysiology to new treatment options2026-10-20OpenAlex10.3389/fimmu.2026.2020350Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223032002
W7223067728Editorial: Predictive biomarkers to immune checkpoint inhibitors in lung cancer2026-10-20OpenAlex10.3389/fimmu.2026.2011872Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223067728
W7223062563Marine Natural Products with Novel Mechanisms of Action: From Disrupting Gene Expression to Reshaping the Tumor Microenvironment and Beyond2026-10-20OpenAlex10.3390/chemistry8100145Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223062563
W7223032108Nanomedicine and the innate immune system: immunogenicity, nanoparticle-immune cell interactions and implications for cancer immunotherapy2026-10-20OpenAlex10.3389/fimmu.2026.1946595Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223032108
W7223091550AI agent planning, learning, and adaptation2026-10-21OpenAlex10.1201/9781003753728-4Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7223091550
W7223159227Artificial Intelligence Triage for Snakebite Envenoming Under Variable Antivenom Stock-Out Conditions: A Constraint-Aware Evaluation of Referral Timing Errors Across Rural Health Centres2026-10-21OpenAlex10.5281/zenodo.23542140Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223159227
W7223148967Artificial Intelligence in the Next Decade: Opportunities, Risks, and a Proposed Framework for Human-Centered AI Adoption2026-10-21OpenAlex10.64388/irev10i4-1724023Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223148967
W7223099046Brain cytoprotection in acute ischemic stroke in the reperfusion era: neuroimmune networks, clinical evidence, and translational barriers2026-10-21OpenAlex10.3389/fimmu.2026.1984227Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223099046
W7223150075Cognitive Task Substitution, Cognitive Offloading, and Behavioral Dependency on Artificial Intelligence-Assisted Technologies: A Scoping Review2026-10-21OpenAlex10.7759/cureus.118334Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223150075
W7223572491Fifth Universal Definition of Myocardial Infarction and an update on lipoprotein(a) and inflammation2026-10-21OpenAlex10.1093/eurheartj/ehag840Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223572491
W7223238610MOSAIC: An Omni-Modal Benchmark for Long-Term Memory and Cross-Modal Reasoning in Conversational Agents2026-10-21OpenAlex2610.2924910.48550/arxiv.2610.29249Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7223238610
W7223154226Robust Safe Reinforcement Learning2026-10-21OpenAlex10.17635/lancaster/thesis/3472Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223154226
W7223136719Targeting Peripheral T-Cell Lymphomas with Chimeric Antigen Receptor Therapy: Mechanistic Challenges, Clinical Landscape and Future Engineering Perspectives2026-10-21OpenAlex10.3390/cancers18203400Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223136719
W7224735635Artificial Intelligence in Social Science, Humanities and Health: A Path Towards Trustworthy AI and Human-AI Symbiosis2026-10-22OpenAlex10.2174/97988988181661260101Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224735635
W7223693614Case Report of Atypical Steven Johnson Syndrome in a Paediatric Patient2026-10-22OpenAlex10.33178/smj.2026.11Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223693614
W7223177063Nanoparticle-based T-cell engagers: from T-cell redirection to programmable immune platforms2026-10-22OpenAlex10.1186/s12951-026-05178-4Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223177063
W7224691341Probabilistic Modeling for Trustworthy Computer Vision2026-10-22OpenAlexTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224691341
W7223171620Rehabilitating the nation2026-10-22OpenAlex10.4324/9781003748373-5Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223171620
W7223246894Thanks for Nothing: Gratitude, Model Revisability, and the Practice of Realizing Emptiness2026-10-22OpenAlex10.5281/zenodo.23402516Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223246894
W7223199350VulnPilot: A Multi-agent LLM Framework for Automated Penetration Testing2026-10-22OpenAlex10.1007/978-981-92-6843-6_5Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7223199350
W7223178493What would John Maynard Keynes say about contemporary oral health? Reflections on preferences, social conventions, and marketisation2026-10-22OpenAlex10.3389/froh.2026.1986109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223178493
W7223280583Artificial Intelligence2026-10-23OpenAlex10.4324/9781003631958-3Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223280583; https://openalex.org/W7155703509; https://openalex.org/W4402403884
W7163523187Artificial Intelligence Applications in Pregnancy, Childbirth, and the Postpartum Period: A Scoping Review2026-10-23OpenAlex10.3390/nursrep16110377Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163523187
W7223365583Holding the Whole Portfolio, Ethical Data Infrastructure for AI in Art Therapy2026-10-23OpenAlex10.4324/9781003631958-14Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223365583
W7223509741Screening Models and Evaluation Techniques for Neuromuscular Blocking Agents: From Animal Studies to Clinical Applications2026-10-23OpenAlexTitle/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7223509741; https://openalex.org/W7113901599
W7223448578Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates in Children: A Three-Year Study From North India2026-10-23OpenAlex10.7759/cureus.118483Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223448578
W7223319057The neutrophilic dermatitides: a contemporary reassessment of pathophysiological mechanisms, clinical phenotypes and therapeutic stratification2026-10-23OpenAlex10.18203/issn.2455-4529.intjresdermatol20263750Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223319057
W7224604889Unlocking Cardiovascular Health: The Synergy of Genetics, Pharmacotherapy, Comorbidities, and Herbal Medicine2026-10-23OpenAlex10.5530/ijper.20274003Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224604889
W7223695754[Expert consensus on detection and clinical application of alterations in PIK3CA/AKT1/PTEN genes (2026 edition)].2026-10-23OpenAlex10.3760/cma.j.cn112152-20260430-00218Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223695754
W7223442647C.E.R.B.E.R.U.S. — Acute Biological Containment: A Systems Architecture for Biological Threat Detection, Emergency Containment, and Protective Intervention2026-10-24OpenAlex10.17605/osf.io/n3gjaTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223442647
W7223452112From mutations to relapse: Transcriptional rewiring, leukemic stem cell persistence, and therapeutic resistance in acute myeloid leukemia: A systematic review2026-10-24OpenAlex10.1016/j.humgen.2026.201613Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223452112
W7223441585Killing Mr. Renton; or, How to Turn a Murder into an International Incident2026-10-24OpenAlex10.1093/dh/dhag051Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7223441585
W7223456656LongHaul-Bench: A Reproducible Benchmark for Long-Horizon Reliability of Self-Improving LLM Agents Under Industrial Edge Constraints2026-10-24OpenAlex10.5281/zenodo.23624798Title/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7223456656
W7223477369MRI of brain metastases in the era of immunotherapy, targeted agents, and artificial intelligence: from detection to treatment response assessment2026-10-24OpenAlex10.1007/s10334-026-01433-9Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223477369
W7223455476OmiCairn: an accountable self-learning platform for hypothesis-driven biomedical multi-omics analysis2026-10-24OpenAlex10.5281/zenodo.23619723Full textExcludedF2: The primary tasks are multi-omics biological discovery and hypothesis testing; no clinical patient-care/diagnostic main task is established.https://openalex.org/W7223455476https://zenodo.org/records/23619724Complete repository description/abstract; ZIP contains supplementary materials, not downloaded/opened.
W7223453599PGMem 1.2.1: Reference implementation, synthetic dataset and Colab notebook for "Provenance-governed agentic AI for personal knowledge and memory support: a framework and rule-level demonstration"2026-10-24OpenAlex10.5281/zenodo.23618804Title/abstractExcludedE3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent.https://openalex.org/W7223453599
W7223466710Severe Chronic Constipation and Fecaloma in a Patient With Partial Agenesis of the Corpus Callosum: A Case Report2026-10-24OpenAlex10.7759/cureus.118495Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223466710
W7223575764Qe[ŋɯ]-SÆORYN // ƎR: A Proof-Carrying Architecture for Game-Driven Algorithmic Self-Improvement, Exact Behavioral Retention, and Cost-Optimal Error-Correcting Experiments2026-10-25OpenAlex10.5281/zenodo.23649449Title/abstractExcludedE2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task.https://openalex.org/W7223575764
W7223697985What Remains of Dr. Watson? Boundary-Constrained Dialogue for Human–LLM Decision Support and Training2026-10-25OpenAlex10.5281/zenodo.23653109Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223697985
W7223659602[Evolution of later-line treatment strategies for advanced colorectal cancer: seeking balance between survival benefit and quality of life].2026-10-25OpenAlex10.3760/cma.j.cn441530-20260323-00127Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223659602
W7223805804Advances in Invasive Breast Cancer: Emerging Diagnostic Tools and Evolving Therapeutic Approaches2026-10-26OpenAlex10.20944/preprints202610.2475.v1Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7223805804
W7223662901Developing a community of practice in health professions education: reflections from the Africa HPE ECHO project2026-10-26OpenAlex10.61473/001c.170559Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223662901
W7223673128IgA nephropathy: evolving pathogenic concepts and emerging targeted therapies2026-10-26OpenAlex10.1016/j.humimm.2026.112112Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223673128
W7223684468Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications2026-10-26OpenAlex10.1016/j.addr.2026.115980Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223684468
W7223682757Optimizing cefiderocol use in clinical practice2026-10-26OpenAlex10.1097/qco.0000000000001243Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223682757
W7224121018PO011 | A TWO CENTERS REAL-WORLD EXPERIENCE WITH ANTI-XA DIRECT ORAL ANTICOAGULANTS IN CANCER PATIENTS WITH UNUSUAL SITE VEIN THROMBOSIS2026-10-26OpenAlex10.4081/btvb.2026.827Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224121018
W7223794340RoboDoctor: Training-Free Recursive Self-Improvement for Robot Policies2026-10-26OpenAlex2610.3560410.48550/arxiv.2610.35604Title/abstractExcludedE2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task.https://openalex.org/W7223794340
W7223897458Beyond screen time: artificial intelligence, algorithmic media and the future of child health2026-10-27OpenAlex10.18203/2349-3291.ijcp20263830Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223897458
W7223790825Editorial: Targeted therapies in gastric cancer: molecular signatures and immune microenvironment insights2026-10-27OpenAlex10.3389/fimmu.2026.2013952Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223790825
W7223942482Gastric Ulcer 2030: Insights from yesterday, today and future trends2026-10-27OpenAlex10.5281/zenodo.23685251Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223942482
W7223974776HER2 in mullerian malignancies: diagnostic challenges and the emerging HER2-low paradigm2026-10-27OpenAlex10.5468/ogs.26195Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223974776
W7224025336New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer2026-10-27OpenAlex10.6004/jnccn.2026.7061Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224025336
W7224119680Nipah Virus (NiV) in Focus: Molecular Insights Into Pathogenesis, Transmission Dynamics, and Evolving Epidemiology From Malaysia to Recent Indian Outbreaks2026-10-27OpenAlex10.1002/rmv.70221Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224119680
W7224132980Pulmonary hypertension: modern approaches to diagnosis and treatment2026-10-27OpenAlex10.51922/2074-5044.2026.4.110Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224132980
W7223830503Sixteen-Year Trends in Antimicrobial Resistance among Enterobacteriaceae Causing Bloodstream Infections in a Tertiary Teaching Hospital in Iran: A Joinpoint Regression Analysis2026-10-27OpenAlex10.21203/rs.3.rs-11215097/v1Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223830503
W7223914181The immunological landscape of antibody-drug conjugates: from target to payload biology2026-10-27OpenAlex10.3389/fimmu.2026.1964101Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7223914181
W7224118943Animal Venoms as a Source of Therapeutics: Insights into Anticancer, Cardiovascular, Antimicrobial, Analgesic, Antiparasitic and Emerging Applications2026-10-28OpenAlex10.5281/zenodo.23727410Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224118943
W7224463072HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation2026-10-28OpenAlex10.1186/s40164-026-00850-9Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224463072
W7163581084Large language models in healthcare simulation education: a bibliometric analysis of simulation approaches and non-technical skills2026-10-28OpenAlex10.1007/s44186-026-00592-6Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7163581084
W7224859663MAS-Loop: Beyond One-Shot Orchestration towards Self-Evolving Multi-Agent Systems2026-10-28OpenAlex2610.3894610.48550/arxiv.2610.38946Title/abstractExcludedE2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task.https://openalex.org/W7224859663
W7224120316Management strategies of noninfectious scleritis: An update2026-10-28OpenAlex10.4103/ijo.ijo_1004_26Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224120316
W7224094994Polysaccharides in Modern Therapeutics: Structural Diversity, Delivery Platforms, and Antitumor Applications2026-10-28OpenAlex10.1080/1061186x.2026.2756476Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224094994
W7223879639Potassium-Competitive Acid Blockers in GERD and Helicobacter pylori Infection: The Emerging Role of Fexuprazan2026-10-28OpenAlex10.1007/s40265-026-02379-xTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7223879639
W7224119183The evolution of therapeutics: A comparative review of small-molecule drugs and RNA-based medicines2026-10-28OpenAlex10.1016/j.nxnano.2026.100902Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224119183
W7224229087A Digital Ecosystem Using Artificial Intelligence Solutions in Musculoskeletal Health Care2026-10-29OpenAlex10.1002/arj.70704Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224229087
W7224501981Engineering smart liposomes to combat antimicrobial resistance: from mechanistic design to clinical translation2026-10-29OpenAlex10.1080/14787210.2026.2756297Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224501981
W7224650435Intratumoral Therapeutic Injections for Lung Cancer: Current Evidence, Personalized Therapeutic Approaches, and Future Directions2026-10-29OpenAlex10.3390/jpm16110554Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224650435
W7214712196Maintenance Therapy After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: Still an Open Question?2026-10-29OpenAlex10.3390/cancers18213487Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7214712196
W7224105059Preclinical parameters of anti-human immunodeficiency virus (HIV) lentivector transduction of haematopoietic stem, progenitor, and T cells2026-10-29OpenAlex10.25403/upresearchdata.32898965Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224105059
W7224417835The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies2026-10-29OpenAlex10.1007/s11899-026-00791-4Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224417835
W7224668911Ultrasound-Stimulated Microbubbles in Cancer Therapy: A Review of Clinical and Translational Evidence2026-10-29OpenAlex10.26599/audt.2026.260027Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224668911
W7168065837WHY PBL 4.0? THE STRATEGIC CASE FOR CAPABILITY FORMATION IN AN AI-AUGMENTED EDUCATIONAL ENVIRONMENT2026-10-29OpenAlex10.13140/rg.2.2.29826.24003Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7168065837
W7225078571FROM INTELLIGENT SYSTEMS TO TRUSTWORTHY AGENTS: A COMPREHENSIVE SURVEY OF AGENTIC AI IN SMART HEALTHCARE2026-10-30OpenAlex10.62441/actainnovations.vi.2741Title/abstractExcludedE1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system.https://openalex.org/W7225078571
W7224938536From MEK inhibition to rational combination strategies for NF1-associated plexiform neurofibromas2026-10-30OpenAlex10.3389/fonc.2026.1976580Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224938536
W7224756933Human-led, AI-enabled: preventing another AI winter through workforce transformation2026-10-30OpenAlex10.3389/fsci.2026.2015324Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224756933
W7224751454Living evidence map of the global climate and health literature2026-10-30OpenAlex10.1002/14651858.cd016408Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224751454
W7224918753Mission: Fighting Chagas Disease2026-10-30OpenAlex10.6084/m9.figshare.34867947Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224918753
W7224818581Near-Infrared Fluorescent Probes and NIR-Responsive Nanomaterials for Inflammatory Bowel Disease: Advances in Imaging and Therapy2026-10-30OpenAlex10.3390/pharmaceutics18111396Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224818581
W7167249586Right-Sided Infective Endocarditis: A 6-Year Retrospective Cohort Study from a Tertiary Care Center in Türkiye2026-10-30OpenAlex10.14744/anatoljcardiol.2026.6054Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7167249586
W7225009645Risk-stratified surveillance in inflammatory bowel disease2026-10-30OpenAlex10.7196/samj.2026.v116i10.5671Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225009645
W7224780096THE ROLE OF STEM CELLS IN ATHEROSCLEROSIS TREATMENT AND FUTURE PERSPECTIVES2026-10-30OpenAlex10.4274/tmsj.galenos.2026.2026-4-3Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224780096
W7225085690The Era of Neoadjuvant Chemotherapy for Cholangiocarcinoma: Has It Already Begun?2026-10-30OpenAlex10.15279/kpba.2026.31.4.142Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225085690
W7224957432The clinical translation dilemma of mesenchymal stem cell-based therapies for cardiac repair: What can tissue engineering do?2026-10-30OpenAlex10.1186/s13287-026-05380-zTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224957432
W7224871136Vasopressor and Fluid Management of Neuraxial Labor Analgesia-Associated Hypotension in Vaginal Delivery: A Scoping Review2026-10-30OpenAlex10.17605/osf.io/e948qTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7224871136
W7224992253ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT2026-10-31OpenAlex10.4084/mjhid.2026.088Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7224992253
W7225085094Carbapenem-Resistant Acinetobacter baumannii: Treatment, PK/PD Considerations, and Emerging Strategies2026-10-31OpenAlex10.3390/pathogens15111136Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225085094
W7224991481EFT–MAST CooperBench Reproducibility Dataset: Frozen Holdout Predictions, Brier Decomposition, and Analysis Code (Phases 8–17)2026-10-31OpenAlex10.5281/zenodo.23826367Title/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7224991481
W7225007520Nebivolol: A Comprehensive Pharmacological Review of a Third-Generation Cardioselective Beta-Blocker with Nitric Oxide-Mediated Vasodilatory Properties2026-10-31OpenAlex10.5281/zenodo.23841452Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225007520
W722504796746/60 SWARM NANOROBOTIC COOPERATIVE CELLULAR ASSEMBLY AT THE LIMIT SWARM NANOROBOTIC COOPERATIVE CELLULAR ASSEMBLY AT THE LIMIT is a 777-page English-language Research Design Working Edition in the STARLI Micro/Nanorobot Fabrication and Regenerative Biomanufacturing Sixty-Flagship series (Flagship 46/60). It investigates distributed multirobot scaling versus throughput-induced injury. The research coupling is swarm cooperation x cell transport x decentralized decision making. All proposed work is restricted to nonclinical in-vitro, organ-on-chip, synthetic phantom or authorized ex-vivo environments. No experiments were executed in preparing this edition; no human treatment, clinical efficacy or regulatory clearance is claimed. Its falsifiable candidate is: From one to twenty agents, a frozen decentralized policy will improve qualified live-cell throughput without increasing cell damage or per-cell resource burden. The Atlas minimum demonstrator is: Scale one to twenty microagents to construct a one-hundred-cell heterogeneous spatial pattern. Strong comparators include single-arm micromanipulation and centralized multi-arm coordination. A central rival account is faster operation purchased through damage, added energy or unreported human rescue. The nonnegotiable stop condition is: unselected cell viability declines as agent number increases. Each failed, aborted, hidden-fault and incomplete run is retained in the experimental denominator, and observation of a finished form is never substituted for independently measured function. Thirty mathematical plates address domain-specific metrics and established model families across transport, measurement, elasticity, time-dependent dynamics, causal attribution, calibration and uncertainty. Eighty-two chapters and 410 separately paginated scientific investigations organize six research arcs. Two hundred Research Gates have been revised with independent observables, one of fifteen blinded causal intervention families, orthogonal controls and noncompensatory refusal criteria. Thirty mathematical plates now carry model-specific physical derivation commentary, explicit applicability limits and distinct flagship-level blind checks. Thirty-three Phoenix Answer Embryos propose unbuilt future instruments and succession artifacts, each requiring its own bench validation. This version is a research design and not a report of validated physical findings. It draws scientific method and conceptual boundaries from the user-supplied Atlas and research mother volumes; especially the Atlas-supplied ancestry DOI 10.5281/zenodo.23046134 and 10.5281/zenodo.23486020. Full external bibliographic DOI checking and scientific peer review have not been completed. Domain-specific sensitivity, causal identifiability and independent replication require qualified laboratory evaluation before any scientific superiority claim. Author: Feng Cheng-en (33) x STARLI / Xingli Series: STARLI Nano Regenerative Biomanufacturing / Flagship 46 of 60 Edition: Research Design Working Edition v1.1 / 2 November 2026 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/2026-11-01OpenAlex10.5281/zenodo.23864959Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225047967
W722506539747/60 AUTONOMOUS MICRO-TISSUE CONSTRUCTION BY MICROROBOTIC SWARMS AT THE LIMIT AUTONOMOUS MICRO-TISSUE CONSTRUCTION BY MICROROBOTIC SWARMS AT THE LIMIT is a 777-page English-language Research Design Working Edition in the STARLI Micro/Nanorobot Fabrication and Regenerative Biomanufacturing Sixty-Flagship series (Flagship 47/60). It investigates true local-rule generalization beyond memorized target geometry. The research coupling is swarm local rules x three-dimensional microtissue topology x independent structural qualification. All proposed work is restricted to nonclinical in-vitro, organ-on-chip, synthetic phantom or authorized ex-vivo environments. No experiments were executed in preparing this edition; no human treatment, clinical efficacy or regulatory clearance is claimed. Its falsifiable candidate is: A frozen swarm rule set will match target physical graphs and preserve function under unseen initial states better than centralized scheduling and fixed paths. The Atlas minimum demonstrator is: Use thirty agents with identical rules to assemble three distinct blind microtissue targets. Strong comparators include competent centralized scheduler and preregistered fixed paths. A central rival account is prestored shape templates or training leakage masquerading as emergent assembly. The nonnegotiable stop condition is: an unknown configuration triggers neither abstention nor safe stop, or a topology error self-amplifies. Each failed, aborted, hidden-fault and incomplete run is retained in the experimental denominator, and observation of a finished form is never substituted for independently measured function. Thirty mathematical plates address domain-specific metrics and established model families across transport, measurement, elasticity, time-dependent dynamics, causal attribution, calibration and uncertainty. Eighty-two chapters and 410 separately paginated scientific investigations organize six research arcs. Two hundred Research Gates have been revised with independent observables, one of fifteen blinded causal intervention families, orthogonal controls and noncompensatory refusal criteria. Thirty mathematical plates now carry model-specific physical derivation commentary, explicit applicability limits and distinct flagship-level blind checks. Thirty-three Phoenix Answer Embryos propose unbuilt future instruments and succession artifacts, each requiring its own bench validation. This version is a research design and not a report of validated physical findings. It draws scientific method and conceptual boundaries from the user-supplied Atlas and research mother volumes; especially the Atlas-supplied ancestry DOI 10.5281/zenodo.23046134 and 10.5281/zenodo.23486020. Full external bibliographic DOI checking and scientific peer review have not been completed. Domain-specific sensitivity, causal identifiability and independent replication require qualified laboratory evaluation before any scientific superiority claim. Author: Feng Cheng-en (33) x STARLI / Xingli Series: STARLI Nano Regenerative Biomanufacturing / Flagship 47 of 60 Edition: Research Design Working Edition v1.1 / 2 November 2026 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/2026-11-01OpenAlex10.5281/zenodo.23865019Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225065397
W7225045906Hyping Bariatric Surgery Research in the Glucagon-Like Peptide-1 Era2026-11-01OpenAlex10.21203/rs.3.rs-11110167/v1Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225045906
W7225055951Inhaled Nitric Oxide: A Comprehensive Pharmacological and Clinical Review2026-11-01OpenAlex10.5281/zenodo.23852488Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225055951
W7225056140Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes2026-11-01OpenAlex10.1016/j.msard.2026.108033Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225056140
W7225045545Toward cognitive design intelligence: a mixed-methods systematic review and an evidence-informed representation-reasoning-synthesis framework for complex product design in the era of foundation models2026-11-01OpenAlex10.1016/j.aei.2026.105446Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225045545
W7225098932Attention-Guided Deep Reinforcement Learning for Seizure Prediction using Cross-Cohort EEG and fMRI Feature Integration2026-11-02OpenAlex10.1007/s42979-026-05428-0Title/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225098932
W7225060160Autonomous Reservoir Injection-Production Optimization Through Multi-Agent Collaboration and Self-Evolving Skills2026-11-02OpenAlex10.2118/236222-msTitle/abstractExcludedE2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task.https://openalex.org/W7225060160
W7225098293Emerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions2026-11-02OpenAlex10.1007/s12185-026-04307-xTitle/abstractExcludedE3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study.https://openalex.org/W7225098293
W7225059141Enabling Resilient and Adaptive Production Operations Through AI-Enabled Production System Optimization at Scale2026-11-02OpenAlex10.2118/236237-msTitle/abstractExcludedE2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark.https://openalex.org/W7225059141
W7225121726Evolving treatment algorithm for hormone receptor-positive, HER2-negative metastatic breast cancer: new drugs and future therapeutic strategies2026-11-02OpenAlex10.1007/s12254-026-01136-wTitle/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225121726
W7225119973Nanomaterials in Wound Healing: Revolutionizing the Road to Recovery2026-11-02OpenAlex10.1201/9781779644411-11Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225119973
W7225116745Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions2026-11-02OpenAlex10.3389/fonc.2026.1893067Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225116745
W7225115744Overview of Resistance Mechanisms in Dermatophytosis, Pharmacology and Uses of Fosravuconazole and Its Place in Potential Treatment Options for Trichophyton indotineae2026-11-02OpenAlex10.3390/ph19111739Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225115744
W7225104746The Evolving Landscape of Stage III Endometrial Cancer—A Narrative Review of Management in Australia2026-11-02OpenAlex10.1111/1754-9485.70216Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225104746
W7225084306The Frozen Overseer: What a Fixed Tier-0 Monitor Can and Cannot Bound in a Self-Improving System — a pre-registered map, an impossibility, a dual-reference escape, and a reduction to practice on commodity silicon2026-11-02OpenAlex10.5281/zenodo.23893944Title/abstractExcludedE2: General-domain method or evaluation uses medicine/ECG as one of several demonstrations or benchmark domains; fixed P2 applies.https://openalex.org/W7225084306
W7225115158The Modern Continuum of Care for Colorectal Liver Metastases: A Comprehensive Review2026-11-02OpenAlex10.1177/00031348261504348Title/abstractExcludedE1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark.https://openalex.org/W7225115158